<?xml version="1.0"?>
<rdf:RDF xmlns="http://www.w3.org/2002/07/owl#"
     xml:base="http://www.w3.org/2002/07/owl"
     xmlns:dc="http://purl.org/dc/elements/1.1/"
     xmlns:obo="http://purl.obolibrary.org/obo/"
     xmlns:owl="http://www.w3.org/2002/07/owl#"
     xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
     xmlns:xml="http://www.w3.org/XML/1998/namespace"
     xmlns:xsd="http://www.w3.org/2001/XMLSchema#"
     xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#"
     xmlns:skos="http://www.w3.org/2004/02/skos/core#"
     xmlns:oboInOwl="http://www.geneontology.org/formats/oboInOwl#">
    <Ontology/>
    


    <!-- 
    ///////////////////////////////////////////////////////////////////////////////////////
    //
    // Annotation properties
    //
    ///////////////////////////////////////////////////////////////////////////////////////
     -->

    


    <!-- http://purl.obolibrary.org/obo/IAO_0000115 -->

    <AnnotationProperty rdf:about="http://purl.obolibrary.org/obo/IAO_0000115"/>
    


    <!-- http://purl.org/dc/elements/1.1/type -->

    <AnnotationProperty rdf:about="http://purl.org/dc/elements/1.1/type"/>
    


    <!-- http://www.geneontology.org/formats/oboInOwl#hasDbXref -->

    <AnnotationProperty rdf:about="http://www.geneontology.org/formats/oboInOwl#hasDbXref"/>
    


    <!-- http://www.w3.org/2004/02/skos/core#relatedMatch -->

    <AnnotationProperty rdf:about="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
    


    <!-- 
    ///////////////////////////////////////////////////////////////////////////////////////
    //
    // Classes
    //
    ///////////////////////////////////////////////////////////////////////////////////////
     -->

    


    <!-- http://example.org/a00de183-b435-45de-995f-2f0c724378a0 -->

    <Class rdf:about="http://example.org/a00de183-b435-45de-995f-2f0c724378a0">
        <obo:IAO_0000115>a Schematic of the experimental pipeline. Created with BioRender.com b UMAP visualization of peritoneal immune cells. c Ratio of each population in cell number. d VlnPlot of characteristic gene expressions for macrophage subpopulations. Sham sham control, ELL endometriosis-like lesions, ELL_N niclosamide administration to ELL-induced mouse, Pre-SPMs premature &quot;small&quot; peritoneal macrophages, SPMs &quot;small&quot; peritoneal macrophages, ##IM##1-3 intermediate macrophages subtype 1-3, Timd4+ LPMs Timd4+ &quot;large&quot; peritoneal macrophages, PMs proliferating macrophages, B1a B1a cells, B1b B1b cells, B2 B2 cells, GCBs germinal-centre B cells, PBs plasma blast B cells, Cd4+ Ts Cd4+ T cells, Cd8+ Ts Cd8+ T cells, DN1 double negative T cells 1, DN2 double negative T cells 2, cDC1 conventional dendritic cells 1, MCs Mast cells, NTPs neutrophils.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9652344</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36369244</oboInOwl:hasDbXref>
        <rdfs:label>IM</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/a00de183-b435-45de-995f-2f0c724378a0"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/a013341c-c496-4b6b-b0ae-9700fdea3401 -->

    <Class rdf:about="http://example.org/a013341c-c496-4b6b-b0ae-9700fdea3401">
        <obo:IAO_0000115>a Line drawing of a cross section of the floor of the cochlear duct at P1. Distinct cell types within the organ of Corti (OC) are color coded. b Heat map for ~14,000 cochlear cells collected from four separate experiments at P1. Top 25 differentially expressed (DE) genes for the 15 identified clusters are shown. Cellular identity for each cluster is indicated by a color bar at the top of the heat map, which corresponds to the legend in a, and by a cell name at the bottom. c tSNE plot for the same cells as in b. Cluster identities are indicated. d Violin plots showing normalized log-transformed expression values for the top five DE genes for each cell type (color coded as in c) by comparison with all other P1 cells (gray on the right in each graph). Bars indicate median expression level. e Upper left panel, tSNE plot of cells determined to be derived from KO (between the OC and medial edge of the cochlear duct). Lower left panel, feature plot for the same cells as in the upper panel indicating high expression of Otoa, Calb1, and Fabp7 (based on color) in different clusters of cells. Lower right panel, cross sections through the cochlear duct at P1, illustrating expression of CALB1 in the medial region of KO and FABP7 directly adjacent to the OC (arrow; scale bars, 20 mum). Lowest panel shows high-magnification view of expression of FABP7 (arrow, gray scale) at the lateral KO border (green line; scale bar, 10 mum). Upper right panel, summary diagram of the spatial distribution of KO cell clusters at P1. HC hair cells, IPhC inner phalangeal cells/border cells, IPC inner pillar cells, OPC outer pillar cells, DC1/2 Deiters&apos; cells rows 1 and 2, DC3, Deiters&apos; cells row 3, HeC Hensen&apos;s cells, CC/OSC Claudius cells/outer sulcus cells, IdC interdental cells, ##ISC## inner sulcus cells, KO Kolliker&apos;s organ cells, L.KO lateral Kolliker&apos;s organ cells, M.KO medial Kolliker&apos;s organ cells, OC90 OC90+ cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7221106</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32404924</oboInOwl:hasDbXref>
        <rdfs:label>ISC</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000589"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/a013341c-c496-4b6b-b0ae-9700fdea3401"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000589"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/a01d94a1-2add-4d8f-88e1-1905b1dee3f6 -->

    <Class rdf:about="http://example.org/a01d94a1-2add-4d8f-88e1-1905b1dee3f6">
        <obo:IAO_0000115>CD301b+ macrophages have been recently identified as a group of macrophages focused on regulating the immune response and regeneration functions. Sommerfeld et al. demonstrated for the first time that macrophages could be divided by the surface marker CD301b, and CD301b+ macrophages were specific to the regenerative microenvironment, rather than CD206+ macrophages (M2-macrophage) or CD86+ macrophages (M1-macrophage). In another recent research, transplantation with CD301b+/CD206+ macrophages achieved better skin regeneration compared with CD301b-/CD206+ macrophages. Notably, ##CD301b+ macrophage## was not a subpopulation of M2 macrophages, as CD301b+ macrophages possessed both M1 functional factors such as IL1 and M2 functional cytokine genes such as Arg1, which implied a more comprehensive role in conducting tissue regeneration. Our recent study found that there existed strong correlations between the dynamic changes in CD301b+ macrophages and CD206+ macrophages during periodontitis progression, however, the expression pattern and localization of CD301b+ macrophages were largely different from those of CD206+ macrophages in periodontal tissue. Considering the specificity of CD301b+ macrophage phenotype, it is reasonable to explore the strategy to specifically induce CD301b+ macrophages.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10902347</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38418808</oboInOwl:hasDbXref>
        <rdfs:label>CD301b+ macrophage</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/a01d94a1-2add-4d8f-88e1-1905b1dee3f6"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/a01e92ae-8220-4109-91f5-133c8a8edeac -->

    <Class rdf:about="http://example.org/a01e92ae-8220-4109-91f5-133c8a8edeac">
        <obo:IAO_0000115>To gain a comprehensive view of immune interactions, we performed correlation analyses between the frequency of ##Ki67+ Tregs## and the frequencies of all identified immune cell subpopulations. We did not observe significant association of the frequency of Ki67+ Tregs with lymphocytic subsets (Supplementary Fig. 8). On the other hand, myeloid cells, particularly dendritic cells (DCs), are known to facilitate Treg generation. Therefore, we analyzed the correlation between the frequency of Ki67+ Tregs and that of myeloid cell subsets (including cMo, iMo, ncMo, and DC). The frequency of Ki67+ Tregs was positively associated with the frequencies of HLA-DR+ and CD86+ monocytes and dendritic cells (Supplementary Fig. 9), suggesting their potential roles in the generation of Ki67+ Treg cells via antigen presentation and CD28-dependent signaling. Interestingly, we found that the frequency of Ki67+ Tregs was also positively associated with the frequencies of PD-L1+ monocytes and dendritic cells (Supplementary Fig. 9), which is consistent with previous reports that DCs could induce Treg cells via PD-L1. These results indicate that myeloid cells might play a crucial role in Treg generation.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11496634</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:39438442</oboInOwl:hasDbXref>
        <rdfs:label>Ki67+ Tregs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000815"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/a01e92ae-8220-4109-91f5-133c8a8edeac"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000815"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/a084e592-55e1-4f3d-a882-013078b31b25 -->

    <Class rdf:about="http://example.org/a084e592-55e1-4f3d-a882-013078b31b25">
        <obo:IAO_0000115>Other groups have used murine- and blood-based immune population gene profiles to characterize lung adenocarcinoma immune microenvironments with digital cytometry. In order to develop human tumor infiltrating leukocyte profiles specific to stage I lung adenocarcinomas, we performed single-cell RNA-seq (scRNA-seq) analysis on freshly resected samples from six patients who underwent complete surgical resection of stage I tumors at UCSF. Twenty distinct immune cell populations were identified by scRNA-seq analysis including 10 adaptive immune populations (helper T-cells, cytotoxic T-cells, exhausted cytotoxic T-cells, deltagamma T-cells, naive T-cells, regulatory T-cells, B cells, plasma cells, NKT cells, and NK cells) and 10 innate immune populations (M1 macrophages, M2 macrophages, classical monocytes, intermediate monocytes, non-classical monocytes, mast cells, conventional dendritic cells 1, ##conventional dendritic cells 2##, plasmacytoid dendritic cells, and neutrophils) (Fig. 5A). These novel tumor infiltrating leukocyte profiles were used to calculate immune cell population densities from bulk RNA-seq data in the TCGA stage I lung adenocarcinoma population using digital cytometry.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8654957</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34880292</oboInOwl:hasDbXref>
        <rdfs:label>conventional dendritic cells 2</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000990"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/a084e592-55e1-4f3d-a882-013078b31b25"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000990"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/a0a2a775-e2d8-46df-a829-9a3520e51ebe -->

    <Class rdf:about="http://example.org/a0a2a775-e2d8-46df-a829-9a3520e51ebe">
        <obo:IAO_0000115>The mammalian retina is a highly organized neuronal tissue lining the back of the eye. Five major classes of retinal cell types are organized into complex circuits that are responsible for extracting valuable features from the visual scene, such as color, contrast, luminance and motion. Signal detection and transduction originate in photoreceptors (PRs), which use the rate of release of glutamate to signal light level information to bipolar (BP) neurons. Most BP cells, which are also glutamatergic, signal to the output neurons of the retina, the retinal ganglion cells (RGCs). Rod BPs constitute a separate major pathway where they route the rod PR signal to AII amacrine cells (ACs) that in turn connect with RGCs and cone BP cells. RGCs relay these signals to specialized retinorecipient areas in the brain. ##Inhibitory neurons## are critical to the proper information transformations conducted by the many types of circuits. These inhibitory neurons are ACs and horizontal cells (HCs), with ACs being &gt;10-fold more abundant than HCs. GABA and glycine are the principal neurotransmitters used by ACs, which can also use other neurotransmitters, such as dopamine and serotonin, as well as a variety of neuropeptides. The contribution of ACs to the complexity of retinal processing is also indicated by their diversity. Single-cell RNA sequencing (scRNA-seq), as well as more classical anatomic and physiological descriptions, have defined at least 63 types of ACs in the mammalian retina.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8856716</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35045975</oboInOwl:hasDbXref>
        <rdfs:label>Inhibitory neurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000498"/>
        <skos:relatedMatch rdf:resource="CL:0000617"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/a0a2a775-e2d8-46df-a829-9a3520e51ebe"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000498"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/a0a2a775-e2d8-46df-a829-9a3520e51ebe"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000617"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/a0dc028a-dae4-4677-ae83-88448865a6a4 -->

    <Class rdf:about="http://example.org/a0dc028a-dae4-4677-ae83-88448865a6a4">
        <obo:IAO_0000115>PROBLEM: During pregnancy, the decidual spiral arterioles (SpAs) that supply maternal blood to the placenta undergo a series of changes to optimise the transfer of nutrients and oxygen to the developing foetus. Recent studies have shown that initiation of SpA transformation coincides with decidual leucocyte infiltration. Leucocytes are known to be a source of matrix metalloproteinases (MMPs); however, the complete profile of MMPs expressed by decidual NK cells (dNK) and macrophages has not been characterised. We hypothesised that leucocyte-derived MMPs contribute to SpA remodelling. METHODS: Decidual NK cells and macrophages were isolated from first trimester decidua and their MMP repertoire profiled by qRT-PCR (n = 10; 5-11 weeks). Dual immunofluorescence was used to localise MMP expression in situ (n = 3; 5-12 weeks). Gelatin zymography was carried out to assess whether leucocyte-derived MMPs can degrade ECM. In situ zymography and immunofluorescence identified MMP activity in ##tissue-resident dNK and macrophages##. RESULTS: Decidual NK cells cells and macrophages expressed MMP2, -7, -9, -11, -16, -19 and tissue inhibitors of metalloproteinase-1, -2, and -3. Both cell types degraded gelatin using MMP2 and MMP9 and broke down collagen in an in vitro model of the SpA. Extravillous trophoblasts (EVTs) expressed a similar repertoire of MMPs. CONCLUSION: We suggest that matrix remodelling in SpA is initiated by infiltrating leucocytes, while EVTs become involved at later stages.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMID:30267451</oboInOwl:hasDbXref>
        <rdfs:label>tissue-resident dNK and macrophages</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000864"/>
        <skos:relatedMatch rdf:resource="CL:0002343"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/a0dc028a-dae4-4677-ae83-88448865a6a4"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002343"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/a0dc028a-dae4-4677-ae83-88448865a6a4"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000864"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/a0e6e74b-fd14-4829-aa80-723d7c91b9c7 -->

    <Class rdf:about="http://example.org/a0e6e74b-fd14-4829-aa80-723d7c91b9c7">
        <obo:IAO_0000115>a Due to single-cell annotation and in situ validation (Fig. 2; Supplementary Fig. 3), a draft model of the oral-to-tooth transition zone in humans is presented, with basal and suprabasal keratinocyte markers uniquely identifying the alveolar mucosa (AM), attached gingiva (AG), gingival margin (GM), sulcular epithelium (SK) and junctional epithelium (JK). b These markers allowed for KRT19-high keratinocyte (KC) cell subclustering for the first time (2504 cells in total), including gingival margin keratinocytes (GM), sulcular keratinocytes (SK), and junctional keratinocytes (##JK##). c A more granular draft (Tier 4) annotation of epithelial cells of the gingival attachment. d Assaying differentially expressed genes in periodontitis, SKs and JKs only share about a quarter of upregulated genes. JKs displayed nearly 125 unique upregulated genes in diseased cells. e Further analysis of basal and suprabasal (differentiating) SK and JK keratinocytes revealed unique cell signatures between basal and suprabasal cell types. This full list is included in Supplementary Data 1. f-i To understand SK and JK developmental progression and cell state alterations, we used partitioned-based graph abstraction (PAGA). f Examining the basal to suprabasal transition, JKs display altered gene expressed comparing health to disease cell types, including broader expression of KRT17 and more expression of JUND, COL17A1, and CDH3. Key differentiation genes such as SPRR family members were also downregulated. g JKs displayed robust cell signaling and inflammatory phenotypes, which appear exacerbated in disease states. h In SKs, differentiation-related genes were uniquely expressed compared to JKs in health but also appeared altered in disease along the basal to suprabasal trajectory. i SKs appeared generally less reactive compared to JKs in disease, with lower overall expression of effector molecules such as CXCL1, CXCL8, IL1A, IL1B, and IL1RN. Abbreviations: Merk Merkel Cells, LC langerhans cells, Mela melanocytes, Muc mucosa, SB suprabasal Keratinocytes; for others, see Fig. 1 legend. For this figure, n = 30-sample, 2504-cell for scRNAseq.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11178863</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38876998</oboInOwl:hasDbXref>
        <rdfs:label>JK</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002170"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/a0e6e74b-fd14-4829-aa80-723d7c91b9c7"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002170"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/a116572a-2404-4ec4-84dc-726119239f07 -->

    <Class rdf:about="http://example.org/a116572a-2404-4ec4-84dc-726119239f07">
        <obo:IAO_0000115>SCN	Suprachiasmatic nucleus	 	ROR	Retinoic acid receptor-related orphan receptor	 	Rev-ErbA	Reverse c-erb A	 	RRE	Rev-ErbA/ROR response element	 	ROS	Reactive oxygen species	 	UV	Ultraviolet	 	CBC	Crypt-base columnar cell	 	ISC	Intestinal stem cell	 	TA	Transit-amplifying	 	EC	Enterocyte	 	GC	Goblet cell	 	EEC	Enteroendocrine cell	 	PC	Paneth cell	 	GI	Gastrointestinal	 	DSS	Dextran-sodium sulfate	 	CRD	Circadian rhythm disruption	 	RNAi	RNA interference	 	ZT	Zeitgeber time	 	BM	Bone marrow	 	HSC	Hematopoietic stem cell 	 	HSPC	Hematopoietic stem and progenitor cell	 	MPP	Multipotent progenitor	 	LT-HSC	Long-term hematopoietic stem cell	 	SP	Side population	 	##CAR##	CXCL12-abundant reticular	 	NE	Norepinephrine	 	TNF	Tumor necrosis factor	 	MAPK	Mitogen-activated protein kinase	 	</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6539890</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31071906</oboInOwl:hasDbXref>
        <rdfs:label>CAR</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000432"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/a116572a-2404-4ec4-84dc-726119239f07"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000432"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/a1ae7cd5-4f66-41c5-b365-69bee466dc10 -->

    <Class rdf:about="http://example.org/a1ae7cd5-4f66-41c5-b365-69bee466dc10">
        <obo:IAO_0000115>Next, we merged the datasets for the five time-points using the merge function of the Seurat pipeline, which combines multiple datasets without transforming the data. The merged dataset with a total of 62,202 cells was processed for clustering and then the data were visualized as a UMAP plot (Fig. 3). The same set of cell clusters identified in individual time-point data was also identified in the merged dataset (Fig. 3A,E and Fig. S6). The downregulation of PAX2 and upregulation of FBXO2 from otic prosensory cells to intermediate otic cells and supporting cells were confirmed with this analysis (Fig. 3E). A DACH1+ SPP1+ population was detected adjacent to OC90+ intermediate otic cells (Fig. 3D, Figs S7 and S8), suggesting the existence of another lineage direction in the otic lineage other than the sensory epithelium. TFAP2B+ surface ectoderm cells, NEUROD1+ neuroblasts and S100B+ neural crest/Schwann cells were identified as distinctive clusters (Fig. 3A,D and Fig. S7). An intermediate population between otic prosensory cells and supporting cells expressed not only otic epithelium markers EPCAM and FBXO2, but also other ##otic progenitor## markers COL9A1, SERPINF1, HES1, AATF, COL14A1, OC90, PRSS8 and EYA4 (Fig. S7), suggesting that this is an otic epithelial cell population differentiating into hair cells and supporting cells. Adjacent to the supporting cell cluster, there was a POU4F3+ hair cell cluster that expressed vestibular hair cell markers [CD164L2, ZBBX, TEKT1, SKOR1, TCTEX1D1 (DYNLT5) and NEUROD6] and type II hair cell markers (ANXA4, MAPT and NHLH1) (Fig. 3D and Fig. S8), indicative of an immature type II hair cell identity. However, we were unable to detect the cochlear marker GATA3 or INSM1 in PCP4+ hair cells (Fig. S8G,H). Surprisingly, we were unable to identify common progenitor populations that differentiate into both hair cells and supporting cells in the merged datasets.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10323240</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37381908</oboInOwl:hasDbXref>
        <rdfs:label>otic progenitor</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000048"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/a1ae7cd5-4f66-41c5-b365-69bee466dc10"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000048"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/a1b73296-0d92-4601-b54e-0b0a7c928a0d -->

    <Class rdf:about="http://example.org/a1b73296-0d92-4601-b54e-0b0a7c928a0d">
        <obo:IAO_0000115>Checkpoint immunotherapy unleashes T cell control of tumors, but is undermined by immunosuppressive myeloid cells. TREM2 is a myeloid receptor that transmits intracellular signals that sustain microglial responses during Alzheimer&apos;s disease. TREM2 is also expressed by tumor-infiltrating macrophages. Here, we found that Trem2-/- mice are more resistant to growth of various cancers than wild-type mice and are more responsive to anti-PD-1 immunotherapy. Furthermore, treatment with anti-TREM2 mAb curbed tumor growth and fostered regression when combined with anti-PD-1. scRNA-seq revealed that both TREM2 deletion and anti-TREM2 are associated with scant MRC1+ and CX3CR1+ macrophages in the tumor infiltrate, paralleled by expansion of myeloid subsets expressing immunostimulatory molecules that promote improved T cell responses. TREM2 was expressed in ##tumor macrophages## in over 200 human cancer cases and inversely correlated with prolonged survival for two types of cancer. Thus, TREM2 might be targeted to modify tumor myeloid infiltrates and augment checkpoint immunotherapy.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7485282</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32783918</oboInOwl:hasDbXref>
        <rdfs:label>tumor macrophages</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/a1b73296-0d92-4601-b54e-0b0a7c928a0d"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/a1ccb8a7-72ec-487c-b918-886df12c6f3e -->

    <Class rdf:about="http://example.org/a1ccb8a7-72ec-487c-b918-886df12c6f3e">
        <obo:IAO_0000115>Hierarchical clustering was then used to map the relationship between subsets based on gene expression (Figure 1C). Average signal values from duplicate samples were used for clustering. Genes were included which showed expression in at least one subset (signal value &gt;=100), giving a sample set of 8508 genes. The analysis indicated a close relationship between &quot;##L-DC##&quot; and resident monocytes and then between these two subsets and inflammatory monocytes. CD8+ cDC and CD8- cDC were closely related and distinct from the cluster of &quot;L-DC,&quot; resident monocytes and inflammatory monocytes. As predicted from PCA analysis, eosinophils were quite distinct as a subset and lineage.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6653018</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31210415</oboInOwl:hasDbXref>
        <rdfs:label>L-DC</rdfs:label>
    </Class>
    


    <!-- http://example.org/a20acfbd-6308-425b-a2f0-8d2756e1df59 -->

    <Class rdf:about="http://example.org/a20acfbd-6308-425b-a2f0-8d2756e1df59">
        <obo:IAO_0000115>Gene-Set Significant Cell Types from Zeisel That Are Common between Mouse MIA and Human GWAS Significant Cell Types from Saunders That Are Common between Mouse MIA and Human GWAS   Individual Study DEGs mPFC -Excitatory Neurons (Hindbrain)[SCZ, ASD, EA] No cell types   AM -Inhibitory D1 &amp; D2 Medium Spiny Neurons (Striatum) [EA] -Inhibitory direct/indirect Spiny Projection Neurons (Striatum) [SCZ, EA, IQ]   Meta-analysisDEGs Upregulated -Excitatory Neurons, Pyramidal Cells (Cerebral Cortex) [SCZ, IQ] -Excitatory Neurons, Deep-layer Pyramidal cells (Frontal Cortex)[SCZ, IQ]-Excitatory Neurons (Posterior Cortex) [SCZ, IQ]-Excitatory Neurons, Entorhinal Cortex Cells (Hippocampus)[SCZ, IQ]-##Excitatory Neurons, CA1 Principal Cells## (Hippocampus)[IQ]   </obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8471627</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34573345</oboInOwl:hasDbXref>
        <rdfs:label>Excitatory Neurons, CA1 Principal Cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:4023060"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/a20acfbd-6308-425b-a2f0-8d2756e1df59"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4023060"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/a2438fef-7170-4ebf-a520-2658e502142d -->

    <Class rdf:about="http://example.org/a2438fef-7170-4ebf-a520-2658e502142d">
        <obo:IAO_0000115>The above presented results indicate that the enhanced intestinal abundance of B. vulgatus leads to an increase in regulatory/anti-inflammatory CD4+ T cell subsets whereas higher numbers of E. coli promote differentiation of pro-inflammatory CD4+ T cells in an immune-compromised host with a presumably dysbiotic microbiota. However, a differential activation of DCs by the two commensals could not be clearly observed in these mice. To directly link our in vitro results with those obtained in the model of T cell transfer colitis, we collected fecal samples from representative Rag1-/- mice with a presumably dysbiotic microbiota (DYS) prior to bacterial administration and from T cell transplanted mice with or without commensal enrichment after development of colitis (DYS + TC, DYS + TC + BV, DYS + TC + EC). Heat-inactivated fecal samples were then used to stimulate WT ##BMDCs## ( Figure 7A ). Increased abundance of E. coli induced significantly higher Nfkbiz gene expression ( Figure 7B ) and IkappaBzeta-protein levels ( Figure 7C ) than all the other microbiota. However, we did not observe a significant increase in the secretion of pro-inflammatory cytokines in response to DYS + TC + EC- stimulation as compared to DYS+TC ( Figure 7D ). Rather, 4 h stimulation of BMDC with DYS + TC + BV decreased the secretion of pro-inflammatory cytokines, with a slight but not significant decrease of secreted IL-6, and a significant lower secretion of IL-23 compared to DYS + TC or DYS + TC + EC. The levels of IL-10 decreased as a result of T cell transfer.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7851057</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33542719</oboInOwl:hasDbXref>
        <rdfs:label>BMDCs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000451"/>
        <skos:relatedMatch rdf:resource="CL:0002092"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/a2438fef-7170-4ebf-a520-2658e502142d"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000451"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/a2438fef-7170-4ebf-a520-2658e502142d"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002092"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/a25cb1f8-c51b-4473-b477-e5edfb96442d -->

    <Class rdf:about="http://example.org/a25cb1f8-c51b-4473-b477-e5edfb96442d">
        <obo:IAO_0000115>High levels of Oct4 mRNA were found in the 2-cell blastomere population in all conditions, followed by a decrease at the 4-cell stage and a strong increase in 8-cell blastomeres (Fig. 5E), an expression pattern reflecting the transition of maternal-to-zygotic Oct4 transcripts at the 4-cell stage (Wu and Scholer). There was a decrease of Oct4 expression in the bulk of both Ahr-/- and Ahr+/+-TCDD groups relative to Ahr+/+ at the 8-cell stage and in Ahr-/- than in Ahr+/+ 2-cell blastomeres. Similarly, we found a significant decrease of Oct4 expression in both Ahr-/- and Ahr+/+-TCDD, notably in both embryonic and differentiating blastomeres relative to the corresponding Ahr+/+ 8-cell subpopulations; in all conditions, differentiating blastomeres at 8-cell stage had higher expression levels than their embryonic counterparts (Fig. 5F). Furthermore, the levels of Oct4 transcription in Ahr-/- and Ahr+/+-TCDD 4-cell embryonic blastomeres decreased or had a trend to decrease, respectively, relative to the corresponding ##Ahr+/+ blastomeres##. The levels of Cdx2 mRNA were high in all 8-cell blastomeres analyzed and were significantly decreased or trended to decrease in the bulk of Ahr-/- and Ahr+/+-TCDD relative to the Ahr+/+ 8-cell population (Fig. 5G). The Cdx2 mRNA levels were higher in Ahr+/+ and Ahr-/- 8-cell differentiating blastomeres than in their embryonic counterparts, with the Ahr-/- 8-cell differentiating blastomeres showing lower expression than the corresponding Ahr+/+ subpopulation (Fig. 5H). Additionally, some Ahr+/+-TCDD 8-cell embryonic blastomeres showed unusually high levels of Cdx2 mRNA causing the indistinguishable difference between embryonic and differentiating subpopulations.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10425484</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36029422</oboInOwl:hasDbXref>
        <rdfs:label>Ahr+/+ blastomeres</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000353"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/a25cb1f8-c51b-4473-b477-e5edfb96442d"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000353"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/a27b4caf-9921-46f2-b15d-55f1dd63f46e -->

    <Class rdf:about="http://example.org/a27b4caf-9921-46f2-b15d-55f1dd63f46e">
        <obo:IAO_0000115>LSECs Liver sinusoidal endothelial cells   HHSEC Human hepatic sinusoidal endothelial cells   HPAEC Human pulmonary arterial endothelial cells   HPMEC Human pulmonary microvascular endothelial cells   ##HCMEC## Human cardiac microvascular endothelial cells   EC Endothelial cells   DEGs Differentially expressed genes   DMCs Differentially methylated CpGs   DMRs Differentially methylated regions   vECs Vascular endothelial cells   iPS Induced pluripotent stem cells   EPCs Erythroid progenitor cells   </obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7589710</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33096636</oboInOwl:hasDbXref>
        <rdfs:label>HCMEC</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:2000008"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/a27b4caf-9921-46f2-b15d-55f1dd63f46e"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:2000008"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/a2afa588-d56c-4213-95b3-87f2680d714d -->

    <Class rdf:about="http://example.org/a2afa588-d56c-4213-95b3-87f2680d714d">
        <obo:IAO_0000115>The intrinsic micro-circuitry regulation of intestinal function consists of five neuronal classes with distinct functional specializations. Sensory neurons, also referred to as ##intrinsic primary afferent neurons## (IPANs), detect chemical and physical alterations in the intestine and transmit the signal via interneurons to excitatory motor neurons, inhibitory motor neurons or secretomotor/vasodilator neurons ( Figure 1 ). Enteric neurons are replenished from neuronal stem cells of the intestine. While the traditional sub-classification was based on the neuronal type, the anatomic location and axonal projection as well as neurochemical signature, recent advances in single-cell sequencing has enabled a comprehensive clustering based on gene expression.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8312561</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34322118</oboInOwl:hasDbXref>
        <rdfs:label>intrinsic primary afferent neurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000526"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/a2afa588-d56c-4213-95b3-87f2680d714d"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000526"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/a2dbde7e-aac4-4915-8b9c-0bbcc3176129 -->

    <Class rdf:about="http://example.org/a2dbde7e-aac4-4915-8b9c-0bbcc3176129">
        <obo:IAO_0000115>Meningeal ILC2s express Thy1.2, ST2, CD25, spinocerebellar ataxia type 1 (Sca10), and low levels of c-Kit and IL-7Ralpha and are major producers of IL-13 in tissues. As tissue-resident cells, ILC2s exhibit tissue-specific receptor expression patterns, which are imprinted by local signals. Likewise, dural ILC2s are distinct from lung ILC2s. The basal activation state of meningeal ILC2s is lower than that of lung-resident cells. The proximity to brain-derived signals may explain the differences in basal activation observed between the two tissue types. ##ILC2 precursors## originate from bone marrow. Future studies should determine the functional and phenotypic differences between blood-derived ILC2s and the adjacent bone marrow.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10616183</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37429945</oboInOwl:hasDbXref>
        <rdfs:label>ILC2 precursors</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000051"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/a2dbde7e-aac4-4915-8b9c-0bbcc3176129"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000051"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/a2ed77df-4068-4617-9df6-8deff211e84d -->

    <Class rdf:about="http://example.org/a2ed77df-4068-4617-9df6-8deff211e84d">
        <obo:IAO_0000115>With our single-cell sequencing analysis, we could observe the presence of nine distinct cell populations. Among them were the main cell types of the colon, intestinal stem cells, TA cells as well as cells of the secretory and absorptive lineage. Within the goblet cell population, we could identify not only different goblet cell types with specific function but also a small subfraction of enteroendocrine and Tuft cells. The absorptive lineage was composed of three distinct population whereof one could be assigned to ##colonocyte progenitors## (eCL) and the other two as differentiated colonocytes. Among these two distinct clusters, we identified a canonical colonocyte population that was highlighted by the expression of markers such as SLC26A3, CA2, and FABP1. Interestingly, the second colonocyte population was marked by a unique expression profile with increased expression of REG4, MMP7, LYZ, and the cytokines IL-18, IL-23, IL33 (Dataset EV7). For these genes it has been shown that they can be induced by pro-inflammatory cytokines in vitro and in vivo (Schumacher et al,; Takasawa et al,; Jin et al,; Dotti et al,; Mahapatro et al,; Hasegawa et al,; Xiao et al,). In addition, we could observe the presence of interferon-inducible genes IFI27, ISG15, and ISG20. These findings indicate that the expression profile of this noncanonical colonocyte population was shaped by the cytokine cocktail contained in the serum and identifies a cell population with a specialized function connected to immune defense. Deeper analysis is needed to classify the relevance and function of this cell type in vivo. Further studies will be required to fully understand the implications of these findings and their possible relevance in the generation of complex in vitro models. Nevertheless, given that most cell types of the descending colon were represented in our model, we could utilize it to study the effects of SLE serum on the intestinal epithelial barrier.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10940301</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38316934</oboInOwl:hasDbXref>
        <rdfs:label>colonocyte progenitors</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:4047018"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/a2ed77df-4068-4617-9df6-8deff211e84d"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4047018"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/a301e9a2-5b28-44ef-8447-dab430402720 -->

    <Class rdf:about="http://example.org/a301e9a2-5b28-44ef-8447-dab430402720">
        <obo:IAO_0000115>MOUSE SYMPATHO-ADRENAL CELL TYPES MARKERS   SNPCs Ret Phox2b Ascl1 Mycn Hand2 Gata3Sox10- Plp1-   Sympathoblasts extra-adrenal Phox2b Mycn Th Dbh Ret Cart CartptSox10- Plp1- Sgc10- Ascl1 -   Sympathetic neurons/ganglia/SRG Ret Scg10 Cart Ascl1 Phox2b Th DbhSox10- Plp1-   SCPs Sox10 Plp1 Ascl1 Phox2bRet-   Schwann cells Sox10 Plp1 GfapPhox2b-   Bridge cells Sox10 Plp1 Chga Penk Htr3a Ascl1 Phox2bTh- Ret-   ##Immature chromaffin cells## Chga Chgb Penk Th DbhSox10- Plp1- Ret-   Chromaffin cells Chga Penk Ascl1 Phox2b Th DbhSox10- Plp1- Ret-   Sympathoblasts intra-adrenal Ret Cart Cartpt Phox2b Th Alk Hmx1 PrphSox10- Plp1-   Sympathetic neurons intra-adrenal Ret Cart Ascl1 Phox2b ThSox10- Plp1-   </obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8915499</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35277192</oboInOwl:hasDbXref>
        <rdfs:label>Immature chromaffin cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000166"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/a301e9a2-5b28-44ef-8447-dab430402720"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000166"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/a3036387-f930-4527-873d-8ff23ed4f806 -->

    <Class rdf:about="http://example.org/a3036387-f930-4527-873d-8ff23ed4f806">
        <obo:IAO_0000115>Auditory sensory hair cells (HCs) and surrounding nonsensory supporting cells (SCs) differentiate from the common pool of inner ear progenitor cells. HCs in the sensory epithelium are precisely arranged into outer HCs (OHCs) and inner HCs (IHCs), intermixed with various types of SCs, including Deiter&apos; cells (DCs), Hensen&apos;s cells, ##inner border cells## (IBCs), and inner phalangeal cells (IPhCs), etc. Sensory HCs act as the mechanoreceptors that transform acoustic waves into electrical signals transmitted to the brain through spiral ganglion neurons innervating the HCs. As terminally differentiated cells, mammalian cochlear HCs are susceptible to genetic mutations and environmental stress. Irreversible damage to HCs is one of the leading causes of sensorineural hearing loss in mammalian or mammalian species. </obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11304307</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38810137</oboInOwl:hasDbXref>
        <rdfs:label>inner border cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002168"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/a3036387-f930-4527-873d-8ff23ed4f806"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002168"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/a3151b14-bc7e-4e46-9681-01afd36b8cb8 -->

    <Class rdf:about="http://example.org/a3151b14-bc7e-4e46-9681-01afd36b8cb8">
        <obo:IAO_0000115>Besides these omental cell types, tumour-associated macrophages (TAM) clearly are instrumental in metastasis, in particular the CD163+Tim4+ subset, which promotes the stemness, invasive properties and epithelial to mesenchymal transition (EMT) of tumour cells by paracrine mechanisms. While omentectomy or depletion of CD163+Tim4+ cells prevented metastatic dissemination in a mouse model of ovarian cancer, depletion of monocyte-derived TAM had little impact, emphasising the role of resident ##omental macrophages##. In keeping with these findings, TAM from HGSC patients show a high degree of phenotypic, ontogenetic and tumour-promoting heterogeneity, reflected, for example, by the differential expression of CD163 and cytokines associated with tumour progression. </obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8574964</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34841720</oboInOwl:hasDbXref>
        <rdfs:label>omental macrophages</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/a3151b14-bc7e-4e46-9681-01afd36b8cb8"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/a325d61c-2f26-4e2a-aa11-11cd659096eb -->

    <Class rdf:about="http://example.org/a325d61c-2f26-4e2a-aa11-11cd659096eb">
        <obo:IAO_0000115>Innate Immune Cells	 	Primary Cell Type	Cell subsets	Metabolic Processes	References	 	   Innate Lymphoid Cells	Non-cytolytic:Innate lymphoid cell 1 (ILC1) Innate lymphoid cell 2 (ILC2) Innate lymphoid cell 3 (ILC3)/Lymphoid Tissue Inducers (LTi)Cytolytic:Natural Killer cells (NK)	 Gly FAO/OXPHOS, LM/LDF, Arginine catabolism, Gly Gly/OXPHOS, Vitamin A metabolismGly, AAM, FAO	     	 	  Dendritic Cells	Conventional:Conventional dendritic cell 1 (##cDC1##) Conventional dendritic cell 2 (cDC2) Conventional dendritic cell 3 (cDC3) Tolerogenic DCs Plasmacytoid DCs (pDCs) Inflammatory DCs Langerhans cells Mononuclear Phagocytes (tumor)	 Na: OXPHOS, Ac: GU, Gly, PPP, Dys: LDFNa: OXPHOS, Ac: GU, Gly, PPP, Dys: LDF Not reported FAO/OXPHOS Gly/OXPHOS/FAO Gly Na/Ac/Ma: Not reported Dys: LDFNa: OXPHOS, Ac: Gly, PPP In tumors/Dys: LM/LDF	         	 	 Macrophages	Inflammatory &quot;M1&quot; macrophage Reparative &quot;M2&quot; macrophage  Tumor Associated macrophage (TAM)	Na: OXPHOS, Ac: GU, Gly, PPP. Arg catabolismNa: FAO/OXPHOS, Ac: FAO/OXPHOS, Gly, PPP.  Upregulates Arg1 Na: OXPHOS, Ac: GU, Gly, Tumor/Dys: FAO, LM/LDF	   	 	</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11240245</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:39007133</oboInOwl:hasDbXref>
        <rdfs:label>cDC1</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000990"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/a325d61c-2f26-4e2a-aa11-11cd659096eb"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000990"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/a33484db-bbd0-4e83-8d9d-7b73c2a9a448 -->

    <Class rdf:about="http://example.org/a33484db-bbd0-4e83-8d9d-7b73c2a9a448">
        <obo:IAO_0000115>tSNE plot colored by the 17 Seurat clusters including hepatocytes, endothelial cells (liver sinusoidal endothelial cells:LSEC, non-tumor liver vascular endothelial cells:LVEC, and tumor liver vascular endothelial cells:LVECt), mesenchymal cells (Stellate cells, ##cancer-associated fibroblasts##:CAFs, Pericytes, vascular smooth muscle cells:vSMC), immune cells (Kupffer cells, scar-associated macrophages:SAMs, tissue monocytes 1:TM1, cDC1, cDC2, T cells, and B cells), proliferating cells, and carcinoma cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7746227</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33332768</oboInOwl:hasDbXref>
        <rdfs:label>cancer-associated fibroblasts</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000057"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/a33484db-bbd0-4e83-8d9d-7b73c2a9a448"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000057"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/a343981a-4f73-49c8-a969-474210f9fddd -->

    <Class rdf:about="http://example.org/a343981a-4f73-49c8-a969-474210f9fddd">
        <obo:IAO_0000115>Last, we investigated whether the human materno-fetal immune system in HIS mice was functional. Human decidua and splenic CD4+CD25+ Treg cells were purified from pregnant HIS mice and incubated with the CFSE-labeled human ##CD45+CD25- splenic cells## (responder cells from pregnant HIS mice) in the presence of 30 Gy irradiated BALB/c mouse splenic cells (stimulator). The proliferation of responder cells was quantified 4 days later using FCM. Proliferation of maternal human splenic CD4+ effector T cells after stimulation with paternally (BALB/c) derived antigen reflects the presence of fetal reactive human maternal T cells (Figure 5A). STreg cells were capable of suppressing Tconv cells at 1:2 ratio (Treg/Tconv) (Supplemental Figure 11). However, under a low Treg/Tconv ratio (1:16) condition, the maternal versus fetal T cell reactions (MvFRs) of maternal T cells were significantly inhibited by dTreg but not by sTreg cells (or were only minimally suppressed; Figure 5A).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11529984</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:39435662</oboInOwl:hasDbXref>
        <rdfs:label>CD45+CD25- splenic cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000738"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/a343981a-4f73-49c8-a969-474210f9fddd"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000738"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/a3d59530-e1f5-4a26-99f4-d81dc5f1174d -->

    <Class rdf:about="http://example.org/a3d59530-e1f5-4a26-99f4-d81dc5f1174d">
        <obo:IAO_0000115>To develop a deeper understanding of the nature of B-cell responses in COVID-19, we further divided the B-cell population into more detailed subclusters using their transcriptional signatures and SHM rate obtained from scRNA datasets ( Figures 3A-C ). Previous high-dimensional flow cytometry data indicated that severe COVID-19 patients displayed hallmarks of EF B-cell activation and shared B-cell repertoire features in autoimmune settings. Therefore, our study primarily focused on B-cell subsets representing EF responses. Here, 13 B-cell subclusters, including 3 subsets of plasma cells and 5 subsets of memory B cells, were identified by cluster analysis on UMAP ( Figure 3A ). IGHD-expressing naive B cells were subdivided into TR B cells, resting naive (RN) B cells, and activated naive (AN) B cells according to the differential expression of the specific signature gene set ( Figure 3B ). The AN B cells were IGHD-positive clusters with comparatively higher SHM rates ( Figure 3C ) than other naive B cells and expressed distinct genes, such as FGR and MPP6. During the EF response, AN B cells differentiate into effector cells lacking naive (IgD) and memory (CD27) markers or DN B cells. DN B cells showed a higher SHM rate than AN B cells and expressed ITGAX (CD11C) and CD86 ( Figures 3B, C ). A previous study also reported that the human EF effector B-cell responses are mediated by the expansion of a unique population of CD11c+ AN B cells. Two clusters of atypical memory (AM1 and AM2) B cells were identified within the memory B-cell compartment, which overexpressed CD1C. Interestingly, ##AM2 B cells## shared several transcriptional signatures, including FGR and HLA-DRB1, with EF B-cell subsets, including AN and DN cells. Both AM2 and DN B cells express ITGAX, TBX21, CD86, and ITGB2, but AM2 uniquely expressed CXCR3 and GSN (gelsolin).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9309264</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35899045</oboInOwl:hasDbXref>
        <rdfs:label>AM2 B cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000787"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/a3d59530-e1f5-4a26-99f4-d81dc5f1174d"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000787"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/a3de8421-80de-4662-9b18-e34debaf771c -->

    <Class rdf:about="http://example.org/a3de8421-80de-4662-9b18-e34debaf771c">
        <obo:IAO_0000115>##CD90-negative colonic lamina propria CD127+ ILC## produce cytokines upon induced colitis</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10126679</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37114052</oboInOwl:hasDbXref>
        <rdfs:label>CD90-negative colonic lamina propria CD127+ ILC</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0001065"/>
        <skos:relatedMatch rdf:resource="CL:0009018"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/a3de8421-80de-4662-9b18-e34debaf771c"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0001065"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/a3de8421-80de-4662-9b18-e34debaf771c"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0009018"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/a3e60da3-34f9-4b8f-ad9b-1bc16a803ad0 -->

    <Class rdf:about="http://example.org/a3e60da3-34f9-4b8f-ad9b-1bc16a803ad0">
        <obo:IAO_0000115>(A and B) Isolated CD4+ TILs were stimulated in vitro with PMA/ionomycin and stained and analyzed by flow cytometry. (A) Top left dot plot shows PD-1 versus CD39 expression in CD4 Tconvs. IFN-gamma versus TNF-alpha expression is shown in the indicated CD4 Tconv populations. Proportions of cytokine+ (IFN-gamma and/or TNF-alpha; bottom left) and TNF-alpha+IFN-gamma-, TNF-alpha-IFN-gamma+, and TNF-alpha+IFN-gamma+ cells in PD-1-CD39-, PD-1loCD39-, PD-1hiCD39-, and PD-1hiCD39+ subsets and according to TIM-3 expression (n = 8). (B) Dot plots show CD39 versus IFN-gamma or TNF-alpha in CD4 Tconvs. Numbers in dot plots correspond to MFI of cytokine staining. MFI of IFN-gamma and TNF-alpha staining in IFN-gamma+ and TNF-alpha+ cells, respectively, are summarized for Tconv subpopulations defined as in A (n = 8). Samples in A and B are shown according to the proportion of TIM-3+ cells among PD-1hiCD39+ CD4 Tconv (&lt;50% TIM-3+, square; &gt;=50% TIM-3+, triangle; unknown, round) (C) CD4 Tconv TIL subsets PD-1-CD39- (gray), PD-1loCD39- (green), PD-1hiCD39- (blue), and PD-1hiCD39+ (red) were sorted, expanded in vitro for 10 days, and restimulated or not with PMA/ionomycin overnight. TNF-alpha and IFN-gamma secretion was quantified by CBA in the supernatant (n = 5). (D) Isolated CD4+ TILs were stained ex vivo and analyzed by flow cytometry. Proportions of TOX+ cells in each Tconv subset are summarized (n = 10). Data are presented as mean +- SD. **P &lt; 0.01; ***P &lt; 0.001; ****P &lt; 0.0001. P values were determined using the Wilcoxon (A and B) and 2-tailed paired t tests (D). Bonferroni&apos;s correction was applied to account for multiple testing in D and significance level was adjusted accordingly (*P &lt; 0.0083; **P &lt; 0.00166; ***P &lt; 0.000166). Tconvs, conventional FOXP3- CD4 T cells; CBA, cytometric bead array; ##TILs##, tumor-infiltrating lymphocytes.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7934837</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33332284</oboInOwl:hasDbXref>
        <rdfs:label>TILs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000542"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/a3e60da3-34f9-4b8f-ad9b-1bc16a803ad0"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000542"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/a3f259a5-80be-4ba9-bc82-1a1963b36a51 -->

    <Class rdf:about="http://example.org/a3f259a5-80be-4ba9-bc82-1a1963b36a51">
        <obo:IAO_0000115>Downstream of the multipotent HSCs and MPPs, the original lineage bifurcation model strictly separated oligopotent Common Lymphoid Progenitors (CLP) from Common Myeloid Progenitors (CMP) which could further diverge into Megakaryocyte/Erythrocyte Progenitors (MEPs), Monocyte (Mo)/Dendritic cell (DC) Progenitors (MDPs) and Granulocyte/Mo Progenitors (GMPs). However, this model has been the subject of ongoing revision in the scRNA-seq era. On the one hand, a Lymphoid-primed MultiPotent Progenitor (LMPP) with combined lymphoid and myeloid potential has been shown to gradually lose myeloid potential by upregulating the interleukin-7 receptor alpha-chain (IL7Ralpha) and differentiate into Dach1- Lymphoid-Primed Progenitors (LPPs) prior to CLPs. On the other hand, erythroid-versus-myeloid fate decisions seem to be made prior to CMP commitment, calling for in-depth revision of all CMP progeny (MEPs, MDPs and GMPs) as well. While the Flt3L+CD115lo CMPs give rise to oligopotent MDPs, the Flt3-CD115- CMPs give rise to GMPs. The former are defined by TF co-expression of CEBPA, IRF8 and RUNX1. MDPs can give rise to IRF8/SATB1 plasmacytoid DC (pDC) Progenitors (pDCPs) and ##HLA-DR/IRF8/CEBPA Mo/conventional DC (cDC) Progenitors## (McDPs). The latter bifurcate in CD11c/CD172ab/CD14 (human) or Ly6C+ Mo (mouse) or IRF8/HLA-DR/CD84/CD172ab Common DC Progenitors (CDPs). In contrast, GMPs (Kit, CD34, Sox4) are very heterogeneous at the transcriptomic and proteomic level and can adjust their functional output towards common Mo Progenitors (cMoP) and Granulocyte Progenitors (GPs).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11324509</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:39148724</oboInOwl:hasDbXref>
        <rdfs:label>HLA-DR/IRF8/CEBPA Mo/conventional DC (cDC) Progenitors</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002009"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/a3f259a5-80be-4ba9-bc82-1a1963b36a51"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002009"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/a43c16c6-ee17-4d15-bff8-4fdcd4e8ce96 -->

    <Class rdf:about="http://example.org/a43c16c6-ee17-4d15-bff8-4fdcd4e8ce96">
        <obo:IAO_0000115>HSPCs, human hematopoietic stem and progenitor cells; IFNgamma, interferon gamma; IL, interleukin; ILCs, innate lymphoid cells; ##ILCPs##, innate lymphoid cell precursors; IV, intravenous; Lin, lineage; NK, natural killer; TCF-1, T cell factor-1; UMAP, Uniform Manifold Approximation and Projection.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9364238</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35967297</oboInOwl:hasDbXref>
        <rdfs:label>ILCPs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0001065"/>
        <skos:relatedMatch rdf:resource="CL:0011115"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/a43c16c6-ee17-4d15-bff8-4fdcd4e8ce96"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0001065"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/a43c16c6-ee17-4d15-bff8-4fdcd4e8ce96"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0011115"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/a47bea84-2a09-47f8-a597-fe4d29bedbdc -->

    <Class rdf:about="http://example.org/a47bea84-2a09-47f8-a597-fe4d29bedbdc">
        <obo:IAO_0000115>SCN	Suprachiasmatic nucleus	 	ROR	Retinoic acid receptor-related orphan receptor	 	Rev-ErbA	Reverse c-erb A	 	RRE	Rev-ErbA/ROR response element	 	ROS	Reactive oxygen species	 	UV	Ultraviolet	 	CBC	##Crypt-base columnar cell##	 	ISC	Intestinal stem cell	 	TA	Transit-amplifying	 	EC	Enterocyte	 	GC	Goblet cell	 	EEC	Enteroendocrine cell	 	PC	Paneth cell	 	GI	Gastrointestinal	 	DSS	Dextran-sodium sulfate	 	CRD	Circadian rhythm disruption	 	RNAi	RNA interference	 	ZT	Zeitgeber time	 	BM	Bone marrow	 	HSC	Hematopoietic stem cell 	 	HSPC	Hematopoietic stem and progenitor cell	 	MPP	Multipotent progenitor	 	LT-HSC	Long-term hematopoietic stem cell	 	SP	Side population	 	CAR	CXCL12-abundant reticular	 	NE	Norepinephrine	 	TNF	Tumor necrosis factor	 	MAPK	Mitogen-activated protein kinase	 	</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6539890</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31071906</oboInOwl:hasDbXref>
        <rdfs:label>Crypt-base columnar cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002250"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/a47bea84-2a09-47f8-a597-fe4d29bedbdc"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002250"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/a4a12e7a-ce2f-4d66-ae85-5335f3707334 -->

    <Class rdf:about="http://example.org/a4a12e7a-ce2f-4d66-ae85-5335f3707334">
        <obo:IAO_0000115>These findings indicate that fibroblast associations with ##metaplastic epithelial cells## can facilitate direct transition of metaplastic spasmolytic polypeptide-expressing metaplasia cell lineages into dysplastic lineages.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10375042</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37196797</oboInOwl:hasDbXref>
        <rdfs:label>metaplastic epithelial cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000066"/>
        <skos:relatedMatch rdf:resource="CL:0001061"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/a4a12e7a-ce2f-4d66-ae85-5335f3707334"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000066"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/a4a12e7a-ce2f-4d66-ae85-5335f3707334"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0001061"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/a4ba3cdf-a86f-460a-b554-8b0e86967db8 -->

    <Class rdf:about="http://example.org/a4ba3cdf-a86f-460a-b554-8b0e86967db8">
        <obo:IAO_0000115>In conclusion, we have developed a minimally damaging approach to imaging the live SVZ in postnatal and juvenile mice. This 3PM approach is well suited for imaging ##SVZ cell## dynamics of stem cell activation, proliferation and migration and could be used over several hours to visualize fast events such as calcium dynamics, neuroblast migration, microglial activation, and over days to weeks in the same animals to visualize slow events such as stem cell activation, lineage progression, and attempts at regeneration. Similar to, 3PM could be used over several days for imaging clonal evolution and also the impacts of aging on the SVZ. We plan to use 3PM for imaging combined with the study of molecular mechanisms and the response of the SVZ to models of disease, such as gliomagenesis.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9290563</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35029646</oboInOwl:hasDbXref>
        <rdfs:label>SVZ cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:4042021"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/a4ba3cdf-a86f-460a-b554-8b0e86967db8"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4042021"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/a4bde301-2de2-4fe9-84cd-af9a918432db -->

    <Class rdf:about="http://example.org/a4bde301-2de2-4fe9-84cd-af9a918432db">
        <obo:IAO_0000115>By the time the mouse blastocyst is ready to implant into the uterus, it comprises three cell types: pluripotent epiblast and two types of extra-embryonic tissue; primitive endoderm (PE), that will become visceral endoderm (VE) that gives rise to the yolk sac; and trophectoderm (TE), progenitor of the placenta (figure 1). ESCs represent the pluripotent epiblast that forms a compartment distinct from the extra-embryonic cells in the blastocyst. The epiblast arises from a set of cells internalized during the 8- to 16-cell and 16- to 32-cell cleavage stages, the inner cell mass. The cells remaining on the outside of the embryo at this time become the TE. Before implantation, a salt and pepper mixture of inside cells, now specified as PE and epiblast, sort from each other into distinct layers. Just as the epiblast is represented by ESCs, cultured stem cell lines of trophoblast stem cells (TSCs) have been established from the TE and of eXtraEmbryoNic stem cells (XEN cells) from the PE/VE. The trick in recapitulating development beyond gastrulation to form structures representing the entire body plan has been to recreate interactions between the ##pluripotent ESCs## and the two extra-embryonic stem cell types. </obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9833437</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36630196</oboInOwl:hasDbXref>
        <rdfs:label>pluripotent ESCs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002248"/>
        <skos:relatedMatch rdf:resource="CL:0002322"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/a4bde301-2de2-4fe9-84cd-af9a918432db"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002248"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/a4bde301-2de2-4fe9-84cd-af9a918432db"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002322"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/a4c608ed-ea8e-4ec3-80a1-e25612ac9c52 -->

    <Class rdf:about="http://example.org/a4c608ed-ea8e-4ec3-80a1-e25612ac9c52">
        <obo:IAO_0000115>Our novel multi-color flow cytometry panel was also tested on mouse skin. After excluding cellular debris, doublets, and dead cells, we gated with the help of FMO controls (Fig. S10) on viable CD45+ cells (Fig. 2A). In healthy skin, the CD3+ T cell population consists of CD3intCD4+ T cells and CD3highgammadelta T cells, whereas CD8+ T cells, NK cells, B cells, neutrophils and pDC are rare in healthy skin (Fig. 2B). By following gating published earlier, we identified several ##myeloid non-DC## populations (P1-P5) in the dermis (Fig. 2C) and different DC-subsets (Fig. 2D, E). From the non CD11b+CD24- population we identified CD11c+MHC-II+ DC. Next, we divided DC into XCR1+ cDC1, which contain CD103+ and CD103- subsets, and CD172a+ DC which consists mainly of CD207+ LC (Fig. 2D). Dermal cDC2 are characterized from the CD64-Ly-6C- population by gating on CD11c+MHC-II+ cells that express CD11b and CD172a (Fig. 2E). In addition, we investigated CD115, F4/80 and CD64 expression on the non-DC myeloid cell populations P1-P5 (Fig. 2F). Analysis of CD40, PD-L1, PD-L2 and CCR7 on the different DC-subets allows further phenotypical characterization (Fig. 2G). An example for UMAP analysis is shown in Figure S11 confirming manual gating for DC-subsets and non-DC populations.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10087122</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35944142</oboInOwl:hasDbXref>
        <rdfs:label>myeloid non-DC</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000763"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/a4c608ed-ea8e-4ec3-80a1-e25612ac9c52"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000763"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/a51f3c0d-f5e7-4d65-a4fe-d7c049021eb2 -->

    <Class rdf:about="http://example.org/a51f3c0d-f5e7-4d65-a4fe-d7c049021eb2">
        <obo:IAO_0000115>GDNF, Glial cell line-derived neurotrophic factor; SOX1, Sex-determining region Y box1; TGF-beta, Transforming Growth Factor beta; EGFR, epidermal growth factor receptor; PI3-K, phosphatidylinositide 3-kinase; STAT3, signal transduction activator of transcription 3; GSK3 beta, Glycogen synthase kinase 3 beta; PTEN, Phosphatase and Tensin, VEGF, Vascular endothelial growth factor; TMZ, temozolomide; ##CAF##, Cancer-Associated Fibroblast; IL-6, interleukins and TNF-alpha, tumor necrosis factor-alpha.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8980436</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35392088</oboInOwl:hasDbXref>
        <rdfs:label>CAF</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000057"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/a51f3c0d-f5e7-4d65-a4fe-d7c049021eb2"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000057"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/a57a0d76-f7a0-4fe1-bd8c-5a712deb7d32 -->

    <Class rdf:about="http://example.org/a57a0d76-f7a0-4fe1-bd8c-5a712deb7d32">
        <obo:IAO_0000115>MiR-425-5p is upregulated in oocytes after in vitro oxidative stress induction and natural aging. (A) Upper and lower images: Representative images of small antral GV oocytes from young and reproductively older mice stained with CM-H2DCFAD fluorescence to evaluate ROS levels. Scale bar: 100 mum. (B) Quantitative analysis of the CM-H2DCFAD fluorescence intensity in ##GV oocytes## from young and reproductively older mice (n = 20 in each group). P values were determined by the unpaired samples T-test. (C) Venn diagram for upregulated miRNAs in GV oocytes(green), embryos(cornflower blue), and sperm(pink) in reproductively older mice versus young mice. The miRNAs found to be exclusively upregulated in the GV oocytes were filtered with a publicly available miRNA expression database that included miRNAs altered after H2O2 exposure(sky blue). (D) MiR-425-5p expression levels in GV oocytes of young and reproductively older mice. P values were determined by the unpaired samples T-test. (E) Upper and lower images: Representative images of oocytes cultured in vitro for 3 h and 14 h after being treated with different concentrations of H2O2 for different times (0 muM*0.5 h, 25 muM*0.5 h, 25 muM*1 h, 25 muM*1.5 h, 50 muM*1.5 h, 75 muM*1.5 h and 100 muM*1.5 h). Scale bar = 100 mum. (F) The GVBD rate and PBE rate of oocytes after being treated with different concentrations of H2O2 for different times (n = 80 to 90 in each group). P values were determined by two-way ANOVA. (G) MiR-425-5p expression levels in GV oocytes after being treated with different concentrations of H2O2 for different times. P values were determined by one-way ANOVA. Results were representative of at least three independent experiments.*P &lt; 0.05 and **P &lt; 0.01</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11226420</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37532927</oboInOwl:hasDbXref>
        <rdfs:label>GV oocytes</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000023"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/a57a0d76-f7a0-4fe1-bd8c-5a712deb7d32"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000023"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/a593389c-f56b-4a6a-b3a1-207062f02bce -->

    <Class rdf:about="http://example.org/a593389c-f56b-4a6a-b3a1-207062f02bce">
        <obo:IAO_0000115>Single-cell analysis identified neurons expressing sympathetic and parasympathetic markers (Fig. 3c), thus leading to the speculation of whether ##parasympathetic marker-positive neurons## herein are actually parasympathetic neurons differentiated directly from ANS progenitors or cholinergic sympathetic neurons converted from noradrenergic sympathetic neurons herein. During early development, parasympathetic neurons transiently co-express sympathetic markers including TH and DBH, and sympathetic neurons co-express parasympathetic markers, indicating the possibility that double-positive neurons are immature or intermediate neurons. However, as described above, traditional in vitro studies and recent in vivo studies reported that sympathetic neurons acquire cholinergic properties via the effects of trophic factors including BDNF, CNTF, and leukaemia inhibitory factor. Furthermore, HMX2 and HMX3 were not upregulated or relevant herein, being newly identified definitive parasympathetic markers in mice, in the induced ANS progenitors and induced neurons (data not shown). Although it remains unclear whether these new findings regarding parasympathetic neurons in mice are applicable among humans, the present results suggest that the parasympathetic-like neurons herein are not parasympathetic. On the other hand, chromaffin cells are also derived from Schwann cell progenitors, which also give rise to parasympathetic neurons. Although we have not confirmed the involvement of Schwann cell precursors in the induction of parasympathetic-like neurons or chromaffin cells, Therefore, we considered that the generation of PNMT-positive chromaffin cells (Supplementary Fig. 2c) did not completely eliminate the possibility of the induction of parasympathetic neurons. Further studies are required to identify the origins or developmental pathways of human parasympathetic neurons in vitro, such as whether the intermediate Schwann cell precursor stage is involved.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7289887</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32528170</oboInOwl:hasDbXref>
        <rdfs:label>parasympathetic marker-positive neurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0011102"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/a593389c-f56b-4a6a-b3a1-207062f02bce"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0011102"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/a5a0b459-30f3-4075-af7b-7d5477cafa10 -->

    <Class rdf:about="http://example.org/a5a0b459-30f3-4075-af7b-7d5477cafa10">
        <obo:IAO_0000115>Schematic of the postnatal murine pituitary. The postnatal pituitary gland consists of the Posterior Pituitary (PP) and the Anterior Pituitary (AP), the latter of which houses the anterior lobe (AL) and intermediate lobe (IL). Hormone-producing cells, resident stem cells and non-hormonal support cells such as ##endothelia## and connective tissue are present with the AP. Melanotrophs (secreting MSH) are present uniquely within the IL, whilst Lactotrophs (PRL), Somatotrophs (GH), Thyrotrophs (TSH), Gonadotrophs (LH/FSH) and Corticotrophs (ACTH) are present within the parenchyma of the AL. Stem cells reside within the marginal zone between the IL and the AL in the AP and as epithelial clusters within the parenchyma of the AL. Vasculature is present throughout the AP. For the axes, D dorsal, V ventral, L left, R right, Ro rostral, C caudal.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9712314</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36451046</oboInOwl:hasDbXref>
        <rdfs:label>endothelia</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:4052016"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/a5a0b459-30f3-4075-af7b-7d5477cafa10"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4052016"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/a5af5c0b-45cc-4f00-b90c-2fe2b735a7ff -->

    <Class rdf:about="http://example.org/a5af5c0b-45cc-4f00-b90c-2fe2b735a7ff">
        <obo:IAO_0000115>Macrophages are multi-functional innate immune cells that orchestrate tissue repair, immune responses and inflammation. First described by Elie Metchnikoff, macrophages are derived from embryonic haematopoietic progenitors or monocytes and differentiate into tissue macrophages after entering the tissue. Because macrophages play an indispensable role in maintaining systemic homeostasis and participating in immune defence against pathogens and cellular debris, they are widely distributed across various tissues, including the salivary glands. Recent studies have shown that macrophages perform several other functions in addition to phagocytosis. Macrophages and T cells can collectively regulate inflammation and participate in various functions such as phagocytosis and antigen presentation. This phenomenon has been partly confirmed in a noninflamed murine submandibular salivary gland model, as macrophages facilitate the local accumulation of tissue-resident memory CD8+ T cells (T+ RM) at the site of inflammation. Tissue-resident immune cells are thought to be complemented by salivary gland progenitor cells (##SGPCs##) for the maintenance of normal salivary gland homeostasis. Upon tissue damage, epithelial cells release inflammatory factors and recruit macrophages to induce inflammatory responses. Through their uncontrolled and rapid cytokine production, macrophages recruit more immune cells to amplify the local inflammatory response, thereby bridging innate and adaptive immunity.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10656691</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38022546</oboInOwl:hasDbXref>
        <rdfs:label>SGPCs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0009005"/>
        <skos:relatedMatch rdf:resource="CL:0011026"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/a5af5c0b-45cc-4f00-b90c-2fe2b735a7ff"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0009005"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/a5af5c0b-45cc-4f00-b90c-2fe2b735a7ff"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0011026"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/a5cfae70-6ca2-4dd4-99f5-ae192a72bac0 -->

    <Class rdf:about="http://example.org/a5cfae70-6ca2-4dd4-99f5-ae192a72bac0">
        <obo:IAO_0000115>Extensive studies on vitiligo have focused on T cell suppression, and Jak inhibitors to suppress T cell recruitment have been approved for vitiligo therapy. Even though significant amounts of repigmentation is often achieved from this treatment, efficacy is still limited and varies among patients. Previous studies have suggested that achieving durable repigmentation will likely require combinatorial approaches that address both vitiligo pathogenesis and epidermal melanocyte repopulation. In this study, we aimed to increase the level of epidermal melanocyte translocation that normally occurs by phototherapy-induced migration of ##hair follicle McSCs##. We found that the UVB-induced inflammatory response underlies McSC migration to the epidermis and that the gender-specific differences in inflammation levels translate to differences in McSC translocation rates. We also demonstrated that applying supplemental dmPGE2 promotes UVB-induced inflammation and further addition of JAK inhibitor treatment results in a significantly higher number of epidermal melanocytes than any single therapy alone.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10821900</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38280858</oboInOwl:hasDbXref>
        <rdfs:label>hair follicle McSCs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002483"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/a5cfae70-6ca2-4dd4-99f5-ae192a72bac0"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002483"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/a5de3743-ab35-4249-8aad-28a2dfee216e -->

    <Class rdf:about="http://example.org/a5de3743-ab35-4249-8aad-28a2dfee216e">
        <obo:IAO_0000115>A reduction in bile acid metabolism-related ##SPP1+ epithelial cells## and VEGFA+ endothelial cells, along with explosive infiltration of plasma cells and dysfunction of T- and NK cells in NAS patients.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10938070</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38481381</oboInOwl:hasDbXref>
        <rdfs:label>SPP1+ epithelial cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000066"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/a5de3743-ab35-4249-8aad-28a2dfee216e"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000066"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/a5e653fc-1e01-4674-bf92-62a1e91096a6 -->

    <Class rdf:about="http://example.org/a5e653fc-1e01-4674-bf92-62a1e91096a6">
        <obo:IAO_0000115>The cellular content of human myocardium (in descending order by number) predominantly consists of cardiomyocytes, fibroblasts, pericytes and smooth muscle cells, endothelial cells, and immune cells. In the murine heart, macrophage populations can be discerned based on their expression of C-C chemokine receptor type 2 (CCR2), major histocompatibility complex-II (MHC-II), T cell immunoglobulin and mucin domain containing 4 (TIMD4), and Lymphatic Vessel Endothelial Hyaluronan Receptor 1 (LYVE1). Four populations of macrophages have been identified in the murine heart (Fig. 1). The minority are two subsets of CCR2+MHC-IIhigh macrophage populations derived from hematopoietic stem cells, whereas the most dominant subset, ##cardiac resident macrophages## derived from the yolk sac, are CCR2-MHC-IIlowTIMD4+LYVE1-. There also exists a fourth subset that consists of CCR2-MHC-IIhighTIMD4+LYVE1+ macrophages, which are likely derived from CCR2-MHC-IIlow macrophages during postnatal development and partially maintained by CCR2+MHC-IIhigh macrophages. CCR2+MHC-IIhigh macrophages populate the heart soon after birth and are maintained through monocyte recruitment and proliferation. Also, under homeostasis, cardiac macrophages continually self-renew with a turnover period of almost 5 weeks. Recently, this same CCR2+ and CCR2- macrophage distinction has been identified in humans, with the yolk sac-derived CCR2- human counterpart showing CD14+CD45+CD64+CCR2-HLA-DRhigh expression. In a more recent study, Tucker et al. reported two cardiac macrophage subsets within the human heart, which were positive for CD163, COLEC12, mannose receptor MRC1, E3 ubiquitin ligase MARCH1, and natural resistance-associated macrophage protein 1 (NRAMP1). Both of the identified subsets expressed anti-inflammatory (M2) polarization-associated genes, whereas one subset particularly expressed RBPJ, F13A1 and the other expressed transmembrane collagen COL23A1.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9242717</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34088222</oboInOwl:hasDbXref>
        <rdfs:label>cardiac resident macrophages</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000864"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/a5e653fc-1e01-4674-bf92-62a1e91096a6"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000864"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/a5ef1322-6a89-4d70-925d-c2932bedc743 -->

    <Class rdf:about="http://example.org/a5ef1322-6a89-4d70-925d-c2932bedc743">
        <obo:IAO_0000115>Variable Name Data used   TN Naive T-cells Combination of CD4 naive and memory resting T-cells and resting NK cells   Th Helper T-cells Combination of memory activated CD4 T-cells and follicular helper T-cells   TC Cytotoxic cells Combination of CD8 T-cells and activated NK cells   Tr Regulatory T-cells Regulatory T-cells   DN Naive dendritic cells Naive dendritic cells   D Activated dendritic cells Activated dendritic cells   MN Naive Macrophages Combination of Macrophages M0 and Monocytes   M Macrophages Combination of M1 and M2 Macrophages   C Cancer cells Estimated   N Necrotic cells Estimated   A ##Cancer Associated Adipocytes## Assumed to be twice of the total number of immune cells   H HMGB1 HMGB1 gene expression   IL12 IL-12 IL12A and IL12B gene expressions   IL10 IL-10 IL10, IL10RA and IL10RB gene expressions   IL6 IL-6 IL6, IL6ST and IL6RA gene expressions   </obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8959189</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35294447</oboInOwl:hasDbXref>
        <rdfs:label>Cancer Associated Adipocytes</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000136"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/a5ef1322-6a89-4d70-925d-c2932bedc743"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000136"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/a61557c5-277b-4391-83da-1f1bf7af0a7d -->

    <Class rdf:about="http://example.org/a61557c5-277b-4391-83da-1f1bf7af0a7d">
        <obo:IAO_0000115>##Tonsillar CD4+ T cell## subsets can be divided into three major groups. Most intrafollicular T cells belong to the follicular B helper T cell group (follicular Th [TFH], CD4+PD1+CXCR5+BCL6high). B cell and TFH interactions are crucial for the formation of the humoral immune response and support B cell somatic hypermutation and Ab class switching. Other tonsillar CD4+ T cell subsets include non-TFH (CD4+PD1-CXCR5-BCL6low) and pre-TFH (CD4+PD1+CXCR5-BCL6mid). Pre-TFH cells develop from activated Ag-specific CD4+ T cells. The transcriptional program that is initiated in pre-TFH cells can induce CXCR5 expression, enabling the cells to migrate toward the B cell follicle.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8278278</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34099545</oboInOwl:hasDbXref>
        <rdfs:label>Tonsillar CD4+ T cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000624"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/a61557c5-277b-4391-83da-1f1bf7af0a7d"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000624"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/a63bd002-583e-4eef-b263-401cfb96b02a -->

    <Class rdf:about="http://example.org/a63bd002-583e-4eef-b263-401cfb96b02a">
        <obo:IAO_0000115>Potential sources, morphological and phenotypic characterizations of different types of urine-derived stem cells. Upper urinary tract cells can be derived from renal cortical nephron part-renal tubular cells from proximal and distal convoluted tubules, glomerular pericytes, renal interstitial cells and vascular endothelial cells. Lower urinary tract urine-derived stem cells (##UDSC##) belong to epithelial (urothelial) cells from ureter, urinary bladder and urethra. Original source of UDSC determines their morphology in vitro, culture conditions, phenotype and differentiation capabilities. Image was adapted from original images from Servier Medical Art, as licensed under a Creative Commons Attribution 3.0 Unported License. Text was added to the original images.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7140531</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32121221</oboInOwl:hasDbXref>
        <rdfs:label>UDSC</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000034"/>
        <skos:relatedMatch rdf:resource="CL:1000600"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/a63bd002-583e-4eef-b263-401cfb96b02a"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000034"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/a63bd002-583e-4eef-b263-401cfb96b02a"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:1000600"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/a6458dbd-9bbd-4e08-92c7-9853149d60ac -->

    <Class rdf:about="http://example.org/a6458dbd-9bbd-4e08-92c7-9853149d60ac">
        <obo:IAO_0000115>Our findings support the theory of a consistently altered bioenergetic state in ME/CFS immune cells, specific to certain immune cell types that rely on fatty acids more heavily than healthy control subjects. This study detected increases in fatty acid oxidation in CD4+ T cells, CD8+ T cells, and NK cells at varying degrees, with CD4+ T cell fatty acid utilization correlating with ME/CFS illness duration. This data indicates that ME/CFS NK cell dysfunction could be in part due to greater levels of lipid accumulation and subsequent fatty acid oxidation. We also propose that the combined metabolic profile of ##ME/CFS T cells## suggests an exhausted T cell state, resulting in reduced effector functions that may contribute to ME/CFS symptom presentation.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9916395</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36768336</oboInOwl:hasDbXref>
        <rdfs:label>ME/CFS T cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000084"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/a6458dbd-9bbd-4e08-92c7-9853149d60ac"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000084"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/a64b730f-acd2-47e1-87ce-d3b7a726fa17 -->

    <Class rdf:about="http://example.org/a64b730f-acd2-47e1-87ce-d3b7a726fa17">
        <obo:IAO_0000115>Deletion of TREM2 suppresses the development of ##disease-associated microglia## (DAMs) in vivo.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7584603</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33097708</oboInOwl:hasDbXref>
        <rdfs:label>disease-associated microglia</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000129"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/a64b730f-acd2-47e1-87ce-d3b7a726fa17"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000129"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/a66ad84b-abe8-4174-bc63-095cba615cf2 -->

    <Class rdf:about="http://example.org/a66ad84b-abe8-4174-bc63-095cba615cf2">
        <obo:IAO_0000115>Moreover, Zhang et al. identified the Arg1+ microglial subtype located in the hippocampus, the proliferation, and maturation of which were driven by IL-4 signaling. This ##Arg1+ microglia## subtype is responsible for secreting additional BDNF which maintains microglial self-renewal, adult neurogenesis in the DG, and working memory under stress conditions. However, BDNF released from microglia was also reported to promote the transdifferentiation of astrocytes and microglia to release proinflammatory cytokines, causing aggravated neuroinflammation. In conclusion, the neuroprotective effects exerted by microglia under both physiological and pathological conditions should not be neglected.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10683283</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38012702</oboInOwl:hasDbXref>
        <rdfs:label>Arg1+ microglia</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000129"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/a66ad84b-abe8-4174-bc63-095cba615cf2"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000129"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/a6742615-4ec3-417d-9942-8c88c75c4d78 -->

    <Class rdf:about="http://example.org/a6742615-4ec3-417d-9942-8c88c75c4d78">
        <obo:IAO_0000115>Although considerable advances have been made toward understanding human T-cell development, several major questions remain obscure regarding the heterogeneity and molecular mechanisms underlying the fate bifurcation of certain T progenitors. Several laboratories have largely resolved these long-standing questions by using single-cell RNA sequencing (scRNA-seq) technologies to study human T-cell development in both the developing fetus and postnatal thymus. Our group first revealed thymus organogenesis, early T lymphopoiesis, and their pre-thymic lymphoid progenitors in the early human fetus at single-cell resolution. Following studies further transcriptomically characterized the ##TSPs## and revealed T lineage specification, commitment, and subsequent differentiation in both the prenatal and postnatal thymus. A recent work profiled the complete thymocyte populations in postnatal samples, especially the three CD4-CD8- DN subsets and identified three distinct TSP subpopulations as well as revealed T-cell lineage commitment and divergence of non-T-cell lineages. Despite that the characteristics of immature DN subsets have been characterized in the human postnatal thymus, less is known regarding the nature of distinct DN subpopulations and cell fate decision (T lineage versus non-T lineage) during DN stages of T-cell development in human fetus. Furthermore, mouse studies have well documented that fetal and adult DN cells (including ETP) are not equivalent, reflecting the origin of ETP (HSC-dependent or HSC-independent), thymic outputs, differentiation speed, and gene expression transition, so whether these differences existing between prenatal and postnatal human thymocytes are also worth to be addressed.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10565475</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37828991</oboInOwl:hasDbXref>
        <rdfs:label>TSPs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000827"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/a6742615-4ec3-417d-9942-8c88c75c4d78"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000827"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/a68a9e8f-0edb-427d-bf9d-32d7654511fd -->

    <Class rdf:about="http://example.org/a68a9e8f-0edb-427d-bf9d-32d7654511fd">
        <obo:IAO_0000115>Within the 1397 B-cells, we obtained 4 separate clusters (Fig. 6j; Supplementary information, Fig. S6k). Follicular B-cells were composed of &apos;mature-naive&apos; (CD27-) and &apos;memory&apos; (CD27+) B-cells. The former were characterized by a unique CD27-/IGHD+(IgD)/IGHM+(IgM) signature and give rise to the latter by migrating through the germinal center to form CD27+/IGHD-(IgD)/IGHM-(IgM) memory B-cells (Fig. 6k, l). Memory B-cells then further differentiate into antibody-secreting plasma cells (IGHA1, IGHG1, JCHAIN), which themselves can be further classified into short-lived and long-lived plasma cells. We failed to identify long-lived plasma cells (as these are non-proliferating cells residing in bone marrow and spleen, but were able to divide short-lived plasma cells into two subclusters. A first subcluster of &apos;active&apos; plasma cells expressed high levels of PRDM1(Blimp-1) and XBP1, indicating high antibody-secretion capacity, while a second cluster referred to as &apos;terminal&apos; plasma cells was enriched for CCL2 and CCL5, but also characterized by reduced G2M and S cell cycle scores and increased expression of mitochondrial genes, indicating ongoing stress (Fig. 6m). Notably, the latter population was characterized by increased BCR clonality and reduced BCR evenness (Fig. 6n). Compared to non-COVID-19, mature-naive B-cells and ##active plasma cells## were increased in COVID-19, while terminal plasma cells were reduced in COVID-19, albeit non-significantly (Fig. 6o). Although these effects were mainly driven by critical COVID-19 vs non-COVID-19 (Supplementary information, Fig. S6l), there were no significant differences between mild vs critical COVID-19 (Fig. 6p). Overall, this suggests terminal plasma cells in COVID-19 are characterized by sub-optimal differentiation or activation, which may cause defective or counter-productive (possibly low-quality) antibody responses in COVID-19.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8027624</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33473155</oboInOwl:hasDbXref>
        <rdfs:label>active plasma cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000975"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/a68a9e8f-0edb-427d-bf9d-32d7654511fd"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000975"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/a789dadf-5a9d-4f0f-97a4-2faeffda41ca -->

    <Class rdf:about="http://example.org/a789dadf-5a9d-4f0f-97a4-2faeffda41ca">
        <obo:IAO_0000115>(A and B) Isolated CD4+ TILs were stimulated in vitro with PMA/ionomycin and stained and analyzed by flow cytometry. (A) Top left dot plot shows PD-1 versus CD39 expression in CD4 Tconvs. IFN-gamma versus TNF-alpha expression is shown in the indicated CD4 Tconv populations. Proportions of cytokine+ (IFN-gamma and/or TNF-alpha; bottom left) and TNF-alpha+IFN-gamma-, TNF-alpha-IFN-gamma+, and TNF-alpha+IFN-gamma+ cells in PD-1-CD39-, PD-1loCD39-, PD-1hiCD39-, and PD-1hiCD39+ subsets and according to TIM-3 expression (n = 8). (B) Dot plots show CD39 versus IFN-gamma or TNF-alpha in CD4 Tconvs. Numbers in dot plots correspond to MFI of cytokine staining. MFI of IFN-gamma and TNF-alpha staining in IFN-gamma+ and TNF-alpha+ cells, respectively, are summarized for Tconv subpopulations defined as in A (n = 8). Samples in A and B are shown according to the proportion of TIM-3+ cells among PD-1hiCD39+ CD4 Tconv (&lt;50% TIM-3+, square; &gt;=50% TIM-3+, triangle; unknown, round) (C) CD4 Tconv TIL subsets PD-1-CD39- (gray), PD-1loCD39- (green), PD-1hiCD39- (blue), and PD-1hiCD39+ (red) were sorted, expanded in vitro for 10 days, and restimulated or not with PMA/ionomycin overnight. TNF-alpha and IFN-gamma secretion was quantified by CBA in the supernatant (n = 5). (D) Isolated CD4+ TILs were stained ex vivo and analyzed by flow cytometry. Proportions of TOX+ cells in each Tconv subset are summarized (n = 10). Data are presented as mean +- SD. **P &lt; 0.01; ***P &lt; 0.001; ****P &lt; 0.0001. P values were determined using the Wilcoxon (A and B) and 2-tailed paired t tests (D). Bonferroni&apos;s correction was applied to account for multiple testing in D and significance level was adjusted accordingly (*P &lt; 0.0083; **P &lt; 0.00166; ***P &lt; 0.000166). Tconvs, ##conventional FOXP3- CD4 T cells##; CBA, cytometric bead array; TILs, tumor-infiltrating lymphocytes.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7934837</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33332284</oboInOwl:hasDbXref>
        <rdfs:label>conventional FOXP3- CD4 T cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000624"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/a789dadf-5a9d-4f0f-97a4-2faeffda41ca"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000624"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/a79d31e9-408c-42d5-bad9-54ca354d12b5 -->

    <Class rdf:about="http://example.org/a79d31e9-408c-42d5-bad9-54ca354d12b5">
        <obo:IAO_0000115>Using pS6 immunoreactivity to detect activated VSNs, and cFos to detect signal transduction in the AOB revealed that ectopic mutants have an overall decreased ##apical cells##&apos; ability to detect and transduce signals to the aAOB (Figure 6). Notably these defects resulted more obvious, in both males and females, after female bedding exposure (Figure 6).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9525060</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36111787</oboInOwl:hasDbXref>
        <rdfs:label>apical cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:1001561"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/a79d31e9-408c-42d5-bad9-54ca354d12b5"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:1001561"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/a7b4b471-cd9b-4f72-b208-8d60991c8d84 -->

    <Class rdf:about="http://example.org/a7b4b471-cd9b-4f72-b208-8d60991c8d84">
        <obo:IAO_0000115>Postnatal neurogenic zones, such as the V-SVZ (ventricular-subventricular zone) that lines the lateral ventricle walls, have an embryonic origin. Interestingly, a fraction of radial glial cells (RGCs) in the forebrain LGEs (lateral ganglionic eminences) and pallium becomes quiescent. ZEB2 was studied in LGE-derived neurons for LGEs using mainly the Gsh2-Cre driver, hence ZEB2 co-steers the anlage of part of the V-SVZ. After birth, these cells are reactivated and differentiate into the different cell types of the V-SVZ, which in the mouse are architecturally grouped, and produce supportive cells (ependymal or E cells) or RGC-like neural stem cells (NSCs or B1 cells) of the V-SVZ. The latter cells generate C cells (transit amplifying cells), which give rise to ##A cells## (immature, including migratory neuroblasts). As cells migrate via the rostral migratory stream (RMS) to the olfactory bulb (OB) and emanate as network-integrated different types of interneuron. The V-SVZ and its RMS expresses miR-200 class of micro-RNAs (that target Zeb2) and, at the time B cells are set aside in the embryonic brain, ZEB2 mRNA/protein is present in the ventral telencephalon, including the aforementioned LGE. In Gsh2-Cre;Zeb2-cKO LGEs, about 70% of postnatal V-SVZ cells are detectably targeted at E14.5, and this is confirmed in P2 and P5 mice. Pronounced defects are seen in these KO mice in OB development, for they have more scattered distribution of the various cell types and. Additionally, at P17-P18, the fewer OB interneurons results in OBs that are 70% smaller than normal. This suggested an important role of ZEB2 in postnatal neurogenesis.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8304685</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34356053</oboInOwl:hasDbXref>
        <rdfs:label>A cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000031"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/a7b4b471-cd9b-4f72-b208-8d60991c8d84"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000031"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/a7bab7a4-8222-4830-8bb9-fb50821bc41c -->

    <Class rdf:about="http://example.org/a7bab7a4-8222-4830-8bb9-fb50821bc41c">
        <obo:IAO_0000115>Skeletal stem and progenitor cell populations are crucial for bone physiology. Characterization of these cell types remains restricted to heterogenous bulk populations with limited information on whether they are unique or overlap with previously characterized cell types. Here we show, through comprehensive functional and single-cell transcriptomic analyses, that postnatal long bones of mice contain at least two types of bone progenitors with bona fide skeletal stem cell (SSC) characteristics. An early osteochondral SSC (ocSSC) facilitates long bone growth and repair, while a second type, a perivascular SSC (pvSSC), co-emerges with long bone marrow and contributes to shape the hematopoietic stem cell niche and regenerative demand. We establish that pvSSCs, but not ##ocSSCs##, are the origin of bone marrow adipose tissue. Lastly, we also provide insight into residual SSC heterogeneity as well as potential crosstalk between the two spatially distinct cell populations. These findings comprehensively address previously unappreciated shortcomings of SSC research.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8289409</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34280086</oboInOwl:hasDbXref>
        <rdfs:label>ocSSCs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000134"/>
        <skos:relatedMatch rdf:resource="CL:0000138"/>
        <skos:relatedMatch rdf:resource="CL:0007010"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/a7bab7a4-8222-4830-8bb9-fb50821bc41c"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000134"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/a7bab7a4-8222-4830-8bb9-fb50821bc41c"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000138"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/a7bab7a4-8222-4830-8bb9-fb50821bc41c"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0007010"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/a80f39c0-f700-4af9-a741-513790052d64 -->

    <Class rdf:about="http://example.org/a80f39c0-f700-4af9-a741-513790052d64">
        <obo:IAO_0000115>Enrichment map of the clusters ##Hepatocytes##1, Hepatocytes2, Hepatocytes3, and Hepatocytes4 based on GSEA.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9248293</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35783358</oboInOwl:hasDbXref>
        <rdfs:label>Hepatocytes</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000182"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/a80f39c0-f700-4af9-a741-513790052d64"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000182"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/a811cc70-17ab-4e6d-ae9f-6ae20f54a1ae -->

    <Class rdf:about="http://example.org/a811cc70-17ab-4e6d-ae9f-6ae20f54a1ae">
        <obo:IAO_0000115>Sl. no	Starting cell	Reprogrammed cell	Factors used	References	 	1	Fibroblast	Neurons	Ascl1, Brn2 and Myt1l	Vierbuchen et al. 2010 	 	2	Fibroblast	Cardiomyocytes	Gata4, Mef2c and Tbx5	Ieda et al. 2010 	 	3	Fibroblast	Hepatocytes	HNF1alpha, Foxa3 and Gata4	Huang et al. 2011 	 	4	Fibroblast	iPSCs	Oct4, Klf4, Sox2 and cMyc	Yamanaka et al. 2006 	 	5	Fibroblast	##Myogenic cells##	MyoD	Ito et al. 2017 	 	6	Fibroblast	Neuron	miR-9/9* and miR-124	Yoo et al. 2011 	 	7	Non-myocytes	Induced cardiomyocyte	miR-1, miR-133, miR-208 and miR-499	Jayawardena et al. 2012 	 	8	B and T-cells	Macrophages	C/EBPalpha	Xie et al. 2004 	 	9	ESCs	Trophoectodermal cells	Cdx2	Strumpf et al. 2005 	 	10	Acinar cells	Insulin producing B cells	MafA, Pdx1 and Ngn3	Xu et al. 2013 	 	11	Astrocytes	Glutamatergic Neurons	NeuroD1	Guo et al. 2014 	 	12	mESC	Neurons	NeuroD1	Pataskar et. al. 2016 	 	13	Neural precursor cell	Astrocyte	NFIA, ATF3 and RunX2	Tiwari et. al. 2018 	 	14	Fibroblast	Oligodendrocyte	SOX10, ZFP536, OLIG2	Yang et al. 2013 	 	15	Brain Pericytes	Neurons	Ascl1 and Sox2	Karow et. al. 2018 	 	16	Pluripotent stem cell	Adipocyte	CEBPb, PRDM16	Ahfeldt et al. 2012 	 	17	Fibroblast	Osteoblast	OCT4, RUNX2, OSX, MYC	Yamamoto et al. 2015 	 	18	Fibroblast	iPSCs	CRISPR-dCas9 activation-OSKM and Lin28	Weltner et al. 2018 	 	19	Fibroblast	Myoblast	CRISPR-dCcas9 activation of Myod enhancer	Liu et al. 2016 	 	20	Neural progenitor cell	Neuron	CRISPR-dCcas9 activation of Sox1 promoter	Baumann et al. 2019 	 	21	Fibroblasts	Neurons	CRISPR-dCcas9 activation of Brn2, Ascl1, and Myt1l	Black et al. 2016 	 	</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8305869</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34301318</oboInOwl:hasDbXref>
        <rdfs:label>Myogenic cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0008020"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/a811cc70-17ab-4e6d-ae9f-6ae20f54a1ae"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0008020"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/a81ed312-c9c1-4592-a05b-0f6e338e157f -->

    <Class rdf:about="http://example.org/a81ed312-c9c1-4592-a05b-0f6e338e157f">
        <obo:IAO_0000115>MSCpos-EVs modulate the phenotype and angiogenic ability of endothelial cells. A) Quantification of the number of intersections and network perimeters formed by HUVECs on the Matrigel layer after MSCpos- and MSCneg-EV treatment. Untreated cells were used as a control. (n = 5 per group). B) Flow cytometric analysis of the activated HUVEC phenotype (CD31+/CD34+/CXCR4+) after MSCpos- and MSCneg-EV treatment. Untreated cells (NT) were used as a control (n = 5). C) Tumor growth curves and CD31 IHC staining of 104 lung cancer (A549) cells coinjected with HUVECs pretreated with MSCpos- and MSCneg-EVs in immunodeficient mice (n = 7 for each group). D) Analysis of the relative expression levels of miR-126, pre-miR-126, SPRED1 and VEGF in HUVECs treated with MSCpos- and MSCneg-EVs. Untreated cells (NT) were used as a control (n = 5). E) Tube formation assay of miR-126-overexpressing HUVECs compared to control SCR-expressing HUVECs on Matrigel (n = 5). F) The graphs show the percentages of the CD31+/CD34+/CXCR4+ population among miR-126-overexpressing cells (n = 5) and (G) the in vivo growth curves of 105 A549 cells coinjected with the same HUVECs (n = 5 mice per group). H) Cells pretransfected with LNA 126 were incubated with MSCpos-EVs, and capillary-like structure formation was analyzed (n = 4). I) The panel shows a reduction in the ##CD31+/CD34+/CXCR4+ HUVEC##-LNA126 population after treatment with MSCpos-EVs compared to the corresponding control treatment (n = 4). L) Vessel network formation and M) activation of endothelial cells after treatment with MSCneg-EVs and MSCneg-EVs enriched with mimic-126 (n = 5). *p &lt; 0.05 versus controls. The data are expressed as the mean +- S.E.M. values</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8293562</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34289890</oboInOwl:hasDbXref>
        <rdfs:label>CD31+/CD34+/CXCR4+ HUVEC</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002618"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/a81ed312-c9c1-4592-a05b-0f6e338e157f"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002618"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/a844e6bf-c4b7-4397-b476-460ff8d38b57 -->

    <Class rdf:about="http://example.org/a844e6bf-c4b7-4397-b476-460ff8d38b57">
        <obo:IAO_0000115>Brain-derived neurotrophic factor (BDNF) and neurotrophin 3 (NT-3) are known to regulate neuronal morphology and the formation of neural circuits, yet the neuronal targets of each neurotrophin are still to be defined. To address how these neurotrophins regulate the morphological and synaptic differentiation of developing olfactory bulb (OB) GABAergic interneurons, we analyzed the effect of BDNF and NT-3 on GABA+-neurons and on different subtypes of these neurons: tyrosine hydroxylase (TH+); calretinin (##Calr+##); calbindin (Calb+); and parvalbumin (PVA+). These cells were generated from cultured embryonic mouse olfactory bulb neural stem cells (eOBNSCs) and after 14 days in vitro (DIV), when the neurons expressed TrkB and/or TrkC receptors, BDNF and NT-3 did not significantly change the number of neurons. However, long-term BDNF treatment did produce a longer total dendrite length and/or more dendritic branches in all the interneuron populations studied, except for PVA+-neurons. Similarly, BDNF caused an increase in the cell body perimeter in all the interneuron populations analyzed, except for PVA+-neurons. GABA+- and TH+-neurons were also studied at 21 DIV, when BDNF produced significantly longer neurites with no clear change in their number. Notably, these neurons developed synaptophysin+ boutons at 21 DIV, the size of which augmented significantly following exposure to either BDNF or NT-3. Our results show that in conditions that maintain neuronal survival, BDNF but not NT-3 promotes the morphological differentiation of developing OB interneurons in a cell-type-specific manner. In addition, our findings suggest that BDNF and NT-3 may promote synapse maturation by enhancing the size of synaptic boutons.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMID:33392918</oboInOwl:hasDbXref>
        <rdfs:label>Calr+</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000759"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/a844e6bf-c4b7-4397-b476-460ff8d38b57"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000759"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/a84dbc66-58f5-42ee-a040-b64928d66ad7 -->

    <Class rdf:about="http://example.org/a84dbc66-58f5-42ee-a040-b64928d66ad7">
        <obo:IAO_0000115>CD301b+ macrophages have been recently identified as a group of macrophages focused on regulating the immune response and regeneration functions. Sommerfeld et al. demonstrated for the first time that macrophages could be divided by the surface marker CD301b, and CD301b+ macrophages were specific to the regenerative microenvironment, rather than CD206+ macrophages (M2-macrophage) or CD86+ macrophages (M1-macrophage). In another recent research, transplantation with ##CD301b+/CD206+ macrophages## achieved better skin regeneration compared with CD301b-/CD206+ macrophages. Notably, CD301b+ macrophage was not a subpopulation of M2 macrophages, as CD301b+ macrophages possessed both M1 functional factors such as IL1 and M2 functional cytokine genes such as Arg1, which implied a more comprehensive role in conducting tissue regeneration. Our recent study found that there existed strong correlations between the dynamic changes in CD301b+ macrophages and CD206+ macrophages during periodontitis progression, however, the expression pattern and localization of CD301b+ macrophages were largely different from those of CD206+ macrophages in periodontal tissue. Considering the specificity of CD301b+ macrophage phenotype, it is reasonable to explore the strategy to specifically induce CD301b+ macrophages.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10902347</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38418808</oboInOwl:hasDbXref>
        <rdfs:label>CD301b+/CD206+ macrophages</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000890"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/a84dbc66-58f5-42ee-a040-b64928d66ad7"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000890"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/a8780ba6-4f44-483b-a92c-b8e6806d5f0e -->

    <Class rdf:about="http://example.org/a8780ba6-4f44-483b-a92c-b8e6806d5f0e">
        <obo:IAO_0000115>The trajectory to ##bone marrow adipocytes## is now becoming clearer. The remaining task is to clarify if there are discrete precursor cell populations that contribute to two types of BMATs. It is possible that bone marrow adipocytes of &quot;regulated&quot; rBMAT are also contributed to by an alternative bone-specific pathway originating from preosteoblasts, although this pathway has been demonstrated so far only in extreme adipocyte scarcity in lipodystrophic fat-free mice. Clarifying further cellular origins of bone marrow adipocytes of cBMAT and rBMAT will give us the opportunity to clarify the formation and the disappearance of marrow adipocytes in normal development, pathological conditions and therapeutic responses. These future endeavors will lead to a more detailed understanding of the function of bone marrow adipocytes that have incredibly diverse functions through local and systemic regulations.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9075612</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35528017</oboInOwl:hasDbXref>
        <rdfs:label>bone marrow adipocytes</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000136"/>
        <skos:relatedMatch rdf:resource="CL:0002092"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/a8780ba6-4f44-483b-a92c-b8e6806d5f0e"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000136"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/a8780ba6-4f44-483b-a92c-b8e6806d5f0e"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002092"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/a8b7012c-9f4f-4064-90c8-65f3d84abb06 -->

    <Class rdf:about="http://example.org/a8b7012c-9f4f-4064-90c8-65f3d84abb06">
        <obo:IAO_0000115>BACKGROUND Rotator cuff injury is the most common cause of shoulder disability, and although the repair technique has improved, the rate of rotator cuff reduction after repair is still high. The fibrocartilage region, which appears to be histologically inserted, cannot be regenerated. In recent years, studies have reported that mesenchymal stem cells (MSCs) have enhanced cartilage regeneration in the tendon and bone interface after rotator cuff repair, which has become a hot topic of research. MATERIAL AND METHODS Two mesenchymal stem cell types, SMSC (synovial-derived mesenchymal stem cells) and BMSC (bone marrow-derived mesenchymal stem cells) were intervened using kartogenin (KGN). The cytotoxicity was evaluated and the proliferation of the 2 cells was observed. Four commonly used cartilage phenotype genes were detected by quantitative real-time polymerase chain reaction, and the cartilage differentiation of MSCs induced by KGN was explored. The bidirectional regulation of the expression of BMP-7 and the downstream gene Smad5 was observed by constructing a lentiviral overexpression vector containing the target gene BMP-7. To explore whether BMP-7/Smad5 pathway activation promotes differentiation of ##SMSCs## into chondrocytes. RESULTS KGN can induce the selective differentiation of endogenous MSCs into chondrocytes by activating the BMP-7/Smad5 pathway, which promotes the regeneration of interfacial cartilage, and improves the quality of tendon healing of the tendon after rotator cuff repair. CONCLUSIONS This study found a new biological intervention method to promote the effect of tendon on bone healing after rotator cuff repair.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6625576</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31271564</oboInOwl:hasDbXref>
        <rdfs:label>SMSCs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000134"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/a8b7012c-9f4f-4064-90c8-65f3d84abb06"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000134"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/a90db276-f2c1-4840-b104-1d157fd4c475 -->

    <Class rdf:about="http://example.org/a90db276-f2c1-4840-b104-1d157fd4c475">
        <obo:IAO_0000115>Lens epithelial cells (LECs) were divided into seven subclusters, classified by specific gene markers. The expression of crystallin, cell-cycle, and metabolic genes was not uniform, indicating distinct functional roles of LECs. Trajectory analysis predicted a bifurcation of differentiating and cycling cells from an ##Igfbp5+ progenitor## pool. We also identified heterogeneity in signaling molecules and pathways, suggesting that cycling and progenitor subclusters have prominent roles in coordinating crosstalk.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10599162</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37870847</oboInOwl:hasDbXref>
        <rdfs:label>Igfbp5+ progenitor</rdfs:label>
    </Class>
    


    <!-- http://example.org/a94170a9-eb49-4823-91c8-1b1a29b0f0ce -->

    <Class rdf:about="http://example.org/a94170a9-eb49-4823-91c8-1b1a29b0f0ce">
        <obo:IAO_0000115>The dermal sheath: An emerging component of the ##hair follicle stem cell## niche.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8016715</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33006790</oboInOwl:hasDbXref>
        <rdfs:label>hair follicle stem cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000356"/>
        <skos:relatedMatch rdf:resource="CL:0002337"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/a94170a9-eb49-4823-91c8-1b1a29b0f0ce"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000356"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/a94170a9-eb49-4823-91c8-1b1a29b0f0ce"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002337"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/a95bf624-c7b1-4fc0-ab7e-2af6aed4d332 -->

    <Class rdf:about="http://example.org/a95bf624-c7b1-4fc0-ab7e-2af6aed4d332">
        <obo:IAO_0000115>The cellular content of human myocardium (in descending order by number) predominantly consists of cardiomyocytes, fibroblasts, pericytes and smooth muscle cells, endothelial cells, and immune cells. In the murine heart, macrophage populations can be discerned based on their expression of C-C chemokine receptor type 2 (CCR2), major histocompatibility complex-II (MHC-II), T cell immunoglobulin and mucin domain containing 4 (TIMD4), and Lymphatic Vessel Endothelial Hyaluronan Receptor 1 (LYVE1). Four populations of macrophages have been identified in the murine heart (Fig. 1). The minority are two subsets of CCR2+MHC-IIhigh macrophage populations derived from hematopoietic stem cells, whereas the most dominant subset, cardiac resident macrophages derived from the yolk sac, are CCR2-MHC-IIlowTIMD4+LYVE1-. There also exists a fourth subset that consists of CCR2-MHC-IIhighTIMD4+LYVE1+ macrophages, which are likely derived from CCR2-MHC-IIlow macrophages during postnatal development and partially maintained by CCR2+MHC-IIhigh macrophages. CCR2+MHC-IIhigh macrophages populate the heart soon after birth and are maintained through monocyte recruitment and proliferation. Also, under homeostasis, ##cardiac macrophages## continually self-renew with a turnover period of almost 5 weeks. Recently, this same CCR2+ and CCR2- macrophage distinction has been identified in humans, with the yolk sac-derived CCR2- human counterpart showing CD14+CD45+CD64+CCR2-HLA-DRhigh expression. In a more recent study, Tucker et al. reported two cardiac macrophage subsets within the human heart, which were positive for CD163, COLEC12, mannose receptor MRC1, E3 ubiquitin ligase MARCH1, and natural resistance-associated macrophage protein 1 (NRAMP1). Both of the identified subsets expressed anti-inflammatory (M2) polarization-associated genes, whereas one subset particularly expressed RBPJ, F13A1 and the other expressed transmembrane collagen COL23A1.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9242717</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34088222</oboInOwl:hasDbXref>
        <rdfs:label>cardiac macrophages</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/a95bf624-c7b1-4fc0-ab7e-2af6aed4d332"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/a95c02d1-ca34-4c96-af85-5e83f800cbef -->

    <Class rdf:about="http://example.org/a95c02d1-ca34-4c96-af85-5e83f800cbef">
        <obo:IAO_0000115>Distinct therapy-induced cancer cell transcriptomes were associated with clinical response. Cancer cells from MPR patients exhibited a signature of activated antigen presentation via major histocompatibility complex class II (MHC-II). Further, the transcriptional signatures of FCRL4+FCRL5+ memory B cells and CD16+CX3CR1+ monocytes were enriched in MPR patients and are predictors of immunotherapy response. Cancer cells from NMPR patients exhibited overexpression of estrogen metabolism enzymes and elevated serum estradiol. In all patients, therapy promoted expansion and activation of cytotoxic T cells and CD16+ NK cells, reduction of immunosuppressive Tregs, and activation of memory CD8+T cells into an effector phenotype. Tissue-resident macrophages were expanded after therapy, and tumor-associated macrophages (##TAMs##) were remodeled into a neutral instead of an anti-tumor phenotype. We revealed the heterogeneity of neutrophils during immunotherapy and identified an aged CCL3+ neutrophil subset was decreased in MPR patients. The aged CCL3+ neutrophils were predicted to interact with SPP1+ TAMs through a positive feedback loop to contribute to a poor therapy response.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9985263</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36869384</oboInOwl:hasDbXref>
        <rdfs:label>TAMs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/a95c02d1-ca34-4c96-af85-5e83f800cbef"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/a9a2a4f8-21a9-4d84-8377-8726cda1fe0d -->

    <Class rdf:about="http://example.org/a9a2a4f8-21a9-4d84-8377-8726cda1fe0d">
        <obo:IAO_0000115>The composition of cell subsets across all cell lineages differed between the YA and AA groups. Among TCs, CD4+ TCs were increased, CD8+ TCs were decreased, and CD4+CD8+ and proliferating T cells were increased in the AA group (Fig. 2B and 2C). Moreover, naive TCs, especially CD4 Naive and CD8 Naive, showed a common distribution in the YA group but were reduced in the aged group (P = 0.0175, Fig. 2D-G). Conversely, effector, memory and exhausted cell subsets were dominant in the aged group (Fig. 2H-K). The AA group also had a diminished proportion of the CD56bright NK1 population and an expansion of the NK2 and late NK3 populations (Fig. S5C and S5D). Analysis of BC clusters revealed that Naive BCs were decreased while ##ABCs## were mildly increased in the AA group compared to the YA group (Fig. S5E and S5F).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7417788</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32780218</oboInOwl:hasDbXref>
        <rdfs:label>ABCs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000236"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/a9a2a4f8-21a9-4d84-8377-8726cda1fe0d"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000236"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/a9b65430-6564-40c2-ac41-b94d962e1526 -->

    <Class rdf:about="http://example.org/a9b65430-6564-40c2-ac41-b94d962e1526">
        <obo:IAO_0000115>The following are available online at , Figure S1: Time course of the specific uptake of 5-HT into human primary trophoblasts and feto-placental endothelial cells, Figure S2: Uptake of 5-HT into feto-placental endothelial cells, measured over the high-affinity range of 5-HT concentrations, Figure S3: RT-qPCR analysis of SERT, PMAT, OCT1, -2, and -3 mRNAs in pooled samples of human primary trophoblasts and feto-placental endothelial cells, Table S1: Kinetic parameters of 5-HT uptake in human primary trophoblasts, feto-placental endothelial cells, and cord blood platelets, Table S2: Quantification cycle values obtained in RT-qPCR analysis of individual trophoblast and ##feto-placental endothelial cell## samples, Table S3: Characteristics of participants who donated tissue for trophoblast, feto-placental endothelial cell, and cord blood platelet isolation for the study, Table S4: The primer sequences used in qualitative end-point and quantitative real-time PCR analyses.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8346107</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34360573</oboInOwl:hasDbXref>
        <rdfs:label>feto-placental endothelial cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0009092"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/a9b65430-6564-40c2-ac41-b94d962e1526"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0009092"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/a9c9d86e-73a5-4754-9f7b-59c040323d65 -->

    <Class rdf:about="http://example.org/a9c9d86e-73a5-4754-9f7b-59c040323d65">
        <obo:IAO_0000115>Myofibroblasts are central mediators of the dysregulated wound-healing programme that defines fibrosis, therefore we studied this population in detail. Graph based clustering of the single cell RNA-seq data defined four major subsets (Fig. 3a) that included a cycling population (##Cycling MFB##) (Fig. 3a, b). After this, we sought to confirm that proliferating stromal cells (Ki67+) were myofibroblasts (Fig. 3c-e, Supplementary Fig. 4a-d). Using flow cytometry, we stained freshly disaggregated nodular cells and gated on myofibroblasts (CD45-CD31-CD146-ITGbeta1high) and fibroblasts (CD45-CD31-CD146-ITGbeta1low) and demonstrated Ki67high cells were a subset of myofibroblasts. In the single cell RNA-seq, a second subset was characterised by lower expression of ACTA2 and intermediate expression of fibroblast marker genes (CXCL14, PLA2G2A and C1R), we termed the ACTA2low myofibroblast (Fig. 3a, b, Supplementary Fig. 5a). A third comprised a discrete CD82highOX40L+ population (CD82, OX40L, MMP11, MMP14 and CD82) (Fig. 3a, g, Supplementary Fig. 5b-e). Finally, a fourth less distinct community we termed the intermediate myofibroblast (Fig. 3a, b, Supplementary Fig. 15a). GO analysis demonstrated that CD82highOX40L+ myofibroblast marker genes showed the strongest enrichment for cell contraction pathways (Fig. 3f). In contrast, differential gene expression and pathway analysis revealed ACTA2low myofibroblasts resembled a general fibroblast phenotype, without clear characteristics of any one subtype. In addition to ACTA2, significant ACTA2low myofibroblasts markers were general fibroblasts markers including PLA2G2A and CXCL14. ACTA2low myofibroblasts also shared pathways enriched in fibroblasts such as &apos;interleukin signalling&apos; and &apos;chemotaxis&apos; (Fig. 3f).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7265502</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32488016</oboInOwl:hasDbXref>
        <rdfs:label>Cycling MFB</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000186"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/a9c9d86e-73a5-4754-9f7b-59c040323d65"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000186"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/a9d53380-60bb-40bf-8ec9-2f4da4767198 -->

    <Class rdf:about="http://example.org/a9d53380-60bb-40bf-8ec9-2f4da4767198">
        <obo:IAO_0000115>##Layer 5/6 cortico-cortical projection neurons##</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9059394</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35501678</oboInOwl:hasDbXref>
        <rdfs:label>Layer 5/6 cortico-cortical projection neurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:4023009"/>
        <skos:relatedMatch rdf:resource="CL:4023041"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/a9d53380-60bb-40bf-8ec9-2f4da4767198"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4023009"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/a9d53380-60bb-40bf-8ec9-2f4da4767198"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4023041"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/a9e04d47-4ab8-4c3a-b596-be2cc1fe8465 -->

    <Class rdf:about="http://example.org/a9e04d47-4ab8-4c3a-b596-be2cc1fe8465">
        <obo:IAO_0000115>##Premalignant Oligodendrocyte Precursor Cells## Stall in a Heterogeneous State of Replication Stress Prior to Gliomagenesis.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8137536</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33531372</oboInOwl:hasDbXref>
        <rdfs:label>Premalignant Oligodendrocyte Precursor Cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0001064"/>
        <skos:relatedMatch rdf:resource="CL:0002453"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/a9e04d47-4ab8-4c3a-b596-be2cc1fe8465"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0001064"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/a9e04d47-4ab8-4c3a-b596-be2cc1fe8465"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002453"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/aa041ca7-479a-449a-80c5-12ba0bd41e78 -->

    <Class rdf:about="http://example.org/aa041ca7-479a-449a-80c5-12ba0bd41e78">
        <obo:IAO_0000115>Interestingly, the majority of non-VIPin cells identified in the same experiments (n = 568/667) also displayed daily variations in firing, although in this case we found cells exhibiting peak firing at all phases across the circadian cycle (Fig. 3b, d, e). Thus, across this population, phase clustering was significantly weaker than that observed for ##VIPin cells## (Fig. 3b), with many non-VIP cells exhibiting peak firing during the mid to late day (Fig. 3d). As expected from the lack of phase clustering in the aggregated cell population, within-slice phase estimates for non-VIPin cells were similarly distributed throughout the circadian cycle (Rayleigh R = 0.1; n = 44 slices). There were also differences in the circadian properties of the non-VIPin cells; specifically, peak widths were narrower and peak to trough amplitudes and mean firing rates lower than observed for VIPin cells (Fig. 3g, h).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7081308</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32193397</oboInOwl:hasDbXref>
        <rdfs:label>VIPin cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000540"/>
        <skos:relatedMatch rdf:resource="CL:0002269"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/aa041ca7-479a-449a-80c5-12ba0bd41e78"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000540"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/aa041ca7-479a-449a-80c5-12ba0bd41e78"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002269"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/aa2cf203-3432-492a-b095-d0c2e5b2adaf -->

    <Class rdf:about="http://example.org/aa2cf203-3432-492a-b095-d0c2e5b2adaf">
        <obo:IAO_0000115>a Line drawing of a cross section of the floor of the cochlear duct at P1. Distinct cell types within the organ of Corti (OC) are color coded. b Heat map for ~14,000 cochlear cells collected from four separate experiments at P1. Top 25 differentially expressed (DE) genes for the 15 identified clusters are shown. Cellular identity for each cluster is indicated by a color bar at the top of the heat map, which corresponds to the legend in a, and by a cell name at the bottom. c tSNE plot for the same cells as in b. Cluster identities are indicated. d Violin plots showing normalized log-transformed expression values for the top five DE genes for each cell type (color coded as in c) by comparison with all other P1 cells (gray on the right in each graph). Bars indicate median expression level. e Upper left panel, tSNE plot of cells determined to be derived from KO (between the OC and medial edge of the cochlear duct). Lower left panel, feature plot for the same cells as in the upper panel indicating high expression of Otoa, Calb1, and Fabp7 (based on color) in different clusters of cells. Lower right panel, cross sections through the cochlear duct at P1, illustrating expression of CALB1 in the medial region of KO and FABP7 directly adjacent to the OC (arrow; scale bars, 20 mum). Lowest panel shows high-magnification view of expression of FABP7 (arrow, gray scale) at the lateral KO border (green line; scale bar, 10 mum). Upper right panel, summary diagram of the spatial distribution of KO cell clusters at P1. HC hair cells, IPhC inner phalangeal cells/border cells, IPC inner pillar cells, OPC outer pillar cells, DC1/2 Deiters&apos; cells rows 1 and 2, DC3, Deiters&apos; cells row 3, HeC Hensen&apos;s cells, CC/##OSC## Claudius cells/outer sulcus cells, IdC interdental cells, ISC inner sulcus cells, KO Kolliker&apos;s organ cells, L.KO lateral Kolliker&apos;s organ cells, M.KO medial Kolliker&apos;s organ cells, OC90 OC90+ cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7221106</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32404924</oboInOwl:hasDbXref>
        <rdfs:label>OSC</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000601"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/aa2cf203-3432-492a-b095-d0c2e5b2adaf"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000601"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/aaaaef23-434f-4897-a3dd-69fe6bb07918 -->

    <Class rdf:about="http://example.org/aaaaef23-434f-4897-a3dd-69fe6bb07918">
        <obo:IAO_0000115>Sensory neurons can be classified into nociceptors, mechanoceptors, and proprioceptors. The first group expresses the nerve growth factor (NGF)-receptor TRKA (encoded by NTRK1) during maturation, while the others depend on TRKB and TRKC tyrosine kinase signaling. While all peripheral neurons are derived from neural crest progenitors, the TRKA-expressing neurons develop from the subgroup of ##NGN1-positive neural crest cells##. They can be further divided into nociceptor subgroups: Peptidergic neurons release the neuropeptides substance P and calcitonin gene-related peptide and maintain TRKA expression. Non-peptidergic neurons lose expression of TRKA upon maturation, and express the RET neurotrophin receptor instead. Nociceptors can also be distinguished according to their expression of different cation channels like the transient receptor potential (TRP) channels or the purinergic receptor ion channels. Notable members of the TRP family are TRPV1, TRPM8, and TRPA1 channels. The respective major functions are the sensing of heat, cold, or electrophilic chemicals. Temperature-sensing TRP channels are polymodal and can respond to chemical agonists. A prominent example is the TRPV1 channel, which is activated by increased temperatures exceeding the threshold of ~43  C, but also by vanilloid compounds like capsaicin. The purinoceptor P2X3 is the main ATP-activated pain-related channel on nociceptors. As TRPV1 and P2X3 are only found on nociceptors and not on other sensory neurons (eg, stretch receptors), they can serve as characteristic functional biomarkers.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9299516</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35689659</oboInOwl:hasDbXref>
        <rdfs:label>NGN1-positive neural crest cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0011012"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/aaaaef23-434f-4897-a3dd-69fe6bb07918"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0011012"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/aacdca8e-2765-4804-8c5e-770a507f1ba5 -->

    <Class rdf:about="http://example.org/aacdca8e-2765-4804-8c5e-770a507f1ba5">
        <obo:IAO_0000115>Supporting cells are essential for the function and survival of inner ear hair cells. During development, hair cells and supporting cells derive from a common progenitor, and the correct proportion of these two cell types is regulated by several signaling pathways, most prominently Notch signaling (reviewed by). Interventions that promote conversion of supporting cells into hair cells without replacing the original supporting cells are unlikely to lead to the restoration of a functional organ of Corti. Non-mammalian vertebrates accomplish this by triggering transient proliferation of at least some supporting cells during the regenerative process, and such transient proliferation may be important to promote functional hair cell regeneration in mammals. However, the generation of reprogrammed hair cells can generate new supporting cells in the surrounding tissue through non-cell-autonomous mechanisms, again including Notch signaling. In the present study, we have shown that the production of large numbers of reprogrammed hair cell-like cells in the GER causes the induction of ##GLAST + supporting cells## that interleave the new hair cells. Of note, the new hair cells produced in the GER resemble inner ear hair cells, and our scRNA-seq and antibody characterization shows that the identity of ectopic supporting cells resembles border cells and inner phalangeal cells, two supporting cell types that normally surround inner hair cells. Reprogramming in the GER is, therefore, able to generate appropriately patterned and location-specific mosaics of hair cells and supporting cells similar to those that occur in vivo.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9708077</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36445327</oboInOwl:hasDbXref>
        <rdfs:label>GLAST + supporting cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002315"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/aacdca8e-2765-4804-8c5e-770a507f1ba5"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002315"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/ab016a1d-9b3c-471b-8eb5-be825144972e -->

    <Class rdf:about="http://example.org/ab016a1d-9b3c-471b-8eb5-be825144972e">
        <obo:IAO_0000115>Comparison of the single cell landscape between healthy human meniscus and degenerated meniscus. (A) Representative polarised light microscopy images of healthy human and degenerated meniscus. The white and red colours in the angle images are 90  apart in orientation. Dashed lines indicate the surface of the meniscus. Scale bar, 100 microm. (B) Merged t-distributed stochastic neighbour embedding (t-SNE) of single-cell RNA sequencing of healthy meniscus cells and degenerated meniscus cells. (C) Twelve healthy human and degenerated meniscus cell clusters at t-SNE. (D) Proportion of each cluster to the total cells. (E) Proportion of healthy and degenerated meniscus cells in each cluster. (F) Expression of representative marker genes in Vin plot. (G) Heatmap revealing the scaled expression of differentially expressed genes for each cluster. (H) CD146 and CD318 expression in healthy human meniscus cells and degenerated meniscus cells determined by flow cytometry. n&gt;=5, **p&lt;0.01. (I) Representative IHC staining of COL1A1 and COL2A1 healthy human meniscus and degenerated meniscus, and quantification of positive cells. Scale bar, 50 microm. n&gt;=5, **p&lt;0.01. (J) The expression of indicated marker genes in human healthy meniscus cells and degenerated meniscus cells were detected by qRT-PCR. *p&lt;0.05, **p&lt;0.01, otherwise, not significant. n=3, *p&lt;0.05, **p&lt;0.01. CPC, cartilage progenitor cells; DegP, degenerated meniscus progenitor cells; EC, endothelial cells; FC, fibrochondrocytes; FCP, fibrochondrocyte progenitors; HTC, hypertrophic chondrocytes; MoDC, monocyte-derived dendritic cells; PreHTC, prehypertrophic chondrocytes; ##ProFC##, proliferate fibrochondrocytes; RegC, regulatory chondrocytes.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7034356</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31871141</oboInOwl:hasDbXref>
        <rdfs:label>ProFC</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000138"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/ab016a1d-9b3c-471b-8eb5-be825144972e"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000138"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/ab40e634-2a6e-40b9-b163-abdb77ac488f -->

    <Class rdf:about="http://example.org/ab40e634-2a6e-40b9-b163-abdb77ac488f">
        <obo:IAO_0000115>A, B, tSNE plot of 4659 CD45+ immune cells from the CNS. Data from this study is integrated with data from; Table 6). C, D, Each dataset represented by one tSNE. Cells are annotated using color representing their cell type. bMicroglia: baseline microglia; aMicroglia: activated microglia; pmMicroglia: proliferation-mediating microglia; maMicroglia: monocyte-activating microglia; DAM: disease-associated microglia in SCI; elMicroglia: embryonic-like microglia; pvMacrophages: perivascular macrophages; mdMacrophages: monocyte-derived macrophages; DCs: dendritic cells; imB-cells: immature B-cells; mB-cells: mature B-cells; pimMicroglia: postnatal immature microglia; IEG+Microglia: immediate early genes microglia; sMicroglia: s-phase microglia; pPAM: postnatal proliferative-region-associated microglia; eMicroglia: ##embryonic microglia##; pcpMacrophages: postnatal choroid plexus macrophages; acpMacrophages: adult choroid plexus macrophages; iMonocytes: inflammatory monocytes; pMonocytes: patrolling monocytes; cpEpithelial cells: choroid plexus epithelial cells. E, tSNE plots of 4659 CD45+ immune cells for selected genes indicating the log2(cpm) expression with a continuous color for each cell separately. F, Proliferation rate of CD45low and CD45high cells at 7 and 21 d post-SCI. Hoechst 33342 expression presented on a log-scale was used for defining cells in S-phase. Right most plot reports the percentage of cells in S-phase. Each dot represents one biological replicate (four mice per time point). Mean is surrounded by a 95% CI. This figure is extended in Extended Data Figure 8-1.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8496189</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34417326</oboInOwl:hasDbXref>
        <rdfs:label>embryonic microglia</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000129"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/ab40e634-2a6e-40b9-b163-abdb77ac488f"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000129"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/ab4e50de-0f56-4704-ad8f-315c6287882d -->

    <Class rdf:about="http://example.org/ab4e50de-0f56-4704-ad8f-315c6287882d">
        <obo:IAO_0000115>Next, we analyzed the interactions between these ligand-receptor pairs from the TME among 12 kinds of immune cells, and found that CCL5-CCR1 mainly sends signals of CD8+ T cells and NK Cells, which may interact with pDCs, macrophages, ##cDC2s##, and myeloid cells via the interaction of CCL5 and CCR1. The SELPLG-SELL ligand-receptor pair is the main interaction among CD4+ T cells, NK cells, myeloid cells, and naive B cells. Furthermore, NOTCH2-cDCs interact with pDCs, CD4+ T cells, cCD2s, NK cells, myeloid cells, naive B cells, and cDC1s. Both migDCs and cDC1s interact with CD4+ T cells, pDCs, cCD2s, NK Cells, myeloid cells, and naive B cells. The CXCL10-CXCR3 ligand-receptor pair is the main interaction among pDCs, migDCs, and CD4+ T cells, and the CXCL9-CXCR3 ligand-receptor pair is the main interaction among pDCs, cDC1s, migDCs, and CD4+ T cells (Fig. 8C). We also used a violin plot to visualize the signal gene expression distribution in the three signaling pathways inferred by CellChat. The results showed that CCL5 is mainly expressed on CD8+ T and NK cells, and its corresponding receptors are mainly in macrophages, myeloid cells, cCD2s, and pDCs. SELPLG is mainly expressed on CD4+ T cells, NOTCH2-cDCs, migDCs, and cDC1s, and its corresponding receptor, SELL, is mainly expressed on naive B cells, myeloid cells, NK cells, cCD2s, pDCs, CD4+ T cells, and cCD1s. CXCL9 is mainly expressed on pDCs, migDCs, and cDC1s, CXCL10 is mainly expressed on pDCs and migDCs, and their corresponding receptor, CXCR3, is mainly expressed on CD4+ T cells (Fig. 8D).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9203818</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35710862</oboInOwl:hasDbXref>
        <rdfs:label>cDC2s</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000990"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/ab4e50de-0f56-4704-ad8f-315c6287882d"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000990"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/ab7ccae1-d5a5-46f1-8324-e3d10c4533a5 -->

    <Class rdf:about="http://example.org/ab7ccae1-d5a5-46f1-8324-e3d10c4533a5">
        <obo:IAO_0000115>To investigate the universal transcriptional program between group 1 ILCs across liver and spleen, we have explored DEGs in Prdm1 cko ##liver cNK cells## and ILC1s using our scRNA-seq data. Compared with liver ILC1s, more DEGs was observed in liver cNK cells, including Junb, Kit, Tcf7, Gzmb, Prf1, etc. (Figure 5:figure supplement 2, A and B). Through the integration of the bulk RNA-seq and scRNA-seq data, we identified 17 DEGs that are regulated by Prdm1 among liver cNK cells, splenic cNK cells, and liver ILC1s. Batf3, Junb, Tcf7, and Nfkb1 was upregulated, whereas Gzmb, Prf1, and Fgl2 downregulated, in both Prdm1 cko liver and splenic cNK cells (Figure 5J). Cxcr6 was downregulated in liver ILC1s and splenic cNK cells in Prdm1 cko mice (Figure 5J). Previous research found that spleen NK cells could be divided into three distinct groups based on their expression levels of CD27, CD62L, CD49a, and CD49b. CD27+CD62L- NK cells have remarkable high expression of Batf3, while it was only barely expressed in CD27+CD62L+ and CD27-CD62L+ NK cells. Based on the sequencing data published by Flommersfeld et al. (GSE180978), a notable negative correlation was observed between the expression levels of Prdm1 and Batf3 (Figure 5:figure supplement 2I). On top of that, our findings unveiled the negative regulatory influence of Prdm1 on Batf3 within both spleen and liver NK cells. This discovery highlights a potential upstream mechanism that may influence the hemostasis of the spleen NK cell subpopulations through Batf3.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11318973</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:39133873</oboInOwl:hasDbXref>
        <rdfs:label>liver cNK cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000623"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/ab7ccae1-d5a5-46f1-8324-e3d10c4533a5"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000623"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/abc05661-3092-4b9c-9240-b8558cbf649b -->

    <Class rdf:about="http://example.org/abc05661-3092-4b9c-9240-b8558cbf649b">
        <obo:IAO_0000115>(A, C) Expression level of select marker genes for each identified cluster (A: VGlut2 cKO model; C: Ip3r2 KO model). Circle size denotes expression ratio (percent cells expressing the gene), color represents expression level (in log2 CPM). Bar chart on the left shows cell numbers identified for each cluster are similar for WT and KO groups for each cluster in each model. (B) UMAP clustering of different cell types identified in the NEUN-negative population of the combined samples from Ip3r2 WT and KO mice. 17 clusters were identified including the three main types of glia: astrocytes, oligodendrocytes, and microglia, as well as endothelial cells, and two subtypes of neurons (for A-C - M-astrocyte: mitotic astrocyte; M-OPC: mitotic oligodendrocyte precursor cell; OPC: oligodendrocyte precursor cell; MFOL: ##myelin-forming oligodendrocyte##; NFOL: newly formed oligodendrocyte; MOL: mature oligodendrocyte; VLMC: vascular and leptomeningeal cell; EC: endothelial cell; PC: pericyte; PVM: perivascular macrophage).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8497060</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34494546</oboInOwl:hasDbXref>
        <rdfs:label>myelin-forming oligodendrocyte</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000128"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/abc05661-3092-4b9c-9240-b8558cbf649b"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000128"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/abc553b9-dfa3-4f5f-99e0-bdaaa4317f72 -->

    <Class rdf:about="http://example.org/abc553b9-dfa3-4f5f-99e0-bdaaa4317f72">
        <obo:IAO_0000115>Pseudobulk differential gene expression analysis showed significant upregulation of genes in all the B cell subclusters in INS, except for atBCs and ASCs (Fig. 2e and Supplementary Fig. 5a). Pathway analysis revealed an enrichment of functions associated with actin cytoskeletal dynamics in all B cell subclusters in INS, while some subclusters (Naive-1, actMBCs, MBC-2, and MZ-like B cells) also showed an enrichment of B cell activation pathways (Supplementary Fig. 5b). The antigen-inexperienced and recently activated B cell subsets (##Naive##-1 and actMBC) showed the greatest differences in gene expression suggesting that the transcriptional events leading to B cell dysregulation occur early during B cell activation (Fig. 2e and Supplementary Fig. 5a). There was a substantial overlap in the upregulated genes between Naive-1 B cells, actMBCs, MBC-2, and MZ-like B cells including many atBC-associated genes (e.g., ITGB2, ITGB7, FCRLA, FCRL2), POU2F2, POU2AF1, and the extrafollicular response genes TNFRSF13B and GPR183, suggesting a possible developmental sequence or cooperation between these B cell subclusters in generating an extrafollicular B cell response in INS (Fig. 2e).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10667257</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37996443</oboInOwl:hasDbXref>
        <rdfs:label>Naive</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000788"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/abc553b9-dfa3-4f5f-99e0-bdaaa4317f72"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000788"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/abd6dc83-1835-486a-99a3-3e5a96efb899 -->

    <Class rdf:about="http://example.org/abd6dc83-1835-486a-99a3-3e5a96efb899">
        <obo:IAO_0000115>These findings indicate that fibroblast associations with metaplastic epithelial cells can facilitate direct transition of metaplastic spasmolytic polypeptide-expressing ##metaplasia cell## lineages into dysplastic lineages.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10375042</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37196797</oboInOwl:hasDbXref>
        <rdfs:label>metaplasia cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000066"/>
        <skos:relatedMatch rdf:resource="CL:0001061"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/abd6dc83-1835-486a-99a3-3e5a96efb899"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000066"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/abd6dc83-1835-486a-99a3-3e5a96efb899"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0001061"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/abffcb80-1b70-4fda-9cb3-877cfc3e0c83 -->

    <Class rdf:about="http://example.org/abffcb80-1b70-4fda-9cb3-877cfc3e0c83">
        <obo:IAO_0000115>Focusing on the peripheral, differentiated cDC populations, we next assessed protein expression of the IRF8 transcription factor in tumor-derived cDC populations (Fig. 3a). In the periphery, IRF8 controls survival and function of terminally differentiated cDC1s. Furthermore, increased IRF8 expression in CD11b-CD103- DN cells was shown to promote their differentiation into mature CD103+ cDC1s. Thus, we hypothesized that CD40L-CAR T cell treatment skews the cDC1/##cDC2## ratio towards the cDC1 populations by stimulating the DN cells to expand, upregulate IRF8, and differentiate into cDC1s. We specifically noticed upregulation of IRF8 (readout of DN-to-cDC1 differentiation) and Ki-67 (readout for proliferation) in DN cells treated with CD40L-CAR T cell-treated mice (Fig. 3b). The increased expression of Ki-67 in the tumor-derived DN cells also correlated with the observed increase of the DN population in the tumor of CD40L-CAR T cell-treated mice (Fig. 1f), indicating that DN cells receive a proliferative signal upon CD40L-CAR T cell treatment. Intriguingly, splenic DN cells and DN cells from the tdLNs did not upregulate Ki-67 or IRF8 (Fig. 3c, d). Overall, tdLN cDCs did not present with a stimulated phenotype, as suggested by the lack of CD86 or Ki-67 upregulation (Supplementary Fig. 2D-G). This suggested a tumor-specific effect of cDC DN stimulation after m1928z-CD40L treatment.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7710757</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33268774</oboInOwl:hasDbXref>
        <rdfs:label>cDC2</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000990"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/abffcb80-1b70-4fda-9cb3-877cfc3e0c83"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000990"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/ac047f06-13cc-4496-bae7-c1c8e343c643 -->

    <Class rdf:about="http://example.org/ac047f06-13cc-4496-bae7-c1c8e343c643">
        <obo:IAO_0000115>Adeno-associated virus (AAV)-mediated Cre recombinase expression in ##melanopsin ganglion cells## without leaky expression in rod/cone photoreceptors.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10167896</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36470470</oboInOwl:hasDbXref>
        <rdfs:label>melanopsin ganglion cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000740"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/ac047f06-13cc-4496-bae7-c1c8e343c643"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000740"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/ac2fd050-ce5c-4aaa-ac4c-28f1b9be6795 -->

    <Class rdf:about="http://example.org/ac2fd050-ce5c-4aaa-ac4c-28f1b9be6795">
        <obo:IAO_0000115>In addition, myeloid cells, in particular monocytes and DC subsets, upregulated expression of genes involved in TLR signaling pathway (e.g., MyD88, Cxcl9, and CD40), consistent with the fact that 3M-052 stimulates TLR signaling. Other innate immune processes including complement (e.g., C3, Cfb) and inflammasome (e.g., Casp3, Il18, Il1rn) genes were also found to be significantly upregulated mainly in monocytes and tDCs, and to a lesser extent in XCR1- and XCR1+ DCs (Fig. 2d). In comparison, lymphoid cells such as innate lymphoid cells (ILCs), gammadeltaT cells, and CD8+ lymphocytes, exhibited higher expression of genes that are involved in cytokine responses (e.g., Jak2, Nfkbia) when compared to myeloid cell subsets (Fig. 2d). This may indicate indirect activation through cytokines being produced by monocytes and DCs. Furthermore, we observed a downregulation of antigen processing and presentation gene modules defined by genes such as H2-Eb1, H2-Aa, and Cd74 in monocytes, but an upregulation of these genes in XCR1- DCs, migratory DCs, ILC2, and ILC3 (Fig. 2d). This is consistent with previous reports of MHCII gene expression in ILC2 and ILC3 as well as the involvement of these innate lymphoid subsets in antigen presentation. The decrease in MHCII presentation genes also supports the notion that more inflammatory monocytes, which have a relatively low expression of MHCII genes compared to ##resting monocytes##, were recruited to the lymph nodes on day 1 after stimulation.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8795432</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35087093</oboInOwl:hasDbXref>
        <rdfs:label>resting monocytes</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000576"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/ac2fd050-ce5c-4aaa-ac4c-28f1b9be6795"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000576"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/ac87edff-f4a1-4c31-9b89-19cf4dc96ccb -->

    <Class rdf:about="http://example.org/ac87edff-f4a1-4c31-9b89-19cf4dc96ccb">
        <obo:IAO_0000115>PD: Parkinson&apos;s Disease; AD: Alzheimer&apos;s Disease. SCI: Spinal Cord injury; hESC: human Embryonic Stem Cells; NSC: Neural Stem Cells; NPC: Neuronal Progenitor Cells; hiPSC: human Pluripotent Stem Cells; DANs: Dopaminergic neurons; ##lt-NES##: long-term self-renewing Neuro-Epithelial-like Stem; ML/NEP2: Macrophage-Like/Neprilysin-2; BFCN: Basic Forebrain Cholinergic Neurons; OPC: Oligodendrocyte Progenitor Cells; MGE: Medial Ganglionic Eminence; SNI: Spared Nerve Injury.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7699962</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33233861</oboInOwl:hasDbXref>
        <rdfs:label>lt-NES</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002259"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/ac87edff-f4a1-4c31-9b89-19cf4dc96ccb"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002259"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/acb56a0e-3114-469a-82e0-d51d5ef41ece -->

    <Class rdf:about="http://example.org/acb56a0e-3114-469a-82e0-d51d5ef41ece">
        <obo:IAO_0000115>Ubiquitous overactivation of Hedgehog signaling in adult pituitaries results in increased expression of proopiomelanocortin (Pomc), growth hormone (Gh) and prolactin (Prl), elevated adrenocorticotropic hormone (Acth) production and proliferation of ##Sox2+ cells##. Moreover, ACTH, GH and PRL-expressing human pituitary adenomas strongly express the Hedgehog target GLI1. Accordingly, Hedgehog signaling seems to play an important role in pathology and probably also in homeostasis of the adult hypophysis. However, the specific Hedgehog-responsive pituitary cell type has not yet been identified. We here investigated the Hedgehog pathway activation status and the effects of deregulated Hedgehog signaling cell-specifically in endocrine and non-endocrine pituitary cells. We demonstrate that Hedgehog signaling is unimportant for the homeostasis of corticotrophs, whereas it is active in subpopulations of somatotrophs and folliculo-stellate cells in vivo. Reinforcement of Hedgehog signaling activity in folliculo-stellate cells stimulates growth hormone production/release from somatotrophs in a paracrine manner, which most likely is mediated by the neuropeptide vasoactive intestinal peptide. Overall, our data show that Hedgehog signaling affects the homeostasis of pituitary hormone production via folliculo-stellate cell-mediated regulation of growth hormone production/secretion.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7983331</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33480359</oboInOwl:hasDbXref>
        <rdfs:label>Sox2+ cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000048"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/acb56a0e-3114-469a-82e0-d51d5ef41ece"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000048"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/acb967dd-32dd-4597-9c80-43102b4f6d26 -->

    <Class rdf:about="http://example.org/acb967dd-32dd-4597-9c80-43102b4f6d26">
        <obo:IAO_0000115>(A) FACS gating strategy to purify cardiac Mphis from C57BL/6 mice. (B) From the myeloid cell population (CD45+CD11b+ cells), ##F4/80+Ly6Clow cells## (blue) were isolated at 0, 7, and 28 days post-MI, and F4/80+/Ly6Chigh cells (red) were purified at 3 days post-MI. Representative post-sort plots of Mphis are shown in the lower panel. Sorting was performed with a pool of 3-5 mice per time point.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7609061</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33063665</oboInOwl:hasDbXref>
        <rdfs:label>F4/80+Ly6Clow cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002479"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/acb967dd-32dd-4597-9c80-43102b4f6d26"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002479"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/acd88ea7-a3dd-46c8-b1d5-c44865108da5 -->

    <Class rdf:about="http://example.org/acd88ea7-a3dd-46c8-b1d5-c44865108da5">
        <obo:IAO_0000115>(A, C) Expression level of select marker genes for each identified cluster (A: VGlut2 cKO model; C: Ip3r2 KO model). Circle size denotes expression ratio (percent cells expressing the gene), color represents expression level (in log2 CPM). Bar chart on the left shows cell numbers identified for each cluster are similar for WT and KO groups for each cluster in each model. (B) UMAP clustering of different cell types identified in the NEUN-negative population of the combined samples from Ip3r2 WT and KO mice. 17 clusters were identified including the three main types of glia: astrocytes, oligodendrocytes, and microglia, as well as endothelial cells, and two subtypes of neurons (for A-C - M-astrocyte: mitotic astrocyte; M-OPC: mitotic oligodendrocyte precursor cell; OPC: oligodendrocyte precursor cell; MFOL: myelin-forming oligodendrocyte; ##NFOL##: newly formed oligodendrocyte; MOL: mature oligodendrocyte; VLMC: vascular and leptomeningeal cell; EC: endothelial cell; PC: pericyte; PVM: perivascular macrophage).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8497060</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34494546</oboInOwl:hasDbXref>
        <rdfs:label>NFOL</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000128"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/acd88ea7-a3dd-46c8-b1d5-c44865108da5"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000128"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/ace22ea2-ce71-4272-91b3-428c7819d000 -->

    <Class rdf:about="http://example.org/ace22ea2-ce71-4272-91b3-428c7819d000">
        <obo:IAO_0000115>Such aging-associated inflammation, so-called inflammaging, is reported to be detrimental to several types of tissue-resident stem cells including ##hair follicle stem cells##, hematopoietic stem cells and neural stem cells. In the present study, RNA-seq and qPCR analysis showed that inflammation markedly contributes to the age-associated transcriptional changes in liver ECs including VESCs (Fig. 5a-d). We also confirmed the enrichment of inflammatory cells in the aged liver (Figs. 5e, f and S6). These findings indicate that the activation of inflammatory signals is a primary signature of aged VESCs. However, data illustrating how inflammation affects VESCs mechanistically is lacking in the present study. This limitation arises because aged mice do not survive well after monoclotalin treatment and irradiation; hence, we were unable to obtain sufficient mice to analyze. Although previous studies showed that age-associated inflammation dysregulates stemness of several types of stem cells, at this time, it remains speculative as to whether inflammation is actually the cause of the proliferative deficit of VESCs. Further investigations are needed to elucidate causal relationships.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10542733</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37563497</oboInOwl:hasDbXref>
        <rdfs:label>hair follicle stem cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000356"/>
        <skos:relatedMatch rdf:resource="CL:0002337"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/ace22ea2-ce71-4272-91b3-428c7819d000"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000356"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/ace22ea2-ce71-4272-91b3-428c7819d000"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002337"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/ad39c86c-71a8-4cca-afb1-a22f884dce99 -->

    <Class rdf:about="http://example.org/ad39c86c-71a8-4cca-afb1-a22f884dce99">
        <obo:IAO_0000115>Proper development of the placenta, the transient support organ forms after embryo implantation, is essential for a successful pregnancy. However, the regulation of trophoblast invasion, which is most important during placentation, remains largely unknown. Here, rats, mice, and pigs are used as biomedical models, used scRNA-seq to comparatively elucidate the regulatory mechanism of placental trophoblast invasion, and verified it using a human preeclampsia disease model combined with scStereo-seq. A dual-featured type of immune-featured trophoblast (iTrophoblast) is unexpectedly discovered. Interestingly, iTrophoblast only exists in invasive placentas and regulates trophoblast invasion during placentation. In a normally developing placenta, iTrophoblast gradually transforms from an immature state into a functional mature state as it develops. Whereas in the developmentally abnormal preeclamptic placenta, disordered iTrophoblast transformation leads to the accumulation of immature ##iTrophoblasts##, thereby disrupting trophoblast invasion and ultimately leading to the progression of preeclampsia.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11558115</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:39234818</oboInOwl:hasDbXref>
        <rdfs:label>iTrophoblasts</rdfs:label>
    </Class>
    


    <!-- http://example.org/ad66d3eb-2233-4bd8-b718-e13d8d3c4bc9 -->

    <Class rdf:about="http://example.org/ad66d3eb-2233-4bd8-b718-e13d8d3c4bc9">
        <obo:IAO_0000115>The above analysis was based on a large number of RNA-seq, so we further used scRNA-seq to determine whether our ORGs signature had immune predictive value on the single cell level. Figure 7A showed that the PRAD samples from GEO datasets were annotated into Mast cell, Epithelial-NE, T/NK, Plasma_B, Epithelial, Neuron, SMC, ##Fibroblasts## and Pericytes, Myeloid and Endothelial. It was obvious that ORGs signature was specifically high in Epithelial-Nk, T/Nk and SMC cells (Figure 7B, 7C). Meanwhile, Figure 7D revealed that significant connection probability of ORGs related signaling pathways in cell clusters which showed specifically high ORGs signature. Furthermore, we chose epithelial cell for analysis. Chemotaxis related pathways including cell chemotaxis, leukocyte chemotaxis, regulation of chemotaxis and regulation of leukocyte chemotaxis were significantly up-regulated in the high ORGs signature group (Figure 7E). What&apos;s more, immune related pathways were all up-regulated in the high ORGs signature group both in GO (Figure 7F) and KEGG (Figure 7G) analysis.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10599753</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37788005</oboInOwl:hasDbXref>
        <rdfs:label>Fibroblasts</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000057"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/ad66d3eb-2233-4bd8-b718-e13d8d3c4bc9"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000057"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/ad7a2313-db43-402c-856e-3237c379e8ba -->

    <Class rdf:about="http://example.org/ad7a2313-db43-402c-856e-3237c379e8ba">
        <obo:IAO_0000115>Considering the close relationship between RGPRG score and immune activity, we sought to further explore the immune infiltrate landscape of two RGPRG score groups. The 22 immune cell composition of HCC patients from the TCGA cohort was shown in Fig. 5A. CD8 T cells, resting memory CD4 T cells, M0 Macrophages, M1 Macrophages, and M2 Macrophages were the main immune cell composition of HCC patients. Many differential immune cell infiltrations could be observed between high- and low-RGPRG score groups (Fig. 5B). Patients with high RGPRG score was characterized by the high infiltration of resting memory CD4 T cells, M0 Macrophages, T cells regulatory (Tregs), naive B cells, memory B cells, Plasma cells, naive CD4 T cells, Eosinophils, indicating a status of immunosuppression in this groups. CD8 T cells, activated memory CD4 T cells, activated NK cells, M1 Macrophages, M2 Macrophages, follicular helper T cells, gamma delta T cells, Neutrophils, resting Dendritic cells, activated Dendritic cells, resting NK cells, Monocytes, resting Mast cells, and ##activated Mast cells## were abundant in the patients with low RGPRG score (Fig. 5C), suggesting enhanced antitumor environment. In addition, the expression of 8 classical immune checkpoint genes between two RGPRG score groups was further estimated in the TCGA cohort, and we found that Patients with high RGPRG score had higher expression levels of CD274, CTLA4, LAG3, PDCD1, and TIGIT (Fig. 5D), which presented another characteristic of immunosuppression.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10832138</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38297333</oboInOwl:hasDbXref>
        <rdfs:label>activated Mast cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000097"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/ad7a2313-db43-402c-856e-3237c379e8ba"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000097"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/ad83443e-1530-46ee-82b8-778cf9f89130 -->

    <Class rdf:about="http://example.org/ad83443e-1530-46ee-82b8-778cf9f89130">
        <obo:IAO_0000115>The adipose-derived hormone leptin acts via its receptor (LepRb) in the brain to control energy balance. A potentially unidentified population of GABAergic hypothalamic LepRb neurons plays key roles in the restraint of food intake and body weight by leptin. To identify markers for candidate populations of LepRb neurons in an unbiased manner, we performed single-nucleus RNA-Seq of enriched mouse hypothalamic LepRb cells, identifying several previously unrecognized populations of hypothalamic LepRb neurons. Many of these populations displayed strong conservation across species, including GABAergic Glp1r-expressing LepRb (LepRbGlp1r) neurons, which expressed more Lepr than other ##LepRb cell## populations. Ablating Lepr from LepRbGlp1r cells provoked hyperphagic obesity without impairing energy expenditure. Similarly, improvements in energy balance caused by Lepr reactivation in GABA neurons of otherwise Lepr-null mice required Lepr expression in GABAergic Glp1r-expressing neurons. Furthermore, restoration of Glp1r expression in LepRbGlp1r neurons in otherwise Glp1r-null mice enabled food intake suppression by the GLP1R agonist, liraglutide. Thus, the conserved GABAergic LepRbGlp1r neuron population plays crucial roles in the suppression of food intake by leptin and GLP1R agonists.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10541203</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37581939</oboInOwl:hasDbXref>
        <rdfs:label>LepRb cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:4042033"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/ad83443e-1530-46ee-82b8-778cf9f89130"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4042033"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/ad9e3131-33ba-4b3d-831d-6c89e5d9d76e -->

    <Class rdf:about="http://example.org/ad9e3131-33ba-4b3d-831d-6c89e5d9d76e">
        <obo:IAO_0000115>Another key finding of McCafferty et al. is that T-channel bursts of cortical and NRT neurons are critically involved in the ictal synaptic interactions with ##thalamocortical neurons##, whereas T-channel bursts of thalamocortical neurons do not play a role in the ictal interactions of these neurons with both cortical and NRT neurons. Indeed, localized injection of TTA-P2, a potent and selective pan-T-channel antagonist, by shows that the block of T-channels in the NRT and CIN of GAERS rats drastically decreases absence seizures (see also), whereas blocking T-channels in thalamocortical neurons of the ventrobasal thalamus, one of the somatotopic thalamic nuclei of the GAERS CIN, has no effect on absence seizures (Fig. 5), the rhythmicity of the thalamic output and its synchrony with the SWD spike. Thus, the use of TTA-P2 to provide a fast block of T-channel function without compensatory activities shows that T-channels of ventrobasal thalamocortical neurons (i.e. Cav3.1) are not essential for spontaneous absence seizures in GAERS rats whereas those of the CIN (i.e. Cav3.1, Cav3.2 and Cav3.3) and NRT (i.e Cav3.2 and Cav3.3) are (Fig. 5). </obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7447525</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32437558</oboInOwl:hasDbXref>
        <rdfs:label>thalamocortical neurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:4023068"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/ad9e3131-33ba-4b3d-831d-6c89e5d9d76e"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4023068"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/adaa93b7-4ab2-4f81-a7ad-ce6c1f348cac -->

    <Class rdf:about="http://example.org/adaa93b7-4ab2-4f81-a7ad-ce6c1f348cac">
        <obo:IAO_0000115>We next assessed if iETV2-ECs could also be used to vascularize cerebral organoids (CO), and if presence of ECs would affect the localization of the different neural compartments. We thus generated PSC-derived COs and vascularized COs (eCOs; by allowing organoid formation from a mix of iETV2 and wild type PSCs; PSC:iETV2-hiPSC ratio = 8:2). To generate iETV2-ECs in situ, we activated the ETV2 transgene by addition on day 4 and 7, respectively, low and high concentrations of doxycycline for basal and full transgene activation (Figure  5A). Immunostaining of DIV35 eCO revealed CD31+ vascular structures and relatively smaller and scattered ventricular zones (VZ) (Figure 5B(ii)) in which the radial organization of ##SOX2+ cells## (but not TUJ1+ cells) was less apparent than that of CO not containing ECs (Figure 5B(i)). We also embedded CO and eCO in matrigel alone or in iETV2-ECs laden matrigel. In matrigel alone, we observed VZ-like structures in the CO, however the SOX2+ cells were mostly found outside the VZ (indicated by asterisk; Figure 5B(iii)). In eCO, the radial organization of SOX2+ in VZ was more disrupted (Figure 5B(iv)), whereby the SOX2+ and TUJ1+ cells appeared to spread into the matrigel, and CD31+ cells were found mainly at the periphery. In iETV2-EC</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10837345</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38037510</oboInOwl:hasDbXref>
        <rdfs:label>SOX2+ cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000048"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/adaa93b7-4ab2-4f81-a7ad-ce6c1f348cac"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000048"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/ae072938-a796-4bfd-a8f8-4c7e9e91bccd -->

    <Class rdf:about="http://example.org/ae072938-a796-4bfd-a8f8-4c7e9e91bccd">
        <obo:IAO_0000115>SCLC	Small-cell carcinoma	 	NSCLC	Non-small-cell carcinoma	 	ADC	Adenocarcinoma	 	SqCC	Squamous cell carcinoma	 	LCLC	Large-cell carcinoma	 	PD1	Programmed death 1	 	PDL1	Programmed death 1 ligand	 	ICI	Immune checkpoint inhibitors	 	EV	Extracellular vesicles	 	ESE	Early-sorting endosome	 	ILVs	Intraluminal vesicles	 	MVBs	Multivesicular bodies	 	ESCRT	Endosomal-sorting complex-independent transport	 	ncRNAs	Small noncoding RNAs (ncRNAs)	 	miRNAs	microRNAs	 	TME	Tumor microenvironment	 	circRNA	circular RNA	 	ECM	extracellular matrix	 	HBEC	Human bronchial epithelial cells	 	EMT	Epithelial-mesenchymal transition	 	CRC	colorectal cancer	 	DCs	dendritic cells	 	MSC	Mesenchymal stem cells	 	NK	Natural Killer	 	PBMCs	Peripheral blood mononuclear cells	 	TAMs	Tumor-associated macrophages	 	MDSCs	Myeloid-derived suppressor cells	 	PMN-MDSCs	Polymorphonuclear MDCs	 	M-MDSCs	Monocytic MDSCs	 	LLC	Lewis Lung carcinoma	 	M2 macrophages	Alternatively activated macrophages	 	M1 macrophages	Classically activated macrophages	 	TH1 cell	T helper 1 cell	 	Treg cell	Regulatory T cell	 	Breg cell	Regulatory B cell	 	CTLs	Cytotoxic CD8+ T cells	 	##TILs##	Tumor-infiltrating lymphocytes	 	Tim-3	mucin domain-3 protein	 	TIGIT	T cell immunoglobulin and ITIM domain	 	Lag-3	Lymphocyte-activation gene 3	 	CTLA4	Cytotoxic T lymphocyte antigen-4	 	TH17 cell	T helper 17 cell	 	DNT cell	Double-negative T cells	 	TRAIL	TNF-related apoptosis-inducing ligand	 	MPE	malignant pleural effusions	 	CRISPRi	clustered regularly interspaced short palindromic repeats interference	 	FAP	Fibroblast activation protein- alpha.	 	</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10616833</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37915578</oboInOwl:hasDbXref>
        <rdfs:label>TILs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000542"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/ae072938-a796-4bfd-a8f8-4c7e9e91bccd"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000542"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/ae30074c-8089-4f68-a2c1-ccfbec676464 -->

    <Class rdf:about="http://example.org/ae30074c-8089-4f68-a2c1-ccfbec676464">
        <obo:IAO_0000115>For instance, Yu et al. showed that O6-alkylguanine DNA alkyltransferase (MGMT)-negative glioma cells could take up reactive astrocyte exosomes and obtain a TMZ-resistant phenotype via translation of exogenous exosomal MGMT mRNA both in vitro and in vivo. Exosome-mediated interaction between astrocyte and glioma conferred a chemoresistance property for the relapse of glioma. Sharma et al. further investigated that GDEs were the potential driving force in promoting the differentiation of rNSCs to astrocytes. GDEs induced the astrocytes activation and could shuttle lncRNA-ATB to astrocytes. The shuttled lncRNA-ATB activated recipient astrocytes by inhibiting miR-204-3p in an Argonaute 2-dependent manner and accelerated glioma migration and invasion. Peritumoral hypoxia in solid tumors is characterized by rapid tumor growth that exceeds vascular supply capabilities and/or tumor vasculature malfunctioning. The growth of HT22 cells was restrained by C6 glioma cells under hypoxic conditions, presuming that GDEs might be the communication medium between ##peritumoral neurons## and glioma cells. Hypoxia-induced GDE miRNA-199a-3p was upregulated by the HIF-1alpha activation, and then aggravated oxygen-glucose deprivation and the ischemic injury of peritumoral neurons via repressing the mTOR pathway. GDE ncRNAs mediate the interaction between glioma cells and surrounding non-glioma brain cells to promote tumor evolution in the tumor microenvironment. These results shed light on the underlying mechanism of glioma aggressiveness and may provide new targets based on exosome-mediated peritumoral neuronal or neuroglial signals for combating glioma.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8660802</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34887381</oboInOwl:hasDbXref>
        <rdfs:label>peritumoral neurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000540"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/ae30074c-8089-4f68-a2c1-ccfbec676464"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000540"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/ae395209-97c7-442e-a851-b0d395380b3a -->

    <Class rdf:about="http://example.org/ae395209-97c7-442e-a851-b0d395380b3a">
        <obo:IAO_0000115>Although tumor-infiltrating T cells hold a beneficial prognostic role in colorectal cancer, other lymphocytic populations are less characterized. We developed a multiplexed immunofluorescence assay coupled with digital image analysis and machine learning to identify natural killer (NK) cells (NCAM1+CD3-), natural killer T-like (NKT-like) cells (NCAM1+CD3+), and T cells (NCAM1-CD3+) within the PTPRC+ (CD45+) cell population and to measure their granzyme B (GZMB; cytotoxicity marker) and FCGR3A (CD16a; NK-cell maturity marker) expression. We evaluated immune cell densities and spatial configuration in 907 incident colorectal carcinoma cases within two prospective cohort studies. We found that T cells were approximately 100 times more abundant than ##NK and NKT-like cells##. Overall, NK cells showed high GZMB expression and were located closer to tumor cells than T and NKT-like cells. In T and NKT-like cells, GZMB expression was enriched in cells in closer proximity to tumor cells. Higher densities of both T and NKT-like cells associated with longer cancer-specific survival, independent of potential confounders (P trend &lt; 0.0007). Higher stromal GZMB+ and FCGR3A+ NK-cell densities associated with longer cancer-specific survival (P trend &lt; 0.003). For T and NKT-like cells, greater proximity to tumor cells associated with longer cancer-specific survival (P trend &lt; 0.0001). These findings indicate that cytotoxic NCAM1+CD3-GZMB+ NK cells and NCAM1+CD3+ NKT-like cells are relatively rare lymphocytic populations within the colorectal cancer microenvironment and show distinct spatial configuration and associations with patient outcome. The results highlight the utility of a quantitative multimarker assay for in situ, single-cell immune biomarker evaluation and underscore the importance of spatial context for tumor microenvironment characterization.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8816895</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34937729</oboInOwl:hasDbXref>
        <rdfs:label>NK and NKT-like cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000623"/>
        <skos:relatedMatch rdf:resource="CL:0000814"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/ae395209-97c7-442e-a851-b0d395380b3a"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000623"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/ae395209-97c7-442e-a851-b0d395380b3a"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000814"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/ae63147c-ca01-4206-9a82-8a901ff2eaf1 -->

    <Class rdf:about="http://example.org/ae63147c-ca01-4206-9a82-8a901ff2eaf1">
        <obo:IAO_0000115>a Boxplots showcasing the Accuracy Score of nine different integration methods across all 45 paired datasets, encompassing 28 sequence-based and 17 image-based datasets. The boxplots display data distribution where the box spans from the first to the third quartile, marking the median with a distinct line. The whiskers reach out to the maximum range within 1.5 times the interquartile range, and individual outliers are denoted by separate dots. b A STARmap slide from the STARmap dataset (mouse visual cortex), annotated with various cell types. Each grid portrays a simulated spot encompassing multiple cells. c Illustration of the proportion of ##Layer 4 (L4) excitatory neurons## within simulated spots from the STARmap dataset, alongside predictions from eight integration methods. d Boxplots presenting the PCC, SSIM, RMSE, and JSD for eight integration methods, specifically analyzed for the STARmap dataset. The boxplots display data distribution where the box spans from the first to the third quartile, marking the median with a distinct line. The whiskers reach out to the maximum range within 1.5 times the interquartile range; n = 189 predicted spots. e A seqFISH+ slide from the seqFISH+ dataset (mouse cortex), annotated with cell types. Analogous to the STARmap slide, each grid symbolizes a simulated spot with multiple cells. f Depiction of the proportion of L4 excitatory neurons in simulated spots from the seqFISH+ dataset, accompanied by predictions from eight integration techniques. g Boxplots exhibiting the metrics of PCC, SSIM, RMSE, and JSD for the eight integration methods tested on the seqFISH+ dataset. The boxplots display data distribution where the box spans from the first to the third quartile, marking the median with a distinct line. The whiskers reach out to the maximum range within 1.5 times the interquartile range; n = 72 predicted spots. Source data are provided as a Source Data file.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11330978</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:39155292</oboInOwl:hasDbXref>
        <rdfs:label>Layer 4 (L4) excitatory neurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:4030063"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/ae63147c-ca01-4206-9a82-8a901ff2eaf1"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4030063"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/ae6dc9a1-cb3b-4fc6-840c-683441887073 -->

    <Class rdf:about="http://example.org/ae6dc9a1-cb3b-4fc6-840c-683441887073">
        <obo:IAO_0000115>The lymphoid immune cell cluster is further divided into 14 clusters. Seven main subgroups are identified by annotation: Natural Killer (NK) Cell, CD4 + T Memory Cell, CD8 + T Cell, B Cell, Natural Killer T (NKT) Cell, Regulatory T (Treg) Cell, and Plasma Cell (Fig. 1D and E). Subsequently, myeloid immune cells were roughly further divided into 15 cell clusters. The annotation identified seven major subgroups: Monocyte, Macrophage, Dendritic Cell, Granulocyte-Monocyte Progenitor (GMP), Plasmacytoid Dendritic Cell, Granulosa Cell, and Neutrophil (Fig. 1F and G). For Epithelial/Cancer Cell, we used the CopyKAT algorithm to distinguish between normal epithelial cells and cancer cells (Additional file 2: Fig. S2B). We then further analyzed normal epithelial cells to obtain 18 cell clusters. The annotation identified nine main subgroups: Basal Cell, Pulmonary Alveolar Type II Cell, FOXN4 + Cell, ##Luminal Epithelial Cell##, SLC16A7 + Cell, Ionocyte Cell, Langerhans Cell, Ciliated Cell, and Secretory Cell (Fig. 1H and I). Marker gene expression levels for 28 cell types were shown in Fig. 1C, indicating that different cell types had their own specific marker genes. Cell annotation information is shown in the Additional file 5: Table S1.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9673203</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36401283</oboInOwl:hasDbXref>
        <rdfs:label>Luminal Epithelial Cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002368"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/ae6dc9a1-cb3b-4fc6-840c-683441887073"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002368"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/ae7c599f-c5d8-4f1e-a3aa-7d7152b43996 -->

    <Class rdf:about="http://example.org/ae7c599f-c5d8-4f1e-a3aa-7d7152b43996">
        <obo:IAO_0000115>In addition to our embryonic development, many aspects of adult human health are also highly dependent on tightly controlled cell-type-specific gene regulation. For example, human health and homeostasis are tightly regulated by a myriad of different neuropeptides that need to be expressed in precise regions of the hypothalamus, amygdala and sensory neurons to modulate appropriate levels of food intake, mood and pain perception. Thus, identification of the enhancer regions that control the cell-type-specific expression of these neuropeptides, and how they might be affected by polymorphic variation, will be critical to our understanding of health and disease. For example, substance-P (SP; encoded by TAC1 gene) is a neuropeptide expressed in c-fibre sensory neurons and the medial amygdala where it is critical to pain perception and mood modulation. We first used comparative genomics in species as diverse as mammals and birds to identify a highly conserved enhancer that lay 158kb from the TAC1 gene, which drove reporter gene expression in ##SP expressing amygdala neurons##. Later transgenic analysis of an even remoter conserved enhancer (214kb from TAC1 gene) demonstrated its ability to not only drive reporter expression in SP expressing C-fibre sensory neurons but to also switch reporter gene expression to larger diameter A-fibres in response to inflammatory stimuli:an expression of SP associated with hyperalgesia.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7660172</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33113946</oboInOwl:hasDbXref>
        <rdfs:label>SP expressing amygdala neurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000505"/>
        <skos:relatedMatch rdf:resource="CL:4023039"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/ae7c599f-c5d8-4f1e-a3aa-7d7152b43996"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000505"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/ae7c599f-c5d8-4f1e-a3aa-7d7152b43996"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4023039"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/aeb19451-43af-4d04-b360-5025c5dedd9d -->

    <Class rdf:about="http://example.org/aeb19451-43af-4d04-b360-5025c5dedd9d">
        <obo:IAO_0000115>(A) Anatomical locations of n = 29 recorded preBotC neurons. (B) Example traces of an ##excitatory neuron## with pre-I spiking (orange) and without pre-I spiking (green) and an inhibitory neuron (blue) during the inspiratory burst and inter-burst interval (IBI). (C) Quantified spike frequency as a function of time (normalized to burst duration) from n = 9 pre-I excitatory, n = 13 non pre-I excitatory, and n = 7 inhibitory neurons. (D) Quantified mean spike frequency, duration, and shape of inspiratory bursts generated by each type of neuron (one-way ANOVA with Bonferroni post hoc tests). (E) Example quantification of neuronal burst onset time relative to the preBotC population and Poincare plots showing onset time variability from n = 9 pre-I excitatory, n = 13 non pre-I excitatory, and n = 7 inhibitory neurons (20 inspiratory bursts/neuron). (F) Burst onset time variability or &apos;jitter&apos; quantified as the natural log of the root mean square of successive differences (one-way ANOVA with Bonferroni post hoc tests). Data available in Figure 2:source data 1.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6957314</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31804180</oboInOwl:hasDbXref>
        <rdfs:label>excitatory neuron</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000540"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/aeb19451-43af-4d04-b360-5025c5dedd9d"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000540"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/aeba5ae8-cadc-44b3-8bb9-c4e542e852e0 -->

    <Class rdf:about="http://example.org/aeba5ae8-cadc-44b3-8bb9-c4e542e852e0">
        <obo:IAO_0000115>Compared with widely used high-throughput approaches that primarily involve viral vector-mediated gene transfer with uncontrollable randomness in cell targeting, 2-SPARSE has a unique advantage in that it enables precisely targeted labelling of single, functionally defined neurons after functional population imaging (Fig. 1). This precision is particularly useful when the functionally defined neurons in a specific brain region are sparse in number but exhibit wide spatial distribution and are intermingled with other neurons in the same region. In recent decades, many such neuronal types have been identified across multiple brain regions. For example, feature-specific neurons have been identified in the AUD and visual cortex for processing of sensory information; place cells and grid cells have been identified in the hippocampus and the entorhinal cortex that participate in spatial navigation; ##engram cells## have been identified in the hippocampus and cortex for memory processing, and holistic bursting cells have been identified in the AUD for complex sound encoding. These types of functionally defined cells constitute just a small proportion of the neuronal population in specific brain regions (e.g., grid cells, ~20%; engram cells, ~4%; and holistic bursting cells, ~5%) and are inevitably spatially intermingled. Moreover, these functional neuron types largely lack known molecular markers. Thus, molecular approaches alone are frequently limited in their potential application for mapping between functional and morphological features. In this case, 2-SPARSE not only provides an ideal solution for acquiring precise data but can also serve as an annotation reference for benchmarking and calibration of high-throughput population mapping methods used to correlate functional and morphological features of neurons.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8940919</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35318336</oboInOwl:hasDbXref>
        <rdfs:label>engram cells</rdfs:label>
    </Class>
    


    <!-- http://example.org/aef80d01-2fb5-47f5-95df-975c99ba406a -->

    <Class rdf:about="http://example.org/aef80d01-2fb5-47f5-95df-975c99ba406a">
        <obo:IAO_0000115>Ectopic ossification mimicking pathological cells were reclustered and defined as HO1 (corresponding to Supplementary Figure 2C, cluster 1) and HO2 (corresponding to Supplementary Figure 2C, cluster 0) (Figure 2(d) and Supplementary Figure 2C). The results of the mimetic timing analysis suggested that HO2 was a precursor cell for HO1 differentiation (Figures 2(e) and 2(f)). To further characterize the pathological differentiation of ectopically ossified cells, the proposed chronological expression profile of genes associated with the ectopic ossification phenotype was revealed (Figure 2(g)). The gene expression profiles of Xbp1, E2f7, Fgfr1, Icam1, Jag1, and Ncam1 are shown in Supplementary Figure 2D. Mgp, Bgn, Sox9, Col11a1, Col1a1, Col1a2, Tnmd, Col11a2, Scx, Hivep2, Bcl2, Col2a1, Mkx, Myc, and Dcn were enriched in HO2-like cells. Col5a1, Foxc1, Gli3, Gli2, Pecam1, Klf2, Klf4, Zbtb48, Ptch2, Smad7, Sufu, Igfbp5, Tcf, Fbn1, and Jag1 were enriched mainly in HO1-like cells (Figure 2(g)). Among them, Gli3, Cli2, Pecam1, and Ptch2 are the star genes of the Hh signaling pathway, and Notch2 and Jag1 are the star genes of the Notch signaling pathway, which suggested that the activities of the Notch and Hh signaling pathways may be upregulated in HO1-like cells. According to the expression characteristics of these genes, HO1-like cells are more similar to ##chondrocyte-like cells##, and HO2-like cells are more similar to tenocyte-like cells. Therefore, HO2 cells were defined as &quot;tenocyte-like cells.&quot;</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8563124</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34737845</oboInOwl:hasDbXref>
        <rdfs:label>chondrocyte-like cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000138"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/aef80d01-2fb5-47f5-95df-975c99ba406a"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000138"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/af370e4f-3a5f-43c4-b808-a624da006cd3 -->

    <Class rdf:about="http://example.org/af370e4f-3a5f-43c4-b808-a624da006cd3">
        <obo:IAO_0000115>a Line drawing of a cross section of the floor of the cochlear duct at P1. Distinct cell types within the organ of Corti (OC) are color coded. b Heat map for ~14,000 cochlear cells collected from four separate experiments at P1. Top 25 differentially expressed (DE) genes for the 15 identified clusters are shown. Cellular identity for each cluster is indicated by a color bar at the top of the heat map, which corresponds to the legend in a, and by a cell name at the bottom. c tSNE plot for the same cells as in b. Cluster identities are indicated. d Violin plots showing normalized log-transformed expression values for the top five DE genes for each cell type (color coded as in c) by comparison with all other P1 cells (gray on the right in each graph). Bars indicate median expression level. e Upper left panel, tSNE plot of cells determined to be derived from KO (between the OC and medial edge of the cochlear duct). Lower left panel, feature plot for the same cells as in the upper panel indicating high expression of Otoa, Calb1, and Fabp7 (based on color) in different clusters of cells. Lower right panel, cross sections through the cochlear duct at P1, illustrating expression of CALB1 in the medial region of KO and FABP7 directly adjacent to the OC (arrow; scale bars, 20 mum). Lowest panel shows high-magnification view of expression of FABP7 (arrow, gray scale) at the lateral KO border (green line; scale bar, 10 mum). Upper right panel, summary diagram of the spatial distribution of KO cell clusters at P1. HC hair cells, IPhC inner phalangeal cells/border cells, IPC inner pillar cells, OPC outer pillar cells, DC1/2 ##Deiters&apos; cells rows 1 and 2##, DC3, Deiters&apos; cells row 3, HeC Hensen&apos;s cells, CC/OSC Claudius cells/outer sulcus cells, IdC interdental cells, ISC inner sulcus cells, KO Kolliker&apos;s organ cells, L.KO lateral Kolliker&apos;s organ cells, M.KO medial Kolliker&apos;s organ cells, OC90 OC90+ cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7221106</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32404924</oboInOwl:hasDbXref>
        <rdfs:label>Deiters&apos; cells rows 1 and 2</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000635"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/af370e4f-3a5f-43c4-b808-a624da006cd3"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000635"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/af676816-aeb7-460a-8845-637a0deae1b6 -->

    <Class rdf:about="http://example.org/af676816-aeb7-460a-8845-637a0deae1b6">
        <obo:IAO_0000115>##Nrp1-expresing Skin Tregs## and CD25-, CD39-, CTLA-4-, or GzmB-expressing Skin Tregs Form Distinct Subsets</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6534040</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31156643</oboInOwl:hasDbXref>
        <rdfs:label>Nrp1-expresing Skin Tregs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000815"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/af676816-aeb7-460a-8845-637a0deae1b6"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000815"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/afa00ad5-f5d7-43ec-80ff-27c09f02bebf -->

    <Class rdf:about="http://example.org/afa00ad5-f5d7-43ec-80ff-27c09f02bebf">
        <obo:IAO_0000115>BACKGROUND Rotator cuff injury is the most common cause of shoulder disability, and although the repair technique has improved, the rate of rotator cuff reduction after repair is still high. The fibrocartilage region, which appears to be histologically inserted, cannot be regenerated. In recent years, studies have reported that mesenchymal stem cells (MSCs) have enhanced cartilage regeneration in the tendon and bone interface after rotator cuff repair, which has become a hot topic of research. MATERIAL AND METHODS Two mesenchymal stem cell types, SMSC (##synovial-derived mesenchymal stem cells##) and BMSC (bone marrow-derived mesenchymal stem cells) were intervened using kartogenin (KGN). The cytotoxicity was evaluated and the proliferation of the 2 cells was observed. Four commonly used cartilage phenotype genes were detected by quantitative real-time polymerase chain reaction, and the cartilage differentiation of MSCs induced by KGN was explored. The bidirectional regulation of the expression of BMP-7 and the downstream gene Smad5 was observed by constructing a lentiviral overexpression vector containing the target gene BMP-7. To explore whether BMP-7/Smad5 pathway activation promotes differentiation of SMSCs into chondrocytes. RESULTS KGN can induce the selective differentiation of endogenous MSCs into chondrocytes by activating the BMP-7/Smad5 pathway, which promotes the regeneration of interfacial cartilage, and improves the quality of tendon healing of the tendon after rotator cuff repair. CONCLUSIONS This study found a new biological intervention method to promote the effect of tendon on bone healing after rotator cuff repair.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6625576</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31271564</oboInOwl:hasDbXref>
        <rdfs:label>synovial-derived mesenchymal stem cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000134"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/afa00ad5-f5d7-43ec-80ff-27c09f02bebf"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000134"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/afdc7487-00cb-4a3e-96d8-fea5f0eda6c0 -->

    <Class rdf:about="http://example.org/afdc7487-00cb-4a3e-96d8-fea5f0eda6c0">
        <obo:IAO_0000115>The unwounded, normal corneal stroma is a relatively simple, avascular tissue populated with quiescent keratocytes, along with corneal nerves and a few resident dendritic and monocyte/macrophage cells. In the past, the resting keratocytes were thought of as a homogenous cellular population, but recent work has shown local variations in vimentin and nestin expression, and responsiveness to transforming growth factor (TGF)-beta1. Studies have also supported there being &quot;stromal stem cells&quot; in localized areas. After corneal wounding, depending on the site and severity of injury, profound changes in stromal cellularity occur. Anterior or posterior injuries to the epithelium or endothelium, respectively, trigger apoptosis of adjacent keratocytes. Many contiguous keratocytes transition to ##keratocan-negative corneal fibroblasts## that are proliferative and produce limited amounts of disorganized extracellular matrix components. Simultaneously, large numbers of bone marrow-derived cells, including monocytes, neutrophils, fibrocytes and lymphocytes, invade the stroma from the limbal blood vessels. Ongoing adequate levels of TGFbeta1, TGFbeta2 and platelet-derived growth factor (PDGF) from epithelium, tears, endothelium and aqueous humor that penetrate defective or absent epithelial barrier function (EBF) and epithelial basement membrane (EBM) and/or Descemet&apos;s basement membrane (DBM) drive corneal fibroblasts and fibrocytes to differentiate into alpha-smooth muscle actin (SMA)-positive myofibroblasts. If the EBF, EBM and/or DBM are repaired or replaced in a timely manner, typically measured in weeks, then corneal fibroblast and fibrocyte progeny, deprived of requisite levels of TGFbeta1 and TGFbeta2, undergo apoptosis or revert to their precursor cell-types. If the EBF, EBM and/or DBM are not repaired or replaced, stromal levels of TGFbeta1 and TGFbeta2 remain elevated, and mature myofibroblasts are generated from corneal fibroblasts and fibrocyte precursors that produce prodigious amounts of disordered extracellular matrix materials associated with scarring fibrosis. This fibrotic stromal matrix persists, at least until the EBF, EBM and/or DBM are regenerated or replaced, and keratocytes remove and reorganize the affected stromal matrix.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7855915</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33068626</oboInOwl:hasDbXref>
        <rdfs:label>keratocan-negative corneal fibroblasts</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002363"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/afdc7487-00cb-4a3e-96d8-fea5f0eda6c0"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002363"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/b0490848-774d-44ff-ad64-b36c21aa2215 -->

    <Class rdf:about="http://example.org/b0490848-774d-44ff-ad64-b36c21aa2215">
        <obo:IAO_0000115>Transcriptional signature of pancreas infiltrating and circulating CD4+ and CD8+ T cell subsets at disease onset. (A) UMAP plot of CD4+ and CD8+ T cells from peripheral blood and pancreas of new-onset diabetic NOD mice. (B) Feature plots depicting gene expression levels of distinct markers driving CD4+ and CD8+ T cell activation states. (C, D) UMAP plot of CD4+ (C) and CD8+ (D) T cells grouped by the annotation in A (left) and grouped by T cell subset classified based on the expression of Cd44 and Sell (right). EM = effector memory (Cd44+Sell-), ##CM## = central memory (Cd44+Sell+), naive (Cd44-Sell+), and CD44low CD62L- (Cd44-Sell-). (E, F) Heatmap depicting row-based z-scores of scaled gene expression levels for marker genes driving T cell heterogeneity across the distinct CD4+ (E) and CD8+ (F) T cell subsets. (G, H) Trajectory of CD4+ (G) and CD8+ (H) naive, CD44low CD62L-, effector memory (EM), and central memory (CM) T cell subsets projected onto the UMAP plot (top). Violin plots depicting the pseudotime of CD4+ (G) and CD8+ (H) T cells per subset (bottom). Each dot represents a single cell. (I, J) Differentially expressed genes of CD4+ Cd44-Sell- (I) and CD8+ Cd44-Sell- (J) T cells between peripheral blood and pancreas.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10667927</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38027120</oboInOwl:hasDbXref>
        <rdfs:label>CM</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000904"/>
        <skos:relatedMatch rdf:resource="CL:0000907"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/b0490848-774d-44ff-ad64-b36c21aa2215"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000904"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/b0490848-774d-44ff-ad64-b36c21aa2215"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000907"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/b059a145-a719-47da-b5ad-6a05c9bd31dc -->

    <Class rdf:about="http://example.org/b059a145-a719-47da-b5ad-6a05c9bd31dc">
        <obo:IAO_0000115>15-PGDH activity is highly enriched in ##splenic and marrow mast cells##, megakaryocytes, and macrophages.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8026178</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33600377</oboInOwl:hasDbXref>
        <rdfs:label>splenic and marrow mast cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000097"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/b059a145-a719-47da-b5ad-6a05c9bd31dc"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000097"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/b0611b45-0aa3-4a01-a688-4b346f88219b -->

    <Class rdf:about="http://example.org/b0611b45-0aa3-4a01-a688-4b346f88219b">
        <obo:IAO_0000115>Innate T cells, including CD1d-restricted invariant natural killer T (iNKT) cells, are characterized by their rapid activation in response to non-peptide antigens, such as lipids. While the transcriptional profiles of naive, effector, and memory adaptive T cells have been well studied, less is known about the transcriptional regulation of different iNKT cell activation states. Here, using single-cell RNA-sequencing, we performed longitudinal profiling of activated murine iNKT cells, generating a transcriptomic atlas of iNKT cell activation states. We found that transcriptional signatures of activation are highly conserved among heterogeneous iNKT cell populations, including NKT1, NKT2, and NKT17 subsets, and human iNKT cells. Strikingly, we found that regulatory iNKT cells, such as ##adipose iNKT cells##, undergo blunted activation and display constitutive enrichment of memory-like cMAF+ and KLRG1+ populations. Moreover, we identify a conserved cMAF-associated transcriptional network among NKT10 cells, providing novel insights into the biology of regulatory and antigen-experienced iNKT cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9831610</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36458691</oboInOwl:hasDbXref>
        <rdfs:label>adipose iNKT cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000921"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/b0611b45-0aa3-4a01-a688-4b346f88219b"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000921"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/b06ab7a0-39ea-45de-a981-26f2a63b76e1 -->

    <Class rdf:about="http://example.org/b06ab7a0-39ea-45de-a981-26f2a63b76e1">
        <obo:IAO_0000115>Myofibroblasts are central mediators of the dysregulated wound-healing programme that defines fibrosis, therefore we studied this population in detail. Graph based clustering of the single cell RNA-seq data defined four major subsets (Fig. 3a) that included a cycling population (Cycling MFB) (Fig. 3a, b). After this, we sought to confirm that proliferating stromal cells (Ki67+) were myofibroblasts (Fig. 3c-e, Supplementary Fig. 4a-d). Using flow cytometry, we stained freshly disaggregated nodular cells and gated on myofibroblasts (CD45-CD31-CD146-ITGbeta1high) and fibroblasts (CD45-CD31-CD146-ITGbeta1low) and demonstrated Ki67high cells were a subset of myofibroblasts. In the single cell RNA-seq, a second subset was characterised by lower expression of ACTA2 and intermediate expression of fibroblast marker genes (CXCL14, PLA2G2A and C1R), we termed the ##ACTA2low myofibroblast## (Fig. 3a, b, Supplementary Fig. 5a). A third comprised a discrete CD82highOX40L+ population (CD82, OX40L, MMP11, MMP14 and CD82) (Fig. 3a, g, Supplementary Fig. 5b-e). Finally, a fourth less distinct community we termed the intermediate myofibroblast (Fig. 3a, b, Supplementary Fig. 15a). GO analysis demonstrated that CD82highOX40L+ myofibroblast marker genes showed the strongest enrichment for cell contraction pathways (Fig. 3f). In contrast, differential gene expression and pathway analysis revealed ACTA2low myofibroblasts resembled a general fibroblast phenotype, without clear characteristics of any one subtype. In addition to ACTA2, significant ACTA2low myofibroblasts markers were general fibroblasts markers including PLA2G2A and CXCL14. ACTA2low myofibroblasts also shared pathways enriched in fibroblasts such as &apos;interleukin signalling&apos; and &apos;chemotaxis&apos; (Fig. 3f).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7265502</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32488016</oboInOwl:hasDbXref>
        <rdfs:label>ACTA2low myofibroblast</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000186"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/b06ab7a0-39ea-45de-a981-26f2a63b76e1"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000186"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/b0994095-c9cf-49e7-86a2-fe86e45d5bba -->

    <Class rdf:about="http://example.org/b0994095-c9cf-49e7-86a2-fe86e45d5bba">
        <obo:IAO_0000115>The GEO database (GSE138709) was employed to examine the fluctuation of MAL2 mRNA expression in ##ICC##. From the UMAP plot and heatmap, distinct gene markers helped classify GSE138709 findings into eight cell clusters, namely, cholangiocytes, fibroblast, hepatocyte, TNK, endothelial, MonoMac, B lymphocytes, and dendritic cells (DC), as showcased in Fig. 1A-C and Fig. S1A. A specific expression of CD79A was found in the B cluster, as depicted in Fig. 1B, C and Fig. S1A. Interestingly, cholangiocytes and fibroblasts exhibited more robust expression in tumor tissues than in regular tissues. Conversely, tumor tissues displayed a decrease in the abundance of hepatocytes, TNK, B cells, and DCs when compared to normal tissue samples, as seen in Fig. 1E and Fig. S1B. To our surprise, MAL2 was found to be significantly abundant in cholangiocytes (Fig. 1D and Fig. S1C). The expression levels of MAL2 were more prevalent in tumor tissues than in normal ones (Fig. 1F). Chromosome copy number variation (CNV) of different cells in ICC tissue was analyzed based on CopyKAT, a computational tool. We found that non-immune cells such as endothelial cells were normal diploid, and classified cholangiocytes in ICC into normal cholangiocytes and malignant cholangiocytes based on whether or not there was a change in CNV (Fig. 1G, H). Malignant cholangiocytes were almost distributed in ICC, and MAL2 was expressed mainly in malignant cholangiocytes in ICC (Fig. 1I-K). These revelations point toward the crucial role MAL2 might play in ICC cancer cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11169275</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38866777</oboInOwl:hasDbXref>
        <rdfs:label>ICC</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:1000488"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/b0994095-c9cf-49e7-86a2-fe86e45d5bba"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:1000488"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/b0b7263b-6276-4e85-a8b1-12adb4c78d87 -->

    <Class rdf:about="http://example.org/b0b7263b-6276-4e85-a8b1-12adb4c78d87">
        <obo:IAO_0000115>Innate lymphoid cells (ILCs) belong to a family of immune cells. Recently, ILCs have been classified into five different groups that mirror the function of adaptive T cell subsets counterparts. In particular, NK cells mirror CD8+ cytotoxic T cells while ILC1, ILC2, ILC3, and Lymphoid tissue inducer (LTi)-like cells reflect the function of CD4+T helper (Th) cells (Th1, Th2, and Th17 respectively). ILCs are involved in innate host defenses against pathogens and tumors, in lymphoid organogenesis, and in tissue remodeling/repair. In recent years, important molecular inducible checkpoints (PD-1, TIM3, and TIGIT) were shown to control/inactivate different immune cell types. The expression of many of these receptors has been detected on NK cells and subsets of ##tissue-resident ILCs## in both physiological and pathological conditions, including cancer. In particular, it has been demonstrated that the interaction between PD-1+ immune cells and PD-L1/PD-L2+ tumor cells may compromise the anti-tumor effector function leading to tumor immune escape. However, while the effector function of NK cells in tumor is well-established, limited information exists on the other ILC subsets. We will summarize what is known to date on the expression and function of these checkpoint receptors on NK cells and ILCs, with a particular focus on the recent data that reveal an essential contribution of the blockade of PD-1 and TIGIT on NK cells to the immunotherapy of cancer. A better information regarding the presence and the function of different ILCs and of the inhibitory checkpoints in pathological conditions may offer important clues for the development of new immune therapeutic strategies.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6498986</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31105707</oboInOwl:hasDbXref>
        <rdfs:label>tissue-resident ILCs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0001065"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/b0b7263b-6276-4e85-a8b1-12adb4c78d87"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0001065"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/b0baaf52-b15c-41d7-837c-f431107b9723 -->

    <Class rdf:about="http://example.org/b0baaf52-b15c-41d7-837c-f431107b9723">
        <obo:IAO_0000115>Our recent work demonstrating that kidney-infiltrating T cells (KITs) are functionally and transcriptionally exhausted : much like ##TILs## or CD8+ T cells after chronic viral infection : challenges 2 paradigms. First, it argues against the idea that autoimmune destruction of parenchymal tissue is a direct effector process, akin to a response to virally infected cells. Instead, some tissues may be endowed with natural self-preservation mechanisms that downregulate or suppress infiltrating T cells, which may prevent or attenuate autoimmunity. Second, it suggests that tumors do not evolve a de novo set of pathways to negatively regulate T cells. Instead, such pathways may be native to certain parenchymal tissues, and tumors may amplify them or simply naturally express them.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9089785</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35271505</oboInOwl:hasDbXref>
        <rdfs:label>TILs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000542"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/b0baaf52-b15c-41d7-837c-f431107b9723"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000542"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/b0c2b38c-66b9-4b37-bca6-e0dd569d05a6 -->

    <Class rdf:about="http://example.org/b0c2b38c-66b9-4b37-bca6-e0dd569d05a6">
        <obo:IAO_0000115>The quantification of multipotent HSPCs is commonly performed according to the lineage-relationships proposed by the classical model of human hematopoiesis. According to this classical model, HSCs and multipotent progenitors (MPPs) are the only cells containing both myeloid as well as lymphoid differentiation potentials. However, the classical model of hematopoiesis has meanwhile been challenged by several groups proposing alternative lineage-relationships and read-outs for multipotent HSCs/MPPs. In this context, we have shown that human CD133+CD45RA-CD34+ HSPCs are enriched for multipotent HSPCs. In vitro, more than 80% of these cells perform asymmetric cell divisions to create one CD133+CD45RA+CD34+ and one CD133-CD45RA-CD34+ daughter cell. While ##CD133+CD45RA+CD34+ cells## inherit the potential to create all lymphocytes and neutrophils, CD133-CD45RA-CD34+ cells are limited to erythroid, megakaryocytic, basophilic and eosinophilic potentials. The first cell fulfills the criteria of LMPPs and the latter ones correspond to cells that are commonly known as common myeloid progenitors (CMP). As we demonstrated that they are not able to form neutrophils, it is no longer justified to interpret them as CMPs. Accordingly, we re-named them to erythro-myeloid progenitors (EMPs) and proposed a revised model for human hematopoiesis in which neutrophils arise from the same branch as lymphocytes (Fig. 1A). The segregation of lineage potentials as predicted in our revised model was recently confirmed in mouse as well as in human steady state BM hematopoiesis using single cell transcriptomics. According to the proposed model, multipotent HSPCs can easily and objectively be identified as CD133 expressing HSPCs containing erythroid differentiation potentials (Fig. 1A).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6733927</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31501490</oboInOwl:hasDbXref>
        <rdfs:label>CD133+CD45RA+CD34+ cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000037"/>
        <skos:relatedMatch rdf:resource="CL:0000837"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/b0c2b38c-66b9-4b37-bca6-e0dd569d05a6"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000037"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/b0c2b38c-66b9-4b37-bca6-e0dd569d05a6"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000837"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/b0f3ddfd-07c5-4ed5-bc31-4d137cc47fd4 -->

    <Class rdf:about="http://example.org/b0f3ddfd-07c5-4ed5-bc31-4d137cc47fd4">
        <obo:IAO_0000115>Lymphocytes such as CD4+ T cells and B cells mainly infiltrate the salivary glands; however, the precise roles and targets of autoreactive T cells and autoantibodies in the pathogenesis of Sjogren&apos;s Syndrome (SS) remain unclear. This study was designed to clarify the role of autoreactive T cells and autoantibodies at the single-cell level involved in the development of sialadenitis. Infiltrated CD4+ T and B cells in the salivary glands of a mouse model resembling SS were single-cell-sorted, and their ##T cell## receptor (TCR) and B cell receptor (BCR) sequences were analyzed. The predominant TCR and BCR clonotypes were reconstituted in vitro, and their pathogenicity was evaluated by transferring reconstituted TCR-expressing CD4+ T cells into Rag2-/- mice and administering recombinant IgG in vivo. The reconstitution of Th17 cells expressing TCR (#G) in Rag2-/- mice resulted in the infiltration of T cells into the salivary glands and development of sialadenitis, while an autoantibody (IgGr22) was observed to promote the proliferation of pathogenic T cells. IgGr22 specifically recognizes double-stranded RNA (dsRNA) and induces the activation of dendritic cells, thereby enhancing the expression of IFN signature and inflammatory genes. TCR#G recognizes antigens related to the gut microbiota. Antibiotic treatment severely reduces the activation of TCR#G-expressing Th17 cells and suppresses sialadenitis development. These data suggest that the anti-dsRNA antibodies and, TCR recognizing the gut microbiota involved in the development of sialadenitis like SS. Thus, our model provides a novel strategy for defining the roles of autoreactive TCR and autoantibodies in the development and pathogenesis of SS.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMID:38762063</oboInOwl:hasDbXref>
        <rdfs:label>T cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000084"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/b0f3ddfd-07c5-4ed5-bc31-4d137cc47fd4"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000084"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/b14a79fb-3451-4360-81cd-46fd75d1564e -->

    <Class rdf:about="http://example.org/b14a79fb-3451-4360-81cd-46fd75d1564e">
        <obo:IAO_0000115>The epicardium consists of a single layer of mesothelial cells on the surface of the heart that harbors a population of multipotent progenitors. Following epithelial-to-mesenchymal transition (EMT), epicardium-derived cells (EPDCs) migrate into the compact myocardium and differentiate into cardiac fibroblast and vascular mural cell lineages. Construction of the coronary plexus requires the integration of ##epicardium-derived mural cells## with arterial and venous ECs derived from the sinus venosus and endocardium. Genetic or mechanical disruption of the epicardium has also revealed important paracrine contributions to cardiomyocyte growth and coronary plexus formation. Our previous study found that epicardial EMT is required for coronary blood vessel maturation and integrity, at least partially via contributing vascular pericytes to the growing plexus.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8260743</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34230480</oboInOwl:hasDbXref>
        <rdfs:label>epicardium-derived mural cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0008034"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/b14a79fb-3451-4360-81cd-46fd75d1564e"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0008034"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/b1700222-4cb3-4c6d-9803-12692c97946d -->

    <Class rdf:about="http://example.org/b1700222-4cb3-4c6d-9803-12692c97946d">
        <obo:IAO_0000115>(a) Balloon-plot of known neuronal and glial cell markers (SOX10-MKI67). Progenitor: SOX10, FOXD3, ASCL1, Neuronal: PHOX2B, PRPH, NRG1, TUBB3, Sympathetic neurons: DBH, TH, Parasympathetic neurons: NOS1, VIP, Sensory neurons: PRDM12, P2RY1, TRPV1, Schwann Cell Progenitors (SCPs): CDH19, MPZ, PLP1, Glial cells: GFAP, S100B, Chromaffin cells: PNMT, PENK, CARTPT and Proliferating cells: MKI67, PCNA. The remaining genes correspond to the top-5, most selective genes for each cluster. From the statistically significant genes (adjusted p-value &lt; 0.001, MAST with Bonferroni correction using all features), the top-10 (log2 fold-change) were sorted according to the percent of positive cells and the top-5 were plotted. Gene order follows the cluster order. Balloon size: percent of positive cells. Color intensity: scaled expression. Blue: high, Gray: low. (b) Balloon-plot of the detected cholinergic-synapse pathway genes (KEGG id: 217716). Balloon size: percent of positive cells. Color intensity: log2(normalized UMI-counts+1) (library size was normalized to 10.000) expression. Blue: high, Gray: low. (c) Heatmap of differentially expressed transcription factors (TFs) along the SCP-neuronal trajectory, according to tradeSeq. Stars: analyzed genes in &apos;D-E&apos;. Color intensity: scaled expression. Dark red: high, Gray: low. (d) UMAP-plots of SOX10, ASCL1 and ISL1 TFs. Expression levels: log2(normalized UMI-counts+1) (library size was normalized to 10.000). Blue: high. Gray: zero. (e) Confocal-microscopy image of an 8.5 pcw ganglion, showing SOX10, ASCL1 and ISL1 expression, detected with immunofluorescence. Dashed outlines: manually segmented nuclei. SOX10pos SCPs (arrows), SOX10pos ASCL1pos transitioning SCPs (asterisks), ##ASCL1pos SOX10neg immature neurons## (hashes), ISL1pos ASCL1neg mature neurons (arrowheads). Scale-bar: 5 microm.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9928586</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36646791</oboInOwl:hasDbXref>
        <rdfs:label>ASCL1pos SOX10neg immature neurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:4042028"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/b1700222-4cb3-4c6d-9803-12692c97946d"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4042028"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/b17f2c4c-b990-4837-bd85-7c792974d990 -->

    <Class rdf:about="http://example.org/b17f2c4c-b990-4837-bd85-7c792974d990">
        <obo:IAO_0000115>Organoids are important research tools for studying organ morphogenesis and differentiation because they recapitulate ex vivo the native 3D organization of cells that is essential for proper cell and organ function. The composition of organoids can be manipulated to incorporate specific cell types to facilitate molecular interrogation of cell-cell interactions during organoid formation. A method for generating organoids derived from both ##embryonic salivary gland epithelial progenitor cells## and mesenchymal support cells is described. Methods for isolating enriched populations of the epithelial cells as clusters and the mesenchyme cells as single cells from mouse embryonic submandibular salivary glands are also provided. Separating the epithelial and mesenchymal cell populations allows for independent molecular manipulation of each cell type. In addition, methods for lentiviral transduction of the mesenchyme cells and quantitative image analysis of organoids are provided. The methods described here are useful for exploring mechanisms driving organ formation.   2018 by John Wiley &amp; Sons, Inc.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6948183</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:30394683</oboInOwl:hasDbXref>
        <rdfs:label>embryonic salivary gland epithelial progenitor cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000036"/>
        <skos:relatedMatch rdf:resource="CL:1001596"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/b17f2c4c-b990-4837-bd85-7c792974d990"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000036"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/b17f2c4c-b990-4837-bd85-7c792974d990"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:1001596"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/b1969b90-c389-4ae7-b5c2-6507c529a359 -->

    <Class rdf:about="http://example.org/b1969b90-c389-4ae7-b5c2-6507c529a359">
        <obo:IAO_0000115>Systems Organs Cell Types     Respiratory system Lung AT2 cells 0.79% 21.20%   Nose (nasal turbinate epithelial cells) Mesenchymal stromal cells 1.70% 8.50%   Plasma cells 2.00% 8.80%   Nose (nasal brushing epithelial cells) Plasma cells 4.00% 13.80%   Nose (nasal airway epithelial cells) Nasal airway epithelial cells 8.40% 23.10%   Digestive system Gall bladder ##Primordium cell## 2.20% 2.60%   Small intestine (jejunum) Enterocyte progenitor cell 14.00% 6.60%   Goblet cell 9.10% 2.60%   Small intestine (ileum) Intestinal epithelial stem cell 1.50% 4.20%   Enterocyte progenitor cell 2.40% 3.60%   Small intestine (duodenum) LGR5+ stem cell 5.20% 4.50%   Intestinal epithelial stem cell 3.90% 5.80%   Enterocyte progenitor cell 4.40% 6.80%   Tuft progenitor cell 7.40% 6.60%   Enteroendocrine cell 9.40% 3.80%   Large intestine (rectum) Goblet progenitor cell 2.80% 62.50%   MKI67+ progenitor cell 10.30% 75.40%   Enterocyte 13.20% 77.50%   Goblet cell 18.20% 87.30%   Large intestine (colon) Enterocyte 5.70% 52.10%   Goblet cell 11.00% 78.00%   Esophagus Secretory progenitor cell 9.40% 18.80%   Nervous system Brain (substantia nigra and cortex) Oligodendrocyte precursor cell 1.60% 0.90%   Astrocyte 1.90% 1.00%   Reproductive system Fallopian tube Epithelial cells 1.40% 26.50%   Ovarian somatic cell 1.00% 1.00%   Testis Spermatogonium 1.70% 4.50%   Peritubular myoid cell 1.70% 6.30%   Testis somatic cell 2.10% 4.30%   Spermatogonial stem cell 1.40% 2.10%   Circulatory system Heart Cardiomyocyte 6.60% 0.80%   Cardiovascular progenitor cell 12.50% 0.40%   Urinary system Kidney Nephron epithelial cell 2.70% 10.70%   Epithelial cell 2.70% 9.60%   Endothelial cell 2.70% 12.80%   Mesangial cell 3.00% 14.50%   </obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7794913</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33401657</oboInOwl:hasDbXref>
        <rdfs:label>Primordium cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000223"/>
        <skos:relatedMatch rdf:resource="CL:0011026"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/b1969b90-c389-4ae7-b5c2-6507c529a359"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000223"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/b1969b90-c389-4ae7-b5c2-6507c529a359"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0011026"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/b1a693df-3c99-4fe0-b9e4-79fc2b7b57c9 -->

    <Class rdf:about="http://example.org/b1a693df-3c99-4fe0-b9e4-79fc2b7b57c9">
        <obo:IAO_0000115>Luminal progenitors serve primarily as tumor initiators or cells of origin for prostate cancer. Various hierarchical models have been proposed. A recent model suggests that, during early postnatal development, multipotent basal cells (p63+ CK5+) differentiate into ##unipotent basal progenitors##, luminal progenitors (CK8+ AR low), and NE cells. These unipotent basal and luminal progenitors can undergo self-renewal or differentiate into basal cells and mature luminal cells (AR+ CK8+), respectively. In adults, during homeostasis and regeneration, the bipotent basal progenitor forms unipotent basal and luminal progenitors, which further undergo self-renewal. Unipotent basal progenitors differentiate into basal cells, and luminal cell progenitors differentiate into luminal cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10291985</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37282627</oboInOwl:hasDbXref>
        <rdfs:label>unipotent basal progenitors</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000035"/>
        <skos:relatedMatch rdf:resource="CL:0002341"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/b1a693df-3c99-4fe0-b9e4-79fc2b7b57c9"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000035"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/b1a693df-3c99-4fe0-b9e4-79fc2b7b57c9"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002341"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/b1afdb4e-441a-4519-b4ac-af67effe627c -->

    <Class rdf:about="http://example.org/b1afdb4e-441a-4519-b4ac-af67effe627c">
        <obo:IAO_0000115>A SNORD118 or B SNORD3A expression levels (determined by normalized reads count of small RNA-seq) in AML patients with low (n = 8) versus high ##LSC## frequency (n = 8). C Visualization of H3K27ac signals at SNORD118 locus (left panel) and SNORD3A locus (right panel). D Visualization of transcription level (determined by RNA-seq) of SNORD118 (left panel) and Rnu3b (right panel) in HSPCs from wildtype (WT), single mutant (Npm1c or Flt3-ITD), and double mutant (DM) mice, as well as neutrophils (NE) cells. E Visualization of H3K27ac signals at SNORD118 locus across hematopoietic stem cells (HSCs), progenitors, and mature cells. LT-HSC, long-term HSC; ST-HSC, short-term HSC; MPP, multipotent progenitors; CMP, common myeloid progenitors; GMP, granular-macrophage progenitors; GN, granulocytes; MON, monocytes. In A and B, Student&apos;s unpaired t-tests was performed. ***p &lt; 0.001 (two-sided, not multiple testing corrected). Bars represent the mean.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11286530</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38942785</oboInOwl:hasDbXref>
        <rdfs:label>LSC</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000034"/>
        <skos:relatedMatch rdf:resource="CL:0000164"/>
        <skos:relatedMatch rdf:resource="CL:0000738"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/b1afdb4e-441a-4519-b4ac-af67effe627c"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000034"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/b1afdb4e-441a-4519-b4ac-af67effe627c"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000164"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/b1afdb4e-441a-4519-b4ac-af67effe627c"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000738"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/b1e2bfdc-37e6-40be-9f39-09ed98a1cc5f -->

    <Class rdf:about="http://example.org/b1e2bfdc-37e6-40be-9f39-09ed98a1cc5f">
        <obo:IAO_0000115>It has been well-documented that total CD4+CD45RA+ naive T cells are reduced, and total CD4+CD45RO+ memory T cells are spared following alemtuzumab treatment. Our data show similar changes in total memory (supplementary Figure S3A) and total naive CD4+ T cells (Figure S3B). Figure S3 also illustrates changes over time in subsets of naive and memory CD4+ T cells, defined as described by Lovett-Racke and colleagues. Briefly, lymphocytes were identified in FSC/SSC plots, followed by gating on CD4+CD45RA+ or CD45RA- cells to identify CD27+ and CD27- lymphocytes (FACS gating strategy not illustrated). Figure S3 shows that the percentage of CD4+CD45RA+CD27+ naive T cells (Figure S3C) was reduced at M5 and M17, while CD4+CD45RA-CD27+ central memory T cells (TCM; Figure S3D) remained relatively stable over time. The percentage of CD4+CD45RA-CD27- effector memory T cells (TEM; Figure S3E) increased at M5, along with ##CD4+CD45RA+ new effector T cells## (new Teff; Figure S3F).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7296935</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32539719</oboInOwl:hasDbXref>
        <rdfs:label>CD4+CD45RA+ new effector T cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0001044"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/b1e2bfdc-37e6-40be-9f39-09ed98a1cc5f"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0001044"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/b1ee9284-cacd-4d9f-b4f4-7f8dc5e29621 -->

    <Class rdf:about="http://example.org/b1ee9284-cacd-4d9f-b4f4-7f8dc5e29621">
        <obo:IAO_0000115>a Immune cell subsets analyzed by CellChat in the original tSNE plot. b Enhanced number of interactions and interaction strength noted in cSjD. Differential interaction strength c and numbers d are presented on the heatmap. The overall increase in the interaction strength in the signal-receiving effector immune subsets, along with a dramatic increase in the interaction numbers noted between FOXP3low Tregs (or naive Tregs) and myeloid/B subsets, in cSjD compared to HC. Bars refer to the sum of the computed interaction strength or numbers in each column and row. Relative values = the interaction strength/number from source to target in cSjD-the interaction strength/number from source to target in HC. e-g Identification of significant ligand and receptor pairs between immune subsets of interest. e The communication probability of CLEC2C ligand and KLRB1 receptor genes are significantly upregulated between B and effector memory CD4+ T cell subsets in cSjD. f FOXP3low Tregs show increased communication probability with myeloid subsets through CD4 and MHC class II-related genes in cSjD, compared to HC. g Pairs of CLEC ligands and KLRB receptor genes show increased communication probability in gammadelta-T cells of Bx and BxRP, compared to non-cSjD. Mo monocytes, NK natural killer, eff effector, em ##effector memory##, mem memory, cm central memory T cell, nv naive, pDC plasmacytoid dendritic cells, MAIT mucosal-associated invariant T, act activated or FOXP3high, IFN interferon-related, HC healthy control, cSjD childhood Sjogren&apos;s disease, BX biopsy-positive non-cSjD without RP, BXRP biopsy-positive non-cSjD with RP.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11031574</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38641668</oboInOwl:hasDbXref>
        <rdfs:label>effector memory</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000905"/>
        <skos:relatedMatch rdf:resource="CL:0000913"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/b1ee9284-cacd-4d9f-b4f4-7f8dc5e29621"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000905"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/b1ee9284-cacd-4d9f-b4f4-7f8dc5e29621"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000913"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/b1efc4d6-a187-4a9f-8556-5b1472aac284 -->

    <Class rdf:about="http://example.org/b1efc4d6-a187-4a9f-8556-5b1472aac284">
        <obo:IAO_0000115>Brain-derived neurotrophic factor (BDNF) and neurotrophin 3 (NT-3) are known to regulate neuronal morphology and the formation of neural circuits, yet the neuronal targets of each neurotrophin are still to be defined. To address how these neurotrophins regulate the morphological and synaptic differentiation of developing olfactory bulb (OB) GABAergic interneurons, we analyzed the effect of BDNF and NT-3 on GABA+-neurons and on different subtypes of these neurons: tyrosine hydroxylase (TH+); calretinin (Calr+); calbindin (Calb+); and parvalbumin (##PVA+##). These cells were generated from cultured embryonic mouse olfactory bulb neural stem cells (eOBNSCs) and after 14 days in vitro (DIV), when the neurons expressed TrkB and/or TrkC receptors, BDNF and NT-3 did not significantly change the number of neurons. However, long-term BDNF treatment did produce a longer total dendrite length and/or more dendritic branches in all the interneuron populations studied, except for PVA+-neurons. Similarly, BDNF caused an increase in the cell body perimeter in all the interneuron populations analyzed, except for PVA+-neurons. GABA+- and TH+-neurons were also studied at 21 DIV, when BDNF produced significantly longer neurites with no clear change in their number. Notably, these neurons developed synaptophysin+ boutons at 21 DIV, the size of which augmented significantly following exposure to either BDNF or NT-3. Our results show that in conditions that maintain neuronal survival, BDNF but not NT-3 promotes the morphological differentiation of developing OB interneurons in a cell-type-specific manner. In addition, our findings suggest that BDNF and NT-3 may promote synapse maturation by enhancing the size of synaptic boutons.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMID:33392918</oboInOwl:hasDbXref>
        <rdfs:label>PVA+</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:4023018"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/b1efc4d6-a187-4a9f-8556-5b1472aac284"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4023018"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/b1f2065f-2212-4faf-b465-6ee84e2fdcbe -->

    <Class rdf:about="http://example.org/b1f2065f-2212-4faf-b465-6ee84e2fdcbe">
        <obo:IAO_0000115>Transcriptional signature of pancreas infiltrating and circulating CD4+ and CD8+ T cell subsets at disease onset. (A) UMAP plot of CD4+ and CD8+ T cells from peripheral blood and pancreas of new-onset diabetic NOD mice. (B) Feature plots depicting gene expression levels of distinct markers driving CD4+ and CD8+ T cell activation states. (C, D) UMAP plot of CD4+ (C) and CD8+ (D) T cells grouped by the annotation in A (left) and grouped by T cell subset classified based on the expression of Cd44 and Sell (right). EM = ##effector memory## (Cd44+Sell-), CM = central memory (Cd44+Sell+), naive (Cd44-Sell+), and CD44low CD62L- (Cd44-Sell-). (E, F) Heatmap depicting row-based z-scores of scaled gene expression levels for marker genes driving T cell heterogeneity across the distinct CD4+ (E) and CD8+ (F) T cell subsets. (G, H) Trajectory of CD4+ (G) and CD8+ (H) naive, CD44low CD62L-, effector memory (EM), and central memory (CM) T cell subsets projected onto the UMAP plot (top). Violin plots depicting the pseudotime of CD4+ (G) and CD8+ (H) T cells per subset (bottom). Each dot represents a single cell. (I, J) Differentially expressed genes of CD4+ Cd44-Sell- (I) and CD8+ Cd44-Sell- (J) T cells between peripheral blood and pancreas.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10667927</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38027120</oboInOwl:hasDbXref>
        <rdfs:label>effector memory</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000905"/>
        <skos:relatedMatch rdf:resource="CL:0000913"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/b1f2065f-2212-4faf-b465-6ee84e2fdcbe"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000905"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/b1f2065f-2212-4faf-b465-6ee84e2fdcbe"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000913"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/b1f5ecec-470a-4357-b558-2a5c27c324b7 -->

    <Class rdf:about="http://example.org/b1f5ecec-470a-4357-b558-2a5c27c324b7">
        <obo:IAO_0000115>scRNA sequencing data was analyzed to further explore the synergistic effect of the IRRS and the TME cells in ESCC. We used the previously profiled transcriptomes of ~208,659 single cells with eight main cell populations ( Figures 4A, B ), among which fibroblasts, endothelial cells, T cells, B cells, pericytes and myeloid cells were analyzed. Next, 40 cell clusters, including T helper 17 (TH17) cells, follicular helper T (TFH1/2) cells, naive T (TN) cells, regulatory T (Treg) cells, memory T (TMEM-CD4/CD8) cells, effector T (TEFF) cells, exhausted T (TEX) cells, monocytes (Mono01-03), ##tumor-associated macrophages## (TAM01-04),dendritic cells (tDC, pDC, cDC), mast cells (Mast), resting B cells, activated B cells, germinal center B cells (GCB), plasma cells, normal mucosa fibroblasts (NMF), normal activated fibroblasts (NAF1/2), cancer-associated fibroblasts (CAF1-4), vascular smooth muscle cells (VSMC), normal endothelial cells (NEC1-3) and tumor endothelial cell (TEC1-3) were identified by t-SNE analysis ( Figures 4C-G ;  Figures S6A-E ). We then used CIBERSORTx to infer cell-type abundance from bulk RNA-seq data using scRNA data, and estimated the proportions of the 42 cell types in the training dataset. The proportions of TME cell types between the high- and low-risk groups was compared using the Kruskal-Wallis test. The profiles of the high- and low-risk groups are shown in  Figure 4H  and  Figure S6F . The abundance of TEX, NAF2, CAF4, and VSMC increased, and the abundance of Mono1, TAM03, and NEC2 decreased in the high-risk group (p &lt; 0.05;  Figure 4I ). The cell proportions between low and high risk groups demonstrated significantly distinct TME patterns.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9933905</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36817484</oboInOwl:hasDbXref>
        <rdfs:label>tumor-associated macrophages</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/b1f5ecec-470a-4357-b558-2a5c27c324b7"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/b21b1346-0671-47cd-b0a8-c74c5cc1a3a5 -->

    <Class rdf:about="http://example.org/b21b1346-0671-47cd-b0a8-c74c5cc1a3a5">
        <obo:IAO_0000115>Next, we analyzed the interactions between these ligand-receptor pairs from the TME among 12 kinds of immune cells, and found that CCL5-CCR1 mainly sends signals of CD8+ T cells and NK Cells, which may interact with pDCs, macrophages, cDC2s, and myeloid cells via the interaction of CCL5 and CCR1. The SELPLG-SELL ligand-receptor pair is the main interaction among CD4+ T cells, NK cells, myeloid cells, and naive B cells. Furthermore, NOTCH2-cDCs interact with pDCs, CD4+ T cells, cCD2s, NK cells, myeloid cells, naive B cells, and cDC1s. Both ##migDCs## and cDC1s interact with CD4+ T cells, pDCs, cCD2s, NK Cells, myeloid cells, and naive B cells. The CXCL10-CXCR3 ligand-receptor pair is the main interaction among pDCs, migDCs, and CD4+ T cells, and the CXCL9-CXCR3 ligand-receptor pair is the main interaction among pDCs, cDC1s, migDCs, and CD4+ T cells (Fig. 8C). We also used a violin plot to visualize the signal gene expression distribution in the three signaling pathways inferred by CellChat. The results showed that CCL5 is mainly expressed on CD8+ T and NK cells, and its corresponding receptors are mainly in macrophages, myeloid cells, cCD2s, and pDCs. SELPLG is mainly expressed on CD4+ T cells, NOTCH2-cDCs, migDCs, and cDC1s, and its corresponding receptor, SELL, is mainly expressed on naive B cells, myeloid cells, NK cells, cCD2s, pDCs, CD4+ T cells, and cCD1s. CXCL9 is mainly expressed on pDCs, migDCs, and cDC1s, CXCL10 is mainly expressed on pDCs and migDCs, and their corresponding receptor, CXCR3, is mainly expressed on CD4+ T cells (Fig. 8D).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9203818</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35710862</oboInOwl:hasDbXref>
        <rdfs:label>migDCs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000451"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/b21b1346-0671-47cd-b0a8-c74c5cc1a3a5"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000451"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/b245c2a8-b5f4-4a9d-940a-33f4a909db7c -->

    <Class rdf:about="http://example.org/b245c2a8-b5f4-4a9d-940a-33f4a909db7c">
        <obo:IAO_0000115>To illustrate the application of CSN to developing cells, we feature the developmental trajectory of human excitatory neuron cells in the Developing Cortex Atlas dataset (15), which includes Radial Gila and Progenitors (P), ##Intermediate Progenitors## (IP), Maturing Excitatory (ExN), Migrating Excitatory (ExM), Excitatory Upper-layer enriched (ExM-U), and Excitatory Deep layer (ExDp), with cell type labels determined by the authors (SI Appendix, section 3 and Table S2). Using Slingshot, we estimate the developmental path consists of two trajectories, one ending in upper-layer (U curve) and the other in deep-layer (D curve) excitatory neurons (Fig. 3 A and B).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8713783</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34903665</oboInOwl:hasDbXref>
        <rdfs:label>Intermediate Progenitors</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0011026"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/b245c2a8-b5f4-4a9d-940a-33f4a909db7c"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0011026"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/b2493cee-165c-4e1f-abbd-b3bee330055f -->

    <Class rdf:about="http://example.org/b2493cee-165c-4e1f-abbd-b3bee330055f">
        <obo:IAO_0000115>Brain-derived neurotrophic factor (BDNF) and neurotrophin 3 (NT-3) are known to regulate neuronal morphology and the formation of neural circuits, yet the neuronal targets of each neurotrophin are still to be defined. To address how these neurotrophins regulate the morphological and synaptic differentiation of developing olfactory bulb (OB) GABAergic interneurons, we analyzed the effect of BDNF and NT-3 on GABA+-neurons and on different subtypes of these neurons: tyrosine hydroxylase (TH+); calretinin (Calr+); calbindin (Calb+); and parvalbumin (PVA+). These cells were generated from cultured embryonic mouse olfactory bulb neural stem cells (eOBNSCs) and after 14 days in vitro (DIV), when the neurons expressed TrkB and/or TrkC receptors, BDNF and NT-3 did not significantly change the number of neurons. However, long-term BDNF treatment did produce a longer total dendrite length and/or more dendritic branches in all the interneuron populations studied, except for PVA+-neurons. Similarly, BDNF caused an increase in the cell body perimeter in all the interneuron populations analyzed, except for PVA+-neurons. ##GABA+- and TH+-neurons## were also studied at 21 DIV, when BDNF produced significantly longer neurites with no clear change in their number. Notably, these neurons developed synaptophysin+ boutons at 21 DIV, the size of which augmented significantly following exposure to either BDNF or NT-3. Our results show that in conditions that maintain neuronal survival, BDNF but not NT-3 promotes the morphological differentiation of developing OB interneurons in a cell-type-specific manner. In addition, our findings suggest that BDNF and NT-3 may promote synapse maturation by enhancing the size of synaptic boutons.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMID:33392918</oboInOwl:hasDbXref>
        <rdfs:label>GABA+- and TH+-neurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000617"/>
        <skos:relatedMatch rdf:resource="CL:4023075"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/b2493cee-165c-4e1f-abbd-b3bee330055f"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000617"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/b2493cee-165c-4e1f-abbd-b3bee330055f"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4023075"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/b2843173-427a-4646-92c6-5bde0c55d072 -->

    <Class rdf:about="http://example.org/b2843173-427a-4646-92c6-5bde0c55d072">
        <obo:IAO_0000115>High levels of Oct4 mRNA were found in the 2-cell blastomere population in all conditions, followed by a decrease at the 4-cell stage and a strong increase in 8-cell blastomeres (Fig. 5E), an expression pattern reflecting the transition of maternal-to-zygotic Oct4 transcripts at the 4-cell stage (Wu and Scholer). There was a decrease of Oct4 expression in the bulk of both Ahr-/- and Ahr+/+-TCDD groups relative to Ahr+/+ at the 8-cell stage and in Ahr-/- than in Ahr+/+ 2-cell blastomeres. Similarly, we found a significant decrease of Oct4 expression in both Ahr-/- and Ahr+/+-TCDD, notably in both embryonic and differentiating blastomeres relative to the corresponding Ahr+/+ 8-cell subpopulations; in all conditions, differentiating blastomeres at 8-cell stage had higher expression levels than their embryonic counterparts (Fig. 5F). Furthermore, the levels of Oct4 transcription in Ahr-/- and Ahr+/+-TCDD 4-cell embryonic blastomeres decreased or had a trend to decrease, respectively, relative to the corresponding Ahr+/+ blastomeres. The levels of Cdx2 mRNA were high in all 8-cell blastomeres analyzed and were significantly decreased or trended to decrease in the bulk of Ahr-/- and Ahr+/+-TCDD relative to the Ahr+/+ 8-cell population (Fig. 5G). The Cdx2 mRNA levels were higher in Ahr+/+ and Ahr-/- 8-cell differentiating blastomeres than in their embryonic counterparts, with the Ahr-/- 8-cell differentiating blastomeres showing lower expression than the corresponding Ahr+/+ subpopulation (Fig. 5H). Additionally, some ##Ahr+/+-TCDD 8-cell embryonic blastomeres## showed unusually high levels of Cdx2 mRNA causing the indistinguishable difference between embryonic and differentiating subpopulations.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10425484</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36029422</oboInOwl:hasDbXref>
        <rdfs:label>Ahr+/+-TCDD 8-cell embryonic blastomeres</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000353"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/b2843173-427a-4646-92c6-5bde0c55d072"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000353"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/b2bfba00-6897-4c40-9b54-521b32d5e5eb -->

    <Class rdf:about="http://example.org/b2bfba00-6897-4c40-9b54-521b32d5e5eb">
        <obo:IAO_0000115>Arid1a loss produces an immunosuppressive TME via the induction of ##PMN-MDSC## recruitment.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9701216</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36435834</oboInOwl:hasDbXref>
        <rdfs:label>PMN-MDSC</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000889"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/b2bfba00-6897-4c40-9b54-521b32d5e5eb"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000889"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/b2fbaaa6-132a-435d-aa83-d68531c1af35 -->

    <Class rdf:about="http://example.org/b2fbaaa6-132a-435d-aa83-d68531c1af35">
        <obo:IAO_0000115>Subpopulation identification of pancreatic mesenchymal cells in normal mice. (A) t-SNE illustration of four subgroups identified from sub-clustering of the mesenchymal cell population, colored according to the cluster assignments (left panel). Tables demonstrating the top differentially expressed genes when comparing one subcluster to all other ##mesenchymal cells## (right panel). (B) Violin plots showing representative marker genes in the subgroups. (C) Representative GO terms enriched for marker genes in Mes.4 based on a functional enrichment analysis. (D,E) Representative immunohistochemical images of pancreatic tissues from the control mice stained for Fn1 (red arrow) and Cxcl14 (black arrow). Scale bar = 50 mum.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9222509</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35741777</oboInOwl:hasDbXref>
        <rdfs:label>mesenchymal cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0008019"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/b2fbaaa6-132a-435d-aa83-d68531c1af35"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0008019"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/b3374161-b2cb-4c8e-bf87-711f9ec05dcb -->

    <Class rdf:about="http://example.org/b3374161-b2cb-4c8e-bf87-711f9ec05dcb">
        <obo:IAO_0000115>In addition, myeloid cells, in particular monocytes and DC subsets, upregulated expression of genes involved in TLR signaling pathway (e.g., MyD88, Cxcl9, and CD40), consistent with the fact that 3M-052 stimulates TLR signaling. Other innate immune processes including complement (e.g., C3, Cfb) and inflammasome (e.g., Casp3, Il18, Il1rn) genes were also found to be significantly upregulated mainly in monocytes and tDCs, and to a lesser extent in XCR1- and XCR1+ DCs (Fig. 2d). In comparison, lymphoid cells such as innate lymphoid cells (ILCs), gammadeltaT cells, and CD8+ lymphocytes, exhibited higher expression of genes that are involved in cytokine responses (e.g., Jak2, Nfkbia) when compared to myeloid cell subsets (Fig. 2d). This may indicate indirect activation through cytokines being produced by monocytes and DCs. Furthermore, we observed a downregulation of antigen processing and presentation gene modules defined by genes such as H2-Eb1, H2-Aa, and Cd74 in monocytes, but an upregulation of these genes in ##XCR1- DCs##, migratory DCs, ILC2, and ILC3 (Fig. 2d). This is consistent with previous reports of MHCII gene expression in ILC2 and ILC3 as well as the involvement of these innate lymphoid subsets in antigen presentation. The decrease in MHCII presentation genes also supports the notion that more inflammatory monocytes, which have a relatively low expression of MHCII genes compared to resting monocytes, were recruited to the lymph nodes on day 1 after stimulation.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8795432</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35087093</oboInOwl:hasDbXref>
        <rdfs:label>XCR1- DCs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000451"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/b3374161-b2cb-4c8e-bf87-711f9ec05dcb"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000451"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/b34872e8-f729-4a3e-bec4-092fe55c0549 -->

    <Class rdf:about="http://example.org/b34872e8-f729-4a3e-bec4-092fe55c0549">
        <obo:IAO_0000115>Considering the close relationship between RGPRG score and immune activity, we sought to further explore the immune infiltrate landscape of two RGPRG score groups. The 22 immune cell composition of HCC patients from the TCGA cohort was shown in Fig. 5A. CD8 T cells, resting memory CD4 T cells, M0 Macrophages, M1 Macrophages, and M2 Macrophages were the main immune cell composition of HCC patients. Many differential immune cell infiltrations could be observed between high- and low-RGPRG score groups (Fig. 5B). Patients with high RGPRG score was characterized by the high infiltration of resting memory CD4 T cells, M0 Macrophages, T cells regulatory (Tregs), naive B cells, memory B cells, Plasma cells, naive CD4 T cells, Eosinophils, indicating a status of immunosuppression in this groups. CD8 T cells, activated memory CD4 T cells, activated NK cells, M1 Macrophages, M2 Macrophages, follicular helper T cells, gamma delta T cells, Neutrophils, resting Dendritic cells, ##activated Dendritic cells##, resting NK cells, Monocytes, resting Mast cells, and activated Mast cells were abundant in the patients with low RGPRG score (Fig. 5C), suggesting enhanced antitumor environment. In addition, the expression of 8 classical immune checkpoint genes between two RGPRG score groups was further estimated in the TCGA cohort, and we found that Patients with high RGPRG score had higher expression levels of CD274, CTLA4, LAG3, PDCD1, and TIGIT (Fig. 5D), which presented another characteristic of immunosuppression.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10832138</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38297333</oboInOwl:hasDbXref>
        <rdfs:label>activated Dendritic cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000451"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/b34872e8-f729-4a3e-bec4-092fe55c0549"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000451"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/b350d0b2-e283-420e-9a2c-950ffad6d244 -->

    <Class rdf:about="http://example.org/b350d0b2-e283-420e-9a2c-950ffad6d244">
        <obo:IAO_0000115>Expression patterns of pCMV-SpCas9-RFP and pVMD2-SpCas9-RFP in human retinal organoids. (a) RPE characteristics of pigmentation and hexagonality were confirmed in a 3D sphere and 2D monolayer status (b) Retinal organoids express various retinal markers being appropriate to normal developmental stages. A bright-field image and fluorescent image of the human retinal organoid are displayed in pairs (c,d; e,f). (c,d) The pCMV vector expressed RFP both in the RPE and neural retina; (e,f) whereas the pVMD2 vector expressed RFP only in RPE [c,e = bright-field image; d,f = fluorescent image]. Each protein marks specific structure or cell types as follows: ZO-1: Tight junction; SOX2: Neural progenitor cell; RX: Retinal progenitor cell; CRX: Photoreceptor progenitor cell; Recoverin: Photoreceptor precursor cell; CHX10: ##Neural retinal progenitor cell##; SNCG: Retinal ganglion cell; Ki67: Proliferating cell; RxRgamma: Cone precursor cell; CRALBP: Muller glia cell; Rhodopsin: Rod photoreceptor cell; M/L opsin: M/L cone photoreceptor.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9988861</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36878916</oboInOwl:hasDbXref>
        <rdfs:label>Neural retinal progenitor cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002672"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/b350d0b2-e283-420e-9a2c-950ffad6d244"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002672"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/b356304b-600c-4319-bddc-7dbe4d96974c -->

    <Class rdf:about="http://example.org/b356304b-600c-4319-bddc-7dbe4d96974c">
        <obo:IAO_0000115>Meningeal ILC2s express Thy1.2, ST2, CD25, spinocerebellar ataxia type 1 (Sca10), and low levels of c-Kit and IL-7Ralpha and are major producers of IL-13 in tissues. As tissue-resident cells, ILC2s exhibit tissue-specific receptor expression patterns, which are imprinted by local signals. Likewise, dural ILC2s are distinct from ##lung ILC2s##. The basal activation state of meningeal ILC2s is lower than that of lung-resident cells. The proximity to brain-derived signals may explain the differences in basal activation observed between the two tissue types. ILC2 precursors originate from bone marrow. Future studies should determine the functional and phenotypic differences between blood-derived ILC2s and the adjacent bone marrow.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10616183</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37429945</oboInOwl:hasDbXref>
        <rdfs:label>lung ILC2s</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0001069"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/b356304b-600c-4319-bddc-7dbe4d96974c"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0001069"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/b37beea0-e23b-4a9e-851d-1bbb979ed740 -->

    <Class rdf:about="http://example.org/b37beea0-e23b-4a9e-851d-1bbb979ed740">
        <obo:IAO_0000115>To comprehensively analyze mouse BM hematopoiesis, the present study sorted lineage-negative cells to form single-cell resolution; the marker genes are shown in Figure 2A. The UMAP clustering map of mouse BM stem cells/progenitors (c-kit+) yielded two integrated samples. The UMAP plot showed the distribution of six cellular clusters, in which there were 2 HSC and 3 GMP subclusters color-coded according to cell subclusters (Figure 2B). We then sort cells from HSCs to lineage-specified progenitors in pseudotime to understand different trajectories and development states. As shown in Figure 2C, Monocle illustrated the percentage of cell type at similar branch points. Single-cell resolution also validated the immunophenotype results wherein RalA increased the self-renewal of HSC-1, MPPs, and GMP-1 in RalARosa26-Tg/+mice (Figure 2D). Heatmaps show the expression levels of the 5 most significantly enriched genes in every cluster (Supplementary Figure S5). Next, immunophenotype-defined cellular transcriptomes were comprehensively compared. The unsupervised hierarchical clustering showed transcriptional heterogeneities of immunophenotypical HSCs (##iHSCs##). The iHSCs were classified into two groups with different transcriptional characteristics: HSC-1 (Figure 2E) and HSC-2 (Figure 2F).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10008703</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36923939</oboInOwl:hasDbXref>
        <rdfs:label>iHSCs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000037"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/b37beea0-e23b-4a9e-851d-1bbb979ed740"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000037"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/b385bed2-f461-4812-9ddb-f4aa866fdf25 -->

    <Class rdf:about="http://example.org/b385bed2-f461-4812-9ddb-f4aa866fdf25">
        <obo:IAO_0000115>Cell Population Identity (Abbr.) Up Reg(14,498) IG(85) ORA p ORA q Mean FCIG Mean FCRest GSEA p GSEA q No. IGs with highest expression   Neuroendocrine cells (NendC) 3868 47 2.12E-08 3.82E-07 11.88 5.42 0.0017 0.0051 26   Mature Neurons (all types) (mNEUR) 2968 32 0.0002 0.0035 8.80 9.28 - - 2    Arachnoid barrier cells (ABC) 2287 20 0.0396 0.7120 16.84 22.63 - - 7    Tanycytes (TNC) 1279 12 0.0692 1 6.64 12.01 - - 8    Vascular and leptomeningeal cells (VLMC) 1714 15 0.0724 1 15.06 13.03 0.0468 0.1404 4    Oligodendrocyte precursor cells (OPC) 1524 13 0.1067 1 3.03 7.17 - - 1    Pericytes (PC) 1801 14 0.1649 1 8.20 8.22 - - 2    Olfactory ensheathing glia (OEG) 1086 9 0.1848 1 7.95 26.03 - - 1    Oligodendrocytes (OLG) 1183 9 0.2561 1 3.73 12.91 - - 5   Choroid plexus epithelial cells (CPC) 2602 17 0.3524 1 7.43 19.34 - - 5    Hemoglobin-expressing vascular cells (##Hb_VC##) 1798 11 0.4889 1 5.25 6.33 - - 3    Vascular smooth muscle cells (VSMC) 3006 17 0.6093 1 8.94 6.71 0.1376 0.4128 5    Astrocyte-restricted precursors (ARP) 1445 8 0.6214 1 4.50 5.09 - - 1    Neural stem cells (NSC) 1009 5 0.7138 1 4.00 4.09 - - 0    Ependymocytes (EPC) 3233 17 0.7346 1 15.04 53.27 - - 4    Endothelial cells (EC) 1455 7 0.7619 1 5.80 8.54 - - 0    Hypendymal cells (HypEPC) 1525 6 0.8946 1 17.24 20.80 - - 5    Neuronal-restricted precursor (NRP) 2339 10 0.8979 1 3.07 10.20 - - 1    Astrocytes (ASC) 1384 4 - - 2.22 6.04 - - 0    Dendritic cells (DC) 1209 1 - - 3.50 16.02 - - 1    Immature Neurons (ImmN) 652 4 - - 3.37 5.79 - - 0    Macrophages (MAC) 1222 2 - - 3.47 21.56 - - 0    Microglia (MG) 1342 3 - - 19.28 19.22 - - 3    Monocytes (MNC) 947 2 - - 16.49 19.13 - - 1    Neutrophils (NEUT) 519 2 - - 9.18 62.13 - - 0   </obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9670596</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36384442</oboInOwl:hasDbXref>
        <rdfs:label>Hb_VC</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000071"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/b385bed2-f461-4812-9ddb-f4aa866fdf25"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000071"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/b3ee23b5-d67c-4da3-9624-f4f7239787d8 -->

    <Class rdf:about="http://example.org/b3ee23b5-d67c-4da3-9624-f4f7239787d8">
        <obo:IAO_0000115>a Line drawing of a cross section of the floor of the cochlear duct at P1. Distinct cell types within the organ of Corti (OC) are color coded. b Heat map for ~14,000 cochlear cells collected from four separate experiments at P1. Top 25 differentially expressed (DE) genes for the 15 identified clusters are shown. Cellular identity for each cluster is indicated by a color bar at the top of the heat map, which corresponds to the legend in a, and by a cell name at the bottom. c tSNE plot for the same cells as in b. Cluster identities are indicated. d Violin plots showing normalized log-transformed expression values for the top five DE genes for each cell type (color coded as in c) by comparison with all other P1 cells (gray on the right in each graph). Bars indicate median expression level. e Upper left panel, tSNE plot of cells determined to be derived from KO (between the OC and medial edge of the cochlear duct). Lower left panel, feature plot for the same cells as in the upper panel indicating high expression of Otoa, Calb1, and Fabp7 (based on color) in different clusters of cells. Lower right panel, cross sections through the cochlear duct at P1, illustrating expression of CALB1 in the medial region of KO and FABP7 directly adjacent to the OC (arrow; scale bars, 20 mum). Lowest panel shows high-magnification view of expression of FABP7 (arrow, gray scale) at the lateral KO border (green line; scale bar, 10 mum). Upper right panel, summary diagram of the spatial distribution of KO cell clusters at P1. HC hair cells, IPhC inner phalangeal cells/border cells, IPC inner pillar cells, OPC outer pillar cells, DC1/2 Deiters&apos; cells rows 1 and 2, DC3, Deiters&apos; cells row 3, HeC Hensen&apos;s cells, CC/OSC Claudius cells/outer sulcus cells, IdC interdental cells, ISC inner sulcus cells, KO ##Kolliker&apos;s organ cells##, L.KO lateral Kolliker&apos;s organ cells, M.KO medial Kolliker&apos;s organ cells, OC90 OC90+ cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7221106</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32404924</oboInOwl:hasDbXref>
        <rdfs:label>Kolliker&apos;s organ cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002490"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/b3ee23b5-d67c-4da3-9624-f4f7239787d8"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002490"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/b3fca337-9f63-4f46-ba29-a640fa6f50bf -->

    <Class rdf:about="http://example.org/b3fca337-9f63-4f46-ba29-a640fa6f50bf">
        <obo:IAO_0000115>Comparison of the single cell landscape between healthy human meniscus and degenerated meniscus. (A) Representative polarised light microscopy images of healthy human and degenerated meniscus. The white and red colours in the angle images are 90  apart in orientation. Dashed lines indicate the surface of the meniscus. Scale bar, 100 microm. (B) Merged t-distributed stochastic neighbour embedding (t-SNE) of single-cell RNA sequencing of healthy meniscus cells and degenerated meniscus cells. (C) Twelve healthy human and degenerated meniscus cell clusters at t-SNE. (D) Proportion of each cluster to the total cells. (E) Proportion of healthy and degenerated meniscus cells in each cluster. (F) Expression of representative marker genes in Vin plot. (G) Heatmap revealing the scaled expression of differentially expressed genes for each cluster. (H) CD146 and CD318 expression in healthy human meniscus cells and degenerated meniscus cells determined by flow cytometry. n&gt;=5, **p&lt;0.01. (I) Representative IHC staining of COL1A1 and COL2A1 healthy human meniscus and degenerated meniscus, and quantification of positive cells. Scale bar, 50 microm. n&gt;=5, **p&lt;0.01. (J) The expression of indicated marker genes in human healthy meniscus cells and degenerated meniscus cells were detected by qRT-PCR. *p&lt;0.05, **p&lt;0.01, otherwise, not significant. n=3, *p&lt;0.05, **p&lt;0.01. CPC, cartilage progenitor cells; DegP, degenerated meniscus progenitor cells; EC, endothelial cells; FC, ##fibrochondrocytes##; FCP, fibrochondrocyte progenitors; HTC, hypertrophic chondrocytes; MoDC, monocyte-derived dendritic cells; PreHTC, prehypertrophic chondrocytes; ProFC, proliferate fibrochondrocytes; RegC, regulatory chondrocytes.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7034356</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31871141</oboInOwl:hasDbXref>
        <rdfs:label>fibrochondrocytes</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000138"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/b3fca337-9f63-4f46-ba29-a640fa6f50bf"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000138"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/b42825d7-2a86-45e1-949c-8d4698bee193 -->

    <Class rdf:about="http://example.org/b42825d7-2a86-45e1-949c-8d4698bee193">
        <obo:IAO_0000115>To illustrate the application of CSN to developing cells, we feature the developmental trajectory of human excitatory neuron cells in the Developing Cortex Atlas dataset (15), which includes Radial Gila and Progenitors (P), Intermediate Progenitors (IP), Maturing Excitatory (ExN), Migrating Excitatory (ExM), Excitatory Upper-layer enriched (##ExM-U##), and Excitatory Deep layer (ExDp), with cell type labels determined by the authors (SI Appendix, section 3 and Table S2). Using Slingshot, we estimate the developmental path consists of two trajectories, one ending in upper-layer (U curve) and the other in deep-layer (D curve) excitatory neurons (Fig. 3 A and B).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8713783</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34903665</oboInOwl:hasDbXref>
        <rdfs:label>ExM-U</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:4030059"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/b42825d7-2a86-45e1-949c-8d4698bee193"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4030059"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/b435ea23-8ade-451e-9193-c9eeba6950db -->

    <Class rdf:about="http://example.org/b435ea23-8ade-451e-9193-c9eeba6950db">
        <obo:IAO_0000115>Innate Immune Cells	 	Primary Cell Type	Cell subsets	Metabolic Processes	References	 	   Innate Lymphoid Cells	Non-cytolytic:Innate lymphoid cell 1 (ILC1) Innate lymphoid cell 2 (ILC2) Innate lymphoid cell 3 (ILC3)/Lymphoid Tissue Inducers (LTi)Cytolytic:Natural Killer cells (NK)	 Gly FAO/OXPHOS, LM/LDF, Arginine catabolism, Gly Gly/OXPHOS, Vitamin A metabolismGly, AAM, FAO	     	 	  Dendritic Cells	Conventional:Conventional dendritic cell 1 (cDC1) Conventional dendritic cell 2 (cDC2) Conventional dendritic cell 3 (cDC3) ##Tolerogenic DCs## Plasmacytoid DCs (pDCs) Inflammatory DCs Langerhans cells Mononuclear Phagocytes (tumor)	 Na: OXPHOS, Ac: GU, Gly, PPP, Dys: LDFNa: OXPHOS, Ac: GU, Gly, PPP, Dys: LDF Not reported FAO/OXPHOS Gly/OXPHOS/FAO Gly Na/Ac/Ma: Not reported Dys: LDFNa: OXPHOS, Ac: Gly, PPP In tumors/Dys: LM/LDF	         	 	 Macrophages	Inflammatory &quot;M1&quot; macrophage Reparative &quot;M2&quot; macrophage  Tumor Associated macrophage (TAM)	Na: OXPHOS, Ac: GU, Gly, PPP. Arg catabolismNa: FAO/OXPHOS, Ac: FAO/OXPHOS, Gly, PPP.  Upregulates Arg1 Na: OXPHOS, Ac: GU, Gly, Tumor/Dys: FAO, LM/LDF	   	 	</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11240245</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:39007133</oboInOwl:hasDbXref>
        <rdfs:label>Tolerogenic DCs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000451"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/b435ea23-8ade-451e-9193-c9eeba6950db"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000451"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/b440e930-a717-4574-8a37-04011fbc1dbe -->

    <Class rdf:about="http://example.org/b440e930-a717-4574-8a37-04011fbc1dbe">
        <obo:IAO_0000115>To illustrate the application of CSN to developing cells, we feature the developmental trajectory of human ##excitatory neuron cells## in the Developing Cortex Atlas dataset (15), which includes Radial Gila and Progenitors (P), Intermediate Progenitors (IP), Maturing Excitatory (ExN), Migrating Excitatory (ExM), Excitatory Upper-layer enriched (ExM-U), and Excitatory Deep layer (ExDp), with cell type labels determined by the authors (SI Appendix, section 3 and Table S2). Using Slingshot, we estimate the developmental path consists of two trajectories, one ending in upper-layer (U curve) and the other in deep-layer (D curve) excitatory neurons (Fig. 3 A and B).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8713783</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34903665</oboInOwl:hasDbXref>
        <rdfs:label>excitatory neuron cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000540"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/b440e930-a717-4574-8a37-04011fbc1dbe"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000540"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/b442b72e-b262-4112-98e3-0363faf725fc -->

    <Class rdf:about="http://example.org/b442b72e-b262-4112-98e3-0363faf725fc">
        <obo:IAO_0000115>To develop a deeper understanding of the nature of B-cell responses in COVID-19, we further divided the B-cell population into more detailed subclusters using their transcriptional signatures and SHM rate obtained from scRNA datasets ( Figures 3A-C ). Previous high-dimensional flow cytometry data indicated that severe COVID-19 patients displayed hallmarks of EF B-cell activation and shared B-cell repertoire features in autoimmune settings. Therefore, our study primarily focused on B-cell subsets representing EF responses. Here, 13 B-cell subclusters, including 3 subsets of plasma cells and 5 subsets of memory B cells, were identified by cluster analysis on UMAP ( Figure 3A ). IGHD-expressing naive B cells were subdivided into TR B cells, resting naive (RN) B cells, and activated naive (AN) B cells according to the differential expression of the specific signature gene set ( Figure 3B ). The AN B cells were IGHD-positive clusters with comparatively higher SHM rates ( Figure 3C ) than other naive B cells and expressed distinct genes, such as FGR and MPP6. During the EF response, AN B cells differentiate into effector cells lacking naive (IgD) and memory (CD27) markers or DN B cells. DN B cells showed a higher SHM rate than AN B cells and expressed ITGAX (CD11C) and CD86 ( Figures 3B, C ). A previous study also reported that the human EF effector B-cell responses are mediated by the expansion of a unique population of CD11c+ AN B cells. Two clusters of atypical memory (AM1 and AM2) B cells were identified within the memory B-cell compartment, which overexpressed CD1C. Interestingly, AM2 B cells shared several transcriptional signatures, including FGR and HLA-DRB1, with EF B-cell subsets, including AN and DN cells. Both AM2 and DN B cells express ITGAX, TBX21, CD86, and ITGB2, but ##AM2## uniquely expressed CXCR3 and GSN (gelsolin).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9309264</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35899045</oboInOwl:hasDbXref>
        <rdfs:label>AM2</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000787"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/b442b72e-b262-4112-98e3-0363faf725fc"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000787"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/b44ff61a-ff89-46f8-9040-d203ec0bcd59 -->

    <Class rdf:about="http://example.org/b44ff61a-ff89-46f8-9040-d203ec0bcd59">
        <obo:IAO_0000115>Figure 1 gives a summary of the neuron-derived signals, discussed in the present review that impacts on astrocyte function. Why so many? It makes teleological sense for astrocyte phenotypes to be subject to regulation by neurons, since in theory, it enables neurons to tune the properties of nearby astrocytes to their needs. However, there still remains much to understand about the extent of this control. Over 2000 genes in astrocytes are induced or repressed by neurons, and the functional consequences of these changes is only known for a handful of genes. The relative contribution of Notch versus Neuroligin in mediating these changes is also currently unclear, and it may be that other signalling pathways are involved too. The same knowledge gap exists for astrocytic genes induced or repressed by neuronal activity in that there is much to learn about the functional consequences of most of the transcriptional changes seen. Moreover, the nature of the activity-dependent intercellular signal responsible for inducing these changes awaits discovery. Nevertheless, it is clear that the capacity of astrocytes to perform various homeostatic functions is not fixed but subject to regulation by physiological signalling from neurons. This type of phenotypic plasticity should be viewed as different from the changes that take place in &apos;##reactive astrocytes##&apos; where changes to place in response to pathological situations. Overall, the knowledge that a wide range of astrocytic neurosupportive functions can be controlled raises the possibility of manipulating them artificially for therapeutic benefit in chronic brain disorders.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10011399</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36695493</oboInOwl:hasDbXref>
        <rdfs:label>reactive astrocytes</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002627"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/b44ff61a-ff89-46f8-9040-d203ec0bcd59"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002627"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/b456e47e-80e4-4a44-b8d3-4a6f82557711 -->

    <Class rdf:about="http://example.org/b456e47e-80e4-4a44-b8d3-4a6f82557711">
        <obo:IAO_0000115>a Schematic overview of the experimental workflow. Forebrain samples were collected from Sox2eGFP mice at 11 developmental timepoints, dissociated into single cells followed by sorting of the GFP + ve /-ve cells and performing single-cell RNA-seq using the 10x Genomics Chromium platform. b Left: two-dimensional Uniform manifold approximation and progression (UMAP) plot with Leiden clustering of 102,504 individual cells identifying 28 transcriptionally and biologically distinct cell types (see Supplementary Fig. 3a and Methods). Each dot represents a single cell and colours correspond to the distinct clusters/cell types. Shown on the right is a dot plot showing the relative fraction (dot size) of the 28 cell types at each developmental timepoint normalized by library size. c UMAP plot of the cells as in (b) but coloured by timepoint. Each dot represents a single cell and the colours correspond to the different timepoints. d, UMAP plot showing the coarse annotation of cells into 4 categories (Neuronal, Glial, Immune and Vascular/other) based on logistic regression from Zeisel et al. 2018. The RNA-velocity field is overlaid on the UMAP. Colours represent the 4 categories of cell annotation and the arrows correspond to the direction of the RNA-velocity flow field (see Methods). RG Radial glia, TAPs Transient amplifying progenitors, aNSCs Active neural stem cells, APCs Astrocyte progenitor cells, EmNBs Embryonic neuroblasts, GE NBs ##Ganglionic eminence neuroblasts##, OPCs Oligoprogenitor cells, PreM-ODCs Immature pre-myelinating oligodendrocytes, INs Interneurons, ImStNeurons Immature striatal neurons, VLMC Vascular leptomeningeal cells, Myeloid-DSCs Myeloid-derived suppressor cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9296666</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35853870</oboInOwl:hasDbXref>
        <rdfs:label>Ganglionic eminence neuroblasts</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000031"/>
        <skos:relatedMatch rdf:resource="CL:4023063"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/b456e47e-80e4-4a44-b8d3-4a6f82557711"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000031"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/b456e47e-80e4-4a44-b8d3-4a6f82557711"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4023063"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/b45df91d-282a-47bf-a3a5-db572cbafd1c -->

    <Class rdf:about="http://example.org/b45df91d-282a-47bf-a3a5-db572cbafd1c">
        <obo:IAO_0000115>In this study, using single-cell RNA sequencing (scRNA-seq), genetic tracing, and other experimental approaches, we uncover an underlying mechanism by which aberrant AR activation elevates IGF1 signaling pathways in ##prostatic Osr1-lineage cells## to initiate PIN formation. Subsequently, activated IGF1 signaling further cumulates Wnt/beta-catenin activation in atypical PIN cells to promote tumor development. The correlations in co-occurrences of altered androgen, IGF1, and Wnt/beta-catenin signaling pathways were further identified in human prostate cancer samples. Co-inhibition of androgen and Wnt signaling pathways showed more potent repressive effects on the growth of hARtg+ prostate tumor cells in ex-vivo and xenograft models than either reagent alone, elucidating the promotional role of Wnt activation in hARtg-induced prostate tumorigenesis. These findings uncover a dynamic regulatory loop initiated by aberrant AR expression in prostatic progenitors through altering IGF1 and Wnt signaling pathways in inducing prostate oncogenic transformation and tumor development. They also provide scientific evidence leading to the development of future therapeutic strategies by co-targeting these signaling pathways for achieving better clinical outcomes for advanced prostate cancer.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9334353</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35902588</oboInOwl:hasDbXref>
        <rdfs:label>prostatic Osr1-lineage cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002339"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/b45df91d-282a-47bf-a3a5-db572cbafd1c"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002339"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/b4abc5c2-8a0f-4f0e-8f2e-a1051468d41b -->

    <Class rdf:about="http://example.org/b4abc5c2-8a0f-4f0e-8f2e-a1051468d41b">
        <obo:IAO_0000115>Differential DNA methylation was used as a layer of information to understand potential longer-term regulatory events and cell type distribution linked to anti-TNF non-response. Again, we could not find consistent baseline differences between the discovery and the replication cohort, whereas early longitudinal signatures separating patients with clinical remission at week 14 and non-responders were significantly conserved. Using physical neighborhood for intersecting DNAm changes with DEGs, we show a clear association of an ##inflammatory neutrophil## signature with favorable clinical outcome, corroborating earlier findings that subacute inflammation as a negative predictor of therapy outcome in IBD.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9509553</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36153599</oboInOwl:hasDbXref>
        <rdfs:label>inflammatory neutrophil</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000775"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/b4abc5c2-8a0f-4f0e-8f2e-a1051468d41b"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000775"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/b4af9527-d681-45e1-aad2-2cd26bc0c337 -->

    <Class rdf:about="http://example.org/b4af9527-d681-45e1-aad2-2cd26bc0c337">
        <obo:IAO_0000115>scRNA sequencing data was analyzed to further explore the synergistic effect of the IRRS and the TME cells in ESCC. We used the previously profiled transcriptomes of ~208,659 single cells with eight main cell populations ( Figures 4A, B ), among which fibroblasts, endothelial cells, T cells, B cells, pericytes and myeloid cells were analyzed. Next, 40 cell clusters, including T helper 17 (TH17) cells, follicular helper T (TFH1/2) cells, naive T (TN) cells, regulatory T (Treg) cells, memory T (TMEM-CD4/CD8) cells, effector T (TEFF) cells, exhausted T (TEX) cells, monocytes (Mono01-03), tumor-associated macrophages (TAM01-04),dendritic cells (tDC, pDC, cDC), mast cells (Mast), resting B cells, activated B cells, germinal center B cells (GCB), plasma cells, normal mucosa fibroblasts (NMF), normal activated fibroblasts (NAF1/2), cancer-associated fibroblasts (CAF1-4), vascular smooth muscle cells (VSMC), normal endothelial cells (##NEC##1-3) and tumor endothelial cell (TEC1-3) were identified by t-SNE analysis ( Figures 4C-G ;  Figures S6A-E ). We then used CIBERSORTx to infer cell-type abundance from bulk RNA-seq data using scRNA data, and estimated the proportions of the 42 cell types in the training dataset. The proportions of TME cell types between the high- and low-risk groups was compared using the Kruskal-Wallis test. The profiles of the high- and low-risk groups are shown in  Figure 4H  and  Figure S6F . The abundance of TEX, NAF2, CAF4, and VSMC increased, and the abundance of Mono1, TAM03, and NEC2 decreased in the high-risk group (p &lt; 0.05;  Figure 4I ). The cell proportions between low and high risk groups demonstrated significantly distinct TME patterns.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9933905</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36817484</oboInOwl:hasDbXref>
        <rdfs:label>NEC</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000115"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/b4af9527-d681-45e1-aad2-2cd26bc0c337"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000115"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/b4bd0353-9c1a-4a8f-bfb2-3dae826a7456 -->

    <Class rdf:about="http://example.org/b4bd0353-9c1a-4a8f-bfb2-3dae826a7456">
        <obo:IAO_0000115>Results  A total of 26.53% of gammadelta T DC - control group ( p  &lt; 0.0001) - the proportion of ##alphabeta T DC## was lower in splenic cells than gammadelta T DC ; however, these 2 cell types were reduced in tumor conditions ( p  &lt; 0.0001), and the proportion of IFN-gamma, TNF-alpha, IL-12 and IL-17 cytokines produced by gammadelta T DC was higher than those produced by alphabeta T DC , but it decreased under conditions of tumor-related immune system response ( p  &lt; 0.0001). </obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10302725</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34077988</oboInOwl:hasDbXref>
        <rdfs:label>alphabeta T DC</rdfs:label>
    </Class>
    


    <!-- http://example.org/b4c66cab-66d7-4ed7-95ed-13c5d831c0ce -->

    <Class rdf:about="http://example.org/b4c66cab-66d7-4ed7-95ed-13c5d831c0ce">
        <obo:IAO_0000115>To investigate the universal transcriptional program between group 1 ILCs across liver and spleen, we have explored DEGs in Prdm1 cko liver cNK cells and ILC1s using our scRNA-seq data. Compared with liver ILC1s, more DEGs was observed in liver cNK cells, including Junb, Kit, Tcf7, Gzmb, Prf1, etc. (Figure 5:figure supplement 2, A and B). Through the integration of the bulk RNA-seq and scRNA-seq data, we identified 17 DEGs that are regulated by Prdm1 among liver cNK cells, splenic cNK cells, and liver ILC1s. Batf3, Junb, Tcf7, and Nfkb1 was upregulated, whereas Gzmb, Prf1, and Fgl2 downregulated, in both Prdm1 cko liver and splenic cNK cells (Figure 5J). Cxcr6 was downregulated in ##liver ILC1s## and splenic cNK cells in Prdm1 cko mice (Figure 5J). Previous research found that spleen NK cells could be divided into three distinct groups based on their expression levels of CD27, CD62L, CD49a, and CD49b. CD27+CD62L- NK cells have remarkable high expression of Batf3, while it was only barely expressed in CD27+CD62L+ and CD27-CD62L+ NK cells. Based on the sequencing data published by Flommersfeld et al. (GSE180978), a notable negative correlation was observed between the expression levels of Prdm1 and Batf3 (Figure 5:figure supplement 2I). On top of that, our findings unveiled the negative regulatory influence of Prdm1 on Batf3 within both spleen and liver NK cells. This discovery highlights a potential upstream mechanism that may influence the hemostasis of the spleen NK cell subpopulations through Batf3.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11318973</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:39133873</oboInOwl:hasDbXref>
        <rdfs:label>liver ILC1s</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0001068"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/b4c66cab-66d7-4ed7-95ed-13c5d831c0ce"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0001068"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/b4c6e72f-3709-43ed-b12f-7881d8c356d5 -->

    <Class rdf:about="http://example.org/b4c6e72f-3709-43ed-b12f-7881d8c356d5">
        <obo:IAO_0000115>However, in contrast to previous studies (e.g.) rather than use multiple Cre-lines to distinguish subpopulations of, for example, GABAergic cells, we have rather studied excitatory and inhibitory classes more generally, using Cre-Off and Cre-On AAVs in Gad2-Cre mice. Thus, the primary goal of this study was not to investigate differences in innervation between the many particular subtypes of inhibitory or excitatory cells, but whether these two classes receive anatomically segregated distant inputs. For comparison, we also examined input to ##parvalbumin-expressing cells##, the largest known subtype of GABAergic neuron in the neocortex, and proenkephalin-expressing (penk) cells, a subtype of excitatory cell present in L2/3 and L6. Although the differences were relatively small, there were noticeable qualitative trends in the fraction of inputs to the different classes, suggesting the potential for more subtle diversity in the excitatory and inhibitory populations than our study could detect.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7925549</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33654118</oboInOwl:hasDbXref>
        <rdfs:label>parvalbumin-expressing cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:4023018"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/b4c6e72f-3709-43ed-b12f-7881d8c356d5"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4023018"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/b4dcc526-ddde-489b-8a28-ce35edc7f1f8 -->

    <Class rdf:about="http://example.org/b4dcc526-ddde-489b-8a28-ce35edc7f1f8">
        <obo:IAO_0000115>a Schematic of the experimental pipeline. Created with BioRender.com b UMAP visualization of peritoneal immune cells. c Ratio of each population in cell number. d VlnPlot of characteristic gene expressions for macrophage subpopulations. Sham sham control, ELL endometriosis-like lesions, ELL_N niclosamide administration to ELL-induced mouse, Pre-SPMs premature &quot;small&quot; peritoneal macrophages, SPMs &quot;small&quot; peritoneal macrophages, IM1-3 intermediate macrophages subtype 1-3, Timd4+ LPMs ##Timd4+ &quot;large&quot; peritoneal macrophages##, PMs proliferating macrophages, B1a B1a cells, B1b B1b cells, B2 B2 cells, GCBs germinal-centre B cells, PBs plasma blast B cells, Cd4+ Ts Cd4+ T cells, Cd8+ Ts Cd8+ T cells, DN1 double negative T cells 1, DN2 double negative T cells 2, cDC1 conventional dendritic cells 1, MCs Mast cells, NTPs neutrophils.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9652344</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36369244</oboInOwl:hasDbXref>
        <rdfs:label>Timd4+ &quot;large&quot; peritoneal macrophages</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000581"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/b4dcc526-ddde-489b-8a28-ce35edc7f1f8"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000581"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/b4e2dcd6-efae-4a56-87ef-e9453d34053c -->

    <Class rdf:about="http://example.org/b4e2dcd6-efae-4a56-87ef-e9453d34053c">
        <obo:IAO_0000115>Besides these omental cell types, tumour-associated macrophages (TAM) clearly are instrumental in metastasis, in particular the ##CD163+Tim4+ subset##, which promotes the stemness, invasive properties and epithelial to mesenchymal transition (EMT) of tumour cells by paracrine mechanisms. While omentectomy or depletion of CD163+Tim4+ cells prevented metastatic dissemination in a mouse model of ovarian cancer, depletion of monocyte-derived TAM had little impact, emphasising the role of resident omental macrophages. In keeping with these findings, TAM from HGSC patients show a high degree of phenotypic, ontogenetic and tumour-promoting heterogeneity, reflected, for example, by the differential expression of CD163 and cytokines associated with tumour progression. </obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8574964</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34841720</oboInOwl:hasDbXref>
        <rdfs:label>CD163+Tim4+ subset</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/b4e2dcd6-efae-4a56-87ef-e9453d34053c"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/b4e86900-af30-46cf-80c9-c99b7b700a1f -->

    <Class rdf:about="http://example.org/b4e86900-af30-46cf-80c9-c99b7b700a1f">
        <obo:IAO_0000115>a Schematic overview of the experimental workflow. Forebrain samples were collected from Sox2eGFP mice at 11 developmental timepoints, dissociated into single cells followed by sorting of the GFP + ve /-ve cells and performing single-cell RNA-seq using the 10x Genomics Chromium platform. b Left: two-dimensional Uniform manifold approximation and progression (UMAP) plot with Leiden clustering of 102,504 individual cells identifying 28 transcriptionally and biologically distinct cell types (see Supplementary Fig. 3a and Methods). Each dot represents a single cell and colours correspond to the distinct clusters/cell types. Shown on the right is a dot plot showing the relative fraction (dot size) of the 28 cell types at each developmental timepoint normalized by library size. c UMAP plot of the cells as in (b) but coloured by timepoint. Each dot represents a single cell and the colours correspond to the different timepoints. d, UMAP plot showing the coarse annotation of cells into 4 categories (Neuronal, Glial, Immune and Vascular/other) based on logistic regression from Zeisel et al. 2018. The RNA-velocity field is overlaid on the UMAP. Colours represent the 4 categories of cell annotation and the arrows correspond to the direction of the RNA-velocity flow field (see Methods). RG Radial glia, TAPs Transient amplifying progenitors, aNSCs Active neural stem cells, APCs Astrocyte progenitor cells, EmNBs Embryonic neuroblasts, GE NBs Ganglionic eminence neuroblasts, OPCs Oligoprogenitor cells, ##PreM-ODCs## Immature pre-myelinating oligodendrocytes, INs Interneurons, ImStNeurons Immature striatal neurons, VLMC Vascular leptomeningeal cells, Myeloid-DSCs Myeloid-derived suppressor cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9296666</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35853870</oboInOwl:hasDbXref>
        <rdfs:label>PreM-ODCs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002453"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/b4e86900-af30-46cf-80c9-c99b7b700a1f"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002453"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/b4fbec8b-456a-4574-8eca-055152c62bbd -->

    <Class rdf:about="http://example.org/b4fbec8b-456a-4574-8eca-055152c62bbd">
        <obo:IAO_0000115>Proposed schema of developmental interrelationship between very small embryonic-like stem cells (##VSELs##), and tissue-committed cells. Quiescent VSELs deposited longlife into the bone marrow, may migrate into the blood once activated and give rise not only to HSCs and EPCs but also to other tissue-committed cells, and are also a source of mesenchymal stem cells (MSCs). More particularly, their capability to differentiate along both the cardiac and endothelia pathways favours their clinical use in cardiac diseases. Dotted line pathway still under investigation. Abbreviations: MSC, mesenchymal stem cell; HSC, hematopoietic stem cell; EPC, endothelial progenitor cell; CPC, cardiac progenitor cell; LPC, liver progenitor cell; OPC, osteoblastic progenitor cell</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7253501</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32297205</oboInOwl:hasDbXref>
        <rdfs:label>VSELs</rdfs:label>
    </Class>
    


    <!-- http://example.org/b505dccc-2305-4d01-a5ce-173e8f492572 -->

    <Class rdf:about="http://example.org/b505dccc-2305-4d01-a5ce-173e8f492572">
        <obo:IAO_0000115>Results  A total of 26.53% of ##gammadelta T DC## - control group ( p  &lt; 0.0001) - the proportion of alphabeta T DC was lower in splenic cells than gammadelta T DC ; however, these 2 cell types were reduced in tumor conditions ( p  &lt; 0.0001), and the proportion of IFN-gamma, TNF-alpha, IL-12 and IL-17 cytokines produced by gammadelta T DC was higher than those produced by alphabeta T DC , but it decreased under conditions of tumor-related immune system response ( p  &lt; 0.0001). </obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10302725</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34077988</oboInOwl:hasDbXref>
        <rdfs:label>gammadelta T DC</rdfs:label>
    </Class>
    


    <!-- http://example.org/b530bd10-fb96-4a46-846a-a78e790e2cc3 -->

    <Class rdf:about="http://example.org/b530bd10-fb96-4a46-846a-a78e790e2cc3">
        <obo:IAO_0000115>The overlapped regulation gene expression of monocytes and macrophages in response to avian influenza virus infection. (A) A Venn diagram of the overlap genes between H5N1 and H7N7-infected monocytes and ##monocyte-derived macrophages##; (B) GO biological processes of differentially expressed overlap. The vertical axis shows the functional classification, and the horizontal axis shows the GeneRatio; (C) KEGG pathways of differentially expressed overlap genes. The vertical axis shows the number of genes, and the horizontal axis shows the GeneRatio.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8337049</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34367124</oboInOwl:hasDbXref>
        <rdfs:label>monocyte-derived macrophages</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
        <skos:relatedMatch rdf:resource="CL:0000576"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/b530bd10-fb96-4a46-846a-a78e790e2cc3"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/b530bd10-fb96-4a46-846a-a78e790e2cc3"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000576"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/b5544a3c-e239-4315-bac8-1d3eeea9432c -->

    <Class rdf:about="http://example.org/b5544a3c-e239-4315-bac8-1d3eeea9432c">
        <obo:IAO_0000115>Next, we sought to identify using machine learning, the immune variable (IT or Stromal) that best classifies patients as LTS or NON-LTS and thereby, predicts patient survival. Random-forest (RF) is a decision tree-based machine learning method which uses a bootstrapping method to generate at random, training and testing samples from the dataset. Variable selection was performed through the varSelRF package in R, which uses recursive feature elimination to find a minimal set of variables with the best predictive performance. Using this approach, we determined that stromal densities of iNOS+ and CD68+ cells are the two best discriminatory variables for patient survival. Stromal iNOS+ leukocytes display a potent positive correlation with OS (Figure 7A) while stromal CD68+ (total) macrophages show a strong negative correlation with OS (Figure 7B). The ROC (Receiver Operating Characteristic) curves and ROC values for the final two variables determined by RF selection (i.e., iNOS and CD68) are plotted in Supplementary Figure 7. These findings suggest that ##iNOS+ leukocytes## and CD68+ macrophages are highly relevant prognostic biomarkers in PDAC patients.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7933000</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33679807</oboInOwl:hasDbXref>
        <rdfs:label>iNOS+ leukocytes</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000738"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/b5544a3c-e239-4315-bac8-1d3eeea9432c"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000738"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/b585fccd-00ff-43a2-992f-6d1804c50933 -->

    <Class rdf:about="http://example.org/b585fccd-00ff-43a2-992f-6d1804c50933">
        <obo:IAO_0000115>To develop a deeper understanding of the nature of B-cell responses in COVID-19, we further divided the B-cell population into more detailed subclusters using their transcriptional signatures and SHM rate obtained from scRNA datasets ( Figures 3A-C ). Previous high-dimensional flow cytometry data indicated that severe COVID-19 patients displayed hallmarks of EF B-cell activation and shared B-cell repertoire features in autoimmune settings. Therefore, our study primarily focused on B-cell subsets representing EF responses. Here, 13 B-cell subclusters, including 3 subsets of plasma cells and 5 subsets of memory B cells, were identified by cluster analysis on UMAP ( Figure 3A ). IGHD-expressing naive B cells were subdivided into TR B cells, resting naive (RN) B cells, and activated naive (AN) B cells according to the differential expression of the specific signature gene set ( Figure 3B ). The AN B cells were IGHD-positive clusters with comparatively higher SHM rates ( Figure 3C ) than other naive B cells and expressed distinct genes, such as FGR and MPP6. During the EF response, AN B cells differentiate into effector cells lacking naive (IgD) and memory (CD27) markers or DN B cells. DN B cells showed a higher SHM rate than AN B cells and expressed ITGAX (CD11C) and CD86 ( Figures 3B, C ). A previous study also reported that the human EF effector B-cell responses are mediated by the expansion of a unique population of ##CD11c+ AN B cells##. Two clusters of atypical memory (AM1 and AM2) B cells were identified within the memory B-cell compartment, which overexpressed CD1C. Interestingly, AM2 B cells shared several transcriptional signatures, including FGR and HLA-DRB1, with EF B-cell subsets, including AN and DN cells. Both AM2 and DN B cells express ITGAX, TBX21, CD86, and ITGB2, but AM2 uniquely expressed CXCR3 and GSN (gelsolin).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9309264</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35899045</oboInOwl:hasDbXref>
        <rdfs:label>CD11c+ AN B cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000788"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/b585fccd-00ff-43a2-992f-6d1804c50933"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000788"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/b596474d-94b7-4715-afc8-bcc633a0dd11 -->

    <Class rdf:about="http://example.org/b596474d-94b7-4715-afc8-bcc633a0dd11">
        <obo:IAO_0000115>In severe (or critical) COVID-19 patients, there is a remarkable expansion of TM4SF1+ and KRT5+ lung progenitor cells. The two distinct populations of progenitor cells could play crucial roles in alveolar cell regeneration and epithelial barrier re-establishment, respectively. The transplanted KRT5+ progenitors could long-term engraft into host lung and differentiate into ##HOPX+ OCLN+ alveolar barrier cell## which restored the epithelial barrier and efficiently prevented inflammatory cell infiltration.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7645905</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33094537</oboInOwl:hasDbXref>
        <rdfs:label>HOPX+ OCLN+ alveolar barrier cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002062"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/b596474d-94b7-4715-afc8-bcc633a0dd11"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002062"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/b5d5485a-894d-467e-902a-630788c07138 -->

    <Class rdf:about="http://example.org/b5d5485a-894d-467e-902a-630788c07138">
        <obo:IAO_0000115>Brain-derived neurotrophic factor (BDNF) and neurotrophin 3 (NT-3) are known to regulate neuronal morphology and the formation of neural circuits, yet the neuronal targets of each neurotrophin are still to be defined. To address how these neurotrophins regulate the morphological and synaptic differentiation of developing olfactory bulb (OB) GABAergic interneurons, we analyzed the effect of BDNF and NT-3 on GABA+-neurons and on different subtypes of these neurons: tyrosine hydroxylase (TH+); calretinin (Calr+); calbindin (Calb+); and parvalbumin (PVA+). These cells were generated from cultured embryonic mouse olfactory bulb neural stem cells (eOBNSCs) and after 14 days in vitro (DIV), when the neurons expressed TrkB and/or TrkC receptors, BDNF and NT-3 did not significantly change the number of neurons. However, long-term BDNF treatment did produce a longer total dendrite length and/or more dendritic branches in all the interneuron populations studied, except for ##PVA+-neurons##. Similarly, BDNF caused an increase in the cell body perimeter in all the interneuron populations analyzed, except for PVA+-neurons. GABA+- and TH+-neurons were also studied at 21 DIV, when BDNF produced significantly longer neurites with no clear change in their number. Notably, these neurons developed synaptophysin+ boutons at 21 DIV, the size of which augmented significantly following exposure to either BDNF or NT-3. Our results show that in conditions that maintain neuronal survival, BDNF but not NT-3 promotes the morphological differentiation of developing OB interneurons in a cell-type-specific manner. In addition, our findings suggest that BDNF and NT-3 may promote synapse maturation by enhancing the size of synaptic boutons.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMID:33392918</oboInOwl:hasDbXref>
        <rdfs:label>PVA+-neurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:4023018"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/b5d5485a-894d-467e-902a-630788c07138"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4023018"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/b5e02c17-f374-4422-9799-71df03e35c84 -->

    <Class rdf:about="http://example.org/b5e02c17-f374-4422-9799-71df03e35c84">
        <obo:IAO_0000115>The signals driving the adaptation of type 2 dendritic cells (DC2s) to diverse peripheral environments remain mostly undefined. We show that differentiation of CD11blo migratory DC2s-a DC2 population unique to the dermis-required IL-13 signaling dependent on the transcription factors STAT6 and KLF4, whereas DC2s in lung and small intestine were STAT6-independent. Similarly, human DC2s in skin expressed an IL-4 and IL-13 gene signature that was not found in blood, spleen and lung DCs. In mice, IL-13 was secreted homeostatically by ##dermal innate lymphoid cells## and was independent of microbiota, TSLP or IL-33. In the absence of IL-13 signaling, dermal DC2s were stable in number but remained CD11bhi and showed defective activation in response to allergens, with diminished ability to support the development of IL-4+GATA3+ helper T cells (TH), whereas antifungal IL-17+RORgammat+ TH cells were increased. Therefore, homeostatic IL-13 fosters a noninflammatory skin environment that supports allergic sensitization.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMID:34795444</oboInOwl:hasDbXref>
        <rdfs:label>dermal innate lymphoid cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0001065"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/b5e02c17-f374-4422-9799-71df03e35c84"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0001065"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/b5f1807a-1620-448c-8f6b-7adf495711fd -->

    <Class rdf:about="http://example.org/b5f1807a-1620-448c-8f6b-7adf495711fd">
        <obo:IAO_0000115>B cells can be further divided into B1 B-cells of the innate immune system and &quot;conventional&quot; B2 B-cells of the adaptive immune system. This division is well-established in mice, where sIgM+CD11b+CD5+ B1a B-cells were first identified through the search for, the still elusive, cell of origin of adult human CLL. B1b B-cells (sIgM+CD11b+CD5-) were subsequently described; both these subtypes are seen predominantly in serous cavities. Further characterization of ##splenic B1 cells## have identified them to be CD5+/-CD19hiCD1dmidCD23-CD43+IgMhiIgDlo. Murine B1 B-cell progenitors are found in the yolk sac prior to the emergence of the first definitive HSCs in the FL, which have both B1 and B2 B-cell output. The B-cell output skews toward B2 B-cells over ontogeny, with B1 B-cell output being exceedingly rare in ABM.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7928347</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33679795</oboInOwl:hasDbXref>
        <rdfs:label>splenic B1 cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000819"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/b5f1807a-1620-448c-8f6b-7adf495711fd"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000819"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/b5fd37ea-966e-497e-b7d0-f1f81b7c18a0 -->

    <Class rdf:about="http://example.org/b5fd37ea-966e-497e-b7d0-f1f81b7c18a0">
        <obo:IAO_0000115>In this study, we provided a perspective for understanding the roles of CD14+ monocytes in the development of the calcification paradox in osteoporosis- and atherosclerosis-related cells based on combined scRNA and RNA data. First, using scRNA data, we found a large proportion of delayed premature osteoblasts in osteoporosis and ##osteogenic SMCs## in atherosclerosis. Second, CD14+ monocytes interacted with the intermediate cells, which were at the crossroads of the osteoblast and vascular SMC cell state transitions, by delivering TGFB1 and TNFSF10. This interaction served as the trigger activating the transcription factors SP1 and NFKB1 to upregulate the inflammatory response and cell senescence and led to a delayed premature state in the osteoblast lineage and osteogenic transition in vascular SMCs. Then, using bulk RNA data, we found that most expression patterns in monocytes from osteoporosis and atherosclerosis patients were present in circulating monocytes from both diseases. Circulating monocytes are characterized by the activation of factors associated with chemotaxis, the inflammatory response and the cell response to stress, such as ROS and lipid stimuli. Finally, we identified 7 circulating monocyte calcification paradox-related genes based on the expression patterns of circulating monocytes. The calcification paradox-related markers suggested that circulating monocytes undergo cell aging and activation of DNA repair in response to DNA damage.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9354531</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35937796</oboInOwl:hasDbXref>
        <rdfs:label>osteogenic SMCs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000514"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/b5fd37ea-966e-497e-b7d0-f1f81b7c18a0"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000514"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/b605e10a-8a72-4864-be5b-47049388e2e3 -->

    <Class rdf:about="http://example.org/b605e10a-8a72-4864-be5b-47049388e2e3">
        <obo:IAO_0000115>In the setting of severe versus mild disease, a higher proportion of endometrial CD44+ classical monocytes, CX3CR1+ and CD91+ non-classical monocytes, and dendritic cells were observed, as well as lower levels of ##CD91+ macrophages## (Fig. 6A). Notably, and as shown above, CD91+ macrophages and CD44+ monocytes appear to have different dynamics throughout the cycle in controls and endometriosis patients, as well as different proportions between the two groups, suggesting that they may be key components for the pathophysiology of the disease.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9011995</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35421980</oboInOwl:hasDbXref>
        <rdfs:label>CD91+ macrophages</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/b605e10a-8a72-4864-be5b-47049388e2e3"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/b6125fae-f2cb-4651-9582-a4124b21a3e6 -->

    <Class rdf:about="http://example.org/b6125fae-f2cb-4651-9582-a4124b21a3e6">
        <obo:IAO_0000115>Myelogram Parameters DTCs n Mean Value Errstdmean p   Cellularity negative 19 67.0 6.51 NS*   positive 20 67.3 7.87   Blasts negative 20 1.46 0.14 0.026   positive 25 1.09 0.09   Promyelocytes negative 20 0.44 0.11 NS   positive 25 0.37 0.08   Neutrophilic myelocytes negative 20 7.80 0.72 NS   positive 25 8.95 0.54   Neutrophilic metamyelocytes negative 20 8.58 0.65 NS   positive 25 7.83 0.53   Band neutrophils negative 20 16.50 0.91 NS   positive 25 18.70 1.00   Segmented neutrophils negative 20 24.47 1.39 NS   positive 25 27.266 1.71   All granulocyte cells negative 20 60.76 1.45 0.025   positive 25 65.41 1.38   Neutrophil maturation index negative 20 0.43 0.034 NS   positive 25 0.38 0.034   Monocytes negative 20 2.78 0.26 NS   positive 25 3.30 0.24   Lymphocytes negative 20 12.85 0.79 NS   positive 25 12.02 0.68   Plasmocytes negative 20 0.60 0.10 NS   positive 25 0.77 0.15   Basophilic normoblasts negative 20 1.23 0.17 NS   positive 25 0.97 0.13   Polychromatophilic normoblasts negative 20 11.16 0.91 NS   positive 25 10.19 0.82   Oxyphilic normoblasts negative 20 9.08 0.88 0.006   positive 25 6.25 0.52   Sum of ##nucleated erythroid cells## negative 20 21.47 1.44 0.042   positive 25 17.41 1.29   Erythroid maturation index negative 20 0.96 0.01 NS   positive 25 0.96 0.01   Leuco-erythroid ratio negative 20 4.02 0.39 0.034   positive 25 5.58 0.59   </obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6627631</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31234438</oboInOwl:hasDbXref>
        <rdfs:label>nucleated erythroid cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000562"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/b6125fae-f2cb-4651-9582-a4124b21a3e6"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000562"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/b61d3a2a-4847-4c26-8836-23ab03174b00 -->

    <Class rdf:about="http://example.org/b61d3a2a-4847-4c26-8836-23ab03174b00">
        <obo:IAO_0000115>In the mouse placenta, there are two lineages of trophoblast cells, the invasive and structural cells, which arise from the trophoblast stem progenitor cells. Trophoblast giant cells are the ##invasive cells## responsible for invading the maternal vasculature and transforming the spiral arteries into high-velocity, low-resistant vessels. Four sub-types of trophoblast giant cells exist, including spiral artery trophoblast giant cells and parietal trophoblast giant cells, which reside in the decidual layer. The canal trophoblast giant cells and sinusoidal trophoblast giant cells are in the labyrinth. The structural cells of the placenta include those located within the junctional zone and the remaining cells of the labyrinth. The spongiotrophoblast and glycogen trophoblast cells are within the junctional zone. The spongiotrophoblast cells are thought to contribute a supportive role to the developing labyrinth and feed into the trophoblast giant cell progenitor pool, while glycogen cells, which arise from the spongiotrophoblast cells, are thought to accumulate glycogen and can migrate into the maternal decidua for spiral artery remodeling. The two different types of syncytiotrophoblast cells, syncytiotrophoblast-I and syncytiotrophoblast-II, are located within the labyrinth zone. These cells function in the material exchange between the mother and fetus and, along with the sinusoidal trophoblast giant cells, make up the interhemal membrane. However, the specific functions of some of these cells are not well understood.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10459728</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37630754</oboInOwl:hasDbXref>
        <rdfs:label>invasive cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002488"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/b61d3a2a-4847-4c26-8836-23ab03174b00"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002488"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/b632c7ab-5330-4ba7-9401-4fa3b11b699a -->

    <Class rdf:about="http://example.org/b632c7ab-5330-4ba7-9401-4fa3b11b699a">
        <obo:IAO_0000115>The following are available online at , Figure S1: Time course of the specific uptake of 5-HT into human primary trophoblasts and feto-placental endothelial cells, Figure S2: Uptake of 5-HT into feto-placental endothelial cells, measured over the high-affinity range of 5-HT concentrations, Figure S3: RT-qPCR analysis of SERT, PMAT, OCT1, -2, and -3 mRNAs in pooled samples of human primary trophoblasts and feto-placental endothelial cells, Table S1: Kinetic parameters of 5-HT uptake in human primary trophoblasts, feto-placental endothelial cells, and cord blood platelets, Table S2: Quantification cycle values obtained in RT-qPCR analysis of individual trophoblast and feto-placental endothelial cell samples, Table S3: Characteristics of participants who donated tissue for trophoblast, feto-placental endothelial cell, and ##cord blood platelet## isolation for the study, Table S4: The primer sequences used in qualitative end-point and quantitative real-time PCR analyses.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8346107</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34360573</oboInOwl:hasDbXref>
        <rdfs:label>cord blood platelet</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000233"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/b632c7ab-5330-4ba7-9401-4fa3b11b699a"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000233"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/b6598741-e4be-4642-beec-9a11fe753f64 -->

    <Class rdf:about="http://example.org/b6598741-e4be-4642-beec-9a11fe753f64">
        <obo:IAO_0000115>(a) Balloon-plot of known neuronal and glial cell markers (SOX10-MKI67). Progenitor: SOX10, FOXD3, ASCL1, Neuronal: PHOX2B, PRPH, NRG1, TUBB3, Sympathetic neurons: DBH, TH, Parasympathetic neurons: NOS1, VIP, Sensory neurons: PRDM12, P2RY1, TRPV1, Schwann Cell Progenitors (SCPs): CDH19, MPZ, PLP1, Glial cells: GFAP, S100B, Chromaffin cells: PNMT, PENK, CARTPT and Proliferating cells: MKI67, PCNA. The remaining genes correspond to the top-5, most selective genes for each cluster. From the statistically significant genes (adjusted p-value &lt; 0.001, MAST with Bonferroni correction using all features), the top-10 (log2 fold-change) were sorted according to the percent of positive cells and the top-5 were plotted. Gene order follows the cluster order. Balloon size: percent of positive cells. Color intensity: scaled expression. Blue: high, Gray: low. (b) Balloon-plot of the detected cholinergic-synapse pathway genes (KEGG id: 217716). Balloon size: percent of positive cells. Color intensity: log2(normalized UMI-counts+1) (library size was normalized to 10.000) expression. Blue: high, Gray: low. (c) Heatmap of differentially expressed transcription factors (TFs) along the SCP-neuronal trajectory, according to tradeSeq. Stars: analyzed genes in &apos;D-E&apos;. Color intensity: scaled expression. Dark red: high, Gray: low. (d) UMAP-plots of SOX10, ASCL1 and ISL1 TFs. Expression levels: log2(normalized UMI-counts+1) (library size was normalized to 10.000). Blue: high. Gray: zero. (e) Confocal-microscopy image of an 8.5 pcw ganglion, showing SOX10, ASCL1 and ISL1 expression, detected with immunofluorescence. Dashed outlines: manually segmented nuclei. SOX10pos SCPs (arrows), SOX10pos ASCL1pos transitioning SCPs (asterisks), ASCL1pos SOX10neg immature neurons (hashes), ##ISL1pos ASCL1neg mature neurons## (arrowheads). Scale-bar: 5 microm.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9928586</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36646791</oboInOwl:hasDbXref>
        <rdfs:label>ISL1pos ASCL1neg mature neurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000540"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/b6598741-e4be-4642-beec-9a11fe753f64"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000540"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/b6a65251-afda-4bd6-9075-9e5242e95dac -->

    <Class rdf:about="http://example.org/b6a65251-afda-4bd6-9075-9e5242e95dac">
        <obo:IAO_0000115>Although certain injuries and Rbpj deletion can both trigger neurogenesis by astrocytes, it almost exclusively does so in the striatum. And even within the striatum, primarily the astrocytes in the medial striatum readily activate neurogenic properties (Figure 1a). This suggests that ##neurogenic parenchymal astrocytes## either occupy an environmental niche favorable to neurogenesis or that only they have an inherent neurogenic capacity. In order to recruit astrocytes for therapeutic neurogenesis, a first step is to understand the mechanisms underlying this process. If these mechanisms are understood, they could potentially be targeted to induce localized therapeutic neurogenesis throughout the central nervous system.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7440914</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32744501</oboInOwl:hasDbXref>
        <rdfs:label>neurogenic parenchymal astrocytes</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002626"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/b6a65251-afda-4bd6-9075-9e5242e95dac"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002626"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/b6d4fd3e-4617-49f3-ac07-d1d67c32e8fa -->

    <Class rdf:about="http://example.org/b6d4fd3e-4617-49f3-ac07-d1d67c32e8fa">
        <obo:IAO_0000115>BACKGROUND: Hundreds of ongoing clinical trials combine radiation therapy, mostly delivered as stereotactic body radiotherapy (SBRT), with immune checkpoint blockade. However, our understanding of the effect of radiotherapy on the intratumoral immune balance is inadequate, hindering the optimal design of trials that combine radiation therapy with immunotherapy. Our objective was to characterize the intratumoral immune balance of the malignant prostate after SBRT in patients. METHODS: Sixteen patients with high-risk, non-metastatic prostate cancer at comparable Gleason Grade disease underwent radical prostatectomy with (n = 9) or without (n = 7) neoadjuvant SBRT delivered in three fractions of 8 Gy over 5 days completed 2 weeks before surgery. Freshly resected prostate specimens were processed to obtain single-cell suspensions, and immune-phenotyped for major lymphoid and myeloid cell subsets by staining with two separate 14-antibody panels and multicolor flow cytometry analysis. RESULTS: Malignant prostates 2 weeks after SBRT had an immune infiltrate dominated by myeloid cells, whereas malignant prostates without preoperative treatment were more ##lymphoid##-biased (myeloid CD45+ cells 48.4 +- 19.7% vs. 25.4 +- 7.0%; adjusted p-value = 0.11; and CD45+ lymphocytes 51.6 +- 19.7% vs. 74.5 +- 7.0%; p = 0.11; CD3+ T cells 35.2 +- 23.8% vs. 60.9 +- 9.7%; p = 0.12; mean +- SD). CONCLUSION: SBRT drives a significant lymphoid to myeloid shift in the prostate-tumor immune infiltrate. This may be of interest when combining SBRT with immunotherapies, particularly in prostate cancer.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7794088</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32647353</oboInOwl:hasDbXref>
        <rdfs:label>lymphoid</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0001065"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/b6d4fd3e-4617-49f3-ac07-d1d67c32e8fa"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0001065"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/b757f2d9-b523-49c4-8a93-568893b4ff66 -->

    <Class rdf:about="http://example.org/b757f2d9-b523-49c4-8a93-568893b4ff66">
        <obo:IAO_0000115>The following are available online at , Figure S1: Time course of the specific uptake of 5-HT into human primary trophoblasts and feto-placental endothelial cells, Figure S2: Uptake of 5-HT into feto-placental endothelial cells, measured over the high-affinity range of 5-HT concentrations, Figure S3: RT-qPCR analysis of SERT, PMAT, OCT1, -2, and -3 mRNAs in pooled samples of human primary trophoblasts and feto-placental endothelial cells, Table S1: Kinetic parameters of 5-HT uptake in human primary trophoblasts, feto-placental endothelial cells, and ##cord blood platelets##, Table S2: Quantification cycle values obtained in RT-qPCR analysis of individual trophoblast and feto-placental endothelial cell samples, Table S3: Characteristics of participants who donated tissue for trophoblast, feto-placental endothelial cell, and cord blood platelet isolation for the study, Table S4: The primer sequences used in qualitative end-point and quantitative real-time PCR analyses.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8346107</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34360573</oboInOwl:hasDbXref>
        <rdfs:label>cord blood platelets</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000233"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/b757f2d9-b523-49c4-8a93-568893b4ff66"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000233"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/b768057a-3f71-4c3d-a463-8eafb29dcc50 -->

    <Class rdf:about="http://example.org/b768057a-3f71-4c3d-a463-8eafb29dcc50">
        <obo:IAO_0000115>Despite the crucial physiological processes governed by neurons in the hypothalamic arcuate nucleus (ARC), such as growth, reproduction and energy homeostasis, the developmental pathways and regulators for ARC neurons remain understudied. Our single cell RNA-seq analyses of mouse embryonic ARC revealed many cell type-specific markers for developing ARC neurons. These markers include transcription factors whose expression is enriched in specific neuronal types and often depleted in other closely-related neuronal types, raising the possibility that these transcription factors play important roles in the fate commitment or differentiation of specific ARC neuronal types. We validated this idea with the two transcription factors, Foxp2 enriched for ##Ghrh-neurons## and Sox14 enriched for Kisspeptin-neurons, using Foxp2- and Sox14-deficient mouse models. Taken together, our single cell transcriptome analyses for the developing ARC uncovered a panel of transcription factors that are likely to form a gene regulatory network to orchestrate fate specification and differentiation of ARC neurons.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6697706</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31420539</oboInOwl:hasDbXref>
        <rdfs:label>Ghrh-neurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000110"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/b768057a-3f71-4c3d-a463-8eafb29dcc50"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000110"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/b7704c27-58d9-4e55-a18f-0ac45b53678e -->

    <Class rdf:about="http://example.org/b7704c27-58d9-4e55-a18f-0ac45b53678e">
        <obo:IAO_0000115>To gain a comprehensive view of immune interactions, we performed correlation analyses between the frequency of Ki67+ Tregs and the frequencies of all identified immune cell subpopulations. We did not observe significant association of the frequency of Ki67+ Tregs with lymphocytic subsets (Supplementary Fig. 8). On the other hand, myeloid cells, particularly dendritic cells (DCs), are known to facilitate Treg generation. Therefore, we analyzed the correlation between the frequency of Ki67+ Tregs and that of myeloid cell subsets (including cMo, iMo, ncMo, and DC). The frequency of Ki67+ Tregs was positively associated with the frequencies of HLA-DR+ and CD86+ monocytes and dendritic cells (Supplementary Fig. 9), suggesting their potential roles in the generation of ##Ki67+ Treg cells## via antigen presentation and CD28-dependent signaling. Interestingly, we found that the frequency of Ki67+ Tregs was also positively associated with the frequencies of PD-L1+ monocytes and dendritic cells (Supplementary Fig. 9), which is consistent with previous reports that DCs could induce Treg cells via PD-L1. These results indicate that myeloid cells might play a crucial role in Treg generation.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11496634</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:39438442</oboInOwl:hasDbXref>
        <rdfs:label>Ki67+ Treg cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000815"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/b7704c27-58d9-4e55-a18f-0ac45b53678e"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000815"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/b77f3dc0-0c45-4848-af2b-32b12c3e0ad1 -->

    <Class rdf:about="http://example.org/b77f3dc0-0c45-4848-af2b-32b12c3e0ad1">
        <obo:IAO_0000115>##T zone macrophages## colocalize with FRCs in secondary lymphoid organs</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10947543</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36991561</oboInOwl:hasDbXref>
        <rdfs:label>T zone macrophages</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/b77f3dc0-0c45-4848-af2b-32b12c3e0ad1"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/b7938c78-bdc3-47c1-9da7-3978ab40f66c -->

    <Class rdf:about="http://example.org/b7938c78-bdc3-47c1-9da7-3978ab40f66c">
        <obo:IAO_0000115>HH signaling has been reported to modulate cell proliferation in several contexts. We thus tested whether epithelial deletion of Shh might lead to tracheal epithelial cell proliferation defects. We examined epithelial cell proliferation first by immunostaining for Ki67, a cell cycle marker, and found that ShhCKO tracheae exhibited a reduced number of Ki67+ cells in the CDH1 marked epithelium compared with controls (Fig. 2H,I). Next, we performed an EdU incorporation assay to assess cells that had entered S-phase during the labeling period. After an ex vivo, 21 h long EdU treatment, ShhCKO tracheae displayed fewer EdU+ cells in their epithelium (Fig. 2J,K), indicating that Hedgehog inactivation compromises cell cycle entry. In a more-detailed analysis, we observed a reduced number of Ki67+SCGB1A1+ cells (Fig. 2L,M), but a similar number of PDPN+  and Ki67+PDPN+ basal cells  in ShhCKO tracheae compared with controls. Interestingly, ShhCKO tracheae exhibited increased ratios of KRT5+ basal cells to ##acetylated alpha-tubulin+ ciliated cells## and to SCGB1A1+ club cells compared with controls . We did not find obvious alterations in caspase3 staining between ShhCKO tracheal epithelium and controls at E18.5, suggesting that apoptosis is not affected in the mutants . To examine for changes in the surrounding mesenchyme, we analyzed SOX9+ chondroblasts, alpha-SMA+ smooth muscle cells and mesenchymal cell proliferation. ShhCKO tracheae exhibited SOX9+ chondroblast condensation defects , but no obvious SOX9+ chondroblast differentiation defects . We also detected reduced numbers of alpha-SMA+ smooth muscle cells and increased numbers of CDH1-Ki67+ mesenchymal cells compared with controls . As HH signaling modulates Fgf10 expression in the lung mesenchyme, we examined Fgf10 mRNA expression levels in ShhCKO tracheae. We detected a 1.5-fold increase in Fgf10 mRNA in ShhCKO mutants  but this was not sufficient to increase basal cell number, as might have been expected from previous studies. Altogether, these results indicate that loss of Shh function reduces club cell proliferation and interferes with ciliated cell differentiation and secretory cell maturation in the tracheal epithelium. In the tracheal mesenchyme, Shh promotes chondrocyte and smooth muscle morphogenesis.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8918789</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35112129</oboInOwl:hasDbXref>
        <rdfs:label>acetylated alpha-tubulin+ ciliated cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002145"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/b7938c78-bdc3-47c1-9da7-3978ab40f66c"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002145"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/b797fb4c-d782-4108-9450-794e78724262 -->

    <Class rdf:about="http://example.org/b797fb4c-d782-4108-9450-794e78724262">
        <obo:IAO_0000115>The complex TME of OC is a major influencer of the prognoses of OC patients. Besides tumor cells, the TME also contains ##tumor-associated fibroblasts##, endothelial cells and infiltrating immune cells. The levels of immune cell infiltration in solid tumors are extremely important in tumor development. In this study, the effect of autophagy on the infiltration levels of different immune cells was analyzed. We observed a significantly higher immune score in the autophagy-high group compared to the autophagy-low group. The infiltration ratio of naive B cells, memory resting CD4+ T cells and M2 macrophages was greater in the autophagy-high group. Conversely, memory B cells, CD8+ T cells, follicular helper T cells and gamma delta T cells were more abundant in the autophagy low group. In particular, the proportion of infiltrating M2 macrophages varied dramatically at different levels of autophagy. It has been reported that autophagy can cause M2-like macrophage polarization in chronic inflammatory diseases. However, the impact of autophagy on macrophage polarization in OC is unknown. We explored the interaction pattern between tumor cells with different autophagy levels and macrophages through the scRNA-seq data. The OC cells with high autophagy levels showed an increased interaction with macrophages through SPP1-CD44, RARRES2-CMKLR1, NECTIN3-NECTIN2, LGALS9-CD44, and LAMB1-CD44 signaling, and decreased interaction via SEMA3C-PLXND1, PTN-SDC4, ICAM1-(ITGAX+ITGB2), GAS6-MERTK and CSF1-CSF1R signaling. Emerging evidence demonstrated that the ligand-receptor signaling described above was closely correlated with macrophage polarization. For example, Zhang et al. reported that A549 cells were able to promote the M2 polarization of THP-1 macrophages though the induction of SPP1. In summary, these findings indicated that autophagy might play a key role in the immune microenvironment of OC by affecting macrophage polarization.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9953331</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36830707</oboInOwl:hasDbXref>
        <rdfs:label>tumor-associated fibroblasts</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000057"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/b797fb4c-d782-4108-9450-794e78724262"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000057"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/b7fc2fc2-0acb-44c9-b3f7-160545550962 -->

    <Class rdf:about="http://example.org/b7fc2fc2-0acb-44c9-b3f7-160545550962">
        <obo:IAO_0000115>During valvulogenesis, valvular interstitial cells (VICs) are mainly derived from endocardial cushion cells through an EndoMT process. We investigated whether hPSC-derived VELs could be converted to ##VIC-like (VICL) cells## through EndoMT by treating them with higher concentration of TGFb1 and bFGF over a time course of 6 days (Fig. 7a; Supplementary Fig. 7a). HPSC-derived VELs quickly lose the cobble-stone morphology, and displayed the fibroblastic morphology (Fig. 7b). After 3 days treatment, VIC-type markers such as POSTN, ACTA2, and S100A4/FSP1 were strongly induced (Fig. 7a; Supplementary Fig. 7b), accompanied by upregulation of EndoMT genes such as SNAI1, TWIST1, SOX9, AGGRECAN, TENASCIN, and SCLERAXIS (Supplementary Fig. 7c). We further confirmed these by IF staining and WB analyses (Fig. 7b, c).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8421482</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34489520</oboInOwl:hasDbXref>
        <rdfs:label>VIC-like (VICL) cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:4030032"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/b7fc2fc2-0acb-44c9-b3f7-160545550962"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4030032"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/b817b90c-2034-4c7c-a745-44aada3eefdc -->

    <Class rdf:about="http://example.org/b817b90c-2034-4c7c-a745-44aada3eefdc">
        <obo:IAO_0000115>The Table shows the numerical representations of Excitatory Neurons (Deep and Superficial Pyramidal cells) and Inhibitory neurons (Oriens Lacunosum moleculare cells:OLM; Trilaminar cells:Tri, Backprojection cells:BP, cholecystokinin positive Basket cells:CCKBC, Parvalbumin positive cells:PVBC, AxoAxonic Cells:AA, Ivy Cells:IVY, Bistratified cells:BS, Schaffer Collateral associated cells:SCA, ##Perforant Pathway Associated cell##:PPA, Neurogliaform:NG) subdivided on the basis of the placement classes (SO, SP, SR, SLM).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9381785</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35974119</oboInOwl:hasDbXref>
        <rdfs:label>Perforant Pathway Associated cell</rdfs:label>
    </Class>
    


    <!-- http://example.org/b81df23f-7698-433e-bd00-fed595c5de44 -->

    <Class rdf:about="http://example.org/b81df23f-7698-433e-bd00-fed595c5de44">
        <obo:IAO_0000115>GDF11 correlated positively with resting memory CD4 T cells, memory B cells, naive CD4 T cells, and M2 macrophages and negatively with naive B cells, neutrophils, and plasma cells. HSPA1L correlated positively with gamma delta T cells, neutrophils, and plasma cells and negatively with ##resting NK cells##, CD8 T cells, resting memory CD4 T cells, and naive CD4 T cells. TNFRSF25 correlated positively with CD4 naive T cells and resting NK cells and negatively with CD4 memory activated T cells, neutrophils, plasma cells, and gamma delta T cells. CMTM2 correlated positively with neutrophils, M0 macrophages, and monocytes and negatively with memory B cells, resting memory CD4 T cells, M2 macrophages, and naive CD4 T cells. PRKCA correlated positively with memory B cells, resting memory CD4 T cells, M2 macrophages, and naive CD4 T cells and negatively with neutrophils and plasma cells ( Figure 14 ).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10090698</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37063890</oboInOwl:hasDbXref>
        <rdfs:label>resting NK cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000623"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/b81df23f-7698-433e-bd00-fed595c5de44"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000623"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/b8632a30-3f9a-4921-8fb1-c8b2d5d06bdf -->

    <Class rdf:about="http://example.org/b8632a30-3f9a-4921-8fb1-c8b2d5d06bdf">
        <obo:IAO_0000115>The above analysis was based on a large number of RNA-seq, so we further used scRNA-seq to determine whether our ORGs signature had immune predictive value on the single cell level. Figure 7A showed that the PRAD samples from GEO datasets were annotated into Mast cell, Epithelial-NE, T/NK, Plasma_B, ##Epithelial##, Neuron, SMC, Fibroblasts and Pericytes, Myeloid and Endothelial. It was obvious that ORGs signature was specifically high in Epithelial-Nk, T/Nk and SMC cells (Figure 7B, 7C). Meanwhile, Figure 7D revealed that significant connection probability of ORGs related signaling pathways in cell clusters which showed specifically high ORGs signature. Furthermore, we chose epithelial cell for analysis. Chemotaxis related pathways including cell chemotaxis, leukocyte chemotaxis, regulation of chemotaxis and regulation of leukocyte chemotaxis were significantly up-regulated in the high ORGs signature group (Figure 7E). What&apos;s more, immune related pathways were all up-regulated in the high ORGs signature group both in GO (Figure 7F) and KEGG (Figure 7G) analysis.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10599753</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37788005</oboInOwl:hasDbXref>
        <rdfs:label>Epithelial</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000066"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/b8632a30-3f9a-4921-8fb1-c8b2d5d06bdf"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000066"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/b8927d27-2099-472e-a021-0e3111f2669f -->

    <Class rdf:about="http://example.org/b8927d27-2099-472e-a021-0e3111f2669f">
        <obo:IAO_0000115>Pericytes (PCs) are specialized cells located abluminal of endothelial cells (ECs) on capillaries, embedded within the same basement membrane. They are essential regulators of vascular development, remodeling, and blood-retina-barrier (BRB) tightness and are therefore important components to maintain tissue homeostasis. The perivascular localization and expression of contractile proteins suggest that PCs participate in capillary blood flow regulation and neurovascular coupling. Due to their ability to differentiate into various cell types in vitro, they are regarded as potential cells for tissue repair and therapeutic approaches in regenerative medicine. Altered function or loss of PCs is associated with a multitude of CNS diseases, including diabetic retinopathy (DR). In this chapter, we will provide a short overview of retinal vascular development, the origin of PCs, and focus on PCs in retinopathy of prematurity (ROP) and in the diabetic retina. Further, animal models to study the fate of PCs and the potential role of ##(retinal) PCs## in regeneration and wound healing will be discussed.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMID:30937860</oboInOwl:hasDbXref>
        <rdfs:label>(retinal) PCs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000669"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/b8927d27-2099-472e-a021-0e3111f2669f"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000669"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/b8a33c1e-1873-4071-97e2-667302b54c7c -->

    <Class rdf:about="http://example.org/b8a33c1e-1873-4071-97e2-667302b54c7c">
        <obo:IAO_0000115>MDSC populations were divided into monocyte-derived (CD66b-CD20-CD19-CD3-) and granulocyte-derived (CD66b+) MDSCs (Figure 6G). While the granulocytic MDSC subpopulation remained close to zero, the monocytic MDSCs were about 15% of the total cells stained and dropped nearly 3-fold within the PDAC PBMCs to 5% (p = 0.00018). Even though the total number of monocytic MDSCs decreased and the granulocytic MDSCs were low, both of their populations experienced significantly elevated FcRn positivity in PDAC patients (p = 0.034, p = 0.026, respectively) (Figure 6H). ##Monocytic MDSC## FcRn MMI was significantly increased in PDAC PBMCs (p = 0.021), while granulocytic FcRn MMI had no change (Figure 6I). Together, these results further support the PDAC dependent induction of FcRn expression in highly specific cell populations of monocytic origin.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9266939</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35806069</oboInOwl:hasDbXref>
        <rdfs:label>Monocytic MDSC</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000576"/>
        <skos:relatedMatch rdf:resource="CL:0000889"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/b8a33c1e-1873-4071-97e2-667302b54c7c"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000576"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/b8a33c1e-1873-4071-97e2-667302b54c7c"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000889"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/b8c9d536-a191-4077-a6ec-562a25c447a7 -->

    <Class rdf:about="http://example.org/b8c9d536-a191-4077-a6ec-562a25c447a7">
        <obo:IAO_0000115>In order for the sensitization we observed in excitatory interneurons to drive the psychophysical phenomenon of allodynia, spinal projection neurons must relay these nociceptive signals supraspinally. We found that capsaicin treatment shifted the overall tuning of SPB neurons towards LT input, consistent with the effects of central sensitization producing allodynia (Fig. 8a, b). Because SPB neurons are heterogeneous with respect to their response properties, we classified them as either wide-dynamic range (WDR), high threshold (HT), or low threshold (LT) (Fig. 8c) using previously published criteria. We found that both HT and WDR SPB showed significant increases in tuning to LT input, however the degree of change was much greater for WDR compared to HT SPB neurons (Fig. 8d). Finally, examining CICADA responses across populations, we found that WDR cells were more frequently responsive to CICADA agonists (71.4%), compared to either ##LT (40%) or HT (0%) SPB neurons##. In particular, all SP-responsive SPB neurons were WDR cells (Fig. 8e). Since capsaicin is known to activate peptidergic afferents that release SP, these findings suggest that capsaicin-induced allodynia may be conveyed to the brain through a population of TACR1 expressing WDR SPB neurons and, to a lesser extent, some HT SPB neurons (Fig. 8f).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9440908</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36057681</oboInOwl:hasDbXref>
        <rdfs:label>LT (40%) or HT (0%) SPB neurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000540"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/b8c9d536-a191-4077-a6ec-562a25c447a7"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000540"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/b8da9722-14d8-455f-920a-373d72281c84 -->

    <Class rdf:about="http://example.org/b8da9722-14d8-455f-920a-373d72281c84">
        <obo:IAO_0000115>To illustrate the application of CSN to developing cells, we feature the developmental trajectory of human excitatory neuron cells in the Developing Cortex Atlas dataset (15), which includes Radial Gila and Progenitors (P), Intermediate Progenitors (IP), Maturing Excitatory (ExN), Migrating Excitatory (ExM), Excitatory Upper-layer enriched (ExM-U), and Excitatory Deep layer (##ExDp##), with cell type labels determined by the authors (SI Appendix, section 3 and Table S2). Using Slingshot, we estimate the developmental path consists of two trajectories, one ending in upper-layer (U curve) and the other in deep-layer (D curve) excitatory neurons (Fig. 3 A and B).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8713783</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34903665</oboInOwl:hasDbXref>
        <rdfs:label>ExDp</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:4030064"/>
        <skos:relatedMatch rdf:resource="CL:4030065"/>
        <skos:relatedMatch rdf:resource="CL:4030067"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/b8da9722-14d8-455f-920a-373d72281c84"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4030064"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/b8da9722-14d8-455f-920a-373d72281c84"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4030065"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/b8da9722-14d8-455f-920a-373d72281c84"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4030067"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/b8e681cd-6d33-4053-aae2-c2d7ac5f4849 -->

    <Class rdf:about="http://example.org/b8e681cd-6d33-4053-aae2-c2d7ac5f4849">
        <obo:IAO_0000115>Four independent single cell GBM datasets (Table 1) were used to derive marker genes, or signature gene-expression matrices, for GBM tumor-infiltrating immune cells: B cells, T-cells, natural killer (NK) cells, microglia, tumor associated macrophages (##TAM##), monocytes, mast and dendritic cells (DC). Figure 1A outlines the process. Datasets underwent pre-processing independently to filter out poor quality cells and copy-number analysis to remove neoplastic cells, before being amalgamated. There were significant batch effects owing to different sequencing platforms and originating centres but these were effectively removed using regularized negative binomial regression (Figure 1B and Supplementary Figure S1A). One dataset (GSE163120) included the immune cell annotations determined by the original study. This information was used to guide clustering, with optimization focused first on maximizing cluster stability and then on the best separation of pre-annotated cell types. Owing to the difficulty in separating immune types that are known to have similar and overlapping gene-expression profiles (namely TAM and microglia; and NK and T-cells) cells assigned to any of these groupings were isolated and further sub-clustered, resulting in definitive cluster annotations (Figure 1B and Supplementary Figure S1B).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10326489</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36689332</oboInOwl:hasDbXref>
        <rdfs:label>TAM</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/b8e681cd-6d33-4053-aae2-c2d7ac5f4849"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/b927c937-42dc-4c1f-b99a-96215099309c -->

    <Class rdf:about="http://example.org/b927c937-42dc-4c1f-b99a-96215099309c">
        <obo:IAO_0000115>Applying EmptyDrops to the different time-points consistently increased the number of early spermatocytes from P15 to Adult and also recovered ##FLCs## at P15 and P20, consistent with these cells undergoing gradual atrophy (Supplementary Data 1, Supplementary Fig. 6e-g). Additionally, we detect an increase in transcriptionally quiescent late spermatids, particularly at P35 (Supplementary Fig. 6g).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6424977</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:30890697</oboInOwl:hasDbXref>
        <rdfs:label>FLCs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000178"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/b927c937-42dc-4c1f-b99a-96215099309c"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000178"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/b94a9879-c905-46f8-986b-a1d241de2f04 -->

    <Class rdf:about="http://example.org/b94a9879-c905-46f8-986b-a1d241de2f04">
        <obo:IAO_0000115>Immunosuppressive role of tumour-associated macrophages (##TAMs##). TAMs promote immunosuppression by different mechanisms: TAMs can express programmed cell death ligand 1 and ligand 2 (PD-L1 and PD-L2), which bind the T cell inhibitory receptor programmed cell death protein 1 (PD-1), thereby inducing T cell exhaustion. TAM expression of V-domain Ig suppressor of T cell activation (VISTA) and B7 family molecules, such as B7-H4, can have similar function. TAMs secrete immunosuppressive cytokines such as IL-10 and TGFbeta, which can have direct suppressive functions on CD8+ T cells, or they can induce recruitment of immunosuppressive CD4+ T regulatory (Treg) cells. TAM secreted IL-10 can impair T cells effector functions indirectly either by inhibit dendritic cell (DC) anti-tumorigenic role or by inducing DC expression of PD-L1. Moreover, amino acid metabolism in TAM results in production of arginase and immunosuppressive metabolites via the indoleamine 2,3-dioxygenase (IDO) pathway, which is responsible of metabolic starvation in T cells. TAMs can also indirectly induce immunosuppression by promoting fibrosis. Indeed cancer associated fibroblast (CAF) secreted factors and/or extracellular matrix (ECM) stiffness are responsible for CD8+ T cell immunosuppression and/or exclusion from the tumour nest.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6678757</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31331034</oboInOwl:hasDbXref>
        <rdfs:label>TAMs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/b94a9879-c905-46f8-986b-a1d241de2f04"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/b99695af-82a6-4f1e-b10d-1565af640be6 -->

    <Class rdf:about="http://example.org/b99695af-82a6-4f1e-b10d-1565af640be6">
        <obo:IAO_0000115>Other studies have examined and set out to better characterize human B-1 and B-2 lymphoid development. As indicated earlier, innate-like B-1 (B-1a and B-1b) and conventional B-2 cells constitute two main branches of the murine B cell population. During embryonic and fetal development, murine B-1a subsets are proposed to arise from multiple sites including yolk sac, P-Sp/AGM and fetal liver from HSC independent or dependent precursors, and to a lesser degree from adult bone marrow HSCs. Although much less is known about the equivalent human B-1 B cells, these cells were provisionally identified as ##CD20+CD27+CD43+CD70- cells## in UCB and adult peripheral blood, and in other studies, in fetal liver and fetal bone marrow as well as UCB, reaching their highest frequency in fetal liver around 10 pcw. As this phenotypic cell subset may also contain CD20+CD38hi plasmablast and preplasmablast precursors, it remains possible that the human fetal B-1 B cell frequency has been over estimated. Putative human B-1 cells, the earliest B cells to arise in the human fetus, were therefore subsequently identified phenotypically as CD19+CD20+CD27+CD43+CD38lo/int, while lacking CD3, CD4 and CD8 T cell markers, making them distinct from B-2 lymphoid cells, which are predominantly found in adult tissues. Whether human B-1 and B-2 B cells arise from different progenitors or a common progenitor is unclear. However, recent evidence examining hematopoietic lineage output at the clonal level from the peripheral blood of adult patients with paroxysmal nocturnal hemoglobinuria (PNH) suggests that this putative human B-1 B cell population can also arise in the adult from HSCs, while other studies indicate that human adult B-1 B cell frequency and diversity decline with aging, particularly after the age of 50.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8999121</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35409034</oboInOwl:hasDbXref>
        <rdfs:label>CD20+CD27+CD43+CD70- cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000819"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/b99695af-82a6-4f1e-b10d-1565af640be6"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000819"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/b9b0160b-256b-450d-9d00-0c31055a307c -->

    <Class rdf:about="http://example.org/b9b0160b-256b-450d-9d00-0c31055a307c">
        <obo:IAO_0000115>Downstream of the multipotent HSCs and MPPs, the original lineage bifurcation model strictly separated oligopotent Common Lymphoid Progenitors (CLP) from Common Myeloid Progenitors (CMP) which could further diverge into Megakaryocyte/Erythrocyte Progenitors (MEPs), Monocyte (Mo)/Dendritic cell (DC) Progenitors (MDPs) and Granulocyte/Mo Progenitors (GMPs). However, this model has been the subject of ongoing revision in the scRNA-seq era. On the one hand, a Lymphoid-primed MultiPotent Progenitor (LMPP) with combined lymphoid and myeloid potential has been shown to gradually lose myeloid potential by upregulating the interleukin-7 receptor alpha-chain (IL7Ralpha) and differentiate into Dach1- Lymphoid-Primed Progenitors (LPPs) prior to CLPs. On the other hand, erythroid-versus-myeloid fate decisions seem to be made prior to CMP commitment, calling for in-depth revision of all CMP progeny (MEPs, MDPs and GMPs) as well. While the ##Flt3L+CD115lo CMPs## give rise to oligopotent MDPs, the Flt3-CD115- CMPs give rise to GMPs. The former are defined by TF co-expression of CEBPA, IRF8 and RUNX1. MDPs can give rise to IRF8/SATB1 plasmacytoid DC (pDC) Progenitors (pDCPs) and HLA-DR/IRF8/CEBPA Mo/conventional DC (cDC) Progenitors (McDPs). The latter bifurcate in CD11c/CD172ab/CD14 (human) or Ly6C+ Mo (mouse) or IRF8/HLA-DR/CD84/CD172ab Common DC Progenitors (CDPs). In contrast, GMPs (Kit, CD34, Sox4) are very heterogeneous at the transcriptomic and proteomic level and can adjust their functional output towards common Mo Progenitors (cMoP) and Granulocyte Progenitors (GPs).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11324509</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:39148724</oboInOwl:hasDbXref>
        <rdfs:label>Flt3L+CD115lo CMPs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000049"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/b9b0160b-256b-450d-9d00-0c31055a307c"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000049"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/b9d88945-6b33-4607-83cb-c8f80163a89f -->

    <Class rdf:about="http://example.org/b9d88945-6b33-4607-83cb-c8f80163a89f">
        <obo:IAO_0000115>Extensive studies on vitiligo have focused on T cell suppression, and Jak inhibitors to suppress T cell recruitment have been approved for vitiligo therapy. Even though significant amounts of repigmentation is often achieved from this treatment, efficacy is still limited and varies among patients. Previous studies have suggested that achieving durable repigmentation will likely require combinatorial approaches that address both vitiligo pathogenesis and epidermal melanocyte repopulation. In this study, we aimed to increase the level of epidermal melanocyte translocation that normally occurs by phototherapy-induced migration of hair follicle McSCs. We found that the UVB-induced inflammatory response underlies ##McSC## migration to the epidermis and that the gender-specific differences in inflammation levels translate to differences in McSC translocation rates. We also demonstrated that applying supplemental dmPGE2 promotes UVB-induced inflammation and further addition of JAK inhibitor treatment results in a significantly higher number of epidermal melanocytes than any single therapy alone.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10821900</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38280858</oboInOwl:hasDbXref>
        <rdfs:label>McSC</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002566"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/b9d88945-6b33-4607-83cb-c8f80163a89f"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002566"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/b9ff63d2-14d9-48fa-a5f1-b6fbfa31cf18 -->

    <Class rdf:about="http://example.org/b9ff63d2-14d9-48fa-a5f1-b6fbfa31cf18">
        <obo:IAO_0000115>BP, Biological Processes; CC, Cellular Components; CI, Confidence Interval; DEGs, Differentially Expressed Genes; EFS, Event-free Survival; GEO, Gene Expression Omnibus; GEP, Gene Expression Profiling; GO, Gene Ontology; HEV, High Endothelial Venules; HIER, Heat-Induced Antigen Retrieval; HR, Hazards Ratio; ICB, Immune Checkpoint Blockade; IQR, Interquartile Range; KEGG, Kyoto Encyclopedia of Genes and Genomes; LA, Lymphoid Aggregates; LDH, Lactate Dehydrogenase; LLOQ, Lower Limit of Quantification; LT, Lymphotoxin; MDSC, Myeloid-Derived Suppressor Cells; MF, Molecular Functions; NSCLC, Non-small Cell Lung Cancer; OS, Overall Survival; OSCC, Oral Squamous Cell Carcinoma; SKCM, Skin Cutaneous Melanoma; TCGA, The Cancer Genomic Atlas; ##TIL##, Tumor Infiltrating Lymphocytes; TME, Tumor Microenvironment; TLS-kines, TLS-associated chemokines/cytokines; TLS, Tertiary Lymphoid Structures; mIF, Multispectral Immunofluorescence.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10332263</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37435077</oboInOwl:hasDbXref>
        <rdfs:label>TIL</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000542"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/b9ff63d2-14d9-48fa-a5f1-b6fbfa31cf18"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000542"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/ba033014-0bd6-468d-ab44-f81126e7a6e2 -->

    <Class rdf:about="http://example.org/ba033014-0bd6-468d-ab44-f81126e7a6e2">
        <obo:IAO_0000115>##BLALypd1 neurons## are positive valence neurons and promote normal food uptake</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11316773</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:39127719</oboInOwl:hasDbXref>
        <rdfs:label>BLALypd1 neurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000540"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/ba033014-0bd6-468d-ab44-f81126e7a6e2"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000540"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/ba0a4e3e-024f-4bbb-971a-72281e7dec6d -->

    <Class rdf:about="http://example.org/ba0a4e3e-024f-4bbb-971a-72281e7dec6d">
        <obo:IAO_0000115>tSNE plot colored by the 17 Seurat clusters including hepatocytes, endothelial cells (liver sinusoidal endothelial cells:LSEC, non-tumor liver vascular endothelial cells:LVEC, and tumor liver vascular endothelial cells:LVECt), mesenchymal cells (Stellate cells, cancer-associated fibroblasts:CAFs, Pericytes, vascular smooth muscle cells:vSMC), immune cells (Kupffer cells, scar-associated macrophages:SAMs, tissue monocytes 1:TM1, ##cDC1##, cDC2, T cells, and B cells), proliferating cells, and carcinoma cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7746227</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33332768</oboInOwl:hasDbXref>
        <rdfs:label>cDC1</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000990"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/ba0a4e3e-024f-4bbb-971a-72281e7dec6d"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000990"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/ba19b1f6-1561-4d4c-b513-e39b1949d8c2 -->

    <Class rdf:about="http://example.org/ba19b1f6-1561-4d4c-b513-e39b1949d8c2">
        <obo:IAO_0000115>The Table shows the numerical representations of Excitatory Neurons (Deep and Superficial Pyramidal cells) and Inhibitory neurons (Oriens Lacunosum moleculare cells:OLM; Trilaminar cells:Tri, Backprojection cells:BP, cholecystokinin positive Basket cells:CCKBC, Parvalbumin positive cells:##PVBC##, AxoAxonic Cells:AA, Ivy Cells:IVY, Bistratified cells:BS, Schaffer Collateral associated cells:SCA, Perforant Pathway Associated cell:PPA, Neurogliaform:NG) subdivided on the basis of the placement classes (SO, SP, SR, SLM).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9381785</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35974119</oboInOwl:hasDbXref>
        <rdfs:label>PVBC</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:4023018"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/ba19b1f6-1561-4d4c-b513-e39b1949d8c2"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4023018"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/ba21db3e-16dc-47d2-9b8d-5e4e7a35e889 -->

    <Class rdf:about="http://example.org/ba21db3e-16dc-47d2-9b8d-5e4e7a35e889">
        <obo:IAO_0000115>Next, we merged the datasets for the five time-points using the merge function of the Seurat pipeline, which combines multiple datasets without transforming the data. The merged dataset with a total of 62,202 cells was processed for clustering and then the data were visualized as a UMAP plot (Fig. 3). The same set of cell clusters identified in individual time-point data was also identified in the merged dataset (Fig. 3A,E and Fig. S6). The downregulation of PAX2 and upregulation of FBXO2 from otic prosensory cells to intermediate otic cells and supporting cells were confirmed with this analysis (Fig. 3E). A DACH1+ SPP1+ population was detected adjacent to OC90+ intermediate otic cells (Fig. 3D, Figs S7 and S8), suggesting the existence of another lineage direction in the otic lineage other than the sensory epithelium. TFAP2B+ surface ectoderm cells, ##NEUROD1+ neuroblasts## and S100B+ neural crest/Schwann cells were identified as distinctive clusters (Fig. 3A,D and Fig. S7). An intermediate population between otic prosensory cells and supporting cells expressed not only otic epithelium markers EPCAM and FBXO2, but also other otic progenitor markers COL9A1, SERPINF1, HES1, AATF, COL14A1, OC90, PRSS8 and EYA4 (Fig. S7), suggesting that this is an otic epithelial cell population differentiating into hair cells and supporting cells. Adjacent to the supporting cell cluster, there was a POU4F3+ hair cell cluster that expressed vestibular hair cell markers [CD164L2, ZBBX, TEKT1, SKOR1, TCTEX1D1 (DYNLT5) and NEUROD6] and type II hair cell markers (ANXA4, MAPT and NHLH1) (Fig. 3D and Fig. S8), indicative of an immature type II hair cell identity. However, we were unable to detect the cochlear marker GATA3 or INSM1 in PCP4+ hair cells (Fig. S8G,H). Surprisingly, we were unable to identify common progenitor populations that differentiate into both hair cells and supporting cells in the merged datasets.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10323240</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37381908</oboInOwl:hasDbXref>
        <rdfs:label>NEUROD1+ neuroblasts</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002676"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/ba21db3e-16dc-47d2-9b8d-5e4e7a35e889"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002676"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/ba5772fb-cf42-4c5b-a354-c57f6c1e937d -->

    <Class rdf:about="http://example.org/ba5772fb-cf42-4c5b-a354-c57f6c1e937d">
        <obo:IAO_0000115>The Table shows the numerical representations of Excitatory Neurons (Deep and Superficial Pyramidal cells) and Inhibitory neurons (Oriens Lacunosum moleculare cells:OLM; Trilaminar cells:Tri, Backprojection cells:BP, cholecystokinin positive Basket cells:CCKBC, Parvalbumin positive cells:PVBC, AxoAxonic Cells:##AA##, Ivy Cells:IVY, Bistratified cells:BS, Schaffer Collateral associated cells:SCA, Perforant Pathway Associated cell:PPA, Neurogliaform:NG) subdivided on the basis of the placement classes (SO, SP, SR, SLM).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9381785</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35974119</oboInOwl:hasDbXref>
        <rdfs:label>AA</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000498"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/ba5772fb-cf42-4c5b-a354-c57f6c1e937d"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000498"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/ba9485cd-385e-4d8b-9bac-c9b9be569553 -->

    <Class rdf:about="http://example.org/ba9485cd-385e-4d8b-9bac-c9b9be569553">
        <obo:IAO_0000115>The culmination of our analysis was the establishment of a PCD index (PCDI) for predicting patient prognosis. A robust predictive model was constructed using 17 PCD genes, showcasing a potential prognostic tool for LIHC. Notably, high PCDI was associated with pathways concerning treatment resistance and tumor invasion. This provides potential explanations for the worsened prognosis seen in patients with a high PCDI. Furthermore, the association between PCDI and immune landscapes, particularly the diminished immune responses in patients with high PCDI and the negative correlation with ##activated mast cells##, sheds light on the immune evasion mechanisms at play. Previous study has proved a connection between tumor-infiltrating mast cells and resistance to anti-PD-1 therapy. This connection further underscores the intricate interplay between PCD and the immune microenvironment, suggesting the potential for combined therapeutic strategies targeting both these aspects in LIHC. Meanwhile, our exploration into pharmacotherapeutic approaches offers promise. By correlating PCD gene expression with drug sensitivities, we&apos;ve identified drugs that might be more efficacious in specific patient subgroups, potentially guiding personalized therapy. In comparison to previous studies, our research has provided a more in-depth understanding of the association between PCD and the immune microenvironment. In comparison with previously published prognosis models, we conducted a comprehensive assessment of the intrinsic heterogeneity among patients with high and low PCD levels, highlighting their varying sensitivity to immunotherapy. Furthermore, we have identified personalized therapeutic strategies for drug treatment based on these insights. Lastly, we verified that PRKDC, seldom mentioned in prior cancer studies, correlated with poorer survival outcomes in LIHC patients. Furthermore, elevated PRKDC levels notably enhanced the proliferation and invasive capabilities of LIHC, suggesting it as a potential therapeutic target for this condition.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11164487</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38787389</oboInOwl:hasDbXref>
        <rdfs:label>activated mast cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000097"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/ba9485cd-385e-4d8b-9bac-c9b9be569553"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000097"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/ba9c984c-9ccb-4ce3-a045-8794c9c7ae90 -->

    <Class rdf:about="http://example.org/ba9c984c-9ccb-4ce3-a045-8794c9c7ae90">
        <obo:IAO_0000115>Both spermatogonial stem cells (SSCs) and female germline stem cells (FGSCs) are adult pluripotent stem cells (ASCs) in the germline. SSCs are pluripotent stem cells for generating spermatozoa in the testis, while FGSCs are newly identified pluripotent stem cells for producing oocytes in the ovary. Once gonadal colonization, hPGCs cease to proliferate, and the cells are called gonocytes or prespermatogonia in males. hPGCs will differentiate directly into ##fetal state 0-like spermatogonia## starting at week 14 after fertilization. In humans, spermatogenesis begins 10-13 years after birth at puberty. During the first wave of spermatogenesis, some gonocytes resume proliferation, begin to move toward the periphery (basement membrane) of seminiferous tubules in the testis, and differentiate into spermatogonial stem cells. The SSCs are essential for generating spermatozoa throughout life. As germline stem cells, SSCs have features of stem cells, in addition to maintaining spermatogenesis. The main features of human SSCs include, (1) self-renewing to maintain SSCs population, (2) production of spermatogonia to support daily production of sperm cells, (3) SSC heterogeneity, as discussed below, (4) SSCs can transdifferentiate into other cell types, for example, oocytes, which is functional because the induced ovarian organoids derived from SSCs produced offspring. SSCs could be generated from induction from hPSCs, prepubertal SSCs are also induced to initiate meiosis and produce haploid germ cells in vitro. Somatic Sertoli cells are converted to become into SSCs by overexpression of DAZL, DAZ2, and BOULE, (5) SSCs are rare and account for about 0.02-0.03% of all cells in the testis, and (6) de novo mutations in SSCs increase as men age, which often are associated with congenital disorders.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9527259</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36184610</oboInOwl:hasDbXref>
        <rdfs:label>fetal state 0-like spermatogonia</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000020"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/ba9c984c-9ccb-4ce3-a045-8794c9c7ae90"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000020"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/baa03ff6-8cd7-468e-9165-f8e839463155 -->

    <Class rdf:about="http://example.org/baa03ff6-8cd7-468e-9165-f8e839463155">
        <obo:IAO_0000115>Different pathogenesis of HCC involving viral and non-viral etiology is related to the unique TIME. Chronic infection with hepatitis B virus (HBV) promotes the formation of a tolerant TIME by depletion of the effector CD8+ T cells and attracting immunosuppressive cells including granulomatous myeloid-derived suppressor cells (gMDSCs), Tregs, or regulatory B (Breg) cells. Chronic infection by hepatitis C virus (HCV) depletes CD8+ T cells and promotes immune evasion through spontaneous viral escape and dysregulation of major histocompatibility complex I (MHC I) dependent antigen presentation. In alcoholic steatohepatitis (ASH), alcohol promotes the inhibition of liver immune response by increasing the abundance of M2 TAMs, inhibiting CD8+ T cell activation, and facilitating ##gMDSC## infiltration. In contrast, non-alcoholic steatohepatitis (NASH) activates dysfunctional immune cells, including helper T cell 17 (Th17) cells, natural killer T (NKT) cells, CD8+/PD-1+ T cells and IgA+ plasma cells, disrupting tumor immune surveillance and inducing HCC.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11639598</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:39641225</oboInOwl:hasDbXref>
        <rdfs:label>gMDSC</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000094"/>
        <skos:relatedMatch rdf:resource="CL:0000889"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/baa03ff6-8cd7-468e-9165-f8e839463155"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000094"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/baa03ff6-8cd7-468e-9165-f8e839463155"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000889"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/bad25b9c-5e23-4534-81be-487e8b3961f2 -->

    <Class rdf:about="http://example.org/bad25b9c-5e23-4534-81be-487e8b3961f2">
        <obo:IAO_0000115>Focusing on the peripheral, differentiated cDC populations, we next assessed protein expression of the IRF8 transcription factor in tumor-derived cDC populations (Fig. 3a). In the periphery, IRF8 controls survival and function of terminally differentiated cDC1s. Furthermore, increased IRF8 expression in ##CD11b-CD103- DN cells## was shown to promote their differentiation into mature CD103+ cDC1s. Thus, we hypothesized that CD40L-CAR T cell treatment skews the cDC1/cDC2 ratio towards the cDC1 populations by stimulating the DN cells to expand, upregulate IRF8, and differentiate into cDC1s. We specifically noticed upregulation of IRF8 (readout of DN-to-cDC1 differentiation) and Ki-67 (readout for proliferation) in DN cells treated with CD40L-CAR T cell-treated mice (Fig. 3b). The increased expression of Ki-67 in the tumor-derived DN cells also correlated with the observed increase of the DN population in the tumor of CD40L-CAR T cell-treated mice (Fig. 1f), indicating that DN cells receive a proliferative signal upon CD40L-CAR T cell treatment. Intriguingly, splenic DN cells and DN cells from the tdLNs did not upregulate Ki-67 or IRF8 (Fig. 3c, d). Overall, tdLN cDCs did not present with a stimulated phenotype, as suggested by the lack of CD86 or Ki-67 upregulation (Supplementary Fig. 2D-G). This suggested a tumor-specific effect of cDC DN stimulation after m1928z-CD40L treatment.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7710757</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33268774</oboInOwl:hasDbXref>
        <rdfs:label>CD11b-CD103- DN cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002510"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/bad25b9c-5e23-4534-81be-487e8b3961f2"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002510"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/bad26e42-9561-4636-afbc-e29b43733483 -->

    <Class rdf:about="http://example.org/bad26e42-9561-4636-afbc-e29b43733483">
        <obo:IAO_0000115>Our novel multi-color flow cytometry panel was also tested on mouse skin. After excluding cellular debris, doublets, and dead cells, we gated with the help of FMO controls (Fig. S10) on viable CD45+ cells (Fig. 2A). In healthy skin, the CD3+ T cell population consists of CD3intCD4+ T cells and CD3highgammadelta T cells, whereas CD8+ T cells, NK cells, B cells, neutrophils and pDC are rare in healthy skin (Fig. 2B). By following gating published earlier, we identified several myeloid non-DC populations (P1-P5) in the dermis (Fig. 2C) and different DC-subsets (Fig. 2D, E). From the non CD11b+CD24- population we identified CD11c+MHC-II+ DC. Next, we divided DC into ##XCR1+ cDC1##, which contain CD103+ and CD103- subsets, and CD172a+ DC which consists mainly of CD207+ LC (Fig. 2D). Dermal cDC2 are characterized from the CD64-Ly-6C- population by gating on CD11c+MHC-II+ cells that express CD11b and CD172a (Fig. 2E). In addition, we investigated CD115, F4/80 and CD64 expression on the non-DC myeloid cell populations P1-P5 (Fig. 2F). Analysis of CD40, PD-L1, PD-L2 and CCR7 on the different DC-subets allows further phenotypical characterization (Fig. 2G). An example for UMAP analysis is shown in Figure S11 confirming manual gating for DC-subsets and non-DC populations.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10087122</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35944142</oboInOwl:hasDbXref>
        <rdfs:label>XCR1+ cDC1</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000841"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/bad26e42-9561-4636-afbc-e29b43733483"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000841"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/bb1136fa-bbdb-409a-972d-5d39a610891f -->

    <Class rdf:about="http://example.org/bb1136fa-bbdb-409a-972d-5d39a610891f">
        <obo:IAO_0000115>Embryonic and pluripotent SCs cycle more quickly than the differentiated progenitors they produce. Still, it is unclear whether these cells cycle more quickly in relation to their innate stemness, or instead in relation to their pluripotency. Here we study the CCD of somatic SCs, which are committed to a defined lineage. Here we use 3 complementary methods to show that adult keratinocyte SCs have a shorter CCD than their differentiated progenitor daughters. We first used live cell imaging to examine the proliferation and cycling behavior of individual freshly-isolated passage 0 normal adult human keratinocytes, in vitro, for up to 16 days. We then compared the CCD of SCs and more differentiated ##CPs## using live cell imaging, the proportions of S phase labeled keratinocytes in vitro, and single-cell RNA sequencing.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10935907</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38475896</oboInOwl:hasDbXref>
        <rdfs:label>CPs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0011026"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/bb1136fa-bbdb-409a-972d-5d39a610891f"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0011026"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/bb17daf3-5cae-4ad7-8db6-751f2f24124a -->

    <Class rdf:about="http://example.org/bb17daf3-5cae-4ad7-8db6-751f2f24124a">
        <obo:IAO_0000115>The various TEC subsets constitute the basic thymic microenvironment. They provide cytokines, chemokines, multiple molecular signals, and cell-to-cell interactions to control thymocyte proliferation, differentiation, and selection. This process leads thymocytes from immature to mature, and in turn, TECs themselves also get maturation from ##bi-potent epithelial progenitors## to functional cTECs and mTECs. The added complexity of many different subsets suggests distinct roles for each in the formation and regeneration of the thymus at different stages.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9229346</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35757725</oboInOwl:hasDbXref>
        <rdfs:label>bi-potent epithelial progenitors</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002364"/>
        <skos:relatedMatch rdf:resource="CL:0002365"/>
        <skos:relatedMatch rdf:resource="CL:0011026"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/bb17daf3-5cae-4ad7-8db6-751f2f24124a"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002364"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/bb17daf3-5cae-4ad7-8db6-751f2f24124a"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002365"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/bb17daf3-5cae-4ad7-8db6-751f2f24124a"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0011026"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/bb4a030d-f561-4f07-9e6f-0ac7e70ed02d -->

    <Class rdf:about="http://example.org/bb4a030d-f561-4f07-9e6f-0ac7e70ed02d">
        <obo:IAO_0000115>The Table shows the numerical representations of Excitatory Neurons (Deep and Superficial Pyramidal cells) and Inhibitory neurons (Oriens Lacunosum moleculare cells:OLM; Trilaminar cells:Tri, Backprojection cells:BP, ##cholecystokinin positive Basket cells##:CCKBC, Parvalbumin positive cells:PVBC, AxoAxonic Cells:AA, Ivy Cells:IVY, Bistratified cells:BS, Schaffer Collateral associated cells:SCA, Perforant Pathway Associated cell:PPA, Neurogliaform:NG) subdivided on the basis of the placement classes (SO, SP, SR, SLM).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9381785</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35974119</oboInOwl:hasDbXref>
        <rdfs:label>cholecystokinin positive Basket cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000118"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/bb4a030d-f561-4f07-9e6f-0ac7e70ed02d"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000118"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/bba8e142-072b-44aa-9398-7437e7dec356 -->

    <Class rdf:about="http://example.org/bba8e142-072b-44aa-9398-7437e7dec356">
        <obo:IAO_0000115>Refinement and annotation of cell clusters in colon tissues. A Reclustering of cells and its UMAP projection in colon tissues. B &quot;Ground truth&quot; cell cluster labels derived from manual cell annotation based on the marker map. C Annotation results based on ACT. D A Sankey diagram to show the comparison of annotation results. Cell types that might be mislabeled are shown in the red box. E Epithelial cells and goblet cells correspond to the iCMS2 and iCMS3 subgroups in the original publication, respectively. CD4_Tn, Naive thymus-derived CD4-positive, alpha-beta T cell; Th17, T helper 17 cell; Treg, Regulatory T cell; CD8_Tem, Effector memory CD8-positive alpha, beta T cell; CTL, Cytotoxic T cell; NK, Natural killer cell; FO_B, Follicular B cell; Plasma, Plasma cell; mregDC, ##Migratory dendritic cell##; Glial, Glial cell, i.e., Entericglial cell; Endo, Endothelial cell; Endo_lymphatic, Lymphatic endothelial cell; Fibro, Fibroblast; Myof, Myofibroblast cell; Goblet, Goblet cell; Epi_colon, Colon epithelial cell; Goblet_T, Malignant goblet cell; Goblet_N, Normal goblet cell; McDC, Monocyte conventional dendritic cell; pDC, Plasmacytoid dendritic cell</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10623726</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37924118</oboInOwl:hasDbXref>
        <rdfs:label>Migratory dendritic cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000451"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/bba8e142-072b-44aa-9398-7437e7dec356"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000451"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/bbdb7679-bf25-45fc-8348-a6a51336eb10 -->

    <Class rdf:about="http://example.org/bbdb7679-bf25-45fc-8348-a6a51336eb10">
        <obo:IAO_0000115>a Line drawing of a cross section of the floor of the cochlear duct at P1. Distinct cell types within the organ of Corti (OC) are color coded. b Heat map for ~14,000 cochlear cells collected from four separate experiments at P1. Top 25 differentially expressed (DE) genes for the 15 identified clusters are shown. Cellular identity for each cluster is indicated by a color bar at the top of the heat map, which corresponds to the legend in a, and by a cell name at the bottom. c tSNE plot for the same cells as in b. Cluster identities are indicated. d Violin plots showing normalized log-transformed expression values for the top five DE genes for each cell type (color coded as in c) by comparison with all other P1 cells (gray on the right in each graph). Bars indicate median expression level. e Upper left panel, tSNE plot of cells determined to be derived from KO (between the OC and medial edge of the cochlear duct). Lower left panel, feature plot for the same cells as in the upper panel indicating high expression of Otoa, Calb1, and Fabp7 (based on color) in different clusters of cells. Lower right panel, cross sections through the cochlear duct at P1, illustrating expression of CALB1 in the medial region of KO and FABP7 directly adjacent to the OC (arrow; scale bars, 20 mum). Lowest panel shows high-magnification view of expression of FABP7 (arrow, gray scale) at the lateral KO border (green line; scale bar, 10 mum). Upper right panel, summary diagram of the spatial distribution of ##KO cell## clusters at P1. HC hair cells, IPhC inner phalangeal cells/border cells, IPC inner pillar cells, OPC outer pillar cells, DC1/2 Deiters&apos; cells rows 1 and 2, DC3, Deiters&apos; cells row 3, HeC Hensen&apos;s cells, CC/OSC Claudius cells/outer sulcus cells, IdC interdental cells, ISC inner sulcus cells, KO Kolliker&apos;s organ cells, L.KO lateral Kolliker&apos;s organ cells, M.KO medial Kolliker&apos;s organ cells, OC90 OC90+ cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7221106</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32404924</oboInOwl:hasDbXref>
        <rdfs:label>KO cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002490"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/bbdb7679-bf25-45fc-8348-a6a51336eb10"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002490"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/bbde6404-db29-4a43-8f3f-63d78d5e1392 -->

    <Class rdf:about="http://example.org/bbde6404-db29-4a43-8f3f-63d78d5e1392">
        <obo:IAO_0000115>Our recent work demonstrating that ##kidney-infiltrating T cells## (KITs) are functionally and transcriptionally exhausted : much like TILs or CD8+ T cells after chronic viral infection : challenges 2 paradigms. First, it argues against the idea that autoimmune destruction of parenchymal tissue is a direct effector process, akin to a response to virally infected cells. Instead, some tissues may be endowed with natural self-preservation mechanisms that downregulate or suppress infiltrating T cells, which may prevent or attenuate autoimmunity. Second, it suggests that tumors do not evolve a de novo set of pathways to negatively regulate T cells. Instead, such pathways may be native to certain parenchymal tissues, and tumors may amplify them or simply naturally express them.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9089785</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35271505</oboInOwl:hasDbXref>
        <rdfs:label>kidney-infiltrating T cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000084"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/bbde6404-db29-4a43-8f3f-63d78d5e1392"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000084"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/bbf87aff-cc63-48a0-b645-04a432344933 -->

    <Class rdf:about="http://example.org/bbf87aff-cc63-48a0-b645-04a432344933">
        <obo:IAO_0000115>Data were analyzed using FACSDIVA software, version 8.0.1 (BD Biosciences). Compensation was calculated before each experiment. Approximately 150,000 lymphocytes (50,000 live T cells) were analyzed per colon biopsy. Gating strategies are shown in Figure 1Aix-x. Lymphocyte populations are reported as a proportion of parent populations. Specifically, live CD3+ T cells are reported as percentage of total live lymphocytes (as defined by side scatter vs forward scatter, CD45+, and exclusion of viability dye). CD4+ and CD8+ T cells are reported as a percentage of live T cells. CD8+CD103+CD69+ TRM cells are reported as a percentage of total CD8+ T cells. ##Activated (HLA-DR+CD38+) cells## are reported as percentage of memory CD4+ or CD8+ T cell populations.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8527886</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34147519</oboInOwl:hasDbXref>
        <rdfs:label>Activated (HLA-DR+CD38+) cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0001043"/>
        <skos:relatedMatch rdf:resource="CL:0001049"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/bbf87aff-cc63-48a0-b645-04a432344933"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0001043"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/bbf87aff-cc63-48a0-b645-04a432344933"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0001049"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/bc28a127-b60e-4871-864f-39f80ebb1866 -->

    <Class rdf:about="http://example.org/bc28a127-b60e-4871-864f-39f80ebb1866">
        <obo:IAO_0000115>In the mouse placenta, there are two lineages of trophoblast cells, the invasive and structural cells, which arise from the trophoblast stem progenitor cells. Trophoblast giant cells are the invasive cells responsible for invading the maternal vasculature and transforming the spiral arteries into high-velocity, low-resistant vessels. Four sub-types of trophoblast giant cells exist, including spiral artery trophoblast giant cells and parietal trophoblast giant cells, which reside in the decidual layer. The canal trophoblast giant cells and sinusoidal trophoblast giant cells are in the labyrinth. The structural cells of the placenta include those located within the junctional zone and the remaining cells of the labyrinth. The spongiotrophoblast and glycogen trophoblast cells are within the junctional zone. The spongiotrophoblast cells are thought to contribute a supportive role to the developing labyrinth and feed into the trophoblast giant cell progenitor pool, while glycogen cells, which arise from the spongiotrophoblast cells, are thought to accumulate glycogen and can migrate into the maternal decidua for spiral artery remodeling. The two different types of syncytiotrophoblast cells, syncytiotrophoblast-I and ##syncytiotrophoblast-II##, are located within the labyrinth zone. These cells function in the material exchange between the mother and fetus and, along with the sinusoidal trophoblast giant cells, make up the interhemal membrane. However, the specific functions of some of these cells are not well understood.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10459728</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37630754</oboInOwl:hasDbXref>
        <rdfs:label>syncytiotrophoblast-II</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000525"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/bc28a127-b60e-4871-864f-39f80ebb1866"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000525"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/bc5c57dc-79a9-44c0-aad4-2aaf0b28b6ea -->

    <Class rdf:about="http://example.org/bc5c57dc-79a9-44c0-aad4-2aaf0b28b6ea">
        <obo:IAO_0000115>In Tek-CreERT2;R26T mice, we also observed ##Tek+ bone-lining cells## at the endosteum (Fig. 5a). The frequency of these cells was approximately 2.8 cells/mm endosteum in longitudinal sections, which was significantly higher than that of Cdh5+ bone-lining cells (Fig. 5f). Tek+ endosteal bone-lining cells often exhibited a thin and elongated morphology and were nearly absent for the osteolineage marker RUNX2 (Fig. 5b, g), suggesting that they might correspond to the endosteal fibroblasts detected in the reanalyzed dataset. However, Tek+ osteocytes were hardly detected in these mice (Fig. 5c, h). In other regions of the bone marrow cavity, a small population of trabecular bone-lining cells (Fig. 5d, i) and metaphyseal stromal cells (Fig. 5e, j) were also Tek+.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10733381</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38123537</oboInOwl:hasDbXref>
        <rdfs:label>Tek+ bone-lining cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000115"/>
        <skos:relatedMatch rdf:resource="CL:0001035"/>
        <skos:relatedMatch rdf:resource="CL:0002157"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/bc5c57dc-79a9-44c0-aad4-2aaf0b28b6ea"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000115"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/bc5c57dc-79a9-44c0-aad4-2aaf0b28b6ea"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0001035"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/bc5c57dc-79a9-44c0-aad4-2aaf0b28b6ea"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002157"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/bcaecfa9-a484-4ecd-9ed6-a88bcda999f3 -->

    <Class rdf:about="http://example.org/bcaecfa9-a484-4ecd-9ed6-a88bcda999f3">
        <obo:IAO_0000115>Myofibroblasts are central mediators of the dysregulated wound-healing programme that defines fibrosis, therefore we studied this population in detail. Graph based clustering of the single cell RNA-seq data defined four major subsets (Fig. 3a) that included a cycling population (Cycling MFB) (Fig. 3a, b). After this, we sought to confirm that proliferating stromal cells (Ki67+) were myofibroblasts (Fig. 3c-e, Supplementary Fig. 4a-d). Using flow cytometry, we stained freshly disaggregated nodular cells and gated on myofibroblasts (CD45-CD31-CD146-ITGbeta1high) and fibroblasts (CD45-CD31-CD146-ITGbeta1low) and demonstrated Ki67high cells were a subset of myofibroblasts. In the single cell RNA-seq, a second subset was characterised by lower expression of ACTA2 and intermediate expression of fibroblast marker genes (CXCL14, PLA2G2A and C1R), we termed the ACTA2low myofibroblast (Fig. 3a, b, Supplementary Fig. 5a). A third comprised a discrete CD82highOX40L+ population (CD82, OX40L, MMP11, MMP14 and CD82) (Fig. 3a, g, Supplementary Fig. 5b-e). Finally, a fourth less distinct community we termed the intermediate myofibroblast (Fig. 3a, b, Supplementary Fig. 15a). GO analysis demonstrated that CD82highOX40L+ myofibroblast marker genes showed the strongest enrichment for cell contraction pathways (Fig. 3f). In contrast, differential gene expression and pathway analysis revealed ##ACTA2low myofibroblasts## resembled a general fibroblast phenotype, without clear characteristics of any one subtype. In addition to ACTA2, significant ACTA2low myofibroblasts markers were general fibroblasts markers including PLA2G2A and CXCL14. ACTA2low myofibroblasts also shared pathways enriched in fibroblasts such as &apos;interleukin signalling&apos; and &apos;chemotaxis&apos; (Fig. 3f).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7265502</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32488016</oboInOwl:hasDbXref>
        <rdfs:label>ACTA2low myofibroblasts</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000186"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/bcaecfa9-a484-4ecd-9ed6-a88bcda999f3"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000186"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/bcc7ed7c-e43a-4c10-ad09-7661e60c6cf6 -->

    <Class rdf:about="http://example.org/bcc7ed7c-e43a-4c10-ad09-7661e60c6cf6">
        <obo:IAO_0000115>To further investigate whether somatostatin-expressing CSF-c neurons (pH-sensitive) and dopaminergic CSF-c neurons (non-pH-sensitive) have different types of cilia, expansion was combined with STED microscopy. Using dual-colour imaging of spinal cord slices, either somatostatin or dopamine (TH immunostaining), together with alpha-tubulin immunostaining (Figure 6) was analysed. To have better access to the cilia and ##CSF-c neurons## the central canal of the expanded spinal cord has been cut horizontally and flipped 90  with respect to the coverslip. The central canal can then be visualized in a cylindrical form (Figure 6A-C). To confirm what type of CSF-c neurons the cilia belong to, z-stack scanning for all the imaging was applied. In our data, 70 cilia belong to somatostatin-expressing CSF-c neurons (n = 70). Of these, 60 cilia were primary (9 + 0 symmetry) and 10 cilia were motile (9 + 2 symmetry) (Figure 6D-K, T). Additionally, 20 cilia of dopaminergic CSF-c neurons were all motile cilia (9 + 2 symmetry) (Figure 6L-S, T). We found that somatostatin-expressing CSF-c neurons are sensory neurons expressing mainly sensory cilia. However, the motile cilia in both somatostatin-expressing and dopaminergic CSF-c neurons might be involved in contributing to the flow of CSF through the central canal (Figure 6U).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8809891</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35103591</oboInOwl:hasDbXref>
        <rdfs:label>CSF-c neurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000540"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/bcc7ed7c-e43a-4c10-ad09-7661e60c6cf6"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000540"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/bcdd6b77-ca99-48f6-a260-cac42d290421 -->

    <Class rdf:about="http://example.org/bcdd6b77-ca99-48f6-a260-cac42d290421">
        <obo:IAO_0000115>Cellular immunotherapies represent a promising approach for the treatment of cancer. Engineered adoptive cell therapies redirect and augment a ##leukocyte##&apos;s inherent ability to mount an immune response by introducing novel anti-tumor capabilities and targeting moieties. A prominent example of this approach is the use of T cells engineered to express chimeric antigen receptors (CARs), which have demonstrated significant efficacy against some hematologic malignancies. Despite increasingly sophisticated strategies to harness immune cell function, efficacy against solid tumors has remained elusive for adoptive cell therapies. Amongst cell types used in immunotherapies, however, macrophages have recently emerged as prominent candidates for the treatment of solid tumors. In this review, we discuss the use of monocytes and macrophages as adoptive cell therapies. Macrophages are innate immune cells that are intrinsically equipped with broad therapeutic effector functions, including active trafficking to tumor sites, direct tumor phagocytosis, activation of the tumor microenvironment and professional antigen presentation. We focus on engineering strategies for manipulating macrophages, with a specific focus on CAR macrophages (CAR-M). We highlight CAR design for macrophages, the production of CAR-M for adoptive cell transfer, and clinical considerations for their use in treating solid malignancies. We then outline recent progress and results in applying CAR-M as immunotherapies. The recent development of engineered macrophage-based therapies holds promise as a key weapon in the immune cell therapy armamentarium.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8652144</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34899748</oboInOwl:hasDbXref>
        <rdfs:label>leukocyte</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000738"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/bcdd6b77-ca99-48f6-a260-cac42d290421"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000738"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/bd01b367-97f9-40ba-901a-cce1ff914812 -->

    <Class rdf:about="http://example.org/bd01b367-97f9-40ba-901a-cce1ff914812">
        <obo:IAO_0000115>Our observations were made on RBCs superfused under modest shear rates (gamma) of ~102 s-1, which are representative of large vessels (e.g., aorta). In vivo, RBCs traveling through capillaries will deform to fit through the narrow lumen, at which point gamma can reach 1,500 s-1. With rising shear, RBCs first become cup-shaped ##stomatocytes## (or parachutes) and above gamma &gt; 400 s-1, attain a polylobed shape. However, even at gamma = 2,500 s-1, RBCs do not stretch substantially, meaning that their critical thickness remains a significant diffusional barrier, not dissimilar to that in discocytes. Early experimental designs based on highly viscous media (to increase gamma) reported tank treading, which results in elliptically stretched (i.e., thinner) RBCs. However, tank treading is not normally observed in media of physiological viscosity or in narrow vessels at high gamma. Although our method does not recapitulate the shear rates in capillaries, it stabilizes cell thickness at a level that is relevant to physiologically deformed cells for robust measurements of diffusional delays.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7211990</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32321831</oboInOwl:hasDbXref>
        <rdfs:label>stomatocytes</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000232"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/bd01b367-97f9-40ba-901a-cce1ff914812"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000232"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/bd2ecd3a-25e7-4c2d-a823-b36164ce9774 -->

    <Class rdf:about="http://example.org/bd2ecd3a-25e7-4c2d-a823-b36164ce9774">
        <obo:IAO_0000115>The Table shows the numerical representations of ##Excitatory Neurons## (Deep and Superficial Pyramidal cells) and Inhibitory neurons (Oriens Lacunosum moleculare cells:OLM; Trilaminar cells:Tri, Backprojection cells:BP, cholecystokinin positive Basket cells:CCKBC, Parvalbumin positive cells:PVBC, AxoAxonic Cells:AA, Ivy Cells:IVY, Bistratified cells:BS, Schaffer Collateral associated cells:SCA, Perforant Pathway Associated cell:PPA, Neurogliaform:NG) subdivided on the basis of the placement classes (SO, SP, SR, SLM).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9381785</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35974119</oboInOwl:hasDbXref>
        <rdfs:label>Excitatory Neurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000679"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/bd2ecd3a-25e7-4c2d-a823-b36164ce9774"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000679"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/bd43c64c-54e0-432a-8312-90daef855a46 -->

    <Class rdf:about="http://example.org/bd43c64c-54e0-432a-8312-90daef855a46">
        <obo:IAO_0000115>Cytokines are crucial biomarkers of the progression of various inflammatory disorders including pneumonia. We characterized the relationship between the proinflammatory cytokine IL-6 and T, B, NK, and Treg lymphocyte subsets in the blood samples of 125 COVID-19 patients at inpatient admission. The number of T lymphocyte subsets, including naive T4/T8 cells, central memory T4/T8 cells, PD1+ depletes T8 cells, and effector memory T8 cells, was moderately increased in COVID-19 patients with normal IL-6 levels, and with increasing IL-6 levels, these lymphocyte subset counts declined (Fig. 5A). The other T lymphocyte subset counts showed a decreasing trend with increasing IL-6 levels (Fig. 5A). In B lymphocyte subsets, it is worth noting that the number of plasma blasts was markedly increased in COVID-19 patients, with IL-6 levels above 30-fold higher than normal (Fig. 5B), but other B lymphocyte subsets, including naive B cells, transitional B cells, class switched memory B cells, class unswitched memory B cells, marginal zone B cells, and ##CD21low CD38low B cells##, were obviously decreased with higher IL-6 levels (Fig. 5B). As demonstrated in Fig. 5C, the higher IL-6 the levels in COVID-19 patients, the lower the number of NK lymphocyte subsets, including NKT cells, NK cells, immature NK cells, and mature NK cells (Fig. 5C). Similarly, the numbers of naive Tregs, memory Tregs and activated Tregs were significantly decreased with higher IL-6 levels, but when the level of IL-6 was 30-fold higher than normal, Tregs were instead increased compared to COVID-19 patients with normal IL-6 levels (Fig. 5D).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9675966</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36403042</oboInOwl:hasDbXref>
        <rdfs:label>CD21low CD38low B cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002055"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/bd43c64c-54e0-432a-8312-90daef855a46"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002055"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/be0ea53b-32cb-47bb-b4da-09b1ea3d8308 -->

    <Class rdf:about="http://example.org/be0ea53b-32cb-47bb-b4da-09b1ea3d8308">
        <obo:IAO_0000115>In our previous work, we depicted different T-cell subtypes and found an exhausted cluster that specifically existed in B-ALL patients and possessed remarkable heterogeneity. However, the developmental relationship between T-cell subtypes in relation to B-ALL patient prognosis remains elusive. To address this question, further analysis was performed on these T cells in B-ALL. A subset of T cells with features of tissue-resident memory T (Trm) cells was found in the peripheral blood of B-ALL patients, which we defined as circulating ##CD103+ T cell## or tissue-resident memory-like T (Trm-like) cell. These Trm-like cells expressing high levels of immune checkpoint molecules and cytotoxicity markers also shared similar TCR signatures with exhausted T (Tex) cells and effector T (Teff) cells. The traditional view thought that Trm cells were low in migration and long-term survival in peripheral tissues; however, more recent studies indicated that upon secondary antigen presentation, Trm cells can rejoin the circulation pool, transforming into Teff cells. Through cell fate trajectory analysis, we found that Trm-like cells that were supposed to transit into Teff cells, however, mainly transformed into Tex cells in leukemia environment. Furthermore, Trm-like cell to Tex cell transformation potentially led to poor prognosis of B-ALL patients, while transition toward Teff cells would likely improve prognosis. Our data suggest that Trm-like cells contribute to B-ALL immunosurveillance and may provide valuable prognostic information. Further understanding of the development, maintenance, and regulation of Trm-like cells would be crucial for successful immunotherapeutic development in B-ALL.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9757161</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36532049</oboInOwl:hasDbXref>
        <rdfs:label>CD103+ T cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000813"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/be0ea53b-32cb-47bb-b4da-09b1ea3d8308"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000813"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/be345762-95ec-4d5c-bec2-5b3d40573f74 -->

    <Class rdf:about="http://example.org/be345762-95ec-4d5c-bec2-5b3d40573f74">
        <obo:IAO_0000115>In the mouse placenta, there are two lineages of trophoblast cells, the invasive and structural cells, which arise from the trophoblast stem progenitor cells. Trophoblast giant cells are the invasive cells responsible for invading the maternal vasculature and transforming the spiral arteries into high-velocity, low-resistant vessels. Four sub-types of trophoblast giant cells exist, including spiral artery trophoblast giant cells and parietal trophoblast giant cells, which reside in the decidual layer. The canal trophoblast giant cells and sinusoidal trophoblast giant cells are in the labyrinth. The structural cells of the placenta include those located within the junctional zone and the remaining cells of the labyrinth. The spongiotrophoblast and ##glycogen trophoblast cells## are within the junctional zone. The spongiotrophoblast cells are thought to contribute a supportive role to the developing labyrinth and feed into the trophoblast giant cell progenitor pool, while glycogen cells, which arise from the spongiotrophoblast cells, are thought to accumulate glycogen and can migrate into the maternal decidua for spiral artery remodeling. The two different types of syncytiotrophoblast cells, syncytiotrophoblast-I and syncytiotrophoblast-II, are located within the labyrinth zone. These cells function in the material exchange between the mother and fetus and, along with the sinusoidal trophoblast giant cells, make up the interhemal membrane. However, the specific functions of some of these cells are not well understood.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10459728</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37630754</oboInOwl:hasDbXref>
        <rdfs:label>glycogen trophoblast cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000326"/>
        <skos:relatedMatch rdf:resource="CL:0000351"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/be345762-95ec-4d5c-bec2-5b3d40573f74"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000326"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/be345762-95ec-4d5c-bec2-5b3d40573f74"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000351"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/bebb0946-5ee7-482e-9ea9-fdfdd57a2e04 -->

    <Class rdf:about="http://example.org/bebb0946-5ee7-482e-9ea9-fdfdd57a2e04">
        <obo:IAO_0000115>We identified 23 immune cell subpopulations in the GSE162454 dataset by TSNE analysis at first. Based on the specific markers, we identified NK/T cells, CAFs (cancer associated fibroblasts), endothelial cells, plasma cells, osteoblastic cells, osteoclasts, B cells, M2 TAMs (##tumor associated macrophages##), M1 TAMs, monocytes and mast cells (Figure 10A). The expression of marker genes for different cell clusters was displayed in dot plot format in Figure 10B. The expression of OS-related genes was compared in different cell types. Because of the dropout sign of single-cell sequencing, INS was not detected in the GSE162454 dataset. As shown in Figure 10C, HMOX1 were expressed at higher levels in TAMs and osteoclasts. ATF4 and ACADVL are highly expressed in myeloid cells as well as other cell types, which was suggestive of their roles in osteosarcoma progression.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10292890</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37285835</oboInOwl:hasDbXref>
        <rdfs:label>tumor associated macrophages</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/bebb0946-5ee7-482e-9ea9-fdfdd57a2e04"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/bec56b0b-2bc5-4ba1-9971-120acd2716b2 -->

    <Class rdf:about="http://example.org/bec56b0b-2bc5-4ba1-9971-120acd2716b2">
        <obo:IAO_0000115>Higher immune-suppressive potential coupled with active dysfunction of T cells in cervical cancer compared to precancer: (A) the UMAP plot of T lymphocytes which could be further reclustered into CD8+ T cells and CD4+ T cells; (B) the UMAP plot of the CD8+ T cells reclustered into seven subsets, including CD8+ MAIT, ##CD8+ Trm##, CD8+ Naive, CD8+ Tex, CD8+ intraepithelial lymphocytes (IEL), CD8+ Tem and CD8+ Temra (upper left); the UMAP plot of the CD4+ T cells reclustered into five subsets, including CD4+ Tem, CD4+ Th1-like, CD4+ Th17, CD4+ Naive and CD4+ Treg (lower left); the proportion of different CD8+ T cell subsets (upper right) and CD4+ T cell subsets (lower right), respectively, in four clinical groups, including normal cervix without human papillomavirus (HPV) infection, HPV-infected normal cervix, HPV-infected high-grade squamous intraepithelial lesions (HSIL) and HPV-infected cervical cancer; (C) the violin plots indicating the naiveness score (upper), cytotoxicity score (middle) and exhaustion score (lower) of each CD8+ T cell cluster; (D) the UMAP feature plots of the marker genes of CD8+ Temra (CX3CR1, KLRD1, PRF1) and CD8+ Tex (HAVCR2, CXCL13, CTLA4). (E) The pseudotime plot describing the differentiation trajectories of different subsets of CD8+ T lymphocytes (upper) and trajectory presented in the four clinical groups, respectively, including normal cervix without HPV infection, HPV-infected normal cervix, HPV-infected HSIL and HPV-infected cervical cancer; (F) the UMAP feature plots of the marker genes of CD4+ Th17 (CCR6, IL17A, CTSH), CD4+ Treg (CTLA4, FOXP3, TNFRSF18) and CD4+ Th1-like (CXCL13, IFNG, PDCD1); (G) the pseudotime plot describing the differentiation trajectories of different subsets of CD4+ T lymphocytes (upper) and trajectory presented based on the four clinical groups, including normal cervix without HPV infection, HPV-infected normal cervix, HPV-infected HSIL and HPV-infected cervical cancer; (H) the Kaplan Meier curve predicting the overall survival (OS) of cervical cancer (CC) patients with high and low expression of the Th17 signature (IL17A, CCR6 and CTSH) using TCGA data (p = .02, log rank test).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10040725</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36967539</oboInOwl:hasDbXref>
        <rdfs:label>CD8+ Trm</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000909"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/bec56b0b-2bc5-4ba1-9971-120acd2716b2"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000909"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/beeeecba-f6e6-4355-9d5d-7df8b7aa299a -->

    <Class rdf:about="http://example.org/beeeecba-f6e6-4355-9d5d-7df8b7aa299a">
        <obo:IAO_0000115>DEG Differentially expressed gene   ESC Embryonic stem cell   FACS Fluorescence-activated cell sorting    GC Granulosa cells   hPGC Human primordial germ cell   MACS Magnetic-activated cell sorting   OSC Oogonial stem cell   PCG Primordial germ cell   pre-PGC Progenitor primordial germ cell   RA Retinoic acid   scRNA-seq Single-cell RNA sequencing   SC-seq Single-cell sequencing   SSC ##Spermatogenic stem cells##   TC Theca cell   TF Transcription factors   t-SNE t-stochastic neighbor embedding   UMI Unique molecular identifier   </obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7829788</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33467661</oboInOwl:hasDbXref>
        <rdfs:label>Spermatogenic stem cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000020"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/beeeecba-f6e6-4355-9d5d-7df8b7aa299a"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000020"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/bf0588ce-5edb-4dd9-bdb3-86e87aab9349 -->

    <Class rdf:about="http://example.org/bf0588ce-5edb-4dd9-bdb3-86e87aab9349">
        <obo:IAO_0000115>scRNA-seq of ECs reveal a subpopulation enriched with immune responsive signatures. (A) Schematic showing the experimental design for the scRNA-seq and single-nuclei ATAC sequencing analysis of regenerative mouse hearts (MI at P1 and harvested at P5) and nonregenerative mouse hearts (MI at P8 and harvested at P12). (B) UMAP representation of cardiac cell clusters identified from scRNA-seq analysis. Clusters were color coded according to cell types (left). CM, cardiomyocytes; EC, endothelial cells; CF, fibroblasts; PeriC, pericytes; SMC, smooth muscle cells; EndoC, endocardial cells; EpiC, epicardial cells; MF, macrophages; TC, T-cells. (C) Gene ontology (GO) analysis of differentially expressed genes up-regulated in ECs of regenerative-stage hearts versus nonregenerative-stage hearts after MI. (D) UMAP representation of CD31+-enriched cell clusters from single-cell RNA sequencing (scRNA-seq), color coded according to cell type. CEC, capillary endothelial cell; ##Angio-EC##, angiogenic endothelial cell; Pro-EC1, proliferative endothelial cell 1; Pro-EC2, proliferative endothelial cell 2; IFN-EC, interferon capillary endothelial cell; CVEC, capillary venous endothelial cell; VEC, venous endothelial cell; AEC, arterial endothelial cell; LEC, lymphatic endothelial cell; EndoC, endocardial cell. (E) Gene ontology (GO) analysis of differentially expressed genes up-regulated in the IFN-EC cluster of regenerative-stage hearts versus nonregenerative-stage hearts after MI.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10681909</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38012001</oboInOwl:hasDbXref>
        <rdfs:label>Angio-EC</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0009088"/>
        <skos:relatedMatch rdf:resource="CL:0010008"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/bf0588ce-5edb-4dd9-bdb3-86e87aab9349"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0009088"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/bf0588ce-5edb-4dd9-bdb3-86e87aab9349"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0010008"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/bf260e73-d4fd-45d3-ae2d-5d1a05a9d0d7 -->

    <Class rdf:about="http://example.org/bf260e73-d4fd-45d3-ae2d-5d1a05a9d0d7">
        <obo:IAO_0000115>Food intake behavior is regulated by a network of appetite-inducing and appetite-suppressing neuronal populations throughout the brain. The parasubthalamic nucleus (PSTN), a relatively unexplored population of neurons in the posterior hypothalamus, has been hypothesized to regulate appetite due to its connectivity with other anorexigenic neuronal populations and because these neurons express Fos, a marker of neuronal activation, following a meal. However, the individual cell types that make up the PSTN are not well characterized, nor are their functional roles in food intake behavior. Here, we identify and distinguish between two discrete PSTN subpopulations, those that express tachykinin-1 (##PSTNTac1 neurons##) and those that express corticotropin-releasing hormone (PSTNCRH neurons), and use a panel of genetically encoded tools in mice to show that PSTNTac1 neurons play an important role in appetite suppression. Both subpopulations increase activity following a meal and in response to administration of the anorexigenic hormones amylin, cholecystokinin (CCK), and peptide YY (PYY). Interestingly, chemogenetic inhibition of PSTNTac1, but not PSTNCRH neurons, reduces the appetite-suppressing effects of these hormones. Consistently, optogenetic and chemogenetic stimulation of PSTNTac1 neurons, but not PSTNCRH neurons, reduces food intake in hungry mice. PSTNTac1 and PSTNCRH neurons project to distinct downstream brain regions, and stimulation of PSTNTac1 projections to individual anorexigenic populations reduces food consumption. Taken together, these results reveal the functional properties and projection patterns of distinct PSTN cell types and demonstrate an anorexigenic role for PSTNTac1 neurons in the hormonal and central regulation of appetite.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9119672</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35507386</oboInOwl:hasDbXref>
        <rdfs:label>PSTNTac1 neurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000540"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/bf260e73-d4fd-45d3-ae2d-5d1a05a9d0d7"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000540"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/bf772b22-8e86-4f0b-bead-207943751606 -->

    <Class rdf:about="http://example.org/bf772b22-8e86-4f0b-bead-207943751606">
        <obo:IAO_0000115>(A, B) Schematic of medial (MOC) and lateral (LOC) olivocochlear neuron (##OCN##) subtypes housed in the brainstem (A) and their projections into the cochlea, shown in cross-section (A) and top-down (B). D, dorsal; L, lateral; LSO, lateral superior olive; VNTB, ventral nucleus of the trapezoid body; SOC, superior olivary complex; IHC, inner hair cell; OHC, outer hair cell; SGN, spiral ganglion neuron; IGSB, intraganglionic spiral bundle; ISB, inner spiral bundle; TSB, tunnel spiral bundle. (C) Schematic of single-nucleus collection protocol. The ventral brainstem of ChatCre; Rosa26Sun1-GFP mice was dissected, including the SOC, facial motor nucleus (VII), and trigeminal motor nucleus (V), followed by collection and sequencing of individual GFP+ nuclei. A, anterior; P, posterior. (D) UMAP plot summarizing sequencing data of 45,828 single nuclei from 61 animals across three ages. The data includes 56 clusters, including MOCs, LOCs, and several different motor neuron types, as well as a few non-neuronal populations. (E-H) Feature plots denoting normalized expression levels of selected genetic markers. For visualization purposes, high expression on the color scale is capped at the 95th percentile of gene expression. The majority of clusters express the neuronal marker Snap25 (E). The main non-neuronal population is labeled by Mog, an oligodendrocyte marker (F). Motor neuron clusters express the motor neuron determinant Isl1 (G). Among these brainstem motor neurons, OCNs are identified by expression of the transcription factor Gata3 (H). (I, J) Differential expression of known markers Ucn (I) and Atp1a3 (J) denotes LOCs and MOCs, respectively. (K-M) Cadps2 is a novel marker for OCNs that is expressed by both MOCs and LOCs but not FMNs. (K) Violin plots summarizing transcriptional expression of Cadps2 in mature LOCs, MOCs, and FMNs. (L, M) Fluorescent in situ hybridization (FISH) verifies that Cadps2 is detected in both MOCs and LOCs (L) but not in FMNs (M). Representative images are shown from a total of three animals of either sex, P28.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10147377</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36876911</oboInOwl:hasDbXref>
        <rdfs:label>OCN</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:2000047"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/bf772b22-8e86-4f0b-bead-207943751606"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:2000047"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/bf9eb527-9c64-4716-b3ce-c544f4cfeb28 -->

    <Class rdf:about="http://example.org/bf9eb527-9c64-4716-b3ce-c544f4cfeb28">
        <obo:IAO_0000115>Proline rich acidic protein 1 (PRAP1) has been implicated as a uterine marker for successful implantation. However, its specific roles in the placenta remain largely unknown. In our study, we made an interesting observation that Prap1 consistently showed upregulation in 26 different cell types, including various trophoblast cell types such as spongiotrophoblasts, labyrinth trophoblasts, S-TGCs, ##GlyT##, and trophoblast progenitor cells, in response to arsenic exposure (Figs. 2,  3a-c). This finding suggests a potential involvement of PRAP1 in regulating placental responses to arsenic exposure.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11297347</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:39095385</oboInOwl:hasDbXref>
        <rdfs:label>GlyT</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000351"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/bf9eb527-9c64-4716-b3ce-c544f4cfeb28"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000351"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/c03c575b-71be-4170-8686-cdb763074b80 -->

    <Class rdf:about="http://example.org/c03c575b-71be-4170-8686-cdb763074b80">
        <obo:IAO_0000115>Considering the close relationship between RGPRG score and immune activity, we sought to further explore the immune infiltrate landscape of two RGPRG score groups. The 22 immune cell composition of HCC patients from the TCGA cohort was shown in Fig. 5A. CD8 T cells, resting memory CD4 T cells, M0 Macrophages, M1 Macrophages, and M2 Macrophages were the main immune cell composition of HCC patients. Many differential immune cell infiltrations could be observed between high- and low-RGPRG score groups (Fig. 5B). Patients with high RGPRG score was characterized by the high infiltration of resting memory CD4 T cells, M0 Macrophages, T cells regulatory (Tregs), naive B cells, memory B cells, Plasma cells, naive CD4 T cells, Eosinophils, indicating a status of immunosuppression in this groups. CD8 T cells, activated memory CD4 T cells, activated NK cells, M1 Macrophages, M2 Macrophages, follicular helper T cells, gamma delta T cells, Neutrophils, ##resting Dendritic cells##, activated Dendritic cells, resting NK cells, Monocytes, resting Mast cells, and activated Mast cells were abundant in the patients with low RGPRG score (Fig. 5C), suggesting enhanced antitumor environment. In addition, the expression of 8 classical immune checkpoint genes between two RGPRG score groups was further estimated in the TCGA cohort, and we found that Patients with high RGPRG score had higher expression levels of CD274, CTLA4, LAG3, PDCD1, and TIGIT (Fig. 5D), which presented another characteristic of immunosuppression.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10832138</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38297333</oboInOwl:hasDbXref>
        <rdfs:label>resting Dendritic cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000451"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/c03c575b-71be-4170-8686-cdb763074b80"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000451"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/c0b02fe9-7513-4b9a-a36a-da1cc9cf232d -->

    <Class rdf:about="http://example.org/c0b02fe9-7513-4b9a-a36a-da1cc9cf232d">
        <obo:IAO_0000115>To illustrate the application of CSN to developing cells, we feature the developmental trajectory of human excitatory neuron cells in the Developing Cortex Atlas dataset (15), which includes Radial Gila and Progenitors (P), Intermediate Progenitors (IP), ##Maturing Excitatory## (ExN), Migrating Excitatory (ExM), Excitatory Upper-layer enriched (ExM-U), and Excitatory Deep layer (ExDp), with cell type labels determined by the authors (SI Appendix, section 3 and Table S2). Using Slingshot, we estimate the developmental path consists of two trajectories, one ending in upper-layer (U curve) and the other in deep-layer (D curve) excitatory neurons (Fig. 3 A and B).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8713783</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34903665</oboInOwl:hasDbXref>
        <rdfs:label>Maturing Excitatory</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000540"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/c0b02fe9-7513-4b9a-a36a-da1cc9cf232d"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000540"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/c0da9bb2-2946-4e19-ab5c-cf8699c283de -->

    <Class rdf:about="http://example.org/c0da9bb2-2946-4e19-ab5c-cf8699c283de">
        <obo:IAO_0000115>##CD8+ tissue-resident memory T cells## are expanded in primary Sjogren&apos;s disease and can be therapeutically targeted by CD103 blockade.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMID:38777379</oboInOwl:hasDbXref>
        <rdfs:label>CD8+ tissue-resident memory T cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000909"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/c0da9bb2-2946-4e19-ab5c-cf8699c283de"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000909"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/c0f5d4ac-cb59-492f-93df-0981e25fb42f -->

    <Class rdf:about="http://example.org/c0f5d4ac-cb59-492f-93df-0981e25fb42f">
        <obo:IAO_0000115>a-o, Subcluster spatial maps on representative sample slices for astrocytes (a), oligodendrocytes and oligodendrocyte precursor cells (b), microglia and perivascular macrophages (c), ependymal cells, choroid plexus epithelial cells and subcommissural organ hypendymal cells (d), olfactory inhibitory neurons (e), cerebellum neurons (f), telencephalon projecting inhibitory neurons (g), di- and mesencephalon excitatory neurons (h), glutamatergic neuroblasts (i), non-glutamatergic neuroblasts (j), ##di- and mesencephalon inhibitory neurons## (k), cholinergic and monoaminergic neurons (l), peptidergic neurons (m), hindbrain/spinal cord neurons (n), and vascular cells (o). Also see Methods and Supplementary Table 4.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10709140</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37758947</oboInOwl:hasDbXref>
        <rdfs:label>di- and mesencephalon inhibitory neurons</rdfs:label>
    </Class>
    


    <!-- http://example.org/c13ef444-a1f6-4506-ac21-2cc7ddf8682a -->

    <Class rdf:about="http://example.org/c13ef444-a1f6-4506-ac21-2cc7ddf8682a">
        <obo:IAO_0000115>We undertook a comprehensive Mendelian randomization study aimed at uncovering the causal relationship between 744 immune cell types and IVDD [ Supplementary Table 2 ]. In our analysis, we identified 24 specific blood types of immune cells that demonstrated a causal association with disc degeneration through univariable MR [ Supplementary Table 3 ], including Memory B cell %B cell, Naive-mature B cell %B cell, IgD-CD38dim B cell %lymphocyte, CD39+activated CD4 regulatory T cell %CD4 regulatory T cell, CD39+ secreting CD4 regulatory T cell %CD4 regulatory T cell, CD45RA+ CD8+ T cell %CD8+ T cell, CD8+ T cell %leukocyte, CD39+CD4+ T cell %T cell, CD39+ CD4+ T cell %CD4+ T cell,CD39+ CD8+ T cell %T cell, CD39+ CD8+ T cell Absolute Count, ##CD127- CD8+ T cell## Absolute Count, CD28- CD8+ T cell Absolute Count, CD19 on IgD+ CD38+ B cell, CD19 on IgD+ CD38dim B cell, CD19 on IgD- CD38- B cell, CD19 on unswitched memory B cell, CD19 on transitional B cell, CD24 on IgD+ CD38+ B cell,CD28 on CD39+ secreting CD4 regulatory T cell, CD25 on CD39+ CD4+ T cell, CD4 on CD39+ CD4+ T cell, CD4 on CD39+ resting CD4 regulatory T cell and Neutrophil count. We excluded certain exposures due to a limited number of available SNPs to prevent potential bias, including Memory B cell %B cell, Naive-mature B cell %B cell, IgD-CD38dim B cell %lymphocyte, CD8+T cell %leukocyte, CD127-CD8+ T cell Absolute Count, CD19 on IgD-CD38-B cell, CD24 on IgD+ CD38+ B cell, CD28 on CD39+ secreting CD4 regulatory T cell and CD4 on CD39+ resting CD4 regulatory T cell.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10806224</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38268919</oboInOwl:hasDbXref>
        <rdfs:label>CD127- CD8+ T cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000625"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/c13ef444-a1f6-4506-ac21-2cc7ddf8682a"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000625"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/c180db8e-8351-4512-8e72-62dee069e17d -->

    <Class rdf:about="http://example.org/c180db8e-8351-4512-8e72-62dee069e17d">
        <obo:IAO_0000115>Downstream of the multipotent HSCs and MPPs, the original lineage bifurcation model strictly separated oligopotent Common Lymphoid Progenitors (CLP) from Common Myeloid Progenitors (CMP) which could further diverge into Megakaryocyte/Erythrocyte Progenitors (MEPs), Monocyte (Mo)/Dendritic cell (DC) Progenitors (MDPs) and Granulocyte/Mo Progenitors (GMPs). However, this model has been the subject of ongoing revision in the scRNA-seq era. On the one hand, a Lymphoid-primed MultiPotent Progenitor (LMPP) with combined lymphoid and myeloid potential has been shown to gradually lose myeloid potential by upregulating the interleukin-7 receptor alpha-chain (IL7Ralpha) and differentiate into Dach1- Lymphoid-Primed Progenitors (LPPs) prior to CLPs. On the other hand, erythroid-versus-myeloid fate decisions seem to be made prior to CMP commitment, calling for in-depth revision of all CMP progeny (MEPs, MDPs and GMPs) as well. While the Flt3L+CD115lo CMPs give rise to oligopotent MDPs, the Flt3-CD115- CMPs give rise to GMPs. The former are defined by TF co-expression of CEBPA, IRF8 and RUNX1. MDPs can give rise to IRF8/SATB1 plasmacytoid DC (pDC) Progenitors (pDCPs) and HLA-DR/IRF8/CEBPA Mo/conventional DC (cDC) Progenitors (McDPs). The latter bifurcate in CD11c/CD172ab/CD14 (human) or Ly6C+ Mo (mouse) or IRF8/HLA-DR/CD84/CD172ab Common DC Progenitors (CDPs). In contrast, GMPs (Kit, CD34, Sox4) are very heterogeneous at the transcriptomic and proteomic level and can adjust their functional output towards common ##Mo Progenitors## (cMoP) and Granulocyte Progenitors (GPs).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11324509</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:39148724</oboInOwl:hasDbXref>
        <rdfs:label>Mo Progenitors</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0001019"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/c180db8e-8351-4512-8e72-62dee069e17d"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0001019"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/c1889e10-a71c-4e79-a748-50812543d538 -->

    <Class rdf:about="http://example.org/c1889e10-a71c-4e79-a748-50812543d538">
        <obo:IAO_0000115>SCLC	Small-cell carcinoma	 	NSCLC	Non-small-cell carcinoma	 	ADC	Adenocarcinoma	 	SqCC	Squamous cell carcinoma	 	LCLC	Large-cell carcinoma	 	PD1	Programmed death 1	 	PDL1	Programmed death 1 ligand	 	ICI	Immune checkpoint inhibitors	 	EV	Extracellular vesicles	 	ESE	Early-sorting endosome	 	ILVs	Intraluminal vesicles	 	MVBs	Multivesicular bodies	 	ESCRT	Endosomal-sorting complex-independent transport	 	ncRNAs	Small noncoding RNAs (ncRNAs)	 	miRNAs	microRNAs	 	TME	Tumor microenvironment	 	circRNA	circular RNA	 	ECM	extracellular matrix	 	HBEC	Human bronchial epithelial cells	 	EMT	Epithelial-mesenchymal transition	 	CRC	colorectal cancer	 	DCs	dendritic cells	 	MSC	Mesenchymal stem cells	 	NK	Natural Killer	 	PBMCs	Peripheral blood mononuclear cells	 	TAMs	Tumor-associated macrophages	 	MDSCs	Myeloid-derived suppressor cells	 	PMN-MDSCs	Polymorphonuclear MDCs	 	M-MDSCs	##Monocytic MDSCs##	 	LLC	Lewis Lung carcinoma	 	M2 macrophages	Alternatively activated macrophages	 	M1 macrophages	Classically activated macrophages	 	TH1 cell	T helper 1 cell	 	Treg cell	Regulatory T cell	 	Breg cell	Regulatory B cell	 	CTLs	Cytotoxic CD8+ T cells	 	TILs	Tumor-infiltrating lymphocytes	 	Tim-3	mucin domain-3 protein	 	TIGIT	T cell immunoglobulin and ITIM domain	 	Lag-3	Lymphocyte-activation gene 3	 	CTLA4	Cytotoxic T lymphocyte antigen-4	 	TH17 cell	T helper 17 cell	 	DNT cell	Double-negative T cells	 	TRAIL	TNF-related apoptosis-inducing ligand	 	MPE	malignant pleural effusions	 	CRISPRi	clustered regularly interspaced short palindromic repeats interference	 	FAP	Fibroblast activation protein- alpha.	 	</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10616833</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37915578</oboInOwl:hasDbXref>
        <rdfs:label>Monocytic MDSCs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000576"/>
        <skos:relatedMatch rdf:resource="CL:0000889"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/c1889e10-a71c-4e79-a748-50812543d538"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000576"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/c1889e10-a71c-4e79-a748-50812543d538"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000889"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/c19af3fd-11f7-477e-a117-1d73a0a02a59 -->

    <Class rdf:about="http://example.org/c19af3fd-11f7-477e-a117-1d73a0a02a59">
        <obo:IAO_0000115>(a) Balloon-plot of known neuronal and glial cell markers (SOX10-MKI67). Progenitor: SOX10, FOXD3, ASCL1, Neuronal: PHOX2B, PRPH, NRG1, TUBB3, Sympathetic neurons: DBH, TH, Parasympathetic neurons: NOS1, VIP, Sensory neurons: PRDM12, P2RY1, TRPV1, Schwann Cell Progenitors (SCPs): CDH19, MPZ, PLP1, Glial cells: GFAP, S100B, Chromaffin cells: PNMT, PENK, CARTPT and Proliferating cells: MKI67, PCNA. The remaining genes correspond to the top-5, most selective genes for each cluster. From the statistically significant genes (adjusted p-value &lt; 0.001, MAST with Bonferroni correction using all features), the top-10 (log2 fold-change) were sorted according to the percent of positive cells and the top-5 were plotted. Gene order follows the cluster order. Balloon size: percent of positive cells. Color intensity: scaled expression. Blue: high, Gray: low. (b) Balloon-plot of the detected cholinergic-synapse pathway genes (KEGG id: 217716). Balloon size: percent of positive cells. Color intensity: log2(normalized UMI-counts+1) (library size was normalized to 10.000) expression. Blue: high, Gray: low. (c) Heatmap of differentially expressed transcription factors (TFs) along the SCP-neuronal trajectory, according to tradeSeq. Stars: analyzed genes in &apos;D-E&apos;. Color intensity: scaled expression. Dark red: high, Gray: low. (d) UMAP-plots of SOX10, ASCL1 and ISL1 TFs. Expression levels: log2(normalized UMI-counts+1) (library size was normalized to 10.000). Blue: high. Gray: zero. (e) Confocal-microscopy image of an 8.5 pcw ganglion, showing SOX10, ASCL1 and ISL1 expression, detected with immunofluorescence. Dashed outlines: manually segmented nuclei. SOX10pos SCPs (arrows), ##SOX10pos ASCL1pos transitioning SCPs## (asterisks), ASCL1pos SOX10neg immature neurons (hashes), ISL1pos ASCL1neg mature neurons (arrowheads). Scale-bar: 5 microm.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9928586</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36646791</oboInOwl:hasDbXref>
        <rdfs:label>SOX10pos ASCL1pos transitioning SCPs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002375"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/c19af3fd-11f7-477e-a117-1d73a0a02a59"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002375"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/c1ccab97-609a-4e05-82e4-31fe106faba7 -->

    <Class rdf:about="http://example.org/c1ccab97-609a-4e05-82e4-31fe106faba7">
        <obo:IAO_0000115>##OXTR##-Venus cells in the AVPV express functional OXTR.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6622548</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31295328</oboInOwl:hasDbXref>
        <rdfs:label>OXTR</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:4023122"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/c1ccab97-609a-4e05-82e4-31fe106faba7"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4023122"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/c1eb5667-6866-46ce-b1b2-6162fc08404e -->

    <Class rdf:about="http://example.org/c1eb5667-6866-46ce-b1b2-6162fc08404e">
        <obo:IAO_0000115>As with most current reprogramming strategies, the efficiency of generating iSGCs is low, not to mention in vivo wound repair. In comparison to previous methods to derive ##SGCs## from fibroblasts or MSCs, the direct inductive methods described here have advantages in saving time and materials. We demonstrated that overexpression of FoxC1 in ECs resulted in an increase in the efficiency of generating functional iSGCs and is a promising resource because they are easy to expand for transplantation-based studies that require large numbers of cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6426881</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:30894517</oboInOwl:hasDbXref>
        <rdfs:label>SGCs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000318"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/c1eb5667-6866-46ce-b1b2-6162fc08404e"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000318"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/c2ddfe6e-4a9e-4945-99c2-e0c21cd99425 -->

    <Class rdf:about="http://example.org/c2ddfe6e-4a9e-4945-99c2-e0c21cd99425">
        <obo:IAO_0000115>While the heterogeneity of CD103+ TRMs is widely discussed in the literature, the characteristics of TRM subpopulations within the tumor or distant tissues of tumor-bearing mice are less well defined. To characterize tumoral TRMs, scRNA-seq technology provides unprecedented analytical power and allows us to dissect cells with thousands of dimensions. With the hypothesis that particular intratumoral T cells are precursors for TRM development, we extended our scRNA-seq approach to include various effector and memory T cell populations to comprehensively depict their transcriptomic program. From the tumor and distant mucosa of mice bearing established 4T1 tumors, we flow sorted distinct memory T cell populations using a strict gating strategy (Figure S3). We constructed single-cell cDNA libraries from paired intratumoral sorted TCR-beta+CD44+CD62L-CD69+CD103+ cells (TRMs), mucosal sorted TCR-beta+CD44+ CD69+CD103+ cells (distant mucosa TRMs), intratumoral TCR-beta+CD44+CD62L+CD69-CD103- cells (TCMs), and TCR-beta+CD44+CD62L-CD69-CD103- cells (##TEMs##) (Table S2). After data processing and normalization, we performed unbiased clustering and visualized the CD8+ clusters using t-distributed stochastic neighbor embedding (t-SNE; Figure 2A). Through this unsupervised analysis, we found that all four samples could distinctly separate into multiple clusters, confirming continued heterogeneity among the single-cell subsets.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8204287</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33979626</oboInOwl:hasDbXref>
        <rdfs:label>TEMs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000913"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/c2ddfe6e-4a9e-4945-99c2-e0c21cd99425"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000913"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/c2e5f46c-311b-4fc1-8c4d-e554252973f6 -->

    <Class rdf:about="http://example.org/c2e5f46c-311b-4fc1-8c4d-e554252973f6">
        <obo:IAO_0000115>Variance results for nRBCs, cRBCPlasma and ##cRBCHPL## for fixed and oscillating traps: A = 5 microm and A = 7 microm, respectively. The distributions of the variance values for each cell type are represented graphically using the boxplot method. The p values are calculated with a Mann-Whitney U test.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7998599</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33806520</oboInOwl:hasDbXref>
        <rdfs:label>cRBCHPL</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000232"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/c2e5f46c-311b-4fc1-8c4d-e554252973f6"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000232"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/c2f3022a-5ccc-4e12-bcad-6bbb28d213f3 -->

    <Class rdf:about="http://example.org/c2f3022a-5ccc-4e12-bcad-6bbb28d213f3">
        <obo:IAO_0000115>MOUSE SYMPATHO-ADRENAL CELL TYPES MARKERS   ##SNPCs## Ret Phox2b Ascl1 Mycn Hand2 Gata3Sox10- Plp1-   Sympathoblasts extra-adrenal Phox2b Mycn Th Dbh Ret Cart CartptSox10- Plp1- Sgc10- Ascl1 -   Sympathetic neurons/ganglia/SRG Ret Scg10 Cart Ascl1 Phox2b Th DbhSox10- Plp1-   SCPs Sox10 Plp1 Ascl1 Phox2bRet-   Schwann cells Sox10 Plp1 GfapPhox2b-   Bridge cells Sox10 Plp1 Chga Penk Htr3a Ascl1 Phox2bTh- Ret-   Immature chromaffin cells Chga Chgb Penk Th DbhSox10- Plp1- Ret-   Chromaffin cells Chga Penk Ascl1 Phox2b Th DbhSox10- Plp1- Ret-   Sympathoblasts intra-adrenal Ret Cart Cartpt Phox2b Th Alk Hmx1 PrphSox10- Plp1-   Sympathetic neurons intra-adrenal Ret Cart Ascl1 Phox2b ThSox10- Plp1-   </obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8915499</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35277192</oboInOwl:hasDbXref>
        <rdfs:label>SNPCs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0011020"/>
        <skos:relatedMatch rdf:resource="CL:0011103"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/c2f3022a-5ccc-4e12-bcad-6bbb28d213f3"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0011020"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/c2f3022a-5ccc-4e12-bcad-6bbb28d213f3"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0011103"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/c3102ef8-80e3-4ef0-97de-a5b402fe1d34 -->

    <Class rdf:about="http://example.org/c3102ef8-80e3-4ef0-97de-a5b402fe1d34">
        <obo:IAO_0000115>Collectively, these studies suggest a level of specialization among CAFs concerning pro-angiogenic behavior or association with tumor vessels, necessitating further investigation. Understanding the specific contributions of the cell of origin to these phenotypes, particularly the relationship between vCAFs and perivascular cells, remains a key area of interest. Recent studies are beginning to uncover the distinct role of ##tumor-associated pericytes## as an independent entity from CAFs. Whether these distinct CAF phenotypes signify particular functions associated with vascular regulation and unique distributions within tumors or represent remnants of their lineage (e.g., mural cell- or EC-derived CAFs) is yet to be determined. Future studies employing techniques like scRNAseq and spatial transcriptomics to map tissue/tumor cell composition and cell communication as well as lineage tracing analyses of CAF subtype cellular origins are expected to provide further evidence on the specific pro- or anti-angiogenic roles of CAF subpopulations (Fig. 3).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11322395</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38453816</oboInOwl:hasDbXref>
        <rdfs:label>tumor-associated pericytes</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000669"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/c3102ef8-80e3-4ef0-97de-a5b402fe1d34"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000669"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/c3455610-9702-4973-84b6-6fe707075e64 -->

    <Class rdf:about="http://example.org/c3455610-9702-4973-84b6-6fe707075e64">
        <obo:IAO_0000115>Tonsillar CD4+ T cell subsets can be divided into three major groups. Most ##intrafollicular T cells## belong to the follicular B helper T cell group (follicular Th [TFH], CD4+PD1+CXCR5+BCL6high). B cell and TFH interactions are crucial for the formation of the humoral immune response and support B cell somatic hypermutation and Ab class switching. Other tonsillar CD4+ T cell subsets include non-TFH (CD4+PD1-CXCR5-BCL6low) and pre-TFH (CD4+PD1+CXCR5-BCL6mid). Pre-TFH cells develop from activated Ag-specific CD4+ T cells. The transcriptional program that is initiated in pre-TFH cells can induce CXCR5 expression, enabling the cells to migrate toward the B cell follicle.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8278278</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34099545</oboInOwl:hasDbXref>
        <rdfs:label>intrafollicular T cells</rdfs:label>
    </Class>
    


    <!-- http://example.org/c34efe3b-888b-4f3d-9f68-9aae77d1bae3 -->

    <Class rdf:about="http://example.org/c34efe3b-888b-4f3d-9f68-9aae77d1bae3">
        <obo:IAO_0000115>Luminal progenitors serve primarily as tumor initiators or cells of origin for prostate cancer. Various hierarchical models have been proposed. A recent model suggests that, during early postnatal development, ##multipotent basal cells## (p63+ CK5+) differentiate into unipotent basal progenitors, luminal progenitors (CK8+ AR low), and NE cells. These unipotent basal and luminal progenitors can undergo self-renewal or differentiate into basal cells and mature luminal cells (AR+ CK8+), respectively. In adults, during homeostasis and regeneration, the bipotent basal progenitor forms unipotent basal and luminal progenitors, which further undergo self-renewal. Unipotent basal progenitors differentiate into basal cells, and luminal cell progenitors differentiate into luminal cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10291985</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37282627</oboInOwl:hasDbXref>
        <rdfs:label>multipotent basal cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000048"/>
        <skos:relatedMatch rdf:resource="CL:0002341"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/c34efe3b-888b-4f3d-9f68-9aae77d1bae3"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000048"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/c34efe3b-888b-4f3d-9f68-9aae77d1bae3"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002341"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/c371e598-370d-499c-961b-c32204a0365c -->

    <Class rdf:about="http://example.org/c371e598-370d-499c-961b-c32204a0365c">
        <obo:IAO_0000115>Despite the crucial physiological processes governed by neurons in the hypothalamic arcuate nucleus (ARC), such as growth, reproduction and energy homeostasis, the developmental pathways and regulators for ARC neurons remain understudied. Our single cell RNA-seq analyses of mouse embryonic ARC revealed many cell type-specific markers for developing ARC neurons. These markers include transcription factors whose expression is enriched in specific neuronal types and often depleted in other closely-related neuronal types, raising the possibility that these transcription factors play important roles in the fate commitment or differentiation of specific ##ARC neuronal## types. We validated this idea with the two transcription factors, Foxp2 enriched for Ghrh-neurons and Sox14 enriched for Kisspeptin-neurons, using Foxp2- and Sox14-deficient mouse models. Taken together, our single cell transcriptome analyses for the developing ARC uncovered a panel of transcription factors that are likely to form a gene regulatory network to orchestrate fate specification and differentiation of ARC neurons.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6697706</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31420539</oboInOwl:hasDbXref>
        <rdfs:label>ARC neuronal</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:4023127"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/c371e598-370d-499c-961b-c32204a0365c"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4023127"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/c38470cb-c3cc-43c6-861c-300ae4bb784f -->

    <Class rdf:about="http://example.org/c38470cb-c3cc-43c6-861c-300ae4bb784f">
        <obo:IAO_0000115>Salivary glands exert exocrine secretory function to provide saliva for lubrication and protection of the oral cavity. Its epithelium consists of several differentiated cell types, including acinar, ductal and myoepithelial cells, that are maintained in a lineage-restricted manner during homeostasis or after mild injuries. Glandular regeneration following a near complete loss of secretory cells, however, may involve cellular plasticity, although the mechanism and extent of such plasticity remain unclear. Here, by combining lineage-tracing experiments with a model of severe glandular injury in the mouse submandibular gland, we show that de novo formation of acini involves induction of cellular plasticity in multiple non-acinar cell populations. Fate-mapping analysis revealed that, although ##ductal stem cells## marked by cytokeratin K14 and Axin2 undergo a multipotency switch, they do not make a significant contribution to acinar regeneration. Intriguingly, more than 80% of regenerated acini derive from differentiated cells, including myoepithelial and ductal cells, that appear to dedifferentiate to a progenitor-like state before re-differentiation into acinar cells. The potential of diverse cell populations serving as a reserve source for acini widens the therapeutic options for hyposalivation.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7561486</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32994165</oboInOwl:hasDbXref>
        <rdfs:label>ductal stem cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000036"/>
        <skos:relatedMatch rdf:resource="CL:4052048"/>
        <skos:relatedMatch rdf:resource="CL:4052049"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/c38470cb-c3cc-43c6-861c-300ae4bb784f"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000036"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/c38470cb-c3cc-43c6-861c-300ae4bb784f"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4052048"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/c38470cb-c3cc-43c6-861c-300ae4bb784f"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4052049"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/c3984335-d73a-4f15-8a08-9d612c972aff -->

    <Class rdf:about="http://example.org/c3984335-d73a-4f15-8a08-9d612c972aff">
        <obo:IAO_0000115>Overall, this study enhances our understanding of the immune mechanisms involved in schistosomiasis. It provides a transcriptional atlas of peripheral immune cells that may contribute to elimination of the disease. This preliminary study suggests that the increased presence of CCR2 + monocyte and ##CXCR2 + NKT cells## might participate in the progression of schistosomiasis.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10563327</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37817226</oboInOwl:hasDbXref>
        <rdfs:label>CXCR2 + NKT cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000814"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/c3984335-d73a-4f15-8a08-9d612c972aff"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000814"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/c3a7092c-4c14-4959-bc3c-6526118368e6 -->

    <Class rdf:about="http://example.org/c3a7092c-4c14-4959-bc3c-6526118368e6">
        <obo:IAO_0000115>Variable Name Data used   TN Naive T-cells Combination of CD4 naive and memory resting T-cells and resting NK cells   Th Helper T-cells Combination of memory activated CD4 T-cells and follicular helper T-cells   TC Cytotoxic cells Combination of CD8 T-cells and activated NK cells   Tr Regulatory T-cells Regulatory T-cells   DN Naive dendritic cells Naive dendritic cells   D ##Activated dendritic cells## Activated dendritic cells   MN Naive Macrophages Combination of Macrophages M0 and Monocytes   M Macrophages Combination of M1 and M2 Macrophages   C Cancer cells Estimated   N Necrotic cells Estimated   A Cancer Associated Adipocytes Assumed to be twice of the total number of immune cells   H HMGB1 HMGB1 gene expression   IL12 IL-12 IL12A and IL12B gene expressions   IL10 IL-10 IL10, IL10RA and IL10RB gene expressions   IL6 IL-6 IL6, IL6ST and IL6RA gene expressions   </obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8959189</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35294447</oboInOwl:hasDbXref>
        <rdfs:label>Activated dendritic cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000451"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/c3a7092c-4c14-4959-bc3c-6526118368e6"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000451"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/c3eec4ea-4d04-4c43-bb2a-a521725f9e5e -->

    <Class rdf:about="http://example.org/c3eec4ea-4d04-4c43-bb2a-a521725f9e5e">
        <obo:IAO_0000115>(A-C) Representative responses to cholinergic agonist (carbachol, 10 muM) by small (L-cells) (A), ##D-stellate## (B), tuberculoventral (TV) cells (C). Small cells were activated by carbachol. D-stellate and TV cells failed to respond to carbachol application. IPSCs in principal cells, bushy cells (D), and T-stellate cells (E) in the VCN were induced by carbachol application, confirming that small inhibitory neurons were local interneurons. (F, H) Time course of sIPSCs from bushy cells and T-stellate (bushy cell, tau = 7.22 +- 1.40 ms, n = 9, T-stellate, tau = 2.28 +- 0.07 ms, n = 9). (G, I) Cumulative histogram of inter-event internal under control and carbachol application. (J). Carbachol application resulted in a significant increase in sIPSCs frequency (inter-event interval, control = 280.44 +- 47.56 ms versus carbachol = 191.21 +- 28.99 ms, p&lt;0.02, t-test).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7744103</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33141020</oboInOwl:hasDbXref>
        <rdfs:label>D-stellate</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000122"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/c3eec4ea-4d04-4c43-bb2a-a521725f9e5e"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000122"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/c40db9f1-6707-4eb2-b281-4d68eb041e24 -->

    <Class rdf:about="http://example.org/c40db9f1-6707-4eb2-b281-4d68eb041e24">
        <obo:IAO_0000115>(A) FACS gating strategy to purify cardiac Mphis from C57BL/6 mice. (B) From the myeloid cell population (CD45+CD11b+ cells), F4/80+Ly6Clow cells (blue) were isolated at 0, 7, and 28 days post-MI, and ##F4/80+/Ly6Chigh cells## (red) were purified at 3 days post-MI. Representative post-sort plots of Mphis are shown in the lower panel. Sorting was performed with a pool of 3-5 mice per time point.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7609061</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33063665</oboInOwl:hasDbXref>
        <rdfs:label>F4/80+/Ly6Chigh cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002479"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/c40db9f1-6707-4eb2-b281-4d68eb041e24"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002479"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/c40f91ad-7fe5-4a56-8af3-c1a59ad522f6 -->

    <Class rdf:about="http://example.org/c40f91ad-7fe5-4a56-8af3-c1a59ad522f6">
        <obo:IAO_0000115>scRNA-seq of ECs reveal a subpopulation enriched with immune responsive signatures. (A) Schematic showing the experimental design for the scRNA-seq and single-nuclei ATAC sequencing analysis of regenerative mouse hearts (MI at P1 and harvested at P5) and nonregenerative mouse hearts (MI at P8 and harvested at P12). (B) UMAP representation of cardiac cell clusters identified from scRNA-seq analysis. Clusters were color coded according to cell types (left). CM, cardiomyocytes; EC, endothelial cells; CF, fibroblasts; PeriC, pericytes; SMC, smooth muscle cells; EndoC, endocardial cells; EpiC, epicardial cells; MF, macrophages; TC, T-cells. (C) Gene ontology (GO) analysis of differentially expressed genes up-regulated in ECs of regenerative-stage hearts versus nonregenerative-stage hearts after MI. (D) UMAP representation of CD31+-enriched cell clusters from single-cell RNA sequencing (scRNA-seq), color coded according to cell type. CEC, capillary endothelial cell; Angio-EC, angiogenic endothelial cell; Pro-EC1, ##proliferative endothelial cell## 1; Pro-EC2, proliferative endothelial cell 2; IFN-EC, interferon capillary endothelial cell; CVEC, capillary venous endothelial cell; VEC, venous endothelial cell; AEC, arterial endothelial cell; LEC, lymphatic endothelial cell; EndoC, endocardial cell. (E) Gene ontology (GO) analysis of differentially expressed genes up-regulated in the IFN-EC cluster of regenerative-stage hearts versus nonregenerative-stage hearts after MI.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10681909</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38012001</oboInOwl:hasDbXref>
        <rdfs:label>proliferative endothelial cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0010008"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/c40f91ad-7fe5-4a56-8af3-c1a59ad522f6"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0010008"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/c42da937-05ae-432f-ac67-f7211156f320 -->

    <Class rdf:about="http://example.org/c42da937-05ae-432f-ac67-f7211156f320">
        <obo:IAO_0000115>The tumor microenvironment (TME) contains diverse population of non-tumor stromal cell that play a role in tumor immune evasion and immunosuppression. The human prostate tumor microenvironment consists of various stromal cells or extracellular matrix, including prostate epithelial cells, myoepithelial cells, fibroblasts, pericytes, endothelial cells, immune cells, adipocytes, neuronal cells, and neuroendocrine cells. Among these, tumor-associated macrophages (##TAMs##), a crucial component of the tumor microenvironment, typically impact tumor growth through activities such as promoting neovascularization, secreting cytokines that inhibit tumor cell apoptosis, stimulating tumor cell proliferation and invasion, and inducing immunosuppression. Based on the concept of classical and alternative activation, macrophages undergo polarization into distinct categories known as M1 and M2. Studies suggest that TAMs predominantly exhibit an M2-like phenotype, characterized by immunosuppressive states and promoting tumor progression. Therefore, it can be served as a strategy to block the downstream signaling pathways of M2 macrophages or inhibit M2-secreted factors that facilitate tumor development and progression for PCa intervention.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10864475</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38349474</oboInOwl:hasDbXref>
        <rdfs:label>TAMs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/c42da937-05ae-432f-ac67-f7211156f320"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/c46fd037-3db0-47b2-b2b5-a37a3671876a -->

    <Class rdf:about="http://example.org/c46fd037-3db0-47b2-b2b5-a37a3671876a">
        <obo:IAO_0000115>In order to investigate the underlying process that may lead to a poor prognosis for high-risk LUAD patients, an analysis of hallmark pathway gene profiles was conducted, revealing distinct characteristics between high- and low-risk groups. A direct comparison between the Risk-High and Risk-Low groups showed that the top five enriched signatures in the high-risk group were MYC target v1, MYC target v2, mTORC1 signaling, G2M checkpoint, and Glycolysis ( Figure 10A ). GSEA enrichment analysis also indicated that the high-risk group had significantly enriched Cell Cycle (NES = 1.93, p&lt; 0.001) and DNA Replication (NES = 1.78, p = 0.000) ( Figure 10B ). The ssGSEA algorithm was employed to examine differences in immune status across distinct risk groups. Low-risk LUAD patients showed increased infiltration of various immune cells, including Active dendritic cells (aDCs), B cells, CD8+ T cells, Dendritic cells (DCs), Immature dendritic cells (##iDCs##), Mast cells, neutrophils, T helper cell, Tumor-infiltrating lymphocytes (TILs), and Regulatory T cells (Treg), in their tumor microenvironment (TME). Furthermore, almost all immune-related pathways were significantly expressed in the low-risk group ( Figures 10C, D ).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10073691</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37033259</oboInOwl:hasDbXref>
        <rdfs:label>iDCs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000840"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/c46fd037-3db0-47b2-b2b5-a37a3671876a"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000840"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/c48bf263-cb7b-48a3-b435-4a79b7f5f9f9 -->

    <Class rdf:about="http://example.org/c48bf263-cb7b-48a3-b435-4a79b7f5f9f9">
        <obo:IAO_0000115>The quantification of multipotent HSPCs is commonly performed according to the lineage-relationships proposed by the classical model of human hematopoiesis. According to this classical model, HSCs and multipotent progenitors (MPPs) are the only cells containing both myeloid as well as lymphoid differentiation potentials. However, the classical model of hematopoiesis has meanwhile been challenged by several groups proposing alternative lineage-relationships and read-outs for multipotent HSCs/MPPs. In this context, we have shown that human CD133+CD45RA-CD34+ HSPCs are enriched for multipotent HSPCs. In vitro, more than 80% of these cells perform asymmetric cell divisions to create one CD133+CD45RA+CD34+ and one CD133-CD45RA-CD34+ daughter cell. While CD133+CD45RA+CD34+ cells inherit the potential to create all lymphocytes and neutrophils, CD133-CD45RA-CD34+ cells are limited to erythroid, megakaryocytic, basophilic and eosinophilic potentials. The first cell fulfills the criteria of ##LMPPs## and the latter ones correspond to cells that are commonly known as common myeloid progenitors (CMP). As we demonstrated that they are not able to form neutrophils, it is no longer justified to interpret them as CMPs. Accordingly, we re-named them to erythro-myeloid progenitors (EMPs) and proposed a revised model for human hematopoiesis in which neutrophils arise from the same branch as lymphocytes (Fig. 1A). The segregation of lineage potentials as predicted in our revised model was recently confirmed in mouse as well as in human steady state BM hematopoiesis using single cell transcriptomics. According to the proposed model, multipotent HSPCs can easily and objectively be identified as CD133 expressing HSPCs containing erythroid differentiation potentials (Fig. 1A).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6733927</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31501490</oboInOwl:hasDbXref>
        <rdfs:label>LMPPs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000837"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/c48bf263-cb7b-48a3-b435-4a79b7f5f9f9"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000837"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/c51a2537-390a-4ae9-acf4-6e25c64c49cc -->

    <Class rdf:about="http://example.org/c51a2537-390a-4ae9-acf4-6e25c64c49cc">
        <obo:IAO_0000115>LSECs Liver sinusoidal endothelial cells   HHSEC Human hepatic sinusoidal endothelial cells   HPAEC Human pulmonary arterial endothelial cells   HPMEC Human pulmonary microvascular endothelial cells   HCMEC ##Human cardiac microvascular endothelial cells##   EC Endothelial cells   DEGs Differentially expressed genes   DMCs Differentially methylated CpGs   DMRs Differentially methylated regions   vECs Vascular endothelial cells   iPS Induced pluripotent stem cells   EPCs Erythroid progenitor cells   </obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7589710</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33096636</oboInOwl:hasDbXref>
        <rdfs:label>Human cardiac microvascular endothelial cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:2000008"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/c51a2537-390a-4ae9-acf4-6e25c64c49cc"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:2000008"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/c546a1b7-9854-415a-aac7-e688f5209d53 -->

    <Class rdf:about="http://example.org/c546a1b7-9854-415a-aac7-e688f5209d53">
        <obo:IAO_0000115>Development of the trophoblastic shell and formation of placental anchoring villi. a Structure of the human trophoblastic shell and its surrounding arterial vessels. b Depiction of a placental anchoring villus, spiral artery (SA) remodelling and interaction of extravillous trophoblasts (EVTs) with different decidual cell types. dCCT distal cell column trophoblast, dMPhi decidual macrophage, DSC decidual stromal cell, eCTB endovascular cytotrophoblast, GC giant cell, iCTB interstitial cytotrophoblast, pCCT proximal cell column trophoblast, pEC placental endothelial cell, pMPhi placental macrophage, ##pSC## placental stromal/mesenchymal cell, SM smooth muscle layer, STB syncytiotrophoblast, TBS trophoblastic shell, TP trophoblast plug, TV tertiary villi, UC umbilical cord, uNK uterine NK cell, vCTB villous cytotrophoblast, YO yolk sac</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6697717</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31049600</oboInOwl:hasDbXref>
        <rdfs:label>pSC</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:2000061"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/c546a1b7-9854-415a-aac7-e688f5209d53"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:2000061"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/c573b530-cb7c-46a5-860c-167c085cf8a0 -->

    <Class rdf:about="http://example.org/c573b530-cb7c-46a5-860c-167c085cf8a0">
        <obo:IAO_0000115>(A-C) In the representative images of superficial (A), intermediate (B), and deep (C) vascular plexuses, white arrowheads identify perivascular macrophages, orange arrowheads show microglia, and red arrowheads highlight hyalocytes. Scale bar: 50 mum. (D) Zoomed-in representative image of each cell type. Scale bars: 50 mum. (E-G) Counts of microglia (E), ##periventricular macrophages## (F), and hyalocytes (G) in each vascular plexus. Microglia were in all 3 plexuses, while perivascular macrophages and hyalocytes were only found in the superficial vascular plexus. **P &lt; 0.01, ***P &lt; 0.001, and ****P &lt; 0.0001, by repeated-measures, 1-way ANOVA followed by Tukey&apos;s multiple-comparison test. (H-K) MotiQ quantitative morphometry showing total area, spanned area, tree length, and ramification index. ****P &lt; 0.0001, by 1-way ANOVA followed by Tukey&apos;s multiple-comparison test. n = 11 per group (E-G); n = 25-50 cells per group (H-K). Data are presented as the mean +- SEM. ONH, optic nerve head.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11473146</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:39207852</oboInOwl:hasDbXref>
        <rdfs:label>periventricular macrophages</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/c573b530-cb7c-46a5-860c-167c085cf8a0"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/c58235af-14fb-44cf-9431-52b7bc3f1e7b -->

    <Class rdf:about="http://example.org/c58235af-14fb-44cf-9431-52b7bc3f1e7b">
        <obo:IAO_0000115>Macrophage-depletion of VEGF1R reduces ##macrophage## number and reduces M2 polarization. (A) ELISA for PlGF levels in tissue from all experimental groups. (B) Representative flow charts for analysis and sorting for CD68 and CD163. (C, D) Quantification of CD68+ macrophage percentage (C) and CD163+ cells in total CD68+ cells (D). *p &lt; 0.05. NS, non-significant.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8511710</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34659227</oboInOwl:hasDbXref>
        <rdfs:label>macrophage</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/c58235af-14fb-44cf-9431-52b7bc3f1e7b"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/c599e753-e5e6-4fb8-ad1d-0e7fd7e0cad2 -->

    <Class rdf:about="http://example.org/c599e753-e5e6-4fb8-ad1d-0e7fd7e0cad2">
        <obo:IAO_0000115>Brain transcriptional changes after MIA require microglia. (A) Simplified schematic of sample processing pipeline from and bar plots of TORCH pathogen and cytokine receptor expression (mean log counts per million) in each cell type across development. (B) Violin plot of CytoTORCH module score for each cell cluster (MG, P&lt;0.05 for ANOVA and for pairwise comparisons between microglia and all other cell types using Tukey&apos;s HST). (C) Overview of experimental design (top) and UMAP visualization of snRNAseq data from the developing somatosensory cortex of E15.5 wild-type and Csf1r-/- mice after saline or Poly(I:C) maternal injection at E12.5 (two or three embryos per condition from a total of four pregnant dams, 42,736 total cells) (bottom). Cells are colored by cell type assignment. (D) Dot plots of log(fold change) in gene expression between MIA and saline for cell types with significant changes at E15.5. DEG analysis was performed using NEBULA. AP, ##apical progenitors##; IP, intermediate progenitors; ImmN, immature neurons, MN, migrating neurons; (UL/DL) CPN, (upper layer/deep layer) callosal projection neurons; SCPN, subcerebral projection neurons; CThPN, corticothalamic projection neurons; LIV, layer IV stellate neurons; IN, interneurons; CR, Cajal-Retzius cells; Astro, astrocytes; CGC, cycling glial cells; Epend; ependymal cells; OL, oligodendroglia; MG, microglia; Peri, pericytes; EC, endothelial cells; VLMC, vascular and leptomeningeal cells. Created with .</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11190434</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38775708</oboInOwl:hasDbXref>
        <rdfs:label>apical progenitors</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000031"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/c599e753-e5e6-4fb8-ad1d-0e7fd7e0cad2"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000031"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/c59be811-bf17-43d1-aaa7-81e099e4a072 -->

    <Class rdf:about="http://example.org/c59be811-bf17-43d1-aaa7-81e099e4a072">
        <obo:IAO_0000115>Proposed schema of developmental interrelationship between ##very small embryonic-like stem cells## (VSELs), and tissue-committed cells. Quiescent VSELs deposited longlife into the bone marrow, may migrate into the blood once activated and give rise not only to HSCs and EPCs but also to other tissue-committed cells, and are also a source of mesenchymal stem cells (MSCs). More particularly, their capability to differentiate along both the cardiac and endothelia pathways favours their clinical use in cardiac diseases. Dotted line pathway still under investigation. Abbreviations: MSC, mesenchymal stem cell; HSC, hematopoietic stem cell; EPC, endothelial progenitor cell; CPC, cardiac progenitor cell; LPC, liver progenitor cell; OPC, osteoblastic progenitor cell</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7253501</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32297205</oboInOwl:hasDbXref>
        <rdfs:label>very small embryonic-like stem cells</rdfs:label>
    </Class>
    


    <!-- http://example.org/c5a4f32b-3022-4d6f-b108-a656a0872c32 -->

    <Class rdf:about="http://example.org/c5a4f32b-3022-4d6f-b108-a656a0872c32">
        <obo:IAO_0000115>To date, it is still disputed whether &quot;senescent&quot; and &quot;dystrophic&quot; microglia are related to the same condition or are distinct. While biochemical and molecular markers of senescence exist, Streit et al. claim that there is no currently straightforward means to identify the dystrophic features of microglial cells, apart from morphological abnormalities, and that changes described in cell morphology cannot be easily correlated with modifications at the molecular level. It has been suggested that over-reactive microglia can reach an exhausted phase, unable to escape their extensive faults in energy metabolism, resulting in ##&quot;senescent&quot; or &quot;dystrophic&quot; microglia.## Considering the above, we believe that microglial &quot;senescence&quot; is related to aging, is accelerated by neurodegeneration, and is one of the major mechanisms leading to the appearance of &quot;dystrophic&quot; morphology, which has no clear molecular signatures because it occurs in now exhausted cells (Figure 3).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10742050</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38132144</oboInOwl:hasDbXref>
        <rdfs:label>&quot;senescent&quot; or &quot;dystrophic&quot; microglia.</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000129"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/c5a4f32b-3022-4d6f-b108-a656a0872c32"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000129"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/c5d661c3-31a3-4d76-aa69-008b52feaf56 -->

    <Class rdf:about="http://example.org/c5d661c3-31a3-4d76-aa69-008b52feaf56">
        <obo:IAO_0000115>We undertook a comprehensive Mendelian randomization study aimed at uncovering the causal relationship between 744 immune cell types and IVDD [ Supplementary Table 2 ]. In our analysis, we identified 24 specific blood types of immune cells that demonstrated a causal association with disc degeneration through univariable MR [ Supplementary Table 3 ], including Memory B cell %B cell, Naive-mature B cell %B cell, IgD-CD38dim B cell %lymphocyte, CD39+activated CD4 regulatory T cell %CD4 regulatory T cell, CD39+ secreting CD4 regulatory T cell %CD4 regulatory T cell, CD45RA+ CD8+ T cell %CD8+ T cell, CD8+ T cell %leukocyte, CD39+CD4+ T cell %T cell, CD39+ CD4+ T cell %CD4+ T cell,##CD39+ CD8+ T cell## %T cell, CD39+ CD8+ T cell Absolute Count, CD127- CD8+ T cell Absolute Count, CD28- CD8+ T cell Absolute Count, CD19 on IgD+ CD38+ B cell, CD19 on IgD+ CD38dim B cell, CD19 on IgD- CD38- B cell, CD19 on unswitched memory B cell, CD19 on transitional B cell, CD24 on IgD+ CD38+ B cell,CD28 on CD39+ secreting CD4 regulatory T cell, CD25 on CD39+ CD4+ T cell, CD4 on CD39+ CD4+ T cell, CD4 on CD39+ resting CD4 regulatory T cell and Neutrophil count. We excluded certain exposures due to a limited number of available SNPs to prevent potential bias, including Memory B cell %B cell, Naive-mature B cell %B cell, IgD-CD38dim B cell %lymphocyte, CD8+T cell %leukocyte, CD127-CD8+ T cell Absolute Count, CD19 on IgD-CD38-B cell, CD24 on IgD+ CD38+ B cell, CD28 on CD39+ secreting CD4 regulatory T cell and CD4 on CD39+ resting CD4 regulatory T cell.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10806224</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38268919</oboInOwl:hasDbXref>
        <rdfs:label>CD39+ CD8+ T cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000625"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/c5d661c3-31a3-4d76-aa69-008b52feaf56"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000625"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/c5dab9d1-7706-4afb-b0aa-8f276d25b87c -->

    <Class rdf:about="http://example.org/c5dab9d1-7706-4afb-b0aa-8f276d25b87c">
        <obo:IAO_0000115>The adipokine leptin regulates energy homeostasis through ubiquitously expressed leptin receptors. Leptin has a number of major signaling targets in the brain, including cells of the anterior pituitary (AP). We have previously reported that mice lacking leptin receptors in AP somatotropes display growth hormone (GH) deficiency, metabolic dysfunction, and adult-onset obesity. Among other targets, leptin signaling promotes increased levels of the pituitary transcription factor POU1F1, which in turn regulates the specification of somatotrope, lactotrope, and thyrotrope cell lineages within the AP. Leptin&apos;s mechanism of action on somatotropes is sex dependent, with females demonstrating posttranscriptional control of Pou1f1 messenger RNA (mRNA) translation. Here, we report that the stem cell marker and mRNA translational control protein, Musashi1, exerts repression of the Pou1f1 mRNA. In female somatotropes, Msi1 mRNA and protein levels are increased in the mouse model that lacks leptin signaling (Gh-CRE Lepr-null), coincident with lack of POU1f1 protein, despite normal levels of Pou1f1 mRNA. Single-cell RNA sequencing of pituitary cells from control female animals indicates that both Msi1 and Pou1f1 mRNAs are expressed in ##Gh-expressing somatotropes##, and immunocytochemistry confirms that Musashi1 protein is present in the somatotrope cell population. We demonstrate that Musashi interacts directly with the Pou1f1 mRNA 3&apos; untranslated region and exerts translational repression of a Pou1f1 mRNA translation reporter in a leptin-sensitive manner. Musashi immunoprecipitation from whole pituitary reveals coassociated Pou1f1 mRNA. These findings suggest a mechanism in which leptin stimulation is required to reverse Musashi-mediated Pou1f1 mRNA translational control to coordinate AP somatotrope function with metabolic status.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7814296</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33373440</oboInOwl:hasDbXref>
        <rdfs:label>Gh-expressing somatotropes</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002312"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/c5dab9d1-7706-4afb-b0aa-8f276d25b87c"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002312"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/c5edcdb8-3482-4990-bc14-b18471ad1033 -->

    <Class rdf:about="http://example.org/c5edcdb8-3482-4990-bc14-b18471ad1033">
        <obo:IAO_0000115>Tumor progression depends not only on the intrinsic hallmarks of cancer cells but also on the formation of a milieu that escapes immune surveillance. Regulatory immune cells including myeloid-derived suppressor cells (MDSCs), ##M2-like tumor-associated macrophages## (TAMs), and CD4+CD25highFoxP3+ regulatory T cells (Tregs) contribute to the inhibition of cytotoxic CD8+T cells and tumor progression. Although the effect of PI3K inhibitors on cancer cells has been extensively studied, their effect on cancer-associated immunity remains largely unknown. Emerging evidence has highlighted the potential novel mechanisms underlying the antitumor effect of PI3K inhibitors. For example, PI3Kgamma inhibition delay tumor growth by inhibiting the function of macrophages and activating CD8+T cells. PI3Kdelta inhibitors inhibit the proliferation of Tregs and attenuate their immunosuppressive effect. PI3Kalpha is the only isoform that frequently mutated and abnormally activated in solid tumors. The intrinsic PI3Kalpha activation in malignant cells may mediate the suppressive tumor microenvironment (TME). For example, the activation of PI3Kalpha limited the infiltration and function of T cells, and contributed to the suppressed expression of major histocompatibility complex I and cluster of differentiation 80 in tumor cells. Despite the potential role of PI3Kalpha in the TME, the efficacy and mechanism of action of PI3Kalpha inhibitors are typically studied in athymic nude mice in preclinical settings. Elucidating the action of PI3Kalpha inhibitors in the immune-competent context will facilitate a better understanding of the impact of the PI3K pathway on the crosstalk between the TME and cancer cells, and allow further exploration of mechanism-driven drug combinations to potentiate the efficacy.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8354295</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34373258</oboInOwl:hasDbXref>
        <rdfs:label>M2-like tumor-associated macrophages</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000890"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/c5edcdb8-3482-4990-bc14-b18471ad1033"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000890"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/c6343edd-83a4-4b58-be36-a19219e5b4be -->

    <Class rdf:about="http://example.org/c6343edd-83a4-4b58-be36-a19219e5b4be">
        <obo:IAO_0000115>Chronic pain is a highly debilitating condition that differs by type, prevalence, and severity between men and women. To uncover the molecular underpinnings of these differences, it is critical to analyze the transcriptomes of spinal cord pain-processing networks for both sexes. Despite several recently published single-nucleus RNA-sequencing (snRNA-seq) studies on the function and composition of the mouse spinal cord, a gene expression analysis investigating the differences between males and females has yet to be performed. Here, we combined data from three different large-scale snRNA-seq studies, which used sex-identified adult mice. Using SeqSeek, we classified more than 37,000 unique viable cells within predicted cell types with the use of machine learning. We then utilized DESeq2 to identify significant differentially expressed genes (DEGs) between males and females in a variety of cell populations, including superficial dorsal horn (SDH) neurons. We found a large number of DEGs between males and females in all cells, in neurons, and in SDH neurons of the mouse spinal cord, with a greater level of differential expression in inhibitory SDH neurons compared to ##excitatory SDH neurons##. The results of these analyses are available on an open-source web-app: https://justinbellavance.shinyapps.io/snRNA_Visualization/. Lastly, we used gene set enrichment analysis to identify sex-enriched pathways from our previously identified DEGs. Through this, we have identified specific genetic players within the rodent spinal cord that diverge between males and females, which may underlie reported sex differences in spinal nociceptive mechanisms and pain processing.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11645520</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:39673257</oboInOwl:hasDbXref>
        <rdfs:label>excitatory SDH neurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0011000"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/c6343edd-83a4-4b58-be36-a19219e5b4be"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0011000"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/c6415e74-89a3-476b-a3de-a1ba60959b6e -->

    <Class rdf:about="http://example.org/c6415e74-89a3-476b-a3de-a1ba60959b6e">
        <obo:IAO_0000115>Downstream of the multipotent HSCs and MPPs, the original lineage bifurcation model strictly separated oligopotent Common Lymphoid Progenitors (CLP) from Common Myeloid Progenitors (CMP) which could further diverge into Megakaryocyte/Erythrocyte Progenitors (MEPs), Monocyte (Mo)/Dendritic cell (DC) Progenitors (MDPs) and Granulocyte/Mo Progenitors (GMPs). However, this model has been the subject of ongoing revision in the scRNA-seq era. On the one hand, a Lymphoid-primed MultiPotent Progenitor (LMPP) with combined lymphoid and myeloid potential has been shown to gradually lose myeloid potential by upregulating the interleukin-7 receptor alpha-chain (IL7Ralpha) and differentiate into Dach1- Lymphoid-Primed Progenitors (LPPs) prior to CLPs. On the other hand, erythroid-versus-myeloid fate decisions seem to be made prior to CMP commitment, calling for in-depth revision of all CMP progeny (MEPs, MDPs and GMPs) as well. While the Flt3L+CD115lo CMPs give rise to oligopotent MDPs, the Flt3-CD115- CMPs give rise to GMPs. The former are defined by TF co-expression of CEBPA, IRF8 and RUNX1. MDPs can give rise to IRF8/SATB1 plasmacytoid DC (pDC) Progenitors (pDCPs) and HLA-DR/IRF8/CEBPA Mo/conventional DC (cDC) Progenitors (##McDPs##). The latter bifurcate in CD11c/CD172ab/CD14 (human) or Ly6C+ Mo (mouse) or IRF8/HLA-DR/CD84/CD172ab Common DC Progenitors (CDPs). In contrast, GMPs (Kit, CD34, Sox4) are very heterogeneous at the transcriptomic and proteomic level and can adjust their functional output towards common Mo Progenitors (cMoP) and Granulocyte Progenitors (GPs).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11324509</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:39148724</oboInOwl:hasDbXref>
        <rdfs:label>McDPs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002009"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/c6415e74-89a3-476b-a3de-a1ba60959b6e"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002009"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/c643caa7-05fb-427e-afc0-e45323d0f3bf -->

    <Class rdf:about="http://example.org/c643caa7-05fb-427e-afc0-e45323d0f3bf">
        <obo:IAO_0000115>(A-C) Representative responses to cholinergic agonist (carbachol, 10 muM) by small (L-cells) (A), D-stellate (B), tuberculoventral (TV) cells (C). Small cells were activated by carbachol. D-stellate and TV cells failed to respond to carbachol application. IPSCs in ##principal cells##, bushy cells (D), and T-stellate cells (E) in the VCN were induced by carbachol application, confirming that small inhibitory neurons were local interneurons. (F, H) Time course of sIPSCs from bushy cells and T-stellate (bushy cell, tau = 7.22 +- 1.40 ms, n = 9, T-stellate, tau = 2.28 +- 0.07 ms, n = 9). (G, I) Cumulative histogram of inter-event internal under control and carbachol application. (J). Carbachol application resulted in a significant increase in sIPSCs frequency (inter-event interval, control = 280.44 +- 47.56 ms versus carbachol = 191.21 +- 28.99 ms, p&lt;0.02, t-test).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7744103</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33141020</oboInOwl:hasDbXref>
        <rdfs:label>principal cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:4023162"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/c643caa7-05fb-427e-afc0-e45323d0f3bf"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4023162"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/c667853f-7cc7-49e8-a340-11ed8e216f82 -->

    <Class rdf:about="http://example.org/c667853f-7cc7-49e8-a340-11ed8e216f82">
        <obo:IAO_0000115>a, b, Uniform manifold approximation and projection (UMAP) of fetal (a) and postnatal (b) epithelial cell types. Key cell types are circled with a dashed line and arrows depict paths of differentiation towards ##secretory and absorptive enterocytes## as determined by scVelo. M cells, microfold cells; TA, transit-amplifying. c, Dot plot of TMPRSS2 and ACE2 expression in epithelial cells in the fetal intestine as in a. d, UMAP of enteroendocrine (EEC) and enterochromaffin (EC) cell subsets. Arrows depict summarised scVelo differentiation trajectories. C9orf16 is also known as BBLN. e, Heat map of genes that change along the differentiation trajectory from NEUROG3-expressing progenitors to enterochromaffin cells (red arrow in d). Arrows indicate genes that have known associations with enterochromaffin cell differentiation. f, Dot plot with expression of molecules upstream or downstream of the PLCG2 pathway in tuft cells and pooled absorptive (TA and enterocytes) and secretory (Paneth, goblet and EEC) cells. g, Per cent expression of Fcgamma receptor by SiglecF+EpCAM+ and SiglecF-EpCAM+ cells in wild-type mice determined by flow cytometry (individual points represent biological replicates; n = 4). Using a two-way ANOVA we observe significant interaction between Fcgamma receptor expression (F(3, 39) = 42.29, P = 3.05 x 10-11). Post-hoc analysis showed significant differences between non-Tuft epithelial cells and Tuft cells for FcgammaRIIB (mean difference = 2.80, 95% CI [1.80, 3.81], P &lt; 0.0001) and FcgammaRIIB/III (mean difference = 4.88, 95% CI [3.88, 5.89], P &lt; 0.0001) expression. ****Padj &lt; 0.0001 values corrected with Tukey&apos;s test for multiple comparisons. h, Schematic of proposed signalling pathways in tuft cells. RTK, receptor tyrosine kinases.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8426186</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34497389</oboInOwl:hasDbXref>
        <rdfs:label>secretory and absorptive enterocytes</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000584"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/c667853f-7cc7-49e8-a340-11ed8e216f82"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000584"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/c66cdade-ff4f-410c-8b95-bfdd3b22baed -->

    <Class rdf:about="http://example.org/c66cdade-ff4f-410c-8b95-bfdd3b22baed">
        <obo:IAO_0000115>Proposed schema of developmental interrelationship between very small embryonic-like stem cells (VSELs), and tissue-committed cells. ##Quiescent VSELs## deposited longlife into the bone marrow, may migrate into the blood once activated and give rise not only to HSCs and EPCs but also to other tissue-committed cells, and are also a source of mesenchymal stem cells (MSCs). More particularly, their capability to differentiate along both the cardiac and endothelia pathways favours their clinical use in cardiac diseases. Dotted line pathway still under investigation. Abbreviations: MSC, mesenchymal stem cell; HSC, hematopoietic stem cell; EPC, endothelial progenitor cell; CPC, cardiac progenitor cell; LPC, liver progenitor cell; OPC, osteoblastic progenitor cell</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7253501</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32297205</oboInOwl:hasDbXref>
        <rdfs:label>Quiescent VSELs</rdfs:label>
    </Class>
    


    <!-- http://example.org/c691f714-dfbf-415f-bc6a-3c271f263c9b -->

    <Class rdf:about="http://example.org/c691f714-dfbf-415f-bc6a-3c271f263c9b">
        <obo:IAO_0000115>Next, we sought to identify using machine learning, the immune variable (IT or Stromal) that best classifies patients as LTS or NON-LTS and thereby, predicts patient survival. Random-forest (RF) is a decision tree-based machine learning method which uses a bootstrapping method to generate at random, training and testing samples from the dataset. Variable selection was performed through the varSelRF package in R, which uses recursive feature elimination to find a minimal set of variables with the best predictive performance. Using this approach, we determined that stromal densities of iNOS+ and CD68+ cells are the two best discriminatory variables for patient survival. Stromal iNOS+ leukocytes display a potent positive correlation with OS (Figure 7A) while stromal CD68+ (total) macrophages show a strong negative correlation with OS (Figure 7B). The ROC (Receiver Operating Characteristic) curves and ROC values for the final two variables determined by RF selection (i.e., iNOS and CD68) are plotted in Supplementary Figure 7. These findings suggest that iNOS+ leukocytes and ##CD68+ macrophages## are highly relevant prognostic biomarkers in PDAC patients.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7933000</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33679807</oboInOwl:hasDbXref>
        <rdfs:label>CD68+ macrophages</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/c691f714-dfbf-415f-bc6a-3c271f263c9b"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/c6b8cd9b-8c8a-4efe-bb8b-2fc9c7b9b389 -->

    <Class rdf:about="http://example.org/c6b8cd9b-8c8a-4efe-bb8b-2fc9c7b9b389">
        <obo:IAO_0000115>Besides these omental cell types, tumour-associated macrophages (TAM) clearly are instrumental in metastasis, in particular the CD163+Tim4+ subset, which promotes the stemness, invasive properties and epithelial to mesenchymal transition (EMT) of tumour cells by paracrine mechanisms. While omentectomy or depletion of CD163+Tim4+ cells prevented metastatic dissemination in a mouse model of ovarian cancer, depletion of ##monocyte-derived TAM## had little impact, emphasising the role of resident omental macrophages. In keeping with these findings, TAM from HGSC patients show a high degree of phenotypic, ontogenetic and tumour-promoting heterogeneity, reflected, for example, by the differential expression of CD163 and cytokines associated with tumour progression. </obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8574964</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34841720</oboInOwl:hasDbXref>
        <rdfs:label>monocyte-derived TAM</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
        <skos:relatedMatch rdf:resource="CL:0000576"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/c6b8cd9b-8c8a-4efe-bb8b-2fc9c7b9b389"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/c6b8cd9b-8c8a-4efe-bb8b-2fc9c7b9b389"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000576"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/c6ca585e-4ebf-4175-b365-d06b422aaccc -->

    <Class rdf:about="http://example.org/c6ca585e-4ebf-4175-b365-d06b422aaccc">
        <obo:IAO_0000115>We compared the functional differences between similar types of epithelial cells in the TZ and the PZ. GSVA revealed that angiogenesis- and inflammation-related pathways were activated in all ##epithelial cells in the TZ## (Figure 4A). Oestrogen, mTOR and stem/progenitor cell biology-regulated NOTCH signalling were more activated in TZ club and hillock cells than in the PZ (Figure 4A). Both oestrogen and mTOR pathways can serve as therapeutic targets for BPH. The E2F targets, the MYC targets and the DNA repair pathway were enriched in PZ luminal cells (Figure 4A).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9574492</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36245324</oboInOwl:hasDbXref>
        <rdfs:label>epithelial cells in the TZ</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002231"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/c6ca585e-4ebf-4175-b365-d06b422aaccc"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002231"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/c6e38404-f49b-4aa7-9c3b-e862120a9293 -->

    <Class rdf:about="http://example.org/c6e38404-f49b-4aa7-9c3b-e862120a9293">
        <obo:IAO_0000115>On occasion Th-CreER; RosaRFP mice were administered tamoxifen and then euthanized shortly after the last injection, within 4 d. When innervation of the tongue was examined using RFP immunolabeling, we observed highly RFP ##(Th)+ taste bud cells## in both fungiform and circumvallate papillae (Fig. 4A). There was never more than one RFP+ cell per taste bud, and only a few taste buds contained these cells. The number of taste buds containing RFP+ receptor cells was quantified, and we observed that only 12% of fungiform taste buds, and 28% of circumvallate taste buds, contained a RFP+ cell (Fig. 4C). If we waited for three weeks after the last tamoxifen injection to euthanize the Th-CreER; RosaRFP mice and perform RFP immunolabeling, no RFP+ cells were observed in any taste bud, indicating that these cells turn over within three weeks. To determine whether these cells were Type II or Type III cells, we used markers specific for these cell classes. CAR4 labels most Type III cells, and CAR4 immunolabeling of taste buds from Th-CreER; RosaRFP mice that were colabeled with RFP demonstrated that these Th-expressing cells did not express CAR4, and were therefore unlikely to be Type III cells (Fig. 4B). Interestingly, immunolabelling taste buds from Th-CreER; RosaRFP mice with TRPM5 antibodies along with RFP antibodies revealed that these Th+ cells were colabeled with TRPM5, indicating that they are a Type II receptor cell (; Fig. 4B). Therefore, Th-expressing taste bud cells are an uncommon Type II cell that turns over within three weeks.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9581578</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36216506</oboInOwl:hasDbXref>
        <rdfs:label>(Th)+ taste bud cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:4033049"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/c6e38404-f49b-4aa7-9c3b-e862120a9293"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4033049"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/c72724e0-9740-45a3-8a7f-7ca8d62acf05 -->

    <Class rdf:about="http://example.org/c72724e0-9740-45a3-8a7f-7ca8d62acf05">
        <obo:IAO_0000115>mFbs resemble fibroblastic reticular cells (FRCs) that form conduit-like network in secondary lymphoid organs, and they have also been known as thymic FRCs. Transcriptome analyses on mFbs and LN FRCs revealed possible functional differences between these two morphologically similar cell types. LN FRCs are subdivided into several types based on their expression of functional genes, including chemokines and cytokines: T-cell zone reticular cell (TRC) expressing Ccl19, Ccl21a, and Il7; follicular dendritic cell (FDC) expressing Cxcl13; marginal reticular cell (MRC) expressing Tnfsf11 (RANKL); Cxcl12-expressing reticular cell (##CRC##); and medullary reticular cell (medRC) expressing Cxcl12, Il6, Tnfsf13, and Tnfsf13b. Most of these FRC-associated genes are not or just barely expressed in mFbs. In the thymus, RANKL is predominantly expressed in SP thymocytes to induce mTEC development, and Ccl19, Ccl21, Cxcl12, and IL-7 are produced by TECs so as to control the relocation and survival of thymocytes. It is likely that the role played by FRCs in the LN is replaced by TECs in the thymus. mFbs highly express other sets of chemokines as well, such as Cx3cl1 and Cxcl14, that are barely expressed in LN FRCs or capFbs, possibly contributing to the regulation of cell migration in the thymic medulla. Thus, mFbs comprise a thymus-specific subset of fibroblasts that is functionally distinct from LN FRCs. It is possible that mFbs also consist of multiple subsets with different functions. A population of CD34+podoplanin+ mFbs are detected in adventitial layers that surround pericytes and endothelial cells, thus referred to as adventitial cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7840694</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33519827</oboInOwl:hasDbXref>
        <rdfs:label>CRC</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000432"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/c72724e0-9740-45a3-8a7f-7ca8d62acf05"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000432"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/c7395777-d613-4009-b865-a51b3a1b98ea -->

    <Class rdf:about="http://example.org/c7395777-d613-4009-b865-a51b3a1b98ea">
        <obo:IAO_0000115>Recognition of low grade or asymptomatic systemic diseases suggests prevention of the worst, yet has been proven challenging ever since. Biomarker-based liquid biopsy has emerged in recent years as a practical platform for the assessment of systemic diseases yet, technical realizations were mainly focused on cancer, faced challenges in accuracy at early stage and are lacking provision of sufficient evidence of disease. In particular in cell-based cancer liquid biopsy, obstacles are rarity and heterogeneity of circulating tumor and tumor-associated rare cells. Evidence is mounting about an entire spectrum of distinct circulating rare cell types that denotes the systemic component of a certain physiological state. Therefore, ##circulating rare cells## in combination may arise from yet, also account for systemic diseases, which we denote as multi-rare cell association and involves foremost bone marrow-derived progenitor and stem cells yet, also matured somatic cell types. One would expect immense diagnostic value in the read-out of the so called rare cell population which represents cytological evidence of abnormality. We hypothesize that comprehensive rare cell population profiling as contrasted to the biomarker screening approach may realize the premise of a biopsy as to confirm, characterize, grade, stage or predict a systemic disease. This novel approach represents the &quot;missing link&quot; in diagnostic care of in particular early or residual systemic disease and presumes a steady gain in knowledge about the clinical interpretation of rare cell population profiles thus, expecting the knowledge-driven transformation of cell-based liquid biopsy from suggestion to confirmation. We support our hypothesis by past findings made by others and us and provide insights how to interpret a certain rare cell population profile.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMID:34598097</oboInOwl:hasDbXref>
        <rdfs:label>circulating rare cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000080"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/c7395777-d613-4009-b865-a51b3a1b98ea"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000080"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/c74cb198-36db-4c02-8daf-c23d58293a4b -->

    <Class rdf:about="http://example.org/c74cb198-36db-4c02-8daf-c23d58293a4b">
        <obo:IAO_0000115>Finally, in the ##CD56+ NK cell## compartment, despite the lower level of functional heterogeneity and differentiation (Fig. 4d, e), we found that the increased frequency of CD56br NK cells after IL-2 treatment, was driven particularly by an increased relative proportion of an activated HLA-II+ subset (Fig. 4f). By contrast we found no alterations in the relative composition of CD56dim subsets (Fig. 4g and Supplementary Fig. 14). Consistent with the activation phenotype and increased expression of CD56 on CD56br NK cells after treatment, we observed a reduced frequency of contaminating CD56dim and CD56br NK cells sorted from the CD56br and CD56dim NK cell gates, respectively at Day 27 (Fig. 4f, g). The alterations in the CD56br NK cells were also transient and were not maintained one month after treatment (Supplementary Fig. 14b, c).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9705541</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36443294</oboInOwl:hasDbXref>
        <rdfs:label>CD56+ NK cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000938"/>
        <skos:relatedMatch rdf:resource="CL:0000939"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/c74cb198-36db-4c02-8daf-c23d58293a4b"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000938"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/c74cb198-36db-4c02-8daf-c23d58293a4b"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000939"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/c76c6139-15fa-4a6b-8a58-5edbfd9fac7d -->

    <Class rdf:about="http://example.org/c76c6139-15fa-4a6b-8a58-5edbfd9fac7d">
        <obo:IAO_0000115>scRNA sequencing data was analyzed to further explore the synergistic effect of the IRRS and the TME cells in ESCC. We used the previously profiled transcriptomes of ~208,659 single cells with eight main cell populations ( Figures 4A, B ), among which fibroblasts, endothelial cells, T cells, B cells, pericytes and myeloid cells were analyzed. Next, 40 cell clusters, including T helper 17 (TH17) cells, follicular helper T (TFH1/2) cells, naive T (TN) cells, regulatory T (Treg) cells, memory T (TMEM-CD4/CD8) cells, effector T (TEFF) cells, exhausted T (TEX) cells, monocytes (Mono01-03), tumor-associated macrophages (##TAM##01-04),dendritic cells (tDC, pDC, cDC), mast cells (Mast), resting B cells, activated B cells, germinal center B cells (GCB), plasma cells, normal mucosa fibroblasts (NMF), normal activated fibroblasts (NAF1/2), cancer-associated fibroblasts (CAF1-4), vascular smooth muscle cells (VSMC), normal endothelial cells (NEC1-3) and tumor endothelial cell (TEC1-3) were identified by t-SNE analysis ( Figures 4C-G ;  Figures S6A-E ). We then used CIBERSORTx to infer cell-type abundance from bulk RNA-seq data using scRNA data, and estimated the proportions of the 42 cell types in the training dataset. The proportions of TME cell types between the high- and low-risk groups was compared using the Kruskal-Wallis test. The profiles of the high- and low-risk groups are shown in  Figure 4H  and  Figure S6F . The abundance of TEX, NAF2, CAF4, and VSMC increased, and the abundance of Mono1, TAM03, and NEC2 decreased in the high-risk group (p &lt; 0.05;  Figure 4I ). The cell proportions between low and high risk groups demonstrated significantly distinct TME patterns.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9933905</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36817484</oboInOwl:hasDbXref>
        <rdfs:label>TAM</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/c76c6139-15fa-4a6b-8a58-5edbfd9fac7d"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/c79618f2-9874-4687-aa7b-7a3d7aac3158 -->

    <Class rdf:about="http://example.org/c79618f2-9874-4687-aa7b-7a3d7aac3158">
        <obo:IAO_0000115>PD: Parkinson&apos;s Disease; AD: Alzheimer&apos;s Disease. SCI: Spinal Cord injury; hESC: human Embryonic Stem Cells; NSC: Neural Stem Cells; NPC: Neuronal Progenitor Cells; hiPSC: human Pluripotent Stem Cells; DANs: Dopaminergic neurons; lt-NES: ##long-term self-renewing Neuro-Epithelial-like Stem##; ML/NEP2: Macrophage-Like/Neprilysin-2; BFCN: Basic Forebrain Cholinergic Neurons; OPC: Oligodendrocyte Progenitor Cells; MGE: Medial Ganglionic Eminence; SNI: Spared Nerve Injury.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7699962</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33233861</oboInOwl:hasDbXref>
        <rdfs:label>long-term self-renewing Neuro-Epithelial-like Stem</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002259"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/c79618f2-9874-4687-aa7b-7a3d7aac3158"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002259"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/c7e0a9ce-f88e-4e5a-a528-5818412927d4 -->

    <Class rdf:about="http://example.org/c7e0a9ce-f88e-4e5a-a528-5818412927d4">
        <obo:IAO_0000115>a Due to single-cell annotation and in situ validation (Fig. 2; Supplementary Fig. 3), a draft model of the oral-to-tooth transition zone in humans is presented, with basal and suprabasal keratinocyte markers uniquely identifying the alveolar mucosa (AM), attached gingiva (AG), gingival margin (GM), sulcular epithelium (SK) and junctional epithelium (JK). b These markers allowed for KRT19-high keratinocyte (KC) cell subclustering for the first time (2504 cells in total), including gingival margin keratinocytes (GM), sulcular keratinocytes (SK), and junctional keratinocytes (JK). c A more granular draft (Tier 4) annotation of epithelial cells of the gingival attachment. d Assaying differentially expressed genes in periodontitis, SKs and JKs only share about a quarter of upregulated genes. JKs displayed nearly 125 unique upregulated genes in diseased cells. e Further analysis of basal and suprabasal (differentiating) SK and JK keratinocytes revealed unique cell signatures between basal and suprabasal cell types. This full list is included in Supplementary Data 1. f-i To understand SK and JK developmental progression and cell state alterations, we used partitioned-based graph abstraction (PAGA). f Examining the basal to suprabasal transition, JKs display altered gene expressed comparing health to disease cell types, including broader expression of KRT17 and more expression of JUND, COL17A1, and CDH3. Key differentiation genes such as SPRR family members were also downregulated. g JKs displayed robust cell signaling and inflammatory phenotypes, which appear exacerbated in disease states. h In SKs, differentiation-related genes were uniquely expressed compared to JKs in health but also appeared altered in disease along the basal to suprabasal trajectory. i SKs appeared generally less reactive compared to JKs in disease, with lower overall expression of effector molecules such as CXCL1, CXCL8, IL1A, IL1B, and IL1RN. Abbreviations: Merk Merkel Cells, LC langerhans cells, Mela melanocytes, ##Muc## mucosa, SB suprabasal Keratinocytes; for others, see Fig. 1 legend. For this figure, n = 30-sample, 2504-cell for scRNAseq.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11178863</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38876998</oboInOwl:hasDbXref>
        <rdfs:label>Muc</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002170"/>
        <skos:relatedMatch rdf:resource="CL:0002336"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/c7e0a9ce-f88e-4e5a-a528-5818412927d4"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002170"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/c7e0a9ce-f88e-4e5a-a528-5818412927d4"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002336"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/c82c5166-e079-499a-9903-5e39a3301038 -->

    <Class rdf:about="http://example.org/c82c5166-e079-499a-9903-5e39a3301038">
        <obo:IAO_0000115>In our next analysis, we examined how ARGs impacted the prognosis of patients with pancreatic cancer. As autophagy is correlated with immune cell infiltration and immune cell infiltration has been linked to cancer development and prognosis, we used CIBERSORT to compare the abundance of 22 immune cell types between the high- and low-risk groups in TCGA-PAAD (Fig. 8A-B). A total of six immune cells were found to show varying degrees of infiltration between the two groups with respect to the 22 types that were studied: the infiltration levels of naive B cells (p = 0.003) and plasma cells (p = 0.044) were higher in the low-risk group, and the infiltration levels of memory CD4 T cells (p = 0.016), ##resting NK cells## (p = 0.025), M2 macrophages (p = 0.020) and mast cells (p = 0.007) were higher in the high-risk group. In addition, the CD8 T-cell infiltration level was nearly significantly lower in the high-risk group (p = 0.080). The immune infiltration landscape is summarized in a radar plot in Fig. 8B. Additionally, the correlation between the risk score and the infiltration of the seven immune cells was investigated by Spearman correlation analysis. According to our results, the infiltration levels of naive B cells (r = -0.29, p &lt; 0.001, Fig. 8C), M2 macrophages (r = 0.19, p = 0.033, Fig. 8D), mast cells (r = 0.20, p = 0.019, Fig. 8E), CD8 T cells (r = -0.24, p &lt; 0.001, Fig. 8F) and NK resting cells (r = 0.20, p = 0.022, Fig. 8G) were statistically correlated with the ARG risk scores.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9054801</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35488119</oboInOwl:hasDbXref>
        <rdfs:label>resting NK cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000623"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/c82c5166-e079-499a-9903-5e39a3301038"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000623"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/c838fcda-20fd-43a1-b955-5ab058905784 -->

    <Class rdf:about="http://example.org/c838fcda-20fd-43a1-b955-5ab058905784">
        <obo:IAO_0000115>To further investigate whether somatostatin-expressing CSF-c neurons (pH-sensitive) and dopaminergic CSF-c neurons (non-pH-sensitive) have different types of cilia, expansion was combined with STED microscopy. Using dual-colour imaging of spinal cord slices, either somatostatin or dopamine (TH immunostaining), together with alpha-tubulin immunostaining (Figure 6) was analysed. To have better access to the cilia and CSF-c neurons the central canal of the expanded spinal cord has been cut horizontally and flipped 90  with respect to the coverslip. The central canal can then be visualized in a cylindrical form (Figure 6A-C). To confirm what type of CSF-c neurons the cilia belong to, z-stack scanning for all the imaging was applied. In our data, 70 cilia belong to somatostatin-expressing CSF-c neurons (n = 70). Of these, 60 cilia were primary (9 + 0 symmetry) and 10 cilia were motile (9 + 2 symmetry) (Figure 6D-K, T). Additionally, 20 cilia of dopaminergic CSF-c neurons were all motile cilia (9 + 2 symmetry) (Figure 6L-S, T). We found that somatostatin-expressing CSF-c neurons are sensory neurons expressing mainly sensory cilia. However, the motile cilia in both ##somatostatin-expressing and dopaminergic CSF-c neurons## might be involved in contributing to the flow of CSF through the central canal (Figure 6U).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8809891</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35103591</oboInOwl:hasDbXref>
        <rdfs:label>somatostatin-expressing and dopaminergic CSF-c neurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000540"/>
        <skos:relatedMatch rdf:resource="CL:0000700"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/c838fcda-20fd-43a1-b955-5ab058905784"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000540"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/c838fcda-20fd-43a1-b955-5ab058905784"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000700"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/c8529d0a-8031-43dd-ab88-47f99194a21a -->

    <Class rdf:about="http://example.org/c8529d0a-8031-43dd-ab88-47f99194a21a">
        <obo:IAO_0000115>Deletion of TREM2 suppresses the development of disease-associated microglia (##DAMs##) in vivo.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7584603</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33097708</oboInOwl:hasDbXref>
        <rdfs:label>DAMs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000129"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/c8529d0a-8031-43dd-ab88-47f99194a21a"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000129"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/c8808b73-7e21-4e7c-9e35-cecb1211e1f1 -->

    <Class rdf:about="http://example.org/c8808b73-7e21-4e7c-9e35-cecb1211e1f1">
        <obo:IAO_0000115>Not all EVs have the same qualities. Tissue source has been found to affect EV cargo. For example, a comparison of EVs from different tissue sources regarding the effects on neuronal growth revealed that EVs from ##menstrual fluid MSCs## had enhancing effects on neurite outgrowth compared with BM-MSC EVs, umbilical cord MSC EVs and chorion MSC EVs. In addition, a comparison of hASC EVs and human BM-MSCs regarding their ability to promote tube formation and mitochondrial respiration in vitro indicated that hASC EVs outperformed BM-MSCs and that culture conditions also affected the results:more specifically, EVs from spheroid cultured hASCs had a greater effect. These results suggest that special attention should be paid to the purpose of the study and the culture conditions in the selection process of MSC cell type. As the paracrine mechanisms and the secretome of MSCs differ depending on their tissue origin, MSCs should be standardized in order to consider them as a form of therapeutics. Therefore, it would be important to establish concrete parameters to obtain a signature of MSCs with respect to their pro-angiogenic role and high-quality control prior to the purification of cell-secreted factors and EVs. To improve MSCs, their secretome characterization and the reproducibility of co-culture systems between donors and different cell passages, and to standardize MSCs from different sources, novel technologies such as label-free functional tests would be advantageous to profile cells and to control their quality.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8509224</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34639228</oboInOwl:hasDbXref>
        <rdfs:label>menstrual fluid MSCs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000134"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/c8808b73-7e21-4e7c-9e35-cecb1211e1f1"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000134"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/c88e7611-9e96-4deb-b978-6684e830e2d6 -->

    <Class rdf:about="http://example.org/c88e7611-9e96-4deb-b978-6684e830e2d6">
        <obo:IAO_0000115>The most representative cell types in women&apos;s stenotic aortic valve leaflets were chondrocytes, fibroblasts, osteoblasts, and pericytes. Conversely, men&apos;s stenotic aortic valve leaflets were characterized by the presence of i) innate immune system cells (monocytes, macrophages, and dendritic cells), ii) ##adaptive immune system cells## (B and T lymphocytes), and iii) mesenchymal stem cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8907138</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35280999</oboInOwl:hasDbXref>
        <rdfs:label>adaptive immune system cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000084"/>
        <skos:relatedMatch rdf:resource="CL:0000945"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/c88e7611-9e96-4deb-b978-6684e830e2d6"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000084"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/c88e7611-9e96-4deb-b978-6684e830e2d6"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000945"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/c8b74f02-b02a-45cc-a1ca-740cde344581 -->

    <Class rdf:about="http://example.org/c8b74f02-b02a-45cc-a1ca-740cde344581">
        <obo:IAO_0000115>Downstream of the multipotent HSCs and MPPs, the original lineage bifurcation model strictly separated oligopotent Common Lymphoid Progenitors (CLP) from Common Myeloid Progenitors (CMP) which could further diverge into Megakaryocyte/Erythrocyte Progenitors (MEPs), Monocyte (Mo)/Dendritic cell (DC) Progenitors (MDPs) and Granulocyte/Mo Progenitors (GMPs). However, this model has been the subject of ongoing revision in the scRNA-seq era. On the one hand, a Lymphoid-primed MultiPotent Progenitor (LMPP) with combined lymphoid and myeloid potential has been shown to gradually lose myeloid potential by upregulating the interleukin-7 receptor alpha-chain (IL7Ralpha) and differentiate into Dach1- Lymphoid-Primed Progenitors (LPPs) prior to CLPs. On the other hand, erythroid-versus-myeloid fate decisions seem to be made prior to CMP commitment, calling for in-depth revision of all CMP progeny (MEPs, MDPs and GMPs) as well. While the Flt3L+CD115lo CMPs give rise to oligopotent MDPs, the Flt3-CD115- CMPs give rise to GMPs. The former are defined by TF co-expression of CEBPA, IRF8 and RUNX1. MDPs can give rise to IRF8/SATB1 plasmacytoid DC (pDC) Progenitors (pDCPs) and HLA-DR/IRF8/CEBPA Mo/conventional DC (cDC) Progenitors (McDPs). The latter bifurcate in ##CD11c/CD172ab/CD14 (human) or Ly6C+ Mo (mouse) or IRF8/HLA-DR/CD84/CD172ab Common DC Progenitors## (CDPs). In contrast, GMPs (Kit, CD34, Sox4) are very heterogeneous at the transcriptomic and proteomic level and can adjust their functional output towards common Mo Progenitors (cMoP) and Granulocyte Progenitors (GPs).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11324509</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:39148724</oboInOwl:hasDbXref>
        <rdfs:label>CD11c/CD172ab/CD14 (human) or Ly6C+ Mo (mouse) or IRF8/HLA-DR/CD84/CD172ab Common DC Progenitors</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0001029"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/c8b74f02-b02a-45cc-a1ca-740cde344581"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0001029"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/c8ba6236-1c75-4fa5-bace-595feb0f0724 -->

    <Class rdf:about="http://example.org/c8ba6236-1c75-4fa5-bace-595feb0f0724">
        <obo:IAO_0000115>Identification of cell types from whole-brain cells. a UMAP plot shows the unsupervised clustering of 16,028 cells derived from mouse brain (for details, see &quot;Methods&quot;). The 15 cell types were classified by their transcriptional profiles. b Dot plot shows the expression levels of a representative cell-specific marker gene for each cell type. c UMAP plot shows the distribution of Olig2 expression. d Violin plot shows Olig2 expression across all clusters. e UMAP plot shows the distribution of GFAP expression. f Violin plot shows GFAP expression across all clusters. g A total of 3522 cells of the astrocyte subset were derived from cells in mouse brain. They were classified into Olig2(+)/GFAP(-) astrocytes (347 cells), Olig2(+)/GFAP(+) astrocytes (104 cells), Olig2(-)/GFAP(+) astrocytes (848 cells) and Olig2(-)/GFAP(-) astrocytes (2,223 cells). immNEU immature neuron, mNEU mature neuron, OPC oligodendrocyte precursor cell, immOLG immature oligodendrocyte, OLG oligodendrocyte, ASC astrocyte, OEG olfactory ensheathing glia, MG microglia; MAC macrophage, EC endothelial cell, PC pericyte, EPC ependymal cell, VLMC vascular and leptomeningeal cell, ABC arachnoid barrier cell, CP ##cycling progenitor##</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8573876</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34749773</oboInOwl:hasDbXref>
        <rdfs:label>cycling progenitor</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0011026"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/c8ba6236-1c75-4fa5-bace-595feb0f0724"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0011026"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/c8e6257f-2631-4e14-8bb4-b106cc251b81 -->

    <Class rdf:about="http://example.org/c8e6257f-2631-4e14-8bb4-b106cc251b81">
        <obo:IAO_0000115>To test the pathological relevance of HPVCs and derived ##valvular cells##, we used a patient-specific iPS cell model. iPS cells were derived from valvular interstitial cells (VICs) isolated from the explanted mitral valve of a patient harboring a mutation in Dachsous gene (DCHS1) a likely cause for mitral valve prolapse. In contrast to primary VIC culture, which is limited by the number of passages, iPS cells provide a means to recapitulate the stepwise determination of distinct endocardial, valve endothelial, and valve interstitial cell phenotypes. HiPS cells allow replication of separate differentiation experiments both with HPVCs/VECs and VICs. Patient-derived hiPs cells expressed OCT4, SOX2 and NANOG (Fig. 5a). DNA sequencing confirmed that the patient-specific DCHS1 mutation c-6988C&gt;T was conserved (Fig. 5b) and digital PCR of copy number variants of main recurrent abnormalities loci found in pluripotent stem cells (http://www.stemgenomics.com/) revealed that genomic integrity was conserved. Using directed differentiation protocols, cells were capable of differentiation into the three germ layers following treatment with specific morphogens as shown by expression of SOX17, and FOXA2 (endoderm), BRACHYURY (T) and MIXL1, (mesoderm), and NESTIN and PAX6 (ectoderm) (Fig. 5c).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6486645</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31028265</oboInOwl:hasDbXref>
        <rdfs:label>valvular cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:1000147"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/c8e6257f-2631-4e14-8bb4-b106cc251b81"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:1000147"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/c8fbebac-3ffa-4135-8308-4327a9b2096e -->

    <Class rdf:about="http://example.org/c8fbebac-3ffa-4135-8308-4327a9b2096e">
        <obo:IAO_0000115>High levels of Oct4 mRNA were found in the 2-cell blastomere population in all conditions, followed by a decrease at the 4-cell stage and a strong increase in 8-cell blastomeres (Fig. 5E), an expression pattern reflecting the transition of maternal-to-zygotic Oct4 transcripts at the 4-cell stage (Wu and Scholer). There was a decrease of Oct4 expression in the bulk of both Ahr-/- and Ahr+/+-TCDD groups relative to Ahr+/+ at the 8-cell stage and in Ahr-/- than in Ahr+/+ 2-cell blastomeres. Similarly, we found a significant decrease of Oct4 expression in both Ahr-/- and Ahr+/+-TCDD, notably in both embryonic and differentiating blastomeres relative to the corresponding Ahr+/+ 8-cell subpopulations; in all conditions, differentiating blastomeres at 8-cell stage had higher expression levels than their embryonic counterparts (Fig. 5F). Furthermore, the levels of Oct4 transcription in Ahr-/- and Ahr+/+-TCDD 4-cell embryonic blastomeres decreased or had a trend to decrease, respectively, relative to the corresponding Ahr+/+ blastomeres. The levels of Cdx2 mRNA were high in all 8-cell blastomeres analyzed and were significantly decreased or trended to decrease in the bulk of Ahr-/- and Ahr+/+-TCDD relative to the Ahr+/+ 8-cell population (Fig. 5G). The Cdx2 mRNA levels were higher in ##Ahr+/+ and Ahr-/- 8-cell differentiating blastomeres## than in their embryonic counterparts, with the Ahr-/- 8-cell differentiating blastomeres showing lower expression than the corresponding Ahr+/+ subpopulation (Fig. 5H). Additionally, some Ahr+/+-TCDD 8-cell embryonic blastomeres showed unusually high levels of Cdx2 mRNA causing the indistinguishable difference between embryonic and differentiating subpopulations.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10425484</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36029422</oboInOwl:hasDbXref>
        <rdfs:label>Ahr+/+ and Ahr-/- 8-cell differentiating blastomeres</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000353"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/c8fbebac-3ffa-4135-8308-4327a9b2096e"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000353"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/c90d6421-c927-4044-9be1-2a5584f0eb34 -->

    <Class rdf:about="http://example.org/c90d6421-c927-4044-9be1-2a5584f0eb34">
        <obo:IAO_0000115>As macrophages exhibit variable outcomes in response to pathogenic microbes:no infection, infection with pathogen destruction, infection with pathogen persistence:one study performed scRNA-seq on Salmonella-exposed mouse ##bone marrow-derived macrophages## (BMMs) to distinguish transcriptional changes alongside immunological response outcomes (Avraham et al.,). Principle component analysis revealed gene clusters that stratified macrophages by exposure and non-exposure to pathogen as well as by infected and uninfected macrophages. One gene cluster enriched for type I interferon (IFN) response, however, was induced in a subset of macrophages and found to distinguish infected from uninfected, yet pathogen exposed, macrophages. Among the sub-population of infected macrophages, genes primarily responsive to intracellular signals of infection were more variable than those responsive to extracellular cues of bacterial expression. This difference suggests the inherent heterogeneity even among phenotypically homogenous populations of infected cells. Upon further investigation of infected macrophages, the expression level of Salmonella virulence factor PhoPQ, known to upregulate genes important for intramacrophage survival, was found to determine the level of type I IFN induction in infected macrophages. In this study, single-cell analysis was critical in the identification of such a population as the type I IFN gene cluster was not highly induced when averaging over all cells. This work highlights the importance of pathogenic variability and host response heterogeneity of infected and bystander cells, suggesting that the state of immune activation does not operate in a silo of the host, but also mirrors the intrinsic variation found in pathogens that subsequently mold the host response.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7591464</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33163417</oboInOwl:hasDbXref>
        <rdfs:label>bone marrow-derived macrophages</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
        <skos:relatedMatch rdf:resource="CL:0000559"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/c90d6421-c927-4044-9be1-2a5584f0eb34"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/c90d6421-c927-4044-9be1-2a5584f0eb34"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000559"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/c92beaa3-0987-40a8-b309-b6552c4e62d4 -->

    <Class rdf:about="http://example.org/c92beaa3-0987-40a8-b309-b6552c4e62d4">
        <obo:IAO_0000115>Fifteen types of major cells were annotated by expressions of canonical gene markers, which included monocytes (LYZ+ and S100A9+), natural killer (NK) cells (GNLY+ and NKG7+), neutrophils (FCGR3B+ and IFITM2+), macrophages (IL7R+ and TCF7+), memory CD8+ t-cells (CD8A+, CD8B+ and GNLY+), B cells (MS4A1+ and CD79A), naive CD4+ t-cells (CD3+, CD4+ and TCF7+), plasmablasts (PPBP+ and TUBB1+), myeloid dendritic cells (STMN1+ and H4C3+), regulatory t-cells (IL7R+ and IL32+), naive CD8+ t-cells (CD8B+ and CRR7+), natural killer T (NKT) cells (IL32+, NKG7+ and CD3+), erythroid cells (HBB+ and HBA2+), plasmacytoid dendritic cells (LILRA+), and ##progenitor cells## (SPINK2+ and SOX4+) ( Figures 3A-C ). Fifteen clusters of PBMCs were identified using unsupervised hierarchical clustering and visualized with uniform manifold approximation and projection (UMAP); the cells of each group were then visualized with UMAP plots, individually ( Figures 3D, E ). We further explored the effect of major trauma on the composition of immune cells in PBMCs according to the scRNA-seq data analysis. Only cell types with a number of cells that met the statistical requirement were included in the analysis. As is shown in  Figures 3F, G , the proportion of NK cells, CD8+ memory t-cells, CD4+ naive t-cells, CD8+ naive t-cells, B cells, Tregs and NKT cells decreased during the early stages of major trauma. The proportion of DCs did not significantly change. Compared with control participants, major trauma patients had significantly increased proportions of monocytes/macrophages and neutrophils ( Figure 3G ).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9879135</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36713435</oboInOwl:hasDbXref>
        <rdfs:label>progenitor cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002032"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/c92beaa3-0987-40a8-b309-b6552c4e62d4"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002032"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/c9319306-e19c-4869-9d8a-0a5a3e7c19a2 -->

    <Class rdf:about="http://example.org/c9319306-e19c-4869-9d8a-0a5a3e7c19a2">
        <obo:IAO_0000115>Recently, evidence suggested that SERPINE1 was associated with immune infiltrates in gastric cancer. SERPINE1 enhanced the inhibitory TIME, which was positively associated with the infiltration level of neutrophils, macrophage M2, resting NK cells, and ##activated mast cells##. SERPINE1 was negatively associated with plasma cells and B cell memory in gastric cancer. Consistently, in our study, we identified that SERPINE1 expression was positively correlated with neutrophils in gastric cancer.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10495442</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37696973</oboInOwl:hasDbXref>
        <rdfs:label>activated mast cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000097"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/c9319306-e19c-4869-9d8a-0a5a3e7c19a2"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000097"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/c9397483-7e8b-49cf-a259-947b112ec758 -->

    <Class rdf:about="http://example.org/c9397483-7e8b-49cf-a259-947b112ec758">
        <obo:IAO_0000115>As shown in Fig. 4B-F, we further assessed post-sorting viability and functionality by comparing (i) undifferentiated OP9 cells that were subject to neither sample preparation nor sorting (Control), (ii) undifferentiated-OP9 cells remaining unsorted at the input vial (Unsorted leftover), and (iii) sorted undifferentiated OP9 progenitor cells (Sorted). Undifferentiated cultures were chosen for these experiments to ensure adherence for downstream differentiation assays, as otherwise, the low adherence displayed by mature adipocytes from induced-OP9 cultures would have made the sorted cell fractions very difficult to compare. Time-lapse phase contrast microscopy and fluorescence (LipidTOX) images were captured on days 1, 3, 5, and 7. Notably, the sorted OP9 cells, unsorted leftover cells, and control cell fractions all adhered and proliferated at days 1 and 3, which further confirms post-sorting viability. To determine functionality, we induced differentiation of the three samples. Subsequent imaging on days 5 and 7 revealed clear evidence of adipocytic differentiation, confirmed by LipidTOX staining, which reflected lipid droplet accumulation. Therefore, neither the sorting nor the sample preparation and stirring affected the ability of OP9 progenitors to differentiate in BMAds. Overall, we could thus validate the reliable performance of MarrowCellDLD in isolating different phenotypes of induced-OP9 ##adipocytic cells## with preserved viability and functionality post-sorting.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10725893</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38105340</oboInOwl:hasDbXref>
        <rdfs:label>adipocytic cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000136"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/c9397483-7e8b-49cf-a259-947b112ec758"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000136"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/c94f96cd-b5ed-447c-ab2c-1a01a3baa16c -->

    <Class rdf:about="http://example.org/c94f96cd-b5ed-447c-ab2c-1a01a3baa16c">
        <obo:IAO_0000115>We next employed SAPAS to study the genome-wide landscape of APA in phenotype-characterized GABAergic interneurons, using recently published 3&apos;-tag-based scRNA-seq data generated from six non-overlapping GABAergic subpopulations with anatomical, physiological, and molecular evidence. These GABAergic neurons include 64 CCK-positive basket cells (CCKC), 132 chandelier cells (CHC) that innervate the axon initial segment of pyramidal neurons, 63 ##interneuron-selective cells## (ISC), 136 long-range-projecting GABAergic neurons (LPC), 62 Martinotti cells (MNC), and 127 fast-spiking parvalbumin-positive interneurons (PVBC). These individual neurons were manually sorted from micro-dissected motor and somatosensory cortexes of 6-week-old mice.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8299648</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34301239</oboInOwl:hasDbXref>
        <rdfs:label>interneuron-selective cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000099"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/c94f96cd-b5ed-447c-ab2c-1a01a3baa16c"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000099"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/c99ad21e-c7c6-4215-b19f-ce46dae48124 -->

    <Class rdf:about="http://example.org/c99ad21e-c7c6-4215-b19f-ce46dae48124">
        <obo:IAO_0000115>Overexpression of ICOS rescues iNKT2 and iNKT17 cells of GATA-3-deficient mice. (A) The thymocytes and splenocytes from GATA-3 FF and FFcre mice were stained with TCRbeta, CD4, CD8, CD44, CD62L, NK1.1, loaded CD1d tetramer, CD127, and ICOS. The histogram plots show the surface expression levels of CD127 and ICOS on ##thymic iNKT cells## (TCRbeta+ tetramer+), CD8 single-positive thymocyte (TCRbetahiCD4-CD8+), splenic naive (TCRbeta+CD4-CD8+CD44-CD62L+), and activated/memory (TCRbeta+CD4-CD8+CD44hiCD62L-) CD8 T cells. (B) The gating strategy for identifying iNKT17 and iNKT2 cells from FFcre thymocytes overexpressing ICOS and CD127 via retroviral transduction is illustrated. Cumulative results are presented in the (lower panel). (two-sided unpaired t-test, ns, * p &lt; 0.05, ** p &lt; 0.01).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11201670</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38920701</oboInOwl:hasDbXref>
        <rdfs:label>thymic iNKT cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000921"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/c99ad21e-c7c6-4215-b19f-ce46dae48124"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000921"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/c9ae60b0-c4c3-4ee0-b003-db78e91da2c9 -->

    <Class rdf:about="http://example.org/c9ae60b0-c4c3-4ee0-b003-db78e91da2c9">
        <obo:IAO_0000115>The GEO database (GSE138709) was employed to examine the fluctuation of MAL2 mRNA expression in ICC. From the UMAP plot and heatmap, distinct gene markers helped classify GSE138709 findings into eight cell clusters, namely, cholangiocytes, fibroblast, hepatocyte, TNK, endothelial, MonoMac, B lymphocytes, and dendritic cells (DC), as showcased in Fig. 1A-C and Fig. S1A. A specific expression of CD79A was found in the B cluster, as depicted in Fig. 1B, C and Fig. S1A. Interestingly, cholangiocytes and fibroblasts exhibited more robust expression in tumor tissues than in regular tissues. Conversely, tumor tissues displayed a decrease in the abundance of hepatocytes, TNK, B cells, and DCs when compared to normal tissue samples, as seen in Fig. 1E and Fig. S1B. To our surprise, MAL2 was found to be significantly abundant in cholangiocytes (Fig. 1D and Fig. S1C). The expression levels of MAL2 were more prevalent in tumor tissues than in normal ones (Fig. 1F). Chromosome copy number variation (CNV) of different cells in ICC tissue was analyzed based on CopyKAT, a computational tool. We found that non-immune cells such as endothelial cells were normal diploid, and classified cholangiocytes in ICC into normal cholangiocytes and ##malignant cholangiocytes## based on whether or not there was a change in CNV (Fig. 1G, H). Malignant cholangiocytes were almost distributed in ICC, and MAL2 was expressed mainly in malignant cholangiocytes in ICC (Fig. 1I-K). These revelations point toward the crucial role MAL2 might play in ICC cancer cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11169275</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38866777</oboInOwl:hasDbXref>
        <rdfs:label>malignant cholangiocytes</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:1000488"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/c9ae60b0-c4c3-4ee0-b003-db78e91da2c9"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:1000488"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/c9df9fe0-50a7-49c9-b9c8-091eb02cb48e -->

    <Class rdf:about="http://example.org/c9df9fe0-50a7-49c9-b9c8-091eb02cb48e">
        <obo:IAO_0000115>BACKGROUND: A major current challenge is to exploit tertiary lymphoid structures (TLSs) to promote the lymphocyte infiltration, activation and differentiation by tumor antigens to increase antitumor immune responses. The mechanisms that underlie the role of TLS formation in the adaptive immune responses against nasopharyngeal carcinoma (NPC) remain largely unknown. METHODS: Cell populations and the corresponding markers were identified by single-cell RNA sequencing and fluorescence-activated cell sorting analysis. In vitro differentiation experiments were used to simulate the generation, regulation and function of the Th-CXCL13 cell subset in the tumor microenvironment of NPC. These were followed by histological evaluation of the colocalization of tumor-associated B cells (TABs) and ##Th-CXCL13 cells## within TLSs, and statistical analysis of the relationship between the cells in TLSs and overall survival. RESULTS: A PD-1+CXCR5-CD4+ Th-CXCL13 cell subset was identified in NPC. This subset was a major source of CXCL13, representing the majority of the CD4+ T cells at levels comparable with Th1 and Tfh cells present in the TLSs. Monocytes activated by toll-like receptor 4 agonists served as the antigen-presenting cells that most efficiently triggered the expansion of Th-CXCL13 cells. Transforming growth factor beta 1 (TGF-beta1) stimulation and activation of Sox4 were critical for the induction and polarization of Th-CXCL13 cells in this process. The potential functional contributions of TABs recruited by Th-CXCL13 cells which induced plasma cell differentiation and immunoglobulin production via interleukin-21 and CD84 interactions in the TLSs demonstrated improved survival. CONCLUSIONS: Induction of Th-CXCL13 cells links innate inflammation to immune privilege in tumor-associated TLSs and might predict better survival.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8276302</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34253636</oboInOwl:hasDbXref>
        <rdfs:label>Th-CXCL13 cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000492"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/c9df9fe0-50a7-49c9-b9c8-091eb02cb48e"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000492"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/c9e4d3b7-2b0c-41bf-b855-7925860336af -->

    <Class rdf:about="http://example.org/c9e4d3b7-2b0c-41bf-b855-7925860336af">
        <obo:IAO_0000115>Innate Immune Cells	 	Primary Cell Type	Cell subsets	Metabolic Processes	References	 	   Innate Lymphoid Cells	Non-cytolytic:Innate lymphoid cell 1 (ILC1) Innate lymphoid cell 2 (ILC2) Innate lymphoid cell 3 (ILC3)/Lymphoid Tissue Inducers (LTi)Cytolytic:Natural Killer cells (NK)	 Gly FAO/OXPHOS, LM/LDF, Arginine catabolism, Gly Gly/OXPHOS, Vitamin A metabolismGly, AAM, FAO	     	 	  Dendritic Cells	Conventional:Conventional dendritic cell 1 (cDC1) Conventional dendritic cell 2 (cDC2) Conventional dendritic cell 3 (##cDC3##) Tolerogenic DCs Plasmacytoid DCs (pDCs) Inflammatory DCs Langerhans cells Mononuclear Phagocytes (tumor)	 Na: OXPHOS, Ac: GU, Gly, PPP, Dys: LDFNa: OXPHOS, Ac: GU, Gly, PPP, Dys: LDF Not reported FAO/OXPHOS Gly/OXPHOS/FAO Gly Na/Ac/Ma: Not reported Dys: LDFNa: OXPHOS, Ac: Gly, PPP In tumors/Dys: LM/LDF	         	 	 Macrophages	Inflammatory &quot;M1&quot; macrophage Reparative &quot;M2&quot; macrophage  Tumor Associated macrophage (TAM)	Na: OXPHOS, Ac: GU, Gly, PPP. Arg catabolismNa: FAO/OXPHOS, Ac: FAO/OXPHOS, Gly, PPP.  Upregulates Arg1 Na: OXPHOS, Ac: GU, Gly, Tumor/Dys: FAO, LM/LDF	   	 	</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11240245</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:39007133</oboInOwl:hasDbXref>
        <rdfs:label>Conventional dendritic cell 3</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000990"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/c9e4d3b7-2b0c-41bf-b855-7925860336af"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000990"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/ca174349-21bb-4ba2-88a6-49439e939546 -->

    <Class rdf:about="http://example.org/ca174349-21bb-4ba2-88a6-49439e939546">
        <obo:IAO_0000115>The CB parenchyma is organized into clusters of cells called glomeruli. Each glomerulus is considered an independent chemo-sensitive unit composed by four to eight neuron-like glomus cells, also called type I cells, which are richly innervated by sensory fibers of the petrosal ganglion and in close contact with a profuse network of fenestrated capillaries. Glomus cells are the O2-sensing elements in the CB; they contain abundant synaptic vesicles with several neurotransmitters and neuropeptides (see below), which are rapidly released in response to hypoxia to activate the afferent sensory fibers. Glomus cells contain a broad variety of voltage- and ligand-gated ion channels, are electrically excitable, and can generate action potentials repetitively. Hypoxia leads to glomus cell depolarization, extracellular Ca2+ influx and transmitter release due to modulation of O2-sensitive membrane ion channels. Responsiveness to hypoxia is an intrinsic property of glomus cells, although it can be modulated by auto- and paracrine interactions within the glomerulus and by circulating agents such as cytokines or hormones (see). The mechanisms underlying O2 sensing have remained elusive, although recent data strongly suggest that molecular specializations in glomus cell mitochondria confer upon them special sensitivity to hypoxia, with the generation of mitochondrial signals (NADH and reactive oxygen species) that modulate membrane ion channels. In addition to the chemo-sensitive glomus cells, which are highly dopaminergic and can be easily identified using antibodies against tyrosine hydroxylase (TH), the CB glomeruli also contain a smaller number of type II, or sustentacular, cells with interdigitating processes that envelop glomus cells. Type II cells can be stained with antibodies against glial fibrillary acidic protein (GFAP), an intermediate filament commonly expressed in glial cells. Although type II cells were originally described as supportive cells, with little functional relevance, this view has completely changed in recent years (see below). Type II cells contribute to potentiation of the glomus cell-afferent sensory fiber synapse. Moreover, type II cells, or a subpopulation of them, are tissue-specific adult multipotent stem cells that support CB structural plasticity. In addition to the two main cell types, the CB contains ##intermediate progenitors##, abundant macrophages, and fat cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7662800</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33153142</oboInOwl:hasDbXref>
        <rdfs:label>intermediate progenitors</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000125"/>
        <skos:relatedMatch rdf:resource="CL:0002292"/>
        <skos:relatedMatch rdf:resource="CL:0011026"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/ca174349-21bb-4ba2-88a6-49439e939546"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000125"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/ca174349-21bb-4ba2-88a6-49439e939546"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002292"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/ca174349-21bb-4ba2-88a6-49439e939546"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0011026"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/ca2cfabe-a200-4a58-a1f3-884a5426dc8e -->

    <Class rdf:about="http://example.org/ca2cfabe-a200-4a58-a1f3-884a5426dc8e">
        <obo:IAO_0000115>a Due to single-cell annotation and in situ validation (Fig. 2; Supplementary Fig. 3), a draft model of the oral-to-tooth transition zone in humans is presented, with basal and suprabasal keratinocyte markers uniquely identifying the alveolar mucosa (AM), attached gingiva (AG), gingival margin (GM), sulcular epithelium (SK) and junctional epithelium (JK). b These markers allowed for KRT19-high keratinocyte (KC) cell subclustering for the first time (2504 cells in total), including gingival margin keratinocytes (GM), sulcular keratinocytes (SK), and junctional keratinocytes (JK). c A more granular draft (Tier 4) annotation of epithelial cells of the gingival attachment. d Assaying differentially expressed genes in periodontitis, SKs and JKs only share about a quarter of upregulated genes. JKs displayed nearly 125 unique upregulated genes in diseased cells. e Further analysis of basal and suprabasal (differentiating) SK and JK keratinocytes revealed unique cell signatures between basal and suprabasal cell types. This full list is included in Supplementary Data 1. f-i To understand SK and JK developmental progression and cell state alterations, we used partitioned-based graph abstraction (PAGA). f Examining the ##basal to suprabasal## transition, JKs display altered gene expressed comparing health to disease cell types, including broader expression of KRT17 and more expression of JUND, COL17A1, and CDH3. Key differentiation genes such as SPRR family members were also downregulated. g JKs displayed robust cell signaling and inflammatory phenotypes, which appear exacerbated in disease states. h In SKs, differentiation-related genes were uniquely expressed compared to JKs in health but also appeared altered in disease along the basal to suprabasal trajectory. i SKs appeared generally less reactive compared to JKs in disease, with lower overall expression of effector molecules such as CXCL1, CXCL8, IL1A, IL1B, and IL1RN. Abbreviations: Merk Merkel Cells, LC langerhans cells, Mela melanocytes, Muc mucosa, SB suprabasal Keratinocytes; for others, see Fig. 1 legend. For this figure, n = 30-sample, 2504-cell for scRNAseq.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11178863</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38876998</oboInOwl:hasDbXref>
        <rdfs:label>basal to suprabasal</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002170"/>
        <skos:relatedMatch rdf:resource="CL:0002187"/>
        <skos:relatedMatch rdf:resource="CL:4033013"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/ca2cfabe-a200-4a58-a1f3-884a5426dc8e"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002170"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/ca2cfabe-a200-4a58-a1f3-884a5426dc8e"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002187"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/ca2cfabe-a200-4a58-a1f3-884a5426dc8e"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4033013"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/ca5681ff-75ce-4258-8cb7-08feefd2ed02 -->

    <Class rdf:about="http://example.org/ca5681ff-75ce-4258-8cb7-08feefd2ed02">
        <obo:IAO_0000115>BACKGROUND: Hundreds of ongoing clinical trials combine radiation therapy, mostly delivered as stereotactic body radiotherapy (SBRT), with immune checkpoint blockade. However, our understanding of the effect of radiotherapy on the intratumoral immune balance is inadequate, hindering the optimal design of trials that combine radiation therapy with immunotherapy. Our objective was to characterize the intratumoral immune balance of the malignant prostate after SBRT in patients. METHODS: Sixteen patients with high-risk, non-metastatic prostate cancer at comparable Gleason Grade disease underwent radical prostatectomy with (n = 9) or without (n = 7) neoadjuvant SBRT delivered in three fractions of 8 Gy over 5 days completed 2 weeks before surgery. Freshly resected prostate specimens were processed to obtain single-cell suspensions, and immune-phenotyped for major lymphoid and myeloid cell subsets by staining with two separate 14-antibody panels and multicolor flow cytometry analysis. RESULTS: Malignant prostates 2 weeks after SBRT had an immune infiltrate dominated by myeloid cells, whereas malignant prostates without preoperative treatment were more lymphoid-biased (myeloid CD45+ cells 48.4 +- 19.7% vs. 25.4 +- 7.0%; adjusted p-value = 0.11; and CD45+ lymphocytes 51.6 +- 19.7% vs. 74.5 +- 7.0%; p = 0.11; ##CD3+ T cells## 35.2 +- 23.8% vs. 60.9 +- 9.7%; p = 0.12; mean +- SD). CONCLUSION: SBRT drives a significant lymphoid to myeloid shift in the prostate-tumor immune infiltrate. This may be of interest when combining SBRT with immunotherapies, particularly in prostate cancer.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7794088</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32647353</oboInOwl:hasDbXref>
        <rdfs:label>CD3+ T cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000084"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/ca5681ff-75ce-4258-8cb7-08feefd2ed02"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000084"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/ca57ed74-ddc9-4b31-8ce8-bdbc81f2d87c -->

    <Class rdf:about="http://example.org/ca57ed74-ddc9-4b31-8ce8-bdbc81f2d87c">
        <obo:IAO_0000115>GDF11 correlated positively with ##resting memory CD4 T cells##, memory B cells, naive CD4 T cells, and M2 macrophages and negatively with naive B cells, neutrophils, and plasma cells. HSPA1L correlated positively with gamma delta T cells, neutrophils, and plasma cells and negatively with resting NK cells, CD8 T cells, resting memory CD4 T cells, and naive CD4 T cells. TNFRSF25 correlated positively with CD4 naive T cells and resting NK cells and negatively with CD4 memory activated T cells, neutrophils, plasma cells, and gamma delta T cells. CMTM2 correlated positively with neutrophils, M0 macrophages, and monocytes and negatively with memory B cells, resting memory CD4 T cells, M2 macrophages, and naive CD4 T cells. PRKCA correlated positively with memory B cells, resting memory CD4 T cells, M2 macrophages, and naive CD4 T cells and negatively with neutrophils and plasma cells ( Figure 14 ).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10090698</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37063890</oboInOwl:hasDbXref>
        <rdfs:label>resting memory CD4 T cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000897"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/ca57ed74-ddc9-4b31-8ce8-bdbc81f2d87c"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000897"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/ca88db50-75e1-4570-9344-81f6687013b2 -->

    <Class rdf:about="http://example.org/ca88db50-75e1-4570-9344-81f6687013b2">
        <obo:IAO_0000115>Distinct therapy-induced cancer cell transcriptomes were associated with clinical response. Cancer cells from MPR patients exhibited a signature of activated antigen presentation via major histocompatibility complex class II (MHC-II). Further, the transcriptional signatures of FCRL4+FCRL5+ memory B cells and CD16+CX3CR1+ monocytes were enriched in MPR patients and are predictors of immunotherapy response. Cancer cells from NMPR patients exhibited overexpression of estrogen metabolism enzymes and elevated serum estradiol. In all patients, therapy promoted expansion and activation of cytotoxic T cells and ##CD16+ NK cells##, reduction of immunosuppressive Tregs, and activation of memory CD8+T cells into an effector phenotype. Tissue-resident macrophages were expanded after therapy, and tumor-associated macrophages (TAMs) were remodeled into a neutral instead of an anti-tumor phenotype. We revealed the heterogeneity of neutrophils during immunotherapy and identified an aged CCL3+ neutrophil subset was decreased in MPR patients. The aged CCL3+ neutrophils were predicted to interact with SPP1+ TAMs through a positive feedback loop to contribute to a poor therapy response.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9985263</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36869384</oboInOwl:hasDbXref>
        <rdfs:label>CD16+ NK cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000824"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/ca88db50-75e1-4570-9344-81f6687013b2"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000824"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/ca8ba7e0-a7e1-4a8d-8fce-6f210d43b0ee -->

    <Class rdf:about="http://example.org/ca8ba7e0-a7e1-4a8d-8fce-6f210d43b0ee">
        <obo:IAO_0000115>Based on improved knowledge of human B cell populations derived from recent studies, we sought to characterize the B cell precursors of IgE ASC through a combination of phenotypic, BCR repertoire and molecular analyses. Our experimental model was based on the hypothesis that the study of nasal polyps (NP), would provide a rich environment for ongoing IgE ASC differentiation from different cellular precursors in the absence of GC. In keeping with this model, we identified a novel human ##EF mucosal B cell## population (CD19+IgD+CD27-) as the origin of mucosal IgE ASC. This population shared many of the phenotypic and transcriptional features of activated naive B cells recently shown in the EF response of patients with active autoimmune disease and severe SARS-CoV-2 infection. These mucosal IgD+ B cells are characterized by: (1) a high degree of clonal connectivity with IgE ASC, (2) an activated phenotype (CD11c+CD86+CD71+Nur77+CD21-), (3) a progressive transcriptome between resting blood naive B cells and NP ASC, and (4) the highest level of germline epsilon transcripts. Notably, the majority of the IgD+ NP B cells expressed IgM sequences with low mutation rates, a profile consistent with activated naive B cells. However, IgD+ NP B cells also contained a smaller fraction of cells with very high rates of somatic hypermutation previously demonstrated in class-switched IgD-only B cells (IgD+IgM-; Cdelta-CS), reported in the literature within either GC, memory and ASC populations. Interestingly, the analysis of single cell IgE ASC demonstrated lower mutation relative to ASC of other isotypes including IgG, IgA, or the highly mutated IgD ASC. In summary, human mucosal IgE ASC originate from an EF mucosal activated IgD+ B cell subset in patients with atopic and non-atopic airways disease.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8160425</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34050324</oboInOwl:hasDbXref>
        <rdfs:label>EF mucosal B cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000236"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/ca8ba7e0-a7e1-4a8d-8fce-6f210d43b0ee"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000236"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/ca8d425e-02a9-4b51-a164-021b95fc8940 -->

    <Class rdf:about="http://example.org/ca8d425e-02a9-4b51-a164-021b95fc8940">
        <obo:IAO_0000115>To illustrate the application of CSN to developing cells, we feature the developmental trajectory of human excitatory neuron cells in the Developing Cortex Atlas dataset (15), which includes Radial Gila and Progenitors (P), Intermediate Progenitors (IP), Maturing Excitatory (ExN), Migrating Excitatory (ExM), Excitatory Upper-layer enriched (ExM-U), and ##Excitatory Deep layer## (ExDp), with cell type labels determined by the authors (SI Appendix, section 3 and Table S2). Using Slingshot, we estimate the developmental path consists of two trajectories, one ending in upper-layer (U curve) and the other in deep-layer (D curve) excitatory neurons (Fig. 3 A and B).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8713783</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34903665</oboInOwl:hasDbXref>
        <rdfs:label>Excitatory Deep layer</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:4030064"/>
        <skos:relatedMatch rdf:resource="CL:4030065"/>
        <skos:relatedMatch rdf:resource="CL:4030067"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/ca8d425e-02a9-4b51-a164-021b95fc8940"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4030064"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/ca8d425e-02a9-4b51-a164-021b95fc8940"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4030065"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/ca8d425e-02a9-4b51-a164-021b95fc8940"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4030067"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/ca9d01d4-963d-41eb-b196-4e00e1225a50 -->

    <Class rdf:about="http://example.org/ca9d01d4-963d-41eb-b196-4e00e1225a50">
        <obo:IAO_0000115>ChoK-alpha impairment, by simultaneously interfering with multiple mechanisms on which tumor cells rely for proliferation/survival, would reduce the fitness of tumor cells making them more vulnerable to external stress. The consequential weakness is expected to ultimately reduce the ability of ##OC cells## to resist to drug and/or cytokine treatments.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7780408</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33390181</oboInOwl:hasDbXref>
        <rdfs:label>OC cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:2000064"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/ca9d01d4-963d-41eb-b196-4e00e1225a50"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:2000064"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/cb720772-9056-4e3c-9d4d-b0fc47a39be4 -->

    <Class rdf:about="http://example.org/cb720772-9056-4e3c-9d4d-b0fc47a39be4">
        <obo:IAO_0000115>After assessing heterogeneity within PRPCs, heterogeneity within ##NRPCs## was examined. As the transition cell state, NRPCs give rise to all retinal neurons. Interestingly, unlike the continuous distribution observed for PRPCs, distinct clusters are observed for NRPCs, suggesting distinct subgroups might exist.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11310509</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:39117640</oboInOwl:hasDbXref>
        <rdfs:label>NRPCs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000540"/>
        <skos:relatedMatch rdf:resource="CL:0002672"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/cb720772-9056-4e3c-9d4d-b0fc47a39be4"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000540"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/cb720772-9056-4e3c-9d4d-b0fc47a39be4"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002672"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/cba3c059-c88b-457a-87e5-1432a467defe -->

    <Class rdf:about="http://example.org/cba3c059-c88b-457a-87e5-1432a467defe">
        <obo:IAO_0000115>Skeletal stem and progenitor cell populations are crucial for bone physiology. Characterization of these cell types remains restricted to heterogenous bulk populations with limited information on whether they are unique or overlap with previously characterized cell types. Here we show, through comprehensive functional and single-cell transcriptomic analyses, that postnatal long bones of mice contain at least two types of bone progenitors with bona fide ##skeletal stem cell## (SSC) characteristics. An early osteochondral SSC (ocSSC) facilitates long bone growth and repair, while a second type, a perivascular SSC (pvSSC), co-emerges with long bone marrow and contributes to shape the hematopoietic stem cell niche and regenerative demand. We establish that pvSSCs, but not ocSSCs, are the origin of bone marrow adipose tissue. Lastly, we also provide insight into residual SSC heterogeneity as well as potential crosstalk between the two spatially distinct cell populations. These findings comprehensively address previously unappreciated shortcomings of SSC research.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8289409</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34280086</oboInOwl:hasDbXref>
        <rdfs:label>skeletal stem cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000134"/>
        <skos:relatedMatch rdf:resource="CL:0007001"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/cba3c059-c88b-457a-87e5-1432a467defe"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000134"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/cba3c059-c88b-457a-87e5-1432a467defe"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0007001"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/cbb52a9a-ee1a-4ce0-8d18-5af646f1d3bf -->

    <Class rdf:about="http://example.org/cbb52a9a-ee1a-4ce0-8d18-5af646f1d3bf">
        <obo:IAO_0000115>Macrophages have been shown to play a key role in regulating HSC quiescence and retention in the BM. ##DRAC+ macrophages## have been shown to regulate HSC quiescence through the activation of the TGFbeta1-Smad3 pathway downstream of CD82/KAI1. CD82/KAI1 is predominantly expressed in LT-HSCs, and when knocked out, HSC proliferation increases. Depletion of DRAC (CD82/KAI1-binding partner) expressing macrophages leads to a reduction of CD82/KAI1 levels in HSCs, increased proliferation, and differentiation. CD169+ macrophages constitute another example of cells regulating HSC retention in the BM. In CD169-iDTR mice, it has been shown that the depletion of CD169+ macrophages after DTR treatment causes an increase of HSCs and progenitor cells in peripheral blood. Ablation of CD169+ macrophages in CD169-iDTR mice upon DTR administration significantly reduced not only the HSC number in the BM but also the HSC, LSK, and GMP frequencies in the spleen. In line with their function in the BM, macrophages are also responsible for the retention of HSCs into the spleen, selectively through VCAM1-mediated signaling. Knockdown of VCAM1 expression in macrophages, using siRNA targeting VCAM-1 within macrophage-avid lipidic nanoparticles, causes reduced retention of splenic HSCs, LSKs, and GMPs, without affecting HSC retention into the BM.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8631970</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34858399</oboInOwl:hasDbXref>
        <rdfs:label>DRAC+ macrophages</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/cbb52a9a-ee1a-4ce0-8d18-5af646f1d3bf"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/cbfcb36a-13dd-492d-b8bd-9b2d43b3f657 -->

    <Class rdf:about="http://example.org/cbfcb36a-13dd-492d-b8bd-9b2d43b3f657">
        <obo:IAO_0000115>Inflammatory (M1) macrophages regulate colonic epithelial cell differentiation through direct macrophage-crypt contact, not observed with anti-inflammatory (M2) macrophages. ##Crypt cell## growth is induced by both macrophage subsets, but for M1, it occurs via a secreted factor, while M2 requires physical contact with the crypt epithelium.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11219479</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38001043</oboInOwl:hasDbXref>
        <rdfs:label>Crypt cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0009016"/>
        <skos:relatedMatch rdf:resource="CL:0009043"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/cbfcb36a-13dd-492d-b8bd-9b2d43b3f657"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0009016"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/cbfcb36a-13dd-492d-b8bd-9b2d43b3f657"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0009043"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/cc014349-08af-4b3d-9299-521f17900dd4 -->

    <Class rdf:about="http://example.org/cc014349-08af-4b3d-9299-521f17900dd4">
        <obo:IAO_0000115> (A) Clusters 2U and 2Sb represent the abundance of manually gated subsets previously identified by the CyTOF automated clustering pipeline, shown here with median and interquartile range. Parent population is labelled on the y-axis. (B) Clusters 1U and 1S represent the expression of CCR7 on Th1-like IL-17+ cells, with median and interquartile range. Points represent RA and HC samples. Mann Whitney U P values are shown above the pairwise comparisons. TEM, ##T effector memory cell##; TCM, T central memory cell.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10196473</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37215131</oboInOwl:hasDbXref>
        <rdfs:label>T effector memory cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000905"/>
        <skos:relatedMatch rdf:resource="CL:0000913"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/cc014349-08af-4b3d-9299-521f17900dd4"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000905"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/cc014349-08af-4b3d-9299-521f17900dd4"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000913"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/cc43b86e-d763-45b4-9378-707fa69a7bcc -->

    <Class rdf:about="http://example.org/cc43b86e-d763-45b4-9378-707fa69a7bcc">
        <obo:IAO_0000115>In addition, myeloid cells, in particular monocytes and DC subsets, upregulated expression of genes involved in TLR signaling pathway (e.g., MyD88, Cxcl9, and CD40), consistent with the fact that 3M-052 stimulates TLR signaling. Other innate immune processes including complement (e.g., C3, Cfb) and inflammasome (e.g., Casp3, Il18, Il1rn) genes were also found to be significantly upregulated mainly in monocytes and ##tDCs##, and to a lesser extent in XCR1- and XCR1+ DCs (Fig. 2d). In comparison, lymphoid cells such as innate lymphoid cells (ILCs), gammadeltaT cells, and CD8+ lymphocytes, exhibited higher expression of genes that are involved in cytokine responses (e.g., Jak2, Nfkbia) when compared to myeloid cell subsets (Fig. 2d). This may indicate indirect activation through cytokines being produced by monocytes and DCs. Furthermore, we observed a downregulation of antigen processing and presentation gene modules defined by genes such as H2-Eb1, H2-Aa, and Cd74 in monocytes, but an upregulation of these genes in XCR1- DCs, migratory DCs, ILC2, and ILC3 (Fig. 2d). This is consistent with previous reports of MHCII gene expression in ILC2 and ILC3 as well as the involvement of these innate lymphoid subsets in antigen presentation. The decrease in MHCII presentation genes also supports the notion that more inflammatory monocytes, which have a relatively low expression of MHCII genes compared to resting monocytes, were recruited to the lymph nodes on day 1 after stimulation.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8795432</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35087093</oboInOwl:hasDbXref>
        <rdfs:label>tDCs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000451"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/cc43b86e-d763-45b4-9378-707fa69a7bcc"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000451"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/cc5490e5-10a5-43e8-a374-ba4414ecb1af -->

    <Class rdf:about="http://example.org/cc5490e5-10a5-43e8-a374-ba4414ecb1af">
        <obo:IAO_0000115>GSVA between clusters 6 and 10 of ##fibrotic and regenerative myofibroblasts##. (A-D) Heatmaps showing the differences in activation of biological processes, cellular components, molecular functions, and KEGG pathways between clusters 6 and 10 of fibrotic (fib) and regenerative (reg) myofibroblasts.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9156976</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35664010</oboInOwl:hasDbXref>
        <rdfs:label>fibrotic and regenerative myofibroblasts</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000186"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/cc5490e5-10a5-43e8-a374-ba4414ecb1af"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000186"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/cc5eff9a-fe38-4c42-9862-16c894a4c547 -->

    <Class rdf:about="http://example.org/cc5eff9a-fe38-4c42-9862-16c894a4c547">
        <obo:IAO_0000115>Within the 1397 B-cells, we obtained 4 separate clusters (Fig. 6j; Supplementary information, Fig. S6k). Follicular B-cells were composed of &apos;mature-naive&apos; (CD27-) and &apos;memory&apos; (CD27+) B-cells. The former were characterized by a unique CD27-/IGHD+(IgD)/IGHM+(IgM) signature and give rise to the latter by migrating through the germinal center to form CD27+/IGHD-(IgD)/IGHM-(IgM) memory B-cells (Fig. 6k, l). Memory B-cells then further differentiate into antibody-secreting plasma cells (IGHA1, IGHG1, JCHAIN), which themselves can be further classified into short-lived and long-lived plasma cells. We failed to identify long-lived plasma cells (as these are non-proliferating cells residing in bone marrow and spleen, but were able to divide short-lived plasma cells into two subclusters. A first subcluster of ##&apos;active&apos; plasma cells## expressed high levels of PRDM1(Blimp-1) and XBP1, indicating high antibody-secretion capacity, while a second cluster referred to as &apos;terminal&apos; plasma cells was enriched for CCL2 and CCL5, but also characterized by reduced G2M and S cell cycle scores and increased expression of mitochondrial genes, indicating ongoing stress (Fig. 6m). Notably, the latter population was characterized by increased BCR clonality and reduced BCR evenness (Fig. 6n). Compared to non-COVID-19, mature-naive B-cells and active plasma cells were increased in COVID-19, while terminal plasma cells were reduced in COVID-19, albeit non-significantly (Fig. 6o). Although these effects were mainly driven by critical COVID-19 vs non-COVID-19 (Supplementary information, Fig. S6l), there were no significant differences between mild vs critical COVID-19 (Fig. 6p). Overall, this suggests terminal plasma cells in COVID-19 are characterized by sub-optimal differentiation or activation, which may cause defective or counter-productive (possibly low-quality) antibody responses in COVID-19.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8027624</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33473155</oboInOwl:hasDbXref>
        <rdfs:label>&apos;active&apos; plasma cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000975"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/cc5eff9a-fe38-4c42-9862-16c894a4c547"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000975"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/cc7235ef-2b31-4b31-84d2-71861e190355 -->

    <Class rdf:about="http://example.org/cc7235ef-2b31-4b31-84d2-71861e190355">
        <obo:IAO_0000115>##Thymic SCs## give rise to cTECs including a functionally distinct cell cluster (cTEC-IEGs) that constitutively express PD-L1 and may play a role in controlling the activation of immature thymocytes; they also generate specialized medullary cell types, including myoid and neuroendocrine cells that were hitherto not assigned to the epithelial lineage and previously considered of uncertain origin.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10957394</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37652013</oboInOwl:hasDbXref>
        <rdfs:label>Thymic SCs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000048"/>
        <skos:relatedMatch rdf:resource="CL:4030001"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/cc7235ef-2b31-4b31-84d2-71861e190355"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000048"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/cc7235ef-2b31-4b31-84d2-71861e190355"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4030001"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/cc796456-c35e-42f6-89e7-f66d481a5776 -->

    <Class rdf:about="http://example.org/cc796456-c35e-42f6-89e7-f66d481a5776">
        <obo:IAO_0000115>a Line drawing of a cross section of the floor of the cochlear duct at P1. Distinct cell types within the organ of Corti (OC) are color coded. b Heat map for ~14,000 cochlear cells collected from four separate experiments at P1. Top 25 differentially expressed (DE) genes for the 15 identified clusters are shown. Cellular identity for each cluster is indicated by a color bar at the top of the heat map, which corresponds to the legend in a, and by a cell name at the bottom. c tSNE plot for the same cells as in b. Cluster identities are indicated. d Violin plots showing normalized log-transformed expression values for the top five DE genes for each cell type (color coded as in c) by comparison with all other P1 cells (gray on the right in each graph). Bars indicate median expression level. e Upper left panel, tSNE plot of cells determined to be derived from KO (between the OC and medial edge of the cochlear duct). Lower left panel, feature plot for the same cells as in the upper panel indicating high expression of Otoa, Calb1, and Fabp7 (based on color) in different clusters of cells. Lower right panel, cross sections through the cochlear duct at P1, illustrating expression of CALB1 in the medial region of KO and FABP7 directly adjacent to the OC (arrow; scale bars, 20 mum). Lowest panel shows high-magnification view of expression of FABP7 (arrow, gray scale) at the lateral KO border (green line; scale bar, 10 mum). Upper right panel, summary diagram of the spatial distribution of KO cell clusters at P1. HC hair cells, IPhC inner phalangeal cells/border cells, IPC inner pillar cells, OPC outer pillar cells, DC1/2 Deiters&apos; cells rows 1 and 2, DC3, Deiters&apos; cells row 3, HeC Hensen&apos;s cells, CC/OSC Claudius cells/outer sulcus cells, IdC interdental cells, ISC ##inner sulcus cells##, KO Kolliker&apos;s organ cells, L.KO lateral Kolliker&apos;s organ cells, M.KO medial Kolliker&apos;s organ cells, OC90 OC90+ cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7221106</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32404924</oboInOwl:hasDbXref>
        <rdfs:label>inner sulcus cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000589"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/cc796456-c35e-42f6-89e7-f66d481a5776"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000589"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/cc808e28-2eaf-4a51-a23b-9df09cc0ac79 -->

    <Class rdf:about="http://example.org/cc808e28-2eaf-4a51-a23b-9df09cc0ac79">
        <obo:IAO_0000115>In severe (or critical) COVID-19 patients, there is a remarkable expansion of ##TM4SF1+ and KRT5+ lung progenitor cells##. The two distinct populations of progenitor cells could play crucial roles in alveolar cell regeneration and epithelial barrier re-establishment, respectively. The transplanted KRT5+ progenitors could long-term engraft into host lung and differentiate into HOPX+ OCLN+ alveolar barrier cell which restored the epithelial barrier and efficiently prevented inflammatory cell infiltration.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7645905</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33094537</oboInOwl:hasDbXref>
        <rdfs:label>TM4SF1+ and KRT5+ lung progenitor cells</rdfs:label>
    </Class>
    


    <!-- http://example.org/cc83edbe-704a-48fb-ac85-6ef79bae508a -->

    <Class rdf:about="http://example.org/cc83edbe-704a-48fb-ac85-6ef79bae508a">
        <obo:IAO_0000115>Here, we analyzed the capacity of MSCs from the bone marrow (BM) of healthy donors (BM-MSCs) to transfer mitochondria to primary CD4+CCR6+CD45RO+ T helper 17 (Th17) cells by confocal microscopy and fluorescent-activated cell sorting (FACS). We then evaluated the Th17 cell inflammatory phenotype and bioenergetics at 4 h and 24 h of co-culture with BM-MSCs. We found that Th17 cells can take up mitochondria from BM-MSCs already after 4 h of co-culture. Moreover, IL-17 production by Th17 cells co-cultured with BM-MSCs was significantly impaired in a contact-dependent manner. This inhibition was associated with oxygen consumption increase by Th17 cells and interconversion into T regulatory cells. Finally, by co-culturing human synovial MSCs (##sMSCs##) from patients with rheumatoid arthritis (RA) with Th17 cells, we found that compared with healthy BM-MSCs, mitochondrial transfer to Th17 cells was impaired in RA-sMSCs. Moreover, artificial mitochondrial transfer also significantly reduced IL-17 production by Th17 cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6676586</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31370879</oboInOwl:hasDbXref>
        <rdfs:label>sMSCs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000134"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/cc83edbe-704a-48fb-ac85-6ef79bae508a"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000134"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/cc8f5b1e-42aa-4348-a6bf-eddf90b05781 -->

    <Class rdf:about="http://example.org/cc8f5b1e-42aa-4348-a6bf-eddf90b05781">
        <obo:IAO_0000115>In Tek-CreERT2;R26T mice, we also observed Tek+ bone-lining cells at the endosteum (Fig. 5a). The frequency of these cells was approximately 2.8 cells/mm endosteum in longitudinal sections, which was significantly higher than that of Cdh5+ bone-lining cells (Fig. 5f). Tek+ endosteal bone-lining cells often exhibited a thin and elongated morphology and were nearly absent for the osteolineage marker RUNX2 (Fig. 5b, g), suggesting that they might correspond to the endosteal fibroblasts detected in the reanalyzed dataset. However, Tek+ osteocytes were hardly detected in these mice (Fig. 5c, h). In other regions of the bone marrow cavity, a small population of trabecular bone-lining cells (Fig. 5d, i) and ##metaphyseal stromal cells## (Fig. 5e, j) were also Tek+.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10733381</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38123537</oboInOwl:hasDbXref>
        <rdfs:label>metaphyseal stromal cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0010001"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/cc8f5b1e-42aa-4348-a6bf-eddf90b05781"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0010001"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/cc941497-1c4d-4d7f-ae0b-385f87579482 -->

    <Class rdf:about="http://example.org/cc941497-1c4d-4d7f-ae0b-385f87579482">
        <obo:IAO_0000115>Taken together, two types of arterial VECs, namely the ##major artery VECs## (EP3 and EP5) and arterial plexus VECs (EP7) could be readily discriminated, whereas the morphologically well-defined major veins and venous plexus were largely indistinguishable on a molecular basis. The asymmetric arteriovenous characteristics are different to those seen in adults, where VECs display different properties that correspond to distinct vascular beds (Fig. 2f).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8975889</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35079138</oboInOwl:hasDbXref>
        <rdfs:label>major artery VECs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:1000413"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/cc941497-1c4d-4d7f-ae0b-385f87579482"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:1000413"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/cca560f9-fda2-432a-9132-220a19a46a9e -->

    <Class rdf:about="http://example.org/cca560f9-fda2-432a-9132-220a19a46a9e">
        <obo:IAO_0000115>Multipotent adult progenitor cells (MAPC) are not only found in bone marrow but also distributed throughout all organs. These neural stem cells can also differentiate into various hematopoietic cells. It is known that mesodermal-derived cells originate outside of the nervous system, migrate into the hypothalamus where they transdifferentiate into LHRH-producing neurons. Similarly, bone marrow-resident cells can migrate to the brain and differentiate into cells typically found in the CNS. These cells, such as Purkinje cells, demonstrate the capacity of mesodermal-derived cells to adopt neural cell fates. The mechanisms behind this interconversion are still under investigation, but it is known that bone-marrow-derived cells (##BMDCs##) fuse spontaneously with several cell types like Purkinje neurons, cardiomyocytes and hepatocytes, creating heterokaryons.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11599565</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:39592661</oboInOwl:hasDbXref>
        <rdfs:label>BMDCs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002540"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/cca560f9-fda2-432a-9132-220a19a46a9e"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002540"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/ccc4a59f-6bda-4bc8-b941-3bc27d22a87a -->

    <Class rdf:about="http://example.org/ccc4a59f-6bda-4bc8-b941-3bc27d22a87a">
        <obo:IAO_0000115>T cell development stages and transcription factor expression kinetics. (A) Diagram depicts different stages of early thymic T cell development that T-progenitor cells sequentially go through. Informative surface proteins that are utilized to define each stage are indicated (cKit, CD44, CD25 for ETP to DN3; CD4 and CD8 for DP). Developmental plasticity to generate alternative, non-T-lineage cells is shown with dotted arrows. Note that these alternative lineage potentials are silenced after T-lineage commitment. Lineage commitment to a T cell fate distinguishes Phase 1 (before T-lineage commitment) and Phase 2 (after T-lineage commitment). CLP, Common lymphoid progenitor, LMPP, lympho-myeloid primed progenitor. (B) Graphs show mRNA expression kinetics of important transcription factors involved in early T cell gene regulation programs. Left: Transcription factors inherited from the ##bone-marrow progenitor cells## whose expressions gradually decline during T-development (Spi1, Bcl11a, Erg, Lyl1, and Lmo2). Middle: transcription factors upregulated in pro-T cells by thymic microenvironment (Tcf7, Gata3, and Bcl11b). Right: transcription factors expressed from the bone-marrow progenitor cells and stably and maintained during T cell development (Ikzf1, Tcf3, Tcf12, Runx1, and Runx3). Gene expression data was plotted by utilizing publicly available mRNA expression datasets for immune cells with curve smoothing . (C) Diagram illustrates transcription factors (arrows) providing distinct forces to different gene expression program modules in individual cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9928580</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36817475</oboInOwl:hasDbXref>
        <rdfs:label>bone-marrow progenitor cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002540"/>
        <skos:relatedMatch rdf:resource="CL:1001610"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/ccc4a59f-6bda-4bc8-b941-3bc27d22a87a"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002540"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/ccc4a59f-6bda-4bc8-b941-3bc27d22a87a"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:1001610"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/cce5023e-d227-43f4-bb2f-d43dcf4535ef -->

    <Class rdf:about="http://example.org/cce5023e-d227-43f4-bb2f-d43dcf4535ef">
        <obo:IAO_0000115>a Line drawing of a cross section of the floor of the cochlear duct at P1. Distinct cell types within the organ of Corti (OC) are color coded. b Heat map for ~14,000 cochlear cells collected from four separate experiments at P1. Top 25 differentially expressed (DE) genes for the 15 identified clusters are shown. Cellular identity for each cluster is indicated by a color bar at the top of the heat map, which corresponds to the legend in a, and by a cell name at the bottom. c tSNE plot for the same cells as in b. Cluster identities are indicated. d Violin plots showing normalized log-transformed expression values for the top five DE genes for each cell type (color coded as in c) by comparison with all other P1 cells (gray on the right in each graph). Bars indicate median expression level. e Upper left panel, tSNE plot of cells determined to be derived from KO (between the OC and medial edge of the cochlear duct). Lower left panel, feature plot for the same cells as in the upper panel indicating high expression of Otoa, Calb1, and Fabp7 (based on color) in different clusters of cells. Lower right panel, cross sections through the cochlear duct at P1, illustrating expression of CALB1 in the medial region of KO and FABP7 directly adjacent to the OC (arrow; scale bars, 20 mum). Lowest panel shows high-magnification view of expression of FABP7 (arrow, gray scale) at the lateral KO border (green line; scale bar, 10 mum). Upper right panel, summary diagram of the spatial distribution of KO cell clusters at P1. HC hair cells, IPhC inner phalangeal cells/border cells, IPC inner pillar cells, OPC outer pillar cells, DC1/2 Deiters&apos; cells rows 1 and 2, DC3, Deiters&apos; cells row 3, HeC Hensen&apos;s cells, CC/OSC Claudius cells/outer sulcus cells, IdC interdental cells, ISC inner sulcus cells, KO Kolliker&apos;s organ cells, L.KO lateral Kolliker&apos;s organ cells, ##M.KO## medial Kolliker&apos;s organ cells, OC90 OC90+ cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7221106</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32404924</oboInOwl:hasDbXref>
        <rdfs:label>M.KO</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002490"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/cce5023e-d227-43f4-bb2f-d43dcf4535ef"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002490"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/cce5e335-d005-4c26-a209-d47771e5b34c -->

    <Class rdf:about="http://example.org/cce5e335-d005-4c26-a209-d47771e5b34c">
        <obo:IAO_0000115>human ##atrial appendage-derived cells##</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6665953</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31396228</oboInOwl:hasDbXref>
        <rdfs:label>atrial appendage-derived cells</rdfs:label>
    </Class>
    


    <!-- http://example.org/ccf77acb-8216-4658-afa6-c955357e148b -->

    <Class rdf:about="http://example.org/ccf77acb-8216-4658-afa6-c955357e148b">
        <obo:IAO_0000115>a Schematic of study design. Diagrams depict the brain region of interest, Brodmann area 9, corresponding to the dlPFC. b UMAP plot colored by the broad cell types. c UMAP plot colored by the individual clusters identified and annotated. For UMAP plots, the x and y-axes represent the first and second UMAP co-ordinates respectively. d DotPlot depicting the expression of marker genes (SNAP25 - neurons, SLC17A7 - excitatory neurons, GAD1 - inhibitory neurons, ALDH1L1 - astrocytes, PDGFRA - oligodendrocyte precursor cells, PLP1 - oligodendrocytes, CLDN5 - endothelial cells, CX3CR1 - microglia). The dendrogram next to the cluster names shows the relationship between the clusters by using the distance based on average expression of highly variable genes. e Best hits heatmap from MetaNeighbor showing the correspondence between the clusters in our dataset (columns) and the broad categories of cells identified in the Allen Brain Institute human motor cortex snRNA-seq dataset (rows). f Boxplots showing the proportion of nuclei in each cluster for each subject split by cases and controls for the broad OPC, astrocyte, and excitatory neuron cell types and the Ast1, Ast2, OPC1, and OPC2 clusters (n = 37 cases, 34 controls, representing biologically independent samples for each cluster or broad cell type). The middle line is the median. The lower and upper hinges correspond to the 25th and 75th percentiles. Upper and lower whiskers extend from the upper or lower hinges to the largest or smallest value no further than 1.5 times the inter-quartile range from the hinge, where the inter-quartile range is the distance between the first and third quartiles. Points beyond the end of the whiskers are plotted individually. In Fig. 1c-e, ##excitatory neuronal## cluster names contain approximate layer annotations and inhibitory neuronal cluster names contain MGE or CGE specific marker information as a suffix where applicable, as described in methods: Cluster annotation. For example, ExN10_L46 denotes a cluster of excitatory neurons with enrichment of marker genes from layer 4 to layer 6 of the cortex and InN1_PV denotes a cluster on inhibitory neurons with enrichment of the MGE specific marker PV. This convention is used throughout the paper. Brain diagram in 1a was created with BioRender.com. Source data are provided as a Source Data file.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10203145</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37217515</oboInOwl:hasDbXref>
        <rdfs:label>excitatory neuronal</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000540"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/ccf77acb-8216-4658-afa6-c955357e148b"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000540"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/cd08d733-a3ee-414b-a470-6a5376f7aea4 -->

    <Class rdf:about="http://example.org/cd08d733-a3ee-414b-a470-6a5376f7aea4">
        <obo:IAO_0000115>BACKGROUND: A major current challenge is to exploit tertiary lymphoid structures (TLSs) to promote the lymphocyte infiltration, activation and differentiation by tumor antigens to increase antitumor immune responses. The mechanisms that underlie the role of TLS formation in the adaptive immune responses against nasopharyngeal carcinoma (NPC) remain largely unknown. METHODS: Cell populations and the corresponding markers were identified by single-cell RNA sequencing and fluorescence-activated cell sorting analysis. In vitro differentiation experiments were used to simulate the generation, regulation and function of the Th-CXCL13 cell subset in the tumor microenvironment of NPC. These were followed by histological evaluation of the colocalization of tumor-associated B cells (##TABs##) and Th-CXCL13 cells within TLSs, and statistical analysis of the relationship between the cells in TLSs and overall survival. RESULTS: A PD-1+CXCR5-CD4+ Th-CXCL13 cell subset was identified in NPC. This subset was a major source of CXCL13, representing the majority of the CD4+ T cells at levels comparable with Th1 and Tfh cells present in the TLSs. Monocytes activated by toll-like receptor 4 agonists served as the antigen-presenting cells that most efficiently triggered the expansion of Th-CXCL13 cells. Transforming growth factor beta 1 (TGF-beta1) stimulation and activation of Sox4 were critical for the induction and polarization of Th-CXCL13 cells in this process. The potential functional contributions of TABs recruited by Th-CXCL13 cells which induced plasma cell differentiation and immunoglobulin production via interleukin-21 and CD84 interactions in the TLSs demonstrated improved survival. CONCLUSIONS: Induction of Th-CXCL13 cells links innate inflammation to immune privilege in tumor-associated TLSs and might predict better survival.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8276302</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34253636</oboInOwl:hasDbXref>
        <rdfs:label>TABs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000236"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/cd08d733-a3ee-414b-a470-6a5376f7aea4"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000236"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/cd1bc90e-22c3-494c-87dd-b8bdb4b0a8bd -->

    <Class rdf:about="http://example.org/cd1bc90e-22c3-494c-87dd-b8bdb4b0a8bd">
        <obo:IAO_0000115>a Line drawing of a cross section of the floor of the cochlear duct at P1. Distinct cell types within the organ of Corti (OC) are color coded. b Heat map for ~14,000 cochlear cells collected from four separate experiments at P1. Top 25 differentially expressed (DE) genes for the 15 identified clusters are shown. Cellular identity for each cluster is indicated by a color bar at the top of the heat map, which corresponds to the legend in a, and by a cell name at the bottom. c tSNE plot for the same cells as in b. Cluster identities are indicated. d Violin plots showing normalized log-transformed expression values for the top five DE genes for each cell type (color coded as in c) by comparison with all other P1 cells (gray on the right in each graph). Bars indicate median expression level. e Upper left panel, tSNE plot of cells determined to be derived from KO (between the OC and medial edge of the cochlear duct). Lower left panel, feature plot for the same cells as in the upper panel indicating high expression of Otoa, Calb1, and Fabp7 (based on color) in different clusters of cells. Lower right panel, cross sections through the cochlear duct at P1, illustrating expression of CALB1 in the medial region of KO and FABP7 directly adjacent to the OC (arrow; scale bars, 20 mum). Lowest panel shows high-magnification view of expression of FABP7 (arrow, gray scale) at the lateral KO border (green line; scale bar, 10 mum). Upper right panel, summary diagram of the spatial distribution of KO cell clusters at P1. HC hair cells, IPhC inner phalangeal cells/border cells, IPC inner pillar cells, OPC outer pillar cells, ##DC1/2## Deiters&apos; cells rows 1 and 2, DC3, Deiters&apos; cells row 3, HeC Hensen&apos;s cells, CC/OSC Claudius cells/outer sulcus cells, IdC interdental cells, ISC inner sulcus cells, KO Kolliker&apos;s organ cells, L.KO lateral Kolliker&apos;s organ cells, M.KO medial Kolliker&apos;s organ cells, OC90 OC90+ cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7221106</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32404924</oboInOwl:hasDbXref>
        <rdfs:label>DC1/2</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000635"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/cd1bc90e-22c3-494c-87dd-b8bdb4b0a8bd"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000635"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/cd2ead96-3800-4f34-b3f0-319c36d02afa -->

    <Class rdf:about="http://example.org/cd2ead96-3800-4f34-b3f0-319c36d02afa">
        <obo:IAO_0000115>a, b, Uniform manifold approximation and projection (UMAP) of fetal (a) and postnatal (b) epithelial cell types. Key cell types are circled with a dashed line and arrows depict paths of differentiation towards secretory and absorptive enterocytes as determined by scVelo. M cells, microfold cells; TA, transit-amplifying. c, Dot plot of TMPRSS2 and ACE2 expression in epithelial cells in the fetal intestine as in a. d, UMAP of enteroendocrine (EEC) and enterochromaffin (EC) cell subsets. Arrows depict summarised scVelo differentiation trajectories. C9orf16 is also known as BBLN. e, Heat map of genes that change along the differentiation trajectory from ##NEUROG3-expressing progenitors## to enterochromaffin cells (red arrow in d). Arrows indicate genes that have known associations with enterochromaffin cell differentiation. f, Dot plot with expression of molecules upstream or downstream of the PLCG2 pathway in tuft cells and pooled absorptive (TA and enterocytes) and secretory (Paneth, goblet and EEC) cells. g, Per cent expression of Fcgamma receptor by SiglecF+EpCAM+ and SiglecF-EpCAM+ cells in wild-type mice determined by flow cytometry (individual points represent biological replicates; n = 4). Using a two-way ANOVA we observe significant interaction between Fcgamma receptor expression (F(3, 39) = 42.29, P = 3.05 x 10-11). Post-hoc analysis showed significant differences between non-Tuft epithelial cells and Tuft cells for FcgammaRIIB (mean difference = 2.80, 95% CI [1.80, 3.81], P &lt; 0.0001) and FcgammaRIIB/III (mean difference = 4.88, 95% CI [3.88, 5.89], P &lt; 0.0001) expression. ****Padj &lt; 0.0001 values corrected with Tukey&apos;s test for multiple comparisons. h, Schematic of proposed signalling pathways in tuft cells. RTK, receptor tyrosine kinases.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8426186</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34497389</oboInOwl:hasDbXref>
        <rdfs:label>NEUROG3-expressing progenitors</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000165"/>
        <skos:relatedMatch rdf:resource="CL:0011026"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/cd2ead96-3800-4f34-b3f0-319c36d02afa"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000165"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/cd2ead96-3800-4f34-b3f0-319c36d02afa"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0011026"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/cd53b583-f4f2-42bb-9928-d5198341faaa -->

    <Class rdf:about="http://example.org/cd53b583-f4f2-42bb-9928-d5198341faaa">
        <obo:IAO_0000115>Transcriptomic data were used for correlation analysis between human in vivo fetal yolk sac (YS) hematopoietic clusters (YS_EC, endothelial cells; ##YS_Mac##, macrophages; and YS_YSMP1,2, myeloid-biased progenitors) and PD-L1 WT hematopoietic cell populations (PD-L1_EC, endothelial cells; MC/Mphis, monocyte/macrophages; CMPs, common myeloid progenitors; and granulocytes).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10638094</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37949473</oboInOwl:hasDbXref>
        <rdfs:label>YS_Mac</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
        <skos:relatedMatch rdf:resource="CL:0000428"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/cd53b583-f4f2-42bb-9928-d5198341faaa"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/cd53b583-f4f2-42bb-9928-d5198341faaa"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000428"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/cd63f62c-0679-4fae-97fd-c3a41918f56c -->

    <Class rdf:about="http://example.org/cd63f62c-0679-4fae-97fd-c3a41918f56c">
        <obo:IAO_0000115>Regarding the metabolic effects of the orexin system, orexin receptors are abundantly expressed in brain regions regulating energy metabolism, such as the medullary raphe, DMH, and ARC. More than 50% of serotonergic neurons in the medullary raphe, including the raphe pallidus nucleus (B1), raphe obscurus nucleus (B2), and raphe magnus nucleus (B3), express Ox1r but not Ox2r, which serve as sympathetic premotor neurons to enhance thermogenesis by brown adipose tissue (BAT). The DMH is one of the major upstream regions of ##medullary raphe neurons##, and the excitatory projection from the DMH to the medullary raphe enhances sympathetic outflows. However, Ox2r-expressing DMH cells were mainly GABAergic. The role of DMH GABAergic neurons in the regulation of sympathetic and other functions remains unclear. In the ARC, GABAergic neurons express Ox2r but not Ox1r. Orexin activates ARC GABAergic neurons and suppresses POMC neurons, a subpopulation of ARC GABAergic neurons. Since the loss of either Ox1r or Ox2r only partially mimics the obesity-prone phenotype of orexin-deficient mice, it is suggested that both Ox1r and Ox2r may function independently to render mice less prone to obesity.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10883752</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38199807</oboInOwl:hasDbXref>
        <rdfs:label>medullary raphe neurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002610"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/cd63f62c-0679-4fae-97fd-c3a41918f56c"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002610"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/cd7365f1-707a-44b2-af8e-57e58eec5b6c -->

    <Class rdf:about="http://example.org/cd7365f1-707a-44b2-af8e-57e58eec5b6c">
        <obo:IAO_0000115>Overview of human bone marrow adult definitive erythropoiesis. Multipotent haematopoietic stem cells with long term self-renewal capacity differentiate along a continuum of cell stages defined by their expansive capacity, degree of commitment to the erythroid lineage and morphological characteristics as illustrated. Burst forming units (BFU-E), the earliest committed erythroid cells expand predominantly in response to stem cell factor with the combined synergistic influence of erythropoietin driving continued proliferation of Colony forming units (CFU-E). Terminal differentiation of resultant proerythroblasts to enucleated reticulocytes takes place within the bone marrow niche within erythroblastic islands that consist of multiple ##differentiating erythroblasts## docked to a central macrophage. Terminal differentiation is characterised by progression through a series of morphologically defined stages (proerythroblast, basophilic erythoblast, polychromatic erythroblasts, orthochromatic erythroblast and reticulocyte). The process is characterised by loss of cellular volume, haemoglobinisation, expression of erythroid specific genes, nuclear condensation, organelle degradation and extrusion of the condensed nucleus (pyrenocyte) to generate a nascent reticulocyte. The pyrenocyte is phagocytosed by the macrophage and the reticulocyte enters the bloodstream, completing its maturation to definitive biconcave erythrocyte in the circulation over the subsequent 24-48 hours. Figure created with .</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9702814</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36452302</oboInOwl:hasDbXref>
        <rdfs:label>differentiating erythroblasts</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000765"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/cd7365f1-707a-44b2-af8e-57e58eec5b6c"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000765"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/ce5a147c-3e92-4a50-a2a0-48600a43ceb2 -->

    <Class rdf:about="http://example.org/ce5a147c-3e92-4a50-a2a0-48600a43ceb2">
        <obo:IAO_0000115>scRNA-seq of ECs reveal a subpopulation enriched with immune responsive signatures. (A) Schematic showing the experimental design for the scRNA-seq and single-nuclei ATAC sequencing analysis of regenerative mouse hearts (MI at P1 and harvested at P5) and nonregenerative mouse hearts (MI at P8 and harvested at P12). (B) UMAP representation of cardiac cell clusters identified from scRNA-seq analysis. Clusters were color coded according to cell types (left). CM, cardiomyocytes; EC, endothelial cells; CF, fibroblasts; PeriC, pericytes; SMC, smooth muscle cells; EndoC, endocardial cells; EpiC, epicardial cells; MF, macrophages; TC, T-cells. (C) Gene ontology (GO) analysis of differentially expressed genes up-regulated in ECs of regenerative-stage hearts versus nonregenerative-stage hearts after MI. (D) UMAP representation of CD31+-enriched cell clusters from single-cell RNA sequencing (scRNA-seq), color coded according to cell type. CEC, capillary endothelial cell; Angio-EC, angiogenic endothelial cell; Pro-EC1, proliferative endothelial cell 1; Pro-EC2, proliferative endothelial cell 2; IFN-EC, ##interferon capillary endothelial cell##; CVEC, capillary venous endothelial cell; VEC, venous endothelial cell; AEC, arterial endothelial cell; LEC, lymphatic endothelial cell; EndoC, endocardial cell. (E) Gene ontology (GO) analysis of differentially expressed genes up-regulated in the IFN-EC cluster of regenerative-stage hearts versus nonregenerative-stage hearts after MI.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10681909</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38012001</oboInOwl:hasDbXref>
        <rdfs:label>interferon capillary endothelial cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002144"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/ce5a147c-3e92-4a50-a2a0-48600a43ceb2"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002144"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/ce676f08-3560-4c56-8c3b-31e74ae429ea -->

    <Class rdf:about="http://example.org/ce676f08-3560-4c56-8c3b-31e74ae429ea">
        <obo:IAO_0000115>Comparison of the single cell landscape between healthy human meniscus and degenerated meniscus. (A) Representative polarised light microscopy images of healthy human and degenerated meniscus. The white and red colours in the angle images are 90  apart in orientation. Dashed lines indicate the surface of the meniscus. Scale bar, 100 microm. (B) Merged t-distributed stochastic neighbour embedding (t-SNE) of single-cell RNA sequencing of healthy meniscus cells and degenerated meniscus cells. (C) Twelve healthy human and degenerated meniscus cell clusters at t-SNE. (D) Proportion of each cluster to the total cells. (E) Proportion of healthy and degenerated meniscus cells in each cluster. (F) Expression of representative marker genes in Vin plot. (G) Heatmap revealing the scaled expression of differentially expressed genes for each cluster. (H) CD146 and CD318 expression in healthy human meniscus cells and degenerated meniscus cells determined by flow cytometry. n&gt;=5, **p&lt;0.01. (I) Representative IHC staining of COL1A1 and COL2A1 healthy human meniscus and degenerated meniscus, and quantification of positive cells. Scale bar, 50 microm. n&gt;=5, **p&lt;0.01. (J) The expression of indicated marker genes in human healthy meniscus cells and degenerated meniscus cells were detected by qRT-PCR. *p&lt;0.05, **p&lt;0.01, otherwise, not significant. n=3, *p&lt;0.05, **p&lt;0.01. CPC, cartilage progenitor cells; DegP, degenerated meniscus progenitor cells; EC, endothelial cells; ##FC##, fibrochondrocytes; FCP, fibrochondrocyte progenitors; HTC, hypertrophic chondrocytes; MoDC, monocyte-derived dendritic cells; PreHTC, prehypertrophic chondrocytes; ProFC, proliferate fibrochondrocytes; RegC, regulatory chondrocytes.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7034356</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31871141</oboInOwl:hasDbXref>
        <rdfs:label>FC</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000138"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/ce676f08-3560-4c56-8c3b-31e74ae429ea"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000138"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/ce94d418-30e6-45b8-ada4-d07da61596f9 -->

    <Class rdf:about="http://example.org/ce94d418-30e6-45b8-ada4-d07da61596f9">
        <obo:IAO_0000115>The signals driving the adaptation of type 2 dendritic cells (##DC2s##) to diverse peripheral environments remain mostly undefined. We show that differentiation of CD11blo migratory DC2s-a DC2 population unique to the dermis-required IL-13 signaling dependent on the transcription factors STAT6 and KLF4, whereas DC2s in lung and small intestine were STAT6-independent. Similarly, human DC2s in skin expressed an IL-4 and IL-13 gene signature that was not found in blood, spleen and lung DCs. In mice, IL-13 was secreted homeostatically by dermal innate lymphoid cells and was independent of microbiota, TSLP or IL-33. In the absence of IL-13 signaling, dermal DC2s were stable in number but remained CD11bhi and showed defective activation in response to allergens, with diminished ability to support the development of IL-4+GATA3+ helper T cells (TH), whereas antifungal IL-17+RORgammat+ TH cells were increased. Therefore, homeostatic IL-13 fosters a noninflammatory skin environment that supports allergic sensitization.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMID:34795444</oboInOwl:hasDbXref>
        <rdfs:label>DC2s</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000990"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/ce94d418-30e6-45b8-ada4-d07da61596f9"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000990"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/cebc396c-0783-406c-821f-06581742f1c7 -->

    <Class rdf:about="http://example.org/cebc396c-0783-406c-821f-06581742f1c7">
        <obo:IAO_0000115>Tonsillar CD4+ T cell subsets can be divided into three major groups. Most intrafollicular T cells belong to the follicular B helper T cell group (follicular Th [TFH], CD4+PD1+CXCR5+BCL6high). B cell and TFH interactions are crucial for the formation of the humoral immune response and support B cell somatic hypermutation and Ab class switching. Other ##tonsillar CD4+ T cell## subsets include non-TFH (CD4+PD1-CXCR5-BCL6low) and pre-TFH (CD4+PD1+CXCR5-BCL6mid). Pre-TFH cells develop from activated Ag-specific CD4+ T cells. The transcriptional program that is initiated in pre-TFH cells can induce CXCR5 expression, enabling the cells to migrate toward the B cell follicle.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8278278</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34099545</oboInOwl:hasDbXref>
        <rdfs:label>tonsillar CD4+ T cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000624"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/cebc396c-0783-406c-821f-06581742f1c7"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000624"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/cf24363e-58ef-4dfd-9eb8-d7a94e9d92e7 -->

    <Class rdf:about="http://example.org/cf24363e-58ef-4dfd-9eb8-d7a94e9d92e7">
        <obo:IAO_0000115>TFH responses might be self-perpetuating in EOMG if (i) AChR persists on ##TMCs## that are damaged by complement but do not disappear; (ii) Tregs are functionally compromised; and (iii) TLR-expressing antigen-presenting cells are abnormally active. Finally, autoreactive T- and B-cells spread to the periphery, where, hypothetically, the flow of skeletal muscle-derived AChR/antibody-complexes to regional lymph nodes and functionally impaired Tregs perpetuate EOMG even after thymectomy.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7925479</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33537838</oboInOwl:hasDbXref>
        <rdfs:label>TMCs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000893"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/cf24363e-58ef-4dfd-9eb8-d7a94e9d92e7"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000893"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/cf6c7c89-49c3-4bb3-86bf-ad1ed00cc12b -->

    <Class rdf:about="http://example.org/cf6c7c89-49c3-4bb3-86bf-ad1ed00cc12b">
        <obo:IAO_0000115>The ANRIL/p15 expression in human TM cells and its relationship with TM stiffness. (A) The proportion of p15-expressed cells in each cell type in human aqueous outflow pathways. From left to right: 1 beam cells A, 2 beam cells B, 3 juxtacanalicular tissue cells, 4 ciliary muscle cells, 5 collector channels cells, 6 Schwalbe line cells, 7 myelinating Schwann cells, 8 non-myelinating Schwann cells, 9 vascular endothelium cells, 10 pericyte cells, 11 ##Schlemm canal endothelium cells##, 12 macrophages, 13 melanocytes, 14 mast cells, 15 neurons. (B) The proportion of ANRIL-expressed cells in each cell type in human aqueous outflow pathways (cell-type order is the same as in panel A). (C) The normalized expression level of p15 and ANRIL in each cell type are present in heatmap (blue shallow indicates no expression). (D) The expression level (RPKM) of p15 in different TM stiffness are presented.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9101924</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35563774</oboInOwl:hasDbXref>
        <rdfs:label>Schlemm canal endothelium cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000115"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/cf6c7c89-49c3-4bb3-86bf-ad1ed00cc12b"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000115"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/cf797b9a-dfcd-4688-be0d-fe5d02bd296d -->

    <Class rdf:about="http://example.org/cf797b9a-dfcd-4688-be0d-fe5d02bd296d">
        <obo:IAO_0000115>In summary, from work done in frontal areas, it is clear that I-S cells are involved in enhancing learning and memory discrimination, are recruited during theta rhythms, and primarily target SOM+ cells, but also PV+ cells (i.e., similar to ##hippocampal CA1 I-S3 cells##; Figures 1A,B). Further characterization of VIP+ cell types in frontal areas is needed to distinguish how much I-S cell types in these areas contact pyramidal cells, compared to non-I-S VIP+ cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7296096</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32581726</oboInOwl:hasDbXref>
        <rdfs:label>hippocampal CA1 I-S3 cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:1001571"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/cf797b9a-dfcd-4688-be0d-fe5d02bd296d"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:1001571"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/cfa714b2-ff61-40b0-a394-cbd96db9d8a8 -->

    <Class rdf:about="http://example.org/cfa714b2-ff61-40b0-a394-cbd96db9d8a8">
        <obo:IAO_0000115>Such aging-associated inflammation, so-called inflammaging, is reported to be detrimental to several types of ##tissue-resident stem cells## including hair follicle stem cells, hematopoietic stem cells and neural stem cells. In the present study, RNA-seq and qPCR analysis showed that inflammation markedly contributes to the age-associated transcriptional changes in liver ECs including VESCs (Fig. 5a-d). We also confirmed the enrichment of inflammatory cells in the aged liver (Figs. 5e, f and S6). These findings indicate that the activation of inflammatory signals is a primary signature of aged VESCs. However, data illustrating how inflammation affects VESCs mechanistically is lacking in the present study. This limitation arises because aged mice do not survive well after monoclotalin treatment and irradiation; hence, we were unable to obtain sufficient mice to analyze. Although previous studies showed that age-associated inflammation dysregulates stemness of several types of stem cells, at this time, it remains speculative as to whether inflammation is actually the cause of the proliferative deficit of VESCs. Further investigations are needed to elucidate causal relationships.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10542733</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37563497</oboInOwl:hasDbXref>
        <rdfs:label>tissue-resident stem cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000034"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/cfa714b2-ff61-40b0-a394-cbd96db9d8a8"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000034"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/cfb78bdc-2b76-40d6-9735-8086c80dfe83 -->

    <Class rdf:about="http://example.org/cfb78bdc-2b76-40d6-9735-8086c80dfe83">
        <obo:IAO_0000115>Crossed activation of ##thoracic trunk motoneurons## by medullary reticulospinal neurons.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6957368</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31664872</oboInOwl:hasDbXref>
        <rdfs:label>thoracic trunk motoneurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0005024"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/cfb78bdc-2b76-40d6-9735-8086c80dfe83"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0005024"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/cfe2d06a-f4da-4c91-8f7a-dd009591def4 -->

    <Class rdf:about="http://example.org/cfe2d06a-f4da-4c91-8f7a-dd009591def4">
        <obo:IAO_0000115>tSNE plot colored by the 17 Seurat clusters including hepatocytes, endothelial cells (liver sinusoidal endothelial cells:LSEC, non-tumor liver vascular endothelial cells:LVEC, and tumor liver vascular endothelial cells:LVECt), mesenchymal cells (Stellate cells, cancer-associated fibroblasts:CAFs, Pericytes, vascular smooth muscle cells:vSMC), immune cells (Kupffer cells, scar-associated macrophages:SAMs, ##tissue monocytes 1##:TM1, cDC1, cDC2, T cells, and B cells), proliferating cells, and carcinoma cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7746227</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33332768</oboInOwl:hasDbXref>
        <rdfs:label>tissue monocytes 1</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000576"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/cfe2d06a-f4da-4c91-8f7a-dd009591def4"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000576"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/d01eda2c-5054-45c0-8145-dd826c4acde0 -->

    <Class rdf:about="http://example.org/d01eda2c-5054-45c0-8145-dd826c4acde0">
        <obo:IAO_0000115>The Table shows the numerical representations of Excitatory Neurons (Deep and Superficial Pyramidal cells) and Inhibitory neurons (Oriens Lacunosum moleculare cells:OLM; ##Trilaminar cells##:Tri, Backprojection cells:BP, cholecystokinin positive Basket cells:CCKBC, Parvalbumin positive cells:PVBC, AxoAxonic Cells:AA, Ivy Cells:IVY, Bistratified cells:BS, Schaffer Collateral associated cells:SCA, Perforant Pathway Associated cell:PPA, Neurogliaform:NG) subdivided on the basis of the placement classes (SO, SP, SR, SLM).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9381785</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35974119</oboInOwl:hasDbXref>
        <rdfs:label>Trilaminar cells</rdfs:label>
    </Class>
    


    <!-- http://example.org/d048734e-fc69-44a2-8bba-5f023ba9999c -->

    <Class rdf:about="http://example.org/d048734e-fc69-44a2-8bba-5f023ba9999c">
        <obo:IAO_0000115>We identified 23 immune cell subpopulations in the GSE162454 dataset by TSNE analysis at first. Based on the specific markers, we identified NK/T cells, ##CAFs## (cancer associated fibroblasts), endothelial cells, plasma cells, osteoblastic cells, osteoclasts, B cells, M2 TAMs (tumor associated macrophages), M1 TAMs, monocytes and mast cells (Figure 10A). The expression of marker genes for different cell clusters was displayed in dot plot format in Figure 10B. The expression of OS-related genes was compared in different cell types. Because of the dropout sign of single-cell sequencing, INS was not detected in the GSE162454 dataset. As shown in Figure 10C, HMOX1 were expressed at higher levels in TAMs and osteoclasts. ATF4 and ACADVL are highly expressed in myeloid cells as well as other cell types, which was suggestive of their roles in osteosarcoma progression.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10292890</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37285835</oboInOwl:hasDbXref>
        <rdfs:label>CAFs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000057"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/d048734e-fc69-44a2-8bba-5f023ba9999c"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000057"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/d08bd572-19fe-4d54-b4d7-31c7a7b63896 -->

    <Class rdf:about="http://example.org/d08bd572-19fe-4d54-b4d7-31c7a7b63896">
        <obo:IAO_0000115>The Table shows the numerical representations of Excitatory Neurons (Deep and Superficial Pyramidal cells) and Inhibitory neurons (Oriens Lacunosum moleculare cells:OLM; Trilaminar cells:Tri, Backprojection cells:BP, cholecystokinin positive Basket cells:CCKBC, Parvalbumin positive cells:PVBC, AxoAxonic Cells:AA, Ivy Cells:IVY, Bistratified cells:BS, Schaffer Collateral associated cells:SCA, Perforant Pathway Associated cell:PPA, ##Neurogliaform##:NG) subdivided on the basis of the placement classes (SO, SP, SR, SLM).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9381785</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35974119</oboInOwl:hasDbXref>
        <rdfs:label>Neurogliaform</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0010011"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/d08bd572-19fe-4d54-b4d7-31c7a7b63896"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0010011"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/d0a3541b-0948-46ad-970f-b91f943e6a49 -->

    <Class rdf:about="http://example.org/d0a3541b-0948-46ad-970f-b91f943e6a49">
        <obo:IAO_0000115>To illustrate the application of CSN to developing cells, we feature the developmental trajectory of human excitatory neuron cells in the Developing Cortex Atlas dataset (15), which includes Radial Gila and Progenitors (P), Intermediate Progenitors (IP), Maturing Excitatory (ExN), ##Migrating Excitatory## (ExM), Excitatory Upper-layer enriched (ExM-U), and Excitatory Deep layer (ExDp), with cell type labels determined by the authors (SI Appendix, section 3 and Table S2). Using Slingshot, we estimate the developmental path consists of two trajectories, one ending in upper-layer (U curve) and the other in deep-layer (D curve) excitatory neurons (Fig. 3 A and B).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8713783</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34903665</oboInOwl:hasDbXref>
        <rdfs:label>Migrating Excitatory</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000540"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/d0a3541b-0948-46ad-970f-b91f943e6a49"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000540"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/d0ae7e1e-bfa8-43dd-9997-4dce34b601b2 -->

    <Class rdf:about="http://example.org/d0ae7e1e-bfa8-43dd-9997-4dce34b601b2">
        <obo:IAO_0000115>In Tek-CreERT2;R26T mice, we also observed Tek+ bone-lining cells at the endosteum (Fig. 5a). The frequency of these cells was approximately 2.8 cells/mm endosteum in longitudinal sections, which was significantly higher than that of Cdh5+ bone-lining cells (Fig. 5f). Tek+ endosteal bone-lining cells often exhibited a thin and elongated morphology and were nearly absent for the osteolineage marker RUNX2 (Fig. 5b, g), suggesting that they might correspond to the endosteal fibroblasts detected in the reanalyzed dataset. However, Tek+ osteocytes were hardly detected in these mice (Fig. 5c, h). In other regions of the bone marrow cavity, a small population of ##trabecular bone-lining cells## (Fig. 5d, i) and metaphyseal stromal cells (Fig. 5e, j) were also Tek+.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10733381</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38123537</oboInOwl:hasDbXref>
        <rdfs:label>trabecular bone-lining cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0001035"/>
        <skos:relatedMatch rdf:resource="CL:0002157"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/d0ae7e1e-bfa8-43dd-9997-4dce34b601b2"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0001035"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/d0ae7e1e-bfa8-43dd-9997-4dce34b601b2"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002157"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/d1331f4d-7a5e-4913-8284-3f7ae3a8c33d -->

    <Class rdf:about="http://example.org/d1331f4d-7a5e-4913-8284-3f7ae3a8c33d">
        <obo:IAO_0000115>In humans, the number of ENS neurons is about 500 million, many more than in the other parts of the peripheral autonomic nervous system. The longitudinal and circular layers of the muscularis externa are innervated by nerve fibres of sympathetic extrinsic ganglia and nerve fibres of ##Auerbach&apos;s plexus motoneurons## and such organisation regulates proper intestinal motility. Moreover, the peristaltic reflexes of the intestine are coordinated by an abundant network of the myenteric plexuses descending and ascending nerve fibres. The intestinal mucosa is innervated by fibres of secretomotor neurons originating from submucosal plexuses. Secretomotor neurons regulate fluid exchange, intestinal permeability and coordinate proper intestinal reflexes. The lumen of submucosal blood vessels is regulated by axons of the vasomotor neurons (dilatory function) of submucosal plexuses and/or nitrergic (neuronal nitric oxide synthase, i.e., nNOS) neurons and axons of sympathetic neurons of extrinsic ganglia (constrictory function). Moreover, all the layers of the intestine and blood vessels are innervated by the sensory neurons (with mechano-, thermo- and chemoreceptors) of submucosal and myenteric plexuses as well as dorsal root ganglia. All components of the ENS are interconnected by numerous interneurons which functionally integrate them into one system which functions are based on physiological reflexes.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7247003</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32403316</oboInOwl:hasDbXref>
        <rdfs:label>Auerbach&apos;s plexus motoneurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000100"/>
        <skos:relatedMatch rdf:resource="CL:0007011"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/d1331f4d-7a5e-4913-8284-3f7ae3a8c33d"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000100"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/d1331f4d-7a5e-4913-8284-3f7ae3a8c33d"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0007011"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/d14205ad-56df-44a4-912a-ebbb448dbdc1 -->

    <Class rdf:about="http://example.org/d14205ad-56df-44a4-912a-ebbb448dbdc1">
        <obo:IAO_0000115>The classification of pericyte-derived and non-pericyte-derived myofibroblasts (PDGFRbeta-constitutively-expressing and PDGFRbeta-de novo-expressing, respectively) indicates different roles of pulmonary myofibroblasts. With PDGFRbeta as a &apos;specific&apos; marker for pericytes, PDGFRbeta-regulated Cre expression has been used to trace the fate of these cells. However, the constitutive PDGFRbeta-Cre line employed in other studies does not allow discriminating between the two types of myofibroblasts identified in this study, as, after injury, both indistinguishably express PDGFRbeta. Here, we employed the tamoxifen inducible PDGFRbeta-CreERT2 to induce temporally controlled labeling of cells with active PDGFRbeta promotor in the adult lung; in fact, as the intra-alveolar myofibroblasts were found to acquire PDGFRbeta expression after injury, only the inducible lineage tracing strategy allowed us to differentiate between the two types of myofibroblasts. Using a PDGFRbeta-tdTomato reporter mouse in combination with the fact that SMC do not contribute to myofibroblasts, the interstitial myofibroblast can be shown to derive from NO-GC+/PDGFRbeta+ pericytes. We have not yet determined the precursor for the intra-alveolar myofibroblast, although we can exclude pericytes based on our lineage tracing studies. Lipofibroblasts have been shown to be potential ##myofibroblasts precursors##; whether this cell type is linked to the formation of intra-alveolar myofibroblasts has yet to be clarified.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10288756</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37349733</oboInOwl:hasDbXref>
        <rdfs:label>myofibroblasts precursors</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000186"/>
        <skos:relatedMatch rdf:resource="CL:0011115"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/d14205ad-56df-44a4-912a-ebbb448dbdc1"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000186"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/d14205ad-56df-44a4-912a-ebbb448dbdc1"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0011115"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/d14e3003-099e-4e5c-baef-b3435edab20d -->

    <Class rdf:about="http://example.org/d14e3003-099e-4e5c-baef-b3435edab20d">
        <obo:IAO_0000115>Luminal progenitors serve primarily as tumor initiators or cells of origin for prostate cancer. Various hierarchical models have been proposed. A recent model suggests that, during early postnatal development, multipotent basal cells (p63+ CK5+) differentiate into unipotent basal progenitors, luminal progenitors (CK8+ AR low), and NE cells. These unipotent basal and luminal progenitors can undergo self-renewal or differentiate into basal cells and ##mature luminal cells## (AR+ CK8+), respectively. In adults, during homeostasis and regeneration, the bipotent basal progenitor forms unipotent basal and luminal progenitors, which further undergo self-renewal. Unipotent basal progenitors differentiate into basal cells, and luminal cell progenitors differentiate into luminal cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10291985</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37282627</oboInOwl:hasDbXref>
        <rdfs:label>mature luminal cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002340"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/d14e3003-099e-4e5c-baef-b3435edab20d"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002340"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/d1627d85-1d14-4a12-a118-03e3532ce052 -->

    <Class rdf:about="http://example.org/d1627d85-1d14-4a12-a118-03e3532ce052">
        <obo:IAO_0000115>(A, C) Expression level of select marker genes for each identified cluster (A: VGlut2 cKO model; C: Ip3r2 KO model). Circle size denotes expression ratio (percent cells expressing the gene), color represents expression level (in log2 CPM). Bar chart on the left shows cell numbers identified for each cluster are similar for WT and KO groups for each cluster in each model. (B) UMAP clustering of different cell types identified in the NEUN-negative population of the combined samples from Ip3r2 WT and KO mice. 17 clusters were identified including the three main types of glia: astrocytes, oligodendrocytes, and microglia, as well as endothelial cells, and two subtypes of neurons (for A-C - M-astrocyte: mitotic astrocyte; M-OPC: mitotic oligodendrocyte precursor cell; OPC: oligodendrocyte precursor cell; MFOL: myelin-forming oligodendrocyte; NFOL: ##newly formed oligodendrocyte##; MOL: mature oligodendrocyte; VLMC: vascular and leptomeningeal cell; EC: endothelial cell; PC: pericyte; PVM: perivascular macrophage).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8497060</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34494546</oboInOwl:hasDbXref>
        <rdfs:label>newly formed oligodendrocyte</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000128"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/d1627d85-1d14-4a12-a118-03e3532ce052"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000128"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/d16470cc-455d-4622-9634-1394445c2048 -->

    <Class rdf:about="http://example.org/d16470cc-455d-4622-9634-1394445c2048">
        <obo:IAO_0000115>(A, B) Volcano plots showing differentially expressed genes (FDR corrected p-value &lt;0.05, indicated by colors) in DCs (A) and ##MdMs## (B) from tumor periphery versus center. (C) Volcano plot showing differentially expressed genes (FDR corrected p-value &lt;0.05, indicated by colors) in DCs from tumor periphery versus PBMC. (D) Heatmap representation of GSEA between DCs from tumor periphery and PBMC using Hallmark collection of major biological categories. (E) Heatmap displaying the cluster-specific genes identifying MG_1 and MG_2 subclusters. Columns are ordered by site and cell type, and rows show centered and scaled normalized average expression values, hierarchically clustered. (F, G) Violin plots showing average expression levels (log2 counts) of selected markers among mononuclear phagocyte populations. (H) Frequencies of MG_1 and MG_2 subpopulations among total microglia between center and periphery, shown as boxplots. Symbols represent individual patients (n=5) and paired samples are indicated by connecting lines. Statistical significance was assessed by diffcyt-DA-voom method (Supplementary file 5), ***FDR corrected p value p&lt;=0.001, ****FDR corrected p-value &lt;=0.0001.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10735226</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38127790</oboInOwl:hasDbXref>
        <rdfs:label>MdMs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
        <skos:relatedMatch rdf:resource="CL:0000576"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/d16470cc-455d-4622-9634-1394445c2048"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/d16470cc-455d-4622-9634-1394445c2048"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000576"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/d16c2747-f4ba-420b-bd77-dbddf3d75d51 -->

    <Class rdf:about="http://example.org/d16c2747-f4ba-420b-bd77-dbddf3d75d51">
        <obo:IAO_0000115>We observed multiple features of Immature #1 and mature Sertoli cells that distinguish them from Immature #2 cells, including high AR (Androgen Receptor) target gene expression (defined by a set of ~70 known AR-dependent genes), high mitochondrial transcription, and lower expression of ribosomal protein genes (Figure 3F). Gene Ontology (GO) analysis revealed enrichment for terms such as nucleus and transcription in ##Immature## #1 (Figure S3H). IF co-staining for AR and SOX9 confirms this sequence of events, by showing gradual AR upregulation and co-localization in Sertoli cells as puberty proceeds (Figure 3H). Immature #2 cells have the converse properties of Immature #1 described above and are enriched in GO terms for translation and ribosome function (Figure S3H). They exhibit higher transcription of ribosomal protein genes, mitochondrial ATPases (e.g., ATP5E), and mitochondrial membrane proteins (e.g., TOMM7) and contain a higher fraction of cells in the G1 phase of the cell cycle (Figures 3F and S3E). Taken together, these two immature Sertoli cell states differ markedly in their metabolic/mitochondrial, translational, and cell-cycle properties (as indicated by transcriptional signatures).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7298616</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31928944</oboInOwl:hasDbXref>
        <rdfs:label>Immature</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000216"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/d16c2747-f4ba-420b-bd77-dbddf3d75d51"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000216"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/d17a2926-7afb-444f-abbc-b5848e7da8bb -->

    <Class rdf:about="http://example.org/d17a2926-7afb-444f-abbc-b5848e7da8bb">
        <obo:IAO_0000115>Myofibroblasts are central mediators of the dysregulated wound-healing programme that defines fibrosis, therefore we studied this population in detail. Graph based clustering of the single cell RNA-seq data defined four major subsets (Fig. 3a) that included a cycling population (Cycling MFB) (Fig. 3a, b). After this, we sought to confirm that proliferating stromal cells (Ki67+) were myofibroblasts (Fig. 3c-e, Supplementary Fig. 4a-d). Using flow cytometry, we stained freshly disaggregated nodular cells and gated on myofibroblasts (CD45-CD31-CD146-ITGbeta1high) and fibroblasts (CD45-CD31-CD146-ITGbeta1low) and demonstrated Ki67high cells were a subset of myofibroblasts. In the single cell RNA-seq, a second subset was characterised by lower expression of ACTA2 and intermediate expression of fibroblast marker genes (CXCL14, PLA2G2A and C1R), we termed the ACTA2low myofibroblast (Fig. 3a, b, Supplementary Fig. 5a). A third comprised a discrete ##CD82highOX40L+## population (CD82, OX40L, MMP11, MMP14 and CD82) (Fig. 3a, g, Supplementary Fig. 5b-e). Finally, a fourth less distinct community we termed the intermediate myofibroblast (Fig. 3a, b, Supplementary Fig. 15a). GO analysis demonstrated that CD82highOX40L+ myofibroblast marker genes showed the strongest enrichment for cell contraction pathways (Fig. 3f). In contrast, differential gene expression and pathway analysis revealed ACTA2low myofibroblasts resembled a general fibroblast phenotype, without clear characteristics of any one subtype. In addition to ACTA2, significant ACTA2low myofibroblasts markers were general fibroblasts markers including PLA2G2A and CXCL14. ACTA2low myofibroblasts also shared pathways enriched in fibroblasts such as &apos;interleukin signalling&apos; and &apos;chemotaxis&apos; (Fig. 3f).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7265502</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32488016</oboInOwl:hasDbXref>
        <rdfs:label>CD82highOX40L+</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000186"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/d17a2926-7afb-444f-abbc-b5848e7da8bb"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000186"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/d1889d7c-2562-4bdc-97d0-48fe7f82ad45 -->

    <Class rdf:about="http://example.org/d1889d7c-2562-4bdc-97d0-48fe7f82ad45">
        <obo:IAO_0000115>Using WOT, we then identified the descendants of presumptive I-RGCs at later ages. We found that I-RGCs comprised 4.3% of adult RGCs, consistent with the range of 3-5% noted above. We queried these cells to identify the genes that distinguished putative I-RGCs and ##C-RGCs## throughout the developmental time course. At a fold change of &gt;=1.5, we found 59 differentially expressed (DE) genes at E13 and 89 at E14 (Figure 7e and f). In addition to Zic2, Igfbp5, Isl2, and Igf1, which had been used to define I-RGCs and C-RGCs at E13, they included Igfbpl1, Pou3f1, and Cntn2 enriched in I-RGCs, and Lmo2, Pcsk1n, and Syt4 enriched in C-RGCs. The number of genes differentially expressed between I- and C-RGCs decreased after E14, with 20, 9, and 0 significant genes at E16, P0, and P5, respectively (Figure 7:figure supplement 1d and e), presumably reflecting the downregulation of axon guidance programs once retinorecipient targets have been reached (see Discussion).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8956290</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35191836</oboInOwl:hasDbXref>
        <rdfs:label>C-RGCs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000740"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/d1889d7c-2562-4bdc-97d0-48fe7f82ad45"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000740"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/d19f64d3-b742-4679-b449-b6e41607e8f3 -->

    <Class rdf:about="http://example.org/d19f64d3-b742-4679-b449-b6e41607e8f3">
        <obo:IAO_0000115>The scRNA-seq data also identified a fourth cluster of cells which could not, based on the top enriched genes, be easily assigned to a known neural cell type (Supplementary Data 2, Supplementary Fig. 4b). Gene enrichment analysis using the top distinguishing genes of this cluster identified highly significant biological functions associated with vasculature and connective tissue, including genes encoding collagens and other extracellular components (Fig. 2f, Supplementary Fig. 6a, Supplementary Data 3). We then probed a large scRNA-seq dataset from the mouse brain interrogating more than 400,000 cells organized into 250 annotated clusters representing diverse cell types such as central and peripheral neurons, astrocytes, oligodendrocytes, Schwann cells, immune cells, and brain vascular cell types (Mouse Brain Atlas, http://mousebrain.org/). When this dataset was searched for cell types co-expressing enriched genes of the fourth cluster, &quot;enteric glia&quot; and &quot;vascular leptomeningeal cells&quot; (VLMCs) were identified as cell type categories with highly related gene expression profiles (Supplementary Fig. 6b, c). ##Enteric mesothelial fibroblasts##, the closest matching cell type among &quot;enteric glia&quot;, and VLMCs belong to a family of highly related organ barrier-forming fibroblast populations. Recent scRNA-seq analyses have identified related cells associated with the mouse brain vasculature, characterized by the co-expression of Pdgfra, Col1a1, Col1a2, Lum, and Dcn. Additionally, the human homologs of these genes were all expressed in the unknown cluster (Fig. 2f, Supplementary Fig. 4g). Therefore, we refer to these cells as VLMCs as this cluster consists of cells with striking transcriptional resemblance to previously described populations of barrier-forming fibroblasts, including VLMCs of the mouse central nervous system.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7229159</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32415072</oboInOwl:hasDbXref>
        <rdfs:label>Enteric mesothelial fibroblasts</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:4023054"/>
        <skos:relatedMatch rdf:resource="CL:4040002"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/d19f64d3-b742-4679-b449-b6e41607e8f3"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4023054"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/d19f64d3-b742-4679-b449-b6e41607e8f3"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4040002"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/d1c76f78-0868-4c04-b560-4f336cff6a64 -->

    <Class rdf:about="http://example.org/d1c76f78-0868-4c04-b560-4f336cff6a64">
        <obo:IAO_0000115>Our data showed that the induction of IL-10 production in macrophages reported in IV and IP MSC treatment is also relevant in SC MSC treatment. When administered directly into the inflamed tissue, SC MSC injection induced immunoregulatory macrophages in the local LN draining the inflamed tissue. Interestingly, an expansion in IL-10-producing macrophages was observed only in the MerTK+ SSM and TZM populations, and not in the F4/80+ macrophage populations (MSM and MCM). This could be due to the F4/80+ macrophages residing deeper within the LN and are therefore less accessible. MerTK is an efferocytic receptor, and MerTK+ TZMs have been reported to have a role in clearing apoptotic cells and maintaining immune homeostasis and tolerance. In addition, studies have demonstrated a role for MerTK signalling in attenuating inflammation. The inhibitory role of MerTK signalling pathway has been previously reported in an LPS-induced lung inflammation model. Whether the selective expansion of IL-10-producing ##MerTK+ macrophages## is associated with activation of MerTK-related immunomodulatory pathway should be investigated further.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11572146</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:39551813</oboInOwl:hasDbXref>
        <rdfs:label>MerTK+ macrophages</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/d1c76f78-0868-4c04-b560-4f336cff6a64"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/d1f497e4-0fa3-4811-a7dc-ee61c7e4d146 -->

    <Class rdf:about="http://example.org/d1f497e4-0fa3-4811-a7dc-ee61c7e4d146">
        <obo:IAO_0000115>(D) Pie chart showing the proportions of ##hippocampal input cell## types to the single starter cell in (C) 30 days after rabies injection (n = 26 input cells to a single starter cell). DG, dentate gyrus; Sub, subiculum.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9142754</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35637903</oboInOwl:hasDbXref>
        <rdfs:label>hippocampal input cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002608"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/d1f497e4-0fa3-4811-a7dc-ee61c7e4d146"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002608"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/d209e4c7-c1cf-46ed-809e-54d5331da00c -->

    <Class rdf:about="http://example.org/d209e4c7-c1cf-46ed-809e-54d5331da00c">
        <obo:IAO_0000115>To test this, we leveraged our multi-species limb atlas, which underscored a transcriptional program related to ##AER cell## identity across analyzed species (Fig. 1c, d; Supplementary Figs. 3 and 4). First, we identified the differentially expressed genes in the AER cluster in the atlas (Supplementary Data 4). Second, we used consensus non-negative matrix factorization (cNMF) to detect transcriptional modules related to cell-identity and cell-activity within specific populations (Supplementary Fig. 16 and Supplementary Data 4). Then, using these AER-related gene sets, we surveyed the expression pattern in mesodermal populations, including using gene set enrichment analysis (Supplementary Fig. 17). In parallel, we also tested whether clustering based on these gene sets would aggregate AER-related ectodermal cells and mesodermal cells together, indicative of a high degree of similarity (Fig. 4a-c and Supplementary Figs. 18-22).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10564727</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37816738</oboInOwl:hasDbXref>
        <rdfs:label>AER cell</rdfs:label>
    </Class>
    


    <!-- http://example.org/d214716e-023f-4148-b091-217b391cd4f6 -->

    <Class rdf:about="http://example.org/d214716e-023f-4148-b091-217b391cd4f6">
        <obo:IAO_0000115>a Due to single-cell annotation and in situ validation (Fig. 2; Supplementary Fig. 3), a draft model of the oral-to-tooth transition zone in humans is presented, with basal and suprabasal keratinocyte markers uniquely identifying the alveolar mucosa (AM), attached gingiva (AG), gingival margin (GM), sulcular epithelium (SK) and junctional epithelium (JK). b These markers allowed for KRT19-high keratinocyte (KC) cell subclustering for the first time (2504 cells in total), including gingival margin keratinocytes (GM), sulcular keratinocytes (SK), and junctional keratinocytes (JK). c A more granular draft (Tier 4) annotation of ##epithelial cells of the gingival attachment##. d Assaying differentially expressed genes in periodontitis, SKs and JKs only share about a quarter of upregulated genes. JKs displayed nearly 125 unique upregulated genes in diseased cells. e Further analysis of basal and suprabasal (differentiating) SK and JK keratinocytes revealed unique cell signatures between basal and suprabasal cell types. This full list is included in Supplementary Data 1. f-i To understand SK and JK developmental progression and cell state alterations, we used partitioned-based graph abstraction (PAGA). f Examining the basal to suprabasal transition, JKs display altered gene expressed comparing health to disease cell types, including broader expression of KRT17 and more expression of JUND, COL17A1, and CDH3. Key differentiation genes such as SPRR family members were also downregulated. g JKs displayed robust cell signaling and inflammatory phenotypes, which appear exacerbated in disease states. h In SKs, differentiation-related genes were uniquely expressed compared to JKs in health but also appeared altered in disease along the basal to suprabasal trajectory. i SKs appeared generally less reactive compared to JKs in disease, with lower overall expression of effector molecules such as CXCL1, CXCL8, IL1A, IL1B, and IL1RN. Abbreviations: Merk Merkel Cells, LC langerhans cells, Mela melanocytes, Muc mucosa, SB suprabasal Keratinocytes; for others, see Fig. 1 legend. For this figure, n = 30-sample, 2504-cell for scRNAseq.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11178863</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38876998</oboInOwl:hasDbXref>
        <rdfs:label>epithelial cells of the gingival attachment</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002621"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/d214716e-023f-4148-b091-217b391cd4f6"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002621"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/d23020e3-1a1e-49b7-9c64-8200a0a444a1 -->

    <Class rdf:about="http://example.org/d23020e3-1a1e-49b7-9c64-8200a0a444a1">
        <obo:IAO_0000115>Pancreatic ductal adenocarcinoma (PDAC) has a poor clinical outlook. Responses to immune checkpoint blockade are suboptimal and a much more detailed understanding of the tumor immune microenvironment is needed if this situation is to be improved. Here, we characterized tumor-infiltrating T-cell populations in patients with PDAC using cytometry by time of flight (CyTOF) and single-cell RNA sequencing. T cells were the predominant immune cell subset observed within tumors. Over 30% of CD4+ T cells expressed a CCR6+CD161+ Th17 phenotype and 17% displayed an activated regulatory T-cell profile. Large populations of CD8+ tissue-resident memory (TRM) T cells were also present and expressed high levels of programmed cell death protein 1 (PD-1) and TIGIT. A population of putative tumor-reactive CD103+CD39+ T cells was also observed within the ##CD8+ tumor-infiltrating lymphocytes## population. The expression of PD-1 ligands was limited largely to hemopoietic cells whilst TIGIT ligands were expressed widely within the tumor microenvironment. Programmed death-ligand 1 and CD155 were expressed within the T-cell area of ectopic lymphoid structures and colocalized with PD-1+TIGIT+ CD8+ T cells. Combinatorial anti-PD-1 and TIGIT blockade enhanced IFNgamma secretion and proliferation of T cells in the presence of PD-1 and TIGIT ligands. As such, we showed that the PDAC microenvironment is characterized by the presence of substantial populations of TRM cells with an exhausted PD-1+TIGIT+ phenotype where dual checkpoint receptor blockade represents a promising avenue for future immunotherapy.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10068448</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36689623</oboInOwl:hasDbXref>
        <rdfs:label>CD8+ tumor-infiltrating lymphocytes</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000625"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/d23020e3-1a1e-49b7-9c64-8200a0a444a1"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000625"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/d273c261-d175-4398-be86-a377ff128d73 -->

    <Class rdf:about="http://example.org/d273c261-d175-4398-be86-a377ff128d73">
        <obo:IAO_0000115>Developmental processes contributing to cell fate decisions are mediated by precise cell-cell signaling interactions within a cell&apos;s microenvironment. While cells may share transcriptomic gene signatures, cell-autonomous and/or non-cell-autonomous signaling may dictate how these cells develop. Here, we focused on signaling communications between epithelial-epithelial and epithelial-stromal cells. However, it does not preclude the contributions of the immune, endothelial, and neural (Schwann) cells that are also co-developed and residing near the former two cell types. Indeed, contributions of the immune cell population to epithelial development has recently been shown in the fetal lungs. Correspondingly, we saw the expression of interleukin pathways in our trajectory analysis of epithelial cells (Fig. 6), which may indicate signaling from immune cells, and supports recent findings by Barnes et al. In our cell communication and trajectory analysis, we showed temporal changes in the signaling pathways for FGF, WNT, and NOTCH targeting the TP cells. Both spatial and temporal regulation of signaling can alter the intricate microenvironment of the cell and influence its behavior and potential cell fate changes. Previous studies have demonstrated all three pathways play a role in lung branching morphogenesis and epithelial differentiation. For example, lateral inhibition of NOTCH signaling increases PNEC differentiation in Hes1-null mice. Similarly, we observed a dramatic decrease in PNEC in later gestational lung tissues as NOTCH signaling to TP cells increased with signaling from SOX2highCFTR + cells and basal cells. To confirm our lower-resolution Visium results, we used Xenium to refine the spatial proximity of epithelial and stromal cell types and analyzed the putative signaling through ##TP##.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11246468</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:39003323</oboInOwl:hasDbXref>
        <rdfs:label>TP</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:4033048"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/d273c261-d175-4398-be86-a377ff128d73"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4033048"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/d295a7f4-f636-4a87-a8ac-1bcf03818a58 -->

    <Class rdf:about="http://example.org/d295a7f4-f636-4a87-a8ac-1bcf03818a58">
        <obo:IAO_0000115>Inflammatory (M1) macrophages regulate colonic epithelial cell differentiation through direct macrophage-crypt contact, not observed with anti-inflammatory (M2) macrophages. Crypt cell growth is induced by both macrophage subsets, but for M1, it occurs via a secreted factor, while M2 requires physical contact with the ##crypt epithelium##.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11219479</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38001043</oboInOwl:hasDbXref>
        <rdfs:label>crypt epithelium</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000510"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/d295a7f4-f636-4a87-a8ac-1bcf03818a58"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000510"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/d2b67e85-3699-4694-81e7-6229a73f54d8 -->

    <Class rdf:about="http://example.org/d2b67e85-3699-4694-81e7-6229a73f54d8">
        <obo:IAO_0000115>##Area Postrema Cell## Types that Mediate Nausea-Associated Behaviors.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7864887</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33278342</oboInOwl:hasDbXref>
        <rdfs:label>Area Postrema Cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000540"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/d2b67e85-3699-4694-81e7-6229a73f54d8"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000540"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/d2b82e5f-9b5b-47d4-be27-fd42cb18c428 -->

    <Class rdf:about="http://example.org/d2b82e5f-9b5b-47d4-be27-fd42cb18c428">
        <obo:IAO_0000115>Vascular inflammation begins with antigen recognition in vascular dendritic cells (vasDCs). Essentially every artery contains vasDCs, which allow for early detection of foreign antigens. Proliferation of T cells with the shared T cell receptor is confirmed in distinct vascular lesions of GCA, which indicates that T cells undergo clonal expansion after recognizing certain antigens. Herpes zoster virus and others have been proposed as antigens, but this has not yet been verified. VasDCs express unique Toll-like receptor patterns in each artery. In non-inflamed temporal arteritis, the vasDCs are immature and located at the media-adventitia border. Once activated, vasDCs expand and express costimulatory molecules such as CD80 and CD86. They also produce excess chemokines and cytokines, which prime naive CD4+ T cells and facilitate monocyte migration. A recent study demonstrated that defective expression of programmed death ligand 1 in vasDCs also contributes to the maintenance of T cell activation. Monocytes then differentiate into tissue macrophages, which are activated by cytokines, particularly interferon (IFN)-gamma, released by ##activated T cells##. Activated macrophages in turn start to produce large amounts of cytokines (e.g., IL-6), chemokines, proteolytic enzymes (e.g., matrix metalloprotease), and various growth factors, such as vascular endothelial growth factors (VEGF), fibroblast growth factor, and platelet-derived growth factor. These growth factors act on endothelial cells (ECs) and vascular smooth muscle cells (VSMCs), transforming them into myofibroblasts, and accelerate intimal hyperplasia and adventitial neoangiogenesis. Thus, the conventional inflammatory cascade in GCA includes three major players: vasDCs, CD4+ T cells, and macrophages. However, several new cell populations have emerged in the pathomechanisms of GCA.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9240193</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35784327</oboInOwl:hasDbXref>
        <rdfs:label>activated T cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000896"/>
        <skos:relatedMatch rdf:resource="CL:0001049"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/d2b82e5f-9b5b-47d4-be27-fd42cb18c428"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000896"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/d2b82e5f-9b5b-47d4-be27-fd42cb18c428"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0001049"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/d2c9af73-d9a4-4529-9020-2d3c260bbfc2 -->

    <Class rdf:about="http://example.org/d2c9af73-d9a4-4529-9020-2d3c260bbfc2">
        <obo:IAO_0000115>The adipose-derived hormone leptin acts via its receptor (LepRb) in the brain to control energy balance. A potentially unidentified population of GABAergic hypothalamic LepRb neurons plays key roles in the restraint of food intake and body weight by leptin. To identify markers for candidate populations of LepRb neurons in an unbiased manner, we performed single-nucleus RNA-Seq of enriched mouse hypothalamic LepRb cells, identifying several previously unrecognized populations of hypothalamic LepRb neurons. Many of these populations displayed strong conservation across species, including GABAergic Glp1r-expressing LepRb (LepRbGlp1r) neurons, which expressed more Lepr than other LepRb cell populations. Ablating Lepr from LepRbGlp1r cells provoked hyperphagic obesity without impairing energy expenditure. Similarly, improvements in energy balance caused by Lepr reactivation in GABA neurons of otherwise Lepr-null mice required Lepr expression in GABAergic Glp1r-expressing neurons. Furthermore, restoration of Glp1r expression in LepRbGlp1r neurons in otherwise Glp1r-null mice enabled food intake suppression by the GLP1R agonist, liraglutide. Thus, the conserved ##GABAergic LepRbGlp1r neuron## population plays crucial roles in the suppression of food intake by leptin and GLP1R agonists.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10541203</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37581939</oboInOwl:hasDbXref>
        <rdfs:label>GABAergic LepRbGlp1r neuron</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000617"/>
        <skos:relatedMatch rdf:resource="CL:4042033"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/d2c9af73-d9a4-4529-9020-2d3c260bbfc2"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000617"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/d2c9af73-d9a4-4529-9020-2d3c260bbfc2"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4042033"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/d30dcbfd-b869-4cb0-bab1-61761a159a3a -->

    <Class rdf:about="http://example.org/d30dcbfd-b869-4cb0-bab1-61761a159a3a">
        <obo:IAO_0000115>Luminal progenitors serve primarily as tumor initiators or cells of origin for prostate cancer. Various hierarchical models have been proposed. A recent model suggests that, during early postnatal development, multipotent basal cells (p63+ CK5+) differentiate into unipotent basal progenitors, luminal progenitors (CK8+ AR low), and NE cells. These unipotent basal and luminal progenitors can undergo self-renewal or differentiate into basal cells and mature luminal cells (AR+ CK8+), respectively. In adults, during homeostasis and regeneration, the bipotent basal progenitor forms unipotent basal and luminal progenitors, which further undergo self-renewal. Unipotent basal progenitors differentiate into basal cells, and ##luminal cell progenitors## differentiate into luminal cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10291985</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37282627</oboInOwl:hasDbXref>
        <rdfs:label>luminal cell progenitors</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002340"/>
        <skos:relatedMatch rdf:resource="CL:0011026"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/d30dcbfd-b869-4cb0-bab1-61761a159a3a"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002340"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/d30dcbfd-b869-4cb0-bab1-61761a159a3a"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0011026"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/d3292d57-076e-4c32-9f6a-e857735a8282 -->

    <Class rdf:about="http://example.org/d3292d57-076e-4c32-9f6a-e857735a8282">
        <obo:IAO_0000115>Innate Immune Cells	 	Primary Cell Type	Cell subsets	Metabolic Processes	References	 	   Innate Lymphoid Cells	Non-cytolytic:Innate lymphoid cell 1 (ILC1) Innate lymphoid cell 2 (ILC2) Innate lymphoid cell 3 (ILC3)/Lymphoid Tissue Inducers (LTi)Cytolytic:Natural Killer cells (NK)	 Gly FAO/OXPHOS, LM/LDF, Arginine catabolism, Gly Gly/OXPHOS, Vitamin A metabolismGly, AAM, FAO	     	 	  Dendritic Cells	Conventional:Conventional dendritic cell 1 (cDC1) ##Conventional dendritic cell 2## (cDC2) Conventional dendritic cell 3 (cDC3) Tolerogenic DCs Plasmacytoid DCs (pDCs) Inflammatory DCs Langerhans cells Mononuclear Phagocytes (tumor)	 Na: OXPHOS, Ac: GU, Gly, PPP, Dys: LDFNa: OXPHOS, Ac: GU, Gly, PPP, Dys: LDF Not reported FAO/OXPHOS Gly/OXPHOS/FAO Gly Na/Ac/Ma: Not reported Dys: LDFNa: OXPHOS, Ac: Gly, PPP In tumors/Dys: LM/LDF	         	 	 Macrophages	Inflammatory &quot;M1&quot; macrophage Reparative &quot;M2&quot; macrophage  Tumor Associated macrophage (TAM)	Na: OXPHOS, Ac: GU, Gly, PPP. Arg catabolismNa: FAO/OXPHOS, Ac: FAO/OXPHOS, Gly, PPP.  Upregulates Arg1 Na: OXPHOS, Ac: GU, Gly, Tumor/Dys: FAO, LM/LDF	   	 	</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11240245</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:39007133</oboInOwl:hasDbXref>
        <rdfs:label>Conventional dendritic cell 2</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000990"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/d3292d57-076e-4c32-9f6a-e857735a8282"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000990"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/d32e9940-ca3b-4951-b1b9-c8ce3103436c -->

    <Class rdf:about="http://example.org/d32e9940-ca3b-4951-b1b9-c8ce3103436c">
        <obo:IAO_0000115>A, B, tSNE plot of 4659 CD45+ immune cells from the CNS. Data from this study is integrated with data from; Table 6). C, D, Each dataset represented by one tSNE. Cells are annotated using color representing their cell type. bMicroglia: baseline microglia; aMicroglia: activated microglia; pmMicroglia: proliferation-mediating microglia; maMicroglia: monocyte-activating microglia; DAM: disease-associated microglia in SCI; elMicroglia: embryonic-like microglia; pvMacrophages: perivascular macrophages; mdMacrophages: ##monocyte-derived macrophages##; DCs: dendritic cells; imB-cells: immature B-cells; mB-cells: mature B-cells; pimMicroglia: postnatal immature microglia; IEG+Microglia: immediate early genes microglia; sMicroglia: s-phase microglia; pPAM: postnatal proliferative-region-associated microglia; eMicroglia: embryonic microglia; pcpMacrophages: postnatal choroid plexus macrophages; acpMacrophages: adult choroid plexus macrophages; iMonocytes: inflammatory monocytes; pMonocytes: patrolling monocytes; cpEpithelial cells: choroid plexus epithelial cells. E, tSNE plots of 4659 CD45+ immune cells for selected genes indicating the log2(cpm) expression with a continuous color for each cell separately. F, Proliferation rate of CD45low and CD45high cells at 7 and 21 d post-SCI. Hoechst 33342 expression presented on a log-scale was used for defining cells in S-phase. Right most plot reports the percentage of cells in S-phase. Each dot represents one biological replicate (four mice per time point). Mean is surrounded by a 95% CI. This figure is extended in Extended Data Figure 8-1.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8496189</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34417326</oboInOwl:hasDbXref>
        <rdfs:label>monocyte-derived macrophages</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
        <skos:relatedMatch rdf:resource="CL:0000576"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/d32e9940-ca3b-4951-b1b9-c8ce3103436c"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/d32e9940-ca3b-4951-b1b9-c8ce3103436c"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000576"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/d38d18f3-e205-4ad3-bea7-e41d4e8640ff -->

    <Class rdf:about="http://example.org/d38d18f3-e205-4ad3-bea7-e41d4e8640ff">
        <obo:IAO_0000115>Obesity impairs a variety of cell types including adipose-derived mesenchymal stem cells (ASCs). ASCs are indispensable for tissue homeostasis/repair, immunomodulation, and cell renewal. It has been demonstrated that ##obese ASCs## are defective in differentiation, motility, immunomodulation, and replication. We have recently reported that some of these defects are linked to impaired primary cilia, which are unable to properly convey and coordinate a variety of signaling pathways. We hypothesized that the rescue of the primary cilium in obese ASCs would restore their functional properties.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6694567</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31412932</oboInOwl:hasDbXref>
        <rdfs:label>obese ASCs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002570"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/d38d18f3-e205-4ad3-bea7-e41d4e8640ff"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002570"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/d3cf957b-28cc-44f4-bf06-f7a192ff948d -->

    <Class rdf:about="http://example.org/d3cf957b-28cc-44f4-bf06-f7a192ff948d">
        <obo:IAO_0000115>(A) Immunocytochemistry analysis of claudin-5, caveolin-1, and GLUT-1 expression in Passage 1 endothelial cells (ECs) treated with DMSO or 4 microM CHIR. Hoechst nuclear counterstain is overlaid in the merged images. Dashed lines indicate the border between an EC colony and smooth muscle-like cells (##SMLCs##) in the DMSO condition. Scale bars: 200 mum. (B) Quantification of images from the conditions described in (A) for number of ECs per 20x field, percentage of ECs (claudin-5+ cells relative to total nuclei), percentage of GLUT-1+ ECs (relative to total claudin-5+ ECs), and mean fluorescence intensity of claudin-5, caveolin-1, and GLUT-1 normalized to Hoechst mean fluorescence intensity within the area of claudin-5+ ECs only. Points represent replicate wells from 2 to 6 independent differentiations of the IMR90-4 line, each differentiation indicated with a different color. Bars indicate mean values. For the fluorescence intensity plots, values were normalized within each differentiation such that the mean of the DMSO condition equals 1. p-values: two-way ANOVA on unnormalized data.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8664294</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34755601</oboInOwl:hasDbXref>
        <rdfs:label>SMLCs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000192"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/d3cf957b-28cc-44f4-bf06-f7a192ff948d"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000192"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/d4238347-aaf7-40c3-83c4-523b74d3d2ad -->

    <Class rdf:about="http://example.org/d4238347-aaf7-40c3-83c4-523b74d3d2ad">
        <obo:IAO_0000115>scRNA sequencing data was analyzed to further explore the synergistic effect of the IRRS and the TME cells in ESCC. We used the previously profiled transcriptomes of ~208,659 single cells with eight main cell populations ( Figures 4A, B ), among which fibroblasts, endothelial cells, T cells, B cells, pericytes and myeloid cells were analyzed. Next, 40 cell clusters, including T helper 17 (TH17) cells, follicular helper T (TFH1/2) cells, naive T (TN) cells, regulatory T (Treg) cells, memory T (TMEM-CD4/CD8) cells, effector T (TEFF) cells, exhausted T (TEX) cells, monocytes (Mono01-03), tumor-associated macrophages (TAM01-04),dendritic cells (tDC, pDC, cDC), mast cells (Mast), resting B cells, activated B cells, germinal center B cells (GCB), plasma cells, normal mucosa fibroblasts (NMF), normal activated fibroblasts (##NAF##1/2), cancer-associated fibroblasts (CAF1-4), vascular smooth muscle cells (VSMC), normal endothelial cells (NEC1-3) and tumor endothelial cell (TEC1-3) were identified by t-SNE analysis ( Figures 4C-G ;  Figures S6A-E ). We then used CIBERSORTx to infer cell-type abundance from bulk RNA-seq data using scRNA data, and estimated the proportions of the 42 cell types in the training dataset. The proportions of TME cell types between the high- and low-risk groups was compared using the Kruskal-Wallis test. The profiles of the high- and low-risk groups are shown in  Figure 4H  and  Figure S6F . The abundance of TEX, NAF2, CAF4, and VSMC increased, and the abundance of Mono1, TAM03, and NEC2 decreased in the high-risk group (p &lt; 0.05;  Figure 4I ). The cell proportions between low and high risk groups demonstrated significantly distinct TME patterns.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9933905</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36817484</oboInOwl:hasDbXref>
        <rdfs:label>NAF</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000057"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/d4238347-aaf7-40c3-83c4-523b74d3d2ad"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000057"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/d42858dd-ce42-4766-8d69-24775023fe18 -->

    <Class rdf:about="http://example.org/d42858dd-ce42-4766-8d69-24775023fe18">
        <obo:IAO_0000115>In all three datasets, neural progenitors with temporally progressing transcriptional states, glioblasts and astrocytes (SLC1A3 and AQP4) form the most abundant glial lineage (Fig. 1b-e and Extended Data Fig. 6a-f):hereafter collectively referred to as astroglia. In the oligodendrocyte lineage, we discerned proliferating oligodendrocyte progenitor cells (OPCs) (PDGFRA), committed oligodendrocyte precursors (TNR) and postmitotic oligodendrocytes (MAG) (Extended Data Fig. 6a-d,f). Additionally, in human and opossum, we detected an intermediate cell population between glioblasts and OPCs, probably representing a pre-OPC state (EGFR) (Extended Data Fig. 6a-d,f). We distinguished ependymal cells (SPAG17) in the mouse and opossum but not in the human dataset, and in opossum, we further identified ##ependymal progenitors## that share transcriptional traits with glioblasts but express ciliogenesis-related SPAG17 (Extended Data Fig. 6a-d,f). We also detected neural crest- and mesoderm-derived cell types (meningeal, immune (mostly microglia), vascular (mural and endothelial) and erythroid) and small groups of neural cells from neighbouring brain regions, resulting from the migration of a midbrain-originating cell population (LEF1) to the cerebellar primordia or sample contamination (isthmic and midbrain neuroblasts, GABAergic midbrain cells and motor neurons; Fig. 1b,c and Extended Data Fig. 6j).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10808058</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38029793</oboInOwl:hasDbXref>
        <rdfs:label>ependymal progenitors</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000065"/>
        <skos:relatedMatch rdf:resource="CL:0011026"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/d42858dd-ce42-4766-8d69-24775023fe18"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000065"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/d42858dd-ce42-4766-8d69-24775023fe18"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0011026"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/d42bc762-c013-4091-a50b-f45e1fd90826 -->

    <Class rdf:about="http://example.org/d42bc762-c013-4091-a50b-f45e1fd90826">
        <obo:IAO_0000115>The unwounded, normal corneal stroma is a relatively simple, avascular tissue populated with quiescent keratocytes, along with corneal nerves and a few resident dendritic and monocyte/macrophage cells. In the past, the ##resting keratocytes## were thought of as a homogenous cellular population, but recent work has shown local variations in vimentin and nestin expression, and responsiveness to transforming growth factor (TGF)-beta1. Studies have also supported there being &quot;stromal stem cells&quot; in localized areas. After corneal wounding, depending on the site and severity of injury, profound changes in stromal cellularity occur. Anterior or posterior injuries to the epithelium or endothelium, respectively, trigger apoptosis of adjacent keratocytes. Many contiguous keratocytes transition to keratocan-negative corneal fibroblasts that are proliferative and produce limited amounts of disorganized extracellular matrix components. Simultaneously, large numbers of bone marrow-derived cells, including monocytes, neutrophils, fibrocytes and lymphocytes, invade the stroma from the limbal blood vessels. Ongoing adequate levels of TGFbeta1, TGFbeta2 and platelet-derived growth factor (PDGF) from epithelium, tears, endothelium and aqueous humor that penetrate defective or absent epithelial barrier function (EBF) and epithelial basement membrane (EBM) and/or Descemet&apos;s basement membrane (DBM) drive corneal fibroblasts and fibrocytes to differentiate into alpha-smooth muscle actin (SMA)-positive myofibroblasts. If the EBF, EBM and/or DBM are repaired or replaced in a timely manner, typically measured in weeks, then corneal fibroblast and fibrocyte progeny, deprived of requisite levels of TGFbeta1 and TGFbeta2, undergo apoptosis or revert to their precursor cell-types. If the EBF, EBM and/or DBM are not repaired or replaced, stromal levels of TGFbeta1 and TGFbeta2 remain elevated, and mature myofibroblasts are generated from corneal fibroblasts and fibrocyte precursors that produce prodigious amounts of disordered extracellular matrix materials associated with scarring fibrosis. This fibrotic stromal matrix persists, at least until the EBF, EBM and/or DBM are regenerated or replaced, and keratocytes remove and reorganize the affected stromal matrix.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7855915</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33068626</oboInOwl:hasDbXref>
        <rdfs:label>resting keratocytes</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002363"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/d42bc762-c013-4091-a50b-f45e1fd90826"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002363"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/d43a66ca-777d-4c0b-abd4-d7a59cb1c325 -->

    <Class rdf:about="http://example.org/d43a66ca-777d-4c0b-abd4-d7a59cb1c325">
        <obo:IAO_0000115>Lymphocytes such as CD4+ T cells and B cells mainly infiltrate the salivary glands; however, the precise roles and targets of autoreactive T cells and autoantibodies in the pathogenesis of Sjogren&apos;s Syndrome (SS) remain unclear. This study was designed to clarify the role of autoreactive T cells and autoantibodies at the single-cell level involved in the development of sialadenitis. Infiltrated CD4+ T and B cells in the salivary glands of a mouse model resembling SS were single-cell-sorted, and their T cell receptor (TCR) and B cell receptor (BCR) sequences were analyzed. The predominant TCR and BCR clonotypes were reconstituted in vitro, and their pathogenicity was evaluated by transferring reconstituted TCR-expressing CD4+ T cells into Rag2-/- mice and administering recombinant IgG in vivo. The reconstitution of Th17 cells expressing TCR (#G) in Rag2-/- mice resulted in the infiltration of T cells into the salivary glands and development of sialadenitis, while an autoantibody (IgGr22) was observed to promote the proliferation of ##pathogenic T cells##. IgGr22 specifically recognizes double-stranded RNA (dsRNA) and induces the activation of dendritic cells, thereby enhancing the expression of IFN signature and inflammatory genes. TCR#G recognizes antigens related to the gut microbiota. Antibiotic treatment severely reduces the activation of TCR#G-expressing Th17 cells and suppresses sialadenitis development. These data suggest that the anti-dsRNA antibodies and, TCR recognizing the gut microbiota involved in the development of sialadenitis like SS. Thus, our model provides a novel strategy for defining the roles of autoreactive TCR and autoantibodies in the development and pathogenesis of SS.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMID:38762063</oboInOwl:hasDbXref>
        <rdfs:label>pathogenic T cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000084"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/d43a66ca-777d-4c0b-abd4-d7a59cb1c325"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000084"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/d46981be-c1a4-4f8c-b863-9e3b480ad8b8 -->

    <Class rdf:about="http://example.org/d46981be-c1a4-4f8c-b863-9e3b480ad8b8">
        <obo:IAO_0000115>In contrast to brown adipocytes, the principal role of white adipocytes is to sequester lipid by lipogenesis or regulating lipolysis. They also secrete bioactive molecules (e.g., extracellular vesicles, lipokines, and adipokines) that target systemic organs. The mean volume of a white adipocyte is proportional to the rate of lipogenesis, the rate of lipolysis, and the nutrient supply/blood flow. EAT and visceral adipose are both predominantly white adipose depots and similar in many respects. Generally, EAT volume correlates with visceral adiposity, as measured by echocardiogram and CT. Epicardial adipocytes and ##adipocytes from visceral fat## depots are smaller than subcutaneous adipocytes. EAT has a greater concentration of capillaries and increased expression of a broad array of inflammatory markers. On the other hand, there are subtle differences between epicardial and adipocytes from fat within the abdominal cavity. Ovine epicardial adipocytes have a greater ratio of oleic acid (18:1) to stearic acid (18:0) than peri-renal or omental adipocytes. Although stearoyl-CoA desaturase (SCD) expression was lowest in epicardial fat compared to all other depots, there was a high correlation between SCD expression and oleic acid content in epicardial adipocytes, whereas there was no correlation in visceral adipocytes. Like visceral adipose tissue, EAT has a greater expression of inflammatory genes than subcutaneous adipose tissue. This is true even in the absence of cardiovascular disease or obesity. In humans with obesity and in animal models of high fat feeding visceral adipose becomes inflamed which leads to dysfunctional adipocyte biology, lipotoxicity, and insulin resistance in remote tissues. This vast field of research (immunometabolism) has ushered in a new era of discovery, investigation, and therapeutic opportunity that is beyond the scope of this review. However, whether epicardial adipose tissue responds in the same way to high fat feeding/obesity has yet to be shown. White perivascular adipose tissue surrounding the abdominal aorta in mice becomes severely inflamed with HFD. Given the similarities between VAT and EAT, it is reasonable to consider the possibility that epicardial fat does too.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10067711</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37020587</oboInOwl:hasDbXref>
        <rdfs:label>adipocytes from visceral fat</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000136"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/d46981be-c1a4-4f8c-b863-9e3b480ad8b8"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000136"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/d477948f-458b-459a-82c0-b34692604eff -->

    <Class rdf:about="http://example.org/d477948f-458b-459a-82c0-b34692604eff">
        <obo:IAO_0000115>alpha-SMA	Alpha smooth muscle actin	LEC	Lymphatic endothelial cell	 	ADSCs	Adipose-derived stem cells	Lymphoid-like	Lymphoid-like cell	 	ADAMTS	Disintegrin and metalloproteinase with thrombospondin motifs	Mac	Macrophage	 	AEC	Arterial endothelial cells	MAIT	Mucosal-associated invariant T cell	 	AFG	Autologous fat grafting	MMPs	Matrix metalloproteinases	 	APC	Adipocyte precursor cells	MC	Mast cell	 	BC	B cell	mCD8 T	Mature CD8 T cell	 	BKC	Basal keratinocyte	mNK	Mature natural killer cell	 	BMI	Body mass index	Myeloid-like	Myeloid-like cell	 	CCNs	Cellular communication network factors	nCD4 T	Naive CD4 T cell	 	cDC	Classic dendritic cell	nCD8 T	Naive CD8 T cell	 	CEC	Capillary endothelial cell	ncMos	Non-classic monocytes	 	DC	Dendritic cell	NK-like	Natural killer-like cell	 	CD	Cluster of differentiation	PC	Pericyte	 	CTGF	Connective tissue growth factor	PCA	Principal component analysis	 	DEGs	Differentially expressed genes	scRNA-seq	Single-cell RNA sequencing	 	##DKC##	Differentiating keratinocytes	SMC	Smooth muscle cell	 	EC	Endothelial cell	SNN	Shared nearest neighbour	 	ECM	Extracellular matrix	SSc	Scleroderma	 	EMT	Epithelial-to-mesenchymal transition	SVF	Stromal vascular fraction	 	FACS	Fluorescence-activated cell sorting	TC	T cell	 	FB	Fibroblast	TGF-beta1	Transforming growth factor 1	 	FGFRs	Fibroblast growth factor receptors	TIMPs	Tissue inhibitors of metalloproteinases	 	GEO	Gene expression omnibus	TREG	Regulatory T cells	 	GO	Gene Ontology	UMAP	Uniform manifold approximation and projection	 	IFATS	International Federation for Adipose Therapeutics and Science	VEC	Venous endothelial cell	 	ILC	Innate lymphoid cell	WAT	White adipose tissue	 	KEGG	Kyoto Encyclopedia of Genes and Genomes			 	</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10341100</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37443817</oboInOwl:hasDbXref>
        <rdfs:label>DKC</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000312"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/d477948f-458b-459a-82c0-b34692604eff"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000312"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/d4997003-d24c-4394-9972-5beae283b74a -->

    <Class rdf:about="http://example.org/d4997003-d24c-4394-9972-5beae283b74a">
        <obo:IAO_0000115>Our results implicated CD49f+/ERalpha + prostate cancer cells associated with basal stem-like and EMT features, named EMT-##PCBSLCs##, in heightened potential for promoting metastasis. NOTCH1 was regulated by E2 in CD49fHi EMT-PCBSLCs. These results contribute to insights into the metastatic mechanisms of EMT-PCBSLCs in PCa.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6533681</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31122254</oboInOwl:hasDbXref>
        <rdfs:label>PCBSLCs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002341"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/d4997003-d24c-4394-9972-5beae283b74a"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002341"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/d4b091e7-3aaf-48dd-8ce7-7811db640c00 -->

    <Class rdf:about="http://example.org/d4b091e7-3aaf-48dd-8ce7-7811db640c00">
        <obo:IAO_0000115>Within a limbic cortico-basal ganglia-thalamo-cortical signaling loop, the nucleus accumbens (NAc), in particular the dorsolateral NAc subregion, is suggested to play an important role in decision-making via its role in linking information concerning outcome values with that related to goal selection. ##NAc medium spiny projection neurons## (MSN), the major neuron type, are typically anatomically divided into two roughly equal subpopulations; dopamine D1 receptor-expressing MSNs (D1-MSN) that project predominantly to the ventral pallidum (VP) and substantia nigra pars reticulata (SNr), and dopamine D2 receptor-expressing MSNs (D2-MSN) that project predominantly to the VP. While previous studies have demonstrated NAc D1-MSNs to be implicated in reward-related learning and D2-MSNs to be involved in aversion-related learning and behavioral flexibility, the specific role that NAc D1- and D2-MSNs may play in the inhibition of behavioral responses is less clear.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10121661</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37085502</oboInOwl:hasDbXref>
        <rdfs:label>NAc medium spiny projection neurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:4030051"/>
        <skos:relatedMatch rdf:resource="CL:4030052"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/d4b091e7-3aaf-48dd-8ce7-7811db640c00"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4030051"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/d4b091e7-3aaf-48dd-8ce7-7811db640c00"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4030052"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/d4b25b4a-ac8c-41bf-b12f-191c1113cb7d -->

    <Class rdf:about="http://example.org/d4b25b4a-ac8c-41bf-b12f-191c1113cb7d">
        <obo:IAO_0000115>BST-1hi TPECs Function as the Exit Site for ##Mature Thymocytes##, While BST-1lo/- TPECs Serve as the Entry Sites for HPCs</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8281811</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34276703</oboInOwl:hasDbXref>
        <rdfs:label>Mature Thymocytes</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000893"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/d4b25b4a-ac8c-41bf-b12f-191c1113cb7d"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000893"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/d4c18b41-eb3c-4123-a101-480fad1e6eef -->

    <Class rdf:about="http://example.org/d4c18b41-eb3c-4123-a101-480fad1e6eef">
        <obo:IAO_0000115>The implications of specific immune cell types on GBM disease status were unknown. In most cancers, the presence of tumor-infiltrating lymphocytes (##TILs##) is positively correlated with the improvement of overall survival in patients, but the correlation between the presence of TILs and the improvement of overall survival in GBM patients has not been clearly established. Myeloid cells, especially microglia and macrophages, in the tumor microenvironment regulate GBM progression and influence therapeutic outcomes. Besides, resident fibroblasts, endothelial cells, pericytes, and the extracellular matrix also contribute to cancer progression. Abnormal cytokine expression was found to be associated with glioma progression. Within the heterogeneous GBM microenvironment, tumor cells, normal brain cells, immune cells, and stem cells interact with each other through the complex cytokine network. The formation of the GBM tumor microenvironment has been associated with specific mutations. For example, the IDH mutation has recently been found to be associated with decreased immune cell infiltration, whereas inactivated NF1 has been associated with increased macrophage infiltration. In addition, several major signaling pathways like NFkappaB, Wnt, and PI3K-AKT-mTOR are reported to be involved in the pathogenesis of GBM and have been used as therapeutic targets for GBM.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9851159</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36685556</oboInOwl:hasDbXref>
        <rdfs:label>TILs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000542"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/d4c18b41-eb3c-4123-a101-480fad1e6eef"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000542"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/d4cab44d-a8c2-4567-b5d4-5a8db2e5ebf4 -->

    <Class rdf:about="http://example.org/d4cab44d-a8c2-4567-b5d4-5a8db2e5ebf4">
        <obo:IAO_0000115>Sjogren&apos;s syndrome is a chronic autoimmune disorder whose pathogenesis is poorly understood and that lacks effective therapies. Detailed quantitative and spatial analyses of tissues affected by Sjogren&apos;s syndrome were undertaken, including the quantitation of the frequency of selected cell-cell interactions in the disease milieu. Quantitative analyses of CD4+ T cell subsets and of CD8+ T cells in the labial salivary glands from untreated patients with primary Sjogren&apos;s syndrome revealed that activated CD8+ cytotoxic T cells (CD8+CTLs) were the most prominent T cells in these infiltrates. An accumulation of ##apoptotic glandular epithelial cells##, mainly ductal and acinar cells, was observed, consistent with the impaired salivary secretion often observed in patients with this disease. FasL expressing activated CD8+ T cells were seen to accumulate around Fas expressing apoptotic epithelial cells. Quantitative analyses of apoptotic cell types and of conjugates between cytotoxic T cells and epithelial cells undergoing apoptosis suggest that Sjogren&apos;s syndrome is primarily driven by CD8+CTL mediated execution of epithelial cells mainly represented by ductal and acinar cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9475031</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36104369</oboInOwl:hasDbXref>
        <rdfs:label>apoptotic glandular epithelial cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000445"/>
        <skos:relatedMatch rdf:resource="CL:1001596"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/d4cab44d-a8c2-4567-b5d4-5a8db2e5ebf4"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000445"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/d4cab44d-a8c2-4567-b5d4-5a8db2e5ebf4"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:1001596"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/d4f35711-f6e6-41ef-bc52-9dc6bf7000a6 -->

    <Class rdf:about="http://example.org/d4f35711-f6e6-41ef-bc52-9dc6bf7000a6">
        <obo:IAO_0000115>Top marker characterization has enabled us to distinguish between the following cell types: B cells, CD4 T cytotoxic, ##CD4 T self-renewing##, CD8 T cytotoxic, CD8 T exhausted, CD8 T memory, DC plasmacytoid, Macrophages, NK cells, Plasma cells, T gamma delta cells and T-reg cells (Figure 3a). Additionally, we have managed to increase the resolution of the B-cell lineage to refine it into four different cell subtypes representing known functions and differentiation stages, as well as phenotypes that have not been characterized before and might be induced by the tumor: Naive B cells, featured by MS4A1, IRF8, BANK1, CD22, and TXNIP expression; Naive B cells Immunoglobulins Kappa Light chains (IGK)-high, with the following specific expression markers: IGKV1-39, IGKV1-12, FLJ20373, MS4A1, and ARHGEF39; Naive B cells Immunoglobulins Lambda Light chains (IGL)-high, characterized by the specific expression of IGLV2-23, IGLV2-11, IGLV2-14, IGLC3, IGLC1; Plasma cells, with SDC1, IGHG3, IGJ, CD38, and XBP1 as cell-type markers and Plasmablasts, with the specific expression of IGKV2-28, IGKV2D-28, CD5, IL2RA and FGR) (Figure 3a, Figure S3). Interestingly, apart from the general B-cell lineage, we have managed to identify the specific B-cell population associated with response: the Naive B-cell population, in particular the one characterized by overexpression of IGK (Naive B cells IGK-high) (Figure 3b, Table S7). In addition, we have identified three stromal immune cell types associated with bad response: Plasmacytoid Dendritic Cells, Macrophages and Gamma Delta T cells (Table S7).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9408876</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36012390</oboInOwl:hasDbXref>
        <rdfs:label>CD4 T self-renewing</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000624"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/d4f35711-f6e6-41ef-bc52-9dc6bf7000a6"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000624"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/d4fb3893-1e97-4aee-87f8-6632fde2fbd3 -->

    <Class rdf:about="http://example.org/d4fb3893-1e97-4aee-87f8-6632fde2fbd3">
        <obo:IAO_0000115>K2Taxonomer was remarkably accurate in capturing the higher-order organization of the 28 cell types. The first partition separated all epithelial cell subtypes from non-epithelial cell types (Figure 4B). Further partitioning of the 17 epithelial cell subtypes yielded five subgroups, characterized by shared morphology, labeled as &apos;Ciliated&apos;, &apos;Basal&apos;, &apos;Submucosal&apos;, &apos;##Brush-like##&apos; and &apos;AE&apos; (Alveolar Epithelium). The &apos;Ciliated&apos; subgroup was comprised of differentiated multiciliated cells and their precursor, deuterosomal cells. The &apos;Basal&apos; subgroup was comprised of epithelial cell progenitors, basal and cycling basal cells, as well as epithelial cell intermediary, suprabasal cells. The &apos;Brush-like&apos; subgroup was comprised of three rare airway epithelial cell types: brush, ionocyte, and pulmonary neuroendocrine cells (PNECs), as well as their likely shared &apos;brush-like&apos; precursor cells, as suggested in the original publication of these data. Further partitioning of the 11 non-epithelial cell types yielded two main subgroups characterized by shared progenitor cells: immune and mesenchymal stem cells, with the immune cell subgroup also including endothelial cells. Further partitions of the immune cell subgroup included progeny of monoblasts: monocytes, dendritic cells, and macrophages , followed by endothelial cells separated from all non-monoblast progeny immune cells subtypes in the adjacent subgroup.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8464061</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34226941</oboInOwl:hasDbXref>
        <rdfs:label>Brush-like</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002204"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/d4fb3893-1e97-4aee-87f8-6632fde2fbd3"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002204"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/d4fc903d-d063-4835-bc37-3693b375c865 -->

    <Class rdf:about="http://example.org/d4fc903d-d063-4835-bc37-3693b375c865">
        <obo:IAO_0000115>Up-regulated DEGs in ##I-MSCs## compared with Mx- and Md-MSCs</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7310078</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32571211</oboInOwl:hasDbXref>
        <rdfs:label>I-MSCs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000134"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/d4fc903d-d063-4835-bc37-3693b375c865"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000134"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/d51ee371-d9e4-4e1c-a277-e6e2b7385369 -->

    <Class rdf:about="http://example.org/d51ee371-d9e4-4e1c-a277-e6e2b7385369">
        <obo:IAO_0000115>Immune regulation by helminths acts at many levels to interfere with innate antigen sensitization, induction of adaptive immunity, and mobilization of effector mechanisms. 7  One of the most prominent pathways for parasite immunomodulation is through regulatory T-cells (Tregs). Tregs are classified by their expression of the transcription factor Foxp3 (FOXP3 in humans) and can express a number of surface markers that are key for their function, including CD25, cytotoxic T-lymphocyte-associated protein 4 (CTLA-4), inducible T-cell co-stimulator (ICOS) and T-cell immunoreceptor with Ig and ITIM domains (TIGIT). 8  In both mouse and human studies, Tregs are often defined as CD3+ CD4+ CD25+ Foxp3+ cells, although Treg cells comprise a diverse population. During development, the first set of Tregs are formed in the thymus, making up the natural Treg population (nTreg), while a second type of Tregs can be induced in the periphery from naive CD4 T-cells [induced Tregs (iTreg)/peripheral Tregs (##pTreg##)] in the presence of specific cytokines such as interleukin (IL)-2 and transforming growth factor beta (TGF-beta); however, the expression of Foxp3, and indeed regulatory activity, is variable depending on the level of demethylation at the Foxp3 locus, and recent studies have identified a number of Treg subtypes delineated by CD25, Foxp3 and the epigenome. 9  Regulatory activity can also be found in other lymphocyte subsets, such as the Foxp3-IL-10+ Tr1 cells (previously defined as Th3 10 ), although their role in controlling immune responses in helminth infection has yet to be established.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7341546</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32153025</oboInOwl:hasDbXref>
        <rdfs:label>pTreg</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000815"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/d51ee371-d9e4-4e1c-a277-e6e2b7385369"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000815"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/d5318882-97cb-4a53-91e4-318fd823c375 -->

    <Class rdf:about="http://example.org/d5318882-97cb-4a53-91e4-318fd823c375">
        <obo:IAO_0000115>Initially, intratumor heterogeneity was investigated when biopsy specimens were taken from spatially separated areas of a single tumor. The transition to a new level in studies of intratumor heterogeneity, including highly heterogeneous glioblastoma, became possible with the development of single-cell approaches with dramatically increased resolution. Single-cell RNA sequencing (scRNA-seq) has become a key method for comprehensively analyzing cellular states in tissues, both in normal conditions and during pathological processes. It was shown by scRNA-seq that a single glioblastoma tumor consisted of a heterogeneous mixture of cells representing a wide variety of subgroups. Malignant glioblastoma cells from different patients have been found to exist in four reproducible cell states, namely neural progenitor like (NPC-like), oligodendrocyte progenitor like (OPC-like), astrocyte like (AC-like), and mesenchymal like (##MES##-like). Moreover, intratumor heterogeneity includes non-malignant cells in the tumor microenvironment, such as neuronal, glial, and immune populations, as well as endothelial cells, which can functionally interact with cancer cells and promote tumor development.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11313325</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:39126040</oboInOwl:hasDbXref>
        <rdfs:label>MES</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0008019"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/d5318882-97cb-4a53-91e4-318fd823c375"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0008019"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/d56064a2-5192-47d9-b0a4-db2b70d4189b -->

    <Class rdf:about="http://example.org/d56064a2-5192-47d9-b0a4-db2b70d4189b">
        <obo:IAO_0000115>Highly regulated processes establish intercellular communication between bone-resident cells, each with its own distinctive role, to ensure a finely tuned balance between bone resorption and bone formation. The major bone-resorbing cell type is the osteoclast. Osteoclasts are multinucleated cells formed by the fusion of mononuclear, monocyte-derived, macrophage precursors, and their main function is resorption of cartilage and bone matrices. Vessel-associated osteoclasts drive cartilage resorption during bone growth, whereas ##bona fide osteoclasts## regulate resorption of mineralised bone matrix during bone maintenance and repair. Furthermore, with bone being the largest reservoir for calcium storage in the body, resorption also facilitates calcium release to maintain optimal circulating levels. Osteoblasts play the opposite role to osteoclasts, constituting the major bone-forming cell type. Mesenchymal stem cells (MSCs) are situated at the apex of the osteoblast lineage cell hierarchy, differentiating stepwise into osteoprogenitors, bone lining cells, osteoblasts, and, ultimately, osteocytes. Osteoblast lineage cells have numerous roles depending on their differentiation stage. Osteoprogenitors and bone lining cells constitute a pool of immature osteoblasts, maintained in a quiescent state that can be utilized for bone remodelling and repair. Mature osteoblasts ensure production and secretion of a new protein-rich bone matrix and its subsequent mineralization. Osteocytes are terminally differentiated osteoblasts, entombed within mineralised bone, acting as the main regulatory unit of skeletal homeostasis. Additional cells supporting bone homeostasis include endothelial cells (ECs), adipocytes, and chondrocytes.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8305002</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34298886</oboInOwl:hasDbXref>
        <rdfs:label>bona fide osteoclasts</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000779"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/d56064a2-5192-47d9-b0a4-db2b70d4189b"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000779"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/d5919592-bd64-4442-85fb-5529de38f1d8 -->

    <Class rdf:about="http://example.org/d5919592-bd64-4442-85fb-5529de38f1d8">
        <obo:IAO_0000115>In summary, from work done in frontal areas, it is clear that I-S cells are involved in enhancing learning and memory discrimination, are recruited during theta rhythms, and primarily target SOM+ cells, but also PV+ cells (i.e., similar to hippocampal CA1 I-S3 cells; Figures 1A,B). Further characterization of VIP+ cell types in frontal areas is needed to distinguish how much I-S cell types in these areas contact pyramidal cells, compared to ##non-I-S VIP+ cells##.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7296096</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32581726</oboInOwl:hasDbXref>
        <rdfs:label>non-I-S VIP+ cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:4023016"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/d5919592-bd64-4442-85fb-5529de38f1d8"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4023016"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/d5c67b0a-be90-4404-87b7-7ae9ef740183 -->

    <Class rdf:about="http://example.org/d5c67b0a-be90-4404-87b7-7ae9ef740183">
        <obo:IAO_0000115>Molecular characteristics of ##perimeningeal astrocytes## (PMA) and mature lesion border astrocytes (LBA).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11303254</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38907165</oboInOwl:hasDbXref>
        <rdfs:label>perimeningeal astrocytes</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000127"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/d5c67b0a-be90-4404-87b7-7ae9ef740183"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000127"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/d5dff34f-9796-4dc3-a435-89b1b79feb95 -->

    <Class rdf:about="http://example.org/d5dff34f-9796-4dc3-a435-89b1b79feb95">
        <obo:IAO_0000115>a Line drawing of a cross section of the floor of the cochlear duct at P1. Distinct cell types within the organ of Corti (OC) are color coded. b Heat map for ~14,000 cochlear cells collected from four separate experiments at P1. Top 25 differentially expressed (DE) genes for the 15 identified clusters are shown. Cellular identity for each cluster is indicated by a color bar at the top of the heat map, which corresponds to the legend in a, and by a cell name at the bottom. c tSNE plot for the same cells as in b. Cluster identities are indicated. d Violin plots showing normalized log-transformed expression values for the top five DE genes for each cell type (color coded as in c) by comparison with all other P1 cells (gray on the right in each graph). Bars indicate median expression level. e Upper left panel, tSNE plot of cells determined to be derived from KO (between the OC and medial edge of the cochlear duct). Lower left panel, feature plot for the same cells as in the upper panel indicating high expression of Otoa, Calb1, and Fabp7 (based on color) in different clusters of cells. Lower right panel, cross sections through the cochlear duct at P1, illustrating expression of CALB1 in the medial region of KO and FABP7 directly adjacent to the OC (arrow; scale bars, 20 mum). Lowest panel shows high-magnification view of expression of FABP7 (arrow, gray scale) at the lateral KO border (green line; scale bar, 10 mum). Upper right panel, summary diagram of the spatial distribution of KO cell clusters at P1. HC hair cells, IPhC inner phalangeal cells/border cells, IPC inner pillar cells, OPC outer pillar cells, DC1/2 Deiters&apos; cells rows 1 and 2, DC3, ##Deiters&apos; cells row 3##, HeC Hensen&apos;s cells, CC/OSC Claudius cells/outer sulcus cells, IdC interdental cells, ISC inner sulcus cells, KO Kolliker&apos;s organ cells, L.KO lateral Kolliker&apos;s organ cells, M.KO medial Kolliker&apos;s organ cells, OC90 OC90+ cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7221106</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32404924</oboInOwl:hasDbXref>
        <rdfs:label>Deiters&apos; cells row 3</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000635"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/d5dff34f-9796-4dc3-a435-89b1b79feb95"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000635"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/d6013100-7371-4efd-9dab-5302b2fb9d9d -->

    <Class rdf:about="http://example.org/d6013100-7371-4efd-9dab-5302b2fb9d9d">
        <obo:IAO_0000115>Tonsillar CD4+ T cell subsets can be divided into three major groups. Most intrafollicular T cells belong to the follicular B helper T cell group (follicular Th [TFH], CD4+PD1+CXCR5+BCL6high). B cell and TFH interactions are crucial for the formation of the humoral immune response and support B cell somatic hypermutation and Ab class switching. Other tonsillar CD4+ T cell subsets include non-TFH (CD4+PD1-CXCR5-BCL6low) and pre-TFH (CD4+PD1+CXCR5-BCL6mid). Pre-TFH cells develop from activated Ag-specific CD4+ T cells. The transcriptional program that is initiated in ##pre-TFH cells## can induce CXCR5 expression, enabling the cells to migrate toward the B cell follicle.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8278278</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34099545</oboInOwl:hasDbXref>
        <rdfs:label>pre-TFH cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002038"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/d6013100-7371-4efd-9dab-5302b2fb9d9d"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002038"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/d615ca31-dbc4-4464-ac83-8dab18b30b75 -->

    <Class rdf:about="http://example.org/d615ca31-dbc4-4464-ac83-8dab18b30b75">
        <obo:IAO_0000115>Immunological changes in Foxp3+Helios+ and Foxp3+CD25+ Tregs during T. pallidum/HIV-1 co-infection. The gating strategy for the analysis of Foxp3+CD25+ and Foxp3+Helios+ (A) cells is indicated. The frequencies of Foxp3+CD25+ Treg cells (B) and Foxp3+Helios+ Treg cells (C) were analyzed by flow cytometry in the HC, RPR+, CHI, and CHI&amp;RPR+ groups. Frequencies of Foxp3+CD25+CD45RA+ Treg cells (D), ##Foxp3+Helios+CD45RA+ Treg cells## (E), Foxp3+CD25+CD45RO+ Tregs (F), and Foxp3+Helios+CD45RO+ Tregs (G) were analyzed by flow cytometry in the HC, RPR+, CHI, and CHI&amp;RPR+ groups. The correlations between the CD4+ T-cell counts and the frequencies of Foxp3+Helios+ Treg cells (H) and Foxp3+Helios+CD45RO+ cells (I) in the CHI group were evaluated with Spearman&apos;s rank correlation test. Significance was assessed by calculating p-values using ANOVA, Student&apos;s t-tests, or Mann-Whitney U-tests, with values of p &lt; 0.05 considered significant.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6465566</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31024549</oboInOwl:hasDbXref>
        <rdfs:label>Foxp3+Helios+CD45RA+ Treg cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000815"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/d615ca31-dbc4-4464-ac83-8dab18b30b75"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000815"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/d6433bd7-f1c8-4f2a-9536-ddd4a28c62f9 -->

    <Class rdf:about="http://example.org/d6433bd7-f1c8-4f2a-9536-ddd4a28c62f9">
        <obo:IAO_0000115>To explore this hypothesis, we first evaluated the size and weight of the spleens in mice, as well as the total number of splenocytes ( Figure 1A ). In Lrba-/-  mice, signs of splenomegaly were observed despite a healthy phenotype. These findings suggest lymphocyte expansion in the absence of infection, similar to that observed in patients with human LRBA deficiency. In addition, we evaluated the splenic stages of B cell differentiation. Naive B cells that egress from the bone marrow toward the spleen can be distinguished using cellular markers. These were categorized as transitional type 1 (T1) and T2 B cells. Upon encountering antigens, T1 B cells undergo apoptosis. This process helps to deplete ##autoreactive B cells## through apoptosis. T2 B cells respond positively to BCR crosslinking and proliferate to differentiate into mature B cells. When T1, T2, and follicular B cells were examined, a slight yet significant reduction in the proportion of T1 cells was observed in Lrba-/-  mice ( Figure 1B ). Similar data was obtained after the total counts of T1, T2, MZ and follicular B cells were calculated ( Figure 1B ). Analysis of MZ B cells showed slightly increased proportions and total numbers in Lrba-/- mice. MZ B cells are important for immunity to encapsulated bacteria, and their development has been suggested to depend on BCR signaling strength.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11284061</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:39076990</oboInOwl:hasDbXref>
        <rdfs:label>autoreactive B cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000236"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/d6433bd7-f1c8-4f2a-9536-ddd4a28c62f9"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000236"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/d64f6444-d7d5-4e0e-95f8-2c3e7483d03f -->

    <Class rdf:about="http://example.org/d64f6444-d7d5-4e0e-95f8-2c3e7483d03f">
        <obo:IAO_0000115>Transcriptional signature of pancreas infiltrating and circulating CD4+ and CD8+ T cell subsets at disease onset. (A) UMAP plot of CD4+ and CD8+ T cells from peripheral blood and pancreas of new-onset diabetic NOD mice. (B) Feature plots depicting gene expression levels of distinct markers driving CD4+ and CD8+ T cell activation states. (C, D) UMAP plot of CD4+ (C) and CD8+ (D) T cells grouped by the annotation in A (left) and grouped by T cell subset classified based on the expression of Cd44 and Sell (right). EM = effector memory (Cd44+Sell-), CM = ##central memory## (Cd44+Sell+), naive (Cd44-Sell+), and CD44low CD62L- (Cd44-Sell-). (E, F) Heatmap depicting row-based z-scores of scaled gene expression levels for marker genes driving T cell heterogeneity across the distinct CD4+ (E) and CD8+ (F) T cell subsets. (G, H) Trajectory of CD4+ (G) and CD8+ (H) naive, CD44low CD62L-, effector memory (EM), and central memory (CM) T cell subsets projected onto the UMAP plot (top). Violin plots depicting the pseudotime of CD4+ (G) and CD8+ (H) T cells per subset (bottom). Each dot represents a single cell. (I, J) Differentially expressed genes of CD4+ Cd44-Sell- (I) and CD8+ Cd44-Sell- (J) T cells between peripheral blood and pancreas.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10667927</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38027120</oboInOwl:hasDbXref>
        <rdfs:label>central memory</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000904"/>
        <skos:relatedMatch rdf:resource="CL:0000907"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/d64f6444-d7d5-4e0e-95f8-2c3e7483d03f"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000904"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/d64f6444-d7d5-4e0e-95f8-2c3e7483d03f"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000907"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/d68a3695-3414-4305-9488-7120d2c07c89 -->

    <Class rdf:about="http://example.org/d68a3695-3414-4305-9488-7120d2c07c89">
        <obo:IAO_0000115>Multiple lines of evidence indicate that quantification of immune cell infiltrates in primary prostate cancer can predict outcomes after radical prostatectomy, including biochemical recurrence, metastasis, and death from prostate cancer. In a recent issue of The Journal of Pathology, Andersen et al explored the predictive value of cancer tissue infiltration of seven immune cell types (mast cells, M1 macrophages, M2 macrophages, B cells, T helper cells, cytotoxic T cells, and regulatory T cells) in association with biochemical recurrence after radical prostatectomy. In addition to reporting a potential association between ##cancer-infiltrating regulatory T cells## and M1 and M2 macrophages and biochemical recurrence, the study also highlighted the use of multiplex digital pathology analyses to assess adverse predictors of prostate cancer outcomes.   2021 The Pathological Society of Great Britain and Ireland. Published by John Wiley &amp; Sons, Ltd.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMID:34694014</oboInOwl:hasDbXref>
        <rdfs:label>cancer-infiltrating regulatory T cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000815"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/d68a3695-3414-4305-9488-7120d2c07c89"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000815"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/d6c32076-3009-4fe8-b288-901de52eaf92 -->

    <Class rdf:about="http://example.org/d6c32076-3009-4fe8-b288-901de52eaf92">
        <obo:IAO_0000115>Collectively, these studies suggest a level of specialization among ##CAFs## concerning pro-angiogenic behavior or association with tumor vessels, necessitating further investigation. Understanding the specific contributions of the cell of origin to these phenotypes, particularly the relationship between vCAFs and perivascular cells, remains a key area of interest. Recent studies are beginning to uncover the distinct role of tumor-associated pericytes as an independent entity from CAFs. Whether these distinct CAF phenotypes signify particular functions associated with vascular regulation and unique distributions within tumors or represent remnants of their lineage (e.g., mural cell- or EC-derived CAFs) is yet to be determined. Future studies employing techniques like scRNAseq and spatial transcriptomics to map tissue/tumor cell composition and cell communication as well as lineage tracing analyses of CAF subtype cellular origins are expected to provide further evidence on the specific pro- or anti-angiogenic roles of CAF subpopulations (Fig. 3).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11322395</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38453816</oboInOwl:hasDbXref>
        <rdfs:label>CAFs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000057"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/d6c32076-3009-4fe8-b288-901de52eaf92"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000057"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/d6e7f9e8-4dda-4a1c-b417-f9edf8ea23a6 -->

    <Class rdf:about="http://example.org/d6e7f9e8-4dda-4a1c-b417-f9edf8ea23a6">
        <obo:IAO_0000115>(A) Example flow cytometry plots for the expression of Cx3cr1GFP and TIM4 on thymic macrophages at different times during embryonic development (E14.5, E17.5), immediately after birth, at 7 days, and 6 weeks of age. (B) Frequencies of Timd4+Cx3cr1- (Timd4 single-positive or Timd4SP), Timd4+Cx3cr1+ (double-positive or DP), and Cx3cr1+Timd4- (Cx3cr1 single-positive or Cx3cr1SP) thymic macrophages at the indicated time points. (C) Kinetics of the changes in different subpopulations of thymic macrophages from E14.5-6 weeks. (D) Frequencies at E15.5 and E19.5 of GFP-labeled cells among TIM4+ or TIM4- cells in Cx3cr1CreER x ROSA26LSL-GFP embryos treated with 4-OHT at E9.5. (E) Scheme of the fate-mapping experiments showing the relationship between ##Cx3cr1+ and Timd4+ thymic macrophages## during embryonic development. E15.5 pregnant ROSA26LSL-GFP mice mated with Cx3cr1CreER males were injected with 4-hydroxytamoxifen (4-OHT) and sacrificed at E19.5. (F) Representative flow cytometry staining for TIM4 and CX3CR1 in fate-mapped GFP+ thymic macrophages at E19.5. The panel to the right is the isotype control for CX3CR1-PE staining. (G) Frequencies of TIM4+CX3CR1- cells among fate-mapped GFP+ macrophages. Data are shown as meanSEM and are from at least two independent experiments for each panel. Each symbol is an individual mouse or embryo.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9754631</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36449334</oboInOwl:hasDbXref>
        <rdfs:label>Cx3cr1+ and Timd4+ thymic macrophages</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000866"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/d6e7f9e8-4dda-4a1c-b417-f9edf8ea23a6"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000866"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/d70dbd19-0101-40c9-8803-fd7c73250edd -->

    <Class rdf:about="http://example.org/d70dbd19-0101-40c9-8803-fd7c73250edd">
        <obo:IAO_0000115>The Table shows the numerical representations of Excitatory Neurons (Deep and Superficial Pyramidal cells) and Inhibitory neurons (Oriens Lacunosum moleculare cells:OLM; Trilaminar cells:Tri, Backprojection cells:BP, cholecystokinin positive Basket cells:CCKBC, Parvalbumin positive cells:PVBC, ##AxoAxonic Cells##:AA, Ivy Cells:IVY, Bistratified cells:BS, Schaffer Collateral associated cells:SCA, Perforant Pathway Associated cell:PPA, Neurogliaform:NG) subdivided on the basis of the placement classes (SO, SP, SR, SLM).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9381785</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35974119</oboInOwl:hasDbXref>
        <rdfs:label>AxoAxonic Cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000498"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/d70dbd19-0101-40c9-8803-fd7c73250edd"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000498"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/d726dbd7-d418-4570-81e8-668c5aa953ac -->

    <Class rdf:about="http://example.org/d726dbd7-d418-4570-81e8-668c5aa953ac">
        <obo:IAO_0000115>Childhood neuroblastoma has a remarkable variability in outcome. Age at diagnosis is one of the most important prognostic factors, with children less than 1 year old having favorable outcomes. Here we study single-cell and single-nuclei transcriptomes of neuroblastoma with different clinical risk groups and stages, including healthy adrenal gland. We compare tumor cell populations with embryonic mouse sympatho-adrenal derivatives, and post-natal human adrenal gland. We provide evidence that low and high-risk neuroblastoma have different cell identities, representing two disease entities. Low-risk neuroblastoma presents a transcriptome that resembles ##sympatho- and chromaffin cells##, whereas malignant cells enriched in high-risk neuroblastoma resembles a subtype of TRKB+ cholinergic progenitor population identified in human post-natal gland. Analyses of these populations reveal different gene expression programs for worst and better survival in correlation with age at diagnosis. Our findings reveal two cellular identities and a composition of human neuroblastoma tumors reflecting clinical heterogeneity and outcome.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8423786</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34493726</oboInOwl:hasDbXref>
        <rdfs:label>sympatho- and chromaffin cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0011103"/>
        <skos:relatedMatch rdf:resource="CL:1000426"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/d726dbd7-d418-4570-81e8-668c5aa953ac"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0011103"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/d726dbd7-d418-4570-81e8-668c5aa953ac"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:1000426"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/d72b78b9-a4cb-4df4-84ad-c4513891b214 -->

    <Class rdf:about="http://example.org/d72b78b9-a4cb-4df4-84ad-c4513891b214">
        <obo:IAO_0000115> Effect of AXL/MERTK knockdown on microglial uptake of alpha-synuclein preformed fibrils. Microglia were transfected with siCON, siAXL and/or siMERTK. (A) Cell surface expression of AXL and MerTK assessed by flow cytometry on live induced pluripotent stem cell-derived microglia (iMGL) 48 h following transfection. Repeated measure one-way ANOVA were performed followed by Dunnett&apos;s post hoc test. Mean +- SEM of n = 5; *P &lt; 0.05, **P &lt; 0.01; MFI = median fluorescence intensity. (B) Quantification of mean green fluorescence intensity (MFI) in induced pluripotent stem cell-derived microglia (iMGL) culture challenged with pHrodoTM Green-labelled alpha-synuclein (alpha-syn) preformed fibrils (PFFs) for 2 h. A repeated measure one-way ANOVA was performed followed by Dunnett&apos;s post hoc test. Mean +- SEM of n = 5; **P &lt; 0.01. (C) Representative images of iMGL challenged with pHrodoTM Green-labelled alpha-syn PFFs for 2 h and counterstained with Hoechst 33342 (blue). Scale bar = 150 mum. (D) qRT-PCR assessment of AXL and MERTK expression in ##fetal microglia## (fMGL) 48 h following transfection. Repeated measure one-way ANOVA were performed followed by Dunnett&apos;s post hoc test. Mean +- SEM of n = 3; *P &lt; 0.05, ***P &lt; 0.001. (E) Quantification of mean green fluorescence intensity (MFI) in fMGL culture challenged with pHrodoTM Green-labelled alpha-syn PFFs for 2 h. A repeated measure one-way ANOVA was performed followed by Dunnett&apos;s post hoc test. Mean +- SEM of n = 4; *P &lt; 0.05, **P &lt; 0.01. (F) Representative fluorescence images of fMGL challenged with pHrodoTM Green-labelled alpha-syn PFFs for 2 h and counterstained with Hoechst 33342 (blue). Scale bar = 200 mum. (G) Viability of fMGL 48 h following transfection. A repeated measure one-way ANOVA was performed followed by Dunnett&apos;s post hoc test. Mean +- SEM of n = 4.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10834256</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37671615</oboInOwl:hasDbXref>
        <rdfs:label>fetal microglia</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000129"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/d72b78b9-a4cb-4df4-84ad-c4513891b214"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000129"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/d75d5a98-0ead-43cd-9a7e-b9907e759e3d -->

    <Class rdf:about="http://example.org/d75d5a98-0ead-43cd-9a7e-b9907e759e3d">
        <obo:IAO_0000115>Coexpression of natural killer cell antigens by ##T-cell large granular lymphocytes## in hydroa vacciniforme lymphoproliferative disorder and the involvement of Vdelta1 + epithelial-type gammadeltaT cells</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10285018</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37133637</oboInOwl:hasDbXref>
        <rdfs:label>T-cell large granular lymphocytes</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000084"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/d75d5a98-0ead-43cd-9a7e-b9907e759e3d"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000084"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/d7637010-e0f1-4fdb-8972-d226252878d0 -->

    <Class rdf:about="http://example.org/d7637010-e0f1-4fdb-8972-d226252878d0">
        <obo:IAO_0000115>We found that NKG7 was downregulated in CD8+ TEMRAs, CD8+ EM, non-VD2 gamma deltas, and gamma delta T cells when compared to baseline (day -2) in COVID-19-treated subjects but not untreated controls (SI Appendix, Fig. S5A). TGFB1 was increased in multiple ##CD3+## subsets including CD4+ TEMRA, CD8+ TEMRA, CD8+ EM, non-VD2 gamma-delta, and VD2 gamma-delta T cells following Foralumab treatment when compared to both healthy controls and untreated COVID-19 subjects. The TGFB1 gene expression increase was found in cell types with known effector function that not classical Treg cells (SI Appendix, Fig. S5B).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10243127</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36881624</oboInOwl:hasDbXref>
        <rdfs:label>CD3+</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002419"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/d7637010-e0f1-4fdb-8972-d226252878d0"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002419"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/d7a74367-5404-4984-9a67-e1980dc29105 -->

    <Class rdf:about="http://example.org/d7a74367-5404-4984-9a67-e1980dc29105">
        <obo:IAO_0000115>Highly regulated processes establish intercellular communication between bone-resident cells, each with its own distinctive role, to ensure a finely tuned balance between bone resorption and bone formation. The major bone-resorbing cell type is the osteoclast. Osteoclasts are multinucleated cells formed by the fusion of mononuclear, monocyte-derived, macrophage precursors, and their main function is resorption of cartilage and bone matrices. Vessel-associated osteoclasts drive cartilage resorption during bone growth, whereas bona fide osteoclasts regulate resorption of mineralised bone matrix during bone maintenance and repair. Furthermore, with bone being the largest reservoir for calcium storage in the body, resorption also facilitates calcium release to maintain optimal circulating levels. Osteoblasts play the opposite role to osteoclasts, constituting the major bone-forming cell type. Mesenchymal stem cells (MSCs) are situated at the apex of the osteoblast lineage cell hierarchy, differentiating stepwise into osteoprogenitors, bone lining cells, osteoblasts, and, ultimately, osteocytes. ##Osteoblast lineage cells## have numerous roles depending on their differentiation stage. Osteoprogenitors and bone lining cells constitute a pool of immature osteoblasts, maintained in a quiescent state that can be utilized for bone remodelling and repair. Mature osteoblasts ensure production and secretion of a new protein-rich bone matrix and its subsequent mineralization. Osteocytes are terminally differentiated osteoblasts, entombed within mineralised bone, acting as the main regulatory unit of skeletal homeostasis. Additional cells supporting bone homeostasis include endothelial cells (ECs), adipocytes, and chondrocytes.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8305002</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34298886</oboInOwl:hasDbXref>
        <rdfs:label>Osteoblast lineage cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000062"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/d7a74367-5404-4984-9a67-e1980dc29105"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000062"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/d7d3017e-0557-4332-b756-b1bb9976bd82 -->

    <Class rdf:about="http://example.org/d7d3017e-0557-4332-b756-b1bb9976bd82">
        <obo:IAO_0000115>##Innate T cells##, including CD1d-restricted invariant natural killer T (iNKT) cells, are characterized by their rapid activation in response to non-peptide antigens, such as lipids. While the transcriptional profiles of naive, effector, and memory adaptive T cells have been well studied, less is known about the transcriptional regulation of different iNKT cell activation states. Here, using single-cell RNA-sequencing, we performed longitudinal profiling of activated murine iNKT cells, generating a transcriptomic atlas of iNKT cell activation states. We found that transcriptional signatures of activation are highly conserved among heterogeneous iNKT cell populations, including NKT1, NKT2, and NKT17 subsets, and human iNKT cells. Strikingly, we found that regulatory iNKT cells, such as adipose iNKT cells, undergo blunted activation and display constitutive enrichment of memory-like cMAF+ and KLRG1+ populations. Moreover, we identify a conserved cMAF-associated transcriptional network among NKT10 cells, providing novel insights into the biology of regulatory and antigen-experienced iNKT cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9831610</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36458691</oboInOwl:hasDbXref>
        <rdfs:label>Innate T cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002127"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/d7d3017e-0557-4332-b756-b1bb9976bd82"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002127"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/d7f1da39-189f-496f-bc22-2ab00b4ad8b7 -->

    <Class rdf:about="http://example.org/d7f1da39-189f-496f-bc22-2ab00b4ad8b7">
        <obo:IAO_0000115>The ANRIL/p15 expression in human TM cells and its relationship with TM stiffness. (A) The proportion of p15-expressed cells in each cell type in human aqueous outflow pathways. From left to right: 1 beam cells A, 2 ##beam cells B##, 3 juxtacanalicular tissue cells, 4 ciliary muscle cells, 5 collector channels cells, 6 Schwalbe line cells, 7 myelinating Schwann cells, 8 non-myelinating Schwann cells, 9 vascular endothelium cells, 10 pericyte cells, 11 Schlemm canal endothelium cells, 12 macrophages, 13 melanocytes, 14 mast cells, 15 neurons. (B) The proportion of ANRIL-expressed cells in each cell type in human aqueous outflow pathways (cell-type order is the same as in panel A). (C) The normalized expression level of p15 and ANRIL in each cell type are present in heatmap (blue shallow indicates no expression). (D) The expression level (RPKM) of p15 in different TM stiffness are presented.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9101924</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35563774</oboInOwl:hasDbXref>
        <rdfs:label>beam cells B</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002367"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/d7f1da39-189f-496f-bc22-2ab00b4ad8b7"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002367"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/d81b9674-bf75-4831-a0e2-dc1bbfe70f6d -->

    <Class rdf:about="http://example.org/d81b9674-bf75-4831-a0e2-dc1bbfe70f6d">
        <obo:IAO_0000115>High levels of Oct4 mRNA were found in the 2-cell blastomere population in all conditions, followed by a decrease at the 4-cell stage and a strong increase in 8-cell blastomeres (Fig. 5E), an expression pattern reflecting the transition of maternal-to-zygotic Oct4 transcripts at the 4-cell stage (Wu and Scholer). There was a decrease of Oct4 expression in the bulk of both Ahr-/- and Ahr+/+-TCDD groups relative to Ahr+/+ at the 8-cell stage and in Ahr-/- than in Ahr+/+ 2-cell blastomeres. Similarly, we found a significant decrease of Oct4 expression in both Ahr-/- and Ahr+/+-TCDD, notably in both embryonic and differentiating blastomeres relative to the corresponding Ahr+/+ 8-cell subpopulations; in all conditions, differentiating blastomeres at 8-cell stage had higher expression levels than their embryonic counterparts (Fig. 5F). Furthermore, the levels of Oct4 transcription in Ahr-/- and Ahr+/+-TCDD 4-cell embryonic blastomeres decreased or had a trend to decrease, respectively, relative to the corresponding Ahr+/+ blastomeres. The levels of Cdx2 mRNA were high in all 8-cell blastomeres analyzed and were significantly decreased or trended to decrease in the bulk of Ahr-/- and Ahr+/+-TCDD relative to the Ahr+/+ 8-cell population (Fig. 5G). The Cdx2 mRNA levels were higher in Ahr+/+ and Ahr-/- 8-cell differentiating blastomeres than in their embryonic counterparts, with the ##Ahr-/- 8-cell differentiating blastomeres## showing lower expression than the corresponding Ahr+/+ subpopulation (Fig. 5H). Additionally, some Ahr+/+-TCDD 8-cell embryonic blastomeres showed unusually high levels of Cdx2 mRNA causing the indistinguishable difference between embryonic and differentiating subpopulations.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10425484</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36029422</oboInOwl:hasDbXref>
        <rdfs:label>Ahr-/- 8-cell differentiating blastomeres</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000353"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/d81b9674-bf75-4831-a0e2-dc1bbfe70f6d"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000353"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/d83d2a49-4c6d-4e14-9dc3-06e537a08784 -->

    <Class rdf:about="http://example.org/d83d2a49-4c6d-4e14-9dc3-06e537a08784">
        <obo:IAO_0000115>Tumor types Mutant genes The contributed cells for tumors References   Trichofolliculomas/papillomatricomas beta-catenin Krt 14+ cells    Pilomatricomas beta-catenin Lgr5+ cells    Dermatofibromas beta-catenin Lgr6+ cells    Trichoadenomas beta-catenin Lrig1+ cells    No tumor beta-catenin Krt15+ cells    Sebaceous tumors Lef1 Krt14+ cells    Basal cell carcinoma(BCC) Patched ##IFE cells##/bulge stem cells(major contribution)    BCC Smoothened IFE cells    BCC Smoothened (in the context of wound) Krt15+ bulge stem cells    Papillomas KRAS Krt19+, Krt15+ and Involucrin+ cells    Invasive squamous cell carcinoma (SCC) P53 and KRAS --    SCC (DMBA-TPA method) HRAS Long-lived stem cells    Papilloma and SCC HRAS Krt5+ cells    </obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9391238</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35143021</oboInOwl:hasDbXref>
        <rdfs:label>IFE cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000362"/>
        <skos:relatedMatch rdf:resource="CL:0000674"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/d83d2a49-4c6d-4e14-9dc3-06e537a08784"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000362"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/d83d2a49-4c6d-4e14-9dc3-06e537a08784"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000674"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/d86bb8db-2777-49d5-bd8d-e8be2fdc80f1 -->

    <Class rdf:about="http://example.org/d86bb8db-2777-49d5-bd8d-e8be2fdc80f1">
        <obo:IAO_0000115>Notch signaling is a highly conserved signal transduction pathway, which plays a critical role in cell differentiation and proliferation, and influences cell fate decision in multiple organisms and tissues, including epidermis and its appendages. The mammalian Notch signaling pathway consists of four Notch receptors (Notch 1, 2, 3, and 4) and five Notch ligands (Jagged-1 and Jagged-2 and Delta-like 1, 3, and 4). In psoriatic lesions, Notch signaling molecules have been found to be highly expressed with a frequent and diffuse mode. In addition, Notch signaling is hyperactivated and participated in the regulation of keratinocyte proliferation and differentiation and vascular endothelial cell function as well as ##early T cell## development in the thymus and modulation of peripheral T cell differentiation. Hes1, an important downstream target gene of Notch signaling, has been reported to be critically involved in the development of IL-17-producing gammadeltaT cells. To determine whether Notch-Hes1 signaling can regulate the function of IL-17A+gammadelta+T cells within the disease situation of psoriasis, we inhibit Notch-Hes1 signaling by gamma-secretase inhibitor DAPT to determine the possible regulating function of Notch-Hes1 signaling on IL-17A+gammadelta+T cell expression and IL-17A secretion in mouse psoriasis-like skin inflammation.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7240798</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32454795</oboInOwl:hasDbXref>
        <rdfs:label>early T cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000084"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/d86bb8db-2777-49d5-bd8d-e8be2fdc80f1"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000084"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/d8840476-4a3d-400a-a68e-1d2ce6da9593 -->

    <Class rdf:about="http://example.org/d8840476-4a3d-400a-a68e-1d2ce6da9593">
        <obo:IAO_0000115>A, B, C. Using an FDR &lt;0.05 and a fold-change &gt;, we detected 370, 231, and 424 DRGs, between YFPpos and YFPneg cells in AM (A), ##CD11cHiMDC## (B), and RM (C) from infected mice, respectively. For each of these cell types, the log2 expression differences between YFPpos and YFPneg cells is plotted. The line of identity is the dashed line; the solid line represents +-2, and the dotted line is +-4-fold difference. Red dots identify genes that were differentially regulated in all three cell types. Green dots identify other genes of interest. The identities of some genes are annotated. D. Ingenuity pathway analysis (IPA) predicted upstream signals for each cell type based on the DRGs. Each bar represents the -log10(p value). E, F, G. IPA predicted canonical pathways based on DRGs. Pathways predicted to be upregulated are shaded using warm colors; pathways predicted to be downregulated are shaded with cool colors. The bars indicate the log10 p values; the line indicates the fraction of genes from each pathway that were identified as DRGs. H. Top pathways predicted by GSEA for each cell type. Bars, normalized enrichment score (NES). FDR&lt;0.05 (solid bars); FDR&gt;0.05 (open bars).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7319360</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32544188</oboInOwl:hasDbXref>
        <rdfs:label>CD11cHiMDC</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002010"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/d8840476-4a3d-400a-a68e-1d2ce6da9593"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002010"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/d8a499c7-89f9-4c45-b43b-7bf5c0f73af8 -->

    <Class rdf:about="http://example.org/d8a499c7-89f9-4c45-b43b-7bf5c0f73af8">
        <obo:IAO_0000115>Last, we investigated whether the human materno-fetal immune system in HIS mice was functional. Human decidua and splenic CD4+CD25+ Treg cells were purified from pregnant HIS mice and incubated with the CFSE-labeled human CD45+CD25- splenic cells (responder cells from pregnant HIS mice) in the presence of 30 Gy irradiated BALB/c mouse splenic cells (stimulator). The proliferation of responder cells was quantified 4 days later using FCM. Proliferation of maternal human splenic CD4+ effector T cells after stimulation with paternally (BALB/c) derived antigen reflects the presence of fetal reactive human maternal T cells (Figure 5A). STreg cells were capable of suppressing Tconv cells at 1:2 ratio (Treg/Tconv) (Supplemental Figure 11). However, under a low Treg/Tconv ratio (1:16) condition, the maternal versus fetal T cell reactions (MvFRs) of maternal T cells were significantly inhibited by dTreg but not by ##sTreg cells## (or were only minimally suppressed; Figure 5A).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11529984</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:39435662</oboInOwl:hasDbXref>
        <rdfs:label>sTreg cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000815"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/d8a499c7-89f9-4c45-b43b-7bf5c0f73af8"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000815"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/d8aa0655-1fa1-4dbb-ba15-def466c59961 -->

    <Class rdf:about="http://example.org/d8aa0655-1fa1-4dbb-ba15-def466c59961">
        <obo:IAO_0000115>Recently several studies have demonstrated efficient gene editing of bulk CD34+ populations that are enriched for human HSPCs. Highly efficient non-homologous end joining (NHEJ)-mediated gene disruption of up to 80-90% efficiency has been reported in ##CD34+ HSPCs##. In addition, homology-directed repair (HDR)-mediated knock-ins, with or without selectable fluorescent reporter genes, have been established with an efficiency of up to 20% in CD34+ HSPCs. Stable integration of a fluorescent reporter using rAAV6 combined with flow cytometry-based sorting enabled enrichment of CRISPR/Cas9-edited HSPCs. Because LT-HSCs represent only 0.1-1% of CD34+ populations, these studies did not address LT-HSC targeting in the most direct manner. Previous studies have reported long-term engraftment of up to 16 weeks following xenotransplantation of CRISPR/Cas9 edited human CD34+ HSPCs, suggesting that rare LT-HSCs within the CD34+ population can be gene edited. However, these studies utilized considerable numbers of CD34+ HSPCs and lacked the resolution to functionally interrogate the differentiation and proliferation properties of individual LT-HSCs. In order to simplify LT-HSC targeting within heterogeneous CD34+ HSPCs, we explored the possibility of CRISPR/Cas9 editing in highly purified LT-HSCs. This approach would enable direct functional characterization of LT-HSCs, rather than bulk populations. Here, we show successful editing of highly purified LT-HSCs via CRISPR/Cas9-mediated NHEJ or HDR and their subsequent functional investigation using single cell in vitro differentiation and near-clonal xenotransplantation assays.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6802205</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31628330</oboInOwl:hasDbXref>
        <rdfs:label>CD34+ HSPCs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000037"/>
        <skos:relatedMatch rdf:resource="CL:0000837"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/d8aa0655-1fa1-4dbb-ba15-def466c59961"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000037"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/d8aa0655-1fa1-4dbb-ba15-def466c59961"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000837"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/d8ac6adf-67e8-4494-94c5-5e5efd65c193 -->

    <Class rdf:about="http://example.org/d8ac6adf-67e8-4494-94c5-5e5efd65c193">
        <obo:IAO_0000115>Brain-derived neurotrophic factor (BDNF) and neurotrophin 3 (NT-3) are known to regulate neuronal morphology and the formation of neural circuits, yet the neuronal targets of each neurotrophin are still to be defined. To address how these neurotrophins regulate the morphological and synaptic differentiation of developing olfactory bulb (OB) GABAergic interneurons, we analyzed the effect of BDNF and NT-3 on GABA+-neurons and on different subtypes of these neurons: tyrosine hydroxylase (##TH+##); calretinin (Calr+); calbindin (Calb+); and parvalbumin (PVA+). These cells were generated from cultured embryonic mouse olfactory bulb neural stem cells (eOBNSCs) and after 14 days in vitro (DIV), when the neurons expressed TrkB and/or TrkC receptors, BDNF and NT-3 did not significantly change the number of neurons. However, long-term BDNF treatment did produce a longer total dendrite length and/or more dendritic branches in all the interneuron populations studied, except for PVA+-neurons. Similarly, BDNF caused an increase in the cell body perimeter in all the interneuron populations analyzed, except for PVA+-neurons. GABA+- and TH+-neurons were also studied at 21 DIV, when BDNF produced significantly longer neurites with no clear change in their number. Notably, these neurons developed synaptophysin+ boutons at 21 DIV, the size of which augmented significantly following exposure to either BDNF or NT-3. Our results show that in conditions that maintain neuronal survival, BDNF but not NT-3 promotes the morphological differentiation of developing OB interneurons in a cell-type-specific manner. In addition, our findings suggest that BDNF and NT-3 may promote synapse maturation by enhancing the size of synaptic boutons.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMID:33392918</oboInOwl:hasDbXref>
        <rdfs:label>TH+</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:4023075"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/d8ac6adf-67e8-4494-94c5-5e5efd65c193"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4023075"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/d8b70db9-c933-41ac-af6c-10b0e32b4f1d -->

    <Class rdf:about="http://example.org/d8b70db9-c933-41ac-af6c-10b0e32b4f1d">
        <obo:IAO_0000115>We identified 23 immune cell subpopulations in the GSE162454 dataset by TSNE analysis at first. Based on the specific markers, we identified NK/T cells, CAFs (##cancer associated fibroblasts##), endothelial cells, plasma cells, osteoblastic cells, osteoclasts, B cells, M2 TAMs (tumor associated macrophages), M1 TAMs, monocytes and mast cells (Figure 10A). The expression of marker genes for different cell clusters was displayed in dot plot format in Figure 10B. The expression of OS-related genes was compared in different cell types. Because of the dropout sign of single-cell sequencing, INS was not detected in the GSE162454 dataset. As shown in Figure 10C, HMOX1 were expressed at higher levels in TAMs and osteoclasts. ATF4 and ACADVL are highly expressed in myeloid cells as well as other cell types, which was suggestive of their roles in osteosarcoma progression.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10292890</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37285835</oboInOwl:hasDbXref>
        <rdfs:label>cancer associated fibroblasts</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000057"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/d8b70db9-c933-41ac-af6c-10b0e32b4f1d"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000057"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/d8c78078-2f16-4af0-80a7-a7f15d64cff3 -->

    <Class rdf:about="http://example.org/d8c78078-2f16-4af0-80a7-a7f15d64cff3">
        <obo:IAO_0000115>To date, it is still disputed whether &quot;senescent&quot; and &quot;dystrophic&quot; microglia are related to the same condition or are distinct. While biochemical and molecular markers of senescence exist, Streit et al. claim that there is no currently straightforward means to identify the dystrophic features of microglial cells, apart from morphological abnormalities, and that changes described in cell morphology cannot be easily correlated with modifications at the molecular level. It has been suggested that ##over-reactive microglia## can reach an exhausted phase, unable to escape their extensive faults in energy metabolism, resulting in &quot;senescent&quot; or &quot;dystrophic&quot; microglia. Considering the above, we believe that microglial &quot;senescence&quot; is related to aging, is accelerated by neurodegeneration, and is one of the major mechanisms leading to the appearance of &quot;dystrophic&quot; morphology, which has no clear molecular signatures because it occurs in now exhausted cells (Figure 3).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10742050</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38132144</oboInOwl:hasDbXref>
        <rdfs:label>over-reactive microglia</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002629"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/d8c78078-2f16-4af0-80a7-a7f15d64cff3"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002629"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/d8d98120-8983-4027-b786-6096edea2109 -->

    <Class rdf:about="http://example.org/d8d98120-8983-4027-b786-6096edea2109">
        <obo:IAO_0000115>Due to microfluidic channel limitations on the 10x Genomics platform, only oocytes with a diameter less than 50 microm could be obtained. To determine the oocyte stage, previously reported stage-specific markers, including LMOD3 and FOS for ##primordial oocytes##, RPS4X and FIGLA for primary oocytes, SYT5, STK26 and TAF1A for secondary oocytes, UBOX5 and CCDC25 for antral oocytes, and HTRA3 and NBPF12 for preovulatory oocytes, were analyzed. scRNA-seq results indicated high expression of LMOD3, FOS, RPS4X and FIGLA in these oocytes, suggesting that they were at the primordial or primary stage (Extended Data Fig. 4a).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11031396</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38594460</oboInOwl:hasDbXref>
        <rdfs:label>primordial oocytes</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000654"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/d8d98120-8983-4027-b786-6096edea2109"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000654"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/d8efa7cc-53b0-4c01-9a86-c9295533543d -->

    <Class rdf:about="http://example.org/d8efa7cc-53b0-4c01-9a86-c9295533543d">
        <obo:IAO_0000115>Brain-derived neurotrophic factor (BDNF) and neurotrophin 3 (NT-3) are known to regulate neuronal morphology and the formation of neural circuits, yet the neuronal targets of each neurotrophin are still to be defined. To address how these neurotrophins regulate the morphological and synaptic differentiation of developing olfactory bulb (OB) GABAergic interneurons, we analyzed the effect of BDNF and NT-3 on GABA+-neurons and on different subtypes of these neurons: tyrosine hydroxylase (TH+); calretinin (Calr+); calbindin (Calb+); and parvalbumin (PVA+). These cells were generated from cultured ##embryonic mouse olfactory bulb neural stem cells## (eOBNSCs) and after 14 days in vitro (DIV), when the neurons expressed TrkB and/or TrkC receptors, BDNF and NT-3 did not significantly change the number of neurons. However, long-term BDNF treatment did produce a longer total dendrite length and/or more dendritic branches in all the interneuron populations studied, except for PVA+-neurons. Similarly, BDNF caused an increase in the cell body perimeter in all the interneuron populations analyzed, except for PVA+-neurons. GABA+- and TH+-neurons were also studied at 21 DIV, when BDNF produced significantly longer neurites with no clear change in their number. Notably, these neurons developed synaptophysin+ boutons at 21 DIV, the size of which augmented significantly following exposure to either BDNF or NT-3. Our results show that in conditions that maintain neuronal survival, BDNF but not NT-3 promotes the morphological differentiation of developing OB interneurons in a cell-type-specific manner. In addition, our findings suggest that BDNF and NT-3 may promote synapse maturation by enhancing the size of synaptic boutons.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMID:33392918</oboInOwl:hasDbXref>
        <rdfs:label>embryonic mouse olfactory bulb neural stem cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000047"/>
        <skos:relatedMatch rdf:resource="CL:1001434"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/d8efa7cc-53b0-4c01-9a86-c9295533543d"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000047"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/d8efa7cc-53b0-4c01-9a86-c9295533543d"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:1001434"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/d90302c9-7352-4593-a754-ee8d8b8f3a4e -->

    <Class rdf:about="http://example.org/d90302c9-7352-4593-a754-ee8d8b8f3a4e">
        <obo:IAO_0000115>In conclusion, our study highlights the potential role of ##CD63 + TAMs## in regulating HCC progression and opens up new possibilities for targeted therapy. Recognizing CD63 + TAMs as crucial regulators of HCC progression offer opportunities for therapeutic intervention. Targeting CD63 + TAMs could disrupt the pre-tumorigenic communication between TAMs and HCC cells, leading to the development of novel immunotherapeutic strategies. Additionally, the use of CD63 as a prognostic marker may help guide personalized treatment approaches for HCC patients.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11157766</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38849760</oboInOwl:hasDbXref>
        <rdfs:label>CD63 + TAMs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/d90302c9-7352-4593-a754-ee8d8b8f3a4e"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/d91be272-9211-4d20-864f-99e2551b1882 -->

    <Class rdf:about="http://example.org/d91be272-9211-4d20-864f-99e2551b1882">
        <obo:IAO_0000115>A, B, tSNE plot of 4659 CD45+ immune cells from the CNS. Data from this study is integrated with data from; Table 6). C, D, Each dataset represented by one tSNE. Cells are annotated using color representing their cell type. bMicroglia: baseline microglia; aMicroglia: activated microglia; pmMicroglia: proliferation-mediating microglia; maMicroglia: monocyte-activating microglia; DAM: disease-associated microglia in SCI; elMicroglia: embryonic-like microglia; pvMacrophages: perivascular macrophages; ##mdMacrophages##: monocyte-derived macrophages; DCs: dendritic cells; imB-cells: immature B-cells; mB-cells: mature B-cells; pimMicroglia: postnatal immature microglia; IEG+Microglia: immediate early genes microglia; sMicroglia: s-phase microglia; pPAM: postnatal proliferative-region-associated microglia; eMicroglia: embryonic microglia; pcpMacrophages: postnatal choroid plexus macrophages; acpMacrophages: adult choroid plexus macrophages; iMonocytes: inflammatory monocytes; pMonocytes: patrolling monocytes; cpEpithelial cells: choroid plexus epithelial cells. E, tSNE plots of 4659 CD45+ immune cells for selected genes indicating the log2(cpm) expression with a continuous color for each cell separately. F, Proliferation rate of CD45low and CD45high cells at 7 and 21 d post-SCI. Hoechst 33342 expression presented on a log-scale was used for defining cells in S-phase. Right most plot reports the percentage of cells in S-phase. Each dot represents one biological replicate (four mice per time point). Mean is surrounded by a 95% CI. This figure is extended in Extended Data Figure 8-1.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8496189</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34417326</oboInOwl:hasDbXref>
        <rdfs:label>mdMacrophages</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
        <skos:relatedMatch rdf:resource="CL:0000576"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/d91be272-9211-4d20-864f-99e2551b1882"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/d91be272-9211-4d20-864f-99e2551b1882"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000576"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/d9396a48-7768-4950-802d-490356921212 -->

    <Class rdf:about="http://example.org/d9396a48-7768-4950-802d-490356921212">
        <obo:IAO_0000115>MSCs, with their inherent ability to take up a wide range of products including anti-cancer drugs from the culture medium, have emerged as a key tool in cancer therapy. Research has shown that human bone marrow-derived MSCs (hBM-MSCs) can be effectively primed with several chemotherapeutic agents, such as doxorubicin, paclitaxel, gemcitabine and sorafenib, through a simple incubation process. This process facilitates the uptake of these drugs by the MSCs, albeit with varying degrees of efficiency. In particular, while hBM-MSCs show significant uptake of paclitaxel and other drugs, their interaction with pemetrexed is less effective, resulting in insufficient drug internalisation to adversely affect tumour cells. Further investigation on MSCs from other sources, such as human adipose tissue (hAd-MSCs) or dental tissues, reveals a similar capacity to absorb several anti-cancer drugs, including cisplatin and paclitaxel. This uptake is not uniform across MSC types, suggesting a dependence on the cellular properties specific to each MSC type. For example, the amount of paclitaxel absorbed by each hBM-MSC was quantified at approximately 2.7 pg/cell, whereas for other type of cells such as human ##olfactory bulb stem cells##, it was 0.19 pg/cell, indicating a substantial capacity of uptake of MSCs that might involve specific transporters or membrane properties inherent to these cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11275142</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:39062449</oboInOwl:hasDbXref>
        <rdfs:label>olfactory bulb stem cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000034"/>
        <skos:relatedMatch rdf:resource="CL:1001434"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/d9396a48-7768-4950-802d-490356921212"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000034"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/d9396a48-7768-4950-802d-490356921212"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:1001434"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/d93af43b-0f02-4e5b-a8a6-27387f3bd34f -->

    <Class rdf:about="http://example.org/d93af43b-0f02-4e5b-a8a6-27387f3bd34f">
        <obo:IAO_0000115>Postnatal development of the organ of Corti. The postnatal development is shown in this colour-coded illustration: brown = ##Kolliker&apos;s organ##, pink = inner phalangeal cell, dark blue = inner hair cell, orange = inner pillar cell, green = outer pillar cell, light grey = Deiters&apos; cells, yellow = outer hair cells, cyan = Hensen&apos;s cells, red = tectal cells, dark grey = Bottcher and Claudius cells. a P1; In newborn mice, the organ of Corti presents itself as an epithelium of columnar cells. There are no extracellular spaces. b P7; The Corti tunnel initially opens basally between the inner and outer pillared cells. c P14; The Corti tunnel has reached its full size. During the entire development, the cells increase only slightly in height. Cells of Kolliker&apos;s organ have gradually transformed into cuboidal cells of the inner sulcus and are no longer part of the cortical organ</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7723944</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32712744</oboInOwl:hasDbXref>
        <rdfs:label>Kolliker&apos;s organ</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002490"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/d93af43b-0f02-4e5b-a8a6-27387f3bd34f"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002490"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/d97c357a-1bdb-406d-a4e0-53ee76477385 -->

    <Class rdf:about="http://example.org/d97c357a-1bdb-406d-a4e0-53ee76477385">
        <obo:IAO_0000115>a Schematic of study design. Diagrams depict the brain region of interest, Brodmann area 9, corresponding to the dlPFC. b UMAP plot colored by the broad cell types. c UMAP plot colored by the individual clusters identified and annotated. For UMAP plots, the x and y-axes represent the first and second UMAP co-ordinates respectively. d DotPlot depicting the expression of marker genes (SNAP25 - neurons, SLC17A7 - excitatory neurons, GAD1 - inhibitory neurons, ALDH1L1 - astrocytes, PDGFRA - oligodendrocyte precursor cells, PLP1 - oligodendrocytes, CLDN5 - endothelial cells, CX3CR1 - microglia). The dendrogram next to the cluster names shows the relationship between the clusters by using the distance based on average expression of highly variable genes. e Best hits heatmap from MetaNeighbor showing the correspondence between the clusters in our dataset (columns) and the broad categories of cells identified in the Allen Brain Institute human motor cortex snRNA-seq dataset (rows). f Boxplots showing the proportion of nuclei in each cluster for each subject split by cases and controls for the broad OPC, astrocyte, and excitatory neuron cell types and the ##Ast##1, Ast2, OPC1, and OPC2 clusters (n = 37 cases, 34 controls, representing biologically independent samples for each cluster or broad cell type). The middle line is the median. The lower and upper hinges correspond to the 25th and 75th percentiles. Upper and lower whiskers extend from the upper or lower hinges to the largest or smallest value no further than 1.5 times the inter-quartile range from the hinge, where the inter-quartile range is the distance between the first and third quartiles. Points beyond the end of the whiskers are plotted individually. In Fig. 1c-e, excitatory neuronal cluster names contain approximate layer annotations and inhibitory neuronal cluster names contain MGE or CGE specific marker information as a suffix where applicable, as described in methods: Cluster annotation. For example, ExN10_L46 denotes a cluster of excitatory neurons with enrichment of marker genes from layer 4 to layer 6 of the cortex and InN1_PV denotes a cluster on inhibitory neurons with enrichment of the MGE specific marker PV. This convention is used throughout the paper. Brain diagram in 1a was created with BioRender.com. Source data are provided as a Source Data file.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10203145</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37217515</oboInOwl:hasDbXref>
        <rdfs:label>Ast</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000127"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/d97c357a-1bdb-406d-a4e0-53ee76477385"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000127"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/d98601e1-2d6b-45db-93d3-ee32dab2d717 -->

    <Class rdf:about="http://example.org/d98601e1-2d6b-45db-93d3-ee32dab2d717">
        <obo:IAO_0000115>It has been well-documented that total CD4+CD45RA+ naive T cells are reduced, and total CD4+CD45RO+ memory T cells are spared following alemtuzumab treatment. Our data show similar changes in total memory (supplementary Figure S3A) and total naive CD4+ T cells (Figure S3B). Figure S3 also illustrates changes over time in subsets of naive and memory CD4+ T cells, defined as described by Lovett-Racke and colleagues. Briefly, lymphocytes were identified in FSC/SSC plots, followed by gating on CD4+CD45RA+ or CD45RA- cells to identify CD27+ and CD27- lymphocytes (FACS gating strategy not illustrated). Figure S3 shows that the percentage of CD4+CD45RA+CD27+ naive T cells (Figure S3C) was reduced at M5 and M17, while CD4+CD45RA-CD27+ central memory T cells (TCM; Figure S3D) remained relatively stable over time. The percentage of ##CD4+CD45RA-CD27- effector memory T cells## (TEM; Figure S3E) increased at M5, along with CD4+CD45RA+ new effector T cells (new Teff; Figure S3F).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7296935</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32539719</oboInOwl:hasDbXref>
        <rdfs:label>CD4+CD45RA-CD27- effector memory T cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000905"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/d98601e1-2d6b-45db-93d3-ee32dab2d717"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000905"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/d9c363ee-a955-45f2-a7c0-5b77056fc42c -->

    <Class rdf:about="http://example.org/d9c363ee-a955-45f2-a7c0-5b77056fc42c">
        <obo:IAO_0000115>##Activated endothelial cells## may cause aggregation of fibroblasts</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10748394</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38144556</oboInOwl:hasDbXref>
        <rdfs:label>Activated endothelial cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000115"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/d9c363ee-a955-45f2-a7c0-5b77056fc42c"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000115"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/d9c49ec1-5b32-4e9b-bff2-bc15bb4912f3 -->

    <Class rdf:about="http://example.org/d9c49ec1-5b32-4e9b-bff2-bc15bb4912f3">
        <obo:IAO_0000115>Here, we analyzed the capacity of MSCs from the bone marrow (BM) of healthy donors (BM-MSCs) to transfer mitochondria to primary CD4+CCR6+CD45RO+ T helper 17 (Th17) cells by confocal microscopy and fluorescent-activated cell sorting (FACS). We then evaluated the Th17 cell inflammatory phenotype and bioenergetics at 4 h and 24 h of co-culture with BM-MSCs. We found that Th17 cells can take up mitochondria from BM-MSCs already after 4 h of co-culture. Moreover, IL-17 production by Th17 cells co-cultured with BM-MSCs was significantly impaired in a contact-dependent manner. This inhibition was associated with oxygen consumption increase by Th17 cells and interconversion into T regulatory cells. Finally, by co-culturing human ##synovial MSCs## (sMSCs) from patients with rheumatoid arthritis (RA) with Th17 cells, we found that compared with healthy BM-MSCs, mitochondrial transfer to Th17 cells was impaired in RA-sMSCs. Moreover, artificial mitochondrial transfer also significantly reduced IL-17 production by Th17 cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6676586</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31370879</oboInOwl:hasDbXref>
        <rdfs:label>synovial MSCs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000134"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/d9c49ec1-5b32-4e9b-bff2-bc15bb4912f3"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000134"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/d9d58e98-8756-4132-b751-4399c74a7bfe -->

    <Class rdf:about="http://example.org/d9d58e98-8756-4132-b751-4399c74a7bfe">
        <obo:IAO_0000115>We compared the performance of GapClust to GiniClust, RaceID, CellSIUS and FiRE using a simulation-based experiment in the presence of ground truth cell-type identity. For this, we used a widely utilised public scRNA-seq dataset consisting of transcription profiles of ~68,000 peripheral blood mononuclear cells (PBMCs), which were classified into 11 sub-types. We focused on three large sub-populations: ##CD56 + natural killer (NK) cells##, CD14 + monocytes and CD19 + B cells, whose transcriptomic profiles were distinct from one another (Fig. 2a). To mimic the rare cell phenomenon systemically, we added between 2 and 100 monocytes (0.2-10% of rare cell-type proportions) to two homogeneous populations of 500 NK cells and B cells (Methods).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8263561</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34234139</oboInOwl:hasDbXref>
        <rdfs:label>CD56 + natural killer (NK) cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000938"/>
        <skos:relatedMatch rdf:resource="CL:0000939"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/d9d58e98-8756-4132-b751-4399c74a7bfe"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000938"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/d9d58e98-8756-4132-b751-4399c74a7bfe"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000939"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/d9dbcca2-49e3-406c-87e2-b94992749282 -->

    <Class rdf:about="http://example.org/d9dbcca2-49e3-406c-87e2-b94992749282">
        <obo:IAO_0000115>a, Frequencies of T cells, monocytes, regulatory T cells (Tregs), and monocytic myeloid-derived suppressor cells (##mo-MDSC##) within PBMCs were determined at V07 by flow cytometry and are shown according to disease course at EOS (top) and SOC treatment (bottom). CD3+, T cells. n(SD) = 15; n(PsPD) = 11; n(PD) = 4; n(RT) = 5; n(RT + TMZ) = 22; n(TMZ) = 3. Red line, median; dotted lines, quartiles. Two-sided Kruskal-Wallis test with Dunn&apos;s multiple comparison. b, Gating strategy for flow cytometric analysis.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8046668</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33762734</oboInOwl:hasDbXref>
        <rdfs:label>mo-MDSC</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000576"/>
        <skos:relatedMatch rdf:resource="CL:0000889"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/d9dbcca2-49e3-406c-87e2-b94992749282"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000576"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/d9dbcca2-49e3-406c-87e2-b94992749282"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000889"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/da23670b-1dd8-40e2-8571-5f3c90ef8320 -->

    <Class rdf:about="http://example.org/da23670b-1dd8-40e2-8571-5f3c90ef8320">
        <obo:IAO_0000115>Although tumor-infiltrating T cells hold a beneficial prognostic role in colorectal cancer, other lymphocytic populations are less characterized. We developed a multiplexed immunofluorescence assay coupled with digital image analysis and machine learning to identify natural killer (NK) cells (NCAM1+CD3-), natural killer T-like (NKT-like) cells (NCAM1+CD3+), and T cells (NCAM1-CD3+) within the PTPRC+ (CD45+) cell population and to measure their granzyme B (GZMB; cytotoxicity marker) and FCGR3A (CD16a; NK-cell maturity marker) expression. We evaluated immune cell densities and spatial configuration in 907 incident colorectal carcinoma cases within two prospective cohort studies. We found that T cells were approximately 100 times more abundant than NK and NKT-like cells. Overall, NK cells showed high GZMB expression and were located closer to tumor cells than T and NKT-like cells. In T and NKT-like cells, GZMB expression was enriched in cells in closer proximity to tumor cells. Higher densities of both T and NKT-like cells associated with longer cancer-specific survival, independent of potential confounders (P trend &lt; 0.0007). Higher stromal GZMB+ and FCGR3A+ NK-cell densities associated with longer cancer-specific survival (P trend &lt; 0.003). For T and NKT-like cells, greater proximity to tumor cells associated with longer cancer-specific survival (P trend &lt; 0.0001). These findings indicate that ##cytotoxic NCAM1+CD3-GZMB+ NK cells## and NCAM1+CD3+ NKT-like cells are relatively rare lymphocytic populations within the colorectal cancer microenvironment and show distinct spatial configuration and associations with patient outcome. The results highlight the utility of a quantitative multimarker assay for in situ, single-cell immune biomarker evaluation and underscore the importance of spatial context for tumor microenvironment characterization.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8816895</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34937729</oboInOwl:hasDbXref>
        <rdfs:label>cytotoxic NCAM1+CD3-GZMB+ NK cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000824"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/da23670b-1dd8-40e2-8571-5f3c90ef8320"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000824"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/da39246d-c3c1-4d9b-b7d6-d42821381fff -->

    <Class rdf:about="http://example.org/da39246d-c3c1-4d9b-b7d6-d42821381fff">
        <obo:IAO_0000115>Next, we examined the upregulated CD marker genes and plasma membrane protein genes in VSMCs stimulated by aortic disease conditions in 8065 markers of human 79 cell types identified in the tissue cell type section in the HPA database (https://www.proteinatlas.org/humanproteome/tissue+cell+type) ( Figure 7C ) and found that 18 cell types exhibit a proportion of upregulated plasma membrane protein genes within the cell-type markers that ranges from 2% to less than 5%, including ##proximal enterocytes##, paneth cells, intestinal goblet cells, basal keratinocytes, squamous epithelial cells, cholangiocytes, enteroendocrine cells, pancreatic endocrine cells, microglial cells, syncytiotrophoblasts, extravillous trophoblasts, cardiomyocytes, skeletal myocytes, melanocytes, monocytes, macrophages, Hofbauer cells, Kupffer cells; 12 cell types exhibit a proportion of upregulated plasma membrane protein genes within the cell-type markers that equal to or greater than 5%, including alveolar cells type 1, alveolar cells type 2, thymic epithelial cells, Leydig cells, endothelial cells, smooth muscle cells, adipocytes, fibroblasts, peritubular cells, endometrial stromal cells, granulocytes, Langerhans cells; 20 cell types exhibit a proportion of upregulated CD marker genes within the cell-type markers that ranges from 2% to less than 5%, including paneth cells, distal enterocytes, basal prostatic cells, glandular and luminal cells, thymic epithelial cells, Leydig cells, extravillous trophoblasts, endothelial cells, smooth muscle cells, adipocytes, melanocytes, fibroblasts, peritubular cells, T-cells, NK-cells, monocytes, macrophages, Hofbauer cells, Kupffer cells, dendritic cells; and 3 cell types exhibit a proportion of upregulated CD marker genes within the cell-type markers that equal to or greater than 5%, including endometrial stromal cells, granulocytes, and Langerhans cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10847266</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38327764</oboInOwl:hasDbXref>
        <rdfs:label>proximal enterocytes</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000584"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/da39246d-c3c1-4d9b-b7d6-d42821381fff"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000584"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/da6b23a6-7624-4ea0-9455-dc3d49d3e634 -->

    <Class rdf:about="http://example.org/da6b23a6-7624-4ea0-9455-dc3d49d3e634">
        <obo:IAO_0000115>a Line drawing of a cross section of the floor of the cochlear duct at P1. Distinct cell types within the organ of Corti (OC) are color coded. b Heat map for ~14,000 cochlear cells collected from four separate experiments at P1. Top 25 differentially expressed (DE) genes for the 15 identified clusters are shown. Cellular identity for each cluster is indicated by a color bar at the top of the heat map, which corresponds to the legend in a, and by a cell name at the bottom. c tSNE plot for the same cells as in b. Cluster identities are indicated. d Violin plots showing normalized log-transformed expression values for the top five DE genes for each cell type (color coded as in c) by comparison with all other P1 cells (gray on the right in each graph). Bars indicate median expression level. e Upper left panel, tSNE plot of cells determined to be derived from KO (between the OC and medial edge of the cochlear duct). Lower left panel, feature plot for the same cells as in the upper panel indicating high expression of Otoa, Calb1, and Fabp7 (based on color) in different clusters of cells. Lower right panel, cross sections through the cochlear duct at P1, illustrating expression of CALB1 in the medial region of KO and FABP7 directly adjacent to the OC (arrow; scale bars, 20 mum). Lowest panel shows high-magnification view of expression of FABP7 (arrow, gray scale) at the lateral KO border (green line; scale bar, 10 mum). Upper right panel, summary diagram of the spatial distribution of KO cell clusters at P1. HC hair cells, IPhC inner phalangeal cells/border cells, IPC inner pillar cells, OPC outer pillar cells, DC1/2 Deiters&apos; cells rows 1 and 2, DC3, Deiters&apos; cells row 3, HeC Hensen&apos;s cells, CC/OSC Claudius cells/outer sulcus cells, IdC interdental cells, ISC inner sulcus cells, KO Kolliker&apos;s organ cells, ##L.KO## lateral Kolliker&apos;s organ cells, M.KO medial Kolliker&apos;s organ cells, OC90 OC90+ cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7221106</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32404924</oboInOwl:hasDbXref>
        <rdfs:label>L.KO</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002490"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/da6b23a6-7624-4ea0-9455-dc3d49d3e634"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002490"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/dab5969a-8b87-44b5-80ea-04f83806badc -->

    <Class rdf:about="http://example.org/dab5969a-8b87-44b5-80ea-04f83806badc">
        <obo:IAO_0000115>Brain transcriptional changes after MIA require microglia. (A) Simplified schematic of sample processing pipeline from and bar plots of TORCH pathogen and cytokine receptor expression (mean log counts per million) in each cell type across development. (B) Violin plot of CytoTORCH module score for each cell cluster (MG, P&lt;0.05 for ANOVA and for pairwise comparisons between microglia and all other cell types using Tukey&apos;s HST). (C) Overview of experimental design (top) and UMAP visualization of snRNAseq data from the developing somatosensory cortex of E15.5 wild-type and Csf1r-/- mice after saline or Poly(I:C) maternal injection at E12.5 (two or three embryos per condition from a total of four pregnant dams, 42,736 total cells) (bottom). Cells are colored by cell type assignment. (D) Dot plots of log(fold change) in gene expression between MIA and saline for cell types with significant changes at E15.5. DEG analysis was performed using NEBULA. AP, apical progenitors; ##IP##, intermediate progenitors; ImmN, immature neurons, MN, migrating neurons; (UL/DL) CPN, (upper layer/deep layer) callosal projection neurons; SCPN, subcerebral projection neurons; CThPN, corticothalamic projection neurons; LIV, layer IV stellate neurons; IN, interneurons; CR, Cajal-Retzius cells; Astro, astrocytes; CGC, cycling glial cells; Epend; ependymal cells; OL, oligodendroglia; MG, microglia; Peri, pericytes; EC, endothelial cells; VLMC, vascular and leptomeningeal cells. Created with .</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11190434</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38775708</oboInOwl:hasDbXref>
        <rdfs:label>IP</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0011020"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/dab5969a-8b87-44b5-80ea-04f83806badc"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0011020"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/dadb6b55-c056-4e8a-9180-0e446cc5194a -->

    <Class rdf:about="http://example.org/dadb6b55-c056-4e8a-9180-0e446cc5194a">
        <obo:IAO_0000115>Furthermore, there are several other origins of CAFs, such as a subset derived from the macrophage lineage found in non-small-cell lung carcinoma, regulated by Smad3-induced macrophage-myofibroblast transition (MMT). Mesothelial cells can also transform into a typical antigen-presenting CAFs (##apCAFs##) when induced by IL-1 and TGF-beta, discovered in pancreatic cancer. The exact origin of CAFs still lacks precise elaboration, and further approaches like lineage tracing, fate-mapping, pseudotime analysis, and RNA velocity may help uncover new primogenitors of CAFs.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11300527</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38602594</oboInOwl:hasDbXref>
        <rdfs:label>apCAFs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000057"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/dadb6b55-c056-4e8a-9180-0e446cc5194a"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000057"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/dae169e3-09c6-4156-8a6f-1ca1717a2f95 -->

    <Class rdf:about="http://example.org/dae169e3-09c6-4156-8a6f-1ca1717a2f95">
        <obo:IAO_0000115>Transcriptome of the ##active NK## subset at steady state</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6718415</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31477722</oboInOwl:hasDbXref>
        <rdfs:label>active NK</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000623"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/dae169e3-09c6-4156-8a6f-1ca1717a2f95"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000623"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/db130d97-bf74-4cca-b188-c404f438dd44 -->

    <Class rdf:about="http://example.org/db130d97-bf74-4cca-b188-c404f438dd44">
        <obo:IAO_0000115>It has been reported that cortical-projecting subpopulations of ##DRN 5-HT neurons## express Slc17a8, in agreement with the extensive overlap between the spatial distribution of cortical-projecting neurons and Slc17a8 expression. This suggests that cortical-projecting subpopulations should correspond to subtype 5-HT-IV from the scRNA-seq dataset, which is Slc17a8-expressing and distributed to the ventral DRN. Additionally, we would predict that the Str-projecting subpopulation corresponds to the subtype 5-HT-III, since their distributions overlap extensively in the dorsomedial DRN. Consistent with our hypothesis that 5-HT neuron subtypes innervate different brain regions, we found that the inferred distributions of each 5-HT neuron subtype coincides with a different set of projection-defined subpopulations - the distribution of subtype 5-HT-III was most similar to the distribution of Str-projecting neurons (Figure 6F), whereas the distribution of subtype 5-HT-IV was more similar to that of M1-projecting neurons (Figure 6G). However, neither Str-projecting nor M1-projecting subpopulations were fully contained within the distribution of a single 5-HT neuron subtype. Str-projecting neurons in the ventrolateral DRN (marked cyan in Figure 6D,F,G), where neurons innervating both Str and M1 are located, fell within the distribution of subtype 5-HT-IV but not of subtype 5-HT-III. This suggests that Str is a target of multiple molecular subtypes of 5-HT neurons, and supports the model that some structures are innervated by multiple 5-HT neuron subtypes due to overlaps in the axonal projection fields of different subtypes.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6726424</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31411560</oboInOwl:hasDbXref>
        <rdfs:label>DRN 5-HT neurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000850"/>
        <skos:relatedMatch rdf:resource="CL:0002610"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/db130d97-bf74-4cca-b188-c404f438dd44"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000850"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/db130d97-bf74-4cca-b188-c404f438dd44"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002610"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/db20170b-307e-4c0b-98d7-f316bef56ca6 -->

    <Class rdf:about="http://example.org/db20170b-307e-4c0b-98d7-f316bef56ca6">
        <obo:IAO_0000115>Sjogren&apos;s syndrome is a chronic autoimmune disorder whose pathogenesis is poorly understood and that lacks effective therapies. Detailed quantitative and spatial analyses of tissues affected by Sjogren&apos;s syndrome were undertaken, including the quantitation of the frequency of selected cell-cell interactions in the disease milieu. Quantitative analyses of CD4+ T cell subsets and of CD8+ T cells in the labial salivary glands from untreated patients with primary Sjogren&apos;s syndrome revealed that activated CD8+ cytotoxic T cells (CD8+CTLs) were the most prominent T cells in these infiltrates. An accumulation of apoptotic glandular epithelial cells, mainly ductal and acinar cells, was observed, consistent with the impaired salivary secretion often observed in patients with this disease. ##FasL expressing activated CD8+ T cells## were seen to accumulate around Fas expressing apoptotic epithelial cells. Quantitative analyses of apoptotic cell types and of conjugates between cytotoxic T cells and epithelial cells undergoing apoptosis suggest that Sjogren&apos;s syndrome is primarily driven by CD8+CTL mediated execution of epithelial cells mainly represented by ductal and acinar cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9475031</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36104369</oboInOwl:hasDbXref>
        <rdfs:label>FasL expressing activated CD8+ T cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0001049"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/db20170b-307e-4c0b-98d7-f316bef56ca6"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0001049"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/db24cf49-58fc-498b-a963-19b479245cfc -->

    <Class rdf:about="http://example.org/db24cf49-58fc-498b-a963-19b479245cfc">
        <obo:IAO_0000115>The above analysis was based on a large number of RNA-seq, so we further used scRNA-seq to determine whether our ORGs signature had immune predictive value on the single cell level. Figure 7A showed that the PRAD samples from GEO datasets were annotated into Mast cell, ##Epithelial-NE##, T/NK, Plasma_B, Epithelial, Neuron, SMC, Fibroblasts and Pericytes, Myeloid and Endothelial. It was obvious that ORGs signature was specifically high in Epithelial-Nk, T/Nk and SMC cells (Figure 7B, 7C). Meanwhile, Figure 7D revealed that significant connection probability of ORGs related signaling pathways in cell clusters which showed specifically high ORGs signature. Furthermore, we chose epithelial cell for analysis. Chemotaxis related pathways including cell chemotaxis, leukocyte chemotaxis, regulation of chemotaxis and regulation of leukocyte chemotaxis were significantly up-regulated in the high ORGs signature group (Figure 7E). What&apos;s more, immune related pathways were all up-regulated in the high ORGs signature group both in GO (Figure 7F) and KEGG (Figure 7G) analysis.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10599753</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37788005</oboInOwl:hasDbXref>
        <rdfs:label>Epithelial-NE</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000066"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/db24cf49-58fc-498b-a963-19b479245cfc"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000066"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/db54b82b-44e3-4b92-a423-1ea5f257077f -->

    <Class rdf:about="http://example.org/db54b82b-44e3-4b92-a423-1ea5f257077f">
        <obo:IAO_0000115>The signals driving the adaptation of type 2 dendritic cells (DC2s) to diverse peripheral environments remain mostly undefined. We show that differentiation of CD11blo migratory DC2s-a DC2 population unique to the dermis-required IL-13 signaling dependent on the transcription factors STAT6 and KLF4, whereas DC2s in lung and small intestine were STAT6-independent. Similarly, human DC2s in skin expressed an IL-4 and IL-13 gene signature that was not found in blood, spleen and lung DCs. In mice, IL-13 was secreted homeostatically by dermal innate lymphoid cells and was independent of microbiota, TSLP or IL-33. In the absence of IL-13 signaling, ##dermal DC2s## were stable in number but remained CD11bhi and showed defective activation in response to allergens, with diminished ability to support the development of IL-4+GATA3+ helper T cells (TH), whereas antifungal IL-17+RORgammat+ TH cells were increased. Therefore, homeostatic IL-13 fosters a noninflammatory skin environment that supports allergic sensitization.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMID:34795444</oboInOwl:hasDbXref>
        <rdfs:label>dermal DC2s</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000784"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/db54b82b-44e3-4b92-a423-1ea5f257077f"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000784"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/db61ceb6-913f-4c55-8229-c7f4ec1fffd9 -->

    <Class rdf:about="http://example.org/db61ceb6-913f-4c55-8229-c7f4ec1fffd9">
        <obo:IAO_0000115>Such aging-associated inflammation, so-called inflammaging, is reported to be detrimental to several types of tissue-resident stem cells including hair follicle stem cells, hematopoietic stem cells and neural stem cells. In the present study, RNA-seq and qPCR analysis showed that inflammation markedly contributes to the age-associated transcriptional changes in liver ECs including ##VESCs## (Fig. 5a-d). We also confirmed the enrichment of inflammatory cells in the aged liver (Figs. 5e, f and S6). These findings indicate that the activation of inflammatory signals is a primary signature of aged VESCs. However, data illustrating how inflammation affects VESCs mechanistically is lacking in the present study. This limitation arises because aged mice do not survive well after monoclotalin treatment and irradiation; hence, we were unable to obtain sufficient mice to analyze. Although previous studies showed that age-associated inflammation dysregulates stemness of several types of stem cells, at this time, it remains speculative as to whether inflammation is actually the cause of the proliferative deficit of VESCs. Further investigations are needed to elucidate causal relationships.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10542733</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37563497</oboInOwl:hasDbXref>
        <rdfs:label>VESCs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000048"/>
        <skos:relatedMatch rdf:resource="CL:0002139"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/db61ceb6-913f-4c55-8229-c7f4ec1fffd9"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000048"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/db61ceb6-913f-4c55-8229-c7f4ec1fffd9"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002139"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/db77ce89-c895-4d3b-a65e-8bc0045ff14a -->

    <Class rdf:about="http://example.org/db77ce89-c895-4d3b-a65e-8bc0045ff14a">
        <obo:IAO_0000115>We performed de novo alignment of T cells from the CD8+ and CD4+ T cell clusters along a pseudo-temporal axis representing the continuum of blinatumomab-induced activation. CD8+ cells formed a trajectory from the TC0-CD8+ Naive T cluster, followed by clusters TC1-CD8+ TEM and TC2-CD8+ CTL towards cluster TC4-CD8+ Activated T (Additional file 1, Fig. S7A). Similarly, the TC10-CD4+ Activated T cluster was chronologically ordered at the terminal end of the CD4+ activation trajectory (Additional file 1, Fig. S7B). Genes associated with activation were mapped onto the activation trajectory, confirming an increased expression of the genes IL2RA, CD69, TNFRSF18 and TNFRSF4 at the end of the trajectories (Additional file 1, Fig. S7C-D). Both trajectories suggest that the activated CD8+ and CD4+ T cells did not originate from naive T cells, but rather from CD8+ TEM and CD4+ TCM cells, respectively. By contrast, cells from the TC13-##Activated T## cluster expressed high levels of naive marker genes (Fig. 2b), leading to the conclusion that cells from this CD8+/CD4+ mixed activated T cell cluster arose from naive T cells (TC0 and TC5).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7923532</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33648458</oboInOwl:hasDbXref>
        <rdfs:label>Activated T</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000896"/>
        <skos:relatedMatch rdf:resource="CL:0001049"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/db77ce89-c895-4d3b-a65e-8bc0045ff14a"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000896"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/db77ce89-c895-4d3b-a65e-8bc0045ff14a"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0001049"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/db8536b1-edf6-476f-a555-af76e62b98a8 -->

    <Class rdf:about="http://example.org/db8536b1-edf6-476f-a555-af76e62b98a8">
        <obo:IAO_0000115>While the heterogeneity of CD103+ TRMs is widely discussed in the literature, the characteristics of TRM subpopulations within the tumor or distant tissues of tumor-bearing mice are less well defined. To characterize tumoral TRMs, scRNA-seq technology provides unprecedented analytical power and allows us to dissect cells with thousands of dimensions. With the hypothesis that particular intratumoral T cells are precursors for TRM development, we extended our scRNA-seq approach to include various effector and memory T cell populations to comprehensively depict their transcriptomic program. From the tumor and distant mucosa of mice bearing established 4T1 tumors, we flow sorted distinct memory T cell populations using a strict gating strategy (Figure S3). We constructed single-cell cDNA libraries from paired intratumoral sorted ##TCR-beta+CD44+CD62L-CD69+CD103+ cells## (TRMs), mucosal sorted TCR-beta+CD44+ CD69+CD103+ cells (distant mucosa TRMs), intratumoral TCR-beta+CD44+CD62L+CD69-CD103- cells (TCMs), and TCR-beta+CD44+CD62L-CD69-CD103- cells (TEMs) (Table S2). After data processing and normalization, we performed unbiased clustering and visualized the CD8+ clusters using t-distributed stochastic neighbor embedding (t-SNE; Figure 2A). Through this unsupervised analysis, we found that all four samples could distinctly separate into multiple clusters, confirming continued heterogeneity among the single-cell subsets.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8204287</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33979626</oboInOwl:hasDbXref>
        <rdfs:label>TCR-beta+CD44+CD62L-CD69+CD103+ cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000909"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/db8536b1-edf6-476f-a555-af76e62b98a8"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000909"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/dbc02988-51c8-4388-bc59-ea550ba3e850 -->

    <Class rdf:about="http://example.org/dbc02988-51c8-4388-bc59-ea550ba3e850">
        <obo:IAO_0000115>(A) Immunocytochemistry analysis of claudin-5, caveolin-1, and GLUT-1 expression in Passage 1 endothelial cells (ECs) treated with DMSO or 4 microM CHIR. Hoechst nuclear counterstain is overlaid in the merged images. Dashed lines indicate the border between an EC colony and smooth muscle-like cells (SMLCs) in the DMSO condition. Scale bars: 200 mum. (B) Quantification of images from the conditions described in (A) for number of ECs per 20x field, percentage of ECs (claudin-5+ cells relative to total nuclei), percentage of ##GLUT-1+ ECs## (relative to total claudin-5+ ECs), and mean fluorescence intensity of claudin-5, caveolin-1, and GLUT-1 normalized to Hoechst mean fluorescence intensity within the area of claudin-5+ ECs only. Points represent replicate wells from 2 to 6 independent differentiations of the IMR90-4 line, each differentiation indicated with a different color. Bars indicate mean values. For the fluorescence intensity plots, values were normalized within each differentiation such that the mean of the DMSO condition equals 1. p-values: two-way ANOVA on unnormalized data.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8664294</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34755601</oboInOwl:hasDbXref>
        <rdfs:label>GLUT-1+ ECs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:2000044"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/dbc02988-51c8-4388-bc59-ea550ba3e850"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:2000044"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/dbc8dd94-6c55-43dc-9f49-f6effe9cf603 -->

    <Class rdf:about="http://example.org/dbc8dd94-6c55-43dc-9f49-f6effe9cf603">
        <obo:IAO_0000115>Identification of cell types from whole-brain cells. a UMAP plot shows the unsupervised clustering of 16,028 cells derived from mouse brain (for details, see &quot;Methods&quot;). The 15 cell types were classified by their transcriptional profiles. b Dot plot shows the expression levels of a representative cell-specific marker gene for each cell type. c UMAP plot shows the distribution of Olig2 expression. d Violin plot shows Olig2 expression across all clusters. e UMAP plot shows the distribution of GFAP expression. f Violin plot shows GFAP expression across all clusters. g A total of 3522 cells of the astrocyte subset were derived from cells in mouse brain. They were classified into Olig2(+)/GFAP(-) astrocytes (347 cells), Olig2(+)/GFAP(+) astrocytes (104 cells), Olig2(-)/GFAP(+) astrocytes (848 cells) and Olig2(-)/GFAP(-) astrocytes (2,223 cells). immNEU immature neuron, mNEU mature neuron, OPC oligodendrocyte precursor cell, immOLG immature oligodendrocyte, OLG oligodendrocyte, ASC astrocyte, OEG olfactory ensheathing glia, MG microglia; MAC macrophage, EC endothelial cell, PC pericyte, EPC ependymal cell, VLMC vascular and leptomeningeal cell, ABC arachnoid barrier cell, ##CP## cycling progenitor</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8573876</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34749773</oboInOwl:hasDbXref>
        <rdfs:label>CP</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0011026"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/dbc8dd94-6c55-43dc-9f49-f6effe9cf603"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0011026"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/dbd4460d-233a-427a-a2d7-46d17971b83a -->

    <Class rdf:about="http://example.org/dbd4460d-233a-427a-a2d7-46d17971b83a">
        <obo:IAO_0000115>Community 3 contained information on the frequency of innate and adaptive immune cells (Figure 4A). Within the innate cellular compartment, the strongest correlations (Spearman) with GA were increasing frequencies of granulocytes and CD14+CD16- classical monocytes (cMCs) (Figures 4B, C), which are front-line defenders that rapidly respond to injury or infection. In term infants, granulocytes comprised the majority (58%) of immune cell subsets in cord blood, but at earlier GA the proportion of granulocytes falls (average 24.5% of live leukocytes in infants &lt;30 weeks GA) and T lymphocytes predominate (average 47.3% of live leukocytes in infants &lt;30 weeks, of which 64% are CD4+ T cells). In contrast, in the adaptive compartment, the strongest correlations with GA were decreasing frequencies of regulatory T cells (Treg) and CD161+ T cells, including the CD4+ and CD8+ subsets (Figures 4G-I). Treg cells [and possibly ##fetal CD161+CD4+ T cells## ] are immune-regulatory cell subsets that can suppress antigen-specific T cell inflammatory responses. CD8+CD161+ T cells are enriched in mucosal associated invariant T (MAIT) cells that recognize riboflavin metabolites presented by MHC-related 1 (MR1) protein (although our assay did not include MR1 tetramers, which are necessary for the definitive identification of MAITs). Also decreasing in frequency with GA were Natural Killer (NK) T cells, which are enriched in invariant NK (iNK) T cells with a limited T cell receptor (TCR) repertoire specific for lipid antigens presented by the non-classical MHC class I protein CD1d (Figures 4D-F). Together these findings indicate that at early GA the cellular composition of the neonatal immune system is characterized by deficiencies in innate cells involved in the acute response to infection or danger and a relative abundance of suppressor T cells and a reliance on nonconventional T-cell populations with restricted TCR repertoires directed to non-peptide antigens.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8420969</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34497610</oboInOwl:hasDbXref>
        <rdfs:label>fetal CD161+CD4+ T cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000624"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/dbd4460d-233a-427a-a2d7-46d17971b83a"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000624"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/dc0878d7-81c1-49f0-8720-1314b7ea3224 -->

    <Class rdf:about="http://example.org/dc0878d7-81c1-49f0-8720-1314b7ea3224">
        <obo:IAO_0000115>Expression heterogeneity of CD8+ and CD4+ T cells in the OSCC ecosystem. (A) The t-distributed stochastic neighbor embedding (t-SNE) projection of T cells from cancerous tissue of patients with OSCC, showing the formation of 11 main clusters in different colors. The functional description of each cluster is determined by the gene expression characteristics. Cluster 0: resident memory CD8+ T Cells (C0_CD8+ TRM); Cluster 1: effector memory CD8+ T cells (C1_CD8+ TEM); Cluster 2: regulatory CD4+ T cells (C2_CD4+ Treg); Cluster 3: exhausted CD8+ T cells (C3_CD8+ T Exhausted); Cluster 4: effector memory M-phage CD8+ T cells (C4_CD8+ Mitotic TEM); Cluster 5: effector memory CD4+ T cells (C5_CD4+ TEM); Cluster 6: effector memory CD8+ T cells (C6_CD8+ TEM); Cluster 7: effector memory CD4+ T cells (C7_CD4+ TEM); Cluster 8: effector memory CD8+ T cells (C8_CD8+ TEM); Cluster 9: effector memory CD8+ T cells (C9_CD8+ TEM); Cluster 10: effector memory M-phage CD4+ T cells (C10_CD4+ Mitotic TEM); Cluster 11: effector memory CD8+ T cells (C11_CD8+ TEM); Cluster 12: effector memory CD8+ T cells (C12_CD8+ TEM); Cluster 13: gammadelta T. (B) Cell-Cycle Scoring of T cells from cancerous tissue of patients with OSCC, showing the three clusters of cells in different cell cycles in different colors. (C) Heatmap of key genes expressed in each cluster of CD8+ tumor-infiltrating lymphocytes (TILs) with cells grouped by clusters. The columns correspond to the cells; the rows correspond to the genes. Yellow: high expression; purple: low expression. Selected key markers are shown on the right. (D) Heatmap of key genes expressed in each cluster of ##CD4+ TILs## with cells grouped by clusters. The columns correspond to the cells; the rows correspond to the genes. Yellow: high expression; purple: low expression. Selected key genes are shown on the right.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8024729</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33513276</oboInOwl:hasDbXref>
        <rdfs:label>CD4+ TILs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000624"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/dc0878d7-81c1-49f0-8720-1314b7ea3224"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000624"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/dc3c5bab-438c-430f-a9d0-09459277a4af -->

    <Class rdf:about="http://example.org/dc3c5bab-438c-430f-a9d0-09459277a4af">
        <obo:IAO_0000115>Pancreatic ductal adenocarcinoma (PDAC) has a poor clinical outlook. Responses to immune checkpoint blockade are suboptimal and a much more detailed understanding of the tumor immune microenvironment is needed if this situation is to be improved. Here, we characterized tumor-infiltrating T-cell populations in patients with PDAC using cytometry by time of flight (CyTOF) and single-cell RNA sequencing. T cells were the predominant immune cell subset observed within tumors. Over 30% of CD4+ T cells expressed a CCR6+CD161+ Th17 phenotype and 17% displayed an activated regulatory T-cell profile. Large populations of CD8+ tissue-resident memory (TRM) T cells were also present and expressed high levels of programmed cell death protein 1 (PD-1) and TIGIT. A population of putative tumor-reactive CD103+CD39+ T cells was also observed within the CD8+ tumor-infiltrating lymphocytes population. The expression of PD-1 ligands was limited largely to hemopoietic cells whilst TIGIT ligands were expressed widely within the tumor microenvironment. Programmed death-ligand 1 and CD155 were expressed within the T-cell area of ectopic lymphoid structures and colocalized with PD-1+TIGIT+ CD8+ T cells. Combinatorial anti-PD-1 and TIGIT blockade enhanced IFNgamma secretion and proliferation of T cells in the presence of PD-1 and TIGIT ligands. As such, we showed that the PDAC microenvironment is characterized by the presence of substantial populations of ##TRM cells with an exhausted PD-1+TIGIT+ phenotype## where dual checkpoint receptor blockade represents a promising avenue for future immunotherapy.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10068448</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36689623</oboInOwl:hasDbXref>
        <rdfs:label>TRM cells with an exhausted PD-1+TIGIT+ phenotype</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000813"/>
        <skos:relatedMatch rdf:resource="CL:0011025"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/dc3c5bab-438c-430f-a9d0-09459277a4af"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000813"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/dc3c5bab-438c-430f-a9d0-09459277a4af"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0011025"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/dc5ee47d-98c7-4a9c-828c-5e6c1b405684 -->

    <Class rdf:about="http://example.org/dc5ee47d-98c7-4a9c-828c-5e6c1b405684">
        <obo:IAO_0000115>Our results so far indicate that the dura mater layer of the meninges contains a diverse population of stromal cells, including GP38+ and GP38- stromal cells that resemble the stroma of other lymphoid tissues and ECM remodelling. Consistent with our scRNAseq data, using flow cytometry, we observed a significant expansion of GP38+ FRCs, and a distinctive population of MAdCAM1+ CD21/CD35+ cells indicative of the presence of FDC-like cells in the infected murine meninges compared to naive controls (Fig 3D-3F; Gating strategy in S2A Fig, S5 and S6 Data), without significant changes in the lymphatic endothelial cells (LECs) or blood endothelial cells (BECs) (Fig 3E and 3F). Furthermore, using module scoring analysis, which allows us to assess global gene signatures associated with a gene set or pathway (in this case, ectopic lymphoid tissue signatures), we were able to identify that cells within cluster 5 were enriched for genes associated with FDC-like function and stromal lymphoid tissues, including Ccl19 and Cxcl13, compared to the other fibroblast clusters (Fig 3H), and may be derived from Ly6a+ pericytes with a precursor capacity as previously reported. Indeed, using in situ hybridisation on independent tissue sections, we were able to confirm the presence of Ly6a+ Rarres2+ cells that expressed Cxcl13+ during infection (Fig 3I). Together, our data demonstrate the presence of a rich diverse fibroblast population, encompassing Ly6a+ Rarres2+ FRC-like pericytes, including ##Aldh1a2+ Ccl19+ FRC-like pericytes##, myofibroblasts, Fth1+ fibroblasts, and perivascular dura fibroblasts. Our data also suggests that chronic T. brucei infection induces an extensive remodelling of the meningeal stroma compartment, resulting in the expansion of FRCs and FDC-like cells without significant changes in the vasculature (LECs and BECs).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10723712</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37983289</oboInOwl:hasDbXref>
        <rdfs:label>Aldh1a2+ Ccl19+ FRC-like pericytes</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000669"/>
        <skos:relatedMatch rdf:resource="CL:0009102"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/dc5ee47d-98c7-4a9c-828c-5e6c1b405684"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000669"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/dc5ee47d-98c7-4a9c-828c-5e6c1b405684"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0009102"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/dc815320-df91-4121-b6a1-9c187015d1e1 -->

    <Class rdf:about="http://example.org/dc815320-df91-4121-b6a1-9c187015d1e1">
        <obo:IAO_0000115>##nephron progenitor cells##</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6400406</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:30789893</oboInOwl:hasDbXref>
        <rdfs:label>nephron progenitor cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0011026"/>
        <skos:relatedMatch rdf:resource="CL:1000507"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/dc815320-df91-4121-b6a1-9c187015d1e1"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0011026"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/dc815320-df91-4121-b6a1-9c187015d1e1"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:1000507"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/dca9d30d-b462-42b3-a90f-ad0aa9497473 -->

    <Class rdf:about="http://example.org/dca9d30d-b462-42b3-a90f-ad0aa9497473">
        <obo:IAO_0000115>After ##SPNs##, most of the remaining neurons of the striatum are constituted by a diverse variety of GABAergic interneurons. The most commonly used markers to distinguish between subtypes of striatal GABAergic interneurons are parvalbumin, calretinin, and nitric oxide synthase. In human tissue, apparent LRRK2 expression has been observed in a majority of calretinin-expressing interneurons, as well as a small subset of parvalbumin- and nitric-oxide-synthase-expressing neurons. However, in mice, LRRK2 staining was observed in most parvalbumin- and nitric-oxide-synthase-positive neurons and only a few calretinin-positive cells. In contrast, other groups have found no colocalization between LRRK2 and any of these markers. Single-cell mRNA expression across all types of GABAergic interneurons is approximately an order of magnitude lower than in SPNs. If the expression of the LRRK2 protein correlates with the mRNA levels reported by Saunders and colleagues, striatal interneurons would contain much less protein than the surrounding SPNs. This would increase the difficulty of detection, potentially explaining part of the apparent discrepancy among these studies. </obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8750662</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35011731</oboInOwl:hasDbXref>
        <rdfs:label>SPNs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:1001474"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/dca9d30d-b462-42b3-a90f-ad0aa9497473"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:1001474"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/dcc7c029-4099-4fb2-b263-c714406fe502 -->

    <Class rdf:about="http://example.org/dcc7c029-4099-4fb2-b263-c714406fe502">
        <obo:IAO_0000115>We undertook a comprehensive Mendelian randomization study aimed at uncovering the causal relationship between 744 immune cell types and IVDD [ Supplementary Table 2 ]. In our analysis, we identified 24 specific blood types of immune cells that demonstrated a causal association with disc degeneration through univariable MR [ Supplementary Table 3 ], including Memory B cell %B cell, Naive-mature B cell %B cell, IgD-CD38dim B cell %lymphocyte, CD39+activated CD4 regulatory T cell %CD4 regulatory T cell, CD39+ secreting CD4 regulatory T cell %CD4 regulatory T cell, CD45RA+ CD8+ T cell %CD8+ T cell, CD8+ T cell %leukocyte, CD39+CD4+ T cell %T cell, CD39+ CD4+ T cell %CD4+ T cell,CD39+ CD8+ T cell %T cell, CD39+ CD8+ T cell Absolute Count, CD127- CD8+ T cell Absolute Count, CD28- CD8+ T cell Absolute Count, CD19 on IgD+ CD38+ B cell, CD19 on IgD+ CD38dim B cell, CD19 on IgD- CD38- B cell, CD19 on unswitched memory B cell, CD19 on transitional B cell, CD24 on IgD+ CD38+ B cell,CD28 on CD39+ secreting CD4 regulatory T cell, CD25 on CD39+ CD4+ T cell, CD4 on CD39+ CD4+ T cell, CD4 on CD39+ resting CD4 regulatory T cell and Neutrophil count. We excluded certain exposures due to a limited number of available SNPs to prevent potential bias, including Memory B cell %B cell, Naive-mature B cell %B cell, IgD-CD38dim B cell %lymphocyte, CD8+T cell %leukocyte, CD127-CD8+ T cell Absolute Count, CD19 on ##IgD-CD38-B cell##, CD24 on IgD+ CD38+ B cell, CD28 on CD39+ secreting CD4 regulatory T cell and CD4 on CD39+ resting CD4 regulatory T cell.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10806224</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38268919</oboInOwl:hasDbXref>
        <rdfs:label>IgD-CD38-B cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000236"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/dcc7c029-4099-4fb2-b263-c714406fe502"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000236"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/dcda7fcc-d2a0-416a-a9eb-c651df0da00e -->

    <Class rdf:about="http://example.org/dcda7fcc-d2a0-416a-a9eb-c651df0da00e">
        <obo:IAO_0000115>In humans, the number of ENS neurons is about 500 million, many more than in the other parts of the peripheral autonomic nervous system. The longitudinal and circular layers of the muscularis externa are innervated by nerve fibres of sympathetic extrinsic ganglia and nerve fibres of Auerbach&apos;s plexus motoneurons and such organisation regulates proper intestinal motility. Moreover, the peristaltic reflexes of the intestine are coordinated by an abundant network of the myenteric plexuses descending and ascending nerve fibres. The intestinal mucosa is innervated by fibres of ##secretomotor neurons## originating from submucosal plexuses. Secretomotor neurons regulate fluid exchange, intestinal permeability and coordinate proper intestinal reflexes. The lumen of submucosal blood vessels is regulated by axons of the vasomotor neurons (dilatory function) of submucosal plexuses and/or nitrergic (neuronal nitric oxide synthase, i.e., nNOS) neurons and axons of sympathetic neurons of extrinsic ganglia (constrictory function). Moreover, all the layers of the intestine and blood vessels are innervated by the sensory neurons (with mechano-, thermo- and chemoreceptors) of submucosal and myenteric plexuses as well as dorsal root ganglia. All components of the ENS are interconnected by numerous interneurons which functionally integrate them into one system which functions are based on physiological reflexes.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7247003</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32403316</oboInOwl:hasDbXref>
        <rdfs:label>secretomotor neurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000100"/>
        <skos:relatedMatch rdf:resource="CL:0007011"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/dcda7fcc-d2a0-416a-a9eb-c651df0da00e"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000100"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/dcda7fcc-d2a0-416a-a9eb-c651df0da00e"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0007011"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/dd0a3532-9fc2-48fb-9d8d-7369663bbed1 -->

    <Class rdf:about="http://example.org/dd0a3532-9fc2-48fb-9d8d-7369663bbed1">
        <obo:IAO_0000115>After SPNs, most of the remaining neurons of the striatum are constituted by a diverse variety of GABAergic interneurons. The most commonly used markers to distinguish between subtypes of ##striatal GABAergic interneurons## are parvalbumin, calretinin, and nitric oxide synthase. In human tissue, apparent LRRK2 expression has been observed in a majority of calretinin-expressing interneurons, as well as a small subset of parvalbumin- and nitric-oxide-synthase-expressing neurons. However, in mice, LRRK2 staining was observed in most parvalbumin- and nitric-oxide-synthase-positive neurons and only a few calretinin-positive cells. In contrast, other groups have found no colocalization between LRRK2 and any of these markers. Single-cell mRNA expression across all types of GABAergic interneurons is approximately an order of magnitude lower than in SPNs. If the expression of the LRRK2 protein correlates with the mRNA levels reported by Saunders and colleagues, striatal interneurons would contain much less protein than the surrounding SPNs. This would increase the difficulty of detection, potentially explaining part of the apparent discrepancy among these studies. </obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8750662</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35011731</oboInOwl:hasDbXref>
        <rdfs:label>striatal GABAergic interneurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0011005"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/dd0a3532-9fc2-48fb-9d8d-7369663bbed1"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0011005"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/dd39641b-b718-4aaf-9d78-b1930d9a660f -->

    <Class rdf:about="http://example.org/dd39641b-b718-4aaf-9d78-b1930d9a660f">
        <obo:IAO_0000115>We undertook a comprehensive Mendelian randomization study aimed at uncovering the causal relationship between 744 immune cell types and IVDD [ Supplementary Table 2 ]. In our analysis, we identified 24 specific blood types of immune cells that demonstrated a causal association with disc degeneration through univariable MR [ Supplementary Table 3 ], including Memory B cell %B cell, Naive-mature B cell %B cell, IgD-CD38dim B cell %lymphocyte, CD39+activated CD4 regulatory T cell %CD4 regulatory T cell, CD39+ secreting CD4 regulatory T cell %CD4 regulatory T cell, CD45RA+ CD8+ T cell %CD8+ T cell, CD8+ T cell %leukocyte, CD39+CD4+ T cell %T cell, CD39+ CD4+ T cell %CD4+ T cell,CD39+ CD8+ T cell %T cell, CD39+ CD8+ T cell Absolute Count, CD127- CD8+ T cell Absolute Count, CD28- CD8+ T cell Absolute Count, CD19 on IgD+ CD38+ B cell, CD19 on IgD+ CD38dim B cell, CD19 on ##IgD- CD38- B cell##, CD19 on unswitched memory B cell, CD19 on transitional B cell, CD24 on IgD+ CD38+ B cell,CD28 on CD39+ secreting CD4 regulatory T cell, CD25 on CD39+ CD4+ T cell, CD4 on CD39+ CD4+ T cell, CD4 on CD39+ resting CD4 regulatory T cell and Neutrophil count. We excluded certain exposures due to a limited number of available SNPs to prevent potential bias, including Memory B cell %B cell, Naive-mature B cell %B cell, IgD-CD38dim B cell %lymphocyte, CD8+T cell %leukocyte, CD127-CD8+ T cell Absolute Count, CD19 on IgD-CD38-B cell, CD24 on IgD+ CD38+ B cell, CD28 on CD39+ secreting CD4 regulatory T cell and CD4 on CD39+ resting CD4 regulatory T cell.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10806224</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38268919</oboInOwl:hasDbXref>
        <rdfs:label>IgD- CD38- B cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000236"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/dd39641b-b718-4aaf-9d78-b1930d9a660f"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000236"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/dd967ea6-c846-40c8-8681-33354f7dc9bc -->

    <Class rdf:about="http://example.org/dd967ea6-c846-40c8-8681-33354f7dc9bc">
        <obo:IAO_0000115>Distinct Roles for ##Prefrontal Dopamine D1 and D2 Neurons## in Social Hierarchy.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8802944</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34844989</oboInOwl:hasDbXref>
        <rdfs:label>Prefrontal Dopamine D1 and D2 Neurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:4023026"/>
        <skos:relatedMatch rdf:resource="CL:4023029"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/dd967ea6-c846-40c8-8681-33354f7dc9bc"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4023026"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/dd967ea6-c846-40c8-8681-33354f7dc9bc"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4023029"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/dda73f3e-3dfb-48cf-95d7-7446893fecb0 -->

    <Class rdf:about="http://example.org/dda73f3e-3dfb-48cf-95d7-7446893fecb0">
        <obo:IAO_0000115>Lymphocytes such as CD4+ T cells and B cells mainly infiltrate the salivary glands; however, the precise roles and targets of autoreactive T cells and autoantibodies in the pathogenesis of Sjogren&apos;s Syndrome (SS) remain unclear. This study was designed to clarify the role of autoreactive T cells and autoantibodies at the single-cell level involved in the development of sialadenitis. Infiltrated ##CD4+ T and B cells## in the salivary glands of a mouse model resembling SS were single-cell-sorted, and their T cell receptor (TCR) and B cell receptor (BCR) sequences were analyzed. The predominant TCR and BCR clonotypes were reconstituted in vitro, and their pathogenicity was evaluated by transferring reconstituted TCR-expressing CD4+ T cells into Rag2-/- mice and administering recombinant IgG in vivo. The reconstitution of Th17 cells expressing TCR (#G) in Rag2-/- mice resulted in the infiltration of T cells into the salivary glands and development of sialadenitis, while an autoantibody (IgGr22) was observed to promote the proliferation of pathogenic T cells. IgGr22 specifically recognizes double-stranded RNA (dsRNA) and induces the activation of dendritic cells, thereby enhancing the expression of IFN signature and inflammatory genes. TCR#G recognizes antigens related to the gut microbiota. Antibiotic treatment severely reduces the activation of TCR#G-expressing Th17 cells and suppresses sialadenitis development. These data suggest that the anti-dsRNA antibodies and, TCR recognizing the gut microbiota involved in the development of sialadenitis like SS. Thus, our model provides a novel strategy for defining the roles of autoreactive TCR and autoantibodies in the development and pathogenesis of SS.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMID:38762063</oboInOwl:hasDbXref>
        <rdfs:label>CD4+ T and B cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000236"/>
        <skos:relatedMatch rdf:resource="CL:0000624"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/dda73f3e-3dfb-48cf-95d7-7446893fecb0"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000236"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/dda73f3e-3dfb-48cf-95d7-7446893fecb0"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000624"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/ddae5be0-2a86-417f-8d20-84bcc681005d -->

    <Class rdf:about="http://example.org/ddae5be0-2a86-417f-8d20-84bcc681005d">
        <obo:IAO_0000115>Sjogren&apos;s syndrome is a chronic autoimmune disorder whose pathogenesis is poorly understood and that lacks effective therapies. Detailed quantitative and spatial analyses of tissues affected by Sjogren&apos;s syndrome were undertaken, including the quantitation of the frequency of selected cell-cell interactions in the disease milieu. Quantitative analyses of CD4+ T cell subsets and of CD8+ T cells in the labial salivary glands from untreated patients with primary Sjogren&apos;s syndrome revealed that activated CD8+ cytotoxic T cells (CD8+CTLs) were the most prominent T cells in these infiltrates. An accumulation of apoptotic glandular epithelial cells, mainly ductal and acinar cells, was observed, consistent with the impaired salivary secretion often observed in patients with this disease. FasL expressing activated CD8+ T cells were seen to accumulate around Fas expressing apoptotic epithelial cells. Quantitative analyses of apoptotic cell types and of conjugates between ##cytotoxic T cells## and epithelial cells undergoing apoptosis suggest that Sjogren&apos;s syndrome is primarily driven by CD8+CTL mediated execution of epithelial cells mainly represented by ductal and acinar cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9475031</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36104369</oboInOwl:hasDbXref>
        <rdfs:label>cytotoxic T cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000910"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/ddae5be0-2a86-417f-8d20-84bcc681005d"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000910"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/ddd6e73b-41f9-49f5-89d1-681da36d6be4 -->

    <Class rdf:about="http://example.org/ddd6e73b-41f9-49f5-89d1-681da36d6be4">
        <obo:IAO_0000115>In order to investigate the underlying process that may lead to a poor prognosis for high-risk LUAD patients, an analysis of hallmark pathway gene profiles was conducted, revealing distinct characteristics between high- and low-risk groups. A direct comparison between the Risk-High and Risk-Low groups showed that the top five enriched signatures in the high-risk group were MYC target v1, MYC target v2, mTORC1 signaling, G2M checkpoint, and Glycolysis ( Figure 10A ). GSEA enrichment analysis also indicated that the high-risk group had significantly enriched Cell Cycle (NES = 1.93, p&lt; 0.001) and DNA Replication (NES = 1.78, p = 0.000) ( Figure 10B ). The ssGSEA algorithm was employed to examine differences in immune status across distinct risk groups. Low-risk LUAD patients showed increased infiltration of various immune cells, including Active dendritic cells (aDCs), B cells, CD8+ T cells, Dendritic cells (DCs), ##Immature dendritic cells## (iDCs), Mast cells, neutrophils, T helper cell, Tumor-infiltrating lymphocytes (TILs), and Regulatory T cells (Treg), in their tumor microenvironment (TME). Furthermore, almost all immune-related pathways were significantly expressed in the low-risk group ( Figures 10C, D ).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10073691</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37033259</oboInOwl:hasDbXref>
        <rdfs:label>Immature dendritic cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000840"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/ddd6e73b-41f9-49f5-89d1-681da36d6be4"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000840"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/ddf8eeb3-e678-49b4-9063-fe17bccdca3f -->

    <Class rdf:about="http://example.org/ddf8eeb3-e678-49b4-9063-fe17bccdca3f">
        <obo:IAO_0000115>Up-regulated DEGs in I-MSCs compared with ##Mx- and Md-MSCs##</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7310078</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32571211</oboInOwl:hasDbXref>
        <rdfs:label>Mx- and Md-MSCs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000134"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/ddf8eeb3-e678-49b4-9063-fe17bccdca3f"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000134"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/de25278d-f3cb-4c44-97d4-3269af277243 -->

    <Class rdf:about="http://example.org/de25278d-f3cb-4c44-97d4-3269af277243">
        <obo:IAO_0000115>To determine if certain neurons have a molecular predisposition to express RAGs over others, we applied single nucleus ATAC-seq to the lumbar spinal cord of uninjured mice. We leveraged our snRNA-seq annotations to identify cell types, first assessing neurons compared to non-neurons (Supplementary Fig. 12a-d). We detected increased chromatin accessibility of Sprr1a, Sox11, and Gap43 RAG loci within neurons. To provide greater resolution of neurons, we next grouped these into families of cell types, including ##dorsal excitatory (DE), dorsal inhibitory (DI), mid-excitatory (ME), mid-inhibitory (MI), ventral excitatory (VE), ventral inhibitory (VI) and motoneurons##. We found no clear differential pattern of chromatin accessibility between families of neurons (Supplementary Fig. 12e-h). Although this dataset did not provide deep neuronal subtype resolution, these findings do not support the existence of specific neuronal subpopulations that are primed to express RAG genes.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9513082</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36163250</oboInOwl:hasDbXref>
        <rdfs:label>dorsal excitatory (DE), dorsal inhibitory (DI), mid-excitatory (ME), mid-inhibitory (MI), ventral excitatory (VE), ventral inhibitory (VI) and motoneurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002611"/>
        <skos:relatedMatch rdf:resource="CL:0002612"/>
        <skos:relatedMatch rdf:resource="CL:0011001"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/de25278d-f3cb-4c44-97d4-3269af277243"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002611"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/de25278d-f3cb-4c44-97d4-3269af277243"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002612"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/de25278d-f3cb-4c44-97d4-3269af277243"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0011001"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/de614834-20b0-4e33-a8da-afba1a74e27b -->

    <Class rdf:about="http://example.org/de614834-20b0-4e33-a8da-afba1a74e27b">
        <obo:IAO_0000115>scRNA-seq of ECs reveal a subpopulation enriched with immune responsive signatures. (A) Schematic showing the experimental design for the scRNA-seq and single-nuclei ATAC sequencing analysis of regenerative mouse hearts (MI at P1 and harvested at P5) and nonregenerative mouse hearts (MI at P8 and harvested at P12). (B) UMAP representation of cardiac cell clusters identified from scRNA-seq analysis. Clusters were color coded according to cell types (left). CM, cardiomyocytes; EC, endothelial cells; CF, fibroblasts; PeriC, pericytes; SMC, smooth muscle cells; EndoC, endocardial cells; EpiC, epicardial cells; MF, macrophages; TC, T-cells. (C) Gene ontology (GO) analysis of differentially expressed genes up-regulated in ECs of regenerative-stage hearts versus nonregenerative-stage hearts after MI. (D) UMAP representation of CD31+-enriched cell clusters from single-cell RNA sequencing (scRNA-seq), color coded according to cell type. CEC, capillary endothelial cell; Angio-EC, angiogenic endothelial cell; ##Pro-EC##1, proliferative endothelial cell 1; Pro-EC2, proliferative endothelial cell 2; IFN-EC, interferon capillary endothelial cell; CVEC, capillary venous endothelial cell; VEC, venous endothelial cell; AEC, arterial endothelial cell; LEC, lymphatic endothelial cell; EndoC, endocardial cell. (E) Gene ontology (GO) analysis of differentially expressed genes up-regulated in the IFN-EC cluster of regenerative-stage hearts versus nonregenerative-stage hearts after MI.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10681909</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38012001</oboInOwl:hasDbXref>
        <rdfs:label>Pro-EC</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0010008"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/de614834-20b0-4e33-a8da-afba1a74e27b"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0010008"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/de63121c-9a3c-495f-b0c8-72cb3f0fbbad -->

    <Class rdf:about="http://example.org/de63121c-9a3c-495f-b0c8-72cb3f0fbbad">
        <obo:IAO_0000115>The above analysis was based on a large number of RNA-seq, so we further used scRNA-seq to determine whether our ORGs signature had immune predictive value on the single cell level. Figure 7A showed that the PRAD samples from GEO datasets were annotated into Mast cell, Epithelial-NE, T/NK, ##Plasma_B##, Epithelial, Neuron, SMC, Fibroblasts and Pericytes, Myeloid and Endothelial. It was obvious that ORGs signature was specifically high in Epithelial-Nk, T/Nk and SMC cells (Figure 7B, 7C). Meanwhile, Figure 7D revealed that significant connection probability of ORGs related signaling pathways in cell clusters which showed specifically high ORGs signature. Furthermore, we chose epithelial cell for analysis. Chemotaxis related pathways including cell chemotaxis, leukocyte chemotaxis, regulation of chemotaxis and regulation of leukocyte chemotaxis were significantly up-regulated in the high ORGs signature group (Figure 7E). What&apos;s more, immune related pathways were all up-regulated in the high ORGs signature group both in GO (Figure 7F) and KEGG (Figure 7G) analysis.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10599753</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37788005</oboInOwl:hasDbXref>
        <rdfs:label>Plasma_B</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000980"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/de63121c-9a3c-495f-b0c8-72cb3f0fbbad"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000980"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/de7bbe01-3aa7-437d-be73-7d602cb289a8 -->

    <Class rdf:about="http://example.org/de7bbe01-3aa7-437d-be73-7d602cb289a8">
        <obo:IAO_0000115>Based on the observations described above, we chose Day 3 as the most appropriate time to define the state of cell differentiation as primitive streak mesoderm (PSM) cells, and we therefore used cells at Day 3 for the next step. To confirm the exclusive mesodermal differentiation and homogeneity of the PSM population, the cells were tested for surface markers expression associated with mesoderm (CXCR4) and endoderm (Sox17). The flow cytometry clearly shows that the ##PSM cells## are homogenic in their mesodermal profile and no off-target differentiation to endoderm was detected (Fig. 1E).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6831475</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31695783</oboInOwl:hasDbXref>
        <rdfs:label>PSM cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0011007"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/de7bbe01-3aa7-437d-be73-7d602cb289a8"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0011007"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/de7d9c92-e9ea-4938-9cab-997f0c9ea51f -->

    <Class rdf:about="http://example.org/de7d9c92-e9ea-4938-9cab-997f0c9ea51f">
        <obo:IAO_0000115>T cell development stages and transcription factor expression kinetics. (A) Diagram depicts different stages of early thymic T cell development that T-progenitor cells sequentially go through. Informative surface proteins that are utilized to define each stage are indicated (cKit, CD44, CD25 for ETP to DN3; CD4 and CD8 for DP). Developmental plasticity to generate alternative, non-T-lineage cells is shown with dotted arrows. Note that these alternative lineage potentials are silenced after T-lineage commitment. Lineage commitment to a T cell fate distinguishes Phase 1 (before T-lineage commitment) and Phase 2 (after T-lineage commitment). CLP, Common lymphoid progenitor, LMPP, ##lympho-myeloid primed progenitor##. (B) Graphs show mRNA expression kinetics of important transcription factors involved in early T cell gene regulation programs. Left: Transcription factors inherited from the bone-marrow progenitor cells whose expressions gradually decline during T-development (Spi1, Bcl11a, Erg, Lyl1, and Lmo2). Middle: transcription factors upregulated in pro-T cells by thymic microenvironment (Tcf7, Gata3, and Bcl11b). Right: transcription factors expressed from the bone-marrow progenitor cells and stably and maintained during T cell development (Ikzf1, Tcf3, Tcf12, Runx1, and Runx3). Gene expression data was plotted by utilizing publicly available mRNA expression datasets for immune cells with curve smoothing . (C) Diagram illustrates transcription factors (arrows) providing distinct forces to different gene expression program modules in individual cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9928580</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36817475</oboInOwl:hasDbXref>
        <rdfs:label>lympho-myeloid primed progenitor</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000837"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/de7d9c92-e9ea-4938-9cab-997f0c9ea51f"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000837"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/deaeef79-f1a8-4b0f-9bd4-80204c5c17a4 -->

    <Class rdf:about="http://example.org/deaeef79-f1a8-4b0f-9bd4-80204c5c17a4">
        <obo:IAO_0000115>To develop a deeper understanding of the nature of B-cell responses in COVID-19, we further divided the B-cell population into more detailed subclusters using their transcriptional signatures and SHM rate obtained from scRNA datasets ( Figures 3A-C ). Previous high-dimensional flow cytometry data indicated that severe COVID-19 patients displayed hallmarks of EF B-cell activation and shared B-cell repertoire features in autoimmune settings. Therefore, our study primarily focused on B-cell subsets representing EF responses. Here, 13 B-cell subclusters, including 3 subsets of plasma cells and 5 subsets of memory B cells, were identified by cluster analysis on UMAP ( Figure 3A ). IGHD-expressing naive B cells were subdivided into TR B cells, resting naive (RN) B cells, and activated naive (AN) B cells according to the differential expression of the specific signature gene set ( Figure 3B ). The AN B cells were IGHD-positive clusters with comparatively higher SHM rates ( Figure 3C ) than other naive B cells and expressed distinct genes, such as FGR and MPP6. During the EF response, AN B cells differentiate into effector cells lacking naive (IgD) and memory (CD27) markers or DN B cells. DN B cells showed a higher SHM rate than AN B cells and expressed ITGAX (CD11C) and CD86 ( Figures 3B, C ). A previous study also reported that the human EF effector B-cell responses are mediated by the expansion of a unique population of CD11c+ AN B cells. Two clusters of atypical memory (AM1 and AM2) B cells were identified within the memory B-cell compartment, which overexpressed CD1C. Interestingly, AM2 B cells shared several transcriptional signatures, including FGR and HLA-DRB1, with EF B-cell subsets, including ##AN and DN cells##. Both AM2 and DN B cells express ITGAX, TBX21, CD86, and ITGB2, but AM2 uniquely expressed CXCR3 and GSN (gelsolin).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9309264</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35899045</oboInOwl:hasDbXref>
        <rdfs:label>AN and DN cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000788"/>
        <skos:relatedMatch rdf:resource="CL:0000981"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/deaeef79-f1a8-4b0f-9bd4-80204c5c17a4"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000788"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/deaeef79-f1a8-4b0f-9bd4-80204c5c17a4"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000981"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/deb6db73-0660-41b6-9a31-360c49862f72 -->

    <Class rdf:about="http://example.org/deb6db73-0660-41b6-9a31-360c49862f72">
        <obo:IAO_0000115>Tonsillar CD4+ T cell subsets can be divided into three major groups. Most intrafollicular T cells belong to the follicular B helper T cell group (follicular Th [TFH], CD4+PD1+CXCR5+BCL6high). B cell and TFH interactions are crucial for the formation of the humoral immune response and support B cell somatic hypermutation and Ab class switching. Other tonsillar CD4+ T cell subsets include non-TFH (CD4+PD1-CXCR5-BCL6low) and pre-TFH (CD4+PD1+CXCR5-BCL6mid). ##Pre-TFH cells## develop from activated Ag-specific CD4+ T cells. The transcriptional program that is initiated in pre-TFH cells can induce CXCR5 expression, enabling the cells to migrate toward the B cell follicle.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8278278</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34099545</oboInOwl:hasDbXref>
        <rdfs:label>Pre-TFH cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002038"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/deb6db73-0660-41b6-9a31-360c49862f72"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002038"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/decd02e8-fa16-44e1-8029-6cdbfc441e23 -->

    <Class rdf:about="http://example.org/decd02e8-fa16-44e1-8029-6cdbfc441e23">
        <obo:IAO_0000115>##Macrophage##-depletion of VEGF1R reduces macrophage number and reduces M2 polarization. (A) ELISA for PlGF levels in tissue from all experimental groups. (B) Representative flow charts for analysis and sorting for CD68 and CD163. (C, D) Quantification of CD68+ macrophage percentage (C) and CD163+ cells in total CD68+ cells (D). *p &lt; 0.05. NS, non-significant.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8511710</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34659227</oboInOwl:hasDbXref>
        <rdfs:label>Macrophage</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/decd02e8-fa16-44e1-8029-6cdbfc441e23"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/dedf01a2-3c65-461e-91c1-ba90930dc665 -->

    <Class rdf:about="http://example.org/dedf01a2-3c65-461e-91c1-ba90930dc665">
        <obo:IAO_0000115>a, Frequencies of T cells, monocytes, regulatory T cells (Tregs), and ##monocytic myeloid-derived suppressor cells## (mo-MDSC) within PBMCs were determined at V07 by flow cytometry and are shown according to disease course at EOS (top) and SOC treatment (bottom). CD3+, T cells. n(SD) = 15; n(PsPD) = 11; n(PD) = 4; n(RT) = 5; n(RT + TMZ) = 22; n(TMZ) = 3. Red line, median; dotted lines, quartiles. Two-sided Kruskal-Wallis test with Dunn&apos;s multiple comparison. b, Gating strategy for flow cytometric analysis.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8046668</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33762734</oboInOwl:hasDbXref>
        <rdfs:label>monocytic myeloid-derived suppressor cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000576"/>
        <skos:relatedMatch rdf:resource="CL:0000889"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/dedf01a2-3c65-461e-91c1-ba90930dc665"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000576"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/dedf01a2-3c65-461e-91c1-ba90930dc665"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000889"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/df019864-d4bc-4495-bfa5-19b245c86e00 -->

    <Class rdf:about="http://example.org/df019864-d4bc-4495-bfa5-19b245c86e00">
        <obo:IAO_0000115>The Table shows the numerical representations of Excitatory Neurons (Deep and Superficial Pyramidal cells) and Inhibitory neurons (Oriens Lacunosum moleculare cells:OLM; Trilaminar cells:Tri, Backprojection cells:BP, cholecystokinin positive Basket cells:CCKBC, Parvalbumin positive cells:PVBC, AxoAxonic Cells:AA, Ivy Cells:IVY, Bistratified cells:BS, Schaffer Collateral associated cells:SCA, Perforant Pathway Associated cell:PPA, Neurogliaform:##NG##) subdivided on the basis of the placement classes (SO, SP, SR, SLM).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9381785</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35974119</oboInOwl:hasDbXref>
        <rdfs:label>NG</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0010011"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/df019864-d4bc-4495-bfa5-19b245c86e00"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0010011"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/df68874f-b04f-495b-b01e-aad9c71fd0ff -->

    <Class rdf:about="http://example.org/df68874f-b04f-495b-b01e-aad9c71fd0ff">
        <obo:IAO_0000115>Based on the observations described above, we chose Day 3 as the most appropriate time to define the state of cell differentiation as primitive streak mesoderm (PSM) cells, and we therefore used cells at Day 3 for the next step. To confirm the exclusive mesodermal differentiation and homogeneity of the ##PSM## population, the cells were tested for surface markers expression associated with mesoderm (CXCR4) and endoderm (Sox17). The flow cytometry clearly shows that the PSM cells are homogenic in their mesodermal profile and no off-target differentiation to endoderm was detected (Fig. 1E).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6831475</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31695783</oboInOwl:hasDbXref>
        <rdfs:label>PSM</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0011007"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/df68874f-b04f-495b-b01e-aad9c71fd0ff"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0011007"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/df90934e-29ec-4418-84ed-0a1c0ffa778a -->

    <Class rdf:about="http://example.org/df90934e-29ec-4418-84ed-0a1c0ffa778a">
        <obo:IAO_0000115>Transcriptional signature of pancreas ##infiltrating and circulating CD4+ and CD8+ T cell## subsets at disease onset. (A) UMAP plot of CD4+ and CD8+ T cells from peripheral blood and pancreas of new-onset diabetic NOD mice. (B) Feature plots depicting gene expression levels of distinct markers driving CD4+ and CD8+ T cell activation states. (C, D) UMAP plot of CD4+ (C) and CD8+ (D) T cells grouped by the annotation in A (left) and grouped by T cell subset classified based on the expression of Cd44 and Sell (right). EM = effector memory (Cd44+Sell-), CM = central memory (Cd44+Sell+), naive (Cd44-Sell+), and CD44low CD62L- (Cd44-Sell-). (E, F) Heatmap depicting row-based z-scores of scaled gene expression levels for marker genes driving T cell heterogeneity across the distinct CD4+ (E) and CD8+ (F) T cell subsets. (G, H) Trajectory of CD4+ (G) and CD8+ (H) naive, CD44low CD62L-, effector memory (EM), and central memory (CM) T cell subsets projected onto the UMAP plot (top). Violin plots depicting the pseudotime of CD4+ (G) and CD8+ (H) T cells per subset (bottom). Each dot represents a single cell. (I, J) Differentially expressed genes of CD4+ Cd44-Sell- (I) and CD8+ Cd44-Sell- (J) T cells between peripheral blood and pancreas.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10667927</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38027120</oboInOwl:hasDbXref>
        <rdfs:label>infiltrating and circulating CD4+ and CD8+ T cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000624"/>
        <skos:relatedMatch rdf:resource="CL:0000625"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/df90934e-29ec-4418-84ed-0a1c0ffa778a"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000624"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/df90934e-29ec-4418-84ed-0a1c0ffa778a"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000625"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/df9a9b35-23a4-442d-be49-9fd2c80c497f -->

    <Class rdf:about="http://example.org/df9a9b35-23a4-442d-be49-9fd2c80c497f">
        <obo:IAO_0000115>The classification of pericyte-derived and non-pericyte-derived myofibroblasts (PDGFRbeta-constitutively-expressing and PDGFRbeta-de novo-expressing, respectively) indicates different roles of pulmonary myofibroblasts. With PDGFRbeta as a &apos;specific&apos; marker for pericytes, PDGFRbeta-regulated Cre expression has been used to trace the fate of these cells. However, the constitutive PDGFRbeta-Cre line employed in other studies does not allow discriminating between the two types of myofibroblasts identified in this study, as, after injury, both indistinguishably express PDGFRbeta. Here, we employed the tamoxifen inducible PDGFRbeta-CreERT2 to induce temporally controlled labeling of cells with active PDGFRbeta promotor in the adult lung; in fact, as the intra-alveolar myofibroblasts were found to acquire PDGFRbeta expression after injury, only the inducible lineage tracing strategy allowed us to differentiate between the two types of myofibroblasts. Using a PDGFRbeta-tdTomato reporter mouse in combination with the fact that SMC do not contribute to myofibroblasts, the interstitial myofibroblast can be shown to derive from NO-GC+/PDGFRbeta+ pericytes. We have not yet determined the precursor for the ##intra-alveolar myofibroblast##, although we can exclude pericytes based on our lineage tracing studies. Lipofibroblasts have been shown to be potential myofibroblasts precursors; whether this cell type is linked to the formation of intra-alveolar myofibroblasts has yet to be clarified.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10288756</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37349733</oboInOwl:hasDbXref>
        <rdfs:label>intra-alveolar myofibroblast</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000186"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/df9a9b35-23a4-442d-be49-9fd2c80c497f"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000186"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/dfa5dc03-8cca-459f-8bec-770cecf059fe -->

    <Class rdf:about="http://example.org/dfa5dc03-8cca-459f-8bec-770cecf059fe">
        <obo:IAO_0000115>(A, C) Expression level of select marker genes for each identified cluster (A: VGlut2 cKO model; C: Ip3r2 KO model). Circle size denotes expression ratio (percent cells expressing the gene), color represents expression level (in log2 CPM). Bar chart on the left shows cell numbers identified for each cluster are similar for WT and KO groups for each cluster in each model. (B) UMAP clustering of different cell types identified in the NEUN-negative population of the combined samples from Ip3r2 WT and KO mice. 17 clusters were identified including the three main types of glia: astrocytes, oligodendrocytes, and microglia, as well as endothelial cells, and two subtypes of neurons (for A-C - M-astrocyte: ##mitotic astrocyte##; M-OPC: mitotic oligodendrocyte precursor cell; OPC: oligodendrocyte precursor cell; MFOL: myelin-forming oligodendrocyte; NFOL: newly formed oligodendrocyte; MOL: mature oligodendrocyte; VLMC: vascular and leptomeningeal cell; EC: endothelial cell; PC: pericyte; PVM: perivascular macrophage).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8497060</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34494546</oboInOwl:hasDbXref>
        <rdfs:label>mitotic astrocyte</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000127"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/dfa5dc03-8cca-459f-8bec-770cecf059fe"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000127"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/dfac46bb-542e-44b9-9a14-6ba9394d1b90 -->

    <Class rdf:about="http://example.org/dfac46bb-542e-44b9-9a14-6ba9394d1b90">
        <obo:IAO_0000115>scRNA-seq of ECs reveal a subpopulation enriched with immune responsive signatures. (A) Schematic showing the experimental design for the scRNA-seq and single-nuclei ATAC sequencing analysis of regenerative mouse hearts (MI at P1 and harvested at P5) and nonregenerative mouse hearts (MI at P8 and harvested at P12). (B) UMAP representation of cardiac cell clusters identified from scRNA-seq analysis. Clusters were color coded according to cell types (left). CM, cardiomyocytes; EC, endothelial cells; CF, fibroblasts; PeriC, pericytes; SMC, smooth muscle cells; EndoC, endocardial cells; EpiC, epicardial cells; MF, macrophages; TC, T-cells. (C) Gene ontology (GO) analysis of differentially expressed genes up-regulated in ##ECs## of regenerative-stage hearts versus nonregenerative-stage hearts after MI. (D) UMAP representation of CD31+-enriched cell clusters from single-cell RNA sequencing (scRNA-seq), color coded according to cell type. CEC, capillary endothelial cell; Angio-EC, angiogenic endothelial cell; Pro-EC1, proliferative endothelial cell 1; Pro-EC2, proliferative endothelial cell 2; IFN-EC, interferon capillary endothelial cell; CVEC, capillary venous endothelial cell; VEC, venous endothelial cell; AEC, arterial endothelial cell; LEC, lymphatic endothelial cell; EndoC, endocardial cell. (E) Gene ontology (GO) analysis of differentially expressed genes up-regulated in the IFN-EC cluster of regenerative-stage hearts versus nonregenerative-stage hearts after MI.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10681909</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38012001</oboInOwl:hasDbXref>
        <rdfs:label>ECs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0010008"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/dfac46bb-542e-44b9-9a14-6ba9394d1b90"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0010008"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/dfb506b1-ba63-4a77-a1c5-30ba9bc57c1a -->

    <Class rdf:about="http://example.org/dfb506b1-ba63-4a77-a1c5-30ba9bc57c1a">
        <obo:IAO_0000115>##RECs## are devoid of intrinsic stemness capacity but have in situ proximity to putative CD34+ LSCs</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11031376</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38582086</oboInOwl:hasDbXref>
        <rdfs:label>RECs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000766"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/dfb506b1-ba63-4a77-a1c5-30ba9bc57c1a"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000766"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/dfcd1d07-ac5b-442a-9427-c1b1d30a08c8 -->

    <Class rdf:about="http://example.org/dfcd1d07-ac5b-442a-9427-c1b1d30a08c8">
        <obo:IAO_0000115>PD: Parkinson&apos;s Disease; AD: Alzheimer&apos;s Disease. SCI: Spinal Cord injury; hESC: human Embryonic Stem Cells; NSC: Neural Stem Cells; NPC: Neuronal Progenitor Cells; hiPSC: human Pluripotent Stem Cells; DANs: Dopaminergic neurons; lt-NES: long-term self-renewing Neuro-Epithelial-like Stem; ML/NEP2: Macrophage-Like/Neprilysin-2; ##BFCN##: Basic Forebrain Cholinergic Neurons; OPC: Oligodendrocyte Progenitor Cells; MGE: Medial Ganglionic Eminence; SNI: Spared Nerve Injury.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7699962</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33233861</oboInOwl:hasDbXref>
        <rdfs:label>BFCN</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000108"/>
        <skos:relatedMatch rdf:resource="CL:0012001"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/dfcd1d07-ac5b-442a-9427-c1b1d30a08c8"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000108"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/dfcd1d07-ac5b-442a-9427-c1b1d30a08c8"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0012001"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/dfd40e68-ac4e-4885-b685-f13a77a267a5 -->

    <Class rdf:about="http://example.org/dfd40e68-ac4e-4885-b685-f13a77a267a5">
        <obo:IAO_0000115>Among spatial features, the dispersion of the FMC event between recording sites made the highest contribution to the prediction. The FMC is a putative extracellular analog of the initial depolarization phase at the recording site. Thus, the lower interelectrode variance of FMC among PYR cells compared with PV cells indicates higher spatial synchrony at the beginning of the spike. This observation is consistent with known morphologic and electrotonic differences between the proximal dendrites of ##PYR and PV cells##. Since the probes were always inserted perpendicularly to CA1 stratum pyramidale, the vertical dendritic tree of both PYR and PV cells was parallel to the extracellular electrode arrays. In CA1, PYR have thick apical dendrites extending for up to 250 mum (diameter, 1.6-2.5 mum), whereas PV cell dendrites in stratum pyramidale are thinner (diameter, 1.3-1.7 mum). The higher FMC synchrony of PYR spikes is consistent with lower axial resistance of the thicker proximal PYR dendrites, yielding synchronized somatic and dendritic potentials.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9744183</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36414411</oboInOwl:hasDbXref>
        <rdfs:label>PYR and PV cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000598"/>
        <skos:relatedMatch rdf:resource="CL:4023018"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/dfd40e68-ac4e-4885-b685-f13a77a267a5"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000598"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/dfd40e68-ac4e-4885-b685-f13a77a267a5"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4023018"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/dfdff5cd-40a4-47b5-a880-f2b259376a38 -->

    <Class rdf:about="http://example.org/dfdff5cd-40a4-47b5-a880-f2b259376a38">
        <obo:IAO_0000115>Schematic diagram of the mechanisms that Dermo1+ mesenchymal progenitor cells repaired the damaged airway epithelium. ##Dermo1+ mesenchymal stem cells## firstly differentiated into epithelial stem cells and then regenerated the damaged epithelial cells via epithelial stem cells</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6889622</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31791401</oboInOwl:hasDbXref>
        <rdfs:label>Dermo1+ mesenchymal stem cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000134"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/dfdff5cd-40a4-47b5-a880-f2b259376a38"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000134"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/e00f886b-50b7-4c57-8e09-b71d3d50bfb8 -->

    <Class rdf:about="http://example.org/e00f886b-50b7-4c57-8e09-b71d3d50bfb8">
        <obo:IAO_0000115>&lt;p&gt;Chronic hidradenitis suppurativa is orchestrated by ##pro-inflammatory fibroblast## subsets that shape the immune infiltrate and promote aberrant, Hippo pathway-dependent fibrosis.&lt;/p&gt;</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10836805</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38051587</oboInOwl:hasDbXref>
        <rdfs:label>pro-inflammatory fibroblast</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000057"/>
        <skos:relatedMatch rdf:resource="CL:0009002"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/e00f886b-50b7-4c57-8e09-b71d3d50bfb8"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000057"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/e00f886b-50b7-4c57-8e09-b71d3d50bfb8"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0009002"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/e0181066-36ea-4626-a39b-abfe1bca5751 -->

    <Class rdf:about="http://example.org/e0181066-36ea-4626-a39b-abfe1bca5751">
        <obo:IAO_0000115>Expression heterogeneity of CD8+ and CD4+ T cells in the OSCC ecosystem. (A) The t-distributed stochastic neighbor embedding (t-SNE) projection of T cells from cancerous tissue of patients with OSCC, showing the formation of 11 main clusters in different colors. The functional description of each cluster is determined by the gene expression characteristics. Cluster 0: resident memory CD8+ T Cells (C0_CD8+ TRM); Cluster 1: effector memory CD8+ T cells (C1_CD8+ TEM); Cluster 2: regulatory CD4+ T cells (C2_CD4+ Treg); Cluster 3: exhausted CD8+ T cells (C3_CD8+ T Exhausted); Cluster 4: effector memory M-phage CD8+ T cells (C4_CD8+ Mitotic TEM); Cluster 5: effector memory CD4+ T cells (C5_CD4+ TEM); Cluster 6: effector memory CD8+ T cells (C6_##CD8+ TEM##); Cluster 7: effector memory CD4+ T cells (C7_CD4+ TEM); Cluster 8: effector memory CD8+ T cells (C8_CD8+ TEM); Cluster 9: effector memory CD8+ T cells (C9_CD8+ TEM); Cluster 10: effector memory M-phage CD4+ T cells (C10_CD4+ Mitotic TEM); Cluster 11: effector memory CD8+ T cells (C11_CD8+ TEM); Cluster 12: effector memory CD8+ T cells (C12_CD8+ TEM); Cluster 13: gammadelta T. (B) Cell-Cycle Scoring of T cells from cancerous tissue of patients with OSCC, showing the three clusters of cells in different cell cycles in different colors. (C) Heatmap of key genes expressed in each cluster of CD8+ tumor-infiltrating lymphocytes (TILs) with cells grouped by clusters. The columns correspond to the cells; the rows correspond to the genes. Yellow: high expression; purple: low expression. Selected key markers are shown on the right. (D) Heatmap of key genes expressed in each cluster of CD4+ TILs with cells grouped by clusters. The columns correspond to the cells; the rows correspond to the genes. Yellow: high expression; purple: low expression. Selected key genes are shown on the right.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8024729</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33513276</oboInOwl:hasDbXref>
        <rdfs:label>CD8+ TEM</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000913"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/e0181066-36ea-4626-a39b-abfe1bca5751"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000913"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/e0386a4a-be43-44c6-bee8-771ab6731c8e -->

    <Class rdf:about="http://example.org/e0386a4a-be43-44c6-bee8-771ab6731c8e">
        <obo:IAO_0000115>a Boxplots showcasing the Accuracy Score of nine different integration methods across all 45 paired datasets, encompassing 28 sequence-based and 17 image-based datasets. The boxplots display data distribution where the box spans from the first to the third quartile, marking the median with a distinct line. The whiskers reach out to the maximum range within 1.5 times the interquartile range, and individual outliers are denoted by separate dots. b A STARmap slide from the STARmap dataset (mouse visual cortex), annotated with various cell types. Each grid portrays a simulated spot encompassing multiple cells. c Illustration of the proportion of Layer 4 (L4) excitatory neurons within simulated spots from the STARmap dataset, alongside predictions from eight integration methods. d Boxplots presenting the PCC, SSIM, RMSE, and JSD for eight integration methods, specifically analyzed for the STARmap dataset. The boxplots display data distribution where the box spans from the first to the third quartile, marking the median with a distinct line. The whiskers reach out to the maximum range within 1.5 times the interquartile range; n = 189 predicted spots. e A seqFISH+ slide from the seqFISH+ dataset (mouse cortex), annotated with cell types. Analogous to the STARmap slide, each grid symbolizes a simulated spot with multiple cells. f Depiction of the proportion of ##L4 excitatory neurons## in simulated spots from the seqFISH+ dataset, accompanied by predictions from eight integration techniques. g Boxplots exhibiting the metrics of PCC, SSIM, RMSE, and JSD for the eight integration methods tested on the seqFISH+ dataset. The boxplots display data distribution where the box spans from the first to the third quartile, marking the median with a distinct line. The whiskers reach out to the maximum range within 1.5 times the interquartile range; n = 72 predicted spots. Source data are provided as a Source Data file.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11330978</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:39155292</oboInOwl:hasDbXref>
        <rdfs:label>L4 excitatory neurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:4030063"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/e0386a4a-be43-44c6-bee8-771ab6731c8e"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4030063"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/e0582e3f-e204-426a-8b28-5a94d968aa2a -->

    <Class rdf:about="http://example.org/e0582e3f-e204-426a-8b28-5a94d968aa2a">
        <obo:IAO_0000115>The change of ILC cell populations during a cascade of colonic lesions. (A-C) Flow cytometry quantification of the frequency of Lin-CD127+CRTH2-CD117- ILC1 cells (A), ##Lin-CD127+CRTH2+CD117- ILC2 cells## (B), and Lin-CD127+CRTH2-CD117+ ILC3 cells (C) in CD45+ PBMCs during a cascade of colonic lesions. (D-F) Flow cytometry quantification of the frequency of Lin-CD127+IFN-gamma+ cells (D), Lin-CD127+IL-5+ cells (E), and Lin-CD127+IL-22+ cells (F) in CD45+ PBMCs during a cascade of colonic lesions. Each dot represents one donor. HC, healthy control. Error bars represent the SEM. *P &lt; 0.05; **P &lt; 0.01 (ANOVA or non-parametric test as appropriate). n = 10-19 in each group.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10853383</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38343544</oboInOwl:hasDbXref>
        <rdfs:label>Lin-CD127+CRTH2+CD117- ILC2 cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0001069"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/e0582e3f-e204-426a-8b28-5a94d968aa2a"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0001069"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/e06535dc-159b-444d-bdd3-39d96f664d85 -->

    <Class rdf:about="http://example.org/e06535dc-159b-444d-bdd3-39d96f664d85">
        <obo:IAO_0000115>Molecules	Cell types that express the molecules at the mRNA level with relative expression levels indicated	 	Ffar2/GPR43	ILC3s &gt; Neutrophils &gt; MZ B cells &gt; Pre-T cells (double-negative thymocytes) &gt; DCs (spleen) &gt; ILC2s &gt; Alveolar macrophages	 	Ffar3/GPR41	Thymic medullary epithelial cells &gt; Follicular B cells &gt; GC B cells &gt; DCs (CD8) &gt; B1b cells   Neutrophils   Nkp46+ ILC3s   Blood monocytes	 	Gpr109a/Hcar2	Neutrophils &gt; Red pulp macrophages &gt; Alveolar macrophages	 	Olfr78	CD8 T cells (memory) &gt; gammadelta T cells &gt; Follicular B cells &gt; GC B cells &gt; NKT cells &gt; ILC2s	 	Slc5a8	Thymic medullary epithelial cells &gt;&gt; NKT cells = Neutrophils	 	Slc5a12	Thymic medullary epithelial cells &gt; Mast cells &gt; NK cells   NKT cells = ILC3s &gt; ILC2s   ##Thymocytes (double positive)##   pDCs &gt; Macrophages &gt; DCs (CD8)	 	Slc16a1	Pro-B cells &gt; Mast cells   Thymocytes (double-negative and positive) &gt; Naive CD8 T cells &gt; Effector CD8 T cells   GC B cells   NKT cells   ILC2s	 	</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8093302</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33850311</oboInOwl:hasDbXref>
        <rdfs:label>Thymocytes (double positive)</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000893"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/e06535dc-159b-444d-bdd3-39d96f664d85"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000893"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/e06c15a4-097d-42b9-ac27-f8f70cb7abde -->

    <Class rdf:about="http://example.org/e06c15a4-097d-42b9-ac27-f8f70cb7abde">
        <obo:IAO_0000115>To characterize the dynamics of neutrophil recruitment to omFALCs during peritonitis, we used the well-established murine model, Zymosan-A-induced peritonitis. Peritonitis led to a transient increase in the number of Ly6G+ neutrophils in the omentum, peaking at 24 h (Figures 3A and S5A). Wholemount immunofluorescence staining and confocal analysis revealed that FALCs were the site of extensive recruitment of ##Ly6G+ Myeloperoxidase+ (MPO) neutrophils##, which formed dense cellular aggregates between 6 and 24 h post-induction of peritonitis (Figures 3B, 3C, and S5B). The volume of omFALCs increased exponentially during the first 18 h post-Zymosan injection (75-fold) before rapidly contracting back to their normal size by 24 h (Figure 3D). This timing coincided with the influx of MPO+ neutrophils and their disappearance by 24 h (Figures 3C and 3D). This accretion of neutrophils was specific to omFALCs and did not happen on the rest of the surface of the omentum, the diaphragm, or the parietal wall (Figures 3E, S5C, and S5D). We then tested whether CXCL1 was involved in the accumulation of neutrophils at omFALCs during peritonitis, using an anti-CXCL1 blocking antibody. Eighteen hours post-Zymosan injection, CXCL1 blockade led to a 2.6-fold decrease in the number of neutrophils recovered from the omentum compared to mice treated with isotype control antibodies. There was no difference in the number of neutrophils recovered from the peritoneal cavity, suggesting that the trafficking of neutrophils through omFALC HEVs was not altered (Figure 3F). Thus, the extensive recruitment of neutrophils to FALCs is not simply a consequence of increased trafficking of neutrophils through HEVs, but the result of active retention dependent upon CXCL1.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7156918</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32294409</oboInOwl:hasDbXref>
        <rdfs:label>Ly6G+ Myeloperoxidase+ (MPO) neutrophils</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000775"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/e06c15a4-097d-42b9-ac27-f8f70cb7abde"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000775"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/e093633d-8208-49d9-b49d-1cf9c50b23e1 -->

    <Class rdf:about="http://example.org/e093633d-8208-49d9-b49d-1cf9c50b23e1">
        <obo:IAO_0000115>TCR repertoire analysis of the five ##CMV CD4+ T cell## subsets. (A) Diversity measures based on clonotypes by cluster using Shannon, Inverse Simpson, Chao, and abundance-based coverage estimator (ACE) indices. (B) Clonal overlaps among the five CMV CD4+ T cell subsets. (C) Cloning frequency distribution in each subset. (D) Transcriptome similarity among CMV CD4+ CTLs, CD4+ Tra cells, and Treg cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8691692</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34950144</oboInOwl:hasDbXref>
        <rdfs:label>CMV CD4+ T cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000624"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/e093633d-8208-49d9-b49d-1cf9c50b23e1"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000624"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/e09b6f0c-8fa9-4166-94a7-9687d859bfca -->

    <Class rdf:about="http://example.org/e09b6f0c-8fa9-4166-94a7-9687d859bfca">
        <obo:IAO_0000115>Other groups have used murine- and blood-based immune population gene profiles to characterize lung adenocarcinoma immune microenvironments with digital cytometry. In order to develop human tumor infiltrating leukocyte profiles specific to stage I lung adenocarcinomas, we performed single-cell RNA-seq (scRNA-seq) analysis on freshly resected samples from six patients who underwent complete surgical resection of stage I tumors at UCSF. Twenty distinct immune cell populations were identified by scRNA-seq analysis including 10 adaptive immune populations (helper T-cells, cytotoxic T-cells, ##exhausted cytotoxic T-cells##, deltagamma T-cells, naive T-cells, regulatory T-cells, B cells, plasma cells, NKT cells, and NK cells) and 10 innate immune populations (M1 macrophages, M2 macrophages, classical monocytes, intermediate monocytes, non-classical monocytes, mast cells, conventional dendritic cells 1, conventional dendritic cells 2, plasmacytoid dendritic cells, and neutrophils) (Fig. 5A). These novel tumor infiltrating leukocyte profiles were used to calculate immune cell population densities from bulk RNA-seq data in the TCGA stage I lung adenocarcinoma population using digital cytometry.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8654957</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34880292</oboInOwl:hasDbXref>
        <rdfs:label>exhausted cytotoxic T-cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000910"/>
        <skos:relatedMatch rdf:resource="CL:0011025"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/e09b6f0c-8fa9-4166-94a7-9687d859bfca"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000910"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/e09b6f0c-8fa9-4166-94a7-9687d859bfca"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0011025"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/e0aa1da9-6c92-47a3-9bff-c8ce77717443 -->

    <Class rdf:about="http://example.org/e0aa1da9-6c92-47a3-9bff-c8ce77717443">
        <obo:IAO_0000115>Several reports found that circulating blood or bone-marrow-derived cells of the monocyte-macrophage lineage are ##progenitors of LECs## in lymphatic neovascularization under pathological conditions. Thus, peripheral blood monocytes were stimulated in vitro to induce podoplanin and other lymphatic endothelial markers by mimicking an inflammatory environment with VEGF-C, fibronectin, TNF-alpha, IL-3, or LPS (Table 1). Also, CD34+ human fetal liver-derived cells expressing CD133, podoplanin, and VEGFR-3, as well as podoplanin-positive mouse bone-marrow-derived cells, were found to behave as LEC progenitors and contribute to postnatal lymphatic neovascularization. More recently, Cimini and colleagues found that the podoplanin-positive cell population associated with the lymphangiogenic and fibrogenic responses during myocardial wound repair after infarction is widely heterogeneous and displays epitopes of fibrogenic and endothelial commitment, suggesting an alternate ability of podoplanin-positive cardiac cells to generate lymphatic endothelium and pro-fibrotic cells. In a pioneering work, Maruyama and coworkers reported the incorporation of mouse CD11b+ and F4/80+ macrophages into lymphatic vessels in the inflamed cornea. These cells, which express podoplanin, LYVE-1. and VEGFR-3 lymphatic markers, were critical for the development and maintenance of inflammation-dependent lymphangiogenesis. In fact, a reduction in the number of these podoplanin-positive cells was associated with delayed wound repair in diabetic mice. Interestingly, podoplanin neutralization with a specific monoclonal antibody (mAb) resulted in suppression of lymphangiogenesis and macrophage infiltration during corneal inflammation and ear wound healing, pointing to podoplanin as a novel therapeutic target for lymphangiogenesis and macrophage-related inflammation.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6386838</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:30736372</oboInOwl:hasDbXref>
        <rdfs:label>progenitors of LECs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002138"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/e0aa1da9-6c92-47a3-9bff-c8ce77717443"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002138"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/e0be1e83-e273-4ade-b3d0-7084a5f25e69 -->

    <Class rdf:about="http://example.org/e0be1e83-e273-4ade-b3d0-7084a5f25e69">
        <obo:IAO_0000115>(A) Anatomical locations of n = 29 recorded preBotC neurons. (B) Example traces of an excitatory neuron with pre-I spiking (orange) and without pre-I spiking (green) and an ##inhibitory neuron## (blue) during the inspiratory burst and inter-burst interval (IBI). (C) Quantified spike frequency as a function of time (normalized to burst duration) from n = 9 pre-I excitatory, n = 13 non pre-I excitatory, and n = 7 inhibitory neurons. (D) Quantified mean spike frequency, duration, and shape of inspiratory bursts generated by each type of neuron (one-way ANOVA with Bonferroni post hoc tests). (E) Example quantification of neuronal burst onset time relative to the preBotC population and Poincare plots showing onset time variability from n = 9 pre-I excitatory, n = 13 non pre-I excitatory, and n = 7 inhibitory neurons (20 inspiratory bursts/neuron). (F) Burst onset time variability or &apos;jitter&apos; quantified as the natural log of the root mean square of successive differences (one-way ANOVA with Bonferroni post hoc tests). Data available in Figure 2:source data 1.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6957314</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31804180</oboInOwl:hasDbXref>
        <rdfs:label>inhibitory neuron</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000498"/>
        <skos:relatedMatch rdf:resource="CL:0000617"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/e0be1e83-e273-4ade-b3d0-7084a5f25e69"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000498"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/e0be1e83-e273-4ade-b3d0-7084a5f25e69"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000617"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/e0fdc8fb-cb5d-4ae5-9e14-c1b0252502c1 -->

    <Class rdf:about="http://example.org/e0fdc8fb-cb5d-4ae5-9e14-c1b0252502c1">
        <obo:IAO_0000115>WNT signaling basal progenitors form opposing intracellular morphogen gradients of WNT inhibitors and WNT ligands/activators. In so doing, they preserve their own WNT signaling and identity and directionally permit (dermal condensate) or restrict (##suprabasal hair bud cells##) WNT signaling in surrounding neighbors.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7224699</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32310087</oboInOwl:hasDbXref>
        <rdfs:label>suprabasal hair bud cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002559"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/e0fdc8fb-cb5d-4ae5-9e14-c1b0252502c1"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002559"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/e10ab162-eaee-4ab6-b242-6558236ac990 -->

    <Class rdf:about="http://example.org/e10ab162-eaee-4ab6-b242-6558236ac990">
        <obo:IAO_0000115>Lymphocytes such as CD4+ T cells and B cells mainly infiltrate the salivary glands; however, the precise roles and targets of ##autoreactive T cells## and autoantibodies in the pathogenesis of Sjogren&apos;s Syndrome (SS) remain unclear. This study was designed to clarify the role of autoreactive T cells and autoantibodies at the single-cell level involved in the development of sialadenitis. Infiltrated CD4+ T and B cells in the salivary glands of a mouse model resembling SS were single-cell-sorted, and their T cell receptor (TCR) and B cell receptor (BCR) sequences were analyzed. The predominant TCR and BCR clonotypes were reconstituted in vitro, and their pathogenicity was evaluated by transferring reconstituted TCR-expressing CD4+ T cells into Rag2-/- mice and administering recombinant IgG in vivo. The reconstitution of Th17 cells expressing TCR (#G) in Rag2-/- mice resulted in the infiltration of T cells into the salivary glands and development of sialadenitis, while an autoantibody (IgGr22) was observed to promote the proliferation of pathogenic T cells. IgGr22 specifically recognizes double-stranded RNA (dsRNA) and induces the activation of dendritic cells, thereby enhancing the expression of IFN signature and inflammatory genes. TCR#G recognizes antigens related to the gut microbiota. Antibiotic treatment severely reduces the activation of TCR#G-expressing Th17 cells and suppresses sialadenitis development. These data suggest that the anti-dsRNA antibodies and, TCR recognizing the gut microbiota involved in the development of sialadenitis like SS. Thus, our model provides a novel strategy for defining the roles of autoreactive TCR and autoantibodies in the development and pathogenesis of SS.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMID:38762063</oboInOwl:hasDbXref>
        <rdfs:label>autoreactive T cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000084"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/e10ab162-eaee-4ab6-b242-6558236ac990"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000084"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/e149ac20-4f0d-4347-96e6-b41a2fa6f6f9 -->

    <Class rdf:about="http://example.org/e149ac20-4f0d-4347-96e6-b41a2fa6f6f9">
        <obo:IAO_0000115>(A) Immunocytochemistry analysis of claudin-5, caveolin-1, and GLUT-1 expression in Passage 1 endothelial cells (ECs) treated with DMSO or 4 microM CHIR. Hoechst nuclear counterstain is overlaid in the merged images. Dashed lines indicate the border between an EC colony and ##smooth muscle-like cells## (SMLCs) in the DMSO condition. Scale bars: 200 mum. (B) Quantification of images from the conditions described in (A) for number of ECs per 20x field, percentage of ECs (claudin-5+ cells relative to total nuclei), percentage of GLUT-1+ ECs (relative to total claudin-5+ ECs), and mean fluorescence intensity of claudin-5, caveolin-1, and GLUT-1 normalized to Hoechst mean fluorescence intensity within the area of claudin-5+ ECs only. Points represent replicate wells from 2 to 6 independent differentiations of the IMR90-4 line, each differentiation indicated with a different color. Bars indicate mean values. For the fluorescence intensity plots, values were normalized within each differentiation such that the mean of the DMSO condition equals 1. p-values: two-way ANOVA on unnormalized data.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8664294</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34755601</oboInOwl:hasDbXref>
        <rdfs:label>smooth muscle-like cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000192"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/e149ac20-4f0d-4347-96e6-b41a2fa6f6f9"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000192"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/e15f82bb-660f-422e-bbae-ef4b4a71d758 -->

    <Class rdf:about="http://example.org/e15f82bb-660f-422e-bbae-ef4b4a71d758">
        <obo:IAO_0000115>Sjogren&apos;s syndrome is a chronic autoimmune disorder whose pathogenesis is poorly understood and that lacks effective therapies. Detailed quantitative and spatial analyses of tissues affected by Sjogren&apos;s syndrome were undertaken, including the quantitation of the frequency of selected cell-cell interactions in the disease milieu. Quantitative analyses of CD4+ T cell subsets and of CD8+ T cells in the labial salivary glands from untreated patients with primary Sjogren&apos;s syndrome revealed that activated CD8+ cytotoxic T cells (CD8+CTLs) were the most prominent T cells in these infiltrates. An accumulation of apoptotic glandular epithelial cells, mainly ductal and acinar cells, was observed, consistent with the impaired salivary secretion often observed in patients with this disease. FasL expressing activated CD8+ T cells were seen to accumulate around Fas expressing ##apoptotic epithelial cells##. Quantitative analyses of apoptotic cell types and of conjugates between cytotoxic T cells and epithelial cells undergoing apoptosis suggest that Sjogren&apos;s syndrome is primarily driven by CD8+CTL mediated execution of epithelial cells mainly represented by ductal and acinar cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9475031</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36104369</oboInOwl:hasDbXref>
        <rdfs:label>apoptotic epithelial cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000445"/>
        <skos:relatedMatch rdf:resource="CL:4052048"/>
        <skos:relatedMatch rdf:resource="CL:4052049"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/e15f82bb-660f-422e-bbae-ef4b4a71d758"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000445"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/e15f82bb-660f-422e-bbae-ef4b4a71d758"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4052048"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/e15f82bb-660f-422e-bbae-ef4b4a71d758"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4052049"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/e17b01da-ff03-4a57-b963-0889f38f0b0f -->

    <Class rdf:about="http://example.org/e17b01da-ff03-4a57-b963-0889f38f0b0f">
        <obo:IAO_0000115>Food intake behavior is regulated by a network of appetite-inducing and appetite-suppressing neuronal populations throughout the brain. The parasubthalamic nucleus (PSTN), a relatively unexplored population of neurons in the posterior hypothalamus, has been hypothesized to regulate appetite due to its connectivity with other anorexigenic neuronal populations and because these neurons express Fos, a marker of neuronal activation, following a meal. However, the individual cell types that make up the PSTN are not well characterized, nor are their functional roles in food intake behavior. Here, we identify and distinguish between two discrete PSTN subpopulations, those that express tachykinin-1 (PSTNTac1 neurons) and those that express corticotropin-releasing hormone (PSTNCRH neurons), and use a panel of genetically encoded tools in mice to show that PSTNTac1 neurons play an important role in appetite suppression. Both subpopulations increase activity following a meal and in response to administration of the anorexigenic hormones amylin, cholecystokinin (CCK), and peptide YY (PYY). Interestingly, chemogenetic inhibition of PSTNTac1, but not PSTNCRH neurons, reduces the appetite-suppressing effects of these hormones. Consistently, optogenetic and chemogenetic stimulation of PSTNTac1 neurons, but not PSTNCRH neurons, reduces food intake in hungry mice. PSTNTac1 and PSTNCRH neurons project to distinct downstream brain regions, and stimulation of PSTNTac1 projections to individual anorexigenic populations reduces food consumption. Taken together, these results reveal the functional properties and projection patterns of distinct ##PSTN cell## types and demonstrate an anorexigenic role for PSTNTac1 neurons in the hormonal and central regulation of appetite.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9119672</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35507386</oboInOwl:hasDbXref>
        <rdfs:label>PSTN cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000540"/>
        <skos:relatedMatch rdf:resource="CL:2000030"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/e17b01da-ff03-4a57-b963-0889f38f0b0f"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000540"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/e17b01da-ff03-4a57-b963-0889f38f0b0f"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:2000030"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/e1d2e36b-fc07-4a81-9fb4-d06adfbf3e11 -->

    <Class rdf:about="http://example.org/e1d2e36b-fc07-4a81-9fb4-d06adfbf3e11">
        <obo:IAO_0000115>The signals driving the adaptation of type 2 dendritic cells (DC2s) to diverse peripheral environments remain mostly undefined. We show that differentiation of CD11blo migratory DC2s-a ##DC2## population unique to the dermis-required IL-13 signaling dependent on the transcription factors STAT6 and KLF4, whereas DC2s in lung and small intestine were STAT6-independent. Similarly, human DC2s in skin expressed an IL-4 and IL-13 gene signature that was not found in blood, spleen and lung DCs. In mice, IL-13 was secreted homeostatically by dermal innate lymphoid cells and was independent of microbiota, TSLP or IL-33. In the absence of IL-13 signaling, dermal DC2s were stable in number but remained CD11bhi and showed defective activation in response to allergens, with diminished ability to support the development of IL-4+GATA3+ helper T cells (TH), whereas antifungal IL-17+RORgammat+ TH cells were increased. Therefore, homeostatic IL-13 fosters a noninflammatory skin environment that supports allergic sensitization.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMID:34795444</oboInOwl:hasDbXref>
        <rdfs:label>DC2</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000990"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/e1d2e36b-fc07-4a81-9fb4-d06adfbf3e11"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000990"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/e1dfa60c-fa6a-4c92-93a7-976aeeb280a0 -->

    <Class rdf:about="http://example.org/e1dfa60c-fa6a-4c92-93a7-976aeeb280a0">
        <obo:IAO_0000115>Variance results for nRBCs, ##cRBCPlasma## and cRBCHPL for fixed and oscillating traps: A = 5 microm and A = 7 microm, respectively. The distributions of the variance values for each cell type are represented graphically using the boxplot method. The p values are calculated with a Mann-Whitney U test.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7998599</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33806520</oboInOwl:hasDbXref>
        <rdfs:label>cRBCPlasma</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000232"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/e1dfa60c-fa6a-4c92-93a7-976aeeb280a0"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000232"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/e1e3267c-a58f-479c-95c8-f0574a8531ec -->

    <Class rdf:about="http://example.org/e1e3267c-a58f-479c-95c8-f0574a8531ec">
        <obo:IAO_0000115>alpha-SMA	Alpha smooth muscle actin	LEC	Lymphatic endothelial cell	 	ADSCs	Adipose-derived stem cells	Lymphoid-like	Lymphoid-like cell	 	ADAMTS	Disintegrin and metalloproteinase with thrombospondin motifs	Mac	Macrophage	 	AEC	Arterial endothelial cells	MAIT	Mucosal-associated invariant T cell	 	AFG	Autologous fat grafting	MMPs	Matrix metalloproteinases	 	APC	Adipocyte precursor cells	MC	Mast cell	 	BC	B cell	mCD8 T	Mature CD8 T cell	 	BKC	Basal keratinocyte	mNK	Mature natural killer cell	 	BMI	Body mass index	Myeloid-like	Myeloid-like cell	 	CCNs	Cellular communication network factors	nCD4 T	Naive CD4 T cell	 	cDC	Classic dendritic cell	nCD8 T	Naive CD8 T cell	 	CEC	Capillary endothelial cell	ncMos	Non-classic monocytes	 	DC	Dendritic cell	NK-like	##Natural killer-like cell##	 	CD	Cluster of differentiation	PC	Pericyte	 	CTGF	Connective tissue growth factor	PCA	Principal component analysis	 	DEGs	Differentially expressed genes	scRNA-seq	Single-cell RNA sequencing	 	DKC	Differentiating keratinocytes	SMC	Smooth muscle cell	 	EC	Endothelial cell	SNN	Shared nearest neighbour	 	ECM	Extracellular matrix	SSc	Scleroderma	 	EMT	Epithelial-to-mesenchymal transition	SVF	Stromal vascular fraction	 	FACS	Fluorescence-activated cell sorting	TC	T cell	 	FB	Fibroblast	TGF-beta1	Transforming growth factor 1	 	FGFRs	Fibroblast growth factor receptors	TIMPs	Tissue inhibitors of metalloproteinases	 	GEO	Gene expression omnibus	TREG	Regulatory T cells	 	GO	Gene Ontology	UMAP	Uniform manifold approximation and projection	 	IFATS	International Federation for Adipose Therapeutics and Science	VEC	Venous endothelial cell	 	ILC	Innate lymphoid cell	WAT	White adipose tissue	 	KEGG	Kyoto Encyclopedia of Genes and Genomes			 	</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10341100</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37443817</oboInOwl:hasDbXref>
        <rdfs:label>Natural killer-like cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000623"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/e1e3267c-a58f-479c-95c8-f0574a8531ec"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000623"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/e1f00654-4ded-4676-89c3-64bda8296c75 -->

    <Class rdf:about="http://example.org/e1f00654-4ded-4676-89c3-64bda8296c75">
        <obo:IAO_0000115>The Table shows the numerical representations of Excitatory Neurons (Deep and Superficial Pyramidal cells) and Inhibitory neurons (Oriens Lacunosum moleculare cells:OLM; Trilaminar cells:Tri, Backprojection cells:##BP##, cholecystokinin positive Basket cells:CCKBC, Parvalbumin positive cells:PVBC, AxoAxonic Cells:AA, Ivy Cells:IVY, Bistratified cells:BS, Schaffer Collateral associated cells:SCA, Perforant Pathway Associated cell:PPA, Neurogliaform:NG) subdivided on the basis of the placement classes (SO, SP, SR, SLM).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9381785</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35974119</oboInOwl:hasDbXref>
        <rdfs:label>BP</rdfs:label>
    </Class>
    


    <!-- http://example.org/e2124f47-6fb9-444d-993e-aa3db9a11dca -->

    <Class rdf:about="http://example.org/e2124f47-6fb9-444d-993e-aa3db9a11dca">
        <obo:IAO_0000115>We undertook a comprehensive Mendelian randomization study aimed at uncovering the causal relationship between 744 immune cell types and IVDD [ Supplementary Table 2 ]. In our analysis, we identified 24 specific blood types of immune cells that demonstrated a causal association with disc degeneration through univariable MR [ Supplementary Table 3 ], including Memory B cell %B cell, Naive-mature B cell %B cell, ##IgD-CD38dim B cell## %lymphocyte, CD39+activated CD4 regulatory T cell %CD4 regulatory T cell, CD39+ secreting CD4 regulatory T cell %CD4 regulatory T cell, CD45RA+ CD8+ T cell %CD8+ T cell, CD8+ T cell %leukocyte, CD39+CD4+ T cell %T cell, CD39+ CD4+ T cell %CD4+ T cell,CD39+ CD8+ T cell %T cell, CD39+ CD8+ T cell Absolute Count, CD127- CD8+ T cell Absolute Count, CD28- CD8+ T cell Absolute Count, CD19 on IgD+ CD38+ B cell, CD19 on IgD+ CD38dim B cell, CD19 on IgD- CD38- B cell, CD19 on unswitched memory B cell, CD19 on transitional B cell, CD24 on IgD+ CD38+ B cell,CD28 on CD39+ secreting CD4 regulatory T cell, CD25 on CD39+ CD4+ T cell, CD4 on CD39+ CD4+ T cell, CD4 on CD39+ resting CD4 regulatory T cell and Neutrophil count. We excluded certain exposures due to a limited number of available SNPs to prevent potential bias, including Memory B cell %B cell, Naive-mature B cell %B cell, IgD-CD38dim B cell %lymphocyte, CD8+T cell %leukocyte, CD127-CD8+ T cell Absolute Count, CD19 on IgD-CD38-B cell, CD24 on IgD+ CD38+ B cell, CD28 on CD39+ secreting CD4 regulatory T cell and CD4 on CD39+ resting CD4 regulatory T cell.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10806224</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38268919</oboInOwl:hasDbXref>
        <rdfs:label>IgD-CD38dim B cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000236"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/e2124f47-6fb9-444d-993e-aa3db9a11dca"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000236"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/e21aae9b-e13d-448d-a4f0-c25c7ce0a706 -->

    <Class rdf:about="http://example.org/e21aae9b-e13d-448d-a4f0-c25c7ce0a706">
        <obo:IAO_0000115>A reduction in bile acid metabolism-related SPP1+ epithelial cells and ##VEGFA+ endothelial cells##, along with explosive infiltration of plasma cells and dysfunction of T- and NK cells in NAS patients.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10938070</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38481381</oboInOwl:hasDbXref>
        <rdfs:label>VEGFA+ endothelial cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000115"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/e21aae9b-e13d-448d-a4f0-c25c7ce0a706"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000115"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/e22cf576-3dec-41ad-9910-6f3dc3a6fdf4 -->

    <Class rdf:about="http://example.org/e22cf576-3dec-41ad-9910-6f3dc3a6fdf4">
        <obo:IAO_0000115>Gene-Set Significant Cell Types from Zeisel That Are Common between Mouse MIA and Human GWAS Significant Cell Types from Saunders That Are Common between Mouse MIA and Human GWAS   Individual Study DEGs mPFC -Excitatory Neurons (Hindbrain)[SCZ, ASD, EA] No cell types   AM -Inhibitory D1 &amp; D2 Medium Spiny Neurons (Striatum) [EA] -Inhibitory direct/indirect Spiny Projection Neurons (Striatum) [SCZ, EA, IQ]   Meta-analysisDEGs Upregulated -Excitatory Neurons, Pyramidal Cells (Cerebral Cortex) [SCZ, IQ] -Excitatory Neurons, Deep-layer Pyramidal cells (Frontal Cortex)[SCZ, IQ]-Excitatory Neurons (Posterior Cortex) [SCZ, IQ]-##Excitatory Neurons, Entorhinal Cortex Cells## (Hippocampus)[SCZ, IQ]-Excitatory Neurons, CA1 Principal Cells (Hippocampus)[IQ]   </obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8471627</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34573345</oboInOwl:hasDbXref>
        <rdfs:label>Excitatory Neurons, Entorhinal Cortex Cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0010012"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/e22cf576-3dec-41ad-9910-6f3dc3a6fdf4"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0010012"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/e2374bfc-816d-460b-8314-7354771c72e5 -->

    <Class rdf:about="http://example.org/e2374bfc-816d-460b-8314-7354771c72e5">
        <obo:IAO_0000115>Molecules	Cell types that express the molecules at the mRNA level with relative expression levels indicated	 	Ffar2/GPR43	ILC3s &gt; Neutrophils &gt; MZ B cells &gt; Pre-T cells (double-negative thymocytes) &gt; DCs (spleen) &gt; ILC2s &gt; Alveolar macrophages	 	Ffar3/GPR41	Thymic medullary epithelial cells &gt; Follicular B cells &gt; GC B cells &gt; DCs (CD8) &gt; B1b cells   Neutrophils   Nkp46+ ILC3s   Blood monocytes	 	Gpr109a/Hcar2	Neutrophils &gt; Red pulp macrophages &gt; Alveolar macrophages	 	Olfr78	CD8 T cells (memory) &gt; gammadelta T cells &gt; Follicular B cells &gt; GC B cells &gt; NKT cells &gt; ILC2s	 	Slc5a8	Thymic medullary epithelial cells &gt;&gt; NKT cells = Neutrophils	 	Slc5a12	Thymic medullary epithelial cells &gt; Mast cells &gt; NK cells   NKT cells = ILC3s &gt; ILC2s   Thymocytes (double positive)   pDCs &gt; Macrophages &gt; DCs (CD8)	 	Slc16a1	Pro-B cells &gt; Mast cells   ##Thymocytes (double-negative and positive)## &gt; Naive CD8 T cells &gt; Effector CD8 T cells   GC B cells   NKT cells   ILC2s	 	</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8093302</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33850311</oboInOwl:hasDbXref>
        <rdfs:label>Thymocytes (double-negative and positive)</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000893"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/e2374bfc-816d-460b-8314-7354771c72e5"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000893"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/e238381b-541c-4bdd-9808-0399719f1236 -->

    <Class rdf:about="http://example.org/e238381b-541c-4bdd-9808-0399719f1236">
        <obo:IAO_0000115>The classification of pericyte-derived and non-pericyte-derived myofibroblasts (PDGFRbeta-constitutively-expressing and PDGFRbeta-de novo-expressing, respectively) indicates different roles of pulmonary myofibroblasts. With PDGFRbeta as a &apos;specific&apos; marker for pericytes, PDGFRbeta-regulated Cre expression has been used to trace the fate of these cells. However, the constitutive PDGFRbeta-Cre line employed in other studies does not allow discriminating between the two types of myofibroblasts identified in this study, as, after injury, both indistinguishably express PDGFRbeta. Here, we employed the tamoxifen inducible PDGFRbeta-CreERT2 to induce temporally controlled labeling of cells with active PDGFRbeta promotor in the adult lung; in fact, as the intra-alveolar myofibroblasts were found to acquire PDGFRbeta expression after injury, only the inducible lineage tracing strategy allowed us to differentiate between the two types of myofibroblasts. Using a PDGFRbeta-tdTomato reporter mouse in combination with the fact that SMC do not contribute to myofibroblasts, the interstitial myofibroblast can be shown to derive from NO-GC+/PDGFRbeta+ pericytes. We have not yet determined the precursor for the intra-alveolar myofibroblast, although we can exclude pericytes based on our lineage tracing studies. ##Lipofibroblasts## have been shown to be potential myofibroblasts precursors; whether this cell type is linked to the formation of intra-alveolar myofibroblasts has yet to be clarified.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10288756</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37349733</oboInOwl:hasDbXref>
        <rdfs:label>Lipofibroblasts</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0009099"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/e238381b-541c-4bdd-9808-0399719f1236"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0009099"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/e26a825e-8b38-4e83-a764-ab0588945270 -->

    <Class rdf:about="http://example.org/e26a825e-8b38-4e83-a764-ab0588945270">
        <obo:IAO_0000115>Meningeal ILC2s express Thy1.2, ST2, CD25, spinocerebellar ataxia type 1 (Sca10), and low levels of c-Kit and IL-7Ralpha and are major producers of IL-13 in tissues. As tissue-resident cells, ILC2s exhibit tissue-specific receptor expression patterns, which are imprinted by local signals. Likewise, ##dural ILC2s## are distinct from lung ILC2s. The basal activation state of meningeal ILC2s is lower than that of lung-resident cells. The proximity to brain-derived signals may explain the differences in basal activation observed between the two tissue types. ILC2 precursors originate from bone marrow. Future studies should determine the functional and phenotypic differences between blood-derived ILC2s and the adjacent bone marrow.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10616183</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37429945</oboInOwl:hasDbXref>
        <rdfs:label>dural ILC2s</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0001069"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/e26a825e-8b38-4e83-a764-ab0588945270"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0001069"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/e27a74d6-70af-4fff-b506-609a284d67b8 -->

    <Class rdf:about="http://example.org/e27a74d6-70af-4fff-b506-609a284d67b8">
        <obo:IAO_0000115>Focusing on the peripheral, differentiated cDC populations, we next assessed protein expression of the IRF8 transcription factor in tumor-derived cDC populations (Fig. 3a). In the periphery, IRF8 controls survival and function of terminally differentiated cDC1s. Furthermore, increased IRF8 expression in CD11b-CD103- DN cells was shown to promote their differentiation into mature CD103+ cDC1s. Thus, we hypothesized that CD40L-CAR T cell treatment skews the cDC1/cDC2 ratio towards the cDC1 populations by stimulating the DN cells to expand, upregulate IRF8, and differentiate into cDC1s. We specifically noticed upregulation of IRF8 (readout of ##DN##-to-cDC1 differentiation) and Ki-67 (readout for proliferation) in DN cells treated with CD40L-CAR T cell-treated mice (Fig. 3b). The increased expression of Ki-67 in the tumor-derived DN cells also correlated with the observed increase of the DN population in the tumor of CD40L-CAR T cell-treated mice (Fig. 1f), indicating that DN cells receive a proliferative signal upon CD40L-CAR T cell treatment. Intriguingly, splenic DN cells and DN cells from the tdLNs did not upregulate Ki-67 or IRF8 (Fig. 3c, d). Overall, tdLN cDCs did not present with a stimulated phenotype, as suggested by the lack of CD86 or Ki-67 upregulation (Supplementary Fig. 2D-G). This suggested a tumor-specific effect of cDC DN stimulation after m1928z-CD40L treatment.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7710757</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33268774</oboInOwl:hasDbXref>
        <rdfs:label>DN</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002510"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/e27a74d6-70af-4fff-b506-609a284d67b8"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002510"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/e285bed2-466c-45b6-b288-e1a8632d5b98 -->

    <Class rdf:about="http://example.org/e285bed2-466c-45b6-b288-e1a8632d5b98">
        <obo:IAO_0000115>AIMS: Data suggest pharmacological treatment of depression with selective serotonin reuptake inhibitors (SSRI) may impair bone health. Our group has previously modeled compromised craniofacial healing after treatment with sertraline, a commonly prescribed SSRI, and hypothesized potential culprits: alterations in bone cells, collagen, and/or inflammation. Here we interrogate ##bone lineage cell## alterations due to sertraline treatment as a potential cause of the noted compromised bone healing. MAIN METHODS: Murine pre-osteoblast, pre-osteoclast, osteoblast, and osteoclast cells were treated with clinically relevant concentrations of the SSRI. Studies focused on serotonin pathway targets, cell viability, apoptosis, differentiation, and the osteoblast/osteoclast feedback loop. KEY FINDINGS: All cells studied express neurotransmitters (e.g. serotonin transporter, SLC6A4, SSRI target) and G-protein-coupled receptors associated with the serotonin pathway. Osteoclasts presented the greatest native expression of Slc6a4 with all cell types exhibiting decreases in Slc6a4 expression after SSRI treatment. Pre-osteoclasts exhibited alteration to their differentiation pathway after treatment. Pre-osteoblasts and osteoclasts showed reduced apoptosis after treatment but showed no significant differences in functional assays. RANKL: OPG mRNA and protein ratios were decreased in the osteoblast lineage. Osteoclast lineage cells treated with sertraline demonstrated diminished TRAP positive cells when pre-exposed to sertraline prior to RANKL-induced differentiation. SIGNIFICANCE: These data suggest osteoclasts are a likely target of bone homeostasis disruption due to sertraline treatment, most potently through the osteoblast/clast feedback loop.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7336288</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32450170</oboInOwl:hasDbXref>
        <rdfs:label>bone lineage cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0001035"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/e285bed2-466c-45b6-b288-e1a8632d5b98"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0001035"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/e29277fd-61c5-41a8-8bd3-8b55a38bf520 -->

    <Class rdf:about="http://example.org/e29277fd-61c5-41a8-8bd3-8b55a38bf520">
        <obo:IAO_0000115>Single-cell sequencing of E18.5 intestinal cells identifies ##ILC progenitors## and mature subsets.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7614953</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34556887</oboInOwl:hasDbXref>
        <rdfs:label>ILC progenitors</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0001082"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/e29277fd-61c5-41a8-8bd3-8b55a38bf520"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0001082"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/e29a5ebc-cd3e-40c6-b972-51de33d5f485 -->

    <Class rdf:about="http://example.org/e29a5ebc-cd3e-40c6-b972-51de33d5f485">
        <obo:IAO_0000115>We found that Pianno&apos;s prediction of the distribution of ##excitatory neuron## subtypes displayed similar pattern as Tangram and RCTD (Supplementary Fig. S3), exhibited a high level of consistency with their known locations across the various layers (Fig. 3c). In contrast, the spatial distribution obtained from unsupervised clustering of cell bins in the original paper presented clusters containing neurons from both L5/6 and L2-3. These clusters included neurons assigned as EX L5/6 but displayed a significant enrichment also in upper layers (Fig. 3d). Ectopic mapping of L5/6 neurons to L2-3 was also observed in the results obtained from Cell2location (Supplementary Fig. S3), the tool showing top-performance in a previous benchmarking study of spatial deconvolution methods. These results suggest that even the most advanced deconvolution tool available at the time struggled with precisely assigning these neurons to their correct layers. The mispositioning of L5/6 neurons to L2-3 can likely be attributed to the fact that L2-3 and L5 pyramidal neurons share some similar electrophysiological properties, morphological features, and connectivity patterns, leading to an increased transcriptomic similarity between them.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11271244</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38565531</oboInOwl:hasDbXref>
        <rdfs:label>excitatory neuron</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000540"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/e29a5ebc-cd3e-40c6-b972-51de33d5f485"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000540"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/e2f239dc-d7e4-460e-9559-3bd6f7e24c43 -->

    <Class rdf:about="http://example.org/e2f239dc-d7e4-460e-9559-3bd6f7e24c43">
        <obo:IAO_0000115>(A) Points denoting individual ##excitatory neurons## in mFISH data, colored according to respective coronal section. (B) t-SNE visualization of mFISH data for the cells shown in (A). (C) Spatial location of cells comprising two clusters. (D) t-SNE visualization for two excitatory neuron clusters, colored according to cluster identity from (C). (E,F) As in (C,D), but for six clusters.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7486123</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32869744</oboInOwl:hasDbXref>
        <rdfs:label>excitatory neurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000540"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/e2f239dc-d7e4-460e-9559-3bd6f7e24c43"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000540"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/e2fe7e8b-74f3-4d3d-9c4d-f34c3f5927af -->

    <Class rdf:about="http://example.org/e2fe7e8b-74f3-4d3d-9c4d-f34c3f5927af">
        <obo:IAO_0000115>scRNAseq analysis of WT ##BM neutrophils##.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9007399</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35418110</oboInOwl:hasDbXref>
        <rdfs:label>BM neutrophils</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000775"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/e2fe7e8b-74f3-4d3d-9c4d-f34c3f5927af"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000775"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/e30f0af9-ec68-49e1-a29e-5a1305eec491 -->

    <Class rdf:about="http://example.org/e30f0af9-ec68-49e1-a29e-5a1305eec491">
        <obo:IAO_0000115>Individuals with 46,XX/XY chimerism can display a wide range of characteristics, varying from hermaphroditism to complete male or female, and can display sex chromosome chimerism in multiple tissues, including the gonads. The gonadal tissues of females contain both granulosa and germ cells. However, the specific sex chromosome composition of the granulosa and germ cells in 46,XX/XY chimeric female is currently unknown. Here, we reported a 30-year-old woman with secondary infertility who displayed a 46,XX/46,XY chimerism in the peripheral blood. FISH testing revealed varying degrees of XX/XY chimerism in multiple tissues of the female patient. Subsequently, the patient underwent preimplantation genetic testing (PGT) treatment, and 26 oocytes were retrieved. From the twenty-four biopsied mature oocytes, a total of 23 first polar bodies (PBs) and 10 second PBs were obtained. These PBs and two immature metaphase I (MI) oocytes only displayed X chromosome signals with no presence of the Y, suggesting that all oocytes in this chimeric female were of XX germ cell origin. On the other hand, granulosa cells obtained from individual follicles exhibited varied proportions of XX/XY cell types, and six follicles possessed 100% ##XX or XY granulosa cells##. A total of 24 oocytes were successfully fertilized, and 12 developed into blastocysts, where 5 being XY and 5 were XX. Two blastocysts were transferred with one originating from an oocyte aspirated from a follicle containing 100% XY granulosa cells. This resulted in a twin pregnancy. Subsequent prenatal diagnosis confirmed normal male and female karyotypes. Ultimately, healthy boy-girl twins were delivered at full term. In summary, this 46,XX/XY chimerism with XX germ cells presented complete female, suggesting that germ cells may exert a significant influence on the sexual determination of an individual, which provide valuable insights into the intricate processes associated with sexual development and reproduction.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMID:38420683</oboInOwl:hasDbXref>
        <rdfs:label>XX or XY granulosa cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000501"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/e30f0af9-ec68-49e1-a29e-5a1305eec491"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000501"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/e31d4f4e-c7b3-4d8f-9b94-693b6a1d032f -->

    <Class rdf:about="http://example.org/e31d4f4e-c7b3-4d8f-9b94-693b6a1d032f">
        <obo:IAO_0000115>To gain a comprehensive view of immune interactions, we performed correlation analyses between the frequency of Ki67+ Tregs and the frequencies of all identified immune cell subpopulations. We did not observe significant association of the frequency of Ki67+ Tregs with lymphocytic subsets (Supplementary Fig. 8). On the other hand, myeloid cells, particularly dendritic cells (DCs), are known to facilitate Treg generation. Therefore, we analyzed the correlation between the frequency of Ki67+ Tregs and that of myeloid cell subsets (including cMo, iMo, ##ncMo##, and DC). The frequency of Ki67+ Tregs was positively associated with the frequencies of HLA-DR+ and CD86+ monocytes and dendritic cells (Supplementary Fig. 9), suggesting their potential roles in the generation of Ki67+ Treg cells via antigen presentation and CD28-dependent signaling. Interestingly, we found that the frequency of Ki67+ Tregs was also positively associated with the frequencies of PD-L1+ monocytes and dendritic cells (Supplementary Fig. 9), which is consistent with previous reports that DCs could induce Treg cells via PD-L1. These results indicate that myeloid cells might play a crucial role in Treg generation.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11496634</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:39438442</oboInOwl:hasDbXref>
        <rdfs:label>ncMo</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000576"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/e31d4f4e-c7b3-4d8f-9b94-693b6a1d032f"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000576"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/e334345d-5565-419e-9b81-ec1a336cd41e -->

    <Class rdf:about="http://example.org/e334345d-5565-419e-9b81-ec1a336cd41e">
        <obo:IAO_0000115>Variable Name Data used   TN Naive T-cells Combination of CD4 naive and memory resting T-cells and resting NK cells   Th Helper T-cells Combination of memory activated CD4 T-cells and follicular helper T-cells   TC Cytotoxic cells Combination of CD8 T-cells and activated NK cells   Tr Regulatory T-cells Regulatory T-cells   DN ##Naive dendritic cells## Naive dendritic cells   D Activated dendritic cells Activated dendritic cells   MN Naive Macrophages Combination of Macrophages M0 and Monocytes   M Macrophages Combination of M1 and M2 Macrophages   C Cancer cells Estimated   N Necrotic cells Estimated   A Cancer Associated Adipocytes Assumed to be twice of the total number of immune cells   H HMGB1 HMGB1 gene expression   IL12 IL-12 IL12A and IL12B gene expressions   IL10 IL-10 IL10, IL10RA and IL10RB gene expressions   IL6 IL-6 IL6, IL6ST and IL6RA gene expressions   </obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8959189</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35294447</oboInOwl:hasDbXref>
        <rdfs:label>Naive dendritic cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000451"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/e334345d-5565-419e-9b81-ec1a336cd41e"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000451"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/e34dccf7-5545-4799-a34f-6693a1bebce9 -->

    <Class rdf:about="http://example.org/e34dccf7-5545-4799-a34f-6693a1bebce9">
        <obo:IAO_0000115>Here we hypothesized that upon activation, memory CD8 T cells acquire a noncytotoxic function whereby they interact with naive CD8 T cells and alter their phenotype and activation state. To test this hypothesis, we designed an in vitro system in which human polyclonal naive CD8 T cells were co-cultured with autologous, activated memory CD8 T cell subsets. The phenotype and transcriptional profile of naive cells was analyzed at the end of the co-culture period. We report that in the presence of ##activated TCM or stem cell memory (TSCM) cells##, a small proportion (~3%) of autologous naive CD8 T cells acquired phenotypic and transcriptional features of activated/memory CD8 T cells in an MHC class I-dependent manner, whereas a much larger proportion (~84%) transitioned to a unique activated state, hybrid between naive and activated memory. These findings imply that activated memory T cells can set the activation threshold of neighboring naive T cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9243096</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35768564</oboInOwl:hasDbXref>
        <rdfs:label>activated TCM or stem cell memory (TSCM) cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000907"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/e34dccf7-5545-4799-a34f-6693a1bebce9"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000907"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/e3c04f9c-fa61-4922-8abc-a142bd01292d -->

    <Class rdf:about="http://example.org/e3c04f9c-fa61-4922-8abc-a142bd01292d">
        <obo:IAO_0000115>Chondroblastic differentiation was evaluated by visualization of typical morphological changes of cells as well by Alcian blue staining on day 28 of differentiation. ##DFSCs## and DPSCs showed a rapid cell aggregation as condrocytes spheroids, which increased in volume over time and were positive for Alcian blue, a stain for acidic polysaccharides such as glycosaminoglycans, some types of mucopolysaccharides, and sialylated glycocalyx. APSCs showed a much slower and less intense process of chondroblastic differentiation (Figure 5). </obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7697067</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33198232</oboInOwl:hasDbXref>
        <rdfs:label>DFSCs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:4030035"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/e3c04f9c-fa61-4922-8abc-a142bd01292d"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4030035"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/e3c779f1-e2c5-4853-8b72-75d9e1c662dd -->

    <Class rdf:about="http://example.org/e3c779f1-e2c5-4853-8b72-75d9e1c662dd">
        <obo:IAO_0000115>MiR-425-5p is upregulated in oocytes after in vitro oxidative stress induction and natural aging. (A) Upper and lower images: Representative images of ##small antral GV oocytes## from young and reproductively older mice stained with CM-H2DCFAD fluorescence to evaluate ROS levels. Scale bar: 100 mum. (B) Quantitative analysis of the CM-H2DCFAD fluorescence intensity in GV oocytes from young and reproductively older mice (n = 20 in each group). P values were determined by the unpaired samples T-test. (C) Venn diagram for upregulated miRNAs in GV oocytes(green), embryos(cornflower blue), and sperm(pink) in reproductively older mice versus young mice. The miRNAs found to be exclusively upregulated in the GV oocytes were filtered with a publicly available miRNA expression database that included miRNAs altered after H2O2 exposure(sky blue). (D) MiR-425-5p expression levels in GV oocytes of young and reproductively older mice. P values were determined by the unpaired samples T-test. (E) Upper and lower images: Representative images of oocytes cultured in vitro for 3 h and 14 h after being treated with different concentrations of H2O2 for different times (0 muM*0.5 h, 25 muM*0.5 h, 25 muM*1 h, 25 muM*1.5 h, 50 muM*1.5 h, 75 muM*1.5 h and 100 muM*1.5 h). Scale bar = 100 mum. (F) The GVBD rate and PBE rate of oocytes after being treated with different concentrations of H2O2 for different times (n = 80 to 90 in each group). P values were determined by two-way ANOVA. (G) MiR-425-5p expression levels in GV oocytes after being treated with different concentrations of H2O2 for different times. P values were determined by one-way ANOVA. Results were representative of at least three independent experiments.*P &lt; 0.05 and **P &lt; 0.01</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11226420</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37532927</oboInOwl:hasDbXref>
        <rdfs:label>small antral GV oocytes</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000023"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/e3c779f1-e2c5-4853-8b72-75d9e1c662dd"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000023"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/e3db96a2-4c75-4707-ad44-bafc3f5439c0 -->

    <Class rdf:about="http://example.org/e3db96a2-4c75-4707-ad44-bafc3f5439c0">
        <obo:IAO_0000115>In all three datasets, neural progenitors with temporally progressing transcriptional states, glioblasts and astrocytes (SLC1A3 and AQP4) form the most abundant glial lineage (Fig. 1b-e and Extended Data Fig. 6a-f):hereafter collectively referred to as astroglia. In the oligodendrocyte lineage, we discerned proliferating oligodendrocyte progenitor cells (OPCs) (PDGFRA), committed oligodendrocyte precursors (TNR) and postmitotic oligodendrocytes (MAG) (Extended Data Fig. 6a-d,f). Additionally, in human and opossum, we detected an intermediate cell population between glioblasts and OPCs, probably representing a pre-OPC state (EGFR) (Extended Data Fig. 6a-d,f). We distinguished ependymal cells (SPAG17) in the mouse and opossum but not in the human dataset, and in opossum, we further identified ependymal progenitors that share transcriptional traits with glioblasts but express ciliogenesis-related SPAG17 (Extended Data Fig. 6a-d,f). We also detected neural crest- and mesoderm-derived cell types (meningeal, immune (mostly microglia), vascular (mural and endothelial) and erythroid) and small groups of neural cells from neighbouring brain regions, resulting from the migration of a midbrain-originating cell population (LEF1) to the cerebellar primordia or sample contamination (##isthmic and midbrain neuroblasts##, GABAergic midbrain cells and motor neurons; Fig. 1b,c and Extended Data Fig. 6j).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10808058</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38029793</oboInOwl:hasDbXref>
        <rdfs:label>isthmic and midbrain neuroblasts</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002676"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/e3db96a2-4c75-4707-ad44-bafc3f5439c0"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002676"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/e3dddd0a-f38a-4809-976d-cbde9bc592f4 -->

    <Class rdf:about="http://example.org/e3dddd0a-f38a-4809-976d-cbde9bc592f4">
        <obo:IAO_0000115>(A-C) Representative responses to cholinergic agonist (carbachol, 10 muM) by small (L-cells) (A), D-stellate (B), ##tuberculoventral (TV) cells## (C). Small cells were activated by carbachol. D-stellate and TV cells failed to respond to carbachol application. IPSCs in principal cells, bushy cells (D), and T-stellate cells (E) in the VCN were induced by carbachol application, confirming that small inhibitory neurons were local interneurons. (F, H) Time course of sIPSCs from bushy cells and T-stellate (bushy cell, tau = 7.22 +- 1.40 ms, n = 9, T-stellate, tau = 2.28 +- 0.07 ms, n = 9). (G, I) Cumulative histogram of inter-event internal under control and carbachol application. (J). Carbachol application resulted in a significant increase in sIPSCs frequency (inter-event interval, control = 280.44 +- 47.56 ms versus carbachol = 191.21 +- 28.99 ms, p&lt;0.02, t-test).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7744103</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33141020</oboInOwl:hasDbXref>
        <rdfs:label>tuberculoventral (TV) cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:1001509"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/e3dddd0a-f38a-4809-976d-cbde9bc592f4"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:1001509"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/e4168e82-9c38-4c89-9d07-143b256fc39c -->

    <Class rdf:about="http://example.org/e4168e82-9c38-4c89-9d07-143b256fc39c">
        <obo:IAO_0000115>Notably, although CD8+ T cells have been only occasionally described in patient cohorts or animal studies in the allergy fields, the percentage of CCR4+CXCR3  type-2 cytotoxic CD8+ T cells (CD8+ Tc2, Fig. 3d, e) among living cells was also higher in VAP vs. HC at each time point including baseline, while the percentage of CCR4 CXCR3+ type-1 CD8+ T cells (CD8+ Tc1) was modestly but significantly decreased (Supplementary Fig. 3A). CD8+ Tc2-like cells, referred to as the direct parent gate of CD8+ Tc2 (Supplementary Fig. 1), were also among the two significantly higher immune subsets in PAP vs. HC at several time points (Supplementary Figs. 2b, 3b). Remarkably, the percentage of CD45RA+CD8+ regulatory T cells (Tregs) (CD8+CD25highCD127lowCD45RA+) was significantly lower in VAP vs. HC at both baseline and D7 (Figs. 2b and 3f). A lower percentage of CD45RA+ and total CD8+ Tregs (CD8+CD25highCD127low) was also noticed among PAP vs. HC (Fig. 3f, Supplementary Figs. 2C, 3C). These findings demonstrated that type-2 CD8+ T cells charaterize the peripheral immune profile in VAP while the fraction of ##CD45RA+ CD8+ Tregs## in VAP is inferior to that in HC at baseline and during the AIT initiation phase. In short, our data underscore an unrecognized link between several CD8+ T-cell subsets and insect-venom allergy pathogenesis and possibly the long-term immune-tolerance induced by AIT.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11599746</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:39592626</oboInOwl:hasDbXref>
        <rdfs:label>CD45RA+ CD8+ Tregs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000795"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/e4168e82-9c38-4c89-9d07-143b256fc39c"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000795"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/e4331f9d-0eb3-461b-ad7d-e8b7054985d8 -->

    <Class rdf:about="http://example.org/e4331f9d-0eb3-461b-ad7d-e8b7054985d8">
        <obo:IAO_0000115>Systems Organs Cell Types     Respiratory system Lung AT2 cells 0.79% 21.20%   Nose (nasal turbinate epithelial cells) Mesenchymal stromal cells 1.70% 8.50%   Plasma cells 2.00% 8.80%   Nose (nasal brushing epithelial cells) Plasma cells 4.00% 13.80%   Nose (nasal airway epithelial cells) Nasal airway epithelial cells 8.40% 23.10%   Digestive system Gall bladder Primordium cell 2.20% 2.60%   Small intestine (jejunum) Enterocyte progenitor cell 14.00% 6.60%   Goblet cell 9.10% 2.60%   Small intestine (ileum) Intestinal epithelial stem cell 1.50% 4.20%   Enterocyte progenitor cell 2.40% 3.60%   Small intestine (duodenum) LGR5+ stem cell 5.20% 4.50%   Intestinal epithelial stem cell 3.90% 5.80%   Enterocyte progenitor cell 4.40% 6.80%   Tuft progenitor cell 7.40% 6.60%   Enteroendocrine cell 9.40% 3.80%   Large intestine (rectum) Goblet progenitor cell 2.80% 62.50%   MKI67+ progenitor cell 10.30% 75.40%   Enterocyte 13.20% 77.50%   Goblet cell 18.20% 87.30%   Large intestine (colon) Enterocyte 5.70% 52.10%   Goblet cell 11.00% 78.00%   Esophagus ##Secretory progenitor cell## 9.40% 18.80%   Nervous system Brain (substantia nigra and cortex) Oligodendrocyte precursor cell 1.60% 0.90%   Astrocyte 1.90% 1.00%   Reproductive system Fallopian tube Epithelial cells 1.40% 26.50%   Ovarian somatic cell 1.00% 1.00%   Testis Spermatogonium 1.70% 4.50%   Peritubular myoid cell 1.70% 6.30%   Testis somatic cell 2.10% 4.30%   Spermatogonial stem cell 1.40% 2.10%   Circulatory system Heart Cardiomyocyte 6.60% 0.80%   Cardiovascular progenitor cell 12.50% 0.40%   Urinary system Kidney Nephron epithelial cell 2.70% 10.70%   Epithelial cell 2.70% 9.60%   Endothelial cell 2.70% 12.80%   Mesangial cell 3.00% 14.50%   </obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7794913</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33401657</oboInOwl:hasDbXref>
        <rdfs:label>Secretory progenitor cell</rdfs:label>
    </Class>
    


    <!-- http://example.org/e4b54e47-0d55-42cd-a788-ef6b2d64ad2b -->

    <Class rdf:about="http://example.org/e4b54e47-0d55-42cd-a788-ef6b2d64ad2b">
        <obo:IAO_0000115>Tumor types Mutant genes The contributed cells for tumors References   Trichofolliculomas/papillomatricomas beta-catenin ##Krt 14+ cells##    Pilomatricomas beta-catenin Lgr5+ cells    Dermatofibromas beta-catenin Lgr6+ cells    Trichoadenomas beta-catenin Lrig1+ cells    No tumor beta-catenin Krt15+ cells    Sebaceous tumors Lef1 Krt14+ cells    Basal cell carcinoma(BCC) Patched IFE cells/bulge stem cells(major contribution)    BCC Smoothened IFE cells    BCC Smoothened (in the context of wound) Krt15+ bulge stem cells    Papillomas KRAS Krt19+, Krt15+ and Involucrin+ cells    Invasive squamous cell carcinoma (SCC) P53 and KRAS --    SCC (DMBA-TPA method) HRAS Long-lived stem cells    Papilloma and SCC HRAS Krt5+ cells    </obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9391238</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35143021</oboInOwl:hasDbXref>
        <rdfs:label>Krt 14+ cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000066"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/e4b54e47-0d55-42cd-a788-ef6b2d64ad2b"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000066"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/e4b5bd90-f611-45a9-ae52-f1f9903dbfa4 -->

    <Class rdf:about="http://example.org/e4b5bd90-f611-45a9-ae52-f1f9903dbfa4">
        <obo:IAO_0000115>Numerous human placental disorders have their pathophysiological roots at the early developmental stages. However, molecular studies of the underlying causes were long hampered by the inaccessibility of placental tissue and the lack of suitable in vitro models. Researchers mainly relied on the scarcely available primary tissue and several transformed and cancer cell lines of restricted potential. While animal models, in particular mice, are widely used to study the development and function of human organs, their ability to model the placenta is limited. As described above, the development of the specific trophoblast lineages and cell types differ between the two species. For instance, various types of the trophoblast giant cells feature prominently in the murine placenta while these are limited to EVT subtypes in humans. The recent establishment of the human trophoblast stem cells (hTSCs) and self-organizing trophoblast organoids (TOs) was a major breakthrough and provided novel, reliable tools to study molecular mechanisms driving trophoblast development and disease (Fig. 3). The hTSCs represent the CTB population of the first trimester placenta. In culture conditions activating EGF and WNT and inhibiting TGF-beta and ROCK signaling, they self-renew and remain bipotent. Upon induction, hTSCs can differentiate into STB or EVT, providing a versatile in vitro system to follow trophoblast development. TOs require similar signaling inputs to self-organize in 3D into the outer ##CTB-like## layer and the inner STB-like compartment, representing the inside-out model of the human villi. While these models have already proven to be a powerful tool to interrogate TF function in CTB, naive human embryonic stem cells (hESCs) conversion into hTSCs and recently-derived human blastoids can be used to dissect even earlier stages of human trophoblast development.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9166831</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35657505</oboInOwl:hasDbXref>
        <rdfs:label>CTB-like</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000523"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/e4b5bd90-f611-45a9-ae52-f1f9903dbfa4"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000523"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/e4b83b33-46e5-4035-8b7c-e81fb5ab8766 -->

    <Class rdf:about="http://example.org/e4b83b33-46e5-4035-8b7c-e81fb5ab8766">
        <obo:IAO_0000115>Early expression of Pax5 reduced Fbxo7 expression in pro-B cells but not in ##later stage B cells##</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8082276</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33774278</oboInOwl:hasDbXref>
        <rdfs:label>later stage B cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000236"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/e4b83b33-46e5-4035-8b7c-e81fb5ab8766"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000236"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/e4cd86c7-d1c9-45bf-a763-6a98548ccb5c -->

    <Class rdf:about="http://example.org/e4cd86c7-d1c9-45bf-a763-6a98548ccb5c">
        <obo:IAO_0000115>Reassessing Long-Term Cryopreservation Strategies for Improved Quality, Safety, and Clinical Use of Allogeneic ##Dermal Progenitor Cells##.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMID:39217536</oboInOwl:hasDbXref>
        <rdfs:label>Dermal Progenitor Cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0011026"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/e4cd86c7-d1c9-45bf-a763-6a98548ccb5c"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0011026"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/e4d9ad0e-c872-4bcd-b41c-a03ec8ff078b -->

    <Class rdf:about="http://example.org/e4d9ad0e-c872-4bcd-b41c-a03ec8ff078b">
        <obo:IAO_0000115>scRNA sequencing data was analyzed to further explore the synergistic effect of the IRRS and the TME cells in ESCC. We used the previously profiled transcriptomes of ~208,659 single cells with eight main cell populations ( Figures 4A, B ), among which fibroblasts, endothelial cells, T cells, B cells, pericytes and myeloid cells were analyzed. Next, 40 cell clusters, including T helper 17 (TH17) cells, follicular helper T (TFH1/2) cells, naive T (TN) cells, regulatory T (Treg) cells, memory T (TMEM-CD4/CD8) cells, effector T (TEFF) cells, exhausted T (TEX) cells, monocytes (Mono01-03), tumor-associated macrophages (TAM01-04),dendritic cells (tDC, pDC, cDC), mast cells (Mast), resting B cells, activated B cells, germinal center B cells (GCB), plasma cells, normal mucosa fibroblasts (NMF), normal ##activated fibroblasts## (NAF1/2), cancer-associated fibroblasts (CAF1-4), vascular smooth muscle cells (VSMC), normal endothelial cells (NEC1-3) and tumor endothelial cell (TEC1-3) were identified by t-SNE analysis ( Figures 4C-G ;  Figures S6A-E ). We then used CIBERSORTx to infer cell-type abundance from bulk RNA-seq data using scRNA data, and estimated the proportions of the 42 cell types in the training dataset. The proportions of TME cell types between the high- and low-risk groups was compared using the Kruskal-Wallis test. The profiles of the high- and low-risk groups are shown in  Figure 4H  and  Figure S6F . The abundance of TEX, NAF2, CAF4, and VSMC increased, and the abundance of Mono1, TAM03, and NEC2 decreased in the high-risk group (p &lt; 0.05;  Figure 4I ). The cell proportions between low and high risk groups demonstrated significantly distinct TME patterns.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9933905</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36817484</oboInOwl:hasDbXref>
        <rdfs:label>activated fibroblasts</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000057"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/e4d9ad0e-c872-4bcd-b41c-a03ec8ff078b"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000057"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/e4eb6dc2-9655-4eb5-baf7-4bfb3c4aa653 -->

    <Class rdf:about="http://example.org/e4eb6dc2-9655-4eb5-baf7-4bfb3c4aa653">
        <obo:IAO_0000115>The mammalian retina is a highly organized neuronal tissue lining the back of the eye. Five major classes of retinal cell types are organized into complex circuits that are responsible for extracting valuable features from the visual scene, such as color, contrast, luminance and motion. Signal detection and transduction originate in photoreceptors (PRs), which use the rate of release of glutamate to signal light level information to bipolar (BP) neurons. Most BP cells, which are also glutamatergic, signal to the output neurons of the retina, the retinal ganglion cells (RGCs). Rod BPs constitute a separate major pathway where they route the rod PR signal to AII amacrine cells (ACs) that in turn connect with RGCs and cone BP cells. RGCs relay these signals to specialized retinorecipient areas in the brain. Inhibitory neurons are critical to the proper information transformations conducted by the many types of circuits. These ##inhibitory neurons## are ACs and horizontal cells (HCs), with ACs being &gt;10-fold more abundant than HCs. GABA and glycine are the principal neurotransmitters used by ACs, which can also use other neurotransmitters, such as dopamine and serotonin, as well as a variety of neuropeptides. The contribution of ACs to the complexity of retinal processing is also indicated by their diversity. Single-cell RNA sequencing (scRNA-seq), as well as more classical anatomic and physiological descriptions, have defined at least 63 types of ACs in the mammalian retina.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8856716</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35045975</oboInOwl:hasDbXref>
        <rdfs:label>inhibitory neurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000498"/>
        <skos:relatedMatch rdf:resource="CL:0000617"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/e4eb6dc2-9655-4eb5-baf7-4bfb3c4aa653"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000498"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/e4eb6dc2-9655-4eb5-baf7-4bfb3c4aa653"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000617"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/e541027b-7342-4039-bd66-41566fd64176 -->

    <Class rdf:about="http://example.org/e541027b-7342-4039-bd66-41566fd64176">
        <obo:IAO_0000115>Cone photoreceptors mediate color perception and daylight vision through intricate synaptic circuitry. In most mammalian retina, cones are greatly outnumbered by rods and exhibit inter-dependence for functional maintenance and survival. Currently, we have limited understanding of cone-specific molecular components that mediate response to extrinsic signaling factors or are involved in communication with rods and other retinal cells. To fulfill this gap, we compared the recently-published transcriptomes of developing S-cone-like photoreceptors from the Nrl-/- mouse retina with those of rods and identified candidate genes responsible for cone cell functions and communication. We generated an in silico expression profile of 823 genes that encode candidate transmembrane and secretory proteins and are up-regulated in ##Nrl-/- cone photoreceptors## compared to wild type cones. In situ hybridization analysis validated high expression of seven of the selected candidate genes in the Nrl-/- retina. To examine their relevance to cone function, we performed in vivo knockdown of Epha10 in the Nrl-/- retina and demonstrated aberrant morphology and mislocalization of the photoreceptor cell bodies. Thus, the receptor tyrosine kinase Ephrin type-A receptor 10 appears to influence cone morphogenesis. Our studies reveal novel cone-enriched genes involved in interaction of cones with other retinal cell types and provide a framework for examining molecular pathways associated with intercellular communication.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6239890</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:30260491</oboInOwl:hasDbXref>
        <rdfs:label>Nrl-/- cone photoreceptors</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000573"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/e541027b-7342-4039-bd66-41566fd64176"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000573"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/e55fc616-c5d1-4363-81f4-d273f4f53500 -->

    <Class rdf:about="http://example.org/e55fc616-c5d1-4363-81f4-d273f4f53500">
        <obo:IAO_0000115>While the heterogeneity of CD103+ TRMs is widely discussed in the literature, the characteristics of TRM subpopulations within the tumor or distant tissues of tumor-bearing mice are less well defined. To characterize tumoral TRMs, scRNA-seq technology provides unprecedented analytical power and allows us to dissect cells with thousands of dimensions. With the hypothesis that particular intratumoral T cells are precursors for TRM development, we extended our scRNA-seq approach to include various effector and memory T cell populations to comprehensively depict their transcriptomic program. From the tumor and distant mucosa of mice bearing established 4T1 tumors, we flow sorted distinct memory T cell populations using a strict gating strategy (Figure S3). We constructed single-cell cDNA libraries from paired intratumoral sorted TCR-beta+CD44+CD62L-CD69+CD103+ cells (TRMs), ##mucosal sorted TCR-beta+CD44+ CD69+CD103+ cells## (distant mucosa TRMs), intratumoral TCR-beta+CD44+CD62L+CD69-CD103- cells (TCMs), and TCR-beta+CD44+CD62L-CD69-CD103- cells (TEMs) (Table S2). After data processing and normalization, we performed unbiased clustering and visualized the CD8+ clusters using t-distributed stochastic neighbor embedding (t-SNE; Figure 2A). Through this unsupervised analysis, we found that all four samples could distinctly separate into multiple clusters, confirming continued heterogeneity among the single-cell subsets.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8204287</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33979626</oboInOwl:hasDbXref>
        <rdfs:label>mucosal sorted TCR-beta+CD44+ CD69+CD103+ cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000909"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/e55fc616-c5d1-4363-81f4-d273f4f53500"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000909"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/e5673f69-d236-4e90-a674-58f1cf35d840 -->

    <Class rdf:about="http://example.org/e5673f69-d236-4e90-a674-58f1cf35d840">
        <obo:IAO_0000115>Deep learning-based multipotency prediction for ##hNTSCs## from different donors. (A) Schematic images presenting the procedure of the proposed deep learning algorithm: single-cell image acquisition (preprocessing), deep learning model, and multipotency computation. (B) Bayesian optimization for learning rate: the results are visualized as a probabilistic model of the loss function (dotted line), uncertainty at each point (green region), and expected improvement (EI) for expensive optimization problems (blue region). (C) ROC-AUC score plotted over 10 iterations according to Bayesian optimization. (D) Confusion matrix: Predicted (x-axis) represents results through the deep learning; ground truth (y-axis) represents multipotency data revealed by immunofluorescence staining of SSEA3, and deep learning distinguishes cells with high/low multipotency. (E) Classification results of the proposed CNN model. (F) Ratio corresponding to the multipotent stem cell for each donor.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9749643</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36517519</oboInOwl:hasDbXref>
        <rdfs:label>hNTSCs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000048"/>
        <skos:relatedMatch rdf:resource="CL:1001573"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/e5673f69-d236-4e90-a674-58f1cf35d840"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000048"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/e5673f69-d236-4e90-a674-58f1cf35d840"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:1001573"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/e57c2d06-3a69-4d25-9865-c0813384e2fd -->

    <Class rdf:about="http://example.org/e57c2d06-3a69-4d25-9865-c0813384e2fd">
        <obo:IAO_0000115>X-axis are the cell types denoted by layer and gene marker. Y-axis is the GWAS summary statistics used. Class is colour coded, purple are excitatory neurons, pink are ##inhibitory neurons##, white are oligodendrocytes, hot pink are astrocytes, grey are newborn inhibitory neurons, forest green are intermediate progenitor cells, light pink are radial glia (RG), and black are non-neural cells (endothelial, pericytes). The blue is the negative log10 of the FDR q-value (mean analysis). Black boxes represent cell types that reached significance (FDR &lt; 0.05). a Allen Brain Bank adult single nuclei RNA sequencing data. b Kriegstein fetal single cell RNA sequencing data. c Shen fetal RNA sequencing data.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10208966</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36750735</oboInOwl:hasDbXref>
        <rdfs:label>inhibitory neurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000498"/>
        <skos:relatedMatch rdf:resource="CL:0000617"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/e57c2d06-3a69-4d25-9865-c0813384e2fd"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000498"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/e57c2d06-3a69-4d25-9865-c0813384e2fd"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000617"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/e5d383ce-ce21-49fc-9795-553faa272d8c -->

    <Class rdf:about="http://example.org/e5d383ce-ce21-49fc-9795-553faa272d8c">
        <obo:IAO_0000115>a Due to single-cell annotation and in situ validation (Fig. 2; Supplementary Fig. 3), a draft model of the oral-to-tooth transition zone in humans is presented, with basal and suprabasal keratinocyte markers uniquely identifying the alveolar mucosa (AM), attached gingiva (AG), gingival margin (GM), sulcular epithelium (SK) and junctional epithelium (JK). b These markers allowed for KRT19-high keratinocyte (KC) cell subclustering for the first time (2504 cells in total), including gingival margin keratinocytes (GM), sulcular keratinocytes (SK), and junctional keratinocytes (JK). c A more granular draft (Tier 4) annotation of epithelial cells of the gingival attachment. d Assaying differentially expressed genes in periodontitis, SKs and JKs only share about a quarter of upregulated genes. JKs displayed nearly 125 unique upregulated genes in diseased cells. e Further analysis of ##basal and suprabasal (differentiating) SK and JK keratinocytes## revealed unique cell signatures between basal and suprabasal cell types. This full list is included in Supplementary Data 1. f-i To understand SK and JK developmental progression and cell state alterations, we used partitioned-based graph abstraction (PAGA). f Examining the basal to suprabasal transition, JKs display altered gene expressed comparing health to disease cell types, including broader expression of KRT17 and more expression of JUND, COL17A1, and CDH3. Key differentiation genes such as SPRR family members were also downregulated. g JKs displayed robust cell signaling and inflammatory phenotypes, which appear exacerbated in disease states. h In SKs, differentiation-related genes were uniquely expressed compared to JKs in health but also appeared altered in disease along the basal to suprabasal trajectory. i SKs appeared generally less reactive compared to JKs in disease, with lower overall expression of effector molecules such as CXCL1, CXCL8, IL1A, IL1B, and IL1RN. Abbreviations: Merk Merkel Cells, LC langerhans cells, Mela melanocytes, Muc mucosa, SB suprabasal Keratinocytes; for others, see Fig. 1 legend. For this figure, n = 30-sample, 2504-cell for scRNAseq.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11178863</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38876998</oboInOwl:hasDbXref>
        <rdfs:label>basal and suprabasal (differentiating) SK and JK keratinocytes</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002170"/>
        <skos:relatedMatch rdf:resource="CL:0002187"/>
        <skos:relatedMatch rdf:resource="CL:4033013"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/e5d383ce-ce21-49fc-9795-553faa272d8c"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002170"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/e5d383ce-ce21-49fc-9795-553faa272d8c"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002187"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/e5d383ce-ce21-49fc-9795-553faa272d8c"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4033013"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/e5da9e27-064e-4d9f-9155-a902a4ca39d5 -->

    <Class rdf:about="http://example.org/e5da9e27-064e-4d9f-9155-a902a4ca39d5">
        <obo:IAO_0000115>DEG Differentially expressed gene   ESC Embryonic stem cell   FACS Fluorescence-activated cell sorting    GC Granulosa cells   hPGC Human primordial germ cell   MACS Magnetic-activated cell sorting   OSC Oogonial stem cell   PCG Primordial germ cell   pre-PGC Progenitor primordial germ cell   RA Retinoic acid   scRNA-seq Single-cell RNA sequencing   SC-seq Single-cell sequencing   ##SSC## Spermatogenic stem cells   TC Theca cell   TF Transcription factors   t-SNE t-stochastic neighbor embedding   UMI Unique molecular identifier   </obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7829788</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33467661</oboInOwl:hasDbXref>
        <rdfs:label>SSC</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000020"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/e5da9e27-064e-4d9f-9155-a902a4ca39d5"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000020"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/e5e4297d-00a1-4083-8a7a-cb5f44618c89 -->

    <Class rdf:about="http://example.org/e5e4297d-00a1-4083-8a7a-cb5f44618c89">
        <obo:IAO_0000115>The classification of ##pericyte-derived and non-pericyte-derived myofibroblasts## (PDGFRbeta-constitutively-expressing and PDGFRbeta-de novo-expressing, respectively) indicates different roles of pulmonary myofibroblasts. With PDGFRbeta as a &apos;specific&apos; marker for pericytes, PDGFRbeta-regulated Cre expression has been used to trace the fate of these cells. However, the constitutive PDGFRbeta-Cre line employed in other studies does not allow discriminating between the two types of myofibroblasts identified in this study, as, after injury, both indistinguishably express PDGFRbeta. Here, we employed the tamoxifen inducible PDGFRbeta-CreERT2 to induce temporally controlled labeling of cells with active PDGFRbeta promotor in the adult lung; in fact, as the intra-alveolar myofibroblasts were found to acquire PDGFRbeta expression after injury, only the inducible lineage tracing strategy allowed us to differentiate between the two types of myofibroblasts. Using a PDGFRbeta-tdTomato reporter mouse in combination with the fact that SMC do not contribute to myofibroblasts, the interstitial myofibroblast can be shown to derive from NO-GC+/PDGFRbeta+ pericytes. We have not yet determined the precursor for the intra-alveolar myofibroblast, although we can exclude pericytes based on our lineage tracing studies. Lipofibroblasts have been shown to be potential myofibroblasts precursors; whether this cell type is linked to the formation of intra-alveolar myofibroblasts has yet to be clarified.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10288756</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37349733</oboInOwl:hasDbXref>
        <rdfs:label>pericyte-derived and non-pericyte-derived myofibroblasts</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000186"/>
        <skos:relatedMatch rdf:resource="CL:0000669"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/e5e4297d-00a1-4083-8a7a-cb5f44618c89"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000186"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/e5e4297d-00a1-4083-8a7a-cb5f44618c89"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000669"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/e61e77f6-b504-4298-b1ea-4442d585e09f -->

    <Class rdf:about="http://example.org/e61e77f6-b504-4298-b1ea-4442d585e09f">
        <obo:IAO_0000115>Schematic diagram of the mechanisms that ##Dermo1+ mesenchymal progenitor cells## repaired the damaged airway epithelium. Dermo1+ mesenchymal stem cells firstly differentiated into epithelial stem cells and then regenerated the damaged epithelial cells via epithelial stem cells</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6889622</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31791401</oboInOwl:hasDbXref>
        <rdfs:label>Dermo1+ mesenchymal progenitor cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000134"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/e61e77f6-b504-4298-b1ea-4442d585e09f"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000134"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/e64e0c23-3167-4d1f-af74-8d5d71f8dd8b -->

    <Class rdf:about="http://example.org/e64e0c23-3167-4d1f-af74-8d5d71f8dd8b">
        <obo:IAO_0000115>Transcriptomic data were used for correlation analysis between human in vivo fetal yolk sac (YS) hematopoietic clusters (YS_EC, endothelial cells; YS_Mac, macrophages; and ##YS_YSMP##1,2, myeloid-biased progenitors) and PD-L1 WT hematopoietic cell populations (PD-L1_EC, endothelial cells; MC/Mphis, monocyte/macrophages; CMPs, common myeloid progenitors; and granulocytes).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10638094</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37949473</oboInOwl:hasDbXref>
        <rdfs:label>YS_YSMP</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002354"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/e64e0c23-3167-4d1f-af74-8d5d71f8dd8b"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002354"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/e6a54bb9-d980-44ff-a937-c9e032d4ed55 -->

    <Class rdf:about="http://example.org/e6a54bb9-d980-44ff-a937-c9e032d4ed55">
        <obo:IAO_0000115>Differentiation trajectory of pathological osteoclasts in arthritis. BM-derived CX3CR1loLy6Chi cells (R1) ingress into the synovium (R2) and produce inflammatory cytokines, chemokines, and VEGFA. Abundant M-CSF in the inflamed synovium induces maturation of some R2 cells into osteoclast precursors, ##arthritis-associated osteoclastogenic macrophages## (AtoMs/R3 cells). When AtoMs localize adjacent to the bone surface, simultaneous stimulation with RANKL and TNF promotes osteoclast formation, leading to joint destruction in arthritis.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9024112</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35464401</oboInOwl:hasDbXref>
        <rdfs:label>arthritis-associated osteoclastogenic macrophages</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
        <skos:relatedMatch rdf:resource="CL:0000778"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/e6a54bb9-d980-44ff-a937-c9e032d4ed55"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/e6a54bb9-d980-44ff-a937-c9e032d4ed55"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000778"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/e6b0f0d3-856b-49ce-aa2b-01f2ddfa909c -->

    <Class rdf:about="http://example.org/e6b0f0d3-856b-49ce-aa2b-01f2ddfa909c">
        <obo:IAO_0000115>Next, we sought to identify using machine learning, the immune variable (IT or Stromal) that best classifies patients as LTS or NON-LTS and thereby, predicts patient survival. Random-forest (RF) is a decision tree-based machine learning method which uses a bootstrapping method to generate at random, training and testing samples from the dataset. Variable selection was performed through the varSelRF package in R, which uses recursive feature elimination to find a minimal set of variables with the best predictive performance. Using this approach, we determined that stromal densities of iNOS+ and CD68+ cells are the two best discriminatory variables for patient survival. Stromal iNOS+ leukocytes display a potent positive correlation with OS (Figure 7A) while ##stromal CD68+ (total) macrophages## show a strong negative correlation with OS (Figure 7B). The ROC (Receiver Operating Characteristic) curves and ROC values for the final two variables determined by RF selection (i.e., iNOS and CD68) are plotted in Supplementary Figure 7. These findings suggest that iNOS+ leukocytes and CD68+ macrophages are highly relevant prognostic biomarkers in PDAC patients.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7933000</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33679807</oboInOwl:hasDbXref>
        <rdfs:label>stromal CD68+ (total) macrophages</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/e6b0f0d3-856b-49ce-aa2b-01f2ddfa909c"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/e6e0b8dd-873e-49ea-bd35-2734cd38f4e5 -->

    <Class rdf:about="http://example.org/e6e0b8dd-873e-49ea-bd35-2734cd38f4e5">
        <obo:IAO_0000115>This evolution generated the need to unify the nomenclature and refine the concepts that precisely define astrocyte heterogeneity by using a systematic approach to contextualize the contribution of astrocytes to CNS disorders. Recent studies have proposed that mouse astrocytes have two discrete pathological conditions: The A1 neurotoxic phenotype when exposed to specific cytokines secreted by activated microglia and the A2 neuroprotective phenotype when exposed to an experimental paradigm mimicking ischemic stroke. However, this binary polarization should be approached cautiously since more recent studies recommend moving beyond the ##A1##-A2 classification. Indeed, only a subset of mixed A1 and A2 or pan-reactive transcripts are up-regulated in astrocytes of human patients or mouse models of chronic diseases or acute CNS injuries. Moreover, advanced multidimensional data and the co-clustering statistical approach revealed that the A1 and A2 transcriptomes represent only two of the many potential astrocyte transcriptomes. As transcriptomic data are a fundamental tool used to characterize the functional diversity of reactive astrocytes, a multidimensional analysis should be applied to establish the uniqueness of astrocyte phenotypes.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8945600</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35327542</oboInOwl:hasDbXref>
        <rdfs:label>A1</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000127"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/e6e0b8dd-873e-49ea-bd35-2734cd38f4e5"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000127"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/e705cca4-6f8d-4f30-8ba3-0fe7a31ae5f5 -->

    <Class rdf:about="http://example.org/e705cca4-6f8d-4f30-8ba3-0fe7a31ae5f5">
        <obo:IAO_0000115>Collectively, these data indicated that healthy proliferating ##esMSCs## undergoing replicative senescence sequentially transition into cells experiencing metabolic and oxidative stress, then into a pre-senescent state characterised by ER-stress and p53 regulated senescence, before transitioning into cells experiencing oncogene-induced senescence that split either into deep senescent cells with strong SASP secretions or into aneuploid cells that have been permanently arrested in G2M. </obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10828319</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37314668</oboInOwl:hasDbXref>
        <rdfs:label>esMSCs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000134"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/e705cca4-6f8d-4f30-8ba3-0fe7a31ae5f5"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000134"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/e7539b71-b2f0-4e1d-a7a8-1555a827c8ef -->

    <Class rdf:about="http://example.org/e7539b71-b2f0-4e1d-a7a8-1555a827c8ef">
        <obo:IAO_0000115>Our consecutive gating strategy was based on previously published approaches distinguishing between memory B cells and plasma cells/blasts based on the surface markers CD38 in conjunction with negative staining for IgM and IgD. In contrast to previous strategies, we did not further select for IgA and IgG negative cells for two reasons: Firstly, omalizumab is the first antibody used in flow cytometry that is able to directly identify B cells bearing membrane-bound IgE without need for additional selection steps. Secondly, B cells bear the Fcgamma receptors family member FcgammaRIIB and thus gating for IgG negative cells may also exclude IgE+ B cells with Fcgamma receptor bound IgG as commercial available anti-human IgG antibodies are not exclusively directed to free IgG present in the BCR. Alternatively, to using negative staining for IgM and IgD to select class switched B cells, CD27 in conjunction with CD19 and CD38 has been used as a marker to discriminate between naive, memory cells and cells of the plasma cell lineage. However, it has been shown that CD27 is not expressed by all memory B cells but is rather an additional marker to discriminate memory B cell subsets. In this line using a stepwise exclusion approach by gating on CD19+CD38dim cells followed by exclusion of ##IgM+IgD+IgG+IgA+ cells## it has been demonstrated that IgE+ memory B cells expressing CD27 are most likely derived from a germinal center T cell-dependent pathway whereas IgE+ memory B cells lacking expression of CD27 most likely have a T cell-independent origin. Thus, as a substantial portion of IgE+ B cells do not express CD27, we did not use this marker for our gating approach.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8721004</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34987522</oboInOwl:hasDbXref>
        <rdfs:label>IgM+IgD+IgG+IgA+ cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000786"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/e7539b71-b2f0-4e1d-a7a8-1555a827c8ef"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000786"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/e75ddf9c-cfaa-493e-b9cd-ef0b03812875 -->

    <Class rdf:about="http://example.org/e75ddf9c-cfaa-493e-b9cd-ef0b03812875">
        <obo:IAO_0000115>Myeloid cell differentiation and developmental arrest are characteristics of immune dysregulation in patients with cancer. Regarding erythroid hematopoiesis, extramedullary hematopoiesis occurs during cancer and anemia. ##CD71+ erythroid progenitor cells## (EPCs) are produced during the differentiation of megakaryocyte-erythrocyte progenitor cells into erythrocytes, which are a new type of immune cell that can promote the re-occurrence and development of tumors. The number of EPCs in HCC tissue is positively correlated with PVTT. In myeloid hematopoiesis, the maturation of granulocyte-monocyte progenitor cells is blocked, resulting in the accumulation of myeloid-derived suppressor cells (MDSCs). MDSCs are also associated with prognosis in HCC and are reported to induce vascular VEC migration. VEC migration may destroy the endodermis and promote PVTT. Recently, Long et al. found that tumors induced a subset of CD45+ EPCs to differentiate into a cellular &quot;erythroid-myeloid hybrid&quot; population, named erythroid-differentiated myeloid cells (EDMCs), which may present a connection between MDSCs and EPCs. Thus, EDMCs may play a critical role in PVTT development.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10465220</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37649603</oboInOwl:hasDbXref>
        <rdfs:label>CD71+ erythroid progenitor cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000038"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/e75ddf9c-cfaa-493e-b9cd-ef0b03812875"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000038"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/e7a07ce4-f0a2-45b0-8211-8120b6c5c29d -->

    <Class rdf:about="http://example.org/e7a07ce4-f0a2-45b0-8211-8120b6c5c29d">
        <obo:IAO_0000115>Our observations were made on RBCs superfused under modest shear rates (gamma) of ~102 s-1, which are representative of large vessels (e.g., aorta). In vivo, RBCs traveling through capillaries will deform to fit through the narrow lumen, at which point gamma can reach 1,500 s-1. With rising shear, RBCs first become cup-shaped stomatocytes (or parachutes) and above gamma &gt; 400 s-1, attain a polylobed shape. However, even at gamma = 2,500 s-1, RBCs do not stretch substantially, meaning that their critical thickness remains a significant diffusional barrier, not dissimilar to that in ##discocytes##. Early experimental designs based on highly viscous media (to increase gamma) reported tank treading, which results in elliptically stretched (i.e., thinner) RBCs. However, tank treading is not normally observed in media of physiological viscosity or in narrow vessels at high gamma. Although our method does not recapitulate the shear rates in capillaries, it stabilizes cell thickness at a level that is relevant to physiologically deformed cells for robust measurements of diffusional delays.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7211990</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32321831</oboInOwl:hasDbXref>
        <rdfs:label>discocytes</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000232"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/e7a07ce4-f0a2-45b0-8211-8120b6c5c29d"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000232"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/e7cbb49d-ad5d-4097-bf3d-ab9fdc2eedfc -->

    <Class rdf:about="http://example.org/e7cbb49d-ad5d-4097-bf3d-ab9fdc2eedfc">
        <obo:IAO_0000115>We next assessed if iETV2-##ECs## could also be used to vascularize cerebral organoids (CO), and if presence of ECs would affect the localization of the different neural compartments. We thus generated PSC-derived COs and vascularized COs (eCOs; by allowing organoid formation from a mix of iETV2 and wild type PSCs; PSC:iETV2-hiPSC ratio = 8:2). To generate iETV2-ECs in situ, we activated the ETV2 transgene by addition on day 4 and 7, respectively, low and high concentrations of doxycycline for basal and full transgene activation (Figure  5A). Immunostaining of DIV35 eCO revealed CD31+ vascular structures and relatively smaller and scattered ventricular zones (VZ) (Figure 5B(ii)) in which the radial organization of SOX2+ cells (but not TUJ1+ cells) was less apparent than that of CO not containing ECs (Figure 5B(i)). We also embedded CO and eCO in matrigel alone or in iETV2-ECs laden matrigel. In matrigel alone, we observed VZ-like structures in the CO, however the SOX2+ cells were mostly found outside the VZ (indicated by asterisk; Figure 5B(iii)). In eCO, the radial organization of SOX2+ in VZ was more disrupted (Figure 5B(iv)), whereby the SOX2+ and TUJ1+ cells appeared to spread into the matrigel, and CD31+ cells were found mainly at the periphery. In iETV2-EC</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10837345</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38037510</oboInOwl:hasDbXref>
        <rdfs:label>ECs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000115"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/e7cbb49d-ad5d-4097-bf3d-ab9fdc2eedfc"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000115"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/e7d32e56-e87a-4315-a2e3-e4294bc0d6ad -->

    <Class rdf:about="http://example.org/e7d32e56-e87a-4315-a2e3-e4294bc0d6ad">
        <obo:IAO_0000115>Comparison of the single cell landscape between healthy human meniscus and degenerated meniscus. (A) Representative polarised light microscopy images of healthy human and degenerated meniscus. The white and red colours in the angle images are 90  apart in orientation. Dashed lines indicate the surface of the meniscus. Scale bar, 100 microm. (B) Merged t-distributed stochastic neighbour embedding (t-SNE) of single-cell RNA sequencing of healthy meniscus cells and degenerated meniscus cells. (C) Twelve healthy human and degenerated meniscus cell clusters at t-SNE. (D) Proportion of each cluster to the total cells. (E) Proportion of healthy and degenerated meniscus cells in each cluster. (F) Expression of representative marker genes in Vin plot. (G) Heatmap revealing the scaled expression of differentially expressed genes for each cluster. (H) CD146 and CD318 expression in healthy human meniscus cells and degenerated meniscus cells determined by flow cytometry. n&gt;=5, **p&lt;0.01. (I) Representative IHC staining of COL1A1 and COL2A1 healthy human meniscus and degenerated meniscus, and quantification of positive cells. Scale bar, 50 microm. n&gt;=5, **p&lt;0.01. (J) The expression of indicated marker genes in human healthy meniscus cells and degenerated meniscus cells were detected by qRT-PCR. *p&lt;0.05, **p&lt;0.01, otherwise, not significant. n=3, *p&lt;0.05, **p&lt;0.01. CPC, cartilage progenitor cells; DegP, degenerated meniscus progenitor cells; EC, endothelial cells; FC, fibrochondrocytes; ##FCP##, fibrochondrocyte progenitors; HTC, hypertrophic chondrocytes; MoDC, monocyte-derived dendritic cells; PreHTC, prehypertrophic chondrocytes; ProFC, proliferate fibrochondrocytes; RegC, regulatory chondrocytes.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7034356</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31871141</oboInOwl:hasDbXref>
        <rdfs:label>FCP</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000138"/>
        <skos:relatedMatch rdf:resource="CL:0011026"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/e7d32e56-e87a-4315-a2e3-e4294bc0d6ad"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000138"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/e7d32e56-e87a-4315-a2e3-e4294bc0d6ad"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0011026"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/e7dea7bf-aaf4-4f2a-a51b-6dee2313a5f8 -->

    <Class rdf:about="http://example.org/e7dea7bf-aaf4-4f2a-a51b-6dee2313a5f8">
        <obo:IAO_0000115>Combined evidence from immunohistochemistry (IHC), in situ hybridization (ISH), and high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS) indicates that ##extrahypothalamic gonadotropin-releasing hormone (GnRH) neurons## synthesize bona fide GnRH decapeptide derived from the GNRH1 transcript.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8245125</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34128468</oboInOwl:hasDbXref>
        <rdfs:label>extrahypothalamic gonadotropin-releasing hormone (GnRH) neurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0011111"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/e7dea7bf-aaf4-4f2a-a51b-6dee2313a5f8"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0011111"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/e7f501e3-e90f-4ef4-9041-deb43d43811e -->

    <Class rdf:about="http://example.org/e7f501e3-e90f-4ef4-9041-deb43d43811e">
        <obo:IAO_0000115>Establishing the left-right (LR) axis during early embryogenesis is critical for placement and patterning of the heart and visceral organs. In the mouse embryo, the first molecular evidence of LR asymmetry appears at the ventral LRO. The LRO contains two distinct cell types: the central cells, referred to as pit cells, and the outer cells referred to as ##crown cells##. Both cell types contain a single cilium on the ventral surface of the cell, but the pit cilia rotate whereas the crown cilia are immotile.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10314903</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37393374</oboInOwl:hasDbXref>
        <rdfs:label>crown cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000221"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/e7f501e3-e90f-4ef4-9041-deb43d43811e"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000221"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/e835d548-72b3-4618-bb9c-d5769bfa6f2a -->

    <Class rdf:about="http://example.org/e835d548-72b3-4618-bb9c-d5769bfa6f2a">
        <obo:IAO_0000115>Expression heterogeneity of CD8+ and CD4+ T cells in the OSCC ecosystem. (A) The t-distributed stochastic neighbor embedding (t-SNE) projection of T cells from cancerous tissue of patients with OSCC, showing the formation of 11 main clusters in different colors. The functional description of each cluster is determined by the gene expression characteristics. Cluster 0: resident memory CD8+ T Cells (C0_CD8+ TRM); Cluster 1: effector memory CD8+ T cells (C1_CD8+ TEM); Cluster 2: regulatory CD4+ T cells (C2_CD4+ Treg); Cluster 3: exhausted CD8+ T cells (C3_CD8+ T Exhausted); Cluster 4: effector memory M-phage CD8+ T cells (C4_CD8+ Mitotic TEM); Cluster 5: effector memory CD4+ T cells (C5_##CD4+ TEM##); Cluster 6: effector memory CD8+ T cells (C6_CD8+ TEM); Cluster 7: effector memory CD4+ T cells (C7_CD4+ TEM); Cluster 8: effector memory CD8+ T cells (C8_CD8+ TEM); Cluster 9: effector memory CD8+ T cells (C9_CD8+ TEM); Cluster 10: effector memory M-phage CD4+ T cells (C10_CD4+ Mitotic TEM); Cluster 11: effector memory CD8+ T cells (C11_CD8+ TEM); Cluster 12: effector memory CD8+ T cells (C12_CD8+ TEM); Cluster 13: gammadelta T. (B) Cell-Cycle Scoring of T cells from cancerous tissue of patients with OSCC, showing the three clusters of cells in different cell cycles in different colors. (C) Heatmap of key genes expressed in each cluster of CD8+ tumor-infiltrating lymphocytes (TILs) with cells grouped by clusters. The columns correspond to the cells; the rows correspond to the genes. Yellow: high expression; purple: low expression. Selected key markers are shown on the right. (D) Heatmap of key genes expressed in each cluster of CD4+ TILs with cells grouped by clusters. The columns correspond to the cells; the rows correspond to the genes. Yellow: high expression; purple: low expression. Selected key genes are shown on the right.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8024729</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33513276</oboInOwl:hasDbXref>
        <rdfs:label>CD4+ TEM</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000905"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/e835d548-72b3-4618-bb9c-d5769bfa6f2a"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000905"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/e854ed29-f98e-464b-9f28-af699c2dcf6f -->

    <Class rdf:about="http://example.org/e854ed29-f98e-464b-9f28-af699c2dcf6f">
        <obo:IAO_0000115>To understand the observed differential survival, we analyzed differentially expressed genes (DEGs) within the pre-defined ##terminally exhausted CD8-positive TIL## cluster versus all the other tumor infiltrating immune cell clusters. This analysis revealed co-expression of several genes associated with exhaustion, such as Lymphocyte Activating 3 (LAG3), TIM-3, T Cell Immunoreceptor With Ig And ITIM Domains (TIGIT), Programmed cell death protein 1 (PDCD1), CD39 (encoded by the ENTPD1 gene) and Cytotoxic T Lymphocyte Associated Protein 4 (CTLA4) ( Figure 4A , left). Genes associated with cytotoxicity, such as Granzyme B (GZMB), Natural Killer Cell Granule Protein 7 (NKG7), Interferon Gamma (IFNG), Granzyme A (GZMA), Granulysin (GNLY), TNF Receptor Superfamily Member 9 (TNFRSF9/4-1BB) and CD27 were likewise upregulated ( Figure 4A , left).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9633842</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36341460</oboInOwl:hasDbXref>
        <rdfs:label>terminally exhausted CD8-positive TIL</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000625"/>
        <skos:relatedMatch rdf:resource="CL:0011025"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/e854ed29-f98e-464b-9f28-af699c2dcf6f"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000625"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/e854ed29-f98e-464b-9f28-af699c2dcf6f"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0011025"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/e85d068d-d2f9-4f6e-81a3-bafa46d9e9b6 -->

    <Class rdf:about="http://example.org/e85d068d-d2f9-4f6e-81a3-bafa46d9e9b6">
        <obo:IAO_0000115>HH signaling has been reported to modulate cell proliferation in several contexts. We thus tested whether epithelial deletion of Shh might lead to tracheal epithelial cell proliferation defects. We examined epithelial cell proliferation first by immunostaining for Ki67, a cell cycle marker, and found that ShhCKO tracheae exhibited a reduced number of Ki67+ cells in the CDH1 marked epithelium compared with controls (Fig. 2H,I). Next, we performed an EdU incorporation assay to assess cells that had entered S-phase during the labeling period. After an ex vivo, 21 h long EdU treatment, ShhCKO tracheae displayed fewer EdU+ cells in their epithelium (Fig. 2J,K), indicating that Hedgehog inactivation compromises cell cycle entry. In a more-detailed analysis, we observed a reduced number of Ki67+SCGB1A1+ cells (Fig. 2L,M), but a similar number of PDPN+  and Ki67+PDPN+ basal cells  in ShhCKO tracheae compared with controls. Interestingly, ShhCKO tracheae exhibited increased ratios of KRT5+ basal cells to acetylated alpha-tubulin+ ciliated cells and to SCGB1A1+ club cells compared with controls . We did not find obvious alterations in caspase3 staining between ShhCKO tracheal epithelium and controls at E18.5, suggesting that apoptosis is not affected in the mutants . To examine for changes in the surrounding mesenchyme, we analyzed SOX9+ chondroblasts, alpha-SMA+ smooth muscle cells and mesenchymal cell proliferation. ShhCKO tracheae exhibited SOX9+ chondroblast condensation defects , but no obvious SOX9+ chondroblast differentiation defects . We also detected reduced numbers of alpha-SMA+ smooth muscle cells and increased numbers of CDH1-Ki67+ mesenchymal cells compared with controls . As HH signaling modulates Fgf10 expression in the lung mesenchyme, we examined Fgf10 mRNA expression levels in ShhCKO tracheae. We detected a 1.5-fold increase in Fgf10 mRNA in ShhCKO mutants  but this was not sufficient to increase basal cell number, as might have been expected from previous studies. Altogether, these results indicate that loss of Shh function reduces club cell proliferation and interferes with ciliated cell differentiation and ##secretory cell## maturation in the tracheal epithelium. In the tracheal mesenchyme, Shh promotes chondrocyte and smooth muscle morphogenesis.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8918789</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35112129</oboInOwl:hasDbXref>
        <rdfs:label>secretory cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:4052031"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/e85d068d-d2f9-4f6e-81a3-bafa46d9e9b6"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4052031"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/e86724a7-5b91-4716-88f3-94f6d68b1e0f -->

    <Class rdf:about="http://example.org/e86724a7-5b91-4716-88f3-94f6d68b1e0f">
        <obo:IAO_0000115>2.2. Proliferation of ##BCSCs## Was Inhibited after Chemotherapeutic Stress and Recovered Gradually</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7014166</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31936348</oboInOwl:hasDbXref>
        <rdfs:label>BCSCs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002451"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/e86724a7-5b91-4716-88f3-94f6d68b1e0f"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002451"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/e86811b9-057b-4158-af2d-179a240ba4f2 -->

    <Class rdf:about="http://example.org/e86811b9-057b-4158-af2d-179a240ba4f2">
        <obo:IAO_0000115>Downstream of the multipotent HSCs and MPPs, the original lineage bifurcation model strictly separated oligopotent Common Lymphoid Progenitors (CLP) from Common Myeloid Progenitors (CMP) which could further diverge into Megakaryocyte/Erythrocyte Progenitors (MEPs), Monocyte (Mo)/Dendritic cell (DC) Progenitors (MDPs) and Granulocyte/Mo Progenitors (GMPs). However, this model has been the subject of ongoing revision in the scRNA-seq era. On the one hand, a Lymphoid-primed MultiPotent Progenitor (LMPP) with combined lymphoid and myeloid potential has been shown to gradually lose myeloid potential by upregulating the interleukin-7 receptor alpha-chain (IL7Ralpha) and differentiate into Dach1- Lymphoid-Primed Progenitors (LPPs) prior to CLPs. On the other hand, erythroid-versus-myeloid fate decisions seem to be made prior to CMP commitment, calling for in-depth revision of all CMP progeny (MEPs, MDPs and GMPs) as well. While the Flt3L+CD115lo CMPs give rise to oligopotent MDPs, the Flt3-CD115- CMPs give rise to GMPs. The former are defined by TF co-expression of CEBPA, IRF8 and RUNX1. MDPs can give rise to IRF8/SATB1 plasmacytoid DC (pDC) Progenitors (pDCPs) and HLA-DR/IRF8/CEBPA Mo/conventional DC (cDC) Progenitors (McDPs). The latter bifurcate in CD11c/CD172ab/CD14 (human) or Ly6C+ Mo (mouse) or IRF8/HLA-DR/CD84/CD172ab Common DC Progenitors (CDPs). In contrast, GMPs (Kit, CD34, Sox4) are very heterogeneous at the transcriptomic and proteomic level and can adjust their functional output towards common Mo Progenitors (cMoP) and Granulocyte Progenitors (##GPs##).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11324509</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:39148724</oboInOwl:hasDbXref>
        <rdfs:label>GPs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000557"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/e86811b9-057b-4158-af2d-179a240ba4f2"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000557"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/e875ee1d-29c5-432d-9cc6-55cb6bc38fc6 -->

    <Class rdf:about="http://example.org/e875ee1d-29c5-432d-9cc6-55cb6bc38fc6">
        <obo:IAO_0000115>a Schematic overview of the experimental workflow. Forebrain samples were collected from Sox2eGFP mice at 11 developmental timepoints, dissociated into single cells followed by sorting of the GFP + ve /-ve cells and performing single-cell RNA-seq using the 10x Genomics Chromium platform. b Left: two-dimensional Uniform manifold approximation and progression (UMAP) plot with Leiden clustering of 102,504 individual cells identifying 28 transcriptionally and biologically distinct cell types (see Supplementary Fig. 3a and Methods). Each dot represents a single cell and colours correspond to the distinct clusters/cell types. Shown on the right is a dot plot showing the relative fraction (dot size) of the 28 cell types at each developmental timepoint normalized by library size. c UMAP plot of the cells as in (b) but coloured by timepoint. Each dot represents a single cell and the colours correspond to the different timepoints. d, UMAP plot showing the coarse annotation of cells into 4 categories (Neuronal, Glial, Immune and Vascular/other) based on logistic regression from Zeisel et al. 2018. The RNA-velocity field is overlaid on the UMAP. Colours represent the 4 categories of cell annotation and the arrows correspond to the direction of the RNA-velocity flow field (see Methods). RG Radial glia, TAPs Transient amplifying progenitors, aNSCs Active neural stem cells, APCs Astrocyte progenitor cells, EmNBs Embryonic neuroblasts, GE NBs Ganglionic eminence neuroblasts, OPCs Oligoprogenitor cells, PreM-ODCs ##Immature pre-myelinating oligodendrocytes##, INs Interneurons, ImStNeurons Immature striatal neurons, VLMC Vascular leptomeningeal cells, Myeloid-DSCs Myeloid-derived suppressor cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9296666</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35853870</oboInOwl:hasDbXref>
        <rdfs:label>Immature pre-myelinating oligodendrocytes</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002453"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/e875ee1d-29c5-432d-9cc6-55cb6bc38fc6"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002453"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/e880a6a5-7ef1-4cae-bf3e-901a341be78c -->

    <Class rdf:about="http://example.org/e880a6a5-7ef1-4cae-bf3e-901a341be78c">
        <obo:IAO_0000115>Community 3 contained information on the frequency of innate and adaptive immune cells (Figure 4A). Within the innate cellular compartment, the strongest correlations (Spearman) with GA were increasing frequencies of granulocytes and CD14+CD16- classical monocytes (cMCs) (Figures 4B, C), which are front-line defenders that rapidly respond to injury or infection. In term infants, granulocytes comprised the majority (58%) of immune cell subsets in cord blood, but at earlier GA the proportion of granulocytes falls (average 24.5% of live leukocytes in infants &lt;30 weeks GA) and T lymphocytes predominate (average 47.3% of live leukocytes in infants &lt;30 weeks, of which 64% are CD4+ T cells). In contrast, in the adaptive compartment, the strongest correlations with GA were decreasing frequencies of regulatory T cells (Treg) and CD161+ T cells, including the CD4+ and CD8+ subsets (Figures 4G-I). Treg cells [and possibly fetal CD161+CD4+ T cells ] are immune-regulatory cell subsets that can suppress antigen-specific T cell inflammatory responses. CD8+CD161+ T cells are enriched in mucosal associated invariant T (MAIT) cells that recognize riboflavin metabolites presented by MHC-related 1 (MR1) protein (although our assay did not include MR1 tetramers, which are necessary for the definitive identification of MAITs). Also decreasing in frequency with GA were Natural Killer (NK) T cells, which are enriched in ##invariant NK (iNK) T cells## with a limited T cell receptor (TCR) repertoire specific for lipid antigens presented by the non-classical MHC class I protein CD1d (Figures 4D-F). Together these findings indicate that at early GA the cellular composition of the neonatal immune system is characterized by deficiencies in innate cells involved in the acute response to infection or danger and a relative abundance of suppressor T cells and a reliance on nonconventional T-cell populations with restricted TCR repertoires directed to non-peptide antigens.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8420969</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34497610</oboInOwl:hasDbXref>
        <rdfs:label>invariant NK (iNK) T cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000921"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/e880a6a5-7ef1-4cae-bf3e-901a341be78c"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000921"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/e8aff693-d1fb-45c3-8bfb-3aec32f4c418 -->

    <Class rdf:about="http://example.org/e8aff693-d1fb-45c3-8bfb-3aec32f4c418">
        <obo:IAO_0000115>Translatome analysis with RiboTag reveals cell type-specific responses in HD. A HdhQ7/Q200 mice homozygous for RiboTag were crossed with homozygous Cre-driver lines to facilitate cell type-specific expression of Rpl22-HA in glutamatergic (vGluT2+) and GABAergic (Gad2+) neurons in the cerebellum and cerebrum, and ##parvalbumin (PV+)-expressing neurons in the cerebrum##. Cerebellum and cerebrum (without olfactory bulb) were separated and flash frozen at 9 months. For RiboTag IPs, cell type-specific HA-tagged ribosomes were immunoprecipitated from tissue homogenate using anti-HA antibody bound to magnetic beads. Total RNA was prepared from an aliquot of the same tissue homogenate. B Expression levels of Htt mRNA were slightly reduced in all cell types, significantly in cerebral vGluT2+ and PV+ neurons (* FDR &lt;= 0.05; ** FDR &lt;= 0.01; *** FDR &lt;= 0.001). C HD-typical genes showed downregulation in cerebral cell types. D Differentially expressed genes (DEGs) (FDR &lt;= 0.05) for each cell type. E Top five significantly enriched terms (FDR &lt;= 0.05) among DEGs reveal cell type-specific responses to mHtt</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9854201</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36670467</oboInOwl:hasDbXref>
        <rdfs:label>parvalbumin (PV+)-expressing neurons in the cerebrum</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:4023018"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/e8aff693-d1fb-45c3-8bfb-3aec32f4c418"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4023018"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/e8cb4b15-e90f-4254-b7ab-57abd6336399 -->

    <Class rdf:about="http://example.org/e8cb4b15-e90f-4254-b7ab-57abd6336399">
        <obo:IAO_0000115>The above presented results indicate that the enhanced intestinal abundance of B. vulgatus leads to an increase in regulatory/anti-inflammatory CD4+ T cell subsets whereas higher numbers of E. coli promote differentiation of pro-inflammatory CD4+ T cells in an immune-compromised host with a presumably dysbiotic microbiota. However, a differential activation of DCs by the two commensals could not be clearly observed in these mice. To directly link our in vitro results with those obtained in the model of T cell transfer colitis, we collected fecal samples from representative Rag1-/- mice with a presumably dysbiotic microbiota (DYS) prior to bacterial administration and from T cell transplanted mice with or without commensal enrichment after development of colitis (DYS + TC, DYS + TC + BV, DYS + TC + EC). Heat-inactivated fecal samples were then used to stimulate WT BMDCs ( Figure 7A ). Increased abundance of E. coli induced significantly higher Nfkbiz gene expression ( Figure 7B ) and IkappaBzeta-protein levels ( Figure 7C ) than all the other microbiota. However, we did not observe a significant increase in the secretion of pro-inflammatory cytokines in response to DYS + TC + EC- stimulation as compared to DYS+TC ( Figure 7D ). Rather, 4 h stimulation of ##BMDC## with DYS + TC + BV decreased the secretion of pro-inflammatory cytokines, with a slight but not significant decrease of secreted IL-6, and a significant lower secretion of IL-23 compared to DYS + TC or DYS + TC + EC. The levels of IL-10 decreased as a result of T cell transfer.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7851057</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33542719</oboInOwl:hasDbXref>
        <rdfs:label>BMDC</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000451"/>
        <skos:relatedMatch rdf:resource="CL:0002092"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/e8cb4b15-e90f-4254-b7ab-57abd6336399"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000451"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/e8cb4b15-e90f-4254-b7ab-57abd6336399"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002092"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/e97e7ce6-379f-42e0-9ade-5c3ff5fd7a59 -->

    <Class rdf:about="http://example.org/e97e7ce6-379f-42e0-9ade-5c3ff5fd7a59">
        <obo:IAO_0000115>(A and B) Isolated CD4+ TILs were stimulated in vitro with PMA/ionomycin and stained and analyzed by flow cytometry. (A) Top left dot plot shows PD-1 versus CD39 expression in CD4 Tconvs. IFN-gamma versus TNF-alpha expression is shown in the indicated CD4 Tconv populations. Proportions of cytokine+ (IFN-gamma and/or TNF-alpha; bottom left) and TNF-alpha+IFN-gamma-, TNF-alpha-IFN-gamma+, and TNF-alpha+IFN-gamma+ cells in PD-1-CD39-, PD-1loCD39-, PD-1hiCD39-, and PD-1hiCD39+ subsets and according to TIM-3 expression (n = 8). (B) Dot plots show CD39 versus IFN-gamma or TNF-alpha in CD4 Tconvs. Numbers in dot plots correspond to MFI of cytokine staining. MFI of IFN-gamma and TNF-alpha staining in IFN-gamma+ and TNF-alpha+ cells, respectively, are summarized for Tconv subpopulations defined as in A (n = 8). Samples in A and B are shown according to the proportion of TIM-3+ cells among PD-1hiCD39+ CD4 Tconv (&lt;50% TIM-3+, square; &gt;=50% TIM-3+, triangle; unknown, round) (C) CD4 Tconv TIL subsets PD-1-CD39- (gray), PD-1loCD39- (green), PD-1hiCD39- (blue), and PD-1hiCD39+ (red) were sorted, expanded in vitro for 10 days, and restimulated or not with PMA/ionomycin overnight. TNF-alpha and IFN-gamma secretion was quantified by CBA in the supernatant (n = 5). (D) Isolated CD4+ TILs were stained ex vivo and analyzed by flow cytometry. Proportions of TOX+ cells in each Tconv subset are summarized (n = 10). Data are presented as mean +- SD. **P &lt; 0.01; ***P &lt; 0.001; ****P &lt; 0.0001. P values were determined using the Wilcoxon (A and B) and 2-tailed paired t tests (D). Bonferroni&apos;s correction was applied to account for multiple testing in D and significance level was adjusted accordingly (*P &lt; 0.0083; **P &lt; 0.00166; ***P &lt; 0.000166). Tconvs, conventional FOXP3- CD4 T cells; CBA, cytometric bead array; TILs, ##tumor-infiltrating lymphocytes##.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7934837</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33332284</oboInOwl:hasDbXref>
        <rdfs:label>tumor-infiltrating lymphocytes</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000542"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/e97e7ce6-379f-42e0-9ade-5c3ff5fd7a59"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000542"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/e992c6ca-e296-4847-b647-705016f72ad5 -->

    <Class rdf:about="http://example.org/e992c6ca-e296-4847-b647-705016f72ad5">
        <obo:IAO_0000115>a Line drawing of a cross section of the floor of the cochlear duct at P1. Distinct cell types within the organ of Corti (OC) are color coded. b Heat map for ~14,000 cochlear cells collected from four separate experiments at P1. Top 25 differentially expressed (DE) genes for the 15 identified clusters are shown. Cellular identity for each cluster is indicated by a color bar at the top of the heat map, which corresponds to the legend in a, and by a cell name at the bottom. c tSNE plot for the same cells as in b. Cluster identities are indicated. d Violin plots showing normalized log-transformed expression values for the top five DE genes for each cell type (color coded as in c) by comparison with all other P1 cells (gray on the right in each graph). Bars indicate median expression level. e Upper left panel, tSNE plot of cells determined to be derived from KO (between the OC and medial edge of the cochlear duct). Lower left panel, feature plot for the same cells as in the upper panel indicating high expression of Otoa, Calb1, and Fabp7 (based on color) in different clusters of cells. Lower right panel, cross sections through the cochlear duct at P1, illustrating expression of CALB1 in the medial region of KO and FABP7 directly adjacent to the OC (arrow; scale bars, 20 mum). Lowest panel shows high-magnification view of expression of FABP7 (arrow, gray scale) at the lateral KO border (green line; scale bar, 10 mum). Upper right panel, summary diagram of the spatial distribution of KO cell clusters at P1. HC hair cells, IPhC inner phalangeal cells/border cells, IPC inner pillar cells, OPC outer pillar cells, DC1/2 Deiters&apos; cells rows 1 and 2, DC3, Deiters&apos; cells row 3, HeC Hensen&apos;s cells, CC/OSC Claudius cells/outer sulcus cells, IdC interdental cells, ISC inner sulcus cells, ##KO## Kolliker&apos;s organ cells, L.KO lateral Kolliker&apos;s organ cells, M.KO medial Kolliker&apos;s organ cells, OC90 OC90+ cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7221106</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32404924</oboInOwl:hasDbXref>
        <rdfs:label>KO</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002490"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/e992c6ca-e296-4847-b647-705016f72ad5"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002490"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/ea1ea933-5f5b-411e-a100-ce8920d750cc -->

    <Class rdf:about="http://example.org/ea1ea933-5f5b-411e-a100-ce8920d750cc">
        <obo:IAO_0000115>Previous work revealed that GM-CSF cultured ##BMDCs## are a heterogeneous myeloid cell population consisting of bona fide DCs (termed &quot;GM-DC&quot;) and a minor fraction of macrophage-like CD11c+ MHCII+ cells (termed &quot;GM-Mac&quot;). When we refined our flow cytometric analysis for distinguishing GM-DCs and GM-Macs in BMDC cultures, we found a clear shift between both cell populations in 3xGrk -/- BMDC cultures. Among CD11c+ MHCII+ cells, the fraction of GM-DCs was decreased, whereas GM-Macs were markedly increased in both unstimulated and LPS-stimulated 3xGrk -/- GM-CSF cultures ( Figure 5E ). Importantly, the remaining bona fide GM-DCs, which still developed in 3xGrk -/- cultures, also showed reduced expression of CCR7, MHCII and CD40 ( Figure 5F ). Together, these findings provide an explanation for the two observed phenotypes of 3xGrk -/- cells in the under-agarose chemotaxis assays; (a) less responding cells, because GM-Macs do not migrate to CCL19, and (b) reduced displacement of the responding cells, because the remaining bona fide GM-DCs remain lowered in CCR7-expression. Additionally, we noticed that not only DCs derived from GM-CSF cultures showed an altered phenotype, but also DC development in the presence of Flt3 ligand was impaired. In particular, the number of CD11b- DCs was strongly reduced, whereas the CD11b+ DC population was not significantly altered ( Supplementary Figure 3A ).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9703078</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36451830</oboInOwl:hasDbXref>
        <rdfs:label>BMDCs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000451"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/ea1ea933-5f5b-411e-a100-ce8920d750cc"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000451"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/ea43b0cd-f405-4060-8d23-000eec513f5d -->

    <Class rdf:about="http://example.org/ea43b0cd-f405-4060-8d23-000eec513f5d">
        <obo:IAO_0000115>Individuals with 46,XX/XY chimerism can display a wide range of characteristics, varying from hermaphroditism to complete male or female, and can display sex chromosome chimerism in multiple tissues, including the gonads. The gonadal tissues of females contain both granulosa and germ cells. However, the specific sex chromosome composition of the granulosa and germ cells in 46,XX/XY chimeric female is currently unknown. Here, we reported a 30-year-old woman with secondary infertility who displayed a 46,XX/46,XY chimerism in the peripheral blood. FISH testing revealed varying degrees of XX/XY chimerism in multiple tissues of the female patient. Subsequently, the patient underwent preimplantation genetic testing (PGT) treatment, and 26 oocytes were retrieved. From the twenty-four biopsied mature oocytes, a total of 23 first polar bodies (PBs) and 10 second PBs were obtained. These PBs and two immature metaphase I (MI) oocytes only displayed X chromosome signals with no presence of the Y, suggesting that all oocytes in this chimeric female were of XX germ cell origin. On the other hand, granulosa cells obtained from individual follicles exhibited varied proportions of XX/XY cell types, and six follicles possessed 100% XX or XY granulosa cells. A total of 24 oocytes were successfully fertilized, and 12 developed into blastocysts, where 5 being XY and 5 were XX. Two blastocysts were transferred with one originating from an oocyte aspirated from a follicle containing 100% ##XY granulosa cells##. This resulted in a twin pregnancy. Subsequent prenatal diagnosis confirmed normal male and female karyotypes. Ultimately, healthy boy-girl twins were delivered at full term. In summary, this 46,XX/XY chimerism with XX germ cells presented complete female, suggesting that germ cells may exert a significant influence on the sexual determination of an individual, which provide valuable insights into the intricate processes associated with sexual development and reproduction.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMID:38420683</oboInOwl:hasDbXref>
        <rdfs:label>XY granulosa cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000501"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/ea43b0cd-f405-4060-8d23-000eec513f5d"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000501"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/ea561df2-1830-4a9c-a5e4-1a76dd266f18 -->

    <Class rdf:about="http://example.org/ea561df2-1830-4a9c-a5e4-1a76dd266f18">
        <obo:IAO_0000115>Overview of interactions among chondrocyte subtypes. (A,B) Total number and intensity of interactions in chondrocytes. (C-J) Interactions between different subtypes of chondrocytes. (C) indicates undefined cell subtypes, (D) indicates ECs, (E) indicates FCs, (F) indicates HomCs, (G) indicates HTCs, (H) indicates ##preHTCs##, (I) indicates ProCs, and (J) indicates RegCs.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10475121</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37660146</oboInOwl:hasDbXref>
        <rdfs:label>preHTCs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000743"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/ea561df2-1830-4a9c-a5e4-1a76dd266f18"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000743"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/ea5fd1ad-6d48-4366-b3e2-044a3d3fe85e -->

    <Class rdf:about="http://example.org/ea5fd1ad-6d48-4366-b3e2-044a3d3fe85e">
        <obo:IAO_0000115>In summary, ##Scgb1a1+ cell## loss induces widespread cellular activation with immediate proliferation of several populations in the lung rather than triggering a specific cell type. Among the dividing cells were goblet, basal-goblet, and AT2-primed club cell populations, which might represent progenitors or intermediate cell states in the distal lung.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10933319</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38472236</oboInOwl:hasDbXref>
        <rdfs:label>Scgb1a1+ cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002638"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/ea5fd1ad-6d48-4366-b3e2-044a3d3fe85e"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002638"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/ea63ddfd-6eb7-4f4f-b446-a0b6476c2656 -->

    <Class rdf:about="http://example.org/ea63ddfd-6eb7-4f4f-b446-a0b6476c2656">
        <obo:IAO_0000115>(A and B) Isolated CD4+ TILs were stimulated in vitro with PMA/ionomycin and stained and analyzed by flow cytometry. (A) Top left dot plot shows PD-1 versus CD39 expression in CD4 Tconvs. IFN-gamma versus TNF-alpha expression is shown in the indicated CD4 Tconv populations. Proportions of cytokine+ (IFN-gamma and/or TNF-alpha; bottom left) and TNF-alpha+IFN-gamma-, TNF-alpha-IFN-gamma+, and TNF-alpha+IFN-gamma+ cells in PD-1-CD39-, PD-1loCD39-, PD-1hiCD39-, and PD-1hiCD39+ subsets and according to TIM-3 expression (n = 8). (B) Dot plots show CD39 versus IFN-gamma or TNF-alpha in CD4 Tconvs. Numbers in dot plots correspond to MFI of cytokine staining. MFI of IFN-gamma and TNF-alpha staining in IFN-gamma+ and TNF-alpha+ cells, respectively, are summarized for Tconv subpopulations defined as in A (n = 8). Samples in A and B are shown according to the proportion of TIM-3+ cells among PD-1hiCD39+ CD4 Tconv (&lt;50% TIM-3+, square; &gt;=50% TIM-3+, triangle; unknown, round) (C) ##CD4 Tconv TIL## subsets PD-1-CD39- (gray), PD-1loCD39- (green), PD-1hiCD39- (blue), and PD-1hiCD39+ (red) were sorted, expanded in vitro for 10 days, and restimulated or not with PMA/ionomycin overnight. TNF-alpha and IFN-gamma secretion was quantified by CBA in the supernatant (n = 5). (D) Isolated CD4+ TILs were stained ex vivo and analyzed by flow cytometry. Proportions of TOX+ cells in each Tconv subset are summarized (n = 10). Data are presented as mean +- SD. **P &lt; 0.01; ***P &lt; 0.001; ****P &lt; 0.0001. P values were determined using the Wilcoxon (A and B) and 2-tailed paired t tests (D). Bonferroni&apos;s correction was applied to account for multiple testing in D and significance level was adjusted accordingly (*P &lt; 0.0083; **P &lt; 0.00166; ***P &lt; 0.000166). Tconvs, conventional FOXP3- CD4 T cells; CBA, cytometric bead array; TILs, tumor-infiltrating lymphocytes.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7934837</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33332284</oboInOwl:hasDbXref>
        <rdfs:label>CD4 Tconv TIL</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000624"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/ea63ddfd-6eb7-4f4f-b446-a0b6476c2656"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000624"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/ea6b7f4d-03d9-4b4b-ab75-6e28b402e4dc -->

    <Class rdf:about="http://example.org/ea6b7f4d-03d9-4b4b-ab75-6e28b402e4dc">
        <obo:IAO_0000115>Previous work revealed that GM-CSF cultured BMDCs are a heterogeneous myeloid cell population consisting of bona fide DCs (termed &quot;##GM-DC##&quot;) and a minor fraction of macrophage-like CD11c+ MHCII+ cells (termed &quot;GM-Mac&quot;). When we refined our flow cytometric analysis for distinguishing GM-DCs and GM-Macs in BMDC cultures, we found a clear shift between both cell populations in 3xGrk -/- BMDC cultures. Among CD11c+ MHCII+ cells, the fraction of GM-DCs was decreased, whereas GM-Macs were markedly increased in both unstimulated and LPS-stimulated 3xGrk -/- GM-CSF cultures ( Figure 5E ). Importantly, the remaining bona fide GM-DCs, which still developed in 3xGrk -/- cultures, also showed reduced expression of CCR7, MHCII and CD40 ( Figure 5F ). Together, these findings provide an explanation for the two observed phenotypes of 3xGrk -/- cells in the under-agarose chemotaxis assays; (a) less responding cells, because GM-Macs do not migrate to CCL19, and (b) reduced displacement of the responding cells, because the remaining bona fide GM-DCs remain lowered in CCR7-expression. Additionally, we noticed that not only DCs derived from GM-CSF cultures showed an altered phenotype, but also DC development in the presence of Flt3 ligand was impaired. In particular, the number of CD11b- DCs was strongly reduced, whereas the CD11b+ DC population was not significantly altered ( Supplementary Figure 3A ).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9703078</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36451830</oboInOwl:hasDbXref>
        <rdfs:label>GM-DC</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000451"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/ea6b7f4d-03d9-4b4b-ab75-6e28b402e4dc"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000451"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/eaa03fa3-490c-4e11-8ddd-7f7ec00d57fa -->

    <Class rdf:about="http://example.org/eaa03fa3-490c-4e11-8ddd-7f7ec00d57fa">
        <obo:IAO_0000115>Although the exact etiology of OLP remains largely unknown, accumulating evidence suggests that keratinocyte destruction mediated by hyper-activated T lymphocytes is a crucial step for OLP pathogenesis. Aberrant expression or unmasking of keratinocyte antigen may cause the initial inflammatory status of OLP. Subsequently, T lymphocytes (predominately CD8+ cells, but some CD4+ cells) invade the epithelium, and CD4+ T helper (Th) cells trigger the activation of CD8+ cytotoxic T lymphocytes (CTLs), causing the excessive production of pro-inflammatory cytokines and the apoptosis of ##basal keratinocytes##.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10669845</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38002328</oboInOwl:hasDbXref>
        <rdfs:label>basal keratinocytes</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002187"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/eaa03fa3-490c-4e11-8ddd-7f7ec00d57fa"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002187"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/eaeb2992-4a38-439c-b09a-6839a7b7c68b -->

    <Class rdf:about="http://example.org/eaeb2992-4a38-439c-b09a-6839a7b7c68b">
        <obo:IAO_0000115>Transcriptomic data were used for correlation analysis between human in vivo fetal yolk sac (YS) hematopoietic clusters (YS_EC, endothelial cells; YS_Mac, macrophages; and YS_YSMP1,2, ##myeloid-biased progenitors##) and PD-L1 WT hematopoietic cell populations (PD-L1_EC, endothelial cells; MC/Mphis, monocyte/macrophages; CMPs, common myeloid progenitors; and granulocytes).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10638094</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37949473</oboInOwl:hasDbXref>
        <rdfs:label>myeloid-biased progenitors</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002354"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/eaeb2992-4a38-439c-b09a-6839a7b7c68b"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002354"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/eb3d27a3-f14f-4a5e-bbcc-2ce727fe4f53 -->

    <Class rdf:about="http://example.org/eb3d27a3-f14f-4a5e-bbcc-2ce727fe4f53">
        <obo:IAO_0000115>In our next analysis, we examined how ARGs impacted the prognosis of patients with pancreatic cancer. As autophagy is correlated with immune cell infiltration and immune cell infiltration has been linked to cancer development and prognosis, we used CIBERSORT to compare the abundance of 22 immune cell types between the high- and low-risk groups in TCGA-PAAD (Fig. 8A-B). A total of six immune cells were found to show varying degrees of infiltration between the two groups with respect to the 22 types that were studied: the infiltration levels of naive B cells (p = 0.003) and plasma cells (p = 0.044) were higher in the low-risk group, and the infiltration levels of memory CD4 T cells (p = 0.016), resting NK cells (p = 0.025), M2 macrophages (p = 0.020) and mast cells (p = 0.007) were higher in the high-risk group. In addition, the CD8 T-cell infiltration level was nearly significantly lower in the high-risk group (p = 0.080). The immune infiltration landscape is summarized in a radar plot in Fig. 8B. Additionally, the correlation between the risk score and the infiltration of the seven immune cells was investigated by Spearman correlation analysis. According to our results, the infiltration levels of naive B cells (r = -0.29, p &lt; 0.001, Fig. 8C), M2 macrophages (r = 0.19, p = 0.033, Fig. 8D), mast cells (r = 0.20, p = 0.019, Fig. 8E), CD8 T cells (r = -0.24, p &lt; 0.001, Fig. 8F) and ##NK resting cells## (r = 0.20, p = 0.022, Fig. 8G) were statistically correlated with the ARG risk scores.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9054801</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35488119</oboInOwl:hasDbXref>
        <rdfs:label>NK resting cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000824"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/eb3d27a3-f14f-4a5e-bbcc-2ce727fe4f53"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000824"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/eb4d51ee-cbe1-44a6-95eb-39c8ee538a1c -->

    <Class rdf:about="http://example.org/eb4d51ee-cbe1-44a6-95eb-39c8ee538a1c">
        <obo:IAO_0000115>The TIME is composed of various immune cells with diverse functions. These immune cells can distribute in clusters, interspersed within tumor cells or surrounding tumor margins in response to tumor-intrinsic or extrinsic signals. Analysis of cell composition, spatial distribution, functional and transcriptional analysis provides an archetypal classification of the TIME, which dictates the vulnerability of the tumors to different immunotherapeutic strategies. Compelling evidence has linked these functional classifications of TIME to treatment responses and clinical outcomes. Moreover, a detailed analysis of tumor-infiltrating immune cell subtypes provides additional indicators for patient prognosis. For instance, higher levels of estimated effector T cell fractions are generally correlated with better survival, while increasing levels of myeloid populations are primarily associated with poorer survival. On the other hand, ##tumor-associated M2 macrophages## predict worse outcomes as opposed to pro-inflammatory M1 macrophages. These prognostic landscapes of individual immune cell types within the TIME highlight the importance of understanding the fundamental regulatory mechanisms that delineate the complexity of cell composition, mediate functional plasticity and tip the balance between anti-tumor and pro-tumor immunities to affect clinical outcomes.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9832644</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36627707</oboInOwl:hasDbXref>
        <rdfs:label>tumor-associated M2 macrophages</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000890"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/eb4d51ee-cbe1-44a6-95eb-39c8ee538a1c"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000890"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/eb5ab583-e150-4996-97e5-805049d75b03 -->

    <Class rdf:about="http://example.org/eb5ab583-e150-4996-97e5-805049d75b03">
        <obo:IAO_0000115>To test the pathological relevance of ##HPVCs## and derived valvular cells, we used a patient-specific iPS cell model. iPS cells were derived from valvular interstitial cells (VICs) isolated from the explanted mitral valve of a patient harboring a mutation in Dachsous gene (DCHS1) a likely cause for mitral valve prolapse. In contrast to primary VIC culture, which is limited by the number of passages, iPS cells provide a means to recapitulate the stepwise determination of distinct endocardial, valve endothelial, and valve interstitial cell phenotypes. HiPS cells allow replication of separate differentiation experiments both with HPVCs/VECs and VICs. Patient-derived hiPs cells expressed OCT4, SOX2 and NANOG (Fig. 5a). DNA sequencing confirmed that the patient-specific DCHS1 mutation c-6988C&gt;T was conserved (Fig. 5b) and digital PCR of copy number variants of main recurrent abnormalities loci found in pluripotent stem cells (http://www.stemgenomics.com/) revealed that genomic integrity was conserved. Using directed differentiation protocols, cells were capable of differentiation into the three germ layers following treatment with specific morphogens as shown by expression of SOX17, and FOXA2 (endoderm), BRACHYURY (T) and MIXL1, (mesoderm), and NESTIN and PAX6 (ectoderm) (Fig. 5c).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6486645</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31028265</oboInOwl:hasDbXref>
        <rdfs:label>HPVCs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:4030033"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/eb5ab583-e150-4996-97e5-805049d75b03"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4030033"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/eb67279b-4c21-4f69-9af9-cfc0b706599c -->

    <Class rdf:about="http://example.org/eb67279b-4c21-4f69-9af9-cfc0b706599c">
        <obo:IAO_0000115>This evolution generated the need to unify the nomenclature and refine the concepts that precisely define astrocyte heterogeneity by using a systematic approach to contextualize the contribution of astrocytes to CNS disorders. Recent studies have proposed that mouse astrocytes have two discrete pathological conditions: The A1 neurotoxic phenotype when exposed to specific cytokines secreted by activated microglia and the A2 neuroprotective phenotype when exposed to an experimental paradigm mimicking ischemic stroke. However, this binary polarization should be approached cautiously since more recent studies recommend moving beyond the A1-##A2## classification. Indeed, only a subset of mixed A1 and A2 or pan-reactive transcripts are up-regulated in astrocytes of human patients or mouse models of chronic diseases or acute CNS injuries. Moreover, advanced multidimensional data and the co-clustering statistical approach revealed that the A1 and A2 transcriptomes represent only two of the many potential astrocyte transcriptomes. As transcriptomic data are a fundamental tool used to characterize the functional diversity of reactive astrocytes, a multidimensional analysis should be applied to establish the uniqueness of astrocyte phenotypes.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8945600</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35327542</oboInOwl:hasDbXref>
        <rdfs:label>A2</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000127"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/eb67279b-4c21-4f69-9af9-cfc0b706599c"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000127"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/eb87c748-7137-46d9-8ede-8288c374e608 -->

    <Class rdf:about="http://example.org/eb87c748-7137-46d9-8ede-8288c374e608">
        <obo:IAO_0000115>(B-D) Gating the ISL1+PDGFRalpha+ MCPs (day 3; B), the ISL1+Lin+ cardiac intermediates (day 6; C), and the ISL1-Lin+ differentiated cardiac cells (day 10; D). The plots of cells stained with isotype controls are also shown, respectively. CI, cardiomyocyte intermediate; CM, cardiomyocyte; EC, endothelial cell; EI, endothelial intermediate; MCP, multipotent cardiac progenitor; PI, pacemaker intermediate; PM, pacemaker cell; SMC, smooth muscle cell; SMI, ##smooth muscle## intermediate.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7887647</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33644774</oboInOwl:hasDbXref>
        <rdfs:label>smooth muscle</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000514"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/eb87c748-7137-46d9-8ede-8288c374e608"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000514"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/eb8eb0c1-cee9-4021-a3a9-bb1ee86725cc -->

    <Class rdf:about="http://example.org/eb8eb0c1-cee9-4021-a3a9-bb1ee86725cc">
        <obo:IAO_0000115>Nrk disruption in homozygous mutant led to a defect in adrenergic phenotype acquisition in the adrenal chromaffin cells. (A) Immunostaining of transverse sections through the adrenal region of E18.75 mouse embryos in wild type and Nrk mutant mice, showing TH (green) and PNMT (magenta) immunoreactivity. (A-C) Is from a wild type E18.75 mouse. (D-F) Show a section from an Nrk-het mutant mouse. (G-I) Is from an Nrk-null mutant mouse. The prevertebral suprarenal ganglia and the adrenal glands are outlined in a solid line and dashed line respectively, based on bisbenzimide (BB, cyan) staining (A,D,G). (J) Loss of Nrk reduces the proportion of adrenergic chromaffin cell in the adrenal glands. The number of ##TH+ noradrenergic adrenal chromaffin cells## and their PNMT+ adrenergic subpopulation cells were counted in sections from wild-type, Nrk-het and Nrk-null (both Nrk-/- female and Nrk-/Y male) mutant mice with n = 4. The proportion of PNMT+ adrenergic chromaffin cells were calculated by number of PNMT+ (adrenergic) cells/number PNMT-, TH+ (noradrenergic) adrenal chromaffin cells and shown here as mean proportion +- SEM along with individual measures for each embryo. (K) Growth fractions for adrenergic chromaffin cells, noradrenergic chromaffin cells and sympathetic neurons were examined using Ki67 immunostaining for cycling cells in and calculated as proportion of total cells of each type.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6408553</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:30850723</oboInOwl:hasDbXref>
        <rdfs:label>TH+ noradrenergic adrenal chromaffin cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002083"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/eb8eb0c1-cee9-4021-a3a9-bb1ee86725cc"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002083"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/ebcc7177-2f89-4ee9-a8b9-f7204a7bedaf -->

    <Class rdf:about="http://example.org/ebcc7177-2f89-4ee9-a8b9-f7204a7bedaf">
        <obo:IAO_0000115>A key result of our study is the presence of Cplx 2 and the most likely absence of Cplx 1 in conventional chemical synapses of normal and displaced amacrine cells (Figure 2, Figure 6, Figure 8 and Figure 10). Cplx 2 (protein and mRNA) was found in GABAergic, cholinergic and dopaminergic amacrine cells but not in glycinergic amacrine cells (Figure 6 and Figure 10), which contain Cplx 3. The glutamatergic vGluT3 amacrine cells also contained no Cplx 2 (Figure 7 and Figure 10). ##VGluT3 amacrine cells## represent an unconventional type of amacrine cell with dual release of glycine and glutamate at segregated synaptic sites. It is suggested that the release of an inhibitory and an excitatory neurotransmitter into two separate neuronal circuits by the vGluT3 amacrine cells facilitates differential detection of visual field uniformity and contrast. As Cplx 3 is found in glycinergic amacrine cells and glutamatergic rod bipolar cells, we analyzed its presence in vGluT3 amacrine cells. We could not detect Cplx 3 in these retinal interneurons, just as we could not detect Cplx 4 in vGluT3 amacrine cells (Figure 7). The absence of Cplxs 1 to 4 from vGluT3 amacrine cells suggests a Cplx-independent release of neurotransmitters. Likewise, for the auditory sensory cells of the cochlea, the inner hair cells, it has been suggested that they release glutamate at their ribbon synapses independent of neuronal SNARE proteins and SNARE regulators, such as Cplxs and synaptotagmins.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8348166</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34360929</oboInOwl:hasDbXref>
        <rdfs:label>VGluT3 amacrine cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000561"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/ebcc7177-2f89-4ee9-a8b9-f7204a7bedaf"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000561"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/ebffb94d-0a89-4b82-b537-f07acb234872 -->

    <Class rdf:about="http://example.org/ebffb94d-0a89-4b82-b537-f07acb234872">
        <obo:IAO_0000115>Expression patterns of pCMV-SpCas9-RFP and pVMD2-SpCas9-RFP in human retinal organoids. (a) RPE characteristics of pigmentation and hexagonality were confirmed in a 3D sphere and 2D monolayer status (b) Retinal organoids express various retinal markers being appropriate to normal developmental stages. A bright-field image and fluorescent image of the human retinal organoid are displayed in pairs (c,d; e,f). (c,d) The pCMV vector expressed RFP both in the RPE and neural retina; (e,f) whereas the pVMD2 vector expressed RFP only in RPE [c,e = bright-field image; d,f = fluorescent image]. Each protein marks specific structure or cell types as follows: ZO-1: Tight junction; SOX2: Neural progenitor cell; RX: Retinal progenitor cell; CRX: Photoreceptor progenitor cell; Recoverin: Photoreceptor precursor cell; CHX10: Neural retinal progenitor cell; SNCG: Retinal ganglion cell; Ki67: Proliferating cell; RxRgamma: ##Cone precursor cell##; CRALBP: Muller glia cell; Rhodopsin: Rod photoreceptor cell; M/L opsin: M/L cone photoreceptor.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9988861</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36878916</oboInOwl:hasDbXref>
        <rdfs:label>Cone precursor cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000573"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/ebffb94d-0a89-4b82-b537-f07acb234872"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000573"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/ec030724-e580-47d9-a397-7a14886cac1a -->

    <Class rdf:about="http://example.org/ec030724-e580-47d9-a397-7a14886cac1a">
        <obo:IAO_0000115>Macrophages, which are immune cells with heterogeneous phenotypes and complex functions, can be divided into circulating and resident macrophages. Primitive hematopoiesis is a source of macrophages in embryos, and the majority of resident macrophages originate from yolk sac erythro-myeloid progenitors. Bone-BM macrophages, synovial macrophages, and microglia play a key role in maintaining tissue homeostasis; phagocytosis and removal of cellular debris and foreign substances; tissue repair, regeneration, and remodeling; and the development and resolution of inflammation. Under physiological conditions, the bone-BM contains multiple different resident macrophage populations, including osteal macrophages, hematopoietic stem cell niche macrophages, and ##erythroblast island macrophages##. Macrophages have remarkable plasticity that allows them to respond efficiently to environmental signals and change their phenotypes.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9226340</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35757427</oboInOwl:hasDbXref>
        <rdfs:label>erythroblast island macrophages</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
        <skos:relatedMatch rdf:resource="CL:0000765"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/ec030724-e580-47d9-a397-7a14886cac1a"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/ec030724-e580-47d9-a397-7a14886cac1a"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000765"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/ec56ded5-5b46-43b8-ae8d-e612d79b03eb -->

    <Class rdf:about="http://example.org/ec56ded5-5b46-43b8-ae8d-e612d79b03eb">
        <obo:IAO_0000115>Tumor progression depends not only on the intrinsic hallmarks of cancer cells but also on the formation of a milieu that escapes immune surveillance. Regulatory immune cells including myeloid-derived suppressor cells (MDSCs), M2-like tumor-associated macrophages (##TAMs##), and CD4+CD25highFoxP3+ regulatory T cells (Tregs) contribute to the inhibition of cytotoxic CD8+T cells and tumor progression. Although the effect of PI3K inhibitors on cancer cells has been extensively studied, their effect on cancer-associated immunity remains largely unknown. Emerging evidence has highlighted the potential novel mechanisms underlying the antitumor effect of PI3K inhibitors. For example, PI3Kgamma inhibition delay tumor growth by inhibiting the function of macrophages and activating CD8+T cells. PI3Kdelta inhibitors inhibit the proliferation of Tregs and attenuate their immunosuppressive effect. PI3Kalpha is the only isoform that frequently mutated and abnormally activated in solid tumors. The intrinsic PI3Kalpha activation in malignant cells may mediate the suppressive tumor microenvironment (TME). For example, the activation of PI3Kalpha limited the infiltration and function of T cells, and contributed to the suppressed expression of major histocompatibility complex I and cluster of differentiation 80 in tumor cells. Despite the potential role of PI3Kalpha in the TME, the efficacy and mechanism of action of PI3Kalpha inhibitors are typically studied in athymic nude mice in preclinical settings. Elucidating the action of PI3Kalpha inhibitors in the immune-competent context will facilitate a better understanding of the impact of the PI3K pathway on the crosstalk between the TME and cancer cells, and allow further exploration of mechanism-driven drug combinations to potentiate the efficacy.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8354295</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34373258</oboInOwl:hasDbXref>
        <rdfs:label>TAMs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/ec56ded5-5b46-43b8-ae8d-e612d79b03eb"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/ecf79557-b3ad-4342-8216-31bc10488a40 -->

    <Class rdf:about="http://example.org/ecf79557-b3ad-4342-8216-31bc10488a40">
        <obo:IAO_0000115>The classification of pericyte-derived and non-pericyte-derived myofibroblasts (PDGFRbeta-constitutively-expressing and PDGFRbeta-de novo-expressing, respectively) indicates different roles of pulmonary myofibroblasts. With PDGFRbeta as a &apos;specific&apos; marker for pericytes, PDGFRbeta-regulated Cre expression has been used to trace the fate of these cells. However, the constitutive PDGFRbeta-Cre line employed in other studies does not allow discriminating between the two types of myofibroblasts identified in this study, as, after injury, both indistinguishably express PDGFRbeta. Here, we employed the tamoxifen inducible PDGFRbeta-CreERT2 to induce temporally controlled labeling of cells with active PDGFRbeta promotor in the adult lung; in fact, as the intra-alveolar myofibroblasts were found to acquire PDGFRbeta expression after injury, only the inducible lineage tracing strategy allowed us to differentiate between the two types of myofibroblasts. Using a PDGFRbeta-tdTomato reporter mouse in combination with the fact that SMC do not contribute to myofibroblasts, the ##interstitial myofibroblast## can be shown to derive from NO-GC+/PDGFRbeta+ pericytes. We have not yet determined the precursor for the intra-alveolar myofibroblast, although we can exclude pericytes based on our lineage tracing studies. Lipofibroblasts have been shown to be potential myofibroblasts precursors; whether this cell type is linked to the formation of intra-alveolar myofibroblasts has yet to be clarified.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10288756</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37349733</oboInOwl:hasDbXref>
        <rdfs:label>interstitial myofibroblast</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000186"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/ecf79557-b3ad-4342-8216-31bc10488a40"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000186"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/ed192be0-9a21-40b8-864b-125a4b2b6023 -->

    <Class rdf:about="http://example.org/ed192be0-9a21-40b8-864b-125a4b2b6023">
        <obo:IAO_0000115>We found that Pianno&apos;s prediction of the distribution of excitatory neuron subtypes displayed similar pattern as Tangram and RCTD (Supplementary Fig. S3), exhibited a high level of consistency with their known locations across the various layers (Fig. 3c). In contrast, the spatial distribution obtained from unsupervised clustering of cell bins in the original paper presented clusters containing neurons from both L5/6 and L2-3. These clusters included neurons assigned as EX L5/6 but displayed a significant enrichment also in upper layers (Fig. 3d). Ectopic mapping of L5/6 neurons to ##L2-3## was also observed in the results obtained from Cell2location (Supplementary Fig. S3), the tool showing top-performance in a previous benchmarking study of spatial deconvolution methods. These results suggest that even the most advanced deconvolution tool available at the time struggled with precisely assigning these neurons to their correct layers. The mispositioning of L5/6 neurons to L2-3 can likely be attributed to the fact that L2-3 and L5 pyramidal neurons share some similar electrophysiological properties, morphological features, and connectivity patterns, leading to an increased transcriptomic similarity between them.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11271244</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38565531</oboInOwl:hasDbXref>
        <rdfs:label>L2-3</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000540"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/ed192be0-9a21-40b8-864b-125a4b2b6023"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000540"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/ed1cae4d-acf8-401f-8e82-d051558f0270 -->

    <Class rdf:about="http://example.org/ed1cae4d-acf8-401f-8e82-d051558f0270">
        <obo:IAO_0000115>In our previous work, we depicted different T-cell subtypes and found an exhausted cluster that specifically existed in B-ALL patients and possessed remarkable heterogeneity. However, the developmental relationship between T-cell subtypes in relation to B-ALL patient prognosis remains elusive. To address this question, further analysis was performed on these T cells in B-ALL. A subset of T cells with features of tissue-resident memory T (Trm) cells was found in the peripheral blood of B-ALL patients, which we defined as circulating CD103+ T cell or tissue-resident memory-like T (Trm-like) cell. These Trm-like cells expressing high levels of immune checkpoint molecules and cytotoxicity markers also shared similar TCR signatures with exhausted T (Tex) cells and effector T (Teff) cells. The traditional view thought that ##Trm cells## were low in migration and long-term survival in peripheral tissues; however, more recent studies indicated that upon secondary antigen presentation, Trm cells can rejoin the circulation pool, transforming into Teff cells. Through cell fate trajectory analysis, we found that Trm-like cells that were supposed to transit into Teff cells, however, mainly transformed into Tex cells in leukemia environment. Furthermore, Trm-like cell to Tex cell transformation potentially led to poor prognosis of B-ALL patients, while transition toward Teff cells would likely improve prognosis. Our data suggest that Trm-like cells contribute to B-ALL immunosurveillance and may provide valuable prognostic information. Further understanding of the development, maintenance, and regulation of Trm-like cells would be crucial for successful immunotherapeutic development in B-ALL.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9757161</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36532049</oboInOwl:hasDbXref>
        <rdfs:label>Trm cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000813"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/ed1cae4d-acf8-401f-8e82-d051558f0270"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000813"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/ed21bcf8-3623-4472-85f7-aaf644d0b5b6 -->

    <Class rdf:about="http://example.org/ed21bcf8-3623-4472-85f7-aaf644d0b5b6">
        <obo:IAO_0000115>BACKGROUND: A major current challenge is to exploit tertiary lymphoid structures (TLSs) to promote the lymphocyte infiltration, activation and differentiation by tumor antigens to increase antitumor immune responses. The mechanisms that underlie the role of TLS formation in the adaptive immune responses against nasopharyngeal carcinoma (NPC) remain largely unknown. METHODS: Cell populations and the corresponding markers were identified by single-cell RNA sequencing and fluorescence-activated cell sorting analysis. In vitro differentiation experiments were used to simulate the generation, regulation and function of the Th-CXCL13 cell subset in the tumor microenvironment of NPC. These were followed by histological evaluation of the colocalization of ##tumor-associated B cells## (TABs) and Th-CXCL13 cells within TLSs, and statistical analysis of the relationship between the cells in TLSs and overall survival. RESULTS: A PD-1+CXCR5-CD4+ Th-CXCL13 cell subset was identified in NPC. This subset was a major source of CXCL13, representing the majority of the CD4+ T cells at levels comparable with Th1 and Tfh cells present in the TLSs. Monocytes activated by toll-like receptor 4 agonists served as the antigen-presenting cells that most efficiently triggered the expansion of Th-CXCL13 cells. Transforming growth factor beta 1 (TGF-beta1) stimulation and activation of Sox4 were critical for the induction and polarization of Th-CXCL13 cells in this process. The potential functional contributions of TABs recruited by Th-CXCL13 cells which induced plasma cell differentiation and immunoglobulin production via interleukin-21 and CD84 interactions in the TLSs demonstrated improved survival. CONCLUSIONS: Induction of Th-CXCL13 cells links innate inflammation to immune privilege in tumor-associated TLSs and might predict better survival.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8276302</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34253636</oboInOwl:hasDbXref>
        <rdfs:label>tumor-associated B cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000236"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/ed21bcf8-3623-4472-85f7-aaf644d0b5b6"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000236"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/ed48c503-ff3c-4deb-a9aa-1eac87ee5880 -->

    <Class rdf:about="http://example.org/ed48c503-ff3c-4deb-a9aa-1eac87ee5880">
        <obo:IAO_0000115>The retinal neurovascular unit refers to the interdependency between vascular endothelial cells, pericytes, glia, ##neurons##, and immune cells. A better understanding of the contribution of each cell type to DR progression and the molecular mechanisms regulating their crosstalk could be the key to identify new therapeutic targets. In addition to retinal vascular alterations, fibrovascular scarring can ultimately lead to blindness. Fibrosis is an intricate, reparative process that develops in response to acute or chronic injury. The mechanisms that drive fibrosis in DR are not fully understood; hence, there is a great need to better understand this important cause of vision loss. This would be a first step toward new therapies to address progressive preretinal fibrosis and traction detachment and to avoid the concomitant poor visual and anatomic outcomes.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10896003</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37917183</oboInOwl:hasDbXref>
        <rdfs:label>neurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000748"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/ed48c503-ff3c-4deb-a9aa-1eac87ee5880"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000748"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/ed550da0-03f0-4b71-8b80-b4b9de4f6dc6 -->

    <Class rdf:about="http://example.org/ed550da0-03f0-4b71-8b80-b4b9de4f6dc6">
        <obo:IAO_0000115>Brain transcriptional changes after MIA require microglia. (A) Simplified schematic of sample processing pipeline from and bar plots of TORCH pathogen and cytokine receptor expression (mean log counts per million) in each cell type across development. (B) Violin plot of CytoTORCH module score for each cell cluster (MG, P&lt;0.05 for ANOVA and for pairwise comparisons between microglia and all other cell types using Tukey&apos;s HST). (C) Overview of experimental design (top) and UMAP visualization of snRNAseq data from the developing somatosensory cortex of E15.5 wild-type and Csf1r-/- mice after saline or Poly(I:C) maternal injection at E12.5 (two or three embryos per condition from a total of four pregnant dams, 42,736 total cells) (bottom). Cells are colored by cell type assignment. (D) Dot plots of log(fold change) in gene expression between MIA and saline for cell types with significant changes at E15.5. DEG analysis was performed using NEBULA. AP, apical progenitors; IP, ##intermediate progenitors##; ImmN, immature neurons, MN, migrating neurons; (UL/DL) CPN, (upper layer/deep layer) callosal projection neurons; SCPN, subcerebral projection neurons; CThPN, corticothalamic projection neurons; LIV, layer IV stellate neurons; IN, interneurons; CR, Cajal-Retzius cells; Astro, astrocytes; CGC, cycling glial cells; Epend; ependymal cells; OL, oligodendroglia; MG, microglia; Peri, pericytes; EC, endothelial cells; VLMC, vascular and leptomeningeal cells. Created with .</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11190434</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38775708</oboInOwl:hasDbXref>
        <rdfs:label>intermediate progenitors</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0011020"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/ed550da0-03f0-4b71-8b80-b4b9de4f6dc6"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0011020"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/ed638311-8c31-4484-9972-9e4bdac68a72 -->

    <Class rdf:about="http://example.org/ed638311-8c31-4484-9972-9e4bdac68a72">
        <obo:IAO_0000115>Innate T cells, including CD1d-restricted invariant natural killer T (iNKT) cells, are characterized by their rapid activation in response to non-peptide antigens, such as lipids. While the transcriptional profiles of naive, effector, and memory adaptive T cells have been well studied, less is known about the transcriptional regulation of different iNKT cell activation states. Here, using single-cell RNA-sequencing, we performed longitudinal profiling of activated murine iNKT cells, generating a transcriptomic atlas of iNKT cell activation states. We found that transcriptional signatures of activation are highly conserved among heterogeneous iNKT cell populations, including NKT1, NKT2, and NKT17 subsets, and human iNKT cells. Strikingly, we found that ##regulatory iNKT cells##, such as adipose iNKT cells, undergo blunted activation and display constitutive enrichment of memory-like cMAF+ and KLRG1+ populations. Moreover, we identify a conserved cMAF-associated transcriptional network among NKT10 cells, providing novel insights into the biology of regulatory and antigen-experienced iNKT cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9831610</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36458691</oboInOwl:hasDbXref>
        <rdfs:label>regulatory iNKT cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000921"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/ed638311-8c31-4484-9972-9e4bdac68a72"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000921"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/edaa1a94-3dbf-44c5-8a7c-f0dd92d36b9a -->

    <Class rdf:about="http://example.org/edaa1a94-3dbf-44c5-8a7c-f0dd92d36b9a">
        <obo:IAO_0000115>Combining Seurat clustering analysis with known molecular markers for various cell types (Fig. 2B; Tables S2, S3), we segregated the single cells into 9 major cell clusters based on cell types: immune cells [Microglia, Monocyte/Macrophage, and T/NK (T cell/natural killer cell)], retinal cells [AC/HC/RGC (amacrine cell/horizontal cell/retinal ganglion cell), BC (bipolar cell), Cone, MG (Muller glia)/Astrocyte, and Rod], and vascular endothelial cells (VEC) (Fig. 2A). Comparison of control and EAU cell clusters revealed a decrease in the number of multiple neuronal types in EAU retinas, especially in the BC cluster (20.34-5.02%), Cone cluster (9.49-2.94%), and AC/HC/RGC cluster (3.76-1.28%) (Fig. 2C). In agreement, bulk RNA-seq analysis showed that in EAU retinas, there was downregulation of marker genes for all 6 retinal neuron types including rods, cones, BCs, ACs, HCs, and RGCs (Fig. 2D; S2A, B). Immunostaining analysis further validated these results. In EAU retinas, there was obvious degeneration of rhodopsin+ rod inner and outer segments (Fig. 2E), and in general, progressive loss of ##Arrestin+ cones##, Chx10+ BCs, Tfap2a+ ACs, Rbpms+ RGCs, and Calbindin+ HCs (Fig. 2F-J, L-P). By contrast, EAU did not appear to significantly alter Sox9+ Muller glia although resulting in an upregulation of their marker genes (Fig. 2K, Q). Therefore, EAU may cause not only progressive degeneration of all retinal neuron types but also a switch in the expression profile of Muller glia.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11131209</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38802924</oboInOwl:hasDbXref>
        <rdfs:label>Arrestin+ cones</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000573"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/edaa1a94-3dbf-44c5-8a7c-f0dd92d36b9a"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000573"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/ee0d38c4-08f5-4eb8-9fc4-e7ef44571a03 -->

    <Class rdf:about="http://example.org/ee0d38c4-08f5-4eb8-9fc4-e7ef44571a03">
        <obo:IAO_0000115>Single-cell analysis identified neurons expressing sympathetic and parasympathetic markers (Fig. 3c), thus leading to the speculation of whether parasympathetic marker-positive neurons herein are actually parasympathetic neurons differentiated directly from ANS progenitors or cholinergic sympathetic neurons converted from noradrenergic sympathetic neurons herein. During early development, parasympathetic neurons transiently co-express sympathetic markers including TH and DBH, and sympathetic neurons co-express parasympathetic markers, indicating the possibility that ##double-positive neurons## are immature or intermediate neurons. However, as described above, traditional in vitro studies and recent in vivo studies reported that sympathetic neurons acquire cholinergic properties via the effects of trophic factors including BDNF, CNTF, and leukaemia inhibitory factor. Furthermore, HMX2 and HMX3 were not upregulated or relevant herein, being newly identified definitive parasympathetic markers in mice, in the induced ANS progenitors and induced neurons (data not shown). Although it remains unclear whether these new findings regarding parasympathetic neurons in mice are applicable among humans, the present results suggest that the parasympathetic-like neurons herein are not parasympathetic. On the other hand, chromaffin cells are also derived from Schwann cell progenitors, which also give rise to parasympathetic neurons. Although we have not confirmed the involvement of Schwann cell precursors in the induction of parasympathetic-like neurons or chromaffin cells, Therefore, we considered that the generation of PNMT-positive chromaffin cells (Supplementary Fig. 2c) did not completely eliminate the possibility of the induction of parasympathetic neurons. Further studies are required to identify the origins or developmental pathways of human parasympathetic neurons in vitro, such as whether the intermediate Schwann cell precursor stage is involved.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7289887</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32528170</oboInOwl:hasDbXref>
        <rdfs:label>double-positive neurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000540"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/ee0d38c4-08f5-4eb8-9fc4-e7ef44571a03"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000540"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/ee0dd7d1-a51f-40ae-88ae-45869c91f09f -->

    <Class rdf:about="http://example.org/ee0dd7d1-a51f-40ae-88ae-45869c91f09f">
        <obo:IAO_0000115>Downstream of the multipotent HSCs and MPPs, the original lineage bifurcation model strictly separated oligopotent Common Lymphoid Progenitors (CLP) from Common Myeloid Progenitors (CMP) which could further diverge into Megakaryocyte/Erythrocyte Progenitors (MEPs), Monocyte (Mo)/Dendritic cell (DC) Progenitors (MDPs) and Granulocyte/Mo Progenitors (GMPs). However, this model has been the subject of ongoing revision in the scRNA-seq era. On the one hand, a Lymphoid-primed MultiPotent Progenitor (LMPP) with combined lymphoid and myeloid potential has been shown to gradually lose myeloid potential by upregulating the interleukin-7 receptor alpha-chain (IL7Ralpha) and differentiate into Dach1- Lymphoid-Primed Progenitors (LPPs) prior to CLPs. On the other hand, erythroid-versus-myeloid fate decisions seem to be made prior to CMP commitment, calling for in-depth revision of all CMP progeny (MEPs, MDPs and GMPs) as well. While the Flt3L+CD115lo CMPs give rise to oligopotent MDPs, the Flt3-CD115- CMPs give rise to GMPs. The former are defined by TF co-expression of CEBPA, IRF8 and RUNX1. MDPs can give rise to IRF8/SATB1 plasmacytoid DC (pDC) Progenitors (pDCPs) and HLA-DR/IRF8/CEBPA Mo/conventional DC (cDC) Progenitors (McDPs). The latter bifurcate in CD11c/CD172ab/CD14 (human) or Ly6C+ Mo (mouse) or IRF8/HLA-DR/CD84/CD172ab Common DC Progenitors (CDPs). In contrast, GMPs (Kit, CD34, Sox4) are very heterogeneous at the transcriptomic and proteomic level and can adjust their functional output towards common Mo Progenitors (cMoP) and ##Granulocyte Progenitors## (GPs).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11324509</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:39148724</oboInOwl:hasDbXref>
        <rdfs:label>Granulocyte Progenitors</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000557"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/ee0dd7d1-a51f-40ae-88ae-45869c91f09f"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000557"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/ee3e8852-0cf7-4c86-b330-cf89ef61c014 -->

    <Class rdf:about="http://example.org/ee3e8852-0cf7-4c86-b330-cf89ef61c014">
        <obo:IAO_0000115>a Due to single-cell annotation and in situ validation (Fig. 2; Supplementary Fig. 3), a draft model of the oral-to-tooth transition zone in humans is presented, with basal and suprabasal keratinocyte markers uniquely identifying the alveolar mucosa (AM), attached gingiva (AG), gingival margin (GM), sulcular epithelium (SK) and junctional epithelium (JK). b These markers allowed for ##KRT19-high keratinocyte (KC) cell## subclustering for the first time (2504 cells in total), including gingival margin keratinocytes (GM), sulcular keratinocytes (SK), and junctional keratinocytes (JK). c A more granular draft (Tier 4) annotation of epithelial cells of the gingival attachment. d Assaying differentially expressed genes in periodontitis, SKs and JKs only share about a quarter of upregulated genes. JKs displayed nearly 125 unique upregulated genes in diseased cells. e Further analysis of basal and suprabasal (differentiating) SK and JK keratinocytes revealed unique cell signatures between basal and suprabasal cell types. This full list is included in Supplementary Data 1. f-i To understand SK and JK developmental progression and cell state alterations, we used partitioned-based graph abstraction (PAGA). f Examining the basal to suprabasal transition, JKs display altered gene expressed comparing health to disease cell types, including broader expression of KRT17 and more expression of JUND, COL17A1, and CDH3. Key differentiation genes such as SPRR family members were also downregulated. g JKs displayed robust cell signaling and inflammatory phenotypes, which appear exacerbated in disease states. h In SKs, differentiation-related genes were uniquely expressed compared to JKs in health but also appeared altered in disease along the basal to suprabasal trajectory. i SKs appeared generally less reactive compared to JKs in disease, with lower overall expression of effector molecules such as CXCL1, CXCL8, IL1A, IL1B, and IL1RN. Abbreviations: Merk Merkel Cells, LC langerhans cells, Mela melanocytes, Muc mucosa, SB suprabasal Keratinocytes; for others, see Fig. 1 legend. For this figure, n = 30-sample, 2504-cell for scRNAseq.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11178863</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38876998</oboInOwl:hasDbXref>
        <rdfs:label>KRT19-high keratinocyte (KC) cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000237"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/ee3e8852-0cf7-4c86-b330-cf89ef61c014"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000237"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/ee4e22de-d0fb-4f35-aa8a-6686b92c48a3 -->

    <Class rdf:about="http://example.org/ee4e22de-d0fb-4f35-aa8a-6686b92c48a3">
        <obo:IAO_0000115>Last, we investigated whether the human materno-fetal immune system in HIS mice was functional. Human decidua and splenic CD4+CD25+ Treg cells were purified from pregnant HIS mice and incubated with the CFSE-labeled human CD45+CD25- splenic cells (responder cells from pregnant HIS mice) in the presence of 30 Gy irradiated BALB/c mouse ##splenic cells## (stimulator). The proliferation of responder cells was quantified 4 days later using FCM. Proliferation of maternal human splenic CD4+ effector T cells after stimulation with paternally (BALB/c) derived antigen reflects the presence of fetal reactive human maternal T cells (Figure 5A). STreg cells were capable of suppressing Tconv cells at 1:2 ratio (Treg/Tconv) (Supplemental Figure 11). However, under a low Treg/Tconv ratio (1:16) condition, the maternal versus fetal T cell reactions (MvFRs) of maternal T cells were significantly inhibited by dTreg but not by sTreg cells (or were only minimally suppressed; Figure 5A).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11529984</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:39435662</oboInOwl:hasDbXref>
        <rdfs:label>splenic cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000738"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/ee4e22de-d0fb-4f35-aa8a-6686b92c48a3"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000738"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/ee5e5b7a-93a5-4053-820f-d1eeab97a773 -->

    <Class rdf:about="http://example.org/ee5e5b7a-93a5-4053-820f-d1eeab97a773">
        <obo:IAO_0000115>To date, it is still disputed whether ##&quot;senescent&quot; and &quot;dystrophic&quot; microglia## are related to the same condition or are distinct. While biochemical and molecular markers of senescence exist, Streit et al. claim that there is no currently straightforward means to identify the dystrophic features of microglial cells, apart from morphological abnormalities, and that changes described in cell morphology cannot be easily correlated with modifications at the molecular level. It has been suggested that over-reactive microglia can reach an exhausted phase, unable to escape their extensive faults in energy metabolism, resulting in &quot;senescent&quot; or &quot;dystrophic&quot; microglia. Considering the above, we believe that microglial &quot;senescence&quot; is related to aging, is accelerated by neurodegeneration, and is one of the major mechanisms leading to the appearance of &quot;dystrophic&quot; morphology, which has no clear molecular signatures because it occurs in now exhausted cells (Figure 3).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10742050</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38132144</oboInOwl:hasDbXref>
        <rdfs:label>&quot;senescent&quot; and &quot;dystrophic&quot; microglia</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000129"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/ee5e5b7a-93a5-4053-820f-d1eeab97a773"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000129"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/ee7b6b47-9a46-4da7-bf0c-7a2c24c30993 -->

    <Class rdf:about="http://example.org/ee7b6b47-9a46-4da7-bf0c-7a2c24c30993">
        <obo:IAO_0000115>Advances in the field of T cell memory, including the discovery of tissue residency, continue to add to the list of defined T cell subsets. Here, we briefly review the role of ##resident memory T cells## (TRM) in protective immunity, and propose that they exhibit developmental and migrational plasticity. We discuss T cell classification, the concept of cell type versus &apos;subset&apos;, and the difficulty of inferring developmental relationships between cells occupying malleable differentiation states. We propose that popular subsetting strategies do not perfectly define boundaries of developmental potential. We integrate TRM into a &apos;terrace&apos; model that classifies memory T cells along a continuous axis of decreasing developmental potential. This model also segregates cells on the basis of migration properties, although different migration properties are viewed as parallel differentiation states that may be permissive to change.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7198345</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32018169</oboInOwl:hasDbXref>
        <rdfs:label>resident memory T cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000813"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/ee7b6b47-9a46-4da7-bf0c-7a2c24c30993"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000813"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/ee7bfbfa-09c8-4d3f-97c8-0fd6dbe43af2 -->

    <Class rdf:about="http://example.org/ee7bfbfa-09c8-4d3f-97c8-0fd6dbe43af2">
        <obo:IAO_0000115>The adipose-derived hormone leptin acts via its receptor (LepRb) in the brain to control energy balance. A potentially unidentified population of GABAergic hypothalamic LepRb neurons plays key roles in the restraint of food intake and body weight by leptin. To identify markers for candidate populations of LepRb neurons in an unbiased manner, we performed single-nucleus RNA-Seq of enriched mouse hypothalamic LepRb cells, identifying several previously unrecognized populations of hypothalamic LepRb neurons. Many of these populations displayed strong conservation across species, including GABAergic Glp1r-expressing LepRb (LepRbGlp1r) neurons, which expressed more Lepr than other LepRb cell populations. Ablating Lepr from LepRbGlp1r cells provoked hyperphagic obesity without impairing energy expenditure. Similarly, improvements in energy balance caused by Lepr reactivation in GABA neurons of otherwise Lepr-null mice required Lepr expression in ##GABAergic Glp1r-expressing neurons##. Furthermore, restoration of Glp1r expression in LepRbGlp1r neurons in otherwise Glp1r-null mice enabled food intake suppression by the GLP1R agonist, liraglutide. Thus, the conserved GABAergic LepRbGlp1r neuron population plays crucial roles in the suppression of food intake by leptin and GLP1R agonists.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10541203</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37581939</oboInOwl:hasDbXref>
        <rdfs:label>GABAergic Glp1r-expressing neurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000617"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/ee7bfbfa-09c8-4d3f-97c8-0fd6dbe43af2"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000617"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/eeac3b32-1967-4b7d-af39-d65a3402b5fa -->

    <Class rdf:about="http://example.org/eeac3b32-1967-4b7d-af39-d65a3402b5fa">
        <obo:IAO_0000115>Single-cell RNA sequencing reveals ##PDFGRalpha+ stromal cell## subpopulations that promote proacinar cell differentiation in embryonic salivary gland organoids.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8977102</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35224622</oboInOwl:hasDbXref>
        <rdfs:label>PDFGRalpha+ stromal cell</rdfs:label>
    </Class>
    


    <!-- http://example.org/eeb0a571-0975-48ae-95b9-dbfbf52ad37a -->

    <Class rdf:about="http://example.org/eeb0a571-0975-48ae-95b9-dbfbf52ad37a">
        <obo:IAO_0000115>scRNA-seq of ECs reveal a subpopulation enriched with immune responsive signatures. (A) Schematic showing the experimental design for the scRNA-seq and single-nuclei ATAC sequencing analysis of regenerative mouse hearts (MI at P1 and harvested at P5) and nonregenerative mouse hearts (MI at P8 and harvested at P12). (B) UMAP representation of cardiac cell clusters identified from scRNA-seq analysis. Clusters were color coded according to cell types (left). CM, cardiomyocytes; EC, ##endothelial cells##; CF, fibroblasts; PeriC, pericytes; SMC, smooth muscle cells; EndoC, endocardial cells; EpiC, epicardial cells; MF, macrophages; TC, T-cells. (C) Gene ontology (GO) analysis of differentially expressed genes up-regulated in ECs of regenerative-stage hearts versus nonregenerative-stage hearts after MI. (D) UMAP representation of CD31+-enriched cell clusters from single-cell RNA sequencing (scRNA-seq), color coded according to cell type. CEC, capillary endothelial cell; Angio-EC, angiogenic endothelial cell; Pro-EC1, proliferative endothelial cell 1; Pro-EC2, proliferative endothelial cell 2; IFN-EC, interferon capillary endothelial cell; CVEC, capillary venous endothelial cell; VEC, venous endothelial cell; AEC, arterial endothelial cell; LEC, lymphatic endothelial cell; EndoC, endocardial cell. (E) Gene ontology (GO) analysis of differentially expressed genes up-regulated in the IFN-EC cluster of regenerative-stage hearts versus nonregenerative-stage hearts after MI.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10681909</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38012001</oboInOwl:hasDbXref>
        <rdfs:label>endothelial cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0010008"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/eeb0a571-0975-48ae-95b9-dbfbf52ad37a"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0010008"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/eebaaf99-3471-45e1-b486-a3f91129b7f3 -->

    <Class rdf:about="http://example.org/eebaaf99-3471-45e1-b486-a3f91129b7f3">
        <obo:IAO_0000115>Our consecutive gating strategy was based on previously published approaches distinguishing between memory B cells and plasma cells/blasts based on the surface markers CD38 in conjunction with negative staining for IgM and IgD. In contrast to previous strategies, we did not further select for IgA and IgG negative cells for two reasons: Firstly, omalizumab is the first antibody used in flow cytometry that is able to directly identify B cells bearing membrane-bound IgE without need for additional selection steps. Secondly, B cells bear the Fcgamma receptors family member FcgammaRIIB and thus gating for IgG negative cells may also exclude IgE+ B cells with Fcgamma receptor bound IgG as commercial available anti-human IgG antibodies are not exclusively directed to free IgG present in the BCR. Alternatively, to using negative staining for IgM and IgD to select class switched B cells, CD27 in conjunction with CD19 and CD38 has been used as a marker to discriminate between naive, memory cells and cells of the plasma cell lineage. However, it has been shown that CD27 is not expressed by all memory B cells but is rather an additional marker to discriminate memory B cell subsets. In this line using a stepwise exclusion approach by gating on ##CD19+CD38dim cells## followed by exclusion of IgM+IgD+IgG+IgA+ cells it has been demonstrated that IgE+ memory B cells expressing CD27 are most likely derived from a germinal center T cell-dependent pathway whereas IgE+ memory B cells lacking expression of CD27 most likely have a T cell-independent origin. Thus, as a substantial portion of IgE+ B cells do not express CD27, we did not use this marker for our gating approach.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8721004</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34987522</oboInOwl:hasDbXref>
        <rdfs:label>CD19+CD38dim cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002105"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/eebaaf99-3471-45e1-b486-a3f91129b7f3"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002105"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/eebc6c8d-8615-4069-808b-ff3450f016fc -->

    <Class rdf:about="http://example.org/eebc6c8d-8615-4069-808b-ff3450f016fc">
        <obo:IAO_0000115>It has been reported that cortical-projecting subpopulations of DRN 5-HT neurons express Slc17a8, in agreement with the extensive overlap between the spatial distribution of cortical-projecting neurons and Slc17a8 expression. This suggests that cortical-projecting subpopulations should correspond to subtype 5-HT-IV from the scRNA-seq dataset, which is Slc17a8-expressing and distributed to the ventral DRN. Additionally, we would predict that the Str-projecting subpopulation corresponds to the subtype 5-HT-III, since their distributions overlap extensively in the dorsomedial DRN. Consistent with our hypothesis that 5-HT neuron subtypes innervate different brain regions, we found that the inferred distributions of each 5-HT neuron subtype coincides with a different set of projection-defined subpopulations - the distribution of subtype 5-HT-III was most similar to the distribution of Str-projecting neurons (Figure 6F), whereas the distribution of subtype 5-HT-IV was more similar to that of M1-projecting neurons (Figure 6G). However, neither Str-projecting nor M1-projecting subpopulations were fully contained within the distribution of a single 5-HT neuron subtype. ##Str-projecting neurons in the ventrolateral DRN## (marked cyan in Figure 6D,F,G), where neurons innervating both Str and M1 are located, fell within the distribution of subtype 5-HT-IV but not of subtype 5-HT-III. This suggests that Str is a target of multiple molecular subtypes of 5-HT neurons, and supports the model that some structures are innervated by multiple 5-HT neuron subtypes due to overlaps in the axonal projection fields of different subtypes.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6726424</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31411560</oboInOwl:hasDbXref>
        <rdfs:label>Str-projecting neurons in the ventrolateral DRN</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000540"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/eebc6c8d-8615-4069-808b-ff3450f016fc"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000540"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/eee8b8a2-2098-42d4-98c1-ea1ebe6558fb -->

    <Class rdf:about="http://example.org/eee8b8a2-2098-42d4-98c1-ea1ebe6558fb">
        <obo:IAO_0000115>Immune checkpoint inhibitors exert clinical efficacy against various types of cancer through reinvigoration of exhausted CD8+ T cells that attack cancer cells directly in the tumor microenvironment (TME). Using single-cell sequencing and mouse models, we show that CXCL13, highly expressed in tumor-infiltrating exhausted CD8+ T cells, induces CD4+ follicular helper T (TFH) cell infiltration, contributing to anti-tumor immunity. Furthermore, a part of the TFH cells in the TME exhibits cytotoxicity and directly attacks major histocompatibility complex-II-expressing tumors. TFH-like cytotoxic CD4+ T cells have high LAG-3/BLIMP1 and low TCF1 expression without self-renewal ability, whereas non-cytotoxic TFH cells express low LAG-3/BLIMP1 and high TCF1 with self-renewal ability, closely resembling the relationship between terminally differentiated and stem-like progenitor exhaustion in CD8+ T cells, respectively. Our findings provide deep insights into TFH-like CD4+ T cell exhaustion with helper progenitor and ##cytotoxic## differentiated functions, mediating anti-tumor immunity orchestrally with CD8+ T cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMID:38363680</oboInOwl:hasDbXref>
        <rdfs:label>cytotoxic</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000910"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/eee8b8a2-2098-42d4-98c1-ea1ebe6558fb"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000910"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/ef2d312a-0bda-4155-9780-7bab4b6f6a1d -->

    <Class rdf:about="http://example.org/ef2d312a-0bda-4155-9780-7bab4b6f6a1d">
        <obo:IAO_0000115>Stem cell therapy constitutes a pivotal subject in contemporary discourse, with donor stem cells having been employed in research and clinical treatments for several decades. Primary cell transplantation encompasses diverse stem cell types, including ##ectomesenchymal stem cells##, hematopoietic stem cells, and various stem cell derivatives such as vesicles and extracellular vesicles. Nevertheless, the emergence of cell engineering techniques has heralded a new epoch in stem cell therapy, markedly broadening their therapeutic potential. Induced pluripotent stem cells (iPSCs) epitomize a significant milestone in modern medical biology. This groundbreaking discovery offers significant potential in disciplines such as biology, pathophysiology, and cellular regenerative medicine. As a result, iPSCs derived differentiated cells have become a pioneering avenue for cell therapy research. Induced mesenchymal stem cells (iMSCs), derived from iPSCs, represent a novel frontier in MSCs related research. Empirical evidence suggests that iMSCs demonstrate enhanced proliferative capacities compared to natural MSCs, with diminished age-related variability and heterogeneity. Numerous clinical trials have highlighted the prospective superiority of iMSCs. This article synthesizes current basic research and clinical trials pertaining to iMSCs, aiming to provide a reference point for future research endeavors.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11484330</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:39415276</oboInOwl:hasDbXref>
        <rdfs:label>ectomesenchymal stem cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000134"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/ef2d312a-0bda-4155-9780-7bab4b6f6a1d"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000134"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/ef2da8ea-0021-45cd-88ec-c09e79e73efd -->

    <Class rdf:about="http://example.org/ef2da8ea-0021-45cd-88ec-c09e79e73efd">
        <obo:IAO_0000115>Different pathogenesis of HCC involving viral and non-viral etiology is related to the unique TIME. Chronic infection with hepatitis B virus (HBV) promotes the formation of a tolerant TIME by depletion of the effector CD8+ T cells and attracting immunosuppressive cells including granulomatous myeloid-derived suppressor cells (gMDSCs), Tregs, or regulatory B (Breg) cells. Chronic infection by hepatitis C virus (HCV) depletes CD8+ T cells and promotes immune evasion through spontaneous viral escape and dysregulation of major histocompatibility complex I (MHC I) dependent antigen presentation. In alcoholic steatohepatitis (ASH), alcohol promotes the inhibition of liver immune response by increasing the abundance of M2 TAMs, inhibiting CD8+ T cell activation, and facilitating gMDSC infiltration. In contrast, non-alcoholic steatohepatitis (NASH) activates dysfunctional immune cells, including helper T cell 17 (Th17) cells, natural killer T (NKT) cells, ##CD8+/PD-1+ T cells## and IgA+ plasma cells, disrupting tumor immune surveillance and inducing HCC.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11639598</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:39641225</oboInOwl:hasDbXref>
        <rdfs:label>CD8+/PD-1+ T cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000625"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/ef2da8ea-0021-45cd-88ec-c09e79e73efd"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000625"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/efd390cb-e678-4112-ae10-812fe01dca07 -->

    <Class rdf:about="http://example.org/efd390cb-e678-4112-ae10-812fe01dca07">
        <obo:IAO_0000115>Furthermore, there are several other origins of ##CAFs##, such as a subset derived from the macrophage lineage found in non-small-cell lung carcinoma, regulated by Smad3-induced macrophage-myofibroblast transition (MMT). Mesothelial cells can also transform into a typical antigen-presenting CAFs (apCAFs) when induced by IL-1 and TGF-beta, discovered in pancreatic cancer. The exact origin of CAFs still lacks precise elaboration, and further approaches like lineage tracing, fate-mapping, pseudotime analysis, and RNA velocity may help uncover new primogenitors of CAFs.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11300527</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38602594</oboInOwl:hasDbXref>
        <rdfs:label>CAFs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000057"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/efd390cb-e678-4112-ae10-812fe01dca07"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000057"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/efde0ded-d321-4a0a-91b2-b417805e3b11 -->

    <Class rdf:about="http://example.org/efde0ded-d321-4a0a-91b2-b417805e3b11">
        <obo:IAO_0000115>Immune regulation by helminths acts at many levels to interfere with innate antigen sensitization, induction of adaptive immunity, and mobilization of effector mechanisms. 7  One of the most prominent pathways for parasite immunomodulation is through regulatory T-cells (Tregs). Tregs are classified by their expression of the transcription factor Foxp3 (FOXP3 in humans) and can express a number of surface markers that are key for their function, including CD25, cytotoxic T-lymphocyte-associated protein 4 (CTLA-4), inducible T-cell co-stimulator (ICOS) and T-cell immunoreceptor with Ig and ITIM domains (TIGIT). 8  In both mouse and human studies, Tregs are often defined as CD3+ CD4+ CD25+ Foxp3+ cells, although Treg cells comprise a diverse population. During development, the first set of Tregs are formed in the thymus, making up the natural Treg population (nTreg), while a second type of Tregs can be induced in the periphery from naive CD4 T-cells [induced Tregs (iTreg)/##peripheral Tregs## (pTreg)] in the presence of specific cytokines such as interleukin (IL)-2 and transforming growth factor beta (TGF-beta); however, the expression of Foxp3, and indeed regulatory activity, is variable depending on the level of demethylation at the Foxp3 locus, and recent studies have identified a number of Treg subtypes delineated by CD25, Foxp3 and the epigenome. 9  Regulatory activity can also be found in other lymphocyte subsets, such as the Foxp3-IL-10+ Tr1 cells (previously defined as Th3 10 ), although their role in controlling immune responses in helminth infection has yet to be established.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7341546</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32153025</oboInOwl:hasDbXref>
        <rdfs:label>peripheral Tregs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000815"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/efde0ded-d321-4a0a-91b2-b417805e3b11"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000815"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/effeb7f2-3901-42e3-b1c1-83dedd2c4db7 -->

    <Class rdf:about="http://example.org/effeb7f2-3901-42e3-b1c1-83dedd2c4db7">
        <obo:IAO_0000115>Last, we investigated whether the human materno-fetal immune system in HIS mice was functional. Human decidua and splenic CD4+CD25+ Treg cells were purified from pregnant HIS mice and incubated with the CFSE-labeled human CD45+CD25- splenic cells (responder cells from pregnant HIS mice) in the presence of 30 Gy irradiated BALB/c mouse splenic cells (stimulator). The proliferation of responder cells was quantified 4 days later using FCM. Proliferation of maternal human ##splenic CD4+ effector T cells## after stimulation with paternally (BALB/c) derived antigen reflects the presence of fetal reactive human maternal T cells (Figure 5A). STreg cells were capable of suppressing Tconv cells at 1:2 ratio (Treg/Tconv) (Supplemental Figure 11). However, under a low Treg/Tconv ratio (1:16) condition, the maternal versus fetal T cell reactions (MvFRs) of maternal T cells were significantly inhibited by dTreg but not by sTreg cells (or were only minimally suppressed; Figure 5A).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11529984</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:39435662</oboInOwl:hasDbXref>
        <rdfs:label>splenic CD4+ effector T cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0001044"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/effeb7f2-3901-42e3-b1c1-83dedd2c4db7"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0001044"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/f0027c3b-f3f9-4ffb-8ced-2ad549387f4f -->

    <Class rdf:about="http://example.org/f0027c3b-f3f9-4ffb-8ced-2ad549387f4f">
        <obo:IAO_0000115>ACS, acute compartment syndrome; scRNA-seq, single-cell RNA sequencing; HG, high-stress group; NG, normal-stress group; DEGs, differentially expressed genes; GO, Gene Ontology; KEGG, Kyoto Encyclopedia of Genes and Genomes; ##TCM##, central memory T-cell; Teff, effector T-cell; Treg, regulatory T-cell; NKT, nature killer T-cell; ILC, innate lymphoid cell; HSP, heat shock protein; MT,metallothionein; Mac, macrophages; DCs, dendritic cells; Mon, monocytes; Fib, fibroblasts.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9889980</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36741388</oboInOwl:hasDbXref>
        <rdfs:label>TCM</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000904"/>
        <skos:relatedMatch rdf:resource="CL:0000907"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/f0027c3b-f3f9-4ffb-8ced-2ad549387f4f"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000904"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/f0027c3b-f3f9-4ffb-8ced-2ad549387f4f"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000907"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/f0c9bdbb-d1de-4e97-b14c-5673d412b473 -->

    <Class rdf:about="http://example.org/f0c9bdbb-d1de-4e97-b14c-5673d412b473">
        <obo:IAO_0000115>Functional clusters of genes differentially expressed in ##LYVE1+ and LYVE1- macrophages## following single-cell RNA-sequencing (scRNA-seq) analysis.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9629833</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36259488</oboInOwl:hasDbXref>
        <rdfs:label>LYVE1+ and LYVE1- macrophages</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000864"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/f0c9bdbb-d1de-4e97-b14c-5673d412b473"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000864"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/f0ca5dab-898a-4300-8af0-9e681b040d12 -->

    <Class rdf:about="http://example.org/f0ca5dab-898a-4300-8af0-9e681b040d12">
        <obo:IAO_0000115>##Cancer-associated fibroblasts## (CAF) form the basis of tumor microenvironment and possess immunomodulatory functions by interacting with other cells surrounding tumor, including T lymphocytes, macrophages, dendritic cells and natural killer cells. Ionizing radiation is a broadly-used method in radiotherapy to target tumors. In mammalian cells, ionizing radiation induces various types of DNA damages and DNA damage response. Being unspecific, radiotherapy affects all the cells in tumor microenvironment, including the tumor itself, CAFs and immune cells. CAFs are extremely radio-resistant and do not initiate apoptosis even at high doses of radiation. However, following radiation, CAFs become senescent and produce a distinct combination of immunoregulatory molecules. Radiosensitivity of immune cells varies depending on the cell type due to inefficient DNA repair in, for example, monocytes and granulocytes. In this minireview, we are summarizing recent findings on the interaction between CAF, ionizing radiation and immune cells in the tumor microenvironment.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7696681</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33207781</oboInOwl:hasDbXref>
        <rdfs:label>Cancer-associated fibroblasts</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000057"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/f0ca5dab-898a-4300-8af0-9e681b040d12"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000057"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/f0edb0e5-6f0b-4188-9dc9-e35a765d240e -->

    <Class rdf:about="http://example.org/f0edb0e5-6f0b-4188-9dc9-e35a765d240e">
        <obo:IAO_0000115>In order to understand the gene expression profile characteristics of invasive cSCC, we identified and analyzed gene function enrichment of significantly up-regulated DEGs in important cell subpopulations of cSCC compared to normal skin tissues. 778, 1044, 1159, and 760 significantly up-regulated DEGs were identified among Basal1, Basal2, Pro KCs, and Follicular2 cell subpopulations, respectively (Supplementary file 1j-m, Wilcoxon test, p_val_adj &lt;0.05). GO analysis was mainly concentrated in various tumor-related biological processes such as cell morphological change and adhesion, signaling pathway regulation, apoptosis and angiogenesis, as well as processes related to immunity including antigen processing and presentation, myeloid cell differentiation, and negative regulation of immune response, etc. (Figure 5:figure supplement 3A). There were 888 and 247 significantly up-regulated DEGs in ##Spinous1 and Spinous2 cell## subpopulations, respectively (Supplementary file 1n, o, Wilcoxon test, p_val_adj &lt;0.05). In addition to the biological process similar to basal cells, GO enrichment analysis showed that DEGs were mainly enriched in the regulation of programmed death, ATP metabolism, and the production of type I interferon (Figure 5:figure supplement 3A). Based on above differential gene expression and functional enrichment analysis, we identified a group of important candidate genes that may be closely related to tumor genesis and development in cSCC including CD74, CDKN2A, COL17A1, JUND, MMP1, BST2, LGALS1, IFITM3, ISG15, IFI6, FTH1, LAMA3, LAMC2, SAT1, and so on (Figure 5:figure supplement 3B).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10783873</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38099574</oboInOwl:hasDbXref>
        <rdfs:label>Spinous1 and Spinous2 cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000312"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/f0edb0e5-6f0b-4188-9dc9-e35a765d240e"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000312"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/f11d2f75-c21b-4bac-9fe6-972be7160684 -->

    <Class rdf:about="http://example.org/f11d2f75-c21b-4bac-9fe6-972be7160684">
        <obo:IAO_0000115>Taken together, these data demonstrate both phenotypical and functional differences of the specific APC subsets at the site of inflammation when compared to peripheral blood. Here, cDC1 lack the pro-inflammatory phenotype and function displayed by the ##cDC2## and monocytes that were derived from the same inflammatory environment.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9846246</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36685500</oboInOwl:hasDbXref>
        <rdfs:label>cDC2</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000990"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/f11d2f75-c21b-4bac-9fe6-972be7160684"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000990"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/f139ac8e-9244-4bc8-8816-83ca6937810f -->

    <Class rdf:about="http://example.org/f139ac8e-9244-4bc8-8816-83ca6937810f">
        <obo:IAO_0000115>Combining Seurat clustering analysis with known molecular markers for various cell types (Fig. 2B; Tables S2, S3), we segregated the single cells into 9 major cell clusters based on cell types: immune cells [Microglia, Monocyte/Macrophage, and T/NK (T cell/natural killer cell)], retinal cells [AC/HC/RGC (amacrine cell/horizontal cell/retinal ganglion cell), BC (bipolar cell), Cone, MG (Muller glia)/Astrocyte, and Rod], and vascular endothelial cells (VEC) (Fig. 2A). Comparison of control and EAU cell clusters revealed a decrease in the number of multiple neuronal types in EAU retinas, especially in the BC cluster (20.34-5.02%), Cone cluster (9.49-2.94%), and AC/HC/RGC cluster (3.76-1.28%) (Fig. 2C). In agreement, bulk RNA-seq analysis showed that in EAU retinas, there was downregulation of marker genes for all 6 retinal neuron types including rods, cones, BCs, ACs, HCs, and RGCs (Fig. 2D; S2A, B). Immunostaining analysis further validated these results. In EAU retinas, there was obvious degeneration of ##rhodopsin+ rod## inner and outer segments (Fig. 2E), and in general, progressive loss of Arrestin+ cones, Chx10+ BCs, Tfap2a+ ACs, Rbpms+ RGCs, and Calbindin+ HCs (Fig. 2F-J, L-P). By contrast, EAU did not appear to significantly alter Sox9+ Muller glia although resulting in an upregulation of their marker genes (Fig. 2K, Q). Therefore, EAU may cause not only progressive degeneration of all retinal neuron types but also a switch in the expression profile of Muller glia.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11131209</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38802924</oboInOwl:hasDbXref>
        <rdfs:label>rhodopsin+ rod</rdfs:label>
    </Class>
    


    <!-- http://example.org/f1534f85-0ad0-42ad-b458-d9b0cd56a8dd -->

    <Class rdf:about="http://example.org/f1534f85-0ad0-42ad-b458-d9b0cd56a8dd">
        <obo:IAO_0000115>Translatome analysis with RiboTag reveals cell type-specific responses in HD. A HdhQ7/Q200 mice homozygous for RiboTag were crossed with homozygous Cre-driver lines to facilitate cell type-specific expression of Rpl22-HA in glutamatergic (vGluT2+) and GABAergic (Gad2+) neurons in the cerebellum and cerebrum, and parvalbumin (PV+)-expressing neurons in the cerebrum. Cerebellum and cerebrum (without olfactory bulb) were separated and flash frozen at 9 months. For RiboTag IPs, cell type-specific HA-tagged ribosomes were immunoprecipitated from tissue homogenate using anti-HA antibody bound to magnetic beads. Total RNA was prepared from an aliquot of the same tissue homogenate. B Expression levels of Htt mRNA were slightly reduced in all cell types, significantly in ##cerebral vGluT2+ and PV+ neurons## (* FDR &lt;= 0.05; ** FDR &lt;= 0.01; *** FDR &lt;= 0.001). C HD-typical genes showed downregulation in cerebral cell types. D Differentially expressed genes (DEGs) (FDR &lt;= 0.05) for each cell type. E Top five significantly enriched terms (FDR &lt;= 0.05) among DEGs reveal cell type-specific responses to mHtt</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9854201</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36670467</oboInOwl:hasDbXref>
        <rdfs:label>cerebral vGluT2+ and PV+ neurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000679"/>
        <skos:relatedMatch rdf:resource="CL:4023018"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/f1534f85-0ad0-42ad-b458-d9b0cd56a8dd"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000679"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/f1534f85-0ad0-42ad-b458-d9b0cd56a8dd"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4023018"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/f16d7c12-5dab-4863-91f2-e933b90d53e7 -->

    <Class rdf:about="http://example.org/f16d7c12-5dab-4863-91f2-e933b90d53e7">
        <obo:IAO_0000115>Collectively, these studies suggest a level of specialization among CAFs concerning pro-angiogenic behavior or association with tumor vessels, necessitating further investigation. Understanding the specific contributions of the cell of origin to these phenotypes, particularly the relationship between ##vCAFs## and perivascular cells, remains a key area of interest. Recent studies are beginning to uncover the distinct role of tumor-associated pericytes as an independent entity from CAFs. Whether these distinct CAF phenotypes signify particular functions associated with vascular regulation and unique distributions within tumors or represent remnants of their lineage (e.g., mural cell- or EC-derived CAFs) is yet to be determined. Future studies employing techniques like scRNAseq and spatial transcriptomics to map tissue/tumor cell composition and cell communication as well as lineage tracing analyses of CAF subtype cellular origins are expected to provide further evidence on the specific pro- or anti-angiogenic roles of CAF subpopulations (Fig. 3).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11322395</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38453816</oboInOwl:hasDbXref>
        <rdfs:label>vCAFs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000057"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/f16d7c12-5dab-4863-91f2-e933b90d53e7"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000057"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/f1777934-7bc2-4a3a-80a8-649342102f7d -->

    <Class rdf:about="http://example.org/f1777934-7bc2-4a3a-80a8-649342102f7d">
        <obo:IAO_0000115>SCLC	Small-cell carcinoma	 	NSCLC	Non-small-cell carcinoma	 	ADC	Adenocarcinoma	 	SqCC	Squamous cell carcinoma	 	LCLC	Large-cell carcinoma	 	PD1	Programmed death 1	 	PDL1	Programmed death 1 ligand	 	ICI	Immune checkpoint inhibitors	 	EV	Extracellular vesicles	 	ESE	Early-sorting endosome	 	ILVs	Intraluminal vesicles	 	MVBs	Multivesicular bodies	 	ESCRT	Endosomal-sorting complex-independent transport	 	ncRNAs	Small noncoding RNAs (ncRNAs)	 	miRNAs	microRNAs	 	TME	Tumor microenvironment	 	circRNA	circular RNA	 	ECM	extracellular matrix	 	HBEC	Human bronchial epithelial cells	 	EMT	Epithelial-mesenchymal transition	 	CRC	colorectal cancer	 	DCs	dendritic cells	 	MSC	Mesenchymal stem cells	 	NK	Natural Killer	 	PBMCs	Peripheral blood mononuclear cells	 	TAMs	Tumor-associated macrophages	 	MDSCs	Myeloid-derived suppressor cells	 	##PMN-MDSCs##	Polymorphonuclear MDCs	 	M-MDSCs	Monocytic MDSCs	 	LLC	Lewis Lung carcinoma	 	M2 macrophages	Alternatively activated macrophages	 	M1 macrophages	Classically activated macrophages	 	TH1 cell	T helper 1 cell	 	Treg cell	Regulatory T cell	 	Breg cell	Regulatory B cell	 	CTLs	Cytotoxic CD8+ T cells	 	TILs	Tumor-infiltrating lymphocytes	 	Tim-3	mucin domain-3 protein	 	TIGIT	T cell immunoglobulin and ITIM domain	 	Lag-3	Lymphocyte-activation gene 3	 	CTLA4	Cytotoxic T lymphocyte antigen-4	 	TH17 cell	T helper 17 cell	 	DNT cell	Double-negative T cells	 	TRAIL	TNF-related apoptosis-inducing ligand	 	MPE	malignant pleural effusions	 	CRISPRi	clustered regularly interspaced short palindromic repeats interference	 	FAP	Fibroblast activation protein- alpha.	 	</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10616833</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37915578</oboInOwl:hasDbXref>
        <rdfs:label>PMN-MDSCs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000094"/>
        <skos:relatedMatch rdf:resource="CL:0000889"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/f1777934-7bc2-4a3a-80a8-649342102f7d"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000094"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/f1777934-7bc2-4a3a-80a8-649342102f7d"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000889"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/f1d81492-704e-4c3d-b0ec-64787190b888 -->

    <Class rdf:about="http://example.org/f1d81492-704e-4c3d-b0ec-64787190b888">
        <obo:IAO_0000115>Brain transcriptional changes after MIA require microglia. (A) Simplified schematic of sample processing pipeline from and bar plots of TORCH pathogen and cytokine receptor expression (mean log counts per million) in each cell type across development. (B) Violin plot of CytoTORCH module score for each cell cluster (MG, P&lt;0.05 for ANOVA and for pairwise comparisons between microglia and all other cell types using Tukey&apos;s HST). (C) Overview of experimental design (top) and UMAP visualization of snRNAseq data from the developing somatosensory cortex of E15.5 wild-type and Csf1r-/- mice after saline or Poly(I:C) maternal injection at E12.5 (two or three embryos per condition from a total of four pregnant dams, 42,736 total cells) (bottom). Cells are colored by cell type assignment. (D) Dot plots of log(fold change) in gene expression between MIA and saline for cell types with significant changes at E15.5. DEG analysis was performed using NEBULA. AP, apical progenitors; IP, intermediate progenitors; ImmN, immature neurons, MN, ##migrating neurons##; (UL/DL) CPN, (upper layer/deep layer) callosal projection neurons; SCPN, subcerebral projection neurons; CThPN, corticothalamic projection neurons; LIV, layer IV stellate neurons; IN, interneurons; CR, Cajal-Retzius cells; Astro, astrocytes; CGC, cycling glial cells; Epend; ependymal cells; OL, oligodendroglia; MG, microglia; Peri, pericytes; EC, endothelial cells; VLMC, vascular and leptomeningeal cells. Created with .</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11190434</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38775708</oboInOwl:hasDbXref>
        <rdfs:label>migrating neurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000540"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/f1d81492-704e-4c3d-b0ec-64787190b888"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000540"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/f1e97932-236d-49aa-8b01-dea3909cd9f7 -->

    <Class rdf:about="http://example.org/f1e97932-236d-49aa-8b01-dea3909cd9f7">
        <obo:IAO_0000115>Immunological changes in Foxp3+Helios+ and Foxp3+CD25+ Tregs during T. pallidum/HIV-1 co-infection. The gating strategy for the analysis of Foxp3+CD25+ and Foxp3+Helios+ (A) cells is indicated. The frequencies of Foxp3+CD25+ Treg cells (B) and Foxp3+Helios+ Treg cells (C) were analyzed by flow cytometry in the HC, RPR+, CHI, and CHI&amp;RPR+ groups. Frequencies of Foxp3+CD25+CD45RA+ Treg cells (D), Foxp3+Helios+CD45RA+ Treg cells (E), Foxp3+CD25+CD45RO+ Tregs (F), and Foxp3+Helios+CD45RO+ Tregs (G) were analyzed by flow cytometry in the HC, RPR+, CHI, and CHI&amp;RPR+ groups. The correlations between the CD4+ T-cell counts and the frequencies of Foxp3+Helios+ Treg cells (H) and ##Foxp3+Helios+CD45RO+ cells## (I) in the CHI group were evaluated with Spearman&apos;s rank correlation test. Significance was assessed by calculating p-values using ANOVA, Student&apos;s t-tests, or Mann-Whitney U-tests, with values of p &lt; 0.05 considered significant.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6465566</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31024549</oboInOwl:hasDbXref>
        <rdfs:label>Foxp3+Helios+CD45RO+ cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000815"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/f1e97932-236d-49aa-8b01-dea3909cd9f7"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000815"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/f1ea5e8b-550b-475e-8aef-33511b2248b3 -->

    <Class rdf:about="http://example.org/f1ea5e8b-550b-475e-8aef-33511b2248b3">
        <obo:IAO_0000115>Next, we merged the datasets for the five time-points using the merge function of the Seurat pipeline, which combines multiple datasets without transforming the data. The merged dataset with a total of 62,202 cells was processed for clustering and then the data were visualized as a UMAP plot (Fig. 3). The same set of cell clusters identified in individual time-point data was also identified in the merged dataset (Fig. 3A,E and Fig. S6). The downregulation of PAX2 and upregulation of FBXO2 from otic prosensory cells to ##intermediate otic cells## and supporting cells were confirmed with this analysis (Fig. 3E). A DACH1+ SPP1+ population was detected adjacent to OC90+ intermediate otic cells (Fig. 3D, Figs S7 and S8), suggesting the existence of another lineage direction in the otic lineage other than the sensory epithelium. TFAP2B+ surface ectoderm cells, NEUROD1+ neuroblasts and S100B+ neural crest/Schwann cells were identified as distinctive clusters (Fig. 3A,D and Fig. S7). An intermediate population between otic prosensory cells and supporting cells expressed not only otic epithelium markers EPCAM and FBXO2, but also other otic progenitor markers COL9A1, SERPINF1, HES1, AATF, COL14A1, OC90, PRSS8 and EYA4 (Fig. S7), suggesting that this is an otic epithelial cell population differentiating into hair cells and supporting cells. Adjacent to the supporting cell cluster, there was a POU4F3+ hair cell cluster that expressed vestibular hair cell markers [CD164L2, ZBBX, TEKT1, SKOR1, TCTEX1D1 (DYNLT5) and NEUROD6] and type II hair cell markers (ANXA4, MAPT and NHLH1) (Fig. 3D and Fig. S8), indicative of an immature type II hair cell identity. However, we were unable to detect the cochlear marker GATA3 or INSM1 in PCP4+ hair cells (Fig. S8G,H). Surprisingly, we were unable to identify common progenitor populations that differentiate into both hair cells and supporting cells in the merged datasets.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10323240</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37381908</oboInOwl:hasDbXref>
        <rdfs:label>intermediate otic cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000048"/>
        <skos:relatedMatch rdf:resource="CL:0000202"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/f1ea5e8b-550b-475e-8aef-33511b2248b3"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000048"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/f1ea5e8b-550b-475e-8aef-33511b2248b3"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000202"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/f1eede1e-189e-4472-ba3a-5ba9654e5aba -->

    <Class rdf:about="http://example.org/f1eede1e-189e-4472-ba3a-5ba9654e5aba">
        <obo:IAO_0000115>Differentiation trajectory of pathological osteoclasts in arthritis. BM-derived CX3CR1loLy6Chi cells (R1) ingress into the synovium (R2) and produce inflammatory cytokines, chemokines, and VEGFA. Abundant M-CSF in the inflamed synovium induces maturation of some R2 cells into osteoclast precursors, arthritis-associated osteoclastogenic macrophages (##AtoMs##/R3 cells). When AtoMs localize adjacent to the bone surface, simultaneous stimulation with RANKL and TNF promotes osteoclast formation, leading to joint destruction in arthritis.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9024112</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35464401</oboInOwl:hasDbXref>
        <rdfs:label>AtoMs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
        <skos:relatedMatch rdf:resource="CL:0000778"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/f1eede1e-189e-4472-ba3a-5ba9654e5aba"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/f1eede1e-189e-4472-ba3a-5ba9654e5aba"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000778"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/f1faea1f-e31b-4a2b-9703-e8abbe00fb57 -->

    <Class rdf:about="http://example.org/f1faea1f-e31b-4a2b-9703-e8abbe00fb57">
        <obo:IAO_0000115>The composition of cell subsets across all cell lineages differed between the YA and AA groups. Among TCs, CD4+ TCs were increased, CD8+ TCs were decreased, and CD4+CD8+ and proliferating T cells were increased in the AA group (Fig. 2B and 2C). Moreover, naive TCs, especially CD4 Naive and CD8 Naive, showed a common distribution in the YA group but were reduced in the aged group (P = 0.0175, Fig. 2D-G). Conversely, effector, memory and exhausted cell subsets were dominant in the aged group (Fig. 2H-K). The AA group also had a diminished proportion of the CD56bright NK1 population and an expansion of the ##NK##2 and late NK3 populations (Fig. S5C and S5D). Analysis of BC clusters revealed that Naive BCs were decreased while ABCs were mildly increased in the AA group compared to the YA group (Fig. S5E and S5F).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7417788</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32780218</oboInOwl:hasDbXref>
        <rdfs:label>NK</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000623"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/f1faea1f-e31b-4a2b-9703-e8abbe00fb57"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000623"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/f24e19a2-e7d5-42b9-ad2f-be203e2d1217 -->

    <Class rdf:about="http://example.org/f24e19a2-e7d5-42b9-ad2f-be203e2d1217">
        <obo:IAO_0000115>Tumor types Mutant genes The contributed cells for tumors References   Trichofolliculomas/papillomatricomas beta-catenin Krt 14+ cells    Pilomatricomas beta-catenin Lgr5+ cells    Dermatofibromas beta-catenin Lgr6+ cells    Trichoadenomas beta-catenin Lrig1+ cells    No tumor beta-catenin Krt15+ cells    Sebaceous tumors Lef1 ##Krt14+ cells##    Basal cell carcinoma(BCC) Patched IFE cells/bulge stem cells(major contribution)    BCC Smoothened IFE cells    BCC Smoothened (in the context of wound) Krt15+ bulge stem cells    Papillomas KRAS Krt19+, Krt15+ and Involucrin+ cells    Invasive squamous cell carcinoma (SCC) P53 and KRAS --    SCC (DMBA-TPA method) HRAS Long-lived stem cells    Papilloma and SCC HRAS Krt5+ cells    </obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9391238</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35143021</oboInOwl:hasDbXref>
        <rdfs:label>Krt14+ cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000066"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/f24e19a2-e7d5-42b9-ad2f-be203e2d1217"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000066"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/f250417a-396f-47e2-8386-8fd5deee3208 -->

    <Class rdf:about="http://example.org/f250417a-396f-47e2-8386-8fd5deee3208">
        <obo:IAO_0000115>a Line drawing of a cross section of the floor of the cochlear duct at P1. Distinct cell types within the organ of Corti (OC) are color coded. b Heat map for ~14,000 cochlear cells collected from four separate experiments at P1. Top 25 differentially expressed (DE) genes for the 15 identified clusters are shown. Cellular identity for each cluster is indicated by a color bar at the top of the heat map, which corresponds to the legend in a, and by a cell name at the bottom. c tSNE plot for the same cells as in b. Cluster identities are indicated. d Violin plots showing normalized log-transformed expression values for the top five DE genes for each cell type (color coded as in c) by comparison with all other P1 cells (gray on the right in each graph). Bars indicate median expression level. e Upper left panel, tSNE plot of cells determined to be derived from KO (between the OC and medial edge of the cochlear duct). Lower left panel, feature plot for the same cells as in the upper panel indicating high expression of Otoa, Calb1, and Fabp7 (based on color) in different clusters of cells. Lower right panel, cross sections through the cochlear duct at P1, illustrating expression of CALB1 in the medial region of KO and FABP7 directly adjacent to the OC (arrow; scale bars, 20 mum). Lowest panel shows high-magnification view of expression of FABP7 (arrow, gray scale) at the lateral KO border (green line; scale bar, 10 mum). Upper right panel, summary diagram of the spatial distribution of KO cell clusters at P1. HC hair cells, IPhC inner phalangeal cells/border cells, IPC inner pillar cells, OPC outer pillar cells, DC1/2 Deiters&apos; cells rows 1 and 2, ##DC3##, Deiters&apos; cells row 3, HeC Hensen&apos;s cells, CC/OSC Claudius cells/outer sulcus cells, IdC interdental cells, ISC inner sulcus cells, KO Kolliker&apos;s organ cells, L.KO lateral Kolliker&apos;s organ cells, M.KO medial Kolliker&apos;s organ cells, OC90 OC90+ cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7221106</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32404924</oboInOwl:hasDbXref>
        <rdfs:label>DC3</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000635"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/f250417a-396f-47e2-8386-8fd5deee3208"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000635"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/f25dca7d-ed39-4709-9143-7e1ca1c624e1 -->

    <Class rdf:about="http://example.org/f25dca7d-ed39-4709-9143-7e1ca1c624e1">
        <obo:IAO_0000115>Focusing on the peripheral, differentiated cDC populations, we next assessed protein expression of the IRF8 transcription factor in tumor-derived cDC populations (Fig. 3a). In the periphery, IRF8 controls survival and function of terminally differentiated cDC1s. Furthermore, increased IRF8 expression in CD11b-CD103- DN cells was shown to promote their differentiation into mature CD103+ cDC1s. Thus, we hypothesized that CD40L-CAR T cell treatment skews the cDC1/cDC2 ratio towards the cDC1 populations by stimulating the DN cells to expand, upregulate IRF8, and differentiate into cDC1s. We specifically noticed upregulation of IRF8 (readout of DN-to-cDC1 differentiation) and Ki-67 (readout for proliferation) in DN cells treated with CD40L-CAR T cell-treated mice (Fig. 3b). The increased expression of Ki-67 in the tumor-derived DN cells also correlated with the observed increase of the DN population in the tumor of CD40L-CAR T cell-treated mice (Fig. 1f), indicating that DN cells receive a proliferative signal upon CD40L-CAR T cell treatment. Intriguingly, splenic DN cells and DN cells from the tdLNs did not upregulate Ki-67 or IRF8 (Fig. 3c, d). Overall, tdLN cDCs did not present with a stimulated phenotype, as suggested by the lack of CD86 or Ki-67 upregulation (Supplementary Fig. 2D-G). This suggested a tumor-specific effect of ##cDC DN## stimulation after m1928z-CD40L treatment.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7710757</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33268774</oboInOwl:hasDbXref>
        <rdfs:label>cDC DN</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002510"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/f25dca7d-ed39-4709-9143-7e1ca1c624e1"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002510"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/f266403a-556d-4aa8-8e0d-9cf843698c30 -->

    <Class rdf:about="http://example.org/f266403a-556d-4aa8-8e0d-9cf843698c30">
        <obo:IAO_0000115>a Due to single-cell annotation and in situ validation (Fig. 2; Supplementary Fig. 3), a draft model of the oral-to-tooth transition zone in humans is presented, with basal and suprabasal keratinocyte markers uniquely identifying the alveolar mucosa (AM), attached gingiva (AG), gingival margin (GM), sulcular epithelium (SK) and junctional epithelium (JK). b These markers allowed for KRT19-high keratinocyte (KC) cell subclustering for the first time (2504 cells in total), including gingival margin keratinocytes (GM), sulcular keratinocytes (SK), and junctional keratinocytes (JK). c A more granular draft (Tier 4) annotation of epithelial cells of the gingival attachment. d Assaying differentially expressed genes in periodontitis, SKs and ##JKs## only share about a quarter of upregulated genes. JKs displayed nearly 125 unique upregulated genes in diseased cells. e Further analysis of basal and suprabasal (differentiating) SK and JK keratinocytes revealed unique cell signatures between basal and suprabasal cell types. This full list is included in Supplementary Data 1. f-i To understand SK and JK developmental progression and cell state alterations, we used partitioned-based graph abstraction (PAGA). f Examining the basal to suprabasal transition, JKs display altered gene expressed comparing health to disease cell types, including broader expression of KRT17 and more expression of JUND, COL17A1, and CDH3. Key differentiation genes such as SPRR family members were also downregulated. g JKs displayed robust cell signaling and inflammatory phenotypes, which appear exacerbated in disease states. h In SKs, differentiation-related genes were uniquely expressed compared to JKs in health but also appeared altered in disease along the basal to suprabasal trajectory. i SKs appeared generally less reactive compared to JKs in disease, with lower overall expression of effector molecules such as CXCL1, CXCL8, IL1A, IL1B, and IL1RN. Abbreviations: Merk Merkel Cells, LC langerhans cells, Mela melanocytes, Muc mucosa, SB suprabasal Keratinocytes; for others, see Fig. 1 legend. For this figure, n = 30-sample, 2504-cell for scRNAseq.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11178863</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38876998</oboInOwl:hasDbXref>
        <rdfs:label>JKs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002170"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/f266403a-556d-4aa8-8e0d-9cf843698c30"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002170"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/f27dd3f8-11ae-42df-babb-a73517b38029 -->

    <Class rdf:about="http://example.org/f27dd3f8-11ae-42df-babb-a73517b38029">
        <obo:IAO_0000115>Transcriptional analysis of induced ##hair cells## (iHCs) indicates expression profile similarity to primary cochlear hair cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7326493</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32602462</oboInOwl:hasDbXref>
        <rdfs:label>hair cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:4023120"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/f27dd3f8-11ae-42df-babb-a73517b38029"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4023120"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/f29be601-5a46-49a7-a3e9-6b43068ccc38 -->

    <Class rdf:about="http://example.org/f29be601-5a46-49a7-a3e9-6b43068ccc38">
        <obo:IAO_0000115>As can be seen from Fig. 2b, the fibroblasts which highly expressed HBEGF (average expression of HBEGF higher than 1.5) were distributed into a small group. Then we defined them as ##HBEGF+ fibroblasts## and fibroblasts with low expression of HBEGF were defined as HBEGF- fibroblasts. Referring to the previous studies, macrophages with high or low expression of HBEGF were defined as HBEGF+ macrophages and HBEGF- macrophages separately (Fig. 3a).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9446562</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36068607</oboInOwl:hasDbXref>
        <rdfs:label>HBEGF+ fibroblasts</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000057"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/f29be601-5a46-49a7-a3e9-6b43068ccc38"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000057"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/f2b5f3f3-a35f-44e0-83ad-9e2fb1fbfd37 -->

    <Class rdf:about="http://example.org/f2b5f3f3-a35f-44e0-83ad-9e2fb1fbfd37">
        <obo:IAO_0000115>Transplanted DASCs give rise to AT1 cells and ##proliferating DASCs## in vivo. (A) Pseudo-time trajectory projected onto a UMAP of all engrafted cells. The red dot indicates the start point of the trajectory. Pseudo-time values are colour coded. (B) Cell density of three clusters along inferred cellular trajectory reflecting differentiation process. Cells are ordered by pseudo-time (cell-to-cell distance metric). (C) Expression of specific genes along the cell trajectory important for the differentiation paths. The dots indicate the gene expression of individual cells. Trp63 = p63</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8168420</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33960563</oboInOwl:hasDbXref>
        <rdfs:label>proliferating DASCs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002633"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/f2b5f3f3-a35f-44e0-83ad-9e2fb1fbfd37"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002633"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/f2cac447-9e34-461b-8612-48a09cf53a64 -->

    <Class rdf:about="http://example.org/f2cac447-9e34-461b-8612-48a09cf53a64">
        <obo:IAO_0000115>A key result of our study is the presence of Cplx 2 and the most likely absence of Cplx 1 in conventional chemical synapses of normal and displaced amacrine cells (Figure 2, Figure 6, Figure 8 and Figure 10). Cplx 2 (protein and mRNA) was found in GABAergic, cholinergic and dopaminergic amacrine cells but not in glycinergic amacrine cells (Figure 6 and Figure 10), which contain Cplx 3. The glutamatergic vGluT3 amacrine cells also contained no Cplx 2 (Figure 7 and Figure 10). VGluT3 amacrine cells represent an unconventional type of amacrine cell with dual release of glycine and glutamate at segregated synaptic sites. It is suggested that the release of an inhibitory and an excitatory neurotransmitter into two separate neuronal circuits by the ##vGluT3 amacrine cells## facilitates differential detection of visual field uniformity and contrast. As Cplx 3 is found in glycinergic amacrine cells and glutamatergic rod bipolar cells, we analyzed its presence in vGluT3 amacrine cells. We could not detect Cplx 3 in these retinal interneurons, just as we could not detect Cplx 4 in vGluT3 amacrine cells (Figure 7). The absence of Cplxs 1 to 4 from vGluT3 amacrine cells suggests a Cplx-independent release of neurotransmitters. Likewise, for the auditory sensory cells of the cochlea, the inner hair cells, it has been suggested that they release glutamate at their ribbon synapses independent of neuronal SNARE proteins and SNARE regulators, such as Cplxs and synaptotagmins.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8348166</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34360929</oboInOwl:hasDbXref>
        <rdfs:label>vGluT3 amacrine cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000561"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/f2cac447-9e34-461b-8612-48a09cf53a64"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000561"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/f33ab599-e5cd-4696-8f58-e9234347f5e9 -->

    <Class rdf:about="http://example.org/f33ab599-e5cd-4696-8f58-e9234347f5e9">
        <obo:IAO_0000115>Brain-derived neurotrophic factor (BDNF) and neurotrophin 3 (NT-3) are known to regulate neuronal morphology and the formation of neural circuits, yet the neuronal targets of each neurotrophin are still to be defined. To address how these neurotrophins regulate the morphological and synaptic differentiation of developing olfactory bulb (OB) GABAergic interneurons, we analyzed the effect of BDNF and NT-3 on GABA+-neurons and on different subtypes of these neurons: tyrosine hydroxylase (TH+); calretinin (Calr+); ##calbindin## (Calb+); and parvalbumin (PVA+). These cells were generated from cultured embryonic mouse olfactory bulb neural stem cells (eOBNSCs) and after 14 days in vitro (DIV), when the neurons expressed TrkB and/or TrkC receptors, BDNF and NT-3 did not significantly change the number of neurons. However, long-term BDNF treatment did produce a longer total dendrite length and/or more dendritic branches in all the interneuron populations studied, except for PVA+-neurons. Similarly, BDNF caused an increase in the cell body perimeter in all the interneuron populations analyzed, except for PVA+-neurons. GABA+- and TH+-neurons were also studied at 21 DIV, when BDNF produced significantly longer neurites with no clear change in their number. Notably, these neurons developed synaptophysin+ boutons at 21 DIV, the size of which augmented significantly following exposure to either BDNF or NT-3. Our results show that in conditions that maintain neuronal survival, BDNF but not NT-3 promotes the morphological differentiation of developing OB interneurons in a cell-type-specific manner. In addition, our findings suggest that BDNF and NT-3 may promote synapse maturation by enhancing the size of synaptic boutons.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMID:33392918</oboInOwl:hasDbXref>
        <rdfs:label>calbindin</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:4033029"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/f33ab599-e5cd-4696-8f58-e9234347f5e9"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4033029"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/f3541186-b4e6-4034-a356-d8ec5130dfc2 -->

    <Class rdf:about="http://example.org/f3541186-b4e6-4034-a356-d8ec5130dfc2">
        <obo:IAO_0000115>Within a limbic cortico-basal ganglia-thalamo-cortical signaling loop, the nucleus accumbens (NAc), in particular the dorsolateral NAc subregion, is suggested to play an important role in decision-making via its role in linking information concerning outcome values with that related to goal selection. NAc medium spiny projection neurons (MSN), the major neuron type, are typically anatomically divided into two roughly equal subpopulations; dopamine D1 receptor-expressing MSNs (D1-MSN) that project predominantly to the ventral pallidum (VP) and substantia nigra pars reticulata (SNr), and dopamine D2 receptor-expressing MSNs (D2-MSN) that project predominantly to the VP. While previous studies have demonstrated ##NAc D1-MSNs## to be implicated in reward-related learning and D2-MSNs to be involved in aversion-related learning and behavioral flexibility, the specific role that NAc D1- and D2-MSNs may play in the inhibition of behavioral responses is less clear.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10121661</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37085502</oboInOwl:hasDbXref>
        <rdfs:label>NAc D1-MSNs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:4030051"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/f3541186-b4e6-4034-a356-d8ec5130dfc2"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4030051"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/f38490e5-e24d-41cd-b3b5-5bb2a3e0a2b6 -->

    <Class rdf:about="http://example.org/f38490e5-e24d-41cd-b3b5-5bb2a3e0a2b6">
        <obo:IAO_0000115>Childhood neuroblastoma has a remarkable variability in outcome. Age at diagnosis is one of the most important prognostic factors, with children less than 1 year old having favorable outcomes. Here we study single-cell and single-nuclei transcriptomes of neuroblastoma with different clinical risk groups and stages, including healthy adrenal gland. We compare tumor cell populations with embryonic mouse sympatho-adrenal derivatives, and post-natal human adrenal gland. We provide evidence that low and high-risk neuroblastoma have different cell identities, representing two disease entities. Low-risk neuroblastoma presents a transcriptome that resembles sympatho- and chromaffin cells, whereas malignant cells enriched in high-risk neuroblastoma resembles a subtype of ##TRKB+ cholinergic progenitor## population identified in human post-natal gland. Analyses of these populations reveal different gene expression programs for worst and better survival in correlation with age at diagnosis. Our findings reveal two cellular identities and a composition of human neuroblastoma tumors reflecting clinical heterogeneity and outcome.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8423786</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34493726</oboInOwl:hasDbXref>
        <rdfs:label>TRKB+ cholinergic progenitor</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:3000003"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/f38490e5-e24d-41cd-b3b5-5bb2a3e0a2b6"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:3000003"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/f3d046b0-de64-46a4-9d65-fe92d61afd04 -->

    <Class rdf:about="http://example.org/f3d046b0-de64-46a4-9d65-fe92d61afd04">
        <obo:IAO_0000115>Focusing on the peripheral, differentiated cDC populations, we next assessed protein expression of the IRF8 transcription factor in tumor-derived cDC populations (Fig. 3a). In the periphery, IRF8 controls survival and function of terminally differentiated cDC1s. Furthermore, increased IRF8 expression in CD11b-CD103- DN cells was shown to promote their differentiation into mature CD103+ cDC1s. Thus, we hypothesized that CD40L-CAR T cell treatment skews the ##cDC1##/cDC2 ratio towards the cDC1 populations by stimulating the DN cells to expand, upregulate IRF8, and differentiate into cDC1s. We specifically noticed upregulation of IRF8 (readout of DN-to-cDC1 differentiation) and Ki-67 (readout for proliferation) in DN cells treated with CD40L-CAR T cell-treated mice (Fig. 3b). The increased expression of Ki-67 in the tumor-derived DN cells also correlated with the observed increase of the DN population in the tumor of CD40L-CAR T cell-treated mice (Fig. 1f), indicating that DN cells receive a proliferative signal upon CD40L-CAR T cell treatment. Intriguingly, splenic DN cells and DN cells from the tdLNs did not upregulate Ki-67 or IRF8 (Fig. 3c, d). Overall, tdLN cDCs did not present with a stimulated phenotype, as suggested by the lack of CD86 or Ki-67 upregulation (Supplementary Fig. 2D-G). This suggested a tumor-specific effect of cDC DN stimulation after m1928z-CD40L treatment.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7710757</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33268774</oboInOwl:hasDbXref>
        <rdfs:label>cDC1</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000990"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/f3d046b0-de64-46a4-9d65-fe92d61afd04"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000990"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/f3dbbbde-1987-4dc4-99fe-0cdb6c4291fd -->

    <Class rdf:about="http://example.org/f3dbbbde-1987-4dc4-99fe-0cdb6c4291fd">
        <obo:IAO_0000115>One possible explanation for these results is that products of NADPH oxidase can compensate for the mitochondrion-targeted catalase-catalyzed H2O2 breakdown. To test this hypothesis, we crossed the mCAT transgene to the p91phox-/- background and generated mixed bone marrow chimeric mice to compare the cell intrinsic fungicidal activities of CD45.1+ p91phox-/- and CD45.2+ p91phox-/- mCATTg/+ leukocytes in the same lung (Fig. S1 and S2), as outlined above. Following infection with FLARE conidia, AM conidial uptake was reduced in ##p91phox-/- mCATTg/+ AMs## (34% +- 5%) compared to p91phox-/- (50% +- 6%) counterparts at 24 h postinfection (Fig. 4A and B). In addition, intraleukocyte conidial viability was higher in p91phox-/- mCATTg/+ AMs (60% +- 2%) compared to p91phox-/- (28% +- 7%) counterparts that had intact mtH2O2 levels, though the difference did not reach statistical significance (Fig. 4C). The previously observed mCAT-dependent defect in conidial uptake by Mo-DCs was not observed in the context of NADPH oxidase deficiency (Fig. 4B). Mo-DC and neutrophil intracellular conidial killing in p91phox-/- mice was slightly higher with mCAT transgene expression compared to nontransgenic counterparts, consistent with the idea that mtH2O2 did not contribute to conidiacidal activity in these cell types (Fig. 4C).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8265640</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34077261</oboInOwl:hasDbXref>
        <rdfs:label>p91phox-/- mCATTg/+ AMs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000583"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/f3dbbbde-1987-4dc4-99fe-0cdb6c4291fd"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000583"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/f3dc3980-dd8f-44be-b6f7-943b2d7b110b -->

    <Class rdf:about="http://example.org/f3dc3980-dd8f-44be-b6f7-943b2d7b110b">
        <obo:IAO_0000115>Immunological changes in Foxp3+Helios+ and Foxp3+CD25+ Tregs during T. pallidum/HIV-1 co-infection. The gating strategy for the analysis of Foxp3+CD25+ and Foxp3+Helios+ (A) cells is indicated. The frequencies of Foxp3+CD25+ Treg cells (B) and Foxp3+Helios+ Treg cells (C) were analyzed by flow cytometry in the HC, RPR+, CHI, and CHI&amp;RPR+ groups. Frequencies of Foxp3+CD25+CD45RA+ Treg cells (D), Foxp3+Helios+CD45RA+ Treg cells (E), ##Foxp3+CD25+CD45RO+ Tregs## (F), and Foxp3+Helios+CD45RO+ Tregs (G) were analyzed by flow cytometry in the HC, RPR+, CHI, and CHI&amp;RPR+ groups. The correlations between the CD4+ T-cell counts and the frequencies of Foxp3+Helios+ Treg cells (H) and Foxp3+Helios+CD45RO+ cells (I) in the CHI group were evaluated with Spearman&apos;s rank correlation test. Significance was assessed by calculating p-values using ANOVA, Student&apos;s t-tests, or Mann-Whitney U-tests, with values of p &lt; 0.05 considered significant.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6465566</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31024549</oboInOwl:hasDbXref>
        <rdfs:label>Foxp3+CD25+CD45RO+ Tregs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000815"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/f3dc3980-dd8f-44be-b6f7-943b2d7b110b"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000815"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/f4573075-df99-4086-b2fb-d0f818b212ee -->

    <Class rdf:about="http://example.org/f4573075-df99-4086-b2fb-d0f818b212ee">
        <obo:IAO_0000115>Overview of human bone marrow adult definitive erythropoiesis. Multipotent haematopoietic stem cells with long term self-renewal capacity differentiate along a continuum of cell stages defined by their expansive capacity, degree of commitment to the erythroid lineage and morphological characteristics as illustrated. Burst forming units (BFU-E), the earliest committed erythroid cells expand predominantly in response to stem cell factor with the combined synergistic influence of erythropoietin driving continued proliferation of Colony forming units (CFU-E). Terminal differentiation of resultant proerythroblasts to enucleated reticulocytes takes place within the bone marrow niche within erythroblastic islands that consist of multiple differentiating erythroblasts docked to a central macrophage. Terminal differentiation is characterised by progression through a series of morphologically defined stages (proerythroblast, basophilic erythoblast, polychromatic erythroblasts, orthochromatic erythroblast and reticulocyte). The process is characterised by loss of cellular volume, haemoglobinisation, expression of erythroid specific genes, nuclear condensation, organelle degradation and extrusion of the condensed nucleus (pyrenocyte) to generate a ##nascent reticulocyte##. The pyrenocyte is phagocytosed by the macrophage and the reticulocyte enters the bloodstream, completing its maturation to definitive biconcave erythrocyte in the circulation over the subsequent 24-48 hours. Figure created with .</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9702814</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36452302</oboInOwl:hasDbXref>
        <rdfs:label>nascent reticulocyte</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000558"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/f4573075-df99-4086-b2fb-d0f818b212ee"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000558"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/f462025c-21e9-40ff-ba92-c69fc66bd30f -->

    <Class rdf:about="http://example.org/f462025c-21e9-40ff-ba92-c69fc66bd30f">
        <obo:IAO_0000115>Based on improved knowledge of human B cell populations derived from recent studies, we sought to characterize the B cell precursors of IgE ASC through a combination of phenotypic, BCR repertoire and molecular analyses. Our experimental model was based on the hypothesis that the study of nasal polyps (NP), would provide a rich environment for ongoing IgE ASC differentiation from different cellular precursors in the absence of GC. In keeping with this model, we identified a novel human EF mucosal B cell population (CD19+IgD+CD27-) as the origin of mucosal IgE ASC. This population shared many of the phenotypic and transcriptional features of activated naive B cells recently shown in the EF response of patients with active autoimmune disease and severe SARS-CoV-2 infection. These mucosal IgD+ B cells are characterized by: (1) a high degree of clonal connectivity with IgE ASC, (2) an activated phenotype (CD11c+CD86+CD71+Nur77+CD21-), (3) a progressive transcriptome between resting blood naive B cells and NP ASC, and (4) the highest level of germline epsilon transcripts. Notably, the majority of the IgD+ NP B cells expressed IgM sequences with low mutation rates, a profile consistent with activated naive B cells. However, IgD+ NP B cells also contained a smaller fraction of cells with very high rates of somatic hypermutation previously demonstrated in ##class-switched IgD-only B cells## (IgD+IgM-; Cdelta-CS), reported in the literature within either GC, memory and ASC populations. Interestingly, the analysis of single cell IgE ASC demonstrated lower mutation relative to ASC of other isotypes including IgG, IgA, or the highly mutated IgD ASC. In summary, human mucosal IgE ASC originate from an EF mucosal activated IgD+ B cell subset in patients with atopic and non-atopic airways disease.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8160425</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34050324</oboInOwl:hasDbXref>
        <rdfs:label>class-switched IgD-only B cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000236"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/f462025c-21e9-40ff-ba92-c69fc66bd30f"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000236"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/f47de483-b7e9-4dca-905c-519f59409a16 -->

    <Class rdf:about="http://example.org/f47de483-b7e9-4dca-905c-519f59409a16">
        <obo:IAO_0000115>Two identified L2 marginal neurons (L2MN, with an AD that runs oblique to the pial surface, Figure 5a,) showed putative inhibitory synapse fractions at their main bifurcation that were consistent with that of other ##L2 neurons## (Figure 5e, 53.2% and 27.8% putative inhibitory fraction for L2MN).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7297530</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32108571</oboInOwl:hasDbXref>
        <rdfs:label>L2 neurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:4042012"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/f47de483-b7e9-4dca-905c-519f59409a16"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4042012"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/f4af5d9f-359a-46f4-a7cd-35cedb7e4fd7 -->

    <Class rdf:about="http://example.org/f4af5d9f-359a-46f4-a7cd-35cedb7e4fd7">
        <obo:IAO_0000115>Variants within the high copy number mitochondrial genome (mtDNA) can disrupt organelle function and lead to severe multisystem disease. The wide range of manifestations observed in patients with mitochondrial disease results from varying fractions of abnormal mtDNA molecules in different cells and tissues, a phenomenon termed heteroplasmy. However, the landscape of heteroplasmy across cell types within tissues and its influence on phenotype expression in affected patients remains largely unexplored. Here, we identify nonrandom distribution of a pathogenic mtDNA variant across a complex tissue using single-cell RNA-Seq, mitochondrial single-cell ATAC sequencing, and multimodal single-cell sequencing. We profiled the transcriptome, chromatin accessibility state, and heteroplasmy in cells from the eyes of a patient with mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) and from healthy control donors. Utilizing the retina as a model for complex multilineage tissues, we found that the proportion of the pathogenic m.3243A&gt;G allele was neither evenly nor randomly distributed across diverse cell types. All neuroectoderm-derived neural cells exhibited a high percentage of the mutant variant. However, a subset of mesoderm-derived lineage, namely the vasculature of the choroid, was near homoplasmic for the WT allele. Gene expression and chromatin accessibility profiles of cell types with high and low proportions of m.3243A&gt;G implicate mTOR signaling in the cellular response to heteroplasmy. We further found by multimodal single-cell sequencing of ##retinal pigment epithelial cells## that a high proportion of the pathogenic mtDNA variant was associated with transcriptionally and morphologically abnormal cells. Together, these findings show the nonrandom nature of mitochondrial variant partitioning in human mitochondrial disease and underscore its implications for mitochondrial disease pathogenesis and treatment.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10443808</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37289546</oboInOwl:hasDbXref>
        <rdfs:label>retinal pigment epithelial cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002586"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/f4af5d9f-359a-46f4-a7cd-35cedb7e4fd7"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002586"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/f4be0c84-ea98-4b8a-9635-3050525d2969 -->

    <Class rdf:about="http://example.org/f4be0c84-ea98-4b8a-9635-3050525d2969">
        <obo:IAO_0000115>a Schematic overview of the experimental workflow. Forebrain samples were collected from Sox2eGFP mice at 11 developmental timepoints, dissociated into single cells followed by sorting of the GFP + ve /-ve cells and performing single-cell RNA-seq using the 10x Genomics Chromium platform. b Left: two-dimensional Uniform manifold approximation and progression (UMAP) plot with Leiden clustering of 102,504 individual cells identifying 28 transcriptionally and biologically distinct cell types (see Supplementary Fig. 3a and Methods). Each dot represents a single cell and colours correspond to the distinct clusters/cell types. Shown on the right is a dot plot showing the relative fraction (dot size) of the 28 cell types at each developmental timepoint normalized by library size. c UMAP plot of the cells as in (b) but coloured by timepoint. Each dot represents a single cell and the colours correspond to the different timepoints. d, UMAP plot showing the coarse annotation of cells into 4 categories (Neuronal, Glial, Immune and Vascular/other) based on logistic regression from Zeisel et al. 2018. The RNA-velocity field is overlaid on the UMAP. Colours represent the 4 categories of cell annotation and the arrows correspond to the direction of the RNA-velocity flow field (see Methods). RG Radial glia, TAPs Transient amplifying progenitors, aNSCs Active neural stem cells, APCs Astrocyte progenitor cells, EmNBs Embryonic neuroblasts, GE NBs Ganglionic eminence neuroblasts, OPCs Oligoprogenitor cells, PreM-ODCs Immature pre-myelinating oligodendrocytes, INs Interneurons, ImStNeurons ##Immature striatal neurons##, VLMC Vascular leptomeningeal cells, Myeloid-DSCs Myeloid-derived suppressor cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9296666</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35853870</oboInOwl:hasDbXref>
        <rdfs:label>Immature striatal neurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002613"/>
        <skos:relatedMatch rdf:resource="CL:4042028"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/f4be0c84-ea98-4b8a-9635-3050525d2969"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002613"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/f4be0c84-ea98-4b8a-9635-3050525d2969"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4042028"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/f5446ab3-0561-4240-99b6-5f8b7d0af281 -->

    <Class rdf:about="http://example.org/f5446ab3-0561-4240-99b6-5f8b7d0af281">
        <obo:IAO_0000115>In RA, fibroblast-like synoviocytes (FLS) play a significant role in the initiation and perpetuation of destructive joint inflammation. ##RA FLS## express immuno-modulating cytokines, a variety of adhesion molecules and matrix remodelling enzymes. These cells display tumour-like characteristics like anchorage-independent growth, resistance to apoptosis, and elevated rates of cellular proliferation. In addition, they can cause damage by invading and attacking the adjacent cartilage and bone. Therefore, FLS-targeted therapies could be proposed as complementary approaches to immune-directed treatments to alleviate the debilitating symptoms of the disease.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7529794</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33004899</oboInOwl:hasDbXref>
        <rdfs:label>RA FLS</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002301"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/f5446ab3-0561-4240-99b6-5f8b7d0af281"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002301"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/f564c5ed-8e95-416c-a449-1cabed8bc94e -->

    <Class rdf:about="http://example.org/f564c5ed-8e95-416c-a449-1cabed8bc94e">
        <obo:IAO_0000115>In this review, we will discuss the phenotypic and functional heterogeneity of ##tissue resident synovial cells## in the context of joint homeostasis, inflammation and resolution. Furthermore, we will focus on important cross-talk which exist between different synovial tissue cells and finally, we will discuss potential new therapeutic strategies that target tissue resident synovial cells which could potentially restore homeostasis following chronic disease.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8446662</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34539648</oboInOwl:hasDbXref>
        <rdfs:label>tissue resident synovial cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000214"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/f564c5ed-8e95-416c-a449-1cabed8bc94e"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000214"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/f5e28724-8adf-4cb6-b391-2f1c5e2eaa32 -->

    <Class rdf:about="http://example.org/f5e28724-8adf-4cb6-b391-2f1c5e2eaa32">
        <obo:IAO_0000115>Our results so far indicate that the dura mater layer of the meninges contains a diverse population of stromal cells, including GP38+ and GP38- stromal cells that resemble the stroma of other lymphoid tissues and ECM remodelling. Consistent with our scRNAseq data, using flow cytometry, we observed a significant expansion of GP38+ FRCs, and a distinctive population of MAdCAM1+ CD21/CD35+ cells indicative of the presence of FDC-like cells in the infected murine meninges compared to naive controls (Fig 3D-3F; Gating strategy in S2A Fig, S5 and S6 Data), without significant changes in the lymphatic endothelial cells (LECs) or blood endothelial cells (BECs) (Fig 3E and 3F). Furthermore, using module scoring analysis, which allows us to assess global gene signatures associated with a gene set or pathway (in this case, ectopic lymphoid tissue signatures), we were able to identify that cells within cluster 5 were enriched for genes associated with FDC-like function and stromal lymphoid tissues, including Ccl19 and Cxcl13, compared to the other fibroblast clusters (Fig 3H), and may be derived from Ly6a+ pericytes with a precursor capacity as previously reported. Indeed, using in situ hybridisation on independent tissue sections, we were able to confirm the presence of Ly6a+ Rarres2+ cells that expressed Cxcl13+ during infection (Fig 3I). Together, our data demonstrate the presence of a rich diverse fibroblast population, encompassing ##Ly6a+ Rarres2+ FRC-like pericytes##, including Aldh1a2+ Ccl19+ FRC-like pericytes, myofibroblasts, Fth1+ fibroblasts, and perivascular dura fibroblasts. Our data also suggests that chronic T. brucei infection induces an extensive remodelling of the meningeal stroma compartment, resulting in the expansion of FRCs and FDC-like cells without significant changes in the vasculature (LECs and BECs).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10723712</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37983289</oboInOwl:hasDbXref>
        <rdfs:label>Ly6a+ Rarres2+ FRC-like pericytes</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000669"/>
        <skos:relatedMatch rdf:resource="CL:0009102"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/f5e28724-8adf-4cb6-b391-2f1c5e2eaa32"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000669"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/f5e28724-8adf-4cb6-b391-2f1c5e2eaa32"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0009102"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/f604c7d6-43cf-4f0f-ae35-68be86e170a6 -->

    <Class rdf:about="http://example.org/f604c7d6-43cf-4f0f-ae35-68be86e170a6">
        <obo:IAO_0000115>Innate T cells (##ITC##) contain many subsets and are poised to promptly respond to antigens and pathogens, but how this poised state is maintained is still unclear. Here the authors perform single-cell RNA-seq to align the various ITC subsets along an &apos;innateness gradient&apos; that is associated with changes in proliferation and effector functions.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6368609</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:30737409</oboInOwl:hasDbXref>
        <rdfs:label>ITC</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002127"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/f604c7d6-43cf-4f0f-ae35-68be86e170a6"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002127"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/f61f8463-1673-42a5-aa7b-ca5b6fb2a125 -->

    <Class rdf:about="http://example.org/f61f8463-1673-42a5-aa7b-ca5b6fb2a125">
        <obo:IAO_0000115>Overview of interactions among chondrocyte subtypes. (A,B) Total number and intensity of interactions in chondrocytes. (C-J) Interactions between different subtypes of chondrocytes. (C) indicates undefined cell subtypes, (D) indicates ECs, (E) indicates FCs, (F) indicates HomCs, (G) indicates HTCs, (H) indicates preHTCs, (I) indicates ##ProCs##, and (J) indicates RegCs.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10475121</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37660146</oboInOwl:hasDbXref>
        <rdfs:label>ProCs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000744"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/f61f8463-1673-42a5-aa7b-ca5b6fb2a125"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000744"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/f6252fad-1207-4fa1-ba89-0a8bc7481219 -->

    <Class rdf:about="http://example.org/f6252fad-1207-4fa1-ba89-0a8bc7481219">
        <obo:IAO_0000115>L5 NMC connectivity onto ##L4 FS cells##.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6422636</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:30883329</oboInOwl:hasDbXref>
        <rdfs:label>L4 FS cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:4030063"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/f6252fad-1207-4fa1-ba89-0a8bc7481219"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4030063"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/f62816c6-3ccb-42ae-bfe2-9c96c635c66b -->

    <Class rdf:about="http://example.org/f62816c6-3ccb-42ae-bfe2-9c96c635c66b">
        <obo:IAO_0000115>Immune cell markers in human blood and nasal polyp. (A, B) Opt-SNE plots show selected markers of the modified Maxpar Direct Immune Profiling Assay (MMDIPA panel), namely CD3, CD4, CD8a, CD11b, CD14, CD19, CD23, CD38, CD56, and FcepsilonRI in (A) Blood and (B) nasal polyp single cell suspensions acquired in Helios  (Standard BioTools). The scales vary throughout the plots according to the intensity presented by the markers. Plots shown are representative of three independent experiments. (C) Identification of immune cell populations in blood using mass cytometry. Opt-SNE show manually selected cell populations: Antibody Secreting Cells (ASCs), B Cells, CD4+ T Cells, CD8+ T Cells, Gamma-Delta T Cells, Mucosal-associated invariant T (MAIT) Cells, Natural Killer (NK) Cells, Myeloid Dendritic Cells (mDCs), Plasmacytoid Dendritic Cells (pDCs), Classical Monocytes, Non-classical Monocytes, and Basophils. (D) Identification of immune cell populations in nasal polyp using mass cytometry. Opt-SNE s show manually selected cell populations: ASCs, B Cells, CD4+ T Cells, CD8+ T Cells, Gamma-Delta T Cells, MAIT Cells, Type 2 Innate Lymphoid Cells (ILC2s), NK Cells, Dendritic Cells (DCs), Macrophages, Mast Cells, ##CD38+CD56+CD161+ Cells##. The manually annotated populations in (C) and (D) are overlaid as a color-dimension.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9791368</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36578479</oboInOwl:hasDbXref>
        <rdfs:label>CD38+CD56+CD161+ Cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000939"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/f62816c6-3ccb-42ae-bfe2-9c96c635c66b"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000939"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/f66d191a-6f0f-4e36-bd35-896e7bbcef5c -->

    <Class rdf:about="http://example.org/f66d191a-6f0f-4e36-bd35-896e7bbcef5c">
        <obo:IAO_0000115>Sequencing of CD45+ cells from 12- and 21-week-old WT and DB hindpaws generated an integrated dataset of 21,661 cells grouped into 12 clusters (Fig. 1c-f), defined as: macrophages (Pf4, C1qa, C1qc, Apoe, C1qb), type 2 conventional dendritic cells (cDC2) (CD74, H2-Aa, H2-Ab1, H2-Eb1, Mgl1), mast cells/basophils (M/B) (Mcpt2, Cma1, Cpa3, Mcpt4, Tpsb2), dermal gammadelta T (dTgammadelta) cells (Trdc, Cd163l1, Trdv4, Cxcr6, F2r), heterogeneous T (Thet) cells (Ikzf2, Ctla4, CD28, Trac, Icos), Type 2 innate lymphoid cells (ILC2) (Ctla2a, Gata3, Lmo4, Hlf, Il13), natural killer (NK) cells (Ccl5, xcl1, AW112010, Txk, Ly6c2), dendritic epidermal T cells (DETC; Cd7, Trat1, CD3e, Gem, Fermt2), ##type 1 conventional dendritic cells## (cDC1) cells (Irf8, CD207, Tbc1d4, Cst3, Naaa), B cells (Igkc, Ighm, Ebf1, CD79a, Iglc2), monocyte-derived macrophages (MdMacro) (Plac8, Ifitm3, Lst1, Chil3, Thbs1), and neutrophils (Neut) (S100a9, S100a8, Retnlg, G0s2, Acod1) (Fig. 1g, Supplementary Fig. 1 and Supplementary Table 2). After quality control and filtering, the number of single-cell transcriptomes was 3,946 (12-week-WT), 5,413 (12-week-DB), 4,852 (21-week-WT), and 7,450 (21-week-DB). When each sample was represented as a proportion of the integrated cluster total, variation in cell numbers in each cluster was apparent (Fig. 1e, f). Macrophages were the most abundant cell type across all samples, while mast cell/basophil (M/B), dermal gammadelta T cell (dTgammadelta), heterogeneous T cell (Thet), and Type 2 innate lymphoid cell (ILC2) populations were substantially increased in 21-week-DB mice (Fig. 1f and Supplementary Table 3).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10951029</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38502310</oboInOwl:hasDbXref>
        <rdfs:label>type 1 conventional dendritic cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000990"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/f66d191a-6f0f-4e36-bd35-896e7bbcef5c"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000990"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/f68b1511-8e62-4422-b98f-9b40deb9b634 -->

    <Class rdf:about="http://example.org/f68b1511-8e62-4422-b98f-9b40deb9b634">
        <obo:IAO_0000115>To decipher the cellular composition of CRC in a larger population, we employed the newly developed deconvolution tool CIBERSORTx.Signature templates derived from the SMC cohort were created with simplified T-cell subgroups: CD4+ T cells, Treg cells, CD8 + T cells, TEX cells and ILCs (Fig. 2A, Additional file 4: Table S4). The epithelial cell proportions of the SMC cohort skewed toward a low detection rate compared with tumor purity. However, the epithelial cell proportions estimated with CIBERSORTx using our CRC-SRM exhibited a high correlation with the ABSOLUTE estimated purity in the cohort TCGA-COADREAD, indicating the reliability of our CRC-SRM (Fig. 2B). In addition, CIBERSORTx inferred cellular patterns among different consensus molecular subtypes (CMS: CMS1-4) and our TME-driven subtypes (active immune (A.I.), active stroma (A.S.), and mixed types)), revealing increased immune cells in the CMS1 and A.I. subtypes and higher stromal infiltration in the CMS4 and A.S. subtypes, consistent with previous reports (Fig. 2C bottom). However, these immune/stromal cell infiltration patterns of CMS1 and CMS4 were not observed in the SMC cohort (Fig. 2C top). T cells, B cells, ##TAMs##, endothelial cells and CAFs constituted the TME ecosystem of CRCs (Fig. 2D). Increased abundances of epithelial cells, B cells, and stromal cells and fewer T cells and myeloid cells were observed using the cellular deconvolution method (Fig. 2D). Bias exists when inferring cellular compositions using scRNA-seq data. The discrepancy between the immune/stromal cell proportions was largely due to differences in cellular dissociation efficiencies, with stromal cells being more difficult to dissociate due to the extracellular matrix.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9548187</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36209225</oboInOwl:hasDbXref>
        <rdfs:label>TAMs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/f68b1511-8e62-4422-b98f-9b40deb9b634"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/f6c058b2-bff8-4bc4-ba05-048c13f2c999 -->

    <Class rdf:about="http://example.org/f6c058b2-bff8-4bc4-ba05-048c13f2c999">
        <obo:IAO_0000115>Distinct therapy-induced cancer cell transcriptomes were associated with clinical response. Cancer cells from MPR patients exhibited a signature of activated antigen presentation via major histocompatibility complex class II (MHC-II). Further, the transcriptional signatures of FCRL4+FCRL5+ memory B cells and CD16+CX3CR1+ monocytes were enriched in MPR patients and are predictors of immunotherapy response. Cancer cells from NMPR patients exhibited overexpression of estrogen metabolism enzymes and elevated serum estradiol. In all patients, therapy promoted expansion and activation of cytotoxic T cells and CD16+ NK cells, reduction of immunosuppressive Tregs, and activation of memory CD8+T cells into an effector phenotype. Tissue-resident macrophages were expanded after therapy, and ##tumor-associated macrophages## (TAMs) were remodeled into a neutral instead of an anti-tumor phenotype. We revealed the heterogeneity of neutrophils during immunotherapy and identified an aged CCL3+ neutrophil subset was decreased in MPR patients. The aged CCL3+ neutrophils were predicted to interact with SPP1+ TAMs through a positive feedback loop to contribute to a poor therapy response.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9985263</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36869384</oboInOwl:hasDbXref>
        <rdfs:label>tumor-associated macrophages</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/f6c058b2-bff8-4bc4-ba05-048c13f2c999"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/f70af33b-7a9c-4247-900b-56813bb5a550 -->

    <Class rdf:about="http://example.org/f70af33b-7a9c-4247-900b-56813bb5a550">
        <obo:IAO_0000115>Identification of cell types from whole-brain cells. a UMAP plot shows the unsupervised clustering of 16,028 cells derived from mouse brain (for details, see &quot;Methods&quot;). The 15 cell types were classified by their transcriptional profiles. b Dot plot shows the expression levels of a representative cell-specific marker gene for each cell type. c UMAP plot shows the distribution of Olig2 expression. d Violin plot shows Olig2 expression across all clusters. e UMAP plot shows the distribution of GFAP expression. f Violin plot shows GFAP expression across all clusters. g A total of 3522 cells of the astrocyte subset were derived from cells in mouse brain. They were classified into Olig2(+)/GFAP(-) astrocytes (347 cells), Olig2(+)/GFAP(+) astrocytes (104 cells), Olig2(-)/GFAP(+) astrocytes (848 cells) and ##Olig2(-)/GFAP(-) astrocytes## (2,223 cells). immNEU immature neuron, mNEU mature neuron, OPC oligodendrocyte precursor cell, immOLG immature oligodendrocyte, OLG oligodendrocyte, ASC astrocyte, OEG olfactory ensheathing glia, MG microglia; MAC macrophage, EC endothelial cell, PC pericyte, EPC ependymal cell, VLMC vascular and leptomeningeal cell, ABC arachnoid barrier cell, CP cycling progenitor</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8573876</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34749773</oboInOwl:hasDbXref>
        <rdfs:label>Olig2(-)/GFAP(-) astrocytes</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000127"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/f70af33b-7a9c-4247-900b-56813bb5a550"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000127"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/f7330677-620a-42b8-92e5-200b7d21b832 -->

    <Class rdf:about="http://example.org/f7330677-620a-42b8-92e5-200b7d21b832">
        <obo:IAO_0000115>A Gating strategy for the Lin-Sca-1 + c-Kit + (LSK) compartment and multipotent progenitors (MPPs), including long-term HSCs (HSCLT), short-term HSCs (HSCST), ##MPP2##, MPP3, and MPP4. PV IgG1, n = 15; PV anti-CD47, n = 15. B LSK fraction determined in the bone marrow (BM) and spleen (SPL). C Composition of the LSK compartment and MPPs in PV mice treated with IgG1 or anti-CD47 determined by flow cytometry at terminal analysis in the BM (top) and SPL (bottom). D Gating strategy for erythroid differentiation. Proerythroblasts (I; FSChi CD44hi), basophilic erythroblasts (II; FSCint CD44hi), polychromatic erythroblasts (III; FSCint CD44int), orthochromatic erythroblasts (IV; FSClo CD44int), and erythroblasts (V; FSClo CD44-). WT IgG1, n = 4; WT anti-CD47, n = 4; PV IgG1, n = 15; PV anti-CD47, n = 15. E Percentages of erythroid progenitors in the BM (left) and SPL (right) (% of FSC CD44 out of CD11b-CD45.2-Ter119+) determined by flow cytometry at terminal analysis. Results are represented as mean +- standard deviation. ns not significant, *p &lt; 0.05 (Kruskal-Wallis test with Dunn&apos;s multiple comparisons for B (BM LSK fraction); two-way ANOVA with Tukey&apos;s multiple comparisons test for B (SPL LSK fraction); unpaired student&apos;s t-test or Mann-Whitney test for C).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10244168</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37095207</oboInOwl:hasDbXref>
        <rdfs:label>MPP2</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000837"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/f7330677-620a-42b8-92e5-200b7d21b832"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000837"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/f7c8a9f4-15ed-45fe-897d-d0e0f564a53f -->

    <Class rdf:about="http://example.org/f7c8a9f4-15ed-45fe-897d-d0e0f564a53f">
        <obo:IAO_0000115>In order for the sensitization we observed in excitatory interneurons to drive the psychophysical phenomenon of allodynia, spinal projection neurons must relay these nociceptive signals supraspinally. We found that capsaicin treatment shifted the overall tuning of SPB neurons towards LT input, consistent with the effects of central sensitization producing allodynia (Fig. 8a, b). Because SPB neurons are heterogeneous with respect to their response properties, we classified them as either ##wide-dynamic range (WDR)##, high threshold (HT), or low threshold (LT) (Fig. 8c) using previously published criteria. We found that both HT and WDR SPB showed significant increases in tuning to LT input, however the degree of change was much greater for WDR compared to HT SPB neurons (Fig. 8d). Finally, examining CICADA responses across populations, we found that WDR cells were more frequently responsive to CICADA agonists (71.4%), compared to either LT (40%) or HT (0%) SPB neurons. In particular, all SP-responsive SPB neurons were WDR cells (Fig. 8e). Since capsaicin is known to activate peptidergic afferents that release SP, these findings suggest that capsaicin-induced allodynia may be conveyed to the brain through a population of TACR1 expressing WDR SPB neurons and, to a lesser extent, some HT SPB neurons (Fig. 8f).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9440908</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36057681</oboInOwl:hasDbXref>
        <rdfs:label>wide-dynamic range (WDR)</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000540"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/f7c8a9f4-15ed-45fe-897d-d0e0f564a53f"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000540"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/f7fba063-f184-4c0d-9afa-b184b28a3088 -->

    <Class rdf:about="http://example.org/f7fba063-f184-4c0d-9afa-b184b28a3088">
        <obo:IAO_0000115>The cellular content of human myocardium (in descending order by number) predominantly consists of cardiomyocytes, fibroblasts, pericytes and smooth muscle cells, endothelial cells, and immune cells. In the murine heart, macrophage populations can be discerned based on their expression of C-C chemokine receptor type 2 (CCR2), major histocompatibility complex-II (MHC-II), T cell immunoglobulin and mucin domain containing 4 (TIMD4), and Lymphatic Vessel Endothelial Hyaluronan Receptor 1 (LYVE1). Four populations of macrophages have been identified in the murine heart (Fig. 1). The minority are two subsets of CCR2+MHC-IIhigh macrophage populations derived from hematopoietic stem cells, whereas the most dominant subset, cardiac resident macrophages derived from the yolk sac, are CCR2-MHC-IIlowTIMD4+LYVE1-. There also exists a fourth subset that consists of CCR2-MHC-IIhighTIMD4+LYVE1+ macrophages, which are likely derived from ##CCR2-MHC-IIlow macrophages## during postnatal development and partially maintained by CCR2+MHC-IIhigh macrophages. CCR2+MHC-IIhigh macrophages populate the heart soon after birth and are maintained through monocyte recruitment and proliferation. Also, under homeostasis, cardiac macrophages continually self-renew with a turnover period of almost 5 weeks. Recently, this same CCR2+ and CCR2- macrophage distinction has been identified in humans, with the yolk sac-derived CCR2- human counterpart showing CD14+CD45+CD64+CCR2-HLA-DRhigh expression. In a more recent study, Tucker et al. reported two cardiac macrophage subsets within the human heart, which were positive for CD163, COLEC12, mannose receptor MRC1, E3 ubiquitin ligase MARCH1, and natural resistance-associated macrophage protein 1 (NRAMP1). Both of the identified subsets expressed anti-inflammatory (M2) polarization-associated genes, whereas one subset particularly expressed RBPJ, F13A1 and the other expressed transmembrane collagen COL23A1.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9242717</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34088222</oboInOwl:hasDbXref>
        <rdfs:label>CCR2-MHC-IIlow macrophages</rdfs:label>
    </Class>
    


    <!-- http://example.org/f859befe-28ae-46e1-b385-c6ea7c6de145 -->

    <Class rdf:about="http://example.org/f859befe-28ae-46e1-b385-c6ea7c6de145">
        <obo:IAO_0000115>Focusing on the peripheral, differentiated cDC populations, we next assessed protein expression of the IRF8 transcription factor in tumor-derived cDC populations (Fig. 3a). In the periphery, IRF8 controls survival and function of terminally differentiated cDC1s. Furthermore, increased IRF8 expression in CD11b-CD103- DN cells was shown to promote their differentiation into mature CD103+ cDC1s. Thus, we hypothesized that CD40L-CAR T cell treatment skews the cDC1/cDC2 ratio towards the cDC1 populations by stimulating the DN cells to expand, upregulate IRF8, and differentiate into cDC1s. We specifically noticed upregulation of IRF8 (readout of DN-to-cDC1 differentiation) and Ki-67 (readout for proliferation) in DN cells treated with CD40L-CAR T cell-treated mice (Fig. 3b). The increased expression of Ki-67 in the tumor-derived DN cells also correlated with the observed increase of the DN population in the tumor of CD40L-CAR T cell-treated mice (Fig. 1f), indicating that DN cells receive a proliferative signal upon CD40L-CAR T cell treatment. Intriguingly, ##splenic DN cells## and DN cells from the tdLNs did not upregulate Ki-67 or IRF8 (Fig. 3c, d). Overall, tdLN cDCs did not present with a stimulated phenotype, as suggested by the lack of CD86 or Ki-67 upregulation (Supplementary Fig. 2D-G). This suggested a tumor-specific effect of cDC DN stimulation after m1928z-CD40L treatment.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7710757</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33268774</oboInOwl:hasDbXref>
        <rdfs:label>splenic DN cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002510"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/f859befe-28ae-46e1-b385-c6ea7c6de145"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002510"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/f85d0337-9865-4b67-90b4-efd25e3b9948 -->

    <Class rdf:about="http://example.org/f85d0337-9865-4b67-90b4-efd25e3b9948">
        <obo:IAO_0000115>MP cells, in particular macrophages, have a key role in tissue repair. Many studies have shown that inflammatory monocytes can be converted in situ into cells exhibiting a reparative phenotype. Our findings show that following corneal chemical injury, ##Ly6Cint restorative MP## (CD11Bhi F4/80int) are mostly highly expressed on day 3 post-injury. Differentiation of corneal MPs based on surface markers is not trivial, and although many studies have considered that all CD11b+ F4/80+ represent macrophages, recent studies have suggested that CD64 surface marker can help differentiate corneal macrophages from monocytes. Our subsequent analysis of the Ly6C expression gating for CD11b+ F4/80int CD11c- CD64+ recruited macrophages showed a similar frequency pattern with a gradual shift in frequency from Ly6Chigh to Ly6Cint on day 3 and Ly6Cneg on day 6.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8910730</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35269717</oboInOwl:hasDbXref>
        <rdfs:label>Ly6Cint restorative MP</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000113"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/f85d0337-9865-4b67-90b4-efd25e3b9948"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000113"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/f888a5b2-c79b-4874-9b8c-d5e3b184e356 -->

    <Class rdf:about="http://example.org/f888a5b2-c79b-4874-9b8c-d5e3b184e356">
        <obo:IAO_0000115>Transplanted ##DASCs## give rise to AT1 cells and proliferating DASCs in vivo. (A) Pseudo-time trajectory projected onto a UMAP of all engrafted cells. The red dot indicates the start point of the trajectory. Pseudo-time values are colour coded. (B) Cell density of three clusters along inferred cellular trajectory reflecting differentiation process. Cells are ordered by pseudo-time (cell-to-cell distance metric). (C) Expression of specific genes along the cell trajectory important for the differentiation paths. The dots indicate the gene expression of individual cells. Trp63 = p63</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8168420</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33960563</oboInOwl:hasDbXref>
        <rdfs:label>DASCs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002633"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/f888a5b2-c79b-4874-9b8c-d5e3b184e356"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002633"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/f8934552-f488-4871-af74-55ae6a6139c0 -->

    <Class rdf:about="http://example.org/f8934552-f488-4871-af74-55ae6a6139c0">
        <obo:IAO_0000115>NK/T cells contain ten clusters of ##NK, NKT, CD8+ T, CD4+ T, and DNT cells##</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10507359</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37731504</oboInOwl:hasDbXref>
        <rdfs:label>NK, NKT, CD8+ T, CD4+ T, and DNT cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000084"/>
        <skos:relatedMatch rdf:resource="CL:0000623"/>
        <skos:relatedMatch rdf:resource="CL:0000624"/>
        <skos:relatedMatch rdf:resource="CL:0000625"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/f8934552-f488-4871-af74-55ae6a6139c0"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000084"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/f8934552-f488-4871-af74-55ae6a6139c0"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000623"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/f8934552-f488-4871-af74-55ae6a6139c0"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000624"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/f8934552-f488-4871-af74-55ae6a6139c0"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000625"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/f89d039b-493b-4e53-90a7-0aa8e78f7723 -->

    <Class rdf:about="http://example.org/f89d039b-493b-4e53-90a7-0aa8e78f7723">
        <obo:IAO_0000115>Sjogren&apos;s syndrome is a chronic autoimmune disorder whose pathogenesis is poorly understood and that lacks effective therapies. Detailed quantitative and spatial analyses of tissues affected by Sjogren&apos;s syndrome were undertaken, including the quantitation of the frequency of selected cell-cell interactions in the disease milieu. Quantitative analyses of CD4+ T cell subsets and of CD8+ T cells in the labial salivary glands from untreated patients with primary Sjogren&apos;s syndrome revealed that activated CD8+ cytotoxic T cells (CD8+CTLs) were the most prominent T cells in these infiltrates. An accumulation of apoptotic glandular epithelial cells, mainly ductal and acinar cells, was observed, consistent with the impaired salivary secretion often observed in patients with this disease. FasL expressing activated CD8+ T cells were seen to accumulate around Fas expressing apoptotic epithelial cells. Quantitative analyses of apoptotic cell types and of conjugates between cytotoxic T cells and ##epithelial cells## undergoing apoptosis suggest that Sjogren&apos;s syndrome is primarily driven by CD8+CTL mediated execution of epithelial cells mainly represented by ductal and acinar cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9475031</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36104369</oboInOwl:hasDbXref>
        <rdfs:label>epithelial cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:4052048"/>
        <skos:relatedMatch rdf:resource="CL:4052049"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/f89d039b-493b-4e53-90a7-0aa8e78f7723"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4052048"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/f89d039b-493b-4e53-90a7-0aa8e78f7723"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4052049"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/f8c4501e-b295-4217-8b90-7a8fee28fbe8 -->

    <Class rdf:about="http://example.org/f8c4501e-b295-4217-8b90-7a8fee28fbe8">
        <obo:IAO_0000115>Cancer-associated fibroblasts (##CAF##) form the basis of tumor microenvironment and possess immunomodulatory functions by interacting with other cells surrounding tumor, including T lymphocytes, macrophages, dendritic cells and natural killer cells. Ionizing radiation is a broadly-used method in radiotherapy to target tumors. In mammalian cells, ionizing radiation induces various types of DNA damages and DNA damage response. Being unspecific, radiotherapy affects all the cells in tumor microenvironment, including the tumor itself, CAFs and immune cells. CAFs are extremely radio-resistant and do not initiate apoptosis even at high doses of radiation. However, following radiation, CAFs become senescent and produce a distinct combination of immunoregulatory molecules. Radiosensitivity of immune cells varies depending on the cell type due to inefficient DNA repair in, for example, monocytes and granulocytes. In this minireview, we are summarizing recent findings on the interaction between CAF, ionizing radiation and immune cells in the tumor microenvironment.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7696681</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33207781</oboInOwl:hasDbXref>
        <rdfs:label>CAF</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000057"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/f8c4501e-b295-4217-8b90-7a8fee28fbe8"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000057"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/f9077c51-5c4b-40f4-b6b4-077400a14e4f -->

    <Class rdf:about="http://example.org/f9077c51-5c4b-40f4-b6b4-077400a14e4f">
        <obo:IAO_0000115>The above analysis was based on a large number of RNA-seq, so we further used scRNA-seq to determine whether our ORGs signature had immune predictive value on the single cell level. Figure 7A showed that the PRAD samples from GEO datasets were annotated into Mast cell, Epithelial-NE, T/NK, Plasma_B, Epithelial, Neuron, SMC, Fibroblasts and Pericytes, Myeloid and Endothelial. It was obvious that ORGs signature was specifically high in Epithelial-Nk, T/Nk and SMC cells (Figure 7B, 7C). Meanwhile, Figure 7D revealed that significant connection probability of ORGs related signaling pathways in cell clusters which showed specifically high ORGs signature. Furthermore, we chose ##epithelial cell## for analysis. Chemotaxis related pathways including cell chemotaxis, leukocyte chemotaxis, regulation of chemotaxis and regulation of leukocyte chemotaxis were significantly up-regulated in the high ORGs signature group (Figure 7E). What&apos;s more, immune related pathways were all up-regulated in the high ORGs signature group both in GO (Figure 7F) and KEGG (Figure 7G) analysis.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10599753</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37788005</oboInOwl:hasDbXref>
        <rdfs:label>epithelial cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000066"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/f9077c51-5c4b-40f4-b6b4-077400a14e4f"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000066"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/f9139fa9-23cb-43ca-b82d-35445fbc7925 -->

    <Class rdf:about="http://example.org/f9139fa9-23cb-43ca-b82d-35445fbc7925">
        <obo:IAO_0000115>Immune regulation by helminths acts at many levels to interfere with innate antigen sensitization, induction of adaptive immunity, and mobilization of effector mechanisms. 7  One of the most prominent pathways for parasite immunomodulation is through regulatory T-cells (Tregs). Tregs are classified by their expression of the transcription factor Foxp3 (FOXP3 in humans) and can express a number of surface markers that are key for their function, including CD25, cytotoxic T-lymphocyte-associated protein 4 (CTLA-4), inducible T-cell co-stimulator (ICOS) and T-cell immunoreceptor with Ig and ITIM domains (TIGIT). 8  In both mouse and human studies, Tregs are often defined as ##CD3+ CD4+ CD25+ Foxp3+ cells##, although Treg cells comprise a diverse population. During development, the first set of Tregs are formed in the thymus, making up the natural Treg population (nTreg), while a second type of Tregs can be induced in the periphery from naive CD4 T-cells [induced Tregs (iTreg)/peripheral Tregs (pTreg)] in the presence of specific cytokines such as interleukin (IL)-2 and transforming growth factor beta (TGF-beta); however, the expression of Foxp3, and indeed regulatory activity, is variable depending on the level of demethylation at the Foxp3 locus, and recent studies have identified a number of Treg subtypes delineated by CD25, Foxp3 and the epigenome. 9  Regulatory activity can also be found in other lymphocyte subsets, such as the Foxp3-IL-10+ Tr1 cells (previously defined as Th3 10 ), although their role in controlling immune responses in helminth infection has yet to be established.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7341546</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32153025</oboInOwl:hasDbXref>
        <rdfs:label>CD3+ CD4+ CD25+ Foxp3+ cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000815"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/f9139fa9-23cb-43ca-b82d-35445fbc7925"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000815"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/f96d3e0f-b039-411a-878b-0b43cab3bc9c -->

    <Class rdf:about="http://example.org/f96d3e0f-b039-411a-878b-0b43cab3bc9c">
        <obo:IAO_0000115>In our previous work, we depicted different T-cell subtypes and found an exhausted cluster that specifically existed in B-ALL patients and possessed remarkable heterogeneity. However, the developmental relationship between T-cell subtypes in relation to B-ALL patient prognosis remains elusive. To address this question, further analysis was performed on these T cells in B-ALL. A subset of T cells with features of tissue-resident memory T (Trm) cells was found in the peripheral blood of B-ALL patients, which we defined as circulating CD103+ T cell or ##tissue-resident memory-like T (Trm-like) cell##. These Trm-like cells expressing high levels of immune checkpoint molecules and cytotoxicity markers also shared similar TCR signatures with exhausted T (Tex) cells and effector T (Teff) cells. The traditional view thought that Trm cells were low in migration and long-term survival in peripheral tissues; however, more recent studies indicated that upon secondary antigen presentation, Trm cells can rejoin the circulation pool, transforming into Teff cells. Through cell fate trajectory analysis, we found that Trm-like cells that were supposed to transit into Teff cells, however, mainly transformed into Tex cells in leukemia environment. Furthermore, Trm-like cell to Tex cell transformation potentially led to poor prognosis of B-ALL patients, while transition toward Teff cells would likely improve prognosis. Our data suggest that Trm-like cells contribute to B-ALL immunosurveillance and may provide valuable prognostic information. Further understanding of the development, maintenance, and regulation of Trm-like cells would be crucial for successful immunotherapeutic development in B-ALL.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9757161</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36532049</oboInOwl:hasDbXref>
        <rdfs:label>tissue-resident memory-like T (Trm-like) cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000813"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/f96d3e0f-b039-411a-878b-0b43cab3bc9c"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000813"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/f986cb1e-39de-43be-8af3-e05c94fbf885 -->

    <Class rdf:about="http://example.org/f986cb1e-39de-43be-8af3-e05c94fbf885">
        <obo:IAO_0000115>mFbs resemble fibroblastic reticular cells (FRCs) that form conduit-like network in secondary lymphoid organs, and they have also been known as thymic FRCs. Transcriptome analyses on mFbs and LN FRCs revealed possible functional differences between these two morphologically similar cell types. LN FRCs are subdivided into several types based on their expression of functional genes, including chemokines and cytokines: T-cell zone reticular cell (TRC) expressing Ccl19, Ccl21a, and Il7; follicular dendritic cell (FDC) expressing Cxcl13; marginal reticular cell (MRC) expressing Tnfsf11 (RANKL); Cxcl12-expressing reticular cell (CRC); and medullary reticular cell (medRC) expressing Cxcl12, Il6, Tnfsf13, and Tnfsf13b. Most of these FRC-associated genes are not or just barely expressed in mFbs. In the thymus, RANKL is predominantly expressed in ##SP thymocytes## to induce mTEC development, and Ccl19, Ccl21, Cxcl12, and IL-7 are produced by TECs so as to control the relocation and survival of thymocytes. It is likely that the role played by FRCs in the LN is replaced by TECs in the thymus. mFbs highly express other sets of chemokines as well, such as Cx3cl1 and Cxcl14, that are barely expressed in LN FRCs or capFbs, possibly contributing to the regulation of cell migration in the thymic medulla. Thus, mFbs comprise a thymus-specific subset of fibroblasts that is functionally distinct from LN FRCs. It is possible that mFbs also consist of multiple subsets with different functions. A population of CD34+podoplanin+ mFbs are detected in adventitial layers that surround pericytes and endothelial cells, thus referred to as adventitial cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7840694</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33519827</oboInOwl:hasDbXref>
        <rdfs:label>SP thymocytes</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000805"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/f986cb1e-39de-43be-8af3-e05c94fbf885"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000805"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/f9cc3bb4-ab03-4612-842f-99e6d8bef063 -->

    <Class rdf:about="http://example.org/f9cc3bb4-ab03-4612-842f-99e6d8bef063">
        <obo:IAO_0000115>MOUSE SYMPATHO-ADRENAL CELL TYPES MARKERS   SNPCs Ret Phox2b Ascl1 Mycn Hand2 Gata3Sox10- Plp1-   Sympathoblasts extra-adrenal Phox2b Mycn Th Dbh Ret Cart CartptSox10- Plp1- Sgc10- Ascl1 -   Sympathetic neurons/ganglia/SRG Ret Scg10 Cart Ascl1 Phox2b Th DbhSox10- Plp1-   SCPs Sox10 Plp1 Ascl1 Phox2bRet-   Schwann cells Sox10 Plp1 GfapPhox2b-   ##Bridge cells## Sox10 Plp1 Chga Penk Htr3a Ascl1 Phox2bTh- Ret-   Immature chromaffin cells Chga Chgb Penk Th DbhSox10- Plp1- Ret-   Chromaffin cells Chga Penk Ascl1 Phox2b Th DbhSox10- Plp1- Ret-   Sympathoblasts intra-adrenal Ret Cart Cartpt Phox2b Th Alk Hmx1 PrphSox10- Plp1-   Sympathetic neurons intra-adrenal Ret Cart Ascl1 Phox2b ThSox10- Plp1-   </obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8915499</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35277192</oboInOwl:hasDbXref>
        <rdfs:label>Bridge cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000166"/>
        <skos:relatedMatch rdf:resource="CL:0002375"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/f9cc3bb4-ab03-4612-842f-99e6d8bef063"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000166"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/f9cc3bb4-ab03-4612-842f-99e6d8bef063"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002375"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/fa0e5a72-7b71-4605-80dc-1a25702dd33b -->

    <Class rdf:about="http://example.org/fa0e5a72-7b71-4605-80dc-1a25702dd33b">
        <obo:IAO_0000115>Recent findings have demonstrated a synergic crosstalk between SHH/GLI and PI3K/Akt/mTORC1 signaling in glioblastoma progression cells in vitro and in tumors in mice, but it is not known if this also occurs in human gliomas. We then aimed to investigate the expression of key proteins of these pathways in different human gliomas. The expression of PTEN, phospho-Akt (Ser473), phospho-S6K1 (Thr389), SHH, GLI1, GLI2 and GLI3 was assessed by immunohistochemistry in gliomas and in control brain tissues. The pattern of expression of each protein was established according to glioma type, glioma grade and to cell type; the relative expression of each protein was used to perform statistical analyses. We found that the expression of proteins of both signaling pathways differs between normal brain and glioma tissues. For instance, normal astrocytes had a different protein expression pattern compared with ##reactive and tumoral astrocytes##. Interestingly, we detected a recurrent pattern of expression of GLI3 in oligodendrocytes and of phospho-S6K1 in mitotic neoplastic cells. We also identified differences of cell signaling according to glioma type: oligodendrogliomas and ependymomas are related with the expression of SHH/GLI proteins. Finally, we detected that high grade gliomas statistically correlate with the expression of GLI1 and GLI2, and that GLI1, GLI2, phospho-Akt and phospho-S6K1 are more expressed in patients with less survival, suggesting that activation of these cell signaling influences glioma outcome and patient survival. In summary, our results show that proteins of PI3K/Akt/mTORC1 and SHH/GLI pathways are differentially expressed in human gliomas according to tumor type and grade, and suggest that the activation of these signaling networks is associated with glioma progression.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMID:34371011</oboInOwl:hasDbXref>
        <rdfs:label>reactive and tumoral astrocytes</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000127"/>
        <skos:relatedMatch rdf:resource="CL:0002627"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/fa0e5a72-7b71-4605-80dc-1a25702dd33b"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000127"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/fa0e5a72-7b71-4605-80dc-1a25702dd33b"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002627"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/fa1171b3-a33b-437a-b1f4-a939e46f04b5 -->

    <Class rdf:about="http://example.org/fa1171b3-a33b-437a-b1f4-a939e46f04b5">
        <obo:IAO_0000115>In addition, myeloid cells, in particular monocytes and DC subsets, upregulated expression of genes involved in TLR signaling pathway (e.g., MyD88, Cxcl9, and CD40), consistent with the fact that 3M-052 stimulates TLR signaling. Other innate immune processes including complement (e.g., C3, Cfb) and inflammasome (e.g., Casp3, Il18, Il1rn) genes were also found to be significantly upregulated mainly in monocytes and tDCs, and to a lesser extent in ##XCR1- and XCR1+ DCs## (Fig. 2d). In comparison, lymphoid cells such as innate lymphoid cells (ILCs), gammadeltaT cells, and CD8+ lymphocytes, exhibited higher expression of genes that are involved in cytokine responses (e.g., Jak2, Nfkbia) when compared to myeloid cell subsets (Fig. 2d). This may indicate indirect activation through cytokines being produced by monocytes and DCs. Furthermore, we observed a downregulation of antigen processing and presentation gene modules defined by genes such as H2-Eb1, H2-Aa, and Cd74 in monocytes, but an upregulation of these genes in XCR1- DCs, migratory DCs, ILC2, and ILC3 (Fig. 2d). This is consistent with previous reports of MHCII gene expression in ILC2 and ILC3 as well as the involvement of these innate lymphoid subsets in antigen presentation. The decrease in MHCII presentation genes also supports the notion that more inflammatory monocytes, which have a relatively low expression of MHCII genes compared to resting monocytes, were recruited to the lymph nodes on day 1 after stimulation.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8795432</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35087093</oboInOwl:hasDbXref>
        <rdfs:label>XCR1- and XCR1+ DCs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000451"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/fa1171b3-a33b-437a-b1f4-a939e46f04b5"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000451"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/fa11e60b-bd4d-475b-b746-728e275198e3 -->

    <Class rdf:about="http://example.org/fa11e60b-bd4d-475b-b746-728e275198e3">
        <obo:IAO_0000115>Different pathogenesis of HCC involving viral and non-viral etiology is related to the unique TIME. Chronic infection with hepatitis B virus (HBV) promotes the formation of a tolerant TIME by depletion of the effector CD8+ T cells and attracting immunosuppressive cells including granulomatous myeloid-derived suppressor cells (gMDSCs), Tregs, or regulatory B (Breg) cells. Chronic infection by hepatitis C virus (HCV) depletes CD8+ T cells and promotes immune evasion through spontaneous viral escape and dysregulation of major histocompatibility complex I (MHC I) dependent antigen presentation. In alcoholic steatohepatitis (ASH), alcohol promotes the inhibition of liver immune response by increasing the abundance of ##M2 TAMs##, inhibiting CD8+ T cell activation, and facilitating gMDSC infiltration. In contrast, non-alcoholic steatohepatitis (NASH) activates dysfunctional immune cells, including helper T cell 17 (Th17) cells, natural killer T (NKT) cells, CD8+/PD-1+ T cells and IgA+ plasma cells, disrupting tumor immune surveillance and inducing HCC.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11639598</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:39641225</oboInOwl:hasDbXref>
        <rdfs:label>M2 TAMs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000890"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/fa11e60b-bd4d-475b-b746-728e275198e3"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000890"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/fa193f8e-e757-4ae3-9775-b6201bd9c5f8 -->

    <Class rdf:about="http://example.org/fa193f8e-e757-4ae3-9775-b6201bd9c5f8">
        <obo:IAO_0000115>Here we hypothesized that upon activation, memory CD8 T cells acquire a noncytotoxic function whereby they interact with naive CD8 T cells and alter their phenotype and activation state. To test this hypothesis, we designed an in vitro system in which human polyclonal naive CD8 T cells were co-cultured with autologous, ##activated memory CD8 T cell## subsets. The phenotype and transcriptional profile of naive cells was analyzed at the end of the co-culture period. We report that in the presence of activated TCM or stem cell memory (TSCM) cells, a small proportion (~3%) of autologous naive CD8 T cells acquired phenotypic and transcriptional features of activated/memory CD8 T cells in an MHC class I-dependent manner, whereas a much larger proportion (~84%) transitioned to a unique activated state, hybrid between naive and activated memory. These findings imply that activated memory T cells can set the activation threshold of neighboring naive T cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9243096</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35768564</oboInOwl:hasDbXref>
        <rdfs:label>activated memory CD8 T cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000909"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/fa193f8e-e757-4ae3-9775-b6201bd9c5f8"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000909"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/fa1ea48b-d8f9-441e-a578-33751f09d2f8 -->

    <Class rdf:about="http://example.org/fa1ea48b-d8f9-441e-a578-33751f09d2f8">
        <obo:IAO_0000115>a Line drawing of a cross section of the floor of the cochlear duct at P1. Distinct cell types within the organ of Corti (OC) are color coded. b Heat map for ~14,000 cochlear cells collected from four separate experiments at P1. Top 25 differentially expressed (DE) genes for the 15 identified clusters are shown. Cellular identity for each cluster is indicated by a color bar at the top of the heat map, which corresponds to the legend in a, and by a cell name at the bottom. c tSNE plot for the same cells as in b. Cluster identities are indicated. d Violin plots showing normalized log-transformed expression values for the top five DE genes for each cell type (color coded as in c) by comparison with all other P1 cells (gray on the right in each graph). Bars indicate median expression level. e Upper left panel, tSNE plot of cells determined to be derived from KO (between the OC and medial edge of the cochlear duct). Lower left panel, feature plot for the same cells as in the upper panel indicating high expression of Otoa, Calb1, and Fabp7 (based on color) in different clusters of cells. Lower right panel, cross sections through the cochlear duct at P1, illustrating expression of CALB1 in the medial region of KO and FABP7 directly adjacent to the OC (arrow; scale bars, 20 mum). Lowest panel shows high-magnification view of expression of FABP7 (arrow, gray scale) at the lateral KO border (green line; scale bar, 10 mum). Upper right panel, summary diagram of the spatial distribution of KO cell clusters at P1. HC hair cells, IPhC inner phalangeal cells/border cells, IPC inner pillar cells, OPC outer pillar cells, DC1/2 Deiters&apos; cells rows 1 and 2, DC3, Deiters&apos; cells row 3, HeC Hensen&apos;s cells, CC/OSC Claudius cells/outer sulcus cells, IdC interdental cells, ISC inner sulcus cells, KO Kolliker&apos;s organ cells, L.KO lateral Kolliker&apos;s organ cells, M.KO ##medial Kolliker&apos;s organ cells##, OC90 OC90+ cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7221106</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32404924</oboInOwl:hasDbXref>
        <rdfs:label>medial Kolliker&apos;s organ cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002490"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/fa1ea48b-d8f9-441e-a578-33751f09d2f8"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002490"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/fa39e882-ad30-469c-9065-0f738f3d5005 -->

    <Class rdf:about="http://example.org/fa39e882-ad30-469c-9065-0f738f3d5005">
        <obo:IAO_0000115>a Schematic overview of the experimental workflow. Forebrain samples were collected from Sox2eGFP mice at 11 developmental timepoints, dissociated into single cells followed by sorting of the GFP + ve /-ve cells and performing single-cell RNA-seq using the 10x Genomics Chromium platform. b Left: two-dimensional Uniform manifold approximation and progression (UMAP) plot with Leiden clustering of 102,504 individual cells identifying 28 transcriptionally and biologically distinct cell types (see Supplementary Fig. 3a and Methods). Each dot represents a single cell and colours correspond to the distinct clusters/cell types. Shown on the right is a dot plot showing the relative fraction (dot size) of the 28 cell types at each developmental timepoint normalized by library size. c UMAP plot of the cells as in (b) but coloured by timepoint. Each dot represents a single cell and the colours correspond to the different timepoints. d, UMAP plot showing the coarse annotation of cells into 4 categories (Neuronal, Glial, Immune and Vascular/other) based on logistic regression from Zeisel et al. 2018. The RNA-velocity field is overlaid on the UMAP. Colours represent the 4 categories of cell annotation and the arrows correspond to the direction of the RNA-velocity flow field (see Methods). RG Radial glia, ##TAPs## Transient amplifying progenitors, aNSCs Active neural stem cells, APCs Astrocyte progenitor cells, EmNBs Embryonic neuroblasts, GE NBs Ganglionic eminence neuroblasts, OPCs Oligoprogenitor cells, PreM-ODCs Immature pre-myelinating oligodendrocytes, INs Interneurons, ImStNeurons Immature striatal neurons, VLMC Vascular leptomeningeal cells, Myeloid-DSCs Myeloid-derived suppressor cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9296666</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35853870</oboInOwl:hasDbXref>
        <rdfs:label>TAPs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0009010"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/fa39e882-ad30-469c-9065-0f738f3d5005"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0009010"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/fa5fd4d7-8e7e-4408-a848-3132fcc64f48 -->

    <Class rdf:about="http://example.org/fa5fd4d7-8e7e-4408-a848-3132fcc64f48">
        <obo:IAO_0000115>We analyzed the distribution of the four cell lineages in the retina, including seven neuronal classes, Rod, Cone, cone bipolar cell (CBC), rod bipolar cell (RBC), amacrine cell (AC), horizontal cell (HC), and retinal ganglion cell (RGC), one glial class, macroglia (Mag), three immune classes, monocyte macrophage and microglia (Myeloid), Neutrophil, and T cell and dendritic cells (T&amp;DC), and vascular endothelial cell (VEC), based on canonical markers and the most variable upregulated genes (Fig. 1A). Notably, we found that a group of Myeloid cells with high expression of ITGAM appeared during retinal I/R injury, including ##retina microglia##, blood-derived macrophages and monocytes (Additional file 1: Fig. S1A). The number of cells and relative per-class cell types in the retinal I/R and blank groups are depicted in Additional file 1: Fig. S1B. Many clusters were differentially represented in the two groups. Myeloid, and T&amp;DC subsets were over-represented in the I/R model and ROD, CBC, RBC, AC, RGC, and VEC subsets were underrepresented (Fig. 1B). Compared to the blank group, the I/R model had a markedly higher proportion of retinal cells in the Neutrophil and T&amp;DC subsets and lower in the CBC, RBC, AC, Mag, RGC, and VEC subsets (p &lt; 0.05; Fig. 1C). Four subsets (CONE, ROD, HC, and Myeloid) were similarly present in both groups (Additional file 1: Fig. S1B). scRNA-seq analysis revealed cell cluster differences between the groups.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9597965</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36289494</oboInOwl:hasDbXref>
        <rdfs:label>retina microglia</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000129"/>
        <skos:relatedMatch rdf:resource="CL:0009004"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/fa5fd4d7-8e7e-4408-a848-3132fcc64f48"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000129"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/fa5fd4d7-8e7e-4408-a848-3132fcc64f48"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0009004"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/fa8e8f8b-b6ab-4829-bb8d-d752ddd9ca4c -->

    <Class rdf:about="http://example.org/fa8e8f8b-b6ab-4829-bb8d-d752ddd9ca4c">
        <obo:IAO_0000115>A Gating strategy for the Lin-Sca-1 + c-Kit + (LSK) compartment and multipotent progenitors (MPPs), including long-term HSCs (HSCLT), short-term HSCs (HSCST), MPP2, MPP3, and ##MPP4##. PV IgG1, n = 15; PV anti-CD47, n = 15. B LSK fraction determined in the bone marrow (BM) and spleen (SPL). C Composition of the LSK compartment and MPPs in PV mice treated with IgG1 or anti-CD47 determined by flow cytometry at terminal analysis in the BM (top) and SPL (bottom). D Gating strategy for erythroid differentiation. Proerythroblasts (I; FSChi CD44hi), basophilic erythroblasts (II; FSCint CD44hi), polychromatic erythroblasts (III; FSCint CD44int), orthochromatic erythroblasts (IV; FSClo CD44int), and erythroblasts (V; FSClo CD44-). WT IgG1, n = 4; WT anti-CD47, n = 4; PV IgG1, n = 15; PV anti-CD47, n = 15. E Percentages of erythroid progenitors in the BM (left) and SPL (right) (% of FSC CD44 out of CD11b-CD45.2-Ter119+) determined by flow cytometry at terminal analysis. Results are represented as mean +- standard deviation. ns not significant, *p &lt; 0.05 (Kruskal-Wallis test with Dunn&apos;s multiple comparisons for B (BM LSK fraction); two-way ANOVA with Tukey&apos;s multiple comparisons test for B (SPL LSK fraction); unpaired student&apos;s t-test or Mann-Whitney test for C).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10244168</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37095207</oboInOwl:hasDbXref>
        <rdfs:label>MPP4</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000837"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/fa8e8f8b-b6ab-4829-bb8d-d752ddd9ca4c"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000837"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/fab2eaa5-a686-40ca-91fe-c9f2f3fe758e -->

    <Class rdf:about="http://example.org/fab2eaa5-a686-40ca-91fe-c9f2f3fe758e">
        <obo:IAO_0000115>To further investigate whether ##somatostatin-expressing CSF-c neurons## (pH-sensitive) and dopaminergic CSF-c neurons (non-pH-sensitive) have different types of cilia, expansion was combined with STED microscopy. Using dual-colour imaging of spinal cord slices, either somatostatin or dopamine (TH immunostaining), together with alpha-tubulin immunostaining (Figure 6) was analysed. To have better access to the cilia and CSF-c neurons the central canal of the expanded spinal cord has been cut horizontally and flipped 90  with respect to the coverslip. The central canal can then be visualized in a cylindrical form (Figure 6A-C). To confirm what type of CSF-c neurons the cilia belong to, z-stack scanning for all the imaging was applied. In our data, 70 cilia belong to somatostatin-expressing CSF-c neurons (n = 70). Of these, 60 cilia were primary (9 + 0 symmetry) and 10 cilia were motile (9 + 2 symmetry) (Figure 6D-K, T). Additionally, 20 cilia of dopaminergic CSF-c neurons were all motile cilia (9 + 2 symmetry) (Figure 6L-S, T). We found that somatostatin-expressing CSF-c neurons are sensory neurons expressing mainly sensory cilia. However, the motile cilia in both somatostatin-expressing and dopaminergic CSF-c neurons might be involved in contributing to the flow of CSF through the central canal (Figure 6U).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8809891</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35103591</oboInOwl:hasDbXref>
        <rdfs:label>somatostatin-expressing CSF-c neurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000540"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/fab2eaa5-a686-40ca-91fe-c9f2f3fe758e"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000540"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/fab9627d-b140-43fa-ac8e-8c7766c4d9b0 -->

    <Class rdf:about="http://example.org/fab9627d-b140-43fa-ac8e-8c7766c4d9b0">
        <obo:IAO_0000115>Proline rich acidic protein 1 (PRAP1) has been implicated as a uterine marker for successful implantation. However, its specific roles in the placenta remain largely unknown. In our study, we made an interesting observation that Prap1 consistently showed upregulation in 26 different cell types, including various trophoblast cell types such as spongiotrophoblasts, ##labyrinth trophoblasts##, S-TGCs, GlyT, and trophoblast progenitor cells, in response to arsenic exposure (Figs. 2,  3a-c). This finding suggests a potential involvement of PRAP1 in regulating placental responses to arsenic exposure.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11297347</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:39095385</oboInOwl:hasDbXref>
        <rdfs:label>labyrinth trophoblasts</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000351"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/fab9627d-b140-43fa-ac8e-8c7766c4d9b0"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000351"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/fabda8d1-2864-48b5-80a6-cf65b4155fba -->

    <Class rdf:about="http://example.org/fabda8d1-2864-48b5-80a6-cf65b4155fba">
        <obo:IAO_0000115>Molecules	Cell types that express the molecules at the mRNA level with relative expression levels indicated	 	Ffar2/GPR43	ILC3s &gt; Neutrophils &gt; MZ B cells &gt; Pre-T cells (double-negative thymocytes) &gt; DCs (spleen) &gt; ILC2s &gt; Alveolar macrophages	 	Ffar3/GPR41	Thymic medullary epithelial cells &gt; Follicular B cells &gt; GC B cells &gt; DCs (CD8) &gt; B1b cells   Neutrophils   Nkp46+ ILC3s   ##Blood monocytes##	 	Gpr109a/Hcar2	Neutrophils &gt; Red pulp macrophages &gt; Alveolar macrophages	 	Olfr78	CD8 T cells (memory) &gt; gammadelta T cells &gt; Follicular B cells &gt; GC B cells &gt; NKT cells &gt; ILC2s	 	Slc5a8	Thymic medullary epithelial cells &gt;&gt; NKT cells = Neutrophils	 	Slc5a12	Thymic medullary epithelial cells &gt; Mast cells &gt; NK cells   NKT cells = ILC3s &gt; ILC2s   Thymocytes (double positive)   pDCs &gt; Macrophages &gt; DCs (CD8)	 	Slc16a1	Pro-B cells &gt; Mast cells   Thymocytes (double-negative and positive) &gt; Naive CD8 T cells &gt; Effector CD8 T cells   GC B cells   NKT cells   ILC2s	 	</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8093302</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33850311</oboInOwl:hasDbXref>
        <rdfs:label>Blood monocytes</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000081"/>
        <skos:relatedMatch rdf:resource="CL:0000576"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/fabda8d1-2864-48b5-80a6-cf65b4155fba"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000081"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/fabda8d1-2864-48b5-80a6-cf65b4155fba"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000576"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/fb3e9151-1f72-4dc9-96c0-93aaab59a090 -->

    <Class rdf:about="http://example.org/fb3e9151-1f72-4dc9-96c0-93aaab59a090">
        <obo:IAO_0000115>Immune checkpoint inhibitors exert clinical efficacy against various types of cancer through reinvigoration of ##exhausted CD8+ T cells## that attack cancer cells directly in the tumor microenvironment (TME). Using single-cell sequencing and mouse models, we show that CXCL13, highly expressed in tumor-infiltrating exhausted CD8+ T cells, induces CD4+ follicular helper T (TFH) cell infiltration, contributing to anti-tumor immunity. Furthermore, a part of the TFH cells in the TME exhibits cytotoxicity and directly attacks major histocompatibility complex-II-expressing tumors. TFH-like cytotoxic CD4+ T cells have high LAG-3/BLIMP1 and low TCF1 expression without self-renewal ability, whereas non-cytotoxic TFH cells express low LAG-3/BLIMP1 and high TCF1 with self-renewal ability, closely resembling the relationship between terminally differentiated and stem-like progenitor exhaustion in CD8+ T cells, respectively. Our findings provide deep insights into TFH-like CD4+ T cell exhaustion with helper progenitor and cytotoxic differentiated functions, mediating anti-tumor immunity orchestrally with CD8+ T cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMID:38363680</oboInOwl:hasDbXref>
        <rdfs:label>exhausted CD8+ T cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000625"/>
        <skos:relatedMatch rdf:resource="CL:0011025"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/fb3e9151-1f72-4dc9-96c0-93aaab59a090"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000625"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/fb3e9151-1f72-4dc9-96c0-93aaab59a090"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0011025"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/fb4d08a7-c0a1-4555-b851-ae0aab0456a1 -->

    <Class rdf:about="http://example.org/fb4d08a7-c0a1-4555-b851-ae0aab0456a1">
        <obo:IAO_0000115>Subclustering of DCs revealed eight clusters converting to six differentiation states, including CD141+ DCs (DC1); CD1c+ A DCs (Langerhans cells, DC2); CD163+ CD14+ DCs (CD1c+ B DCs, DC3); ##CD1c- CD141- CD11c+ DCs## (DC4); AXL+ SIGLEC6+ DCs (DC5); and plasmacytoid DCs (pDCs, DC6) with distinct markers (Fig. 7a and Supplementary Fig. S8a-c online). Among DC subsets, the proportion of DC6 increased in group C compared to groups A and B (Fig. 7b, Supplementary Fig. S8d,e online, and Supplementary Tables S3 and S4 online). GO analysis of DEGS in DC6 compared to other DC subsets indicated significant increase in response to ER stress (Fig. 7c). Also, PCBP1 was highly expressed in subgroup C-1 compared to C-2 among DC subtypes (Fig. 7d).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11231222</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38977917</oboInOwl:hasDbXref>
        <rdfs:label>CD1c- CD141- CD11c+ DCs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000451"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/fb4d08a7-c0a1-4555-b851-ae0aab0456a1"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000451"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/fb8b139e-f58d-4b41-b52d-6a839b2cafb3 -->

    <Class rdf:about="http://example.org/fb8b139e-f58d-4b41-b52d-6a839b2cafb3">
        <obo:IAO_0000115>Taken together, the data-driven FACS gating strategy allowed us to isolate distinct stromal subsets for functional investigation. Both MSSCs and HAGEPs demonstrated considerably higher in vitro colony-forming capacities in comparison with balanced progenitors, ##OCs##, pre-osteoblasts, and pre-fibroblasts. While MSSCs and HAGEPs exhibited full multi-differentiation potentials, pre-fibroblasts had only limited differentiation potentials. OCs showed enhanced osteoblastic and chondrogenic differentiation capacities and compromised adipogenic potential, which is consistent with their differentiation marker expression profiles (Figure 2).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10097421</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36876630</oboInOwl:hasDbXref>
        <rdfs:label>OCs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002540"/>
        <skos:relatedMatch rdf:resource="CL:0007009"/>
        <skos:relatedMatch rdf:resource="CL:0007010"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/fb8b139e-f58d-4b41-b52d-6a839b2cafb3"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002540"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/fb8b139e-f58d-4b41-b52d-6a839b2cafb3"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0007009"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/fb8b139e-f58d-4b41-b52d-6a839b2cafb3"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0007010"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/fba9867a-e769-4023-96c8-02041aa068a1 -->

    <Class rdf:about="http://example.org/fba9867a-e769-4023-96c8-02041aa068a1">
        <obo:IAO_0000115>Loss of Gba disrupts microglial homeostasis and induces damage-associated microglia (##DAM##) phenotype and immune cell infiltration in neuronopathic Gaucher disease (nGD) (Gbalsl/lsl) brain.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9381039</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35972072</oboInOwl:hasDbXref>
        <rdfs:label>DAM</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000129"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/fba9867a-e769-4023-96c8-02041aa068a1"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000129"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/fbc65a35-a2d2-429e-8512-9d419340b071 -->

    <Class rdf:about="http://example.org/fbc65a35-a2d2-429e-8512-9d419340b071">
        <obo:IAO_0000115>Pseudobulk differential gene expression analysis showed significant upregulation of genes in all the B cell subclusters in INS, except for atBCs and ASCs (Fig. 2e and Supplementary Fig. 5a). Pathway analysis revealed an enrichment of functions associated with actin cytoskeletal dynamics in all B cell subclusters in INS, while some subclusters (Naive-1, actMBCs, MBC-2, and MZ-like B cells) also showed an enrichment of B cell activation pathways (Supplementary Fig. 5b). The antigen-inexperienced and recently activated B cell subsets (Naive-1 and actMBC) showed the greatest differences in gene expression suggesting that the transcriptional events leading to B cell dysregulation occur early during B cell activation (Fig. 2e and Supplementary Fig. 5a). There was a substantial overlap in the upregulated genes between Naive-1 B cells, actMBCs, MBC-2, and MZ-like B cells including many ##atBC##-associated genes (e.g., ITGB2, ITGB7, FCRLA, FCRL2), POU2F2, POU2AF1, and the extrafollicular response genes TNFRSF13B and GPR183, suggesting a possible developmental sequence or cooperation between these B cell subclusters in generating an extrafollicular B cell response in INS (Fig. 2e).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10667257</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37996443</oboInOwl:hasDbXref>
        <rdfs:label>atBC</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000236"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/fbc65a35-a2d2-429e-8512-9d419340b071"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000236"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/fbcb4472-e81d-44c1-9d0f-1430a4835b57 -->

    <Class rdf:about="http://example.org/fbcb4472-e81d-44c1-9d0f-1430a4835b57">
        <obo:IAO_0000115>Higher immune-suppressive potential coupled with active dysfunction of T cells in cervical cancer compared to precancer: (A) the UMAP plot of T lymphocytes which could be further reclustered into CD8+ T cells and CD4+ T cells; (B) the UMAP plot of the CD8+ T cells reclustered into seven subsets, including CD8+ MAIT, CD8+ Trm, CD8+ Naive, ##CD8+ Tex##, CD8+ intraepithelial lymphocytes (IEL), CD8+ Tem and CD8+ Temra (upper left); the UMAP plot of the CD4+ T cells reclustered into five subsets, including CD4+ Tem, CD4+ Th1-like, CD4+ Th17, CD4+ Naive and CD4+ Treg (lower left); the proportion of different CD8+ T cell subsets (upper right) and CD4+ T cell subsets (lower right), respectively, in four clinical groups, including normal cervix without human papillomavirus (HPV) infection, HPV-infected normal cervix, HPV-infected high-grade squamous intraepithelial lesions (HSIL) and HPV-infected cervical cancer; (C) the violin plots indicating the naiveness score (upper), cytotoxicity score (middle) and exhaustion score (lower) of each CD8+ T cell cluster; (D) the UMAP feature plots of the marker genes of CD8+ Temra (CX3CR1, KLRD1, PRF1) and CD8+ Tex (HAVCR2, CXCL13, CTLA4). (E) The pseudotime plot describing the differentiation trajectories of different subsets of CD8+ T lymphocytes (upper) and trajectory presented in the four clinical groups, respectively, including normal cervix without HPV infection, HPV-infected normal cervix, HPV-infected HSIL and HPV-infected cervical cancer; (F) the UMAP feature plots of the marker genes of CD4+ Th17 (CCR6, IL17A, CTSH), CD4+ Treg (CTLA4, FOXP3, TNFRSF18) and CD4+ Th1-like (CXCL13, IFNG, PDCD1); (G) the pseudotime plot describing the differentiation trajectories of different subsets of CD4+ T lymphocytes (upper) and trajectory presented based on the four clinical groups, including normal cervix without HPV infection, HPV-infected normal cervix, HPV-infected HSIL and HPV-infected cervical cancer; (H) the Kaplan Meier curve predicting the overall survival (OS) of cervical cancer (CC) patients with high and low expression of the Th17 signature (IL17A, CCR6 and CTSH) using TCGA data (p = .02, log rank test).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10040725</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36967539</oboInOwl:hasDbXref>
        <rdfs:label>CD8+ Tex</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000625"/>
        <skos:relatedMatch rdf:resource="CL:0011025"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/fbcb4472-e81d-44c1-9d0f-1430a4835b57"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000625"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/fbcb4472-e81d-44c1-9d0f-1430a4835b57"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0011025"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/fbe0122e-d3ca-497d-a179-0a584bae362d -->

    <Class rdf:about="http://example.org/fbe0122e-d3ca-497d-a179-0a584bae362d">
        <obo:IAO_0000115>In order for the sensitization we observed in excitatory interneurons to drive the psychophysical phenomenon of allodynia, spinal projection neurons must relay these nociceptive signals supraspinally. We found that capsaicin treatment shifted the overall tuning of SPB neurons towards LT input, consistent with the effects of central sensitization producing allodynia (Fig. 8a, b). Because SPB neurons are heterogeneous with respect to their response properties, we classified them as either wide-dynamic range (WDR), high threshold (HT), or low threshold (LT) (Fig. 8c) using previously published criteria. We found that both HT and WDR SPB showed significant increases in tuning to LT input, however the degree of change was much greater for WDR compared to ##HT SPB neurons## (Fig. 8d). Finally, examining CICADA responses across populations, we found that WDR cells were more frequently responsive to CICADA agonists (71.4%), compared to either LT (40%) or HT (0%) SPB neurons. In particular, all SP-responsive SPB neurons were WDR cells (Fig. 8e). Since capsaicin is known to activate peptidergic afferents that release SP, these findings suggest that capsaicin-induced allodynia may be conveyed to the brain through a population of TACR1 expressing WDR SPB neurons and, to a lesser extent, some HT SPB neurons (Fig. 8f).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9440908</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36057681</oboInOwl:hasDbXref>
        <rdfs:label>HT SPB neurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000540"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/fbe0122e-d3ca-497d-a179-0a584bae362d"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000540"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/fc14bef6-2eeb-4700-9608-0284240faa14 -->

    <Class rdf:about="http://example.org/fc14bef6-2eeb-4700-9608-0284240faa14">
        <obo:IAO_0000115>Subclustering of DCs revealed eight clusters converting to six differentiation states, including CD141+ DCs (DC1); CD1c+ A DCs (Langerhans cells, DC2); CD163+ CD14+ DCs (CD1c+ B DCs, DC3); CD1c- CD141- CD11c+ DCs (##DC##4); AXL+ SIGLEC6+ DCs (DC5); and plasmacytoid DCs (pDCs, DC6) with distinct markers (Fig. 7a and Supplementary Fig. S8a-c online). Among DC subsets, the proportion of DC6 increased in group C compared to groups A and B (Fig. 7b, Supplementary Fig. S8d,e online, and Supplementary Tables S3 and S4 online). GO analysis of DEGS in DC6 compared to other DC subsets indicated significant increase in response to ER stress (Fig. 7c). Also, PCBP1 was highly expressed in subgroup C-1 compared to C-2 among DC subtypes (Fig. 7d).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11231222</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38977917</oboInOwl:hasDbXref>
        <rdfs:label>DC</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000451"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/fc14bef6-2eeb-4700-9608-0284240faa14"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000451"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/fcb72e63-71cd-4e71-aa3d-a9397c959a0c -->

    <Class rdf:about="http://example.org/fcb72e63-71cd-4e71-aa3d-a9397c959a0c">
        <obo:IAO_0000115>In the present study, the cell calcification ability, osteogenic differentiation potential, and osteogenic gene expression of ##DFAT cells## and ASCs were compared by in vitro assays. Our findings revealed that both cell types had osteogenic differentiation properties; however, the in vitro results showed that ASCs possessed higher and earlier osteogenic differentiation potential than DFAT cells (Figure 3). In addition, ASCs showed higher expression of early osteoblast marker genes than DFAT cells (Figure 4). Other studies have indicated that DFAT cells have a higher proliferation rate, availability, and cell number than ASCs. The cell population heterogeneity could be induced by local variations in cell density, local buildup of extracellular matrix, and be amplified as the cells grow. Additionally, cell growth and local cell death may trigger some cell differentiation and the loss of all or some pluripotency markers. Therefore, differences between DFAT cells and ASCs in their rate of differentiation into bone tissue and differences in expression markers are thought to be due to the composition of these cell populations. Additionally, we introduced additional steps to enhance DFAT cell preparation, in which DFAT cells were separated from the floating adipocytes and passed through a mesh on the way to the dish bottom. In this way, we addressed disadvantages such as the potential attachment of contaminating cells to the ceiling. This mesh method, and the separation of DFAT cells from adipocytes during preparation improved the homogeneity of DFAT cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8620969</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34830277</oboInOwl:hasDbXref>
        <rdfs:label>DFAT cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002334"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/fcb72e63-71cd-4e71-aa3d-a9397c959a0c"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002334"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/fcbec9ba-a292-4fbb-a0d5-734d5687c4e5 -->

    <Class rdf:about="http://example.org/fcbec9ba-a292-4fbb-a0d5-734d5687c4e5">
        <obo:IAO_0000115>Cells are colored by cluster assignment at resolution 0.1. Cluster 0 corresponds to pluripotent cells, cluster 1 to ##early ectoderm##, cluster 2 to mesoderm, cluster 3 to neural crest, cluster 4 to endoderm, cluster 5 to neurons, and cluster 6 to endothelial cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8830892</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35142607</oboInOwl:hasDbXref>
        <rdfs:label>early ectoderm</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000221"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/fcbec9ba-a292-4fbb-a0d5-734d5687c4e5"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000221"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/fceb1866-bbc7-4143-9858-205dc8a0c74f -->

    <Class rdf:about="http://example.org/fceb1866-bbc7-4143-9858-205dc8a0c74f">
        <obo:IAO_0000115>The first blood and immune cells arise from extra-embryonic yolk sac progenitors and for some cell types, such as macrophages or mast cells, yolk sac-derived cells can persist in tissues for extended periods of time after birth. cDCs first arise during embryogenesis in mice and humans, when they are thought to critically contribute to fetomaternal tolerance. However, the origins of cDCs in early life have not been investigated. In adults, cDCs develop downstream of hematopoietic stem cells (HSCs) from a fraction of myeloid bone marrow progenitors capable of generating plasmacytoid DCs (pDCs) and cDCs that has been termed common DC progenitor (CDP). Within CDPs in mice, expression of the C-type lectin receptor DNGR-1 (encoded by the Clec9a gene) distinguishes ##cDC-restricted progenitors##. CDPs further differentiate into pre-cDCs, which continue to express DNGR-1, exit the bone marrow and terminally differentiate into cDC subtypes in peripheral organs and in response to environmental cues. The Clec9a promoter is also active in cDC1 and to a lower extent on pDCs but it is not active in cDC2 and other lymphoid or myeloid cells. By crossing mice expressing CRE-recombinase under the Clec9a promoter to Rosalox-stop-lox-yellow fluorescent protein (YFP) or Rosalox-stop-lox-TOMATO mice, we have generated mice that faithfully track cells belonging to the cDC lineage in steady state and under inflammatory conditions. Using these mice, we have found that cDC2 in adult spleen are predominantly derived from CDP/pre-cDC, which is consistent with other studies.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7815729</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33469015</oboInOwl:hasDbXref>
        <rdfs:label>cDC-restricted progenitors</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0001029"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/fceb1866-bbc7-4143-9858-205dc8a0c74f"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0001029"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/fcf5cd24-4609-49b7-b7e4-fc2206d4ec3d -->

    <Class rdf:about="http://example.org/fcf5cd24-4609-49b7-b7e4-fc2206d4ec3d">
        <obo:IAO_0000115>In the steady-state, macrophages represented the largest cell population (58.7% of total CD45+ cells) in the mouse hearts, followed by B cells (18.2%), NK cells (8.6%), T cells (4.3%), monocytes (3.7%), and neutrophils (3.1%) (Fig. 1d and Supplementary Table 1); the other cardiac leukocyte populations occupied less than 3% in the steady state. Interestingly, the proportion of macrophages drastically dropped at day 1 (24.9%) but then gradually recovered from day 3 (66.8%), reaching a peak on day 7 (84.0%) post-MI (Fig. 1d). On the contrary, the proportion of neutrophils increased steeply at day 1 (54.4%) and then decreased rapidly (14.8, 1.7, and 1.6% on days 3, 5, and 7, respectively), which was consistent with previous reports. Monocytes were increased in the early phase of MI (days 1 and 3) and then decreased in the late phase of MI (days 5 and 7), while DCs were predominant at days 3 and 5. Lymphocytes (T cells, B cells, NK cells, and ILC2 cells), occupying 31.9% of total CD45+ cells in the steady state, decreased at day 1 and did not reach the steady-state values until day 7 post-MI. Collectively, scRNA-seq targeting ##cardiac leukocytes## showed not only major cell populations but also minor populations, such as mast cells and DC subtypes; our data clearly show that the temporal dynamics after MI are different depending on the cell populations.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9357004</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35933399</oboInOwl:hasDbXref>
        <rdfs:label>cardiac leukocytes</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000738"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/fcf5cd24-4609-49b7-b7e4-fc2206d4ec3d"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000738"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/fd1cfb13-f644-4287-8ac9-eff60ce04f97 -->

    <Class rdf:about="http://example.org/fd1cfb13-f644-4287-8ac9-eff60ce04f97">
        <obo:IAO_0000115>While the heterogeneity of CD103+ TRMs is widely discussed in the literature, the characteristics of TRM subpopulations within the tumor or distant tissues of tumor-bearing mice are less well defined. To characterize tumoral TRMs, scRNA-seq technology provides unprecedented analytical power and allows us to dissect cells with thousands of dimensions. With the hypothesis that particular ##intratumoral T cells## are precursors for TRM development, we extended our scRNA-seq approach to include various effector and memory T cell populations to comprehensively depict their transcriptomic program. From the tumor and distant mucosa of mice bearing established 4T1 tumors, we flow sorted distinct memory T cell populations using a strict gating strategy (Figure S3). We constructed single-cell cDNA libraries from paired intratumoral sorted TCR-beta+CD44+CD62L-CD69+CD103+ cells (TRMs), mucosal sorted TCR-beta+CD44+ CD69+CD103+ cells (distant mucosa TRMs), intratumoral TCR-beta+CD44+CD62L+CD69-CD103- cells (TCMs), and TCR-beta+CD44+CD62L-CD69-CD103- cells (TEMs) (Table S2). After data processing and normalization, we performed unbiased clustering and visualized the CD8+ clusters using t-distributed stochastic neighbor embedding (t-SNE; Figure 2A). Through this unsupervised analysis, we found that all four samples could distinctly separate into multiple clusters, confirming continued heterogeneity among the single-cell subsets.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8204287</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33979626</oboInOwl:hasDbXref>
        <rdfs:label>intratumoral T cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000084"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/fd1cfb13-f644-4287-8ac9-eff60ce04f97"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000084"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/fd2773f5-4bb5-4378-b0d1-073b5a373cdf -->

    <Class rdf:about="http://example.org/fd2773f5-4bb5-4378-b0d1-073b5a373cdf">
        <obo:IAO_0000115>Pseudobulk differential gene expression analysis showed significant upregulation of genes in all the B cell subclusters in INS, except for atBCs and ASCs (Fig. 2e and Supplementary Fig. 5a). Pathway analysis revealed an enrichment of functions associated with actin cytoskeletal dynamics in all B cell subclusters in INS, while some subclusters (Naive-1, actMBCs, MBC-2, and MZ-like B cells) also showed an enrichment of B cell activation pathways (Supplementary Fig. 5b). The antigen-inexperienced and recently activated B cell subsets (Naive-1 and actMBC) showed the greatest differences in gene expression suggesting that the transcriptional events leading to B cell dysregulation occur early during B cell activation (Fig. 2e and Supplementary Fig. 5a). There was a substantial overlap in the upregulated genes between Naive-1 B cells, actMBCs, ##MBC##-2, and MZ-like B cells including many atBC-associated genes (e.g., ITGB2, ITGB7, FCRLA, FCRL2), POU2F2, POU2AF1, and the extrafollicular response genes TNFRSF13B and GPR183, suggesting a possible developmental sequence or cooperation between these B cell subclusters in generating an extrafollicular B cell response in INS (Fig. 2e).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10667257</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37996443</oboInOwl:hasDbXref>
        <rdfs:label>MBC</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000788"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/fd2773f5-4bb5-4378-b0d1-073b5a373cdf"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000788"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/fd3098fd-e267-4ea4-9cec-ede7f7219d27 -->

    <Class rdf:about="http://example.org/fd3098fd-e267-4ea4-9cec-ede7f7219d27">
        <obo:IAO_0000115>Sequencing of CD45+ cells from 12- and 21-week-old WT and DB hindpaws generated an integrated dataset of 21,661 cells grouped into 12 clusters (Fig. 1c-f), defined as: macrophages (Pf4, C1qa, C1qc, Apoe, C1qb), ##type 2 conventional dendritic cells## (cDC2) (CD74, H2-Aa, H2-Ab1, H2-Eb1, Mgl1), mast cells/basophils (M/B) (Mcpt2, Cma1, Cpa3, Mcpt4, Tpsb2), dermal gammadelta T (dTgammadelta) cells (Trdc, Cd163l1, Trdv4, Cxcr6, F2r), heterogeneous T (Thet) cells (Ikzf2, Ctla4, CD28, Trac, Icos), Type 2 innate lymphoid cells (ILC2) (Ctla2a, Gata3, Lmo4, Hlf, Il13), natural killer (NK) cells (Ccl5, xcl1, AW112010, Txk, Ly6c2), dendritic epidermal T cells (DETC; Cd7, Trat1, CD3e, Gem, Fermt2), type 1 conventional dendritic cells (cDC1) cells (Irf8, CD207, Tbc1d4, Cst3, Naaa), B cells (Igkc, Ighm, Ebf1, CD79a, Iglc2), monocyte-derived macrophages (MdMacro) (Plac8, Ifitm3, Lst1, Chil3, Thbs1), and neutrophils (Neut) (S100a9, S100a8, Retnlg, G0s2, Acod1) (Fig. 1g, Supplementary Fig. 1 and Supplementary Table 2). After quality control and filtering, the number of single-cell transcriptomes was 3,946 (12-week-WT), 5,413 (12-week-DB), 4,852 (21-week-WT), and 7,450 (21-week-DB). When each sample was represented as a proportion of the integrated cluster total, variation in cell numbers in each cluster was apparent (Fig. 1e, f). Macrophages were the most abundant cell type across all samples, while mast cell/basophil (M/B), dermal gammadelta T cell (dTgammadelta), heterogeneous T cell (Thet), and Type 2 innate lymphoid cell (ILC2) populations were substantially increased in 21-week-DB mice (Fig. 1f and Supplementary Table 3).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10951029</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38502310</oboInOwl:hasDbXref>
        <rdfs:label>type 2 conventional dendritic cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000990"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/fd3098fd-e267-4ea4-9cec-ede7f7219d27"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000990"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/fd67601c-d22d-4df2-99b5-3e0741b5d0d4 -->

    <Class rdf:about="http://example.org/fd67601c-d22d-4df2-99b5-3e0741b5d0d4">
        <obo:IAO_0000115>In summary, from work done in frontal areas, it is clear that I-S cells are involved in enhancing learning and memory discrimination, are recruited during theta rhythms, and primarily target SOM+ cells, but also PV+ cells (i.e., similar to hippocampal CA1 I-S3 cells; Figures 1A,B). Further characterization of VIP+ cell types in frontal areas is needed to distinguish how much ##I-S cell## types in these areas contact pyramidal cells, compared to non-I-S VIP+ cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7296096</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32581726</oboInOwl:hasDbXref>
        <rdfs:label>I-S cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000099"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/fd67601c-d22d-4df2-99b5-3e0741b5d0d4"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000099"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/fd803d0d-ce12-48b0-af2a-46570210d4b2 -->

    <Class rdf:about="http://example.org/fd803d0d-ce12-48b0-af2a-46570210d4b2">
        <obo:IAO_0000115>Immunosuppressive role of ##tumour-associated macrophages## (TAMs). TAMs promote immunosuppression by different mechanisms: TAMs can express programmed cell death ligand 1 and ligand 2 (PD-L1 and PD-L2), which bind the T cell inhibitory receptor programmed cell death protein 1 (PD-1), thereby inducing T cell exhaustion. TAM expression of V-domain Ig suppressor of T cell activation (VISTA) and B7 family molecules, such as B7-H4, can have similar function. TAMs secrete immunosuppressive cytokines such as IL-10 and TGFbeta, which can have direct suppressive functions on CD8+ T cells, or they can induce recruitment of immunosuppressive CD4+ T regulatory (Treg) cells. TAM secreted IL-10 can impair T cells effector functions indirectly either by inhibit dendritic cell (DC) anti-tumorigenic role or by inducing DC expression of PD-L1. Moreover, amino acid metabolism in TAM results in production of arginase and immunosuppressive metabolites via the indoleamine 2,3-dioxygenase (IDO) pathway, which is responsible of metabolic starvation in T cells. TAMs can also indirectly induce immunosuppression by promoting fibrosis. Indeed cancer associated fibroblast (CAF) secreted factors and/or extracellular matrix (ECM) stiffness are responsible for CD8+ T cell immunosuppression and/or exclusion from the tumour nest.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6678757</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31331034</oboInOwl:hasDbXref>
        <rdfs:label>tumour-associated macrophages</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/fd803d0d-ce12-48b0-af2a-46570210d4b2"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/fd81a5b5-ef01-4ae2-9213-55ca6aa4969c -->

    <Class rdf:about="http://example.org/fd81a5b5-ef01-4ae2-9213-55ca6aa4969c">
        <obo:IAO_0000115>Development of the urogenital organs prostate and bladder involves intercellular signaling in differentiation. This cell-to-cell communication is controlled by secreted hormone molecules of stromal mesenchyme cells and heterotypic cell contact. Prostate stromal proenkephalin (PENK) was identified by a comparative transcriptome analysis between sorted CD49a+ prostate stromal cells and ##CD13+ bladder stromal cells## of the lamina propria, the rationale being that genes encoding these molecules are likely organ specific (i.e., either prostate or bladder). From this analysis, 288 prostate and 91 bladder stromal genes were identified. Organ-specific expression was validated by reverse-transcriptase polymerase chain reaction (RT-PCR) analysis. Genes encoding secreted proteins were identified by the presence of N-terminal signal peptide sequences. PENK was the lead differentially expressed gene in prostate. Immunostaining with a PENK polyclonal antibody raised against the peptide sequence T163-E179 detected strong reactivity in the stroma of benign prostate tissue and no reactivity in the bladder lamina propria. This result validated the RNA expression analysis. Parenthetically, prostate PENK was not processed to enkephalin opioids as indicated by the immunostaining pattern of enkephalin antibodies reported in the literature. Prostate stromal cells are not known as a source of these opioids.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8675470</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34911496</oboInOwl:hasDbXref>
        <rdfs:label>CD13+ bladder stromal cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:1000600"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/fd81a5b5-ef01-4ae2-9213-55ca6aa4969c"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:1000600"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/fda55462-e36f-4450-a413-2c83e534cc57 -->

    <Class rdf:about="http://example.org/fda55462-e36f-4450-a413-2c83e534cc57">
        <obo:IAO_0000115>Variable Name Data used   TN Naive T-cells Combination of CD4 naive and memory resting T-cells and resting NK cells   Th Helper T-cells Combination of memory activated CD4 T-cells and follicular helper T-cells   TC Cytotoxic cells Combination of CD8 T-cells and activated NK cells   Tr Regulatory T-cells Regulatory T-cells   DN Naive dendritic cells Naive dendritic cells   D Activated dendritic cells Activated dendritic cells   ##MN## Naive Macrophages Combination of Macrophages M0 and Monocytes   M Macrophages Combination of M1 and M2 Macrophages   C Cancer cells Estimated   N Necrotic cells Estimated   A Cancer Associated Adipocytes Assumed to be twice of the total number of immune cells   H HMGB1 HMGB1 gene expression   IL12 IL-12 IL12A and IL12B gene expressions   IL10 IL-10 IL10, IL10RA and IL10RB gene expressions   IL6 IL-6 IL6, IL6ST and IL6RA gene expressions   </obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8959189</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35294447</oboInOwl:hasDbXref>
        <rdfs:label>MN</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/fda55462-e36f-4450-a413-2c83e534cc57"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/fda5ff0b-8d05-4fe8-902f-683ecb45db6a -->

    <Class rdf:about="http://example.org/fda5ff0b-8d05-4fe8-902f-683ecb45db6a">
        <obo:IAO_0000115>Our results indicated that immune cell composition and immune-related genes in the tumors differed between the high-risk and low-risk groups. Accordingly, we evaluated the relationship between glycolysis and immune cell infiltration. We uploaded the entire cohort&apos;s transcriptome data to ImmuCellAI to analyze each group&apos;s immune cell composition (Fig. 5B). In total, 13 of 24 immune cell types differed between the groups, including naive CD4 T cells, naive CD8 T cells, cytotoxic T cells, exhausted T cells, inducible regulatory T cells (iTreg), helper T cells 1 (Th1), follicular helper T cells (Tfh), central memory T cells (Tcm), mucosal-associated invariant T cells (MAIT), DCs, Macrophages, Neutrophils, and gamma delta T cells (gammadelta T) (Fig. 5C). Correlations between the expression levels of the eight risk genes and immune cell components were also evaluated (Additional file 2: Table S3). The expression of ARTN was related to cellular components, including ##neutral and central_ memory##, Gamma_ delta, Tr1, B_ Cell, and Tfh. Moreover, the risk score negatively correlated with the immune infiltration score (R = - 0.22) (Fig. 5D).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8425093</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34496868</oboInOwl:hasDbXref>
        <rdfs:label>neutral and central_ memory</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000813"/>
        <skos:relatedMatch rdf:resource="CL:0000904"/>
        <skos:relatedMatch rdf:resource="CL:0000907"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/fda5ff0b-8d05-4fe8-902f-683ecb45db6a"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000813"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/fda5ff0b-8d05-4fe8-902f-683ecb45db6a"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000904"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/fda5ff0b-8d05-4fe8-902f-683ecb45db6a"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000907"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/fdd87253-8ec3-4225-9e88-a428d28204b3 -->

    <Class rdf:about="http://example.org/fdd87253-8ec3-4225-9e88-a428d28204b3">
        <obo:IAO_0000115>In all tumor tissues, ##TAMs## replaced resident populations such as lung alveolar macrophages, prostate CTRB1+ macrophages, and renal GPX3+ macrophages (Supplementary Fig. 1a, b, and Supplementary Table 1). Plasmacytoid dendritic cells (pDCs) were marginally elevated in lung, colon, and pancreatic cancers, whereas conventional DCs were drastically reduced in colorectal cancer (Supplementary Fig. 1c). T cells exhibited diverse gene expression profiles including naive-like, activated, follicular helper, and regulatory CD4+ T cells, in addition to cytokine-rich, highly cytotoxic, and exhausted CD8+ effector T cells (Supplementary Fig. 1d-f, and Supplementary Table 1). Compared to normal tissues, CD4+ regulatory and follicular helper T cells were commonly elevated, whereas overall cytotoxic immune cell clusters (CD8 Cytotoxic, NK Cytotoxic, and Innate Lymphoid) were reduced (Supplementary Fig. 1g). In contrast, CD8+ T cell states were differentially regulated in each tumor type. The degree of mixing among four datasets in embeddings of CD45+ cells, Myeloid, and T/NK cells was evaluated by LISI metric. Integration of the four datasets was performed appropriately to assign cell identity covering tissue-specific cell types such as lung alveolar macrophages (Supplementary Fig. 1h).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11014989</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38424167</oboInOwl:hasDbXref>
        <rdfs:label>TAMs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/fdd87253-8ec3-4225-9e88-a428d28204b3"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/fdfa9b16-165b-48e8-bf93-36a14beaf97b -->

    <Class rdf:about="http://example.org/fdfa9b16-165b-48e8-bf93-36a14beaf97b">
        <obo:IAO_0000115>The movement and cell characteristics were contrasted between platelet-interacting (shaded circles) and non-interacting (open circles) treponemes utilizing high-resolution darkfield videos at 1000x magnification. (A) Treponeme wavelength (green bracket) and amplitude (yellow bracket) were measured only when the cell body waveform was in the plane of focus (grey bracket). Two ##activated platelets## (white arrowheads) are bound by one treponeme. The grey bracket shows a segment of the treponeme with cell peak and troughs in the same focal plane. (B) Treponeme length was measured when the full treponeme was in the same focal plane (magenta bracket). (C) Platelet-interacting treponemes demonstrated a higher translational velocity (mean = 1.68 +- 0.10 mum/sec [SEM] *P &lt; 0.0001, n = 24) compared with non-interacting treponemes (mean = 0.65 +- 0.10 mum/sec [SEM], n = 12). (D) Frame by frame analysis determined platelet-interacting treponemes rotate at a higher frequency (mean = 2.60 +- 0.27 Hz [SEM] **P = 0.0060, n = 12) versus non-interacting treponemes (mean = 1.46 +- 0.25 Hz [SEM], n = 11). (E) Top panel: Platelet-interacting treponemes maintained a more tightly coiled helix resulting in a shorter wavelength (mean = 0.79 +- 0.02 mum [SEM] ***P = 0.0237) versus non-interacting treponemes (mean = 0.86 +- 0.02 mum [SEM]), n = 15. Middle panel: Platelet-interacting treponemes demonstrated a trend towards a higher amplitude (mean = 0.30 +- 0.02 mum [SEM]) compared with non-interacting treponemes (mean = 0.27 +- 0.01 mum [SEM]), n = 15. Bottom panel: Platelet-interacting treponemes also displayed a trend towards a shorter, more compact coiled shape (mean cell length = 9.56 +- 0.65 mum [SEM]) compared with non-interacting treponemes (mean cell length = 10.46 +- 0.66 mum [SEM]), n = 15. Student&apos;s unpaired two-tailed t tests were used to calculate statistical significance. Scale bars = 5 mum.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6338379</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:30657796</oboInOwl:hasDbXref>
        <rdfs:label>activated platelets</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000233"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/fdfa9b16-165b-48e8-bf93-36a14beaf97b"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000233"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/fe1ee96d-9690-45f2-8a17-30efb5451956 -->

    <Class rdf:about="http://example.org/fe1ee96d-9690-45f2-8a17-30efb5451956">
        <obo:IAO_0000115>By the time the mouse blastocyst is ready to implant into the uterus, it comprises three cell types: pluripotent epiblast and two types of extra-embryonic tissue; primitive endoderm (PE), that will become visceral endoderm (##VE##) that gives rise to the yolk sac; and trophectoderm (TE), progenitor of the placenta (figure 1). ESCs represent the pluripotent epiblast that forms a compartment distinct from the extra-embryonic cells in the blastocyst. The epiblast arises from a set of cells internalized during the 8- to 16-cell and 16- to 32-cell cleavage stages, the inner cell mass. The cells remaining on the outside of the embryo at this time become the TE. Before implantation, a salt and pepper mixture of inside cells, now specified as PE and epiblast, sort from each other into distinct layers. Just as the epiblast is represented by ESCs, cultured stem cell lines of trophoblast stem cells (TSCs) have been established from the TE and of eXtraEmbryoNic stem cells (XEN cells) from the PE/VE. The trick in recapitulating development beyond gastrulation to form structures representing the entire body plan has been to recreate interactions between the pluripotent ESCs and the two extra-embryonic stem cell types. </obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9833437</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36630196</oboInOwl:hasDbXref>
        <rdfs:label>VE</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000223"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/fe1ee96d-9690-45f2-8a17-30efb5451956"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000223"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/fe301640-d1ee-4686-bbba-30442be61326 -->

    <Class rdf:about="http://example.org/fe301640-d1ee-4686-bbba-30442be61326">
        <obo:IAO_0000115>The Table shows the numerical representations of Excitatory Neurons (Deep and Superficial Pyramidal cells) and Inhibitory neurons (##Oriens Lacunosum moleculare cells##:OLM; Trilaminar cells:Tri, Backprojection cells:BP, cholecystokinin positive Basket cells:CCKBC, Parvalbumin positive cells:PVBC, AxoAxonic Cells:AA, Ivy Cells:IVY, Bistratified cells:BS, Schaffer Collateral associated cells:SCA, Perforant Pathway Associated cell:PPA, Neurogliaform:NG) subdivided on the basis of the placement classes (SO, SP, SR, SLM).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9381785</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35974119</oboInOwl:hasDbXref>
        <rdfs:label>Oriens Lacunosum moleculare cells</rdfs:label>
    </Class>
    


    <!-- http://example.org/fe662aa5-9cca-4bc5-8adc-9f9a2bd99029 -->

    <Class rdf:about="http://example.org/fe662aa5-9cca-4bc5-8adc-9f9a2bd99029">
        <obo:IAO_0000115>Pancreatic ductal adenocarcinoma (PDAC) has a poor clinical outlook. Responses to immune checkpoint blockade are suboptimal and a much more detailed understanding of the tumor immune microenvironment is needed if this situation is to be improved. Here, we characterized tumor-infiltrating T-cell populations in patients with PDAC using cytometry by time of flight (CyTOF) and single-cell RNA sequencing. T cells were the predominant immune cell subset observed within tumors. Over 30% of CD4+ T cells expressed a CCR6+CD161+ Th17 phenotype and 17% displayed an activated regulatory T-cell profile. Large populations of ##CD8+ tissue-resident memory (TRM) T cells## were also present and expressed high levels of programmed cell death protein 1 (PD-1) and TIGIT. A population of putative tumor-reactive CD103+CD39+ T cells was also observed within the CD8+ tumor-infiltrating lymphocytes population. The expression of PD-1 ligands was limited largely to hemopoietic cells whilst TIGIT ligands were expressed widely within the tumor microenvironment. Programmed death-ligand 1 and CD155 were expressed within the T-cell area of ectopic lymphoid structures and colocalized with PD-1+TIGIT+ CD8+ T cells. Combinatorial anti-PD-1 and TIGIT blockade enhanced IFNgamma secretion and proliferation of T cells in the presence of PD-1 and TIGIT ligands. As such, we showed that the PDAC microenvironment is characterized by the presence of substantial populations of TRM cells with an exhausted PD-1+TIGIT+ phenotype where dual checkpoint receptor blockade represents a promising avenue for future immunotherapy.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10068448</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36689623</oboInOwl:hasDbXref>
        <rdfs:label>CD8+ tissue-resident memory (TRM) T cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000909"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/fe662aa5-9cca-4bc5-8adc-9f9a2bd99029"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000909"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/fe865bb0-6870-4fda-9e25-ae48cc18a7d7 -->

    <Class rdf:about="http://example.org/fe865bb0-6870-4fda-9e25-ae48cc18a7d7">
        <obo:IAO_0000115>Taken together, the data-driven FACS gating strategy allowed us to isolate distinct stromal subsets for functional investigation. Both MSSCs and ##HAGEPs## demonstrated considerably higher in vitro colony-forming capacities in comparison with balanced progenitors, OCs, pre-osteoblasts, and pre-fibroblasts. While MSSCs and HAGEPs exhibited full multi-differentiation potentials, pre-fibroblasts had only limited differentiation potentials. OCs showed enhanced osteoblastic and chondrogenic differentiation capacities and compromised adipogenic potential, which is consistent with their differentiation marker expression profiles (Figure 2).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10097421</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36876630</oboInOwl:hasDbXref>
        <rdfs:label>HAGEPs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0009099"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/fe865bb0-6870-4fda-9e25-ae48cc18a7d7"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0009099"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/fe94a873-9cd2-4d79-a1f2-3d47632479dd -->

    <Class rdf:about="http://example.org/fe94a873-9cd2-4d79-a1f2-3d47632479dd">
        <obo:IAO_0000115>Innate T cells, including CD1d-restricted invariant natural killer T (iNKT) cells, are characterized by their rapid activation in response to non-peptide antigens, such as lipids. While the transcriptional profiles of naive, effector, and memory adaptive T cells have been well studied, less is known about the transcriptional regulation of different iNKT cell activation states. Here, using single-cell RNA-sequencing, we performed longitudinal profiling of activated murine iNKT cells, generating a transcriptomic atlas of iNKT cell activation states. We found that transcriptional signatures of activation are highly conserved among heterogeneous iNKT cell populations, including NKT1, NKT2, and NKT17 subsets, and human iNKT cells. Strikingly, we found that regulatory iNKT cells, such as adipose iNKT cells, undergo blunted activation and display constitutive enrichment of memory-like cMAF+ and KLRG1+ populations. Moreover, we identify a conserved cMAF-associated transcriptional network among ##NKT10 cells##, providing novel insights into the biology of regulatory and antigen-experienced iNKT cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9831610</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36458691</oboInOwl:hasDbXref>
        <rdfs:label>NKT10 cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000814"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/fe94a873-9cd2-4d79-a1f2-3d47632479dd"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000814"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/fed090d9-9f24-4381-b78a-8211e8aed34a -->

    <Class rdf:about="http://example.org/fed090d9-9f24-4381-b78a-8211e8aed34a">
        <obo:IAO_0000115>The tumor microenvironment (TME) contains diverse population of non-tumor stromal cell that play a role in tumor immune evasion and immunosuppression. The human prostate tumor microenvironment consists of various stromal cells or extracellular matrix, including prostate epithelial cells, myoepithelial cells, fibroblasts, pericytes, endothelial cells, immune cells, adipocytes, neuronal cells, and neuroendocrine cells. Among these, ##tumor-associated macrophages## (TAMs), a crucial component of the tumor microenvironment, typically impact tumor growth through activities such as promoting neovascularization, secreting cytokines that inhibit tumor cell apoptosis, stimulating tumor cell proliferation and invasion, and inducing immunosuppression. Based on the concept of classical and alternative activation, macrophages undergo polarization into distinct categories known as M1 and M2. Studies suggest that TAMs predominantly exhibit an M2-like phenotype, characterized by immunosuppressive states and promoting tumor progression. Therefore, it can be served as a strategy to block the downstream signaling pathways of M2 macrophages or inhibit M2-secreted factors that facilitate tumor development and progression for PCa intervention.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10864475</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38349474</oboInOwl:hasDbXref>
        <rdfs:label>tumor-associated macrophages</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/fed090d9-9f24-4381-b78a-8211e8aed34a"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/fef3a327-15cc-4061-ad21-8dcdda7a7d9d -->

    <Class rdf:about="http://example.org/fef3a327-15cc-4061-ad21-8dcdda7a7d9d">
        <obo:IAO_0000115>The unwounded, normal corneal stroma is a relatively simple, avascular tissue populated with quiescent keratocytes, along with corneal nerves and a few resident dendritic and monocyte/macrophage cells. In the past, the resting keratocytes were thought of as a homogenous cellular population, but recent work has shown local variations in vimentin and nestin expression, and responsiveness to transforming growth factor (TGF)-beta1. Studies have also supported there being &quot;stromal stem cells&quot; in localized areas. After corneal wounding, depending on the site and severity of injury, profound changes in stromal cellularity occur. Anterior or posterior injuries to the epithelium or endothelium, respectively, trigger apoptosis of adjacent keratocytes. Many contiguous keratocytes transition to keratocan-negative corneal fibroblasts that are proliferative and produce limited amounts of disorganized extracellular matrix components. Simultaneously, large numbers of bone marrow-derived cells, including monocytes, neutrophils, fibrocytes and lymphocytes, invade the stroma from the limbal blood vessels. Ongoing adequate levels of TGFbeta1, TGFbeta2 and platelet-derived growth factor (PDGF) from epithelium, tears, endothelium and aqueous humor that penetrate defective or absent epithelial barrier function (EBF) and epithelial basement membrane (EBM) and/or Descemet&apos;s basement membrane (DBM) drive ##corneal fibroblasts## and fibrocytes to differentiate into alpha-smooth muscle actin (SMA)-positive myofibroblasts. If the EBF, EBM and/or DBM are repaired or replaced in a timely manner, typically measured in weeks, then corneal fibroblast and fibrocyte progeny, deprived of requisite levels of TGFbeta1 and TGFbeta2, undergo apoptosis or revert to their precursor cell-types. If the EBF, EBM and/or DBM are not repaired or replaced, stromal levels of TGFbeta1 and TGFbeta2 remain elevated, and mature myofibroblasts are generated from corneal fibroblasts and fibrocyte precursors that produce prodigious amounts of disordered extracellular matrix materials associated with scarring fibrosis. This fibrotic stromal matrix persists, at least until the EBF, EBM and/or DBM are regenerated or replaced, and keratocytes remove and reorganize the affected stromal matrix.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7855915</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33068626</oboInOwl:hasDbXref>
        <rdfs:label>corneal fibroblasts</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002363"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/fef3a327-15cc-4061-ad21-8dcdda7a7d9d"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002363"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/ff1bb50b-34c9-4429-9c71-3e328e67c7ea -->

    <Class rdf:about="http://example.org/ff1bb50b-34c9-4429-9c71-3e328e67c7ea">
        <obo:IAO_0000115>One possible explanation for these results is that products of NADPH oxidase can compensate for the mitochondrion-targeted catalase-catalyzed H2O2 breakdown. To test this hypothesis, we crossed the mCAT transgene to the p91phox-/- background and generated mixed bone marrow chimeric mice to compare the cell intrinsic fungicidal activities of ##CD45.1+ p91phox-/- and CD45.2+ p91phox-/- mCATTg/+ leukocytes## in the same lung (Fig. S1 and S2), as outlined above. Following infection with FLARE conidia, AM conidial uptake was reduced in p91phox-/- mCATTg/+ AMs (34% +- 5%) compared to p91phox-/- (50% +- 6%) counterparts at 24 h postinfection (Fig. 4A and B). In addition, intraleukocyte conidial viability was higher in p91phox-/- mCATTg/+ AMs (60% +- 2%) compared to p91phox-/- (28% +- 7%) counterparts that had intact mtH2O2 levels, though the difference did not reach statistical significance (Fig. 4C). The previously observed mCAT-dependent defect in conidial uptake by Mo-DCs was not observed in the context of NADPH oxidase deficiency (Fig. 4B). Mo-DC and neutrophil intracellular conidial killing in p91phox-/- mice was slightly higher with mCAT transgene expression compared to nontransgenic counterparts, consistent with the idea that mtH2O2 did not contribute to conidiacidal activity in these cell types (Fig. 4C).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8265640</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34077261</oboInOwl:hasDbXref>
        <rdfs:label>CD45.1+ p91phox-/- and CD45.2+ p91phox-/- mCATTg/+ leukocytes</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000738"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/ff1bb50b-34c9-4429-9c71-3e328e67c7ea"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000738"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/ff2ef9fb-c169-4a43-8da7-dbc2a73d6f1c -->

    <Class rdf:about="http://example.org/ff2ef9fb-c169-4a43-8da7-dbc2a73d6f1c">
        <obo:IAO_0000115>Within a limbic cortico-basal ganglia-thalamo-cortical signaling loop, the nucleus accumbens (NAc), in particular the dorsolateral NAc subregion, is suggested to play an important role in decision-making via its role in linking information concerning outcome values with that related to goal selection. NAc medium spiny projection neurons (MSN), the major neuron type, are typically anatomically divided into two roughly equal subpopulations; dopamine D1 receptor-expressing MSNs (D1-MSN) that project predominantly to the ventral pallidum (VP) and substantia nigra pars reticulata (SNr), and dopamine D2 receptor-expressing MSNs (D2-MSN) that project predominantly to the VP. While previous studies have demonstrated NAc D1-MSNs to be implicated in reward-related learning and D2-MSNs to be involved in aversion-related learning and behavioral flexibility, the specific role that ##NAc D1- and D2-MSNs## may play in the inhibition of behavioral responses is less clear.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10121661</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37085502</oboInOwl:hasDbXref>
        <rdfs:label>NAc D1- and D2-MSNs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:4030051"/>
        <skos:relatedMatch rdf:resource="CL:4030052"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/ff2ef9fb-c169-4a43-8da7-dbc2a73d6f1c"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4030051"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/ff2ef9fb-c169-4a43-8da7-dbc2a73d6f1c"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4030052"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/ff6fb562-f9be-418d-8f9f-5101091e157c -->

    <Class rdf:about="http://example.org/ff6fb562-f9be-418d-8f9f-5101091e157c">
        <obo:IAO_0000115>(A) Points denoting individual excitatory neurons in mFISH data, colored according to respective coronal section. (B) t-SNE visualization of mFISH data for the cells shown in (A). (C) Spatial location of cells comprising two clusters. (D) t-SNE visualization for two ##excitatory neuron## clusters, colored according to cluster identity from (C). (E,F) As in (C,D), but for six clusters.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7486123</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32869744</oboInOwl:hasDbXref>
        <rdfs:label>excitatory neuron</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000540"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/ff6fb562-f9be-418d-8f9f-5101091e157c"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000540"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/ff8925c5-61d0-4644-bad6-d5d5e6e47ee7 -->

    <Class rdf:about="http://example.org/ff8925c5-61d0-4644-bad6-d5d5e6e47ee7">
        <obo:IAO_0000115>Systems Organs Cell Types     Respiratory system Lung AT2 cells 0.79% 21.20%   Nose (nasal turbinate epithelial cells) Mesenchymal stromal cells 1.70% 8.50%   Plasma cells 2.00% 8.80%   Nose (nasal brushing epithelial cells) Plasma cells 4.00% 13.80%   Nose (nasal airway epithelial cells) Nasal airway epithelial cells 8.40% 23.10%   Digestive system Gall bladder Primordium cell 2.20% 2.60%   Small intestine (jejunum) Enterocyte progenitor cell 14.00% 6.60%   Goblet cell 9.10% 2.60%   Small intestine (ileum) Intestinal epithelial stem cell 1.50% 4.20%   Enterocyte progenitor cell 2.40% 3.60%   Small intestine (duodenum) LGR5+ stem cell 5.20% 4.50%   Intestinal epithelial stem cell 3.90% 5.80%   Enterocyte progenitor cell 4.40% 6.80%   Tuft progenitor cell 7.40% 6.60%   Enteroendocrine cell 9.40% 3.80%   Large intestine (rectum) Goblet progenitor cell 2.80% 62.50%   ##MKI67+ progenitor cell## 10.30% 75.40%   Enterocyte 13.20% 77.50%   Goblet cell 18.20% 87.30%   Large intestine (colon) Enterocyte 5.70% 52.10%   Goblet cell 11.00% 78.00%   Esophagus Secretory progenitor cell 9.40% 18.80%   Nervous system Brain (substantia nigra and cortex) Oligodendrocyte precursor cell 1.60% 0.90%   Astrocyte 1.90% 1.00%   Reproductive system Fallopian tube Epithelial cells 1.40% 26.50%   Ovarian somatic cell 1.00% 1.00%   Testis Spermatogonium 1.70% 4.50%   Peritubular myoid cell 1.70% 6.30%   Testis somatic cell 2.10% 4.30%   Spermatogonial stem cell 1.40% 2.10%   Circulatory system Heart Cardiomyocyte 6.60% 0.80%   Cardiovascular progenitor cell 12.50% 0.40%   Urinary system Kidney Nephron epithelial cell 2.70% 10.70%   Epithelial cell 2.70% 9.60%   Endothelial cell 2.70% 12.80%   Mesangial cell 3.00% 14.50%   </obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7794913</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33401657</oboInOwl:hasDbXref>
        <rdfs:label>MKI67+ progenitor cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0009016"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/ff8925c5-61d0-4644-bad6-d5d5e6e47ee7"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0009016"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/ffb40f4c-65ca-4ec3-b2d0-bd12b34343b1 -->

    <Class rdf:about="http://example.org/ffb40f4c-65ca-4ec3-b2d0-bd12b34343b1">
        <obo:IAO_0000115>Luminal progenitors serve primarily as tumor initiators or cells of origin for prostate cancer. Various hierarchical models have been proposed. A recent model suggests that, during early postnatal development, multipotent basal cells (p63+ CK5+) differentiate into unipotent basal progenitors, luminal progenitors (CK8+ AR low), and NE cells. These unipotent basal and luminal progenitors can undergo self-renewal or differentiate into basal cells and mature luminal cells (AR+ CK8+), respectively. In adults, during homeostasis and regeneration, the ##bipotent basal progenitor## forms unipotent basal and luminal progenitors, which further undergo self-renewal. Unipotent basal progenitors differentiate into basal cells, and luminal cell progenitors differentiate into luminal cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10291985</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37282627</oboInOwl:hasDbXref>
        <rdfs:label>bipotent basal progenitor</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002341"/>
        <skos:relatedMatch rdf:resource="CL:0011026"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/ffb40f4c-65ca-4ec3-b2d0-bd12b34343b1"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002341"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/ffb40f4c-65ca-4ec3-b2d0-bd12b34343b1"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0011026"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/ffbc78c3-85a0-48ad-9da8-d0d38b9b672e -->

    <Class rdf:about="http://example.org/ffbc78c3-85a0-48ad-9da8-d0d38b9b672e">
        <obo:IAO_0000115>A key result of our study is the presence of Cplx 2 and the most likely absence of Cplx 1 in conventional chemical synapses of normal and displaced amacrine cells (Figure 2, Figure 6, Figure 8 and Figure 10). Cplx 2 (protein and mRNA) was found in GABAergic, cholinergic and dopaminergic amacrine cells but not in glycinergic amacrine cells (Figure 6 and Figure 10), which contain Cplx 3. The ##glutamatergic vGluT3 amacrine cells## also contained no Cplx 2 (Figure 7 and Figure 10). VGluT3 amacrine cells represent an unconventional type of amacrine cell with dual release of glycine and glutamate at segregated synaptic sites. It is suggested that the release of an inhibitory and an excitatory neurotransmitter into two separate neuronal circuits by the vGluT3 amacrine cells facilitates differential detection of visual field uniformity and contrast. As Cplx 3 is found in glycinergic amacrine cells and glutamatergic rod bipolar cells, we analyzed its presence in vGluT3 amacrine cells. We could not detect Cplx 3 in these retinal interneurons, just as we could not detect Cplx 4 in vGluT3 amacrine cells (Figure 7). The absence of Cplxs 1 to 4 from vGluT3 amacrine cells suggests a Cplx-independent release of neurotransmitters. Likewise, for the auditory sensory cells of the cochlea, the inner hair cells, it has been suggested that they release glutamate at their ribbon synapses independent of neuronal SNARE proteins and SNARE regulators, such as Cplxs and synaptotagmins.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8348166</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34360929</oboInOwl:hasDbXref>
        <rdfs:label>glutamatergic vGluT3 amacrine cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000561"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/ffbc78c3-85a0-48ad-9da8-d0d38b9b672e"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000561"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/ffc0d05f-63c7-444a-a66a-d98e8fdaa5c3 -->

    <Class rdf:about="http://example.org/ffc0d05f-63c7-444a-a66a-d98e8fdaa5c3">
        <obo:IAO_0000115>a Schematic of study design. Diagrams depict the brain region of interest, Brodmann area 9, corresponding to the dlPFC. b UMAP plot colored by the broad cell types. c UMAP plot colored by the individual clusters identified and annotated. For UMAP plots, the x and y-axes represent the first and second UMAP co-ordinates respectively. d DotPlot depicting the expression of marker genes (SNAP25 - neurons, SLC17A7 - excitatory neurons, GAD1 - ##inhibitory neurons##, ALDH1L1 - astrocytes, PDGFRA - oligodendrocyte precursor cells, PLP1 - oligodendrocytes, CLDN5 - endothelial cells, CX3CR1 - microglia). The dendrogram next to the cluster names shows the relationship between the clusters by using the distance based on average expression of highly variable genes. e Best hits heatmap from MetaNeighbor showing the correspondence between the clusters in our dataset (columns) and the broad categories of cells identified in the Allen Brain Institute human motor cortex snRNA-seq dataset (rows). f Boxplots showing the proportion of nuclei in each cluster for each subject split by cases and controls for the broad OPC, astrocyte, and excitatory neuron cell types and the Ast1, Ast2, OPC1, and OPC2 clusters (n = 37 cases, 34 controls, representing biologically independent samples for each cluster or broad cell type). The middle line is the median. The lower and upper hinges correspond to the 25th and 75th percentiles. Upper and lower whiskers extend from the upper or lower hinges to the largest or smallest value no further than 1.5 times the inter-quartile range from the hinge, where the inter-quartile range is the distance between the first and third quartiles. Points beyond the end of the whiskers are plotted individually. In Fig. 1c-e, excitatory neuronal cluster names contain approximate layer annotations and inhibitory neuronal cluster names contain MGE or CGE specific marker information as a suffix where applicable, as described in methods: Cluster annotation. For example, ExN10_L46 denotes a cluster of excitatory neurons with enrichment of marker genes from layer 4 to layer 6 of the cortex and InN1_PV denotes a cluster on inhibitory neurons with enrichment of the MGE specific marker PV. This convention is used throughout the paper. Brain diagram in 1a was created with BioRender.com. Source data are provided as a Source Data file.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10203145</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37217515</oboInOwl:hasDbXref>
        <rdfs:label>inhibitory neurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000498"/>
        <skos:relatedMatch rdf:resource="CL:0000617"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/ffc0d05f-63c7-444a-a66a-d98e8fdaa5c3"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000498"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/ffc0d05f-63c7-444a-a66a-d98e8fdaa5c3"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000617"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/0a35422d-1a54-4b86-9c1d-97f921ee276c -->

    <Class rdf:about="http://example.org/0a35422d-1a54-4b86-9c1d-97f921ee276c">
        <obo:IAO_0000115>The classification of pericyte-derived and non-pericyte-derived myofibroblasts (PDGFRbeta-constitutively-expressing and PDGFRbeta-de novo-expressing, respectively) indicates different roles of pulmonary myofibroblasts. With PDGFRbeta as a &apos;specific&apos; marker for pericytes, PDGFRbeta-regulated Cre expression has been used to trace the fate of these cells. However, the constitutive PDGFRbeta-Cre line employed in other studies does not allow discriminating between the two types of myofibroblasts identified in this study, as, after injury, both indistinguishably express PDGFRbeta. Here, we employed the tamoxifen inducible PDGFRbeta-CreERT2 to induce temporally controlled labeling of cells with active PDGFRbeta promotor in the adult lung; in fact, as the ##intra-alveolar myofibroblasts## were found to acquire PDGFRbeta expression after injury, only the inducible lineage tracing strategy allowed us to differentiate between the two types of myofibroblasts. Using a PDGFRbeta-tdTomato reporter mouse in combination with the fact that SMC do not contribute to myofibroblasts, the interstitial myofibroblast can be shown to derive from NO-GC+/PDGFRbeta+ pericytes. We have not yet determined the precursor for the intra-alveolar myofibroblast, although we can exclude pericytes based on our lineage tracing studies. Lipofibroblasts have been shown to be potential myofibroblasts precursors; whether this cell type is linked to the formation of intra-alveolar myofibroblasts has yet to be clarified.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10288756</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37349733</oboInOwl:hasDbXref>
        <rdfs:label>intra-alveolar myofibroblasts</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000186"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/0a35422d-1a54-4b86-9c1d-97f921ee276c"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000186"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/0a819c77-6ead-4807-8d9a-cf3e546e8b3a -->

    <Class rdf:about="http://example.org/0a819c77-6ead-4807-8d9a-cf3e546e8b3a">
        <obo:IAO_0000115>We observed multiple features of Immature #1 and mature Sertoli cells that distinguish them from ##Immature #2 cells##, including high AR (Androgen Receptor) target gene expression (defined by a set of ~70 known AR-dependent genes), high mitochondrial transcription, and lower expression of ribosomal protein genes (Figure 3F). Gene Ontology (GO) analysis revealed enrichment for terms such as nucleus and transcription in Immature #1 (Figure S3H). IF co-staining for AR and SOX9 confirms this sequence of events, by showing gradual AR upregulation and co-localization in Sertoli cells as puberty proceeds (Figure 3H). Immature #2 cells have the converse properties of Immature #1 described above and are enriched in GO terms for translation and ribosome function (Figure S3H). They exhibit higher transcription of ribosomal protein genes, mitochondrial ATPases (e.g., ATP5E), and mitochondrial membrane proteins (e.g., TOMM7) and contain a higher fraction of cells in the G1 phase of the cell cycle (Figures 3F and S3E). Taken together, these two immature Sertoli cell states differ markedly in their metabolic/mitochondrial, translational, and cell-cycle properties (as indicated by transcriptional signatures).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7298616</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31928944</oboInOwl:hasDbXref>
        <rdfs:label>Immature #2 cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000216"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/0a819c77-6ead-4807-8d9a-cf3e546e8b3a"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000216"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/0a8b6290-55b9-489e-a97c-996386093771 -->

    <Class rdf:about="http://example.org/0a8b6290-55b9-489e-a97c-996386093771">
        <obo:IAO_0000115>(A) FACS gating strategy to purify ##cardiac Mphis## from C57BL/6 mice. (B) From the myeloid cell population (CD45+CD11b+ cells), F4/80+Ly6Clow cells (blue) were isolated at 0, 7, and 28 days post-MI, and F4/80+/Ly6Chigh cells (red) were purified at 3 days post-MI. Representative post-sort plots of Mphis are shown in the lower panel. Sorting was performed with a pool of 3-5 mice per time point.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7609061</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33063665</oboInOwl:hasDbXref>
        <rdfs:label>cardiac Mphis</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/0a8b6290-55b9-489e-a97c-996386093771"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/0abbcdf8-fd95-43fc-b209-d5e319116062 -->

    <Class rdf:about="http://example.org/0abbcdf8-fd95-43fc-b209-d5e319116062">
        <obo:IAO_0000115>Myelogram Parameters DTCs n Mean Value Errstdmean p   Cellularity negative 19 67.0 6.51 NS*   positive 20 67.3 7.87   Blasts negative 20 1.46 0.14 0.026   positive 25 1.09 0.09   Promyelocytes negative 20 0.44 0.11 NS   positive 25 0.37 0.08   Neutrophilic myelocytes negative 20 7.80 0.72 NS   positive 25 8.95 0.54   Neutrophilic metamyelocytes negative 20 8.58 0.65 NS   positive 25 7.83 0.53   Band neutrophils negative 20 16.50 0.91 NS   positive 25 18.70 1.00   Segmented neutrophils negative 20 24.47 1.39 NS   positive 25 27.266 1.71   All granulocyte cells negative 20 60.76 1.45 0.025   positive 25 65.41 1.38   Neutrophil maturation index negative 20 0.43 0.034 NS   positive 25 0.38 0.034   Monocytes negative 20 2.78 0.26 NS   positive 25 3.30 0.24   Lymphocytes negative 20 12.85 0.79 NS   positive 25 12.02 0.68   ##Plasmocytes## negative 20 0.60 0.10 NS   positive 25 0.77 0.15   Basophilic normoblasts negative 20 1.23 0.17 NS   positive 25 0.97 0.13   Polychromatophilic normoblasts negative 20 11.16 0.91 NS   positive 25 10.19 0.82   Oxyphilic normoblasts negative 20 9.08 0.88 0.006   positive 25 6.25 0.52   Sum of nucleated erythroid cells negative 20 21.47 1.44 0.042   positive 25 17.41 1.29   Erythroid maturation index negative 20 0.96 0.01 NS   positive 25 0.96 0.01   Leuco-erythroid ratio negative 20 4.02 0.39 0.034   positive 25 5.58 0.59   </obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6627631</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31234438</oboInOwl:hasDbXref>
        <rdfs:label>Plasmocytes</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000786"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/0abbcdf8-fd95-43fc-b209-d5e319116062"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000786"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/0abdd6a3-451d-4c6a-ae51-d80faafbd205 -->

    <Class rdf:about="http://example.org/0abdd6a3-451d-4c6a-ae51-d80faafbd205">
        <obo:IAO_0000115>The intrinsic micro-circuitry regulation of intestinal function consists of five neuronal classes with distinct functional specializations. Sensory neurons, also referred to as intrinsic primary afferent neurons (##IPANs##), detect chemical and physical alterations in the intestine and transmit the signal via interneurons to excitatory motor neurons, inhibitory motor neurons or secretomotor/vasodilator neurons ( Figure 1 ). Enteric neurons are replenished from neuronal stem cells of the intestine. While the traditional sub-classification was based on the neuronal type, the anatomic location and axonal projection as well as neurochemical signature, recent advances in single-cell sequencing has enabled a comprehensive clustering based on gene expression.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8312561</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34322118</oboInOwl:hasDbXref>
        <rdfs:label>IPANs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000526"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/0abdd6a3-451d-4c6a-ae51-d80faafbd205"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000526"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/0ac75ca9-af89-422d-aa4d-2262b91ecd7c -->

    <Class rdf:about="http://example.org/0ac75ca9-af89-422d-aa4d-2262b91ecd7c">
        <obo:IAO_0000115>We performed bronchoscopy with bronchoalveolar lavage (BAL) on 8 individuals with acute hypoxemic respiratory failure supported with invasive mechanical ventilation (Bronchoscopy 1 = B1). Four of the participants were sampled again 4 days later (Bronchoscopy 2 = B2). We isolated single cells and assessed them with CITE-seq. A Uniform manifold approximation and projection (UMAP) plot displaying clustering of 64,317 cells based on gene expression. We annotated the clusters by mapping them to published datasets to identify B cell, T cell, myeloid (alveolar macrophages = AM, alveolar monocytes = ##mono##, classical dendritic cells = cDCs), and other cell-types (designated by color). B Cells identified as myeloid (including macrophages, monocytes, and cDCs) in panel A were re-clustered. Color designates assignment of cells to one of the 9 clusters identified by Seurat. C Dot plot comparing the expression of marker genes (x-axis) across nine alveolar myeloid cell clusters (y-axis). Each cluster is annotated based on the marker genes (Table S5). The proportion of each cluster as a percentage of all alveolar myeloid cells is displayed. The dot size is proportional the percentage of cells expressing the gene in each color. The color intensity is proportional to the average scaled log-normalized expression within a cluster. D Bar plot displaying the individual percentages, median, and interquartile range of each subset as a proportion of all alveolar myeloid cells at B1 and B2.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10656558</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37978185</oboInOwl:hasDbXref>
        <rdfs:label>mono</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000576"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/0ac75ca9-af89-422d-aa4d-2262b91ecd7c"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000576"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/0b0211a7-4f7c-4b91-8912-3c540f69655c -->

    <Class rdf:about="http://example.org/0b0211a7-4f7c-4b91-8912-3c540f69655c">
        <obo:IAO_0000115>Cell Population Identity (Abbr.) Up Reg(14,498) IG(85) ORA p ORA q Mean FCIG Mean FCRest GSEA p GSEA q No. IGs with highest expression   Neuroendocrine cells (NendC) 3868 47 2.12E-08 3.82E-07 11.88 5.42 0.0017 0.0051 26   Mature Neurons (all types) (mNEUR) 2968 32 0.0002 0.0035 8.80 9.28 - - 2    Arachnoid barrier cells (ABC) 2287 20 0.0396 0.7120 16.84 22.63 - - 7    Tanycytes (TNC) 1279 12 0.0692 1 6.64 12.01 - - 8    Vascular and leptomeningeal cells (VLMC) 1714 15 0.0724 1 15.06 13.03 0.0468 0.1404 4    Oligodendrocyte precursor cells (OPC) 1524 13 0.1067 1 3.03 7.17 - - 1    Pericytes (PC) 1801 14 0.1649 1 8.20 8.22 - - 2    Olfactory ensheathing glia (OEG) 1086 9 0.1848 1 7.95 26.03 - - 1    Oligodendrocytes (OLG) 1183 9 0.2561 1 3.73 12.91 - - 5   Choroid plexus epithelial cells (CPC) 2602 17 0.3524 1 7.43 19.34 - - 5    ##Hemoglobin-expressing vascular cells## (Hb_VC) 1798 11 0.4889 1 5.25 6.33 - - 3    Vascular smooth muscle cells (VSMC) 3006 17 0.6093 1 8.94 6.71 0.1376 0.4128 5    Astrocyte-restricted precursors (ARP) 1445 8 0.6214 1 4.50 5.09 - - 1    Neural stem cells (NSC) 1009 5 0.7138 1 4.00 4.09 - - 0    Ependymocytes (EPC) 3233 17 0.7346 1 15.04 53.27 - - 4    Endothelial cells (EC) 1455 7 0.7619 1 5.80 8.54 - - 0    Hypendymal cells (HypEPC) 1525 6 0.8946 1 17.24 20.80 - - 5    Neuronal-restricted precursor (NRP) 2339 10 0.8979 1 3.07 10.20 - - 1    Astrocytes (ASC) 1384 4 - - 2.22 6.04 - - 0    Dendritic cells (DC) 1209 1 - - 3.50 16.02 - - 1    Immature Neurons (ImmN) 652 4 - - 3.37 5.79 - - 0    Macrophages (MAC) 1222 2 - - 3.47 21.56 - - 0    Microglia (MG) 1342 3 - - 19.28 19.22 - - 3    Monocytes (MNC) 947 2 - - 16.49 19.13 - - 1    Neutrophils (NEUT) 519 2 - - 9.18 62.13 - - 0   </obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9670596</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36384442</oboInOwl:hasDbXref>
        <rdfs:label>Hemoglobin-expressing vascular cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000071"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/0b0211a7-4f7c-4b91-8912-3c540f69655c"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000071"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/0b095f20-42a4-45be-b50a-624ad2955b4f -->

    <Class rdf:about="http://example.org/0b095f20-42a4-45be-b50a-624ad2955b4f">
        <obo:IAO_0000115>Next, we analyzed the interactions between these ligand-receptor pairs from the TME among 12 kinds of immune cells, and found that CCL5-CCR1 mainly sends signals of CD8+ T cells and NK Cells, which may interact with pDCs, macrophages, cDC2s, and myeloid cells via the interaction of CCL5 and CCR1. The SELPLG-SELL ligand-receptor pair is the main interaction among CD4+ T cells, NK cells, myeloid cells, and naive B cells. Furthermore, NOTCH2-cDCs interact with pDCs, CD4+ T cells, cCD2s, NK cells, myeloid cells, naive B cells, and cDC1s. Both migDCs and cDC1s interact with CD4+ T cells, pDCs, cCD2s, NK Cells, myeloid cells, and naive B cells. The CXCL10-CXCR3 ligand-receptor pair is the main interaction among pDCs, migDCs, and CD4+ T cells, and the CXCL9-CXCR3 ligand-receptor pair is the main interaction among pDCs, cDC1s, migDCs, and CD4+ T cells (Fig. 8C). We also used a violin plot to visualize the signal gene expression distribution in the three signaling pathways inferred by CellChat. The results showed that CCL5 is mainly expressed on CD8+ T and NK cells, and its corresponding receptors are mainly in macrophages, myeloid cells, cCD2s, and pDCs. SELPLG is mainly expressed on CD4+ T cells, NOTCH2-cDCs, migDCs, and ##cDC1s##, and its corresponding receptor, SELL, is mainly expressed on naive B cells, myeloid cells, NK cells, cCD2s, pDCs, CD4+ T cells, and cCD1s. CXCL9 is mainly expressed on pDCs, migDCs, and cDC1s, CXCL10 is mainly expressed on pDCs and migDCs, and their corresponding receptor, CXCR3, is mainly expressed on CD4+ T cells (Fig. 8D).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9203818</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35710862</oboInOwl:hasDbXref>
        <rdfs:label>cDC1s</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000990"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/0b095f20-42a4-45be-b50a-624ad2955b4f"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000990"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/0b1c38c0-c8a9-4c58-9d9a-b89d14085cd8 -->

    <Class rdf:about="http://example.org/0b1c38c0-c8a9-4c58-9d9a-b89d14085cd8">
        <obo:IAO_0000115>Embryonic and pluripotent SCs cycle more quickly than the ##differentiated progenitors## they produce. Still, it is unclear whether these cells cycle more quickly in relation to their innate stemness, or instead in relation to their pluripotency. Here we study the CCD of somatic SCs, which are committed to a defined lineage. Here we use 3 complementary methods to show that adult keratinocyte SCs have a shorter CCD than their differentiated progenitor daughters. We first used live cell imaging to examine the proliferation and cycling behavior of individual freshly-isolated passage 0 normal adult human keratinocytes, in vitro, for up to 16 days. We then compared the CCD of SCs and more differentiated CPs using live cell imaging, the proportions of S phase labeled keratinocytes in vitro, and single-cell RNA sequencing.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10935907</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38475896</oboInOwl:hasDbXref>
        <rdfs:label>differentiated progenitors</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0011026"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/0b1c38c0-c8a9-4c58-9d9a-b89d14085cd8"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0011026"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/0b4d2c8a-3397-4ba9-aba4-cfaa6aa9fb97 -->

    <Class rdf:about="http://example.org/0b4d2c8a-3397-4ba9-aba4-cfaa6aa9fb97">
        <obo:IAO_0000115>We observed multiple features of Immature #1 and mature Sertoli cells that distinguish them from Immature #2 cells, including high AR (Androgen Receptor) target gene expression (defined by a set of ~70 known AR-dependent genes), high mitochondrial transcription, and lower expression of ribosomal protein genes (Figure 3F). Gene Ontology (GO) analysis revealed enrichment for terms such as nucleus and transcription in Immature #1 (Figure S3H). IF co-staining for AR and SOX9 confirms this sequence of events, by showing gradual AR upregulation and co-localization in Sertoli cells as puberty proceeds (Figure 3H). Immature #2 cells have the converse properties of Immature #1 described above and are enriched in GO terms for translation and ribosome function (Figure S3H). They exhibit higher transcription of ribosomal protein genes, mitochondrial ATPases (e.g., ATP5E), and mitochondrial membrane proteins (e.g., TOMM7) and contain a higher fraction of cells in the G1 phase of the cell cycle (Figures 3F and S3E). Taken together, these two ##immature Sertoli cell## states differ markedly in their metabolic/mitochondrial, translational, and cell-cycle properties (as indicated by transcriptional signatures).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7298616</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31928944</oboInOwl:hasDbXref>
        <rdfs:label>immature Sertoli cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000216"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/0b4d2c8a-3397-4ba9-aba4-cfaa6aa9fb97"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000216"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/0bbadc18-1b32-40cc-8885-88913b989a02 -->

    <Class rdf:about="http://example.org/0bbadc18-1b32-40cc-8885-88913b989a02">
        <obo:IAO_0000115>BACKGROUND: A major current challenge is to exploit tertiary lymphoid structures (TLSs) to promote the lymphocyte infiltration, activation and differentiation by tumor antigens to increase antitumor immune responses. The mechanisms that underlie the role of TLS formation in the adaptive immune responses against nasopharyngeal carcinoma (NPC) remain largely unknown. METHODS: Cell populations and the corresponding markers were identified by single-cell RNA sequencing and fluorescence-activated cell sorting analysis. In vitro differentiation experiments were used to simulate the generation, regulation and function of the ##Th-CXCL13 cell## subset in the tumor microenvironment of NPC. These were followed by histological evaluation of the colocalization of tumor-associated B cells (TABs) and Th-CXCL13 cells within TLSs, and statistical analysis of the relationship between the cells in TLSs and overall survival. RESULTS: A PD-1+CXCR5-CD4+ Th-CXCL13 cell subset was identified in NPC. This subset was a major source of CXCL13, representing the majority of the CD4+ T cells at levels comparable with Th1 and Tfh cells present in the TLSs. Monocytes activated by toll-like receptor 4 agonists served as the antigen-presenting cells that most efficiently triggered the expansion of Th-CXCL13 cells. Transforming growth factor beta 1 (TGF-beta1) stimulation and activation of Sox4 were critical for the induction and polarization of Th-CXCL13 cells in this process. The potential functional contributions of TABs recruited by Th-CXCL13 cells which induced plasma cell differentiation and immunoglobulin production via interleukin-21 and CD84 interactions in the TLSs demonstrated improved survival. CONCLUSIONS: Induction of Th-CXCL13 cells links innate inflammation to immune privilege in tumor-associated TLSs and might predict better survival.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8276302</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34253636</oboInOwl:hasDbXref>
        <rdfs:label>Th-CXCL13 cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000492"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/0bbadc18-1b32-40cc-8885-88913b989a02"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000492"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/0c26908a-2205-4b8d-834a-58f292532dea -->

    <Class rdf:about="http://example.org/0c26908a-2205-4b8d-834a-58f292532dea">
        <obo:IAO_0000115>Transcriptomic data were used for correlation analysis between human in vivo fetal yolk sac (YS) hematopoietic clusters (##YS_EC##, endothelial cells; YS_Mac, macrophages; and YS_YSMP1,2, myeloid-biased progenitors) and PD-L1 WT hematopoietic cell populations (PD-L1_EC, endothelial cells; MC/Mphis, monocyte/macrophages; CMPs, common myeloid progenitors; and granulocytes).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10638094</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37949473</oboInOwl:hasDbXref>
        <rdfs:label>YS_EC</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000115"/>
        <skos:relatedMatch rdf:resource="CL:0000428"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/0c26908a-2205-4b8d-834a-58f292532dea"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000115"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/0c26908a-2205-4b8d-834a-58f292532dea"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000428"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/0c348e8a-fadf-499e-b722-e7d0ab6a9502 -->

    <Class rdf:about="http://example.org/0c348e8a-fadf-499e-b722-e7d0ab6a9502">
        <obo:IAO_0000115>HH signaling has been reported to modulate cell proliferation in several contexts. We thus tested whether epithelial deletion of Shh might lead to tracheal epithelial cell proliferation defects. We examined epithelial cell proliferation first by immunostaining for Ki67, a cell cycle marker, and found that ShhCKO tracheae exhibited a reduced number of Ki67+ cells in the CDH1 marked epithelium compared with controls (Fig. 2H,I). Next, we performed an EdU incorporation assay to assess cells that had entered S-phase during the labeling period. After an ex vivo, 21 h long EdU treatment, ShhCKO tracheae displayed fewer EdU+ cells in their epithelium (Fig. 2J,K), indicating that Hedgehog inactivation compromises cell cycle entry. In a more-detailed analysis, we observed a reduced number of Ki67+SCGB1A1+ cells (Fig. 2L,M), but a similar number of PDPN+  and Ki67+PDPN+ basal cells  in ShhCKO tracheae compared with controls. Interestingly, ShhCKO tracheae exhibited increased ratios of KRT5+ basal cells to acetylated alpha-tubulin+ ciliated cells and to ##SCGB1A1+ club cells## compared with controls . We did not find obvious alterations in caspase3 staining between ShhCKO tracheal epithelium and controls at E18.5, suggesting that apoptosis is not affected in the mutants . To examine for changes in the surrounding mesenchyme, we analyzed SOX9+ chondroblasts, alpha-SMA+ smooth muscle cells and mesenchymal cell proliferation. ShhCKO tracheae exhibited SOX9+ chondroblast condensation defects , but no obvious SOX9+ chondroblast differentiation defects . We also detected reduced numbers of alpha-SMA+ smooth muscle cells and increased numbers of CDH1-Ki67+ mesenchymal cells compared with controls . As HH signaling modulates Fgf10 expression in the lung mesenchyme, we examined Fgf10 mRNA expression levels in ShhCKO tracheae. We detected a 1.5-fold increase in Fgf10 mRNA in ShhCKO mutants  but this was not sufficient to increase basal cell number, as might have been expected from previous studies. Altogether, these results indicate that loss of Shh function reduces club cell proliferation and interferes with ciliated cell differentiation and secretory cell maturation in the tracheal epithelium. In the tracheal mesenchyme, Shh promotes chondrocyte and smooth muscle morphogenesis.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8918789</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35112129</oboInOwl:hasDbXref>
        <rdfs:label>SCGB1A1+ club cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000158"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/0c348e8a-fadf-499e-b722-e7d0ab6a9502"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000158"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/0c3cbb17-7f8e-4b02-8206-514cbc1dd952 -->

    <Class rdf:about="http://example.org/0c3cbb17-7f8e-4b02-8206-514cbc1dd952">
        <obo:IAO_0000115>Other groups have used murine- and blood-based immune population gene profiles to characterize lung adenocarcinoma immune microenvironments with digital cytometry. In order to develop human tumor infiltrating leukocyte profiles specific to stage I lung adenocarcinomas, we performed single-cell RNA-seq (scRNA-seq) analysis on freshly resected samples from six patients who underwent complete surgical resection of stage I tumors at UCSF. Twenty distinct immune cell populations were identified by scRNA-seq analysis including 10 adaptive immune populations (helper T-cells, cytotoxic T-cells, exhausted cytotoxic T-cells, deltagamma T-cells, naive T-cells, regulatory T-cells, B cells, plasma cells, NKT cells, and NK cells) and 10 innate immune populations (M1 macrophages, M2 macrophages, classical monocytes, intermediate monocytes, non-classical monocytes, mast cells, ##conventional dendritic cells 1##, conventional dendritic cells 2, plasmacytoid dendritic cells, and neutrophils) (Fig. 5A). These novel tumor infiltrating leukocyte profiles were used to calculate immune cell population densities from bulk RNA-seq data in the TCGA stage I lung adenocarcinoma population using digital cytometry.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8654957</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34880292</oboInOwl:hasDbXref>
        <rdfs:label>conventional dendritic cells 1</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000990"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/0c3cbb17-7f8e-4b02-8206-514cbc1dd952"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000990"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/0c4e374c-8905-4eeb-95d2-b36fb424402c -->

    <Class rdf:about="http://example.org/0c4e374c-8905-4eeb-95d2-b36fb424402c">
        <obo:IAO_0000115>SHP2 incites myometrium contraction by regulating PGF2alpha production in epithlium to participate smooth muscle contraction via justacrine. ##LE## Luminal epithelial cells, Str1 stromal cells 1, Str2 stromal cells 2, Dec decidual cells, NK natural killer cells, Mac macrophage cells, Muscle muscle cells, Gland glandular epithelial cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10646072</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37963860</oboInOwl:hasDbXref>
        <rdfs:label>LE</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002149"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/0c4e374c-8905-4eeb-95d2-b36fb424402c"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002149"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/0c567f76-3f7a-4606-a771-5529e425cd11 -->

    <Class rdf:about="http://example.org/0c567f76-3f7a-4606-a771-5529e425cd11">
        <obo:IAO_0000115>Our data showed that the induction of IL-10 production in macrophages reported in IV and IP MSC treatment is also relevant in SC MSC treatment. When administered directly into the inflamed tissue, SC MSC injection induced immunoregulatory macrophages in the local LN draining the inflamed tissue. Interestingly, an expansion in IL-10-producing macrophages was observed only in the MerTK+ SSM and TZM populations, and not in the F4/80+ macrophage populations (MSM and ##MCM##). This could be due to the F4/80+ macrophages residing deeper within the LN and are therefore less accessible. MerTK is an efferocytic receptor, and MerTK+ TZMs have been reported to have a role in clearing apoptotic cells and maintaining immune homeostasis and tolerance. In addition, studies have demonstrated a role for MerTK signalling in attenuating inflammation. The inhibitory role of MerTK signalling pathway has been previously reported in an LPS-induced lung inflammation model. Whether the selective expansion of IL-10-producing MerTK+ macrophages is associated with activation of MerTK-related immunomodulatory pathway should be investigated further.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11572146</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:39551813</oboInOwl:hasDbXref>
        <rdfs:label>MCM</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000868"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/0c567f76-3f7a-4606-a771-5529e425cd11"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000868"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/0c6ef6f8-41f2-434a-819a-42b95821bd71 -->

    <Class rdf:about="http://example.org/0c6ef6f8-41f2-434a-819a-42b95821bd71">
        <obo:IAO_0000115>Comparison of the single cell landscape between healthy human meniscus and degenerated meniscus. (A) Representative polarised light microscopy images of healthy human and degenerated meniscus. The white and red colours in the angle images are 90  apart in orientation. Dashed lines indicate the surface of the meniscus. Scale bar, 100 microm. (B) Merged t-distributed stochastic neighbour embedding (t-SNE) of single-cell RNA sequencing of healthy meniscus cells and degenerated meniscus cells. (C) Twelve healthy human and degenerated meniscus cell clusters at t-SNE. (D) Proportion of each cluster to the total cells. (E) Proportion of healthy and degenerated meniscus cells in each cluster. (F) Expression of representative marker genes in Vin plot. (G) Heatmap revealing the scaled expression of differentially expressed genes for each cluster. (H) CD146 and CD318 expression in healthy human meniscus cells and degenerated meniscus cells determined by flow cytometry. n&gt;=5, **p&lt;0.01. (I) Representative IHC staining of COL1A1 and COL2A1 healthy human meniscus and degenerated meniscus, and quantification of positive cells. Scale bar, 50 microm. n&gt;=5, **p&lt;0.01. (J) The expression of indicated marker genes in human healthy meniscus cells and degenerated meniscus cells were detected by qRT-PCR. *p&lt;0.05, **p&lt;0.01, otherwise, not significant. n=3, *p&lt;0.05, **p&lt;0.01. CPC, cartilage progenitor cells; DegP, degenerated meniscus progenitor cells; EC, endothelial cells; FC, fibrochondrocytes; FCP, fibrochondrocyte progenitors; HTC, hypertrophic chondrocytes; MoDC, monocyte-derived dendritic cells; PreHTC, prehypertrophic chondrocytes; ProFC, ##proliferate fibrochondrocytes##; RegC, regulatory chondrocytes.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7034356</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31871141</oboInOwl:hasDbXref>
        <rdfs:label>proliferate fibrochondrocytes</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000138"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/0c6ef6f8-41f2-434a-819a-42b95821bd71"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000138"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/0ca4c670-e762-44ae-beeb-9a6a1f4c6ad9 -->

    <Class rdf:about="http://example.org/0ca4c670-e762-44ae-beeb-9a6a1f4c6ad9">
        <obo:IAO_0000115>Differentiation trajectory of pathological osteoclasts in arthritis. BM-derived CX3CR1loLy6Chi cells (R1) ingress into the synovium (R2) and produce inflammatory cytokines, chemokines, and VEGFA. Abundant M-CSF in the inflamed synovium induces maturation of some R2 cells into osteoclast precursors, arthritis-associated osteoclastogenic macrophages (AtoMs/##R3 cells##). When AtoMs localize adjacent to the bone surface, simultaneous stimulation with RANKL and TNF promotes osteoclast formation, leading to joint destruction in arthritis.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9024112</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35464401</oboInOwl:hasDbXref>
        <rdfs:label>R3 cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
        <skos:relatedMatch rdf:resource="CL:0000778"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/0ca4c670-e762-44ae-beeb-9a6a1f4c6ad9"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/0ca4c670-e762-44ae-beeb-9a6a1f4c6ad9"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000778"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/0cbd2c1c-f67c-43a9-abe1-33d0e6d3f0ff -->

    <Class rdf:about="http://example.org/0cbd2c1c-f67c-43a9-abe1-33d0e6d3f0ff">
        <obo:IAO_0000115>It has been reported that cortical-projecting subpopulations of DRN 5-HT neurons express Slc17a8, in agreement with the extensive overlap between the spatial distribution of ##cortical-projecting neurons## and Slc17a8 expression. This suggests that cortical-projecting subpopulations should correspond to subtype 5-HT-IV from the scRNA-seq dataset, which is Slc17a8-expressing and distributed to the ventral DRN. Additionally, we would predict that the Str-projecting subpopulation corresponds to the subtype 5-HT-III, since their distributions overlap extensively in the dorsomedial DRN. Consistent with our hypothesis that 5-HT neuron subtypes innervate different brain regions, we found that the inferred distributions of each 5-HT neuron subtype coincides with a different set of projection-defined subpopulations - the distribution of subtype 5-HT-III was most similar to the distribution of Str-projecting neurons (Figure 6F), whereas the distribution of subtype 5-HT-IV was more similar to that of M1-projecting neurons (Figure 6G). However, neither Str-projecting nor M1-projecting subpopulations were fully contained within the distribution of a single 5-HT neuron subtype. Str-projecting neurons in the ventrolateral DRN (marked cyan in Figure 6D,F,G), where neurons innervating both Str and M1 are located, fell within the distribution of subtype 5-HT-IV but not of subtype 5-HT-III. This suggests that Str is a target of multiple molecular subtypes of 5-HT neurons, and supports the model that some structures are innervated by multiple 5-HT neuron subtypes due to overlaps in the axonal projection fields of different subtypes.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6726424</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31411560</oboInOwl:hasDbXref>
        <rdfs:label>cortical-projecting neurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000540"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/0cbd2c1c-f67c-43a9-abe1-33d0e6d3f0ff"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000540"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/0cce076c-863e-4dfe-b2fc-602af3857ba6 -->

    <Class rdf:about="http://example.org/0cce076c-863e-4dfe-b2fc-602af3857ba6">
        <obo:IAO_0000115>Expression heterogeneity of CD8+ and CD4+ T cells in the OSCC ecosystem. (A) The t-distributed stochastic neighbor embedding (t-SNE) projection of T cells from cancerous tissue of patients with OSCC, showing the formation of 11 main clusters in different colors. The functional description of each cluster is determined by the gene expression characteristics. Cluster 0: ##resident memory CD8+ T Cells## (C0_CD8+ TRM); Cluster 1: effector memory CD8+ T cells (C1_CD8+ TEM); Cluster 2: regulatory CD4+ T cells (C2_CD4+ Treg); Cluster 3: exhausted CD8+ T cells (C3_CD8+ T Exhausted); Cluster 4: effector memory M-phage CD8+ T cells (C4_CD8+ Mitotic TEM); Cluster 5: effector memory CD4+ T cells (C5_CD4+ TEM); Cluster 6: effector memory CD8+ T cells (C6_CD8+ TEM); Cluster 7: effector memory CD4+ T cells (C7_CD4+ TEM); Cluster 8: effector memory CD8+ T cells (C8_CD8+ TEM); Cluster 9: effector memory CD8+ T cells (C9_CD8+ TEM); Cluster 10: effector memory M-phage CD4+ T cells (C10_CD4+ Mitotic TEM); Cluster 11: effector memory CD8+ T cells (C11_CD8+ TEM); Cluster 12: effector memory CD8+ T cells (C12_CD8+ TEM); Cluster 13: gammadelta T. (B) Cell-Cycle Scoring of T cells from cancerous tissue of patients with OSCC, showing the three clusters of cells in different cell cycles in different colors. (C) Heatmap of key genes expressed in each cluster of CD8+ tumor-infiltrating lymphocytes (TILs) with cells grouped by clusters. The columns correspond to the cells; the rows correspond to the genes. Yellow: high expression; purple: low expression. Selected key markers are shown on the right. (D) Heatmap of key genes expressed in each cluster of CD4+ TILs with cells grouped by clusters. The columns correspond to the cells; the rows correspond to the genes. Yellow: high expression; purple: low expression. Selected key genes are shown on the right.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8024729</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33513276</oboInOwl:hasDbXref>
        <rdfs:label>resident memory CD8+ T Cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000907"/>
        <skos:relatedMatch rdf:resource="CL:0000909"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/0cce076c-863e-4dfe-b2fc-602af3857ba6"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000907"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/0cce076c-863e-4dfe-b2fc-602af3857ba6"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000909"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/0d127c21-876b-4468-9592-a2b313a89c4f -->

    <Class rdf:about="http://example.org/0d127c21-876b-4468-9592-a2b313a89c4f">
        <obo:IAO_0000115>Tumor-associated macrophages (TAMs) are innate immune cells of the myeloid lineage that reside within the tumor following infiltration as either immature monocyte/macrophages or ##monocytic myeloid-derived suppressor cells## (MDSCs). TAMs are increasingly being recognized as central determinants in the shaping of the angiogenic, matricellular, and immune composition of tumor microenvironments [reviewed in ]:so much so that there are now numerous active clinical trials seeking to modify or disrupt TAM-dependent pro-tumorigenic phenotypes.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7724107</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33324425</oboInOwl:hasDbXref>
        <rdfs:label>monocytic myeloid-derived suppressor cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000576"/>
        <skos:relatedMatch rdf:resource="CL:0000889"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/0d127c21-876b-4468-9592-a2b313a89c4f"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000576"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/0d127c21-876b-4468-9592-a2b313a89c4f"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000889"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/0d248ed6-a83d-43c2-8a16-00131f3b2e0c -->

    <Class rdf:about="http://example.org/0d248ed6-a83d-43c2-8a16-00131f3b2e0c">
        <obo:IAO_0000115>Comparison of the single cell landscape between healthy human meniscus and degenerated meniscus. (A) Representative polarised light microscopy images of healthy human and degenerated meniscus. The white and red colours in the angle images are 90  apart in orientation. Dashed lines indicate the surface of the meniscus. Scale bar, 100 microm. (B) Merged t-distributed stochastic neighbour embedding (t-SNE) of single-cell RNA sequencing of healthy meniscus cells and degenerated meniscus cells. (C) Twelve healthy human and degenerated meniscus cell clusters at t-SNE. (D) Proportion of each cluster to the total cells. (E) Proportion of healthy and degenerated meniscus cells in each cluster. (F) Expression of representative marker genes in Vin plot. (G) Heatmap revealing the scaled expression of differentially expressed genes for each cluster. (H) CD146 and CD318 expression in healthy human meniscus cells and degenerated meniscus cells determined by flow cytometry. n&gt;=5, **p&lt;0.01. (I) Representative IHC staining of COL1A1 and COL2A1 healthy human meniscus and degenerated meniscus, and quantification of positive cells. Scale bar, 50 microm. n&gt;=5, **p&lt;0.01. (J) The expression of indicated marker genes in human healthy meniscus cells and degenerated meniscus cells were detected by qRT-PCR. *p&lt;0.05, **p&lt;0.01, otherwise, not significant. n=3, *p&lt;0.05, **p&lt;0.01. CPC, cartilage progenitor cells; DegP, degenerated meniscus progenitor cells; EC, endothelial cells; FC, fibrochondrocytes; FCP, fibrochondrocyte progenitors; HTC, hypertrophic chondrocytes; MoDC, monocyte-derived dendritic cells; PreHTC, ##prehypertrophic chondrocytes##; ProFC, proliferate fibrochondrocytes; RegC, regulatory chondrocytes.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7034356</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31871141</oboInOwl:hasDbXref>
        <rdfs:label>prehypertrophic chondrocytes</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000138"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/0d248ed6-a83d-43c2-8a16-00131f3b2e0c"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000138"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/0d3c0859-0469-43f0-a93c-cb7ffff8b446 -->

    <Class rdf:about="http://example.org/0d3c0859-0469-43f0-a93c-cb7ffff8b446">
        <obo:IAO_0000115>Furthermore, microRNA (miRNA)-155 is best characterized as a pro-inflammatory miRNA since it enhances M1-like macrophage activation by decreasing inhibitors of pro-inflammatory responses and targets the IL-13 receptor to reduce alternative macrophage activation. Currently, several miRNAs are implicated in the regulation of macrophage activation and polarization in cancer, and developments of pharmacological formulations that either suppress or enhance the activity of selected miRNAs to reprogram the ##TAM## phenotype are emerging. For instance, targeting of miRNA-processing enzyme DICER in macrophages with lysozyme-M-driven Cre prompts M1-like TAM reprogramming in lung carcinoma and MC38 tumors.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6801830</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31547627</oboInOwl:hasDbXref>
        <rdfs:label>TAM</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/0d3c0859-0469-43f0-a93c-cb7ffff8b446"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/0d4731ac-fcf0-45d8-8c7d-8cb9725d626b -->

    <Class rdf:about="http://example.org/0d4731ac-fcf0-45d8-8c7d-8cb9725d626b">
        <obo:IAO_0000115>Measuring the relationships between spiking and DeltaF/F in MCs and EGCs did not account for the sparseness of observed EGC tuning. Moreover, DeltaF/F-to-spiking estimates were made using artificial spike-inducing protocols that may not reflect spiking conditions in the ex vivo chemosensory tuning experiments. Another possible explanation for EGC tuning sparseness could be the highly hyperpolarized resting membrane potentials of EGCs, which our data and previous studies indicated are ~15 to 20 mV hyperpolarized compared with other AOB neurons. This extreme resting hyperpolarization could prevent EGC spiking in all but the strongest stimulation conditions, potentially preventing the observation of robust GCaMP6f signals. We therefore performed 2-photon fluorescence-guided whole-cell patch-clamp recordings on ##Cort+ EGCs## in the ex vivo preparation (Fig. 7). We performed these experiments in Cort-T2A-Cre mice crossed to a cre-dependent tdTomato reporter line, which improved our ability to identify EGC somata at rest. Using techniques similar to those in the study by, we achieved the whole-cell configuration, then maintained each cell in current clamp near its initial resting potential via DC current injection. EGC resting membrane potentials in the ex vivo preparations, measured immediately after break-in, were depolarized compared with AOB slices (-63.7 +- 2.0 mV, n = 18). The reasons for the discrepancy were not clear, given that the internal and external solutions were identical to those in slice experiments. Nevertheless, we decided to maintain patched EGCs at these relatively depolarized potentials because they more likely reflected the state of EGCs in this ex vivo preparation (i.e., during GCaMP6f imaging experiments; Figs. 2, 4). Importantly, the observation that EGCs had relatively depolarized resting membrane potentials in the ex vivo preparation suggests that, if anything, EGCs in this preparation might be much closer to action potential threshold than was suggested by resting potentials measured in slice experiments.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7329303</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32503886</oboInOwl:hasDbXref>
        <rdfs:label>Cort+ EGCs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000626"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/0d4731ac-fcf0-45d8-8c7d-8cb9725d626b"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000626"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/0d4ee087-4733-4d0c-aef7-83ffeca664a5 -->

    <Class rdf:about="http://example.org/0d4ee087-4733-4d0c-aef7-83ffeca664a5">
        <obo:IAO_0000115>The ANRIL/p15 expression in human TM cells and its relationship with TM stiffness. (A) The proportion of p15-expressed cells in each cell type in human aqueous outflow pathways. From left to right: 1 ##beam cells A##, 2 beam cells B, 3 juxtacanalicular tissue cells, 4 ciliary muscle cells, 5 collector channels cells, 6 Schwalbe line cells, 7 myelinating Schwann cells, 8 non-myelinating Schwann cells, 9 vascular endothelium cells, 10 pericyte cells, 11 Schlemm canal endothelium cells, 12 macrophages, 13 melanocytes, 14 mast cells, 15 neurons. (B) The proportion of ANRIL-expressed cells in each cell type in human aqueous outflow pathways (cell-type order is the same as in panel A). (C) The normalized expression level of p15 and ANRIL in each cell type are present in heatmap (blue shallow indicates no expression). (D) The expression level (RPKM) of p15 in different TM stiffness are presented.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9101924</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35563774</oboInOwl:hasDbXref>
        <rdfs:label>beam cells A</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002367"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/0d4ee087-4733-4d0c-aef7-83ffeca664a5"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002367"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/0d60ad11-fcf0-4ad1-924c-ec37268191d0 -->

    <Class rdf:about="http://example.org/0d60ad11-fcf0-4ad1-924c-ec37268191d0">
        <obo:IAO_0000115>BACKGROUND Rotator cuff injury is the most common cause of shoulder disability, and although the repair technique has improved, the rate of rotator cuff reduction after repair is still high. The fibrocartilage region, which appears to be histologically inserted, cannot be regenerated. In recent years, studies have reported that mesenchymal stem cells (MSCs) have enhanced cartilage regeneration in the tendon and bone interface after rotator cuff repair, which has become a hot topic of research. MATERIAL AND METHODS Two mesenchymal stem cell types, ##SMSC## (synovial-derived mesenchymal stem cells) and BMSC (bone marrow-derived mesenchymal stem cells) were intervened using kartogenin (KGN). The cytotoxicity was evaluated and the proliferation of the 2 cells was observed. Four commonly used cartilage phenotype genes were detected by quantitative real-time polymerase chain reaction, and the cartilage differentiation of MSCs induced by KGN was explored. The bidirectional regulation of the expression of BMP-7 and the downstream gene Smad5 was observed by constructing a lentiviral overexpression vector containing the target gene BMP-7. To explore whether BMP-7/Smad5 pathway activation promotes differentiation of SMSCs into chondrocytes. RESULTS KGN can induce the selective differentiation of endogenous MSCs into chondrocytes by activating the BMP-7/Smad5 pathway, which promotes the regeneration of interfacial cartilage, and improves the quality of tendon healing of the tendon after rotator cuff repair. CONCLUSIONS This study found a new biological intervention method to promote the effect of tendon on bone healing after rotator cuff repair.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6625576</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31271564</oboInOwl:hasDbXref>
        <rdfs:label>SMSC</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000134"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/0d60ad11-fcf0-4ad1-924c-ec37268191d0"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000134"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/0d813436-4b01-4c53-8450-b2b19c0546f7 -->

    <Class rdf:about="http://example.org/0d813436-4b01-4c53-8450-b2b19c0546f7">
        <obo:IAO_0000115>Lymphocytes such as CD4+ T cells and B cells mainly infiltrate the salivary glands; however, the precise roles and targets of autoreactive T cells and autoantibodies in the pathogenesis of Sjogren&apos;s Syndrome (SS) remain unclear. This study was designed to clarify the role of autoreactive T cells and autoantibodies at the single-cell level involved in the development of sialadenitis. Infiltrated CD4+ T and B cells in the salivary glands of a mouse model resembling SS were single-cell-sorted, and their T cell receptor (TCR) and B cell receptor (BCR) sequences were analyzed. The predominant TCR and BCR clonotypes were reconstituted in vitro, and their pathogenicity was evaluated by transferring reconstituted TCR-expressing ##CD4+ T cells## into Rag2-/- mice and administering recombinant IgG in vivo. The reconstitution of Th17 cells expressing TCR (#G) in Rag2-/- mice resulted in the infiltration of T cells into the salivary glands and development of sialadenitis, while an autoantibody (IgGr22) was observed to promote the proliferation of pathogenic T cells. IgGr22 specifically recognizes double-stranded RNA (dsRNA) and induces the activation of dendritic cells, thereby enhancing the expression of IFN signature and inflammatory genes. TCR#G recognizes antigens related to the gut microbiota. Antibiotic treatment severely reduces the activation of TCR#G-expressing Th17 cells and suppresses sialadenitis development. These data suggest that the anti-dsRNA antibodies and, TCR recognizing the gut microbiota involved in the development of sialadenitis like SS. Thus, our model provides a novel strategy for defining the roles of autoreactive TCR and autoantibodies in the development and pathogenesis of SS.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMID:38762063</oboInOwl:hasDbXref>
        <rdfs:label>CD4+ T cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000624"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/0d813436-4b01-4c53-8450-b2b19c0546f7"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000624"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/0da2daef-bdb1-499b-a647-03d8551fa078 -->

    <Class rdf:about="http://example.org/0da2daef-bdb1-499b-a647-03d8551fa078">
        <obo:IAO_0000115>Luminal progenitors serve primarily as tumor initiators or cells of origin for prostate cancer. Various hierarchical models have been proposed. A recent model suggests that, during early postnatal development, multipotent basal cells (p63+ CK5+) differentiate into unipotent basal progenitors, luminal progenitors (CK8+ AR low), and NE cells. These unipotent basal and luminal progenitors can undergo self-renewal or differentiate into basal cells and mature luminal cells (AR+ CK8+), respectively. In adults, during homeostasis and regeneration, the bipotent basal progenitor forms unipotent basal and luminal progenitors, which further undergo self-renewal. Unipotent basal progenitors differentiate into basal cells, and luminal cell progenitors differentiate into ##luminal cells##.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10291985</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37282627</oboInOwl:hasDbXref>
        <rdfs:label>luminal cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002340"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/0da2daef-bdb1-499b-a647-03d8551fa078"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002340"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/0db2c32d-8a86-47da-b788-9270f95a7228 -->

    <Class rdf:about="http://example.org/0db2c32d-8a86-47da-b788-9270f95a7228">
        <obo:IAO_0000115>(A-C) Representative responses to cholinergic agonist (carbachol, 10 muM) by small (L-cells) (A), D-stellate (B), tuberculoventral (TV) cells (C). Small cells were activated by carbachol. D-stellate and TV cells failed to respond to carbachol application. IPSCs in principal cells, bushy cells (D), and T-stellate cells (E) in the VCN were induced by carbachol application, confirming that small inhibitory neurons were local interneurons. (F, H) Time course of sIPSCs from bushy cells and ##T-stellate## (bushy cell, tau = 7.22 +- 1.40 ms, n = 9, T-stellate, tau = 2.28 +- 0.07 ms, n = 9). (G, I) Cumulative histogram of inter-event internal under control and carbachol application. (J). Carbachol application resulted in a significant increase in sIPSCs frequency (inter-event interval, control = 280.44 +- 47.56 ms versus carbachol = 191.21 +- 28.99 ms, p&lt;0.02, t-test).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7744103</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33141020</oboInOwl:hasDbXref>
        <rdfs:label>T-stellate</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000122"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/0db2c32d-8a86-47da-b788-9270f95a7228"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000122"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/0e06a31e-7d1e-4c2d-a26e-a2e85adc1a32 -->

    <Class rdf:about="http://example.org/0e06a31e-7d1e-4c2d-a26e-a2e85adc1a32">
        <obo:IAO_0000115>Immunological changes in Foxp3+Helios+ and Foxp3+CD25+ Tregs during T. pallidum/HIV-1 co-infection. The gating strategy for the analysis of Foxp3+CD25+ and Foxp3+Helios+ (A) cells is indicated. The frequencies of Foxp3+CD25+ Treg cells (B) and ##Foxp3+Helios+ Treg cells## (C) were analyzed by flow cytometry in the HC, RPR+, CHI, and CHI&amp;RPR+ groups. Frequencies of Foxp3+CD25+CD45RA+ Treg cells (D), Foxp3+Helios+CD45RA+ Treg cells (E), Foxp3+CD25+CD45RO+ Tregs (F), and Foxp3+Helios+CD45RO+ Tregs (G) were analyzed by flow cytometry in the HC, RPR+, CHI, and CHI&amp;RPR+ groups. The correlations between the CD4+ T-cell counts and the frequencies of Foxp3+Helios+ Treg cells (H) and Foxp3+Helios+CD45RO+ cells (I) in the CHI group were evaluated with Spearman&apos;s rank correlation test. Significance was assessed by calculating p-values using ANOVA, Student&apos;s t-tests, or Mann-Whitney U-tests, with values of p &lt; 0.05 considered significant.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6465566</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31024549</oboInOwl:hasDbXref>
        <rdfs:label>Foxp3+Helios+ Treg cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000815"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/0e06a31e-7d1e-4c2d-a26e-a2e85adc1a32"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000815"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/0e4fc473-cd89-404e-84b9-f6e3ba937d62 -->

    <Class rdf:about="http://example.org/0e4fc473-cd89-404e-84b9-f6e3ba937d62">
        <obo:IAO_0000115>Tumor-associated macrophages (TAMs) are innate immune cells of the myeloid lineage that reside within the tumor following infiltration as either immature monocyte/macrophages or monocytic myeloid-derived suppressor cells (MDSCs). TAMs are increasingly being recognized as central determinants in the shaping of the angiogenic, matricellular, and immune composition of tumor microenvironments [reviewed in ]:so much so that there are now numerous active clinical trials seeking to modify or disrupt ##TAM##-dependent pro-tumorigenic phenotypes.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7724107</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33324425</oboInOwl:hasDbXref>
        <rdfs:label>TAM</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/0e4fc473-cd89-404e-84b9-f6e3ba937d62"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/0e51e048-8a45-4887-a2c2-c429d127363a -->

    <Class rdf:about="http://example.org/0e51e048-8a45-4887-a2c2-c429d127363a">
        <obo:IAO_0000115>A dizzying array of morphological, molecular, and electrophysiological details for different cell types exist and appropriate classifications are being determined. How these different cell types contribute to brain function is challenging to determine, but it is clear that a homeostatic balance of cell excitability, together with excitatory and inhibitory synaptic inputs is essential for normal brain function. The irregular firing of neurons in vivo is well-known and is believed to confer computational benefits, with inhibition being recognized as a crucial shaper of these asynchronous activities. Recently, in directly fitting a deterministic firing network model to several sets of in vivo multi-neuron data, it was found that the intrinsically generated variability obtained in experiment was mainly due to feedback inhibition. In essence, it is critical to understand these inhibitory components. However, we are cognisant of the much more diverse nature of inhibitory cells relative to ##excitatory cells## in our brains, despite their smaller overall numbers. While the examination of individual neuron activities in the behaving animal is becoming less uncommon, there are certainly more caveats and technical difficulties relative to in vitro studies. Further, the smaller numbers and sizes of inhibitory cells as well as being in hard to access locations create additional challenges for identification and patching. Indeed, the activity of several inhibitory cell types in vivo remains unknown.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6324795</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:30620732</oboInOwl:hasDbXref>
        <rdfs:label>excitatory cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000540"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/0e51e048-8a45-4887-a2c2-c429d127363a"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000540"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/0e53ab4b-9e65-45df-9db5-c119b24738c3 -->

    <Class rdf:about="http://example.org/0e53ab4b-9e65-45df-9db5-c119b24738c3">
        <obo:IAO_0000115>Development of the trophoblastic shell and formation of placental anchoring villi. a Structure of the human trophoblastic shell and its surrounding arterial vessels. b Depiction of a placental anchoring villus, spiral artery (SA) remodelling and interaction of extravillous trophoblasts (EVTs) with different decidual cell types. dCCT distal cell column trophoblast, dMPhi decidual macrophage, DSC decidual stromal cell, ##eCTB## endovascular cytotrophoblast, GC giant cell, iCTB interstitial cytotrophoblast, pCCT proximal cell column trophoblast, pEC placental endothelial cell, pMPhi placental macrophage, pSC placental stromal/mesenchymal cell, SM smooth muscle layer, STB syncytiotrophoblast, TBS trophoblastic shell, TP trophoblast plug, TV tertiary villi, UC umbilical cord, uNK uterine NK cell, vCTB villous cytotrophoblast, YO yolk sac</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6697717</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31049600</oboInOwl:hasDbXref>
        <rdfs:label>eCTB</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000523"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/0e53ab4b-9e65-45df-9db5-c119b24738c3"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000523"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/0e9c5d87-1dec-4330-b87c-24a835e882b0 -->

    <Class rdf:about="http://example.org/0e9c5d87-1dec-4330-b87c-24a835e882b0">
        <obo:IAO_0000115>Lymphocytes such as CD4+ T cells and B cells mainly infiltrate the salivary glands; however, the precise roles and targets of autoreactive T cells and autoantibodies in the pathogenesis of Sjogren&apos;s Syndrome (SS) remain unclear. This study was designed to clarify the role of autoreactive T cells and autoantibodies at the single-cell level involved in the development of sialadenitis. Infiltrated CD4+ T and B cells in the salivary glands of a mouse model resembling SS were single-cell-sorted, and their T cell receptor (TCR) and ##B cell## receptor (BCR) sequences were analyzed. The predominant TCR and BCR clonotypes were reconstituted in vitro, and their pathogenicity was evaluated by transferring reconstituted TCR-expressing CD4+ T cells into Rag2-/- mice and administering recombinant IgG in vivo. The reconstitution of Th17 cells expressing TCR (#G) in Rag2-/- mice resulted in the infiltration of T cells into the salivary glands and development of sialadenitis, while an autoantibody (IgGr22) was observed to promote the proliferation of pathogenic T cells. IgGr22 specifically recognizes double-stranded RNA (dsRNA) and induces the activation of dendritic cells, thereby enhancing the expression of IFN signature and inflammatory genes. TCR#G recognizes antigens related to the gut microbiota. Antibiotic treatment severely reduces the activation of TCR#G-expressing Th17 cells and suppresses sialadenitis development. These data suggest that the anti-dsRNA antibodies and, TCR recognizing the gut microbiota involved in the development of sialadenitis like SS. Thus, our model provides a novel strategy for defining the roles of autoreactive TCR and autoantibodies in the development and pathogenesis of SS.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMID:38762063</oboInOwl:hasDbXref>
        <rdfs:label>B cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000236"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/0e9c5d87-1dec-4330-b87c-24a835e882b0"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000236"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/0eb8f3bd-38a0-4686-ae01-98c6d95eb3e5 -->

    <Class rdf:about="http://example.org/0eb8f3bd-38a0-4686-ae01-98c6d95eb3e5">
        <obo:IAO_0000115>Innate T cells, including CD1d-restricted ##invariant natural killer T (iNKT) cells##, are characterized by their rapid activation in response to non-peptide antigens, such as lipids. While the transcriptional profiles of naive, effector, and memory adaptive T cells have been well studied, less is known about the transcriptional regulation of different iNKT cell activation states. Here, using single-cell RNA-sequencing, we performed longitudinal profiling of activated murine iNKT cells, generating a transcriptomic atlas of iNKT cell activation states. We found that transcriptional signatures of activation are highly conserved among heterogeneous iNKT cell populations, including NKT1, NKT2, and NKT17 subsets, and human iNKT cells. Strikingly, we found that regulatory iNKT cells, such as adipose iNKT cells, undergo blunted activation and display constitutive enrichment of memory-like cMAF+ and KLRG1+ populations. Moreover, we identify a conserved cMAF-associated transcriptional network among NKT10 cells, providing novel insights into the biology of regulatory and antigen-experienced iNKT cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9831610</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36458691</oboInOwl:hasDbXref>
        <rdfs:label>invariant natural killer T (iNKT) cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000921"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/0eb8f3bd-38a0-4686-ae01-98c6d95eb3e5"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000921"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/0ecdb803-8b77-4b91-a1ef-34f6ef7c7fae -->

    <Class rdf:about="http://example.org/0ecdb803-8b77-4b91-a1ef-34f6ef7c7fae">
        <obo:IAO_0000115>DEG Differentially expressed gene   ESC Embryonic stem cell   FACS Fluorescence-activated cell sorting    GC Granulosa cells   hPGC Human primordial germ cell   MACS Magnetic-activated cell sorting   OSC Oogonial stem cell   PCG Primordial germ cell   pre-PGC ##Progenitor primordial germ cell##   RA Retinoic acid   scRNA-seq Single-cell RNA sequencing   SC-seq Single-cell sequencing   SSC Spermatogenic stem cells   TC Theca cell   TF Transcription factors   t-SNE t-stochastic neighbor embedding   UMI Unique molecular identifier   </obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7829788</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33467661</oboInOwl:hasDbXref>
        <rdfs:label>Progenitor primordial germ cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000670"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/0ecdb803-8b77-4b91-a1ef-34f6ef7c7fae"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000670"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/0f1590d9-c922-490f-b6fc-7f8ab2418eeb -->

    <Class rdf:about="http://example.org/0f1590d9-c922-490f-b6fc-7f8ab2418eeb">
        <obo:IAO_0000115>Schwann-cell-like cells (##SCLCs##) and putative paracrine signaling with NEO cells</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9587261</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36271074</oboInOwl:hasDbXref>
        <rdfs:label>SCLCs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002573"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/0f1590d9-c922-490f-b6fc-7f8ab2418eeb"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002573"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/0f4da15d-cb32-4a3f-8648-664e184dfbbb -->

    <Class rdf:about="http://example.org/0f4da15d-cb32-4a3f-8648-664e184dfbbb">
        <obo:IAO_0000115>Although considerable advances have been made toward understanding human T-cell development, several major questions remain obscure regarding the heterogeneity and molecular mechanisms underlying the fate bifurcation of certain T progenitors. Several laboratories have largely resolved these long-standing questions by using single-cell RNA sequencing (scRNA-seq) technologies to study human T-cell development in both the developing fetus and postnatal thymus. Our group first revealed thymus organogenesis, early T lymphopoiesis, and their ##pre-thymic lymphoid progenitors## in the early human fetus at single-cell resolution. Following studies further transcriptomically characterized the TSPs and revealed T lineage specification, commitment, and subsequent differentiation in both the prenatal and postnatal thymus. A recent work profiled the complete thymocyte populations in postnatal samples, especially the three CD4-CD8- DN subsets and identified three distinct TSP subpopulations as well as revealed T-cell lineage commitment and divergence of non-T-cell lineages. Despite that the characteristics of immature DN subsets have been characterized in the human postnatal thymus, less is known regarding the nature of distinct DN subpopulations and cell fate decision (T lineage versus non-T lineage) during DN stages of T-cell development in human fetus. Furthermore, mouse studies have well documented that fetal and adult DN cells (including ETP) are not equivalent, reflecting the origin of ETP (HSC-dependent or HSC-independent), thymic outputs, differentiation speed, and gene expression transition, so whether these differences existing between prenatal and postnatal human thymocytes are also worth to be addressed.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10565475</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37828991</oboInOwl:hasDbXref>
        <rdfs:label>pre-thymic lymphoid progenitors</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000936"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/0f4da15d-cb32-4a3f-8648-664e184dfbbb"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000936"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/0fd54bc1-cbb8-49ef-b5a0-fa450179f7c3 -->

    <Class rdf:about="http://example.org/0fd54bc1-cbb8-49ef-b5a0-fa450179f7c3">
        <obo:IAO_0000115>We next leveraged the high number of nuclei and developmental time points sampled in our dataset to quantify cell types across gestational age. Focusing on the germinal matrix where gliogenesis begins, samples were grouped into four stages spanning the latter half of second trimester and third trimester: 17-20 gw (Stage 1), 20-24 gw (Stage 2), 24-28 gw (Stage 3), and 31-41 gw (Stage 4). The stages differed statistically by gestational age but not by sex or tissue collection postmortem interval (Supplementary Data 1-2). By plotting mean fraction of cell type by stage, we observe two trends from second to third trimester: a decrease in the fraction of nIPCs and ##excitatory neurons## (EN: CPN and SPN) and an increase in the fraction of glia (RG/AC, gIPC, astrocyte, OPC, and microglia) (Fig. 1f). To study these trends further, we correlated the fraction of cell types to sample age in gestational weeks (Supplementary Fig. 3). This reveals a significant increase with gestational age in the fraction of gIPCs (p = 0.003; two-tailed Spearman Rank-Order Correlation test), astrocytes (p = 0.015), OPCs (p = 0.0008), and microglia (p = 0.002) (Supplementary Fig. 3a). The fraction of MSNs also increase significantly (p = 0.002). Conversely, there is a significant decrease in the fraction of nIPCs (p = 0.034), late-born L2/3 CPNs (p = 0.009), and TAC (p = 0.002) (Supplementary Fig. 3a). Our GM dataset, therefore, captures the start of the gliogenic period. In the CP, the fraction of TACs, nIPCs, and CRNs exhibit a significant decrease over time (p = 0.002, ~0, 0.0001, respectively), while L4/5a CPNs show a significant increase (p = 0.002) (Supplementary Fig. 3b). Interneurons also increase from second to third trimester (p = 0.001), consistent with their migration into the neocortex. While the fraction of CP glia exhibit a positive trend, only OPC numbers show a significant positive correlation with gestational age (p = 0.026).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9744747</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36509746</oboInOwl:hasDbXref>
        <rdfs:label>excitatory neurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000540"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/0fd54bc1-cbb8-49ef-b5a0-fa450179f7c3"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000540"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/0fdd7c15-60a4-4282-bfca-420f9ddf3d69 -->

    <Class rdf:about="http://example.org/0fdd7c15-60a4-4282-bfca-420f9ddf3d69">
        <obo:IAO_0000115>Introduction: Macrophages and T cells play crucial roles in liver physiology, but their functional diversity in hepatocellular carcinoma (HCC) remains largely unknown. Methods: Two bulk RNA-sequencing (RNA-seq) cohorts for HCC were analyzed using gene co-expression network analysis. Key gene modules and networks were mapped to single-cell RNA-sequencing (scRNA-seq) data of HCC. Cell type fraction of bulk RNA-seq data was estimated by deconvolution approach using single-cell RNA-sequencing data as a reference. Survival analysis was carried out to estimate the prognosis of different immune cell types in bulk RNA-seq cohorts. Cell-cell interaction analysis was performed to identify potential links between immune cell types in HCC. Results: In this study, we analyzed RNA-seq data from two large-scale HCC cohorts, revealing a major and consensus gene co-expression cluster with significant implications for immunosuppression. Notably, these genes exhibited higher enrichment in liver macrophages than T cells, as confirmed by scRNA-seq data from HCC patients. Integrative analysis of bulk and single-cell RNA-seq data pinpointed SPP1 + macrophages as an unfavorable cell type, while ##VCAN + macrophages##, C1QA + macrophages, and CD8 + T cells were associated with a more favorable prognosis for HCC patients. Subsequent scRNA-seq investigations and in vitro experiments elucidated that SPP1, predominantly secreted by SPP1 + macrophages, inhibits CD8 + T cell proliferation. Finally, targeting SPP1 in tumor-associated macrophages through inhibition led to a shift towards a favorable phenotype. Discussion: This study underpins the potential of SPP1 as a translational target in immunotherapy for HCC.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11649653</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:39691723</oboInOwl:hasDbXref>
        <rdfs:label>VCAN + macrophages</rdfs:label>
    </Class>
    


    <!-- http://example.org/0fff6e07-4602-4791-93b1-ff91a369f387 -->

    <Class rdf:about="http://example.org/0fff6e07-4602-4791-93b1-ff91a369f387">
        <obo:IAO_0000115>Molecular characteristics of perimeningeal astrocytes (PMA) and ##mature lesion border astrocytes## (LBA).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11303254</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38907165</oboInOwl:hasDbXref>
        <rdfs:label>mature lesion border astrocytes</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002627"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/0fff6e07-4602-4791-93b1-ff91a369f387"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002627"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/00be2bb4-af3a-453d-95ff-581e0738f1b8 -->

    <Class rdf:about="http://example.org/00be2bb4-af3a-453d-95ff-581e0738f1b8">
        <obo:IAO_0000115>Focusing on the peripheral, differentiated cDC populations, we next assessed protein expression of the IRF8 transcription factor in tumor-derived cDC populations (Fig. 3a). In the periphery, IRF8 controls survival and function of terminally differentiated cDC1s. Furthermore, increased IRF8 expression in CD11b-CD103- DN cells was shown to promote their differentiation into mature CD103+ cDC1s. Thus, we hypothesized that CD40L-CAR T cell treatment skews the cDC1/cDC2 ratio towards the cDC1 populations by stimulating the ##DN cells## to expand, upregulate IRF8, and differentiate into cDC1s. We specifically noticed upregulation of IRF8 (readout of DN-to-cDC1 differentiation) and Ki-67 (readout for proliferation) in DN cells treated with CD40L-CAR T cell-treated mice (Fig. 3b). The increased expression of Ki-67 in the tumor-derived DN cells also correlated with the observed increase of the DN population in the tumor of CD40L-CAR T cell-treated mice (Fig. 1f), indicating that DN cells receive a proliferative signal upon CD40L-CAR T cell treatment. Intriguingly, splenic DN cells and DN cells from the tdLNs did not upregulate Ki-67 or IRF8 (Fig. 3c, d). Overall, tdLN cDCs did not present with a stimulated phenotype, as suggested by the lack of CD86 or Ki-67 upregulation (Supplementary Fig. 2D-G). This suggested a tumor-specific effect of cDC DN stimulation after m1928z-CD40L treatment.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7710757</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33268774</oboInOwl:hasDbXref>
        <rdfs:label>DN cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002510"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/00be2bb4-af3a-453d-95ff-581e0738f1b8"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002510"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/004d8d10-f1ff-4d08-8337-087ad9f9a024 -->

    <Class rdf:about="http://example.org/004d8d10-f1ff-4d08-8337-087ad9f9a024">
        <obo:IAO_0000115>Applying EmptyDrops to the different time-points consistently increased the number of ##early spermatocytes## from P15 to Adult and also recovered FLCs at P15 and P20, consistent with these cells undergoing gradual atrophy (Supplementary Data 1, Supplementary Fig. 6e-g). Additionally, we detect an increase in transcriptionally quiescent late spermatids, particularly at P35 (Supplementary Fig. 6g).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6424977</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:30890697</oboInOwl:hasDbXref>
        <rdfs:label>early spermatocytes</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000017"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/004d8d10-f1ff-4d08-8337-087ad9f9a024"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000017"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/007e64f5-923a-4dde-a9a4-137a4743d5e6 -->

    <Class rdf:about="http://example.org/007e64f5-923a-4dde-a9a4-137a4743d5e6">
        <obo:IAO_0000115>BACKGROUND: Hundreds of ongoing clinical trials combine radiation therapy, mostly delivered as stereotactic body radiotherapy (SBRT), with immune checkpoint blockade. However, our understanding of the effect of radiotherapy on the intratumoral immune balance is inadequate, hindering the optimal design of trials that combine radiation therapy with immunotherapy. Our objective was to characterize the intratumoral immune balance of the malignant prostate after SBRT in patients. METHODS: Sixteen patients with high-risk, non-metastatic prostate cancer at comparable Gleason Grade disease underwent radical prostatectomy with (n = 9) or without (n = 7) neoadjuvant SBRT delivered in three fractions of 8 Gy over 5 days completed 2 weeks before surgery. Freshly resected prostate specimens were processed to obtain single-cell suspensions, and immune-phenotyped for major lymphoid and myeloid cell subsets by staining with two separate 14-antibody panels and multicolor flow cytometry analysis. RESULTS: Malignant prostates 2 weeks after SBRT had an immune infiltrate dominated by myeloid cells, whereas malignant prostates without preoperative treatment were more lymphoid-biased (myeloid CD45+ cells 48.4 +- 19.7% vs. 25.4 +- 7.0%; adjusted p-value = 0.11; and ##CD45+ lymphocytes## 51.6 +- 19.7% vs. 74.5 +- 7.0%; p = 0.11; CD3+ T cells 35.2 +- 23.8% vs. 60.9 +- 9.7%; p = 0.12; mean +- SD). CONCLUSION: SBRT drives a significant lymphoid to myeloid shift in the prostate-tumor immune infiltrate. This may be of interest when combining SBRT with immunotherapies, particularly in prostate cancer.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7794088</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32647353</oboInOwl:hasDbXref>
        <rdfs:label>CD45+ lymphocytes</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000542"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/007e64f5-923a-4dde-a9a4-137a4743d5e6"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000542"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/008cbd7a-39ad-444e-931d-acd4eba7239e -->

    <Class rdf:about="http://example.org/008cbd7a-39ad-444e-931d-acd4eba7239e">
        <obo:IAO_0000115>Within the identified cluster of ##pituitary endocrine cells## (Fig. 4A and C), multiple subpopulations of PG endocrine cells could be identified (Additional file 1: Fig. S1). Within the generated endocrine cell-specific heat-map, there were identifiable clusters of corticotrophs (129 cells, Tbx19+, Rspo3+, Tnnt1+, Pomc+), gonadotrophs (27 cells, Fshb+, Gnrhr+, Lhb+, Hpgd+), somatotrophs (388 cells, Gh+, Rxrg+, Wnt10a+, Pappa2+) lactotrophs (125 cells, Prl+, A2m+, Ramp1+, Spock1+) and melanotrophs (19 cells, Pax7+, Prrx1+, Cd24a+, Oacyl+).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10996213</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38575991</oboInOwl:hasDbXref>
        <rdfs:label>pituitary endocrine cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:2000004"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/008cbd7a-39ad-444e-931d-acd4eba7239e"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:2000004"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/01d1bc0b-f9cf-40c1-a8f5-ed55cd53ffec -->

    <Class rdf:about="http://example.org/01d1bc0b-f9cf-40c1-a8f5-ed55cd53ffec">
        <obo:IAO_0000115>Next, we analyzed the interactions between these ligand-receptor pairs from the TME among 12 kinds of immune cells, and found that CCL5-CCR1 mainly sends signals of CD8+ T cells and NK Cells, which may interact with pDCs, macrophages, cDC2s, and myeloid cells via the interaction of CCL5 and CCR1. The SELPLG-SELL ligand-receptor pair is the main interaction among CD4+ T cells, NK cells, myeloid cells, and naive B cells. Furthermore, NOTCH2-cDCs interact with pDCs, CD4+ T cells, ##cCD2s##, NK cells, myeloid cells, naive B cells, and cDC1s. Both migDCs and cDC1s interact with CD4+ T cells, pDCs, cCD2s, NK Cells, myeloid cells, and naive B cells. The CXCL10-CXCR3 ligand-receptor pair is the main interaction among pDCs, migDCs, and CD4+ T cells, and the CXCL9-CXCR3 ligand-receptor pair is the main interaction among pDCs, cDC1s, migDCs, and CD4+ T cells (Fig. 8C). We also used a violin plot to visualize the signal gene expression distribution in the three signaling pathways inferred by CellChat. The results showed that CCL5 is mainly expressed on CD8+ T and NK cells, and its corresponding receptors are mainly in macrophages, myeloid cells, cCD2s, and pDCs. SELPLG is mainly expressed on CD4+ T cells, NOTCH2-cDCs, migDCs, and cDC1s, and its corresponding receptor, SELL, is mainly expressed on naive B cells, myeloid cells, NK cells, cCD2s, pDCs, CD4+ T cells, and cCD1s. CXCL9 is mainly expressed on pDCs, migDCs, and cDC1s, CXCL10 is mainly expressed on pDCs and migDCs, and their corresponding receptor, CXCR3, is mainly expressed on CD4+ T cells (Fig. 8D).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9203818</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35710862</oboInOwl:hasDbXref>
        <rdfs:label>cCD2s</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000990"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/01d1bc0b-f9cf-40c1-a8f5-ed55cd53ffec"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000990"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/01ec9b6b-cca8-4849-afc1-e550318d4400 -->

    <Class rdf:about="http://example.org/01ec9b6b-cca8-4849-afc1-e550318d4400">
        <obo:IAO_0000115>Previous work revealed that GM-CSF cultured BMDCs are a heterogeneous myeloid cell population consisting of bona fide DCs (termed &quot;GM-DC&quot;) and a minor fraction of macrophage-like CD11c+ MHCII+ cells (termed &quot;##GM-Mac##&quot;). When we refined our flow cytometric analysis for distinguishing GM-DCs and GM-Macs in BMDC cultures, we found a clear shift between both cell populations in 3xGrk -/- BMDC cultures. Among CD11c+ MHCII+ cells, the fraction of GM-DCs was decreased, whereas GM-Macs were markedly increased in both unstimulated and LPS-stimulated 3xGrk -/- GM-CSF cultures ( Figure 5E ). Importantly, the remaining bona fide GM-DCs, which still developed in 3xGrk -/- cultures, also showed reduced expression of CCR7, MHCII and CD40 ( Figure 5F ). Together, these findings provide an explanation for the two observed phenotypes of 3xGrk -/- cells in the under-agarose chemotaxis assays; (a) less responding cells, because GM-Macs do not migrate to CCL19, and (b) reduced displacement of the responding cells, because the remaining bona fide GM-DCs remain lowered in CCR7-expression. Additionally, we noticed that not only DCs derived from GM-CSF cultures showed an altered phenotype, but also DC development in the presence of Flt3 ligand was impaired. In particular, the number of CD11b- DCs was strongly reduced, whereas the CD11b+ DC population was not significantly altered ( Supplementary Figure 3A ).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9703078</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36451830</oboInOwl:hasDbXref>
        <rdfs:label>GM-Mac</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/01ec9b6b-cca8-4849-afc1-e550318d4400"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/0109bc6d-d54a-407d-9a0a-a20e5ad39498 -->

    <Class rdf:about="http://example.org/0109bc6d-d54a-407d-9a0a-a20e5ad39498">
        <obo:IAO_0000115>It has been reported that cortical-projecting subpopulations of DRN 5-HT neurons express Slc17a8, in agreement with the extensive overlap between the spatial distribution of cortical-projecting neurons and Slc17a8 expression. This suggests that ##cortical-projecting## subpopulations should correspond to subtype 5-HT-IV from the scRNA-seq dataset, which is Slc17a8-expressing and distributed to the ventral DRN. Additionally, we would predict that the Str-projecting subpopulation corresponds to the subtype 5-HT-III, since their distributions overlap extensively in the dorsomedial DRN. Consistent with our hypothesis that 5-HT neuron subtypes innervate different brain regions, we found that the inferred distributions of each 5-HT neuron subtype coincides with a different set of projection-defined subpopulations - the distribution of subtype 5-HT-III was most similar to the distribution of Str-projecting neurons (Figure 6F), whereas the distribution of subtype 5-HT-IV was more similar to that of M1-projecting neurons (Figure 6G). However, neither Str-projecting nor M1-projecting subpopulations were fully contained within the distribution of a single 5-HT neuron subtype. Str-projecting neurons in the ventrolateral DRN (marked cyan in Figure 6D,F,G), where neurons innervating both Str and M1 are located, fell within the distribution of subtype 5-HT-IV but not of subtype 5-HT-III. This suggests that Str is a target of multiple molecular subtypes of 5-HT neurons, and supports the model that some structures are innervated by multiple 5-HT neuron subtypes due to overlaps in the axonal projection fields of different subtypes.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6726424</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31411560</oboInOwl:hasDbXref>
        <rdfs:label>cortical-projecting</rdfs:label>
    </Class>
    


    <!-- http://example.org/0136b8a5-76d5-4c22-a962-9e0705e68919 -->

    <Class rdf:about="http://example.org/0136b8a5-76d5-4c22-a962-9e0705e68919">
        <obo:IAO_0000115>Resilience of ##alpha-Syn positive RGCs## to traumatic injury</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11186421</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38903914</oboInOwl:hasDbXref>
        <rdfs:label>alpha-Syn positive RGCs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000740"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/0136b8a5-76d5-4c22-a962-9e0705e68919"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000740"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/0161286f-f8fc-4c3c-b179-b0dbe4f39c3a -->

    <Class rdf:about="http://example.org/0161286f-f8fc-4c3c-b179-b0dbe4f39c3a">
        <obo:IAO_0000115>Development of the trophoblastic shell and formation of placental anchoring villi. a Structure of the human trophoblastic shell and its surrounding arterial vessels. b Depiction of a placental anchoring villus, spiral artery (SA) remodelling and interaction of extravillous trophoblasts (EVTs) with different decidual cell types. dCCT distal cell column trophoblast, dMPhi decidual macrophage, DSC decidual stromal cell, eCTB endovascular cytotrophoblast, GC giant cell, iCTB interstitial cytotrophoblast, pCCT ##proximal cell column trophoblast##, pEC placental endothelial cell, pMPhi placental macrophage, pSC placental stromal/mesenchymal cell, SM smooth muscle layer, STB syncytiotrophoblast, TBS trophoblastic shell, TP trophoblast plug, TV tertiary villi, UC umbilical cord, uNK uterine NK cell, vCTB villous cytotrophoblast, YO yolk sac</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6697717</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31049600</oboInOwl:hasDbXref>
        <rdfs:label>proximal cell column trophoblast</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000351"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/0161286f-f8fc-4c3c-b179-b0dbe4f39c3a"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000351"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/0175779c-fcdd-48dc-ab6a-a97e3daef7a0 -->

    <Class rdf:about="http://example.org/0175779c-fcdd-48dc-ab6a-a97e3daef7a0">
        <obo:IAO_0000115>	Method of HSC Inhibition and Injury Model	Functional Impact of HSC Targeting	 	Shen et al. (2011)(50)	Depletion of activated HSCs with gliotoxinAPAP-induced injury in mice	Reduced aHSCs ( alpha-SMA)Significantly more necrosisMore infiltrating CD45+ cells66% decrease in ##proliferating hepatocytes##Reduced expression of genes usually up-regulated during liver regeneration (i.e., HGF and EGF)	 				 	Pintille et al. (2010)(49)	Inhibition of HSC activation with L-cysteine.2AAF/PHx injury model in rats	11.1-fold reduction of aHSCs ( desmin)Reduction in proliferating cells of all lineagesReduced oval cell response	 				 	Kalinichenko et al. (2003)(55)	Deficient HSC activation in Foxf1-depleted miceCCl4injury	- Defective HSC activation ( alpha-SMA,  col)- More severe pericentral necrosis and apoptosis- Increased mortality (seems to be somethingwrong with the table formating here - there is greater spacing between the bullet points in this row of the column and they didnt line up!)	 				 	Passino et al. (2007)(52)	Defective HSC activation in P75NTR-/- miceCrossed with plg-/- mice (spontaneously develop liver disease)	Failure of HSC activation ( alpha-SMA,  col)Reduced hepatocyte proliferation (in vivo and in vitro)2/3 reduction of HGF in liver homogenatesMore severe liver disease and reduced survival	 				 	</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7917274</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33681672</oboInOwl:hasDbXref>
        <rdfs:label>proliferating hepatocytes</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000182"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/0175779c-fcdd-48dc-ab6a-a97e3daef7a0"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000182"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/018b7619-a06c-41ff-a36e-1689e0a2642c -->

    <Class rdf:about="http://example.org/018b7619-a06c-41ff-a36e-1689e0a2642c">
        <obo:IAO_0000115>Development of the trophoblastic shell and formation of placental anchoring villi. a Structure of the human trophoblastic shell and its surrounding arterial vessels. b Depiction of a placental anchoring villus, spiral artery (SA) remodelling and interaction of extravillous trophoblasts (EVTs) with different decidual cell types. dCCT distal cell column trophoblast, dMPhi decidual macrophage, DSC decidual stromal cell, eCTB ##endovascular cytotrophoblast##, GC giant cell, iCTB interstitial cytotrophoblast, pCCT proximal cell column trophoblast, pEC placental endothelial cell, pMPhi placental macrophage, pSC placental stromal/mesenchymal cell, SM smooth muscle layer, STB syncytiotrophoblast, TBS trophoblastic shell, TP trophoblast plug, TV tertiary villi, UC umbilical cord, uNK uterine NK cell, vCTB villous cytotrophoblast, YO yolk sac</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6697717</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31049600</oboInOwl:hasDbXref>
        <rdfs:label>endovascular cytotrophoblast</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000523"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/018b7619-a06c-41ff-a36e-1689e0a2642c"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000523"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/02acb96e-e6ad-410a-85c6-73b9c580bba5 -->

    <Class rdf:about="http://example.org/02acb96e-e6ad-410a-85c6-73b9c580bba5">
        <obo:IAO_0000115>The unique multilayered structure of the skin enables an effective barrier against a relentless barrage of pathogens and insults. Anatomically, the skin comprises three consecutive layers, including the stratified epidermis, the fibroblast-rich dermis, and the dermal fat (also known as dermal white adipose tissue (##dWAT##)). Keratinocytes (KCs) are the main epidermal cell type (~95%), and the remaining epidermal cells include Langerhans cells, melanocytes, Merkel cells, and infiltrated immune cells. Dermal fibroblasts (dFBs), the major resident cell types in the dermis, are highly heterogeneous. While dFBs located in the upper (papilla) dermis support epidermal growth and regulate hair cycling, dFBs located in the lower (reticular) dermis have the potential to commit to preadipocytes (pAd) and differentiate to adipocytes, forming the last and deepest barrier of the skin, dWAT. PRR-mediated innate immune activation of these skin resident cells by PAMPs or DAMPs leads to the production of antimicrobial peptides as well as proinflammatory cytokines that recruit and activate myeloid and lymphatic immune cells, such as neutrophils, monocytes, dendritic cells, macrophages, and T lymphocytes. A proper interplay between innate and adaptive immune cells confers immediate and long-term immune protection against pathogens and insults.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6877906</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31815151</oboInOwl:hasDbXref>
        <rdfs:label>dWAT</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000448"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/02acb96e-e6ad-410a-85c6-73b9c580bba5"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000448"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/02b9e548-a366-4e9b-b8be-52e30533aa46 -->

    <Class rdf:about="http://example.org/02b9e548-a366-4e9b-b8be-52e30533aa46">
        <obo:IAO_0000115>Besides the importance of IFN-I in SjS, the calcium and Wnt pathways were identified as important regulatory molecules in the salivary gland epithelial cells (##SGECs##) in the course of SjS progression. Cell-specific epigenome-wide analysis showed that genes involved in these pathways are enriched for hypomethylation and hypermethylation at differentially methylated CpG sites (DMCs). The alteration in the DNA methylation of critical pathways provides a theoretical basis for a therapeutic target in SjS ( Table 2 ).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10950951</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38510251</oboInOwl:hasDbXref>
        <rdfs:label>SGECs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000066"/>
        <skos:relatedMatch rdf:resource="CL:0009005"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/02b9e548-a366-4e9b-b8be-52e30533aa46"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000066"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/02b9e548-a366-4e9b-b8be-52e30533aa46"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0009005"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/02f69007-0d19-40bb-b2be-3c820b320b67 -->

    <Class rdf:about="http://example.org/02f69007-0d19-40bb-b2be-3c820b320b67">
        <obo:IAO_0000115>Myeloid cell differentiation and developmental arrest are characteristics of immune dysregulation in patients with cancer. Regarding erythroid hematopoiesis, extramedullary hematopoiesis occurs during cancer and anemia. CD71+ erythroid progenitor cells (##EPCs##) are produced during the differentiation of megakaryocyte-erythrocyte progenitor cells into erythrocytes, which are a new type of immune cell that can promote the re-occurrence and development of tumors. The number of EPCs in HCC tissue is positively correlated with PVTT. In myeloid hematopoiesis, the maturation of granulocyte-monocyte progenitor cells is blocked, resulting in the accumulation of myeloid-derived suppressor cells (MDSCs). MDSCs are also associated with prognosis in HCC and are reported to induce vascular VEC migration. VEC migration may destroy the endodermis and promote PVTT. Recently, Long et al. found that tumors induced a subset of CD45+ EPCs to differentiate into a cellular &quot;erythroid-myeloid hybrid&quot; population, named erythroid-differentiated myeloid cells (EDMCs), which may present a connection between MDSCs and EPCs. Thus, EDMCs may play a critical role in PVTT development.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10465220</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37649603</oboInOwl:hasDbXref>
        <rdfs:label>EPCs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000038"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/02f69007-0d19-40bb-b2be-3c820b320b67"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000038"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/020dfd47-a62c-4eaa-8d94-f5d00954ec57 -->

    <Class rdf:about="http://example.org/020dfd47-a62c-4eaa-8d94-f5d00954ec57">
        <obo:IAO_0000115>To investigate the developmental origin of the ##CD34+PRLR+ cells##, freshly isolated CD34+ HSCs were sorted into MLP, CMP, GMP and NK/BP (Fig. 2A), and cultured as described above. PRLR-expressing cells were mainly generated from the GMP compartment (Fig. 2B-D). At day 4 of culture, FACS sorted PRLR+ progenitors lacked all lineage markers except for CD15 and CD43, further supporting their myeloid origin (Fig. 2E). Evaluation of these cells at later time points (day + 14) showed that they remain CD15+, and acquired CD11a, CD11b, CD11c, CD16, CD18, CD45RO and CD123 (Fig. 2F). To study their differentiation, we sorted CD34+PRLR+ cells from four-day expanded CD34+ HSCs (as shown in Fig. 1A). As above, in the presence of ILC promoting cytokines (IL-3, IL-7, IL-15, IL-23, SCF and FLT3L) the CD34+PRLR+ progenitors differentiate into immature myeloid cells (Fig. 3A-C). Addition of GM-CSF at later times (day + 21) resulted in the generation of mature granulocytes expressing CD15, CD16 and CD66b (Fig. 3A-C). Previously, we showed that some myeloid progenitors could give rise to CD56+ lymphocytes. However, sorted CD34+PRLR-, but not CD34+PRLR+ cells gave rise to CD56+ lymphocytes (Fig. 4A-C). Moreover, the CD34+PRLR+ progenitors do not express integrin alpha4beta7, a marker that defines innate lymphoid precursors with the potential to develop into ILCs (Fig. 4C). In further support of these findings, the CD34+PRLR+ progenitors do not differentiate into CD94+, CD127+ and CD336+ lymphocytes (Fig. 4D). Collectively, these findings show that CD34+PRLR+ progenitors develop from the GMPs under the influence of SCF and FLT3L, thereby acquire various myeloid markers and seem to lack lymphoid potential.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7156717</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32286456</oboInOwl:hasDbXref>
        <rdfs:label>CD34+PRLR+ cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0001059"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/020dfd47-a62c-4eaa-8d94-f5d00954ec57"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0001059"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/0241cbbd-4fe4-4087-ab7b-45475a72ad83 -->

    <Class rdf:about="http://example.org/0241cbbd-4fe4-4087-ab7b-45475a72ad83">
        <obo:IAO_0000115>The trajectory to bone marrow adipocytes is now becoming clearer. The remaining task is to clarify if there are discrete precursor cell populations that contribute to two types of BMATs. It is possible that bone marrow adipocytes of &quot;regulated&quot; rBMAT are also contributed to by an alternative bone-specific pathway originating from preosteoblasts, although this pathway has been demonstrated so far only in extreme adipocyte scarcity in lipodystrophic fat-free mice. Clarifying further cellular origins of bone marrow adipocytes of cBMAT and rBMAT will give us the opportunity to clarify the formation and the disappearance of ##marrow adipocytes## in normal development, pathological conditions and therapeutic responses. These future endeavors will lead to a more detailed understanding of the function of bone marrow adipocytes that have incredibly diverse functions through local and systemic regulations.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9075612</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35528017</oboInOwl:hasDbXref>
        <rdfs:label>marrow adipocytes</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000136"/>
        <skos:relatedMatch rdf:resource="CL:0002092"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/0241cbbd-4fe4-4087-ab7b-45475a72ad83"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000136"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/0241cbbd-4fe4-4087-ab7b-45475a72ad83"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002092"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/02533e32-1003-4b8e-9c10-2ab577b9f318 -->

    <Class rdf:about="http://example.org/02533e32-1003-4b8e-9c10-2ab577b9f318">
        <obo:IAO_0000115>A, B, tSNE plot of 4659 CD45+ immune cells from the CNS. Data from this study is integrated with data from; Table 6). C, D, Each dataset represented by one tSNE. Cells are annotated using color representing their cell type. bMicroglia: baseline microglia; aMicroglia: activated microglia; ##pmMicroglia##: proliferation-mediating microglia; maMicroglia: monocyte-activating microglia; DAM: disease-associated microglia in SCI; elMicroglia: embryonic-like microglia; pvMacrophages: perivascular macrophages; mdMacrophages: monocyte-derived macrophages; DCs: dendritic cells; imB-cells: immature B-cells; mB-cells: mature B-cells; pimMicroglia: postnatal immature microglia; IEG+Microglia: immediate early genes microglia; sMicroglia: s-phase microglia; pPAM: postnatal proliferative-region-associated microglia; eMicroglia: embryonic microglia; pcpMacrophages: postnatal choroid plexus macrophages; acpMacrophages: adult choroid plexus macrophages; iMonocytes: inflammatory monocytes; pMonocytes: patrolling monocytes; cpEpithelial cells: choroid plexus epithelial cells. E, tSNE plots of 4659 CD45+ immune cells for selected genes indicating the log2(cpm) expression with a continuous color for each cell separately. F, Proliferation rate of CD45low and CD45high cells at 7 and 21 d post-SCI. Hoechst 33342 expression presented on a log-scale was used for defining cells in S-phase. Right most plot reports the percentage of cells in S-phase. Each dot represents one biological replicate (four mice per time point). Mean is surrounded by a 95% CI. This figure is extended in Extended Data Figure 8-1.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8496189</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34417326</oboInOwl:hasDbXref>
        <rdfs:label>pmMicroglia</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002629"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/02533e32-1003-4b8e-9c10-2ab577b9f318"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002629"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/02904b08-33f7-44d1-bdc3-7e2e4ffc4ee5 -->

    <Class rdf:about="http://example.org/02904b08-33f7-44d1-bdc3-7e2e4ffc4ee5">
        <obo:IAO_0000115>In this integrated space, we performed graph-based clustering and visualization with UMAP (Uniform Manifold Approximation and Projection). We identified 9 major cell-type clusters (Fig. 1e) present in all six tissues (Fig. 1f) and diseases (Additional file 2: Figure S2b). We labeled the clusters with canonical markers (Fig. 1g, Additional file 3: Table S2): CD3D+ T cells, NCAM1+ NK cells, MS4A1+ B cells, MZB1+ plasma cells, ##FCGR3A+/CD14+ macrophages##, CD1C+ dendritic cells (DCs), TPSAB1+ mast cells, and MKI67+ cycling T and B cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8057009</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33879239</oboInOwl:hasDbXref>
        <rdfs:label>FCGR3A+/CD14+ macrophages</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000863"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/02904b08-33f7-44d1-bdc3-7e2e4ffc4ee5"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000863"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/03bbddd9-996a-4b4f-925f-6304794fcdc9 -->

    <Class rdf:about="http://example.org/03bbddd9-996a-4b4f-925f-6304794fcdc9">
        <obo:IAO_0000115> (A-C) ADT is associated with greater distance to ##cytotoxic T lymphocytes## from epithelial cells. (D, E) ADT is associated with less cytotoxic T lymphocytes engaged epithelial cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9729332</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36506053</oboInOwl:hasDbXref>
        <rdfs:label>cytotoxic T lymphocytes</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000910"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/03bbddd9-996a-4b4f-925f-6304794fcdc9"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000910"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/032cc2c8-0977-410e-9344-081dd443413a -->

    <Class rdf:about="http://example.org/032cc2c8-0977-410e-9344-081dd443413a">
        <obo:IAO_0000115>Specifically, we show here that PLZF-defined spermatogonia, though retaining PLZF-positivity, are transcriptionally distinct at PND6 compared to later developmental time points. These transcriptional dynamics are also reflected by distinct differences at the protein level, with proteins such ASRGL1 being localized strongly in PLZF+ spermatogonia during the first weeks of life, but decreasing in expression in these cells around three weeks of age (Fig 8). Similarly, we show that ##Prophase I spermatocytes## possess significant transcriptional differences in the first-wave compared to subsequent spermatogenic waves, with hundreds of differentially expressed genes across multiple regulatory pathways. Furthermore, direct inspection of pachytene spermatocytes from the first wave at PND13 to later spermatogenic waves reveals that, like spermatogonia, transcript dynamics are also reflected at the protein level. For example, proteins such as DMRTB1 are found only in the nuclei of first-wave leptotene spermatocytes as they transition from differentiated spermatogonia into the meiotic program, but not in spermatocytes from older mice (Fig 10). By contrast, other proteins such as ASRGL1 are in low abundance in early first-wave spermatocytes, but become more strongly immunolocalized in spermatocytes at increasing ages (Fig 9).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6443194</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:30893341</oboInOwl:hasDbXref>
        <rdfs:label>Prophase I spermatocytes</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000656"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/032cc2c8-0977-410e-9344-081dd443413a"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000656"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/0334a0cb-2ec4-4c7d-8116-31a19d7a9af3 -->

    <Class rdf:about="http://example.org/0334a0cb-2ec4-4c7d-8116-31a19d7a9af3">
        <obo:IAO_0000115>The unwounded, normal corneal stroma is a relatively simple, avascular tissue populated with quiescent keratocytes, along with corneal nerves and a few resident dendritic and monocyte/macrophage cells. In the past, the resting keratocytes were thought of as a homogenous cellular population, but recent work has shown local variations in vimentin and nestin expression, and responsiveness to transforming growth factor (TGF)-beta1. Studies have also supported there being &quot;stromal stem cells&quot; in localized areas. After corneal wounding, depending on the site and severity of injury, profound changes in stromal cellularity occur. Anterior or posterior injuries to the epithelium or endothelium, respectively, trigger apoptosis of adjacent keratocytes. Many contiguous keratocytes transition to keratocan-negative corneal fibroblasts that are proliferative and produce limited amounts of disorganized extracellular matrix components. Simultaneously, large numbers of bone marrow-derived cells, including monocytes, neutrophils, fibrocytes and lymphocytes, invade the stroma from the limbal blood vessels. Ongoing adequate levels of TGFbeta1, TGFbeta2 and platelet-derived growth factor (PDGF) from epithelium, tears, endothelium and aqueous humor that penetrate defective or absent epithelial barrier function (EBF) and epithelial basement membrane (EBM) and/or Descemet&apos;s basement membrane (DBM) drive corneal fibroblasts and fibrocytes to differentiate into alpha-smooth muscle actin (SMA)-positive myofibroblasts. If the EBF, EBM and/or DBM are repaired or replaced in a timely manner, typically measured in weeks, then ##corneal fibroblast## and fibrocyte progeny, deprived of requisite levels of TGFbeta1 and TGFbeta2, undergo apoptosis or revert to their precursor cell-types. If the EBF, EBM and/or DBM are not repaired or replaced, stromal levels of TGFbeta1 and TGFbeta2 remain elevated, and mature myofibroblasts are generated from corneal fibroblasts and fibrocyte precursors that produce prodigious amounts of disordered extracellular matrix materials associated with scarring fibrosis. This fibrotic stromal matrix persists, at least until the EBF, EBM and/or DBM are regenerated or replaced, and keratocytes remove and reorganize the affected stromal matrix.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7855915</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33068626</oboInOwl:hasDbXref>
        <rdfs:label>corneal fibroblast</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002363"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/0334a0cb-2ec4-4c7d-8116-31a19d7a9af3"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002363"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/034f5d4c-aa01-43c7-884f-3137e393db7a -->

    <Class rdf:about="http://example.org/034f5d4c-aa01-43c7-884f-3137e393db7a">
        <obo:IAO_0000115>Compared with widely used high-throughput approaches that primarily involve viral vector-mediated gene transfer with uncontrollable randomness in cell targeting, 2-SPARSE has a unique advantage in that it enables precisely targeted labelling of single, functionally defined neurons after functional population imaging (Fig. 1). This precision is particularly useful when the functionally defined neurons in a specific brain region are sparse in number but exhibit wide spatial distribution and are intermingled with other neurons in the same region. In recent decades, many such neuronal types have been identified across multiple brain regions. For example, feature-specific neurons have been identified in the AUD and visual cortex for processing of sensory information; place cells and grid cells have been identified in the hippocampus and the entorhinal cortex that participate in spatial navigation; engram cells have been identified in the hippocampus and cortex for memory processing, and ##holistic bursting cells## have been identified in the AUD for complex sound encoding. These types of functionally defined cells constitute just a small proportion of the neuronal population in specific brain regions (e.g., grid cells, ~20%; engram cells, ~4%; and holistic bursting cells, ~5%) and are inevitably spatially intermingled. Moreover, these functional neuron types largely lack known molecular markers. Thus, molecular approaches alone are frequently limited in their potential application for mapping between functional and morphological features. In this case, 2-SPARSE not only provides an ideal solution for acquiring precise data but can also serve as an annotation reference for benchmarking and calibration of high-throughput population mapping methods used to correlate functional and morphological features of neurons.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8940919</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35318336</oboInOwl:hasDbXref>
        <rdfs:label>holistic bursting cells</rdfs:label>
    </Class>
    


    <!-- http://example.org/035acee5-905b-401f-bd44-7d9a4c025534 -->

    <Class rdf:about="http://example.org/035acee5-905b-401f-bd44-7d9a4c025534">
        <obo:IAO_0000115>Our results indicated that immune cell composition and immune-related genes in the tumors differed between the high-risk and low-risk groups. Accordingly, we evaluated the relationship between glycolysis and immune cell infiltration. We uploaded the entire cohort&apos;s transcriptome data to ImmuCellAI to analyze each group&apos;s immune cell composition (Fig. 5B). In total, 13 of 24 immune cell types differed between the groups, including naive CD4 T cells, naive CD8 T cells, cytotoxic T cells, exhausted T cells, inducible regulatory T cells (iTreg), helper T cells 1 (Th1), follicular helper T cells (Tfh), central memory T cells (##Tcm##), mucosal-associated invariant T cells (MAIT), DCs, Macrophages, Neutrophils, and gamma delta T cells (gammadelta T) (Fig. 5C). Correlations between the expression levels of the eight risk genes and immune cell components were also evaluated (Additional file 2: Table S3). The expression of ARTN was related to cellular components, including neutral and central_ memory, Gamma_ delta, Tr1, B_ Cell, and Tfh. Moreover, the risk score negatively correlated with the immune infiltration score (R = - 0.22) (Fig. 5D).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8425093</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34496868</oboInOwl:hasDbXref>
        <rdfs:label>Tcm</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000904"/>
        <skos:relatedMatch rdf:resource="CL:0000907"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/035acee5-905b-401f-bd44-7d9a4c025534"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000904"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/035acee5-905b-401f-bd44-7d9a4c025534"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000907"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/0354505a-bd9d-4e92-b6ca-de57496a1ba4 -->

    <Class rdf:about="http://example.org/0354505a-bd9d-4e92-b6ca-de57496a1ba4">
        <obo:IAO_0000115>Ethanol withdrawal-induced adaptations in ##prefrontal corticotropin releasing factor receptor 1-expressing neurons## regulate anxiety and conditioned rewarding effects of ethanol</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9708587</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35668157</oboInOwl:hasDbXref>
        <rdfs:label>prefrontal corticotropin releasing factor receptor 1-expressing neurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000540"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/0354505a-bd9d-4e92-b6ca-de57496a1ba4"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000540"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/0385215b-c2a1-422e-bbf8-d5d05e4eed3b -->

    <Class rdf:about="http://example.org/0385215b-c2a1-422e-bbf8-d5d05e4eed3b">
        <obo:IAO_0000115>Macrophages have been shown to play a key role in regulating HSC quiescence and retention in the BM. DRAC+ macrophages have been shown to regulate HSC quiescence through the activation of the TGFbeta1-Smad3 pathway downstream of CD82/KAI1. CD82/KAI1 is predominantly expressed in LT-HSCs, and when knocked out, HSC proliferation increases. Depletion of ##DRAC (CD82/KAI1-binding partner) expressing macrophages## leads to a reduction of CD82/KAI1 levels in HSCs, increased proliferation, and differentiation. CD169+ macrophages constitute another example of cells regulating HSC retention in the BM. In CD169-iDTR mice, it has been shown that the depletion of CD169+ macrophages after DTR treatment causes an increase of HSCs and progenitor cells in peripheral blood. Ablation of CD169+ macrophages in CD169-iDTR mice upon DTR administration significantly reduced not only the HSC number in the BM but also the HSC, LSK, and GMP frequencies in the spleen. In line with their function in the BM, macrophages are also responsible for the retention of HSCs into the spleen, selectively through VCAM1-mediated signaling. Knockdown of VCAM1 expression in macrophages, using siRNA targeting VCAM-1 within macrophage-avid lipidic nanoparticles, causes reduced retention of splenic HSCs, LSKs, and GMPs, without affecting HSC retention into the BM.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8631970</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34858399</oboInOwl:hasDbXref>
        <rdfs:label>DRAC (CD82/KAI1-binding partner) expressing macrophages</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/0385215b-c2a1-422e-bbf8-d5d05e4eed3b"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/03946271-2e8c-49bd-b26e-eb3eddb7231e -->

    <Class rdf:about="http://example.org/03946271-2e8c-49bd-b26e-eb3eddb7231e">
        <obo:IAO_0000115>Different pathogenesis of HCC involving viral and non-viral etiology is related to the unique TIME. Chronic infection with hepatitis B virus (HBV) promotes the formation of a tolerant TIME by depletion of the effector CD8+ T cells and attracting immunosuppressive cells including granulomatous myeloid-derived suppressor cells (##gMDSCs##), Tregs, or regulatory B (Breg) cells. Chronic infection by hepatitis C virus (HCV) depletes CD8+ T cells and promotes immune evasion through spontaneous viral escape and dysregulation of major histocompatibility complex I (MHC I) dependent antigen presentation. In alcoholic steatohepatitis (ASH), alcohol promotes the inhibition of liver immune response by increasing the abundance of M2 TAMs, inhibiting CD8+ T cell activation, and facilitating gMDSC infiltration. In contrast, non-alcoholic steatohepatitis (NASH) activates dysfunctional immune cells, including helper T cell 17 (Th17) cells, natural killer T (NKT) cells, CD8+/PD-1+ T cells and IgA+ plasma cells, disrupting tumor immune surveillance and inducing HCC.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11639598</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:39641225</oboInOwl:hasDbXref>
        <rdfs:label>gMDSCs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000094"/>
        <skos:relatedMatch rdf:resource="CL:0000889"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/03946271-2e8c-49bd-b26e-eb3eddb7231e"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000094"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/03946271-2e8c-49bd-b26e-eb3eddb7231e"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000889"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/0397bf07-3b61-40d8-b6f8-215314acc4de -->

    <Class rdf:about="http://example.org/0397bf07-3b61-40d8-b6f8-215314acc4de">
        <obo:IAO_0000115>Combining Seurat clustering analysis with known molecular markers for various cell types (Fig. 2B; Tables S2, S3), we segregated the single cells into 9 major cell clusters based on cell types: immune cells [Microglia, Monocyte/Macrophage, and T/NK (T cell/natural killer cell)], retinal cells [AC/HC/RGC (amacrine cell/horizontal cell/retinal ganglion cell), BC (bipolar cell), Cone, MG (Muller glia)/Astrocyte, and Rod], and vascular endothelial cells (VEC) (Fig. 2A). Comparison of control and EAU cell clusters revealed a decrease in the number of multiple neuronal types in EAU retinas, especially in the BC cluster (20.34-5.02%), Cone cluster (9.49-2.94%), and AC/HC/RGC cluster (3.76-1.28%) (Fig. 2C). In agreement, bulk RNA-seq analysis showed that in EAU retinas, there was downregulation of marker genes for all 6 retinal neuron types including rods, cones, BCs, ACs, HCs, and RGCs (Fig. 2D; S2A, B). Immunostaining analysis further validated these results. In EAU retinas, there was obvious degeneration of rhodopsin+ rod inner and outer segments (Fig. 2E), and in general, progressive loss of Arrestin+ cones, Chx10+ BCs, Tfap2a+ ACs, ##Rbpms+ RGCs##, and Calbindin+ HCs (Fig. 2F-J, L-P). By contrast, EAU did not appear to significantly alter Sox9+ Muller glia although resulting in an upregulation of their marker genes (Fig. 2K, Q). Therefore, EAU may cause not only progressive degeneration of all retinal neuron types but also a switch in the expression profile of Muller glia.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11131209</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38802924</oboInOwl:hasDbXref>
        <rdfs:label>Rbpms+ RGCs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000740"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/0397bf07-3b61-40d8-b6f8-215314acc4de"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000740"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/04b5b56f-6087-4cee-bab6-b21ffde3249d -->

    <Class rdf:about="http://example.org/04b5b56f-6087-4cee-bab6-b21ffde3249d">
        <obo:IAO_0000115>SCLC	Small-cell carcinoma	 	NSCLC	Non-small-cell carcinoma	 	ADC	Adenocarcinoma	 	SqCC	Squamous cell carcinoma	 	LCLC	Large-cell carcinoma	 	PD1	Programmed death 1	 	PDL1	Programmed death 1 ligand	 	ICI	Immune checkpoint inhibitors	 	EV	Extracellular vesicles	 	ESE	Early-sorting endosome	 	ILVs	Intraluminal vesicles	 	MVBs	Multivesicular bodies	 	ESCRT	Endosomal-sorting complex-independent transport	 	ncRNAs	Small noncoding RNAs (ncRNAs)	 	miRNAs	microRNAs	 	TME	Tumor microenvironment	 	circRNA	circular RNA	 	ECM	extracellular matrix	 	HBEC	Human bronchial epithelial cells	 	EMT	Epithelial-mesenchymal transition	 	CRC	colorectal cancer	 	DCs	dendritic cells	 	MSC	Mesenchymal stem cells	 	NK	Natural Killer	 	PBMCs	Peripheral blood mononuclear cells	 	TAMs	##Tumor-associated macrophages##	 	MDSCs	Myeloid-derived suppressor cells	 	PMN-MDSCs	Polymorphonuclear MDCs	 	M-MDSCs	Monocytic MDSCs	 	LLC	Lewis Lung carcinoma	 	M2 macrophages	Alternatively activated macrophages	 	M1 macrophages	Classically activated macrophages	 	TH1 cell	T helper 1 cell	 	Treg cell	Regulatory T cell	 	Breg cell	Regulatory B cell	 	CTLs	Cytotoxic CD8+ T cells	 	TILs	Tumor-infiltrating lymphocytes	 	Tim-3	mucin domain-3 protein	 	TIGIT	T cell immunoglobulin and ITIM domain	 	Lag-3	Lymphocyte-activation gene 3	 	CTLA4	Cytotoxic T lymphocyte antigen-4	 	TH17 cell	T helper 17 cell	 	DNT cell	Double-negative T cells	 	TRAIL	TNF-related apoptosis-inducing ligand	 	MPE	malignant pleural effusions	 	CRISPRi	clustered regularly interspaced short palindromic repeats interference	 	FAP	Fibroblast activation protein- alpha.	 	</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10616833</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37915578</oboInOwl:hasDbXref>
        <rdfs:label>Tumor-associated macrophages</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/04b5b56f-6087-4cee-bab6-b21ffde3249d"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/04285179-8edc-4008-931c-8f8311c36209 -->

    <Class rdf:about="http://example.org/04285179-8edc-4008-931c-8f8311c36209">
        <obo:IAO_0000115>Salivary glands exert exocrine secretory function to provide saliva for lubrication and protection of the oral cavity. Its epithelium consists of several differentiated cell types, including acinar, ductal and myoepithelial cells, that are maintained in a lineage-restricted manner during homeostasis or after mild injuries. Glandular regeneration following a near complete loss of ##secretory cells##, however, may involve cellular plasticity, although the mechanism and extent of such plasticity remain unclear. Here, by combining lineage-tracing experiments with a model of severe glandular injury in the mouse submandibular gland, we show that de novo formation of acini involves induction of cellular plasticity in multiple non-acinar cell populations. Fate-mapping analysis revealed that, although ductal stem cells marked by cytokeratin K14 and Axin2 undergo a multipotency switch, they do not make a significant contribution to acinar regeneration. Intriguingly, more than 80% of regenerated acini derive from differentiated cells, including myoepithelial and ductal cells, that appear to dedifferentiate to a progenitor-like state before re-differentiation into acinar cells. The potential of diverse cell populations serving as a reserve source for acini widens the therapeutic options for hyposalivation.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7561486</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32994165</oboInOwl:hasDbXref>
        <rdfs:label>secretory cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000151"/>
        <skos:relatedMatch rdf:resource="CL:1001596"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/04285179-8edc-4008-931c-8f8311c36209"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000151"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/04285179-8edc-4008-931c-8f8311c36209"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:1001596"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/043fe12c-20c5-471b-9f82-f0006cebf71c -->

    <Class rdf:about="http://example.org/043fe12c-20c5-471b-9f82-f0006cebf71c">
        <obo:IAO_0000115>The human bone tissue is a complex system that consists of diverse cell types including osteoblast/osteocyte, osteoclast, and chondrocyte (collectively known as &quot;bone cells&quot;), together with various supporting cells such as adipocyte, fibroblast, and hematopoietic cells among others. A delicate balance of bone formation/resorption is critical for maintaining bone health, and therefore bone cells must work together to maintain bone strength and mineral homeostasis. Despite the extensive study of bone cells, their underlying biology remains poorly understood. While osteoclasts are of hematopoietic origin and derived from the &quot;monocyte/macrophage-##preosteoclast##-osteoclast&quot; differentiation trajectory, the detailed origins of osteoblast/osteocyte and chondrocyte are not as well characterized.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8579438</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34803492</oboInOwl:hasDbXref>
        <rdfs:label>preosteoclast</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000778"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/043fe12c-20c5-471b-9f82-f0006cebf71c"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000778"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/0450d01e-34cb-4168-b064-87e33cf18426 -->

    <Class rdf:about="http://example.org/0450d01e-34cb-4168-b064-87e33cf18426">
        <obo:IAO_0000115>Prostate cancer (PC) is the second most common malignancy in men worldwide, and is associated with high morbidity and mortality in patients with high-risk disease. There is an urgent need to dissect the pathophysiological mechanisms of PC progression, which will enable the development of new treatment strategies. While the vast majority of research on PC has focused on malignant epithelial cells, it is evident that the tumour microenvironment (TME), comprised of extracellular matrix (ECM) and diverse cell types, plays a major role in cancer development and progression. Stromal fibroblasts, including carcinoma-associated fibroblasts (##CAFs##), are a predominant population of cells in the TME and there is convincing evidence that they actively promote progression to advanced disease. CAFs isolated from human prostatic specimens stimulate cancer cell proliferation, increase neovascularisation within the tumour and enhance epithelial-mesenchymal transition (EMT) to facilitate metastasis. CAFs communicate with each other, the other cells within the TME as well as cancer cells in a reciprocal manner via soluble mediators and paracrine signalling. Further understanding the complex signalling mechanisms underpinning tumour stroma-cancer cell interactions during PC progression will enable the identification of novel biomarkers and/or treatment strategies.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9747870</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36169805</oboInOwl:hasDbXref>
        <rdfs:label>CAFs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000057"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/0450d01e-34cb-4168-b064-87e33cf18426"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000057"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/04514c89-6957-478c-9d8d-b98a64756705 -->

    <Class rdf:about="http://example.org/04514c89-6957-478c-9d8d-b98a64756705">
        <obo:IAO_0000115>The cellular states and fates of ##shed intestinal cells##.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMID:37857731</oboInOwl:hasDbXref>
        <rdfs:label>shed intestinal cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002563"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/04514c89-6957-478c-9d8d-b98a64756705"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002563"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/046dc648-0913-4aa2-bf68-f595c2815ffd -->

    <Class rdf:about="http://example.org/046dc648-0913-4aa2-bf68-f595c2815ffd">
        <obo:IAO_0000115>Metformin has been shown to have the inhibitory effect on ##esophageal carcinoma cells##. However, few studies focused on the relationship between metformin and normal esophageal cells. Our previous experiment had confirmed the inhibitory effect of metformin on the proliferation of esophageal carcinoma cells. Based on this, we found that metformin had less antiproliferation and no antiapoptosis effects on normal esophageal epithelial cells compared with ESCC cells (Figures 1 and 2). The significantly high IC50 in HEECs indicated that HEECs have a great tolerance to metformin than EC109 cells. In other words, the therapeutic dosage of metformin on ESCC is harmless to the normal esophageal tissue. Another report also confirmed metformin marginally reduced the viability of NE3 cells, a kind of esophageal epithelial cell line, which was in line with our result.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7104266</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32258099</oboInOwl:hasDbXref>
        <rdfs:label>esophageal carcinoma cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002252"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/046dc648-0913-4aa2-bf68-f595c2815ffd"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002252"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/05efe98e-bd90-453f-a7a9-e942157cd4ce -->

    <Class rdf:about="http://example.org/05efe98e-bd90-453f-a7a9-e942157cd4ce">
        <obo:IAO_0000115>Schematic of the postnatal murine ##pituitary##. The postnatal pituitary gland consists of the Posterior Pituitary (PP) and the Anterior Pituitary (AP), the latter of which houses the anterior lobe (AL) and intermediate lobe (IL). Hormone-producing cells, resident stem cells and non-hormonal support cells such as endothelia and connective tissue are present with the AP. Melanotrophs (secreting MSH) are present uniquely within the IL, whilst Lactotrophs (PRL), Somatotrophs (GH), Thyrotrophs (TSH), Gonadotrophs (LH/FSH) and Corticotrophs (ACTH) are present within the parenchyma of the AL. Stem cells reside within the marginal zone between the IL and the AL in the AP and as epithelial clusters within the parenchyma of the AL. Vasculature is present throughout the AP. For the axes, D dorsal, V ventral, L left, R right, Ro rostral, C caudal.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9712314</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36451046</oboInOwl:hasDbXref>
        <rdfs:label>pituitary</rdfs:label>
    </Class>
    


    <!-- http://example.org/05162476-f3c5-4058-8869-e76d177223ef -->

    <Class rdf:about="http://example.org/05162476-f3c5-4058-8869-e76d177223ef">
        <obo:IAO_0000115>Identification of cell types from whole-brain cells. a UMAP plot shows the unsupervised clustering of 16,028 cells derived from mouse brain (for details, see &quot;Methods&quot;). The 15 cell types were classified by their transcriptional profiles. b Dot plot shows the expression levels of a representative cell-specific marker gene for each cell type. c UMAP plot shows the distribution of Olig2 expression. d Violin plot shows Olig2 expression across all clusters. e UMAP plot shows the distribution of GFAP expression. f Violin plot shows GFAP expression across all clusters. g A total of 3522 cells of the astrocyte subset were derived from cells in mouse brain. They were classified into Olig2(+)/GFAP(-) astrocytes (347 cells), Olig2(+)/GFAP(+) astrocytes (104 cells), Olig2(-)/GFAP(+) astrocytes (848 cells) and Olig2(-)/GFAP(-) astrocytes (2,223 cells). immNEU immature neuron, mNEU mature neuron, OPC oligodendrocyte precursor cell, immOLG ##immature oligodendrocyte##, OLG oligodendrocyte, ASC astrocyte, OEG olfactory ensheathing glia, MG microglia; MAC macrophage, EC endothelial cell, PC pericyte, EPC ependymal cell, VLMC vascular and leptomeningeal cell, ABC arachnoid barrier cell, CP cycling progenitor</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8573876</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34749773</oboInOwl:hasDbXref>
        <rdfs:label>immature oligodendrocyte</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000128"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/05162476-f3c5-4058-8869-e76d177223ef"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000128"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/052f011e-ba66-400c-a51e-25908314947e -->

    <Class rdf:about="http://example.org/052f011e-ba66-400c-a51e-25908314947e">
        <obo:IAO_0000115>While the heterogeneity of CD103+ TRMs is widely discussed in the literature, the characteristics of TRM subpopulations within the tumor or distant tissues of tumor-bearing mice are less well defined. To characterize tumoral TRMs, scRNA-seq technology provides unprecedented analytical power and allows us to dissect cells with thousands of dimensions. With the hypothesis that particular intratumoral T cells are precursors for TRM development, we extended our scRNA-seq approach to include various effector and memory T cell populations to comprehensively depict their transcriptomic program. From the tumor and distant mucosa of mice bearing established 4T1 tumors, we flow sorted distinct memory T cell populations using a strict gating strategy (Figure S3). We constructed single-cell cDNA libraries from paired intratumoral sorted TCR-beta+CD44+CD62L-CD69+CD103+ cells (TRMs), mucosal sorted TCR-beta+CD44+ CD69+CD103+ cells (distant mucosa TRMs), intratumoral TCR-beta+CD44+CD62L+CD69-CD103- cells (TCMs), and ##TCR-beta+CD44+CD62L-CD69-CD103- cells## (TEMs) (Table S2). After data processing and normalization, we performed unbiased clustering and visualized the CD8+ clusters using t-distributed stochastic neighbor embedding (t-SNE; Figure 2A). Through this unsupervised analysis, we found that all four samples could distinctly separate into multiple clusters, confirming continued heterogeneity among the single-cell subsets.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8204287</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33979626</oboInOwl:hasDbXref>
        <rdfs:label>TCR-beta+CD44+CD62L-CD69-CD103- cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000913"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/052f011e-ba66-400c-a51e-25908314947e"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000913"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/058578e1-30a0-44ed-bf84-925294b3b21d -->

    <Class rdf:about="http://example.org/058578e1-30a0-44ed-bf84-925294b3b21d">
        <obo:IAO_0000115>Within the identified cluster of pituitary endocrine cells (Fig. 4A and C), multiple subpopulations of ##PG endocrine cells## could be identified (Additional file 1: Fig. S1). Within the generated endocrine cell-specific heat-map, there were identifiable clusters of corticotrophs (129 cells, Tbx19+, Rspo3+, Tnnt1+, Pomc+), gonadotrophs (27 cells, Fshb+, Gnrhr+, Lhb+, Hpgd+), somatotrophs (388 cells, Gh+, Rxrg+, Wnt10a+, Pappa2+) lactotrophs (125 cells, Prl+, A2m+, Ramp1+, Spock1+) and melanotrophs (19 cells, Pax7+, Prrx1+, Cd24a+, Oacyl+).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10996213</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38575991</oboInOwl:hasDbXref>
        <rdfs:label>PG endocrine cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:2000004"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/058578e1-30a0-44ed-bf84-925294b3b21d"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:2000004"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/06a7c6e9-385c-42e7-8b4c-c91329cda841 -->

    <Class rdf:about="http://example.org/06a7c6e9-385c-42e7-8b4c-c91329cda841">
        <obo:IAO_0000115>Here we hypothesized that upon activation, memory CD8 T cells acquire a noncytotoxic function whereby they interact with naive CD8 T cells and alter their phenotype and activation state. To test this hypothesis, we designed an in vitro system in which human polyclonal naive CD8 T cells were co-cultured with autologous, activated memory CD8 T cell subsets. The phenotype and transcriptional profile of naive cells was analyzed at the end of the co-culture period. We report that in the presence of activated TCM or stem cell memory (TSCM) cells, a small proportion (~3%) of autologous naive CD8 T cells acquired phenotypic and transcriptional features of activated/memory CD8 T cells in an MHC class I-dependent manner, whereas a much larger proportion (~84%) transitioned to a unique activated state, hybrid between naive and activated memory. These findings imply that ##activated memory T cells## can set the activation threshold of neighboring naive T cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9243096</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35768564</oboInOwl:hasDbXref>
        <rdfs:label>activated memory T cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000813"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/06a7c6e9-385c-42e7-8b4c-c91329cda841"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000813"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/06af7548-2c55-41b2-afe6-8af34ef82c6f -->

    <Class rdf:about="http://example.org/06af7548-2c55-41b2-afe6-8af34ef82c6f">
        <obo:IAO_0000115>a-o, Subcluster spatial maps on representative sample slices for astrocytes (a), oligodendrocytes and oligodendrocyte precursor cells (b), microglia and perivascular macrophages (c), ependymal cells, choroid plexus epithelial cells and subcommissural organ hypendymal cells (d), olfactory inhibitory neurons (e), cerebellum neurons (f), telencephalon projecting inhibitory neurons (g), di- and mesencephalon excitatory neurons (h), ##glutamatergic neuroblasts## (i), non-glutamatergic neuroblasts (j), di- and mesencephalon inhibitory neurons (k), cholinergic and monoaminergic neurons (l), peptidergic neurons (m), hindbrain/spinal cord neurons (n), and vascular cells (o). Also see Methods and Supplementary Table 4.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10709140</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37758947</oboInOwl:hasDbXref>
        <rdfs:label>glutamatergic neuroblasts</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000031"/>
        <skos:relatedMatch rdf:resource="CL:0000679"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/06af7548-2c55-41b2-afe6-8af34ef82c6f"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000031"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/06af7548-2c55-41b2-afe6-8af34ef82c6f"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000679"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/06d848d7-7c55-4adf-8e8a-a4caa406e3e6 -->

    <Class rdf:about="http://example.org/06d848d7-7c55-4adf-8e8a-a4caa406e3e6">
        <obo:IAO_0000115>(A) Example flow cytometry plots for the expression of Cx3cr1GFP and TIM4 on thymic macrophages at different times during embryonic development (E14.5, E17.5), immediately after birth, at 7 days, and 6 weeks of age. (B) Frequencies of ##Timd4+Cx3cr1- (Timd4 single-positive or Timd4SP), Timd4+Cx3cr1+ (double-positive or DP), and Cx3cr1+Timd4- (Cx3cr1 single-positive or Cx3cr1SP) thymic macrophages## at the indicated time points. (C) Kinetics of the changes in different subpopulations of thymic macrophages from E14.5-6 weeks. (D) Frequencies at E15.5 and E19.5 of GFP-labeled cells among TIM4+ or TIM4- cells in Cx3cr1CreER x ROSA26LSL-GFP embryos treated with 4-OHT at E9.5. (E) Scheme of the fate-mapping experiments showing the relationship between Cx3cr1+ and Timd4+ thymic macrophages during embryonic development. E15.5 pregnant ROSA26LSL-GFP mice mated with Cx3cr1CreER males were injected with 4-hydroxytamoxifen (4-OHT) and sacrificed at E19.5. (F) Representative flow cytometry staining for TIM4 and CX3CR1 in fate-mapped GFP+ thymic macrophages at E19.5. The panel to the right is the isotype control for CX3CR1-PE staining. (G) Frequencies of TIM4+CX3CR1- cells among fate-mapped GFP+ macrophages. Data are shown as meanSEM and are from at least two independent experiments for each panel. Each symbol is an individual mouse or embryo.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9754631</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36449334</oboInOwl:hasDbXref>
        <rdfs:label>Timd4+Cx3cr1- (Timd4 single-positive or Timd4SP), Timd4+Cx3cr1+ (double-positive or DP), and Cx3cr1+Timd4- (Cx3cr1 single-positive or Cx3cr1SP) thymic macrophages</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000866"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/06d848d7-7c55-4adf-8e8a-a4caa406e3e6"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000866"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/0609497d-24a9-42c7-a6a1-6de80d681bcf -->

    <Class rdf:about="http://example.org/0609497d-24a9-42c7-a6a1-6de80d681bcf">
        <obo:IAO_0000115>Expression patterns of pCMV-SpCas9-RFP and pVMD2-SpCas9-RFP in human retinal organoids. (a) RPE characteristics of pigmentation and hexagonality were confirmed in a 3D sphere and 2D monolayer status (b) Retinal organoids express various retinal markers being appropriate to normal developmental stages. A bright-field image and fluorescent image of the human retinal organoid are displayed in pairs (c,d; e,f). (c,d) The pCMV vector expressed RFP both in the RPE and neural retina; (e,f) whereas the pVMD2 vector expressed RFP only in RPE [c,e = bright-field image; d,f = fluorescent image]. Each protein marks specific structure or cell types as follows: ZO-1: Tight junction; SOX2: Neural progenitor cell; RX: Retinal progenitor cell; CRX: Photoreceptor progenitor cell; Recoverin: ##Photoreceptor precursor cell##; CHX10: Neural retinal progenitor cell; SNCG: Retinal ganglion cell; Ki67: Proliferating cell; RxRgamma: Cone precursor cell; CRALBP: Muller glia cell; Rhodopsin: Rod photoreceptor cell; M/L opsin: M/L cone photoreceptor.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9988861</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36878916</oboInOwl:hasDbXref>
        <rdfs:label>Photoreceptor precursor cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002672"/>
        <skos:relatedMatch rdf:resource="CL:0010009"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/0609497d-24a9-42c7-a6a1-6de80d681bcf"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002672"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/0609497d-24a9-42c7-a6a1-6de80d681bcf"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0010009"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/061476a3-0599-41d8-abd1-36fd5842dd99 -->

    <Class rdf:about="http://example.org/061476a3-0599-41d8-abd1-36fd5842dd99">
        <obo:IAO_0000115>aRGC, apical radial glial cell; bRGC, basal radial glial cell; IPC, ##intermediate progenitor cell##; ISVZ, inner subventricular zone; NSPC, neural stem and progenitor cell; OSVZ, outer subventricular zone; RGC, radial glial cell; SVZ, subventricular zone; VZ, ventricular zone</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6816450</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31681469</oboInOwl:hasDbXref>
        <rdfs:label>intermediate progenitor cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0011026"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/061476a3-0599-41d8-abd1-36fd5842dd99"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0011026"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/064164aa-8705-4ef4-89f4-e25f72b92109 -->

    <Class rdf:about="http://example.org/064164aa-8705-4ef4-89f4-e25f72b92109">
        <obo:IAO_0000115>Postnatal development of the organ of Corti. The postnatal development is shown in this colour-coded illustration: brown = Kolliker&apos;s organ, pink = inner phalangeal cell, dark blue = inner hair cell, orange = inner pillar cell, green = outer pillar cell, light grey = Deiters&apos; cells, yellow = outer hair cells, cyan = Hensen&apos;s cells, red = tectal cells, dark grey = Bottcher and Claudius cells. a P1; In newborn mice, the organ of Corti presents itself as an epithelium of columnar cells. There are no extracellular spaces. b P7; The Corti tunnel initially opens basally between the inner and outer pillared cells. c P14; The Corti tunnel has reached its full size. During the entire development, the cells increase only slightly in height. ##Cells of Kolliker&apos;s organ## have gradually transformed into cuboidal cells of the inner sulcus and are no longer part of the cortical organ</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7723944</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32712744</oboInOwl:hasDbXref>
        <rdfs:label>Cells of Kolliker&apos;s organ</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002490"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/064164aa-8705-4ef4-89f4-e25f72b92109"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002490"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/06422ee6-2987-4cd0-8d46-95e110912e19 -->

    <Class rdf:about="http://example.org/06422ee6-2987-4cd0-8d46-95e110912e19">
        <obo:IAO_0000115>Known signalling mechanisms that contribute to mammalian digit tip regeneration. Indicated are the signalling mechanisms that originate from the nail organ (1), from the wound epidermis (2), within the blastema (3) and from nerves (4). During distal digit tip amputation the wound site is covered by regenerating nail epithelial cells that arise from the nail stem cells (##NSCs##). This epithelium activates Wnt signalling that promotes differentiation of NSCs that give rise to the nail plate. Additionally, through epithelial-mesenchymal (EM) interactions, this Wnt signalling promotes blastema innervation, which in turn enables FGF2 expression in the nail epithelium and promotes blastema cell proliferation. Blastema cell migration is stimulated by the cytokine SDF-1alpha that is expressed by the wound epidermis while the reciprocal receptors CXCR4/7 are detected on blastema cells, together with BMPs and the anti-angiogenic factor Pedf. Schwann cell precursors that arise from injured peripheral nerves migrate into the blastema and secrete growth factors including oncostatin M (OSM) and platelet derived growth factor AA (PDGFAA) that promote blastema proliferation. Nerves are shown in blue; the wound epidermis is indicated in green; the blastema is indicated by the red-hatched line; the nail epithelium is indicated in blue and the nail plate is coloured grey.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7536070</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32993414</oboInOwl:hasDbXref>
        <rdfs:label>NSCs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000034"/>
        <skos:relatedMatch rdf:resource="CL:4033056"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/06422ee6-2987-4cd0-8d46-95e110912e19"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000034"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/06422ee6-2987-4cd0-8d46-95e110912e19"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4033056"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/06454dfe-f64e-41f1-9d1b-573a75321232 -->

    <Class rdf:about="http://example.org/06454dfe-f64e-41f1-9d1b-573a75321232">
        <obo:IAO_0000115>Overview of interactions among chondrocyte subtypes. (A,B) Total number and intensity of interactions in chondrocytes. (C-J) Interactions between different subtypes of chondrocytes. (C) indicates undefined cell subtypes, (D) indicates ##ECs##, (E) indicates FCs, (F) indicates HomCs, (G) indicates HTCs, (H) indicates preHTCs, (I) indicates ProCs, and (J) indicates RegCs.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10475121</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37660146</oboInOwl:hasDbXref>
        <rdfs:label>ECs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000138"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/06454dfe-f64e-41f1-9d1b-573a75321232"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000138"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/06482148-ada5-4fc6-a86a-b606b9134b11 -->

    <Class rdf:about="http://example.org/06482148-ada5-4fc6-a86a-b606b9134b11">
        <obo:IAO_0000115>Cibersortx identified immune cell infiltration patterns and distinct profiles across three disease subtypes. In disease subtype 1, there was elevated expression of DC cells (Dendritic cells), eosinophils, and neutrophils. Disease subtype 2 exhibited increased expression of plasma cells, macrophages, and resting mast cells. Disease subtype 3 demonstrated heightened expression of CD4 (Clusters of differentiation 4) memory-activated T cells and ##activated mast cells##. Interestingly, regulatory T cells (Tregs) consistently displayed significant downregulation across all three disease subtypes. These variations may play pivotal roles in immune system modulation and contribute to the underlying mechanisms of these diseases (Figure 9A).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11121097</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38791423</oboInOwl:hasDbXref>
        <rdfs:label>activated mast cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000097"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/06482148-ada5-4fc6-a86a-b606b9134b11"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000097"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/06793c4f-531c-4bc6-b344-316c83771ad1 -->

    <Class rdf:about="http://example.org/06793c4f-531c-4bc6-b344-316c83771ad1">
        <obo:IAO_0000115>We first evaluated the performance of RegionalST using simulated spatial transcriptomics datasets, which were generated based on a real scRNA-seq dataset with Dirichlet-distributed cellular compositions and fully defined cell type-specific differential genes in the single-cell references (Details refer to Supplementary Section S2). The simulated dataset consisted of four cell types, CD4 T helper cells, B cells, CD14 monocytes, and ##CD56 NK cells##, with each spot containing 20 individual cells. When combining the single cell to spot level gene expression profiles, we randomly selected 500 genes in the first cell type and 300 genes in the second cell type as DEGs. To generate single-cell gene expression data of the DEGs, we imposed fold changes on the cells from the case group.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11026142</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38579257</oboInOwl:hasDbXref>
        <rdfs:label>CD56 NK cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000938"/>
        <skos:relatedMatch rdf:resource="CL:0000939"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/06793c4f-531c-4bc6-b344-316c83771ad1"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000938"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/06793c4f-531c-4bc6-b344-316c83771ad1"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000939"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/069cc581-5e38-434a-880d-52868e67b9f4 -->

    <Class rdf:about="http://example.org/069cc581-5e38-434a-880d-52868e67b9f4">
        <obo:IAO_0000115>Expression profiles of necroptosis-related biomarkers in the scRNA-seq data. A dimension reduction plot (A) and boxplot (B) showing the profiles of EGF expression in different cell types. The expression levels of PAG1 in scRNA-seq data as shown as a dimension reduction plot (C) and boxplot (D). ZFP36 expression profile in different types of cells in the GSE131882 as shown in a dimension reduction plot (E) and boxplot (F). (Wilcoxon&apos;s test; *p&lt;0.05; **p&lt;0.01; ***p&lt;0.001). Abbreviations: ##LOH##, loop of Henle cell; CD-ICA, collecting duct type A intercalated cell; CT, connecting tubule cell; PEC, parietal epithelial cell; CD-ICB, collecting duct type B intercalated cell; PST, proximal straight tubule cell; DCT, distal convoluted tubule cell; PODO, podocyte cell; ENDO, endothelium cell; PCT, proximal convoluted tubule cell; FIB, fibroblast cell; MES, mesangial cell; LEUK, leukocyte cell; DN: diabetic nephropathy; UMAP: uniform manifold approximation and projection.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10713428</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37988198</oboInOwl:hasDbXref>
        <rdfs:label>LOH</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:1000909"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/069cc581-5e38-434a-880d-52868e67b9f4"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:1000909"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/07a7c51e-e730-4941-b821-9c57e1be02be -->

    <Class rdf:about="http://example.org/07a7c51e-e730-4941-b821-9c57e1be02be">
        <obo:IAO_0000115>Transcriptional signature of pancreas infiltrating and circulating CD4+ and CD8+ T cell subsets at disease onset. (A) UMAP plot of CD4+ and CD8+ T cells from peripheral blood and pancreas of new-onset diabetic NOD mice. (B) Feature plots depicting gene expression levels of distinct markers driving CD4+ and CD8+ T cell activation states. (C, D) UMAP plot of CD4+ (C) and CD8+ (D) T cells grouped by the annotation in A (left) and grouped by T cell subset classified based on the expression of Cd44 and Sell (right). ##EM## = effector memory (Cd44+Sell-), CM = central memory (Cd44+Sell+), naive (Cd44-Sell+), and CD44low CD62L- (Cd44-Sell-). (E, F) Heatmap depicting row-based z-scores of scaled gene expression levels for marker genes driving T cell heterogeneity across the distinct CD4+ (E) and CD8+ (F) T cell subsets. (G, H) Trajectory of CD4+ (G) and CD8+ (H) naive, CD44low CD62L-, effector memory (EM), and central memory (CM) T cell subsets projected onto the UMAP plot (top). Violin plots depicting the pseudotime of CD4+ (G) and CD8+ (H) T cells per subset (bottom). Each dot represents a single cell. (I, J) Differentially expressed genes of CD4+ Cd44-Sell- (I) and CD8+ Cd44-Sell- (J) T cells between peripheral blood and pancreas.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10667927</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38027120</oboInOwl:hasDbXref>
        <rdfs:label>EM</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000905"/>
        <skos:relatedMatch rdf:resource="CL:0000913"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/07a7c51e-e730-4941-b821-9c57e1be02be"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000905"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/07a7c51e-e730-4941-b821-9c57e1be02be"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000913"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/07abde0a-6dbc-4bed-ace5-28025a792f8b -->

    <Class rdf:about="http://example.org/07abde0a-6dbc-4bed-ace5-28025a792f8b">
        <obo:IAO_0000115>(A) Diagram describing the human hematopoietic population hierarchy: long-term hematopoietic stem cell (LT-HSC), short-term hematopoietic stem cell (ST-HSC), multipotent progenitor (MPP), ##lymphomyeloid-primed progenitor## (LMPP), common lymphoid progenitor (CLP), common myeloid progenitor (CMP), granulocyte monocyte progenitor (GMP), and megakaryocytic-erythroid progenitor (MEP). Immunophenotypic markers for each subpopulation were adapted from.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7487781</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32877675</oboInOwl:hasDbXref>
        <rdfs:label>lymphomyeloid-primed progenitor</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000936"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/07abde0a-6dbc-4bed-ace5-28025a792f8b"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000936"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/07bde1ea-d228-490f-8931-1df53a37f291 -->

    <Class rdf:about="http://example.org/07bde1ea-d228-490f-8931-1df53a37f291">
        <obo:IAO_0000115>Based on improved knowledge of human B cell populations derived from recent studies, we sought to characterize the B cell precursors of IgE ASC through a combination of phenotypic, BCR repertoire and molecular analyses. Our experimental model was based on the hypothesis that the study of nasal polyps (NP), would provide a rich environment for ongoing IgE ASC differentiation from different cellular precursors in the absence of GC. In keeping with this model, we identified a novel human EF mucosal B cell population (CD19+IgD+CD27-) as the origin of mucosal IgE ASC. This population shared many of the phenotypic and transcriptional features of activated naive B cells recently shown in the EF response of patients with active autoimmune disease and severe SARS-CoV-2 infection. These ##mucosal IgD+ B cells## are characterized by: (1) a high degree of clonal connectivity with IgE ASC, (2) an activated phenotype (CD11c+CD86+CD71+Nur77+CD21-), (3) a progressive transcriptome between resting blood naive B cells and NP ASC, and (4) the highest level of germline epsilon transcripts. Notably, the majority of the IgD+ NP B cells expressed IgM sequences with low mutation rates, a profile consistent with activated naive B cells. However, IgD+ NP B cells also contained a smaller fraction of cells with very high rates of somatic hypermutation previously demonstrated in class-switched IgD-only B cells (IgD+IgM-; Cdelta-CS), reported in the literature within either GC, memory and ASC populations. Interestingly, the analysis of single cell IgE ASC demonstrated lower mutation relative to ASC of other isotypes including IgG, IgA, or the highly mutated IgD ASC. In summary, human mucosal IgE ASC originate from an EF mucosal activated IgD+ B cell subset in patients with atopic and non-atopic airways disease.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8160425</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34050324</oboInOwl:hasDbXref>
        <rdfs:label>mucosal IgD+ B cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000236"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/07bde1ea-d228-490f-8931-1df53a37f291"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000236"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/07c34d34-dd7b-4a50-8f8c-2b088fe87163 -->

    <Class rdf:about="http://example.org/07c34d34-dd7b-4a50-8f8c-2b088fe87163">
        <obo:IAO_0000115>Last, we investigated whether the human materno-fetal immune system in HIS mice was functional. Human decidua and splenic CD4+CD25+ Treg cells were purified from pregnant HIS mice and incubated with the CFSE-labeled human CD45+CD25- splenic cells (responder cells from pregnant HIS mice) in the presence of 30 Gy irradiated BALB/c mouse splenic cells (stimulator). The proliferation of responder cells was quantified 4 days later using FCM. Proliferation of maternal human splenic CD4+ effector T cells after stimulation with paternally (BALB/c) derived antigen reflects the presence of fetal reactive human maternal T cells (Figure 5A). STreg cells were capable of suppressing Tconv cells at 1:2 ratio (Treg/Tconv) (Supplemental Figure 11). However, under a low Treg/Tconv ratio (1:16) condition, the maternal versus fetal T cell reactions (MvFRs) of maternal T cells were significantly inhibited by ##dTreg## but not by sTreg cells (or were only minimally suppressed; Figure 5A).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11529984</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:39435662</oboInOwl:hasDbXref>
        <rdfs:label>dTreg</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000815"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/07c34d34-dd7b-4a50-8f8c-2b088fe87163"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000815"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/072b4955-680a-457d-a6ff-3e0e97a52cf2 -->

    <Class rdf:about="http://example.org/072b4955-680a-457d-a6ff-3e0e97a52cf2">
        <obo:IAO_0000115>##BST-1hi TPECs## Function as the Exit Site for Mature Thymocytes, While BST-1lo/- TPECs Serve as the Entry Sites for HPCs</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8281811</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34276703</oboInOwl:hasDbXref>
        <rdfs:label>BST-1hi TPECs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0009070"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/072b4955-680a-457d-a6ff-3e0e97a52cf2"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0009070"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/0727273e-80f2-4d4c-a40e-83732faad7cd -->

    <Class rdf:about="http://example.org/0727273e-80f2-4d4c-a40e-83732faad7cd">
        <obo:IAO_0000115>Due to microfluidic channel limitations on the 10x Genomics platform, only oocytes with a diameter less than 50 microm could be obtained. To determine the oocyte stage, previously reported stage-specific markers, including LMOD3 and FOS for primordial oocytes, RPS4X and FIGLA for primary oocytes, SYT5, STK26 and TAF1A for secondary oocytes, UBOX5 and CCDC25 for ##antral oocytes##, and HTRA3 and NBPF12 for preovulatory oocytes, were analyzed. scRNA-seq results indicated high expression of LMOD3, FOS, RPS4X and FIGLA in these oocytes, suggesting that they were at the primordial or primary stage (Extended Data Fig. 4a).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11031396</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38594460</oboInOwl:hasDbXref>
        <rdfs:label>antral oocytes</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000655"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/0727273e-80f2-4d4c-a40e-83732faad7cd"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000655"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/076149c9-c269-467b-b360-e42420cad8e5 -->

    <Class rdf:about="http://example.org/076149c9-c269-467b-b360-e42420cad8e5">
        <obo:IAO_0000115>Schematic of the postnatal murine pituitary. The postnatal pituitary gland consists of the Posterior Pituitary (PP) and the Anterior Pituitary (AP), the latter of which houses the anterior lobe (AL) and intermediate lobe (IL). Hormone-producing cells, resident stem cells and non-hormonal support cells such as endothelia and ##connective tissue## are present with the AP. Melanotrophs (secreting MSH) are present uniquely within the IL, whilst Lactotrophs (PRL), Somatotrophs (GH), Thyrotrophs (TSH), Gonadotrophs (LH/FSH) and Corticotrophs (ACTH) are present within the parenchyma of the AL. Stem cells reside within the marginal zone between the IL and the AL in the AP and as epithelial clusters within the parenchyma of the AL. Vasculature is present throughout the AP. For the axes, D dorsal, V ventral, L left, R right, Ro rostral, C caudal.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9712314</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36451046</oboInOwl:hasDbXref>
        <rdfs:label>connective tissue</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:2000004"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/076149c9-c269-467b-b360-e42420cad8e5"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:2000004"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/0771d229-d002-4958-8a6f-34243f49d5c1 -->

    <Class rdf:about="http://example.org/0771d229-d002-4958-8a6f-34243f49d5c1">
        <obo:IAO_0000115>(A-C) Representative responses to cholinergic agonist (carbachol, 10 muM) by ##small (L-cells)## (A), D-stellate (B), tuberculoventral (TV) cells (C). Small cells were activated by carbachol. D-stellate and TV cells failed to respond to carbachol application. IPSCs in principal cells, bushy cells (D), and T-stellate cells (E) in the VCN were induced by carbachol application, confirming that small inhibitory neurons were local interneurons. (F, H) Time course of sIPSCs from bushy cells and T-stellate (bushy cell, tau = 7.22 +- 1.40 ms, n = 9, T-stellate, tau = 2.28 +- 0.07 ms, n = 9). (G, I) Cumulative histogram of inter-event internal under control and carbachol application. (J). Carbachol application resulted in a significant increase in sIPSCs frequency (inter-event interval, control = 280.44 +- 47.56 ms versus carbachol = 191.21 +- 28.99 ms, p&lt;0.02, t-test).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7744103</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33141020</oboInOwl:hasDbXref>
        <rdfs:label>small (L-cells)</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000122"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/0771d229-d002-4958-8a6f-34243f49d5c1"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000122"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/08ceb279-4220-427b-827d-2b32954e280b -->

    <Class rdf:about="http://example.org/08ceb279-4220-427b-827d-2b32954e280b">
        <obo:IAO_0000115>a Schematic of the experimental pipeline. Created with BioRender.com b UMAP visualization of peritoneal immune cells. c Ratio of each population in cell number. d VlnPlot of characteristic gene expressions for macrophage subpopulations. Sham sham control, ELL endometriosis-like lesions, ELL_N niclosamide administration to ELL-induced mouse, Pre-SPMs premature &quot;small&quot; peritoneal macrophages, SPMs &quot;small&quot; peritoneal macrophages, IM1-3 intermediate macrophages subtype 1-3, Timd4+ LPMs Timd4+ &quot;large&quot; peritoneal macrophages, PMs proliferating macrophages, B1a B1a cells, B1b B1b cells, B2 B2 cells, GCBs germinal-centre B cells, PBs plasma blast B cells, Cd4+ Ts Cd4+ T cells, Cd8+ Ts Cd8+ T cells, DN1 double negative T cells 1, DN2 double negative T cells 2, ##cDC1## conventional dendritic cells 1, MCs Mast cells, NTPs neutrophils.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9652344</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36369244</oboInOwl:hasDbXref>
        <rdfs:label>cDC1</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000990"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/08ceb279-4220-427b-827d-2b32954e280b"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000990"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/083bfa3e-7f32-4a92-8618-c8db985d6d95 -->

    <Class rdf:about="http://example.org/083bfa3e-7f32-4a92-8618-c8db985d6d95">
        <obo:IAO_0000115>Ontogeny and Trophic Factor Sensitivity of ##Gastrointestinal Projecting Vagal Sensory Cell## Types</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10124152</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36973009</oboInOwl:hasDbXref>
        <rdfs:label>Gastrointestinal Projecting Vagal Sensory Cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000101"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/083bfa3e-7f32-4a92-8618-c8db985d6d95"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000101"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/084934d7-78bc-48e9-bcdb-674bfb8c0214 -->

    <Class rdf:about="http://example.org/084934d7-78bc-48e9-bcdb-674bfb8c0214">
        <obo:IAO_0000115>Development of the trophoblastic shell and formation of placental anchoring villi. a Structure of the human trophoblastic shell and its surrounding arterial vessels. b Depiction of a placental anchoring villus, spiral artery (SA) remodelling and interaction of extravillous trophoblasts (EVTs) with different decidual cell types. dCCT distal cell column trophoblast, dMPhi decidual macrophage, DSC decidual stromal cell, eCTB endovascular cytotrophoblast, GC giant cell, iCTB interstitial cytotrophoblast, ##pCCT## proximal cell column trophoblast, pEC placental endothelial cell, pMPhi placental macrophage, pSC placental stromal/mesenchymal cell, SM smooth muscle layer, STB syncytiotrophoblast, TBS trophoblastic shell, TP trophoblast plug, TV tertiary villi, UC umbilical cord, uNK uterine NK cell, vCTB villous cytotrophoblast, YO yolk sac</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6697717</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31049600</oboInOwl:hasDbXref>
        <rdfs:label>pCCT</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000351"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/084934d7-78bc-48e9-bcdb-674bfb8c0214"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000351"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/08734e2e-cf82-4c7b-8751-37ad88ba0bfa -->

    <Class rdf:about="http://example.org/08734e2e-cf82-4c7b-8751-37ad88ba0bfa">
        <obo:IAO_0000115>The first blood and immune cells arise from extra-embryonic yolk sac progenitors and for some cell types, such as macrophages or mast cells, yolk sac-derived cells can persist in tissues for extended periods of time after birth. cDCs first arise during embryogenesis in mice and humans, when they are thought to critically contribute to fetomaternal tolerance. However, the origins of cDCs in early life have not been investigated. In adults, cDCs develop downstream of hematopoietic stem cells (HSCs) from a fraction of myeloid bone marrow progenitors capable of generating plasmacytoid DCs (pDCs) and cDCs that has been termed common DC progenitor (CDP). Within CDPs in mice, expression of the C-type lectin receptor DNGR-1 (encoded by the Clec9a gene) distinguishes cDC-restricted progenitors. CDPs further differentiate into pre-cDCs, which continue to express DNGR-1, exit the bone marrow and terminally differentiate into cDC subtypes in peripheral organs and in response to environmental cues. The Clec9a promoter is also active in ##cDC1## and to a lower extent on pDCs but it is not active in cDC2 and other lymphoid or myeloid cells. By crossing mice expressing CRE-recombinase under the Clec9a promoter to Rosalox-stop-lox-yellow fluorescent protein (YFP) or Rosalox-stop-lox-TOMATO mice, we have generated mice that faithfully track cells belonging to the cDC lineage in steady state and under inflammatory conditions. Using these mice, we have found that cDC2 in adult spleen are predominantly derived from CDP/pre-cDC, which is consistent with other studies.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7815729</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33469015</oboInOwl:hasDbXref>
        <rdfs:label>cDC1</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000990"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/08734e2e-cf82-4c7b-8751-37ad88ba0bfa"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000990"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/09e9336d-12d7-4a1a-9265-c79a0ef25aa6 -->

    <Class rdf:about="http://example.org/09e9336d-12d7-4a1a-9265-c79a0ef25aa6">
        <obo:IAO_0000115>Brain transcriptional changes after MIA require microglia. (A) Simplified schematic of sample processing pipeline from and bar plots of TORCH pathogen and cytokine receptor expression (mean log counts per million) in each cell type across development. (B) Violin plot of CytoTORCH module score for each cell cluster (MG, P&lt;0.05 for ANOVA and for pairwise comparisons between microglia and all other cell types using Tukey&apos;s HST). (C) Overview of experimental design (top) and UMAP visualization of snRNAseq data from the developing somatosensory cortex of E15.5 wild-type and Csf1r-/- mice after saline or Poly(I:C) maternal injection at E12.5 (two or three embryos per condition from a total of four pregnant dams, 42,736 total cells) (bottom). Cells are colored by cell type assignment. (D) Dot plots of log(fold change) in gene expression between MIA and saline for cell types with significant changes at E15.5. DEG analysis was performed using NEBULA. AP, apical progenitors; IP, intermediate progenitors; ImmN, immature neurons, MN, migrating neurons; (UL/DL) CPN, (upper layer/deep layer) callosal projection neurons; SCPN, subcerebral projection neurons; CThPN, corticothalamic projection neurons; LIV, ##layer IV stellate neurons##; IN, interneurons; CR, Cajal-Retzius cells; Astro, astrocytes; CGC, cycling glial cells; Epend; ependymal cells; OL, oligodendroglia; MG, microglia; Peri, pericytes; EC, endothelial cells; VLMC, vascular and leptomeningeal cells. Created with .</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11190434</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38775708</oboInOwl:hasDbXref>
        <rdfs:label>layer IV stellate neurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:4030063"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/09e9336d-12d7-4a1a-9265-c79a0ef25aa6"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4030063"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/09f1392b-51dd-4492-8da7-ec6a83f6d941 -->

    <Class rdf:about="http://example.org/09f1392b-51dd-4492-8da7-ec6a83f6d941">
        <obo:IAO_0000115>The cellular content of human myocardium (in descending order by number) predominantly consists of cardiomyocytes, fibroblasts, pericytes and smooth muscle cells, endothelial cells, and immune cells. In the murine heart, macrophage populations can be discerned based on their expression of C-C chemokine receptor type 2 (CCR2), major histocompatibility complex-II (MHC-II), T cell immunoglobulin and mucin domain containing 4 (TIMD4), and Lymphatic Vessel Endothelial Hyaluronan Receptor 1 (LYVE1). Four populations of macrophages have been identified in the murine heart (Fig. 1). The minority are two subsets of CCR2+MHC-IIhigh macrophage populations derived from hematopoietic stem cells, whereas the most dominant subset, cardiac resident macrophages derived from the yolk sac, are CCR2-MHC-IIlowTIMD4+LYVE1-. There also exists a fourth subset that consists of CCR2-MHC-IIhighTIMD4+LYVE1+ macrophages, which are likely derived from CCR2-MHC-IIlow macrophages during postnatal development and partially maintained by CCR2+MHC-IIhigh macrophages. CCR2+MHC-IIhigh macrophages populate the heart soon after birth and are maintained through monocyte recruitment and proliferation. Also, under homeostasis, cardiac macrophages continually self-renew with a turnover period of almost 5 weeks. Recently, this same ##CCR2+ and CCR2- macrophage## distinction has been identified in humans, with the yolk sac-derived CCR2- human counterpart showing CD14+CD45+CD64+CCR2-HLA-DRhigh expression. In a more recent study, Tucker et al. reported two cardiac macrophage subsets within the human heart, which were positive for CD163, COLEC12, mannose receptor MRC1, E3 ubiquitin ligase MARCH1, and natural resistance-associated macrophage protein 1 (NRAMP1). Both of the identified subsets expressed anti-inflammatory (M2) polarization-associated genes, whereas one subset particularly expressed RBPJ, F13A1 and the other expressed transmembrane collagen COL23A1.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9242717</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34088222</oboInOwl:hasDbXref>
        <rdfs:label>CCR2+ and CCR2- macrophage</rdfs:label>
    </Class>
    


    <!-- http://example.org/09200fc3-78a6-4127-84d0-3d4d9eac0c08 -->

    <Class rdf:about="http://example.org/09200fc3-78a6-4127-84d0-3d4d9eac0c08">
        <obo:IAO_0000115>Our recent work demonstrating that kidney-infiltrating T cells (KITs) are functionally and transcriptionally exhausted : much like TILs or CD8+ T cells after chronic viral infection : challenges 2 paradigms. First, it argues against the idea that autoimmune destruction of parenchymal tissue is a direct effector process, akin to a response to virally infected cells. Instead, some tissues may be endowed with natural self-preservation mechanisms that downregulate or suppress ##infiltrating T cells##, which may prevent or attenuate autoimmunity. Second, it suggests that tumors do not evolve a de novo set of pathways to negatively regulate T cells. Instead, such pathways may be native to certain parenchymal tissues, and tumors may amplify them or simply naturally express them.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9089785</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35271505</oboInOwl:hasDbXref>
        <rdfs:label>infiltrating T cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000084"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/09200fc3-78a6-4127-84d0-3d4d9eac0c08"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000084"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/09400fe5-99dd-49be-b179-ae662ad80af1 -->

    <Class rdf:about="http://example.org/09400fe5-99dd-49be-b179-ae662ad80af1">
        <obo:IAO_0000115>Sequencing of CD45+ cells from 12- and 21-week-old WT and DB hindpaws generated an integrated dataset of 21,661 cells grouped into 12 clusters (Fig. 1c-f), defined as: macrophages (Pf4, C1qa, C1qc, Apoe, C1qb), type 2 conventional dendritic cells (cDC2) (CD74, H2-Aa, H2-Ab1, H2-Eb1, Mgl1), mast cells/basophils (M/B) (Mcpt2, Cma1, Cpa3, Mcpt4, Tpsb2), dermal gammadelta T (dTgammadelta) cells (Trdc, Cd163l1, Trdv4, Cxcr6, F2r), heterogeneous T (Thet) cells (Ikzf2, Ctla4, CD28, Trac, Icos), Type 2 innate lymphoid cells (ILC2) (Ctla2a, Gata3, Lmo4, Hlf, Il13), natural killer (NK) cells (Ccl5, xcl1, AW112010, Txk, Ly6c2), dendritic epidermal T cells (DETC; Cd7, Trat1, CD3e, Gem, Fermt2), type 1 conventional dendritic cells (##cDC1##) cells (Irf8, CD207, Tbc1d4, Cst3, Naaa), B cells (Igkc, Ighm, Ebf1, CD79a, Iglc2), monocyte-derived macrophages (MdMacro) (Plac8, Ifitm3, Lst1, Chil3, Thbs1), and neutrophils (Neut) (S100a9, S100a8, Retnlg, G0s2, Acod1) (Fig. 1g, Supplementary Fig. 1 and Supplementary Table 2). After quality control and filtering, the number of single-cell transcriptomes was 3,946 (12-week-WT), 5,413 (12-week-DB), 4,852 (21-week-WT), and 7,450 (21-week-DB). When each sample was represented as a proportion of the integrated cluster total, variation in cell numbers in each cluster was apparent (Fig. 1e, f). Macrophages were the most abundant cell type across all samples, while mast cell/basophil (M/B), dermal gammadelta T cell (dTgammadelta), heterogeneous T cell (Thet), and Type 2 innate lymphoid cell (ILC2) populations were substantially increased in 21-week-DB mice (Fig. 1f and Supplementary Table 3).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10951029</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38502310</oboInOwl:hasDbXref>
        <rdfs:label>cDC1</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000990"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/09400fe5-99dd-49be-b179-ae662ad80af1"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000990"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/095989f4-1cc0-46d6-8e39-f30f5008c58f -->

    <Class rdf:about="http://example.org/095989f4-1cc0-46d6-8e39-f30f5008c58f">
        <obo:IAO_0000115>Other studies have examined and set out to better characterize human B-1 and B-2 lymphoid development. As indicated earlier, innate-like B-1 (B-1a and B-1b) and conventional B-2 cells constitute two main branches of the murine B cell population. During embryonic and fetal development, murine B-1a subsets are proposed to arise from multiple sites including yolk sac, P-Sp/AGM and fetal liver from HSC independent or dependent precursors, and to a lesser degree from adult bone marrow HSCs. Although much less is known about the equivalent human B-1 B cells, these cells were provisionally identified as CD20+CD27+CD43+CD70- cells in UCB and adult peripheral blood, and in other studies, in fetal liver and fetal bone marrow as well as UCB, reaching their highest frequency in fetal liver around 10 pcw. As this phenotypic cell subset may also contain CD20+CD38hi plasmablast and preplasmablast precursors, it remains possible that the human fetal B-1 B cell frequency has been over estimated. Putative human B-1 cells, the earliest B cells to arise in the human fetus, were therefore subsequently identified phenotypically as ##CD19+CD20+CD27+CD43+CD38lo/int, while lacking CD3, CD4 and CD8 T cell## markers, making them distinct from B-2 lymphoid cells, which are predominantly found in adult tissues. Whether human B-1 and B-2 B cells arise from different progenitors or a common progenitor is unclear. However, recent evidence examining hematopoietic lineage output at the clonal level from the peripheral blood of adult patients with paroxysmal nocturnal hemoglobinuria (PNH) suggests that this putative human B-1 B cell population can also arise in the adult from HSCs, while other studies indicate that human adult B-1 B cell frequency and diversity decline with aging, particularly after the age of 50.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8999121</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35409034</oboInOwl:hasDbXref>
        <rdfs:label>CD19+CD20+CD27+CD43+CD38lo/int, while lacking CD3, CD4 and CD8 T cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000819"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/095989f4-1cc0-46d6-8e39-f30f5008c58f"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000819"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/0985395b-072e-486c-9010-b5cdbc6f4564 -->

    <Class rdf:about="http://example.org/0985395b-072e-486c-9010-b5cdbc6f4564">
        <obo:IAO_0000115>The signals driving the adaptation of type 2 dendritic cells (DC2s) to diverse peripheral environments remain mostly undefined. We show that differentiation of ##CD11blo migratory DC2s##-a DC2 population unique to the dermis-required IL-13 signaling dependent on the transcription factors STAT6 and KLF4, whereas DC2s in lung and small intestine were STAT6-independent. Similarly, human DC2s in skin expressed an IL-4 and IL-13 gene signature that was not found in blood, spleen and lung DCs. In mice, IL-13 was secreted homeostatically by dermal innate lymphoid cells and was independent of microbiota, TSLP or IL-33. In the absence of IL-13 signaling, dermal DC2s were stable in number but remained CD11bhi and showed defective activation in response to allergens, with diminished ability to support the development of IL-4+GATA3+ helper T cells (TH), whereas antifungal IL-17+RORgammat+ TH cells were increased. Therefore, homeostatic IL-13 fosters a noninflammatory skin environment that supports allergic sensitization.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMID:34795444</oboInOwl:hasDbXref>
        <rdfs:label>CD11blo migratory DC2s</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000784"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/0985395b-072e-486c-9010-b5cdbc6f4564"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000784"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/1a03d593-90c4-4906-8aef-4160ff0efd75 -->

    <Class rdf:about="http://example.org/1a03d593-90c4-4906-8aef-4160ff0efd75">
        <obo:IAO_0000115>Limited to the olfactory cleft, the olfactory epithelium (OE) is a true neuroepithelium containing ##bipolar chemosensory neurons##, while the remainder of the nasal cavity is lined by respiratory epithelium consisting of ciliated cells, secretory cells, and basal cells. The OE contains neurogenic populations known as globose basal cells (GBCs) and horizontal basal cells (HBCs). In rodent models, during normal olfactory sensory neuron turnover, the GBCs divide and differentiate to produce new neurons, while the HBCs are relatively quiescent. However, when faced with injuries that disrupt the sustentacular cell layer of the OE, the reserve HBC stem cells are activated and serve as the main source of olfactory sensory neurogenesis. Human OE is exposed continuously to potential damage in the form of viral or other infections, inflammation driven by allergens and other inspired irritants, or trauma. Thus, the proper function of the neurogenic cycle is critical for homeostasis within the OE and, in turn, a functioning sense of smell.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8843745</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34990409</oboInOwl:hasDbXref>
        <rdfs:label>bipolar chemosensory neurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000103"/>
        <skos:relatedMatch rdf:resource="CL:0000207"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/1a03d593-90c4-4906-8aef-4160ff0efd75"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000103"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/1a03d593-90c4-4906-8aef-4160ff0efd75"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000207"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/1a11572e-f646-437b-9edb-4631c70b33c3 -->

    <Class rdf:about="http://example.org/1a11572e-f646-437b-9edb-4631c70b33c3">
        <obo:IAO_0000115>ACS, acute compartment syndrome; scRNA-seq, single-cell RNA sequencing; HG, high-stress group; NG, normal-stress group; DEGs, differentially expressed genes; GO, Gene Ontology; KEGG, Kyoto Encyclopedia of Genes and Genomes; TCM, ##central memory T-cell##; Teff, effector T-cell; Treg, regulatory T-cell; NKT, nature killer T-cell; ILC, innate lymphoid cell; HSP, heat shock protein; MT,metallothionein; Mac, macrophages; DCs, dendritic cells; Mon, monocytes; Fib, fibroblasts.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9889980</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36741388</oboInOwl:hasDbXref>
        <rdfs:label>central memory T-cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000904"/>
        <skos:relatedMatch rdf:resource="CL:0000907"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/1a11572e-f646-437b-9edb-4631c70b33c3"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000904"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/1a11572e-f646-437b-9edb-4631c70b33c3"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000907"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/1a46a2aa-9ae6-498d-b232-8db7b1a72f71 -->

    <Class rdf:about="http://example.org/1a46a2aa-9ae6-498d-b232-8db7b1a72f71">
        <obo:IAO_0000115>We undertook a comprehensive Mendelian randomization study aimed at uncovering the causal relationship between 744 immune cell types and IVDD [ Supplementary Table 2 ]. In our analysis, we identified 24 specific blood types of immune cells that demonstrated a causal association with disc degeneration through univariable MR [ Supplementary Table 3 ], including Memory B cell %B cell, Naive-mature B cell %B cell, IgD-CD38dim B cell %lymphocyte, ##CD39+activated CD4 regulatory T cell## %CD4 regulatory T cell, CD39+ secreting CD4 regulatory T cell %CD4 regulatory T cell, CD45RA+ CD8+ T cell %CD8+ T cell, CD8+ T cell %leukocyte, CD39+CD4+ T cell %T cell, CD39+ CD4+ T cell %CD4+ T cell,CD39+ CD8+ T cell %T cell, CD39+ CD8+ T cell Absolute Count, CD127- CD8+ T cell Absolute Count, CD28- CD8+ T cell Absolute Count, CD19 on IgD+ CD38+ B cell, CD19 on IgD+ CD38dim B cell, CD19 on IgD- CD38- B cell, CD19 on unswitched memory B cell, CD19 on transitional B cell, CD24 on IgD+ CD38+ B cell,CD28 on CD39+ secreting CD4 regulatory T cell, CD25 on CD39+ CD4+ T cell, CD4 on CD39+ CD4+ T cell, CD4 on CD39+ resting CD4 regulatory T cell and Neutrophil count. We excluded certain exposures due to a limited number of available SNPs to prevent potential bias, including Memory B cell %B cell, Naive-mature B cell %B cell, IgD-CD38dim B cell %lymphocyte, CD8+T cell %leukocyte, CD127-CD8+ T cell Absolute Count, CD19 on IgD-CD38-B cell, CD24 on IgD+ CD38+ B cell, CD28 on CD39+ secreting CD4 regulatory T cell and CD4 on CD39+ resting CD4 regulatory T cell.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10806224</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38268919</oboInOwl:hasDbXref>
        <rdfs:label>CD39+activated CD4 regulatory T cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000792"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/1a46a2aa-9ae6-498d-b232-8db7b1a72f71"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000792"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/1a4b87ef-9196-4011-a56c-5535a91172ab -->

    <Class rdf:about="http://example.org/1a4b87ef-9196-4011-a56c-5535a91172ab">
        <obo:IAO_0000115>Immunosuppressive role of tumour-associated macrophages (TAMs). TAMs promote immunosuppression by different mechanisms: TAMs can express programmed cell death ligand 1 and ligand 2 (PD-L1 and PD-L2), which bind the T cell inhibitory receptor programmed cell death protein 1 (PD-1), thereby inducing T cell exhaustion. ##TAM## expression of V-domain Ig suppressor of T cell activation (VISTA) and B7 family molecules, such as B7-H4, can have similar function. TAMs secrete immunosuppressive cytokines such as IL-10 and TGFbeta, which can have direct suppressive functions on CD8+ T cells, or they can induce recruitment of immunosuppressive CD4+ T regulatory (Treg) cells. TAM secreted IL-10 can impair T cells effector functions indirectly either by inhibit dendritic cell (DC) anti-tumorigenic role or by inducing DC expression of PD-L1. Moreover, amino acid metabolism in TAM results in production of arginase and immunosuppressive metabolites via the indoleamine 2,3-dioxygenase (IDO) pathway, which is responsible of metabolic starvation in T cells. TAMs can also indirectly induce immunosuppression by promoting fibrosis. Indeed cancer associated fibroblast (CAF) secreted factors and/or extracellular matrix (ECM) stiffness are responsible for CD8+ T cell immunosuppression and/or exclusion from the tumour nest.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6678757</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31331034</oboInOwl:hasDbXref>
        <rdfs:label>TAM</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/1a4b87ef-9196-4011-a56c-5535a91172ab"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/1a598e02-5085-4c9f-9d24-07e6ce33b67a -->

    <Class rdf:about="http://example.org/1a598e02-5085-4c9f-9d24-07e6ce33b67a">
        <obo:IAO_0000115>Expression heterogeneity of CD8+ and CD4+ T cells in the OSCC ecosystem. (A) The t-distributed stochastic neighbor embedding (t-SNE) projection of T cells from cancerous tissue of patients with OSCC, showing the formation of 11 main clusters in different colors. The functional description of each cluster is determined by the gene expression characteristics. Cluster 0: resident memory CD8+ T Cells (C0_CD8+ TRM); Cluster 1: effector memory CD8+ T cells (C1_CD8+ TEM); Cluster 2: regulatory CD4+ T cells (C2_CD4+ Treg); Cluster 3: exhausted CD8+ T cells (C3_CD8+ T Exhausted); Cluster 4: effector memory M-phage CD8+ T cells (C4_CD8+ Mitotic TEM); Cluster 5: effector memory CD4+ T cells (C5_CD4+ TEM); Cluster 6: effector memory CD8+ T cells (C6_CD8+ TEM); Cluster 7: effector memory CD4+ T cells (C7_CD4+ TEM); Cluster 8: effector memory CD8+ T cells (C8_CD8+ TEM); Cluster 9: effector memory CD8+ T cells (C9_CD8+ TEM); Cluster 10: effector memory M-phage CD4+ T cells (C10_##CD4+ Mitotic TEM##); Cluster 11: effector memory CD8+ T cells (C11_CD8+ TEM); Cluster 12: effector memory CD8+ T cells (C12_CD8+ TEM); Cluster 13: gammadelta T. (B) Cell-Cycle Scoring of T cells from cancerous tissue of patients with OSCC, showing the three clusters of cells in different cell cycles in different colors. (C) Heatmap of key genes expressed in each cluster of CD8+ tumor-infiltrating lymphocytes (TILs) with cells grouped by clusters. The columns correspond to the cells; the rows correspond to the genes. Yellow: high expression; purple: low expression. Selected key markers are shown on the right. (D) Heatmap of key genes expressed in each cluster of CD4+ TILs with cells grouped by clusters. The columns correspond to the cells; the rows correspond to the genes. Yellow: high expression; purple: low expression. Selected key genes are shown on the right.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8024729</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33513276</oboInOwl:hasDbXref>
        <rdfs:label>CD4+ Mitotic TEM</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000905"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/1a598e02-5085-4c9f-9d24-07e6ce33b67a"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000905"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/1a8cb410-b5d2-42b3-b7eb-7e31fd3d7526 -->

    <Class rdf:about="http://example.org/1a8cb410-b5d2-42b3-b7eb-7e31fd3d7526">
        <obo:IAO_0000115>Transcriptional signature of pancreas infiltrating and circulating CD4+ and CD8+ T cell subsets at disease onset. (A) UMAP plot of CD4+ and CD8+ T cells from peripheral blood and pancreas of new-onset diabetic NOD mice. (B) Feature plots depicting gene expression levels of distinct markers driving CD4+ and CD8+ T cell activation states. (C, D) UMAP plot of CD4+ (C) and CD8+ (D) T cells grouped by the annotation in A (left) and grouped by T cell subset classified based on the expression of Cd44 and Sell (right). EM = effector memory (Cd44+Sell-), CM = central memory (Cd44+Sell+), naive (Cd44-Sell+), and CD44low CD62L- (Cd44-Sell-). (E, F) Heatmap depicting row-based z-scores of scaled gene expression levels for marker genes driving T cell heterogeneity across the distinct CD4+ (E) and CD8+ (F) T cell subsets. (G, H) Trajectory of ##CD4+ (G) and CD8+ (H) naive, CD44low CD62L-, effector memory (EM), and central memory (CM) T cell## subsets projected onto the UMAP plot (top). Violin plots depicting the pseudotime of CD4+ (G) and CD8+ (H) T cells per subset (bottom). Each dot represents a single cell. (I, J) Differentially expressed genes of CD4+ Cd44-Sell- (I) and CD8+ Cd44-Sell- (J) T cells between peripheral blood and pancreas.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10667927</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38027120</oboInOwl:hasDbXref>
        <rdfs:label>CD4+ (G) and CD8+ (H) naive, CD44low CD62L-, effector memory (EM), and central memory (CM) T cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000624"/>
        <skos:relatedMatch rdf:resource="CL:0000625"/>
        <skos:relatedMatch rdf:resource="CL:0000895"/>
        <skos:relatedMatch rdf:resource="CL:0000900"/>
        <skos:relatedMatch rdf:resource="CL:0000904"/>
        <skos:relatedMatch rdf:resource="CL:0000905"/>
        <skos:relatedMatch rdf:resource="CL:0000907"/>
        <skos:relatedMatch rdf:resource="CL:0000913"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/1a8cb410-b5d2-42b3-b7eb-7e31fd3d7526"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000624"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/1a8cb410-b5d2-42b3-b7eb-7e31fd3d7526"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000625"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/1a8cb410-b5d2-42b3-b7eb-7e31fd3d7526"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000895"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/1a8cb410-b5d2-42b3-b7eb-7e31fd3d7526"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000900"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/1a8cb410-b5d2-42b3-b7eb-7e31fd3d7526"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000904"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/1a8cb410-b5d2-42b3-b7eb-7e31fd3d7526"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000905"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/1a8cb410-b5d2-42b3-b7eb-7e31fd3d7526"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000907"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/1a8cb410-b5d2-42b3-b7eb-7e31fd3d7526"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000913"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/1aa61d39-7fcb-49e6-aec1-e6cc17e20479 -->

    <Class rdf:about="http://example.org/1aa61d39-7fcb-49e6-aec1-e6cc17e20479">
        <obo:IAO_0000115>Pluripotent stem (PS) cells hold great promise for the development of stem cell therapies to treat diverse human diseases. However, numerous limitations hinder the clinical application of embryonic stem (ES) cells and induced ##pluripotent stem (iPS) cells##, including the tumorigenic risk of transplanted undifferentiated cells. The Kyoto probe 1 (KP-1), which selectively labels human PS cells, was developed as a selection tool. KP-1 rapidly distinguishes between human ES/iPS (hES/hiPS) cells and differentiated cells. Further, KP-1 is a stable, chemically defined small molecule that offers the advantages of ease of use and economy. These properties are critically important for mitigating the risk of stem cell therapy-induced tumorigenesis as well as for conducting basic stem cell research. The unique selectivity of KP-1 is primarily explained by the distinct expression patterns of ATP-binding cassette (ABC) transporters by hiPS cells and differentiated cells. ABCB1 (also known as MDR1, PGY1) and ABCG2 (also known as ABCP, BCRP) mediate the efflux of KP-1, which is repressed in hiPS and hES cells. In contrast, differentiated human cells express ABCB1 and ABCG2. The drug efflux systems mediated by ABC transporters in human cells are well characterized, in contrast to those of mouse cells. </obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7582910</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33093580</oboInOwl:hasDbXref>
        <rdfs:label>pluripotent stem (iPS) cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002248"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/1aa61d39-7fcb-49e6-aec1-e6cc17e20479"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002248"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/1aad4ede-d2c6-47c3-93a7-a1513011a60f -->

    <Class rdf:about="http://example.org/1aad4ede-d2c6-47c3-93a7-a1513011a60f">
        <obo:IAO_0000115>While the heterogeneity of CD103+ TRMs is widely discussed in the literature, the characteristics of TRM subpopulations within the tumor or distant tissues of tumor-bearing mice are less well defined. To characterize ##tumoral TRMs##, scRNA-seq technology provides unprecedented analytical power and allows us to dissect cells with thousands of dimensions. With the hypothesis that particular intratumoral T cells are precursors for TRM development, we extended our scRNA-seq approach to include various effector and memory T cell populations to comprehensively depict their transcriptomic program. From the tumor and distant mucosa of mice bearing established 4T1 tumors, we flow sorted distinct memory T cell populations using a strict gating strategy (Figure S3). We constructed single-cell cDNA libraries from paired intratumoral sorted TCR-beta+CD44+CD62L-CD69+CD103+ cells (TRMs), mucosal sorted TCR-beta+CD44+ CD69+CD103+ cells (distant mucosa TRMs), intratumoral TCR-beta+CD44+CD62L+CD69-CD103- cells (TCMs), and TCR-beta+CD44+CD62L-CD69-CD103- cells (TEMs) (Table S2). After data processing and normalization, we performed unbiased clustering and visualized the CD8+ clusters using t-distributed stochastic neighbor embedding (t-SNE; Figure 2A). Through this unsupervised analysis, we found that all four samples could distinctly separate into multiple clusters, confirming continued heterogeneity among the single-cell subsets.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8204287</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33979626</oboInOwl:hasDbXref>
        <rdfs:label>tumoral TRMs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000909"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/1aad4ede-d2c6-47c3-93a7-a1513011a60f"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000909"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/1ab1b61b-5524-4304-9c54-5cb4424fb514 -->

    <Class rdf:about="http://example.org/1ab1b61b-5524-4304-9c54-5cb4424fb514">
        <obo:IAO_0000115>The generation of terminally differentiated cell lineages during organogenesis requires multiple, coordinated cell fate choice steps. However, this process has not been clearly delineated, especially in complex solid organs such as the pancreas. Here, we performed single-cell RNA-sequencing in pancreatic cells sorted from multiple genetically modified reporter mouse strains at embryonic stages E9.5-E17.5. We deciphered the developmental trajectories and regulatory strategies of the exocrine and endocrine pancreatic lineages as well as intermediate progenitor populations along the developmental pathways. Notably, we discovered previously undefined programs representing the earliest events in islet alpha- and beta-cell lineage allocation as well as the developmental pathway of the &quot;first wave&quot; of alpha-cell generation. Furthermore, we demonstrated that repressing ERK pathway activity is essential for inducing both alpha- and beta-lineage differentiation. This study provides key insights into the regulatory mechanisms underlying cell fate choice and stepwise cell fate commitment and can be used as a resource to guide the induction of functional ##islet lineage cells## from stem cells in vitro.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6463266</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:30737258</oboInOwl:hasDbXref>
        <rdfs:label>islet lineage cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000169"/>
        <skos:relatedMatch rdf:resource="CL:0000171"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/1ab1b61b-5524-4304-9c54-5cb4424fb514"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000169"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/1ab1b61b-5524-4304-9c54-5cb4424fb514"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000171"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/1acfe2a4-0ba0-43d3-a335-e62df1a88772 -->

    <Class rdf:about="http://example.org/1acfe2a4-0ba0-43d3-a335-e62df1a88772">
        <obo:IAO_0000115> Total (N = 56) Group 1 (n = 17) Group 2 (n = 14) Group 3 (n = 25) P value (1 vs 2) P value (1 vs 3) P value (2 vs 3)   Male 40 (71.4) 12 (70.6) 10 (71.4) 18 (72) 1.0 1.0 1.0   Age, y 9.4 (7.8-11.8) 8.5 (7.7-11.5) 8.6 (6.7-11.1) 10.6 (8.5-13.3) .61 .09 .042   Family history of atopy 39/55 (70.9) 12/16 (75) 11 (78.6) 16 (64) 1.0 .51 .48   Serum IgE 196 (49-547) 144 (38-461) 166 (35-479) 318 (118-736) .98 .13 .26   IgE &gt;50 UI/mL 40/53 11/16 (68.8) 8/12 (66.7) 21 (84) 1.0 .44 .39   Positive prick test 29/55 9 (52.9) 6/13 (46.2) 14 (56) 1.0 1.0 .73   Positive RAST test 33/53 9/16 (56.3) 7/12 (58.3) 17 (68) 1.0 .52 .72   Worse eye   ##Epithelial cells## 2 (2-3) 3 (2-3) 2 (1-2) 2 (1.5-3) .0014 .03 .16   Neutrophils 1 (0-1) 1 (1-1) 0.3 (0-0.5) 1 (0.3-1) .0019 .19 .03   Mast cells 1 (0.6-1) 1 (1-2) 1 (0-1) 1 (0.8-2) .01 .60 .045   Mast cell degranulation 1 (0-2) 1 (0.5-2) 1 (0-1) 1 (0-1.5) .16 .43 .45   Eosinophils 0.5 (0-1) 1 (0.5-2) 0.3 (0-1) 0.5 (0-1) .055 .018 .98   Eosinophil degranulation 0 (0-0) 0 (0-0) 0 (0-0) 0 (0-0) .70 .60 .39   Lymphocytes 0 (0-1) 1 (0-1) 0 (0-1) 0 (0-1) .28 .10 .67   Worse eye score 3.3 (1.5-4.4) 4.5 (2.8-5.3) 2.8 (0.5-3.5) 3.0 (1.8-4.0) .0015 .03 .26   </obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7016839</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31804769</oboInOwl:hasDbXref>
        <rdfs:label>Epithelial cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000575"/>
        <skos:relatedMatch rdf:resource="CL:1000432"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/1acfe2a4-0ba0-43d3-a335-e62df1a88772"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000575"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/1acfe2a4-0ba0-43d3-a335-e62df1a88772"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:1000432"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/1ad1e7ec-df24-4c73-b676-6ad6dd004df9 -->

    <Class rdf:about="http://example.org/1ad1e7ec-df24-4c73-b676-6ad6dd004df9">
        <obo:IAO_0000115>Immune checkpoint inhibitors exert clinical efficacy against various types of cancer through reinvigoration of exhausted CD8+ T cells that attack cancer cells directly in the tumor microenvironment (TME). Using single-cell sequencing and mouse models, we show that CXCL13, highly expressed in tumor-infiltrating exhausted CD8+ T cells, induces CD4+ follicular helper T (TFH) cell infiltration, contributing to anti-tumor immunity. Furthermore, a part of the TFH cells in the TME exhibits cytotoxicity and directly attacks major histocompatibility complex-II-expressing tumors. TFH-like cytotoxic CD4+ T cells have high LAG-3/BLIMP1 and low TCF1 expression without self-renewal ability, whereas non-cytotoxic TFH cells express low LAG-3/BLIMP1 and high TCF1 with self-renewal ability, closely resembling the relationship between terminally differentiated and stem-like progenitor exhaustion in CD8+ T cells, respectively. Our findings provide deep insights into TFH-like CD4+ T cell exhaustion with ##helper progenitor## and cytotoxic differentiated functions, mediating anti-tumor immunity orchestrally with CD8+ T cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMID:38363680</oboInOwl:hasDbXref>
        <rdfs:label>helper progenitor</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002038"/>
        <skos:relatedMatch rdf:resource="CL:0011026"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/1ad1e7ec-df24-4c73-b676-6ad6dd004df9"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002038"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/1ad1e7ec-df24-4c73-b676-6ad6dd004df9"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0011026"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/1af1cf72-bb15-44ea-b47c-81818af6f494 -->

    <Class rdf:about="http://example.org/1af1cf72-bb15-44ea-b47c-81818af6f494">
        <obo:IAO_0000115>Acute leukemia is characterized by a rapid expansion of hematopoietic precursors (blast cells), which remain partially differentiated and proliferate in the bone marrow and peripheral blood as the disease progresses. Two of the most common types of pediatric acute leukemias are acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML). ALL is the most prevalent type of cancer in children (80% of leukemias and 25% of childhood cancers), and 10-15% of these cases represent T-cell ALL (T-ALL). T-ALL arises from T-lymphoblasts in the thymus as a result of an accumulation of mutations in immature thymocytes, altering inter alia cell proliferation and differentiation. The lymphoblasts leave the thymus and access the circulation, from where other organs such as the bone marrow or central nervous system are invaded. AML constitutes about 20% of all childhood leukemias and is caused by ##abnormal myeloblasts## (immature leukocytes of the myeloid lineage). Cancerous myeloblasts have the ability of constant proliferation and avoidance of cell death, leading to an expansion in the myeloblast population and to a disturbed hematopoiesis.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8423305</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34492077</oboInOwl:hasDbXref>
        <rdfs:label>abnormal myeloblasts</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000835"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/1af1cf72-bb15-44ea-b47c-81818af6f494"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000835"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/1af4a500-6097-4ffd-9c13-92848d09af0c -->

    <Class rdf:about="http://example.org/1af4a500-6097-4ffd-9c13-92848d09af0c">
        <obo:IAO_0000115>Expression patterns of pCMV-SpCas9-RFP and pVMD2-SpCas9-RFP in human retinal organoids. (a) RPE characteristics of pigmentation and hexagonality were confirmed in a 3D sphere and 2D monolayer status (b) Retinal organoids express various retinal markers being appropriate to normal developmental stages. A bright-field image and fluorescent image of the human retinal organoid are displayed in pairs (c,d; e,f). (c,d) The pCMV vector expressed RFP both in the RPE and neural retina; (e,f) whereas the pVMD2 vector expressed RFP only in RPE [c,e = bright-field image; d,f = fluorescent image]. Each protein marks specific structure or cell types as follows: ZO-1: Tight junction; SOX2: Neural progenitor cell; RX: Retinal progenitor cell; CRX: ##Photoreceptor progenitor cell##; Recoverin: Photoreceptor precursor cell; CHX10: Neural retinal progenitor cell; SNCG: Retinal ganglion cell; Ki67: Proliferating cell; RxRgamma: Cone precursor cell; CRALBP: Muller glia cell; Rhodopsin: Rod photoreceptor cell; M/L opsin: M/L cone photoreceptor.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9988861</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36878916</oboInOwl:hasDbXref>
        <rdfs:label>Photoreceptor progenitor cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002672"/>
        <skos:relatedMatch rdf:resource="CL:0010009"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/1af4a500-6097-4ffd-9c13-92848d09af0c"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002672"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/1af4a500-6097-4ffd-9c13-92848d09af0c"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0010009"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/1b09b167-b2bd-44ea-b598-9e86993bd98f -->

    <Class rdf:about="http://example.org/1b09b167-b2bd-44ea-b598-9e86993bd98f">
        <obo:IAO_0000115>The retinal neurovascular unit refers to the interdependency between vascular endothelial cells, ##pericytes##, glia, neurons, and immune cells. A better understanding of the contribution of each cell type to DR progression and the molecular mechanisms regulating their crosstalk could be the key to identify new therapeutic targets. In addition to retinal vascular alterations, fibrovascular scarring can ultimately lead to blindness. Fibrosis is an intricate, reparative process that develops in response to acute or chronic injury. The mechanisms that drive fibrosis in DR are not fully understood; hence, there is a great need to better understand this important cause of vision loss. This would be a first step toward new therapies to address progressive preretinal fibrosis and traction detachment and to avoid the concomitant poor visual and anatomic outcomes.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10896003</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37917183</oboInOwl:hasDbXref>
        <rdfs:label>pericytes</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000669"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/1b09b167-b2bd-44ea-b598-9e86993bd98f"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000669"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/1b18e2b7-a6f5-4979-909c-eda2e2f77e83 -->

    <Class rdf:about="http://example.org/1b18e2b7-a6f5-4979-909c-eda2e2f77e83">
        <obo:IAO_0000115>a-o, Subcluster spatial maps on representative sample slices for astrocytes (a), oligodendrocytes and oligodendrocyte precursor cells (b), microglia and perivascular macrophages (c), ependymal cells, choroid plexus epithelial cells and subcommissural organ hypendymal cells (d), olfactory inhibitory neurons (e), cerebellum neurons (f), ##telencephalon projecting inhibitory neurons## (g), di- and mesencephalon excitatory neurons (h), glutamatergic neuroblasts (i), non-glutamatergic neuroblasts (j), di- and mesencephalon inhibitory neurons (k), cholinergic and monoaminergic neurons (l), peptidergic neurons (m), hindbrain/spinal cord neurons (n), and vascular cells (o). Also see Methods and Supplementary Table 4.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10709140</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37758947</oboInOwl:hasDbXref>
        <rdfs:label>telencephalon projecting inhibitory neurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000498"/>
        <skos:relatedMatch rdf:resource="CL:4023008"/>
        <skos:relatedMatch rdf:resource="CL:4023009"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/1b18e2b7-a6f5-4979-909c-eda2e2f77e83"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000498"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/1b18e2b7-a6f5-4979-909c-eda2e2f77e83"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4023008"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/1b18e2b7-a6f5-4979-909c-eda2e2f77e83"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4023009"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/1b1c4673-90fd-4c11-b38c-232f02f96c0b -->

    <Class rdf:about="http://example.org/1b1c4673-90fd-4c11-b38c-232f02f96c0b">
        <obo:IAO_0000115>To explore whether fetal adrenal neurocytes have steroidogenic functions, the ##neurocyte## group was further divided into 15 distinct subtypes, including 4 chromaffin cell subtypes, 2 sympathoblast subtypes, and 3 Schwann cell precursor (SCP) subtypes ( Figure 4A, B ;  Table S4 ).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9713933</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36465633</oboInOwl:hasDbXref>
        <rdfs:label>neurocyte</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000166"/>
        <skos:relatedMatch rdf:resource="CL:0000540"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/1b1c4673-90fd-4c11-b38c-232f02f96c0b"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000166"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/1b1c4673-90fd-4c11-b38c-232f02f96c0b"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000540"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/1b2a1ecf-dbd9-4352-88e5-2c7087ff317c -->

    <Class rdf:about="http://example.org/1b2a1ecf-dbd9-4352-88e5-2c7087ff317c">
        <obo:IAO_0000115>Another key finding of McCafferty et al. is that T-channel bursts of cortical and NRT neurons are critically involved in the ictal synaptic interactions with thalamocortical neurons, whereas T-channel bursts of thalamocortical neurons do not play a role in the ictal interactions of these neurons with both cortical and NRT neurons. Indeed, localized injection of TTA-P2, a potent and selective pan-T-channel antagonist, by shows that the block of T-channels in the NRT and CIN of GAERS rats drastically decreases absence seizures (see also), whereas blocking T-channels in thalamocortical neurons of the ventrobasal thalamus, one of the somatotopic thalamic nuclei of the GAERS CIN, has no effect on absence seizures (Fig. 5), the rhythmicity of the thalamic output and its synchrony with the SWD spike. Thus, the use of TTA-P2 to provide a fast block of T-channel function without compensatory activities shows that T-channels of ##ventrobasal thalamocortical neurons## (i.e. Cav3.1) are not essential for spontaneous absence seizures in GAERS rats whereas those of the CIN (i.e. Cav3.1, Cav3.2 and Cav3.3) and NRT (i.e Cav3.2 and Cav3.3) are (Fig. 5). </obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7447525</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32437558</oboInOwl:hasDbXref>
        <rdfs:label>ventrobasal thalamocortical neurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:4023068"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/1b2a1ecf-dbd9-4352-88e5-2c7087ff317c"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4023068"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/1b4f9f33-91a5-46f4-9ab3-f10327ca166d -->

    <Class rdf:about="http://example.org/1b4f9f33-91a5-46f4-9ab3-f10327ca166d">
        <obo:IAO_0000115>Because CD14CTX express chemokine receptors that might facilitate migration into the tissues, we next examined the relationship between circulating and intra-tumoral myeloid states in BTC. We performed scRNA-seq on primary cholangiocarcinoma tumors (n = 4) obtained from standard of care resections (Table S7) and recovered a total of 10,913 myeloid cells. Tissue-associated myeloid cells consisted of dendritic cells (DC), neutrophils (Neut), two populations of macrophages characterized by either high APOE or SPP1 expression (##MacAPOE##, MacSPP1), CD14+ monocytes (CD14+ mono), CD16+ monocytes (CD16+ mono), and intermediate CD14+CD16+ monocytes (CD14+CD16+ mono) (Figures S4A and S4B). Among the tissue-associated myeloid populations, the expression profile of CD14CTX was most correlated with MacSPP1, exemplified by the shared expression of differentially expressed CD14CTX genes including HAVCR2 and ITGB1 (Figures S4C and S4D). Notably, two genes that differ in expression between MacSPP1 and CD14CTX are related to chemotaxis and extravasation (SERPINB2, TIMP1), suggesting a transition in macrophages that have already migrated to the tumor microenvironment. As an alternate approach to assess the relationship between the circulating and tissue-associated myeloid populations, we co-clustered myeloid cells from circulation with those from the tumors, following batch correction. We found that the intra-tumoral MacSPP1 cluster with the circulating CD14CTX (Figure S4E). An alternative approach using partition-based graph abstraction also found close connectivity between CD14CTX and SPP1+ TAM clusters (Figure S4E). We also found evidence of SPP1+HAVCR2+CD68+ myeloid cells within biliary tumor tissue from on-treatment biopsies by combined in situ hybridization and immunofluorescence, further suggesting the existence of a TAM population in BTC analogous to CD14CTX (Figure S4F).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10060099</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36130508</oboInOwl:hasDbXref>
        <rdfs:label>MacAPOE</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/1b4f9f33-91a5-46f4-9ab3-f10327ca166d"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/1b8a3935-162c-496e-aad4-dcc2863a4f8b -->

    <Class rdf:about="http://example.org/1b8a3935-162c-496e-aad4-dcc2863a4f8b">
        <obo:IAO_0000115>The cellular content of human myocardium (in descending order by number) predominantly consists of cardiomyocytes, fibroblasts, pericytes and smooth muscle cells, endothelial cells, and immune cells. In the murine heart, macrophage populations can be discerned based on their expression of C-C chemokine receptor type 2 (CCR2), major histocompatibility complex-II (MHC-II), T cell immunoglobulin and mucin domain containing 4 (TIMD4), and Lymphatic Vessel Endothelial Hyaluronan Receptor 1 (LYVE1). Four populations of macrophages have been identified in the murine heart (Fig. 1). The minority are two subsets of CCR2+MHC-IIhigh macrophage populations derived from hematopoietic stem cells, whereas the most dominant subset, cardiac resident macrophages derived from the yolk sac, are CCR2-MHC-IIlowTIMD4+LYVE1-. There also exists a fourth subset that consists of CCR2-MHC-IIhighTIMD4+LYVE1+ macrophages, which are likely derived from CCR2-MHC-IIlow macrophages during postnatal development and partially maintained by CCR2+MHC-IIhigh macrophages. CCR2+MHC-IIhigh macrophages populate the heart soon after birth and are maintained through monocyte recruitment and proliferation. Also, under homeostasis, cardiac macrophages continually self-renew with a turnover period of almost 5 weeks. Recently, this same CCR2+ and CCR2- macrophage distinction has been identified in humans, with the yolk sac-derived CCR2- human counterpart showing CD14+CD45+CD64+CCR2-HLA-DRhigh expression. In a more recent study, Tucker et al. reported two ##cardiac macrophage## subsets within the human heart, which were positive for CD163, COLEC12, mannose receptor MRC1, E3 ubiquitin ligase MARCH1, and natural resistance-associated macrophage protein 1 (NRAMP1). Both of the identified subsets expressed anti-inflammatory (M2) polarization-associated genes, whereas one subset particularly expressed RBPJ, F13A1 and the other expressed transmembrane collagen COL23A1.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9242717</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34088222</oboInOwl:hasDbXref>
        <rdfs:label>cardiac macrophage</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/1b8a3935-162c-496e-aad4-dcc2863a4f8b"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/1c204449-2ced-4893-83d4-74ba3dac0ff5 -->

    <Class rdf:about="http://example.org/1c204449-2ced-4893-83d4-74ba3dac0ff5">
        <obo:IAO_0000115>During embryonic development, mesenchymal cells provide the FGFR ligands FGF10 and FGF7 required for epithelial development. Here, we found that MECs are one of the major sources of Fgf7 in postnatal SGs. Considering the direct contact between MECs and acinar cells within the basement membrane, identifies them as critical niche cells that may drive seromucous and serous acinar secretory transcriptional profiles. Further, we show expression of FGFR2 and FGF7 in adult acinar and MECs respectively, suggesting continued acinar-MEC crosstalk via FGF7-FGFR2 is important for seromucous differentiation and function, which may stimulate secretion in adult glands. This is supported by the observation of increased saliva flow, evidenced by drooling mice with wet necks and chests, when FGF7 was overexpressed in basal cells and MECs in vivo. Further, Palifermin which is a truncated version of FGF7 and an FDA-approved drug used to treat mucositis in patients receiving chemo- and/or radiation-therapy, caused an increase in acinar area in histology sections and increased acinar proliferation, when injected into mouse SGs before irradiation. Whether such treatment increases the ##seromucous and serous acinar cells## remains to be determined, and further work including deletion of Fgf7 in MECs using a recently reported FGF7flox may support our working model for the critical role of niche cell signals.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10576811</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37838739</oboInOwl:hasDbXref>
        <rdfs:label>seromucous and serous acinar cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000159"/>
        <skos:relatedMatch rdf:resource="CL:0000313"/>
        <skos:relatedMatch rdf:resource="CL:0000622"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/1c204449-2ced-4893-83d4-74ba3dac0ff5"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000159"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/1c204449-2ced-4893-83d4-74ba3dac0ff5"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000313"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/1c204449-2ced-4893-83d4-74ba3dac0ff5"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000622"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/1c3e13dc-97ec-4124-8b74-2c51efbad087 -->

    <Class rdf:about="http://example.org/1c3e13dc-97ec-4124-8b74-2c51efbad087">
        <obo:IAO_0000115>Sjogren&apos;s syndrome is a chronic autoimmune disorder whose pathogenesis is poorly understood and that lacks effective therapies. Detailed quantitative and spatial analyses of tissues affected by Sjogren&apos;s syndrome were undertaken, including the quantitation of the frequency of selected cell-cell interactions in the disease milieu. Quantitative analyses of CD4+ T cell subsets and of CD8+ T cells in the labial salivary glands from untreated patients with primary Sjogren&apos;s syndrome revealed that activated CD8+ cytotoxic T cells (CD8+CTLs) were the most prominent T cells in these infiltrates. An accumulation of apoptotic glandular epithelial cells, mainly ductal and acinar cells, was observed, consistent with the impaired salivary secretion often observed in patients with this disease. FasL expressing activated CD8+ T cells were seen to accumulate around Fas expressing apoptotic epithelial cells. Quantitative analyses of apoptotic cell types and of conjugates between cytotoxic T cells and epithelial cells undergoing apoptosis suggest that Sjogren&apos;s syndrome is primarily driven by ##CD8+CTL## mediated execution of epithelial cells mainly represented by ductal and acinar cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9475031</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36104369</oboInOwl:hasDbXref>
        <rdfs:label>CD8+CTL</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000794"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/1c3e13dc-97ec-4124-8b74-2c51efbad087"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000794"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/1c751176-4080-4387-a924-8f78c2360388 -->

    <Class rdf:about="http://example.org/1c751176-4080-4387-a924-8f78c2360388">
        <obo:IAO_0000115>Reference strains Ba/Apache-2 and E/Bour were used to infect HeLa 229 and immortalized human conjunctival epithelial (HCjE) cells, primary conjunctival epithelial (CjE) cells and stromal fibroblasts (CjS cells), primary endocervical epithelial (EcE) cells and stromal fibroblasts (EcS cells), and endometrial stromal fibroblasts (EmS cells). Cell composition and type were validated prior to our performing each assay using cytokeratin- and fibronectin-specific antibodies (see Fig. S1 in the supplemental material). Table S1 shows the origins of human primary cells by patient age and sex for CjE and CjS cells and by age for EcE, ##EcS##, and EmS cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6426598</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:30890604</oboInOwl:hasDbXref>
        <rdfs:label>EcS</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000057"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/1c751176-4080-4387-a924-8f78c2360388"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000057"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/1ca1a180-f485-446b-b751-8bf6298a7ef9 -->

    <Class rdf:about="http://example.org/1ca1a180-f485-446b-b751-8bf6298a7ef9">
        <obo:IAO_0000115>##Tumor-associated macrophages## (TAMs) are innate immune cells of the myeloid lineage that reside within the tumor following infiltration as either immature monocyte/macrophages or monocytic myeloid-derived suppressor cells (MDSCs). TAMs are increasingly being recognized as central determinants in the shaping of the angiogenic, matricellular, and immune composition of tumor microenvironments [reviewed in ]:so much so that there are now numerous active clinical trials seeking to modify or disrupt TAM-dependent pro-tumorigenic phenotypes.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7724107</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33324425</oboInOwl:hasDbXref>
        <rdfs:label>Tumor-associated macrophages</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/1ca1a180-f485-446b-b751-8bf6298a7ef9"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/1cdd2860-8703-4959-b110-c064cdbdaa53 -->

    <Class rdf:about="http://example.org/1cdd2860-8703-4959-b110-c064cdbdaa53">
        <obo:IAO_0000115>We then assessed whether Pitx1 is differentially expressed among clusters in Pitx1+/+ hindlimbs. Overall, we found Pitx1 expressed in all mesenchymal clusters, yet with a proximal preference (Fig. 2D, F). We then classified ##mesenchymal Pitx1 expressing cells## in three categories: non/low-expressing (transcription values &lt; =0.3, 21% of the hindlimb wildtype cells), intermediate-expressing (transcription &gt; 0.3; &lt;= 1.45, 40% of wildtype cells), and high-expressing (transcription &gt; 1.45, 39% of wildtype cells) (Fig. 2F). As expected, we found that a majority of high expressing cells are located in proximal clusters (PPP, TP, ICT, PC) and a majority of intermediate-expressing cells in distal clusters (DP, DPP, EDC, LDC) (Fig. 2G, H). We also observed that the Ms cluster, previously identified as a cluster originating from the proximal and distal cell-types, is formed by a similar distribution of high-expressing (proximal) and intermediate-expressing (distal) cells in line with a proximo-distal origin (Fig. 2H).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8668926</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34903763</oboInOwl:hasDbXref>
        <rdfs:label>mesenchymal Pitx1 expressing cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0008019"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/1cdd2860-8703-4959-b110-c064cdbdaa53"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0008019"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/1ceb577b-12a6-4a06-9fc7-534b52791914 -->

    <Class rdf:about="http://example.org/1ceb577b-12a6-4a06-9fc7-534b52791914">
        <obo:IAO_0000115>Distinct transcriptional states in ##activated intrarenal and tonsil B cells##</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8285506</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34272370</oboInOwl:hasDbXref>
        <rdfs:label>activated intrarenal and tonsil B cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000980"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/1ceb577b-12a6-4a06-9fc7-534b52791914"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000980"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/1cfc77d4-85d9-4757-a02e-59e0328194d7 -->

    <Class rdf:about="http://example.org/1cfc77d4-85d9-4757-a02e-59e0328194d7">
        <obo:IAO_0000115>Four independent single cell GBM datasets (Table 1) were used to derive marker genes, or signature gene-expression matrices, for GBM tumor-infiltrating immune cells: B cells, T-cells, natural killer (NK) cells, microglia, ##tumor associated macrophages## (TAM), monocytes, mast and dendritic cells (DC). Figure 1A outlines the process. Datasets underwent pre-processing independently to filter out poor quality cells and copy-number analysis to remove neoplastic cells, before being amalgamated. There were significant batch effects owing to different sequencing platforms and originating centres but these were effectively removed using regularized negative binomial regression (Figure 1B and Supplementary Figure S1A). One dataset (GSE163120) included the immune cell annotations determined by the original study. This information was used to guide clustering, with optimization focused first on maximizing cluster stability and then on the best separation of pre-annotated cell types. Owing to the difficulty in separating immune types that are known to have similar and overlapping gene-expression profiles (namely TAM and microglia; and NK and T-cells) cells assigned to any of these groupings were isolated and further sub-clustered, resulting in definitive cluster annotations (Figure 1B and Supplementary Figure S1B).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10326489</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36689332</oboInOwl:hasDbXref>
        <rdfs:label>tumor associated macrophages</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/1cfc77d4-85d9-4757-a02e-59e0328194d7"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/1d1b463a-c8d9-4742-909f-03fd586666c6 -->

    <Class rdf:about="http://example.org/1d1b463a-c8d9-4742-909f-03fd586666c6">
        <obo:IAO_0000115>To understand the observed differential survival, we analyzed differentially expressed genes (DEGs) within the pre-defined terminally exhausted CD8-positive TIL cluster versus all the other tumor infiltrating immune cell clusters. This analysis revealed co-expression of several genes associated with exhaustion, such as Lymphocyte Activating 3 (LAG3), TIM-3, T Cell Immunoreceptor With Ig And ITIM Domains (TIGIT), Programmed cell death protein 1 (PDCD1), CD39 (encoded by the ENTPD1 gene) and ##Cytotoxic T Lymphocyte## Associated Protein 4 (CTLA4) ( Figure 4A , left). Genes associated with cytotoxicity, such as Granzyme B (GZMB), Natural Killer Cell Granule Protein 7 (NKG7), Interferon Gamma (IFNG), Granzyme A (GZMA), Granulysin (GNLY), TNF Receptor Superfamily Member 9 (TNFRSF9/4-1BB) and CD27 were likewise upregulated ( Figure 4A , left).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9633842</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36341460</oboInOwl:hasDbXref>
        <rdfs:label>Cytotoxic T Lymphocyte</rdfs:label>
    </Class>
    


    <!-- http://example.org/1d361841-30a0-474b-95b9-e06bcda8499c -->

    <Class rdf:about="http://example.org/1d361841-30a0-474b-95b9-e06bcda8499c">
        <obo:IAO_0000115>Moreover, between m5C regulatory gene cluster 1 and m5C regulatory gene cluster 2, we identified 9 immune cell phenotypes that were statistically different, including naive B cells (P&lt;0.01), memory B cells (P&lt;0.05), plasma cells (P&lt;0.01), CD8 T cells (P&lt;0.001), resting CD4 T cells (P&lt;0.001), Tregs (P&lt;0.001), M1 macrophages (P&lt;0.001), M2 macrophages (P&lt;0.01), and ##resting dendritic cells## (P&lt;0.001) (Figures 7A-J). We extracted 4 overlapping immune cell phenotypes (naive B cells, CD8 T cells, M1 macrophages, M2 macrophages) for subsequent analyses.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9226312</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35757739</oboInOwl:hasDbXref>
        <rdfs:label>resting dendritic cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000451"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/1d361841-30a0-474b-95b9-e06bcda8499c"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000451"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/1d54906c-1aff-48e1-af86-554fa19f3b2f -->

    <Class rdf:about="http://example.org/1d54906c-1aff-48e1-af86-554fa19f3b2f">
        <obo:IAO_0000115>Postnatal development of the organ of Corti. The postnatal development is shown in this colour-coded illustration: brown = Kolliker&apos;s organ, pink = inner phalangeal cell, dark blue = inner hair cell, orange = inner pillar cell, green = outer pillar cell, light grey = Deiters&apos; cells, yellow = outer hair cells, cyan = Hensen&apos;s cells, red = tectal cells, dark grey = Bottcher and Claudius cells. a P1; In newborn mice, the organ of Corti presents itself as an ##epithelium of columnar cells##. There are no extracellular spaces. b P7; The Corti tunnel initially opens basally between the inner and outer pillared cells. c P14; The Corti tunnel has reached its full size. During the entire development, the cells increase only slightly in height. Cells of Kolliker&apos;s organ have gradually transformed into cuboidal cells of the inner sulcus and are no longer part of the cortical organ</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7723944</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32712744</oboInOwl:hasDbXref>
        <rdfs:label>epithelium of columnar cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000146"/>
        <skos:relatedMatch rdf:resource="CL:0002490"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/1d54906c-1aff-48e1-af86-554fa19f3b2f"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000146"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/1d54906c-1aff-48e1-af86-554fa19f3b2f"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002490"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/1d80cbfb-f648-43ad-9916-ea1a8897f751 -->

    <Class rdf:about="http://example.org/1d80cbfb-f648-43ad-9916-ea1a8897f751">
        <obo:IAO_0000115>Combining Seurat clustering analysis with known molecular markers for various cell types (Fig. 2B; Tables S2, S3), we segregated the single cells into 9 major cell clusters based on cell types: immune cells [Microglia, Monocyte/Macrophage, and T/NK (T cell/natural killer cell)], retinal cells [AC/HC/RGC (amacrine cell/horizontal cell/retinal ganglion cell), BC (bipolar cell), Cone, MG (Muller glia)/Astrocyte, and Rod], and vascular endothelial cells (VEC) (Fig. 2A). Comparison of control and EAU cell clusters revealed a decrease in the number of multiple neuronal types in EAU retinas, especially in the BC cluster (20.34-5.02%), Cone cluster (9.49-2.94%), and AC/HC/RGC cluster (3.76-1.28%) (Fig. 2C). In agreement, bulk RNA-seq analysis showed that in EAU retinas, there was downregulation of marker genes for all 6 ##retinal neuron## types including rods, cones, BCs, ACs, HCs, and RGCs (Fig. 2D; S2A, B). Immunostaining analysis further validated these results. In EAU retinas, there was obvious degeneration of rhodopsin+ rod inner and outer segments (Fig. 2E), and in general, progressive loss of Arrestin+ cones, Chx10+ BCs, Tfap2a+ ACs, Rbpms+ RGCs, and Calbindin+ HCs (Fig. 2F-J, L-P). By contrast, EAU did not appear to significantly alter Sox9+ Muller glia although resulting in an upregulation of their marker genes (Fig. 2K, Q). Therefore, EAU may cause not only progressive degeneration of all retinal neuron types but also a switch in the expression profile of Muller glia.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11131209</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38802924</oboInOwl:hasDbXref>
        <rdfs:label>retinal neuron</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000540"/>
        <skos:relatedMatch rdf:resource="CL:0009004"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/1d80cbfb-f648-43ad-9916-ea1a8897f751"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000540"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/1d80cbfb-f648-43ad-9916-ea1a8897f751"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0009004"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/1d9bbbd3-d94f-471c-818c-919a9a0fedc1 -->

    <Class rdf:about="http://example.org/1d9bbbd3-d94f-471c-818c-919a9a0fedc1">
        <obo:IAO_0000115>tSNE plot colored by the 17 Seurat clusters including hepatocytes, endothelial cells (liver sinusoidal endothelial cells:LSEC, non-tumor liver vascular endothelial cells:LVEC, and tumor liver vascular endothelial cells:LVECt), mesenchymal cells (Stellate cells, cancer-associated fibroblasts:CAFs, Pericytes, vascular smooth muscle cells:vSMC), immune cells (Kupffer cells, scar-associated macrophages:SAMs, tissue monocytes 1:TM1, cDC1, ##cDC2##, T cells, and B cells), proliferating cells, and carcinoma cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7746227</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33332768</oboInOwl:hasDbXref>
        <rdfs:label>cDC2</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000990"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/1d9bbbd3-d94f-471c-818c-919a9a0fedc1"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000990"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/1dc3e428-804a-4eb7-90ff-3af151d7d0fe -->

    <Class rdf:about="http://example.org/1dc3e428-804a-4eb7-90ff-3af151d7d0fe">
        <obo:IAO_0000115>The above analysis was based on a large number of RNA-seq, so we further used scRNA-seq to determine whether our ORGs signature had immune predictive value on the single cell level. Figure 7A showed that the PRAD samples from GEO datasets were annotated into Mast cell, Epithelial-NE, T/NK, Plasma_B, Epithelial, Neuron, SMC, Fibroblasts and Pericytes, Myeloid and ##Endothelial##. It was obvious that ORGs signature was specifically high in Epithelial-Nk, T/Nk and SMC cells (Figure 7B, 7C). Meanwhile, Figure 7D revealed that significant connection probability of ORGs related signaling pathways in cell clusters which showed specifically high ORGs signature. Furthermore, we chose epithelial cell for analysis. Chemotaxis related pathways including cell chemotaxis, leukocyte chemotaxis, regulation of chemotaxis and regulation of leukocyte chemotaxis were significantly up-regulated in the high ORGs signature group (Figure 7E). What&apos;s more, immune related pathways were all up-regulated in the high ORGs signature group both in GO (Figure 7F) and KEGG (Figure 7G) analysis.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10599753</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37788005</oboInOwl:hasDbXref>
        <rdfs:label>Endothelial</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000115"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/1dc3e428-804a-4eb7-90ff-3af151d7d0fe"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000115"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/1e4c882b-ecf6-47bd-89c7-d19ae1ec2b4c -->

    <Class rdf:about="http://example.org/1e4c882b-ecf6-47bd-89c7-d19ae1ec2b4c">
        <obo:IAO_0000115>Clustering of heterogeneous ##SFA interneurons##</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8123538</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33991454</oboInOwl:hasDbXref>
        <rdfs:label>SFA interneurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000099"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/1e4c882b-ecf6-47bd-89c7-d19ae1ec2b4c"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000099"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/1e5ff9be-a3e9-4d51-91c0-0545d96435a6 -->

    <Class rdf:about="http://example.org/1e5ff9be-a3e9-4d51-91c0-0545d96435a6">
        <obo:IAO_0000115>To assess tdTomato reporter functionality, the parental and the NKX2-1GFP;TP63tdTomato hiPSC lines were differentiated into early lung progenitors using a modified version of the protocols published by McCauley et al. (Fig. 2A). At day 15, NKX2-1GFP+ cells were observed in both lines, with a minority of cells tdTomato-positive (tdTomato+) (0.88 +- 1.01, n = 11) (Fig. 2B). Both lines differentiated into ##NKX2-1GFP+ lung progenitors## at similar efficiencies (Fig. 2C). The insertion of P2A-tdTomato into the TP63 locus therefore does not appear to impact lung differentiation efficiency.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7907081</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33633173</oboInOwl:hasDbXref>
        <rdfs:label>NKX2-1GFP+ lung progenitors</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002633"/>
        <skos:relatedMatch rdf:resource="CL:0011026"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/1e5ff9be-a3e9-4d51-91c0-0545d96435a6"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002633"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/1e5ff9be-a3e9-4d51-91c0-0545d96435a6"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0011026"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/1e8a600a-b9ca-495c-8ff7-134d85382660 -->

    <Class rdf:about="http://example.org/1e8a600a-b9ca-495c-8ff7-134d85382660">
        <obo:IAO_0000115>(A-C) Representative responses to cholinergic agonist (carbachol, 10 muM) by small (L-cells) (A), D-stellate (B), tuberculoventral (TV) cells (C). ##Small cells## were activated by carbachol. D-stellate and TV cells failed to respond to carbachol application. IPSCs in principal cells, bushy cells (D), and T-stellate cells (E) in the VCN were induced by carbachol application, confirming that small inhibitory neurons were local interneurons. (F, H) Time course of sIPSCs from bushy cells and T-stellate (bushy cell, tau = 7.22 +- 1.40 ms, n = 9, T-stellate, tau = 2.28 +- 0.07 ms, n = 9). (G, I) Cumulative histogram of inter-event internal under control and carbachol application. (J). Carbachol application resulted in a significant increase in sIPSCs frequency (inter-event interval, control = 280.44 +- 47.56 ms versus carbachol = 191.21 +- 28.99 ms, p&lt;0.02, t-test).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7744103</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33141020</oboInOwl:hasDbXref>
        <rdfs:label>Small cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000122"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/1e8a600a-b9ca-495c-8ff7-134d85382660"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000122"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/1ebaf6ac-4cc9-41f5-9bba-b37542e05420 -->

    <Class rdf:about="http://example.org/1ebaf6ac-4cc9-41f5-9bba-b37542e05420">
        <obo:IAO_0000115>To develop a deeper understanding of the nature of B-cell responses in COVID-19, we further divided the B-cell population into more detailed subclusters using their transcriptional signatures and SHM rate obtained from scRNA datasets ( Figures 3A-C ). Previous high-dimensional flow cytometry data indicated that severe COVID-19 patients displayed hallmarks of EF B-cell activation and shared B-cell repertoire features in autoimmune settings. Therefore, our study primarily focused on B-cell subsets representing EF responses. Here, 13 B-cell subclusters, including 3 subsets of plasma cells and 5 subsets of memory B cells, were identified by cluster analysis on UMAP ( Figure 3A ). IGHD-expressing naive B cells were subdivided into TR B cells, resting naive (RN) B cells, and activated naive (AN) B cells according to the differential expression of the specific signature gene set ( Figure 3B ). The AN B cells were IGHD-positive clusters with comparatively higher SHM rates ( Figure 3C ) than other naive B cells and expressed distinct genes, such as FGR and MPP6. During the EF response, AN B cells differentiate into effector cells lacking naive (IgD) and memory (CD27) markers or DN B cells. DN B cells showed a higher SHM rate than AN B cells and expressed ITGAX (CD11C) and CD86 ( Figures 3B, C ). A previous study also reported that the human ##EF effector B-cell## responses are mediated by the expansion of a unique population of CD11c+ AN B cells. Two clusters of atypical memory (AM1 and AM2) B cells were identified within the memory B-cell compartment, which overexpressed CD1C. Interestingly, AM2 B cells shared several transcriptional signatures, including FGR and HLA-DRB1, with EF B-cell subsets, including AN and DN cells. Both AM2 and DN B cells express ITGAX, TBX21, CD86, and ITGB2, but AM2 uniquely expressed CXCR3 and GSN (gelsolin).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9309264</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35899045</oboInOwl:hasDbXref>
        <rdfs:label>EF effector B-cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000968"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/1ebaf6ac-4cc9-41f5-9bba-b37542e05420"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000968"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/1f0191ab-7357-4680-a310-66a01a857e0d -->

    <Class rdf:about="http://example.org/1f0191ab-7357-4680-a310-66a01a857e0d">
        <obo:IAO_0000115>A, B, tSNE plot of 4659 CD45+ immune cells from the CNS. Data from this study is integrated with data from; Table 6). C, D, Each dataset represented by one tSNE. Cells are annotated using color representing their cell type. bMicroglia: baseline microglia; aMicroglia: activated microglia; pmMicroglia: proliferation-mediating microglia; maMicroglia: monocyte-activating microglia; DAM: disease-associated microglia in SCI; elMicroglia: embryonic-like microglia; pvMacrophages: perivascular macrophages; mdMacrophages: monocyte-derived macrophages; DCs: dendritic cells; imB-cells: immature B-cells; mB-cells: mature B-cells; pimMicroglia: postnatal immature microglia; IEG+Microglia: immediate early genes microglia; sMicroglia: s-phase microglia; pPAM: ##postnatal proliferative-region-associated microglia##; eMicroglia: embryonic microglia; pcpMacrophages: postnatal choroid plexus macrophages; acpMacrophages: adult choroid plexus macrophages; iMonocytes: inflammatory monocytes; pMonocytes: patrolling monocytes; cpEpithelial cells: choroid plexus epithelial cells. E, tSNE plots of 4659 CD45+ immune cells for selected genes indicating the log2(cpm) expression with a continuous color for each cell separately. F, Proliferation rate of CD45low and CD45high cells at 7 and 21 d post-SCI. Hoechst 33342 expression presented on a log-scale was used for defining cells in S-phase. Right most plot reports the percentage of cells in S-phase. Each dot represents one biological replicate (four mice per time point). Mean is surrounded by a 95% CI. This figure is extended in Extended Data Figure 8-1.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8496189</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34417326</oboInOwl:hasDbXref>
        <rdfs:label>postnatal proliferative-region-associated microglia</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000129"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/1f0191ab-7357-4680-a310-66a01a857e0d"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000129"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/1f7eba36-c953-4990-be87-7ca60e0ef50e -->

    <Class rdf:about="http://example.org/1f7eba36-c953-4990-be87-7ca60e0ef50e">
        <obo:IAO_0000115>Mesenchymal stem cells (MSCs) are ##multipotent adult stem cells## capable of self-renewal and differentiation into mesodermal lineages such as osteocytes, adipocytes and chondrocytes, as well as endodermal and ectodermal lineages. MSCs show considerable promise for clinical applications in cell therapy and regenerative medicine, especially because they are easily accessible and hold no ethical concerns, in contrast to embryonic stem cells. MSCs can be isolated from almost all adult tissues (e.g., adipose tissue, dental tissues and bone marrow) and solid organs (e.g., lungs, liver and spleen). Among these sources, adipose tissue is widely regarded as the ideal source for MSC isolation, as it has obvious advantages over other sources. First, subcutaneous adipose depots are ubiquitous and easily accessible in large quantities with a minimally invasive procedure, namely, liposuction. Second, adipose tissue usually contains far more MSCs than other sources contain. For example, MSCs constitute up to 3% of all cells in adipose tissue versus 0.01% in bone marrow. After isolation, these so-called adipose-derived mesenchymal stem cells (ADSCs) can be expanded in vitro while maintaining their differentiation potential during culture. Recently, ADSCs have emerged as a promising class of multipotent stem cells and have been widely applied in tissue repair and regeneration, such as soft tissue reconstruction, cutaneous wound healing and cardiac regeneration.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6390702</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:30806636</oboInOwl:hasDbXref>
        <rdfs:label>multipotent adult stem cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000048"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/1f7eba36-c953-4990-be87-7ca60e0ef50e"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000048"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/1f86d817-a8d3-45e1-ae97-8e08cc494dc2 -->

    <Class rdf:about="http://example.org/1f86d817-a8d3-45e1-ae97-8e08cc494dc2">
        <obo:IAO_0000115>Refinement and annotation of cell clusters in colon tissues. A Reclustering of cells and its UMAP projection in colon tissues. B &quot;Ground truth&quot; cell cluster labels derived from manual cell annotation based on the marker map. C Annotation results based on ACT. D A Sankey diagram to show the comparison of annotation results. Cell types that might be mislabeled are shown in the red box. E Epithelial cells and goblet cells correspond to the iCMS2 and iCMS3 subgroups in the original publication, respectively. CD4_Tn, Naive thymus-derived CD4-positive, alpha-beta T cell; Th17, T helper 17 cell; Treg, Regulatory T cell; CD8_Tem, Effector memory CD8-positive alpha, beta T cell; CTL, Cytotoxic T cell; NK, Natural killer cell; FO_B, Follicular B cell; Plasma, Plasma cell; mregDC, Migratory dendritic cell; Glial, Glial cell, i.e., Entericglial cell; Endo, Endothelial cell; Endo_lymphatic, Lymphatic endothelial cell; Fibro, Fibroblast; Myof, Myofibroblast cell; Goblet, Goblet cell; Epi_colon, Colon epithelial cell; Goblet_T, Malignant goblet cell; Goblet_N, Normal goblet cell; McDC, ##Monocyte conventional dendritic cell##; pDC, Plasmacytoid dendritic cell</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10623726</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37924118</oboInOwl:hasDbXref>
        <rdfs:label>Monocyte conventional dendritic cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000990"/>
        <skos:relatedMatch rdf:resource="CL:0011031"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/1f86d817-a8d3-45e1-ae97-8e08cc494dc2"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000990"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/1f86d817-a8d3-45e1-ae97-8e08cc494dc2"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0011031"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/1fb13f74-f579-4f54-924a-be707134dc9b -->

    <Class rdf:about="http://example.org/1fb13f74-f579-4f54-924a-be707134dc9b">
        <obo:IAO_0000115>We also examined the percentages of individual cell lineages in early quadruplets and control blastocysts (Fig. 5e; Supplementary Tables S5, S6). Quadruplet blastocysts had a higher percentage of TE cells than controls (82.7% +- 7.3% vs. 73.7% +- 7.8%; p = 0.0003). In addition, the proportion of ##PE progenitors## in the quadruplets was smaller compared to the control blastocysts (4.9% +- 4.1% vs. 10.7% +- 2.8%; p &lt; 0.0001). In turn, the percentage of EPI progenitors was similar in both groups: 12.4% +- 6.3% in early quadruplets and 15.6% +- 7.1% in controls.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8563712</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34728646</oboInOwl:hasDbXref>
        <rdfs:label>PE progenitors</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000223"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/1fb13f74-f579-4f54-924a-be707134dc9b"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000223"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/10a295d2-fa44-4b5f-b8c8-0f598dd00d1b -->

    <Class rdf:about="http://example.org/10a295d2-fa44-4b5f-b8c8-0f598dd00d1b">
        <obo:IAO_0000115>As an independent method to establish the similarity between cell types identified in the different studies, we employed neural-network-based probabilistic scoring modules for learning cell-type features between datasets. We trained the modules using both mouse datasets and using all three nomenclature versions (Zeisel and Usoskin nomenclatures for Zeisel data; Sharma nomenclature for Sharma data) (Supplementary Fig. 4a-i). We then tested the performance of these modules in finding the corresponding cell types between the datasets and found that the modules detected with high probability cell types across the different datasets and that the cell-type assignments concurred with the results obtained by the label transfer. For the rest of our analyses we used the Usoskin type nomenclature as the default naming. Taken together, the results confirmed a one-to-one relationship between nociceptor types identified in refs.  although the ##Adelta-nociceptors## of Zeisel were split into two subtypes in Sharma (Fig. 2a-i). Because Usoskin nomenclature performed with the least noise and greatest prediction scores, we used this nomenclature for the rest of our analyses.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7940623</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33686078</oboInOwl:hasDbXref>
        <rdfs:label>Adelta-nociceptors</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000198"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/10a295d2-fa44-4b5f-b8c8-0f598dd00d1b"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000198"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/10c6e921-7a78-401c-b112-3032d31a4279 -->

    <Class rdf:about="http://example.org/10c6e921-7a78-401c-b112-3032d31a4279">
        <obo:IAO_0000115>Specifically, we show here that PLZF-defined spermatogonia, though retaining PLZF-positivity, are transcriptionally distinct at PND6 compared to later developmental time points. These transcriptional dynamics are also reflected by distinct differences at the protein level, with proteins such ASRGL1 being localized strongly in PLZF+ spermatogonia during the first weeks of life, but decreasing in expression in these cells around three weeks of age (Fig 8). Similarly, we show that Prophase I spermatocytes possess significant transcriptional differences in the first-wave compared to subsequent spermatogenic waves, with hundreds of differentially expressed genes across multiple regulatory pathways. Furthermore, direct inspection of pachytene spermatocytes from the first wave at PND13 to later spermatogenic waves reveals that, like spermatogonia, transcript dynamics are also reflected at the protein level. For example, proteins such as DMRTB1 are found only in the nuclei of first-wave ##leptotene spermatocytes## as they transition from differentiated spermatogonia into the meiotic program, but not in spermatocytes from older mice (Fig 10). By contrast, other proteins such as ASRGL1 are in low abundance in early first-wave spermatocytes, but become more strongly immunolocalized in spermatocytes at increasing ages (Fig 9).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6443194</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:30893341</oboInOwl:hasDbXref>
        <rdfs:label>leptotene spermatocytes</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000656"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/10c6e921-7a78-401c-b112-3032d31a4279"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000656"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/10d36496-6876-4f53-ac8d-57cfb3bffd98 -->

    <Class rdf:about="http://example.org/10d36496-6876-4f53-ac8d-57cfb3bffd98">
        <obo:IAO_0000115>Neutrophil CD64 expression has been used as a diagnostic marker of infection and sepsis in the ICU and was found to be superior to C-reactive protein and hematological determinations for detecting systemic infection or sepsis. However, these studies did not distinguish between the differential marker expression due to mature neutrophil activation or due to appearance of another neutrophil population. Because we observed no CD64 expression on mature neutrophils, either from NDN or LDN fractions in GCA (Figure 1), we hypothesize that detection of CD64 expression on neutrophils in sepsis is likely to represent the presence of CD10loCD64+ myelocytes/metamyelocytes in the neutrophil pool. Coincidentally, in a recently deposited open-access manuscript, Meghraoui-Kheddar et al. used a similar single-cell CyToF strategy to identify 2 CD64+ neutrophil subsets unequivocally associated with an onset of sepsis. CD123 and PD-L1 were reported to be the additional and distinctive cellular markers for sepsis-induced CD64+ immature neutrophils compared with noninfectious inflammatory syndrome. Indeed, we observed no CD123 and very weak PD-L1 expression on CD64+ immature neutrophils of GCA patients (Figure 1), supporting a possible new demarcation between ##CD10loCD64+## released in response to infection and sterile inflammation.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7605529</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32960815</oboInOwl:hasDbXref>
        <rdfs:label>CD10loCD64+</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002192"/>
        <skos:relatedMatch rdf:resource="CL:0002193"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/10d36496-6876-4f53-ac8d-57cfb3bffd98"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002192"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/10d36496-6876-4f53-ac8d-57cfb3bffd98"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002193"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/10f031ab-fd2a-45c9-8c1e-d5ae285519b9 -->

    <Class rdf:about="http://example.org/10f031ab-fd2a-45c9-8c1e-d5ae285519b9">
        <obo:IAO_0000115>Transplantation of ##stem cells## from umbilical cord blood as therapy for type I diabetes.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMID:31209568</oboInOwl:hasDbXref>
        <rdfs:label>stem cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002569"/>
        <skos:relatedMatch rdf:resource="CL:2000095"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/10f031ab-fd2a-45c9-8c1e-d5ae285519b9"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002569"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/10f031ab-fd2a-45c9-8c1e-d5ae285519b9"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:2000095"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/10f83c08-a83d-4ee9-93ca-343206a275c4 -->

    <Class rdf:about="http://example.org/10f83c08-a83d-4ee9-93ca-343206a275c4">
        <obo:IAO_0000115>Although the induced Ca2+ activity persisted under the glutamatergic inhibition for c+ primary neurons, excitability of the secondary neurons discontinued. Secondary neurons exhibited two common excitation profiles depending on whether they were silent or spontaneously active before stimulation. These two profiles were encountered in equal frequencies 30% (both 7 out of 22) all throughout the experiments. In Fig 5B, the c+ primary neuron was observed to excite a previously silent ##secondary neuron##. In the blocked case this excitation was not observed as shown via correlation analysis (p&lt;0.05). A video of this experiment is provided in S1A and S1B Video. Fig 5C shows an example for a secondary neuron which was spontaneously active before stimulation. Spontaneous activity of the secondary neuron was modulated with the induced Ca2+ activity of the primary neuron. Excitation of the secondary neuron continued through the stimulation and the in-phase modulation vanished in the blocked case (p&lt;0.05).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7928449</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33657119</oboInOwl:hasDbXref>
        <rdfs:label>secondary neuron</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000540"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/10f83c08-a83d-4ee9-93ca-343206a275c4"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000540"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/100d8593-a316-4581-b25c-9fc0f0c0ac55 -->

    <Class rdf:about="http://example.org/100d8593-a316-4581-b25c-9fc0f0c0ac55">
        <obo:IAO_0000115>Not all M. tuberculosis-specific T cells efficiently recognize M. tuberculosis-infected macrophages, depending on the antigen and the number of bacilli per macrophage. It is unknown whether the interaction of CD4 and CD8 T cells with M. tuberculosis-infected cells varies depending on the type of infected cell. We hypothesize that some M. tuberculosis bacilli occupies a protected cellular niche. We reasoned that for cell types in which M. tuberculosis could be eliminated or its growth restricted by T cells, T cell depletion would lead to an increase in infected cells. In contrast, for cell types in which M. tuberculosis persists, even in the face of T cell pressure, T cell depletion should have minimal effect. Here we report that CD4 and CD8 T cells cooperate to restrict M. tuberculosis infection in several types of infected cells. M. tuberculosis-infection in AM is efficiently controlled by T cells, particularly by CD4 T cells. In contrast, both CD4 and CD8 T cells are required to restrict M. tuberculosis replication in ##MDM##. Interestingly, T cell depletion had the least effect on MDM compared to other cell types. This hierarchy is the reverse of the intrinsic capacity of AM and MDM to control bacterial replication early after infection. Thus, depending on the cell type, the influence of T cells on M. tuberculosis containment varies. We propose that although T cell interact with M. tuberculosis-infected MDM, they have a limited ability to restrict infection in these cells. Although MDM are better than AM in their intrinsic capacity to restrict intracellular M. tuberculosis, once T cell immunity is initiated, AM largely inhibit M. tuberculosis growth while T cells contribute only modestly to the ability of MDM to limit intracellular infection.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11231272</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38977711</oboInOwl:hasDbXref>
        <rdfs:label>MDM</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
        <skos:relatedMatch rdf:resource="CL:0000576"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/100d8593-a316-4581-b25c-9fc0f0c0ac55"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/100d8593-a316-4581-b25c-9fc0f0c0ac55"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000576"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/10094147-c211-455b-9750-9cfece4c7038 -->

    <Class rdf:about="http://example.org/10094147-c211-455b-9750-9cfece4c7038">
        <obo:IAO_0000115>We compared the functional differences between similar types of epithelial cells in the TZ and the PZ. GSVA revealed that angiogenesis- and inflammation-related pathways were activated in all epithelial cells in the TZ (Figure 4A). Oestrogen, mTOR and stem/progenitor cell biology-regulated NOTCH signalling were more activated in TZ club and hillock cells than in the PZ (Figure 4A). Both oestrogen and mTOR pathways can serve as therapeutic targets for BPH. The E2F targets, the MYC targets and the DNA repair pathway were enriched in ##PZ luminal cells## (Figure 4A).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9574492</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36245324</oboInOwl:hasDbXref>
        <rdfs:label>PZ luminal cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002340"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/10094147-c211-455b-9750-9cfece4c7038"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002340"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/1011ec6f-779d-4fa4-bfed-2065502e7c14 -->

    <Class rdf:about="http://example.org/1011ec6f-779d-4fa4-bfed-2065502e7c14">
        <obo:IAO_0000115>Macrophages are multi-functional innate immune cells that orchestrate tissue repair, immune responses and inflammation. First described by Elie Metchnikoff, macrophages are derived from embryonic haematopoietic progenitors or monocytes and differentiate into tissue macrophages after entering the tissue. Because macrophages play an indispensable role in maintaining systemic homeostasis and participating in immune defence against pathogens and cellular debris, they are widely distributed across various tissues, including the salivary glands. Recent studies have shown that macrophages perform several other functions in addition to phagocytosis. Macrophages and T cells can collectively regulate inflammation and participate in various functions such as phagocytosis and antigen presentation. This phenomenon has been partly confirmed in a noninflamed murine submandibular salivary gland model, as macrophages facilitate the local accumulation of ##tissue-resident memory CD8+ T cells## (T+ RM) at the site of inflammation. Tissue-resident immune cells are thought to be complemented by salivary gland progenitor cells (SGPCs) for the maintenance of normal salivary gland homeostasis. Upon tissue damage, epithelial cells release inflammatory factors and recruit macrophages to induce inflammatory responses. Through their uncontrolled and rapid cytokine production, macrophages recruit more immune cells to amplify the local inflammatory response, thereby bridging innate and adaptive immunity.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10656691</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38022546</oboInOwl:hasDbXref>
        <rdfs:label>tissue-resident memory CD8+ T cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000907"/>
        <skos:relatedMatch rdf:resource="CL:0000913"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/1011ec6f-779d-4fa4-bfed-2065502e7c14"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000907"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/1011ec6f-779d-4fa4-bfed-2065502e7c14"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000913"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/1027fdc2-5059-441e-92d2-e5a870b1cc71 -->

    <Class rdf:about="http://example.org/1027fdc2-5059-441e-92d2-e5a870b1cc71">
        <obo:IAO_0000115>Our novel multi-color flow cytometry panel was also tested on mouse skin. After excluding cellular debris, doublets, and dead cells, we gated with the help of FMO controls (Fig. S10) on viable CD45+ cells (Fig. 2A). In healthy skin, the CD3+ T cell population consists of ##CD3intCD4+ T cells## and CD3highgammadelta T cells, whereas CD8+ T cells, NK cells, B cells, neutrophils and pDC are rare in healthy skin (Fig. 2B). By following gating published earlier, we identified several myeloid non-DC populations (P1-P5) in the dermis (Fig. 2C) and different DC-subsets (Fig. 2D, E). From the non CD11b+CD24- population we identified CD11c+MHC-II+ DC. Next, we divided DC into XCR1+ cDC1, which contain CD103+ and CD103- subsets, and CD172a+ DC which consists mainly of CD207+ LC (Fig. 2D). Dermal cDC2 are characterized from the CD64-Ly-6C- population by gating on CD11c+MHC-II+ cells that express CD11b and CD172a (Fig. 2E). In addition, we investigated CD115, F4/80 and CD64 expression on the non-DC myeloid cell populations P1-P5 (Fig. 2F). Analysis of CD40, PD-L1, PD-L2 and CCR7 on the different DC-subets allows further phenotypical characterization (Fig. 2G). An example for UMAP analysis is shown in Figure S11 confirming manual gating for DC-subsets and non-DC populations.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10087122</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35944142</oboInOwl:hasDbXref>
        <rdfs:label>CD3intCD4+ T cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000624"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/1027fdc2-5059-441e-92d2-e5a870b1cc71"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000624"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/10343e28-845f-458c-ac4c-8d18c510ba47 -->

    <Class rdf:about="http://example.org/10343e28-845f-458c-ac4c-8d18c510ba47">
        <obo:IAO_0000115>The retinal neurovascular unit refers to the interdependency between vascular endothelial cells, pericytes, ##glia##, neurons, and immune cells. A better understanding of the contribution of each cell type to DR progression and the molecular mechanisms regulating their crosstalk could be the key to identify new therapeutic targets. In addition to retinal vascular alterations, fibrovascular scarring can ultimately lead to blindness. Fibrosis is an intricate, reparative process that develops in response to acute or chronic injury. The mechanisms that drive fibrosis in DR are not fully understood; hence, there is a great need to better understand this important cause of vision loss. This would be a first step toward new therapies to address progressive preretinal fibrosis and traction detachment and to avoid the concomitant poor visual and anatomic outcomes.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10896003</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37917183</oboInOwl:hasDbXref>
        <rdfs:label>glia</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000636"/>
        <skos:relatedMatch rdf:resource="CL:4033015"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/10343e28-845f-458c-ac4c-8d18c510ba47"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000636"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/10343e28-845f-458c-ac4c-8d18c510ba47"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4033015"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/10348e94-a96e-4627-ba3a-d30f13b0c402 -->

    <Class rdf:about="http://example.org/10348e94-a96e-4627-ba3a-d30f13b0c402">
        <obo:IAO_0000115>PROBLEM: During pregnancy, the decidual spiral arterioles (SpAs) that supply maternal blood to the placenta undergo a series of changes to optimise the transfer of nutrients and oxygen to the developing foetus. Recent studies have shown that initiation of SpA transformation coincides with ##decidual leucocyte## infiltration. Leucocytes are known to be a source of matrix metalloproteinases (MMPs); however, the complete profile of MMPs expressed by decidual NK cells (dNK) and macrophages has not been characterised. We hypothesised that leucocyte-derived MMPs contribute to SpA remodelling. METHODS: Decidual NK cells and macrophages were isolated from first trimester decidua and their MMP repertoire profiled by qRT-PCR (n = 10; 5-11 weeks). Dual immunofluorescence was used to localise MMP expression in situ (n = 3; 5-12 weeks). Gelatin zymography was carried out to assess whether leucocyte-derived MMPs can degrade ECM. In situ zymography and immunofluorescence identified MMP activity in tissue-resident dNK and macrophages. RESULTS: Decidual NK cells cells and macrophages expressed MMP2, -7, -9, -11, -16, -19 and tissue inhibitors of metalloproteinase-1, -2, and -3. Both cell types degraded gelatin using MMP2 and MMP9 and broke down collagen in an in vitro model of the SpA. Extravillous trophoblasts (EVTs) expressed a similar repertoire of MMPs. CONCLUSION: We suggest that matrix remodelling in SpA is initiated by infiltrating leucocytes, while EVTs become involved at later stages.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMID:30267451</oboInOwl:hasDbXref>
        <rdfs:label>decidual leucocyte</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000738"/>
        <skos:relatedMatch rdf:resource="CL:2000002"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/10348e94-a96e-4627-ba3a-d30f13b0c402"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000738"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/10348e94-a96e-4627-ba3a-d30f13b0c402"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:2000002"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/10467de5-7953-499b-bdd4-ffd5b44fe8d7 -->

    <Class rdf:about="http://example.org/10467de5-7953-499b-bdd4-ffd5b44fe8d7">
        <obo:IAO_0000115>Six-week-old male Lgr4iKO mice and littermates were fed normal chow diet (NCD) for 12 weeks. Single cell RNA sequencing was used to obtain intestinal epithelium single cell transcriptome data from 18-week-old Lgr4iKO mice and littermates. n = 3. a t-SNE plot showing stem cell, TA cell, absorptive cell, goblet cell, paneth cell, enteroendocrine cell and tuft cell marker genes expression in intestinal epithelium. b Defining cell populations with marker gene expression. c Pseudotime ordering on intestinal epithelium cells. d Re-clustering absorptive cells. Enterocytes selective for absorption of long-chain fatty acid, carbohydrate, or both were defined by the expression of Cd36 Fatp4 Glut2 and Sglt1. e The proportions of long-chain fatty acid-absorptive enterocytes, ##carbohydrate-absorptive enterocytes##, and long-chain fatty acid and carbohydrate-absorptive enterocytes.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11116434</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38782937</oboInOwl:hasDbXref>
        <rdfs:label>carbohydrate-absorptive enterocytes</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000584"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/10467de5-7953-499b-bdd4-ffd5b44fe8d7"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000584"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/107c7698-e9a6-488a-9e70-8d435fc81f5d -->

    <Class rdf:about="http://example.org/107c7698-e9a6-488a-9e70-8d435fc81f5d">
        <obo:IAO_0000115>We undertook a comprehensive Mendelian randomization study aimed at uncovering the causal relationship between 744 immune cell types and IVDD [ Supplementary Table 2 ]. In our analysis, we identified 24 specific blood types of immune cells that demonstrated a causal association with disc degeneration through univariable MR [ Supplementary Table 3 ], including Memory B cell %B cell, Naive-mature B cell %B cell, IgD-CD38dim B cell %lymphocyte, CD39+activated CD4 regulatory T cell %CD4 regulatory T cell, CD39+ secreting CD4 regulatory T cell %CD4 regulatory T cell, CD45RA+ CD8+ T cell %CD8+ T cell, CD8+ T cell %leukocyte, CD39+CD4+ T cell %T cell, CD39+ CD4+ T cell %CD4+ T cell,CD39+ CD8+ T cell %T cell, CD39+ CD8+ T cell Absolute Count, CD127- CD8+ T cell Absolute Count, ##CD28- CD8+ T cell## Absolute Count, CD19 on IgD+ CD38+ B cell, CD19 on IgD+ CD38dim B cell, CD19 on IgD- CD38- B cell, CD19 on unswitched memory B cell, CD19 on transitional B cell, CD24 on IgD+ CD38+ B cell,CD28 on CD39+ secreting CD4 regulatory T cell, CD25 on CD39+ CD4+ T cell, CD4 on CD39+ CD4+ T cell, CD4 on CD39+ resting CD4 regulatory T cell and Neutrophil count. We excluded certain exposures due to a limited number of available SNPs to prevent potential bias, including Memory B cell %B cell, Naive-mature B cell %B cell, IgD-CD38dim B cell %lymphocyte, CD8+T cell %leukocyte, CD127-CD8+ T cell Absolute Count, CD19 on IgD-CD38-B cell, CD24 on IgD+ CD38+ B cell, CD28 on CD39+ secreting CD4 regulatory T cell and CD4 on CD39+ resting CD4 regulatory T cell.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10806224</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38268919</oboInOwl:hasDbXref>
        <rdfs:label>CD28- CD8+ T cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000625"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/107c7698-e9a6-488a-9e70-8d435fc81f5d"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000625"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/110713f6-186d-4727-b64f-81a48f79fd12 -->

    <Class rdf:about="http://example.org/110713f6-186d-4727-b64f-81a48f79fd12">
        <obo:IAO_0000115>Notch signaling is a highly conserved signal transduction pathway, which plays a critical role in cell differentiation and proliferation, and influences cell fate decision in multiple organisms and tissues, including epidermis and its appendages. The mammalian Notch signaling pathway consists of four Notch receptors (Notch 1, 2, 3, and 4) and five Notch ligands (Jagged-1 and Jagged-2 and Delta-like 1, 3, and 4). In psoriatic lesions, Notch signaling molecules have been found to be highly expressed with a frequent and diffuse mode. In addition, Notch signaling is hyperactivated and participated in the regulation of keratinocyte proliferation and differentiation and vascular endothelial cell function as well as early T cell development in the thymus and modulation of ##peripheral T cell## differentiation. Hes1, an important downstream target gene of Notch signaling, has been reported to be critically involved in the development of IL-17-producing gammadeltaT cells. To determine whether Notch-Hes1 signaling can regulate the function of IL-17A+gammadelta+T cells within the disease situation of psoriasis, we inhibit Notch-Hes1 signaling by gamma-secretase inhibitor DAPT to determine the possible regulating function of Notch-Hes1 signaling on IL-17A+gammadelta+T cell expression and IL-17A secretion in mouse psoriasis-like skin inflammation.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7240798</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32454795</oboInOwl:hasDbXref>
        <rdfs:label>peripheral T cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000084"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/110713f6-186d-4727-b64f-81a48f79fd12"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000084"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/111acf82-60b0-48f1-8c48-fe4b041d4320 -->

    <Class rdf:about="http://example.org/111acf82-60b0-48f1-8c48-fe4b041d4320">
        <obo:IAO_0000115>In the mouse placenta, there are two lineages of trophoblast cells, the invasive and structural cells, which arise from the trophoblast stem progenitor cells. Trophoblast giant cells are the invasive cells responsible for invading the maternal vasculature and transforming the spiral arteries into high-velocity, low-resistant vessels. Four sub-types of trophoblast giant cells exist, including spiral artery trophoblast giant cells and parietal trophoblast giant cells, which reside in the decidual layer. The canal trophoblast giant cells and sinusoidal trophoblast giant cells are in the labyrinth. The structural cells of the placenta include those located within the junctional zone and the remaining cells of the labyrinth. The spongiotrophoblast and glycogen trophoblast cells are within the junctional zone. The spongiotrophoblast cells are thought to contribute a supportive role to the developing labyrinth and feed into the trophoblast giant cell progenitor pool, while glycogen cells, which arise from the spongiotrophoblast cells, are thought to accumulate glycogen and can migrate into the maternal decidua for spiral artery remodeling. The two different types of syncytiotrophoblast cells, ##syncytiotrophoblast-I## and syncytiotrophoblast-II, are located within the labyrinth zone. These cells function in the material exchange between the mother and fetus and, along with the sinusoidal trophoblast giant cells, make up the interhemal membrane. However, the specific functions of some of these cells are not well understood.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10459728</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37630754</oboInOwl:hasDbXref>
        <rdfs:label>syncytiotrophoblast-I</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000525"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/111acf82-60b0-48f1-8c48-fe4b041d4320"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000525"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/113e73b0-9c8a-49b1-bacf-f44d6135fabc -->

    <Class rdf:about="http://example.org/113e73b0-9c8a-49b1-bacf-f44d6135fabc">
        <obo:IAO_0000115>a Schematic overview of the experimental workflow. Forebrain samples were collected from Sox2eGFP mice at 11 developmental timepoints, dissociated into single cells followed by sorting of the GFP + ve /-ve cells and performing single-cell RNA-seq using the 10x Genomics Chromium platform. b Left: two-dimensional Uniform manifold approximation and progression (UMAP) plot with Leiden clustering of 102,504 individual cells identifying 28 transcriptionally and biologically distinct cell types (see Supplementary Fig. 3a and Methods). Each dot represents a single cell and colours correspond to the distinct clusters/cell types. Shown on the right is a dot plot showing the relative fraction (dot size) of the 28 cell types at each developmental timepoint normalized by library size. c UMAP plot of the cells as in (b) but coloured by timepoint. Each dot represents a single cell and the colours correspond to the different timepoints. d, UMAP plot showing the coarse annotation of cells into 4 categories (Neuronal, Glial, Immune and Vascular/other) based on logistic regression from Zeisel et al. 2018. The RNA-velocity field is overlaid on the UMAP. Colours represent the 4 categories of cell annotation and the arrows correspond to the direction of the RNA-velocity flow field (see Methods). RG Radial glia, TAPs Transient amplifying progenitors, ##aNSCs## Active neural stem cells, APCs Astrocyte progenitor cells, EmNBs Embryonic neuroblasts, GE NBs Ganglionic eminence neuroblasts, OPCs Oligoprogenitor cells, PreM-ODCs Immature pre-myelinating oligodendrocytes, INs Interneurons, ImStNeurons Immature striatal neurons, VLMC Vascular leptomeningeal cells, Myeloid-DSCs Myeloid-derived suppressor cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9296666</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35853870</oboInOwl:hasDbXref>
        <rdfs:label>aNSCs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000047"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/113e73b0-9c8a-49b1-bacf-f44d6135fabc"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000047"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/116f7cc6-e08c-4d20-bde5-25443967e74c -->

    <Class rdf:about="http://example.org/116f7cc6-e08c-4d20-bde5-25443967e74c">
        <obo:IAO_0000115>K2Taxonomer was remarkably accurate in capturing the higher-order organization of the 28 cell types. The first partition separated all epithelial cell subtypes from non-epithelial cell types (Figure 4B). Further partitioning of the 17 epithelial cell subtypes yielded five subgroups, characterized by shared morphology, labeled as &apos;Ciliated&apos;, &apos;Basal&apos;, &apos;Submucosal&apos;, &apos;Brush-like&apos; and &apos;AE&apos; (Alveolar Epithelium). The &apos;Ciliated&apos; subgroup was comprised of differentiated multiciliated cells and their precursor, deuterosomal cells. The &apos;Basal&apos; subgroup was comprised of ##epithelial cell progenitors##, basal and cycling basal cells, as well as epithelial cell intermediary, suprabasal cells. The &apos;Brush-like&apos; subgroup was comprised of three rare airway epithelial cell types: brush, ionocyte, and pulmonary neuroendocrine cells (PNECs), as well as their likely shared &apos;brush-like&apos; precursor cells, as suggested in the original publication of these data. Further partitioning of the 11 non-epithelial cell types yielded two main subgroups characterized by shared progenitor cells: immune and mesenchymal stem cells, with the immune cell subgroup also including endothelial cells. Further partitions of the immune cell subgroup included progeny of monoblasts: monocytes, dendritic cells, and macrophages , followed by endothelial cells separated from all non-monoblast progeny immune cells subtypes in the adjacent subgroup.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8464061</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34226941</oboInOwl:hasDbXref>
        <rdfs:label>epithelial cell progenitors</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000066"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/116f7cc6-e08c-4d20-bde5-25443967e74c"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000066"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/1177434f-9300-4f82-ab1c-fe47963a535f -->

    <Class rdf:about="http://example.org/1177434f-9300-4f82-ab1c-fe47963a535f">
        <obo:IAO_0000115>Astrocytes play many important functions in response to spinal cord injury (SCI) in an activated manner, including clearance of necrotic tissue, formation of protective barrier, maintenance of microenvironment balance, interaction with immune cells, and formation of the glial scar. More and more studies have shown that the astrocytes are heterogeneous, such as ##inflammatory astrocyte 1## (A1) and neuroprotective astrocyte 2 (A2) types. However, the subtypes of astrocyte resulting from SCI have not been clearly defined. In this study, using single-cell RNA sequencing, we constructed the transcriptomic profile of astrocytes from uninjured spinal cord tissue and injured tissue nearby the lesion epicenter at 0.5, 1, 3, 7, 14, 60, and 90 days after mouse hemisection spinal cord surgery. Our analysis uncovered six transcriptionally distinct astrocyte states, including Atp1b2+ , S100a4+ , Gpr84+ , C3+ /G0s2+ , GFAP+ /Tm4sf1+ , and Gss+ /Cryab+ astrocytes. We used these new signatures combined with canonical astrocyte markers to determine the distribution of morphologically and physiologically distinct astrocyte population at injured sites by immunofluorescence staining. Then we identified the dynamic evolution process of each astrocyte subtype following SCI. Finally, we also revealed the evolution of highly expressed genes in these astrocyte subtypes at different phases of SCI. Together, we provided six astrocyte subtypes at single-cell resolution following SCI. These data not only contribute to understand the heterogeneity of astrocytes during SCI but also help to find new astrocyte subtypes as a target for SCI repair.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMID:35816276</oboInOwl:hasDbXref>
        <rdfs:label>inflammatory astrocyte 1</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002627"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/1177434f-9300-4f82-ab1c-fe47963a535f"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002627"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/118b0521-8366-473f-b70f-e2d5d50d30d3 -->

    <Class rdf:about="http://example.org/118b0521-8366-473f-b70f-e2d5d50d30d3">
        <obo:IAO_0000115>Interestingly, as MZB numbers rapidly declined following the first peak of infection, so do splenic innate B1 cell number. This population was annotated using S100A6 as a gene marker for differentiation of these cells from the major B2 spleen cell B cell population. This Annexin A2 binding protein coding gene has previously been shown to be upregulated during the B1 activation process. In addition, high expression of the Zbtb20 transcription factor allowed distinguishing these cells from the very similar ##atMBCs##. The Bhlhe41 and Fcrl5 genes on the other hand have been either linked to the generation of B1 B cells or the counter regulation of BCR signaling in innate B cells. So far, there have been no reports on spleen B1 B cell function in experimental mouse trypanosomosis, possibly because of the difficulty to observe these cells in flow cytometry. In contrast, in T. evansi infected sheep and T. congolense infected cattle the presence of CD5+ B1 cells has been reported, indicting the host-specific involvement of these innate cells in trypanosome immunity. Interestingly, mouse B1 B cells are activated by CpG DNA, through TLR9 engagement, driving T cell independent immunity. TLR9 engagement is involved in trypanosomosis associated IFNgamma induction as well as parasitemia control of T. b. rhodesiense. As TLR/MyD88 signaling gives rise to VSG-specific antibody induction, and TLR signaling appears crucial for maintenance of B cell memory, CpG DNA has even been proposed as an adjuvant in anti-trypanosome vaccine approaches. Finally, it is worth nothing that IgM+ B1 B cells have also been shown to play an important role in malaria-associated antibody production as well as M. tuberculosis associated IgM secretion.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8610246</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34762705</oboInOwl:hasDbXref>
        <rdfs:label>atMBCs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000787"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/118b0521-8366-473f-b70f-e2d5d50d30d3"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000787"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/12ad4a8f-2f02-4c1c-96a7-1496d7ee8c74 -->

    <Class rdf:about="http://example.org/12ad4a8f-2f02-4c1c-96a7-1496d7ee8c74">
        <obo:IAO_0000115>Cancer-associated fibroblasts (CAF) form the basis of tumor microenvironment and possess immunomodulatory functions by interacting with other cells surrounding tumor, including T lymphocytes, macrophages, dendritic cells and natural killer cells. Ionizing radiation is a broadly-used method in radiotherapy to target tumors. In mammalian cells, ionizing radiation induces various types of DNA damages and DNA damage response. Being unspecific, radiotherapy affects all the cells in tumor microenvironment, including the tumor itself, ##CAFs## and immune cells. CAFs are extremely radio-resistant and do not initiate apoptosis even at high doses of radiation. However, following radiation, CAFs become senescent and produce a distinct combination of immunoregulatory molecules. Radiosensitivity of immune cells varies depending on the cell type due to inefficient DNA repair in, for example, monocytes and granulocytes. In this minireview, we are summarizing recent findings on the interaction between CAF, ionizing radiation and immune cells in the tumor microenvironment.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7696681</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33207781</oboInOwl:hasDbXref>
        <rdfs:label>CAFs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000057"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/12ad4a8f-2f02-4c1c-96a7-1496d7ee8c74"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000057"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/12eb9930-9c5f-4e65-ab74-31fe029fb0c8 -->

    <Class rdf:about="http://example.org/12eb9930-9c5f-4e65-ab74-31fe029fb0c8">
        <obo:IAO_0000115>Cells Young Lymph Node Old Lymph Node   T lymphocytes effective activation of T cells by antigensefficient proliferationproduction of effector cytokinesmigration to peripheral tissues to fulfill effector functions impaired homeostatic proliferation of T cellsdisturbed movement, localization, and responsesreduced size of the naive T-cell pool including CD4+ and CD8+ T cells, increased memory T lymphocyte poolincreased CD4+ to CD8+ T-cell ratioCD4+ T lymphocyte depletion in the paracortical zonedecreased number of regulatory T-cells in the cords and medullary sinusesreduced number of CD4+ PD1hi Tfh cells and increased number of ##CD4+ FoxP3hi and Lag3hi suppressor T cells## in germinal centers   B lymphocytes correct interactions between B lymphocytes, follicular T helper lymphocytes, and FDCs in germinal centersadequate activation, proliferation, somatic hypermutation, and maturation of antigen-specific B-cellseffective production of antigen-specific antibodies decreased number of CD20hi Ki67hi proliferating B cells in germinal centersloss of an organized B-cell structure in the follicles after immune stimulationdisrupted reciprocal regulation between B and Tfh lymphocytes resulting in an impaired antigen-specific B-cell response and effective selection of lymphocytes producing specific antibodiesimpaired production of IgM and IgG antibodiesdecreased expression of the E47 transcription factor and activation-induced cytidine deaminase resulting in the production of antibodies with reduced affinity for foreign antigensweakened antibody neutralizing function   Neutrophils effective recruitment of neutrophils to the draining lymph nodes upon microbial, viral, or sterile stimulisearch for and capture antigensrelease leukotriene B4 initiating the recruitment of other neutrophils from the vascular systemupon activation, release granular proteins and chromatin, forming extracellular fibers capturing microorganisms to prevent their spread increased number and percentage of not proliferating old neutrophils in the T- and B-cell zones of the lymph nodesweak response to chemotactic signalsdecreased apoptosisdecreased phagocytosisincreased percentage of neutrophils expressing integrin CD11b, ICAM-1, and TGF-beta suggesting involvement in a chronic inflammatory state   </obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8621398</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34831371</oboInOwl:hasDbXref>
        <rdfs:label>CD4+ FoxP3hi and Lag3hi suppressor T cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000902"/>
        <skos:relatedMatch rdf:resource="CL:0000903"/>
        <skos:relatedMatch rdf:resource="CL:0000919"/>
        <skos:relatedMatch rdf:resource="CL:0001041"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/12eb9930-9c5f-4e65-ab74-31fe029fb0c8"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000902"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/12eb9930-9c5f-4e65-ab74-31fe029fb0c8"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000903"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/12eb9930-9c5f-4e65-ab74-31fe029fb0c8"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000919"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/12eb9930-9c5f-4e65-ab74-31fe029fb0c8"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0001041"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/121e8e79-fd92-4cf4-80d6-4faa8efcac35 -->

    <Class rdf:about="http://example.org/121e8e79-fd92-4cf4-80d6-4faa8efcac35">
        <obo:IAO_0000115>a Line drawing of a cross section of the floor of the cochlear duct at P1. Distinct cell types within the organ of Corti (OC) are color coded. b Heat map for ~14,000 cochlear cells collected from four separate experiments at P1. Top 25 differentially expressed (DE) genes for the 15 identified clusters are shown. Cellular identity for each cluster is indicated by a color bar at the top of the heat map, which corresponds to the legend in a, and by a cell name at the bottom. c tSNE plot for the same cells as in b. Cluster identities are indicated. d Violin plots showing normalized log-transformed expression values for the top five DE genes for each cell type (color coded as in c) by comparison with all other P1 cells (gray on the right in each graph). Bars indicate median expression level. e Upper left panel, tSNE plot of cells determined to be derived from KO (between the OC and medial edge of the cochlear duct). Lower left panel, feature plot for the same cells as in the upper panel indicating high expression of Otoa, Calb1, and Fabp7 (based on color) in different clusters of cells. Lower right panel, cross sections through the cochlear duct at P1, illustrating expression of CALB1 in the medial region of KO and FABP7 directly adjacent to the OC (arrow; scale bars, 20 mum). Lowest panel shows high-magnification view of expression of FABP7 (arrow, gray scale) at the lateral KO border (green line; scale bar, 10 mum). Upper right panel, summary diagram of the spatial distribution of KO cell clusters at P1. HC hair cells, IPhC inner phalangeal cells/border cells, IPC inner pillar cells, OPC outer pillar cells, DC1/2 Deiters&apos; cells rows 1 and 2, DC3, Deiters&apos; cells row 3, HeC Hensen&apos;s cells, CC/OSC Claudius cells/outer sulcus cells, IdC interdental cells, ISC inner sulcus cells, KO Kolliker&apos;s organ cells, L.KO lateral Kolliker&apos;s organ cells, M.KO medial Kolliker&apos;s organ cells, ##OC90## OC90+ cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7221106</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32404924</oboInOwl:hasDbXref>
        <rdfs:label>OC90</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002490"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/121e8e79-fd92-4cf4-80d6-4faa8efcac35"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002490"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/122f9031-e6ce-4adb-8c66-1e3469027e13 -->

    <Class rdf:about="http://example.org/122f9031-e6ce-4adb-8c66-1e3469027e13">
        <obo:IAO_0000115>The above analysis was based on a large number of RNA-seq, so we further used scRNA-seq to determine whether our ORGs signature had immune predictive value on the single cell level. Figure 7A showed that the PRAD samples from GEO datasets were annotated into Mast cell, Epithelial-NE, ##T/NK##, Plasma_B, Epithelial, Neuron, SMC, Fibroblasts and Pericytes, Myeloid and Endothelial. It was obvious that ORGs signature was specifically high in Epithelial-Nk, T/Nk and SMC cells (Figure 7B, 7C). Meanwhile, Figure 7D revealed that significant connection probability of ORGs related signaling pathways in cell clusters which showed specifically high ORGs signature. Furthermore, we chose epithelial cell for analysis. Chemotaxis related pathways including cell chemotaxis, leukocyte chemotaxis, regulation of chemotaxis and regulation of leukocyte chemotaxis were significantly up-regulated in the high ORGs signature group (Figure 7E). What&apos;s more, immune related pathways were all up-regulated in the high ORGs signature group both in GO (Figure 7F) and KEGG (Figure 7G) analysis.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10599753</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37788005</oboInOwl:hasDbXref>
        <rdfs:label>T/NK</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000084"/>
        <skos:relatedMatch rdf:resource="CL:0000623"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/122f9031-e6ce-4adb-8c66-1e3469027e13"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000084"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/122f9031-e6ce-4adb-8c66-1e3469027e13"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000623"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/12294789-080e-44bd-b928-73aa5ffce581 -->

    <Class rdf:about="http://example.org/12294789-080e-44bd-b928-73aa5ffce581">
        <obo:IAO_0000115>We undertook a comprehensive Mendelian randomization study aimed at uncovering the causal relationship between 744 immune cell types and IVDD [ Supplementary Table 2 ]. In our analysis, we identified 24 specific blood types of immune cells that demonstrated a causal association with disc degeneration through univariable MR [ Supplementary Table 3 ], including Memory B cell %B cell, Naive-mature B cell %B cell, IgD-CD38dim B cell %lymphocyte, CD39+activated CD4 regulatory T cell %CD4 regulatory T cell, ##CD39+ secreting CD4 regulatory T cell## %CD4 regulatory T cell, CD45RA+ CD8+ T cell %CD8+ T cell, CD8+ T cell %leukocyte, CD39+CD4+ T cell %T cell, CD39+ CD4+ T cell %CD4+ T cell,CD39+ CD8+ T cell %T cell, CD39+ CD8+ T cell Absolute Count, CD127- CD8+ T cell Absolute Count, CD28- CD8+ T cell Absolute Count, CD19 on IgD+ CD38+ B cell, CD19 on IgD+ CD38dim B cell, CD19 on IgD- CD38- B cell, CD19 on unswitched memory B cell, CD19 on transitional B cell, CD24 on IgD+ CD38+ B cell,CD28 on CD39+ secreting CD4 regulatory T cell, CD25 on CD39+ CD4+ T cell, CD4 on CD39+ CD4+ T cell, CD4 on CD39+ resting CD4 regulatory T cell and Neutrophil count. We excluded certain exposures due to a limited number of available SNPs to prevent potential bias, including Memory B cell %B cell, Naive-mature B cell %B cell, IgD-CD38dim B cell %lymphocyte, CD8+T cell %leukocyte, CD127-CD8+ T cell Absolute Count, CD19 on IgD-CD38-B cell, CD24 on IgD+ CD38+ B cell, CD28 on CD39+ secreting CD4 regulatory T cell and CD4 on CD39+ resting CD4 regulatory T cell.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10806224</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38268919</oboInOwl:hasDbXref>
        <rdfs:label>CD39+ secreting CD4 regulatory T cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000792"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/12294789-080e-44bd-b928-73aa5ffce581"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000792"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/123561d4-816a-418c-88e5-8921358b79cd -->

    <Class rdf:about="http://example.org/123561d4-816a-418c-88e5-8921358b79cd">
        <obo:IAO_0000115>Innate Immune Cells	 	Primary Cell Type	Cell subsets	Metabolic Processes	References	 	   Innate Lymphoid Cells	Non-cytolytic:Innate lymphoid cell 1 (ILC1) Innate lymphoid cell 2 (ILC2) Innate lymphoid cell 3 (ILC3)/Lymphoid Tissue Inducers (LTi)Cytolytic:Natural Killer cells (NK)	 Gly FAO/OXPHOS, LM/LDF, Arginine catabolism, Gly Gly/OXPHOS, Vitamin A metabolismGly, AAM, FAO	     	 	  Dendritic Cells	Conventional:Conventional dendritic cell 1 (cDC1) Conventional dendritic cell 2 (cDC2) Conventional dendritic cell 3 (##cDC3##) Tolerogenic DCs Plasmacytoid DCs (pDCs) Inflammatory DCs Langerhans cells Mononuclear Phagocytes (tumor)	 Na: OXPHOS, Ac: GU, Gly, PPP, Dys: LDFNa: OXPHOS, Ac: GU, Gly, PPP, Dys: LDF Not reported FAO/OXPHOS Gly/OXPHOS/FAO Gly Na/Ac/Ma: Not reported Dys: LDFNa: OXPHOS, Ac: Gly, PPP In tumors/Dys: LM/LDF	         	 	 Macrophages	Inflammatory &quot;M1&quot; macrophage Reparative &quot;M2&quot; macrophage  Tumor Associated macrophage (TAM)	Na: OXPHOS, Ac: GU, Gly, PPP. Arg catabolismNa: FAO/OXPHOS, Ac: FAO/OXPHOS, Gly, PPP.  Upregulates Arg1 Na: OXPHOS, Ac: GU, Gly, Tumor/Dys: FAO, LM/LDF	   	 	</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11240245</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:39007133</oboInOwl:hasDbXref>
        <rdfs:label>cDC3</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000990"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/123561d4-816a-418c-88e5-8921358b79cd"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000990"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/12456421-ba97-4731-89fa-633aca49ee4c -->

    <Class rdf:about="http://example.org/12456421-ba97-4731-89fa-633aca49ee4c">
        <obo:IAO_0000115>We next employed SAPAS to study the genome-wide landscape of APA in phenotype-characterized GABAergic interneurons, using recently published 3&apos;-tag-based scRNA-seq data generated from six non-overlapping GABAergic subpopulations with anatomical, physiological, and molecular evidence. These GABAergic neurons include 64 CCK-positive basket cells (CCKC), 132 chandelier cells (CHC) that innervate the axon initial segment of pyramidal neurons, 63 interneuron-selective cells (##ISC##), 136 long-range-projecting GABAergic neurons (LPC), 62 Martinotti cells (MNC), and 127 fast-spiking parvalbumin-positive interneurons (PVBC). These individual neurons were manually sorted from micro-dissected motor and somatosensory cortexes of 6-week-old mice.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8299648</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34301239</oboInOwl:hasDbXref>
        <rdfs:label>ISC</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000099"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/12456421-ba97-4731-89fa-633aca49ee4c"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000099"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/1248fa41-cac1-41d5-bc08-af83644a20e3 -->

    <Class rdf:about="http://example.org/1248fa41-cac1-41d5-bc08-af83644a20e3">
        <obo:IAO_0000115>First, we clarified the differences in intrahepatic NK cells from HCC tissue (Ca) and adjacent non-cancerous liver tissue (NCa) in HCC patients. We evaluated the frequencies of paired ##NCa-NK cells## and Ca-NK cells in 16 HCC patients (Table S5). The frequency of Ca-CD56dimNK cells was reduced compared with that of NCa-CD56dimNK cells as reported previously, while that of CD56bright NK cells was comparable (Figure 3A).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8231799</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34198593</oboInOwl:hasDbXref>
        <rdfs:label>NCa-NK cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:4047101"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/1248fa41-cac1-41d5-bc08-af83644a20e3"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4047101"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/1270b634-78ad-4326-b684-e57fef6bc9ce -->

    <Class rdf:about="http://example.org/1270b634-78ad-4326-b684-e57fef6bc9ce">
        <obo:IAO_0000115>To verify differential gene expression, we employed RNA fluorescence in situ hybridization (FISH) to determine the abundance of select transcripts across spatially-resolved neuronal subsets in prion disease. We examined Ttr and Rbm3 because they were consistently upregulated across multiple neuronal clusters, and Egr1 and Rab6b, which were downregulated in cortical glutamatergic and striatal medium spiny neurons, respectively. Towards this end, six panels of RNA FISH probes were used to measure Ttr, Rbm3, and Egr1, expression in Glutamatergic and GABAergic neurons, and Ttr, Rbm3, and Rab6b expression in medium spiny neurons (Fig. 4 and Supplementary Fig. 6). We collected region of interest (ROI) images targeting the cortex, CA1, and dentate gyrus regions to assess Glutamatergic and GABAergic neurons, and the striatum for medium spiny neurons. This approach confirmed the striking prion-associated increased expression of Rbm3 across several distinct types of neurons (Fig. 4g). Furthermore, Egr1 was strongly downregulated in ##cortical glutamatergic neurons## and GABAergic neurons. We also confirmed the prion-associated downregulation of Rab6b in both Drd1+ and Drd2+ medium spiny neurons. A trend of increased Ttr expression was also detected across the different neuronal classes investigated; however, this trend did not achieve significance. By leveraging previously published bulk RNAseq datasets, we also examined the prion-altered abundance of these genes longitudinally in prion-infected mice (Fig. 4h). Rbm3 upregulation combined with decreased Egr1 and Rab6b was readily detected at the clinical endpoint of prion disease, but not at earlier timepoints. We, therefore, restricted our RNA-FISH validation to the clinical endpoint of prion disease. Overall, these RNA-FISH findings closely resembled the gene expression changes detected within our neuronal single-cell atlas, confirming the robustness of the dataset.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11585576</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:39580485</oboInOwl:hasDbXref>
        <rdfs:label>cortical glutamatergic neurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000679"/>
        <skos:relatedMatch rdf:resource="CL:0008031"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/1270b634-78ad-4326-b684-e57fef6bc9ce"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000679"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/1270b634-78ad-4326-b684-e57fef6bc9ce"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0008031"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/1275091e-4cd0-4a5e-9369-3cf4deead739 -->

    <Class rdf:about="http://example.org/1275091e-4cd0-4a5e-9369-3cf4deead739">
        <obo:IAO_0000115>Reference strains Ba/Apache-2 and E/Bour were used to infect HeLa 229 and immortalized human conjunctival epithelial (HCjE) cells, primary conjunctival epithelial (CjE) cells and stromal fibroblasts (CjS cells), primary ##endocervical epithelial (EcE) cells and stromal fibroblasts## (EcS cells), and endometrial stromal fibroblasts (EmS cells). Cell composition and type were validated prior to our performing each assay using cytokeratin- and fibronectin-specific antibodies (see Fig. S1 in the supplemental material). Table S1 shows the origins of human primary cells by patient age and sex for CjE and CjS cells and by age for EcE, EcS, and EmS cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6426598</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:30890604</oboInOwl:hasDbXref>
        <rdfs:label>endocervical epithelial (EcE) cells and stromal fibroblasts</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000057"/>
        <skos:relatedMatch rdf:resource="CL:0002535"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/1275091e-4cd0-4a5e-9369-3cf4deead739"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000057"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/1275091e-4cd0-4a5e-9369-3cf4deead739"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002535"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/13a0ed0f-c75f-4bea-8011-399da8199d87 -->

    <Class rdf:about="http://example.org/13a0ed0f-c75f-4bea-8011-399da8199d87">
        <obo:IAO_0000115>In order to investigate the underlying process that may lead to a poor prognosis for high-risk LUAD patients, an analysis of hallmark pathway gene profiles was conducted, revealing distinct characteristics between high- and low-risk groups. A direct comparison between the Risk-High and Risk-Low groups showed that the top five enriched signatures in the high-risk group were MYC target v1, MYC target v2, mTORC1 signaling, G2M checkpoint, and Glycolysis ( Figure 10A ). GSEA enrichment analysis also indicated that the high-risk group had significantly enriched Cell Cycle (NES = 1.93, p&lt; 0.001) and DNA Replication (NES = 1.78, p = 0.000) ( Figure 10B ). The ssGSEA algorithm was employed to examine differences in immune status across distinct risk groups. Low-risk LUAD patients showed increased infiltration of various immune cells, including Active dendritic cells (##aDCs##), B cells, CD8+ T cells, Dendritic cells (DCs), Immature dendritic cells (iDCs), Mast cells, neutrophils, T helper cell, Tumor-infiltrating lymphocytes (TILs), and Regulatory T cells (Treg), in their tumor microenvironment (TME). Furthermore, almost all immune-related pathways were significantly expressed in the low-risk group ( Figures 10C, D ).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10073691</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37033259</oboInOwl:hasDbXref>
        <rdfs:label>aDCs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000451"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/13a0ed0f-c75f-4bea-8011-399da8199d87"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000451"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/13b2ed68-26c4-48d3-ac42-ac538975a25f -->

    <Class rdf:about="http://example.org/13b2ed68-26c4-48d3-ac42-ac538975a25f">
        <obo:IAO_0000115>Ectopic ossification mimicking pathological cells were reclustered and defined as HO1 (corresponding to Supplementary Figure 2C, cluster 1) and HO2 (corresponding to Supplementary Figure 2C, cluster 0) (Figure 2(d) and Supplementary Figure 2C). The results of the mimetic timing analysis suggested that HO2 was a precursor cell for HO1 differentiation (Figures 2(e) and 2(f)). To further characterize the pathological differentiation of ectopically ossified cells, the proposed chronological expression profile of genes associated with the ectopic ossification phenotype was revealed (Figure 2(g)). The gene expression profiles of Xbp1, E2f7, Fgfr1, Icam1, Jag1, and Ncam1 are shown in Supplementary Figure 2D. Mgp, Bgn, Sox9, Col11a1, Col1a1, Col1a2, Tnmd, Col11a2, Scx, Hivep2, Bcl2, Col2a1, Mkx, Myc, and Dcn were enriched in HO2-like cells. Col5a1, Foxc1, Gli3, Gli2, Pecam1, Klf2, Klf4, Zbtb48, Ptch2, Smad7, Sufu, Igfbp5, Tcf, Fbn1, and Jag1 were enriched mainly in HO1-like cells (Figure 2(g)). Among them, Gli3, Cli2, Pecam1, and Ptch2 are the star genes of the Hh signaling pathway, and Notch2 and Jag1 are the star genes of the Notch signaling pathway, which suggested that the activities of the Notch and Hh signaling pathways may be upregulated in HO1-like cells. According to the expression characteristics of these genes, HO1-like cells are more similar to chondrocyte-like cells, and HO2-like cells are more similar to ##tenocyte-like cells##. Therefore, HO2 cells were defined as &quot;tenocyte-like cells.&quot;</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8563124</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34737845</oboInOwl:hasDbXref>
        <rdfs:label>tenocyte-like cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000388"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/13b2ed68-26c4-48d3-ac42-ac538975a25f"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000388"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/13c4ccb3-aa93-4920-a04f-7730262363ae -->

    <Class rdf:about="http://example.org/13c4ccb3-aa93-4920-a04f-7730262363ae">
        <obo:IAO_0000115>Chronic pain is a highly debilitating condition that differs by type, prevalence, and severity between men and women. To uncover the molecular underpinnings of these differences, it is critical to analyze the transcriptomes of spinal cord pain-processing networks for both sexes. Despite several recently published single-nucleus RNA-sequencing (snRNA-seq) studies on the function and composition of the mouse spinal cord, a gene expression analysis investigating the differences between males and females has yet to be performed. Here, we combined data from three different large-scale snRNA-seq studies, which used sex-identified adult mice. Using SeqSeek, we classified more than 37,000 unique viable cells within predicted cell types with the use of machine learning. We then utilized DESeq2 to identify significant differentially expressed genes (DEGs) between males and females in a variety of cell populations, including superficial dorsal horn (SDH) neurons. We found a large number of DEGs between males and females in all cells, in neurons, and in SDH neurons of the mouse spinal cord, with a greater level of differential expression in ##inhibitory SDH neurons## compared to excitatory SDH neurons. The results of these analyses are available on an open-source web-app: https://justinbellavance.shinyapps.io/snRNA_Visualization/. Lastly, we used gene set enrichment analysis to identify sex-enriched pathways from our previously identified DEGs. Through this, we have identified specific genetic players within the rodent spinal cord that diverge between males and females, which may underlie reported sex differences in spinal nociceptive mechanisms and pain processing.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11645520</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:39673257</oboInOwl:hasDbXref>
        <rdfs:label>inhibitory SDH neurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0011000"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/13c4ccb3-aa93-4920-a04f-7730262363ae"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0011000"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/13d8f37a-f5bc-4f90-b8d4-2578be28a76a -->

    <Class rdf:about="http://example.org/13d8f37a-f5bc-4f90-b8d4-2578be28a76a">
        <obo:IAO_0000115>(A, C) Expression level of select marker genes for each identified cluster (A: VGlut2 cKO model; C: Ip3r2 KO model). Circle size denotes expression ratio (percent cells expressing the gene), color represents expression level (in log2 CPM). Bar chart on the left shows cell numbers identified for each cluster are similar for WT and KO groups for each cluster in each model. (B) UMAP clustering of different cell types identified in the NEUN-negative population of the combined samples from Ip3r2 WT and KO mice. 17 clusters were identified including the three main types of glia: astrocytes, oligodendrocytes, and microglia, as well as endothelial cells, and two subtypes of neurons (for A-C - M-astrocyte: mitotic astrocyte; M-OPC: ##mitotic oligodendrocyte precursor cell##; OPC: oligodendrocyte precursor cell; MFOL: myelin-forming oligodendrocyte; NFOL: newly formed oligodendrocyte; MOL: mature oligodendrocyte; VLMC: vascular and leptomeningeal cell; EC: endothelial cell; PC: pericyte; PVM: perivascular macrophage).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8497060</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34494546</oboInOwl:hasDbXref>
        <rdfs:label>mitotic oligodendrocyte precursor cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002453"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/13d8f37a-f5bc-4f90-b8d4-2578be28a76a"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002453"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/13f6cb31-9e75-421d-abdc-c0b52def2a97 -->

    <Class rdf:about="http://example.org/13f6cb31-9e75-421d-abdc-c0b52def2a97">
        <obo:IAO_0000115>SCLC	Small-cell carcinoma	 	NSCLC	Non-small-cell carcinoma	 	ADC	Adenocarcinoma	 	SqCC	Squamous cell carcinoma	 	LCLC	Large-cell carcinoma	 	PD1	Programmed death 1	 	PDL1	Programmed death 1 ligand	 	ICI	Immune checkpoint inhibitors	 	EV	Extracellular vesicles	 	ESE	Early-sorting endosome	 	ILVs	Intraluminal vesicles	 	MVBs	Multivesicular bodies	 	ESCRT	Endosomal-sorting complex-independent transport	 	ncRNAs	Small noncoding RNAs (ncRNAs)	 	miRNAs	microRNAs	 	TME	Tumor microenvironment	 	circRNA	circular RNA	 	ECM	extracellular matrix	 	HBEC	Human bronchial epithelial cells	 	EMT	Epithelial-mesenchymal transition	 	CRC	colorectal cancer	 	DCs	dendritic cells	 	MSC	Mesenchymal stem cells	 	NK	Natural Killer	 	PBMCs	Peripheral blood mononuclear cells	 	##TAMs##	Tumor-associated macrophages	 	MDSCs	Myeloid-derived suppressor cells	 	PMN-MDSCs	Polymorphonuclear MDCs	 	M-MDSCs	Monocytic MDSCs	 	LLC	Lewis Lung carcinoma	 	M2 macrophages	Alternatively activated macrophages	 	M1 macrophages	Classically activated macrophages	 	TH1 cell	T helper 1 cell	 	Treg cell	Regulatory T cell	 	Breg cell	Regulatory B cell	 	CTLs	Cytotoxic CD8+ T cells	 	TILs	Tumor-infiltrating lymphocytes	 	Tim-3	mucin domain-3 protein	 	TIGIT	T cell immunoglobulin and ITIM domain	 	Lag-3	Lymphocyte-activation gene 3	 	CTLA4	Cytotoxic T lymphocyte antigen-4	 	TH17 cell	T helper 17 cell	 	DNT cell	Double-negative T cells	 	TRAIL	TNF-related apoptosis-inducing ligand	 	MPE	malignant pleural effusions	 	CRISPRi	clustered regularly interspaced short palindromic repeats interference	 	FAP	Fibroblast activation protein- alpha.	 	</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10616833</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37915578</oboInOwl:hasDbXref>
        <rdfs:label>TAMs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/13f6cb31-9e75-421d-abdc-c0b52def2a97"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/13f8f28c-c281-46e4-b7e1-1fd70d0a3141 -->

    <Class rdf:about="http://example.org/13f8f28c-c281-46e4-b7e1-1fd70d0a3141">
        <obo:IAO_0000115>While the heterogeneity of CD103+ TRMs is widely discussed in the literature, the characteristics of TRM subpopulations within the tumor or distant tissues of tumor-bearing mice are less well defined. To characterize tumoral TRMs, scRNA-seq technology provides unprecedented analytical power and allows us to dissect cells with thousands of dimensions. With the hypothesis that particular intratumoral T cells are precursors for TRM development, we extended our scRNA-seq approach to include various effector and memory T cell populations to comprehensively depict their transcriptomic program. From the tumor and distant mucosa of mice bearing established 4T1 tumors, we flow sorted distinct memory T cell populations using a strict gating strategy (Figure S3). We constructed single-cell cDNA libraries from paired intratumoral sorted TCR-beta+CD44+CD62L-CD69+CD103+ cells (TRMs), mucosal sorted TCR-beta+CD44+ CD69+CD103+ cells (distant mucosa TRMs), ##intratumoral TCR-beta+CD44+CD62L+CD69-CD103- cells## (TCMs), and TCR-beta+CD44+CD62L-CD69-CD103- cells (TEMs) (Table S2). After data processing and normalization, we performed unbiased clustering and visualized the CD8+ clusters using t-distributed stochastic neighbor embedding (t-SNE; Figure 2A). Through this unsupervised analysis, we found that all four samples could distinctly separate into multiple clusters, confirming continued heterogeneity among the single-cell subsets.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8204287</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33979626</oboInOwl:hasDbXref>
        <rdfs:label>intratumoral TCR-beta+CD44+CD62L+CD69-CD103- cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000907"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/13f8f28c-c281-46e4-b7e1-1fd70d0a3141"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000907"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/130fb5f0-d8b0-43b5-9ca3-a36a5e2cd082 -->

    <Class rdf:about="http://example.org/130fb5f0-d8b0-43b5-9ca3-a36a5e2cd082">
        <obo:IAO_0000115>Our novel multi-color flow cytometry panel was also tested on mouse skin. After excluding cellular debris, doublets, and dead cells, we gated with the help of FMO controls (Fig. S10) on viable CD45+ cells (Fig. 2A). In healthy skin, the CD3+ T cell population consists of CD3intCD4+ T cells and CD3highgammadelta T cells, whereas CD8+ T cells, NK cells, B cells, neutrophils and pDC are rare in healthy skin (Fig. 2B). By following gating published earlier, we identified several myeloid non-DC populations (P1-P5) in the dermis (Fig. 2C) and different DC-subsets (Fig. 2D, E). From the non CD11b+CD24- population we identified CD11c+MHC-II+ DC. Next, we divided DC into XCR1+ cDC1, which contain CD103+ and CD103- subsets, and CD172a+ DC which consists mainly of CD207+ LC (Fig. 2D). ##Dermal cDC2## are characterized from the CD64-Ly-6C- population by gating on CD11c+MHC-II+ cells that express CD11b and CD172a (Fig. 2E). In addition, we investigated CD115, F4/80 and CD64 expression on the non-DC myeloid cell populations P1-P5 (Fig. 2F). Analysis of CD40, PD-L1, PD-L2 and CCR7 on the different DC-subets allows further phenotypical characterization (Fig. 2G). An example for UMAP analysis is shown in Figure S11 confirming manual gating for DC-subsets and non-DC populations.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10087122</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35944142</oboInOwl:hasDbXref>
        <rdfs:label>Dermal cDC2</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000990"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/130fb5f0-d8b0-43b5-9ca3-a36a5e2cd082"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000990"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/131e41d9-e1c7-4539-b613-e8b5ba8742f5 -->

    <Class rdf:about="http://example.org/131e41d9-e1c7-4539-b613-e8b5ba8742f5">
        <obo:IAO_0000115>A, B, tSNE plot of 4659 CD45+ immune cells from the CNS. Data from this study is integrated with data from; Table 6). C, D, Each dataset represented by one tSNE. Cells are annotated using color representing their cell type. bMicroglia: baseline microglia; aMicroglia: activated microglia; pmMicroglia: proliferation-mediating microglia; maMicroglia: monocyte-activating microglia; ##DAM##: disease-associated microglia in SCI; elMicroglia: embryonic-like microglia; pvMacrophages: perivascular macrophages; mdMacrophages: monocyte-derived macrophages; DCs: dendritic cells; imB-cells: immature B-cells; mB-cells: mature B-cells; pimMicroglia: postnatal immature microglia; IEG+Microglia: immediate early genes microglia; sMicroglia: s-phase microglia; pPAM: postnatal proliferative-region-associated microglia; eMicroglia: embryonic microglia; pcpMacrophages: postnatal choroid plexus macrophages; acpMacrophages: adult choroid plexus macrophages; iMonocytes: inflammatory monocytes; pMonocytes: patrolling monocytes; cpEpithelial cells: choroid plexus epithelial cells. E, tSNE plots of 4659 CD45+ immune cells for selected genes indicating the log2(cpm) expression with a continuous color for each cell separately. F, Proliferation rate of CD45low and CD45high cells at 7 and 21 d post-SCI. Hoechst 33342 expression presented on a log-scale was used for defining cells in S-phase. Right most plot reports the percentage of cells in S-phase. Each dot represents one biological replicate (four mice per time point). Mean is surrounded by a 95% CI. This figure is extended in Extended Data Figure 8-1.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8496189</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34417326</oboInOwl:hasDbXref>
        <rdfs:label>DAM</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000129"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/131e41d9-e1c7-4539-b613-e8b5ba8742f5"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000129"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/131034e8-1e4b-4949-9a05-b8630692a0fc -->

    <Class rdf:about="http://example.org/131034e8-1e4b-4949-9a05-b8630692a0fc">
        <obo:IAO_0000115>Expression heterogeneity of CD8+ and CD4+ T cells in the OSCC ecosystem. (A) The t-distributed stochastic neighbor embedding (t-SNE) projection of T cells from cancerous tissue of patients with OSCC, showing the formation of 11 main clusters in different colors. The functional description of each cluster is determined by the gene expression characteristics. Cluster 0: resident memory CD8+ T Cells (C0_CD8+ TRM); Cluster 1: effector memory CD8+ T cells (C1_CD8+ TEM); Cluster 2: regulatory CD4+ T cells (C2_CD4+ Treg); Cluster 3: exhausted CD8+ T cells (C3_CD8+ T Exhausted); Cluster 4: effector memory M-phage CD8+ T cells (C4_CD8+ Mitotic TEM); Cluster 5: effector memory CD4+ T cells (C5_CD4+ TEM); Cluster 6: ##effector memory CD8+ T cells## (C6_CD8+ TEM); Cluster 7: effector memory CD4+ T cells (C7_CD4+ TEM); Cluster 8: effector memory CD8+ T cells (C8_CD8+ TEM); Cluster 9: effector memory CD8+ T cells (C9_CD8+ TEM); Cluster 10: effector memory M-phage CD4+ T cells (C10_CD4+ Mitotic TEM); Cluster 11: effector memory CD8+ T cells (C11_CD8+ TEM); Cluster 12: effector memory CD8+ T cells (C12_CD8+ TEM); Cluster 13: gammadelta T. (B) Cell-Cycle Scoring of T cells from cancerous tissue of patients with OSCC, showing the three clusters of cells in different cell cycles in different colors. (C) Heatmap of key genes expressed in each cluster of CD8+ tumor-infiltrating lymphocytes (TILs) with cells grouped by clusters. The columns correspond to the cells; the rows correspond to the genes. Yellow: high expression; purple: low expression. Selected key markers are shown on the right. (D) Heatmap of key genes expressed in each cluster of CD4+ TILs with cells grouped by clusters. The columns correspond to the cells; the rows correspond to the genes. Yellow: high expression; purple: low expression. Selected key genes are shown on the right.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8024729</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33513276</oboInOwl:hasDbXref>
        <rdfs:label>effector memory CD8+ T cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000913"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/131034e8-1e4b-4949-9a05-b8630692a0fc"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000913"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/13192503-39fc-4514-984a-d375b5a59aa5 -->

    <Class rdf:about="http://example.org/13192503-39fc-4514-984a-d375b5a59aa5">
        <obo:IAO_0000115>Wnt/beta-catenin Signaling Involves With CD40-Inducible HPV16-Specific ##CD8 Tscm Cells##</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7267052</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32536922</oboInOwl:hasDbXref>
        <rdfs:label>CD8 Tscm Cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000907"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/13192503-39fc-4514-984a-d375b5a59aa5"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000907"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/135e4039-631b-451e-a5fb-ac44d5792d0e -->

    <Class rdf:about="http://example.org/135e4039-631b-451e-a5fb-ac44d5792d0e">
        <obo:IAO_0000115>In Tek-CreERT2;R26T mice, we also observed Tek+ bone-lining cells at the endosteum (Fig. 5a). The frequency of these cells was approximately 2.8 cells/mm endosteum in longitudinal sections, which was significantly higher than that of ##Cdh5+ bone-lining cells## (Fig. 5f). Tek+ endosteal bone-lining cells often exhibited a thin and elongated morphology and were nearly absent for the osteolineage marker RUNX2 (Fig. 5b, g), suggesting that they might correspond to the endosteal fibroblasts detected in the reanalyzed dataset. However, Tek+ osteocytes were hardly detected in these mice (Fig. 5c, h). In other regions of the bone marrow cavity, a small population of trabecular bone-lining cells (Fig. 5d, i) and metaphyseal stromal cells (Fig. 5e, j) were also Tek+.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10733381</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38123537</oboInOwl:hasDbXref>
        <rdfs:label>Cdh5+ bone-lining cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000071"/>
        <skos:relatedMatch rdf:resource="CL:0001035"/>
        <skos:relatedMatch rdf:resource="CL:0002157"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/135e4039-631b-451e-a5fb-ac44d5792d0e"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000071"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/135e4039-631b-451e-a5fb-ac44d5792d0e"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0001035"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/135e4039-631b-451e-a5fb-ac44d5792d0e"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002157"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/1399c443-60e2-44e3-b959-b81c9d0cb487 -->

    <Class rdf:about="http://example.org/1399c443-60e2-44e3-b959-b81c9d0cb487">
        <obo:IAO_0000115>(A) Immunocytochemistry analysis of claudin-5, caveolin-1, and GLUT-1 expression in Passage 1 endothelial cells (ECs) treated with DMSO or 4 microM CHIR. Hoechst nuclear counterstain is overlaid in the merged images. Dashed lines indicate the border between an EC colony and smooth muscle-like cells (SMLCs) in the DMSO condition. Scale bars: 200 mum. (B) Quantification of images from the conditions described in (A) for number of ECs per 20x field, percentage of ECs (claudin-5+ cells relative to total nuclei), percentage of GLUT-1+ ECs (relative to total ##claudin-5+ ECs##), and mean fluorescence intensity of claudin-5, caveolin-1, and GLUT-1 normalized to Hoechst mean fluorescence intensity within the area of claudin-5+ ECs only. Points represent replicate wells from 2 to 6 independent differentiations of the IMR90-4 line, each differentiation indicated with a different color. Bars indicate mean values. For the fluorescence intensity plots, values were normalized within each differentiation such that the mean of the DMSO condition equals 1. p-values: two-way ANOVA on unnormalized data.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8664294</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34755601</oboInOwl:hasDbXref>
        <rdfs:label>claudin-5+ ECs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:2000044"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/1399c443-60e2-44e3-b959-b81c9d0cb487"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:2000044"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/14b267dc-5e02-45f6-b568-0d4e56efeab7 -->

    <Class rdf:about="http://example.org/14b267dc-5e02-45f6-b568-0d4e56efeab7">
        <obo:IAO_0000115>(A, C) Expression level of select marker genes for each identified cluster (A: VGlut2 cKO model; C: Ip3r2 KO model). Circle size denotes expression ratio (percent cells expressing the gene), color represents expression level (in log2 CPM). Bar chart on the left shows cell numbers identified for each cluster are similar for WT and KO groups for each cluster in each model. (B) UMAP clustering of different cell types identified in the NEUN-negative population of the combined samples from Ip3r2 WT and KO mice. 17 clusters were identified including the three main types of glia: astrocytes, oligodendrocytes, and microglia, as well as endothelial cells, and two subtypes of neurons (for A-C - M-astrocyte: mitotic astrocyte; ##M-OPC##: mitotic oligodendrocyte precursor cell; OPC: oligodendrocyte precursor cell; MFOL: myelin-forming oligodendrocyte; NFOL: newly formed oligodendrocyte; MOL: mature oligodendrocyte; VLMC: vascular and leptomeningeal cell; EC: endothelial cell; PC: pericyte; PVM: perivascular macrophage).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8497060</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34494546</oboInOwl:hasDbXref>
        <rdfs:label>M-OPC</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002453"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/14b267dc-5e02-45f6-b568-0d4e56efeab7"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002453"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/14b54608-d421-41b9-b0b0-9e8b3a7927a6 -->

    <Class rdf:about="http://example.org/14b54608-d421-41b9-b0b0-9e8b3a7927a6">
        <obo:IAO_0000115>KSHV lymphoproliferative disorders occur primarily in the context of immunosuppression, and other studies have shown interactions between T cells and KSHV infected B cells in tonsil lymphocyte cultures affecting the frequency of lytic reactivation. Therefore, we wanted to determine whether the immunological composition of the tonsil lymphocyte environment would affect the establishment of KSHV infection in B lymphocytes and specifically whether overall susceptibility or targeting of particular B cell lineages is influenced by the presence or absence of T cells. Like B cell lineages, levels of CD4+ and CD8+ T cell lineages vary considerably between tonsil donors (Fig 1D). However, unlike B lymphocyte subsets, the distribution of T cell subsets are not generally correlated with donor age (Fig 1E). Examination of whether the ratio of CD4/CD8 T cells in individual tonsil specimens was correlated with the susceptibility of B lymphocytes to KSHV infection revealed no significant correlation (Fig 5A). Next, we examined correlations between B cell infections and baseline levels of various CD4 and CD8+ T cell subsets to determine whether any T cell lineages affected the tropism of KSHV for particular B cell lineages (Fig 5B). Interestingly, levels of ##naive and stem cell memory CD4+ T cells## was positively correlated with infection of plasma cells (Fig 5B and Fig 5C, left panels) with a greater effect on CD20+ plasma cells than CD20- plasma cells, while overall levels of CD45RO+ activated memory T cells were negatively correlated with KSHV infection of plasma cells (Fig 5C, right panel). In addition, although the correlations were too weak to be significant in this data set, nearly every B cell lineage and overall KSHV infection was negatively correlated with the presence of CD4+ T cells expressing a TEMRA phenotype (Fig 5B). Baseline levels of CD8+ T cells had less effect on KSHV infection with only one significant positive correlation observed in our dataset between CD8+ terminal effector cells and KSHV infection of naive B cells (Fig 5B).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7595638</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33075105</oboInOwl:hasDbXref>
        <rdfs:label>naive and stem cell memory CD4+ T cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000034"/>
        <skos:relatedMatch rdf:resource="CL:0000897"/>
        <skos:relatedMatch rdf:resource="CL:0000898"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/14b54608-d421-41b9-b0b0-9e8b3a7927a6"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000034"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/14b54608-d421-41b9-b0b0-9e8b3a7927a6"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000897"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/14b54608-d421-41b9-b0b0-9e8b3a7927a6"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000898"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/14175c5c-55d9-4ece-a58f-c6b8fcf62fa2 -->

    <Class rdf:about="http://example.org/14175c5c-55d9-4ece-a58f-c6b8fcf62fa2">
        <obo:IAO_0000115>The adipose-derived hormone leptin acts via its receptor (LepRb) in the brain to control energy balance. A potentially unidentified population of GABAergic hypothalamic LepRb neurons plays key roles in the restraint of food intake and body weight by leptin. To identify markers for candidate populations of LepRb neurons in an unbiased manner, we performed single-nucleus RNA-Seq of enriched mouse hypothalamic LepRb cells, identifying several previously unrecognized populations of hypothalamic LepRb neurons. Many of these populations displayed strong conservation across species, including ##GABAergic Glp1r-expressing LepRb (LepRbGlp1r) neurons##, which expressed more Lepr than other LepRb cell populations. Ablating Lepr from LepRbGlp1r cells provoked hyperphagic obesity without impairing energy expenditure. Similarly, improvements in energy balance caused by Lepr reactivation in GABA neurons of otherwise Lepr-null mice required Lepr expression in GABAergic Glp1r-expressing neurons. Furthermore, restoration of Glp1r expression in LepRbGlp1r neurons in otherwise Glp1r-null mice enabled food intake suppression by the GLP1R agonist, liraglutide. Thus, the conserved GABAergic LepRbGlp1r neuron population plays crucial roles in the suppression of food intake by leptin and GLP1R agonists.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10541203</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37581939</oboInOwl:hasDbXref>
        <rdfs:label>GABAergic Glp1r-expressing LepRb (LepRbGlp1r) neurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000617"/>
        <skos:relatedMatch rdf:resource="CL:4042033"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/14175c5c-55d9-4ece-a58f-c6b8fcf62fa2"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000617"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/14175c5c-55d9-4ece-a58f-c6b8fcf62fa2"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4042033"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/143afc6c-403c-45bf-89f0-d60f24c1ef23 -->

    <Class rdf:about="http://example.org/143afc6c-403c-45bf-89f0-d60f24c1ef23">
        <obo:IAO_0000115>alpha-SMA	Alpha smooth muscle actin	LEC	Lymphatic endothelial cell	 	ADSCs	Adipose-derived stem cells	##Lymphoid-like##	Lymphoid-like cell	 	ADAMTS	Disintegrin and metalloproteinase with thrombospondin motifs	Mac	Macrophage	 	AEC	Arterial endothelial cells	MAIT	Mucosal-associated invariant T cell	 	AFG	Autologous fat grafting	MMPs	Matrix metalloproteinases	 	APC	Adipocyte precursor cells	MC	Mast cell	 	BC	B cell	mCD8 T	Mature CD8 T cell	 	BKC	Basal keratinocyte	mNK	Mature natural killer cell	 	BMI	Body mass index	Myeloid-like	Myeloid-like cell	 	CCNs	Cellular communication network factors	nCD4 T	Naive CD4 T cell	 	cDC	Classic dendritic cell	nCD8 T	Naive CD8 T cell	 	CEC	Capillary endothelial cell	ncMos	Non-classic monocytes	 	DC	Dendritic cell	NK-like	Natural killer-like cell	 	CD	Cluster of differentiation	PC	Pericyte	 	CTGF	Connective tissue growth factor	PCA	Principal component analysis	 	DEGs	Differentially expressed genes	scRNA-seq	Single-cell RNA sequencing	 	DKC	Differentiating keratinocytes	SMC	Smooth muscle cell	 	EC	Endothelial cell	SNN	Shared nearest neighbour	 	ECM	Extracellular matrix	SSc	Scleroderma	 	EMT	Epithelial-to-mesenchymal transition	SVF	Stromal vascular fraction	 	FACS	Fluorescence-activated cell sorting	TC	T cell	 	FB	Fibroblast	TGF-beta1	Transforming growth factor 1	 	FGFRs	Fibroblast growth factor receptors	TIMPs	Tissue inhibitors of metalloproteinases	 	GEO	Gene expression omnibus	TREG	Regulatory T cells	 	GO	Gene Ontology	UMAP	Uniform manifold approximation and projection	 	IFATS	International Federation for Adipose Therapeutics and Science	VEC	Venous endothelial cell	 	ILC	Innate lymphoid cell	WAT	White adipose tissue	 	KEGG	Kyoto Encyclopedia of Genes and Genomes			 	</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10341100</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37443817</oboInOwl:hasDbXref>
        <rdfs:label>Lymphoid-like</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0001065"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/143afc6c-403c-45bf-89f0-d60f24c1ef23"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0001065"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/145c9a4d-a96c-4144-8fbd-d402095b515d -->

    <Class rdf:about="http://example.org/145c9a4d-a96c-4144-8fbd-d402095b515d">
        <obo:IAO_0000115>Expression heterogeneity of CD8+ and CD4+ T cells in the OSCC ecosystem. (A) The t-distributed stochastic neighbor embedding (t-SNE) projection of T cells from cancerous tissue of patients with OSCC, showing the formation of 11 main clusters in different colors. The functional description of each cluster is determined by the gene expression characteristics. Cluster 0: resident memory CD8+ T Cells (C0_##CD8+ TRM##); Cluster 1: effector memory CD8+ T cells (C1_CD8+ TEM); Cluster 2: regulatory CD4+ T cells (C2_CD4+ Treg); Cluster 3: exhausted CD8+ T cells (C3_CD8+ T Exhausted); Cluster 4: effector memory M-phage CD8+ T cells (C4_CD8+ Mitotic TEM); Cluster 5: effector memory CD4+ T cells (C5_CD4+ TEM); Cluster 6: effector memory CD8+ T cells (C6_CD8+ TEM); Cluster 7: effector memory CD4+ T cells (C7_CD4+ TEM); Cluster 8: effector memory CD8+ T cells (C8_CD8+ TEM); Cluster 9: effector memory CD8+ T cells (C9_CD8+ TEM); Cluster 10: effector memory M-phage CD4+ T cells (C10_CD4+ Mitotic TEM); Cluster 11: effector memory CD8+ T cells (C11_CD8+ TEM); Cluster 12: effector memory CD8+ T cells (C12_CD8+ TEM); Cluster 13: gammadelta T. (B) Cell-Cycle Scoring of T cells from cancerous tissue of patients with OSCC, showing the three clusters of cells in different cell cycles in different colors. (C) Heatmap of key genes expressed in each cluster of CD8+ tumor-infiltrating lymphocytes (TILs) with cells grouped by clusters. The columns correspond to the cells; the rows correspond to the genes. Yellow: high expression; purple: low expression. Selected key markers are shown on the right. (D) Heatmap of key genes expressed in each cluster of CD4+ TILs with cells grouped by clusters. The columns correspond to the cells; the rows correspond to the genes. Yellow: high expression; purple: low expression. Selected key genes are shown on the right.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8024729</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33513276</oboInOwl:hasDbXref>
        <rdfs:label>CD8+ TRM</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000907"/>
        <skos:relatedMatch rdf:resource="CL:0000909"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/145c9a4d-a96c-4144-8fbd-d402095b515d"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000907"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/145c9a4d-a96c-4144-8fbd-d402095b515d"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000909"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/1450cf1a-473a-4600-83ab-eec831be1dde -->

    <Class rdf:about="http://example.org/1450cf1a-473a-4600-83ab-eec831be1dde">
        <obo:IAO_0000115>Here we hypothesized that upon activation, memory CD8 T cells acquire a noncytotoxic function whereby they interact with naive CD8 T cells and alter their phenotype and activation state. To test this hypothesis, we designed an in vitro system in which human polyclonal naive CD8 T cells were co-cultured with autologous, activated memory CD8 T cell subsets. The phenotype and transcriptional profile of naive cells was analyzed at the end of the co-culture period. We report that in the presence of activated TCM or stem cell memory (TSCM) cells, a small proportion (~3%) of autologous naive CD8 T cells acquired phenotypic and transcriptional features of ##activated/memory CD8 T cells## in an MHC class I-dependent manner, whereas a much larger proportion (~84%) transitioned to a unique activated state, hybrid between naive and activated memory. These findings imply that activated memory T cells can set the activation threshold of neighboring naive T cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9243096</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35768564</oboInOwl:hasDbXref>
        <rdfs:label>activated/memory CD8 T cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000909"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/1450cf1a-473a-4600-83ab-eec831be1dde"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000909"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/14560aee-3df8-4714-a435-69d53daa2039 -->

    <Class rdf:about="http://example.org/14560aee-3df8-4714-a435-69d53daa2039">
        <obo:IAO_0000115>(D) Volcano plot showing differentially expressed genes between vestibular supporting cells and ##cochlear duct floor##. Underlined genes are described to be differentially expressed between vestibular and cochlear cell types.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10592453</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37289589</oboInOwl:hasDbXref>
        <rdfs:label>cochlear duct floor</rdfs:label>
    </Class>
    


    <!-- http://example.org/147ad3de-7e59-4ce8-b1ca-b8a520d0497c -->

    <Class rdf:about="http://example.org/147ad3de-7e59-4ce8-b1ca-b8a520d0497c">
        <obo:IAO_0000115>Chronic pain is a highly debilitating condition that differs by type, prevalence, and severity between men and women. To uncover the molecular underpinnings of these differences, it is critical to analyze the transcriptomes of spinal cord pain-processing networks for both sexes. Despite several recently published single-nucleus RNA-sequencing (snRNA-seq) studies on the function and composition of the mouse spinal cord, a gene expression analysis investigating the differences between males and females has yet to be performed. Here, we combined data from three different large-scale snRNA-seq studies, which used sex-identified adult mice. Using SeqSeek, we classified more than 37,000 unique viable cells within predicted cell types with the use of machine learning. We then utilized DESeq2 to identify significant differentially expressed genes (DEGs) between males and females in a variety of cell populations, including superficial dorsal horn (SDH) neurons. We found a large number of DEGs between males and females in all cells, in neurons, and in ##SDH neurons## of the mouse spinal cord, with a greater level of differential expression in inhibitory SDH neurons compared to excitatory SDH neurons. The results of these analyses are available on an open-source web-app: https://justinbellavance.shinyapps.io/snRNA_Visualization/. Lastly, we used gene set enrichment analysis to identify sex-enriched pathways from our previously identified DEGs. Through this, we have identified specific genetic players within the rodent spinal cord that diverge between males and females, which may underlie reported sex differences in spinal nociceptive mechanisms and pain processing.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11645520</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:39673257</oboInOwl:hasDbXref>
        <rdfs:label>SDH neurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0011000"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/147ad3de-7e59-4ce8-b1ca-b8a520d0497c"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0011000"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/147b3a47-1e3f-4e08-95bb-18be41bc12a3 -->

    <Class rdf:about="http://example.org/147b3a47-1e3f-4e08-95bb-18be41bc12a3">
        <obo:IAO_0000115>Myeloid cell differentiation and developmental arrest are characteristics of immune dysregulation in patients with cancer. Regarding erythroid hematopoiesis, extramedullary hematopoiesis occurs during cancer and anemia. CD71+ erythroid progenitor cells (EPCs) are produced during the differentiation of megakaryocyte-erythrocyte progenitor cells into erythrocytes, which are a new type of immune cell that can promote the re-occurrence and development of tumors. The number of EPCs in HCC tissue is positively correlated with PVTT. In myeloid hematopoiesis, the maturation of granulocyte-monocyte progenitor cells is blocked, resulting in the accumulation of myeloid-derived suppressor cells (MDSCs). MDSCs are also associated with prognosis in HCC and are reported to induce vascular VEC migration. VEC migration may destroy the endodermis and promote PVTT. Recently, Long et al. found that tumors induced a subset of ##CD45+ EPCs## to differentiate into a cellular &quot;erythroid-myeloid hybrid&quot; population, named erythroid-differentiated myeloid cells (EDMCs), which may present a connection between MDSCs and EPCs. Thus, EDMCs may play a critical role in PVTT development.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10465220</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37649603</oboInOwl:hasDbXref>
        <rdfs:label>CD45+ EPCs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000038"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/147b3a47-1e3f-4e08-95bb-18be41bc12a3"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000038"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/1487cfbd-041e-463e-b78a-ac9bbde478d5 -->

    <Class rdf:about="http://example.org/1487cfbd-041e-463e-b78a-ac9bbde478d5">
        <obo:IAO_0000115>scRNA-seq of ECs reveal a subpopulation enriched with immune responsive signatures. (A) Schematic showing the experimental design for the scRNA-seq and single-nuclei ATAC sequencing analysis of regenerative mouse hearts (MI at P1 and harvested at P5) and nonregenerative mouse hearts (MI at P8 and harvested at P12). (B) UMAP representation of cardiac cell clusters identified from scRNA-seq analysis. Clusters were color coded according to cell types (left). CM, cardiomyocytes; EC, endothelial cells; CF, fibroblasts; PeriC, pericytes; SMC, smooth muscle cells; EndoC, endocardial cells; EpiC, epicardial cells; MF, macrophages; TC, T-cells. (C) Gene ontology (GO) analysis of differentially expressed genes up-regulated in ECs of regenerative-stage hearts versus nonregenerative-stage hearts after MI. (D) UMAP representation of CD31+-enriched cell clusters from single-cell RNA sequencing (scRNA-seq), color coded according to cell type. CEC, capillary endothelial cell; Angio-EC, ##angiogenic endothelial cell##; Pro-EC1, proliferative endothelial cell 1; Pro-EC2, proliferative endothelial cell 2; IFN-EC, interferon capillary endothelial cell; CVEC, capillary venous endothelial cell; VEC, venous endothelial cell; AEC, arterial endothelial cell; LEC, lymphatic endothelial cell; EndoC, endocardial cell. (E) Gene ontology (GO) analysis of differentially expressed genes up-regulated in the IFN-EC cluster of regenerative-stage hearts versus nonregenerative-stage hearts after MI.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10681909</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38012001</oboInOwl:hasDbXref>
        <rdfs:label>angiogenic endothelial cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0009088"/>
        <skos:relatedMatch rdf:resource="CL:0010008"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/1487cfbd-041e-463e-b78a-ac9bbde478d5"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0009088"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/1487cfbd-041e-463e-b78a-ac9bbde478d5"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0010008"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/149b6af2-68c3-40c7-8fea-3b2eb082cb08 -->

    <Class rdf:about="http://example.org/149b6af2-68c3-40c7-8fea-3b2eb082cb08">
        <obo:IAO_0000115>a Schematic overview of the experimental workflow. Forebrain samples were collected from Sox2eGFP mice at 11 developmental timepoints, dissociated into single cells followed by sorting of the GFP + ve /-ve cells and performing single-cell RNA-seq using the 10x Genomics Chromium platform. b Left: two-dimensional Uniform manifold approximation and progression (UMAP) plot with Leiden clustering of 102,504 individual cells identifying 28 transcriptionally and biologically distinct cell types (see Supplementary Fig. 3a and Methods). Each dot represents a single cell and colours correspond to the distinct clusters/cell types. Shown on the right is a dot plot showing the relative fraction (dot size) of the 28 cell types at each developmental timepoint normalized by library size. c UMAP plot of the cells as in (b) but coloured by timepoint. Each dot represents a single cell and the colours correspond to the different timepoints. d, UMAP plot showing the coarse annotation of cells into 4 categories (Neuronal, Glial, Immune and Vascular/other) based on logistic regression from Zeisel et al. 2018. The RNA-velocity field is overlaid on the UMAP. Colours represent the 4 categories of cell annotation and the arrows correspond to the direction of the RNA-velocity flow field (see Methods). RG Radial glia, TAPs Transient amplifying progenitors, aNSCs Active neural stem cells, APCs Astrocyte progenitor cells, EmNBs Embryonic neuroblasts, GE NBs Ganglionic eminence neuroblasts, OPCs Oligoprogenitor cells, PreM-ODCs Immature pre-myelinating oligodendrocytes, INs Interneurons, ##ImStNeurons## Immature striatal neurons, VLMC Vascular leptomeningeal cells, Myeloid-DSCs Myeloid-derived suppressor cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9296666</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35853870</oboInOwl:hasDbXref>
        <rdfs:label>ImStNeurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002613"/>
        <skos:relatedMatch rdf:resource="CL:4042028"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/149b6af2-68c3-40c7-8fea-3b2eb082cb08"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002613"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/149b6af2-68c3-40c7-8fea-3b2eb082cb08"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4042028"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/15ad4b5a-b152-4a27-9dee-18bbf305f0b3 -->

    <Class rdf:about="http://example.org/15ad4b5a-b152-4a27-9dee-18bbf305f0b3">
        <obo:IAO_0000115>Immunological changes in Foxp3+Helios+ and Foxp3+CD25+ Tregs during T. pallidum/HIV-1 co-infection. The gating strategy for the analysis of Foxp3+CD25+ and Foxp3+Helios+ (A) cells is indicated. The frequencies of Foxp3+CD25+ Treg cells (B) and Foxp3+Helios+ Treg cells (C) were analyzed by flow cytometry in the HC, RPR+, CHI, and CHI&amp;RPR+ groups. Frequencies of Foxp3+CD25+CD45RA+ Treg cells (D), Foxp3+Helios+CD45RA+ Treg cells (E), Foxp3+CD25+CD45RO+ Tregs (F), and ##Foxp3+Helios+CD45RO+ Tregs## (G) were analyzed by flow cytometry in the HC, RPR+, CHI, and CHI&amp;RPR+ groups. The correlations between the CD4+ T-cell counts and the frequencies of Foxp3+Helios+ Treg cells (H) and Foxp3+Helios+CD45RO+ cells (I) in the CHI group were evaluated with Spearman&apos;s rank correlation test. Significance was assessed by calculating p-values using ANOVA, Student&apos;s t-tests, or Mann-Whitney U-tests, with values of p &lt; 0.05 considered significant.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6465566</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31024549</oboInOwl:hasDbXref>
        <rdfs:label>Foxp3+Helios+CD45RO+ Tregs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000815"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/15ad4b5a-b152-4a27-9dee-18bbf305f0b3"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000815"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/15b260cc-d903-45e6-b7a5-a65f4ebe9cab -->

    <Class rdf:about="http://example.org/15b260cc-d903-45e6-b7a5-a65f4ebe9cab">
        <obo:IAO_0000115>A, B, tSNE plot of 4659 CD45+ immune cells from the CNS. Data from this study is integrated with data from; Table 6). C, D, Each dataset represented by one tSNE. Cells are annotated using color representing their cell type. bMicroglia: baseline microglia; aMicroglia: activated microglia; pmMicroglia: proliferation-mediating microglia; maMicroglia: monocyte-activating microglia; DAM: disease-associated microglia in SCI; elMicroglia: embryonic-like microglia; pvMacrophages: perivascular macrophages; mdMacrophages: monocyte-derived macrophages; DCs: dendritic cells; imB-cells: immature B-cells; mB-cells: mature B-cells; pimMicroglia: postnatal immature microglia; IEG+Microglia: immediate early genes microglia; sMicroglia: s-phase microglia; pPAM: postnatal proliferative-region-associated microglia; eMicroglia: embryonic microglia; ##pcpMacrophages##: postnatal choroid plexus macrophages; acpMacrophages: adult choroid plexus macrophages; iMonocytes: inflammatory monocytes; pMonocytes: patrolling monocytes; cpEpithelial cells: choroid plexus epithelial cells. E, tSNE plots of 4659 CD45+ immune cells for selected genes indicating the log2(cpm) expression with a continuous color for each cell separately. F, Proliferation rate of CD45low and CD45high cells at 7 and 21 d post-SCI. Hoechst 33342 expression presented on a log-scale was used for defining cells in S-phase. Right most plot reports the percentage of cells in S-phase. Each dot represents one biological replicate (four mice per time point). Mean is surrounded by a 95% CI. This figure is extended in Extended Data Figure 8-1.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8496189</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34417326</oboInOwl:hasDbXref>
        <rdfs:label>pcpMacrophages</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000880"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/15b260cc-d903-45e6-b7a5-a65f4ebe9cab"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000880"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/15bc63b6-65d3-4ce2-85ef-f50f65de06d7 -->

    <Class rdf:about="http://example.org/15bc63b6-65d3-4ce2-85ef-f50f65de06d7">
        <obo:IAO_0000115>We identified 23 immune cell subpopulations in the GSE162454 dataset by TSNE analysis at first. Based on the specific markers, we identified NK/T cells, CAFs (cancer associated fibroblasts), endothelial cells, plasma cells, osteoblastic cells, osteoclasts, B cells, M2 TAMs (tumor associated macrophages), M1 TAMs, monocytes and mast cells (Figure 10A). The expression of marker genes for different cell clusters was displayed in dot plot format in Figure 10B. The expression of OS-related genes was compared in different cell types. Because of the dropout sign of single-cell sequencing, INS was not detected in the GSE162454 dataset. As shown in Figure 10C, HMOX1 were expressed at higher levels in ##TAMs## and osteoclasts. ATF4 and ACADVL are highly expressed in myeloid cells as well as other cell types, which was suggestive of their roles in osteosarcoma progression.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10292890</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37285835</oboInOwl:hasDbXref>
        <rdfs:label>TAMs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/15bc63b6-65d3-4ce2-85ef-f50f65de06d7"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/15120589-0317-40ee-8dda-05e786de9524 -->

    <Class rdf:about="http://example.org/15120589-0317-40ee-8dda-05e786de9524">
        <obo:IAO_0000115>The Table shows the numerical representations of Excitatory Neurons (Deep and Superficial Pyramidal cells) and Inhibitory neurons (Oriens Lacunosum moleculare cells:OLM; Trilaminar cells:Tri, Backprojection cells:BP, cholecystokinin positive Basket cells:CCKBC, Parvalbumin positive cells:PVBC, AxoAxonic Cells:AA, Ivy Cells:IVY, Bistratified cells:BS, Schaffer Collateral associated cells:SCA, Perforant Pathway Associated cell:##PPA##, Neurogliaform:NG) subdivided on the basis of the placement classes (SO, SP, SR, SLM).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9381785</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35974119</oboInOwl:hasDbXref>
        <rdfs:label>PPA</rdfs:label>
    </Class>
    


    <!-- http://example.org/15588e34-bdfd-4bbb-acc1-735fedb3a532 -->

    <Class rdf:about="http://example.org/15588e34-bdfd-4bbb-acc1-735fedb3a532">
        <obo:IAO_0000115>Among various cell types in the iris/ciliary body, we could detect a distinct population of cells that express markers of stem cells. Even though these cells express markers of retinal progenitor cells or retinal stem cells, such cells need to give rise to ##retinal neurons## in vivo to label them as retinal stem cells. The absence of in vivo experiments limits our work. Previous studies have mentioned that Muller glial cells share 60% of the transcriptome with retinal progenitors in mice. However, transcriptomic similarity or the presence of specific genes markers do not guarantee if a cell is a retinal stem cell or not. Therefore, such cells remain as putative stem cells for now.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8478974</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34584087</oboInOwl:hasDbXref>
        <rdfs:label>retinal neurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0009004"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/15588e34-bdfd-4bbb-acc1-735fedb3a532"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0009004"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/156e512a-820e-4821-9231-abd96f095741 -->

    <Class rdf:about="http://example.org/156e512a-820e-4821-9231-abd96f095741">
        <obo:IAO_0000115>Crossed activation of thoracic trunk motoneurons by ##medullary reticulospinal neurons##.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6957368</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31664872</oboInOwl:hasDbXref>
        <rdfs:label>medullary reticulospinal neurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:4023107"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/156e512a-820e-4821-9231-abd96f095741"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4023107"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/157f62f3-27ca-4129-991e-3b3ba06b8d27 -->

    <Class rdf:about="http://example.org/157f62f3-27ca-4129-991e-3b3ba06b8d27">
        <obo:IAO_0000115>Quantification confirmed the histological observations and revealed a significant decrease of outer hair cells at 6 h post-ho-sisomicin treatment and complete ##outer hair cell## loss after 14 h (Fig. 4D). TUNEL-positive outer hair cell nuclei peaked at 6 h post-treatment, indicating that most cells enter the late stages of apoptotic cell death between 3 and 6 h after exposure to ho-sisomicin. DNA fragmentation in outer hair cells was evident between 6- and 11- hours post treatment (Fig. 4E). Moreover, the number of missing outer hair cells and outer hair cell debris increased gradually, starting from 6 h post-ho-sisomicin treatment (Fig. 4F).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11237112</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38987330</oboInOwl:hasDbXref>
        <rdfs:label>outer hair cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000601"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/157f62f3-27ca-4129-991e-3b3ba06b8d27"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000601"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/16b8045b-b7bc-4b12-b766-3433314e7299 -->

    <Class rdf:about="http://example.org/16b8045b-b7bc-4b12-b766-3433314e7299">
        <obo:IAO_0000115>Over the past decade, exosomes were implicated in diverse activities in biological systems, possibly by modulating intercellular communication or action at a distance. Their immunomodulatory (immunosuppressive or immune-active) effect is one of the different mechanisms caused by regulation of the deliveries of different constituents to recipient cells. These effects attracted the interest of clinical immunologists. Because they produce immunosuppressive molecules, exosomes play dual roles in cancer, that is, they can aid the growth and dissemination of cancer cells by overcoming the activities of T-lymphocytes and natural killer cells (NKCs) and/or modulate the immune system by promoting the differentiation of T-regulatory cells or myeloid cells that elicit anti-tumor responses. In particular, exosomes of dendritic cell origin possess MHC-I and -II on their surface, whose binding to T-cell receptors induce an adaptive immune response by activating CD4+ or CD8+ T cells. However, exosomes from immature DCs reduce adaptive immune responses by inducing apoptosis of the T-cells, thus promoting immunogenic tolerance, as observed in murine models of autoimmune diseases and transplantation. By influencing the balance between ##pro- and anti-inflammatory effector T-cells##, these suppressive exosomes were found to induce the differentiation of T-helper 17 (Th17)/Th1 cells to forkhead box P3 (Foxp3) and Th2 regulatory T cells. Furthermore, Corrado et al. reported on the immune adjuvant potential of exosomes. By acting as antigen-presenting vesicles, exosomes can possibly be exploited to evade graft rejection and treat autoimmune diseases.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6406279</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:30699987</oboInOwl:hasDbXref>
        <rdfs:label>pro- and anti-inflammatory effector T-cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000911"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/16b8045b-b7bc-4b12-b766-3433314e7299"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000911"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/16c87134-9e27-41a0-b374-d42eceeb9947 -->

    <Class rdf:about="http://example.org/16c87134-9e27-41a0-b374-d42eceeb9947">
        <obo:IAO_0000115>We next assessed if iETV2-ECs could also be used to vascularize cerebral organoids (CO), and if presence of ECs would affect the localization of the different neural compartments. We thus generated PSC-derived COs and vascularized COs (eCOs; by allowing organoid formation from a mix of iETV2 and wild type PSCs; PSC:iETV2-hiPSC ratio = 8:2). To generate iETV2-ECs in situ, we activated the ETV2 transgene by addition on day 4 and 7, respectively, low and high concentrations of doxycycline for basal and full transgene activation (Figure  5A). Immunostaining of DIV35 eCO revealed CD31+ vascular structures and relatively smaller and scattered ventricular zones (VZ) (Figure 5B(ii)) in which the radial organization of SOX2+ cells (but not TUJ1+ cells) was less apparent than that of CO not containing ECs (Figure 5B(i)). We also embedded CO and eCO in matrigel alone or in iETV2-ECs laden matrigel. In matrigel alone, we observed VZ-like structures in the CO, however the SOX2+ cells were mostly found outside the VZ (indicated by asterisk; Figure 5B(iii)). In eCO, the radial organization of SOX2+ in VZ was more disrupted (Figure 5B(iv)), whereby the SOX2+ and TUJ1+ cells appeared to spread into the matrigel, and CD31+ cells were found mainly at the periphery. In iETV2-##EC##</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10837345</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38037510</oboInOwl:hasDbXref>
        <rdfs:label>EC</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000115"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/16c87134-9e27-41a0-b374-d42eceeb9947"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000115"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/162c6ada-0ae9-4427-a480-b4ea971dfe3a -->

    <Class rdf:about="http://example.org/162c6ada-0ae9-4427-a480-b4ea971dfe3a">
        <obo:IAO_0000115>A UMAP depicting the del(5q) density across the different hematopoietic progenitors obtained in three patients after lenalidomide treatment. HSC hematopoietic stem cells, LMPP lymphoid-primed multipotent progenitors, GMP granulocyte-monocyte progenitors; granulocyte progenitors; monocyte progenitors; dendritic cell progenitors, CLP common lymphoid progenitors; B-cell progenitors; T-cell progenitors, MEP megakaryocyte-erythroid progenitors, MK_Prog megakaryocyte progenitors; early erythroid progenitors; ##late erythroid progenitors##; basophil progenitors. B Barplots showing the number of del(5q) and non-del(5q) cells composing each cell type for each MDS patient. C Percentage of the cells identified as del(5q) by karyotype, CASPER, CopyKat, and the selection by intersecting the two algorithms. D Heatmap representing the enrichment of del(5q) cells (log10(p-value)) in each cell type. Any color different from white represents a statistically significant enrichment of del(5q) cells (p-value &lt; 0.05). P-values were calculated using the one-sided hypergeometric test. The number of biologically independent replicates (cells) used for the hypergeometric test and the exact enrichment p-values can be found in the Source Data.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11189937</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38902243</oboInOwl:hasDbXref>
        <rdfs:label>late erythroid progenitors</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000038"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/162c6ada-0ae9-4427-a480-b4ea971dfe3a"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000038"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/1620eb8c-732e-480b-8de2-562bf1e3b5ac -->

    <Class rdf:about="http://example.org/1620eb8c-732e-480b-8de2-562bf1e3b5ac">
        <obo:IAO_0000115>As can be seen from Fig. 2b, the fibroblasts which highly expressed HBEGF (average expression of HBEGF higher than 1.5) were distributed into a small group. Then we defined them as HBEGF+ fibroblasts and fibroblasts with low expression of HBEGF were defined as HBEGF- fibroblasts. Referring to the previous studies, macrophages with high or low expression of HBEGF were defined as ##HBEGF+ macrophages## and HBEGF- macrophages separately (Fig. 3a).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9446562</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36068607</oboInOwl:hasDbXref>
        <rdfs:label>HBEGF+ macrophages</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/1620eb8c-732e-480b-8de2-562bf1e3b5ac"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/1664da32-b27b-444d-ad27-a136d5b52fde -->

    <Class rdf:about="http://example.org/1664da32-b27b-444d-ad27-a136d5b52fde">
        <obo:IAO_0000115>To comprehensively analyze mouse BM hematopoiesis, the present study sorted lineage-negative cells to form single-cell resolution; the marker genes are shown in Figure 2A. The UMAP clustering map of mouse ##BM stem cells/progenitors## (c-kit+) yielded two integrated samples. The UMAP plot showed the distribution of six cellular clusters, in which there were 2 HSC and 3 GMP subclusters color-coded according to cell subclusters (Figure 2B). We then sort cells from HSCs to lineage-specified progenitors in pseudotime to understand different trajectories and development states. As shown in Figure 2C, Monocle illustrated the percentage of cell type at similar branch points. Single-cell resolution also validated the immunophenotype results wherein RalA increased the self-renewal of HSC-1, MPPs, and GMP-1 in RalARosa26-Tg/+mice (Figure 2D). Heatmaps show the expression levels of the 5 most significantly enriched genes in every cluster (Supplementary Figure S5). Next, immunophenotype-defined cellular transcriptomes were comprehensively compared. The unsupervised hierarchical clustering showed transcriptional heterogeneities of immunophenotypical HSCs (iHSCs). The iHSCs were classified into two groups with different transcriptional characteristics: HSC-1 (Figure 2E) and HSC-2 (Figure 2F).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10008703</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36923939</oboInOwl:hasDbXref>
        <rdfs:label>BM stem cells/progenitors</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000034"/>
        <skos:relatedMatch rdf:resource="CL:0011026"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/1664da32-b27b-444d-ad27-a136d5b52fde"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000034"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/1664da32-b27b-444d-ad27-a136d5b52fde"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0011026"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/16816413-9e58-4ec1-b0a4-4fd06a1e0641 -->

    <Class rdf:about="http://example.org/16816413-9e58-4ec1-b0a4-4fd06a1e0641">
        <obo:IAO_0000115>T cell development stages and transcription factor expression kinetics. (A) Diagram depicts different stages of early thymic T cell development that T-progenitor cells sequentially go through. Informative surface proteins that are utilized to define each stage are indicated (cKit, CD44, CD25 for ETP to DN3; CD4 and CD8 for DP). Developmental plasticity to generate alternative, non-T-lineage cells is shown with dotted arrows. Note that these alternative lineage potentials are silenced after T-lineage commitment. Lineage commitment to a T cell fate distinguishes Phase 1 (before T-lineage commitment) and Phase 2 (after T-lineage commitment). CLP, Common lymphoid progenitor, ##LMPP##, lympho-myeloid primed progenitor. (B) Graphs show mRNA expression kinetics of important transcription factors involved in early T cell gene regulation programs. Left: Transcription factors inherited from the bone-marrow progenitor cells whose expressions gradually decline during T-development (Spi1, Bcl11a, Erg, Lyl1, and Lmo2). Middle: transcription factors upregulated in pro-T cells by thymic microenvironment (Tcf7, Gata3, and Bcl11b). Right: transcription factors expressed from the bone-marrow progenitor cells and stably and maintained during T cell development (Ikzf1, Tcf3, Tcf12, Runx1, and Runx3). Gene expression data was plotted by utilizing publicly available mRNA expression datasets for immune cells with curve smoothing . (C) Diagram illustrates transcription factors (arrows) providing distinct forces to different gene expression program modules in individual cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9928580</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36817475</oboInOwl:hasDbXref>
        <rdfs:label>LMPP</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000837"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/16816413-9e58-4ec1-b0a4-4fd06a1e0641"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000837"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/1685ad33-88f8-45fa-8486-e94241a9d9e5 -->

    <Class rdf:about="http://example.org/1685ad33-88f8-45fa-8486-e94241a9d9e5">
        <obo:IAO_0000115>In order for the sensitization we observed in excitatory interneurons to drive the psychophysical phenomenon of allodynia, spinal projection neurons must relay these nociceptive signals supraspinally. We found that capsaicin treatment shifted the overall tuning of SPB neurons towards LT input, consistent with the effects of central sensitization producing allodynia (Fig. 8a, b). Because SPB neurons are heterogeneous with respect to their response properties, we classified them as either wide-dynamic range (WDR), high threshold (HT), or low threshold (LT) (Fig. 8c) using previously published criteria. We found that both ##HT and WDR SPB## showed significant increases in tuning to LT input, however the degree of change was much greater for WDR compared to HT SPB neurons (Fig. 8d). Finally, examining CICADA responses across populations, we found that WDR cells were more frequently responsive to CICADA agonists (71.4%), compared to either LT (40%) or HT (0%) SPB neurons. In particular, all SP-responsive SPB neurons were WDR cells (Fig. 8e). Since capsaicin is known to activate peptidergic afferents that release SP, these findings suggest that capsaicin-induced allodynia may be conveyed to the brain through a population of TACR1 expressing WDR SPB neurons and, to a lesser extent, some HT SPB neurons (Fig. 8f).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9440908</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36057681</oboInOwl:hasDbXref>
        <rdfs:label>HT and WDR SPB</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000540"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/1685ad33-88f8-45fa-8486-e94241a9d9e5"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000540"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/17ada32c-997a-423e-b01b-98dbc0c055fd -->

    <Class rdf:about="http://example.org/17ada32c-997a-423e-b01b-98dbc0c055fd">
        <obo:IAO_0000115>Comparison of hiPSCs and immortal cell lines in GPCR research. Immortal cell lines typically rely on exogenous overexpression of the target GPCR and downstream effectors, whereas the types and expression levels of GPCRs and downstream effectors in hiPSCs are patient-specific and endogenous. Immortal cell lines carry the genomic information of the cell donor, whereas hiPSCs carry genomic information from a variety of patients, providing diverse genetic profiles and representing diseases of the heart, lungs, kidneys and cancerous tumors. Furthermore, the limited cell types available in immortal cell lines restrict the study of heterogeneous responses in different tissue types and cell types, with the common immortal cell lines representing only ovary cell type for CHO cell line, ##embryonic kidney cell## type for HEK293 cell line and cervical tumor cell type for Hela cell line. In contrast, hiPSCs can be differentiated into a range of different cell types, including neurons, CMs, adipocytes, hematopoietic, pancreatic, and hepatic cell types.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10244570</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37293485</oboInOwl:hasDbXref>
        <rdfs:label>embryonic kidney cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002518"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/17ada32c-997a-423e-b01b-98dbc0c055fd"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002518"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/17e0077a-8d8f-44f8-857c-318faee6c8e6 -->

    <Class rdf:about="http://example.org/17e0077a-8d8f-44f8-857c-318faee6c8e6">
        <obo:IAO_0000115>A, B, tSNE plot of 4659 CD45+ immune cells from the CNS. Data from this study is integrated with data from; Table 6). C, D, Each dataset represented by one tSNE. Cells are annotated using color representing their cell type. bMicroglia: baseline microglia; aMicroglia: activated microglia; pmMicroglia: proliferation-mediating microglia; maMicroglia: monocyte-activating microglia; DAM: disease-associated microglia in SCI; elMicroglia: embryonic-like microglia; pvMacrophages: perivascular macrophages; mdMacrophages: monocyte-derived macrophages; DCs: dendritic cells; imB-cells: immature B-cells; mB-cells: mature B-cells; pimMicroglia: postnatal immature microglia; IEG+Microglia: immediate early genes microglia; sMicroglia: s-phase microglia; pPAM: postnatal proliferative-region-associated microglia; ##eMicroglia##: embryonic microglia; pcpMacrophages: postnatal choroid plexus macrophages; acpMacrophages: adult choroid plexus macrophages; iMonocytes: inflammatory monocytes; pMonocytes: patrolling monocytes; cpEpithelial cells: choroid plexus epithelial cells. E, tSNE plots of 4659 CD45+ immune cells for selected genes indicating the log2(cpm) expression with a continuous color for each cell separately. F, Proliferation rate of CD45low and CD45high cells at 7 and 21 d post-SCI. Hoechst 33342 expression presented on a log-scale was used for defining cells in S-phase. Right most plot reports the percentage of cells in S-phase. Each dot represents one biological replicate (four mice per time point). Mean is surrounded by a 95% CI. This figure is extended in Extended Data Figure 8-1.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8496189</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34417326</oboInOwl:hasDbXref>
        <rdfs:label>eMicroglia</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000129"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/17e0077a-8d8f-44f8-857c-318faee6c8e6"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000129"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/17e288c1-a026-4c71-9afe-a10d6707e5a8 -->

    <Class rdf:about="http://example.org/17e288c1-a026-4c71-9afe-a10d6707e5a8">
        <obo:IAO_0000115>Meiosis initiation is a crucial step for the production of haploid gametes, which occurs from anterior to posterior in fetal ovaries. The asynchrony of the transition from mitosis to meiosis results in heterogeneity in the female germ cell populations, which limits the studies of meiosis initiation and progression at a higher resolution level. To dissect the process of meiosis initiation, we investigated the transcriptional profiles of 19 363 single germ cells collected from E12.5, E14.5, and E16.5 mouse fetal ovaries. Clustering analysis identified seven groups and defined dozens of corresponding transcription factors, providing a global view of cellular differentiation from primordial germ cells toward ##meiocytes##. Furthermore, we explored the dynamics of gene expression within the developmental trajectory with special focus on the critical state of meiosis. We found that meiosis initiation occurs as early as E12.5 and the cluster of oogonia_4 is the critical state between mitosis and meiosis. Our data provide key insights into the transcriptome features of peri-meiotic female germ cells, which offers new information not only on meiosis initiation and progression but also on screening pathogenic mutations in meiosis-associated diseases.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMID:32716582</oboInOwl:hasDbXref>
        <rdfs:label>meiocytes</rdfs:label>
    </Class>
    


    <!-- http://example.org/17f92ee0-ef80-4776-a2b5-e9ad05e2a9ac -->

    <Class rdf:about="http://example.org/17f92ee0-ef80-4776-a2b5-e9ad05e2a9ac">
        <obo:IAO_0000115>Compared to the normal fibromuscular stroma, PCa-associated reactive stroma is characterised by an increased proportion of fibroblasts/myofibroblasts, showing increased expression of vimentin, alpha-SMA, FAP, fibroblast-specific protein 1 (FSP-1) and desmin, counterbalanced by the loss of differentiated SMCs and by ECM remodelling, e.g. increased production of tenascin and collagen type I. Similar to normal fibroblasts, there are no universal markers for ##CAFs##. For instance, FSP1 is also expressed by macrophages and some cancer cells, while desmin by pericytes. CAFs&apos; immunophenotypic heterogeneity may be partially explained by their different precursors, including tissue-resident fibroblasts, mesenchymal stem cells, bone marrow-derived precursors and endothelial cells. Indeed, integrating spatial, morphological and functional data is necessary to characterise the heterogeneity of CAFs in prostate TME, possibly shedding light on their influence on neoplastic epithelial cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10006214</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36482187</oboInOwl:hasDbXref>
        <rdfs:label>CAFs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:1000299"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/17f92ee0-ef80-4776-a2b5-e9ad05e2a9ac"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:1000299"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/170dc76f-c7de-4c7c-bd7f-1f6f253ab42e -->

    <Class rdf:about="http://example.org/170dc76f-c7de-4c7c-bd7f-1f6f253ab42e">
        <obo:IAO_0000115>The interferon regulatory factor (IRF) family consists of nine transcription factor proteins that play important and diverse functions in regulation of cellular responses. Among them, IRF4 positively regulates lipolysis and suppress lipogenesis in WAT, and plays a central role in adaptive thermogenesis. IRF3 is expressed in ##3T3-L1 pre-adipocytes## and regulates its differentiation to adipocytes. Here we show the roles of IRF3 in adipogenesis, adipocyte function, and WAT macrophage activation, which are important for maintaining metabolic homeostasis.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8563729</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34091599</oboInOwl:hasDbXref>
        <rdfs:label>3T3-L1 pre-adipocytes</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002334"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/170dc76f-c7de-4c7c-bd7f-1f6f253ab42e"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002334"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/175d3776-9852-491c-bf33-01537e1c29f5 -->

    <Class rdf:about="http://example.org/175d3776-9852-491c-bf33-01537e1c29f5">
        <obo:IAO_0000115>Molecular features of ##bone endothelial cells##.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11628402</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:39528700</oboInOwl:hasDbXref>
        <rdfs:label>bone endothelial cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000115"/>
        <skos:relatedMatch rdf:resource="CL:0002092"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/175d3776-9852-491c-bf33-01537e1c29f5"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000115"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/175d3776-9852-491c-bf33-01537e1c29f5"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002092"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/18b2c3bb-5c0c-46ab-8b7e-a8f51fe4c945 -->

    <Class rdf:about="http://example.org/18b2c3bb-5c0c-46ab-8b7e-a8f51fe4c945">
        <obo:IAO_0000115>During valvulogenesis, valvular interstitial cells (VICs) are mainly derived from endocardial cushion cells through an EndoMT process. We investigated whether hPSC-derived VELs could be converted to VIC-like (VICL) cells through EndoMT by treating them with higher concentration of TGFb1 and bFGF over a time course of 6 days (Fig. 7a; Supplementary Fig. 7a). ##HPSC-derived VELs## quickly lose the cobble-stone morphology, and displayed the fibroblastic morphology (Fig. 7b). After 3 days treatment, VIC-type markers such as POSTN, ACTA2, and S100A4/FSP1 were strongly induced (Fig. 7a; Supplementary Fig. 7b), accompanied by upregulation of EndoMT genes such as SNAI1, TWIST1, SOX9, AGGRECAN, TENASCIN, and SCLERAXIS (Supplementary Fig. 7c). We further confirmed these by IF staining and WB analyses (Fig. 7b, c).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8421482</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34489520</oboInOwl:hasDbXref>
        <rdfs:label>HPSC-derived VELs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002248"/>
        <skos:relatedMatch rdf:resource="CL:4030033"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/18b2c3bb-5c0c-46ab-8b7e-a8f51fe4c945"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002248"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/18b2c3bb-5c0c-46ab-8b7e-a8f51fe4c945"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4030033"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/18cfcd2a-626f-4e21-a667-abafac2c1c84 -->

    <Class rdf:about="http://example.org/18cfcd2a-626f-4e21-a667-abafac2c1c84">
        <obo:IAO_0000115>Studies have shown that neutrophils and macrophages are capable of releasing large amounts of pro-inflammatory cytokines, and increased infiltration of pro-inflammatory cells can lead to delayed healing of chronic ulcers. Macrophages are mainly derived from haematopoietic stem cells and belong to the monocyte population of immune cells, which are divided into M1 and M2 macrophages. M1 macrophages, classically activated macrophages, are mainly activated by lipopolysaccharides and IFN-gamma and have a pro-inflammatory effect. M2 macrophages, ##selectively activated macrophages##, are mainly activated by IL-4 and IL-13 and have an anti-inflammatory effect. Normally, in the early stage of inflammation, M1 macrophages are activated to secrete inflammatory factors to accelerate the development of inflammation. And in the late stage of inflammation, M2 macrophages are activated to promote cell proliferation and tissue remodelling. So the polarisation of macrophages from M1 to M2 phenotype can help to heal wounds. Li et al. conducted bioinformatics and high-throughput sequencing data analysis on the GSE 165816 data set, and found that the proportion of M1 and M2 macrophages was higher than that of other cell subpopulations, and the proportion of M1 macrophage clusters was the highest in the non-healing group of DFU. Then, the enrichment analysis of differentially expressed IRGs (immune-associated genes, which are essential for immunological infiltration) in M1 macrophages showed that IRGs may be involved in the immune function of DFU, and the immune-related factors are closely related to the changes in DFU microenvironment. </obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11584366</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:39264020</oboInOwl:hasDbXref>
        <rdfs:label>selectively activated macrophages</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000863"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/18cfcd2a-626f-4e21-a667-abafac2c1c84"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000863"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/18102969-c2eb-4fe6-9bad-f690e50adfba -->

    <Class rdf:about="http://example.org/18102969-c2eb-4fe6-9bad-f690e50adfba">
        <obo:IAO_0000115>Systems Organs Cell Types     Respiratory system Lung AT2 cells 0.79% 21.20%   Nose (nasal turbinate epithelial cells) Mesenchymal stromal cells 1.70% 8.50%   Plasma cells 2.00% 8.80%   Nose (nasal brushing epithelial cells) Plasma cells 4.00% 13.80%   Nose (nasal airway epithelial cells) Nasal airway epithelial cells 8.40% 23.10%   Digestive system Gall bladder Primordium cell 2.20% 2.60%   Small intestine (jejunum) Enterocyte progenitor cell 14.00% 6.60%   Goblet cell 9.10% 2.60%   Small intestine (ileum) Intestinal epithelial stem cell 1.50% 4.20%   Enterocyte progenitor cell 2.40% 3.60%   Small intestine (duodenum) LGR5+ stem cell 5.20% 4.50%   Intestinal epithelial stem cell 3.90% 5.80%   Enterocyte progenitor cell 4.40% 6.80%   Tuft progenitor cell 7.40% 6.60%   Enteroendocrine cell 9.40% 3.80%   Large intestine (rectum) ##Goblet progenitor cell## 2.80% 62.50%   MKI67+ progenitor cell 10.30% 75.40%   Enterocyte 13.20% 77.50%   Goblet cell 18.20% 87.30%   Large intestine (colon) Enterocyte 5.70% 52.10%   Goblet cell 11.00% 78.00%   Esophagus Secretory progenitor cell 9.40% 18.80%   Nervous system Brain (substantia nigra and cortex) Oligodendrocyte precursor cell 1.60% 0.90%   Astrocyte 1.90% 1.00%   Reproductive system Fallopian tube Epithelial cells 1.40% 26.50%   Ovarian somatic cell 1.00% 1.00%   Testis Spermatogonium 1.70% 4.50%   Peritubular myoid cell 1.70% 6.30%   Testis somatic cell 2.10% 4.30%   Spermatogonial stem cell 1.40% 2.10%   Circulatory system Heart Cardiomyocyte 6.60% 0.80%   Cardiovascular progenitor cell 12.50% 0.40%   Urinary system Kidney Nephron epithelial cell 2.70% 10.70%   Epithelial cell 2.70% 9.60%   Endothelial cell 2.70% 12.80%   Mesangial cell 3.00% 14.50%   </obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7794913</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33401657</oboInOwl:hasDbXref>
        <rdfs:label>Goblet progenitor cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0009057"/>
        <skos:relatedMatch rdf:resource="CL:0011026"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/18102969-c2eb-4fe6-9bad-f690e50adfba"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0009057"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/18102969-c2eb-4fe6-9bad-f690e50adfba"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0011026"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/1818b0d1-c637-4519-bad8-5f5d9a8d5696 -->

    <Class rdf:about="http://example.org/1818b0d1-c637-4519-bad8-5f5d9a8d5696">
        <obo:IAO_0000115>We observe that the sickle sample and normal sample morphological parameters histograms are mostly overlapped; however, a nontrivial number of the sickle cells in the distribution exhibit nearly no phenotypic similarities to healthy cells. This unique subset of sickle cells can be extracted from the distribution through implementing a 21:1 SCD-to-normal ratio thresholding criterion. As described above, this means that each criterion is defined by the region in the histogram where the population of ##SCD cells## have 21x greater incidence of that chosen parameter than the normal cell population. The extraction of morphological parameters that uniquely identify sickling cells is a necessary step to constructing a meaningful, pure SCD ground truth set. Without thresholding, the large overlap between the morphological parameters of sickle and normal cells sample will confound the discrimination capacity of a classification algorithm. Furthermore, through refining the training set, we have narrowed down the focus of the classification algorithm to specifically differentiate SCD cells from healthy cells and greatly increase accuracy. The near ideal ROC curves (Figure 2B and Figure 3B) for LR and CNN algorithms when trained on the refined data, indicates that the algorithm practically predicted no false positives and would excel at identifying critically sickled cells. Overall, we have developed a group of metrics that can delineate critically sickling cells in a heterogeneous SCD sample.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10419148</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37569260</oboInOwl:hasDbXref>
        <rdfs:label>SCD cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000232"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/1818b0d1-c637-4519-bad8-5f5d9a8d5696"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000232"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/1838c183-7fa2-4be6-9672-6b9a881bca26 -->

    <Class rdf:about="http://example.org/1838c183-7fa2-4be6-9672-6b9a881bca26">
        <obo:IAO_0000115>(A) Example flow cytometry plots for the expression of Cx3cr1GFP and TIM4 on thymic macrophages at different times during embryonic development (E14.5, E17.5), immediately after birth, at 7 days, and 6 weeks of age. (B) Frequencies of Timd4+Cx3cr1- (Timd4 single-positive or Timd4SP), Timd4+Cx3cr1+ (double-positive or DP), and Cx3cr1+Timd4- (Cx3cr1 single-positive or Cx3cr1SP) thymic macrophages at the indicated time points. (C) Kinetics of the changes in different subpopulations of thymic macrophages from E14.5-6 weeks. (D) Frequencies at E15.5 and E19.5 of GFP-labeled cells among ##TIM4+ or TIM4- cells## in Cx3cr1CreER x ROSA26LSL-GFP embryos treated with 4-OHT at E9.5. (E) Scheme of the fate-mapping experiments showing the relationship between Cx3cr1+ and Timd4+ thymic macrophages during embryonic development. E15.5 pregnant ROSA26LSL-GFP mice mated with Cx3cr1CreER males were injected with 4-hydroxytamoxifen (4-OHT) and sacrificed at E19.5. (F) Representative flow cytometry staining for TIM4 and CX3CR1 in fate-mapped GFP+ thymic macrophages at E19.5. The panel to the right is the isotype control for CX3CR1-PE staining. (G) Frequencies of TIM4+CX3CR1- cells among fate-mapped GFP+ macrophages. Data are shown as meanSEM and are from at least two independent experiments for each panel. Each symbol is an individual mouse or embryo.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9754631</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36449334</oboInOwl:hasDbXref>
        <rdfs:label>TIM4+ or TIM4- cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000866"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/1838c183-7fa2-4be6-9672-6b9a881bca26"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000866"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/189bfa2c-3093-4a29-80d0-baa027ea6d35 -->

    <Class rdf:about="http://example.org/189bfa2c-3093-4a29-80d0-baa027ea6d35">
        <obo:IAO_0000115>By the time the mouse blastocyst is ready to implant into the uterus, it comprises three cell types: pluripotent epiblast and two types of extra-embryonic tissue; primitive endoderm (PE), that will become visceral endoderm (VE) that gives rise to the yolk sac; and trophectoderm (TE), progenitor of the placenta (figure 1). ESCs represent the pluripotent epiblast that forms a compartment distinct from the extra-embryonic cells in the blastocyst. The epiblast arises from a set of cells internalized during the 8- to 16-cell and 16- to 32-cell cleavage stages, the inner cell mass. The cells remaining on the outside of the embryo at this time become the TE. Before implantation, a salt and pepper mixture of inside cells, now specified as PE and epiblast, sort from each other into distinct layers. Just as the epiblast is represented by ESCs, cultured stem cell lines of trophoblast stem cells (TSCs) have been established from the TE and of eXtraEmbryoNic stem cells (XEN cells) from the PE/VE. The trick in recapitulating development beyond gastrulation to form structures representing the entire body plan has been to recreate interactions between the pluripotent ESCs and the two ##extra-embryonic stem cell## types. </obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9833437</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36630196</oboInOwl:hasDbXref>
        <rdfs:label>extra-embryonic stem cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000349"/>
        <skos:relatedMatch rdf:resource="CL:0002322"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/189bfa2c-3093-4a29-80d0-baa027ea6d35"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000349"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/189bfa2c-3093-4a29-80d0-baa027ea6d35"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002322"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/19a5fc91-e431-4172-bc55-2a14e3008688 -->

    <Class rdf:about="http://example.org/19a5fc91-e431-4172-bc55-2a14e3008688">
        <obo:IAO_0000115>Previous work revealed that GM-CSF cultured BMDCs are a heterogeneous myeloid cell population consisting of bona fide DCs (termed &quot;GM-DC&quot;) and a minor fraction of macrophage-like CD11c+ MHCII+ cells (termed &quot;GM-Mac&quot;). When we refined our flow cytometric analysis for distinguishing GM-DCs and ##GM-Macs## in BMDC cultures, we found a clear shift between both cell populations in 3xGrk -/- BMDC cultures. Among CD11c+ MHCII+ cells, the fraction of GM-DCs was decreased, whereas GM-Macs were markedly increased in both unstimulated and LPS-stimulated 3xGrk -/- GM-CSF cultures ( Figure 5E ). Importantly, the remaining bona fide GM-DCs, which still developed in 3xGrk -/- cultures, also showed reduced expression of CCR7, MHCII and CD40 ( Figure 5F ). Together, these findings provide an explanation for the two observed phenotypes of 3xGrk -/- cells in the under-agarose chemotaxis assays; (a) less responding cells, because GM-Macs do not migrate to CCL19, and (b) reduced displacement of the responding cells, because the remaining bona fide GM-DCs remain lowered in CCR7-expression. Additionally, we noticed that not only DCs derived from GM-CSF cultures showed an altered phenotype, but also DC development in the presence of Flt3 ligand was impaired. In particular, the number of CD11b- DCs was strongly reduced, whereas the CD11b+ DC population was not significantly altered ( Supplementary Figure 3A ).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9703078</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36451830</oboInOwl:hasDbXref>
        <rdfs:label>GM-Macs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/19a5fc91-e431-4172-bc55-2a14e3008688"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/19bf0a52-31a0-4611-b17c-1fcd7d404cb2 -->

    <Class rdf:about="http://example.org/19bf0a52-31a0-4611-b17c-1fcd7d404cb2">
        <obo:IAO_0000115>Focusing on the peripheral, differentiated cDC populations, we next assessed protein expression of the IRF8 transcription factor in tumor-derived cDC populations (Fig. 3a). In the periphery, IRF8 controls survival and function of terminally differentiated cDC1s. Furthermore, increased IRF8 expression in CD11b-CD103- DN cells was shown to promote their differentiation into mature ##CD103+ cDC1s##. Thus, we hypothesized that CD40L-CAR T cell treatment skews the cDC1/cDC2 ratio towards the cDC1 populations by stimulating the DN cells to expand, upregulate IRF8, and differentiate into cDC1s. We specifically noticed upregulation of IRF8 (readout of DN-to-cDC1 differentiation) and Ki-67 (readout for proliferation) in DN cells treated with CD40L-CAR T cell-treated mice (Fig. 3b). The increased expression of Ki-67 in the tumor-derived DN cells also correlated with the observed increase of the DN population in the tumor of CD40L-CAR T cell-treated mice (Fig. 1f), indicating that DN cells receive a proliferative signal upon CD40L-CAR T cell treatment. Intriguingly, splenic DN cells and DN cells from the tdLNs did not upregulate Ki-67 or IRF8 (Fig. 3c, d). Overall, tdLN cDCs did not present with a stimulated phenotype, as suggested by the lack of CD86 or Ki-67 upregulation (Supplementary Fig. 2D-G). This suggested a tumor-specific effect of cDC DN stimulation after m1928z-CD40L treatment.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7710757</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33268774</oboInOwl:hasDbXref>
        <rdfs:label>CD103+ cDC1s</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002461"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/19bf0a52-31a0-4611-b17c-1fcd7d404cb2"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002461"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/1905684c-7227-4ede-af3e-75715b03062c -->

    <Class rdf:about="http://example.org/1905684c-7227-4ede-af3e-75715b03062c">
        <obo:IAO_0000115>Numerous human placental disorders have their pathophysiological roots at the early developmental stages. However, molecular studies of the underlying causes were long hampered by the inaccessibility of placental tissue and the lack of suitable in vitro models. Researchers mainly relied on the scarcely available primary tissue and several transformed and cancer cell lines of restricted potential. While animal models, in particular mice, are widely used to study the development and function of human organs, their ability to model the placenta is limited. As described above, the development of the specific trophoblast lineages and cell types differ between the two species. For instance, various types of the trophoblast giant cells feature prominently in the murine placenta while these are limited to EVT subtypes in humans. The recent establishment of the human trophoblast stem cells (hTSCs) and self-organizing trophoblast organoids (TOs) was a major breakthrough and provided novel, reliable tools to study molecular mechanisms driving trophoblast development and disease (Fig. 3). The hTSCs represent the CTB population of the first trimester placenta. In culture conditions activating EGF and WNT and inhibiting TGF-beta and ROCK signaling, they self-renew and remain bipotent. Upon induction, hTSCs can differentiate into STB or EVT, providing a versatile in vitro system to follow trophoblast development. TOs require similar signaling inputs to self-organize in 3D into the outer CTB-like layer and the inner ##STB-like## compartment, representing the inside-out model of the human villi. While these models have already proven to be a powerful tool to interrogate TF function in CTB, naive human embryonic stem cells (hESCs) conversion into hTSCs and recently-derived human blastoids can be used to dissect even earlier stages of human trophoblast development.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9166831</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35657505</oboInOwl:hasDbXref>
        <rdfs:label>STB-like</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000525"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/1905684c-7227-4ede-af3e-75715b03062c"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000525"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/1960ac14-b0e4-4936-896b-1114fced5f3f -->

    <Class rdf:about="http://example.org/1960ac14-b0e4-4936-896b-1114fced5f3f">
        <obo:IAO_0000115>Immunological changes in Foxp3+Helios+ and Foxp3+CD25+ Tregs during T. pallidum/HIV-1 co-infection. The gating strategy for the analysis of ##Foxp3+CD25+ and Foxp3+Helios+ (A) cells## is indicated. The frequencies of Foxp3+CD25+ Treg cells (B) and Foxp3+Helios+ Treg cells (C) were analyzed by flow cytometry in the HC, RPR+, CHI, and CHI&amp;RPR+ groups. Frequencies of Foxp3+CD25+CD45RA+ Treg cells (D), Foxp3+Helios+CD45RA+ Treg cells (E), Foxp3+CD25+CD45RO+ Tregs (F), and Foxp3+Helios+CD45RO+ Tregs (G) were analyzed by flow cytometry in the HC, RPR+, CHI, and CHI&amp;RPR+ groups. The correlations between the CD4+ T-cell counts and the frequencies of Foxp3+Helios+ Treg cells (H) and Foxp3+Helios+CD45RO+ cells (I) in the CHI group were evaluated with Spearman&apos;s rank correlation test. Significance was assessed by calculating p-values using ANOVA, Student&apos;s t-tests, or Mann-Whitney U-tests, with values of p &lt; 0.05 considered significant.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6465566</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31024549</oboInOwl:hasDbXref>
        <rdfs:label>Foxp3+CD25+ and Foxp3+Helios+ (A) cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000815"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/1960ac14-b0e4-4936-896b-1114fced5f3f"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000815"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/2a4cf1d2-303f-43fa-9d80-d94b197c0e52 -->

    <Class rdf:about="http://example.org/2a4cf1d2-303f-43fa-9d80-d94b197c0e52">
        <obo:IAO_0000115>Skeletal stem and progenitor cell populations are crucial for bone physiology. Characterization of these cell types remains restricted to heterogenous bulk populations with limited information on whether they are unique or overlap with previously characterized cell types. Here we show, through comprehensive functional and single-cell transcriptomic analyses, that postnatal long bones of mice contain at least two types of bone progenitors with bona fide skeletal stem cell (SSC) characteristics. An early osteochondral SSC (ocSSC) facilitates long bone growth and repair, while a second type, a perivascular SSC (##pvSSC##), co-emerges with long bone marrow and contributes to shape the hematopoietic stem cell niche and regenerative demand. We establish that pvSSCs, but not ocSSCs, are the origin of bone marrow adipose tissue. Lastly, we also provide insight into residual SSC heterogeneity as well as potential crosstalk between the two spatially distinct cell populations. These findings comprehensively address previously unappreciated shortcomings of SSC research.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8289409</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34280086</oboInOwl:hasDbXref>
        <rdfs:label>pvSSC</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000134"/>
        <skos:relatedMatch rdf:resource="CL:4033054"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/2a4cf1d2-303f-43fa-9d80-d94b197c0e52"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000134"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/2a4cf1d2-303f-43fa-9d80-d94b197c0e52"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4033054"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/2a586e52-2018-493f-95f4-1d938a6f7758 -->

    <Class rdf:about="http://example.org/2a586e52-2018-493f-95f4-1d938a6f7758">
        <obo:IAO_0000115>tSNE plot colored by the 17 Seurat clusters including hepatocytes, endothelial cells (liver sinusoidal endothelial cells:LSEC, non-tumor liver vascular endothelial cells:LVEC, and tumor liver vascular endothelial cells:LVECt), mesenchymal cells (Stellate cells, cancer-associated fibroblasts:CAFs, Pericytes, vascular smooth muscle cells:vSMC), immune cells (Kupffer cells, scar-associated macrophages:SAMs, tissue monocytes 1:##TM1##, cDC1, cDC2, T cells, and B cells), proliferating cells, and carcinoma cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7746227</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33332768</oboInOwl:hasDbXref>
        <rdfs:label>TM1</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000576"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/2a586e52-2018-493f-95f4-1d938a6f7758"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000576"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/2a61bc39-c22a-4366-8192-c89cbdc98394 -->

    <Class rdf:about="http://example.org/2a61bc39-c22a-4366-8192-c89cbdc98394">
        <obo:IAO_0000115>Dissecting hematopoietic cells and cytokine profile of patients with AA and HDs.A) Schematic of the study design. B) Uniform Manifold Approximation and Projection (UMAP) of mononuclear cells (MNCs) from BM and PB of HDs and patients with AA or PNH, colored by cell type. Mono: Monocytes; T/NK: T-cells and NK cells; B/Plasma: B cells and plasma cells; Ery: erythroid cells; ##Pro/pre-B##: pro-B and pre-B cells; Gra: granulocytes; Ery HPC: erythroid progenitor cells; HSPCs: hematopoietic stem/progenitor cells; DC HPC: dendritic cell-biased precursors; DC: dendritic cells; pDC: plasmacytoid dendritic cells; Meg: megakaryocyte-biased cells; EC/FB: endothelial cells and fibroblasts. C) UMAP of BMNCs from typical BM samples of HDs and patients with AA or PNH, colored by cell type. Red dashed lines indicate cells other than B, plasma, and T/NK cells. The blue dashed lines indicate T/NK clusters. D) Circle plot showing cellular communication of non-hematopoietic stromal cells and hematopoietic cells. The thickness of the flow indicates the contribution of the cell group or signaling pathway to each latent pattern. Several representative signaling pathway networks from stromal cells are shown. E) Representative dot plots of BM subset repartitioning in an HD and a patient with AA, were analyzed by mass cytometry. Dead and granulocyte-like cells were removed. cMono: classical monocytes. Dot plot coloring is based on the expression level of the target surface marker, blue indicates the lowest expression, and red indicates the highest expression. F) Cytokine profiles of BM plasma samples. Heatmap showing the relative cytokine concentrations in the BM plasma from patients with AA (n = 48) and HDs (n = 7). G) Column charts presented the concentration of representative cytokines (GM-CSF, IL-1beta, IL-4, IL-6, IL-13, and CCL2). P value was determined by unpaired two-tailed Student&apos;s t-test: * p &lt; 0.05, ** p &lt; 0.01, *** p &lt; 0.001, **** p &lt; 0.0001.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10933602</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38145351</oboInOwl:hasDbXref>
        <rdfs:label>Pro/pre-B</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000817"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/2a61bc39-c22a-4366-8192-c89cbdc98394"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000817"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/2acf6d3e-c872-41d3-84f1-5e68b5d1d53e -->

    <Class rdf:about="http://example.org/2acf6d3e-c872-41d3-84f1-5e68b5d1d53e">
        <obo:IAO_0000115>In this integrated space, we performed graph-based clustering and visualization with UMAP (Uniform Manifold Approximation and Projection). We identified 9 major cell-type clusters (Fig. 1e) present in all six tissues (Fig. 1f) and diseases (Additional file 2: Figure S2b). We labeled the clusters with canonical markers (Fig. 1g, Additional file 3: Table S2): CD3D+ T cells, NCAM1+ NK cells, MS4A1+ B cells, MZB1+ plasma cells, FCGR3A+/CD14+ macrophages, CD1C+ dendritic cells (##DCs##), TPSAB1+ mast cells, and MKI67+ cycling T and B cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8057009</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33879239</oboInOwl:hasDbXref>
        <rdfs:label>DCs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000990"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/2acf6d3e-c872-41d3-84f1-5e68b5d1d53e"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000990"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/2b007966-405d-4308-a405-6a75c5a587d7 -->

    <Class rdf:about="http://example.org/2b007966-405d-4308-a405-6a75c5a587d7">
        <obo:IAO_0000115>Adult patterns of ZFHX3 expression in retina would suggest that the effects of the Zfhx3Sci  allele are mediated through dysfunctions either in GABAergic amacrine cells and/or in subclasses of RGCs including ##ipRGCs##. Furthermore, the mutant allele has previously been shown to mediate its effects through the misregulation of disparate components of multiple neurotransmitter systems in SCN. An initial investigation of a number of neurotransmitter candidate systems in retinal tissue uncovered significant reductions in retinal Gad1 and Gad2 mRNA expression. These genes encode the GABA synthetic enzyme glutamic acid decarboxylase (GAD), and reduced expression should result in reduced GABA production and a consequential decrease in GABA signaling. Although no great differences in the number of GABAergic amacrine cells or in GAD immunoreactivity were detected in Zfhx3Sci/+  mutants, it is still reasonable to consider that disturbed GABAergic amacrine cell activity may underlie a disinhibition of some retinal ganglion cell functions in Zfhx3Sci/+  mice. This is manifest in the increased baseline activity and enhanced sensitivity of retinal light responses to weaker stimuli in Zfhx3Sci/+  mutants. A dis-inhibition of the inner retina may in turn mediate the observed effects on the pupillary response. Indeed, GABA is also documented to be involved in manipulating the circadian responses of the inner retina while GABA(A) receptors have been shown to modulate the responsiveness of the circadian system to light. </obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9292409</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34383984</oboInOwl:hasDbXref>
        <rdfs:label>ipRGCs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000740"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/2b007966-405d-4308-a405-6a75c5a587d7"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000740"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/2b1264f0-c939-4ac6-a990-675fb3439af8 -->

    <Class rdf:about="http://example.org/2b1264f0-c939-4ac6-a990-675fb3439af8">
        <obo:IAO_0000115>By the time the mouse blastocyst is ready to implant into the uterus, it comprises three cell types: pluripotent epiblast and two types of extra-embryonic tissue; primitive endoderm (PE), that will become visceral endoderm (VE) that gives rise to the yolk sac; and trophectoderm (TE), progenitor of the placenta (figure 1). ESCs represent the pluripotent epiblast that forms a compartment distinct from the extra-embryonic cells in the blastocyst. The epiblast arises from a set of cells internalized during the 8- to 16-cell and 16- to 32-cell cleavage stages, the inner cell mass. The cells remaining on the outside of the embryo at this time become the TE. Before implantation, a salt and pepper mixture of inside cells, now specified as PE and epiblast, sort from each other into distinct layers. Just as the epiblast is represented by ESCs, cultured stem cell lines of trophoblast stem cells (TSCs) have been established from the TE and of eXtraEmbryoNic stem cells (##XEN cells##) from the PE/VE. The trick in recapitulating development beyond gastrulation to form structures representing the entire body plan has been to recreate interactions between the pluripotent ESCs and the two extra-embryonic stem cell types. </obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9833437</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36630196</oboInOwl:hasDbXref>
        <rdfs:label>XEN cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000349"/>
        <skos:relatedMatch rdf:resource="CL:0002322"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/2b1264f0-c939-4ac6-a990-675fb3439af8"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000349"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/2b1264f0-c939-4ac6-a990-675fb3439af8"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002322"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/2bb53d8e-8e60-46b0-a66a-378f194aae3f -->

    <Class rdf:about="http://example.org/2bb53d8e-8e60-46b0-a66a-378f194aae3f">
        <obo:IAO_0000115>Besides these omental cell types, ##tumour-associated macrophages## (TAM) clearly are instrumental in metastasis, in particular the CD163+Tim4+ subset, which promotes the stemness, invasive properties and epithelial to mesenchymal transition (EMT) of tumour cells by paracrine mechanisms. While omentectomy or depletion of CD163+Tim4+ cells prevented metastatic dissemination in a mouse model of ovarian cancer, depletion of monocyte-derived TAM had little impact, emphasising the role of resident omental macrophages. In keeping with these findings, TAM from HGSC patients show a high degree of phenotypic, ontogenetic and tumour-promoting heterogeneity, reflected, for example, by the differential expression of CD163 and cytokines associated with tumour progression. </obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8574964</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34841720</oboInOwl:hasDbXref>
        <rdfs:label>tumour-associated macrophages</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/2bb53d8e-8e60-46b0-a66a-378f194aae3f"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/2bb71b86-2c5d-4629-b242-328e71c6ca7d -->

    <Class rdf:about="http://example.org/2bb71b86-2c5d-4629-b242-328e71c6ca7d">
        <obo:IAO_0000115>Skeletal stem and progenitor cell populations are crucial for bone physiology. Characterization of these cell types remains restricted to heterogenous bulk populations with limited information on whether they are unique or overlap with previously characterized cell types. Here we show, through comprehensive functional and single-cell transcriptomic analyses, that postnatal long bones of mice contain at least two types of bone progenitors with bona fide skeletal stem cell (SSC) characteristics. An early ##osteochondral SSC## (ocSSC) facilitates long bone growth and repair, while a second type, a perivascular SSC (pvSSC), co-emerges with long bone marrow and contributes to shape the hematopoietic stem cell niche and regenerative demand. We establish that pvSSCs, but not ocSSCs, are the origin of bone marrow adipose tissue. Lastly, we also provide insight into residual SSC heterogeneity as well as potential crosstalk between the two spatially distinct cell populations. These findings comprehensively address previously unappreciated shortcomings of SSC research.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8289409</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34280086</oboInOwl:hasDbXref>
        <rdfs:label>osteochondral SSC</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000134"/>
        <skos:relatedMatch rdf:resource="CL:0000138"/>
        <skos:relatedMatch rdf:resource="CL:0007010"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/2bb71b86-2c5d-4629-b242-328e71c6ca7d"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000134"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/2bb71b86-2c5d-4629-b242-328e71c6ca7d"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000138"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/2bb71b86-2c5d-4629-b242-328e71c6ca7d"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0007010"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/2bdab40a-f675-4802-ac40-825155755d90 -->

    <Class rdf:about="http://example.org/2bdab40a-f675-4802-ac40-825155755d90">
        <obo:IAO_0000115>PROBLEM: During pregnancy, the decidual spiral arterioles (SpAs) that supply maternal blood to the placenta undergo a series of changes to optimise the transfer of nutrients and oxygen to the developing foetus. Recent studies have shown that initiation of SpA transformation coincides with decidual leucocyte infiltration. Leucocytes are known to be a source of matrix metalloproteinases (MMPs); however, the complete profile of MMPs expressed by decidual NK cells (dNK) and macrophages has not been characterised. We hypothesised that leucocyte-derived MMPs contribute to SpA remodelling. METHODS: Decidual NK cells and macrophages were isolated from first trimester decidua and their MMP repertoire profiled by qRT-PCR (n = 10; 5-11 weeks). Dual immunofluorescence was used to localise MMP expression in situ (n = 3; 5-12 weeks). Gelatin zymography was carried out to assess whether leucocyte-derived MMPs can degrade ECM. In situ zymography and immunofluorescence identified MMP activity in tissue-resident dNK and macrophages. RESULTS: Decidual NK cells cells and macrophages expressed MMP2, -7, -9, -11, -16, -19 and tissue inhibitors of metalloproteinase-1, -2, and -3. Both cell types degraded gelatin using MMP2 and MMP9 and broke down collagen in an in vitro model of the SpA. Extravillous trophoblasts (EVTs) expressed a similar repertoire of MMPs. CONCLUSION: We suggest that matrix remodelling in SpA is initiated by ##infiltrating leucocytes##, while EVTs become involved at later stages.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMID:30267451</oboInOwl:hasDbXref>
        <rdfs:label>infiltrating leucocytes</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000738"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/2bdab40a-f675-4802-ac40-825155755d90"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000738"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/2bdf1c40-fd97-47bf-92b8-dd881ecfb773 -->

    <Class rdf:about="http://example.org/2bdf1c40-fd97-47bf-92b8-dd881ecfb773">
        <obo:IAO_0000115>Cataract is a leading cause of blindness worldwide. Currently, restoration of vision in cataract patients requires surgical removal of the cataract. Due to the large and increasing number of cataract patients, the annual cost of surgical cataract treatment amounts to billions of dollars. Limited access to functional human lens tissue during the early stages of cataract formation has hampered efforts to develop effective anti-cataract drugs. The ability of human pluripotent stem (PS) cells to make large numbers of normal or diseased human cell types raises the possibility that human PS cells may provide a new avenue for defining the molecular mechanisms responsible for different types of human cataract. Towards this end, methods have been established to differentiate human PS cells into both lens cells and transparent, light-focusing human micro-lenses. Sensitive and quantitative assays to measure light transmittance and focusing ability of human PS cell-derived micro-lenses have also been developed. This review will, therefore, examine how human ##PS cell-derived lens cells## and micro-lenses might provide a new avenue for development of much-needed drugs to treat human cataract.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6830331</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31627438</oboInOwl:hasDbXref>
        <rdfs:label>PS cell-derived lens cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002222"/>
        <skos:relatedMatch rdf:resource="CL:0002248"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/2bdf1c40-fd97-47bf-92b8-dd881ecfb773"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002222"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/2bdf1c40-fd97-47bf-92b8-dd881ecfb773"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002248"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/2bf2f1d1-d452-4112-a9f3-d9fcb06f6594 -->

    <Class rdf:about="http://example.org/2bf2f1d1-d452-4112-a9f3-d9fcb06f6594">
        <obo:IAO_0000115>This evolution generated the need to unify the nomenclature and refine the concepts that precisely define astrocyte heterogeneity by using a systematic approach to contextualize the contribution of astrocytes to CNS disorders. Recent studies have proposed that mouse astrocytes have two discrete pathological conditions: The A1 neurotoxic phenotype when exposed to specific cytokines secreted by activated microglia and the ##A2 neuroprotective phenotype## when exposed to an experimental paradigm mimicking ischemic stroke. However, this binary polarization should be approached cautiously since more recent studies recommend moving beyond the A1-A2 classification. Indeed, only a subset of mixed A1 and A2 or pan-reactive transcripts are up-regulated in astrocytes of human patients or mouse models of chronic diseases or acute CNS injuries. Moreover, advanced multidimensional data and the co-clustering statistical approach revealed that the A1 and A2 transcriptomes represent only two of the many potential astrocyte transcriptomes. As transcriptomic data are a fundamental tool used to characterize the functional diversity of reactive astrocytes, a multidimensional analysis should be applied to establish the uniqueness of astrocyte phenotypes.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8945600</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35327542</oboInOwl:hasDbXref>
        <rdfs:label>A2 neuroprotective phenotype</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000127"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/2bf2f1d1-d452-4112-a9f3-d9fcb06f6594"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000127"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/2c15ee19-eac8-4be2-9ea1-84d35baaecf5 -->

    <Class rdf:about="http://example.org/2c15ee19-eac8-4be2-9ea1-84d35baaecf5">
        <obo:IAO_0000115>a Line drawing of a cross section of the floor of the cochlear duct at P1. Distinct cell types within the organ of Corti (OC) are color coded. b Heat map for ~14,000 cochlear cells collected from four separate experiments at P1. Top 25 differentially expressed (DE) genes for the 15 identified clusters are shown. Cellular identity for each cluster is indicated by a color bar at the top of the heat map, which corresponds to the legend in a, and by a cell name at the bottom. c tSNE plot for the same cells as in b. Cluster identities are indicated. d Violin plots showing normalized log-transformed expression values for the top five DE genes for each cell type (color coded as in c) by comparison with all other P1 cells (gray on the right in each graph). Bars indicate median expression level. e Upper left panel, tSNE plot of cells determined to be derived from KO (between the OC and medial edge of the cochlear duct). Lower left panel, feature plot for the same cells as in the upper panel indicating high expression of Otoa, Calb1, and Fabp7 (based on color) in different clusters of cells. Lower right panel, cross sections through the cochlear duct at P1, illustrating expression of CALB1 in the medial region of KO and FABP7 directly adjacent to the OC (arrow; scale bars, 20 mum). Lowest panel shows high-magnification view of expression of FABP7 (arrow, gray scale) at the lateral KO border (green line; scale bar, 10 mum). Upper right panel, summary diagram of the spatial distribution of KO cell clusters at P1. HC hair cells, IPhC inner phalangeal cells/border cells, IPC inner pillar cells, OPC outer pillar cells, DC1/2 Deiters&apos; cells rows 1 and 2, DC3, Deiters&apos; cells row 3, HeC Hensen&apos;s cells, CC/OSC Claudius cells/outer sulcus cells, IdC interdental cells, ISC inner sulcus cells, KO Kolliker&apos;s organ cells, L.KO lateral Kolliker&apos;s organ cells, M.KO medial Kolliker&apos;s organ cells, OC90 ##OC90+ cells##.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7221106</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32404924</oboInOwl:hasDbXref>
        <rdfs:label>OC90+ cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002490"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/2c15ee19-eac8-4be2-9ea1-84d35baaecf5"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002490"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/2c491403-5399-4dd3-9f1f-ecfa1b960f3a -->

    <Class rdf:about="http://example.org/2c491403-5399-4dd3-9f1f-ecfa1b960f3a">
        <obo:IAO_0000115>a Due to single-cell annotation and in situ validation (Fig. 2; Supplementary Fig. 3), a draft model of the oral-to-tooth transition zone in humans is presented, with basal and suprabasal keratinocyte markers uniquely identifying the alveolar mucosa (AM), attached gingiva (AG), gingival margin (GM), sulcular epithelium (SK) and junctional epithelium (JK). b These markers allowed for KRT19-high keratinocyte (KC) cell subclustering for the first time (2504 cells in total), including gingival margin keratinocytes (GM), sulcular keratinocytes (SK), and junctional keratinocytes (JK). c A more granular draft (Tier 4) annotation of epithelial cells of the gingival attachment. d Assaying differentially expressed genes in periodontitis, ##SKs## and JKs only share about a quarter of upregulated genes. JKs displayed nearly 125 unique upregulated genes in diseased cells. e Further analysis of basal and suprabasal (differentiating) SK and JK keratinocytes revealed unique cell signatures between basal and suprabasal cell types. This full list is included in Supplementary Data 1. f-i To understand SK and JK developmental progression and cell state alterations, we used partitioned-based graph abstraction (PAGA). f Examining the basal to suprabasal transition, JKs display altered gene expressed comparing health to disease cell types, including broader expression of KRT17 and more expression of JUND, COL17A1, and CDH3. Key differentiation genes such as SPRR family members were also downregulated. g JKs displayed robust cell signaling and inflammatory phenotypes, which appear exacerbated in disease states. h In SKs, differentiation-related genes were uniquely expressed compared to JKs in health but also appeared altered in disease along the basal to suprabasal trajectory. i SKs appeared generally less reactive compared to JKs in disease, with lower overall expression of effector molecules such as CXCL1, CXCL8, IL1A, IL1B, and IL1RN. Abbreviations: Merk Merkel Cells, LC langerhans cells, Mela melanocytes, Muc mucosa, SB suprabasal Keratinocytes; for others, see Fig. 1 legend. For this figure, n = 30-sample, 2504-cell for scRNAseq.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11178863</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38876998</oboInOwl:hasDbXref>
        <rdfs:label>SKs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002170"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/2c491403-5399-4dd3-9f1f-ecfa1b960f3a"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002170"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/2c52c87f-94f4-4058-be06-f1c595a3e7b5 -->

    <Class rdf:about="http://example.org/2c52c87f-94f4-4058-be06-f1c595a3e7b5">
        <obo:IAO_0000115>Specifically, we show here that PLZF-defined spermatogonia, though retaining PLZF-positivity, are transcriptionally distinct at PND6 compared to later developmental time points. These transcriptional dynamics are also reflected by distinct differences at the protein level, with proteins such ASRGL1 being localized strongly in ##PLZF+ spermatogonia## during the first weeks of life, but decreasing in expression in these cells around three weeks of age (Fig 8). Similarly, we show that Prophase I spermatocytes possess significant transcriptional differences in the first-wave compared to subsequent spermatogenic waves, with hundreds of differentially expressed genes across multiple regulatory pathways. Furthermore, direct inspection of pachytene spermatocytes from the first wave at PND13 to later spermatogenic waves reveals that, like spermatogonia, transcript dynamics are also reflected at the protein level. For example, proteins such as DMRTB1 are found only in the nuclei of first-wave leptotene spermatocytes as they transition from differentiated spermatogonia into the meiotic program, but not in spermatocytes from older mice (Fig 10). By contrast, other proteins such as ASRGL1 are in low abundance in early first-wave spermatocytes, but become more strongly immunolocalized in spermatocytes at increasing ages (Fig 9).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6443194</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:30893341</oboInOwl:hasDbXref>
        <rdfs:label>PLZF+ spermatogonia</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000020"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/2c52c87f-94f4-4058-be06-f1c595a3e7b5"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000020"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/2c61c9ed-469a-4145-958d-8321bdfe5576 -->

    <Class rdf:about="http://example.org/2c61c9ed-469a-4145-958d-8321bdfe5576">
        <obo:IAO_0000115>Specifically, we show here that PLZF-defined spermatogonia, though retaining PLZF-positivity, are transcriptionally distinct at PND6 compared to later developmental time points. These transcriptional dynamics are also reflected by distinct differences at the protein level, with proteins such ASRGL1 being localized strongly in PLZF+ spermatogonia during the first weeks of life, but decreasing in expression in these cells around three weeks of age (Fig 8). Similarly, we show that Prophase I spermatocytes possess significant transcriptional differences in the first-wave compared to subsequent spermatogenic waves, with hundreds of differentially expressed genes across multiple regulatory pathways. Furthermore, direct inspection of ##pachytene spermatocytes## from the first wave at PND13 to later spermatogenic waves reveals that, like spermatogonia, transcript dynamics are also reflected at the protein level. For example, proteins such as DMRTB1 are found only in the nuclei of first-wave leptotene spermatocytes as they transition from differentiated spermatogonia into the meiotic program, but not in spermatocytes from older mice (Fig 10). By contrast, other proteins such as ASRGL1 are in low abundance in early first-wave spermatocytes, but become more strongly immunolocalized in spermatocytes at increasing ages (Fig 9).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6443194</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:30893341</oboInOwl:hasDbXref>
        <rdfs:label>pachytene spermatocytes</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000656"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/2c61c9ed-469a-4145-958d-8321bdfe5576"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000656"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/2c995f8d-e49b-4cb8-9611-e3aed39ae8de -->

    <Class rdf:about="http://example.org/2c995f8d-e49b-4cb8-9611-e3aed39ae8de">
        <obo:IAO_0000115>##C1QC+ macrophages## were transcriptionally similar to neuronal-associated gut-resident macrophages</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10403544</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37542039</oboInOwl:hasDbXref>
        <rdfs:label>C1QC+ macrophages</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/2c995f8d-e49b-4cb8-9611-e3aed39ae8de"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/2cb9727a-3e2e-4049-93e2-6c73ab76a392 -->

    <Class rdf:about="http://example.org/2cb9727a-3e2e-4049-93e2-6c73ab76a392">
        <obo:IAO_0000115>OBJECTIVE: To investigate the heterogeneity of in vitro expanded chondrocytes used for autologous chondrocyte implantation. METHODS: Human articular chondrocytes were expanded in vitro for 14 days, sorted into 86 single cells using fluorescence-activated cell sorting and subjected to single-cell RNA sequencing. Principal component, Cross R2 hierarchical clustering, and differential gene expression analyses were used for data evaluation. Flow cytometry and single-cell RT-qPCR (reverse transcriptase quantitative polymerase chain reaction) was used to validate the results of the RNA sequencing data Polyclonal chondrocyte populations from the same donor were differentiated in vitro toward the osteogenic and adipogenic lineages. RESULTS: There was considerable variation in gene expression between individual cells, but we found no evidence for separate cell subpopulations based on principal component, hierarchical clustering, and differential gene expression analysis. Most of the cells expressed all the markers defining mesenchymal stem cells, and as polyclonal chondrocyte populations from the same donor were shown to differentiate into osteocytes and adipocytes in vitro, these cells formally qualify as mesenchymal stem cells. CONCLUSIONS: In vitro expanded chondrocytes consist of one single population of cells with heterogeneity in gene expression between the cells. ##Dedifferentiated chondrocytes## qualify as mesenchymal stem cells as they fulfill all the criteria suggested by the International Society for Cellular Therapy.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8804791</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31072202</oboInOwl:hasDbXref>
        <rdfs:label>Dedifferentiated chondrocytes</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000138"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/2cb9727a-3e2e-4049-93e2-6c73ab76a392"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000138"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/2cbafeec-1a3e-487b-871e-a57fe74f74d4 -->

    <Class rdf:about="http://example.org/2cbafeec-1a3e-487b-871e-a57fe74f74d4">
        <obo:IAO_0000115>a Line drawing of a cross section of the floor of the cochlear duct at P1. Distinct cell types within the organ of Corti (OC) are color coded. b Heat map for ~14,000 cochlear cells collected from four separate experiments at P1. Top 25 differentially expressed (DE) genes for the 15 identified clusters are shown. Cellular identity for each cluster is indicated by a color bar at the top of the heat map, which corresponds to the legend in a, and by a cell name at the bottom. c tSNE plot for the same cells as in b. Cluster identities are indicated. d Violin plots showing normalized log-transformed expression values for the top five DE genes for each cell type (color coded as in c) by comparison with all other P1 cells (gray on the right in each graph). Bars indicate median expression level. e Upper left panel, tSNE plot of cells determined to be derived from KO (between the OC and medial edge of the cochlear duct). Lower left panel, feature plot for the same cells as in the upper panel indicating high expression of Otoa, Calb1, and Fabp7 (based on color) in different clusters of cells. Lower right panel, cross sections through the cochlear duct at P1, illustrating expression of CALB1 in the medial region of KO and FABP7 directly adjacent to the OC (arrow; scale bars, 20 mum). Lowest panel shows high-magnification view of expression of FABP7 (arrow, gray scale) at the lateral KO border (green line; scale bar, 10 mum). Upper right panel, summary diagram of the spatial distribution of KO cell clusters at P1. HC hair cells, ##IPhC## inner phalangeal cells/border cells, IPC inner pillar cells, OPC outer pillar cells, DC1/2 Deiters&apos; cells rows 1 and 2, DC3, Deiters&apos; cells row 3, HeC Hensen&apos;s cells, CC/OSC Claudius cells/outer sulcus cells, IdC interdental cells, ISC inner sulcus cells, KO Kolliker&apos;s organ cells, L.KO lateral Kolliker&apos;s organ cells, M.KO medial Kolliker&apos;s organ cells, OC90 OC90+ cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7221106</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32404924</oboInOwl:hasDbXref>
        <rdfs:label>IPhC</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002168"/>
        <skos:relatedMatch rdf:resource="CL:0005015"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/2cbafeec-1a3e-487b-871e-a57fe74f74d4"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002168"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/2cbafeec-1a3e-487b-871e-a57fe74f74d4"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0005015"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/2cbd831e-1285-46a2-9f9d-1339c4501db3 -->

    <Class rdf:about="http://example.org/2cbd831e-1285-46a2-9f9d-1339c4501db3">
        <obo:IAO_0000115>UMAP projections and corresponding gene-by-cell expression-level heatmaps of splenocytes from: (A) four adult NMRs (n = 2 of each sex), (B) four adult mice (n = 2 of each sex), and (C) the corresponding heatmap of the NK and T -cell subsets of the two species; T cells from spleens of (D) three adult and four old NMRs (all males), (E) four adult and four old mice (all males), and (F) the corresponding heatmap of the two species; Bone-marrow cells from (G) four adult NMRs (n = 2 of each sex), (H) four adult mice (n = 2 of each sex), and (I) the corresponding heatmap of the T-cell subsets of the two species; T cells from (J) cervical and thoracic thymuses of seven adult NMRs (n = 4 females and n = 3 males), (K) thoracic thymuses of four adult mice (n = 2 of each sex), and (L) the corresponding heatmap of the two species. UMAPs provide a two-dimensional overview of all cells, color-coding them by their annotated cell-type subset. Stacked bar charts to the sides of the UMAPs show the proportions of cells assigned to each T-cell subset out of the total immune-cell population in that tissue, as well as the absolute number of cells in each subset. Heatmaps show normalized expression levels of selected marker genes (marker genes relevant for identification of the various T-cell subsets are labeled in red) in each cell, where cells are faceted by their cell subset. Maturation trajectory arrows in (K, L) are knowledge based. M A violin plot of the distributions of the normalized Itgae expression levels in each of the NMR and mouse thymocyte subsets, highlighting the high expression levels unique to the mouse gammadeltaT-cell subset. Abbreviations: APC Antigen Presenting Cell, Cyt Cytotoxic, DC Dendritic Cell, DP Double Positive, ILC Innate Lymphoid Cell, NK Natural Killer, NKT Natural Killer T, Non-cyt ##Non-cytotoxic##, RBC Red Blood Cell, SP Single Positive, Treg Regulatory T. Source data are provided as Source data file.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11009300</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38605005</oboInOwl:hasDbXref>
        <rdfs:label>Non-cytotoxic</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000893"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/2cbd831e-1285-46a2-9f9d-1339c4501db3"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000893"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/2cd2f4ad-be8d-452a-8945-b438f8fd5453 -->

    <Class rdf:about="http://example.org/2cd2f4ad-be8d-452a-8945-b438f8fd5453">
        <obo:IAO_0000115>We identified a set of seven FRLncs that exhibit potential as prognostic markers and influence factors of the immune microenvironment in the context of OS. This ensemble encompasses three high-risk FRLncs, denoted as APTR, AC105914.2 and AL139246.5, alongside four low-risk FRLncs, designated as DSCR8, LOH12CR2, AC027307.2 and AC025048.2. Furthermore, our analysis revealed notable down-regulation in the high-risk group across four distinct immune cell types, namely neutrophils, natural killer cells, plasmacytoid dendritic cells and ##tumor-infiltrating lymphocytes##. This down-regulation was also reflected in four key immune functions, antigen-presenting cell (APC)-co-stimulation, checkpoint, cytolytic activity and T cell co-inhibition. Additionally, we identified seven immune checkpoint-associated genes with significant implications for OS prognosis, including CD200R1, HAVCR2, LGALS9, CD27, LAIR1, LAG3 and TNFSF4.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10588205</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37858131</oboInOwl:hasDbXref>
        <rdfs:label>tumor-infiltrating lymphocytes</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000542"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/2cd2f4ad-be8d-452a-8945-b438f8fd5453"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000542"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/2cf1f846-a30c-45e2-bf6c-8ddecaf43805 -->

    <Class rdf:about="http://example.org/2cf1f846-a30c-45e2-bf6c-8ddecaf43805">
        <obo:IAO_0000115>Age-related hearing loss (or presbyacusis) is a progressive pathophysiological process. This study addressed the hypothesis that degeneration/dysfunction of multiple nonsensory cell types contributes to presbyacusis by evaluating tissues obtained from young and aged CBA/CaJ mouse ears and human temporal bones. Ultrastructural examination and transcriptomic analysis of mouse cochleas revealed age-dependent pathophysiological alterations in 3 types of ##neural crest-derived cells##, namely intermediate cells in the stria vascularis, outer sulcus cells in the cochlear lateral wall, and satellite cells in the spiral ganglion. A significant decline in immunoreactivity for Kir4.1, an inwardly rectifying potassium channel, was seen in strial intermediate cells and outer sulcus cells in the ears of older mice. Age-dependent alterations in Kir4.1 immunostaining also were observed in satellite cells ensheathing spiral ganglion neurons. Expression alterations of Kir4.1 were observed in these same cell populations in the aged human cochlea. These results suggest that degeneration/dysfunction of neural crest-derived cells maybe an important contributing factor to both metabolic and neural forms of presbyacusis.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6679794</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31220650</oboInOwl:hasDbXref>
        <rdfs:label>neural crest-derived cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0011012"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/2cf1f846-a30c-45e2-bf6c-8ddecaf43805"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0011012"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/2d1700dc-bbc3-4157-ad5f-839b17447bca -->

    <Class rdf:about="http://example.org/2d1700dc-bbc3-4157-ad5f-839b17447bca">
        <obo:IAO_0000115>Correlation analysis revealed that DES expression showed a significant negative correlation with M1 macrophages and a positive correlation with naive B cells. In contrast, HBB expression showed a significant positive correlation with neutrophils and a negative correlation with M1 macrophages. Lastly, SLPI expression showed a significant positive correlation with ##resting dendritic cells##, CD8 T cells, and Tregs and a negative correlation with M2 macrophages (Figs. 4E-4J). We suggest that high expression of SLPI may inhibit the infiltration of M2 macrophages, thereby suppressing tumor growth.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10105558</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37070095</oboInOwl:hasDbXref>
        <rdfs:label>resting dendritic cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000451"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/2d1700dc-bbc3-4157-ad5f-839b17447bca"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000451"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/2d194f25-3a7d-4c50-ae6a-838bb859a368 -->

    <Class rdf:about="http://example.org/2d194f25-3a7d-4c50-ae6a-838bb859a368">
        <obo:IAO_0000115>To illustrate the application of CSN to developing cells, we feature the developmental trajectory of human excitatory neuron cells in the Developing Cortex Atlas dataset (15), which includes Radial Gila and Progenitors (P), Intermediate Progenitors (##IP##), Maturing Excitatory (ExN), Migrating Excitatory (ExM), Excitatory Upper-layer enriched (ExM-U), and Excitatory Deep layer (ExDp), with cell type labels determined by the authors (SI Appendix, section 3 and Table S2). Using Slingshot, we estimate the developmental path consists of two trajectories, one ending in upper-layer (U curve) and the other in deep-layer (D curve) excitatory neurons (Fig. 3 A and B).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8713783</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34903665</oboInOwl:hasDbXref>
        <rdfs:label>IP</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0011026"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/2d194f25-3a7d-4c50-ae6a-838bb859a368"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0011026"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/2d19e746-4676-4982-9f4e-5bc9b71599dd -->

    <Class rdf:about="http://example.org/2d19e746-4676-4982-9f4e-5bc9b71599dd">
        <obo:IAO_0000115>Recognition of low grade or asymptomatic systemic diseases suggests prevention of the worst, yet has been proven challenging ever since. Biomarker-based liquid biopsy has emerged in recent years as a practical platform for the assessment of systemic diseases yet, technical realizations were mainly focused on cancer, faced challenges in accuracy at early stage and are lacking provision of sufficient evidence of disease. In particular in cell-based cancer liquid biopsy, obstacles are rarity and heterogeneity of circulating tumor and tumor-associated rare cells. Evidence is mounting about an entire spectrum of distinct circulating rare cell types that denotes the systemic component of a certain physiological state. Therefore, circulating rare cells in combination may arise from yet, also account for systemic diseases, which we denote as multi-rare cell association and involves foremost ##bone marrow-derived progenitor and stem cells## yet, also matured somatic cell types. One would expect immense diagnostic value in the read-out of the so called rare cell population which represents cytological evidence of abnormality. We hypothesize that comprehensive rare cell population profiling as contrasted to the biomarker screening approach may realize the premise of a biopsy as to confirm, characterize, grade, stage or predict a systemic disease. This novel approach represents the &quot;missing link&quot; in diagnostic care of in particular early or residual systemic disease and presumes a steady gain in knowledge about the clinical interpretation of rare cell population profiles thus, expecting the knowledge-driven transformation of cell-based liquid biopsy from suggestion to confirmation. We support our hypothesis by past findings made by others and us and provide insights how to interpret a certain rare cell population profile.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMID:34598097</oboInOwl:hasDbXref>
        <rdfs:label>bone marrow-derived progenitor and stem cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002540"/>
        <skos:relatedMatch rdf:resource="CL:0011026"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/2d19e746-4676-4982-9f4e-5bc9b71599dd"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002540"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/2d19e746-4676-4982-9f4e-5bc9b71599dd"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0011026"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/2d442c8f-94b9-4c9a-a62f-59013cbab5a9 -->

    <Class rdf:about="http://example.org/2d442c8f-94b9-4c9a-a62f-59013cbab5a9">
        <obo:IAO_0000115>It has been reported that cortical-projecting subpopulations of DRN 5-HT neurons express Slc17a8, in agreement with the extensive overlap between the spatial distribution of cortical-projecting neurons and Slc17a8 expression. This suggests that cortical-projecting subpopulations should correspond to subtype 5-HT-IV from the scRNA-seq dataset, which is Slc17a8-expressing and distributed to the ventral DRN. Additionally, we would predict that the Str-projecting subpopulation corresponds to the subtype 5-HT-III, since their distributions overlap extensively in the dorsomedial DRN. Consistent with our hypothesis that 5-HT neuron subtypes innervate different brain regions, we found that the inferred distributions of each 5-HT neuron subtype coincides with a different set of projection-defined subpopulations - the distribution of subtype 5-HT-III was most similar to the distribution of Str-projecting neurons (Figure 6F), whereas the distribution of subtype 5-HT-IV was more similar to that of M1-projecting neurons (Figure 6G). However, neither ##Str-projecting nor M1-projecting## subpopulations were fully contained within the distribution of a single 5-HT neuron subtype. Str-projecting neurons in the ventrolateral DRN (marked cyan in Figure 6D,F,G), where neurons innervating both Str and M1 are located, fell within the distribution of subtype 5-HT-IV but not of subtype 5-HT-III. This suggests that Str is a target of multiple molecular subtypes of 5-HT neurons, and supports the model that some structures are innervated by multiple 5-HT neuron subtypes due to overlaps in the axonal projection fields of different subtypes.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6726424</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31411560</oboInOwl:hasDbXref>
        <rdfs:label>Str-projecting nor M1-projecting</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000540"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/2d442c8f-94b9-4c9a-a62f-59013cbab5a9"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000540"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/2d5e0ecb-c7d2-49eb-b25a-3b9095fd0f0a -->

    <Class rdf:about="http://example.org/2d5e0ecb-c7d2-49eb-b25a-3b9095fd0f0a">
        <obo:IAO_0000115>Inflammatory (M1) macrophages regulate colonic epithelial cell differentiation through direct macrophage-##crypt## contact, not observed with anti-inflammatory (M2) macrophages. Crypt cell growth is induced by both macrophage subsets, but for M1, it occurs via a secreted factor, while M2 requires physical contact with the crypt epithelium.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11219479</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38001043</oboInOwl:hasDbXref>
        <rdfs:label>crypt</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0009016"/>
        <skos:relatedMatch rdf:resource="CL:0009043"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/2d5e0ecb-c7d2-49eb-b25a-3b9095fd0f0a"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0009016"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/2d5e0ecb-c7d2-49eb-b25a-3b9095fd0f0a"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0009043"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/2d6af147-6703-4057-b8f7-45396c374b47 -->

    <Class rdf:about="http://example.org/2d6af147-6703-4057-b8f7-45396c374b47">
        <obo:IAO_0000115>Development of the trophoblastic shell and formation of placental anchoring villi. a Structure of the human trophoblastic shell and its surrounding arterial vessels. b Depiction of a placental anchoring villus, spiral artery (SA) remodelling and interaction of extravillous trophoblasts (EVTs) with different decidual cell types. dCCT ##distal cell column trophoblast##, dMPhi decidual macrophage, DSC decidual stromal cell, eCTB endovascular cytotrophoblast, GC giant cell, iCTB interstitial cytotrophoblast, pCCT proximal cell column trophoblast, pEC placental endothelial cell, pMPhi placental macrophage, pSC placental stromal/mesenchymal cell, SM smooth muscle layer, STB syncytiotrophoblast, TBS trophoblastic shell, TP trophoblast plug, TV tertiary villi, UC umbilical cord, uNK uterine NK cell, vCTB villous cytotrophoblast, YO yolk sac</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6697717</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31049600</oboInOwl:hasDbXref>
        <rdfs:label>distal cell column trophoblast</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000351"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/2d6af147-6703-4057-b8f7-45396c374b47"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000351"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/2d6cef58-ebcd-4006-92c9-f907efc766c6 -->

    <Class rdf:about="http://example.org/2d6cef58-ebcd-4006-92c9-f907efc766c6">
        <obo:IAO_0000115>Cellular composition of the T cell compartment varied between healthy and infected groups (Fig. 3d). Based on their relative proportions and differential abundance testing (FDR 10%), we found ##activated CD4+ T cells expressing IL22##, circulating follicular helper T (TFH) cells, type 1 helper T (TH1) cells, CD8+ effector memory T (TEM) cells and MAIT cells relatively enriched in individuals with asymptomatic and mild infection, with NKT, proliferating CD8+ and CD4+, and CD8+ terminal effector T (TTE) cells enriched in individuals with more severe infection (Fig. 3e and Extended Data Fig. 5a,b). Treating disease severity as an ordinal variable (Methods), multiple cell populations displayed nonlinear differences across disease severity (proliferating CD4+ and CD8+ T cells, CD8+ TTE, CD4+ TH1, CD4+ TH17, CD4+ central memory T (TCM) and IL-22+CD4+ T cells), illustrating the complex compositional changes to peripheral T cells that occur with COVID-19 (Fig. 3e and Extended Data Fig. 5b). IL-22-expressing CD4+ T cells seen in asymptomatic and mild disease could be associated with tissue-protective responses that may restrict immunopathology (Fig. 3e) as previously shown for IL-22 in influenza A virus infection and lower viral load in COVID-19 patients&apos; lungs. Proliferating CD4+ and CD8+ T cells coexpressed exhaustion marker genes LAG3 and TOX (Extended Data Fig. 5c), in keeping with previous studies of patients with severe COVID-19 (ref. ). In contrast to disease severity, CD4+ TH1, CD4+ TH2, CD4+IL-22+ and CD4+ TCM cells were enriched among individuals with longer symptom duration, while effector populations with a cytotoxic phenotype (CD8+ TTE, CD8+ TEM, MAIT and NK T cells) were enriched in individuals with shorter symptom duration (Extended Data Fig. 5d).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8121667</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33879890</oboInOwl:hasDbXref>
        <rdfs:label>activated CD4+ T cells expressing IL22</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0001043"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/2d6cef58-ebcd-4006-92c9-f907efc766c6"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0001043"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/2d7201c5-8410-4d6e-850b-13630c068ed6 -->

    <Class rdf:about="http://example.org/2d7201c5-8410-4d6e-850b-13630c068ed6">
        <obo:IAO_0000115>Overview of interactions among chondrocyte subtypes. (A,B) Total number and intensity of interactions in chondrocytes. (C-J) Interactions between different subtypes of chondrocytes. (C) indicates undefined cell subtypes, (D) indicates ECs, (E) indicates ##FCs##, (F) indicates HomCs, (G) indicates HTCs, (H) indicates preHTCs, (I) indicates ProCs, and (J) indicates RegCs.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10475121</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37660146</oboInOwl:hasDbXref>
        <rdfs:label>FCs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000138"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/2d7201c5-8410-4d6e-850b-13630c068ed6"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000138"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/2d90ec31-a1cc-46dd-b956-db01bb008b9a -->

    <Class rdf:about="http://example.org/2d90ec31-a1cc-46dd-b956-db01bb008b9a">
        <obo:IAO_0000115>(A, B) Schematic of medial (MOC) and lateral (LOC) olivocochlear neuron (OCN) subtypes housed in the brainstem (A) and their projections into the cochlea, shown in cross-section (A) and top-down (B). D, dorsal; L, lateral; LSO, lateral superior olive; VNTB, ventral nucleus of the trapezoid body; SOC, superior olivary complex; IHC, inner hair cell; OHC, outer hair cell; SGN, spiral ganglion neuron; IGSB, intraganglionic spiral bundle; ISB, inner spiral bundle; TSB, tunnel spiral bundle. (C) Schematic of single-nucleus collection protocol. The ventral brainstem of ChatCre; Rosa26Sun1-GFP mice was dissected, including the SOC, facial motor nucleus (VII), and trigeminal motor nucleus (V), followed by collection and sequencing of individual GFP+ nuclei. A, anterior; P, posterior. (D) UMAP plot summarizing sequencing data of 45,828 single nuclei from 61 animals across three ages. The data includes 56 clusters, including MOCs, LOCs, and several different motor neuron types, as well as a few non-neuronal populations. (E-H) Feature plots denoting normalized expression levels of selected genetic markers. For visualization purposes, high expression on the color scale is capped at the 95th percentile of gene expression. The majority of clusters express the neuronal marker Snap25 (E). The main non-neuronal population is labeled by Mog, an oligodendrocyte marker (F). Motor neuron clusters express the motor neuron determinant Isl1 (G). Among these brainstem motor neurons, ##OCNs## are identified by expression of the transcription factor Gata3 (H). (I, J) Differential expression of known markers Ucn (I) and Atp1a3 (J) denotes LOCs and MOCs, respectively. (K-M) Cadps2 is a novel marker for OCNs that is expressed by both MOCs and LOCs but not FMNs. (K) Violin plots summarizing transcriptional expression of Cadps2 in mature LOCs, MOCs, and FMNs. (L, M) Fluorescent in situ hybridization (FISH) verifies that Cadps2 is detected in both MOCs and LOCs (L) but not in FMNs (M). Representative images are shown from a total of three animals of either sex, P28.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10147377</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36876911</oboInOwl:hasDbXref>
        <rdfs:label>OCNs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:2000047"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/2d90ec31-a1cc-46dd-b956-db01bb008b9a"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:2000047"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/2d9c1e89-8c01-440e-ae64-5ce5707b594e -->

    <Class rdf:about="http://example.org/2d9c1e89-8c01-440e-ae64-5ce5707b594e">
        <obo:IAO_0000115>Identification of cell types from whole-brain cells. a UMAP plot shows the unsupervised clustering of 16,028 cells derived from mouse brain (for details, see &quot;Methods&quot;). The 15 cell types were classified by their transcriptional profiles. b Dot plot shows the expression levels of a representative cell-specific marker gene for each cell type. c UMAP plot shows the distribution of Olig2 expression. d Violin plot shows Olig2 expression across all clusters. e UMAP plot shows the distribution of GFAP expression. f Violin plot shows GFAP expression across all clusters. g A total of 3522 cells of the astrocyte subset were derived from cells in mouse brain. They were classified into ##Olig2(+)/GFAP(-) astrocytes## (347 cells), Olig2(+)/GFAP(+) astrocytes (104 cells), Olig2(-)/GFAP(+) astrocytes (848 cells) and Olig2(-)/GFAP(-) astrocytes (2,223 cells). immNEU immature neuron, mNEU mature neuron, OPC oligodendrocyte precursor cell, immOLG immature oligodendrocyte, OLG oligodendrocyte, ASC astrocyte, OEG olfactory ensheathing glia, MG microglia; MAC macrophage, EC endothelial cell, PC pericyte, EPC ependymal cell, VLMC vascular and leptomeningeal cell, ABC arachnoid barrier cell, CP cycling progenitor</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8573876</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34749773</oboInOwl:hasDbXref>
        <rdfs:label>Olig2(+)/GFAP(-) astrocytes</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000127"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/2d9c1e89-8c01-440e-ae64-5ce5707b594e"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000127"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/2db83740-17c8-4f92-be68-0450fab209db -->

    <Class rdf:about="http://example.org/2db83740-17c8-4f92-be68-0450fab209db">
        <obo:IAO_0000115>In clinical settings, insufficient mechanical loading such as prolonged bed rest after surgery or stress shielding caused by internal fixation impairs fracture healing. Our previous studies showed that the downregulated expression of Piezo1 was caused by insufficient mechanical loading and impaired chondrogenesis and osteogenesis of ##PSCs## during endochondral ossification. Transdifferentiation of chondrocytes into osteoblasts is a primary cellular event in endochondral ossification. However, whether insufficient mechanical loading downregulates Piezo1 expression in chondrocytes and impairs endochondral ossification remains unclear. In this study, we found that insufficient mechanical loading significantly downregulated the expression of Piezo1 in chondrocytes. In addition, our results confirmed that Piezo1 deletion in chondrocytes upregulated the expression of ApoE, resulting in chondrocyte senescence and delayed cartilage-to-bone transition. Based on the above results, we formulated an injectable and thermosensitive hydrogel capable of in situ release of an ApoE antagonist. This hydrogel effectively treated delayed fracture healing caused by insufficient mechanical loading. Collectively, these results provide a novel prospective therapeutic target for the treatment of insufficient mechanical loading-induced delayed fracture healing.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11633519</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:39418070</oboInOwl:hasDbXref>
        <rdfs:label>PSCs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0007001"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/2db83740-17c8-4f92-be68-0450fab209db"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0007001"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/2dd994c9-83be-4fa5-b419-efc5015672af -->

    <Class rdf:about="http://example.org/2dd994c9-83be-4fa5-b419-efc5015672af">
        <obo:IAO_0000115>Microglia reaction in AD was initially evidenced at the genomic level using bulk RNA-seq studies performed on purified microglia. The molecular heterogeneity of microglia in this pathological context was then studied using top-down approaches (typically scRNA-seq). With these approaches, microglia subtypes are first identified based on transcriptomic similarities, their potential functions are then inferred based on gene-ontology analyses, and finally their location in the tissue are assessed retrospectively based on the expression of a handful of markers. Other studies isolated ##PAM## and/or PCM using FACS, relying on specific markers that were shown to be, on average, up-regulated in PAM. These studies then performed thorough characterization of the positive and negative populations.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9508749</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36153535</oboInOwl:hasDbXref>
        <rdfs:label>PAM</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000129"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/2dd994c9-83be-4fa5-b419-efc5015672af"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000129"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/2e2b2981-ac3b-4e44-9256-ed41113b0605 -->

    <Class rdf:about="http://example.org/2e2b2981-ac3b-4e44-9256-ed41113b0605">
        <obo:IAO_0000115>Different pathogenesis of HCC involving viral and non-viral etiology is related to the unique TIME. Chronic infection with hepatitis B virus (HBV) promotes the formation of a tolerant TIME by depletion of the effector CD8+ T cells and attracting immunosuppressive cells including ##granulomatous myeloid-derived suppressor cells## (gMDSCs), Tregs, or regulatory B (Breg) cells. Chronic infection by hepatitis C virus (HCV) depletes CD8+ T cells and promotes immune evasion through spontaneous viral escape and dysregulation of major histocompatibility complex I (MHC I) dependent antigen presentation. In alcoholic steatohepatitis (ASH), alcohol promotes the inhibition of liver immune response by increasing the abundance of M2 TAMs, inhibiting CD8+ T cell activation, and facilitating gMDSC infiltration. In contrast, non-alcoholic steatohepatitis (NASH) activates dysfunctional immune cells, including helper T cell 17 (Th17) cells, natural killer T (NKT) cells, CD8+/PD-1+ T cells and IgA+ plasma cells, disrupting tumor immune surveillance and inducing HCC.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11639598</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:39641225</oboInOwl:hasDbXref>
        <rdfs:label>granulomatous myeloid-derived suppressor cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000094"/>
        <skos:relatedMatch rdf:resource="CL:0000889"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/2e2b2981-ac3b-4e44-9256-ed41113b0605"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000094"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/2e2b2981-ac3b-4e44-9256-ed41113b0605"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000889"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/2e5e2c44-7b93-48c8-967f-4f96d0f09af4 -->

    <Class rdf:about="http://example.org/2e5e2c44-7b93-48c8-967f-4f96d0f09af4">
        <obo:IAO_0000115>It has been reported that cortical-projecting subpopulations of DRN 5-HT neurons express Slc17a8, in agreement with the extensive overlap between the spatial distribution of cortical-projecting neurons and Slc17a8 expression. This suggests that cortical-projecting subpopulations should correspond to subtype 5-HT-IV from the scRNA-seq dataset, which is Slc17a8-expressing and distributed to the ventral DRN. Additionally, we would predict that the Str-projecting subpopulation corresponds to the subtype 5-HT-III, since their distributions overlap extensively in the dorsomedial DRN. Consistent with our hypothesis that 5-HT neuron subtypes innervate different brain regions, we found that the inferred distributions of each 5-HT neuron subtype coincides with a different set of projection-defined subpopulations - the distribution of subtype 5-HT-III was most similar to the distribution of ##Str-projecting neurons## (Figure 6F), whereas the distribution of subtype 5-HT-IV was more similar to that of M1-projecting neurons (Figure 6G). However, neither Str-projecting nor M1-projecting subpopulations were fully contained within the distribution of a single 5-HT neuron subtype. Str-projecting neurons in the ventrolateral DRN (marked cyan in Figure 6D,F,G), where neurons innervating both Str and M1 are located, fell within the distribution of subtype 5-HT-IV but not of subtype 5-HT-III. This suggests that Str is a target of multiple molecular subtypes of 5-HT neurons, and supports the model that some structures are innervated by multiple 5-HT neuron subtypes due to overlaps in the axonal projection fields of different subtypes.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6726424</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31411560</oboInOwl:hasDbXref>
        <rdfs:label>Str-projecting neurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002613"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/2e5e2c44-7b93-48c8-967f-4f96d0f09af4"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002613"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/2e9ffb6b-54de-4908-bced-2b48be8af240 -->

    <Class rdf:about="http://example.org/2e9ffb6b-54de-4908-bced-2b48be8af240">
        <obo:IAO_0000115>Translatome analysis with RiboTag reveals cell type-specific responses in HD. A HdhQ7/Q200 mice homozygous for RiboTag were crossed with homozygous Cre-driver lines to facilitate cell type-specific expression of Rpl22-HA in ##glutamatergic (vGluT2+) and GABAergic (Gad2+) neurons in the cerebellum and cerebrum##, and parvalbumin (PV+)-expressing neurons in the cerebrum. Cerebellum and cerebrum (without olfactory bulb) were separated and flash frozen at 9 months. For RiboTag IPs, cell type-specific HA-tagged ribosomes were immunoprecipitated from tissue homogenate using anti-HA antibody bound to magnetic beads. Total RNA was prepared from an aliquot of the same tissue homogenate. B Expression levels of Htt mRNA were slightly reduced in all cell types, significantly in cerebral vGluT2+ and PV+ neurons (* FDR &lt;= 0.05; ** FDR &lt;= 0.01; *** FDR &lt;= 0.001). C HD-typical genes showed downregulation in cerebral cell types. D Differentially expressed genes (DEGs) (FDR &lt;= 0.05) for each cell type. E Top five significantly enriched terms (FDR &lt;= 0.05) among DEGs reveal cell type-specific responses to mHtt</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9854201</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36670467</oboInOwl:hasDbXref>
        <rdfs:label>glutamatergic (vGluT2+) and GABAergic (Gad2+) neurons in the cerebellum and cerebrum</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000617"/>
        <skos:relatedMatch rdf:resource="CL:0000679"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/2e9ffb6b-54de-4908-bced-2b48be8af240"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000617"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/2e9ffb6b-54de-4908-bced-2b48be8af240"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000679"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/2eb33ccc-ba28-444b-a522-34b0413acb8b -->

    <Class rdf:about="http://example.org/2eb33ccc-ba28-444b-a522-34b0413acb8b">
        <obo:IAO_0000115>MOUSE SYMPATHO-ADRENAL CELL TYPES MARKERS   SNPCs Ret Phox2b Ascl1 Mycn Hand2 Gata3Sox10- Plp1-   Sympathoblasts extra-adrenal Phox2b Mycn Th Dbh Ret Cart CartptSox10- Plp1- Sgc10- Ascl1 -   Sympathetic neurons/ganglia/SRG Ret Scg10 Cart Ascl1 Phox2b Th DbhSox10- Plp1-   SCPs Sox10 Plp1 Ascl1 Phox2bRet-   Schwann cells Sox10 Plp1 GfapPhox2b-   Bridge cells Sox10 Plp1 Chga Penk Htr3a Ascl1 Phox2bTh- Ret-   Immature chromaffin cells Chga Chgb Penk Th DbhSox10- Plp1- Ret-   Chromaffin cells Chga Penk Ascl1 Phox2b Th DbhSox10- Plp1- Ret-   ##Sympathoblasts intra-adrenal## Ret Cart Cartpt Phox2b Th Alk Hmx1 PrphSox10- Plp1-   Sympathetic neurons intra-adrenal Ret Cart Ascl1 Phox2b ThSox10- Plp1-   </obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8915499</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35277192</oboInOwl:hasDbXref>
        <rdfs:label>Sympathoblasts intra-adrenal</rdfs:label>
    </Class>
    


    <!-- http://example.org/2edd716f-d529-4f55-907f-d0ad67dfc7d0 -->

    <Class rdf:about="http://example.org/2edd716f-d529-4f55-907f-d0ad67dfc7d0">
        <obo:IAO_0000115>Moreover, Zhang et al. identified the ##Arg1+ microglial## subtype located in the hippocampus, the proliferation, and maturation of which were driven by IL-4 signaling. This Arg1+ microglia subtype is responsible for secreting additional BDNF which maintains microglial self-renewal, adult neurogenesis in the DG, and working memory under stress conditions. However, BDNF released from microglia was also reported to promote the transdifferentiation of astrocytes and microglia to release proinflammatory cytokines, causing aggravated neuroinflammation. In conclusion, the neuroprotective effects exerted by microglia under both physiological and pathological conditions should not be neglected.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10683283</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38012702</oboInOwl:hasDbXref>
        <rdfs:label>Arg1+ microglial</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000129"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/2edd716f-d529-4f55-907f-d0ad67dfc7d0"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000129"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/2f2deb12-7cfa-404a-8ed7-7d1a467394ca -->

    <Class rdf:about="http://example.org/2f2deb12-7cfa-404a-8ed7-7d1a467394ca">
        <obo:IAO_0000115>scRNA sequencing data was analyzed to further explore the synergistic effect of the IRRS and the TME cells in ESCC. We used the previously profiled transcriptomes of ~208,659 single cells with eight main cell populations ( Figures 4A, B ), among which fibroblasts, endothelial cells, T cells, B cells, pericytes and myeloid cells were analyzed. Next, 40 cell clusters, including T helper 17 (TH17) cells, follicular helper T (TFH1/2) cells, naive T (TN) cells, regulatory T (Treg) cells, memory T (TMEM-CD4/CD8) cells, effector T (TEFF) cells, exhausted T (TEX) cells, monocytes (Mono01-03), tumor-associated macrophages (TAM01-04),dendritic cells (tDC, pDC, cDC), mast cells (Mast), resting B cells, activated B cells, germinal center B cells (GCB), plasma cells, normal mucosa fibroblasts (##NMF##), normal activated fibroblasts (NAF1/2), cancer-associated fibroblasts (CAF1-4), vascular smooth muscle cells (VSMC), normal endothelial cells (NEC1-3) and tumor endothelial cell (TEC1-3) were identified by t-SNE analysis ( Figures 4C-G ;  Figures S6A-E ). We then used CIBERSORTx to infer cell-type abundance from bulk RNA-seq data using scRNA data, and estimated the proportions of the 42 cell types in the training dataset. The proportions of TME cell types between the high- and low-risk groups was compared using the Kruskal-Wallis test. The profiles of the high- and low-risk groups are shown in  Figure 4H  and  Figure S6F . The abundance of TEX, NAF2, CAF4, and VSMC increased, and the abundance of Mono1, TAM03, and NEC2 decreased in the high-risk group (p &lt; 0.05;  Figure 4I ). The cell proportions between low and high risk groups demonstrated significantly distinct TME patterns.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9933905</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36817484</oboInOwl:hasDbXref>
        <rdfs:label>NMF</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000057"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/2f2deb12-7cfa-404a-8ed7-7d1a467394ca"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000057"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/2f35e6ca-d766-4bc8-937e-cc9f2d6914bd -->

    <Class rdf:about="http://example.org/2f35e6ca-d766-4bc8-937e-cc9f2d6914bd">
        <obo:IAO_0000115>After SPNs, most of the remaining neurons of the striatum are constituted by a diverse variety of GABAergic interneurons. The most commonly used markers to distinguish between subtypes of striatal GABAergic interneurons are parvalbumin, calretinin, and nitric oxide synthase. In human tissue, apparent LRRK2 expression has been observed in a majority of ##calretinin-expressing interneurons##, as well as a small subset of parvalbumin- and nitric-oxide-synthase-expressing neurons. However, in mice, LRRK2 staining was observed in most parvalbumin- and nitric-oxide-synthase-positive neurons and only a few calretinin-positive cells. In contrast, other groups have found no colocalization between LRRK2 and any of these markers. Single-cell mRNA expression across all types of GABAergic interneurons is approximately an order of magnitude lower than in SPNs. If the expression of the LRRK2 protein correlates with the mRNA levels reported by Saunders and colleagues, striatal interneurons would contain much less protein than the surrounding SPNs. This would increase the difficulty of detection, potentially explaining part of the apparent discrepancy among these studies. </obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8750662</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35011731</oboInOwl:hasDbXref>
        <rdfs:label>calretinin-expressing interneurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000099"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/2f35e6ca-d766-4bc8-937e-cc9f2d6914bd"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000099"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/2f482b99-c485-43a3-b3e6-04b00fddebf9 -->

    <Class rdf:about="http://example.org/2f482b99-c485-43a3-b3e6-04b00fddebf9">
        <obo:IAO_0000115>TCR repertoire analysis of the five CMV CD4+ T cell subsets. (A) Diversity measures based on clonotypes by cluster using Shannon, Inverse Simpson, Chao, and abundance-based coverage estimator (ACE) indices. (B) Clonal overlaps among the five CMV CD4+ T cell subsets. (C) Cloning frequency distribution in each subset. (D) Transcriptome similarity among ##CMV CD4+ CTLs, CD4+ Tra cells, and Treg cells##.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8691692</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34950144</oboInOwl:hasDbXref>
        <rdfs:label>CMV CD4+ CTLs, CD4+ Tra cells, and Treg cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000815"/>
        <skos:relatedMatch rdf:resource="CL:0000910"/>
        <skos:relatedMatch rdf:resource="CL:0001043"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/2f482b99-c485-43a3-b3e6-04b00fddebf9"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000815"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/2f482b99-c485-43a3-b3e6-04b00fddebf9"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000910"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/2f482b99-c485-43a3-b3e6-04b00fddebf9"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0001043"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/2f520cfb-aa75-46c9-9b2d-c42b7cec51a6 -->

    <Class rdf:about="http://example.org/2f520cfb-aa75-46c9-9b2d-c42b7cec51a6">
        <obo:IAO_0000115>A UMAP depicting the del(5q) density across the different hematopoietic progenitors obtained in three patients after lenalidomide treatment. HSC hematopoietic stem cells, LMPP lymphoid-primed multipotent progenitors, GMP granulocyte-monocyte progenitors; granulocyte progenitors; monocyte progenitors; dendritic cell progenitors, CLP common lymphoid progenitors; B-cell progenitors; T-cell progenitors, MEP megakaryocyte-erythroid progenitors, MK_Prog megakaryocyte progenitors; ##early erythroid progenitors##; late erythroid progenitors; basophil progenitors. B Barplots showing the number of del(5q) and non-del(5q) cells composing each cell type for each MDS patient. C Percentage of the cells identified as del(5q) by karyotype, CASPER, CopyKat, and the selection by intersecting the two algorithms. D Heatmap representing the enrichment of del(5q) cells (log10(p-value)) in each cell type. Any color different from white represents a statistically significant enrichment of del(5q) cells (p-value &lt; 0.05). P-values were calculated using the one-sided hypergeometric test. The number of biologically independent replicates (cells) used for the hypergeometric test and the exact enrichment p-values can be found in the Source Data.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11189937</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38902243</oboInOwl:hasDbXref>
        <rdfs:label>early erythroid progenitors</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000038"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/2f520cfb-aa75-46c9-9b2d-c42b7cec51a6"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000038"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/2f633c04-8dc9-4b12-a875-1d25cb7d95e9 -->

    <Class rdf:about="http://example.org/2f633c04-8dc9-4b12-a875-1d25cb7d95e9">
        <obo:IAO_0000115>GOALS: The aim of this study was to investigate the role of dietary factors, distinct small-bowel mucosal immune cell types, and epithelial integrity in the perpetuation of gastrointestinal symptoms in treated celiac disease patients. BACKGROUND: For unexplained reasons, many celiac disease patients suffer from persistent symptoms, despite a strict gluten-free diet (GFD) and recovered intestinal mucosa. STUDY: We compared clinical and serological data and mucosal recovery in 22 asymptomatic and 25 symptomatic celiac patients on a long-term GFD. The density of CD3 and gammadelta intraepithelial lymphocytes (IELs), CD25 and FOXP3 regulatory T cells, and CD117 mast cells, and the expression of tight junction proteins claudin-3 and occludin, heat shock protein 60, interleukin 15, and Toll-like receptor 2 and 4 were evaluated in duodenal biopsies. RESULTS: All subjects kept a strict GFD and had negative celiac autoantibodies and recovered mucosal morphology. The asymptomatic patients had higher mean fiber intake (20.2 vs. 15.2 g/d, P=0.028) and density of ##CD3 IELs## (59.3 vs. 45.0 cell/mm, P=0.045) than those with persistent symptoms. There was a similar but nonsignificant trend in gammadelta IELs (17.9 vs. 13.5, P=0.149). There were no differences between the groups in other parameters measured. CONCLUSIONS: Low fiber intake may predispose patients to persistent symptoms in celiac disease. There were no differences between the groups in the markers of innate immunity, epithelial stress or epithelial integrity. A higher number of IELs in asymptomatic subjects may indicate that the association between symptoms and mucosal inflammation is more complicated than previously thought.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMID:29505551</oboInOwl:hasDbXref>
        <rdfs:label>CD3 IELs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002496"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/2f633c04-8dc9-4b12-a875-1d25cb7d95e9"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002496"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/2f6e3744-0038-46e2-a98a-5478fabf7c72 -->

    <Class rdf:about="http://example.org/2f6e3744-0038-46e2-a98a-5478fabf7c72">
        <obo:IAO_0000115>The SpatialDecon algorithm was used to compute abundance scores of resident astrocytes, macrophages, microglia, neoplastic cells, neurons, oligodendrocytes, oligodendrocyte precursor cells (OPC), and vascular cells based on glioblastoma scRNA-seq data (Figure 3A). The lack of sufficient ##infiltrating lymphocytes## in the scRNA-seq data precluded the generation of a lymphocyte cell score. Analysis of the SpatialDecon results showed that the ROIs were predominated by neoplastic and vascular cells, albeit in varying relative proportions (Figure 3B-D). The relatedness in the cellular composition of each ROI was assessed using unsupervised hierarchical clustering and was subsequently visualized using spatial cluster maps (Figure 3B-D). Spatial heatmaps were used to localize the relative abundance of each computationally inferred cell type score within different regions of each specimen, illustrating the variable intratumoral distribution of resident glioblastoma cell types (Figure 2E-G).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9937641</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36788070</oboInOwl:hasDbXref>
        <rdfs:label>infiltrating lymphocytes</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000542"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/2f6e3744-0038-46e2-a98a-5478fabf7c72"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000542"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/2f717c13-501f-4204-9383-0a947527054a -->

    <Class rdf:about="http://example.org/2f717c13-501f-4204-9383-0a947527054a">
        <obo:IAO_0000115>Myofibroblasts are central mediators of the dysregulated wound-healing programme that defines fibrosis, therefore we studied this population in detail. Graph based clustering of the single cell RNA-seq data defined four major subsets (Fig. 3a) that included a cycling population (Cycling MFB) (Fig. 3a, b). After this, we sought to confirm that proliferating stromal cells (Ki67+) were myofibroblasts (Fig. 3c-e, Supplementary Fig. 4a-d). Using flow cytometry, we stained freshly disaggregated nodular cells and gated on myofibroblasts (CD45-CD31-CD146-ITGbeta1high) and fibroblasts (CD45-CD31-CD146-ITGbeta1low) and demonstrated Ki67high cells were a subset of myofibroblasts. In the single cell RNA-seq, a second subset was characterised by lower expression of ACTA2 and intermediate expression of fibroblast marker genes (CXCL14, PLA2G2A and C1R), we termed the ACTA2low myofibroblast (Fig. 3a, b, Supplementary Fig. 5a). A third comprised a discrete CD82highOX40L+ population (CD82, OX40L, MMP11, MMP14 and CD82) (Fig. 3a, g, Supplementary Fig. 5b-e). Finally, a fourth less distinct community we termed the ##intermediate myofibroblast## (Fig. 3a, b, Supplementary Fig. 15a). GO analysis demonstrated that CD82highOX40L+ myofibroblast marker genes showed the strongest enrichment for cell contraction pathways (Fig. 3f). In contrast, differential gene expression and pathway analysis revealed ACTA2low myofibroblasts resembled a general fibroblast phenotype, without clear characteristics of any one subtype. In addition to ACTA2, significant ACTA2low myofibroblasts markers were general fibroblasts markers including PLA2G2A and CXCL14. ACTA2low myofibroblasts also shared pathways enriched in fibroblasts such as &apos;interleukin signalling&apos; and &apos;chemotaxis&apos; (Fig. 3f).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7265502</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32488016</oboInOwl:hasDbXref>
        <rdfs:label>intermediate myofibroblast</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000186"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/2f717c13-501f-4204-9383-0a947527054a"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000186"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/2f8325cd-0553-4362-b6a3-23a995b83d2b -->

    <Class rdf:about="http://example.org/2f8325cd-0553-4362-b6a3-23a995b83d2b">
        <obo:IAO_0000115>Food intake behavior is regulated by a network of appetite-inducing and appetite-suppressing neuronal populations throughout the brain. The parasubthalamic nucleus (PSTN), a relatively unexplored population of neurons in the posterior hypothalamus, has been hypothesized to regulate appetite due to its connectivity with other anorexigenic neuronal populations and because these neurons express Fos, a marker of neuronal activation, following a meal. However, the individual cell types that make up the PSTN are not well characterized, nor are their functional roles in food intake behavior. Here, we identify and distinguish between two discrete PSTN subpopulations, those that express tachykinin-1 (PSTNTac1 neurons) and those that express corticotropin-releasing hormone (PSTNCRH neurons), and use a panel of genetically encoded tools in mice to show that PSTNTac1 neurons play an important role in appetite suppression. Both subpopulations increase activity following a meal and in response to administration of the anorexigenic hormones amylin, cholecystokinin (CCK), and peptide YY (PYY). Interestingly, chemogenetic inhibition of PSTNTac1, but not PSTNCRH neurons, reduces the appetite-suppressing effects of these hormones. Consistently, optogenetic and chemogenetic stimulation of PSTNTac1 neurons, but not PSTNCRH neurons, reduces food intake in hungry mice. ##PSTNTac1 and PSTNCRH neurons## project to distinct downstream brain regions, and stimulation of PSTNTac1 projections to individual anorexigenic populations reduces food consumption. Taken together, these results reveal the functional properties and projection patterns of distinct PSTN cell types and demonstrate an anorexigenic role for PSTNTac1 neurons in the hormonal and central regulation of appetite.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9119672</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35507386</oboInOwl:hasDbXref>
        <rdfs:label>PSTNTac1 and PSTNCRH neurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000540"/>
        <skos:relatedMatch rdf:resource="CL:1001505"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/2f8325cd-0553-4362-b6a3-23a995b83d2b"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000540"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/2f8325cd-0553-4362-b6a3-23a995b83d2b"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:1001505"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/2fc19fb8-223d-4c4f-9f40-43654db0ea11 -->

    <Class rdf:about="http://example.org/2fc19fb8-223d-4c4f-9f40-43654db0ea11">
        <obo:IAO_0000115>We performed de novo alignment of T cells from the CD8+ and CD4+ T cell clusters along a pseudo-temporal axis representing the continuum of blinatumomab-induced activation. CD8+ cells formed a trajectory from the TC0-CD8+ Naive T cluster, followed by clusters TC1-CD8+ TEM and TC2-CD8+ CTL towards cluster TC4-CD8+ Activated T (Additional file 1, Fig. S7A). Similarly, the TC10-CD4+ Activated T cluster was chronologically ordered at the terminal end of the CD4+ activation trajectory (Additional file 1, Fig. S7B). Genes associated with activation were mapped onto the activation trajectory, confirming an increased expression of the genes IL2RA, CD69, TNFRSF18 and TNFRSF4 at the end of the trajectories (Additional file 1, Fig. S7C-D). Both trajectories suggest that the activated CD8+ and CD4+ T cells did not originate from naive T cells, but rather from CD8+ TEM and CD4+ TCM cells, respectively. By contrast, cells from the TC13-Activated T cluster expressed high levels of naive marker genes (Fig. 2b), leading to the conclusion that cells from this ##CD8+/CD4+ mixed activated T cell## cluster arose from naive T cells (TC0 and TC5).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7923532</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33648458</oboInOwl:hasDbXref>
        <rdfs:label>CD8+/CD4+ mixed activated T cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000896"/>
        <skos:relatedMatch rdf:resource="CL:0000906"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/2fc19fb8-223d-4c4f-9f40-43654db0ea11"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000896"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/2fc19fb8-223d-4c4f-9f40-43654db0ea11"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000906"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/20a8addd-a43a-4c8e-9c70-01b5995c4e5a -->

    <Class rdf:about="http://example.org/20a8addd-a43a-4c8e-9c70-01b5995c4e5a">
        <obo:IAO_0000115>AIMS: Data suggest pharmacological treatment of depression with selective serotonin reuptake inhibitors (SSRI) may impair bone health. Our group has previously modeled compromised craniofacial healing after treatment with sertraline, a commonly prescribed SSRI, and hypothesized potential culprits: alterations in bone cells, collagen, and/or inflammation. Here we interrogate bone lineage cell alterations due to sertraline treatment as a potential cause of the noted compromised bone healing. MAIN METHODS: Murine pre-osteoblast, pre-osteoclast, osteoblast, and osteoclast cells were treated with clinically relevant concentrations of the SSRI. Studies focused on serotonin pathway targets, cell viability, apoptosis, differentiation, and the osteoblast/osteoclast feedback loop. KEY FINDINGS: All cells studied express neurotransmitters (e.g. serotonin transporter, SLC6A4, SSRI target) and G-protein-coupled receptors associated with the serotonin pathway. Osteoclasts presented the greatest native expression of Slc6a4 with all cell types exhibiting decreases in Slc6a4 expression after SSRI treatment. Pre-osteoclasts exhibited alteration to their differentiation pathway after treatment. Pre-osteoblasts and osteoclasts showed reduced apoptosis after treatment but showed no significant differences in functional assays. RANKL: OPG mRNA and protein ratios were decreased in the osteoblast lineage. ##Osteoclast lineage cells## treated with sertraline demonstrated diminished TRAP positive cells when pre-exposed to sertraline prior to RANKL-induced differentiation. SIGNIFICANCE: These data suggest osteoclasts are a likely target of bone homeostasis disruption due to sertraline treatment, most potently through the osteoblast/clast feedback loop.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7336288</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32450170</oboInOwl:hasDbXref>
        <rdfs:label>Osteoclast lineage cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000092"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/20a8addd-a43a-4c8e-9c70-01b5995c4e5a"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000092"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/20a9009b-d13f-469b-92dc-6929cf40d851 -->

    <Class rdf:about="http://example.org/20a9009b-d13f-469b-92dc-6929cf40d851">
        <obo:IAO_0000115>Combining Seurat clustering analysis with known molecular markers for various cell types (Fig. 2B; Tables S2, S3), we segregated the single cells into 9 major cell clusters based on cell types: immune cells [Microglia, Monocyte/Macrophage, and T/NK (T cell/natural killer cell)], retinal cells [AC/HC/RGC (amacrine cell/horizontal cell/retinal ganglion cell), BC (bipolar cell), Cone, MG (Muller glia)/Astrocyte, and Rod], and vascular endothelial cells (VEC) (Fig. 2A). Comparison of control and EAU cell clusters revealed a decrease in the number of multiple neuronal types in EAU retinas, especially in the BC cluster (20.34-5.02%), Cone cluster (9.49-2.94%), and AC/HC/RGC cluster (3.76-1.28%) (Fig. 2C). In agreement, bulk RNA-seq analysis showed that in EAU retinas, there was downregulation of marker genes for all 6 retinal neuron types including rods, cones, BCs, ACs, HCs, and RGCs (Fig. 2D; S2A, B). Immunostaining analysis further validated these results. In EAU retinas, there was obvious degeneration of rhodopsin+ rod inner and outer segments (Fig. 2E), and in general, progressive loss of Arrestin+ cones, Chx10+ BCs, ##Tfap2a+ ACs##, Rbpms+ RGCs, and Calbindin+ HCs (Fig. 2F-J, L-P). By contrast, EAU did not appear to significantly alter Sox9+ Muller glia although resulting in an upregulation of their marker genes (Fig. 2K, Q). Therefore, EAU may cause not only progressive degeneration of all retinal neuron types but also a switch in the expression profile of Muller glia.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11131209</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38802924</oboInOwl:hasDbXref>
        <rdfs:label>Tfap2a+ ACs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000561"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/20a9009b-d13f-469b-92dc-6929cf40d851"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000561"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/20abee96-d80b-4a7b-ba8b-e45eff16fa22 -->

    <Class rdf:about="http://example.org/20abee96-d80b-4a7b-ba8b-e45eff16fa22">
        <obo:IAO_0000115>Validation of antigen-specific ##activated T cells##.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11222146</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38898278</oboInOwl:hasDbXref>
        <rdfs:label>activated T cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000084"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/20abee96-d80b-4a7b-ba8b-e45eff16fa22"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000084"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/20e22fca-9a19-42eb-b3bf-0847b73c37b7 -->

    <Class rdf:about="http://example.org/20e22fca-9a19-42eb-b3bf-0847b73c37b7">
        <obo:IAO_0000115>Results: We showed that two distinct pericyte subpopulations, marked by NG2+ and Tbx18+, had different potency following brain injury. NG2+ pericytes expressed dominant neural reprogramming potential to produce newborn neurons, while Tbx18+ pericytes displayed dominant multipotency to produce endothelial cells, ##fibroblasts##, and microglia following ischemic stroke. In addition, we discovered that AMPK modulators facilitated pericyte-to-neuron conversion by modulating Ser436 phosphorylation status of CBP, to coordinate an acetylation shift between Sox2 and histone H2B, and to regulate Sox2 nuclear-cytoplasmic trafficking during the reprogramming/differentiation process. Finally, we showed that sequential treatment of compound C (CpdC) and metformin, AMPK inhibitor and activator respectively, robustly facilitated the conversion of human pericytes into functional neurons.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11488099</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:39431007</oboInOwl:hasDbXref>
        <rdfs:label>fibroblasts</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000057"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/20e22fca-9a19-42eb-b3bf-0847b73c37b7"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000057"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/20f84834-312d-476e-b7a1-ca2d67f581e8 -->

    <Class rdf:about="http://example.org/20f84834-312d-476e-b7a1-ca2d67f581e8">
        <obo:IAO_0000115>To determine the cell types and gene features of normal skin and DFU skin cells, we referred to the study by Georgios Theocharidis et al. and downloaded a portion of the raw dataset (GSE165816) for single-cell expression analysis  Supplementary Dataset 2 . We analyzed a total of 25 samples from 11 diabetes patients (7 DFU-Healers and 4 DFU-Non-Healers) and 10 healthy non-diabetic subjects. The study groups, objectives, and analysis strategy are shown in  Figure 1A . In summary, following the cell type marker information provided in the research of Georgios Theocharidis et al., we analyzed 53,199 cells (24,922 from normal skin, 12,173 from DFU-Healers, and 17,743 from DFU-Non-Healers) and created a gene expression matrix for each cell. We used t-SNE plot and graph-based clustering for dimensionality reduction, resulting in the identification of 13 distinct cell types ( Figure 1B ). We identified most of the typical cell types observed in human skin, including smooth muscle cells (SMCs) (TAGLN+, ACTA2+), fibroblasts (Fibro) (DCN+, CFD+), ##HE-fibro## (DCN+, CHI3L1+), vascular endothelial cells (VasEndo) (ACKR1+), differentiated keratinocytes (DiffKera) (KRT1+, KRT10+), basal keratinocytes (BasalKera) (KRT5+, KRT14+), NK and T cells (NKT) (CD3D+, CCL5+), M1 macrophages (M1-macro) (IL1B+), M2 macrophages (M2-macro) (CD163+), melanocytes and Schwann cells (Melano/Schwann) (MLANA+, CDH19+), lymphatic endothelial cells (LymphEndo) (CCL21+), B lymphocytes (B lymphos) (CD79A+, MS4A1+), and mast cells (TPSAB1+) ( Figures 1C, D ,  Supplementary Dataset 3 ). The distribution of the main markers for vascular endothelial cells is shown in the t-SNE plot ( Figure 1E ).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10722230</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38107519</oboInOwl:hasDbXref>
        <rdfs:label>HE-fibro</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000057"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/20f84834-312d-476e-b7a1-ca2d67f581e8"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000057"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/200293cd-a758-4c50-a463-54e5f5a3698b -->

    <Class rdf:about="http://example.org/200293cd-a758-4c50-a463-54e5f5a3698b">
        <obo:IAO_0000115>K2Taxonomer was remarkably accurate in capturing the higher-order organization of the 28 cell types. The first partition separated all epithelial cell subtypes from non-epithelial cell types (Figure 4B). Further partitioning of the 17 epithelial cell subtypes yielded five subgroups, characterized by shared morphology, labeled as &apos;Ciliated&apos;, &apos;Basal&apos;, &apos;Submucosal&apos;, &apos;Brush-like&apos; and &apos;AE&apos; (Alveolar Epithelium). The &apos;Ciliated&apos; subgroup was comprised of differentiated multiciliated cells and their precursor, deuterosomal cells. The &apos;Basal&apos; subgroup was comprised of epithelial cell progenitors, basal and cycling basal cells, as well as ##epithelial cell intermediary##, suprabasal cells. The &apos;Brush-like&apos; subgroup was comprised of three rare airway epithelial cell types: brush, ionocyte, and pulmonary neuroendocrine cells (PNECs), as well as their likely shared &apos;brush-like&apos; precursor cells, as suggested in the original publication of these data. Further partitioning of the 11 non-epithelial cell types yielded two main subgroups characterized by shared progenitor cells: immune and mesenchymal stem cells, with the immune cell subgroup also including endothelial cells. Further partitions of the immune cell subgroup included progeny of monoblasts: monocytes, dendritic cells, and macrophages , followed by endothelial cells separated from all non-monoblast progeny immune cells subtypes in the adjacent subgroup.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8464061</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34226941</oboInOwl:hasDbXref>
        <rdfs:label>epithelial cell intermediary</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000066"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/200293cd-a758-4c50-a463-54e5f5a3698b"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000066"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/2008a5fc-8cdb-4468-943e-e69c621ada55 -->

    <Class rdf:about="http://example.org/2008a5fc-8cdb-4468-943e-e69c621ada55">
        <obo:IAO_0000115>The complex TME of OC is a major influencer of the prognoses of OC patients. Besides tumor cells, the TME also contains tumor-associated fibroblasts, endothelial cells and infiltrating immune cells. The levels of immune cell infiltration in solid tumors are extremely important in tumor development. In this study, the effect of autophagy on the infiltration levels of different immune cells was analyzed. We observed a significantly higher immune score in the autophagy-high group compared to the autophagy-low group. The infiltration ratio of naive B cells, memory resting CD4+ T cells and M2 macrophages was greater in the autophagy-high group. Conversely, memory B cells, CD8+ T cells, follicular helper T cells and gamma delta T cells were more abundant in the autophagy low group. In particular, the proportion of ##infiltrating M2 macrophages## varied dramatically at different levels of autophagy. It has been reported that autophagy can cause M2-like macrophage polarization in chronic inflammatory diseases. However, the impact of autophagy on macrophage polarization in OC is unknown. We explored the interaction pattern between tumor cells with different autophagy levels and macrophages through the scRNA-seq data. The OC cells with high autophagy levels showed an increased interaction with macrophages through SPP1-CD44, RARRES2-CMKLR1, NECTIN3-NECTIN2, LGALS9-CD44, and LAMB1-CD44 signaling, and decreased interaction via SEMA3C-PLXND1, PTN-SDC4, ICAM1-(ITGAX+ITGB2), GAS6-MERTK and CSF1-CSF1R signaling. Emerging evidence demonstrated that the ligand-receptor signaling described above was closely correlated with macrophage polarization. For example, Zhang et al. reported that A549 cells were able to promote the M2 polarization of THP-1 macrophages though the induction of SPP1. In summary, these findings indicated that autophagy might play a key role in the immune microenvironment of OC by affecting macrophage polarization.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9953331</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36830707</oboInOwl:hasDbXref>
        <rdfs:label>infiltrating M2 macrophages</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000890"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/2008a5fc-8cdb-4468-943e-e69c621ada55"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000890"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/202b7858-5ded-4145-8a53-42304bead9a5 -->

    <Class rdf:about="http://example.org/202b7858-5ded-4145-8a53-42304bead9a5">
        <obo:IAO_0000115>In our previous work, we depicted different T-cell subtypes and found an exhausted cluster that specifically existed in B-ALL patients and possessed remarkable heterogeneity. However, the developmental relationship between T-cell subtypes in relation to B-ALL patient prognosis remains elusive. To address this question, further analysis was performed on these T cells in B-ALL. A subset of T cells with features of tissue-resident memory T (Trm) cells was found in the peripheral blood of B-ALL patients, which we defined as circulating CD103+ T cell or tissue-resident memory-like T (Trm-like) cell. These Trm-like cells expressing high levels of immune checkpoint molecules and cytotoxicity markers also shared similar TCR signatures with exhausted T (Tex) cells and effector T (Teff) cells. The traditional view thought that Trm cells were low in migration and long-term survival in peripheral tissues; however, more recent studies indicated that upon secondary antigen presentation, Trm cells can rejoin the circulation pool, transforming into Teff cells. Through cell fate trajectory analysis, we found that Trm-like cells that were supposed to transit into Teff cells, however, mainly transformed into Tex cells in leukemia environment. Furthermore, ##Trm-like cell## to Tex cell transformation potentially led to poor prognosis of B-ALL patients, while transition toward Teff cells would likely improve prognosis. Our data suggest that Trm-like cells contribute to B-ALL immunosurveillance and may provide valuable prognostic information. Further understanding of the development, maintenance, and regulation of Trm-like cells would be crucial for successful immunotherapeutic development in B-ALL.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9757161</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36532049</oboInOwl:hasDbXref>
        <rdfs:label>Trm-like cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000813"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/202b7858-5ded-4145-8a53-42304bead9a5"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000813"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/205007ef-4e80-427f-9168-ae35754624bd -->

    <Class rdf:about="http://example.org/205007ef-4e80-427f-9168-ae35754624bd">
        <obo:IAO_0000115>a UMAP dimensionality reduction embedding of PBMCs from DFU-Healers, DFU-Non-healers, Healthy subjects, and non-DFU DM patients. The identified cell types were DCs: dendritic cells; VasEndo: vascular endothelial cells; T-lympho: T lymphocytes; CD8T1: ##CD8+ T lymphocytes## cluster 1; CD8T2: CD8+ T lymphocytes cluster 2; NK: natural killer cells; NKT: natural killer and T cells; B-lympho: B lymphocytes; CD14Mono: CD14+ monocytes; CD16Mono: CD16+ monocytes. Dotted lines are drawn around cell groups of similar lineages. b Bar plots showing percentage of T-lymphocytes (T-lympho) and CD8+ T lymphocytes cluster 2 (CD8T2) per percentage of NKT cells in the CD45+ subset of cells across various clinical groups. DFU-healers depict significantly higher ratio of T-lympho and CDT2 cell cluster in comparison to DFU-Non-healers and Diabetic. Data represent the mean and standard error of mean (SEM) values from n = 2 Non-Healers, n = 3 Healers, n = 2 Diabetic and n = 3 Healthy subjects. p = 0.01 for Healers vs Non-Healers and p = 0.006 for Healers vs Diabetic in T-Lympho; p = 0.036 for Healers vs Non-Healers and p = 0.035 for Healers vs Diabetic in CD8T2 using two-sided Welch&apos;s t-test. c Heatmap showing significant DEGs in Healers compared to Non-healers in the T-lympho, CD8T2 and NKT cell clusters. d Biological pathways that are significantly (P value &lt; 0.01) activated (Z score &gt;1.5) /inhibited (Z score &lt; -1.5) in T-lympho, CD8T2 cells of Healers in contrast to NKT cells of Non-healers. Activation and inhibition of key upstream regulators is shown in pseudo color, where blue represents inhibition, and red represents activation. e Upstream regulatory molecules significantly inhibited (blue) in the T-lympho and CD8T2 cells of Healers as compared to Non-healers at the systemic level. Legend shows shapes and lines annotation for the regulatory network. f Violin plots showing expression levels of 3 key upstream regulator molecules NFKBIA, CCL5, and TGFB1, in the NKT, T-Lympho, and CD8T2 clusters.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8748704</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35013299</oboInOwl:hasDbXref>
        <rdfs:label>CD8+ T lymphocytes</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000625"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/205007ef-4e80-427f-9168-ae35754624bd"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000625"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/20877da3-deab-4803-99e3-e886273ec06c -->

    <Class rdf:about="http://example.org/20877da3-deab-4803-99e3-e886273ec06c">
        <obo:IAO_0000115>Pseudobulk differential gene expression analysis showed significant upregulation of genes in all the B cell subclusters in INS, except for atBCs and ASCs (Fig. 2e and Supplementary Fig. 5a). Pathway analysis revealed an enrichment of functions associated with actin cytoskeletal dynamics in all B cell subclusters in INS, while some subclusters (Naive-1, actMBCs, MBC-2, and MZ-like B cells) also showed an enrichment of B cell activation pathways (Supplementary Fig. 5b). The antigen-inexperienced and recently activated B cell subsets (Naive-1 and actMBC) showed the greatest differences in gene expression suggesting that the transcriptional events leading to B cell dysregulation occur early during B cell activation (Fig. 2e and Supplementary Fig. 5a). There was a substantial overlap in the upregulated genes between Naive-1 B cells, actMBCs, MBC-2, and MZ-like B cells including many atBC-associated genes (e.g., ITGB2, ITGB7, FCRLA, FCRL2), POU2F2, POU2AF1, and the extrafollicular response genes TNFRSF13B and GPR183, suggesting a possible developmental sequence or cooperation between these B cell subclusters in generating an ##extrafollicular B cell## response in INS (Fig. 2e).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10667257</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37996443</oboInOwl:hasDbXref>
        <rdfs:label>extrafollicular B cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000236"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/20877da3-deab-4803-99e3-e886273ec06c"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000236"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/21ee20e7-aabf-47cf-8e21-ad04b89a382a -->

    <Class rdf:about="http://example.org/21ee20e7-aabf-47cf-8e21-ad04b89a382a">
        <obo:IAO_0000115>To assess tdTomato reporter functionality, the parental and the NKX2-1GFP;TP63tdTomato hiPSC lines were differentiated into early ##lung progenitors## using a modified version of the protocols published by McCauley et al. (Fig. 2A). At day 15, NKX2-1GFP+ cells were observed in both lines, with a minority of cells tdTomato-positive (tdTomato+) (0.88 +- 1.01, n = 11) (Fig. 2B). Both lines differentiated into NKX2-1GFP+ lung progenitors at similar efficiencies (Fig. 2C). The insertion of P2A-tdTomato into the TP63 locus therefore does not appear to impact lung differentiation efficiency.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7907081</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33633173</oboInOwl:hasDbXref>
        <rdfs:label>lung progenitors</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002633"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/21ee20e7-aabf-47cf-8e21-ad04b89a382a"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002633"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/211c7432-1b48-4f45-9b55-ba150d024e7e -->

    <Class rdf:about="http://example.org/211c7432-1b48-4f45-9b55-ba150d024e7e">
        <obo:IAO_0000115>Luminal progenitors serve primarily as tumor initiators or cells of origin for prostate cancer. Various hierarchical models have been proposed. A recent model suggests that, during early postnatal development, multipotent basal cells (p63+ CK5+) differentiate into unipotent basal progenitors, ##luminal progenitors## (CK8+ AR low), and NE cells. These unipotent basal and luminal progenitors can undergo self-renewal or differentiate into basal cells and mature luminal cells (AR+ CK8+), respectively. In adults, during homeostasis and regeneration, the bipotent basal progenitor forms unipotent basal and luminal progenitors, which further undergo self-renewal. Unipotent basal progenitors differentiate into basal cells, and luminal cell progenitors differentiate into luminal cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10291985</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37282627</oboInOwl:hasDbXref>
        <rdfs:label>luminal progenitors</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002340"/>
        <skos:relatedMatch rdf:resource="CL:0011026"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/211c7432-1b48-4f45-9b55-ba150d024e7e"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002340"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/211c7432-1b48-4f45-9b55-ba150d024e7e"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0011026"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/21220018-cfb4-4f6e-ae3c-4d83b0276ead -->

    <Class rdf:about="http://example.org/21220018-cfb4-4f6e-ae3c-4d83b0276ead">
        <obo:IAO_0000115>Together, these results demonstrate that the output of Som+ cells outpaces that of PKCdelta+ cells in the CeLC but that the cellular mechanisms underlying the differences in excitability in ##Som+ and PKCdelta+ neurons## are distinct for late-firing and regular-spiking cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7877473</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33188006</oboInOwl:hasDbXref>
        <rdfs:label>Som+ and PKCdelta+ neurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000540"/>
        <skos:relatedMatch rdf:resource="CL:4023017"/>
        <skos:relatedMatch rdf:resource="CL:4042037"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/21220018-cfb4-4f6e-ae3c-4d83b0276ead"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000540"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/21220018-cfb4-4f6e-ae3c-4d83b0276ead"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4023017"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/21220018-cfb4-4f6e-ae3c-4d83b0276ead"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4042037"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/214c2003-f9ca-4f3a-8a5f-ed0d22a1ca94 -->

    <Class rdf:about="http://example.org/214c2003-f9ca-4f3a-8a5f-ed0d22a1ca94">
        <obo:IAO_0000115>As shown in Table 4, some of the ##pancreatic cell## types are found for pancreas datasets, such as the Baron human dataset within well-defined gene sets in the C8 collection of MSigDB, which includes cell type signature&apos;s gene sets. They include &apos;MURARO PANCREAS ALPHA CELL&apos;, &apos;MURARO PANCREAS ENDOTHELIAL CELL&apos;, &apos;MURARO PANCREAS MESENCHYMAL STROMAL CELL&apos;, &apos;MURARO PANCREAS DUCTAL CELL&apos;, and &apos;MURARO PANCREAS ACINAR CELL&apos;.Other cell types such as HB2 is a cell line originated by epithelial cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8742092</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34996927</oboInOwl:hasDbXref>
        <rdfs:label>pancreatic cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0008024"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/214c2003-f9ca-4f3a-8a5f-ed0d22a1ca94"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0008024"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/214f6dec-66c7-4537-9545-21eaacda5f32 -->

    <Class rdf:about="http://example.org/214f6dec-66c7-4537-9545-21eaacda5f32">
        <obo:IAO_0000115>(F) Relative abundance of each cluster in MMPs of vehicle-versus teriparatide-treated mice. OB, osteoblast; preOB, preosteoblast; COP, ##chondrocyte-like osteoprogenitor##; MALP, marrow adipocyte lineage progenitor.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8432334</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34407400</oboInOwl:hasDbXref>
        <rdfs:label>chondrocyte-like osteoprogenitor</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000138"/>
        <skos:relatedMatch rdf:resource="CL:0007010"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/214f6dec-66c7-4537-9545-21eaacda5f32"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000138"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/214f6dec-66c7-4537-9545-21eaacda5f32"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0007010"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/21547f71-85c8-4ae1-820b-23aa336129a4 -->

    <Class rdf:about="http://example.org/21547f71-85c8-4ae1-820b-23aa336129a4">
        <obo:IAO_0000115>Because ##CD14CTX## express chemokine receptors that might facilitate migration into the tissues, we next examined the relationship between circulating and intra-tumoral myeloid states in BTC. We performed scRNA-seq on primary cholangiocarcinoma tumors (n = 4) obtained from standard of care resections (Table S7) and recovered a total of 10,913 myeloid cells. Tissue-associated myeloid cells consisted of dendritic cells (DC), neutrophils (Neut), two populations of macrophages characterized by either high APOE or SPP1 expression (MacAPOE, MacSPP1), CD14+ monocytes (CD14+ mono), CD16+ monocytes (CD16+ mono), and intermediate CD14+CD16+ monocytes (CD14+CD16+ mono) (Figures S4A and S4B). Among the tissue-associated myeloid populations, the expression profile of CD14CTX was most correlated with MacSPP1, exemplified by the shared expression of differentially expressed CD14CTX genes including HAVCR2 and ITGB1 (Figures S4C and S4D). Notably, two genes that differ in expression between MacSPP1 and CD14CTX are related to chemotaxis and extravasation (SERPINB2, TIMP1), suggesting a transition in macrophages that have already migrated to the tumor microenvironment. As an alternate approach to assess the relationship between the circulating and tissue-associated myeloid populations, we co-clustered myeloid cells from circulation with those from the tumors, following batch correction. We found that the intra-tumoral MacSPP1 cluster with the circulating CD14CTX (Figure S4E). An alternative approach using partition-based graph abstraction also found close connectivity between CD14CTX and SPP1+ TAM clusters (Figure S4E). We also found evidence of SPP1+HAVCR2+CD68+ myeloid cells within biliary tumor tissue from on-treatment biopsies by combined in situ hybridization and immunofluorescence, further suggesting the existence of a TAM population in BTC analogous to CD14CTX (Figure S4F).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10060099</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36130508</oboInOwl:hasDbXref>
        <rdfs:label>CD14CTX</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0001054"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/21547f71-85c8-4ae1-820b-23aa336129a4"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0001054"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/2156893f-9668-4cc3-b225-ec093e8f956a -->

    <Class rdf:about="http://example.org/2156893f-9668-4cc3-b225-ec093e8f956a">
        <obo:IAO_0000115>We have previously reported that after brain exposure to ionizing radiation, proliferating progenitors are highly radiation-sensitive and rapidly eliminated after irradiation. On the contrary qNSC that are radiation resistant repopulate the different SVZ neurogenic cell populations successively the following days after irradiation. We therefore used this model and our transcriptomic signatures of ##SVZ stem and progenitor cells## to gain new insights on the nature and the hierarchical ordering of neural progenitor clusters identified by sc-RNAseq.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11584179</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:39576691</oboInOwl:hasDbXref>
        <rdfs:label>SVZ stem and progenitor cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:4042021"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/2156893f-9668-4cc3-b225-ec093e8f956a"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4042021"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/216e706f-2b91-4981-b2dc-9266d1361e51 -->

    <Class rdf:about="http://example.org/216e706f-2b91-4981-b2dc-9266d1361e51">
        <obo:IAO_0000115>Differentiation trajectory of ##pathological osteoclasts## in arthritis. BM-derived CX3CR1loLy6Chi cells (R1) ingress into the synovium (R2) and produce inflammatory cytokines, chemokines, and VEGFA. Abundant M-CSF in the inflamed synovium induces maturation of some R2 cells into osteoclast precursors, arthritis-associated osteoclastogenic macrophages (AtoMs/R3 cells). When AtoMs localize adjacent to the bone surface, simultaneous stimulation with RANKL and TNF promotes osteoclast formation, leading to joint destruction in arthritis.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9024112</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35464401</oboInOwl:hasDbXref>
        <rdfs:label>pathological osteoclasts</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000092"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/216e706f-2b91-4981-b2dc-9266d1361e51"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000092"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/217bf3ed-6492-480e-a482-7dc2b3fafd6f -->

    <Class rdf:about="http://example.org/217bf3ed-6492-480e-a482-7dc2b3fafd6f">
        <obo:IAO_0000115>##Luminal progenitors## serve primarily as tumor initiators or cells of origin for prostate cancer. Various hierarchical models have been proposed. A recent model suggests that, during early postnatal development, multipotent basal cells (p63+ CK5+) differentiate into unipotent basal progenitors, luminal progenitors (CK8+ AR low), and NE cells. These unipotent basal and luminal progenitors can undergo self-renewal or differentiate into basal cells and mature luminal cells (AR+ CK8+), respectively. In adults, during homeostasis and regeneration, the bipotent basal progenitor forms unipotent basal and luminal progenitors, which further undergo self-renewal. Unipotent basal progenitors differentiate into basal cells, and luminal cell progenitors differentiate into luminal cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10291985</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37282627</oboInOwl:hasDbXref>
        <rdfs:label>Luminal progenitors</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002340"/>
        <skos:relatedMatch rdf:resource="CL:0011026"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/217bf3ed-6492-480e-a482-7dc2b3fafd6f"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002340"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/217bf3ed-6492-480e-a482-7dc2b3fafd6f"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0011026"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/219304db-be9e-41d7-96e1-1a6b0552cbe0 -->

    <Class rdf:about="http://example.org/219304db-be9e-41d7-96e1-1a6b0552cbe0">
        <obo:IAO_0000115>##TAMs##</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7053213</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32194843</oboInOwl:hasDbXref>
        <rdfs:label>TAMs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/219304db-be9e-41d7-96e1-1a6b0552cbe0"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/22d41244-e9c7-4f56-90c6-8355fa0734c7 -->

    <Class rdf:about="http://example.org/22d41244-e9c7-4f56-90c6-8355fa0734c7">
        <obo:IAO_0000115>Results: We showed that two distinct pericyte subpopulations, marked by NG2+ and Tbx18+, had different potency following brain injury. NG2+ pericytes expressed dominant neural reprogramming potential to produce newborn neurons, while Tbx18+ pericytes displayed dominant multipotency to produce ##endothelial cells##, fibroblasts, and microglia following ischemic stroke. In addition, we discovered that AMPK modulators facilitated pericyte-to-neuron conversion by modulating Ser436 phosphorylation status of CBP, to coordinate an acetylation shift between Sox2 and histone H2B, and to regulate Sox2 nuclear-cytoplasmic trafficking during the reprogramming/differentiation process. Finally, we showed that sequential treatment of compound C (CpdC) and metformin, AMPK inhibitor and activator respectively, robustly facilitated the conversion of human pericytes into functional neurons.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11488099</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:39431007</oboInOwl:hasDbXref>
        <rdfs:label>endothelial cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:2000044"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/22d41244-e9c7-4f56-90c6-8355fa0734c7"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:2000044"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/22f5f960-80d8-48f4-b5c1-d7a103e45aa0 -->

    <Class rdf:about="http://example.org/22f5f960-80d8-48f4-b5c1-d7a103e45aa0">
        <obo:IAO_0000115>Expression of UCN3 and CRFR2 in the medial geniculate body (MGB) and the pretectal thalamic transition zones. (A) Sagital view of the brain indicating the level of the schematic coronal section (below) showing the medial geniculate body (MGB) as the region of interest. APT. anterior pretectal nucleus. (B) UCN3-expression in the medial subdivision of the MGB (MGBm), in the posterior intralaminar thalamic nucleus (PIN), and in the pretectal thalamic lamina (PTL). The thin layer of UCN3-positive fibers might occur in the marginal zone of the medial geniculate (white arrows). Calbindin (C) and parvalbumin (D) expression in the MGB were used as counterstain to identify substructures of the MGB. (E) Merge shows parvalbumin (yellow) expression in ventral MGB (MGBv), the suprageniculate thalamic nucleus (SG), and APT. Calbindin is mainly expressed in dorsal MGB (MGBd) and PIN. Neither parvalbumin nor calbindin show strong expression in the UCN3-positive neurons in MGBm and PIN. (F) Few ##CRFR2-positive neuronal cell## bodies are present in the MGBm and the PTL. A network of CRFR2-positive fibers seems to surround the MGB without entering its core. (G-I) VGlutT1 (G) and VGluT2 (H) were used as counterstain.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8633543</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34867212</oboInOwl:hasDbXref>
        <rdfs:label>CRFR2-positive neuronal cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000540"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/22f5f960-80d8-48f4-b5c1-d7a103e45aa0"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000540"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/220b1d19-1b60-459f-bcb0-6364d0b7efc0 -->

    <Class rdf:about="http://example.org/220b1d19-1b60-459f-bcb0-6364d0b7efc0">
        <obo:IAO_0000115>Tumor-associated macrophages (##TAMs##) are innate immune cells of the myeloid lineage that reside within the tumor following infiltration as either immature monocyte/macrophages or monocytic myeloid-derived suppressor cells (MDSCs). TAMs are increasingly being recognized as central determinants in the shaping of the angiogenic, matricellular, and immune composition of tumor microenvironments [reviewed in ]:so much so that there are now numerous active clinical trials seeking to modify or disrupt TAM-dependent pro-tumorigenic phenotypes.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7724107</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33324425</oboInOwl:hasDbXref>
        <rdfs:label>TAMs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/220b1d19-1b60-459f-bcb0-6364d0b7efc0"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/220bb04b-bb8b-4907-a178-5572ab99a6d2 -->

    <Class rdf:about="http://example.org/220bb04b-bb8b-4907-a178-5572ab99a6d2">
        <obo:IAO_0000115>  All patient n = 101 Cluster 1 treg high (n = 10) Cluster 2 macrophage high (n = 16) Cluster 3 immune low (n = 75) p-value   Mean cell density/mm2, (95% CI) Double negative CD3 + T cells 13.4 (9.1-17.8) 33.8 (10.0-57.7) 9.7 (5.2-14.2) 11.5 (6.7-16.3) 0.04   CD4+ T cells 65.6 (25.7-105.5) 112.3 (39.9-184.7) 153.3 (0-398.8) 40.7 (19.6-61.8) 0.007   Macrophages 296.2 (217.3-375.1) 519.1 (211.8-826.4) 940.7 (721.1-1160.2) 129.0 (86.4-171.5)  &lt; 0.001   CD8+ T cells 52.5 (33.6-71.4) 149.6 (92.5-206.6) 46.0 (1.0-91.0) 41.0 (20.1-61.8) 0.01   ##PD1 + CD8 + T cells## 37.8 (19.4-56.1) 82.4 (26.8-138.0) 93.1 (49.2-137.1) 20.0 (0-40.3)  &lt; 0.001   Tregs 21.7 (15.1-28.3) 103.1 (76.2-130.0) 25.9 (12.5-39.3) 10.0 (7.1-12.9)  &lt; 0.001   CD45 + PD-L1- immune cells 351.1 (267.6-434.6) 448.6 (72.9-824.2) 205.2 (140.4-296.9) 369.48 (266.7-472.2) 0.8   Proliferating immune cells 46.9 (35.6-58.1) 94.6 (25.0-164.3) 30.1 (14.3-45.8) 44.0 (32.1-55.9) 0.08   Proliferating tumor cells 102.9 (63.0-142.7) 88.0 (37.6-138.3) 68.1 (23.7-112.5) 112.4 (59.5-165.3) 0.5   Fibroblasts 135.5 (105.8-165.2) 80.6 (0-167.2) 35.4 (21.6-49.2) 164.5 (127.9-201.1)  &lt; 0.001   PD-L1 + tumor cells 41.5 (22.5-60.5) 134.8 (24.6-244.9) 87.4 (26.7-148.0) 19.0 (3.0-34.9)  &lt; 0.001   CD45 + PD-L1 + immune cells 807 (171-1090) 2038 (619-3126) 1377 (711-2074) 511 (132-701)  &lt; 0.001   </obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9930232</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36793050</oboInOwl:hasDbXref>
        <rdfs:label>PD1 + CD8 + T cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000625"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/220bb04b-bb8b-4907-a178-5572ab99a6d2"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000625"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/22375605-d27a-4acf-a395-e337d0141814 -->

    <Class rdf:about="http://example.org/22375605-d27a-4acf-a395-e337d0141814">
        <obo:IAO_0000115>The human spleen is considered immunologically immature at below 2 years; although sMZ B cells are principally detectable, they have been described as antigen naive B cells (NBCs) based on the lack of CD27 expression. Previous studies on human sMZ B-cell development suggest that unique diversification mechanisms and distinct sMZ B-cell precursors exist in infants. Our own data support that infant B-cell subsets differ substantially in their gene expression profiles from adult B cells: human ontogenetically early B cells provide accelerated but transient immune responses and are IGHV gene-unmutated. Throughout life, the accumulation, homeostatic expansion, and recirculation of ##IGHV gene-mutated B cells## shape the sMZ B-cell pool. Notably, homing of memory B cells (MBCs) to the sMZ enhances at approximately 2 years and reaches an adult level at approximately 5 years of age, which coincides with efficient protection from infections with encapsulated bacteria. In older individuals, the aged immune system is compromised on multiple levels, including a significantly reduced IGHV gene repertoire, where large B-cell clones outcompete the smaller ones. We assume that a protective sMZ compartment is affected by age-related changes in the composition of the sMZ B-cell pool, as indicated by, e.g., the abundance of large, class-switched MBC clones in old age.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8828478</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35154145</oboInOwl:hasDbXref>
        <rdfs:label>IGHV gene-mutated B cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000236"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/22375605-d27a-4acf-a395-e337d0141814"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000236"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/2268495e-439a-4911-93d9-828edcf407c4 -->

    <Class rdf:about="http://example.org/2268495e-439a-4911-93d9-828edcf407c4">
        <obo:IAO_0000115>Postnatal development of the organ of Corti. The postnatal development is shown in this colour-coded illustration: brown = Kolliker&apos;s organ, pink = inner phalangeal cell, dark blue = inner hair cell, orange = inner pillar cell, green = outer pillar cell, light grey = Deiters&apos; cells, yellow = outer hair cells, cyan = Hensen&apos;s cells, red = ##tectal cells##, dark grey = Bottcher and Claudius cells. a P1; In newborn mice, the organ of Corti presents itself as an epithelium of columnar cells. There are no extracellular spaces. b P7; The Corti tunnel initially opens basally between the inner and outer pillared cells. c P14; The Corti tunnel has reached its full size. During the entire development, the cells increase only slightly in height. Cells of Kolliker&apos;s organ have gradually transformed into cuboidal cells of the inner sulcus and are no longer part of the cortical organ</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7723944</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32712744</oboInOwl:hasDbXref>
        <rdfs:label>tectal cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000633"/>
        <skos:relatedMatch rdf:resource="CL:0002490"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/2268495e-439a-4911-93d9-828edcf407c4"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000633"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/2268495e-439a-4911-93d9-828edcf407c4"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002490"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/2270d6c6-aace-455f-b6a1-64e515a80c0c -->

    <Class rdf:about="http://example.org/2270d6c6-aace-455f-b6a1-64e515a80c0c">
        <obo:IAO_0000115>a Schematic of the experimental pipeline. Created with BioRender.com b UMAP visualization of peritoneal immune cells. c Ratio of each population in cell number. d VlnPlot of characteristic gene expressions for macrophage subpopulations. Sham sham control, ELL endometriosis-like lesions, ELL_N niclosamide administration to ELL-induced mouse, Pre-SPMs premature &quot;small&quot; peritoneal macrophages, SPMs &quot;small&quot; peritoneal macrophages, IM1-3 ##intermediate macrophages## subtype 1-3, Timd4+ LPMs Timd4+ &quot;large&quot; peritoneal macrophages, PMs proliferating macrophages, B1a B1a cells, B1b B1b cells, B2 B2 cells, GCBs germinal-centre B cells, PBs plasma blast B cells, Cd4+ Ts Cd4+ T cells, Cd8+ Ts Cd8+ T cells, DN1 double negative T cells 1, DN2 double negative T cells 2, cDC1 conventional dendritic cells 1, MCs Mast cells, NTPs neutrophils.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9652344</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36369244</oboInOwl:hasDbXref>
        <rdfs:label>intermediate macrophages</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/2270d6c6-aace-455f-b6a1-64e515a80c0c"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/23e3c7fe-070c-406f-a07c-8f6f22ca34cf -->

    <Class rdf:about="http://example.org/23e3c7fe-070c-406f-a07c-8f6f22ca34cf">
        <obo:IAO_0000115>Gene-Set Significant Cell Types from Zeisel That Are Common between Mouse MIA and Human GWAS Significant Cell Types from Saunders That Are Common between Mouse MIA and Human GWAS   Individual Study DEGs mPFC -Excitatory Neurons (Hindbrain)[SCZ, ASD, EA] No cell types   AM -Inhibitory D1 &amp; D2 Medium Spiny Neurons (Striatum) [EA] -Inhibitory direct/indirect Spiny Projection Neurons (Striatum) [SCZ, EA, IQ]   Meta-analysisDEGs Upregulated -##Excitatory Neurons, Pyramidal Cells## (Cerebral Cortex) [SCZ, IQ] -Excitatory Neurons, Deep-layer Pyramidal cells (Frontal Cortex)[SCZ, IQ]-Excitatory Neurons (Posterior Cortex) [SCZ, IQ]-Excitatory Neurons, Entorhinal Cortex Cells (Hippocampus)[SCZ, IQ]-Excitatory Neurons, CA1 Principal Cells (Hippocampus)[IQ]   </obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8471627</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34573345</oboInOwl:hasDbXref>
        <rdfs:label>Excitatory Neurons, Pyramidal Cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000598"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/23e3c7fe-070c-406f-a07c-8f6f22ca34cf"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000598"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/23e4fc7b-618f-44af-9e67-174aa7a469b5 -->

    <Class rdf:about="http://example.org/23e4fc7b-618f-44af-9e67-174aa7a469b5">
        <obo:IAO_0000115>Compared to the normal fibromuscular stroma, PCa-associated reactive stroma is characterised by an increased proportion of fibroblasts/myofibroblasts, showing increased expression of vimentin, alpha-SMA, FAP, fibroblast-specific protein 1 (FSP-1) and desmin, counterbalanced by the loss of differentiated SMCs and by ECM remodelling, e.g. increased production of tenascin and collagen type I. Similar to normal fibroblasts, there are no universal markers for CAFs. For instance, FSP1 is also expressed by macrophages and some cancer cells, while desmin by pericytes. CAFs&apos; immunophenotypic heterogeneity may be partially explained by their different precursors, including ##tissue-resident fibroblasts##, mesenchymal stem cells, bone marrow-derived precursors and endothelial cells. Indeed, integrating spatial, morphological and functional data is necessary to characterise the heterogeneity of CAFs in prostate TME, possibly shedding light on their influence on neoplastic epithelial cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10006214</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36482187</oboInOwl:hasDbXref>
        <rdfs:label>tissue-resident fibroblasts</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000057"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/23e4fc7b-618f-44af-9e67-174aa7a469b5"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000057"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/23150f14-3542-43a3-88da-a386c4226d3b -->

    <Class rdf:about="http://example.org/23150f14-3542-43a3-88da-a386c4226d3b">
        <obo:IAO_0000115>(A, C) Expression level of select marker genes for each identified cluster (A: VGlut2 cKO model; C: Ip3r2 KO model). Circle size denotes expression ratio (percent cells expressing the gene), color represents expression level (in log2 CPM). Bar chart on the left shows cell numbers identified for each cluster are similar for WT and KO groups for each cluster in each model. (B) UMAP clustering of different cell types identified in the NEUN-negative population of the combined samples from Ip3r2 WT and KO mice. 17 clusters were identified including the three main types of glia: astrocytes, oligodendrocytes, and microglia, as well as endothelial cells, and two subtypes of neurons (for A-C - M-astrocyte: mitotic astrocyte; M-OPC: mitotic oligodendrocyte precursor cell; OPC: oligodendrocyte precursor cell; ##MFOL##: myelin-forming oligodendrocyte; NFOL: newly formed oligodendrocyte; MOL: mature oligodendrocyte; VLMC: vascular and leptomeningeal cell; EC: endothelial cell; PC: pericyte; PVM: perivascular macrophage).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8497060</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34494546</oboInOwl:hasDbXref>
        <rdfs:label>MFOL</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000128"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/23150f14-3542-43a3-88da-a386c4226d3b"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000128"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/232203ca-d40a-4a78-9e86-366c8be12dd0 -->

    <Class rdf:about="http://example.org/232203ca-d40a-4a78-9e86-366c8be12dd0">
        <obo:IAO_0000115>Both spermatogonial stem cells (SSCs) and female germline stem cells (FGSCs) are adult pluripotent stem cells (ASCs) in the germline. SSCs are pluripotent stem cells for generating spermatozoa in the testis, while FGSCs are newly identified pluripotent stem cells for producing oocytes in the ovary. Once gonadal colonization, hPGCs cease to proliferate, and the cells are called gonocytes or prespermatogonia in males. hPGCs will differentiate directly into fetal state 0-like spermatogonia starting at week 14 after fertilization. In humans, spermatogenesis begins 10-13 years after birth at puberty. During the first wave of spermatogenesis, some gonocytes resume proliferation, begin to move toward the periphery (basement membrane) of seminiferous tubules in the testis, and differentiate into spermatogonial stem cells. The SSCs are essential for generating spermatozoa throughout life. As germline stem cells, SSCs have features of stem cells, in addition to maintaining spermatogenesis. The main features of human SSCs include, (1) self-renewing to maintain SSCs population, (2) production of spermatogonia to support daily production of sperm cells, (3) SSC heterogeneity, as discussed below, (4) SSCs can transdifferentiate into other cell types, for example, oocytes, which is functional because the induced ovarian organoids derived from SSCs produced offspring. SSCs could be generated from induction from hPSCs, prepubertal SSCs are also induced to initiate meiosis and produce ##haploid germ cells## in vitro. Somatic Sertoli cells are converted to become into SSCs by overexpression of DAZL, DAZ2, and BOULE, (5) SSCs are rare and account for about 0.02-0.03% of all cells in the testis, and (6) de novo mutations in SSCs increase as men age, which often are associated with congenital disorders.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9527259</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36184610</oboInOwl:hasDbXref>
        <rdfs:label>haploid germ cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000586"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/232203ca-d40a-4a78-9e86-366c8be12dd0"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000586"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/234cc759-6c6e-43ac-b0a3-3cd9b9d29da7 -->

    <Class rdf:about="http://example.org/234cc759-6c6e-43ac-b0a3-3cd9b9d29da7">
        <obo:IAO_0000115>Meningeal ILC2s express Thy1.2, ST2, CD25, spinocerebellar ataxia type 1 (Sca10), and low levels of c-Kit and IL-7Ralpha and are major producers of IL-13 in tissues. As tissue-resident cells, ILC2s exhibit tissue-specific receptor expression patterns, which are imprinted by local signals. Likewise, dural ILC2s are distinct from lung ILC2s. The basal activation state of meningeal ILC2s is lower than that of ##lung-resident cells##. The proximity to brain-derived signals may explain the differences in basal activation observed between the two tissue types. ILC2 precursors originate from bone marrow. Future studies should determine the functional and phenotypic differences between blood-derived ILC2s and the adjacent bone marrow.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10616183</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37429945</oboInOwl:hasDbXref>
        <rdfs:label>lung-resident cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0001069"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/234cc759-6c6e-43ac-b0a3-3cd9b9d29da7"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0001069"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/23829445-40e0-480d-bc99-5392cc4efa01 -->

    <Class rdf:about="http://example.org/23829445-40e0-480d-bc99-5392cc4efa01">
        <obo:IAO_0000115>By the time the mouse blastocyst is ready to implant into the uterus, it comprises three cell types: pluripotent epiblast and two types of extra-embryonic tissue; primitive endoderm (PE), that will become ##visceral endoderm## (VE) that gives rise to the yolk sac; and trophectoderm (TE), progenitor of the placenta (figure 1). ESCs represent the pluripotent epiblast that forms a compartment distinct from the extra-embryonic cells in the blastocyst. The epiblast arises from a set of cells internalized during the 8- to 16-cell and 16- to 32-cell cleavage stages, the inner cell mass. The cells remaining on the outside of the embryo at this time become the TE. Before implantation, a salt and pepper mixture of inside cells, now specified as PE and epiblast, sort from each other into distinct layers. Just as the epiblast is represented by ESCs, cultured stem cell lines of trophoblast stem cells (TSCs) have been established from the TE and of eXtraEmbryoNic stem cells (XEN cells) from the PE/VE. The trick in recapitulating development beyond gastrulation to form structures representing the entire body plan has been to recreate interactions between the pluripotent ESCs and the two extra-embryonic stem cell types. </obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9833437</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36630196</oboInOwl:hasDbXref>
        <rdfs:label>visceral endoderm</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000223"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/23829445-40e0-480d-bc99-5392cc4efa01"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000223"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/23894fa7-4633-41fb-b58d-dba1dd3aaf40 -->

    <Class rdf:about="http://example.org/23894fa7-4633-41fb-b58d-dba1dd3aaf40">
        <obo:IAO_0000115>Compared with widely used high-throughput approaches that primarily involve viral vector-mediated gene transfer with uncontrollable randomness in cell targeting, 2-SPARSE has a unique advantage in that it enables precisely targeted labelling of single, functionally defined neurons after functional population imaging (Fig. 1). This precision is particularly useful when the functionally defined neurons in a specific brain region are sparse in number but exhibit wide spatial distribution and are intermingled with other neurons in the same region. In recent decades, many such neuronal types have been identified across multiple brain regions. For example, feature-specific neurons have been identified in the AUD and visual cortex for processing of sensory information; ##place cells## and grid cells have been identified in the hippocampus and the entorhinal cortex that participate in spatial navigation; engram cells have been identified in the hippocampus and cortex for memory processing, and holistic bursting cells have been identified in the AUD for complex sound encoding. These types of functionally defined cells constitute just a small proportion of the neuronal population in specific brain regions (e.g., grid cells, ~20%; engram cells, ~4%; and holistic bursting cells, ~5%) and are inevitably spatially intermingled. Moreover, these functional neuron types largely lack known molecular markers. Thus, molecular approaches alone are frequently limited in their potential application for mapping between functional and morphological features. In this case, 2-SPARSE not only provides an ideal solution for acquiring precise data but can also serve as an annotation reference for benchmarking and calibration of high-throughput population mapping methods used to correlate functional and morphological features of neurons.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8940919</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35318336</oboInOwl:hasDbXref>
        <rdfs:label>place cells</rdfs:label>
    </Class>
    


    <!-- http://example.org/239c2cfc-b4e8-485e-ada9-ce90fa766fce -->

    <Class rdf:about="http://example.org/239c2cfc-b4e8-485e-ada9-ce90fa766fce">
        <obo:IAO_0000115>In 12 donors with neuropathologic AD and 12 age- and sex-matched controls (Fig. 1a, Supplementary Fig. 1) we obtained snRNAseq profiles from temporal cortex tissue (TCX) using 10x Genomics platform, which yielded 87,493 single nuclei transcriptomes (Fig. 1b, Supplementary Data 1). Most nuclei isolation methods rely on sucrose gradient or fluorescence-activated nuclear sorting (FANS) for optimal nuclear purity and quality; although detection of rare cell types remain relatively limited. We optimized a nuclei isolation method that enables detection of all known major brain cell types with high purity including rarer cell types (Supplementary Figs. 2, 3). Quality control (QC) and filtration steps were applied based on number of genes, unique molecular identifiers (UMIs) per nuclei and predicted doublets (Supplementary Fig. 4), resulting in 78,396 high quality nuclei in 35 clusters that were annotated for their types according to published cellular markers. Heatmap visualization using well-established cell type markers further confirmed the cell type assignment for the clusters (Fig. 1c, d). All clusters include nuclei from &gt; 20 individuals, i.e. &gt; 80% of cohort, except the two smallest clusters which contain 206 and 105 nuclei (Supplementary Data 2, 3). The clusters represent eight cell types (Fig. 1c) as follows: 14 ##excitatory neuronal## (41% nuclei), 9 inhibitory neuronal (20%), 3 oligodendrocytic (22%), 3 astrocytic (8%), 3 vascular (3%), 2 microglial (3%) and 1 oligodendrocyte progenitor nuclei clusters (3%). We tested the associations of each cell cluster proportion with diagnosis, age, sex, APOEepsilon4 and neuropathology measures (Supplementary Figs. 5, 6, Supplementary Data 4-6). An excitatory neuronal cluster 23 (cl.23) has a lower proportion of cells in AD cases, is likewise negatively associated with both Braak stage and Thal phase and is negatively associated with APOEepsilon4; inhibitory neuronal cl.10 is also negatively associated with Braak stage. An inhibitory neuronal cl.7 is positively and an oligodendrocytic cl.14 is negatively associated with APOEepsilon4. No other cell clusters had nuclei proportion associations with the tested variables.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11190273</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38902234</oboInOwl:hasDbXref>
        <rdfs:label>excitatory neuronal</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000540"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/239c2cfc-b4e8-485e-ada9-ce90fa766fce"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000540"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/239621a1-c7c7-4ceb-94ed-6bdbb4277a74 -->

    <Class rdf:about="http://example.org/239621a1-c7c7-4ceb-94ed-6bdbb4277a74">
        <obo:IAO_0000115>In humans, the number of ENS neurons is about 500 million, many more than in the other parts of the peripheral autonomic nervous system. The longitudinal and circular layers of the muscularis externa are innervated by nerve fibres of sympathetic extrinsic ganglia and nerve fibres of Auerbach&apos;s plexus motoneurons and such organisation regulates proper intestinal motility. Moreover, the peristaltic reflexes of the intestine are coordinated by an abundant network of the myenteric plexuses descending and ascending nerve fibres. The intestinal mucosa is innervated by fibres of secretomotor neurons originating from submucosal plexuses. ##Secretomotor neurons## regulate fluid exchange, intestinal permeability and coordinate proper intestinal reflexes. The lumen of submucosal blood vessels is regulated by axons of the vasomotor neurons (dilatory function) of submucosal plexuses and/or nitrergic (neuronal nitric oxide synthase, i.e., nNOS) neurons and axons of sympathetic neurons of extrinsic ganglia (constrictory function). Moreover, all the layers of the intestine and blood vessels are innervated by the sensory neurons (with mechano-, thermo- and chemoreceptors) of submucosal and myenteric plexuses as well as dorsal root ganglia. All components of the ENS are interconnected by numerous interneurons which functionally integrate them into one system which functions are based on physiological reflexes.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7247003</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32403316</oboInOwl:hasDbXref>
        <rdfs:label>Secretomotor neurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000100"/>
        <skos:relatedMatch rdf:resource="CL:0007011"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/239621a1-c7c7-4ceb-94ed-6bdbb4277a74"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000100"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/239621a1-c7c7-4ceb-94ed-6bdbb4277a74"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0007011"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/24aef8d4-3356-4170-a484-6b96f4cbcaca -->

    <Class rdf:about="http://example.org/24aef8d4-3356-4170-a484-6b96f4cbcaca">
        <obo:IAO_0000115>Age-related hearing loss (or presbyacusis) is a progressive pathophysiological process. This study addressed the hypothesis that degeneration/dysfunction of multiple nonsensory cell types contributes to presbyacusis by evaluating tissues obtained from young and aged CBA/CaJ mouse ears and human temporal bones. Ultrastructural examination and transcriptomic analysis of mouse cochleas revealed age-dependent pathophysiological alterations in 3 types of neural crest-derived cells, namely intermediate cells in the stria vascularis, ##outer sulcus cells## in the cochlear lateral wall, and satellite cells in the spiral ganglion. A significant decline in immunoreactivity for Kir4.1, an inwardly rectifying potassium channel, was seen in strial intermediate cells and outer sulcus cells in the ears of older mice. Age-dependent alterations in Kir4.1 immunostaining also were observed in satellite cells ensheathing spiral ganglion neurons. Expression alterations of Kir4.1 were observed in these same cell populations in the aged human cochlea. These results suggest that degeneration/dysfunction of neural crest-derived cells maybe an important contributing factor to both metabolic and neural forms of presbyacusis.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6679794</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31220650</oboInOwl:hasDbXref>
        <rdfs:label>outer sulcus cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000634"/>
        <skos:relatedMatch rdf:resource="CL:0002084"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/24aef8d4-3356-4170-a484-6b96f4cbcaca"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000634"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/24aef8d4-3356-4170-a484-6b96f4cbcaca"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002084"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/24d54cc2-5fd0-4329-97ed-e152e98d4f09 -->

    <Class rdf:about="http://example.org/24d54cc2-5fd0-4329-97ed-e152e98d4f09">
        <obo:IAO_0000115>KSHV lymphoproliferative disorders occur primarily in the context of immunosuppression, and other studies have shown interactions between T cells and KSHV infected B cells in tonsil lymphocyte cultures affecting the frequency of lytic reactivation. Therefore, we wanted to determine whether the immunological composition of the tonsil lymphocyte environment would affect the establishment of KSHV infection in B lymphocytes and specifically whether overall susceptibility or targeting of particular B cell lineages is influenced by the presence or absence of T cells. Like B cell lineages, levels of CD4+ and CD8+ T cell lineages vary considerably between tonsil donors (Fig 1D). However, unlike B lymphocyte subsets, the distribution of T cell subsets are not generally correlated with donor age (Fig 1E). Examination of whether the ratio of CD4/CD8 T cells in individual tonsil specimens was correlated with the susceptibility of B lymphocytes to KSHV infection revealed no significant correlation (Fig 5A). Next, we examined correlations between B cell infections and baseline levels of various CD4 and CD8+ T cell subsets to determine whether any T cell lineages affected the tropism of KSHV for particular B cell lineages (Fig 5B). Interestingly, levels of naive and stem cell memory CD4+ T cells was positively correlated with infection of plasma cells (Fig 5B and Fig 5C, left panels) with a greater effect on ##CD20+ plasma cells## than CD20- plasma cells, while overall levels of CD45RO+ activated memory T cells were negatively correlated with KSHV infection of plasma cells (Fig 5C, right panel). In addition, although the correlations were too weak to be significant in this data set, nearly every B cell lineage and overall KSHV infection was negatively correlated with the presence of CD4+ T cells expressing a TEMRA phenotype (Fig 5B). Baseline levels of CD8+ T cells had less effect on KSHV infection with only one significant positive correlation observed in our dataset between CD8+ terminal effector cells and KSHV infection of naive B cells (Fig 5B).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7595638</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33075105</oboInOwl:hasDbXref>
        <rdfs:label>CD20+ plasma cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000786"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/24d54cc2-5fd0-4329-97ed-e152e98d4f09"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000786"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/24f77171-e9a4-4b77-ba26-385fb2e90979 -->

    <Class rdf:about="http://example.org/24f77171-e9a4-4b77-ba26-385fb2e90979">
        <obo:IAO_0000115>Six-week-old male Lgr4iKO mice and littermates were fed normal chow diet (NCD) for 12 weeks. Single cell RNA sequencing was used to obtain intestinal epithelium single cell transcriptome data from 18-week-old Lgr4iKO mice and littermates. n = 3. a t-SNE plot showing stem cell, TA cell, absorptive cell, goblet cell, paneth cell, enteroendocrine cell and tuft cell marker genes expression in intestinal epithelium. b Defining cell populations with marker gene expression. c Pseudotime ordering on intestinal epithelium cells. d Re-clustering absorptive cells. Enterocytes selective for absorption of long-chain fatty acid, carbohydrate, or both were defined by the expression of Cd36 Fatp4 Glut2 and Sglt1. e The proportions of long-chain fatty acid-absorptive enterocytes, carbohydrate-absorptive enterocytes, and ##long-chain fatty acid and carbohydrate-absorptive enterocytes##.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11116434</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38782937</oboInOwl:hasDbXref>
        <rdfs:label>long-chain fatty acid and carbohydrate-absorptive enterocytes</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000584"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/24f77171-e9a4-4b77-ba26-385fb2e90979"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000584"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/24064836-6035-45d7-8235-32d7cc356a21 -->

    <Class rdf:about="http://example.org/24064836-6035-45d7-8235-32d7cc356a21">
        <obo:IAO_0000115>Myofibroblasts are central mediators of the dysregulated wound-healing programme that defines fibrosis, therefore we studied this population in detail. Graph based clustering of the single cell RNA-seq data defined four major subsets (Fig. 3a) that included a cycling population (Cycling MFB) (Fig. 3a, b). After this, we sought to confirm that proliferating stromal cells (Ki67+) were myofibroblasts (Fig. 3c-e, Supplementary Fig. 4a-d). Using flow cytometry, we stained freshly disaggregated ##nodular cells## and gated on myofibroblasts (CD45-CD31-CD146-ITGbeta1high) and fibroblasts (CD45-CD31-CD146-ITGbeta1low) and demonstrated Ki67high cells were a subset of myofibroblasts. In the single cell RNA-seq, a second subset was characterised by lower expression of ACTA2 and intermediate expression of fibroblast marker genes (CXCL14, PLA2G2A and C1R), we termed the ACTA2low myofibroblast (Fig. 3a, b, Supplementary Fig. 5a). A third comprised a discrete CD82highOX40L+ population (CD82, OX40L, MMP11, MMP14 and CD82) (Fig. 3a, g, Supplementary Fig. 5b-e). Finally, a fourth less distinct community we termed the intermediate myofibroblast (Fig. 3a, b, Supplementary Fig. 15a). GO analysis demonstrated that CD82highOX40L+ myofibroblast marker genes showed the strongest enrichment for cell contraction pathways (Fig. 3f). In contrast, differential gene expression and pathway analysis revealed ACTA2low myofibroblasts resembled a general fibroblast phenotype, without clear characteristics of any one subtype. In addition to ACTA2, significant ACTA2low myofibroblasts markers were general fibroblasts markers including PLA2G2A and CXCL14. ACTA2low myofibroblasts also shared pathways enriched in fibroblasts such as &apos;interleukin signalling&apos; and &apos;chemotaxis&apos; (Fig. 3f).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7265502</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32488016</oboInOwl:hasDbXref>
        <rdfs:label>nodular cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000186"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/24064836-6035-45d7-8235-32d7cc356a21"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000186"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/241076b0-272e-494a-ba23-6919362fa730 -->

    <Class rdf:about="http://example.org/241076b0-272e-494a-ba23-6919362fa730">
        <obo:IAO_0000115>In Tek-CreERT2;R26T mice, we also observed Tek+ bone-lining cells at the endosteum (Fig. 5a). The frequency of these cells was approximately 2.8 cells/mm endosteum in longitudinal sections, which was significantly higher than that of Cdh5+ bone-lining cells (Fig. 5f). Tek+ endosteal bone-lining cells often exhibited a thin and elongated morphology and were nearly absent for the osteolineage marker RUNX2 (Fig. 5b, g), suggesting that they might correspond to the ##endosteal fibroblasts## detected in the reanalyzed dataset. However, Tek+ osteocytes were hardly detected in these mice (Fig. 5c, h). In other regions of the bone marrow cavity, a small population of trabecular bone-lining cells (Fig. 5d, i) and metaphyseal stromal cells (Fig. 5e, j) were also Tek+.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10733381</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38123537</oboInOwl:hasDbXref>
        <rdfs:label>endosteal fibroblasts</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000057"/>
        <skos:relatedMatch rdf:resource="CL:0002157"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/241076b0-272e-494a-ba23-6919362fa730"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000057"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/241076b0-272e-494a-ba23-6919362fa730"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002157"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/2420547a-7f3b-43a7-a4b2-0f86ed7c9100 -->

    <Class rdf:about="http://example.org/2420547a-7f3b-43a7-a4b2-0f86ed7c9100">
        <obo:IAO_0000115>(A) Diagram describing the human hematopoietic population hierarchy: long-term hematopoietic stem cell (LT-HSC), short-term hematopoietic stem cell (ST-HSC), multipotent progenitor (MPP), lymphomyeloid-primed progenitor (##LMPP##), common lymphoid progenitor (CLP), common myeloid progenitor (CMP), granulocyte monocyte progenitor (GMP), and megakaryocytic-erythroid progenitor (MEP). Immunophenotypic markers for each subpopulation were adapted from.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7487781</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32877675</oboInOwl:hasDbXref>
        <rdfs:label>LMPP</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000936"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/2420547a-7f3b-43a7-a4b2-0f86ed7c9100"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000936"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/2469b721-1571-42e1-a952-099ddcc0d39e -->

    <Class rdf:about="http://example.org/2469b721-1571-42e1-a952-099ddcc0d39e">
        <obo:IAO_0000115>During valvulogenesis, valvular interstitial cells (VICs) are mainly derived from endocardial cushion cells through an EndoMT process. We investigated whether ##hPSC-derived VELs## could be converted to VIC-like (VICL) cells through EndoMT by treating them with higher concentration of TGFb1 and bFGF over a time course of 6 days (Fig. 7a; Supplementary Fig. 7a). HPSC-derived VELs quickly lose the cobble-stone morphology, and displayed the fibroblastic morphology (Fig. 7b). After 3 days treatment, VIC-type markers such as POSTN, ACTA2, and S100A4/FSP1 were strongly induced (Fig. 7a; Supplementary Fig. 7b), accompanied by upregulation of EndoMT genes such as SNAI1, TWIST1, SOX9, AGGRECAN, TENASCIN, and SCLERAXIS (Supplementary Fig. 7c). We further confirmed these by IF staining and WB analyses (Fig. 7b, c).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8421482</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34489520</oboInOwl:hasDbXref>
        <rdfs:label>hPSC-derived VELs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002248"/>
        <skos:relatedMatch rdf:resource="CL:4030033"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/2469b721-1571-42e1-a952-099ddcc0d39e"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002248"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/2469b721-1571-42e1-a952-099ddcc0d39e"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4030033"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/2493084d-9584-4f2c-9511-57217556654c -->

    <Class rdf:about="http://example.org/2493084d-9584-4f2c-9511-57217556654c">
        <obo:IAO_0000115>Expression heterogeneity of CD8+ and CD4+ T cells in the OSCC ecosystem. (A) The t-distributed stochastic neighbor embedding (t-SNE) projection of T cells from cancerous tissue of patients with OSCC, showing the formation of 11 main clusters in different colors. The functional description of each cluster is determined by the gene expression characteristics. Cluster 0: resident memory CD8+ T Cells (C0_CD8+ TRM); Cluster 1: effector memory CD8+ T cells (C1_CD8+ TEM); Cluster 2: regulatory CD4+ T cells (C2_CD4+ Treg); Cluster 3: exhausted CD8+ T cells (C3_CD8+ T Exhausted); Cluster 4: effector memory M-phage CD8+ T cells (C4_CD8+ Mitotic TEM); Cluster 5: effector memory CD4+ T cells (C5_CD4+ TEM); Cluster 6: effector memory CD8+ T cells (C6_CD8+ TEM); Cluster 7: effector memory CD4+ T cells (C7_CD4+ TEM); Cluster 8: effector memory CD8+ T cells (C8_CD8+ TEM); Cluster 9: effector memory CD8+ T cells (C9_CD8+ TEM); Cluster 10: effector memory M-phage CD4+ T cells (C10_CD4+ Mitotic TEM); Cluster 11: effector memory CD8+ T cells (C11_CD8+ TEM); Cluster 12: effector memory CD8+ T cells (C12_CD8+ TEM); Cluster 13: gammadelta T. (B) Cell-Cycle Scoring of T cells from cancerous tissue of patients with OSCC, showing the three clusters of cells in different cell cycles in different colors. (C) Heatmap of key genes expressed in each cluster of ##CD8+ tumor-infiltrating lymphocytes## (TILs) with cells grouped by clusters. The columns correspond to the cells; the rows correspond to the genes. Yellow: high expression; purple: low expression. Selected key markers are shown on the right. (D) Heatmap of key genes expressed in each cluster of CD4+ TILs with cells grouped by clusters. The columns correspond to the cells; the rows correspond to the genes. Yellow: high expression; purple: low expression. Selected key genes are shown on the right.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8024729</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33513276</oboInOwl:hasDbXref>
        <rdfs:label>CD8+ tumor-infiltrating lymphocytes</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000625"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/2493084d-9584-4f2c-9511-57217556654c"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000625"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/25aab1ba-3e8c-4a85-a60b-e43169500f5d -->

    <Class rdf:about="http://example.org/25aab1ba-3e8c-4a85-a60b-e43169500f5d">
        <obo:IAO_0000115>The above analysis was based on a large number of RNA-seq, so we further used scRNA-seq to determine whether our ORGs signature had immune predictive value on the single cell level. Figure 7A showed that the PRAD samples from GEO datasets were annotated into Mast cell, Epithelial-NE, T/NK, Plasma_B, Epithelial, Neuron, SMC, Fibroblasts and Pericytes, ##Myeloid## and Endothelial. It was obvious that ORGs signature was specifically high in Epithelial-Nk, T/Nk and SMC cells (Figure 7B, 7C). Meanwhile, Figure 7D revealed that significant connection probability of ORGs related signaling pathways in cell clusters which showed specifically high ORGs signature. Furthermore, we chose epithelial cell for analysis. Chemotaxis related pathways including cell chemotaxis, leukocyte chemotaxis, regulation of chemotaxis and regulation of leukocyte chemotaxis were significantly up-regulated in the high ORGs signature group (Figure 7E). What&apos;s more, immune related pathways were all up-regulated in the high ORGs signature group both in GO (Figure 7F) and KEGG (Figure 7G) analysis.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10599753</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37788005</oboInOwl:hasDbXref>
        <rdfs:label>Myeloid</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000763"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/25aab1ba-3e8c-4a85-a60b-e43169500f5d"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000763"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/25be6b25-8903-4b44-983f-8a0085151c22 -->

    <Class rdf:about="http://example.org/25be6b25-8903-4b44-983f-8a0085151c22">
        <obo:IAO_0000115>All immune cells within tumors originate from hematopoietic stem and progenitor cells (HSPCs). HSPCs are sensitive to external stimuli, such as infection or injury. In response, they enter an extensive proliferative phase to increase the reservoir of required immune cells, shifting the balance between various populations of leucocytes. Once the stimulus ceases, HSPCs return to a quiescent stage, maintaining a normal homeostasis. Tumors also secrete external stimuli, which contribute to HSPC differentiation. It is well established that tumors induce myelopoiesis as a means of supplying ##immature progenitors## that act as immunosuppressive cells. For example, it has been demonstrated that the composition of circulating HSPCs is significantly altered in patients with solid tumors, with increased levels of granulocyte-monocyte progenitors (GMPs) and a general bias toward granulocyte formation, compared with healthy patients. In addition, elevated numbers of circulating HSPCs correlate with tumor aggressiveness and decreased overall survival. In the context of HPSC differentiation, it has been previously thought that GMPs are differentiated into neutrophils or monocyte-dendritic progenitors (MDPs), which further differentiate into monocytes and dendritic cells (DCs). However, a recent study demonstrated that GMPs and MDPs produce functionally distinct monocytes. While GMPs produce neutrophils and monocytes, MDPs are differentiated into monocytes and DCs but not neutrophils. The contribution of these progenitors to external stimuli has been studied in the context of microbial stimuli; however, their differentiation pattern and contribution to tumor aggressiveness and metastasis are not known.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8212411</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34140316</oboInOwl:hasDbXref>
        <rdfs:label>immature progenitors</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0011026"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/25be6b25-8903-4b44-983f-8a0085151c22"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0011026"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/25d34ba0-e69b-47a0-b944-239a4efcd29b -->

    <Class rdf:about="http://example.org/25d34ba0-e69b-47a0-b944-239a4efcd29b">
        <obo:IAO_0000115>Taken together, the data-driven FACS gating strategy allowed us to isolate distinct stromal subsets for functional investigation. Both MSSCs and HAGEPs demonstrated considerably higher in vitro colony-forming capacities in comparison with balanced progenitors, OCs, pre-osteoblasts, and ##pre-fibroblasts##. While MSSCs and HAGEPs exhibited full multi-differentiation potentials, pre-fibroblasts had only limited differentiation potentials. OCs showed enhanced osteoblastic and chondrogenic differentiation capacities and compromised adipogenic potential, which is consistent with their differentiation marker expression profiles (Figure 2).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10097421</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36876630</oboInOwl:hasDbXref>
        <rdfs:label>pre-fibroblasts</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000057"/>
        <skos:relatedMatch rdf:resource="CL:0009099"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/25d34ba0-e69b-47a0-b944-239a4efcd29b"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000057"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/25d34ba0-e69b-47a0-b944-239a4efcd29b"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0009099"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/25d3c917-9dbe-4cba-b970-0c4b7408a458 -->

    <Class rdf:about="http://example.org/25d3c917-9dbe-4cba-b970-0c4b7408a458">
        <obo:IAO_0000115>The CB parenchyma is organized into clusters of cells called glomeruli. Each glomerulus is considered an independent chemo-sensitive unit composed by four to eight neuron-like glomus cells, also called type I cells, which are richly innervated by sensory fibers of the petrosal ganglion and in close contact with a profuse network of fenestrated capillaries. Glomus cells are the O2-sensing elements in the CB; they contain abundant synaptic vesicles with several neurotransmitters and neuropeptides (see below), which are rapidly released in response to hypoxia to activate the afferent sensory fibers. Glomus cells contain a broad variety of voltage- and ligand-gated ion channels, are electrically excitable, and can generate action potentials repetitively. Hypoxia leads to glomus cell depolarization, extracellular Ca2+ influx and transmitter release due to modulation of O2-sensitive membrane ion channels. Responsiveness to hypoxia is an intrinsic property of glomus cells, although it can be modulated by auto- and paracrine interactions within the glomerulus and by circulating agents such as cytokines or hormones (see). The mechanisms underlying O2 sensing have remained elusive, although recent data strongly suggest that molecular specializations in glomus cell mitochondria confer upon them special sensitivity to hypoxia, with the generation of mitochondrial signals (NADH and reactive oxygen species) that modulate membrane ion channels. In addition to the chemo-sensitive glomus cells, which are highly dopaminergic and can be easily identified using antibodies against tyrosine hydroxylase (TH), the CB glomeruli also contain a smaller number of type II, or sustentacular, cells with interdigitating processes that envelop glomus cells. Type II cells can be stained with antibodies against glial fibrillary acidic protein (GFAP), an intermediate filament commonly expressed in glial cells. Although type II cells were originally described as ##supportive cells##, with little functional relevance, this view has completely changed in recent years (see below). Type II cells contribute to potentiation of the glomus cell-afferent sensory fiber synapse. Moreover, type II cells, or a subpopulation of them, are tissue-specific adult multipotent stem cells that support CB structural plasticity. In addition to the two main cell types, the CB contains intermediate progenitors, abundant macrophages, and fat cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7662800</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33153142</oboInOwl:hasDbXref>
        <rdfs:label>supportive cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000630"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/25d3c917-9dbe-4cba-b970-0c4b7408a458"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000630"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/25d57796-200d-4757-bd2e-909784beb67a -->

    <Class rdf:about="http://example.org/25d57796-200d-4757-bd2e-909784beb67a">
        <obo:IAO_0000115>Skeletal stem and progenitor cell populations are crucial for bone physiology. Characterization of these cell types remains restricted to heterogenous bulk populations with limited information on whether they are unique or overlap with previously characterized cell types. Here we show, through comprehensive functional and single-cell transcriptomic analyses, that postnatal long bones of mice contain at least two types of bone progenitors with bona fide skeletal stem cell (SSC) characteristics. An early osteochondral SSC (ocSSC) facilitates long bone growth and repair, while a second type, a ##perivascular SSC## (pvSSC), co-emerges with long bone marrow and contributes to shape the hematopoietic stem cell niche and regenerative demand. We establish that pvSSCs, but not ocSSCs, are the origin of bone marrow adipose tissue. Lastly, we also provide insight into residual SSC heterogeneity as well as potential crosstalk between the two spatially distinct cell populations. These findings comprehensively address previously unappreciated shortcomings of SSC research.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8289409</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34280086</oboInOwl:hasDbXref>
        <rdfs:label>perivascular SSC</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000134"/>
        <skos:relatedMatch rdf:resource="CL:4033054"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/25d57796-200d-4757-bd2e-909784beb67a"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000134"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/25d57796-200d-4757-bd2e-909784beb67a"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4033054"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/25fd2531-5920-47c1-a06c-ee92bec9a428 -->

    <Class rdf:about="http://example.org/25fd2531-5920-47c1-a06c-ee92bec9a428">
        <obo:IAO_0000115>We have previously reported that after brain exposure to ionizing radiation, ##proliferating progenitors## are highly radiation-sensitive and rapidly eliminated after irradiation. On the contrary qNSC that are radiation resistant repopulate the different SVZ neurogenic cell populations successively the following days after irradiation. We therefore used this model and our transcriptomic signatures of SVZ stem and progenitor cells to gain new insights on the nature and the hierarchical ordering of neural progenitor clusters identified by sc-RNAseq.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11584179</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:39576691</oboInOwl:hasDbXref>
        <rdfs:label>proliferating progenitors</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0011026"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/25fd2531-5920-47c1-a06c-ee92bec9a428"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0011026"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/2533970d-baa7-482f-aaab-879e2a82167f -->

    <Class rdf:about="http://example.org/2533970d-baa7-482f-aaab-879e2a82167f">
        <obo:IAO_0000115>It has been reported that cortical-projecting subpopulations of DRN 5-HT neurons express Slc17a8, in agreement with the extensive overlap between the spatial distribution of cortical-projecting neurons and Slc17a8 expression. This suggests that cortical-projecting subpopulations should correspond to subtype 5-HT-IV from the scRNA-seq dataset, which is Slc17a8-expressing and distributed to the ventral DRN. Additionally, we would predict that the Str-projecting subpopulation corresponds to the subtype 5-HT-III, since their distributions overlap extensively in the dorsomedial DRN. Consistent with our hypothesis that 5-HT neuron subtypes innervate different brain regions, we found that the inferred distributions of each 5-HT neuron subtype coincides with a different set of projection-defined subpopulations - the distribution of subtype 5-HT-III was most similar to the distribution of Str-projecting neurons (Figure 6F), whereas the distribution of subtype 5-HT-IV was more similar to that of ##M1-projecting neurons## (Figure 6G). However, neither Str-projecting nor M1-projecting subpopulations were fully contained within the distribution of a single 5-HT neuron subtype. Str-projecting neurons in the ventrolateral DRN (marked cyan in Figure 6D,F,G), where neurons innervating both Str and M1 are located, fell within the distribution of subtype 5-HT-IV but not of subtype 5-HT-III. This suggests that Str is a target of multiple molecular subtypes of 5-HT neurons, and supports the model that some structures are innervated by multiple 5-HT neuron subtypes due to overlaps in the axonal projection fields of different subtypes.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6726424</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31411560</oboInOwl:hasDbXref>
        <rdfs:label>M1-projecting neurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000540"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/2533970d-baa7-482f-aaab-879e2a82167f"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000540"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/25791416-2880-42a4-aff5-5a529c359989 -->

    <Class rdf:about="http://example.org/25791416-2880-42a4-aff5-5a529c359989">
        <obo:IAO_0000115>We also examined the percentages of individual cell lineages in early quadruplets and control blastocysts (Fig. 5e; Supplementary Tables S5, S6). Quadruplet blastocysts had a higher percentage of TE cells than controls (82.7% +- 7.3% vs. 73.7% +- 7.8%; p = 0.0003). In addition, the proportion of PE progenitors in the quadruplets was smaller compared to the control blastocysts (4.9% +- 4.1% vs. 10.7% +- 2.8%; p &lt; 0.0001). In turn, the percentage of ##EPI progenitors## was similar in both groups: 12.4% +- 6.3% in early quadruplets and 15.6% +- 7.1% in controls.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8563712</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34728646</oboInOwl:hasDbXref>
        <rdfs:label>EPI progenitors</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000352"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/25791416-2880-42a4-aff5-5a529c359989"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000352"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/26a42e61-3922-42bb-962e-670c19b33b6b -->

    <Class rdf:about="http://example.org/26a42e61-3922-42bb-962e-670c19b33b6b">
        <obo:IAO_0000115>Pancreatic ductal adenocarcinoma (PDAC) has a poor clinical outlook. Responses to immune checkpoint blockade are suboptimal and a much more detailed understanding of the tumor immune microenvironment is needed if this situation is to be improved. Here, we characterized tumor-infiltrating T-cell populations in patients with PDAC using cytometry by time of flight (CyTOF) and single-cell RNA sequencing. T cells were the predominant immune cell subset observed within tumors. Over 30% of CD4+ T cells expressed a CCR6+CD161+ Th17 phenotype and 17% displayed an activated regulatory T-cell profile. Large populations of CD8+ tissue-resident memory (TRM) T cells were also present and expressed high levels of programmed cell death protein 1 (PD-1) and TIGIT. A population of putative tumor-reactive ##CD103+CD39+ T cells## was also observed within the CD8+ tumor-infiltrating lymphocytes population. The expression of PD-1 ligands was limited largely to hemopoietic cells whilst TIGIT ligands were expressed widely within the tumor microenvironment. Programmed death-ligand 1 and CD155 were expressed within the T-cell area of ectopic lymphoid structures and colocalized with PD-1+TIGIT+ CD8+ T cells. Combinatorial anti-PD-1 and TIGIT blockade enhanced IFNgamma secretion and proliferation of T cells in the presence of PD-1 and TIGIT ligands. As such, we showed that the PDAC microenvironment is characterized by the presence of substantial populations of TRM cells with an exhausted PD-1+TIGIT+ phenotype where dual checkpoint receptor blockade represents a promising avenue for future immunotherapy.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10068448</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36689623</oboInOwl:hasDbXref>
        <rdfs:label>CD103+CD39+ T cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000084"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/26a42e61-3922-42bb-962e-670c19b33b6b"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000084"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/26d23128-c900-42f4-8f40-230fc7273104 -->

    <Class rdf:about="http://example.org/26d23128-c900-42f4-8f40-230fc7273104">
        <obo:IAO_0000115>Based on improved knowledge of human B cell populations derived from recent studies, we sought to characterize the B cell precursors of IgE ASC through a combination of phenotypic, BCR repertoire and molecular analyses. Our experimental model was based on the hypothesis that the study of nasal polyps (NP), would provide a rich environment for ongoing IgE ASC differentiation from different cellular precursors in the absence of GC. In keeping with this model, we identified a novel human EF mucosal B cell population (CD19+IgD+CD27-) as the origin of mucosal IgE ASC. This population shared many of the phenotypic and transcriptional features of activated naive B cells recently shown in the EF response of patients with active autoimmune disease and severe SARS-CoV-2 infection. These mucosal IgD+ B cells are characterized by: (1) a high degree of clonal connectivity with IgE ASC, (2) an activated phenotype (CD11c+CD86+CD71+Nur77+CD21-), (3) a progressive transcriptome between resting blood naive B cells and NP ASC, and (4) the highest level of germline epsilon transcripts. Notably, the majority of the IgD+ NP B cells expressed IgM sequences with low mutation rates, a profile consistent with activated naive B cells. However, IgD+ NP B cells also contained a smaller fraction of cells with very high rates of somatic hypermutation previously demonstrated in class-switched IgD-only B cells (IgD+IgM-; Cdelta-CS), reported in the literature within either GC, memory and ASC populations. Interestingly, the analysis of single cell IgE ASC demonstrated lower mutation relative to ASC of other isotypes including IgG, IgA, or the highly ##mutated IgD ASC##. In summary, human mucosal IgE ASC originate from an EF mucosal activated IgD+ B cell subset in patients with atopic and non-atopic airways disease.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8160425</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34050324</oboInOwl:hasDbXref>
        <rdfs:label>mutated IgD ASC</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000946"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/26d23128-c900-42f4-8f40-230fc7273104"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000946"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/26e456ec-114f-4757-9484-62b792ebcbec -->

    <Class rdf:about="http://example.org/26e456ec-114f-4757-9484-62b792ebcbec">
        <obo:IAO_0000115>a Line drawing of a cross section of the floor of the cochlear duct at P1. Distinct cell types within the organ of Corti (OC) are color coded. b Heat map for ~14,000 cochlear cells collected from four separate experiments at P1. Top 25 differentially expressed (DE) genes for the 15 identified clusters are shown. Cellular identity for each cluster is indicated by a color bar at the top of the heat map, which corresponds to the legend in a, and by a cell name at the bottom. c tSNE plot for the same cells as in b. Cluster identities are indicated. d Violin plots showing normalized log-transformed expression values for the top five DE genes for each cell type (color coded as in c) by comparison with all other P1 cells (gray on the right in each graph). Bars indicate median expression level. e Upper left panel, tSNE plot of cells determined to be derived from KO (between the OC and medial edge of the cochlear duct). Lower left panel, feature plot for the same cells as in the upper panel indicating high expression of Otoa, Calb1, and Fabp7 (based on color) in different clusters of cells. Lower right panel, cross sections through the cochlear duct at P1, illustrating expression of CALB1 in the medial region of KO and FABP7 directly adjacent to the OC (arrow; scale bars, 20 mum). Lowest panel shows high-magnification view of expression of FABP7 (arrow, gray scale) at the lateral KO border (green line; scale bar, 10 mum). Upper right panel, summary diagram of the spatial distribution of KO cell clusters at P1. HC hair cells, IPhC inner phalangeal cells/border cells, IPC inner pillar cells, OPC outer pillar cells, DC1/2 Deiters&apos; cells rows 1 and 2, DC3, Deiters&apos; cells row 3, HeC Hensen&apos;s cells, CC/OSC Claudius cells/##outer sulcus cells##, IdC interdental cells, ISC inner sulcus cells, KO Kolliker&apos;s organ cells, L.KO lateral Kolliker&apos;s organ cells, M.KO medial Kolliker&apos;s organ cells, OC90 OC90+ cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7221106</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32404924</oboInOwl:hasDbXref>
        <rdfs:label>outer sulcus cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000601"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/26e456ec-114f-4757-9484-62b792ebcbec"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000601"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/26337a81-0175-44d0-b04b-7aad97dcccc1 -->

    <Class rdf:about="http://example.org/26337a81-0175-44d0-b04b-7aad97dcccc1">
        <obo:IAO_0000115>Skeletal muscle formation is a highly precise and coordinated process, which requires the proliferation of myoblasts, permanent withdrawal from the cell cycle, differentiation and final fusion into multinucleated muscle fibers. Cell cycle arrest is a prerequisite for differentiation. The abnormal myogenesis observed in SRSF2-null embryos could be the consequences of abnormal apoptosis and proliferative defects of MPCs, premature differentiation of myoblasts, and altered myogenic fate of ##Myf5-derived cells##.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9218650</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35460187</oboInOwl:hasDbXref>
        <rdfs:label>Myf5-derived cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000737"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/26337a81-0175-44d0-b04b-7aad97dcccc1"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000737"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/26394a93-f870-40e9-81ed-311793b386b1 -->

    <Class rdf:about="http://example.org/26394a93-f870-40e9-81ed-311793b386b1">
        <obo:IAO_0000115>scRNA-seq demonstrated that ##hAM-Muse cells## comprised 2 major subpopulations. The large subpopulation seemed to be in a state between the epithelial- and mesenchymal-cell states, while the small subpopulation was in a more mesenchymal state and was enriched for genes relevant for placental formation.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9568515</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36241699</oboInOwl:hasDbXref>
        <rdfs:label>hAM-Muse cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002639"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/26394a93-f870-40e9-81ed-311793b386b1"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002639"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/264e216d-4783-4987-88c5-73fcf8f0e884 -->

    <Class rdf:about="http://example.org/264e216d-4783-4987-88c5-73fcf8f0e884">
        <obo:IAO_0000115>KSHV lymphoproliferative disorders occur primarily in the context of immunosuppression, and other studies have shown interactions between T cells and ##KSHV infected B cells## in tonsil lymphocyte cultures affecting the frequency of lytic reactivation. Therefore, we wanted to determine whether the immunological composition of the tonsil lymphocyte environment would affect the establishment of KSHV infection in B lymphocytes and specifically whether overall susceptibility or targeting of particular B cell lineages is influenced by the presence or absence of T cells. Like B cell lineages, levels of CD4+ and CD8+ T cell lineages vary considerably between tonsil donors (Fig 1D). However, unlike B lymphocyte subsets, the distribution of T cell subsets are not generally correlated with donor age (Fig 1E). Examination of whether the ratio of CD4/CD8 T cells in individual tonsil specimens was correlated with the susceptibility of B lymphocytes to KSHV infection revealed no significant correlation (Fig 5A). Next, we examined correlations between B cell infections and baseline levels of various CD4 and CD8+ T cell subsets to determine whether any T cell lineages affected the tropism of KSHV for particular B cell lineages (Fig 5B). Interestingly, levels of naive and stem cell memory CD4+ T cells was positively correlated with infection of plasma cells (Fig 5B and Fig 5C, left panels) with a greater effect on CD20+ plasma cells than CD20- plasma cells, while overall levels of CD45RO+ activated memory T cells were negatively correlated with KSHV infection of plasma cells (Fig 5C, right panel). In addition, although the correlations were too weak to be significant in this data set, nearly every B cell lineage and overall KSHV infection was negatively correlated with the presence of CD4+ T cells expressing a TEMRA phenotype (Fig 5B). Baseline levels of CD8+ T cells had less effect on KSHV infection with only one significant positive correlation observed in our dataset between CD8+ terminal effector cells and KSHV infection of naive B cells (Fig 5B).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7595638</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33075105</oboInOwl:hasDbXref>
        <rdfs:label>KSHV infected B cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000236"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/264e216d-4783-4987-88c5-73fcf8f0e884"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000236"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/2661e63c-5e5c-4a15-9b1c-d51143c84ea1 -->

    <Class rdf:about="http://example.org/2661e63c-5e5c-4a15-9b1c-d51143c84ea1">
        <obo:IAO_0000115>Comparison of the single cell landscape between healthy human meniscus and degenerated meniscus. (A) Representative polarised light microscopy images of healthy human and degenerated meniscus. The white and red colours in the angle images are 90  apart in orientation. Dashed lines indicate the surface of the meniscus. Scale bar, 100 microm. (B) Merged t-distributed stochastic neighbour embedding (t-SNE) of single-cell RNA sequencing of healthy meniscus cells and degenerated meniscus cells. (C) Twelve healthy human and degenerated meniscus cell clusters at t-SNE. (D) Proportion of each cluster to the total cells. (E) Proportion of healthy and degenerated meniscus cells in each cluster. (F) Expression of representative marker genes in Vin plot. (G) Heatmap revealing the scaled expression of differentially expressed genes for each cluster. (H) CD146 and CD318 expression in healthy human meniscus cells and degenerated meniscus cells determined by flow cytometry. n&gt;=5, **p&lt;0.01. (I) Representative IHC staining of COL1A1 and COL2A1 healthy human meniscus and degenerated meniscus, and quantification of positive cells. Scale bar, 50 microm. n&gt;=5, **p&lt;0.01. (J) The expression of indicated marker genes in human healthy meniscus cells and degenerated meniscus cells were detected by qRT-PCR. *p&lt;0.05, **p&lt;0.01, otherwise, not significant. n=3, *p&lt;0.05, **p&lt;0.01. CPC, cartilage progenitor cells; DegP, degenerated meniscus progenitor cells; EC, endothelial cells; FC, fibrochondrocytes; FCP, ##fibrochondrocyte progenitors##; HTC, hypertrophic chondrocytes; MoDC, monocyte-derived dendritic cells; PreHTC, prehypertrophic chondrocytes; ProFC, proliferate fibrochondrocytes; RegC, regulatory chondrocytes.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7034356</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31871141</oboInOwl:hasDbXref>
        <rdfs:label>fibrochondrocyte progenitors</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000138"/>
        <skos:relatedMatch rdf:resource="CL:0011026"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/2661e63c-5e5c-4a15-9b1c-d51143c84ea1"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000138"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/2661e63c-5e5c-4a15-9b1c-d51143c84ea1"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0011026"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/2663715d-b0a2-481c-a64d-481f072a5ef5 -->

    <Class rdf:about="http://example.org/2663715d-b0a2-481c-a64d-481f072a5ef5">
        <obo:IAO_0000115>Ultimately, to show that human MME+ FAPs are also more highly adipogenic than their MME- counterpart, we isolated ##MME+ and MME- FAPs## from human muscle. FAPs were isolated as (MME+ or MME-)CD34+CD31-CD45-CD56-PI- via FACS (Supplementary Fig. 8e) and brought in culture as described before. When reaching 95% confluence, the medium was changed to an adipogenic differentiation medium. In agreement with our mouse data, human MME+ FAPs differentiated much more readily into adipocytes than the MME- FAPs (Fig. 7g, h). Interestingly, the differences in adipogenic potential of human MME+ and MME- FAPs were apparent under full adipogenic stimulation where we found very few MME- FAPs undergoing adipogenic differentiation. Together, these findings show that, in both mice and humans, MME+ FAPs are a highly adipogenic FAP fraction and that MME+ FAPs are reduced under adipogenic conditions.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9883500</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36707617</oboInOwl:hasDbXref>
        <rdfs:label>MME+ and MME- FAPs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0009099"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/2663715d-b0a2-481c-a64d-481f072a5ef5"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0009099"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/27b92f03-6420-4a9e-ba13-db066604afb5 -->

    <Class rdf:about="http://example.org/27b92f03-6420-4a9e-ba13-db066604afb5">
        <obo:IAO_0000115>(A) Example flow cytometry plots for the expression of Cx3cr1GFP and TIM4 on thymic macrophages at different times during embryonic development (E14.5, E17.5), immediately after birth, at 7 days, and 6 weeks of age. (B) Frequencies of Timd4+Cx3cr1- (Timd4 single-positive or Timd4SP), Timd4+Cx3cr1+ (double-positive or DP), and Cx3cr1+Timd4- (Cx3cr1 single-positive or Cx3cr1SP) thymic macrophages at the indicated time points. (C) Kinetics of the changes in different subpopulations of thymic macrophages from E14.5-6 weeks. (D) Frequencies at E15.5 and E19.5 of GFP-labeled cells among TIM4+ or TIM4- cells in Cx3cr1CreER x ROSA26LSL-GFP embryos treated with 4-OHT at E9.5. (E) Scheme of the fate-mapping experiments showing the relationship between Cx3cr1+ and Timd4+ thymic macrophages during embryonic development. E15.5 pregnant ROSA26LSL-GFP mice mated with Cx3cr1CreER males were injected with 4-hydroxytamoxifen (4-OHT) and sacrificed at E19.5. (F) Representative flow cytometry staining for TIM4 and CX3CR1 in fate-mapped GFP+ thymic macrophages at E19.5. The panel to the right is the isotype control for CX3CR1-PE staining. (G) Frequencies of ##TIM4+CX3CR1- cells## among fate-mapped GFP+ macrophages. Data are shown as meanSEM and are from at least two independent experiments for each panel. Each symbol is an individual mouse or embryo.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9754631</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36449334</oboInOwl:hasDbXref>
        <rdfs:label>TIM4+CX3CR1- cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000866"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/27b92f03-6420-4a9e-ba13-db066604afb5"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000866"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/27b975f7-3172-4a14-915a-e6e68d85da14 -->

    <Class rdf:about="http://example.org/27b975f7-3172-4a14-915a-e6e68d85da14">
        <obo:IAO_0000115>Next, we merged the datasets for the five time-points using the merge function of the Seurat pipeline, which combines multiple datasets without transforming the data. The merged dataset with a total of 62,202 cells was processed for clustering and then the data were visualized as a UMAP plot (Fig. 3). The same set of cell clusters identified in individual time-point data was also identified in the merged dataset (Fig. 3A,E and Fig. S6). The downregulation of PAX2 and upregulation of FBXO2 from otic prosensory cells to intermediate otic cells and supporting cells were confirmed with this analysis (Fig. 3E). A DACH1+ SPP1+ population was detected adjacent to ##OC90+ intermediate otic cells## (Fig. 3D, Figs S7 and S8), suggesting the existence of another lineage direction in the otic lineage other than the sensory epithelium. TFAP2B+ surface ectoderm cells, NEUROD1+ neuroblasts and S100B+ neural crest/Schwann cells were identified as distinctive clusters (Fig. 3A,D and Fig. S7). An intermediate population between otic prosensory cells and supporting cells expressed not only otic epithelium markers EPCAM and FBXO2, but also other otic progenitor markers COL9A1, SERPINF1, HES1, AATF, COL14A1, OC90, PRSS8 and EYA4 (Fig. S7), suggesting that this is an otic epithelial cell population differentiating into hair cells and supporting cells. Adjacent to the supporting cell cluster, there was a POU4F3+ hair cell cluster that expressed vestibular hair cell markers [CD164L2, ZBBX, TEKT1, SKOR1, TCTEX1D1 (DYNLT5) and NEUROD6] and type II hair cell markers (ANXA4, MAPT and NHLH1) (Fig. 3D and Fig. S8), indicative of an immature type II hair cell identity. However, we were unable to detect the cochlear marker GATA3 or INSM1 in PCP4+ hair cells (Fig. S8G,H). Surprisingly, we were unable to identify common progenitor populations that differentiate into both hair cells and supporting cells in the merged datasets.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10323240</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37381908</oboInOwl:hasDbXref>
        <rdfs:label>OC90+ intermediate otic cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000048"/>
        <skos:relatedMatch rdf:resource="CL:0000202"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/27b975f7-3172-4a14-915a-e6e68d85da14"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000048"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/27b975f7-3172-4a14-915a-e6e68d85da14"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000202"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/27d436a9-fc48-4366-9742-54eadbd3f27a -->

    <Class rdf:about="http://example.org/27d436a9-fc48-4366-9742-54eadbd3f27a">
        <obo:IAO_0000115>Variable Name Data used   TN Naive T-cells Combination of CD4 naive and memory resting T-cells and ##resting NK cells##   Th Helper T-cells Combination of memory activated CD4 T-cells and follicular helper T-cells   TC Cytotoxic cells Combination of CD8 T-cells and activated NK cells   Tr Regulatory T-cells Regulatory T-cells   DN Naive dendritic cells Naive dendritic cells   D Activated dendritic cells Activated dendritic cells   MN Naive Macrophages Combination of Macrophages M0 and Monocytes   M Macrophages Combination of M1 and M2 Macrophages   C Cancer cells Estimated   N Necrotic cells Estimated   A Cancer Associated Adipocytes Assumed to be twice of the total number of immune cells   H HMGB1 HMGB1 gene expression   IL12 IL-12 IL12A and IL12B gene expressions   IL10 IL-10 IL10, IL10RA and IL10RB gene expressions   IL6 IL-6 IL6, IL6ST and IL6RA gene expressions   </obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8959189</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35294447</oboInOwl:hasDbXref>
        <rdfs:label>resting NK cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000623"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/27d436a9-fc48-4366-9742-54eadbd3f27a"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000623"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/27de2db4-6f0e-4c0c-91f5-b5c94829755a -->

    <Class rdf:about="http://example.org/27de2db4-6f0e-4c0c-91f5-b5c94829755a">
        <obo:IAO_0000115>The quantification of multipotent HSPCs is commonly performed according to the lineage-relationships proposed by the classical model of human hematopoiesis. According to this classical model, HSCs and multipotent progenitors (MPPs) are the only cells containing both myeloid as well as lymphoid differentiation potentials. However, the classical model of hematopoiesis has meanwhile been challenged by several groups proposing alternative lineage-relationships and read-outs for multipotent HSCs/MPPs. In this context, we have shown that human CD133+CD45RA-CD34+ HSPCs are enriched for multipotent HSPCs. In vitro, more than 80% of these cells perform asymmetric cell divisions to create one CD133+CD45RA+CD34+ and one CD133-CD45RA-CD34+ daughter cell. While CD133+CD45RA+CD34+ cells inherit the potential to create all lymphocytes and neutrophils, CD133-CD45RA-CD34+ cells are limited to erythroid, megakaryocytic, basophilic and eosinophilic potentials. The first cell fulfills the criteria of LMPPs and the latter ones correspond to cells that are commonly known as common myeloid progenitors (CMP). As we demonstrated that they are not able to form neutrophils, it is no longer justified to interpret them as CMPs. Accordingly, we re-named them to ##erythro-myeloid progenitors## (EMPs) and proposed a revised model for human hematopoiesis in which neutrophils arise from the same branch as lymphocytes (Fig. 1A). The segregation of lineage potentials as predicted in our revised model was recently confirmed in mouse as well as in human steady state BM hematopoiesis using single cell transcriptomics. According to the proposed model, multipotent HSPCs can easily and objectively be identified as CD133 expressing HSPCs containing erythroid differentiation potentials (Fig. 1A).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6733927</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31501490</oboInOwl:hasDbXref>
        <rdfs:label>erythro-myeloid progenitors</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000038"/>
        <skos:relatedMatch rdf:resource="CL:0000839"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/27de2db4-6f0e-4c0c-91f5-b5c94829755a"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000038"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/27de2db4-6f0e-4c0c-91f5-b5c94829755a"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000839"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/27174286-bfbe-4e21-aed3-30af8d6cdad3 -->

    <Class rdf:about="http://example.org/27174286-bfbe-4e21-aed3-30af8d6cdad3">
        <obo:IAO_0000115>Tumor types Mutant genes The contributed cells for tumors References   Trichofolliculomas/papillomatricomas beta-catenin Krt 14+ cells    Pilomatricomas beta-catenin Lgr5+ cells    Dermatofibromas beta-catenin Lgr6+ cells    Trichoadenomas beta-catenin Lrig1+ cells    No tumor beta-catenin Krt15+ cells    Sebaceous tumors Lef1 Krt14+ cells    Basal cell carcinoma(BCC) Patched IFE cells/bulge stem cells(major contribution)    BCC Smoothened IFE cells    BCC Smoothened (in the context of wound) Krt15+ bulge stem cells    Papillomas KRAS Krt19+, Krt15+ and Involucrin+ cells    Invasive squamous cell carcinoma (SCC) P53 and KRAS --    SCC (DMBA-TPA method) HRAS Long-lived stem cells    Papilloma and SCC HRAS ##Krt5+ cells##    </obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9391238</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35143021</oboInOwl:hasDbXref>
        <rdfs:label>Krt5+ cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000312"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/27174286-bfbe-4e21-aed3-30af8d6cdad3"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000312"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/27675315-3fd7-4021-aae3-14a308ce6a8f -->

    <Class rdf:about="http://example.org/27675315-3fd7-4021-aae3-14a308ce6a8f">
        <obo:IAO_0000115>Expression of UCN3 and CRFR2 in the medial geniculate body (MGB) and the pretectal thalamic transition zones. (A) Sagital view of the brain indicating the level of the schematic coronal section (below) showing the medial geniculate body (MGB) as the region of interest. APT. anterior pretectal nucleus. (B) UCN3-expression in the medial subdivision of the MGB (MGBm), in the posterior intralaminar thalamic nucleus (PIN), and in the pretectal thalamic lamina (PTL). The thin layer of UCN3-positive fibers might occur in the marginal zone of the medial geniculate (white arrows). Calbindin (C) and parvalbumin (D) expression in the MGB were used as counterstain to identify substructures of the MGB. (E) Merge shows parvalbumin (yellow) expression in ventral MGB (MGBv), the suprageniculate thalamic nucleus (SG), and APT. Calbindin is mainly expressed in dorsal MGB (MGBd) and PIN. Neither parvalbumin nor calbindin show strong expression in the ##UCN3-positive neurons## in MGBm and PIN. (F) Few CRFR2-positive neuronal cell bodies are present in the MGBm and the PTL. A network of CRFR2-positive fibers seems to surround the MGB without entering its core. (G-I) VGlutT1 (G) and VGluT2 (H) were used as counterstain.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8633543</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34867212</oboInOwl:hasDbXref>
        <rdfs:label>UCN3-positive neurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000540"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/27675315-3fd7-4021-aae3-14a308ce6a8f"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000540"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/277c8084-1b53-4b8c-9503-96ce0310ae84 -->

    <Class rdf:about="http://example.org/277c8084-1b53-4b8c-9503-96ce0310ae84">
        <obo:IAO_0000115>Ganglioglioma spatial transcriptomics shown for two samples from tumor 1 and tumor 4. A, B Spatial feature plots of final clusters for tumor 1 (A) and tumor 4 (B). Note &apos;U&apos; in the final cluster name is used to denote union of multiple Space Ranger-generated graph-based (kNN) clusters. C GO term enrichment for select tumor 1 clusters. D, E Cell type proportions per spot as determined by cell2location with snRNA-seq as reference for tumor 1 (D) and tumor 4 (E). OPC = oligodendrocyte precursor cell. VLMC = vascular leptomeningeal cell. F Tumor 1 cell2location-calculated neuroectoderm neural precursor cell-like cell abundance per spot. G Analogous to F but for tumor 4. H-J Inverse correlation of ##neuroectoderm neural precursor-like cell## proportion and that of vascular (H), microglial (I), and lymphoid (J) cells, shown for tumor 1 spot cell proportions calculated by cell2location with snRNA-seq clusters as reference. Points and curves are colored according to the cell type whose proportion is being compared to the proportion of neuroectoderm neural precursor-like cells. Curves (outlined in black to enhance visibility) represent non-linear (exponential) least-squares fit for each reference cell type. (K) Overall (left) and cell type-specific (right) expression of neuroectoderm neural precursor celllike cell markers as well as important transcription factors and ligand-receptor pairs based on snRNA/CITE-seq analysis. L Feature plots of log1p (base 2) [RNA] for examples of top spatially-variable features from tumor 1, as determined by mark-variogram method in Seurat</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10039537</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36966348</oboInOwl:hasDbXref>
        <rdfs:label>neuroectoderm neural precursor-like cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000133"/>
        <skos:relatedMatch rdf:resource="CL:0011020"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/277c8084-1b53-4b8c-9503-96ce0310ae84"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000133"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/277c8084-1b53-4b8c-9503-96ce0310ae84"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0011020"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/28a10bf6-6522-4ddd-b41a-7bdaa4d798fb -->

    <Class rdf:about="http://example.org/28a10bf6-6522-4ddd-b41a-7bdaa4d798fb">
        <obo:IAO_0000115>a Line drawing of a cross section of the floor of the cochlear duct at P1. Distinct cell types within the organ of Corti (OC) are color coded. b Heat map for ~14,000 cochlear cells collected from four separate experiments at P1. Top 25 differentially expressed (DE) genes for the 15 identified clusters are shown. Cellular identity for each cluster is indicated by a color bar at the top of the heat map, which corresponds to the legend in a, and by a cell name at the bottom. c tSNE plot for the same cells as in b. Cluster identities are indicated. d Violin plots showing normalized log-transformed expression values for the top five DE genes for each cell type (color coded as in c) by comparison with all other P1 cells (gray on the right in each graph). Bars indicate median expression level. e Upper left panel, tSNE plot of cells determined to be derived from KO (between the OC and medial edge of the cochlear duct). Lower left panel, feature plot for the same cells as in the upper panel indicating high expression of Otoa, Calb1, and Fabp7 (based on color) in different clusters of cells. Lower right panel, cross sections through the cochlear duct at P1, illustrating expression of CALB1 in the medial region of KO and FABP7 directly adjacent to the OC (arrow; scale bars, 20 mum). Lowest panel shows high-magnification view of expression of FABP7 (arrow, gray scale) at the lateral KO border (green line; scale bar, 10 mum). Upper right panel, summary diagram of the spatial distribution of KO cell clusters at P1. HC hair cells, IPhC inner phalangeal cells/border cells, IPC inner pillar cells, OPC outer pillar cells, DC1/2 Deiters&apos; cells rows 1 and 2, DC3, Deiters&apos; cells row 3, HeC Hensen&apos;s cells, CC/OSC Claudius cells/outer sulcus cells, IdC interdental cells, ISC inner sulcus cells, KO Kolliker&apos;s organ cells, L.KO ##lateral Kolliker&apos;s organ cells##, M.KO medial Kolliker&apos;s organ cells, OC90 OC90+ cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7221106</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32404924</oboInOwl:hasDbXref>
        <rdfs:label>lateral Kolliker&apos;s organ cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002490"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/28a10bf6-6522-4ddd-b41a-7bdaa4d798fb"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002490"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/280d8763-ff2a-46c6-aad8-53c1305a0efc -->

    <Class rdf:about="http://example.org/280d8763-ff2a-46c6-aad8-53c1305a0efc">
        <obo:IAO_0000115>Within the 1397 B-cells, we obtained 4 separate clusters (Fig. 6j; Supplementary information, Fig. S6k). Follicular B-cells were composed of &apos;mature-naive&apos; (CD27-) and &apos;memory&apos; (CD27+) B-cells. The former were characterized by a unique CD27-/IGHD+(IgD)/IGHM+(IgM) signature and give rise to the latter by migrating through the germinal center to form CD27+/IGHD-(IgD)/IGHM-(IgM) memory B-cells (Fig. 6k, l). Memory B-cells then further differentiate into antibody-secreting plasma cells (IGHA1, IGHG1, JCHAIN), which themselves can be further classified into short-lived and long-lived plasma cells. We failed to identify long-lived plasma cells (as these are non-proliferating cells residing in bone marrow and spleen, but were able to divide short-lived plasma cells into two subclusters. A first subcluster of &apos;active&apos; plasma cells expressed high levels of PRDM1(Blimp-1) and XBP1, indicating high antibody-secretion capacity, while a second cluster referred to as ##&apos;terminal&apos; plasma cells## was enriched for CCL2 and CCL5, but also characterized by reduced G2M and S cell cycle scores and increased expression of mitochondrial genes, indicating ongoing stress (Fig. 6m). Notably, the latter population was characterized by increased BCR clonality and reduced BCR evenness (Fig. 6n). Compared to non-COVID-19, mature-naive B-cells and active plasma cells were increased in COVID-19, while terminal plasma cells were reduced in COVID-19, albeit non-significantly (Fig. 6o). Although these effects were mainly driven by critical COVID-19 vs non-COVID-19 (Supplementary information, Fig. S6l), there were no significant differences between mild vs critical COVID-19 (Fig. 6p). Overall, this suggests terminal plasma cells in COVID-19 are characterized by sub-optimal differentiation or activation, which may cause defective or counter-productive (possibly low-quality) antibody responses in COVID-19.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8027624</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33473155</oboInOwl:hasDbXref>
        <rdfs:label>&apos;terminal&apos; plasma cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000975"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/280d8763-ff2a-46c6-aad8-53c1305a0efc"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000975"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/281465f7-fd15-4f23-b900-948e0345200b -->

    <Class rdf:about="http://example.org/281465f7-fd15-4f23-b900-948e0345200b">
        <obo:IAO_0000115>GOALS: The aim of this study was to investigate the role of dietary factors, distinct small-bowel mucosal immune cell types, and epithelial integrity in the perpetuation of gastrointestinal symptoms in treated celiac disease patients. BACKGROUND: For unexplained reasons, many celiac disease patients suffer from persistent symptoms, despite a strict gluten-free diet (GFD) and recovered intestinal mucosa. STUDY: We compared clinical and serological data and mucosal recovery in 22 asymptomatic and 25 symptomatic celiac patients on a long-term GFD. The density of ##CD3 and gammadelta intraepithelial lymphocytes## (IELs), CD25 and FOXP3 regulatory T cells, and CD117 mast cells, and the expression of tight junction proteins claudin-3 and occludin, heat shock protein 60, interleukin 15, and Toll-like receptor 2 and 4 were evaluated in duodenal biopsies. RESULTS: All subjects kept a strict GFD and had negative celiac autoantibodies and recovered mucosal morphology. The asymptomatic patients had higher mean fiber intake (20.2 vs. 15.2 g/d, P=0.028) and density of CD3 IELs (59.3 vs. 45.0 cell/mm, P=0.045) than those with persistent symptoms. There was a similar but nonsignificant trend in gammadelta IELs (17.9 vs. 13.5, P=0.149). There were no differences between the groups in other parameters measured. CONCLUSIONS: Low fiber intake may predispose patients to persistent symptoms in celiac disease. There were no differences between the groups in the markers of innate immunity, epithelial stress or epithelial integrity. A higher number of IELs in asymptomatic subjects may indicate that the association between symptoms and mucosal inflammation is more complicated than previously thought.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMID:29505551</oboInOwl:hasDbXref>
        <rdfs:label>CD3 and gammadelta intraepithelial lymphocytes</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000801"/>
        <skos:relatedMatch rdf:resource="CL:0002496"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/281465f7-fd15-4f23-b900-948e0345200b"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000801"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/281465f7-fd15-4f23-b900-948e0345200b"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002496"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/287545eb-f615-4849-94c1-370c0bfe521d -->

    <Class rdf:about="http://example.org/287545eb-f615-4849-94c1-370c0bfe521d">
        <obo:IAO_0000115>The Table shows the numerical representations of Excitatory Neurons (Deep and Superficial Pyramidal cells) and Inhibitory neurons (Oriens Lacunosum moleculare cells:OLM; Trilaminar cells:Tri, ##Backprojection cells##:BP, cholecystokinin positive Basket cells:CCKBC, Parvalbumin positive cells:PVBC, AxoAxonic Cells:AA, Ivy Cells:IVY, Bistratified cells:BS, Schaffer Collateral associated cells:SCA, Perforant Pathway Associated cell:PPA, Neurogliaform:NG) subdivided on the basis of the placement classes (SO, SP, SR, SLM).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9381785</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35974119</oboInOwl:hasDbXref>
        <rdfs:label>Backprojection cells</rdfs:label>
    </Class>
    


    <!-- http://example.org/29fdb76d-434a-422b-915e-df2d22cf7b71 -->

    <Class rdf:about="http://example.org/29fdb76d-434a-422b-915e-df2d22cf7b71">
        <obo:IAO_0000115>Based on the observations described above, we chose Day 3 as the most appropriate time to define the state of cell differentiation as ##primitive streak mesoderm (PSM) cells##, and we therefore used cells at Day 3 for the next step. To confirm the exclusive mesodermal differentiation and homogeneity of the PSM population, the cells were tested for surface markers expression associated with mesoderm (CXCR4) and endoderm (Sox17). The flow cytometry clearly shows that the PSM cells are homogenic in their mesodermal profile and no off-target differentiation to endoderm was detected (Fig. 1E).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6831475</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31695783</oboInOwl:hasDbXref>
        <rdfs:label>primitive streak mesoderm (PSM) cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0011007"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/29fdb76d-434a-422b-915e-df2d22cf7b71"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0011007"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/2900b8de-c154-4e90-99db-8845ab40c5a6 -->

    <Class rdf:about="http://example.org/2900b8de-c154-4e90-99db-8845ab40c5a6">
        <obo:IAO_0000115>SHP2 incites myometrium contraction by regulating PGF2alpha production in epithlium to participate smooth muscle contraction via justacrine. LE Luminal epithelial cells, ##Str##1 stromal cells 1, Str2 stromal cells 2, Dec decidual cells, NK natural killer cells, Mac macrophage cells, Muscle muscle cells, Gland glandular epithelial cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10646072</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37963860</oboInOwl:hasDbXref>
        <rdfs:label>Str</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000499"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/2900b8de-c154-4e90-99db-8845ab40c5a6"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000499"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/291fd88e-e0cb-4e70-8ff8-60941054b26f -->

    <Class rdf:about="http://example.org/291fd88e-e0cb-4e70-8ff8-60941054b26f">
        <obo:IAO_0000115>A, B, tSNE plot of 4659 CD45+ immune cells from the CNS. Data from this study is integrated with data from; Table 6). C, D, Each dataset represented by one tSNE. Cells are annotated using color representing their cell type. bMicroglia: baseline microglia; aMicroglia: activated microglia; pmMicroglia: proliferation-mediating microglia; maMicroglia: monocyte-activating microglia; DAM: disease-associated microglia in SCI; elMicroglia: embryonic-like microglia; pvMacrophages: perivascular macrophages; mdMacrophages: monocyte-derived macrophages; DCs: dendritic cells; imB-cells: immature B-cells; mB-cells: mature B-cells; pimMicroglia: postnatal immature microglia; IEG+Microglia: immediate early genes microglia; sMicroglia: s-phase microglia; pPAM: postnatal proliferative-region-associated microglia; eMicroglia: embryonic microglia; pcpMacrophages: ##postnatal choroid plexus macrophages##; acpMacrophages: adult choroid plexus macrophages; iMonocytes: inflammatory monocytes; pMonocytes: patrolling monocytes; cpEpithelial cells: choroid plexus epithelial cells. E, tSNE plots of 4659 CD45+ immune cells for selected genes indicating the log2(cpm) expression with a continuous color for each cell separately. F, Proliferation rate of CD45low and CD45high cells at 7 and 21 d post-SCI. Hoechst 33342 expression presented on a log-scale was used for defining cells in S-phase. Right most plot reports the percentage of cells in S-phase. Each dot represents one biological replicate (four mice per time point). Mean is surrounded by a 95% CI. This figure is extended in Extended Data Figure 8-1.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8496189</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34417326</oboInOwl:hasDbXref>
        <rdfs:label>postnatal choroid plexus macrophages</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000880"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/291fd88e-e0cb-4e70-8ff8-60941054b26f"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000880"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/2932b658-e862-46b6-847e-3773c6c746de -->

    <Class rdf:about="http://example.org/2932b658-e862-46b6-847e-3773c6c746de">
        <obo:IAO_0000115>The adipose-derived hormone leptin acts via its receptor (LepRb) in the brain to control energy balance. A potentially unidentified population of GABAergic hypothalamic LepRb neurons plays key roles in the restraint of food intake and body weight by leptin. To identify markers for candidate populations of LepRb neurons in an unbiased manner, we performed single-nucleus RNA-Seq of enriched mouse hypothalamic LepRb cells, identifying several previously unrecognized populations of ##hypothalamic LepRb neurons##. Many of these populations displayed strong conservation across species, including GABAergic Glp1r-expressing LepRb (LepRbGlp1r) neurons, which expressed more Lepr than other LepRb cell populations. Ablating Lepr from LepRbGlp1r cells provoked hyperphagic obesity without impairing energy expenditure. Similarly, improvements in energy balance caused by Lepr reactivation in GABA neurons of otherwise Lepr-null mice required Lepr expression in GABAergic Glp1r-expressing neurons. Furthermore, restoration of Glp1r expression in LepRbGlp1r neurons in otherwise Glp1r-null mice enabled food intake suppression by the GLP1R agonist, liraglutide. Thus, the conserved GABAergic LepRbGlp1r neuron population plays crucial roles in the suppression of food intake by leptin and GLP1R agonists.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10541203</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37581939</oboInOwl:hasDbXref>
        <rdfs:label>hypothalamic LepRb neurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:4042033"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/2932b658-e862-46b6-847e-3773c6c746de"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4042033"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/294b1655-3f35-4680-b6fa-84a6a51e593c -->

    <Class rdf:about="http://example.org/294b1655-3f35-4680-b6fa-84a6a51e593c">
        <obo:IAO_0000115>Here, we analyzed the capacity of MSCs from the bone marrow (BM) of healthy donors (BM-MSCs) to transfer mitochondria to primary CD4+CCR6+CD45RO+ T helper 17 (Th17) cells by confocal microscopy and fluorescent-activated cell sorting (FACS). We then evaluated the Th17 cell inflammatory phenotype and bioenergetics at 4 h and 24 h of co-culture with BM-MSCs. We found that Th17 cells can take up mitochondria from BM-MSCs already after 4 h of co-culture. Moreover, IL-17 production by Th17 cells co-cultured with BM-MSCs was significantly impaired in a contact-dependent manner. This inhibition was associated with oxygen consumption increase by Th17 cells and interconversion into T regulatory cells. Finally, by co-culturing human synovial MSCs (sMSCs) from patients with rheumatoid arthritis (RA) with Th17 cells, we found that compared with healthy BM-MSCs, mitochondrial transfer to Th17 cells was impaired in ##RA-sMSCs##. Moreover, artificial mitochondrial transfer also significantly reduced IL-17 production by Th17 cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6676586</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31370879</oboInOwl:hasDbXref>
        <rdfs:label>RA-sMSCs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000134"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/294b1655-3f35-4680-b6fa-84a6a51e593c"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000134"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/29586b75-5029-4aac-9fc0-e3555bfeb132 -->

    <Class rdf:about="http://example.org/29586b75-5029-4aac-9fc0-e3555bfeb132">
        <obo:IAO_0000115>Currently, there are no definitive histological criteria for diagnosing malignancy in atypical AME because of the rarity of the disease. The malignant tumor cells described in the literature were usually characterized by an invasive growth pattern, marked cytological atypia, the proliferation of ##atypical spindle-shaped myoepithelial cells##, and an increased number of mitotic figures (&gt;5/10 per high-power field). The cytological features described in malignant cases included nuclear enlargement; prominent nucleoli; and open, clumped chromatin in either the ductal epithelial or myoepithelial cells or both.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7572011</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33080708</oboInOwl:hasDbXref>
        <rdfs:label>atypical spindle-shaped myoepithelial cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000185"/>
        <skos:relatedMatch rdf:resource="CL:0001061"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/29586b75-5029-4aac-9fc0-e3555bfeb132"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000185"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/29586b75-5029-4aac-9fc0-e3555bfeb132"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0001061"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/2965cffe-5753-41af-8441-9412821cd988 -->

    <Class rdf:about="http://example.org/2965cffe-5753-41af-8441-9412821cd988">
        <obo:IAO_0000115>Proverbially, the tumor microenvironment (TME) influences the development and recurrence of tumors, and immune cells in TME have been found to either promote or prevent tumor growth. Moreover, immune infiltration, a key element of the TME, has been shown to impact tumor development and response to therapy. Using the TIMER2.0 and CAMOIP databases, we observed a robust correlation between PFKFB4 expression and the levels of infiltration of various immune cells, including CD8+ T cells, CD4+ T cells, regulatory T cells (Tregs), macrophages, neutrophils, dendritic cells, ##activated mast cells##, and resting NK cells. This suggests that PFKFB4 may also be a marker for immune status and provide information for immunotherapies.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10539362</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37770581</oboInOwl:hasDbXref>
        <rdfs:label>activated mast cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000097"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/2965cffe-5753-41af-8441-9412821cd988"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000097"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/2980a5df-670a-4dae-8a0b-e1d522f56880 -->

    <Class rdf:about="http://example.org/2980a5df-670a-4dae-8a0b-e1d522f56880">
        <obo:IAO_0000115>To investigate the developmental origin of the CD34+PRLR+ cells, freshly isolated CD34+ HSCs were sorted into MLP, CMP, GMP and NK/BP (Fig. 2A), and cultured as described above. PRLR-expressing cells were mainly generated from the GMP compartment (Fig. 2B-D). At day 4 of culture, FACS sorted ##PRLR+ progenitors## lacked all lineage markers except for CD15 and CD43, further supporting their myeloid origin (Fig. 2E). Evaluation of these cells at later time points (day + 14) showed that they remain CD15+, and acquired CD11a, CD11b, CD11c, CD16, CD18, CD45RO and CD123 (Fig. 2F). To study their differentiation, we sorted CD34+PRLR+ cells from four-day expanded CD34+ HSCs (as shown in Fig. 1A). As above, in the presence of ILC promoting cytokines (IL-3, IL-7, IL-15, IL-23, SCF and FLT3L) the CD34+PRLR+ progenitors differentiate into immature myeloid cells (Fig. 3A-C). Addition of GM-CSF at later times (day + 21) resulted in the generation of mature granulocytes expressing CD15, CD16 and CD66b (Fig. 3A-C). Previously, we showed that some myeloid progenitors could give rise to CD56+ lymphocytes. However, sorted CD34+PRLR-, but not CD34+PRLR+ cells gave rise to CD56+ lymphocytes (Fig. 4A-C). Moreover, the CD34+PRLR+ progenitors do not express integrin alpha4beta7, a marker that defines innate lymphoid precursors with the potential to develop into ILCs (Fig. 4C). In further support of these findings, the CD34+PRLR+ progenitors do not differentiate into CD94+, CD127+ and CD336+ lymphocytes (Fig. 4D). Collectively, these findings show that CD34+PRLR+ progenitors develop from the GMPs under the influence of SCF and FLT3L, thereby acquire various myeloid markers and seem to lack lymphoid potential.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7156717</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32286456</oboInOwl:hasDbXref>
        <rdfs:label>PRLR+ progenitors</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0001059"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/2980a5df-670a-4dae-8a0b-e1d522f56880"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0001059"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/299754fb-3ec4-4629-a06e-10e602aa163b -->

    <Class rdf:about="http://example.org/299754fb-3ec4-4629-a06e-10e602aa163b">
        <obo:IAO_0000115>The gene signature and signaling pathways of these three AEC2 subsets indicated that AEC2s in subset ##AEC2##-1 were intact, homeostatic AEC2s, while subset AEC2-2 and subset AEC2-3 were injured AEC2s.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10292844</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37314162</oboInOwl:hasDbXref>
        <rdfs:label>AEC2</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002063"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/299754fb-3ec4-4629-a06e-10e602aa163b"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002063"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/3a436355-244f-4ca4-80a1-69ca09f8f93d -->

    <Class rdf:about="http://example.org/3a436355-244f-4ca4-80a1-69ca09f8f93d">
        <obo:IAO_0000115>We next assessed if iETV2-ECs could also be used to vascularize cerebral organoids (CO), and if presence of ECs would affect the localization of the different neural compartments. We thus generated PSC-derived COs and vascularized COs (eCOs; by allowing organoid formation from a mix of iETV2 and wild type PSCs; PSC:iETV2-hiPSC ratio = 8:2). To generate iETV2-ECs in situ, we activated the ETV2 transgene by addition on day 4 and 7, respectively, low and high concentrations of doxycycline for basal and full transgene activation (Figure  5A). Immunostaining of DIV35 eCO revealed CD31+ vascular structures and relatively smaller and scattered ventricular zones (VZ) (Figure 5B(ii)) in which the radial organization of SOX2+ cells (but not TUJ1+ cells) was less apparent than that of CO not containing ECs (Figure 5B(i)). We also embedded CO and eCO in matrigel alone or in iETV2-ECs laden matrigel. In matrigel alone, we observed VZ-like structures in the CO, however the SOX2+ cells were mostly found outside the VZ (indicated by asterisk; Figure 5B(iii)). In eCO, the radial organization of SOX2+ in VZ was more disrupted (Figure 5B(iv)), whereby the SOX2+ and TUJ1+ cells appeared to spread into the matrigel, and ##CD31+ cells## were found mainly at the periphery. In iETV2-EC</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10837345</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38037510</oboInOwl:hasDbXref>
        <rdfs:label>CD31+ cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000115"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/3a436355-244f-4ca4-80a1-69ca09f8f93d"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000115"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/3a541ed9-2781-48d3-977b-45489374b9ad -->

    <Class rdf:about="http://example.org/3a541ed9-2781-48d3-977b-45489374b9ad">
        <obo:IAO_0000115>a Due to single-cell annotation and in situ validation (Fig. 2; Supplementary Fig. 3), a draft model of the oral-to-tooth transition zone in humans is presented, with basal and suprabasal keratinocyte markers uniquely identifying the alveolar mucosa (AM), attached gingiva (AG), gingival margin (GM), sulcular epithelium (SK) and junctional epithelium (JK). b These markers allowed for KRT19-high keratinocyte (KC) cell subclustering for the first time (2504 cells in total), including gingival margin keratinocytes (GM), sulcular keratinocytes (SK), and junctional keratinocytes (JK). c A more granular draft (Tier 4) annotation of epithelial cells of the gingival attachment. d Assaying differentially expressed genes in periodontitis, SKs and JKs only share about a quarter of upregulated genes. JKs displayed nearly 125 unique upregulated genes in diseased cells. e Further analysis of basal and suprabasal (differentiating) SK and JK keratinocytes revealed unique cell signatures between ##basal and suprabasal cell## types. This full list is included in Supplementary Data 1. f-i To understand SK and JK developmental progression and cell state alterations, we used partitioned-based graph abstraction (PAGA). f Examining the basal to suprabasal transition, JKs display altered gene expressed comparing health to disease cell types, including broader expression of KRT17 and more expression of JUND, COL17A1, and CDH3. Key differentiation genes such as SPRR family members were also downregulated. g JKs displayed robust cell signaling and inflammatory phenotypes, which appear exacerbated in disease states. h In SKs, differentiation-related genes were uniquely expressed compared to JKs in health but also appeared altered in disease along the basal to suprabasal trajectory. i SKs appeared generally less reactive compared to JKs in disease, with lower overall expression of effector molecules such as CXCL1, CXCL8, IL1A, IL1B, and IL1RN. Abbreviations: Merk Merkel Cells, LC langerhans cells, Mela melanocytes, Muc mucosa, SB suprabasal Keratinocytes; for others, see Fig. 1 legend. For this figure, n = 30-sample, 2504-cell for scRNAseq.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11178863</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38876998</oboInOwl:hasDbXref>
        <rdfs:label>basal and suprabasal cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002170"/>
        <skos:relatedMatch rdf:resource="CL:0002187"/>
        <skos:relatedMatch rdf:resource="CL:4033013"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/3a541ed9-2781-48d3-977b-45489374b9ad"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002170"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/3a541ed9-2781-48d3-977b-45489374b9ad"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002187"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/3a541ed9-2781-48d3-977b-45489374b9ad"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4033013"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/3a58b9f4-ef86-4068-b6df-5cdbe4d1d5e1 -->

    <Class rdf:about="http://example.org/3a58b9f4-ef86-4068-b6df-5cdbe4d1d5e1">
        <obo:IAO_0000115>a Schematic of study design. Diagrams depict the brain region of interest, Brodmann area 9, corresponding to the dlPFC. b UMAP plot colored by the broad cell types. c UMAP plot colored by the individual clusters identified and annotated. For UMAP plots, the x and y-axes represent the first and second UMAP co-ordinates respectively. d DotPlot depicting the expression of marker genes (SNAP25 - neurons, SLC17A7 - excitatory neurons, GAD1 - inhibitory neurons, ALDH1L1 - astrocytes, PDGFRA - oligodendrocyte precursor cells, PLP1 - oligodendrocytes, CLDN5 - endothelial cells, CX3CR1 - microglia). The dendrogram next to the cluster names shows the relationship between the clusters by using the distance based on average expression of highly variable genes. e Best hits heatmap from MetaNeighbor showing the correspondence between the clusters in our dataset (columns) and the broad categories of cells identified in the Allen Brain Institute human motor cortex snRNA-seq dataset (rows). f Boxplots showing the proportion of nuclei in each cluster for each subject split by cases and controls for the broad OPC, astrocyte, and ##excitatory neuron cell## types and the Ast1, Ast2, OPC1, and OPC2 clusters (n = 37 cases, 34 controls, representing biologically independent samples for each cluster or broad cell type). The middle line is the median. The lower and upper hinges correspond to the 25th and 75th percentiles. Upper and lower whiskers extend from the upper or lower hinges to the largest or smallest value no further than 1.5 times the inter-quartile range from the hinge, where the inter-quartile range is the distance between the first and third quartiles. Points beyond the end of the whiskers are plotted individually. In Fig. 1c-e, excitatory neuronal cluster names contain approximate layer annotations and inhibitory neuronal cluster names contain MGE or CGE specific marker information as a suffix where applicable, as described in methods: Cluster annotation. For example, ExN10_L46 denotes a cluster of excitatory neurons with enrichment of marker genes from layer 4 to layer 6 of the cortex and InN1_PV denotes a cluster on inhibitory neurons with enrichment of the MGE specific marker PV. This convention is used throughout the paper. Brain diagram in 1a was created with BioRender.com. Source data are provided as a Source Data file.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10203145</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37217515</oboInOwl:hasDbXref>
        <rdfs:label>excitatory neuron cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000540"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/3a58b9f4-ef86-4068-b6df-5cdbe4d1d5e1"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000540"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/3a594078-7422-405f-bd39-cea559a3326a -->

    <Class rdf:about="http://example.org/3a594078-7422-405f-bd39-cea559a3326a">
        <obo:IAO_0000115>In order to understand the gene expression profile characteristics of invasive cSCC, we identified and analyzed gene function enrichment of significantly up-regulated DEGs in important cell subpopulations of cSCC compared to normal skin tissues. 778, 1044, 1159, and 760 significantly up-regulated DEGs were identified among ##Basal1, Basal2, Pro KCs, and Follicular2 cell## subpopulations, respectively (Supplementary file 1j-m, Wilcoxon test, p_val_adj &lt;0.05). GO analysis was mainly concentrated in various tumor-related biological processes such as cell morphological change and adhesion, signaling pathway regulation, apoptosis and angiogenesis, as well as processes related to immunity including antigen processing and presentation, myeloid cell differentiation, and negative regulation of immune response, etc. (Figure 5:figure supplement 3A). There were 888 and 247 significantly up-regulated DEGs in Spinous1 and Spinous2 cell subpopulations, respectively (Supplementary file 1n, o, Wilcoxon test, p_val_adj &lt;0.05). In addition to the biological process similar to basal cells, GO enrichment analysis showed that DEGs were mainly enriched in the regulation of programmed death, ATP metabolism, and the production of type I interferon (Figure 5:figure supplement 3A). Based on above differential gene expression and functional enrichment analysis, we identified a group of important candidate genes that may be closely related to tumor genesis and development in cSCC including CD74, CDKN2A, COL17A1, JUND, MMP1, BST2, LGALS1, IFITM3, ISG15, IFI6, FTH1, LAMA3, LAMC2, SAT1, and so on (Figure 5:figure supplement 3B).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10783873</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38099574</oboInOwl:hasDbXref>
        <rdfs:label>Basal1, Basal2, Pro KCs, and Follicular2 cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000646"/>
        <skos:relatedMatch rdf:resource="CL:0002337"/>
        <skos:relatedMatch rdf:resource="CL:0002559"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/3a594078-7422-405f-bd39-cea559a3326a"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000646"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/3a594078-7422-405f-bd39-cea559a3326a"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002337"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/3a594078-7422-405f-bd39-cea559a3326a"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002559"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/3a6fa4bc-f9f9-44d7-9882-04b078837028 -->

    <Class rdf:about="http://example.org/3a6fa4bc-f9f9-44d7-9882-04b078837028">
        <obo:IAO_0000115>The GEO database (GSE138709) was employed to examine the fluctuation of MAL2 mRNA expression in ICC. From the UMAP plot and heatmap, distinct gene markers helped classify GSE138709 findings into eight cell clusters, namely, cholangiocytes, fibroblast, hepatocyte, TNK, endothelial, MonoMac, B lymphocytes, and dendritic cells (DC), as showcased in Fig. 1A-C and Fig. S1A. A specific expression of CD79A was found in the B cluster, as depicted in Fig. 1B, C and Fig. S1A. Interestingly, cholangiocytes and fibroblasts exhibited more robust expression in tumor tissues than in regular tissues. Conversely, tumor tissues displayed a decrease in the abundance of hepatocytes, TNK, B cells, and DCs when compared to normal tissue samples, as seen in Fig. 1E and Fig. S1B. To our surprise, MAL2 was found to be significantly abundant in cholangiocytes (Fig. 1D and Fig. S1C). The expression levels of MAL2 were more prevalent in tumor tissues than in normal ones (Fig. 1F). Chromosome copy number variation (CNV) of different cells in ICC tissue was analyzed based on CopyKAT, a computational tool. We found that non-immune cells such as endothelial cells were normal diploid, and classified cholangiocytes in ICC into normal cholangiocytes and malignant cholangiocytes based on whether or not there was a change in CNV (Fig. 1G, H). Malignant cholangiocytes were almost distributed in ICC, and MAL2 was expressed mainly in malignant cholangiocytes in ICC (Fig. 1I-K). These revelations point toward the crucial role MAL2 might play in ##ICC cancer cells##.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11169275</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38866777</oboInOwl:hasDbXref>
        <rdfs:label>ICC cancer cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:1000488"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/3a6fa4bc-f9f9-44d7-9882-04b078837028"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:1000488"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/3a9c94f6-7513-46aa-ab53-972b05df5606 -->

    <Class rdf:about="http://example.org/3a9c94f6-7513-46aa-ab53-972b05df5606">
        <obo:IAO_0000115>The human spleen is considered immunologically immature at below 2 years; although sMZ B cells are principally detectable, they have been described as antigen naive B cells (NBCs) based on the lack of CD27 expression. Previous studies on human sMZ B-cell development suggest that unique diversification mechanisms and distinct ##sMZ B-cell precursors## exist in infants. Our own data support that infant B-cell subsets differ substantially in their gene expression profiles from adult B cells: human ontogenetically early B cells provide accelerated but transient immune responses and are IGHV gene-unmutated. Throughout life, the accumulation, homeostatic expansion, and recirculation of IGHV gene-mutated B cells shape the sMZ B-cell pool. Notably, homing of memory B cells (MBCs) to the sMZ enhances at approximately 2 years and reaches an adult level at approximately 5 years of age, which coincides with efficient protection from infections with encapsulated bacteria. In older individuals, the aged immune system is compromised on multiple levels, including a significantly reduced IGHV gene repertoire, where large B-cell clones outcompete the smaller ones. We assume that a protective sMZ compartment is affected by age-related changes in the composition of the sMZ B-cell pool, as indicated by, e.g., the abundance of large, class-switched MBC clones in old age.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8828478</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35154145</oboInOwl:hasDbXref>
        <rdfs:label>sMZ B-cell precursors</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000845"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/3a9c94f6-7513-46aa-ab53-972b05df5606"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000845"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/3abb3f94-aa71-459d-ade3-039c282db8af -->

    <Class rdf:about="http://example.org/3abb3f94-aa71-459d-ade3-039c282db8af">
        <obo:IAO_0000115>(A) The percentages of indicated cells among the peripheral blood mononuclear cells of the indicated mice at 12-14 months of age. TWT, n = 12; IL-6 KO, n = 8; DKO, n = 10; TKO, n = 10. Gran, granulocytes, Ly6G+CD11b+; MO, monocytes, Ly6C+CD11b+; B, B cells, B220+; T, T cells, CD3e+. (B) Flow cytometry plots illustrating the gating strategy for MDSCs in cells from A. ##gMDSC##, granulocytic MDSC. (C) Quantification of MDSC populations in B. (D) Flow cytometric analyses of the expression levels of c-Kit among the indicated cell populations from C in the indicated mice. (E) Absolute numbers of cells in the indicated lineages were quantified in the bone marrow and spleens from the indicated mice in A. (F) Cell size of indicated MDSCs in E was measured by flow cytometric forward scatter (FSC-A) and normalized to cells from the TWT group. (G) Absolute number of erythroid cells in various developmental stages (I-VI) from the bone marrow and spleens of the indicated mice in C. The stages were determined by the cell surface expression levels of CD44. Stage I, proerythroblast; stage II, basophilic erythroblast; stage III, polychromatic erythroblast; stage IV, orthochromatic erythroblast; stage V, reticulocyte; stage VI, mature erythrocyte. Data are presented as mean +- SEM. *P &lt; 0.05, **P &lt; 0.01, ***P &lt; 0.001, ****P &lt; 0.0001; 2-way ANOVA.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9435651</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35900794</oboInOwl:hasDbXref>
        <rdfs:label>gMDSC</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000094"/>
        <skos:relatedMatch rdf:resource="CL:0000889"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/3abb3f94-aa71-459d-ade3-039c282db8af"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000094"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/3abb3f94-aa71-459d-ade3-039c282db8af"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000889"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/3ad7506c-6126-4537-9da6-ad47f620f743 -->

    <Class rdf:about="http://example.org/3ad7506c-6126-4537-9da6-ad47f620f743">
        <obo:IAO_0000115>Besides the importance of IFN-I in SjS, the calcium and Wnt pathways were identified as important regulatory molecules in the ##salivary gland epithelial cells## (SGECs) in the course of SjS progression. Cell-specific epigenome-wide analysis showed that genes involved in these pathways are enriched for hypomethylation and hypermethylation at differentially methylated CpG sites (DMCs). The alteration in the DNA methylation of critical pathways provides a theoretical basis for a therapeutic target in SjS ( Table 2 ).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10950951</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38510251</oboInOwl:hasDbXref>
        <rdfs:label>salivary gland epithelial cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000066"/>
        <skos:relatedMatch rdf:resource="CL:0009005"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/3ad7506c-6126-4537-9da6-ad47f620f743"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000066"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/3ad7506c-6126-4537-9da6-ad47f620f743"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0009005"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/3ad80c7f-bbe4-4680-aff6-43907986b093 -->

    <Class rdf:about="http://example.org/3ad80c7f-bbe4-4680-aff6-43907986b093">
        <obo:IAO_0000115>Our data showed that the induction of IL-10 production in macrophages reported in IV and IP MSC treatment is also relevant in SC MSC treatment. When administered directly into the inflamed tissue, SC MSC injection induced immunoregulatory macrophages in the local LN draining the inflamed tissue. Interestingly, an expansion in IL-10-producing macrophages was observed only in the ##MerTK+ SSM and TZM## populations, and not in the F4/80+ macrophage populations (MSM and MCM). This could be due to the F4/80+ macrophages residing deeper within the LN and are therefore less accessible. MerTK is an efferocytic receptor, and MerTK+ TZMs have been reported to have a role in clearing apoptotic cells and maintaining immune homeostasis and tolerance. In addition, studies have demonstrated a role for MerTK signalling in attenuating inflammation. The inhibitory role of MerTK signalling pathway has been previously reported in an LPS-induced lung inflammation model. Whether the selective expansion of IL-10-producing MerTK+ macrophages is associated with activation of MerTK-related immunomodulatory pathway should be investigated further.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11572146</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:39551813</oboInOwl:hasDbXref>
        <rdfs:label>MerTK+ SSM and TZM</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
        <skos:relatedMatch rdf:resource="CL:0009047"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/3ad80c7f-bbe4-4680-aff6-43907986b093"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/3ad80c7f-bbe4-4680-aff6-43907986b093"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0009047"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/3adb4158-e9d5-4c70-9143-13ec007b9afb -->

    <Class rdf:about="http://example.org/3adb4158-e9d5-4c70-9143-13ec007b9afb">
        <obo:IAO_0000115>Finally, we sought to understand whether the unique noncoding signature acquired by different cell types is established during early stages of cell development, and if so, how dynamic it is with respect to cellular transcriptome. To address this question, we referred to an in vitro model of early lineage commitment: the differentiation of pluripotent stem cells into embryoid bodies (EBs). The role of ncRNA in maintaining stem cell pluripotency and lineage commitment has been demonstrated previously through bulk experiments. Thus, we hypothesized that applying Smart-seq-total to single cells at different stages of EB formation would allow us to identify coexpressed coding and noncoding transcripts within emerging lineages. As such, we analyzed the RNAome of ##primed pluripotent stem cells## and that of individual cells obtained from dissociated EB at days 4, 8, and 12 of culture (~200 cells per each time point, 913 cells in total) (Fig. 3A). Consistent with previous studies, the number of coding genes expressed by pluripotent stem cells was also higher compared to differentiated progenitors (SI Appendix, Fig. S16A). This was also the case for several ncRNA types, such as lncRNA, miRNA, and scaRNA (SI Appendix, Fig. S16B). Specifically, we observed that the levels of certain snoRNAs (such as Snord17, Snora23, and Snord87), scaRNAs (such as Scarna13 and Scarna6), lncRNAs (Platr3, Lncenc1, Snhg9, Gm31659, and so forth), and miRNAs (Mir92-2, Mir302b, and Mir19b-2) go down (log2FC &gt; 1, adjusted P &lt; 0.01) after cells exit pluripotency (Fig. 3B). In contrast, we also identified that the levels of several lncRNAs (Tug1, Meg3, Lockd) and miRNAs (Mir298, Mir351, Mir370) increase with differentiation (Fig. 3B).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8713755</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34911763</oboInOwl:hasDbXref>
        <rdfs:label>primed pluripotent stem cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002248"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/3adb4158-e9d5-4c70-9143-13ec007b9afb"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002248"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/3afed480-a419-41e2-b49f-ceffae190d46 -->

    <Class rdf:about="http://example.org/3afed480-a419-41e2-b49f-ceffae190d46">
        <obo:IAO_0000115>Comparison of the single cell landscape between healthy human meniscus and degenerated meniscus. (A) Representative polarised light microscopy images of healthy human and degenerated meniscus. The white and red colours in the angle images are 90  apart in orientation. Dashed lines indicate the surface of the meniscus. Scale bar, 100 microm. (B) Merged t-distributed stochastic neighbour embedding (t-SNE) of single-cell RNA sequencing of healthy meniscus cells and degenerated meniscus cells. (C) Twelve healthy human and degenerated meniscus cell clusters at t-SNE. (D) Proportion of each cluster to the total cells. (E) Proportion of healthy and degenerated meniscus cells in each cluster. (F) Expression of representative marker genes in Vin plot. (G) Heatmap revealing the scaled expression of differentially expressed genes for each cluster. (H) CD146 and CD318 expression in healthy human meniscus cells and degenerated meniscus cells determined by flow cytometry. n&gt;=5, **p&lt;0.01. (I) Representative IHC staining of COL1A1 and COL2A1 healthy human meniscus and degenerated meniscus, and quantification of positive cells. Scale bar, 50 microm. n&gt;=5, **p&lt;0.01. (J) The expression of indicated marker genes in human healthy meniscus cells and degenerated meniscus cells were detected by qRT-PCR. *p&lt;0.05, **p&lt;0.01, otherwise, not significant. n=3, *p&lt;0.05, **p&lt;0.01. CPC, ##cartilage progenitor cells##; DegP, degenerated meniscus progenitor cells; EC, endothelial cells; FC, fibrochondrocytes; FCP, fibrochondrocyte progenitors; HTC, hypertrophic chondrocytes; MoDC, monocyte-derived dendritic cells; PreHTC, prehypertrophic chondrocytes; ProFC, proliferate fibrochondrocytes; RegC, regulatory chondrocytes.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7034356</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31871141</oboInOwl:hasDbXref>
        <rdfs:label>cartilage progenitor cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0007009"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/3afed480-a419-41e2-b49f-ceffae190d46"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0007009"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/3b821479-492c-49a6-b5b9-4cd8c09697e2 -->

    <Class rdf:about="http://example.org/3b821479-492c-49a6-b5b9-4cd8c09697e2">
        <obo:IAO_0000115>Combining Seurat clustering analysis with known molecular markers for various cell types (Fig. 2B; Tables S2, S3), we segregated the single cells into 9 major cell clusters based on cell types: immune cells [Microglia, Monocyte/Macrophage, and T/NK (T cell/natural killer cell)], retinal cells [AC/HC/RGC (amacrine cell/horizontal cell/retinal ganglion cell), BC (bipolar cell), Cone, MG (Muller glia)/Astrocyte, and Rod], and vascular endothelial cells (VEC) (Fig. 2A). Comparison of control and EAU cell clusters revealed a decrease in the number of multiple neuronal types in EAU retinas, especially in the BC cluster (20.34-5.02%), Cone cluster (9.49-2.94%), and AC/HC/RGC cluster (3.76-1.28%) (Fig. 2C). In agreement, bulk RNA-seq analysis showed that in EAU retinas, there was downregulation of marker genes for all 6 retinal neuron types including rods, cones, BCs, ACs, HCs, and RGCs (Fig. 2D; S2A, B). Immunostaining analysis further validated these results. In EAU retinas, there was obvious degeneration of rhodopsin+ rod inner and outer segments (Fig. 2E), and in general, progressive loss of Arrestin+ cones, Chx10+ BCs, Tfap2a+ ACs, Rbpms+ RGCs, and ##Calbindin+ HCs## (Fig. 2F-J, L-P). By contrast, EAU did not appear to significantly alter Sox9+ Muller glia although resulting in an upregulation of their marker genes (Fig. 2K, Q). Therefore, EAU may cause not only progressive degeneration of all retinal neuron types but also a switch in the expression profile of Muller glia.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11131209</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38802924</oboInOwl:hasDbXref>
        <rdfs:label>Calbindin+ HCs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000745"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/3b821479-492c-49a6-b5b9-4cd8c09697e2"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000745"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/3b8b16e1-8463-466c-a897-58e81920a9f0 -->

    <Class rdf:about="http://example.org/3b8b16e1-8463-466c-a897-58e81920a9f0">
        <obo:IAO_0000115>We observed multiple features of ##Immature #1 and mature Sertoli cells## that distinguish them from Immature #2 cells, including high AR (Androgen Receptor) target gene expression (defined by a set of ~70 known AR-dependent genes), high mitochondrial transcription, and lower expression of ribosomal protein genes (Figure 3F). Gene Ontology (GO) analysis revealed enrichment for terms such as nucleus and transcription in Immature #1 (Figure S3H). IF co-staining for AR and SOX9 confirms this sequence of events, by showing gradual AR upregulation and co-localization in Sertoli cells as puberty proceeds (Figure 3H). Immature #2 cells have the converse properties of Immature #1 described above and are enriched in GO terms for translation and ribosome function (Figure S3H). They exhibit higher transcription of ribosomal protein genes, mitochondrial ATPases (e.g., ATP5E), and mitochondrial membrane proteins (e.g., TOMM7) and contain a higher fraction of cells in the G1 phase of the cell cycle (Figures 3F and S3E). Taken together, these two immature Sertoli cell states differ markedly in their metabolic/mitochondrial, translational, and cell-cycle properties (as indicated by transcriptional signatures).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7298616</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31928944</oboInOwl:hasDbXref>
        <rdfs:label>Immature #1 and mature Sertoli cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000216"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/3b8b16e1-8463-466c-a897-58e81920a9f0"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000216"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/3b8d9df8-0cce-41cd-a3e6-e840c2595061 -->

    <Class rdf:about="http://example.org/3b8d9df8-0cce-41cd-a3e6-e840c2595061">
        <obo:IAO_0000115>With our single-cell sequencing analysis, we could observe the presence of nine distinct cell populations. Among them were the main cell types of the colon, intestinal stem cells, TA cells as well as cells of the secretory and absorptive lineage. Within the goblet cell population, we could identify not only different goblet cell types with specific function but also a small subfraction of enteroendocrine and Tuft cells. The absorptive lineage was composed of three distinct population whereof one could be assigned to colonocyte progenitors (##eCL##) and the other two as differentiated colonocytes. Among these two distinct clusters, we identified a canonical colonocyte population that was highlighted by the expression of markers such as SLC26A3, CA2, and FABP1. Interestingly, the second colonocyte population was marked by a unique expression profile with increased expression of REG4, MMP7, LYZ, and the cytokines IL-18, IL-23, IL33 (Dataset EV7). For these genes it has been shown that they can be induced by pro-inflammatory cytokines in vitro and in vivo (Schumacher et al,; Takasawa et al,; Jin et al,; Dotti et al,; Mahapatro et al,; Hasegawa et al,; Xiao et al,). In addition, we could observe the presence of interferon-inducible genes IFI27, ISG15, and ISG20. These findings indicate that the expression profile of this noncanonical colonocyte population was shaped by the cytokine cocktail contained in the serum and identifies a cell population with a specialized function connected to immune defense. Deeper analysis is needed to classify the relevance and function of this cell type in vivo. Further studies will be required to fully understand the implications of these findings and their possible relevance in the generation of complex in vitro models. Nevertheless, given that most cell types of the descending colon were represented in our model, we could utilize it to study the effects of SLE serum on the intestinal epithelial barrier.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10940301</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38316934</oboInOwl:hasDbXref>
        <rdfs:label>eCL</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:4047018"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/3b8d9df8-0cce-41cd-a3e6-e840c2595061"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4047018"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/3b95723c-d879-4752-a079-fc9c372214b8 -->

    <Class rdf:about="http://example.org/3b95723c-d879-4752-a079-fc9c372214b8">
        <obo:IAO_0000115>LSCs can differentiate into basal, suprabasal and superficial cells of the corneal epithelium. Single-cell profiles allow for inferring cell-state transition and molecular dynamics during tissue development and differentiation. In this study, RNA velocity and pseudotime estimations showed that the degree of cell differentiation progressively increased in the order of LSC, basal cells, ##suprabasal cells## and superficial cells. We also revealed the gene acceleration kinetics that was consistent with gene function during CEC differentiation progression. This study provided detailed insights into the molecular dynamics of corneal epithelial development and differentiation, which facilitates us to better understand corneal homeostasis and pathogenesis.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10766623</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38177186</oboInOwl:hasDbXref>
        <rdfs:label>suprabasal cells</rdfs:label>
    </Class>
    


    <!-- http://example.org/3b96efd4-a96e-43b4-8bd5-f2d1dbfe956a -->

    <Class rdf:about="http://example.org/3b96efd4-a96e-43b4-8bd5-f2d1dbfe956a">
        <obo:IAO_0000115>Because CD14CTX express chemokine receptors that might facilitate migration into the tissues, we next examined the relationship between circulating and intra-tumoral myeloid states in BTC. We performed scRNA-seq on primary cholangiocarcinoma tumors (n = 4) obtained from standard of care resections (Table S7) and recovered a total of 10,913 myeloid cells. Tissue-associated myeloid cells consisted of dendritic cells (DC), neutrophils (Neut), two populations of macrophages characterized by either high APOE or SPP1 expression (MacAPOE, MacSPP1), CD14+ monocytes (CD14+ mono), CD16+ monocytes (CD16+ mono), and intermediate CD14+CD16+ monocytes (CD14+CD16+ mono) (Figures S4A and S4B). Among the tissue-associated myeloid populations, the expression profile of CD14CTX was most correlated with MacSPP1, exemplified by the shared expression of differentially expressed CD14CTX genes including HAVCR2 and ITGB1 (Figures S4C and S4D). Notably, two genes that differ in expression between MacSPP1 and CD14CTX are related to chemotaxis and extravasation (SERPINB2, TIMP1), suggesting a transition in macrophages that have already migrated to the tumor microenvironment. As an alternate approach to assess the relationship between the circulating and tissue-associated myeloid populations, we co-clustered myeloid cells from circulation with those from the tumors, following batch correction. We found that the intra-tumoral MacSPP1 cluster with the circulating CD14CTX (Figure S4E). An alternative approach using partition-based graph abstraction also found close connectivity between ##CD14CTX and SPP1+ TAM## clusters (Figure S4E). We also found evidence of SPP1+HAVCR2+CD68+ myeloid cells within biliary tumor tissue from on-treatment biopsies by combined in situ hybridization and immunofluorescence, further suggesting the existence of a TAM population in BTC analogous to CD14CTX (Figure S4F).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10060099</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36130508</oboInOwl:hasDbXref>
        <rdfs:label>CD14CTX and SPP1+ TAM</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
        <skos:relatedMatch rdf:resource="CL:0001054"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/3b96efd4-a96e-43b4-8bd5-f2d1dbfe956a"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/3b96efd4-a96e-43b4-8bd5-f2d1dbfe956a"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0001054"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/3bbf9531-9f15-4e1c-a13f-6637923c2e4b -->

    <Class rdf:about="http://example.org/3bbf9531-9f15-4e1c-a13f-6637923c2e4b">
        <obo:IAO_0000115>Development of the urogenital organs prostate and bladder involves intercellular signaling in differentiation. This cell-to-cell communication is controlled by secreted hormone molecules of ##stromal mesenchyme cells## and heterotypic cell contact. Prostate stromal proenkephalin (PENK) was identified by a comparative transcriptome analysis between sorted CD49a+ prostate stromal cells and CD13+ bladder stromal cells of the lamina propria, the rationale being that genes encoding these molecules are likely organ specific (i.e., either prostate or bladder). From this analysis, 288 prostate and 91 bladder stromal genes were identified. Organ-specific expression was validated by reverse-transcriptase polymerase chain reaction (RT-PCR) analysis. Genes encoding secreted proteins were identified by the presence of N-terminal signal peptide sequences. PENK was the lead differentially expressed gene in prostate. Immunostaining with a PENK polyclonal antibody raised against the peptide sequence T163-E179 detected strong reactivity in the stroma of benign prostate tissue and no reactivity in the bladder lamina propria. This result validated the RNA expression analysis. Parenthetically, prostate PENK was not processed to enkephalin opioids as indicated by the immunostaining pattern of enkephalin antibodies reported in the literature. Prostate stromal cells are not known as a source of these opioids.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8675470</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34911496</oboInOwl:hasDbXref>
        <rdfs:label>stromal mesenchyme cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002622"/>
        <skos:relatedMatch rdf:resource="CL:1000600"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/3bbf9531-9f15-4e1c-a13f-6637923c2e4b"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002622"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/3bbf9531-9f15-4e1c-a13f-6637923c2e4b"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:1000600"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/3bd5e539-c31a-4388-ae41-5d94c4f3f2a2 -->

    <Class rdf:about="http://example.org/3bd5e539-c31a-4388-ae41-5d94c4f3f2a2">
        <obo:IAO_0000115>The Table shows the numerical representations of Excitatory Neurons (Deep and Superficial Pyramidal cells) and Inhibitory neurons (Oriens Lacunosum moleculare cells:OLM; Trilaminar cells:Tri, Backprojection cells:BP, cholecystokinin positive Basket cells:CCKBC, Parvalbumin positive cells:PVBC, AxoAxonic Cells:AA, Ivy Cells:IVY, Bistratified cells:BS, ##Schaffer Collateral associated cells##:SCA, Perforant Pathway Associated cell:PPA, Neurogliaform:NG) subdivided on the basis of the placement classes (SO, SP, SR, SLM).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9381785</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35974119</oboInOwl:hasDbXref>
        <rdfs:label>Schaffer Collateral associated cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:4023060"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/3bd5e539-c31a-4388-ae41-5d94c4f3f2a2"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4023060"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/3bdb237d-6b38-4b3a-a00e-1d9ddd68f503 -->

    <Class rdf:about="http://example.org/3bdb237d-6b38-4b3a-a00e-1d9ddd68f503">
        <obo:IAO_0000115>Checkpoint immunotherapy unleashes T cell control of tumors, but is undermined by immunosuppressive myeloid cells. TREM2 is a myeloid receptor that transmits intracellular signals that sustain microglial responses during Alzheimer&apos;s disease. TREM2 is also expressed by tumor-infiltrating macrophages. Here, we found that Trem2-/- mice are more resistant to growth of various cancers than wild-type mice and are more responsive to anti-PD-1 immunotherapy. Furthermore, treatment with anti-TREM2 mAb curbed tumor growth and fostered regression when combined with anti-PD-1. scRNA-seq revealed that both TREM2 deletion and anti-TREM2 are associated with scant ##MRC1+ and CX3CR1+ macrophages## in the tumor infiltrate, paralleled by expansion of myeloid subsets expressing immunostimulatory molecules that promote improved T cell responses. TREM2 was expressed in tumor macrophages in over 200 human cancer cases and inversely correlated with prolonged survival for two types of cancer. Thus, TREM2 might be targeted to modify tumor myeloid infiltrates and augment checkpoint immunotherapy.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7485282</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32783918</oboInOwl:hasDbXref>
        <rdfs:label>MRC1+ and CX3CR1+ macrophages</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
        <skos:relatedMatch rdf:resource="CL:0000890"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/3bdb237d-6b38-4b3a-a00e-1d9ddd68f503"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/3bdb237d-6b38-4b3a-a00e-1d9ddd68f503"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000890"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/3bee6ce8-d2e6-4fcf-bf27-ced80ba859e2 -->

    <Class rdf:about="http://example.org/3bee6ce8-d2e6-4fcf-bf27-ced80ba859e2">
        <obo:IAO_0000115>In the mouse placenta, there are two lineages of trophoblast cells, the invasive and structural cells, which arise from the trophoblast stem progenitor cells. Trophoblast giant cells are the invasive cells responsible for invading the maternal vasculature and transforming the spiral arteries into high-velocity, low-resistant vessels. Four sub-types of trophoblast giant cells exist, including spiral artery trophoblast giant cells and parietal trophoblast giant cells, which reside in the decidual layer. The canal trophoblast giant cells and ##sinusoidal trophoblast giant cells## are in the labyrinth. The structural cells of the placenta include those located within the junctional zone and the remaining cells of the labyrinth. The spongiotrophoblast and glycogen trophoblast cells are within the junctional zone. The spongiotrophoblast cells are thought to contribute a supportive role to the developing labyrinth and feed into the trophoblast giant cell progenitor pool, while glycogen cells, which arise from the spongiotrophoblast cells, are thought to accumulate glycogen and can migrate into the maternal decidua for spiral artery remodeling. The two different types of syncytiotrophoblast cells, syncytiotrophoblast-I and syncytiotrophoblast-II, are located within the labyrinth zone. These cells function in the material exchange between the mother and fetus and, along with the sinusoidal trophoblast giant cells, make up the interhemal membrane. However, the specific functions of some of these cells are not well understood.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10459728</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37630754</oboInOwl:hasDbXref>
        <rdfs:label>sinusoidal trophoblast giant cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002488"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/3bee6ce8-d2e6-4fcf-bf27-ced80ba859e2"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002488"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/3c0be366-ad38-4d3b-b34e-9986bdbf66ed -->

    <Class rdf:about="http://example.org/3c0be366-ad38-4d3b-b34e-9986bdbf66ed">
        <obo:IAO_0000115>Distinct therapy-induced cancer cell transcriptomes were associated with clinical response. Cancer cells from MPR patients exhibited a signature of activated antigen presentation via major histocompatibility complex class II (MHC-II). Further, the transcriptional signatures of FCRL4+FCRL5+ memory B cells and CD16+CX3CR1+ monocytes were enriched in MPR patients and are predictors of immunotherapy response. Cancer cells from NMPR patients exhibited overexpression of estrogen metabolism enzymes and elevated serum estradiol. In all patients, therapy promoted expansion and activation of cytotoxic T cells and CD16+ NK cells, reduction of immunosuppressive Tregs, and activation of memory CD8+T cells into an effector phenotype. Tissue-resident macrophages were expanded after therapy, and tumor-associated macrophages (TAMs) were remodeled into a neutral instead of an anti-tumor phenotype. We revealed the heterogeneity of neutrophils during immunotherapy and identified an aged CCL3+ neutrophil subset was decreased in MPR patients. The aged ##CCL3+ neutrophils## were predicted to interact with SPP1+ TAMs through a positive feedback loop to contribute to a poor therapy response.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9985263</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36869384</oboInOwl:hasDbXref>
        <rdfs:label>CCL3+ neutrophils</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000775"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/3c0be366-ad38-4d3b-b34e-9986bdbf66ed"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000775"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/3c63bf54-c402-4218-bf01-50c681e7eecb -->

    <Class rdf:about="http://example.org/3c63bf54-c402-4218-bf01-50c681e7eecb">
        <obo:IAO_0000115>To investigate the universal transcriptional program between group 1 ILCs across liver and spleen, we have explored DEGs in Prdm1 cko liver cNK cells and ILC1s using our scRNA-seq data. Compared with liver ILC1s, more DEGs was observed in liver cNK cells, including Junb, Kit, Tcf7, Gzmb, Prf1, etc. (Figure 5:figure supplement 2, A and B). Through the integration of the bulk RNA-seq and scRNA-seq data, we identified 17 DEGs that are regulated by Prdm1 among liver cNK cells, splenic cNK cells, and liver ILC1s. Batf3, Junb, Tcf7, and Nfkb1 was upregulated, whereas Gzmb, Prf1, and Fgl2 downregulated, in both Prdm1 cko liver and splenic cNK cells (Figure 5J). Cxcr6 was downregulated in liver ILC1s and splenic cNK cells in Prdm1 cko mice (Figure 5J). Previous research found that spleen NK cells could be divided into three distinct groups based on their expression levels of CD27, CD62L, CD49a, and CD49b. ##CD27+CD62L- NK cells## have remarkable high expression of Batf3, while it was only barely expressed in CD27+CD62L+ and CD27-CD62L+ NK cells. Based on the sequencing data published by Flommersfeld et al. (GSE180978), a notable negative correlation was observed between the expression levels of Prdm1 and Batf3 (Figure 5:figure supplement 2I). On top of that, our findings unveiled the negative regulatory influence of Prdm1 on Batf3 within both spleen and liver NK cells. This discovery highlights a potential upstream mechanism that may influence the hemostasis of the spleen NK cell subpopulations through Batf3.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11318973</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:39133873</oboInOwl:hasDbXref>
        <rdfs:label>CD27+CD62L- NK cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000823"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/3c63bf54-c402-4218-bf01-50c681e7eecb"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000823"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/3c7ba686-98d6-45a4-9410-d9d5e75cb955 -->

    <Class rdf:about="http://example.org/3c7ba686-98d6-45a4-9410-d9d5e75cb955">
        <obo:IAO_0000115>We next leveraged the high number of nuclei and developmental time points sampled in our dataset to quantify cell types across gestational age. Focusing on the germinal matrix where gliogenesis begins, samples were grouped into four stages spanning the latter half of second trimester and third trimester: 17-20 gw (Stage 1), 20-24 gw (Stage 2), 24-28 gw (Stage 3), and 31-41 gw (Stage 4). The stages differed statistically by gestational age but not by sex or tissue collection postmortem interval (Supplementary Data 1-2). By plotting mean fraction of cell type by stage, we observe two trends from second to third trimester: a decrease in the fraction of nIPCs and excitatory neurons (EN: CPN and SPN) and an increase in the fraction of glia (RG/AC, gIPC, astrocyte, OPC, and microglia) (Fig. 1f). To study these trends further, we correlated the fraction of cell types to sample age in gestational weeks (Supplementary Fig. 3). This reveals a significant increase with gestational age in the fraction of gIPCs (p = 0.003; two-tailed Spearman Rank-Order Correlation test), astrocytes (p = 0.015), OPCs (p = 0.0008), and microglia (p = 0.002) (Supplementary Fig. 3a). The fraction of MSNs also increase significantly (p = 0.002). Conversely, there is a significant decrease in the fraction of nIPCs (p = 0.034), late-born L2/3 CPNs (p = 0.009), and TAC (p = 0.002) (Supplementary Fig. 3a). Our GM dataset, therefore, captures the start of the gliogenic period. In the CP, the fraction of TACs, nIPCs, and CRNs exhibit a significant decrease over time (p = 0.002, ~0, 0.0001, respectively), while ##L4/5a CPNs## show a significant increase (p = 0.002) (Supplementary Fig. 3b). Interneurons also increase from second to third trimester (p = 0.001), consistent with their migration into the neocortex. While the fraction of CP glia exhibit a positive trend, only OPC numbers show a significant positive correlation with gestational age (p = 0.026).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9744747</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36509746</oboInOwl:hasDbXref>
        <rdfs:label>L4/5a CPNs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000540"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/3c7ba686-98d6-45a4-9410-d9d5e75cb955"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000540"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/3cda47d7-ecd8-46cf-8e0c-c08452b69ba5 -->

    <Class rdf:about="http://example.org/3cda47d7-ecd8-46cf-8e0c-c08452b69ba5">
        <obo:IAO_0000115>a Schematic of the experimental pipeline. Created with BioRender.com b UMAP visualization of peritoneal immune cells. c Ratio of each population in cell number. d VlnPlot of characteristic gene expressions for macrophage subpopulations. Sham sham control, ELL endometriosis-like lesions, ELL_N niclosamide administration to ELL-induced mouse, Pre-SPMs premature &quot;small&quot; peritoneal macrophages, SPMs &quot;small&quot; peritoneal macrophages, IM1-3 intermediate macrophages subtype 1-3, ##Timd4+ LPMs## Timd4+ &quot;large&quot; peritoneal macrophages, PMs proliferating macrophages, B1a B1a cells, B1b B1b cells, B2 B2 cells, GCBs germinal-centre B cells, PBs plasma blast B cells, Cd4+ Ts Cd4+ T cells, Cd8+ Ts Cd8+ T cells, DN1 double negative T cells 1, DN2 double negative T cells 2, cDC1 conventional dendritic cells 1, MCs Mast cells, NTPs neutrophils.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9652344</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36369244</oboInOwl:hasDbXref>
        <rdfs:label>Timd4+ LPMs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000581"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/3cda47d7-ecd8-46cf-8e0c-c08452b69ba5"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000581"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/3cdebfbd-82a7-4b42-9f28-5ce4c6cbfcf3 -->

    <Class rdf:about="http://example.org/3cdebfbd-82a7-4b42-9f28-5ce4c6cbfcf3">
        <obo:IAO_0000115>Molecular characteristics of perimeningeal astrocytes (PMA) and mature lesion border astrocytes (##LBA##).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11303254</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38907165</oboInOwl:hasDbXref>
        <rdfs:label>LBA</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002627"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/3cdebfbd-82a7-4b42-9f28-5ce4c6cbfcf3"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002627"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/3ce4ef10-2286-40f3-9ab9-c2c41821f00c -->

    <Class rdf:about="http://example.org/3ce4ef10-2286-40f3-9ab9-c2c41821f00c">
        <obo:IAO_0000115>BACKGROUND: A major current challenge is to exploit tertiary lymphoid structures (TLSs) to promote the lymphocyte infiltration, activation and differentiation by tumor antigens to increase antitumor immune responses. The mechanisms that underlie the role of TLS formation in the adaptive immune responses against nasopharyngeal carcinoma (NPC) remain largely unknown. METHODS: Cell populations and the corresponding markers were identified by single-cell RNA sequencing and fluorescence-activated cell sorting analysis. In vitro differentiation experiments were used to simulate the generation, regulation and function of the Th-CXCL13 cell subset in the tumor microenvironment of NPC. These were followed by histological evaluation of the colocalization of tumor-associated B cells (TABs) and Th-CXCL13 cells within TLSs, and statistical analysis of the relationship between the cells in TLSs and overall survival. RESULTS: A ##PD-1+CXCR5-CD4+ Th-CXCL13 cell## subset was identified in NPC. This subset was a major source of CXCL13, representing the majority of the CD4+ T cells at levels comparable with Th1 and Tfh cells present in the TLSs. Monocytes activated by toll-like receptor 4 agonists served as the antigen-presenting cells that most efficiently triggered the expansion of Th-CXCL13 cells. Transforming growth factor beta 1 (TGF-beta1) stimulation and activation of Sox4 were critical for the induction and polarization of Th-CXCL13 cells in this process. The potential functional contributions of TABs recruited by Th-CXCL13 cells which induced plasma cell differentiation and immunoglobulin production via interleukin-21 and CD84 interactions in the TLSs demonstrated improved survival. CONCLUSIONS: Induction of Th-CXCL13 cells links innate inflammation to immune privilege in tumor-associated TLSs and might predict better survival.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8276302</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34253636</oboInOwl:hasDbXref>
        <rdfs:label>PD-1+CXCR5-CD4+ Th-CXCL13 cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000492"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/3ce4ef10-2286-40f3-9ab9-c2c41821f00c"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000492"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/3d31c6c8-50e4-442f-97e8-ce28cada309f -->

    <Class rdf:about="http://example.org/3d31c6c8-50e4-442f-97e8-ce28cada309f">
        <obo:IAO_0000115>achieved. Both bioprinting of undifferentiated/uncommitted and differentiated (e.g. iPSC-derived cardiomyocytes, endothelial cells, oligodendrocyte precursors, neuronal precursors) have been successful to obtain mature tissue constructs. Bioprinting can support generation of large-scale, highly reproducible organoids with enhanced maturation in a high throughput fashion, thereby overcoming some of the shortcomings of organoid technology. Recently, bioprinting of centimeter-scale tissues was accomplished by Brassard et al. (2020), who applied a novel 3D bioprinting technique, the so-called bioprinting-assisted tissue emergence (BATE), using organoid-forming intestinal stem cells. Notably, maturation and lumenization of bioprinted tissue constructs were achieved by co-deposition of ##intestinal mesenchymal cells##. Together, high-throughput 3D bioprinting of reproducible, large-scale, mature tissues derived from iPSC and/or organoids holds tremendous potential to revolutionize drug discovery and regenerative/personalized medicine.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11222197</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38498295</oboInOwl:hasDbXref>
        <rdfs:label>intestinal mesenchymal cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0008019"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/3d31c6c8-50e4-442f-97e8-ce28cada309f"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0008019"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/3d4e2ed5-e14d-41c6-b715-670ecd029a69 -->

    <Class rdf:about="http://example.org/3d4e2ed5-e14d-41c6-b715-670ecd029a69">
        <obo:IAO_0000115>To analyze the T cell response specifically, we devised a flow cytometry panel to identify CD8+ T cells, CD4+ Tconv and Treg cells. Because repeated exposure to commensal microorganisms (notably C. acnes) is expected to occur in acne and because previous reports showed the importance of the Th1 and Th17 axes in acne, we chose to target Th1, Th17 and TRM cells in our analysis. We employed CXCR3 to identify Th1 cells and CD161 to identify IL-17 producing T cells. Although CXCR3 and CD161 are often found in Th1 and Th17 cell subsets respectively, they do not strictly define them. Nevertheless, these markers provided a reasonable approximation for our analysis of CD4+ Tconv cells. The presence of a substantial contingent of Th17 cells (CD4+CD161+ Tconv cells) in the skin at steady state is not surprising because these cells are known to participate in immune surveillance of barrier organs. CD4+CD161+ Tconv cells are expected to belong to the Th17 subset, but CD161 expression is not synonymous with IL-17 production because these cells need to engage their TCR to produce cytokines. Our work quantifies for the first time ##CD161+ T cells## in acne and we note a clear increase of Th17 cell number in the CC stage, indicating an early involvement of this subset in acne pathogenesis. In line with previous reports, we show that Th17 cell numbers are increased in acne and we support the notion that these cells are recruited and/or proliferate during CC formation while they are already present in UI skin of patients with acne. Moreover, the combined analysis of CXCR3 and CD161 showed the presence of cells expressing both markers (about 15% of Tconv cells) that are reminiscent of pathogenic Th17.1 cells, that produce both IL-17 and IFN-gamma, previously described in autoimmunity or autoinflammation.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8506309</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34650562</oboInOwl:hasDbXref>
        <rdfs:label>CD161+ T cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000084"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/3d4e2ed5-e14d-41c6-b715-670ecd029a69"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000084"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/3d6a533d-79a5-4bf0-88af-b08f0c9b4458 -->

    <Class rdf:about="http://example.org/3d6a533d-79a5-4bf0-88af-b08f0c9b4458">
        <obo:IAO_0000115>Although the induced Ca2+ activity persisted under the glutamatergic inhibition for c+ primary neurons, excitability of the secondary neurons discontinued. Secondary neurons exhibited two common excitation profiles depending on whether they were silent or spontaneously active before stimulation. These two profiles were encountered in equal frequencies 30% (both 7 out of 22) all throughout the experiments. In Fig 5B, the c+ primary neuron was observed to excite a previously silent secondary neuron. In the blocked case this excitation was not observed as shown via correlation analysis (p&lt;0.05). A video of this experiment is provided in S1A and S1B Video. Fig 5C shows an example for a secondary neuron which was spontaneously active before stimulation. Spontaneous activity of the secondary neuron was modulated with the induced Ca2+ activity of the ##primary neuron##. Excitation of the secondary neuron continued through the stimulation and the in-phase modulation vanished in the blocked case (p&lt;0.05).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7928449</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33657119</oboInOwl:hasDbXref>
        <rdfs:label>primary neuron</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000540"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/3d6a533d-79a5-4bf0-88af-b08f0c9b4458"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000540"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/3d75948c-907d-405d-aea3-4ccd55990391 -->

    <Class rdf:about="http://example.org/3d75948c-907d-405d-aea3-4ccd55990391">
        <obo:IAO_0000115>Transcriptomic data were used for correlation analysis between human in vivo fetal yolk sac (YS) hematopoietic clusters (YS_EC, endothelial cells; YS_Mac, macrophages; and YS_YSMP1,2, myeloid-biased progenitors) and PD-L1 WT hematopoietic cell populations (##PD-L1_EC##, endothelial cells; MC/Mphis, monocyte/macrophages; CMPs, common myeloid progenitors; and granulocytes).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10638094</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37949473</oboInOwl:hasDbXref>
        <rdfs:label>PD-L1_EC</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000115"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/3d75948c-907d-405d-aea3-4ccd55990391"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000115"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/3dd7ba61-ca54-4de2-a5c5-aa8d2a502223 -->

    <Class rdf:about="http://example.org/3dd7ba61-ca54-4de2-a5c5-aa8d2a502223">
        <obo:IAO_0000115>However, the expression percentage of surface and molecular pluripotency markers remains variable due to the passage numbers and measuring methods. The fresh isolated hAESCs have a low proliferation efficiency and stop growing after 4-5 passages due to DNA damage or shortened telomeres, which impair their clinical application in regenerative medicine. To meet clinical needs, Kaixuan Zhou et al. established immortalized human amniotic epithelial stem cells (iHAESCs) via introducing viral oncogenes E6/E7 and human telomerase reverse transcriptase (hTERT). They found the immortalized HAESC cells with an extended life span retained characteristics of the original cells, including pluripotent markers and differentiation capabilities. Recently, they showed that the immortalized HAESC cells have relatively higher resistance to oxidative damage compared with immortalized human ##amniotic mesenchymal cells## (iHAMs) because of higher level of basal antioxidant factors (SOD2, Nrf2, HO-1), suggesting AESCs provide protection against oxidative stimulation under oxidative stress. These results offer more choices for their cell therapy and regenerative medicine, reflecting the plasticity of AESCs as a potential clinical tool cell source.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7594030</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33086620</oboInOwl:hasDbXref>
        <rdfs:label>amniotic mesenchymal cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002537"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/3dd7ba61-ca54-4de2-a5c5-aa8d2a502223"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002537"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/3df18b79-7838-4282-b7f9-275c1386f95a -->

    <Class rdf:about="http://example.org/3df18b79-7838-4282-b7f9-275c1386f95a">
        <obo:IAO_0000115>To illustrate the application of CSN to developing cells, we feature the developmental trajectory of human excitatory neuron cells in the Developing Cortex Atlas dataset (15), which includes Radial Gila and Progenitors (P), Intermediate Progenitors (IP), Maturing Excitatory (ExN), Migrating Excitatory (##ExM##), Excitatory Upper-layer enriched (ExM-U), and Excitatory Deep layer (ExDp), with cell type labels determined by the authors (SI Appendix, section 3 and Table S2). Using Slingshot, we estimate the developmental path consists of two trajectories, one ending in upper-layer (U curve) and the other in deep-layer (D curve) excitatory neurons (Fig. 3 A and B).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8713783</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34903665</oboInOwl:hasDbXref>
        <rdfs:label>ExM</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000540"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/3df18b79-7838-4282-b7f9-275c1386f95a"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000540"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/3df32e2b-866f-4795-809c-2d103b696db9 -->

    <Class rdf:about="http://example.org/3df32e2b-866f-4795-809c-2d103b696db9">
        <obo:IAO_0000115>Gene-Set Significant Cell Types from Zeisel That Are Common between Mouse MIA and Human GWAS Significant Cell Types from Saunders That Are Common between Mouse MIA and Human GWAS   Individual Study DEGs mPFC -##Excitatory Neurons## (Hindbrain)[SCZ, ASD, EA] No cell types   AM -Inhibitory D1 &amp; D2 Medium Spiny Neurons (Striatum) [EA] -Inhibitory direct/indirect Spiny Projection Neurons (Striatum) [SCZ, EA, IQ]   Meta-analysisDEGs Upregulated -Excitatory Neurons, Pyramidal Cells (Cerebral Cortex) [SCZ, IQ] -Excitatory Neurons, Deep-layer Pyramidal cells (Frontal Cortex)[SCZ, IQ]-Excitatory Neurons (Posterior Cortex) [SCZ, IQ]-Excitatory Neurons, Entorhinal Cortex Cells (Hippocampus)[SCZ, IQ]-Excitatory Neurons, CA1 Principal Cells (Hippocampus)[IQ]   </obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8471627</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34573345</oboInOwl:hasDbXref>
        <rdfs:label>Excitatory Neurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000540"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/3df32e2b-866f-4795-809c-2d103b696db9"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000540"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/3e23932d-d865-47ba-8077-104d0d946209 -->

    <Class rdf:about="http://example.org/3e23932d-d865-47ba-8077-104d0d946209">
        <obo:IAO_0000115>We examined data from human gastrulation (~2-3 PCW) and CS10-11 (~4 PCW):timepoints prior to AGM-HSPC formation:to explore the differentiation potential of early HSPCs. At gastrulation, the YS hematopoietic landscape had a tripartite differentiation structure, with erythroid, MK, and myeloid differentiation (Fig. 3F). This structure was also observed in mouse YS (fig. S6, A and B, and data S5 and S11). Differential-fate-prediction analysis demonstrated that early HSPCs pre-AGM at CS10-11 (~4 PCW) were myeloid-biased, consistent with previous observations . However, the abundance of differentiating erythroid and MK cells at CS10-11 suggested that an earlier wave of erythroid/MK production had occurred (Fig. 3G and fig. S6C). Post-AGM, the model predicted that remaining early HSPCs were erythroid and MK-biased, whereas definitive HSPCs were lymphoid- and MK-biased (Fig. 3G). This was in keeping with the first appearance of YS lymphoid cells (##ILC progenitors##, NK cells, and B lineage cells) post CS14 (Fig. 1G). Differential-fate-prediction analyses suggested that iPSC-derived HSPCs were embryonic erythroid-, myeloid-, and MK-biased, whereas definitive iPSC-derived HSPCs were lymphoid-, MK-, erythroid-, and myeloid-primed, consistent with the predicted lineage potential of their in vivo early and definitive counterparts (Fig. 3H and fig. S6D).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7614978</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37590359</oboInOwl:hasDbXref>
        <rdfs:label>ILC progenitors</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0001082"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/3e23932d-d865-47ba-8077-104d0d946209"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0001082"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/3e3dbaf1-2b9d-4881-bf3b-2f158bf185a0 -->

    <Class rdf:about="http://example.org/3e3dbaf1-2b9d-4881-bf3b-2f158bf185a0">
        <obo:IAO_0000115>Postnatal neurogenic zones, such as the V-SVZ (ventricular-subventricular zone) that lines the lateral ventricle walls, have an embryonic origin. Interestingly, a fraction of radial glial cells (RGCs) in the forebrain LGEs (lateral ganglionic eminences) and pallium becomes quiescent. ZEB2 was studied in LGE-derived neurons for LGEs using mainly the Gsh2-Cre driver, hence ZEB2 co-steers the anlage of part of the V-SVZ. After birth, these cells are reactivated and differentiate into the different cell types of the V-SVZ, which in the mouse are architecturally grouped, and produce supportive cells (ependymal or E cells) or RGC-like neural stem cells (NSCs or B1 cells) of the V-SVZ. The latter cells generate C cells (transit amplifying cells), which give rise to A cells (immature, including ##migratory neuroblasts##). As cells migrate via the rostral migratory stream (RMS) to the olfactory bulb (OB) and emanate as network-integrated different types of interneuron. The V-SVZ and its RMS expresses miR-200 class of micro-RNAs (that target Zeb2) and, at the time B cells are set aside in the embryonic brain, ZEB2 mRNA/protein is present in the ventral telencephalon, including the aforementioned LGE. In Gsh2-Cre;Zeb2-cKO LGEs, about 70% of postnatal V-SVZ cells are detectably targeted at E14.5, and this is confirmed in P2 and P5 mice. Pronounced defects are seen in these KO mice in OB development, for they have more scattered distribution of the various cell types and. Additionally, at P17-P18, the fewer OB interneurons results in OBs that are 70% smaller than normal. This suggested an important role of ZEB2 in postnatal neurogenesis.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8304685</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34356053</oboInOwl:hasDbXref>
        <rdfs:label>migratory neuroblasts</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000031"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/3e3dbaf1-2b9d-4881-bf3b-2f158bf185a0"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000031"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/3e658657-0704-40c5-a88e-c69c27299533 -->

    <Class rdf:about="http://example.org/3e658657-0704-40c5-a88e-c69c27299533">
        <obo:IAO_0000115>(A, B) Volcano plots showing differentially expressed genes (FDR corrected p-value &lt;0.05, indicated by colors) in DCs (A) and MdMs (B) from tumor periphery versus center. (C) Volcano plot showing differentially expressed genes (FDR corrected p-value &lt;0.05, indicated by colors) in DCs from tumor periphery versus PBMC. (D) Heatmap representation of GSEA between DCs from tumor periphery and PBMC using Hallmark collection of major biological categories. (E) Heatmap displaying the cluster-specific genes identifying ##MG##_1 and MG_2 subclusters. Columns are ordered by site and cell type, and rows show centered and scaled normalized average expression values, hierarchically clustered. (F, G) Violin plots showing average expression levels (log2 counts) of selected markers among mononuclear phagocyte populations. (H) Frequencies of MG_1 and MG_2 subpopulations among total microglia between center and periphery, shown as boxplots. Symbols represent individual patients (n=5) and paired samples are indicated by connecting lines. Statistical significance was assessed by diffcyt-DA-voom method (Supplementary file 5), ***FDR corrected p value p&lt;=0.001, ****FDR corrected p-value &lt;=0.0001.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10735226</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38127790</oboInOwl:hasDbXref>
        <rdfs:label>MG</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000129"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/3e658657-0704-40c5-a88e-c69c27299533"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000129"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/3e7f74a1-1c9d-4b47-8697-6f6079f005e6 -->

    <Class rdf:about="http://example.org/3e7f74a1-1c9d-4b47-8697-6f6079f005e6">
        <obo:IAO_0000115>Variable Name Data used   TN Naive T-cells Combination of CD4 naive and memory resting T-cells and resting NK cells   Th Helper T-cells Combination of ##memory activated CD4 T-cells## and follicular helper T-cells   TC Cytotoxic cells Combination of CD8 T-cells and activated NK cells   Tr Regulatory T-cells Regulatory T-cells   DN Naive dendritic cells Naive dendritic cells   D Activated dendritic cells Activated dendritic cells   MN Naive Macrophages Combination of Macrophages M0 and Monocytes   M Macrophages Combination of M1 and M2 Macrophages   C Cancer cells Estimated   N Necrotic cells Estimated   A Cancer Associated Adipocytes Assumed to be twice of the total number of immune cells   H HMGB1 HMGB1 gene expression   IL12 IL-12 IL12A and IL12B gene expressions   IL10 IL-10 IL10, IL10RA and IL10RB gene expressions   IL6 IL-6 IL6, IL6ST and IL6RA gene expressions   </obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8959189</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35294447</oboInOwl:hasDbXref>
        <rdfs:label>memory activated CD4 T-cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000897"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/3e7f74a1-1c9d-4b47-8697-6f6079f005e6"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000897"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/3ee1289b-e9bb-47db-9169-54604c7bdcff -->

    <Class rdf:about="http://example.org/3ee1289b-e9bb-47db-9169-54604c7bdcff">
        <obo:IAO_0000115>In order to investigate the underlying process that may lead to a poor prognosis for high-risk LUAD patients, an analysis of hallmark pathway gene profiles was conducted, revealing distinct characteristics between high- and low-risk groups. A direct comparison between the Risk-High and Risk-Low groups showed that the top five enriched signatures in the high-risk group were MYC target v1, MYC target v2, mTORC1 signaling, G2M checkpoint, and Glycolysis ( Figure 10A ). GSEA enrichment analysis also indicated that the high-risk group had significantly enriched Cell Cycle (NES = 1.93, p&lt; 0.001) and DNA Replication (NES = 1.78, p = 0.000) ( Figure 10B ). The ssGSEA algorithm was employed to examine differences in immune status across distinct risk groups. Low-risk LUAD patients showed increased infiltration of various immune cells, including ##Active dendritic cells## (aDCs), B cells, CD8+ T cells, Dendritic cells (DCs), Immature dendritic cells (iDCs), Mast cells, neutrophils, T helper cell, Tumor-infiltrating lymphocytes (TILs), and Regulatory T cells (Treg), in their tumor microenvironment (TME). Furthermore, almost all immune-related pathways were significantly expressed in the low-risk group ( Figures 10C, D ).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10073691</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37033259</oboInOwl:hasDbXref>
        <rdfs:label>Active dendritic cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000451"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/3ee1289b-e9bb-47db-9169-54604c7bdcff"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000451"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/3f14d5da-f865-45b2-8728-54148c368931 -->

    <Class rdf:about="http://example.org/3f14d5da-f865-45b2-8728-54148c368931">
        <obo:IAO_0000115>Factor	SMD (95% CI)	I2 (%)	HeterogeneityP value	Effect sizeP value	df	Subgroup differenceP value	 	Stem cell species	 	 Human (n = 7)	2.86 (1.59, 4.13)	70	.003	&lt;.0001	6	.06	 	 Mouse/rat (n = 9)	1.59 (0.42,2.76)	86	&lt;.00001	.008	9	 	 Monkey (n = 2)	1.01(0.13,1.88)	-	-	.48	-	 	Stem cell type	 	 BM-MSC (n = 12)	1.79 (0.90, 2.68)	77	&lt;.00001	&lt;.0001	11	.004	 	 AD-MSC (n = 4)	1.52 (-0.63,3.66)	91	&lt;.00001	.17	3	 	 UC-MSC (n = 1)	2.21 (1.05,3.38)	-	.0002	.0002	-	 	##PDLSC## (n = 1)	9.63 (5.48,13.79)	-	&lt;.00001	&lt;.00001	-	 	EV isolation method	 	 Ultracentrifugation (n = 6)	2.99 [1.52, 4.45]	71	.004	&lt;.00001	5	.29	 	Ultracentrifugation (n = 4) and ultrafiltration	1.43 [-0.34, 3.20]	91	&lt;.00001	.11	3	 	Commercial kits (n = 8)	1.64 (0.42, 2.86)	81	&lt;.00001	.008	7	 	Animal&apos;s age (weeks)	 	 6-8 (n = 12)	1.49 (0.60, 2.38)	83	&lt;.00001	.001	11	.81	 	 &gt;8 (n = 4)	1.67 (0.52, 2.81)	47	.13	.004	3	 	EAE scoring system	 	 0-4 (n = 4)	2.55 (1.03, 2.83)	60	.06	&lt;.00001	3	.002	 	 0-5 (n = 7)	1.35 (-0.02, 2.71)	90	&lt;.00001	&lt;.00001	6	 	 0-7 (n = 6)	1.75 (1.03, 2.47)	25	.24	.05	5	 	 0-10 (n = 1)	9.36 (5.48,13.79)	-	&lt;.00001	.001	-	 	Route of administration	 	 Intravenous (n = 15)	2.31 (1.24, 3.38)	87	&lt;.00001	&lt;.0001	14	.15	 	 Other (n = 2)	0.71 (-1.18, 2.6)	76	.04	.46	1	 	Treatment paradigm	 	 Prophylactic (n = 4)	3.60 (1.38, 5.82)	83	.0005	.0002	3	.09	 	 Therapeutic (n = 14)	1.55 (0.73, 2.37)	80	&lt;.00001	.001	13	 	EV modification (primed/engineered)	 	 Naive (n = 13)	1.91 (0.93, 2.89)	85	&lt;.00001	.0001	12	.66	 	 Engineered/primed (ns = 5)	2.37 (0.56, 4.19)	82	.0002	.01	4	 	</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11092271</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38507620</oboInOwl:hasDbXref>
        <rdfs:label>PDLSC</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000034"/>
        <skos:relatedMatch rdf:resource="CL:2000017"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/3f14d5da-f865-45b2-8728-54148c368931"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000034"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/3f14d5da-f865-45b2-8728-54148c368931"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:2000017"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/3f36cde5-7e3f-4369-8f69-7d88539c9979 -->

    <Class rdf:about="http://example.org/3f36cde5-7e3f-4369-8f69-7d88539c9979">
        <obo:IAO_0000115>We observe that the sickle sample and normal sample morphological parameters histograms are mostly overlapped; however, a nontrivial number of the sickle cells in the distribution exhibit nearly no phenotypic similarities to healthy cells. This unique subset of sickle cells can be extracted from the distribution through implementing a 21:1 SCD-to-normal ratio thresholding criterion. As described above, this means that each criterion is defined by the region in the histogram where the population of SCD cells have 21x greater incidence of that chosen parameter than the normal cell population. The extraction of morphological parameters that uniquely identify sickling cells is a necessary step to constructing a meaningful, pure SCD ground truth set. Without thresholding, the large overlap between the morphological parameters of sickle and normal cells sample will confound the discrimination capacity of a classification algorithm. Furthermore, through refining the training set, we have narrowed down the focus of the classification algorithm to specifically differentiate SCD cells from healthy cells and greatly increase accuracy. The near ideal ROC curves (Figure 2B and Figure 3B) for LR and CNN algorithms when trained on the refined data, indicates that the algorithm practically predicted no false positives and would excel at identifying critically ##sickled cells##. Overall, we have developed a group of metrics that can delineate critically sickling cells in a heterogeneous SCD sample.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10419148</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37569260</oboInOwl:hasDbXref>
        <rdfs:label>sickled cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000232"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/3f36cde5-7e3f-4369-8f69-7d88539c9979"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000232"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/3f4f7c0a-0359-415f-8da8-e60bf2ef4b42 -->

    <Class rdf:about="http://example.org/3f4f7c0a-0359-415f-8da8-e60bf2ef4b42">
        <obo:IAO_0000115>Distinct therapy-induced cancer cell transcriptomes were associated with clinical response. Cancer cells from MPR patients exhibited a signature of activated antigen presentation via major histocompatibility complex class II (MHC-II). Further, the transcriptional signatures of FCRL4+FCRL5+ memory B cells and CD16+CX3CR1+ monocytes were enriched in MPR patients and are predictors of immunotherapy response. Cancer cells from NMPR patients exhibited overexpression of estrogen metabolism enzymes and elevated serum estradiol. In all patients, therapy promoted expansion and activation of cytotoxic T cells and CD16+ NK cells, reduction of immunosuppressive Tregs, and activation of memory CD8+T cells into an effector phenotype. Tissue-resident macrophages were expanded after therapy, and tumor-associated macrophages (TAMs) were remodeled into a neutral instead of an anti-tumor phenotype. We revealed the heterogeneity of neutrophils during immunotherapy and identified an aged CCL3+ neutrophil subset was decreased in MPR patients. The aged CCL3+ neutrophils were predicted to interact with ##SPP1+ TAMs## through a positive feedback loop to contribute to a poor therapy response.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9985263</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36869384</oboInOwl:hasDbXref>
        <rdfs:label>SPP1+ TAMs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/3f4f7c0a-0359-415f-8da8-e60bf2ef4b42"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/3f622698-3486-44b4-be70-15963da32c91 -->

    <Class rdf:about="http://example.org/3f622698-3486-44b4-be70-15963da32c91">
        <obo:IAO_0000115>The relationship between the size of a neuronal soma, the extent of its axodendritic cell volume, or the length and caliber of its axon is complex. It is not necessarily true that large neuronal soma size equates to an extensive axodendritic tree and thus high metabolic demand. The density of afferent and efferent synaptic connectivity, firing rate, and type of neurotransmitter deployed also determine metabolic rate and neuronal soma size (Sengupta et al.,). For example, the axodendritic volume of an adrenergic neuron in the locus coeruleus diffusely projecting to the cerebrum (Chandler et al.,) is likely larger than that of the Betz cell, yet the Betz cell soma is clearly bigger than that of a catecholaminergic neuron in the locus coeruleus. Further, although the soma sizes of certain neuronal classes increase with total brain size, this is not universally true, either; a complex relationship exists, particularly in primates between brain size, increased number of cortical neurons and cell size (Herculano-Houzel,). Nor can the direct monosynaptic connectivity of primate Betz cells with alpha-motoneurons be used as an argument for the large soma size of Betz cells in primates, as carnivores, particularly feliforms, do possess gigantopyramidal neurons which do not make significant monosynaptic contact to anterior horn cells and instead rely on a disynaptic route via spinal cord interneurons (Strick et al.,). Perhaps primate-specific aspects of relative scaling of M1 neurons in relation to spinal cord neurons may contribute to these puzzling observations (Herculano-Houzel et al.,); however, we are not aware of comparative studies on the ##M1 neuron##/spinal cord neuron ratio that specifically stratifies animals by the presence of gigantopyramidal neurons in M1.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10952528</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38289193</oboInOwl:hasDbXref>
        <rdfs:label>M1 neuron</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000540"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/3f622698-3486-44b4-be70-15963da32c91"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000540"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/3f720a10-b83a-4c02-a4b9-2c6384bb35ea -->

    <Class rdf:about="http://example.org/3f720a10-b83a-4c02-a4b9-2c6384bb35ea">
        <obo:IAO_0000115>Comparison of the single cell landscape between healthy human meniscus and degenerated meniscus. (A) Representative polarised light microscopy images of healthy human and degenerated meniscus. The white and red colours in the angle images are 90  apart in orientation. Dashed lines indicate the surface of the meniscus. Scale bar, 100 microm. (B) Merged t-distributed stochastic neighbour embedding (t-SNE) of single-cell RNA sequencing of healthy meniscus cells and degenerated meniscus cells. (C) Twelve healthy human and degenerated meniscus cell clusters at t-SNE. (D) Proportion of each cluster to the total cells. (E) Proportion of healthy and degenerated meniscus cells in each cluster. (F) Expression of representative marker genes in Vin plot. (G) Heatmap revealing the scaled expression of differentially expressed genes for each cluster. (H) CD146 and CD318 expression in healthy human meniscus cells and degenerated meniscus cells determined by flow cytometry. n&gt;=5, **p&lt;0.01. (I) Representative IHC staining of COL1A1 and COL2A1 healthy human meniscus and degenerated meniscus, and quantification of positive cells. Scale bar, 50 microm. n&gt;=5, **p&lt;0.01. (J) The expression of indicated marker genes in human healthy meniscus cells and degenerated meniscus cells were detected by qRT-PCR. *p&lt;0.05, **p&lt;0.01, otherwise, not significant. n=3, *p&lt;0.05, **p&lt;0.01. CPC, cartilage progenitor cells; ##DegP##, degenerated meniscus progenitor cells; EC, endothelial cells; FC, fibrochondrocytes; FCP, fibrochondrocyte progenitors; HTC, hypertrophic chondrocytes; MoDC, monocyte-derived dendritic cells; PreHTC, prehypertrophic chondrocytes; ProFC, proliferate fibrochondrocytes; RegC, regulatory chondrocytes.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7034356</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31871141</oboInOwl:hasDbXref>
        <rdfs:label>DegP</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0011026"/>
        <skos:relatedMatch rdf:resource="CL:2000007"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/3f720a10-b83a-4c02-a4b9-2c6384bb35ea"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0011026"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/3f720a10-b83a-4c02-a4b9-2c6384bb35ea"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:2000007"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/3f7bf7a2-dea2-4d4e-a057-c5eb1378279e -->

    <Class rdf:about="http://example.org/3f7bf7a2-dea2-4d4e-a057-c5eb1378279e">
        <obo:IAO_0000115>SC-EVs have been shown to promote the proliferation and activation of T cells. For example, in mice with type 1 diabetes, islet MSC-derived exosomes were observed to activate APCs and autologous T and B cells in islets, increase their respective specific memory cells, and induce IFN-gamma production, thus accelerating islet destruction. This evidence provides a perspective that certain SC-EVs serve as autoantigen carriers and trigger autoimmune responses. Additionally, The beta-catenin-loading or GM-CSF (granulocyte-macrophage colony-stimulating factor)-expressing EVs derived from SCs could promote T cell antitumor response. For example, the exosomes derived from rat AD-MSCs were observed to accelerate intratumoral ##CD8alpha+ type I NK-T cell## migration and increase circulating NK-T cells to exert antitumor immunity in rats with hepatocellular carcinoma (HCC) (Table 1). In mice with transplanted lung adenocarcinoma, exosomes derived from GM-CSF-expressing embryonic SCs (ESCs) were observed to suppress the migration of immunosuppressive Tregs, whereas they reinforced migration of tumor-reactive CD8+ T effector cells toward intratumor spaces and elevated intratumoral cytokine responses of TNF-alpha and IFN-gamma, contributing to the clearance of foreign components (Table 1). Therefore, EVs derived from engineered SCs may be utilized as a preventive vaccine against the risk of cancer development in human beings.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7026133</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32117221</oboInOwl:hasDbXref>
        <rdfs:label>CD8alpha+ type I NK-T cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000921"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/3f7bf7a2-dea2-4d4e-a057-c5eb1378279e"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000921"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/30b02a3e-1789-42d1-8ecf-ef99127849ac -->

    <Class rdf:about="http://example.org/30b02a3e-1789-42d1-8ecf-ef99127849ac">
        <obo:IAO_0000115>Brain transcriptional changes after MIA require microglia. (A) Simplified schematic of sample processing pipeline from and bar plots of TORCH pathogen and cytokine receptor expression (mean log counts per million) in each cell type across development. (B) Violin plot of CytoTORCH module score for each cell cluster (MG, P&lt;0.05 for ANOVA and for pairwise comparisons between microglia and all other cell types using Tukey&apos;s HST). (C) Overview of experimental design (top) and UMAP visualization of snRNAseq data from the developing somatosensory cortex of E15.5 wild-type and Csf1r-/- mice after saline or Poly(I:C) maternal injection at E12.5 (two or three embryos per condition from a total of four pregnant dams, 42,736 total cells) (bottom). Cells are colored by cell type assignment. (D) Dot plots of log(fold change) in gene expression between MIA and saline for cell types with significant changes at E15.5. DEG analysis was performed using NEBULA. AP, apical progenitors; IP, intermediate progenitors; ImmN, immature neurons, MN, migrating neurons; (UL/DL) CPN, (upper layer/deep layer) callosal projection neurons; ##SCPN##, subcerebral projection neurons; CThPN, corticothalamic projection neurons; LIV, layer IV stellate neurons; IN, interneurons; CR, Cajal-Retzius cells; Astro, astrocytes; CGC, cycling glial cells; Epend; ependymal cells; OL, oligodendroglia; MG, microglia; Peri, pericytes; EC, endothelial cells; VLMC, vascular and leptomeningeal cells. Created with .</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11190434</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38775708</oboInOwl:hasDbXref>
        <rdfs:label>SCPN</rdfs:label>
    </Class>
    


    <!-- http://example.org/30d9368e-3eae-4b2b-9a07-ab5306f4c1b4 -->

    <Class rdf:about="http://example.org/30d9368e-3eae-4b2b-9a07-ab5306f4c1b4">
        <obo:IAO_0000115>Diabetic kidney disease (DKD), a chronic kidney disease, is characterized by progressive fibrosis caused due to persistent hyperglycemia. The development of fibrosis in DKD determines the patient prognosis, but no particularly effective treatment. Here, small extracellular vesicles derived from mesenchymal stem cells (MSC-sEV) have been used to treat DKD fibrosis. Single-cell RNA sequencing was used to analyze 27,424 cells of the kidney, we have found that a novel fibrosis-associated TGF-beta1+Arg1+ macrophage subpopulation, which expanded and polarized in DKD and was noted to be profibrogenic. Additionally, ##Actin+Col4a5+ mesangial cells## in DKD differentiated into myofibroblasts. Multilineage ligand-receptor and cell-communication analysis showed that fibrosis-associated macrophages activated the TGF-beta1/Smad2/3/YAP signal axis, which promotes mesangial fibrosis-like change and accelerates renal fibrosis niche. Subsequently, the transcriptome sequencing and LC-MS/MS analysis indicated that MSC-sEV intervention could restore the levels of the kinase ubiquitin system in DKD and attenuate renal interstitial fibrosis via delivering CK1delta/beta-TRCP to mediate YAP ubiquitination degradation in mesangial cells. Our findings demonstrate the unique cellular and molecular mechanisms of MSC-sEV in treating the DKD fibrosis niche at a single-cell level and provide a novel therapeutic strategy for renal fibrosis.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11184851</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38890734</oboInOwl:hasDbXref>
        <rdfs:label>Actin+Col4a5+ mesangial cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000650"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/30d9368e-3eae-4b2b-9a07-ab5306f4c1b4"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000650"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/30dbea24-b6da-4657-bf73-791a4e293027 -->

    <Class rdf:about="http://example.org/30dbea24-b6da-4657-bf73-791a4e293027">
        <obo:IAO_0000115>Next, we merged the datasets for the five time-points using the merge function of the Seurat pipeline, which combines multiple datasets without transforming the data. The merged dataset with a total of 62,202 cells was processed for clustering and then the data were visualized as a UMAP plot (Fig. 3). The same set of cell clusters identified in individual time-point data was also identified in the merged dataset (Fig. 3A,E and Fig. S6). The downregulation of PAX2 and upregulation of FBXO2 from otic prosensory cells to intermediate otic cells and supporting cells were confirmed with this analysis (Fig. 3E). A DACH1+ SPP1+ population was detected adjacent to OC90+ intermediate otic cells (Fig. 3D, Figs S7 and S8), suggesting the existence of another lineage direction in the otic lineage other than the sensory epithelium. TFAP2B+ surface ectoderm cells, NEUROD1+ neuroblasts and ##S100B+ neural crest/Schwann cells## were identified as distinctive clusters (Fig. 3A,D and Fig. S7). An intermediate population between otic prosensory cells and supporting cells expressed not only otic epithelium markers EPCAM and FBXO2, but also other otic progenitor markers COL9A1, SERPINF1, HES1, AATF, COL14A1, OC90, PRSS8 and EYA4 (Fig. S7), suggesting that this is an otic epithelial cell population differentiating into hair cells and supporting cells. Adjacent to the supporting cell cluster, there was a POU4F3+ hair cell cluster that expressed vestibular hair cell markers [CD164L2, ZBBX, TEKT1, SKOR1, TCTEX1D1 (DYNLT5) and NEUROD6] and type II hair cell markers (ANXA4, MAPT and NHLH1) (Fig. 3D and Fig. S8), indicative of an immature type II hair cell identity. However, we were unable to detect the cochlear marker GATA3 or INSM1 in PCP4+ hair cells (Fig. S8G,H). Surprisingly, we were unable to identify common progenitor populations that differentiate into both hair cells and supporting cells in the merged datasets.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10323240</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37381908</oboInOwl:hasDbXref>
        <rdfs:label>S100B+ neural crest/Schwann cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002377"/>
        <skos:relatedMatch rdf:resource="CL:0011012"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/30dbea24-b6da-4657-bf73-791a4e293027"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002377"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/30dbea24-b6da-4657-bf73-791a4e293027"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0011012"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/300bdc5f-fdad-4a5b-9c58-a84c1cde33e0 -->

    <Class rdf:about="http://example.org/300bdc5f-fdad-4a5b-9c58-a84c1cde33e0">
        <obo:IAO_0000115>To investigate the universal transcriptional program between group 1 ILCs across liver and spleen, we have explored DEGs in Prdm1 cko liver cNK cells and ILC1s using our scRNA-seq data. Compared with liver ILC1s, more DEGs was observed in liver cNK cells, including Junb, Kit, Tcf7, Gzmb, Prf1, etc. (Figure 5:figure supplement 2, A and B). Through the integration of the bulk RNA-seq and scRNA-seq data, we identified 17 DEGs that are regulated by Prdm1 among liver cNK cells, splenic cNK cells, and liver ILC1s. Batf3, Junb, Tcf7, and Nfkb1 was upregulated, whereas Gzmb, Prf1, and Fgl2 downregulated, in both Prdm1 cko liver and splenic cNK cells (Figure 5J). Cxcr6 was downregulated in liver ILC1s and splenic cNK cells in Prdm1 cko mice (Figure 5J). Previous research found that spleen NK cells could be divided into three distinct groups based on their expression levels of CD27, CD62L, CD49a, and CD49b. CD27+CD62L- NK cells have remarkable high expression of Batf3, while it was only barely expressed in CD27+CD62L+ and CD27-CD62L+ NK cells. Based on the sequencing data published by Flommersfeld et al. (GSE180978), a notable negative correlation was observed between the expression levels of Prdm1 and Batf3 (Figure 5:figure supplement 2I). On top of that, our findings unveiled the negative regulatory influence of Prdm1 on Batf3 within both ##spleen and liver NK cells##. This discovery highlights a potential upstream mechanism that may influence the hemostasis of the spleen NK cell subpopulations through Batf3.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11318973</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:39133873</oboInOwl:hasDbXref>
        <rdfs:label>spleen and liver NK cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000623"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/300bdc5f-fdad-4a5b-9c58-a84c1cde33e0"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000623"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/3010c6e5-91b2-444b-b01b-1c7d6c3a8c37 -->

    <Class rdf:about="http://example.org/3010c6e5-91b2-444b-b01b-1c7d6c3a8c37">
        <obo:IAO_0000115>Advances in single-cell RNA-sequencing (scRNA-seq) provide an unprecedented window into cellular identity. The abundance of data requires new theoretical and computational frameworks to analyze the dynamics of differentiation and integrate knowledge from cell atlases. We present single-cell Type Order Parameters (scTOP): a statistical-physics-inspired approach for quantifying cell identity given a reference basis of cell types. scTOP can accurately classify cells, visualize developmental trajectories, and assess the fidelity of engineered cells. Importantly, scTOP does this without feature selection, statistical fitting, or dimensional reduction (e.g. UMAP, PCA, etc.). We illustrate the power of scTOP using human and mouse datasets. By reanalyzing mouse lung data, we characterize a transient hybrid alveolar type 1/alveolar type 2 cell population. Visualizations of lineage tracing hematopoiesis data using scTOP confirm that a single clone can give rise to multiple mature cell types. We assess the transcriptional similarity between endogenous and donor-derived cells in the context of murine ##pulmonary cell## transplantation. Our results suggest physics-inspired order parameters can be an important tool for understanding differentiation and characterizing engineered cells. scTOP is available as an easy-to-use Python package.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10629677</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37756586</oboInOwl:hasDbXref>
        <rdfs:label>pulmonary cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002638"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/3010c6e5-91b2-444b-b01b-1c7d6c3a8c37"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002638"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/3018d7c8-52aa-4710-aed6-8c7ae7cc73a8 -->

    <Class rdf:about="http://example.org/3018d7c8-52aa-4710-aed6-8c7ae7cc73a8">
        <obo:IAO_0000115>In order to investigate the underlying process that may lead to a poor prognosis for high-risk LUAD patients, an analysis of hallmark pathway gene profiles was conducted, revealing distinct characteristics between high- and low-risk groups. A direct comparison between the Risk-High and Risk-Low groups showed that the top five enriched signatures in the high-risk group were MYC target v1, MYC target v2, mTORC1 signaling, G2M checkpoint, and Glycolysis ( Figure 10A ). GSEA enrichment analysis also indicated that the high-risk group had significantly enriched Cell Cycle (NES = 1.93, p&lt; 0.001) and DNA Replication (NES = 1.78, p = 0.000) ( Figure 10B ). The ssGSEA algorithm was employed to examine differences in immune status across distinct risk groups. Low-risk LUAD patients showed increased infiltration of various immune cells, including Active dendritic cells (aDCs), B cells, CD8+ T cells, Dendritic cells (DCs), Immature dendritic cells (iDCs), Mast cells, neutrophils, T helper cell, Tumor-infiltrating lymphocytes (##TILs##), and Regulatory T cells (Treg), in their tumor microenvironment (TME). Furthermore, almost all immune-related pathways were significantly expressed in the low-risk group ( Figures 10C, D ).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10073691</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37033259</oboInOwl:hasDbXref>
        <rdfs:label>TILs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000542"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/3018d7c8-52aa-4710-aed6-8c7ae7cc73a8"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000542"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/30716c8d-d622-4e24-884d-4c3cd78cc181 -->

    <Class rdf:about="http://example.org/30716c8d-d622-4e24-884d-4c3cd78cc181">
        <obo:IAO_0000115>(A) Cluster heatmap of inherited retinal disease-related genes in human ##fetal retinal cells##. (B) Bar plots of representative genes. Cell classes are shown in different colors. AC, amacrine cell; BC, bipolar cell; HC, horizontal cell; PC, photoreceptor cell; RGC, retinal ganglion cell; RPC, retinal progenitor cell; RPE, retinal pigment epithelium; TPM, transcripts per million.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6634428</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31269016</oboInOwl:hasDbXref>
        <rdfs:label>fetal retinal cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:4023129"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/30716c8d-d622-4e24-884d-4c3cd78cc181"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4023129"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/30848519-1887-4cac-b463-f3396f187dac -->

    <Class rdf:about="http://example.org/30848519-1887-4cac-b463-f3396f187dac">
        <obo:IAO_0000115>Cell Population Identity (Abbr.) Up Reg(14,498) IG(85) ORA p ORA q Mean FCIG Mean FCRest GSEA p GSEA q No. IGs with highest expression   Neuroendocrine cells (NendC) 3868 47 2.12E-08 3.82E-07 11.88 5.42 0.0017 0.0051 26   Mature Neurons (all types) (##mNEUR##) 2968 32 0.0002 0.0035 8.80 9.28 - - 2    Arachnoid barrier cells (ABC) 2287 20 0.0396 0.7120 16.84 22.63 - - 7    Tanycytes (TNC) 1279 12 0.0692 1 6.64 12.01 - - 8    Vascular and leptomeningeal cells (VLMC) 1714 15 0.0724 1 15.06 13.03 0.0468 0.1404 4    Oligodendrocyte precursor cells (OPC) 1524 13 0.1067 1 3.03 7.17 - - 1    Pericytes (PC) 1801 14 0.1649 1 8.20 8.22 - - 2    Olfactory ensheathing glia (OEG) 1086 9 0.1848 1 7.95 26.03 - - 1    Oligodendrocytes (OLG) 1183 9 0.2561 1 3.73 12.91 - - 5   Choroid plexus epithelial cells (CPC) 2602 17 0.3524 1 7.43 19.34 - - 5    Hemoglobin-expressing vascular cells (Hb_VC) 1798 11 0.4889 1 5.25 6.33 - - 3    Vascular smooth muscle cells (VSMC) 3006 17 0.6093 1 8.94 6.71 0.1376 0.4128 5    Astrocyte-restricted precursors (ARP) 1445 8 0.6214 1 4.50 5.09 - - 1    Neural stem cells (NSC) 1009 5 0.7138 1 4.00 4.09 - - 0    Ependymocytes (EPC) 3233 17 0.7346 1 15.04 53.27 - - 4    Endothelial cells (EC) 1455 7 0.7619 1 5.80 8.54 - - 0    Hypendymal cells (HypEPC) 1525 6 0.8946 1 17.24 20.80 - - 5    Neuronal-restricted precursor (NRP) 2339 10 0.8979 1 3.07 10.20 - - 1    Astrocytes (ASC) 1384 4 - - 2.22 6.04 - - 0    Dendritic cells (DC) 1209 1 - - 3.50 16.02 - - 1    Immature Neurons (ImmN) 652 4 - - 3.37 5.79 - - 0    Macrophages (MAC) 1222 2 - - 3.47 21.56 - - 0    Microglia (MG) 1342 3 - - 19.28 19.22 - - 3    Monocytes (MNC) 947 2 - - 16.49 19.13 - - 1    Neutrophils (NEUT) 519 2 - - 9.18 62.13 - - 0   </obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9670596</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36384442</oboInOwl:hasDbXref>
        <rdfs:label>mNEUR</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000540"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/30848519-1887-4cac-b463-f3396f187dac"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000540"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/30992089-c6ea-4c05-81b1-cc4911c2ad86 -->

    <Class rdf:about="http://example.org/30992089-c6ea-4c05-81b1-cc4911c2ad86">
        <obo:IAO_0000115>The CellChat analysis was performed to reveal the cell-cell relationships within the progression of BC. According to this result, it was found that the interaction numbers and strength were more prominent in BC patients ( Figure 3A ). More interestingly, except for B and T cells, other cells showed stronger interaction of numbers and strengths in tumor patients relative to normal populations. In contrast, B cells and T cells existed frequent communication with DC cells and ILC cells in healthy groups ( Figure 3B ). Subsequently, the difference in the interaction of different pathways was compared within these two groups. The extraordinary thing was that COMPLEMENT was the only pathway activated in normal populations, whereas other pathways were remarkably activated in BC patients, including CD45, CD99, CCL, IL16 and APP ( Figure 3C ). Furthermore, to constantly detect the changes in submitting or gaining signals between distinctive groups, a comparison based on outgoing and incoming interaction strength in 2D space was conducted. The scatter plot showed that monocytes, DC cells, ILC cells, T cells and B cells served as main sources in normal groups, while macrophages, endothelial cells, mast cells and pDC cells were significant sources in BC patients ( Figure 3D ). Ultimately, the dot plot exhibited stronger interaction possibilities among T cells, B cells and macrophages in BC groups. As the result revealed that almost all molecules were distributed in samples of ##tumor macrophages##, suggesting the interaction of macrophages was the most prominent in tumor samples ( Figure 3E ).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10910050</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38440732</oboInOwl:hasDbXref>
        <rdfs:label>tumor macrophages</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/30992089-c6ea-4c05-81b1-cc4911c2ad86"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/31f1786e-947b-4309-bf54-4ea94e27d15e -->

    <Class rdf:about="http://example.org/31f1786e-947b-4309-bf54-4ea94e27d15e">
        <obo:IAO_0000115>3D spheroids have emerged as powerful drug discovery tools given their high-throughput screening (HTS) compatibility. Here, we describe a method for generating functional neural spheroids by cell-aggregation of differentiated human induced pluripotent stem cell (hiPSC)-derived neurons and ##astrocytes## at cell type compositions mimicking specific regions of the human brain. Recordings of intracellular calcium oscillations were used as functional assays, and the utility of this spheroids system was shown through disease modeling, drug testing, and formation of assembloids to model neurocircuitry. As a proof of concept, we generated spheroids incorporating neurons with Alzheimer&apos;s disease-associated alleles, as well as opioid use disorder modeling spheroids induced by chronic treatment of a mu-opioid receptor agonist. We reversed baseline functional deficits in each pilot disease model with clinically approved treatments and showed that assembloid activity can be chemogenetically manipulated. Here, we lay the groundwork for brain region-specific neural spheroids as a robust functional assay platform for HTS studies.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10684574</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38017066</oboInOwl:hasDbXref>
        <rdfs:label>astrocytes</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000127"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/31f1786e-947b-4309-bf54-4ea94e27d15e"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000127"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/310b6cca-20d7-4858-b53d-0b4caa257268 -->

    <Class rdf:about="http://example.org/310b6cca-20d7-4858-b53d-0b4caa257268">
        <obo:IAO_0000115>In the TME, blocking the CD74-MIF axis restores the antitumor activity of macrophages and dendritic cells against melanoma (Figueiredo et al.). In hypersplenism resulting from HCC, B cells exert antitumor effects on a variety of cells through CD74-COPA (Zhao et al.). Memory B cells in HCC exhibit high proliferation, low differentiation, and low activity, which are induced by the activated MIF-CD74 axis (Bai et al.). CD74-MIF is expressed in the TME of many types of cancer after chemotherapy (Song et al.). Reprogrammed ##TAMs## affect the TME, and the cellular interaction between macrophages and malignant plasma cells is mediated by CD74-MIF, which reshapes the phenotypes of macrophages (Li et al.). The crosstalk among CD8+ T cells, NKT cells, myeloid cells and cytotoxic plasma cells identified the potential immunotarget CD74-MIF (Zhong et al.). In this study, both the interaction between IL-1B-positive macrophages and malignant cells and the interaction between CLEC9A-cDC1-positive DCs and malignant cells were evaluated mainly via the CD74-MIF axis. Therefore, the enriched ligand-receptor pair of CD74-MIF mainly mediated the crosstalk among immune cells and tumor cells in the TME of HCC, possibly through activating macrophages and other immune cells, including B cells, CD8+ T cells and NKT cells, in the TME.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11308498</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:39118044</oboInOwl:hasDbXref>
        <rdfs:label>TAMs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/310b6cca-20d7-4858-b53d-0b4caa257268"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/31117cdd-90a6-429a-9a6b-f8d2258ec4a0 -->

    <Class rdf:about="http://example.org/31117cdd-90a6-429a-9a6b-f8d2258ec4a0">
        <obo:IAO_0000115>Regarding the metabolic effects of the orexin system, orexin receptors are abundantly expressed in brain regions regulating energy metabolism, such as the medullary raphe, DMH, and ARC. More than 50% of serotonergic neurons in the medullary raphe, including the raphe pallidus nucleus (B1), raphe obscurus nucleus (B2), and raphe magnus nucleus (B3), express Ox1r but not Ox2r, which serve as ##sympathetic premotor neurons## to enhance thermogenesis by brown adipose tissue (BAT). The DMH is one of the major upstream regions of medullary raphe neurons, and the excitatory projection from the DMH to the medullary raphe enhances sympathetic outflows. However, Ox2r-expressing DMH cells were mainly GABAergic. The role of DMH GABAergic neurons in the regulation of sympathetic and other functions remains unclear. In the ARC, GABAergic neurons express Ox2r but not Ox1r. Orexin activates ARC GABAergic neurons and suppresses POMC neurons, a subpopulation of ARC GABAergic neurons. Since the loss of either Ox1r or Ox2r only partially mimics the obesity-prone phenotype of orexin-deficient mice, it is suggested that both Ox1r and Ox2r may function independently to render mice less prone to obesity.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10883752</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38199807</oboInOwl:hasDbXref>
        <rdfs:label>sympathetic premotor neurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0011103"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/31117cdd-90a6-429a-9a6b-f8d2258ec4a0"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0011103"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/313b1ba8-de99-4179-9e0f-c3db4c6b511b -->

    <Class rdf:about="http://example.org/313b1ba8-de99-4179-9e0f-c3db4c6b511b">
        <obo:IAO_0000115>In summary, specific imprinted genes have been shown to regulate ##RGP## and adult NSC proliferation behavior and thus their quantitative and qualitative output. The above cited work also supports the hypothesis that imprinted genes encoding for signaling molecules require biallelic expression in adult NSCs to maintain proper OB neuron generation. The control of imprinted gene expression dosage through epigenetic DNA modification represents an intriguing regulatory module with high potential to regulate the generation of cell-type diversity during cortical development.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6587822</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:30276807</oboInOwl:hasDbXref>
        <rdfs:label>RGP</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000681"/>
        <skos:relatedMatch rdf:resource="CL:0011026"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/313b1ba8-de99-4179-9e0f-c3db4c6b511b"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000681"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/313b1ba8-de99-4179-9e0f-c3db4c6b511b"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0011026"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/31552fd5-9501-4b5b-a865-e2af05509146 -->

    <Class rdf:about="http://example.org/31552fd5-9501-4b5b-a865-e2af05509146">
        <obo:IAO_0000115>Besides the 4 leukocyte clusters, we also identified 3 clusters of epithelial cells including podocytes (NPHS2+), renal tubular cells (KRT8+/PSCA-) and urothelial cells (KRT8+/PSCA+). For urine-derived podocyte, Gene Ontology enrichment analysis of the differentially expressed genes identified cell type-specific processes relevant to glomerulus development and renal filtration cell differentiation (Fig. S3A). For urine-derived tubular cells, to further dissect their exact segment localization, we compared our dataset with the previously published kidney single-cell atlas including distinct types of tubular cells from different segments. Based on the &quot;segment gene signature&quot; generated by that kidney single-cell dataset, we classified our urine-derived tubular cells to sub-types. The result showed that the majority (48.8%) of urine-derived tubular cells were collecting duct cells, including principal cells (PCs), intercalated cells (ICs), and the recently identified transitional cell types between PCs and ICs (Park et al.,). Cells from proximal tubule, ##loop of Henle##, and distal tubule are also discovered in the urine (Fig. 1D). Similarly, we dissected that urothelial cells and found that the majority of them (80.7%) were KRT18+ umbrella cells, which were superficial cells covering the urothelium (Fig. S3B).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8018990</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33420958</oboInOwl:hasDbXref>
        <rdfs:label>loop of Henle</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:1000909"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/31552fd5-9501-4b5b-a865-e2af05509146"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:1000909"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/31616005-07e1-4a2e-b56b-229ddf7bd866 -->

    <Class rdf:about="http://example.org/31616005-07e1-4a2e-b56b-229ddf7bd866">
        <obo:IAO_0000115>Using pS6 immunoreactivity to detect ##activated VSNs##, and cFos to detect signal transduction in the AOB revealed that ectopic mutants have an overall decreased apical cells&apos; ability to detect and transduce signals to the aAOB (Figure 6). Notably these defects resulted more obvious, in both males and females, after female bedding exposure (Figure 6).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9525060</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36111787</oboInOwl:hasDbXref>
        <rdfs:label>activated VSNs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:1001561"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/31616005-07e1-4a2e-b56b-229ddf7bd866"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:1001561"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/3169a0bf-e122-45dd-a6f1-df7dac5c4582 -->

    <Class rdf:about="http://example.org/3169a0bf-e122-45dd-a6f1-df7dac5c4582">
        <obo:IAO_0000115>Luteinizing hormone (LH) is a glycoprotein gonadotropin secreted by adenohypophysis cells under the control of GnRH. LH can promote the conversion of cholesterol into sex hormones in ##gonadal cells##. In females, LH stimulates the ovaries to release eggs, and its periodic surge leads to monthly ovulation. Moreover, LH stimulates the production of progesterone and estrogen, as well as the growth of the corpus luteum. In males, LH facilitates the production and release of testosterone from testicular interstitial cells in the testes.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9289199</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35860276</oboInOwl:hasDbXref>
        <rdfs:label>gonadal cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000178"/>
        <skos:relatedMatch rdf:resource="CL:0000501"/>
        <skos:relatedMatch rdf:resource="CL:4052012"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/3169a0bf-e122-45dd-a6f1-df7dac5c4582"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000178"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/3169a0bf-e122-45dd-a6f1-df7dac5c4582"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000501"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/3169a0bf-e122-45dd-a6f1-df7dac5c4582"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4052012"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/3172fb94-a7af-4dd4-8dfd-8f998d11e904 -->

    <Class rdf:about="http://example.org/3172fb94-a7af-4dd4-8dfd-8f998d11e904">
        <obo:IAO_0000115>Sensory neurons can be classified into nociceptors, mechanoceptors, and proprioceptors. The first group expresses the nerve growth factor (NGF)-receptor TRKA (encoded by NTRK1) during maturation, while the others depend on TRKB and TRKC tyrosine kinase signaling. While all peripheral neurons are derived from neural crest progenitors, the ##TRKA-expressing neurons## develop from the subgroup of NGN1-positive neural crest cells. They can be further divided into nociceptor subgroups: Peptidergic neurons release the neuropeptides substance P and calcitonin gene-related peptide and maintain TRKA expression. Non-peptidergic neurons lose expression of TRKA upon maturation, and express the RET neurotrophin receptor instead. Nociceptors can also be distinguished according to their expression of different cation channels like the transient receptor potential (TRP) channels or the purinergic receptor ion channels. Notable members of the TRP family are TRPV1, TRPM8, and TRPA1 channels. The respective major functions are the sensing of heat, cold, or electrophilic chemicals. Temperature-sensing TRP channels are polymodal and can respond to chemical agonists. A prominent example is the TRPV1 channel, which is activated by increased temperatures exceeding the threshold of ~43  C, but also by vanilloid compounds like capsaicin. The purinoceptor P2X3 is the main ATP-activated pain-related channel on nociceptors. As TRPV1 and P2X3 are only found on nociceptors and not on other sensory neurons (eg, stretch receptors), they can serve as characteristic functional biomarkers.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9299516</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35689659</oboInOwl:hasDbXref>
        <rdfs:label>TRKA-expressing neurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000540"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/3172fb94-a7af-4dd4-8dfd-8f998d11e904"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000540"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/3190f37a-be11-44b8-b6f0-fb0257195624 -->

    <Class rdf:about="http://example.org/3190f37a-be11-44b8-b6f0-fb0257195624">
        <obo:IAO_0000115>Due to microfluidic channel limitations on the 10x Genomics platform, only oocytes with a diameter less than 50 microm could be obtained. To determine the oocyte stage, previously reported stage-specific markers, including LMOD3 and FOS for primordial oocytes, RPS4X and FIGLA for primary oocytes, SYT5, STK26 and TAF1A for secondary oocytes, UBOX5 and CCDC25 for antral oocytes, and HTRA3 and NBPF12 for ##preovulatory oocytes##, were analyzed. scRNA-seq results indicated high expression of LMOD3, FOS, RPS4X and FIGLA in these oocytes, suggesting that they were at the primordial or primary stage (Extended Data Fig. 4a).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11031396</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38594460</oboInOwl:hasDbXref>
        <rdfs:label>preovulatory oocytes</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000654"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/3190f37a-be11-44b8-b6f0-fb0257195624"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000654"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/32baaca7-8986-41d8-a476-173070aa1ba9 -->

    <Class rdf:about="http://example.org/32baaca7-8986-41d8-a476-173070aa1ba9">
        <obo:IAO_0000115>A, B, tSNE plot of 4659 CD45+ immune cells from the CNS. Data from this study is integrated with data from; Table 6). C, D, Each dataset represented by one tSNE. Cells are annotated using color representing their cell type. bMicroglia: baseline microglia; aMicroglia: activated microglia; pmMicroglia: proliferation-mediating microglia; maMicroglia: monocyte-activating microglia; DAM: ##disease-associated microglia in SCI##; elMicroglia: embryonic-like microglia; pvMacrophages: perivascular macrophages; mdMacrophages: monocyte-derived macrophages; DCs: dendritic cells; imB-cells: immature B-cells; mB-cells: mature B-cells; pimMicroglia: postnatal immature microglia; IEG+Microglia: immediate early genes microglia; sMicroglia: s-phase microglia; pPAM: postnatal proliferative-region-associated microglia; eMicroglia: embryonic microglia; pcpMacrophages: postnatal choroid plexus macrophages; acpMacrophages: adult choroid plexus macrophages; iMonocytes: inflammatory monocytes; pMonocytes: patrolling monocytes; cpEpithelial cells: choroid plexus epithelial cells. E, tSNE plots of 4659 CD45+ immune cells for selected genes indicating the log2(cpm) expression with a continuous color for each cell separately. F, Proliferation rate of CD45low and CD45high cells at 7 and 21 d post-SCI. Hoechst 33342 expression presented on a log-scale was used for defining cells in S-phase. Right most plot reports the percentage of cells in S-phase. Each dot represents one biological replicate (four mice per time point). Mean is surrounded by a 95% CI. This figure is extended in Extended Data Figure 8-1.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8496189</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34417326</oboInOwl:hasDbXref>
        <rdfs:label>disease-associated microglia in SCI</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000129"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/32baaca7-8986-41d8-a476-173070aa1ba9"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000129"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/32feac35-6b7e-4426-b44b-18f599f6bece -->

    <Class rdf:about="http://example.org/32feac35-6b7e-4426-b44b-18f599f6bece">
        <obo:IAO_0000115> Effect of AXL/MERTK knockdown on microglial uptake of alpha-synuclein preformed fibrils. Microglia were transfected with siCON, siAXL and/or siMERTK. (A) Cell surface expression of AXL and MerTK assessed by flow cytometry on live induced pluripotent stem cell-derived microglia (iMGL) 48 h following transfection. Repeated measure one-way ANOVA were performed followed by Dunnett&apos;s post hoc test. Mean +- SEM of n = 5; *P &lt; 0.05, **P &lt; 0.01; MFI = median fluorescence intensity. (B) Quantification of mean green fluorescence intensity (MFI) in induced pluripotent stem cell-derived microglia (iMGL) culture challenged with pHrodoTM Green-labelled alpha-synuclein (alpha-syn) preformed fibrils (PFFs) for 2 h. A repeated measure one-way ANOVA was performed followed by Dunnett&apos;s post hoc test. Mean +- SEM of n = 5; **P &lt; 0.01. (C) Representative images of iMGL challenged with pHrodoTM Green-labelled alpha-syn PFFs for 2 h and counterstained with Hoechst 33342 (blue). Scale bar = 150 mum. (D) qRT-PCR assessment of AXL and MERTK expression in fetal microglia (##fMGL##) 48 h following transfection. Repeated measure one-way ANOVA were performed followed by Dunnett&apos;s post hoc test. Mean +- SEM of n = 3; *P &lt; 0.05, ***P &lt; 0.001. (E) Quantification of mean green fluorescence intensity (MFI) in fMGL culture challenged with pHrodoTM Green-labelled alpha-syn PFFs for 2 h. A repeated measure one-way ANOVA was performed followed by Dunnett&apos;s post hoc test. Mean +- SEM of n = 4; *P &lt; 0.05, **P &lt; 0.01. (F) Representative fluorescence images of fMGL challenged with pHrodoTM Green-labelled alpha-syn PFFs for 2 h and counterstained with Hoechst 33342 (blue). Scale bar = 200 mum. (G) Viability of fMGL 48 h following transfection. A repeated measure one-way ANOVA was performed followed by Dunnett&apos;s post hoc test. Mean +- SEM of n = 4.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10834256</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37671615</oboInOwl:hasDbXref>
        <rdfs:label>fMGL</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000129"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/32feac35-6b7e-4426-b44b-18f599f6bece"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000129"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/320c5faf-842a-42e1-9798-712d70002c32 -->

    <Class rdf:about="http://example.org/320c5faf-842a-42e1-9798-712d70002c32">
        <obo:IAO_0000115>Cells Young Lymph Node Old Lymph Node   T lymphocytes effective activation of T cells by antigensefficient proliferationproduction of effector cytokinesmigration to peripheral tissues to fulfill effector functions impaired homeostatic proliferation of T cellsdisturbed movement, localization, and responsesreduced size of the naive T-cell pool including CD4+ and CD8+ T cells, increased memory T lymphocyte poolincreased CD4+ to CD8+ T-cell ratioCD4+ T lymphocyte depletion in the paracortical zonedecreased number of regulatory T-cells in the cords and medullary sinusesreduced number of CD4+ PD1hi Tfh cells and increased number of CD4+ FoxP3hi and Lag3hi suppressor T cells in germinal centers   B lymphocytes correct interactions between B lymphocytes, follicular T helper lymphocytes, and FDCs in germinal centersadequate activation, proliferation, somatic hypermutation, and maturation of antigen-specific B-cellseffective production of antigen-specific antibodies decreased number of ##CD20hi Ki67hi proliferating B cells## in germinal centersloss of an organized B-cell structure in the follicles after immune stimulationdisrupted reciprocal regulation between B and Tfh lymphocytes resulting in an impaired antigen-specific B-cell response and effective selection of lymphocytes producing specific antibodiesimpaired production of IgM and IgG antibodiesdecreased expression of the E47 transcription factor and activation-induced cytidine deaminase resulting in the production of antibodies with reduced affinity for foreign antigensweakened antibody neutralizing function   Neutrophils effective recruitment of neutrophils to the draining lymph nodes upon microbial, viral, or sterile stimulisearch for and capture antigensrelease leukotriene B4 initiating the recruitment of other neutrophils from the vascular systemupon activation, release granular proteins and chromatin, forming extracellular fibers capturing microorganisms to prevent their spread increased number and percentage of not proliferating old neutrophils in the T- and B-cell zones of the lymph nodesweak response to chemotactic signalsdecreased apoptosisdecreased phagocytosisincreased percentage of neutrophils expressing integrin CD11b, ICAM-1, and TGF-beta suggesting involvement in a chronic inflammatory state   </obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8621398</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34831371</oboInOwl:hasDbXref>
        <rdfs:label>CD20hi Ki67hi proliferating B cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:4033068"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/320c5faf-842a-42e1-9798-712d70002c32"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4033068"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/322b315b-6b55-4c81-8f01-bbdebdd82ea1 -->

    <Class rdf:about="http://example.org/322b315b-6b55-4c81-8f01-bbdebdd82ea1">
        <obo:IAO_0000115>Sequencing of CD45+ cells from 12- and 21-week-old WT and DB hindpaws generated an integrated dataset of 21,661 cells grouped into 12 clusters (Fig. 1c-f), defined as: macrophages (Pf4, C1qa, C1qc, Apoe, C1qb), type 2 conventional dendritic cells (##cDC2##) (CD74, H2-Aa, H2-Ab1, H2-Eb1, Mgl1), mast cells/basophils (M/B) (Mcpt2, Cma1, Cpa3, Mcpt4, Tpsb2), dermal gammadelta T (dTgammadelta) cells (Trdc, Cd163l1, Trdv4, Cxcr6, F2r), heterogeneous T (Thet) cells (Ikzf2, Ctla4, CD28, Trac, Icos), Type 2 innate lymphoid cells (ILC2) (Ctla2a, Gata3, Lmo4, Hlf, Il13), natural killer (NK) cells (Ccl5, xcl1, AW112010, Txk, Ly6c2), dendritic epidermal T cells (DETC; Cd7, Trat1, CD3e, Gem, Fermt2), type 1 conventional dendritic cells (cDC1) cells (Irf8, CD207, Tbc1d4, Cst3, Naaa), B cells (Igkc, Ighm, Ebf1, CD79a, Iglc2), monocyte-derived macrophages (MdMacro) (Plac8, Ifitm3, Lst1, Chil3, Thbs1), and neutrophils (Neut) (S100a9, S100a8, Retnlg, G0s2, Acod1) (Fig. 1g, Supplementary Fig. 1 and Supplementary Table 2). After quality control and filtering, the number of single-cell transcriptomes was 3,946 (12-week-WT), 5,413 (12-week-DB), 4,852 (21-week-WT), and 7,450 (21-week-DB). When each sample was represented as a proportion of the integrated cluster total, variation in cell numbers in each cluster was apparent (Fig. 1e, f). Macrophages were the most abundant cell type across all samples, while mast cell/basophil (M/B), dermal gammadelta T cell (dTgammadelta), heterogeneous T cell (Thet), and Type 2 innate lymphoid cell (ILC2) populations were substantially increased in 21-week-DB mice (Fig. 1f and Supplementary Table 3).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10951029</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38502310</oboInOwl:hasDbXref>
        <rdfs:label>cDC2</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000990"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/322b315b-6b55-4c81-8f01-bbdebdd82ea1"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000990"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/32233465-ffae-4fb9-b7ab-c86ac8aad0f1 -->

    <Class rdf:about="http://example.org/32233465-ffae-4fb9-b7ab-c86ac8aad0f1">
        <obo:IAO_0000115>In summary, Scgb1a1+ cell loss induces widespread cellular activation with immediate proliferation of several populations in the lung rather than triggering a specific cell type. Among the dividing cells were goblet, ##basal-goblet##, and AT2-primed club cell populations, which might represent progenitors or intermediate cell states in the distal lung.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10933319</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38472236</oboInOwl:hasDbXref>
        <rdfs:label>basal-goblet</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002370"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/32233465-ffae-4fb9-b7ab-c86ac8aad0f1"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002370"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/324257f9-aee6-4e78-b962-5560aecc69e2 -->

    <Class rdf:about="http://example.org/324257f9-aee6-4e78-b962-5560aecc69e2">
        <obo:IAO_0000115>Next, we examined the upregulated CD marker genes and plasma membrane protein genes in VSMCs stimulated by aortic disease conditions in 8065 markers of human 79 cell types identified in the tissue cell type section in the HPA database (https://www.proteinatlas.org/humanproteome/tissue+cell+type) ( Figure 7C ) and found that 18 cell types exhibit a proportion of upregulated plasma membrane protein genes within the cell-type markers that ranges from 2% to less than 5%, including proximal enterocytes, paneth cells, intestinal goblet cells, basal keratinocytes, squamous epithelial cells, cholangiocytes, enteroendocrine cells, pancreatic endocrine cells, microglial cells, syncytiotrophoblasts, extravillous trophoblasts, cardiomyocytes, skeletal myocytes, melanocytes, monocytes, macrophages, Hofbauer cells, Kupffer cells; 12 cell types exhibit a proportion of upregulated plasma membrane protein genes within the cell-type markers that equal to or greater than 5%, including alveolar cells type 1, alveolar cells type 2, thymic epithelial cells, Leydig cells, endothelial cells, smooth muscle cells, adipocytes, fibroblasts, peritubular cells, endometrial stromal cells, granulocytes, Langerhans cells; 20 cell types exhibit a proportion of upregulated CD marker genes within the cell-type markers that ranges from 2% to less than 5%, including paneth cells, ##distal enterocytes##, basal prostatic cells, glandular and luminal cells, thymic epithelial cells, Leydig cells, extravillous trophoblasts, endothelial cells, smooth muscle cells, adipocytes, melanocytes, fibroblasts, peritubular cells, T-cells, NK-cells, monocytes, macrophages, Hofbauer cells, Kupffer cells, dendritic cells; and 3 cell types exhibit a proportion of upregulated CD marker genes within the cell-type markers that equal to or greater than 5%, including endometrial stromal cells, granulocytes, and Langerhans cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10847266</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38327764</oboInOwl:hasDbXref>
        <rdfs:label>distal enterocytes</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000584"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/324257f9-aee6-4e78-b962-5560aecc69e2"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000584"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/3271fffc-4fd7-4a7d-878e-6bc8113a6271 -->

    <Class rdf:about="http://example.org/3271fffc-4fd7-4a7d-878e-6bc8113a6271">
        <obo:IAO_0000115>Considering the close relationship between RGPRG score and immune activity, we sought to further explore the immune infiltrate landscape of two RGPRG score groups. The 22 immune cell composition of HCC patients from the TCGA cohort was shown in Fig. 5A. CD8 T cells, ##resting memory CD4 T cells##, M0 Macrophages, M1 Macrophages, and M2 Macrophages were the main immune cell composition of HCC patients. Many differential immune cell infiltrations could be observed between high- and low-RGPRG score groups (Fig. 5B). Patients with high RGPRG score was characterized by the high infiltration of resting memory CD4 T cells, M0 Macrophages, T cells regulatory (Tregs), naive B cells, memory B cells, Plasma cells, naive CD4 T cells, Eosinophils, indicating a status of immunosuppression in this groups. CD8 T cells, activated memory CD4 T cells, activated NK cells, M1 Macrophages, M2 Macrophages, follicular helper T cells, gamma delta T cells, Neutrophils, resting Dendritic cells, activated Dendritic cells, resting NK cells, Monocytes, resting Mast cells, and activated Mast cells were abundant in the patients with low RGPRG score (Fig. 5C), suggesting enhanced antitumor environment. In addition, the expression of 8 classical immune checkpoint genes between two RGPRG score groups was further estimated in the TCGA cohort, and we found that Patients with high RGPRG score had higher expression levels of CD274, CTLA4, LAG3, PDCD1, and TIGIT (Fig. 5D), which presented another characteristic of immunosuppression.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10832138</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38297333</oboInOwl:hasDbXref>
        <rdfs:label>resting memory CD4 T cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000897"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/3271fffc-4fd7-4a7d-878e-6bc8113a6271"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000897"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/328a03dd-8c5b-40f3-83d6-e5fd25e1ce97 -->

    <Class rdf:about="http://example.org/328a03dd-8c5b-40f3-83d6-e5fd25e1ce97">
        <obo:IAO_0000115>Downstream of the multipotent HSCs and MPPs, the original lineage bifurcation model strictly separated oligopotent Common Lymphoid Progenitors (CLP) from Common Myeloid Progenitors (CMP) which could further diverge into Megakaryocyte/Erythrocyte Progenitors (MEPs), Monocyte (Mo)/Dendritic cell (DC) Progenitors (MDPs) and Granulocyte/Mo Progenitors (GMPs). However, this model has been the subject of ongoing revision in the scRNA-seq era. On the one hand, a Lymphoid-primed MultiPotent Progenitor (LMPP) with combined lymphoid and myeloid potential has been shown to gradually lose myeloid potential by upregulating the interleukin-7 receptor alpha-chain (IL7Ralpha) and differentiate into Dach1- Lymphoid-Primed Progenitors (LPPs) prior to CLPs. On the other hand, erythroid-versus-myeloid fate decisions seem to be made prior to CMP commitment, calling for in-depth revision of all CMP progeny (MEPs, MDPs and GMPs) as well. While the Flt3L+CD115lo CMPs give rise to oligopotent MDPs, the Flt3-CD115- CMPs give rise to GMPs. The former are defined by TF co-expression of CEBPA, IRF8 and RUNX1. MDPs can give rise to IRF8/SATB1 plasmacytoid DC (pDC) Progenitors (##pDCPs##) and HLA-DR/IRF8/CEBPA Mo/conventional DC (cDC) Progenitors (McDPs). The latter bifurcate in CD11c/CD172ab/CD14 (human) or Ly6C+ Mo (mouse) or IRF8/HLA-DR/CD84/CD172ab Common DC Progenitors (CDPs). In contrast, GMPs (Kit, CD34, Sox4) are very heterogeneous at the transcriptomic and proteomic level and can adjust their functional output towards common Mo Progenitors (cMoP) and Granulocyte Progenitors (GPs).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11324509</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:39148724</oboInOwl:hasDbXref>
        <rdfs:label>pDCPs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002009"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/328a03dd-8c5b-40f3-83d6-e5fd25e1ce97"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002009"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/32811043-7df4-4f51-b807-1d7197beab91 -->

    <Class rdf:about="http://example.org/32811043-7df4-4f51-b807-1d7197beab91">
        <obo:IAO_0000115>Signs of mNPDR include microaneurysms and small haemorrhages or transient BRB leakage, which are all related to microvascular damage. Previous studies have demonstrated that STAT3 activation in endothelial cells contributes to the early vascular damage in DR. STAT3 may contribute to the early vascular damage through activating genes related to inflammation and angiogenesis such as VEGF and hypoxia-inducible factor 1. STAT3 activation is also known to be involved in hyperglycaemia-induced endoplasmic reticulum stress in endothelial cells; inhibiting NOX4 can attenuate high-glucose induced reactive oxygen species (ROS) generation and STAT3 activation. Our study suggests that STAT3 activation in ##leukocytes## also contributes to diabetes-induced vascular damage.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6615157</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31286987</oboInOwl:hasDbXref>
        <rdfs:label>leukocytes</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000738"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/32811043-7df4-4f51-b807-1d7197beab91"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000738"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/3293fc28-f948-4006-90c0-a208e51118b1 -->

    <Class rdf:about="http://example.org/3293fc28-f948-4006-90c0-a208e51118b1">
        <obo:IAO_0000115>Reference strains Ba/Apache-2 and E/Bour were used to infect HeLa 229 and immortalized human conjunctival epithelial (HCjE) cells, primary ##conjunctival epithelial (CjE) cells and stromal fibroblasts## (CjS cells), primary endocervical epithelial (EcE) cells and stromal fibroblasts (EcS cells), and endometrial stromal fibroblasts (EmS cells). Cell composition and type were validated prior to our performing each assay using cytokeratin- and fibronectin-specific antibodies (see Fig. S1 in the supplemental material). Table S1 shows the origins of human primary cells by patient age and sex for CjE and CjS cells and by age for EcE, EcS, and EmS cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6426598</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:30890604</oboInOwl:hasDbXref>
        <rdfs:label>conjunctival epithelial (CjE) cells and stromal fibroblasts</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000057"/>
        <skos:relatedMatch rdf:resource="CL:1000432"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/3293fc28-f948-4006-90c0-a208e51118b1"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000057"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/3293fc28-f948-4006-90c0-a208e51118b1"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:1000432"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/33a91916-eb20-4570-951a-2678e416a3e7 -->

    <Class rdf:about="http://example.org/33a91916-eb20-4570-951a-2678e416a3e7">
        <obo:IAO_0000115>Other studies have examined and set out to better characterize human ##B-1 and B-2 lymphoid## development. As indicated earlier, innate-like B-1 (B-1a and B-1b) and conventional B-2 cells constitute two main branches of the murine B cell population. During embryonic and fetal development, murine B-1a subsets are proposed to arise from multiple sites including yolk sac, P-Sp/AGM and fetal liver from HSC independent or dependent precursors, and to a lesser degree from adult bone marrow HSCs. Although much less is known about the equivalent human B-1 B cells, these cells were provisionally identified as CD20+CD27+CD43+CD70- cells in UCB and adult peripheral blood, and in other studies, in fetal liver and fetal bone marrow as well as UCB, reaching their highest frequency in fetal liver around 10 pcw. As this phenotypic cell subset may also contain CD20+CD38hi plasmablast and preplasmablast precursors, it remains possible that the human fetal B-1 B cell frequency has been over estimated. Putative human B-1 cells, the earliest B cells to arise in the human fetus, were therefore subsequently identified phenotypically as CD19+CD20+CD27+CD43+CD38lo/int, while lacking CD3, CD4 and CD8 T cell markers, making them distinct from B-2 lymphoid cells, which are predominantly found in adult tissues. Whether human B-1 and B-2 B cells arise from different progenitors or a common progenitor is unclear. However, recent evidence examining hematopoietic lineage output at the clonal level from the peripheral blood of adult patients with paroxysmal nocturnal hemoglobinuria (PNH) suggests that this putative human B-1 B cell population can also arise in the adult from HSCs, while other studies indicate that human adult B-1 B cell frequency and diversity decline with aging, particularly after the age of 50.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8999121</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35409034</oboInOwl:hasDbXref>
        <rdfs:label>B-1 and B-2 lymphoid</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000819"/>
        <skos:relatedMatch rdf:resource="CL:0000822"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/33a91916-eb20-4570-951a-2678e416a3e7"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000819"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/33a91916-eb20-4570-951a-2678e416a3e7"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000822"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/33b8a307-8307-4c70-9230-5a92131b6c81 -->

    <Class rdf:about="http://example.org/33b8a307-8307-4c70-9230-5a92131b6c81">
        <obo:IAO_0000115>(F) Relative abundance of each cluster in MMPs of vehicle-versus teriparatide-treated mice. OB, osteoblast; preOB, preosteoblast; COP, chondrocyte-like osteoprogenitor; MALP, ##marrow adipocyte lineage progenitor##.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8432334</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34407400</oboInOwl:hasDbXref>
        <rdfs:label>marrow adipocyte lineage progenitor</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0010001"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/33b8a307-8307-4c70-9230-5a92131b6c81"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0010001"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/33bbeb46-0216-433f-921d-69bdbfceea15 -->

    <Class rdf:about="http://example.org/33bbeb46-0216-433f-921d-69bdbfceea15">
        <obo:IAO_0000115>Diagram showing cerebellar neuron and astrocyte cell types and their placement in cerebellar architecture. Neurons = granule neuron, Purkinje neuron, Unipolar brush cell, Lugaro cell, Golgi cell, Basket cell, Stellate cell, neuron of cerebellar nuclei. Astrocytes = Fibrous astrocyte, ##Velate astrocyte##, Bergman glia. (Reprinted from &quot;Cerebellar Astrocytes: Much More Than Passive Bystanders In Ataxia Pathophysiology&quot; by Cerrato, V., 2020, J Clin Med, 9, p. 757)</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11585519</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37950146</oboInOwl:hasDbXref>
        <rdfs:label>Velate astrocyte</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000127"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/33bbeb46-0216-433f-921d-69bdbfceea15"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000127"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/3350315f-c65a-4eaa-97cc-4c6225dd6bf7 -->

    <Class rdf:about="http://example.org/3350315f-c65a-4eaa-97cc-4c6225dd6bf7">
        <obo:IAO_0000115>scRNA sequencing data was analyzed to further explore the synergistic effect of the IRRS and the TME cells in ESCC. We used the previously profiled transcriptomes of ~208,659 single cells with eight main cell populations ( Figures 4A, B ), among which fibroblasts, endothelial cells, T cells, B cells, pericytes and myeloid cells were analyzed. Next, 40 cell clusters, including T helper 17 (TH17) cells, follicular helper T (TFH1/2) cells, naive T (TN) cells, regulatory T (Treg) cells, memory T (TMEM-CD4/CD8) cells, effector T (TEFF) cells, exhausted T (TEX) cells, monocytes (##Mono##01-03), tumor-associated macrophages (TAM01-04),dendritic cells (tDC, pDC, cDC), mast cells (Mast), resting B cells, activated B cells, germinal center B cells (GCB), plasma cells, normal mucosa fibroblasts (NMF), normal activated fibroblasts (NAF1/2), cancer-associated fibroblasts (CAF1-4), vascular smooth muscle cells (VSMC), normal endothelial cells (NEC1-3) and tumor endothelial cell (TEC1-3) were identified by t-SNE analysis ( Figures 4C-G ;  Figures S6A-E ). We then used CIBERSORTx to infer cell-type abundance from bulk RNA-seq data using scRNA data, and estimated the proportions of the 42 cell types in the training dataset. The proportions of TME cell types between the high- and low-risk groups was compared using the Kruskal-Wallis test. The profiles of the high- and low-risk groups are shown in  Figure 4H  and  Figure S6F . The abundance of TEX, NAF2, CAF4, and VSMC increased, and the abundance of Mono1, TAM03, and NEC2 decreased in the high-risk group (p &lt; 0.05;  Figure 4I ). The cell proportions between low and high risk groups demonstrated significantly distinct TME patterns.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9933905</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36817484</oboInOwl:hasDbXref>
        <rdfs:label>Mono</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000576"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/3350315f-c65a-4eaa-97cc-4c6225dd6bf7"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000576"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/338fc704-9293-41a2-9bc1-10a319f20ac9 -->

    <Class rdf:about="http://example.org/338fc704-9293-41a2-9bc1-10a319f20ac9">
        <obo:IAO_0000115>Macrophages are multi-functional innate immune cells that orchestrate tissue repair, immune responses and inflammation. First described by Elie Metchnikoff, macrophages are derived from embryonic haematopoietic progenitors or monocytes and differentiate into tissue macrophages after entering the tissue. Because macrophages play an indispensable role in maintaining systemic homeostasis and participating in immune defence against pathogens and cellular debris, they are widely distributed across various tissues, including the salivary glands. Recent studies have shown that macrophages perform several other functions in addition to phagocytosis. Macrophages and T cells can collectively regulate inflammation and participate in various functions such as phagocytosis and antigen presentation. This phenomenon has been partly confirmed in a noninflamed murine submandibular salivary gland model, as macrophages facilitate the local accumulation of tissue-resident memory CD8+ T cells (T+ RM) at the site of inflammation. Tissue-resident immune cells are thought to be complemented by ##salivary gland progenitor cells## (SGPCs) for the maintenance of normal salivary gland homeostasis. Upon tissue damage, epithelial cells release inflammatory factors and recruit macrophages to induce inflammatory responses. Through their uncontrolled and rapid cytokine production, macrophages recruit more immune cells to amplify the local inflammatory response, thereby bridging innate and adaptive immunity.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10656691</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38022546</oboInOwl:hasDbXref>
        <rdfs:label>salivary gland progenitor cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0009005"/>
        <skos:relatedMatch rdf:resource="CL:0011026"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/338fc704-9293-41a2-9bc1-10a319f20ac9"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0009005"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/338fc704-9293-41a2-9bc1-10a319f20ac9"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0011026"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/3385fde2-1af1-42f3-9cf8-617478c532c6 -->

    <Class rdf:about="http://example.org/3385fde2-1af1-42f3-9cf8-617478c532c6">
        <obo:IAO_0000115>Results: We showed that two distinct pericyte subpopulations, marked by NG2+ and Tbx18+, had different potency following brain injury. ##NG2+ pericytes## expressed dominant neural reprogramming potential to produce newborn neurons, while Tbx18+ pericytes displayed dominant multipotency to produce endothelial cells, fibroblasts, and microglia following ischemic stroke. In addition, we discovered that AMPK modulators facilitated pericyte-to-neuron conversion by modulating Ser436 phosphorylation status of CBP, to coordinate an acetylation shift between Sox2 and histone H2B, and to regulate Sox2 nuclear-cytoplasmic trafficking during the reprogramming/differentiation process. Finally, we showed that sequential treatment of compound C (CpdC) and metformin, AMPK inhibitor and activator respectively, robustly facilitated the conversion of human pericytes into functional neurons.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11488099</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:39431007</oboInOwl:hasDbXref>
        <rdfs:label>NG2+ pericytes</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002575"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/3385fde2-1af1-42f3-9cf8-617478c532c6"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002575"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/34c7b904-3fd4-4295-908f-d5734dab79e4 -->

    <Class rdf:about="http://example.org/34c7b904-3fd4-4295-908f-d5734dab79e4">
        <obo:IAO_0000115>After SPNs, most of the remaining neurons of the striatum are constituted by a diverse variety of GABAergic interneurons. The most commonly used markers to distinguish between subtypes of striatal GABAergic interneurons are parvalbumin, calretinin, and nitric oxide synthase. In human tissue, apparent LRRK2 expression has been observed in a majority of calretinin-expressing interneurons, as well as a small subset of ##parvalbumin- and nitric-oxide-synthase-expressing neurons##. However, in mice, LRRK2 staining was observed in most parvalbumin- and nitric-oxide-synthase-positive neurons and only a few calretinin-positive cells. In contrast, other groups have found no colocalization between LRRK2 and any of these markers. Single-cell mRNA expression across all types of GABAergic interneurons is approximately an order of magnitude lower than in SPNs. If the expression of the LRRK2 protein correlates with the mRNA levels reported by Saunders and colleagues, striatal interneurons would contain much less protein than the surrounding SPNs. This would increase the difficulty of detection, potentially explaining part of the apparent discrepancy among these studies. </obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8750662</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35011731</oboInOwl:hasDbXref>
        <rdfs:label>parvalbumin- and nitric-oxide-synthase-expressing neurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000528"/>
        <skos:relatedMatch rdf:resource="CL:0000540"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/34c7b904-3fd4-4295-908f-d5734dab79e4"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000528"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/34c7b904-3fd4-4295-908f-d5734dab79e4"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000540"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/3438cac4-7c07-4292-aeda-741ff4202561 -->

    <Class rdf:about="http://example.org/3438cac4-7c07-4292-aeda-741ff4202561">
        <obo:IAO_0000115>The unwounded, normal corneal stroma is a relatively simple, avascular tissue populated with ##quiescent keratocytes##, along with corneal nerves and a few resident dendritic and monocyte/macrophage cells. In the past, the resting keratocytes were thought of as a homogenous cellular population, but recent work has shown local variations in vimentin and nestin expression, and responsiveness to transforming growth factor (TGF)-beta1. Studies have also supported there being &quot;stromal stem cells&quot; in localized areas. After corneal wounding, depending on the site and severity of injury, profound changes in stromal cellularity occur. Anterior or posterior injuries to the epithelium or endothelium, respectively, trigger apoptosis of adjacent keratocytes. Many contiguous keratocytes transition to keratocan-negative corneal fibroblasts that are proliferative and produce limited amounts of disorganized extracellular matrix components. Simultaneously, large numbers of bone marrow-derived cells, including monocytes, neutrophils, fibrocytes and lymphocytes, invade the stroma from the limbal blood vessels. Ongoing adequate levels of TGFbeta1, TGFbeta2 and platelet-derived growth factor (PDGF) from epithelium, tears, endothelium and aqueous humor that penetrate defective or absent epithelial barrier function (EBF) and epithelial basement membrane (EBM) and/or Descemet&apos;s basement membrane (DBM) drive corneal fibroblasts and fibrocytes to differentiate into alpha-smooth muscle actin (SMA)-positive myofibroblasts. If the EBF, EBM and/or DBM are repaired or replaced in a timely manner, typically measured in weeks, then corneal fibroblast and fibrocyte progeny, deprived of requisite levels of TGFbeta1 and TGFbeta2, undergo apoptosis or revert to their precursor cell-types. If the EBF, EBM and/or DBM are not repaired or replaced, stromal levels of TGFbeta1 and TGFbeta2 remain elevated, and mature myofibroblasts are generated from corneal fibroblasts and fibrocyte precursors that produce prodigious amounts of disordered extracellular matrix materials associated with scarring fibrosis. This fibrotic stromal matrix persists, at least until the EBF, EBM and/or DBM are regenerated or replaced, and keratocytes remove and reorganize the affected stromal matrix.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7855915</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33068626</oboInOwl:hasDbXref>
        <rdfs:label>quiescent keratocytes</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002363"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/3438cac4-7c07-4292-aeda-741ff4202561"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002363"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/3459094e-38b4-4d24-b0ca-bde199028554 -->

    <Class rdf:about="http://example.org/3459094e-38b4-4d24-b0ca-bde199028554">
        <obo:IAO_0000115>Chronic pain is a highly debilitating condition that differs by type, prevalence, and severity between men and women. To uncover the molecular underpinnings of these differences, it is critical to analyze the transcriptomes of spinal cord pain-processing networks for both sexes. Despite several recently published single-nucleus RNA-sequencing (snRNA-seq) studies on the function and composition of the mouse spinal cord, a gene expression analysis investigating the differences between males and females has yet to be performed. Here, we combined data from three different large-scale snRNA-seq studies, which used sex-identified adult mice. Using SeqSeek, we classified more than 37,000 unique viable cells within predicted cell types with the use of machine learning. We then utilized DESeq2 to identify significant differentially expressed genes (DEGs) between males and females in a variety of cell populations, including ##superficial dorsal horn (SDH) neurons##. We found a large number of DEGs between males and females in all cells, in neurons, and in SDH neurons of the mouse spinal cord, with a greater level of differential expression in inhibitory SDH neurons compared to excitatory SDH neurons. The results of these analyses are available on an open-source web-app: https://justinbellavance.shinyapps.io/snRNA_Visualization/. Lastly, we used gene set enrichment analysis to identify sex-enriched pathways from our previously identified DEGs. Through this, we have identified specific genetic players within the rodent spinal cord that diverge between males and females, which may underlie reported sex differences in spinal nociceptive mechanisms and pain processing.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11645520</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:39673257</oboInOwl:hasDbXref>
        <rdfs:label>superficial dorsal horn (SDH) neurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0011000"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/3459094e-38b4-4d24-b0ca-bde199028554"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0011000"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/346e05d6-3921-4580-a42d-2081a4c7d081 -->

    <Class rdf:about="http://example.org/346e05d6-3921-4580-a42d-2081a4c7d081">
        <obo:IAO_0000115>Based on improved knowledge of human B cell populations derived from recent studies, we sought to characterize the B cell precursors of IgE ASC through a combination of phenotypic, BCR repertoire and molecular analyses. Our experimental model was based on the hypothesis that the study of nasal polyps (NP), would provide a rich environment for ongoing IgE ASC differentiation from different cellular precursors in the absence of GC. In keeping with this model, we identified a novel human EF mucosal B cell population (CD19+IgD+CD27-) as the origin of mucosal IgE ASC. This population shared many of the phenotypic and transcriptional features of activated naive B cells recently shown in the EF response of patients with active autoimmune disease and severe SARS-CoV-2 infection. These mucosal IgD+ B cells are characterized by: (1) a high degree of clonal connectivity with IgE ASC, (2) an activated phenotype (CD11c+CD86+CD71+Nur77+CD21-), (3) a progressive transcriptome between resting blood naive B cells and NP ASC, and (4) the highest level of germline epsilon transcripts. Notably, the majority of the IgD+ NP B cells expressed IgM sequences with low mutation rates, a profile consistent with activated naive B cells. However, IgD+ NP B cells also contained a smaller fraction of cells with very high rates of somatic hypermutation previously demonstrated in class-switched IgD-only B cells (IgD+IgM-; Cdelta-CS), reported in the literature within either GC, memory and ASC populations. Interestingly, the analysis of single cell IgE ASC demonstrated lower mutation relative to ASC of other isotypes including IgG, IgA, or the highly mutated IgD ASC. In summary, human mucosal IgE ASC originate from an ##EF mucosal activated IgD+ B cell## subset in patients with atopic and non-atopic airways disease.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8160425</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34050324</oboInOwl:hasDbXref>
        <rdfs:label>EF mucosal activated IgD+ B cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000236"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/346e05d6-3921-4580-a42d-2081a4c7d081"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000236"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/347362cb-fbc8-481d-a119-84bfe773e7f7 -->

    <Class rdf:about="http://example.org/347362cb-fbc8-481d-a119-84bfe773e7f7">
        <obo:IAO_0000115>Meningeal ILC2s express Thy1.2, ST2, CD25, spinocerebellar ataxia type 1 (Sca10), and low levels of c-Kit and IL-7Ralpha and are major producers of IL-13 in tissues. As tissue-resident cells, ILC2s exhibit tissue-specific receptor expression patterns, which are imprinted by local signals. Likewise, dural ILC2s are distinct from lung ILC2s. The basal activation state of meningeal ILC2s is lower than that of lung-resident cells. The proximity to brain-derived signals may explain the differences in basal activation observed between the two tissue types. ILC2 precursors originate from bone marrow. Future studies should determine the functional and phenotypic differences between ##blood-derived ILC2s## and the adjacent bone marrow.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10616183</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37429945</oboInOwl:hasDbXref>
        <rdfs:label>blood-derived ILC2s</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000081"/>
        <skos:relatedMatch rdf:resource="CL:0001069"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/347362cb-fbc8-481d-a119-84bfe773e7f7"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000081"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/347362cb-fbc8-481d-a119-84bfe773e7f7"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0001069"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/348d9cd7-863a-4912-ae93-d9ac46656a04 -->

    <Class rdf:about="http://example.org/348d9cd7-863a-4912-ae93-d9ac46656a04">
        <obo:IAO_0000115>Distinct therapy-induced cancer cell transcriptomes were associated with clinical response. Cancer cells from MPR patients exhibited a signature of activated antigen presentation via major histocompatibility complex class II (MHC-II). Further, the transcriptional signatures of ##FCRL4+FCRL5+ memory B cells## and CD16+CX3CR1+ monocytes were enriched in MPR patients and are predictors of immunotherapy response. Cancer cells from NMPR patients exhibited overexpression of estrogen metabolism enzymes and elevated serum estradiol. In all patients, therapy promoted expansion and activation of cytotoxic T cells and CD16+ NK cells, reduction of immunosuppressive Tregs, and activation of memory CD8+T cells into an effector phenotype. Tissue-resident macrophages were expanded after therapy, and tumor-associated macrophages (TAMs) were remodeled into a neutral instead of an anti-tumor phenotype. We revealed the heterogeneity of neutrophils during immunotherapy and identified an aged CCL3+ neutrophil subset was decreased in MPR patients. The aged CCL3+ neutrophils were predicted to interact with SPP1+ TAMs through a positive feedback loop to contribute to a poor therapy response.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9985263</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36869384</oboInOwl:hasDbXref>
        <rdfs:label>FCRL4+FCRL5+ memory B cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000787"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/348d9cd7-863a-4912-ae93-d9ac46656a04"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000787"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/35d03da2-33a7-4a92-adb0-f66d4f6bba47 -->

    <Class rdf:about="http://example.org/35d03da2-33a7-4a92-adb0-f66d4f6bba47">
        <obo:IAO_0000115>Our studies show that a PTX treatment induces senescence in CMVECs. The clinical relevance of our findings is supported by studies characterizing the effects of PTX on cultured ##peripheral endothelial cells## in connection to the extensive use of PTX-coated balloons and drug-eluting stents for cardiovascular indications (including treatment of intermittent claudication) (Dake et al., ). These studies confirm that PTX induces senescence in endothelial cells and exert potent antiangiogenic activity (Ota et al., ; Wang et al., ). The pathophysiological consequences of PTX-induced cerebromicrovascular endothelial senescence are likely multifaceted.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10352561</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37243381</oboInOwl:hasDbXref>
        <rdfs:label>peripheral endothelial cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002139"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/35d03da2-33a7-4a92-adb0-f66d4f6bba47"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002139"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/35f269ce-bc3b-44e5-8c05-dfb5faa894b4 -->

    <Class rdf:about="http://example.org/35f269ce-bc3b-44e5-8c05-dfb5faa894b4">
        <obo:IAO_0000115>X-axis are the cell types denoted by layer and gene marker. Y-axis is the GWAS summary statistics used. Class is colour coded, purple are excitatory neurons, pink are inhibitory neurons, white are oligodendrocytes, hot pink are astrocytes, grey are newborn inhibitory neurons, forest green are ##intermediate progenitor cells##, light pink are radial glia (RG), and black are non-neural cells (endothelial, pericytes). The blue is the negative log10 of the FDR q-value (mean analysis). Black boxes represent cell types that reached significance (FDR &lt; 0.05). a Allen Brain Bank adult single nuclei RNA sequencing data. b Kriegstein fetal single cell RNA sequencing data. c Shen fetal RNA sequencing data.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10208966</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36750735</oboInOwl:hasDbXref>
        <rdfs:label>intermediate progenitor cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0011026"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/35f269ce-bc3b-44e5-8c05-dfb5faa894b4"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0011026"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/350b8ed3-e93d-4fda-bf2e-ac7ca376a5ae -->

    <Class rdf:about="http://example.org/350b8ed3-e93d-4fda-bf2e-ac7ca376a5ae">
        <obo:IAO_0000115>The cellular content of human myocardium (in descending order by number) predominantly consists of cardiomyocytes, fibroblasts, pericytes and smooth muscle cells, endothelial cells, and immune cells. In the murine heart, macrophage populations can be discerned based on their expression of C-C chemokine receptor type 2 (CCR2), major histocompatibility complex-II (MHC-II), T cell immunoglobulin and mucin domain containing 4 (TIMD4), and Lymphatic Vessel Endothelial Hyaluronan Receptor 1 (LYVE1). Four populations of macrophages have been identified in the murine heart (Fig. 1). The minority are two subsets of CCR2+MHC-IIhigh macrophage populations derived from hematopoietic stem cells, whereas the most dominant subset, cardiac resident macrophages derived from the yolk sac, are CCR2-MHC-IIlowTIMD4+LYVE1-. There also exists a fourth subset that consists of CCR2-MHC-IIhighTIMD4+LYVE1+ macrophages, which are likely derived from CCR2-MHC-IIlow macrophages during postnatal development and partially maintained by ##CCR2+MHC-IIhigh macrophages##. CCR2+MHC-IIhigh macrophages populate the heart soon after birth and are maintained through monocyte recruitment and proliferation. Also, under homeostasis, cardiac macrophages continually self-renew with a turnover period of almost 5 weeks. Recently, this same CCR2+ and CCR2- macrophage distinction has been identified in humans, with the yolk sac-derived CCR2- human counterpart showing CD14+CD45+CD64+CCR2-HLA-DRhigh expression. In a more recent study, Tucker et al. reported two cardiac macrophage subsets within the human heart, which were positive for CD163, COLEC12, mannose receptor MRC1, E3 ubiquitin ligase MARCH1, and natural resistance-associated macrophage protein 1 (NRAMP1). Both of the identified subsets expressed anti-inflammatory (M2) polarization-associated genes, whereas one subset particularly expressed RBPJ, F13A1 and the other expressed transmembrane collagen COL23A1.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9242717</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34088222</oboInOwl:hasDbXref>
        <rdfs:label>CCR2+MHC-IIhigh macrophages</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/350b8ed3-e93d-4fda-bf2e-ac7ca376a5ae"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/3525871a-22c3-4844-aa5e-a91555bd4905 -->

    <Class rdf:about="http://example.org/3525871a-22c3-4844-aa5e-a91555bd4905">
        <obo:IAO_0000115>Oxidative stress caused by hydrogen peroxide (H2O2) induces premature senescence within a short period of time in many cell types. To determine whether tiron has a protective function against H2O2-induced oxidative stress, we used beta-galactosidase staining to evaluate cellular senescence in ##hPDCs## treated with tiron. The hPDCs displayed irregular shapes and positive beta-galactosidase staining, indicating senescence after exposure to H2O2. The senescence-associated beta-galactosidase activity was clearly reduced when the cells were pretreated with 1 mM tiron before H2O2 exposure (Figure 1C).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9693013</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36430519</oboInOwl:hasDbXref>
        <rdfs:label>hPDCs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0007010"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/3525871a-22c3-4844-aa5e-a91555bd4905"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0007010"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/3548ea21-d62e-4238-8776-daf33f10f4bd -->

    <Class rdf:about="http://example.org/3548ea21-d62e-4238-8776-daf33f10f4bd">
        <obo:IAO_0000115>(a) UMAP depicting the cell populations present in human thymi (CD4 SP, CD4 single positive thymocytes; CD8 SP, CD8 single positive thymocytes; cTEC, cortical thymic epithelial cells; DC, dendritic cells; DN, double negative thymocytes; DP, double positive thymocytes; Mono/Macro, monocytes and macrophages; mTEC, medullary thymic epithelial cells; NK, natural killer cells; NKT, natural killer T cells; pro/pre-B, pro-B and pre-B cells; Th17, T helper 17 cells; Treg, regulatory T cells; VSMC, vascular smooth muscle cell). Cells were clustered in 19 populations based on the expression of marker genes from. (b) Upper panel: heatmap of transposable element (TE) expression during thymic development, with each column representing the expression of one TE subfamily in one cell type. Unsupervised hierarchical clustering was performed, and the dendrogram was manually cut into three clusters (red dashed line). Lower panel: the class of TE subfamilies and significant enrichments in the three clusters (Fisher&apos;s exact tests; ****p&lt;=0.0001). pcw, post-conception week; m, month; y, year. (c) Circos plot showing the expression pattern of TE subfamilies across ##thymic cells##. From outermost to innermost tracks: (i) proportion of cells in embryonic and postnatal samples, (ii) class of TE subfamilies, and (iii) expression pattern of TE subfamilies identified in (b). TE subfamilies are in the same order for all cell types. (d) Histograms showing the number of cell types sharing the same expression pattern for a given TE subfamily. LINE (n = 171), LTR (n = 577), and SINE (n = 60) were compared to a randomly generated distribution (n = 809) (Kolmogorov-Smirnov tests, ****p&lt;=0.0001).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11026094</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38635416</oboInOwl:hasDbXref>
        <rdfs:label>thymic cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000893"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/3548ea21-d62e-4238-8776-daf33f10f4bd"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000893"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/35625378-79ed-4933-87c1-05ac08a6d770 -->

    <Class rdf:about="http://example.org/35625378-79ed-4933-87c1-05ac08a6d770">
        <obo:IAO_0000115>scRNA sequencing data was analyzed to further explore the synergistic effect of the IRRS and the TME cells in ESCC. We used the previously profiled transcriptomes of ~208,659 single cells with eight main cell populations ( Figures 4A, B ), among which fibroblasts, endothelial cells, T cells, B cells, pericytes and myeloid cells were analyzed. Next, 40 cell clusters, including T helper 17 (TH17) cells, follicular helper T (TFH1/2) cells, naive T (TN) cells, regulatory T (Treg) cells, memory T (TMEM-CD4/CD8) cells, effector T (TEFF) cells, exhausted T (TEX) cells, monocytes (Mono01-03), tumor-associated macrophages (TAM01-04),dendritic cells (tDC, pDC, cDC), mast cells (Mast), resting B cells, activated B cells, germinal center B cells (GCB), plasma cells, normal ##mucosa fibroblasts## (NMF), normal activated fibroblasts (NAF1/2), cancer-associated fibroblasts (CAF1-4), vascular smooth muscle cells (VSMC), normal endothelial cells (NEC1-3) and tumor endothelial cell (TEC1-3) were identified by t-SNE analysis ( Figures 4C-G ;  Figures S6A-E ). We then used CIBERSORTx to infer cell-type abundance from bulk RNA-seq data using scRNA data, and estimated the proportions of the 42 cell types in the training dataset. The proportions of TME cell types between the high- and low-risk groups was compared using the Kruskal-Wallis test. The profiles of the high- and low-risk groups are shown in  Figure 4H  and  Figure S6F . The abundance of TEX, NAF2, CAF4, and VSMC increased, and the abundance of Mono1, TAM03, and NEC2 decreased in the high-risk group (p &lt; 0.05;  Figure 4I ). The cell proportions between low and high risk groups demonstrated significantly distinct TME patterns.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9933905</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36817484</oboInOwl:hasDbXref>
        <rdfs:label>mucosa fibroblasts</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000057"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/35625378-79ed-4933-87c1-05ac08a6d770"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000057"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/35759b28-77ec-48c2-8863-7d4201bb06a3 -->

    <Class rdf:about="http://example.org/35759b28-77ec-48c2-8863-7d4201bb06a3">
        <obo:IAO_0000115>Myofibroblasts are central mediators of the dysregulated wound-healing programme that defines fibrosis, therefore we studied this population in detail. Graph based clustering of the single cell RNA-seq data defined four major subsets (Fig. 3a) that included a cycling population (Cycling MFB) (Fig. 3a, b). After this, we sought to confirm that proliferating stromal cells (Ki67+) were myofibroblasts (Fig. 3c-e, Supplementary Fig. 4a-d). Using flow cytometry, we stained freshly disaggregated nodular cells and gated on myofibroblasts (CD45-CD31-CD146-ITGbeta1high) and fibroblasts (CD45-CD31-CD146-ITGbeta1low) and demonstrated Ki67high cells were a subset of myofibroblasts. In the single cell RNA-seq, a second subset was characterised by lower expression of ACTA2 and intermediate expression of fibroblast marker genes (CXCL14, PLA2G2A and C1R), we termed the ACTA2low myofibroblast (Fig. 3a, b, Supplementary Fig. 5a). A third comprised a discrete CD82highOX40L+ population (CD82, OX40L, MMP11, MMP14 and CD82) (Fig. 3a, g, Supplementary Fig. 5b-e). Finally, a fourth less distinct community we termed the intermediate myofibroblast (Fig. 3a, b, Supplementary Fig. 15a). GO analysis demonstrated that ##CD82highOX40L+ myofibroblast## marker genes showed the strongest enrichment for cell contraction pathways (Fig. 3f). In contrast, differential gene expression and pathway analysis revealed ACTA2low myofibroblasts resembled a general fibroblast phenotype, without clear characteristics of any one subtype. In addition to ACTA2, significant ACTA2low myofibroblasts markers were general fibroblasts markers including PLA2G2A and CXCL14. ACTA2low myofibroblasts also shared pathways enriched in fibroblasts such as &apos;interleukin signalling&apos; and &apos;chemotaxis&apos; (Fig. 3f).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7265502</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32488016</oboInOwl:hasDbXref>
        <rdfs:label>CD82highOX40L+ myofibroblast</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000186"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/35759b28-77ec-48c2-8863-7d4201bb06a3"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000186"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/36a492a6-dcc3-4b3b-9440-ca36a19ec88c -->

    <Class rdf:about="http://example.org/36a492a6-dcc3-4b3b-9440-ca36a19ec88c">
        <obo:IAO_0000115>Metformin has been shown to have the inhibitory effect on esophageal carcinoma cells. However, few studies focused on the relationship between metformin and normal esophageal cells. Our previous experiment had confirmed the inhibitory effect of metformin on the proliferation of esophageal carcinoma cells. Based on this, we found that metformin had less antiproliferation and no antiapoptosis effects on normal esophageal epithelial cells compared with ##ESCC cells## (Figures 1 and 2). The significantly high IC50 in HEECs indicated that HEECs have a great tolerance to metformin than EC109 cells. In other words, the therapeutic dosage of metformin on ESCC is harmless to the normal esophageal tissue. Another report also confirmed metformin marginally reduced the viability of NE3 cells, a kind of esophageal epithelial cell line, which was in line with our result.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7104266</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32258099</oboInOwl:hasDbXref>
        <rdfs:label>ESCC cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002221"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/36a492a6-dcc3-4b3b-9440-ca36a19ec88c"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002221"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/36b91db5-29a3-4af8-b5dc-a242f78c501d -->

    <Class rdf:about="http://example.org/36b91db5-29a3-4af8-b5dc-a242f78c501d">
        <obo:IAO_0000115>Collection of morphological different CD71+(green)/CD45-(yellow)/Hoechst+(blue) ##erythroblast-like cells## from healthy donors. Morphology and phenotype are characteristic for erythroblasts. Different stages of maturation may be indicated by the nucleus appearance under brightfield as well as high intensity Hoechst signal and the cell size. Cells (A) is the smallest and most mature measuring 8.4 microm in diameter, Cell (B) is larger and less mature measuring 11.2 microm in diameter, Cell (C) is the largest and less mature measuring 13.4 microm in diameter. White scale bar is 5 microm.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7226460</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32218149</oboInOwl:hasDbXref>
        <rdfs:label>erythroblast-like cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000765"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/36b91db5-29a3-4af8-b5dc-a242f78c501d"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000765"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/36087dc9-c07b-421e-9356-4e58070179b1 -->

    <Class rdf:about="http://example.org/36087dc9-c07b-421e-9356-4e58070179b1">
        <obo:IAO_0000115>Refinement and annotation of cell clusters in colon tissues. A Reclustering of cells and its UMAP projection in colon tissues. B &quot;Ground truth&quot; cell cluster labels derived from manual cell annotation based on the marker map. C Annotation results based on ACT. D A Sankey diagram to show the comparison of annotation results. Cell types that might be mislabeled are shown in the red box. E Epithelial cells and goblet cells correspond to the iCMS2 and iCMS3 subgroups in the original publication, respectively. CD4_Tn, Naive thymus-derived CD4-positive, alpha-beta T cell; Th17, T helper 17 cell; Treg, Regulatory T cell; CD8_Tem, Effector memory CD8-positive alpha, beta T cell; CTL, Cytotoxic T cell; NK, Natural killer cell; FO_B, Follicular B cell; Plasma, Plasma cell; ##mregDC##, Migratory dendritic cell; Glial, Glial cell, i.e., Entericglial cell; Endo, Endothelial cell; Endo_lymphatic, Lymphatic endothelial cell; Fibro, Fibroblast; Myof, Myofibroblast cell; Goblet, Goblet cell; Epi_colon, Colon epithelial cell; Goblet_T, Malignant goblet cell; Goblet_N, Normal goblet cell; McDC, Monocyte conventional dendritic cell; pDC, Plasmacytoid dendritic cell</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10623726</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37924118</oboInOwl:hasDbXref>
        <rdfs:label>mregDC</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000451"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/36087dc9-c07b-421e-9356-4e58070179b1"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000451"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/36500e35-9715-481e-94d8-7c7639756fcf -->

    <Class rdf:about="http://example.org/36500e35-9715-481e-94d8-7c7639756fcf">
        <obo:IAO_0000115>Clusters #3 and #5 expressed the cytokeratins Krt5/14/17 marking the ##basal ductal cells## and MECs in the adult LG (Figure 7A). Both clusters also shared with the MECs the expression of the calcium sensor S100a6. Nonetheless, the ductal clusters #3 and 5 specifically expressed Ly6d that labels luminal progenitors in the prostate, Ly6a (also known as Sca-1) that is found in many stem cells but also in mammary ductal cells and tubular cells in the kidney, and the hormone subunit Gpha2 found in other glands (pancreas and pituitary gland) and in the corneal limbal stem cells that renew corneal epithelium (Figure 7A). These features support our previous cell-lineage tracing studies showing the existence of slow-cycling stem/progenitor cells in the basal ductal compartment of multilayered ducts.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10216974</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37408269</oboInOwl:hasDbXref>
        <rdfs:label>basal ductal cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:1000436"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/36500e35-9715-481e-94d8-7c7639756fcf"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:1000436"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/3707f6c0-0828-43c6-9257-aef2fe159e83 -->

    <Class rdf:about="http://example.org/3707f6c0-0828-43c6-9257-aef2fe159e83">
        <obo:IAO_0000115>SCN	Suprachiasmatic nucleus	 	ROR	Retinoic acid receptor-related orphan receptor	 	Rev-ErbA	Reverse c-erb A	 	RRE	Rev-ErbA/ROR response element	 	ROS	Reactive oxygen species	 	UV	Ultraviolet	 	CBC	Crypt-base columnar cell	 	ISC	Intestinal stem cell	 	TA	Transit-amplifying	 	EC	Enterocyte	 	GC	Goblet cell	 	EEC	Enteroendocrine cell	 	PC	Paneth cell	 	GI	Gastrointestinal	 	DSS	Dextran-sodium sulfate	 	CRD	Circadian rhythm disruption	 	RNAi	RNA interference	 	ZT	Zeitgeber time	 	BM	Bone marrow	 	HSC	Hematopoietic stem cell 	 	HSPC	Hematopoietic stem and progenitor cell	 	MPP	Multipotent progenitor	 	LT-HSC	Long-term hematopoietic stem cell	 	SP	Side population	 	CAR	##CXCL12-abundant reticular##	 	NE	Norepinephrine	 	TNF	Tumor necrosis factor	 	MAPK	Mitogen-activated protein kinase	 	</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6539890</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31071906</oboInOwl:hasDbXref>
        <rdfs:label>CXCL12-abundant reticular</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000432"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/3707f6c0-0828-43c6-9257-aef2fe159e83"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000432"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/371a6bdb-0e2c-4610-ba81-3da295877bee -->

    <Class rdf:about="http://example.org/371a6bdb-0e2c-4610-ba81-3da295877bee">
        <obo:IAO_0000115>In our previous work, we depicted different T-cell subtypes and found an exhausted cluster that specifically existed in B-ALL patients and possessed remarkable heterogeneity. However, the developmental relationship between T-cell subtypes in relation to B-ALL patient prognosis remains elusive. To address this question, further analysis was performed on these T cells in B-ALL. A subset of T cells with features of ##tissue-resident memory T (Trm) cells## was found in the peripheral blood of B-ALL patients, which we defined as circulating CD103+ T cell or tissue-resident memory-like T (Trm-like) cell. These Trm-like cells expressing high levels of immune checkpoint molecules and cytotoxicity markers also shared similar TCR signatures with exhausted T (Tex) cells and effector T (Teff) cells. The traditional view thought that Trm cells were low in migration and long-term survival in peripheral tissues; however, more recent studies indicated that upon secondary antigen presentation, Trm cells can rejoin the circulation pool, transforming into Teff cells. Through cell fate trajectory analysis, we found that Trm-like cells that were supposed to transit into Teff cells, however, mainly transformed into Tex cells in leukemia environment. Furthermore, Trm-like cell to Tex cell transformation potentially led to poor prognosis of B-ALL patients, while transition toward Teff cells would likely improve prognosis. Our data suggest that Trm-like cells contribute to B-ALL immunosurveillance and may provide valuable prognostic information. Further understanding of the development, maintenance, and regulation of Trm-like cells would be crucial for successful immunotherapeutic development in B-ALL.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9757161</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36532049</oboInOwl:hasDbXref>
        <rdfs:label>tissue-resident memory T (Trm) cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000813"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/371a6bdb-0e2c-4610-ba81-3da295877bee"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000813"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/376f619d-3cad-4735-ba4a-2bbbac6482a6 -->

    <Class rdf:about="http://example.org/376f619d-3cad-4735-ba4a-2bbbac6482a6">
        <obo:IAO_0000115>scRNA sequencing data was analyzed to further explore the synergistic effect of the IRRS and the TME cells in ESCC. We used the previously profiled transcriptomes of ~208,659 single cells with eight main cell populations ( Figures 4A, B ), among which fibroblasts, endothelial cells, T cells, B cells, pericytes and myeloid cells were analyzed. Next, 40 cell clusters, including T helper 17 (TH17) cells, follicular helper T (TFH1/2) cells, naive T (TN) cells, regulatory T (Treg) cells, memory T (TMEM-CD4/CD8) cells, effector T (TEFF) cells, exhausted T (TEX) cells, monocytes (Mono01-03), tumor-associated macrophages (TAM01-04),dendritic cells (tDC, pDC, cDC), mast cells (Mast), resting B cells, activated B cells, germinal center B cells (GCB), plasma cells, normal mucosa fibroblasts (NMF), normal activated fibroblasts (NAF1/2), ##cancer-associated fibroblasts## (CAF1-4), vascular smooth muscle cells (VSMC), normal endothelial cells (NEC1-3) and tumor endothelial cell (TEC1-3) were identified by t-SNE analysis ( Figures 4C-G ;  Figures S6A-E ). We then used CIBERSORTx to infer cell-type abundance from bulk RNA-seq data using scRNA data, and estimated the proportions of the 42 cell types in the training dataset. The proportions of TME cell types between the high- and low-risk groups was compared using the Kruskal-Wallis test. The profiles of the high- and low-risk groups are shown in  Figure 4H  and  Figure S6F . The abundance of TEX, NAF2, CAF4, and VSMC increased, and the abundance of Mono1, TAM03, and NEC2 decreased in the high-risk group (p &lt; 0.05;  Figure 4I ). The cell proportions between low and high risk groups demonstrated significantly distinct TME patterns.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9933905</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36817484</oboInOwl:hasDbXref>
        <rdfs:label>cancer-associated fibroblasts</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000057"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/376f619d-3cad-4735-ba4a-2bbbac6482a6"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000057"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/38a2225f-0e8a-4182-9955-a99274539d95 -->

    <Class rdf:about="http://example.org/38a2225f-0e8a-4182-9955-a99274539d95">
        <obo:IAO_0000115>General capillary gCap ECs have been reported to function as progenitor cells capable of differentiating into ##aerocytes## (aCap ECs) in response to injurious lung stimuli. Our lineage mapping of gCap EC dynamics following bleomycin-induced lung injury in young animals revealed that gCap ECs move to an activated state coinciding with fibrosis onset and that this state transitions back to a healthy gCap EC state with injury resolution. The shift to an activated state was independent of genetics background, as observations in this lineage tracing model were from a mixed C57B/6-129 genetic background mirrored those from C57B/6 injured mice. Our lineage tracing also demonstrated that under these injury conditions gCap ECs do not differentiate into aCap ECs, but rather acquire transient transcriptional changes in young lungs that are sustained in aged lungs. Previous studies have reported that lung capillary ECs can transform into collagen-producing mesenchymal cells (endothelial mesenchymal transition, EndMT) in response to bleomycin-induced lung injury to give rise to pathogenic collagen-producing cells. Our lineage tracing study using genetically labeled capillary ECs demonstrated that although injured capillary ECs transiently overexpressed mesenchymal-associated genes, these cells largely maintained their endothelial identity and do not undergo mesenchymal cell differentiation.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11211333</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38937456</oboInOwl:hasDbXref>
        <rdfs:label>aerocytes</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:4028003"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/38a2225f-0e8a-4182-9955-a99274539d95"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4028003"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/38a68b4e-4801-44e1-bb60-736845c5486d -->

    <Class rdf:about="http://example.org/38a68b4e-4801-44e1-bb60-736845c5486d">
        <obo:IAO_0000115>Natural killer (NK) cells are the most abundant leukocytes located at the maternal-fetal interface; they respond to the pregnancy-related hormones and playing a pivotal role in maintaining homeostatic micro-environment during pregnancy. However, due to the high heterogeneity of NK cell subsets, their categorization has been controversial. Here, we systematically review previous studies on uterine NK (uNK) cell subsets, including the classic categorization based on surface markers, functional molecules and developmental stages, as well as single-cell RNA sequencing (scRNA-seq)-based clustering approaches. In addition, we summarize the potential pathways by which ##endometrial NK (eNK) cells## differentiate into decidual NK (dNK) cells, as well as the differentiation pathways of various dNK subsets. Finally, we compared the alterations in the NK cell subsets in various pregnancy-associated diseases, emphasizing the possible contribution of specific subsets to the development of the disease.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMID:39570646</oboInOwl:hasDbXref>
        <rdfs:label>endometrial NK (eNK) cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000623"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/38a68b4e-4801-44e1-bb60-736845c5486d"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000623"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/38aac215-759b-4091-9677-210fdaa75482 -->

    <Class rdf:about="http://example.org/38aac215-759b-4091-9677-210fdaa75482">
        <obo:IAO_0000115>Immunosuppressive role of tumour-associated macrophages (TAMs). TAMs promote immunosuppression by different mechanisms: TAMs can express programmed cell death ligand 1 and ligand 2 (PD-L1 and PD-L2), which bind the T cell inhibitory receptor programmed cell death protein 1 (PD-1), thereby inducing T cell exhaustion. TAM expression of V-domain Ig suppressor of T cell activation (VISTA) and B7 family molecules, such as B7-H4, can have similar function. TAMs secrete immunosuppressive cytokines such as IL-10 and TGFbeta, which can have direct suppressive functions on CD8+ T cells, or they can induce recruitment of immunosuppressive CD4+ T regulatory (Treg) cells. TAM secreted IL-10 can impair T cells effector functions indirectly either by inhibit dendritic cell (DC) anti-tumorigenic role or by inducing DC expression of PD-L1. Moreover, amino acid metabolism in TAM results in production of arginase and immunosuppressive metabolites via the indoleamine 2,3-dioxygenase (IDO) pathway, which is responsible of metabolic starvation in T cells. TAMs can also indirectly induce immunosuppression by promoting fibrosis. Indeed cancer associated fibroblast (##CAF##) secreted factors and/or extracellular matrix (ECM) stiffness are responsible for CD8+ T cell immunosuppression and/or exclusion from the tumour nest.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6678757</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31331034</oboInOwl:hasDbXref>
        <rdfs:label>CAF</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000057"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/38aac215-759b-4091-9677-210fdaa75482"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000057"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/38c366d6-4a15-45e2-ba40-444a780e4d63 -->

    <Class rdf:about="http://example.org/38c366d6-4a15-45e2-ba40-444a780e4d63">
        <obo:IAO_0000115>Because CD14CTX express chemokine receptors that might facilitate migration into the tissues, we next examined the relationship between circulating and intra-tumoral myeloid states in BTC. We performed scRNA-seq on primary cholangiocarcinoma tumors (n = 4) obtained from standard of care resections (Table S7) and recovered a total of 10,913 myeloid cells. Tissue-associated myeloid cells consisted of dendritic cells (DC), neutrophils (Neut), two populations of ##macrophages characterized by either high APOE or SPP1 expression## (MacAPOE, MacSPP1), CD14+ monocytes (CD14+ mono), CD16+ monocytes (CD16+ mono), and intermediate CD14+CD16+ monocytes (CD14+CD16+ mono) (Figures S4A and S4B). Among the tissue-associated myeloid populations, the expression profile of CD14CTX was most correlated with MacSPP1, exemplified by the shared expression of differentially expressed CD14CTX genes including HAVCR2 and ITGB1 (Figures S4C and S4D). Notably, two genes that differ in expression between MacSPP1 and CD14CTX are related to chemotaxis and extravasation (SERPINB2, TIMP1), suggesting a transition in macrophages that have already migrated to the tumor microenvironment. As an alternate approach to assess the relationship between the circulating and tissue-associated myeloid populations, we co-clustered myeloid cells from circulation with those from the tumors, following batch correction. We found that the intra-tumoral MacSPP1 cluster with the circulating CD14CTX (Figure S4E). An alternative approach using partition-based graph abstraction also found close connectivity between CD14CTX and SPP1+ TAM clusters (Figure S4E). We also found evidence of SPP1+HAVCR2+CD68+ myeloid cells within biliary tumor tissue from on-treatment biopsies by combined in situ hybridization and immunofluorescence, further suggesting the existence of a TAM population in BTC analogous to CD14CTX (Figure S4F).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10060099</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36130508</oboInOwl:hasDbXref>
        <rdfs:label>macrophages characterized by either high APOE or SPP1 expression</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/38c366d6-4a15-45e2-ba40-444a780e4d63"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/38fbf999-da93-46e9-bf35-0053f5e73efc -->

    <Class rdf:about="http://example.org/38fbf999-da93-46e9-bf35-0053f5e73efc">
        <obo:IAO_0000115>Immune checkpoint inhibitors exert clinical efficacy against various types of cancer through reinvigoration of exhausted CD8+ T cells that attack cancer cells directly in the tumor microenvironment (TME). Using single-cell sequencing and mouse models, we show that CXCL13, highly expressed in tumor-infiltrating exhausted CD8+ T cells, induces CD4+ follicular helper T (TFH) cell infiltration, contributing to anti-tumor immunity. Furthermore, a part of the TFH cells in the TME exhibits cytotoxicity and directly attacks major histocompatibility complex-II-expressing tumors. TFH-like cytotoxic CD4+ T cells have high LAG-3/BLIMP1 and low TCF1 expression without self-renewal ability, whereas non-cytotoxic TFH cells express low LAG-3/BLIMP1 and high TCF1 with self-renewal ability, closely resembling the relationship between terminally differentiated and stem-like progenitor exhaustion in CD8+ T cells, respectively. Our findings provide deep insights into ##TFH-like CD4+ T cell## exhaustion with helper progenitor and cytotoxic differentiated functions, mediating anti-tumor immunity orchestrally with CD8+ T cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMID:38363680</oboInOwl:hasDbXref>
        <rdfs:label>TFH-like CD4+ T cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002038"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/38fbf999-da93-46e9-bf35-0053f5e73efc"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002038"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/3803a720-a7b9-4ed6-b01f-b7b054c6d03d -->

    <Class rdf:about="http://example.org/3803a720-a7b9-4ed6-b01f-b7b054c6d03d">
        <obo:IAO_0000115>iMPC transcriptome shows similarities to primary ##Hu-MuSCs##</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8691832</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34755602</oboInOwl:hasDbXref>
        <rdfs:label>Hu-MuSCs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000355"/>
        <skos:relatedMatch rdf:resource="CL:0008011"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/3803a720-a7b9-4ed6-b01f-b7b054c6d03d"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000355"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/3803a720-a7b9-4ed6-b01f-b7b054c6d03d"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0008011"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/3822d40f-90a3-49d3-b6df-94078a0e2b4f -->

    <Class rdf:about="http://example.org/3822d40f-90a3-49d3-b6df-94078a0e2b4f">
        <obo:IAO_0000115>Although the induced Ca2+ activity persisted under the glutamatergic inhibition for c+ primary neurons, excitability of the secondary neurons discontinued. ##Secondary neurons## exhibited two common excitation profiles depending on whether they were silent or spontaneously active before stimulation. These two profiles were encountered in equal frequencies 30% (both 7 out of 22) all throughout the experiments. In Fig 5B, the c+ primary neuron was observed to excite a previously silent secondary neuron. In the blocked case this excitation was not observed as shown via correlation analysis (p&lt;0.05). A video of this experiment is provided in S1A and S1B Video. Fig 5C shows an example for a secondary neuron which was spontaneously active before stimulation. Spontaneous activity of the secondary neuron was modulated with the induced Ca2+ activity of the primary neuron. Excitation of the secondary neuron continued through the stimulation and the in-phase modulation vanished in the blocked case (p&lt;0.05).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7928449</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33657119</oboInOwl:hasDbXref>
        <rdfs:label>Secondary neurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000540"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/3822d40f-90a3-49d3-b6df-94078a0e2b4f"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000540"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/388f5ec2-e71e-43b9-a2c0-7db35d186e1b -->

    <Class rdf:about="http://example.org/388f5ec2-e71e-43b9-a2c0-7db35d186e1b">
        <obo:IAO_0000115>In addition to our embryonic development, many aspects of adult human health are also highly dependent on tightly controlled cell-type-specific gene regulation. For example, human health and homeostasis are tightly regulated by a myriad of different neuropeptides that need to be expressed in precise regions of the hypothalamus, amygdala and sensory neurons to modulate appropriate levels of food intake, mood and pain perception. Thus, identification of the enhancer regions that control the cell-type-specific expression of these neuropeptides, and how they might be affected by polymorphic variation, will be critical to our understanding of health and disease. For example, substance-P (SP; encoded by TAC1 gene) is a neuropeptide expressed in c-fibre sensory neurons and the medial amygdala where it is critical to pain perception and mood modulation. We first used comparative genomics in species as diverse as mammals and birds to identify a highly conserved enhancer that lay 158kb from the TAC1 gene, which drove reporter gene expression in SP expressing amygdala neurons. Later transgenic analysis of an even remoter conserved enhancer (214kb from TAC1 gene) demonstrated its ability to not only drive reporter expression in ##SP expressing C-fibre sensory neurons## but to also switch reporter gene expression to larger diameter A-fibres in response to inflammatory stimuli:an expression of SP associated with hyperalgesia.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7660172</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33113946</oboInOwl:hasDbXref>
        <rdfs:label>SP expressing C-fibre sensory neurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000505"/>
        <skos:relatedMatch rdf:resource="CL:3000004"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/388f5ec2-e71e-43b9-a2c0-7db35d186e1b"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000505"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/388f5ec2-e71e-43b9-a2c0-7db35d186e1b"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:3000004"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/39a0f26d-5df4-42d0-858a-d385e0d11415 -->

    <Class rdf:about="http://example.org/39a0f26d-5df4-42d0-858a-d385e0d11415">
        <obo:IAO_0000115>Equation (49) reduces to a hyperbolic PDE at leading order as :Eq. (56) describes the advection, in  space, of ##MDMs## according to a time-dependent velocity field:where the coefficients: ,  and H(t), are time-dependent solutions of the subsystem (32)-(41).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11297092</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:39093509</oboInOwl:hasDbXref>
        <rdfs:label>MDMs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
        <skos:relatedMatch rdf:resource="CL:0000576"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/39a0f26d-5df4-42d0-858a-d385e0d11415"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/39a0f26d-5df4-42d0-858a-d385e0d11415"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000576"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/39a14f25-0ad1-4ee3-8bc7-ef97bc8f9c78 -->

    <Class rdf:about="http://example.org/39a14f25-0ad1-4ee3-8bc7-ef97bc8f9c78">
        <obo:IAO_0000115>PD: Parkinson&apos;s Disease; AD: Alzheimer&apos;s Disease. SCI: Spinal Cord injury; hESC: human Embryonic Stem Cells; NSC: Neural Stem Cells; NPC: Neuronal Progenitor Cells; hiPSC: human Pluripotent Stem Cells; DANs: Dopaminergic neurons; lt-NES: long-term self-renewing Neuro-Epithelial-like Stem; ML/NEP2: Macrophage-Like/Neprilysin-2; BFCN: ##Basic Forebrain Cholinergic Neurons##; OPC: Oligodendrocyte Progenitor Cells; MGE: Medial Ganglionic Eminence; SNI: Spared Nerve Injury.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7699962</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33233861</oboInOwl:hasDbXref>
        <rdfs:label>Basic Forebrain Cholinergic Neurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000108"/>
        <skos:relatedMatch rdf:resource="CL:0012001"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/39a14f25-0ad1-4ee3-8bc7-ef97bc8f9c78"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000108"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/39a14f25-0ad1-4ee3-8bc7-ef97bc8f9c78"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0012001"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/39ad6ce1-11ee-4b51-ac2a-aec4fe66cdbf -->

    <Class rdf:about="http://example.org/39ad6ce1-11ee-4b51-ac2a-aec4fe66cdbf">
        <obo:IAO_0000115>(A, B) Schematic of medial (MOC) and lateral (LOC) olivocochlear neuron (OCN) subtypes housed in the brainstem (A) and their projections into the cochlea, shown in cross-section (A) and top-down (B). D, dorsal; L, lateral; LSO, lateral superior olive; VNTB, ventral nucleus of the trapezoid body; SOC, superior olivary complex; IHC, inner hair cell; OHC, outer hair cell; SGN, spiral ganglion neuron; IGSB, intraganglionic spiral bundle; ISB, inner spiral bundle; TSB, tunnel spiral bundle. (C) Schematic of single-nucleus collection protocol. The ventral brainstem of ChatCre; Rosa26Sun1-GFP mice was dissected, including the SOC, facial motor nucleus (VII), and trigeminal motor nucleus (V), followed by collection and sequencing of individual GFP+ nuclei. A, anterior; P, posterior. (D) UMAP plot summarizing sequencing data of 45,828 single nuclei from 61 animals across three ages. The data includes 56 clusters, including ##MOCs##, LOCs, and several different motor neuron types, as well as a few non-neuronal populations. (E-H) Feature plots denoting normalized expression levels of selected genetic markers. For visualization purposes, high expression on the color scale is capped at the 95th percentile of gene expression. The majority of clusters express the neuronal marker Snap25 (E). The main non-neuronal population is labeled by Mog, an oligodendrocyte marker (F). Motor neuron clusters express the motor neuron determinant Isl1 (G). Among these brainstem motor neurons, OCNs are identified by expression of the transcription factor Gata3 (H). (I, J) Differential expression of known markers Ucn (I) and Atp1a3 (J) denotes LOCs and MOCs, respectively. (K-M) Cadps2 is a novel marker for OCNs that is expressed by both MOCs and LOCs but not FMNs. (K) Violin plots summarizing transcriptional expression of Cadps2 in mature LOCs, MOCs, and FMNs. (L, M) Fluorescent in situ hybridization (FISH) verifies that Cadps2 is detected in both MOCs and LOCs (L) but not in FMNs (M). Representative images are shown from a total of three animals of either sex, P28.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10147377</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36876911</oboInOwl:hasDbXref>
        <rdfs:label>MOCs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:2000047"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/39ad6ce1-11ee-4b51-ac2a-aec4fe66cdbf"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:2000047"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/39d81ee6-8336-481a-8094-a7728aa70253 -->

    <Class rdf:about="http://example.org/39d81ee6-8336-481a-8094-a7728aa70253">
        <obo:IAO_0000115>For the CM/CF/CS production bioprocess, the following stem and progenitor cell types are of interest: pluripotent stem cells:embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs); adult stem cells (##ASCs##):mesenchymal stem cells (MSCs), adipose tissue-derived stem cells (ADSCs) and fibro-adipogenic progenitors (FAP), as well as resident muscle stem cells/muscle satellite cells (SCs), a.k.a. myosatellites and myoblasts as progenitors or more precisely, proliferating activated SCs. </obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9138761</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35625626</oboInOwl:hasDbXref>
        <rdfs:label>ASCs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000034"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/39d81ee6-8336-481a-8094-a7728aa70253"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000034"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/3965eae6-9722-4fef-99d1-90351533aa06 -->

    <Class rdf:about="http://example.org/3965eae6-9722-4fef-99d1-90351533aa06">
        <obo:IAO_0000115>To characterize the dynamics of neutrophil recruitment to omFALCs during peritonitis, we used the well-established murine model, Zymosan-A-induced peritonitis. Peritonitis led to a transient increase in the number of Ly6G+ neutrophils in the omentum, peaking at 24 h (Figures 3A and S5A). Wholemount immunofluorescence staining and confocal analysis revealed that FALCs were the site of extensive recruitment of Ly6G+ Myeloperoxidase+ (MPO) neutrophils, which formed dense cellular aggregates between 6 and 24 h post-induction of peritonitis (Figures 3B, 3C, and S5B). The volume of omFALCs increased exponentially during the first 18 h post-Zymosan injection (75-fold) before rapidly contracting back to their normal size by 24 h (Figure 3D). This timing coincided with the influx of ##MPO+ neutrophils## and their disappearance by 24 h (Figures 3C and 3D). This accretion of neutrophils was specific to omFALCs and did not happen on the rest of the surface of the omentum, the diaphragm, or the parietal wall (Figures 3E, S5C, and S5D). We then tested whether CXCL1 was involved in the accumulation of neutrophils at omFALCs during peritonitis, using an anti-CXCL1 blocking antibody. Eighteen hours post-Zymosan injection, CXCL1 blockade led to a 2.6-fold decrease in the number of neutrophils recovered from the omentum compared to mice treated with isotype control antibodies. There was no difference in the number of neutrophils recovered from the peritoneal cavity, suggesting that the trafficking of neutrophils through omFALC HEVs was not altered (Figure 3F). Thus, the extensive recruitment of neutrophils to FALCs is not simply a consequence of increased trafficking of neutrophils through HEVs, but the result of active retention dependent upon CXCL1.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7156918</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32294409</oboInOwl:hasDbXref>
        <rdfs:label>MPO+ neutrophils</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000775"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/3965eae6-9722-4fef-99d1-90351533aa06"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000775"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/3975630e-a2cd-4702-af8c-6bad5fd9bdee -->

    <Class rdf:about="http://example.org/3975630e-a2cd-4702-af8c-6bad5fd9bdee">
        <obo:IAO_0000115>Tumor types Mutant genes The contributed cells for tumors References   Trichofolliculomas/papillomatricomas beta-catenin Krt 14+ cells    Pilomatricomas beta-catenin Lgr5+ cells    Dermatofibromas beta-catenin Lgr6+ cells    Trichoadenomas beta-catenin Lrig1+ cells    No tumor beta-catenin Krt15+ cells    Sebaceous tumors Lef1 Krt14+ cells    ##Basal cell## carcinoma(BCC) Patched IFE cells/bulge stem cells(major contribution)    BCC Smoothened IFE cells    BCC Smoothened (in the context of wound) Krt15+ bulge stem cells    Papillomas KRAS Krt19+, Krt15+ and Involucrin+ cells    Invasive squamous cell carcinoma (SCC) P53 and KRAS --    SCC (DMBA-TPA method) HRAS Long-lived stem cells    Papilloma and SCC HRAS Krt5+ cells    </obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9391238</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35143021</oboInOwl:hasDbXref>
        <rdfs:label>Basal cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000646"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/3975630e-a2cd-4702-af8c-6bad5fd9bdee"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000646"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/4a047a8d-3b29-452f-8230-309f89eed5cb -->

    <Class rdf:about="http://example.org/4a047a8d-3b29-452f-8230-309f89eed5cb">
        <obo:IAO_0000115>Airway epithelial cells such as goblet and ciliated cells are required for mucociliary clearance of inhaled particles. Alveolar epithelial type 1 (AT1) cells provide a short-distance barrier for diffusion gas exchange. AT2 cells maintain homeostasis, secrete surfactant, mediate defense against pathogens (including MHCII-dependent antigen presentation), and serve as AT1 progenitors. Pulmonary capillary endothelial cells facilitate gas exchange and leukocyte migration. Other subsets of lung endothelial cells from the pulmonary lymphatics, pulmonary blood vessels, and systemic blood vessels in the lung await functional annotations. Mesenchymal cells, including smooth muscle cells, fibroblasts and mesothelial cells, are involved in homeostasis, repair, and wound healing. Mesothelial cells cover the pleural spaces, secrete glycosaminoglycans and surfactant, and initiate inflammatory responses to pathogens via pro-inflammatory mediators such as interleukins (e.g., IL-6, IL-8) and interferons. Amongst myeloid cells, alveolar macrophages are potent airway scavengers and modulate the magnitude of immune responses and tissue homeostasis. Interstitial macrophages, localized in the parenchyma, function in inflammation, wound healing, and tissue repair. Monocytes patrol the blood and play a role in surveillance of endothelial integrity and are recruited to the inflamed lungs. Dendritic cells activate naive T-cells, initiating adaptive immunity. Granulocytes such as neutrophils and eosinophils modulate immune response and are involved in pathogen killing and clearance. ##Resident memory CD4+ and CD8+ T-cells## function in adaptive immune responses through the secretion of cytokines, activation of macrophages and lung stromal cells, and/or elimination of infected cells. Tissue resident B-cells and plasma cells mediate humoral immunity and pathogen clearance through antibody production.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9173662</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35672453</oboInOwl:hasDbXref>
        <rdfs:label>Resident memory CD4+ and CD8+ T-cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000897"/>
        <skos:relatedMatch rdf:resource="CL:0000909"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/4a047a8d-3b29-452f-8230-309f89eed5cb"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000897"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/4a047a8d-3b29-452f-8230-309f89eed5cb"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000909"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/4a048140-3d15-4c89-9c27-a00bebf45516 -->

    <Class rdf:about="http://example.org/4a048140-3d15-4c89-9c27-a00bebf45516">
        <obo:IAO_0000115>To comprehensively analyze mouse BM hematopoiesis, the present study sorted lineage-negative cells to form single-cell resolution; the marker genes are shown in Figure 2A. The UMAP clustering map of mouse BM stem cells/progenitors (c-kit+) yielded two integrated samples. The UMAP plot showed the distribution of six cellular clusters, in which there were 2 HSC and 3 GMP subclusters color-coded according to cell subclusters (Figure 2B). We then sort cells from HSCs to lineage-specified progenitors in pseudotime to understand different trajectories and development states. As shown in Figure 2C, Monocle illustrated the percentage of cell type at similar branch points. Single-cell resolution also validated the immunophenotype results wherein RalA increased the self-renewal of HSC-1, MPPs, and GMP-1 in RalARosa26-Tg/+mice (Figure 2D). Heatmaps show the expression levels of the 5 most significantly enriched genes in every cluster (Supplementary Figure S5). Next, immunophenotype-defined cellular transcriptomes were comprehensively compared. The unsupervised hierarchical clustering showed transcriptional heterogeneities of ##immunophenotypical HSCs## (iHSCs). The iHSCs were classified into two groups with different transcriptional characteristics: HSC-1 (Figure 2E) and HSC-2 (Figure 2F).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10008703</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36923939</oboInOwl:hasDbXref>
        <rdfs:label>immunophenotypical HSCs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000037"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/4a048140-3d15-4c89-9c27-a00bebf45516"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000037"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/4a12145e-b1dd-416a-bfe9-29a3f7a8b9e3 -->

    <Class rdf:about="http://example.org/4a12145e-b1dd-416a-bfe9-29a3f7a8b9e3">
        <obo:IAO_0000115>Brain-derived neurotrophic factor (BDNF) and neurotrophin 3 (NT-3) are known to regulate neuronal morphology and the formation of neural circuits, yet the neuronal targets of each neurotrophin are still to be defined. To address how these neurotrophins regulate the morphological and synaptic differentiation of developing olfactory bulb (OB) GABAergic interneurons, we analyzed the effect of BDNF and NT-3 on GABA+-neurons and on different subtypes of these neurons: ##tyrosine hydroxylase## (TH+); calretinin (Calr+); calbindin (Calb+); and parvalbumin (PVA+). These cells were generated from cultured embryonic mouse olfactory bulb neural stem cells (eOBNSCs) and after 14 days in vitro (DIV), when the neurons expressed TrkB and/or TrkC receptors, BDNF and NT-3 did not significantly change the number of neurons. However, long-term BDNF treatment did produce a longer total dendrite length and/or more dendritic branches in all the interneuron populations studied, except for PVA+-neurons. Similarly, BDNF caused an increase in the cell body perimeter in all the interneuron populations analyzed, except for PVA+-neurons. GABA+- and TH+-neurons were also studied at 21 DIV, when BDNF produced significantly longer neurites with no clear change in their number. Notably, these neurons developed synaptophysin+ boutons at 21 DIV, the size of which augmented significantly following exposure to either BDNF or NT-3. Our results show that in conditions that maintain neuronal survival, BDNF but not NT-3 promotes the morphological differentiation of developing OB interneurons in a cell-type-specific manner. In addition, our findings suggest that BDNF and NT-3 may promote synapse maturation by enhancing the size of synaptic boutons.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMID:33392918</oboInOwl:hasDbXref>
        <rdfs:label>tyrosine hydroxylase</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:4023075"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/4a12145e-b1dd-416a-bfe9-29a3f7a8b9e3"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4023075"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/4a264fdc-826d-4fdb-b99a-4f6a6e39d89e -->

    <Class rdf:about="http://example.org/4a264fdc-826d-4fdb-b99a-4f6a6e39d89e">
        <obo:IAO_0000115>Last, we investigated whether the human materno-fetal immune system in HIS mice was functional. Human decidua and splenic CD4+CD25+ Treg cells were purified from pregnant HIS mice and incubated with the CFSE-labeled human CD45+CD25- splenic cells (responder cells from pregnant HIS mice) in the presence of 30 Gy irradiated BALB/c mouse splenic cells (stimulator). The proliferation of responder cells was quantified 4 days later using FCM. Proliferation of maternal human splenic CD4+ effector T cells after stimulation with paternally (BALB/c) derived antigen reflects the presence of fetal reactive human maternal T cells (Figure 5A). ##STreg cells## were capable of suppressing Tconv cells at 1:2 ratio (Treg/Tconv) (Supplemental Figure 11). However, under a low Treg/Tconv ratio (1:16) condition, the maternal versus fetal T cell reactions (MvFRs) of maternal T cells were significantly inhibited by dTreg but not by sTreg cells (or were only minimally suppressed; Figure 5A).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11529984</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:39435662</oboInOwl:hasDbXref>
        <rdfs:label>STreg cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000815"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/4a264fdc-826d-4fdb-b99a-4f6a6e39d89e"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000815"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/4a3fdcc9-02ae-496d-9fb5-113e6e254859 -->

    <Class rdf:about="http://example.org/4a3fdcc9-02ae-496d-9fb5-113e6e254859">
        <obo:IAO_0000115>Several reports found that circulating blood or bone-marrow-derived cells of the monocyte-macrophage lineage are progenitors of LECs in lymphatic neovascularization under pathological conditions. Thus, peripheral blood monocytes were stimulated in vitro to induce podoplanin and other lymphatic endothelial markers by mimicking an inflammatory environment with VEGF-C, fibronectin, TNF-alpha, IL-3, or LPS (Table 1). Also, CD34+ human fetal liver-derived cells expressing CD133, podoplanin, and VEGFR-3, as well as podoplanin-positive mouse bone-marrow-derived cells, were found to behave as LEC progenitors and contribute to postnatal lymphatic neovascularization. More recently, Cimini and colleagues found that the podoplanin-positive cell population associated with the lymphangiogenic and fibrogenic responses during myocardial wound repair after infarction is widely heterogeneous and displays epitopes of fibrogenic and endothelial commitment, suggesting an alternate ability of ##podoplanin-positive cardiac cells## to generate lymphatic endothelium and pro-fibrotic cells. In a pioneering work, Maruyama and coworkers reported the incorporation of mouse CD11b+ and F4/80+ macrophages into lymphatic vessels in the inflamed cornea. These cells, which express podoplanin, LYVE-1. and VEGFR-3 lymphatic markers, were critical for the development and maintenance of inflammation-dependent lymphangiogenesis. In fact, a reduction in the number of these podoplanin-positive cells was associated with delayed wound repair in diabetic mice. Interestingly, podoplanin neutralization with a specific monoclonal antibody (mAb) resulted in suppression of lymphangiogenesis and macrophage infiltration during corneal inflammation and ear wound healing, pointing to podoplanin as a novel therapeutic target for lymphangiogenesis and macrophage-related inflammation.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6386838</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:30736372</oboInOwl:hasDbXref>
        <rdfs:label>podoplanin-positive cardiac cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002494"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/4a3fdcc9-02ae-496d-9fb5-113e6e254859"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002494"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/4a4ee265-07bb-4957-86b1-71c313a32adb -->

    <Class rdf:about="http://example.org/4a4ee265-07bb-4957-86b1-71c313a32adb">
        <obo:IAO_0000115>Immunological characteristics were estimated by the infiltration of immune cells. The heat map exhibited proportion of immune cells in each endometrium by ssGSEA score (Figure 5A). The violin graph revealed that the infiltration of immature B cells (p = 0.036), activated dendritic cells (DCs) (p &lt; 0.001), regulatory T cells (Tregs) (p = 0.005), gammadelta T cells (p = 0.004) and myeloid-derived suppressor cells (MDSC) (p = 0.019) was markedly lower in RIF patients than controls, while the monocytes (p = 0.034) was higher in RIF patients (Figure 5B). GJA1, an important molecule for cell gap junctions, is positively associated with almost all immune cells. FANCD2 was also positively related to the infiltration of type 2 T helper cells, activated CD4 T cells, activated B cells, and central memory CD4 T cell, while were negatively associated with type 17 T helper cells. Furthermore, MUC1 were negatively correlated with ##immature dendritic cells##, MDSCs, helper T cells, natural killer cells macrophages and activated dendritic cells (Figure 5C).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11472029</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:39400935</oboInOwl:hasDbXref>
        <rdfs:label>immature dendritic cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000840"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/4a4ee265-07bb-4957-86b1-71c313a32adb"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000840"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/4a5500eb-c0b2-4147-969a-6e6339f9301e -->

    <Class rdf:about="http://example.org/4a5500eb-c0b2-4147-969a-6e6339f9301e">
        <obo:IAO_0000115>As mentioned above, RelB has pleiotropic effects on MS or EAE pathogenesis via a cell type-specific manner. RelB activation or inhibition in specific cell types could be achieved by regulating upstream signaling pathway. While decreased RelB expression in Th1, gammadeltaT17, DCs, B cells, macrophages and oligodendrocytes may have a beneficial role in MS or the EAE animal model, suppressive processes in other cell types may also cause greater severity. In this scenario, the use of RelB inhibitors in vivo is still in its infancy, and potential harmful effects must not be ignored by researchers. Therefore, we propose that targeted therapies in more specific cell types, such as RelB-inhibited Th1, gammadeltaT17, DCs, B cells, macrophages and oligodendrocytes need to be further investigated. Considering the fact that our research group has successfully alleviated established EAE by adoptive transfer of 1,25-(OH)2D3-induced ##tolerogenic DCs##, in the future, the adoptive transfer of RelB-silenced tolerogenic DCs may be a promising strategy for the precise treatment of MS. However, to our knowledge, limited data about RelB in patients with MS has been reported and most work has been mainly focused on the animal models of MS. Only when we are sufficiently knowledgeable should we consider targeting RelB as a clinical approach to treat patients with MS.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6935142</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31881915</oboInOwl:hasDbXref>
        <rdfs:label>tolerogenic DCs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000451"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/4a5500eb-c0b2-4147-969a-6e6339f9301e"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000451"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/4a5f0b18-aab7-4cfa-88be-6bbfe5c368a9 -->

    <Class rdf:about="http://example.org/4a5f0b18-aab7-4cfa-88be-6bbfe5c368a9">
        <obo:IAO_0000115>Cibersortx identified immune cell infiltration patterns and distinct profiles across three disease subtypes. In disease subtype 1, there was elevated expression of DC cells (Dendritic cells), eosinophils, and neutrophils. Disease subtype 2 exhibited increased expression of plasma cells, macrophages, and ##resting mast cells##. Disease subtype 3 demonstrated heightened expression of CD4 (Clusters of differentiation 4) memory-activated T cells and activated mast cells. Interestingly, regulatory T cells (Tregs) consistently displayed significant downregulation across all three disease subtypes. These variations may play pivotal roles in immune system modulation and contribute to the underlying mechanisms of these diseases (Figure 9A).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11121097</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38791423</oboInOwl:hasDbXref>
        <rdfs:label>resting mast cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000097"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/4a5f0b18-aab7-4cfa-88be-6bbfe5c368a9"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000097"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/4a6c2686-4c71-4233-8d16-19e55d225b2a -->

    <Class rdf:about="http://example.org/4a6c2686-4c71-4233-8d16-19e55d225b2a">
        <obo:IAO_0000115>a Schematic of the experimental pipeline. Created with BioRender.com b UMAP visualization of peritoneal immune cells. c Ratio of each population in cell number. d VlnPlot of characteristic gene expressions for macrophage subpopulations. Sham sham control, ELL endometriosis-like lesions, ELL_N niclosamide administration to ELL-induced mouse, Pre-SPMs premature &quot;small&quot; peritoneal macrophages, SPMs ##&quot;small&quot; peritoneal macrophages##, IM1-3 intermediate macrophages subtype 1-3, Timd4+ LPMs Timd4+ &quot;large&quot; peritoneal macrophages, PMs proliferating macrophages, B1a B1a cells, B1b B1b cells, B2 B2 cells, GCBs germinal-centre B cells, PBs plasma blast B cells, Cd4+ Ts Cd4+ T cells, Cd8+ Ts Cd8+ T cells, DN1 double negative T cells 1, DN2 double negative T cells 2, cDC1 conventional dendritic cells 1, MCs Mast cells, NTPs neutrophils.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9652344</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36369244</oboInOwl:hasDbXref>
        <rdfs:label>&quot;small&quot; peritoneal macrophages</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000581"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/4a6c2686-4c71-4233-8d16-19e55d225b2a"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000581"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/4a954d7b-6567-4cce-b892-f9e59bbfc0ee -->

    <Class rdf:about="http://example.org/4a954d7b-6567-4cce-b892-f9e59bbfc0ee">
        <obo:IAO_0000115>We identified 23 immune cell subpopulations in the GSE162454 dataset by TSNE analysis at first. Based on the specific markers, we identified NK/T cells, CAFs (cancer associated fibroblasts), endothelial cells, plasma cells, osteoblastic cells, osteoclasts, B cells, M2 TAMs (tumor associated macrophages), ##M1 TAMs##, monocytes and mast cells (Figure 10A). The expression of marker genes for different cell clusters was displayed in dot plot format in Figure 10B. The expression of OS-related genes was compared in different cell types. Because of the dropout sign of single-cell sequencing, INS was not detected in the GSE162454 dataset. As shown in Figure 10C, HMOX1 were expressed at higher levels in TAMs and osteoclasts. ATF4 and ACADVL are highly expressed in myeloid cells as well as other cell types, which was suggestive of their roles in osteosarcoma progression.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10292890</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37285835</oboInOwl:hasDbXref>
        <rdfs:label>M1 TAMs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000863"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/4a954d7b-6567-4cce-b892-f9e59bbfc0ee"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000863"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/4aae7bc5-8251-403f-835c-6e9a2b019dbb -->

    <Class rdf:about="http://example.org/4aae7bc5-8251-403f-835c-6e9a2b019dbb">
        <obo:IAO_0000115>scRNA-seq of ECs reveal a subpopulation enriched with immune responsive signatures. (A) Schematic showing the experimental design for the scRNA-seq and single-nuclei ATAC sequencing analysis of regenerative mouse hearts (MI at P1 and harvested at P5) and nonregenerative mouse hearts (MI at P8 and harvested at P12). (B) UMAP representation of cardiac cell clusters identified from scRNA-seq analysis. Clusters were color coded according to cell types (left). CM, cardiomyocytes; EC, endothelial cells; CF, fibroblasts; PeriC, pericytes; SMC, smooth muscle cells; EndoC, endocardial cells; EpiC, epicardial cells; MF, macrophages; TC, T-cells. (C) Gene ontology (GO) analysis of differentially expressed genes up-regulated in ECs of regenerative-stage hearts versus nonregenerative-stage hearts after MI. (D) UMAP representation of CD31+-enriched cell clusters from single-cell RNA sequencing (scRNA-seq), color coded according to cell type. CEC, capillary endothelial cell; Angio-EC, angiogenic endothelial cell; Pro-EC1, proliferative endothelial cell 1; Pro-EC2, proliferative endothelial cell 2; ##IFN-EC##, interferon capillary endothelial cell; CVEC, capillary venous endothelial cell; VEC, venous endothelial cell; AEC, arterial endothelial cell; LEC, lymphatic endothelial cell; EndoC, endocardial cell. (E) Gene ontology (GO) analysis of differentially expressed genes up-regulated in the IFN-EC cluster of regenerative-stage hearts versus nonregenerative-stage hearts after MI.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10681909</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38012001</oboInOwl:hasDbXref>
        <rdfs:label>IFN-EC</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002144"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/4aae7bc5-8251-403f-835c-6e9a2b019dbb"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002144"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/4b28e487-ed9e-459d-862d-07bf509b836c -->

    <Class rdf:about="http://example.org/4b28e487-ed9e-459d-862d-07bf509b836c">
        <obo:IAO_0000115>Cell heterogeneity in PDAC has been widely investigated using single-cells transcriptomic approaches, but only few studies analyzed the protein expressed by the different cell subpopulations that compose the PDAC microenvironment. In the last decade, multiplexed Imaging Mass Cytometry (IMC) has emerged as a powerful technology to dissect the cell landscape of several TME. IMC combines conventional histology with mass cytometry to identify up to 35-40 metal-tagged antibodies, avoiding limitations related to fluorescence-based imaging technologies, including autofluorescence and spectral overlap. Although several studies used conventional immunohistochemistry or fluorescence-based imaging to target markers of PDAC microenvironment, fewer are the investigations conducted using the multiplexed IMC technology. In addition, these studies mainly focused on the immune cell composition in the PDAC microenvironment, with a limited analysis of the ##CAF## phenotype and localization.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11578750</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:39575252</oboInOwl:hasDbXref>
        <rdfs:label>CAF</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000057"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/4b28e487-ed9e-459d-862d-07bf509b836c"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000057"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/4b81230d-2a26-4bd0-97fb-39243e4e5a31 -->

    <Class rdf:about="http://example.org/4b81230d-2a26-4bd0-97fb-39243e4e5a31">
        <obo:IAO_0000115>To get our bearings, we used Scanpy to generate a global embedding of the 11.4 million cell x 24,552 gene count matrix, and annotated 26 major clusters on the basis of marker genes (Fig. 1b,c and Supplementary Table 4). As expected, cell clusters whose proportions decline over developmental time either stream towards derivatives (for example, neuroectoderm and glia to central nervous system (CNS) neurons and ##intermediate neuronal progenitors##) or are displaced by functionally analogous but developmentally distinct lineages (for example, primitive erythroid to definitive erythroid). However, the resolution of these major clusters was somewhat arbitrary and affected by abundance. To balance the resolution, we performed another iteration of clustering and annotation, resulting in 190 labelled cell types (Extended Data Fig. 3 and Supplementary Table 5). These annotations are preliminary, and we welcome their refinement by the community.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10901739</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38355799</oboInOwl:hasDbXref>
        <rdfs:label>intermediate neuronal progenitors</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0011020"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/4b81230d-2a26-4bd0-97fb-39243e4e5a31"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0011020"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/4bcf9b3d-de54-4285-8fa7-9b8b81d5f34e -->

    <Class rdf:about="http://example.org/4bcf9b3d-de54-4285-8fa7-9b8b81d5f34e">
        <obo:IAO_0000115>To gain a comprehensive view of immune interactions, we performed correlation analyses between the frequency of Ki67+ Tregs and the frequencies of all identified immune cell subpopulations. We did not observe significant association of the frequency of Ki67+ Tregs with lymphocytic subsets (Supplementary Fig. 8). On the other hand, myeloid cells, particularly dendritic cells (DCs), are known to facilitate Treg generation. Therefore, we analyzed the correlation between the frequency of Ki67+ Tregs and that of myeloid cell subsets (including cMo, iMo, ncMo, and DC). The frequency of Ki67+ Tregs was positively associated with the frequencies of HLA-DR+ and CD86+ monocytes and dendritic cells (Supplementary Fig. 9), suggesting their potential roles in the generation of Ki67+ Treg cells via antigen presentation and CD28-dependent signaling. Interestingly, we found that the frequency of Ki67+ Tregs was also positively associated with the frequencies of ##PD-L1+ monocytes and dendritic cells## (Supplementary Fig. 9), which is consistent with previous reports that DCs could induce Treg cells via PD-L1. These results indicate that myeloid cells might play a crucial role in Treg generation.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11496634</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:39438442</oboInOwl:hasDbXref>
        <rdfs:label>PD-L1+ monocytes and dendritic cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000451"/>
        <skos:relatedMatch rdf:resource="CL:0000576"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/4bcf9b3d-de54-4285-8fa7-9b8b81d5f34e"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000451"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/4bcf9b3d-de54-4285-8fa7-9b8b81d5f34e"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000576"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/4bda6edc-acec-4b92-be2a-cc97945f18f6 -->

    <Class rdf:about="http://example.org/4bda6edc-acec-4b92-be2a-cc97945f18f6">
        <obo:IAO_0000115>Postnatal neurogenic zones, such as the V-SVZ (ventricular-subventricular zone) that lines the lateral ventricle walls, have an embryonic origin. Interestingly, a fraction of radial glial cells (RGCs) in the forebrain LGEs (lateral ganglionic eminences) and pallium becomes quiescent. ZEB2 was studied in LGE-derived neurons for LGEs using mainly the Gsh2-Cre driver, hence ZEB2 co-steers the anlage of part of the V-SVZ. After birth, these cells are reactivated and differentiate into the different cell types of the V-SVZ, which in the mouse are architecturally grouped, and produce supportive cells (ependymal or E cells) or ##RGC-like neural stem cells## (NSCs or B1 cells) of the V-SVZ. The latter cells generate C cells (transit amplifying cells), which give rise to A cells (immature, including migratory neuroblasts). As cells migrate via the rostral migratory stream (RMS) to the olfactory bulb (OB) and emanate as network-integrated different types of interneuron. The V-SVZ and its RMS expresses miR-200 class of micro-RNAs (that target Zeb2) and, at the time B cells are set aside in the embryonic brain, ZEB2 mRNA/protein is present in the ventral telencephalon, including the aforementioned LGE. In Gsh2-Cre;Zeb2-cKO LGEs, about 70% of postnatal V-SVZ cells are detectably targeted at E14.5, and this is confirmed in P2 and P5 mice. Pronounced defects are seen in these KO mice in OB development, for they have more scattered distribution of the various cell types and. Additionally, at P17-P18, the fewer OB interneurons results in OBs that are 70% smaller than normal. This suggested an important role of ZEB2 in postnatal neurogenesis.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8304685</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34356053</oboInOwl:hasDbXref>
        <rdfs:label>RGC-like neural stem cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000047"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/4bda6edc-acec-4b92-be2a-cc97945f18f6"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000047"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/4bdc30cc-de0a-4956-8427-90674ee6af7d -->

    <Class rdf:about="http://example.org/4bdc30cc-de0a-4956-8427-90674ee6af7d">
        <obo:IAO_0000115>We found that Pianno&apos;s prediction of the distribution of excitatory neuron subtypes displayed similar pattern as Tangram and RCTD (Supplementary Fig. S3), exhibited a high level of consistency with their known locations across the various layers (Fig. 3c). In contrast, the spatial distribution obtained from unsupervised clustering of cell bins in the original paper presented clusters containing neurons from both L5/6 and L2-3. These clusters included neurons assigned as EX L5/6 but displayed a significant enrichment also in upper layers (Fig. 3d). Ectopic mapping of ##L5/6 neurons## to L2-3 was also observed in the results obtained from Cell2location (Supplementary Fig. S3), the tool showing top-performance in a previous benchmarking study of spatial deconvolution methods. These results suggest that even the most advanced deconvolution tool available at the time struggled with precisely assigning these neurons to their correct layers. The mispositioning of L5/6 neurons to L2-3 can likely be attributed to the fact that L2-3 and L5 pyramidal neurons share some similar electrophysiological properties, morphological features, and connectivity patterns, leading to an increased transcriptomic similarity between them.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11271244</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38565531</oboInOwl:hasDbXref>
        <rdfs:label>L5/6 neurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000540"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/4bdc30cc-de0a-4956-8427-90674ee6af7d"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000540"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/4be8c8c1-a3e1-4286-9fa5-6a4494c37544 -->

    <Class rdf:about="http://example.org/4be8c8c1-a3e1-4286-9fa5-6a4494c37544">
        <obo:IAO_0000115>Our findings support the theory of a consistently altered bioenergetic state in ME/CFS immune cells, specific to certain immune cell types that rely on fatty acids more heavily than healthy control subjects. This study detected increases in fatty acid oxidation in CD4+ T cells, CD8+ T cells, and NK cells at varying degrees, with CD4+ T cell fatty acid utilization correlating with ME/CFS illness duration. This data indicates that ##ME/CFS NK cell## dysfunction could be in part due to greater levels of lipid accumulation and subsequent fatty acid oxidation. We also propose that the combined metabolic profile of ME/CFS T cells suggests an exhausted T cell state, resulting in reduced effector functions that may contribute to ME/CFS symptom presentation.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9916395</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36768336</oboInOwl:hasDbXref>
        <rdfs:label>ME/CFS NK cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000623"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/4be8c8c1-a3e1-4286-9fa5-6a4494c37544"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000623"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/4bec7418-6a98-4352-8e92-495790574e89 -->

    <Class rdf:about="http://example.org/4bec7418-6a98-4352-8e92-495790574e89">
        <obo:IAO_0000115>##Innate T cells## (ITC) contain many subsets and are poised to promptly respond to antigens and pathogens, but how this poised state is maintained is still unclear. Here the authors perform single-cell RNA-seq to align the various ITC subsets along an &apos;innateness gradient&apos; that is associated with changes in proliferation and effector functions.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6368609</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:30737409</oboInOwl:hasDbXref>
        <rdfs:label>Innate T cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002127"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/4bec7418-6a98-4352-8e92-495790574e89"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002127"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/4bf58d58-1d7f-427c-adf2-f28a329b6fa1 -->

    <Class rdf:about="http://example.org/4bf58d58-1d7f-427c-adf2-f28a329b6fa1">
        <obo:IAO_0000115>It has been well-documented that total CD4+CD45RA+ naive T cells are reduced, and total CD4+CD45RO+ memory T cells are spared following alemtuzumab treatment. Our data show similar changes in total memory (supplementary Figure S3A) and total naive CD4+ T cells (Figure S3B). Figure S3 also illustrates changes over time in subsets of naive and memory CD4+ T cells, defined as described by Lovett-Racke and colleagues. Briefly, lymphocytes were identified in FSC/SSC plots, followed by gating on CD4+CD45RA+ or CD45RA- cells to identify CD27+ and CD27- lymphocytes (FACS gating strategy not illustrated). Figure S3 shows that the percentage of ##CD4+CD45RA+CD27+ naive T cells## (Figure S3C) was reduced at M5 and M17, while CD4+CD45RA-CD27+ central memory T cells (TCM; Figure S3D) remained relatively stable over time. The percentage of CD4+CD45RA-CD27- effector memory T cells (TEM; Figure S3E) increased at M5, along with CD4+CD45RA+ new effector T cells (new Teff; Figure S3F).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7296935</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32539719</oboInOwl:hasDbXref>
        <rdfs:label>CD4+CD45RA+CD27+ naive T cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000895"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/4bf58d58-1d7f-427c-adf2-f28a329b6fa1"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000895"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/4c3343c7-f824-4a22-9dac-5ec40ba5c090 -->

    <Class rdf:about="http://example.org/4c3343c7-f824-4a22-9dac-5ec40ba5c090">
        <obo:IAO_0000115>Our recent work demonstrating that kidney-infiltrating T cells (##KITs##) are functionally and transcriptionally exhausted : much like TILs or CD8+ T cells after chronic viral infection : challenges 2 paradigms. First, it argues against the idea that autoimmune destruction of parenchymal tissue is a direct effector process, akin to a response to virally infected cells. Instead, some tissues may be endowed with natural self-preservation mechanisms that downregulate or suppress infiltrating T cells, which may prevent or attenuate autoimmunity. Second, it suggests that tumors do not evolve a de novo set of pathways to negatively regulate T cells. Instead, such pathways may be native to certain parenchymal tissues, and tumors may amplify them or simply naturally express them.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9089785</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35271505</oboInOwl:hasDbXref>
        <rdfs:label>KITs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000084"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/4c3343c7-f824-4a22-9dac-5ec40ba5c090"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000084"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/4c7457cf-c0b2-4022-8cd3-fb6f0cce7dca -->

    <Class rdf:about="http://example.org/4c7457cf-c0b2-4022-8cd3-fb6f0cce7dca">
        <obo:IAO_0000115>The tumor immune microenvironment of 10 patients with TNBC was resolved after single-cell RNA sequencing data were analyzed according to the standard workflow of Seurat. A total of 21 different types of cell clusters were annotated (Fig. 7a,b): Cancer Cell (WFDC2, SAA1, SCGB2A2), Endothelial Cell (PLVAP, ACKR1, VWF), Epithelial Cell (CLDN3, MUCL1, TFF3), Exhausted CD8 + T Cell (CD8A, CD8B, CXCR6), Fibroblast (DCN, APOD, LUM), Granulosa Cell (SPP1), Leydig Cell (ASPH, SERPINE1, PFN2), M1 Macrophage (CXCL9, CXCL10, CXCL2), M2 Macrophage (SEPP1, F13A1, FOLR2), Memory T Cell (TRAC, TRBC2), Mesenchymal Cell (RGS5, NDUFA4L2), MKI67+ Progenitor Cell (MKI67, RRM2, UBE2C), Naive B Cell (MS4A1, CD79B, BANK1), Natural Killer (NK) Cell (GNLY, TRDC, NKG7), Natural Killer T (NKT) Cell (RGCC, DNAJB1, DNAJA1), Neutrophil (S100A8, S100P, PI3), Plasma Cell (IGKV3-15, IGKC, IGHG1), Plasmacytoid Dendritic Cell (LILRA4, PLD4, NPC2), Regulatory T (Treg) Cell (BATF, TNFRSF18, TNFRSF1B), T Helper Cell (IL7R, CCR7, CD40LG), ##Tumor Associate Macrophage##(TAM) (FCN1, VCAN, EREG).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10662149</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37985782</oboInOwl:hasDbXref>
        <rdfs:label>Tumor Associate Macrophage</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/4c7457cf-c0b2-4022-8cd3-fb6f0cce7dca"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/4c84501e-2124-4d13-92c0-3eb04a7a62df -->

    <Class rdf:about="http://example.org/4c84501e-2124-4d13-92c0-3eb04a7a62df">
        <obo:IAO_0000115>Here, we demonstrate that Lepr marks a distinct ##PDLSCs## population that contributes to periodontium homeostasis and responds to mechanical force by Piezo1.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10582421</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37553778</oboInOwl:hasDbXref>
        <rdfs:label>PDLSCs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000134"/>
        <skos:relatedMatch rdf:resource="CL:2000017"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/4c84501e-2124-4d13-92c0-3eb04a7a62df"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000134"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/4c84501e-2124-4d13-92c0-3eb04a7a62df"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:2000017"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/4cab7cc5-8ba7-446d-8499-c63204d87774 -->

    <Class rdf:about="http://example.org/4cab7cc5-8ba7-446d-8499-c63204d87774">
        <obo:IAO_0000115>Brain transcriptional changes after MIA require microglia. (A) Simplified schematic of sample processing pipeline from and bar plots of TORCH pathogen and cytokine receptor expression (mean log counts per million) in each cell type across development. (B) Violin plot of CytoTORCH module score for each cell cluster (MG, P&lt;0.05 for ANOVA and for pairwise comparisons between microglia and all other cell types using Tukey&apos;s HST). (C) Overview of experimental design (top) and UMAP visualization of snRNAseq data from the developing somatosensory cortex of E15.5 wild-type and Csf1r-/- mice after saline or Poly(I:C) maternal injection at E12.5 (two or three embryos per condition from a total of four pregnant dams, 42,736 total cells) (bottom). Cells are colored by cell type assignment. (D) Dot plots of log(fold change) in gene expression between MIA and saline for cell types with significant changes at E15.5. DEG analysis was performed using NEBULA. AP, apical progenitors; IP, intermediate progenitors; ImmN, immature neurons, ##MN##, migrating neurons; (UL/DL) CPN, (upper layer/deep layer) callosal projection neurons; SCPN, subcerebral projection neurons; CThPN, corticothalamic projection neurons; LIV, layer IV stellate neurons; IN, interneurons; CR, Cajal-Retzius cells; Astro, astrocytes; CGC, cycling glial cells; Epend; ependymal cells; OL, oligodendroglia; MG, microglia; Peri, pericytes; EC, endothelial cells; VLMC, vascular and leptomeningeal cells. Created with .</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11190434</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38775708</oboInOwl:hasDbXref>
        <rdfs:label>MN</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000540"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/4cab7cc5-8ba7-446d-8499-c63204d87774"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000540"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/4cc2f383-75d3-4d55-9d9e-28d5810821f5 -->

    <Class rdf:about="http://example.org/4cc2f383-75d3-4d55-9d9e-28d5810821f5">
        <obo:IAO_0000115>GSEA of the 113 microglial-specific genes identified in Figure 3A and the 174 macrophage marker genes identified in Figure 3B revealed overall enrichment of microglial marker genes (Fig. 3E) and depletion of macrophage marker genes (Fig. 3F) when comparing the combined sort fractions from all methods to the Cell-Input. GSEA enrichment scores were similar between the different sort methods (Fig. 3G; Extended Data Fig. 3-1). Based on the flow cytometric and transcriptomic data, all sort methods have high levels of microglial purity and low levels of ##CAM## and monocyte contamination.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8970438</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35228310</oboInOwl:hasDbXref>
        <rdfs:label>CAM</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000880"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/4cc2f383-75d3-4d55-9d9e-28d5810821f5"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000880"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/4cf055ea-21cb-46f8-978c-4c5e3096119f -->

    <Class rdf:about="http://example.org/4cf055ea-21cb-46f8-978c-4c5e3096119f">
        <obo:IAO_0000115>##adventitial endothelial cell##</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6553510</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:30943771</oboInOwl:hasDbXref>
        <rdfs:label>adventitial endothelial cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000115"/>
        <skos:relatedMatch rdf:resource="CL:0002503"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/4cf055ea-21cb-46f8-978c-4c5e3096119f"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000115"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/4cf055ea-21cb-46f8-978c-4c5e3096119f"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002503"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/4cf2b384-0059-4489-a907-0759b4fa2e1b -->

    <Class rdf:about="http://example.org/4cf2b384-0059-4489-a907-0759b4fa2e1b">
        <obo:IAO_0000115>Our results so far indicate that the dura mater layer of the meninges contains a diverse population of stromal cells, including GP38+ and GP38- stromal cells that resemble the stroma of other lymphoid tissues and ECM remodelling. Consistent with our scRNAseq data, using flow cytometry, we observed a significant expansion of GP38+ FRCs, and a distinctive population of MAdCAM1+ CD21/CD35+ cells indicative of the presence of FDC-like cells in the infected murine meninges compared to naive controls (Fig 3D-3F; Gating strategy in S2A Fig, S5 and S6 Data), without significant changes in the lymphatic endothelial cells (LECs) or blood endothelial cells (BECs) (Fig 3E and 3F). Furthermore, using module scoring analysis, which allows us to assess global gene signatures associated with a gene set or pathway (in this case, ectopic lymphoid tissue signatures), we were able to identify that cells within cluster 5 were enriched for genes associated with FDC-like function and stromal lymphoid tissues, including Ccl19 and Cxcl13, compared to the other fibroblast clusters (Fig 3H), and may be derived from Ly6a+ pericytes with a precursor capacity as previously reported. Indeed, using in situ hybridisation on independent tissue sections, we were able to confirm the presence of Ly6a+ Rarres2+ cells that expressed Cxcl13+ during infection (Fig 3I). Together, our data demonstrate the presence of a rich diverse fibroblast population, encompassing Ly6a+ Rarres2+ FRC-like pericytes, including Aldh1a2+ Ccl19+ FRC-like pericytes, myofibroblasts, Fth1+ fibroblasts, and ##perivascular dura fibroblasts##. Our data also suggests that chronic T. brucei infection induces an extensive remodelling of the meningeal stroma compartment, resulting in the expansion of FRCs and FDC-like cells without significant changes in the vasculature (LECs and BECs).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10723712</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37983289</oboInOwl:hasDbXref>
        <rdfs:label>perivascular dura fibroblasts</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000057"/>
        <skos:relatedMatch rdf:resource="CL:4033054"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/4cf2b384-0059-4489-a907-0759b4fa2e1b"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000057"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/4cf2b384-0059-4489-a907-0759b4fa2e1b"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4033054"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/4cf5a5fb-7245-4533-9d1c-942dd423c30d -->

    <Class rdf:about="http://example.org/4cf5a5fb-7245-4533-9d1c-942dd423c30d">
        <obo:IAO_0000115>Our findings revealed a progenitor population hidden among other microglia under steady-state conditions. Unlike other ##terminally differentiated myeloid cells##, microglia are sufficiently self-maintained. Under acute microglial ablation, the 1-10% remaining microglia can restore the entire empty niche, without needing any external progenitor input. However, due to the unusual plasticity of microglia, it still remains unclear whether a specialized adult progenitor is required to maintain microglial homeostasis. It had been proposed that every microglial cell could have the ability to conduct self-renewal when needed. Consistent with this notion, although we found that MAC2+ cells were highly proliferative during early stage microglial repopulation, a large proportion of proliferating microglia did not express MAC2. And the number of MAC2+ cells returned to Ctrl level by D14. The overall contribution of MAC2+ microglia during repopulation is hard to determine with the current approach since MAC2 expression could be very transient, and rapidly turned off once cell cycle is complete. To determine the overall contribution of MAC2+ cells to microgliogenesis, further lineage tracing studies of the descendants of MAC2+ progenitors are needed.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7591254</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33054973</oboInOwl:hasDbXref>
        <rdfs:label>terminally differentiated myeloid cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000763"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/4cf5a5fb-7245-4533-9d1c-942dd423c30d"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000763"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/4d3079a1-ab48-4bd6-b147-a0356a38f7c2 -->

    <Class rdf:about="http://example.org/4d3079a1-ab48-4bd6-b147-a0356a38f7c2">
        <obo:IAO_0000115>Development of the trophoblastic shell and formation of placental anchoring villi. a Structure of the human trophoblastic shell and its surrounding arterial vessels. b Depiction of a placental anchoring villus, spiral artery (SA) remodelling and interaction of extravillous trophoblasts (EVTs) with different decidual cell types. dCCT distal cell column trophoblast, dMPhi decidual macrophage, DSC decidual stromal cell, eCTB endovascular cytotrophoblast, GC giant cell, iCTB interstitial cytotrophoblast, pCCT proximal cell column trophoblast, pEC placental endothelial cell, pMPhi placental macrophage, pSC ##placental stromal/mesenchymal cell##, SM smooth muscle layer, STB syncytiotrophoblast, TBS trophoblastic shell, TP trophoblast plug, TV tertiary villi, UC umbilical cord, uNK uterine NK cell, vCTB villous cytotrophoblast, YO yolk sac</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6697717</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31049600</oboInOwl:hasDbXref>
        <rdfs:label>placental stromal/mesenchymal cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:2000061"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/4d3079a1-ab48-4bd6-b147-a0356a38f7c2"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:2000061"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/4d49dac9-d4d6-4bfe-9011-d35157095f8a -->

    <Class rdf:about="http://example.org/4d49dac9-d4d6-4bfe-9011-d35157095f8a">
        <obo:IAO_0000115>The quantification of ##multipotent HSPCs## is commonly performed according to the lineage-relationships proposed by the classical model of human hematopoiesis. According to this classical model, HSCs and multipotent progenitors (MPPs) are the only cells containing both myeloid as well as lymphoid differentiation potentials. However, the classical model of hematopoiesis has meanwhile been challenged by several groups proposing alternative lineage-relationships and read-outs for multipotent HSCs/MPPs. In this context, we have shown that human CD133+CD45RA-CD34+ HSPCs are enriched for multipotent HSPCs. In vitro, more than 80% of these cells perform asymmetric cell divisions to create one CD133+CD45RA+CD34+ and one CD133-CD45RA-CD34+ daughter cell. While CD133+CD45RA+CD34+ cells inherit the potential to create all lymphocytes and neutrophils, CD133-CD45RA-CD34+ cells are limited to erythroid, megakaryocytic, basophilic and eosinophilic potentials. The first cell fulfills the criteria of LMPPs and the latter ones correspond to cells that are commonly known as common myeloid progenitors (CMP). As we demonstrated that they are not able to form neutrophils, it is no longer justified to interpret them as CMPs. Accordingly, we re-named them to erythro-myeloid progenitors (EMPs) and proposed a revised model for human hematopoiesis in which neutrophils arise from the same branch as lymphocytes (Fig. 1A). The segregation of lineage potentials as predicted in our revised model was recently confirmed in mouse as well as in human steady state BM hematopoiesis using single cell transcriptomics. According to the proposed model, multipotent HSPCs can easily and objectively be identified as CD133 expressing HSPCs containing erythroid differentiation potentials (Fig. 1A).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6733927</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31501490</oboInOwl:hasDbXref>
        <rdfs:label>multipotent HSPCs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000037"/>
        <skos:relatedMatch rdf:resource="CL:0000837"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/4d49dac9-d4d6-4bfe-9011-d35157095f8a"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000037"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/4d49dac9-d4d6-4bfe-9011-d35157095f8a"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000837"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/4d4caec8-fc67-4351-9d2a-07de03d8dce7 -->

    <Class rdf:about="http://example.org/4d4caec8-fc67-4351-9d2a-07de03d8dce7">
        <obo:IAO_0000115>To develop a deeper understanding of the nature of B-cell responses in COVID-19, we further divided the B-cell population into more detailed subclusters using their transcriptional signatures and SHM rate obtained from scRNA datasets ( Figures 3A-C ). Previous high-dimensional flow cytometry data indicated that severe COVID-19 patients displayed hallmarks of EF B-cell activation and shared B-cell repertoire features in autoimmune settings. Therefore, our study primarily focused on B-cell subsets representing EF responses. Here, 13 B-cell subclusters, including 3 subsets of plasma cells and 5 subsets of memory B cells, were identified by cluster analysis on UMAP ( Figure 3A ). IGHD-expressing naive B cells were subdivided into TR B cells, resting naive (RN) B cells, and activated naive (AN) B cells according to the differential expression of the specific signature gene set ( Figure 3B ). The AN B cells were IGHD-positive clusters with comparatively higher SHM rates ( Figure 3C ) than other naive B cells and expressed distinct genes, such as FGR and MPP6. During the EF response, AN B cells differentiate into effector cells lacking naive (IgD) and memory (CD27) markers or DN B cells. DN B cells showed a higher SHM rate than AN B cells and expressed ITGAX (CD11C) and CD86 ( Figures 3B, C ). A previous study also reported that the human EF effector B-cell responses are mediated by the expansion of a unique population of CD11c+ AN B cells. Two clusters of ##atypical memory (AM1 and AM2) B cells## were identified within the memory B-cell compartment, which overexpressed CD1C. Interestingly, AM2 B cells shared several transcriptional signatures, including FGR and HLA-DRB1, with EF B-cell subsets, including AN and DN cells. Both AM2 and DN B cells express ITGAX, TBX21, CD86, and ITGB2, but AM2 uniquely expressed CXCR3 and GSN (gelsolin).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9309264</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35899045</oboInOwl:hasDbXref>
        <rdfs:label>atypical memory (AM1 and AM2) B cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000787"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/4d4caec8-fc67-4351-9d2a-07de03d8dce7"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000787"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/4d534720-21eb-412a-8cad-fdb81d32ad92 -->

    <Class rdf:about="http://example.org/4d534720-21eb-412a-8cad-fdb81d32ad92">
        <obo:IAO_0000115>Multipotent adult progenitor cells (MAPC) are not only found in bone marrow but also distributed throughout all organs. These neural stem cells can also differentiate into various hematopoietic cells. It is known that mesodermal-derived cells originate outside of the nervous system, migrate into the hypothalamus where they transdifferentiate into LHRH-producing neurons. Similarly, bone marrow-resident cells can migrate to the brain and differentiate into cells typically found in the CNS. These cells, such as Purkinje cells, demonstrate the capacity of mesodermal-derived cells to adopt neural cell fates. The mechanisms behind this interconversion are still under investigation, but it is known that ##bone-marrow-derived cells## (BMDCs) fuse spontaneously with several cell types like Purkinje neurons, cardiomyocytes and hepatocytes, creating heterokaryons.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11599565</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:39592661</oboInOwl:hasDbXref>
        <rdfs:label>bone-marrow-derived cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002540"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/4d534720-21eb-412a-8cad-fdb81d32ad92"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002540"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/4d5570ff-a29a-4d42-a5d5-4c6bd751db1f -->

    <Class rdf:about="http://example.org/4d5570ff-a29a-4d42-a5d5-4c6bd751db1f">
        <obo:IAO_0000115>The illustration shows the differences between apocrine (left) and merocrine (right) secretory cells. Apocrine cells are characterised by dome-like protrusions, which pinch off and are released into the lumen. The vesicles in merocrine secretory vesicles are derived from the RER and Golgi apparatus and the contents released via the fusing with the apical membrane and exocytosis. The bottom of the illustration shows a ##sub-epithelial stromal fibroblast## surrounded by collagen fibrils.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6418221</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:30872668</oboInOwl:hasDbXref>
        <rdfs:label>sub-epithelial stromal fibroblast</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:1000301"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/4d5570ff-a29a-4d42-a5d5-4c6bd751db1f"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:1000301"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/4d97e678-f546-4106-bdb2-f7847b8caedf -->

    <Class rdf:about="http://example.org/4d97e678-f546-4106-bdb2-f7847b8caedf">
        <obo:IAO_0000115>We undertook a comprehensive Mendelian randomization study aimed at uncovering the causal relationship between 744 immune cell types and IVDD [ Supplementary Table 2 ]. In our analysis, we identified 24 specific blood types of immune cells that demonstrated a causal association with disc degeneration through univariable MR [ Supplementary Table 3 ], including Memory B cell %B cell, Naive-mature B cell %B cell, IgD-CD38dim B cell %lymphocyte, CD39+activated CD4 regulatory T cell %CD4 regulatory T cell, CD39+ secreting CD4 regulatory T cell %CD4 regulatory T cell, CD45RA+ CD8+ T cell %CD8+ T cell, CD8+ T cell %leukocyte, CD39+CD4+ T cell %T cell, CD39+ CD4+ T cell %CD4+ T cell,CD39+ CD8+ T cell %T cell, CD39+ CD8+ T cell Absolute Count, CD127- CD8+ T cell Absolute Count, CD28- CD8+ T cell Absolute Count, CD19 on IgD+ CD38+ B cell, CD19 on IgD+ CD38dim B cell, CD19 on IgD- CD38- B cell, CD19 on unswitched memory B cell, CD19 on transitional B cell, CD24 on IgD+ CD38+ B cell,CD28 on CD39+ secreting CD4 regulatory T cell, CD25 on CD39+ CD4+ T cell, CD4 on CD39+ CD4+ T cell, CD4 on ##CD39+ resting CD4 regulatory T cell## and Neutrophil count. We excluded certain exposures due to a limited number of available SNPs to prevent potential bias, including Memory B cell %B cell, Naive-mature B cell %B cell, IgD-CD38dim B cell %lymphocyte, CD8+T cell %leukocyte, CD127-CD8+ T cell Absolute Count, CD19 on IgD-CD38-B cell, CD24 on IgD+ CD38+ B cell, CD28 on CD39+ secreting CD4 regulatory T cell and CD4 on CD39+ resting CD4 regulatory T cell.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10806224</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38268919</oboInOwl:hasDbXref>
        <rdfs:label>CD39+ resting CD4 regulatory T cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000792"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/4d97e678-f546-4106-bdb2-f7847b8caedf"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000792"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/4da674d4-3632-4e42-80a1-ac7eecf6c5ab -->

    <Class rdf:about="http://example.org/4da674d4-3632-4e42-80a1-ac7eecf6c5ab">
        <obo:IAO_0000115>Notably, although CD8+ T cells have been only occasionally described in patient cohorts or animal studies in the allergy fields, the percentage of CCR4+CXCR3  type-2 cytotoxic CD8+ T cells (CD8+ Tc2, Fig. 3d, e) among living cells was also higher in VAP vs. HC at each time point including baseline, while the percentage of CCR4 CXCR3+ type-1 CD8+ T cells (CD8+ Tc1) was modestly but significantly decreased (Supplementary Fig. 3A). ##CD8+ Tc2-like cells##, referred to as the direct parent gate of CD8+ Tc2 (Supplementary Fig. 1), were also among the two significantly higher immune subsets in PAP vs. HC at several time points (Supplementary Figs. 2b, 3b). Remarkably, the percentage of CD45RA+CD8+ regulatory T cells (Tregs) (CD8+CD25highCD127lowCD45RA+) was significantly lower in VAP vs. HC at both baseline and D7 (Figs. 2b and 3f). A lower percentage of CD45RA+ and total CD8+ Tregs (CD8+CD25highCD127low) was also noticed among PAP vs. HC (Fig. 3f, Supplementary Figs. 2C, 3C). These findings demonstrated that type-2 CD8+ T cells charaterize the peripheral immune profile in VAP while the fraction of CD45RA+ CD8+ Tregs in VAP is inferior to that in HC at baseline and during the AIT initiation phase. In short, our data underscore an unrecognized link between several CD8+ T-cell subsets and insect-venom allergy pathogenesis and possibly the long-term immune-tolerance induced by AIT.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11599746</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:39592626</oboInOwl:hasDbXref>
        <rdfs:label>CD8+ Tc2-like cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000918"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/4da674d4-3632-4e42-80a1-ac7eecf6c5ab"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000918"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/4dfa7588-74b5-4c8d-a9e2-d5fb7f936a42 -->

    <Class rdf:about="http://example.org/4dfa7588-74b5-4c8d-a9e2-d5fb7f936a42">
        <obo:IAO_0000115>We analyzed the distribution of the four cell lineages in the retina, including seven neuronal classes, Rod, Cone, cone bipolar cell (CBC), rod bipolar cell (RBC), amacrine cell (AC), horizontal cell (HC), and retinal ganglion cell (RGC), one glial class, macroglia (Mag), three immune classes, monocyte macrophage and microglia (Myeloid), Neutrophil, and T cell and dendritic cells (T&amp;DC), and vascular endothelial cell (VEC), based on canonical markers and the most variable upregulated genes (Fig. 1A). Notably, we found that a group of Myeloid cells with high expression of ITGAM appeared during retinal I/R injury, including retina microglia, ##blood-derived macrophages## and monocytes (Additional file 1: Fig. S1A). The number of cells and relative per-class cell types in the retinal I/R and blank groups are depicted in Additional file 1: Fig. S1B. Many clusters were differentially represented in the two groups. Myeloid, and T&amp;DC subsets were over-represented in the I/R model and ROD, CBC, RBC, AC, RGC, and VEC subsets were underrepresented (Fig. 1B). Compared to the blank group, the I/R model had a markedly higher proportion of retinal cells in the Neutrophil and T&amp;DC subsets and lower in the CBC, RBC, AC, Mag, RGC, and VEC subsets (p &lt; 0.05; Fig. 1C). Four subsets (CONE, ROD, HC, and Myeloid) were similarly present in both groups (Additional file 1: Fig. S1B). scRNA-seq analysis revealed cell cluster differences between the groups.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9597965</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36289494</oboInOwl:hasDbXref>
        <rdfs:label>blood-derived macrophages</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/4dfa7588-74b5-4c8d-a9e2-d5fb7f936a42"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/4e152fd8-6b06-450d-9ad0-1e0d17a1c02c -->

    <Class rdf:about="http://example.org/4e152fd8-6b06-450d-9ad0-1e0d17a1c02c">
        <obo:IAO_0000115>A, B t-SNE plot of nontumor cells from 15 tumors (indicated by colors). C t-SNE plot of ##TAFs##, TAMs and LSECs from the diversity-low (gray dots) and diversity-high (red dots) groups. D t-SNE plot showing clusters identified by integrated analysis of TAMs and TAFs in diversity-low and diversity-high tumors. E Heatmap and KEGG analysis of genes in clusters of TAFs. At least two independent experiments were performed for all data. For curve Figures and bar Figures, data are presented as means +- SD. Unpaired Student&apos;s t-tests were used for comparing two variables. One-way ANOVA was used for multiple variables comparison. See also Fig. S1.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8943132</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35322024</oboInOwl:hasDbXref>
        <rdfs:label>TAFs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000057"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/4e152fd8-6b06-450d-9ad0-1e0d17a1c02c"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000057"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/4e482440-5d97-489e-8dfa-065323864e82 -->

    <Class rdf:about="http://example.org/4e482440-5d97-489e-8dfa-065323864e82">
        <obo:IAO_0000115>Molecular characteristics of perimeningeal astrocytes (##PMA##) and mature lesion border astrocytes (LBA).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11303254</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38907165</oboInOwl:hasDbXref>
        <rdfs:label>PMA</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000127"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/4e482440-5d97-489e-8dfa-065323864e82"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000127"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/4e4d191c-c8be-472c-976c-0b1d4fb9dc8d -->

    <Class rdf:about="http://example.org/4e4d191c-c8be-472c-976c-0b1d4fb9dc8d">
        <obo:IAO_0000115>Regarding the metabolic effects of the orexin system, orexin receptors are abundantly expressed in brain regions regulating energy metabolism, such as the medullary raphe, DMH, and ARC. More than 50% of serotonergic neurons in the medullary raphe, including the raphe pallidus nucleus (B1), raphe obscurus nucleus (B2), and raphe magnus nucleus (B3), express Ox1r but not Ox2r, which serve as sympathetic premotor neurons to enhance thermogenesis by brown adipose tissue (BAT). The DMH is one of the major upstream regions of medullary raphe neurons, and the excitatory projection from the DMH to the medullary raphe enhances sympathetic outflows. However, Ox2r-expressing DMH cells were mainly GABAergic. The role of ##DMH GABAergic neurons## in the regulation of sympathetic and other functions remains unclear. In the ARC, GABAergic neurons express Ox2r but not Ox1r. Orexin activates ARC GABAergic neurons and suppresses POMC neurons, a subpopulation of ARC GABAergic neurons. Since the loss of either Ox1r or Ox2r only partially mimics the obesity-prone phenotype of orexin-deficient mice, it is suggested that both Ox1r and Ox2r may function independently to render mice less prone to obesity.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10883752</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38199807</oboInOwl:hasDbXref>
        <rdfs:label>DMH GABAergic neurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000617"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/4e4d191c-c8be-472c-976c-0b1d4fb9dc8d"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000617"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/4e7b2a20-fe89-4ccf-bf57-05386e2be7f4 -->

    <Class rdf:about="http://example.org/4e7b2a20-fe89-4ccf-bf57-05386e2be7f4">
        <obo:IAO_0000115>Nrk disruption in homozygous mutant led to a defect in adrenergic phenotype acquisition in the adrenal chromaffin cells. (A) Immunostaining of transverse sections through the adrenal region of E18.75 mouse embryos in wild type and Nrk mutant mice, showing TH (green) and PNMT (magenta) immunoreactivity. (A-C) Is from a wild type E18.75 mouse. (D-F) Show a section from an Nrk-het mutant mouse. (G-I) Is from an Nrk-null mutant mouse. The prevertebral suprarenal ganglia and the adrenal glands are outlined in a solid line and dashed line respectively, based on bisbenzimide (BB, cyan) staining (A,D,G). (J) Loss of Nrk reduces the proportion of adrenergic chromaffin cell in the adrenal glands. The number of TH+ noradrenergic adrenal chromaffin cells and their PNMT+ adrenergic subpopulation cells were counted in sections from wild-type, Nrk-het and Nrk-null (both Nrk-/- female and Nrk-/Y male) mutant mice with n = 4. The proportion of PNMT+ adrenergic chromaffin cells were calculated by number of PNMT+ (adrenergic) cells/number ##PNMT-, TH+ (noradrenergic) adrenal chromaffin cells## and shown here as mean proportion +- SEM along with individual measures for each embryo. (K) Growth fractions for adrenergic chromaffin cells, noradrenergic chromaffin cells and sympathetic neurons were examined using Ki67 immunostaining for cycling cells in and calculated as proportion of total cells of each type.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6408553</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:30850723</oboInOwl:hasDbXref>
        <rdfs:label>PNMT-, TH+ (noradrenergic) adrenal chromaffin cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002083"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/4e7b2a20-fe89-4ccf-bf57-05386e2be7f4"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002083"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/4e8507c6-9041-416f-b90c-42bf48d12df7 -->

    <Class rdf:about="http://example.org/4e8507c6-9041-416f-b90c-42bf48d12df7">
        <obo:IAO_0000115>(A) The percentages of indicated cells among the peripheral blood mononuclear cells of the indicated mice at 12-14 months of age. TWT, n = 12; IL-6 KO, n = 8; DKO, n = 10; TKO, n = 10. Gran, granulocytes, Ly6G+CD11b+; MO, monocytes, Ly6C+CD11b+; B, B cells, B220+; T, T cells, CD3e+. (B) Flow cytometry plots illustrating the gating strategy for MDSCs in cells from A. gMDSC, ##granulocytic MDSC##. (C) Quantification of MDSC populations in B. (D) Flow cytometric analyses of the expression levels of c-Kit among the indicated cell populations from C in the indicated mice. (E) Absolute numbers of cells in the indicated lineages were quantified in the bone marrow and spleens from the indicated mice in A. (F) Cell size of indicated MDSCs in E was measured by flow cytometric forward scatter (FSC-A) and normalized to cells from the TWT group. (G) Absolute number of erythroid cells in various developmental stages (I-VI) from the bone marrow and spleens of the indicated mice in C. The stages were determined by the cell surface expression levels of CD44. Stage I, proerythroblast; stage II, basophilic erythroblast; stage III, polychromatic erythroblast; stage IV, orthochromatic erythroblast; stage V, reticulocyte; stage VI, mature erythrocyte. Data are presented as mean +- SEM. *P &lt; 0.05, **P &lt; 0.01, ***P &lt; 0.001, ****P &lt; 0.0001; 2-way ANOVA.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9435651</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35900794</oboInOwl:hasDbXref>
        <rdfs:label>granulocytic MDSC</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000094"/>
        <skos:relatedMatch rdf:resource="CL:0000889"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/4e8507c6-9041-416f-b90c-42bf48d12df7"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000094"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/4e8507c6-9041-416f-b90c-42bf48d12df7"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000889"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/4ea231a4-8ac6-45c1-9576-f2977468213a -->

    <Class rdf:about="http://example.org/4ea231a4-8ac6-45c1-9576-f2977468213a">
        <obo:IAO_0000115>In summary, from work done in frontal areas, it is clear that I-S cells are involved in enhancing learning and memory discrimination, are recruited during theta rhythms, and primarily target ##SOM+ cells##, but also PV+ cells (i.e., similar to hippocampal CA1 I-S3 cells; Figures 1A,B). Further characterization of VIP+ cell types in frontal areas is needed to distinguish how much I-S cell types in these areas contact pyramidal cells, compared to non-I-S VIP+ cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7296096</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32581726</oboInOwl:hasDbXref>
        <rdfs:label>SOM+ cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:4023017"/>
        <skos:relatedMatch rdf:resource="CL:4042037"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/4ea231a4-8ac6-45c1-9576-f2977468213a"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4023017"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/4ea231a4-8ac6-45c1-9576-f2977468213a"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4042037"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/4ea9841a-d538-409b-9b88-66eefa3fb4c6 -->

    <Class rdf:about="http://example.org/4ea9841a-d538-409b-9b88-66eefa3fb4c6">
        <obo:IAO_0000115>B cells can be further divided into B1 B-cells of the innate immune system and &quot;conventional&quot; B2 B-cells of the adaptive immune system. This division is well-established in mice, where ##sIgM+CD11b+CD5+ B1a B-cells## were first identified through the search for, the still elusive, cell of origin of adult human CLL. B1b B-cells (sIgM+CD11b+CD5-) were subsequently described; both these subtypes are seen predominantly in serous cavities. Further characterization of splenic B1 cells have identified them to be CD5+/-CD19hiCD1dmidCD23-CD43+IgMhiIgDlo. Murine B1 B-cell progenitors are found in the yolk sac prior to the emergence of the first definitive HSCs in the FL, which have both B1 and B2 B-cell output. The B-cell output skews toward B2 B-cells over ontogeny, with B1 B-cell output being exceedingly rare in ABM.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7928347</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33679795</oboInOwl:hasDbXref>
        <rdfs:label>sIgM+CD11b+CD5+ B1a B-cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000820"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/4ea9841a-d538-409b-9b88-66eefa3fb4c6"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000820"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/4eae7f68-db61-4ffc-b340-38a387553e4a -->

    <Class rdf:about="http://example.org/4eae7f68-db61-4ffc-b340-38a387553e4a">
        <obo:IAO_0000115>The GEO database (GSE138709) was employed to examine the fluctuation of MAL2 mRNA expression in ICC. From the UMAP plot and heatmap, distinct gene markers helped classify GSE138709 findings into eight cell clusters, namely, cholangiocytes, fibroblast, hepatocyte, TNK, endothelial, MonoMac, B lymphocytes, and dendritic cells (DC), as showcased in Fig. 1A-C and Fig. S1A. A specific expression of CD79A was found in the B cluster, as depicted in Fig. 1B, C and Fig. S1A. Interestingly, cholangiocytes and fibroblasts exhibited more robust expression in tumor tissues than in regular tissues. Conversely, tumor tissues displayed a decrease in the abundance of hepatocytes, TNK, B cells, and DCs when compared to normal tissue samples, as seen in Fig. 1E and Fig. S1B. To our surprise, MAL2 was found to be significantly abundant in cholangiocytes (Fig. 1D and Fig. S1C). The expression levels of MAL2 were more prevalent in tumor tissues than in normal ones (Fig. 1F). Chromosome copy number variation (CNV) of different cells in ICC tissue was analyzed based on CopyKAT, a computational tool. We found that non-immune cells such as endothelial cells were normal diploid, and classified cholangiocytes in ICC into normal cholangiocytes and malignant cholangiocytes based on whether or not there was a change in CNV (Fig. 1G, H). ##Malignant cholangiocytes## were almost distributed in ICC, and MAL2 was expressed mainly in malignant cholangiocytes in ICC (Fig. 1I-K). These revelations point toward the crucial role MAL2 might play in ICC cancer cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11169275</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38866777</oboInOwl:hasDbXref>
        <rdfs:label>Malignant cholangiocytes</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:1000488"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/4eae7f68-db61-4ffc-b340-38a387553e4a"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:1000488"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/4ebcbd64-16f0-42ae-b4e3-62c83ee9dda9 -->

    <Class rdf:about="http://example.org/4ebcbd64-16f0-42ae-b4e3-62c83ee9dda9">
        <obo:IAO_0000115>Among spatial features, the dispersion of the FMC event between recording sites made the highest contribution to the prediction. The FMC is a putative extracellular analog of the initial depolarization phase at the recording site. Thus, the lower interelectrode variance of FMC among PYR cells compared with PV cells indicates higher spatial synchrony at the beginning of the spike. This observation is consistent with known morphologic and electrotonic differences between the proximal dendrites of PYR and PV cells. Since the probes were always inserted perpendicularly to CA1 stratum pyramidale, the vertical dendritic tree of both PYR and PV cells was parallel to the extracellular electrode arrays. In CA1, PYR have thick apical dendrites extending for up to 250 mum (diameter, 1.6-2.5 mum), whereas ##PV cell## dendrites in stratum pyramidale are thinner (diameter, 1.3-1.7 mum). The higher FMC synchrony of PYR spikes is consistent with lower axial resistance of the thicker proximal PYR dendrites, yielding synchronized somatic and dendritic potentials.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9744183</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36414411</oboInOwl:hasDbXref>
        <rdfs:label>PV cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:4023018"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/4ebcbd64-16f0-42ae-b4e3-62c83ee9dda9"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4023018"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/4ec28ad3-16f0-4e9e-80f7-8e772625d24c -->

    <Class rdf:about="http://example.org/4ec28ad3-16f0-4e9e-80f7-8e772625d24c">
        <obo:IAO_0000115>Overexpression of ICOS rescues iNKT2 and iNKT17 cells of GATA-3-deficient mice. (A) The thymocytes and splenocytes from GATA-3 FF and FFcre mice were stained with TCRbeta, CD4, CD8, CD44, CD62L, NK1.1, loaded CD1d tetramer, CD127, and ICOS. The histogram plots show the surface expression levels of CD127 and ICOS on thymic iNKT cells (TCRbeta+ tetramer+), CD8 single-positive thymocyte (TCRbetahiCD4-CD8+), ##splenic naive (TCRbeta+CD4-CD8+CD44-CD62L+), and activated/memory (TCRbeta+CD4-CD8+CD44hiCD62L-) CD8 T cells##. (B) The gating strategy for identifying iNKT17 and iNKT2 cells from FFcre thymocytes overexpressing ICOS and CD127 via retroviral transduction is illustrated. Cumulative results are presented in the (lower panel). (two-sided unpaired t-test, ns, * p &lt; 0.05, ** p &lt; 0.01).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11201670</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38920701</oboInOwl:hasDbXref>
        <rdfs:label>splenic naive (TCRbeta+CD4-CD8+CD44-CD62L+), and activated/memory (TCRbeta+CD4-CD8+CD44hiCD62L-) CD8 T cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000900"/>
        <skos:relatedMatch rdf:resource="CL:0001203"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/4ec28ad3-16f0-4e9e-80f7-8e772625d24c"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000900"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/4ec28ad3-16f0-4e9e-80f7-8e772625d24c"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0001203"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/4ee1db49-1631-4ab5-a7d0-c398a21ac612 -->

    <Class rdf:about="http://example.org/4ee1db49-1631-4ab5-a7d0-c398a21ac612">
        <obo:IAO_0000115>Macrophages are multi-functional ##innate immune cells## that orchestrate tissue repair, immune responses and inflammation. First described by Elie Metchnikoff, macrophages are derived from embryonic haematopoietic progenitors or monocytes and differentiate into tissue macrophages after entering the tissue. Because macrophages play an indispensable role in maintaining systemic homeostasis and participating in immune defence against pathogens and cellular debris, they are widely distributed across various tissues, including the salivary glands. Recent studies have shown that macrophages perform several other functions in addition to phagocytosis. Macrophages and T cells can collectively regulate inflammation and participate in various functions such as phagocytosis and antigen presentation. This phenomenon has been partly confirmed in a noninflamed murine submandibular salivary gland model, as macrophages facilitate the local accumulation of tissue-resident memory CD8+ T cells (T+ RM) at the site of inflammation. Tissue-resident immune cells are thought to be complemented by salivary gland progenitor cells (SGPCs) for the maintenance of normal salivary gland homeostasis. Upon tissue damage, epithelial cells release inflammatory factors and recruit macrophages to induce inflammatory responses. Through their uncontrolled and rapid cytokine production, macrophages recruit more immune cells to amplify the local inflammatory response, thereby bridging innate and adaptive immunity.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10656691</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38022546</oboInOwl:hasDbXref>
        <rdfs:label>innate immune cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000766"/>
        <skos:relatedMatch rdf:resource="CL:0001065"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/4ee1db49-1631-4ab5-a7d0-c398a21ac612"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000766"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/4ee1db49-1631-4ab5-a7d0-c398a21ac612"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0001065"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/4f0418f4-d433-464c-94ec-8b6b26c5d3de -->

    <Class rdf:about="http://example.org/4f0418f4-d433-464c-94ec-8b6b26c5d3de">
        <obo:IAO_0000115>Our results so far indicate that the dura mater layer of the meninges contains a diverse population of stromal cells, including GP38+ and GP38- stromal cells that resemble the stroma of other lymphoid tissues and ECM remodelling. Consistent with our scRNAseq data, using flow cytometry, we observed a significant expansion of GP38+ FRCs, and a distinctive population of MAdCAM1+ CD21/CD35+ cells indicative of the presence of FDC-like cells in the infected murine meninges compared to naive controls (Fig 3D-3F; Gating strategy in S2A Fig, S5 and S6 Data), without significant changes in the lymphatic endothelial cells (LECs) or blood endothelial cells (BECs) (Fig 3E and 3F). Furthermore, using module scoring analysis, which allows us to assess global gene signatures associated with a gene set or pathway (in this case, ectopic lymphoid tissue signatures), we were able to identify that cells within cluster 5 were enriched for genes associated with FDC-like function and stromal lymphoid tissues, including Ccl19 and Cxcl13, compared to the other fibroblast clusters (Fig 3H), and may be derived from Ly6a+ pericytes with a precursor capacity as previously reported. Indeed, using in situ hybridisation on independent tissue sections, we were able to confirm the presence of Ly6a+ Rarres2+ cells that expressed Cxcl13+ during infection (Fig 3I). Together, our data demonstrate the presence of a rich diverse fibroblast population, encompassing Ly6a+ Rarres2+ FRC-like pericytes, including Aldh1a2+ Ccl19+ FRC-like pericytes, myofibroblasts, ##Fth1+ fibroblasts##, and perivascular dura fibroblasts. Our data also suggests that chronic T. brucei infection induces an extensive remodelling of the meningeal stroma compartment, resulting in the expansion of FRCs and FDC-like cells without significant changes in the vasculature (LECs and BECs).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10723712</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37983289</oboInOwl:hasDbXref>
        <rdfs:label>Fth1+ fibroblasts</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000057"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/4f0418f4-d433-464c-94ec-8b6b26c5d3de"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000057"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/4f21e59f-d8a7-4be7-854d-77cb690b3535 -->

    <Class rdf:about="http://example.org/4f21e59f-d8a7-4be7-854d-77cb690b3535">
        <obo:IAO_0000115>The Table shows the numerical representations of Excitatory Neurons (Deep and Superficial Pyramidal cells) and Inhibitory neurons (Oriens Lacunosum moleculare cells:##OLM##; Trilaminar cells:Tri, Backprojection cells:BP, cholecystokinin positive Basket cells:CCKBC, Parvalbumin positive cells:PVBC, AxoAxonic Cells:AA, Ivy Cells:IVY, Bistratified cells:BS, Schaffer Collateral associated cells:SCA, Perforant Pathway Associated cell:PPA, Neurogliaform:NG) subdivided on the basis of the placement classes (SO, SP, SR, SLM).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9381785</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35974119</oboInOwl:hasDbXref>
        <rdfs:label>OLM</rdfs:label>
    </Class>
    


    <!-- http://example.org/4f316bf8-738f-49ad-8848-a858dabab811 -->

    <Class rdf:about="http://example.org/4f316bf8-738f-49ad-8848-a858dabab811">
        <obo:IAO_0000115>We next assessed if iETV2-ECs could also be used to vascularize cerebral organoids (CO), and if presence of ECs would affect the localization of the different neural compartments. We thus generated PSC-derived COs and vascularized COs (eCOs; by allowing organoid formation from a mix of iETV2 and wild type PSCs; PSC:iETV2-hiPSC ratio = 8:2). To generate iETV2-ECs in situ, we activated the ETV2 transgene by addition on day 4 and 7, respectively, low and high concentrations of doxycycline for basal and full transgene activation (Figure  5A). Immunostaining of DIV35 eCO revealed CD31+ vascular structures and relatively smaller and scattered ventricular zones (VZ) (Figure 5B(ii)) in which the radial organization of SOX2+ cells (but not TUJ1+ cells) was less apparent than that of CO not containing ECs (Figure 5B(i)). We also embedded CO and eCO in matrigel alone or in iETV2-ECs laden matrigel. In matrigel alone, we observed VZ-like structures in the CO, however the SOX2+ cells were mostly found outside the VZ (indicated by asterisk; Figure 5B(iii)). In eCO, the radial organization of SOX2+ in VZ was more disrupted (Figure 5B(iv)), whereby the ##SOX2+ and TUJ1+ cells## appeared to spread into the matrigel, and CD31+ cells were found mainly at the periphery. In iETV2-EC</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10837345</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38037510</oboInOwl:hasDbXref>
        <rdfs:label>SOX2+ and TUJ1+ cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000047"/>
        <skos:relatedMatch rdf:resource="CL:0000048"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/4f316bf8-738f-49ad-8848-a858dabab811"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000047"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/4f316bf8-738f-49ad-8848-a858dabab811"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000048"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/4f354231-d4bf-4828-96e2-141ae0f0f4b0 -->

    <Class rdf:about="http://example.org/4f354231-d4bf-4828-96e2-141ae0f0f4b0">
        <obo:IAO_0000115>Altogether our studies have provided new reagents for targeting hRpn13 that uncovered the presence of an hRpn13 species upregulated in multiple ##myeloma cell## lines which are known to be more sensitive to proteasome inhibitors. Specific knockdown of hRpn13Pru without simultaneously targeting full-length protein by gene editing or RNAi methods is not feasible. We speculate that full-length hRpn13 and hRpn13Pru are both targets of XL5-PROTACs, however, it appears that these compounds preferentially target the more exposed binding surface of hRpn13Pru. It is intriguing that carfilzomib treatment appears to yield the same ubiquitinated hRpn13 species (Fig. 7a), suggesting a natural process that is mimicked by PROTAC targeting. Specific targeting of hRpn13Pru preferentially to hRpn13 full-length protein may be an effective therapeutic strategy, with less expected toxicity. The mechanism of action for previous hRpn13 targeting compounds failed to be elucidated as interference was not observed for any known hRpn13 activity, including interaction with proteasomes, ubiquitin, or UCHL5. This study provides a viable mechanism of action for future investigations of hRpn13 as a therapeutic target.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8677766</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34916494</oboInOwl:hasDbXref>
        <rdfs:label>myeloma cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000786"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/4f354231-d4bf-4828-96e2-141ae0f0f4b0"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000786"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/4f852814-49b5-4b45-b909-453d7e45c28e -->

    <Class rdf:about="http://example.org/4f852814-49b5-4b45-b909-453d7e45c28e">
        <obo:IAO_0000115>A, B, tSNE plot of 4659 CD45+ immune cells from the CNS. Data from this study is integrated with data from; Table 6). C, D, Each dataset represented by one tSNE. Cells are annotated using color representing their cell type. bMicroglia: baseline microglia; aMicroglia: activated microglia; pmMicroglia: proliferation-mediating microglia; maMicroglia: ##monocyte-activating microglia##; DAM: disease-associated microglia in SCI; elMicroglia: embryonic-like microglia; pvMacrophages: perivascular macrophages; mdMacrophages: monocyte-derived macrophages; DCs: dendritic cells; imB-cells: immature B-cells; mB-cells: mature B-cells; pimMicroglia: postnatal immature microglia; IEG+Microglia: immediate early genes microglia; sMicroglia: s-phase microglia; pPAM: postnatal proliferative-region-associated microglia; eMicroglia: embryonic microglia; pcpMacrophages: postnatal choroid plexus macrophages; acpMacrophages: adult choroid plexus macrophages; iMonocytes: inflammatory monocytes; pMonocytes: patrolling monocytes; cpEpithelial cells: choroid plexus epithelial cells. E, tSNE plots of 4659 CD45+ immune cells for selected genes indicating the log2(cpm) expression with a continuous color for each cell separately. F, Proliferation rate of CD45low and CD45high cells at 7 and 21 d post-SCI. Hoechst 33342 expression presented on a log-scale was used for defining cells in S-phase. Right most plot reports the percentage of cells in S-phase. Each dot represents one biological replicate (four mice per time point). Mean is surrounded by a 95% CI. This figure is extended in Extended Data Figure 8-1.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8496189</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34417326</oboInOwl:hasDbXref>
        <rdfs:label>monocyte-activating microglia</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000129"/>
        <skos:relatedMatch rdf:resource="CL:0000576"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/4f852814-49b5-4b45-b909-453d7e45c28e"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000129"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/4f852814-49b5-4b45-b909-453d7e45c28e"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000576"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/4f97678d-f0f9-4025-8382-3646da17c5a3 -->

    <Class rdf:about="http://example.org/4f97678d-f0f9-4025-8382-3646da17c5a3">
        <obo:IAO_0000115>Although considerable advances have been made toward understanding human T-cell development, several major questions remain obscure regarding the heterogeneity and molecular mechanisms underlying the fate bifurcation of certain T progenitors. Several laboratories have largely resolved these long-standing questions by using single-cell RNA sequencing (scRNA-seq) technologies to study human T-cell development in both the developing fetus and postnatal thymus. Our group first revealed thymus organogenesis, early T lymphopoiesis, and their pre-thymic lymphoid progenitors in the early human fetus at single-cell resolution. Following studies further transcriptomically characterized the TSPs and revealed T lineage specification, commitment, and subsequent differentiation in both the prenatal and postnatal thymus. A recent work profiled the complete thymocyte populations in postnatal samples, especially the three CD4-CD8- DN subsets and identified three distinct ##TSP## subpopulations as well as revealed T-cell lineage commitment and divergence of non-T-cell lineages. Despite that the characteristics of immature DN subsets have been characterized in the human postnatal thymus, less is known regarding the nature of distinct DN subpopulations and cell fate decision (T lineage versus non-T lineage) during DN stages of T-cell development in human fetus. Furthermore, mouse studies have well documented that fetal and adult DN cells (including ETP) are not equivalent, reflecting the origin of ETP (HSC-dependent or HSC-independent), thymic outputs, differentiation speed, and gene expression transition, so whether these differences existing between prenatal and postnatal human thymocytes are also worth to be addressed.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10565475</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37828991</oboInOwl:hasDbXref>
        <rdfs:label>TSP</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000827"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/4f97678d-f0f9-4025-8382-3646da17c5a3"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000827"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/4f9a7ee3-31c6-4923-bd91-39930bde9a56 -->

    <Class rdf:about="http://example.org/4f9a7ee3-31c6-4923-bd91-39930bde9a56">
        <obo:IAO_0000115>Although ##tumor-infiltrating T cells## hold a beneficial prognostic role in colorectal cancer, other lymphocytic populations are less characterized. We developed a multiplexed immunofluorescence assay coupled with digital image analysis and machine learning to identify natural killer (NK) cells (NCAM1+CD3-), natural killer T-like (NKT-like) cells (NCAM1+CD3+), and T cells (NCAM1-CD3+) within the PTPRC+ (CD45+) cell population and to measure their granzyme B (GZMB; cytotoxicity marker) and FCGR3A (CD16a; NK-cell maturity marker) expression. We evaluated immune cell densities and spatial configuration in 907 incident colorectal carcinoma cases within two prospective cohort studies. We found that T cells were approximately 100 times more abundant than NK and NKT-like cells. Overall, NK cells showed high GZMB expression and were located closer to tumor cells than T and NKT-like cells. In T and NKT-like cells, GZMB expression was enriched in cells in closer proximity to tumor cells. Higher densities of both T and NKT-like cells associated with longer cancer-specific survival, independent of potential confounders (P trend &lt; 0.0007). Higher stromal GZMB+ and FCGR3A+ NK-cell densities associated with longer cancer-specific survival (P trend &lt; 0.003). For T and NKT-like cells, greater proximity to tumor cells associated with longer cancer-specific survival (P trend &lt; 0.0001). These findings indicate that cytotoxic NCAM1+CD3-GZMB+ NK cells and NCAM1+CD3+ NKT-like cells are relatively rare lymphocytic populations within the colorectal cancer microenvironment and show distinct spatial configuration and associations with patient outcome. The results highlight the utility of a quantitative multimarker assay for in situ, single-cell immune biomarker evaluation and underscore the importance of spatial context for tumor microenvironment characterization.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8816895</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34937729</oboInOwl:hasDbXref>
        <rdfs:label>tumor-infiltrating T cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000084"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/4f9a7ee3-31c6-4923-bd91-39930bde9a56"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000084"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/4fb7921a-07e0-4988-b6b8-e77cb98aafd5 -->

    <Class rdf:about="http://example.org/4fb7921a-07e0-4988-b6b8-e77cb98aafd5">
        <obo:IAO_0000115>Although tumor-infiltrating T cells hold a beneficial prognostic role in colorectal cancer, other lymphocytic populations are less characterized. We developed a multiplexed immunofluorescence assay coupled with digital image analysis and machine learning to identify natural killer (NK) cells (NCAM1+CD3-), natural killer T-like (NKT-like) cells (NCAM1+CD3+), and T cells (NCAM1-CD3+) within the PTPRC+ (CD45+) cell population and to measure their granzyme B (GZMB; cytotoxicity marker) and FCGR3A (CD16a; NK-cell maturity marker) expression. We evaluated immune cell densities and spatial configuration in 907 incident colorectal carcinoma cases within two prospective cohort studies. We found that T cells were approximately 100 times more abundant than NK and NKT-like cells. Overall, NK cells showed high GZMB expression and were located closer to tumor cells than T and NKT-like cells. In T and NKT-like cells, GZMB expression was enriched in cells in closer proximity to tumor cells. Higher densities of both T and NKT-like cells associated with longer cancer-specific survival, independent of potential confounders (P trend &lt; 0.0007). Higher stromal GZMB+ and FCGR3A+ NK-cell densities associated with longer cancer-specific survival (P trend &lt; 0.003). For T and NKT-like cells, greater proximity to tumor cells associated with longer cancer-specific survival (P trend &lt; 0.0001). These findings indicate that cytotoxic NCAM1+CD3-GZMB+ NK cells and ##NCAM1+CD3+ NKT-like cells## are relatively rare lymphocytic populations within the colorectal cancer microenvironment and show distinct spatial configuration and associations with patient outcome. The results highlight the utility of a quantitative multimarker assay for in situ, single-cell immune biomarker evaluation and underscore the importance of spatial context for tumor microenvironment characterization.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8816895</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34937729</oboInOwl:hasDbXref>
        <rdfs:label>NCAM1+CD3+ NKT-like cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000814"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/4fb7921a-07e0-4988-b6b8-e77cb98aafd5"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000814"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/4ff6bc32-c799-47a6-a61a-2af86f21c678 -->

    <Class rdf:about="http://example.org/4ff6bc32-c799-47a6-a61a-2af86f21c678">
        <obo:IAO_0000115>As TNF affected the expression of specific NSC and astrocytic genes during differentiation of ##NSPs## into astrocytes, we sought to expand our analyses by conducting a genome-wide RNA-sequencing analysis of the astrocytic transcriptome at different time points, both under normal and inflammatory conditions. Principal component analysis (PCA) using the top 1000 variable genes showed distinct clustering corresponding to the different conditions (Figure 3A). We identified differentially expressed genes (p &lt; 0.05) between different conditions and compared them at 24 and 72 h under normal or inflammatory conditions. Specifically, we detected 4187 overexpressed genes and 4544 down-regulated genes at 24 h compared to undifferentiated NSPs, both with or without TNF. On the other hand, we detected 1005 and 756 genes, respectively, exclusively up- or down-regulated at 24 h under control conditions, while 1227 and 922 genes were correspondingly enhanced or decreased only under TNF treatments. We obtained similar results at 72 h (Figure 3B). Hierarchical gene clustering of the differentially expressed genes during normal differentiation (up- and down-regulated genes, adjusted p value &lt; 0.05) revealed five major clusters differentially represented across the specific time points (Figure 3C). Corresponding Gene Ontology (GO) enrichment analyses indicated that proliferating NSPs were mainly associated with cluster 1, largely characterized by terms related to RNA processing. Clusters 2 and 4, largely represented in NSPs and 24 h-differentiated astrocytes, were characterized by processes associated with regulation of cell morphogenesis, motility, and migration. Clusters 3 and 5, mostly enriched in differentiating astrocytes at 72 h and 1 week, were characterized by terms linked to cell projection assembly and cilium organization (Figure 3D).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10047363</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36980289</oboInOwl:hasDbXref>
        <rdfs:label>NSPs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000047"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/4ff6bc32-c799-47a6-a61a-2af86f21c678"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000047"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/4ff7e344-780f-4d83-8904-3f1e08ef0157 -->

    <Class rdf:about="http://example.org/4ff7e344-780f-4d83-8904-3f1e08ef0157">
        <obo:IAO_0000115>We studied the induction of prototypical AhR target gene CYP1A1 by triptans in ##hepatic and intestinal cell## models. Avitriptan and Donitriptan but not Naratriptan, dose-dependently induced CYP1A1 mRNA in intestinal adenocarcinoma cells LS180 after 24 h of incubation (Figure 2A). The induction was rather weak and the levels of CYP1A1 mRNA were increased approx. 38-fold and 8-fold by Avitriptan and Donitriptan in 100 microM concentrations, respectively. The relative efficacies of Avitriptan (~4%) and Donitriptan (~1%) were consistent with those observed in reporter gene assays in AZ-AHR cells. The level of CYP1A1 protein in LS180 cells after 48 h of incubation was significantly increased only by Avitriptan (Figure 2A). Importantly, unlike in hepatoma AZ-AHR cells, Avitriptan and Donitriptan were not cytotoxic in intestinal LS180 cells (Figure 2A). Induction of CYP1A1 mRNA in immortalized human hepatocytes MIHA, incubated for 24 h with TCDD, Avitriptan and Donitriptan was 150-fold, 215-fold and 16-fold, respectively. Triptans did not induce CYP1A1 mRNA in AhR knockout variant of MIHA cells, implying the AhR-dependent induction of CYP1A1 by triptans (Figure 2B). In contrast, in typical primary human hepatocytes cultures, prepared from healthy liver tissue donors, Avitriptan and Donitriptan caused an only weak and non-significant increase of CYP1A1 mRNA, by 2-fold and 4-fold respectively, while TCDD induced CYP1A1 mRNA between 400-fold and 1600-fold (Figure 2C). Cell type-specific induction of CYP1A1 could be due to the extensive oxidative metabolism, which was described for Avitriptan. </obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7216230</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32316498</oboInOwl:hasDbXref>
        <rdfs:label>hepatic and intestinal cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000182"/>
        <skos:relatedMatch rdf:resource="CL:0000584"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/4ff7e344-780f-4d83-8904-3f1e08ef0157"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000182"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/4ff7e344-780f-4d83-8904-3f1e08ef0157"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000584"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/40bec900-f1ef-4cc6-b345-9fea5ee40382 -->

    <Class rdf:about="http://example.org/40bec900-f1ef-4cc6-b345-9fea5ee40382">
        <obo:IAO_0000115>We next checked the differentiation of these cells in cyto-differentiation stage. RUNX2 is required for the differentiation of multipotential mesenchymal progenitor cells into preosteoblasts/preodontoblasts. OSX is required at a later maturation stage of preosteoblasts/preodontoblasts into functional osteoblasts/odontoblasts. Both these proteins are strongly co-expressed with ##PRX1+ cells## (Fig. 2a, b). Although PRX1+ cells are also co-expressed with odontoblast marker COL1A1 (Fig. 2c), these are not co-localized with epithelial-derived ameloblasts (Fig. 2d). Overall, PRX1+ cells differentiate into odontoblasts and dental pulp cells during odontogenesis.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8789835</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35078971</oboInOwl:hasDbXref>
        <rdfs:label>PRX1+ cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000134"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/40bec900-f1ef-4cc6-b345-9fea5ee40382"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000134"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/400c54f3-21ab-454e-8e2d-e56125f21fa5 -->

    <Class rdf:about="http://example.org/400c54f3-21ab-454e-8e2d-e56125f21fa5">
        <obo:IAO_0000115>The killing capacity of infiltrating CLs in PTC differed between tumor tissues and paracancerous tissues. In cases with CCLNM, higher expression of ##CD16-CD56+G+ NK cells## in tumor tissues may be associated with a high risk of lymph node metastasis.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10858496</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38341587</oboInOwl:hasDbXref>
        <rdfs:label>CD16-CD56+G+ NK cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000623"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/400c54f3-21ab-454e-8e2d-e56125f21fa5"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000623"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/4009d658-0464-47a8-9a9b-452ba64b562e -->

    <Class rdf:about="http://example.org/4009d658-0464-47a8-9a9b-452ba64b562e">
        <obo:IAO_0000115>SCLC	Small-cell carcinoma	 	NSCLC	Non-small-cell carcinoma	 	ADC	Adenocarcinoma	 	SqCC	Squamous cell carcinoma	 	LCLC	Large-cell carcinoma	 	PD1	Programmed death 1	 	PDL1	Programmed death 1 ligand	 	ICI	Immune checkpoint inhibitors	 	EV	Extracellular vesicles	 	ESE	Early-sorting endosome	 	ILVs	Intraluminal vesicles	 	MVBs	Multivesicular bodies	 	ESCRT	Endosomal-sorting complex-independent transport	 	ncRNAs	Small noncoding RNAs (ncRNAs)	 	miRNAs	microRNAs	 	TME	Tumor microenvironment	 	circRNA	circular RNA	 	ECM	extracellular matrix	 	HBEC	Human bronchial epithelial cells	 	EMT	Epithelial-mesenchymal transition	 	CRC	colorectal cancer	 	DCs	dendritic cells	 	MSC	Mesenchymal stem cells	 	NK	Natural Killer	 	PBMCs	Peripheral blood mononuclear cells	 	TAMs	Tumor-associated macrophages	 	MDSCs	Myeloid-derived suppressor cells	 	PMN-MDSCs	##Polymorphonuclear MDCs##	 	M-MDSCs	Monocytic MDSCs	 	LLC	Lewis Lung carcinoma	 	M2 macrophages	Alternatively activated macrophages	 	M1 macrophages	Classically activated macrophages	 	TH1 cell	T helper 1 cell	 	Treg cell	Regulatory T cell	 	Breg cell	Regulatory B cell	 	CTLs	Cytotoxic CD8+ T cells	 	TILs	Tumor-infiltrating lymphocytes	 	Tim-3	mucin domain-3 protein	 	TIGIT	T cell immunoglobulin and ITIM domain	 	Lag-3	Lymphocyte-activation gene 3	 	CTLA4	Cytotoxic T lymphocyte antigen-4	 	TH17 cell	T helper 17 cell	 	DNT cell	Double-negative T cells	 	TRAIL	TNF-related apoptosis-inducing ligand	 	MPE	malignant pleural effusions	 	CRISPRi	clustered regularly interspaced short palindromic repeats interference	 	FAP	Fibroblast activation protein- alpha.	 	</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10616833</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37915578</oboInOwl:hasDbXref>
        <rdfs:label>Polymorphonuclear MDCs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000094"/>
        <skos:relatedMatch rdf:resource="CL:0000889"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/4009d658-0464-47a8-9a9b-452ba64b562e"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000094"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/4009d658-0464-47a8-9a9b-452ba64b562e"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000889"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/40235255-dde0-4ff6-88bb-4c90dc4fe6e9 -->

    <Class rdf:about="http://example.org/40235255-dde0-4ff6-88bb-4c90dc4fe6e9">
        <obo:IAO_0000115>We have previously reported that after brain exposure to ionizing radiation, proliferating progenitors are highly radiation-sensitive and rapidly eliminated after irradiation. On the contrary qNSC that are radiation resistant repopulate the different ##SVZ neurogenic cell## populations successively the following days after irradiation. We therefore used this model and our transcriptomic signatures of SVZ stem and progenitor cells to gain new insights on the nature and the hierarchical ordering of neural progenitor clusters identified by sc-RNAseq.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11584179</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:39576691</oboInOwl:hasDbXref>
        <rdfs:label>SVZ neurogenic cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:4042021"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/40235255-dde0-4ff6-88bb-4c90dc4fe6e9"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4042021"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/4084ec1b-5844-4d18-8499-d1fa7ba77f78 -->

    <Class rdf:about="http://example.org/4084ec1b-5844-4d18-8499-d1fa7ba77f78">
        <obo:IAO_0000115>Astrocytes play many important functions in response to spinal cord injury (SCI) in an activated manner, including clearance of necrotic tissue, formation of protective barrier, maintenance of microenvironment balance, interaction with immune cells, and formation of the glial scar. More and more studies have shown that the astrocytes are heterogeneous, such as inflammatory astrocyte 1 (A1) and ##neuroprotective astrocyte 2## (A2) types. However, the subtypes of astrocyte resulting from SCI have not been clearly defined. In this study, using single-cell RNA sequencing, we constructed the transcriptomic profile of astrocytes from uninjured spinal cord tissue and injured tissue nearby the lesion epicenter at 0.5, 1, 3, 7, 14, 60, and 90 days after mouse hemisection spinal cord surgery. Our analysis uncovered six transcriptionally distinct astrocyte states, including Atp1b2+ , S100a4+ , Gpr84+ , C3+ /G0s2+ , GFAP+ /Tm4sf1+ , and Gss+ /Cryab+ astrocytes. We used these new signatures combined with canonical astrocyte markers to determine the distribution of morphologically and physiologically distinct astrocyte population at injured sites by immunofluorescence staining. Then we identified the dynamic evolution process of each astrocyte subtype following SCI. Finally, we also revealed the evolution of highly expressed genes in these astrocyte subtypes at different phases of SCI. Together, we provided six astrocyte subtypes at single-cell resolution following SCI. These data not only contribute to understand the heterogeneity of astrocytes during SCI but also help to find new astrocyte subtypes as a target for SCI repair.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMID:35816276</oboInOwl:hasDbXref>
        <rdfs:label>neuroprotective astrocyte 2</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002627"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/4084ec1b-5844-4d18-8499-d1fa7ba77f78"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002627"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/41c49048-6f8b-49a4-abc5-b44b500fbe16 -->

    <Class rdf:about="http://example.org/41c49048-6f8b-49a4-abc5-b44b500fbe16">
        <obo:IAO_0000115>Collectively, the expression patterns of these representative marker genes (Figure S1c) in our scRNA-seq data led us to define cluster 11 as EC1 (portal venous ECs), cluster 9 as EC2 (zone1, periportal LSECs), cluster 0, 1, 2, 4, 5, 6, 10, 12 as ##EC3## (zone 2, midzonal LSECs), cluster 3, 7as EC4 (zone 3, pericentral LSECs), and cluster 8 as EC5 (central venous ECs), corresponding to liver zonation (Figure S1a).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11241719</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:39000126</oboInOwl:hasDbXref>
        <rdfs:label>EC3</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:1000398"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/41c49048-6f8b-49a4-abc5-b44b500fbe16"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:1000398"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/41d93faa-5806-4726-bd80-2a18b1c8c6ea -->

    <Class rdf:about="http://example.org/41d93faa-5806-4726-bd80-2a18b1c8c6ea">
        <obo:IAO_0000115>In order for the sensitization we observed in excitatory interneurons to drive the psychophysical phenomenon of allodynia, spinal projection neurons must relay these nociceptive signals supraspinally. We found that capsaicin treatment shifted the overall tuning of SPB neurons towards LT input, consistent with the effects of central sensitization producing allodynia (Fig. 8a, b). Because SPB neurons are heterogeneous with respect to their response properties, we classified them as either wide-dynamic range (WDR), high threshold (HT), or ##low threshold (LT)## (Fig. 8c) using previously published criteria. We found that both HT and WDR SPB showed significant increases in tuning to LT input, however the degree of change was much greater for WDR compared to HT SPB neurons (Fig. 8d). Finally, examining CICADA responses across populations, we found that WDR cells were more frequently responsive to CICADA agonists (71.4%), compared to either LT (40%) or HT (0%) SPB neurons. In particular, all SP-responsive SPB neurons were WDR cells (Fig. 8e). Since capsaicin is known to activate peptidergic afferents that release SP, these findings suggest that capsaicin-induced allodynia may be conveyed to the brain through a population of TACR1 expressing WDR SPB neurons and, to a lesser extent, some HT SPB neurons (Fig. 8f).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9440908</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36057681</oboInOwl:hasDbXref>
        <rdfs:label>low threshold (LT)</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000540"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/41d93faa-5806-4726-bd80-2a18b1c8c6ea"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000540"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/41e0829b-6ab0-4d33-8714-bc09b94d09e4 -->

    <Class rdf:about="http://example.org/41e0829b-6ab0-4d33-8714-bc09b94d09e4">
        <obo:IAO_0000115>Transcriptional signature of pancreas infiltrating and circulating CD4+ and CD8+ T cell subsets at disease onset. (A) UMAP plot of CD4+ and CD8+ T cells from peripheral blood and pancreas of new-onset diabetic NOD mice. (B) Feature plots depicting gene expression levels of distinct markers driving CD4+ and CD8+ T cell activation states. (C, D) UMAP plot of CD4+ (C) and CD8+ (D) T cells grouped by the annotation in A (left) and grouped by T cell subset classified based on the expression of Cd44 and Sell (right). EM = effector memory (Cd44+Sell-), CM = central memory (Cd44+Sell+), naive (Cd44-Sell+), and CD44low CD62L- (Cd44-Sell-). (E, F) Heatmap depicting row-based z-scores of scaled gene expression levels for marker genes driving T cell heterogeneity across the distinct CD4+ (E) and CD8+ (F) T cell subsets. (G, H) Trajectory of CD4+ (G) and CD8+ (H) naive, CD44low CD62L-, effector memory (EM), and central memory (CM) T cell subsets projected onto the UMAP plot (top). Violin plots depicting the pseudotime of CD4+ (G) and CD8+ (H) T cells per subset (bottom). Each dot represents a single cell. (I, J) Differentially expressed genes of ##CD4+ Cd44-Sell- (I) and CD8+ Cd44-Sell- (J) T cells## between peripheral blood and pancreas.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10667927</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38027120</oboInOwl:hasDbXref>
        <rdfs:label>CD4+ Cd44-Sell- (I) and CD8+ Cd44-Sell- (J) T cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000624"/>
        <skos:relatedMatch rdf:resource="CL:0000625"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/41e0829b-6ab0-4d33-8714-bc09b94d09e4"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000624"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/41e0829b-6ab0-4d33-8714-bc09b94d09e4"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000625"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/413560c1-94c0-4579-9e4c-0f06e3749962 -->

    <Class rdf:about="http://example.org/413560c1-94c0-4579-9e4c-0f06e3749962">
        <obo:IAO_0000115>	Cell clusters (percentage)	Cell ontogeny	Transmigration pathway	Cell subsets	Subset/tissue-specific signatures	References	 	Dura mater	BAMs(35%)	Bone marrow	Peripheral circulation	Dhi-BAM	H2-Aa, Cd74, Ccr2, H2-Eb1	2019 	 	Dlo-BAM	Ccl8, Pla2g2d, Cfp	 	DCs(19%)	-	-	cDC1	Flt3, Xcr1	 	##cDC2##	Flt3, Cd209a, Itgax	 	migDCs	Ccr7, Nudt17	 	pDCs	Siglech, Ccr9, Pacsin1	 	Monocytes(16%)	Adjacent skull and vertebral bone marrow#; peripheral blood*	Bone marrow-dura channels#; peripheral circulation*	Classical monocytes	Ly6c2	2021, 2019 	 	Non-classical monocytes	Itgal	 	Intermediate monocytes	Fcgr1	 	Neutrophils(12%)	Adjacent skull and vertebral bone marrow#; peripheral blood*	Bone marrow-dura channels#; peripheral circulation*	Neutrophils	Ly6g, Itgam	 	B cells(7%)	Adjacent skull and vertebral bone marrow#; peripheral blood*	Bone marrow-dura channels#; peripheral circulation*	Pro-B cells	Vpreb1, Igll1, Dntt, Lef1, Tspan13, Smarca4	2021, 2019 	 	Pre-B cells	Dnajc7, Rag1, Cecr2, Sox4, Myb	 	Immature B cells	Ms4a1, Ly6d, Hck, Cd24a, Spib, Ccnd2, Cd72	 	Mature naive B cells	Rps29, Rpl38, Rps27, Rpl21, Igkc	 	Mitotic B cells	Top2a, Mki67	 	T cells(4%)	Peripheral blood	Peripheral circulation	T cells	Cd3e	2019 	 	NK cells(4%)	-	-	NK cells	Klrb1c	 	Subdural meninges	Microglia(67%)	Embryo	Tissue residency	Microglia	Sparc, Mertk, Cx3cr1, Csf1r, Itgam, Aif1, Cd68, Fcgr1	2019 	 	BAMs(23%)	Embryo	Tissue residency	BAMs	Lyve1, P2rx7, Egfl7	 	DCs(2.6%)	-	-	cDC1	Flt3, Xcr1	 	cDC2	Flt3, Cd209a, Itgax	 	Monocytes(2%)	-	-	Classical monocytes	Ly6c2	 	Non-classical monocytes	Itgal	 	T cells(3%)	-	-	T cells	Cd3e	 	B cells(1%)	-	-	B cells	Cd19	 	NK cells(1%)	-	-	NK cells	Klrb1c	 	</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10210344</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37231449</oboInOwl:hasDbXref>
        <rdfs:label>cDC2</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000990"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/413560c1-94c0-4579-9e4c-0f06e3749962"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000990"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/41401f0a-a15f-4eef-9e63-5567c63cbb39 -->

    <Class rdf:about="http://example.org/41401f0a-a15f-4eef-9e63-5567c63cbb39">
        <obo:IAO_0000115>To investigate the developmental origin of the CD34+PRLR+ cells, freshly isolated CD34+ HSCs were sorted into MLP, CMP, GMP and NK/BP (Fig. 2A), and cultured as described above. PRLR-expressing cells were mainly generated from the GMP compartment (Fig. 2B-D). At day 4 of culture, FACS sorted PRLR+ progenitors lacked all lineage markers except for CD15 and CD43, further supporting their myeloid origin (Fig. 2E). Evaluation of these cells at later time points (day + 14) showed that they remain CD15+, and acquired CD11a, CD11b, CD11c, CD16, CD18, CD45RO and CD123 (Fig. 2F). To study their differentiation, we sorted CD34+PRLR+ cells from four-day expanded CD34+ HSCs (as shown in Fig. 1A). As above, in the presence of ILC promoting cytokines (IL-3, IL-7, IL-15, IL-23, SCF and FLT3L) the CD34+PRLR+ progenitors differentiate into immature myeloid cells (Fig. 3A-C). Addition of GM-CSF at later times (day + 21) resulted in the generation of mature granulocytes expressing CD15, CD16 and CD66b (Fig. 3A-C). Previously, we showed that some myeloid progenitors could give rise to ##CD56+ lymphocytes##. However, sorted CD34+PRLR-, but not CD34+PRLR+ cells gave rise to CD56+ lymphocytes (Fig. 4A-C). Moreover, the CD34+PRLR+ progenitors do not express integrin alpha4beta7, a marker that defines innate lymphoid precursors with the potential to develop into ILCs (Fig. 4C). In further support of these findings, the CD34+PRLR+ progenitors do not differentiate into CD94+, CD127+ and CD336+ lymphocytes (Fig. 4D). Collectively, these findings show that CD34+PRLR+ progenitors develop from the GMPs under the influence of SCF and FLT3L, thereby acquire various myeloid markers and seem to lack lymphoid potential.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7156717</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32286456</oboInOwl:hasDbXref>
        <rdfs:label>CD56+ lymphocytes</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000542"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/41401f0a-a15f-4eef-9e63-5567c63cbb39"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000542"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/415eb47f-c8c9-47f4-a333-3e938f252026 -->

    <Class rdf:about="http://example.org/415eb47f-c8c9-47f4-a333-3e938f252026">
        <obo:IAO_0000115>	Cell clusters (percentage)	Cell ontogeny	Transmigration pathway	Cell subsets	Subset/tissue-specific signatures	References	 	Dura mater	BAMs(35%)	Bone marrow	Peripheral circulation	Dhi-BAM	H2-Aa, Cd74, Ccr2, H2-Eb1	2019 	 	Dlo-BAM	Ccl8, Pla2g2d, Cfp	 	DCs(19%)	-	-	cDC1	Flt3, Xcr1	 	cDC2	Flt3, Cd209a, Itgax	 	##migDCs##	Ccr7, Nudt17	 	pDCs	Siglech, Ccr9, Pacsin1	 	Monocytes(16%)	Adjacent skull and vertebral bone marrow#; peripheral blood*	Bone marrow-dura channels#; peripheral circulation*	Classical monocytes	Ly6c2	2021, 2019 	 	Non-classical monocytes	Itgal	 	Intermediate monocytes	Fcgr1	 	Neutrophils(12%)	Adjacent skull and vertebral bone marrow#; peripheral blood*	Bone marrow-dura channels#; peripheral circulation*	Neutrophils	Ly6g, Itgam	 	B cells(7%)	Adjacent skull and vertebral bone marrow#; peripheral blood*	Bone marrow-dura channels#; peripheral circulation*	Pro-B cells	Vpreb1, Igll1, Dntt, Lef1, Tspan13, Smarca4	2021, 2019 	 	Pre-B cells	Dnajc7, Rag1, Cecr2, Sox4, Myb	 	Immature B cells	Ms4a1, Ly6d, Hck, Cd24a, Spib, Ccnd2, Cd72	 	Mature naive B cells	Rps29, Rpl38, Rps27, Rpl21, Igkc	 	Mitotic B cells	Top2a, Mki67	 	T cells(4%)	Peripheral blood	Peripheral circulation	T cells	Cd3e	2019 	 	NK cells(4%)	-	-	NK cells	Klrb1c	 	Subdural meninges	Microglia(67%)	Embryo	Tissue residency	Microglia	Sparc, Mertk, Cx3cr1, Csf1r, Itgam, Aif1, Cd68, Fcgr1	2019 	 	BAMs(23%)	Embryo	Tissue residency	BAMs	Lyve1, P2rx7, Egfl7	 	DCs(2.6%)	-	-	cDC1	Flt3, Xcr1	 	cDC2	Flt3, Cd209a, Itgax	 	Monocytes(2%)	-	-	Classical monocytes	Ly6c2	 	Non-classical monocytes	Itgal	 	T cells(3%)	-	-	T cells	Cd3e	 	B cells(1%)	-	-	B cells	Cd19	 	NK cells(1%)	-	-	NK cells	Klrb1c	 	</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10210344</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37231449</oboInOwl:hasDbXref>
        <rdfs:label>migDCs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000451"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/415eb47f-c8c9-47f4-a333-3e938f252026"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000451"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/41675faa-8604-4822-97e3-9df0886d1a80 -->

    <Class rdf:about="http://example.org/41675faa-8604-4822-97e3-9df0886d1a80">
        <obo:IAO_0000115>SHP2 incites myometrium contraction by regulating PGF2alpha production in epithlium to participate smooth muscle contraction via justacrine. LE ##Luminal epithelial cells##, Str1 stromal cells 1, Str2 stromal cells 2, Dec decidual cells, NK natural killer cells, Mac macrophage cells, Muscle muscle cells, Gland glandular epithelial cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10646072</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37963860</oboInOwl:hasDbXref>
        <rdfs:label>Luminal epithelial cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002149"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/41675faa-8604-4822-97e3-9df0886d1a80"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002149"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/42a61e00-678d-416b-8d46-f122eafe312b -->

    <Class rdf:about="http://example.org/42a61e00-678d-416b-8d46-f122eafe312b">
        <obo:IAO_0000115>First, we clarified the differences in intrahepatic NK cells from HCC tissue (Ca) and adjacent non-cancerous liver tissue (NCa) in HCC patients. We evaluated the frequencies of paired NCa-NK cells and Ca-NK cells in 16 HCC patients (Table S5). The frequency of Ca-CD56dimNK cells was reduced compared with that of ##NCa-CD56dimNK cells## as reported previously, while that of CD56bright NK cells was comparable (Figure 3A).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8231799</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34198593</oboInOwl:hasDbXref>
        <rdfs:label>NCa-CD56dimNK cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000939"/>
        <skos:relatedMatch rdf:resource="CL:4047101"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/42a61e00-678d-416b-8d46-f122eafe312b"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000939"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/42a61e00-678d-416b-8d46-f122eafe312b"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4047101"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/42b96c2d-00c7-4b01-8ff0-7e161d45f183 -->

    <Class rdf:about="http://example.org/42b96c2d-00c7-4b01-8ff0-7e161d45f183">
        <obo:IAO_0000115>Although tumor-infiltrating T cells hold a beneficial prognostic role in colorectal cancer, other lymphocytic populations are less characterized. We developed a multiplexed immunofluorescence assay coupled with digital image analysis and machine learning to identify natural killer (NK) cells (NCAM1+CD3-), natural killer T-like (NKT-like) cells (NCAM1+CD3+), and T cells (NCAM1-CD3+) within the PTPRC+ (CD45+) cell population and to measure their granzyme B (GZMB; cytotoxicity marker) and FCGR3A (CD16a; NK-cell maturity marker) expression. We evaluated immune cell densities and spatial configuration in 907 incident colorectal carcinoma cases within two prospective cohort studies. We found that T cells were approximately 100 times more abundant than NK and NKT-like cells. Overall, NK cells showed high GZMB expression and were located closer to tumor cells than T and NKT-like cells. In T and NKT-like cells, GZMB expression was enriched in cells in closer proximity to tumor cells. Higher densities of both T and NKT-like cells associated with longer cancer-specific survival, independent of potential confounders (P trend &lt; 0.0007). Higher stromal ##GZMB+ and FCGR3A+ NK-cell## densities associated with longer cancer-specific survival (P trend &lt; 0.003). For T and NKT-like cells, greater proximity to tumor cells associated with longer cancer-specific survival (P trend &lt; 0.0001). These findings indicate that cytotoxic NCAM1+CD3-GZMB+ NK cells and NCAM1+CD3+ NKT-like cells are relatively rare lymphocytic populations within the colorectal cancer microenvironment and show distinct spatial configuration and associations with patient outcome. The results highlight the utility of a quantitative multimarker assay for in situ, single-cell immune biomarker evaluation and underscore the importance of spatial context for tumor microenvironment characterization.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8816895</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34937729</oboInOwl:hasDbXref>
        <rdfs:label>GZMB+ and FCGR3A+ NK-cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000623"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/42b96c2d-00c7-4b01-8ff0-7e161d45f183"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000623"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/4200bf18-2ab7-4693-b547-e78df9e17798 -->

    <Class rdf:about="http://example.org/4200bf18-2ab7-4693-b547-e78df9e17798">
        <obo:IAO_0000115>Knocking out PDGF-BB expression in ##TRAP+ osteoclasts## decreases CD31hiEmcnhi vasculature and their association with Osterix+ and Gli1+ skeletal progenitors.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8553857</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34711819</oboInOwl:hasDbXref>
        <rdfs:label>TRAP+ osteoclasts</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000092"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/4200bf18-2ab7-4693-b547-e78df9e17798"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000092"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/429047e5-671e-4e38-97a0-402eb1dff58c -->

    <Class rdf:about="http://example.org/429047e5-671e-4e38-97a0-402eb1dff58c">
        <obo:IAO_0000115>Previous work revealed that GM-CSF cultured BMDCs are a heterogeneous myeloid cell population consisting of bona fide DCs (termed &quot;GM-DC&quot;) and a minor fraction of macrophage-like CD11c+ MHCII+ cells (termed &quot;GM-Mac&quot;). When we refined our flow cytometric analysis for distinguishing GM-DCs and GM-Macs in BMDC cultures, we found a clear shift between both cell populations in 3xGrk -/- BMDC cultures. Among CD11c+ MHCII+ cells, the fraction of GM-DCs was decreased, whereas GM-Macs were markedly increased in both unstimulated and LPS-stimulated 3xGrk -/- GM-CSF cultures ( Figure 5E ). Importantly, the remaining bona fide GM-DCs, which still developed in 3xGrk -/- cultures, also showed reduced expression of CCR7, MHCII and CD40 ( Figure 5F ). Together, these findings provide an explanation for the two observed phenotypes of 3xGrk -/- cells in the under-agarose chemotaxis assays; (a) less responding cells, because GM-Macs do not migrate to CCL19, and (b) reduced displacement of the responding cells, because the remaining bona fide GM-DCs remain lowered in CCR7-expression. Additionally, we noticed that not only DCs derived from GM-CSF cultures showed an altered phenotype, but also DC development in the presence of Flt3 ligand was impaired. In particular, the number of ##CD11b- DCs## was strongly reduced, whereas the CD11b+ DC population was not significantly altered ( Supplementary Figure 3A ).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9703078</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36451830</oboInOwl:hasDbXref>
        <rdfs:label>CD11b- DCs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000451"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/429047e5-671e-4e38-97a0-402eb1dff58c"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000451"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/43a1b94f-d3af-400d-8148-40cbcc555d1c -->

    <Class rdf:about="http://example.org/43a1b94f-d3af-400d-8148-40cbcc555d1c">
        <obo:IAO_0000115>We further stratified the T cells into cytotoxic, exhausted, and inflammatory subtypes. The representative T cell cytotoxic include activated CD8+ T cells, CD8 T effector memory cells and nature killer T cells. The inflammatory subtypes include Th17 and Th22 cells. We collected cell markers from for cytotoxic and inflammatory T cell subtypes and for ##exhausted CD8+ T cells##, respectively, and applied single sample Gene Set Enrichment Analysis. As detailed in Methods section, we then performed differential analysis of responders versus nonresponders for the functional categories on GSE3493. We found no statistical significant cell subtypes except lower activated CD8+ T cells in RT responsive groups(p = 0.038), which was consistent with the lower CD8+ T cells from TIMER.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9082952</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35534879</oboInOwl:hasDbXref>
        <rdfs:label>exhausted CD8+ T cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000625"/>
        <skos:relatedMatch rdf:resource="CL:0011025"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/43a1b94f-d3af-400d-8148-40cbcc555d1c"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000625"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/43a1b94f-d3af-400d-8148-40cbcc555d1c"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0011025"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/43c21111-f1e6-48ce-ab59-be35d14bb94d -->

    <Class rdf:about="http://example.org/43c21111-f1e6-48ce-ab59-be35d14bb94d">
        <obo:IAO_0000115>Macrophages have been shown to play a key role in regulating HSC quiescence and retention in the BM. DRAC+ macrophages have been shown to regulate HSC quiescence through the activation of the TGFbeta1-Smad3 pathway downstream of CD82/KAI1. CD82/KAI1 is predominantly expressed in LT-HSCs, and when knocked out, HSC proliferation increases. Depletion of DRAC (CD82/KAI1-binding partner) expressing macrophages leads to a reduction of CD82/KAI1 levels in HSCs, increased proliferation, and differentiation. CD169+ macrophages constitute another example of cells regulating HSC retention in the BM. In CD169-iDTR mice, it has been shown that the depletion of CD169+ macrophages after DTR treatment causes an increase of HSCs and progenitor cells in peripheral blood. Ablation of CD169+ macrophages in CD169-iDTR mice upon DTR administration significantly reduced not only the HSC number in the BM but also the HSC, LSK, and GMP frequencies in the spleen. In line with their function in the BM, macrophages are also responsible for the retention of HSCs into the spleen, selectively through VCAM1-mediated signaling. Knockdown of VCAM1 expression in macrophages, using siRNA targeting VCAM-1 within macrophage-avid lipidic nanoparticles, causes reduced retention of ##splenic HSCs##, LSKs, and GMPs, without affecting HSC retention into the BM.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8631970</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34858399</oboInOwl:hasDbXref>
        <rdfs:label>splenic HSCs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000037"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/43c21111-f1e6-48ce-ab59-be35d14bb94d"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000037"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/43e46fd8-f73f-4876-8f59-8d20c6ae3816 -->

    <Class rdf:about="http://example.org/43e46fd8-f73f-4876-8f59-8d20c6ae3816">
        <obo:IAO_0000115>Using WOT, we then identified the descendants of presumptive ##I-RGCs## at later ages. We found that I-RGCs comprised 4.3% of adult RGCs, consistent with the range of 3-5% noted above. We queried these cells to identify the genes that distinguished putative I-RGCs and C-RGCs throughout the developmental time course. At a fold change of &gt;=1.5, we found 59 differentially expressed (DE) genes at E13 and 89 at E14 (Figure 7e and f). In addition to Zic2, Igfbp5, Isl2, and Igf1, which had been used to define I-RGCs and C-RGCs at E13, they included Igfbpl1, Pou3f1, and Cntn2 enriched in I-RGCs, and Lmo2, Pcsk1n, and Syt4 enriched in C-RGCs. The number of genes differentially expressed between I- and C-RGCs decreased after E14, with 20, 9, and 0 significant genes at E16, P0, and P5, respectively (Figure 7:figure supplement 1d and e), presumably reflecting the downregulation of axon guidance programs once retinorecipient targets have been reached (see Discussion).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8956290</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35191836</oboInOwl:hasDbXref>
        <rdfs:label>I-RGCs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000740"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/43e46fd8-f73f-4876-8f59-8d20c6ae3816"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000740"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/43e5e290-13a6-42e1-9187-828d36416b56 -->

    <Class rdf:about="http://example.org/43e5e290-13a6-42e1-9187-828d36416b56">
        <obo:IAO_0000115>To test whether inflammation was necessary for metaplastic pit cell expansion, we treated Hp+KRAS+ mice with the immunosuppressive glucocorticoid dexamethasone. Mice received dexamethasone ad libitum in the drinking water starting at 2 weeks and were euthanized at 6 weeks. Hp bacterial loads were not significantly different between the two groups (Fig. 3H). As expected, dexamethasone treatment significantly reduced the accumulation of gastric immune cell populations compared with control-treated Hp+KRAS+ mice (Fig. 3A-G). Importantly, gastric Muc4 expression was also significantly reduced, though not eliminated, in dexamethasone-treated mice (Fig. 3I and J). Thus, gastric inflammation is necessary for metaplastic pit cell development in Hp+KRAS+ mice and is primarily comprised of increased ##gastric macrophages## and T cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10478791</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37674528</oboInOwl:hasDbXref>
        <rdfs:label>gastric macrophages</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/43e5e290-13a6-42e1-9187-828d36416b56"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/43e84a9f-2e74-4ed9-a1ec-38615da3adc8 -->

    <Class rdf:about="http://example.org/43e84a9f-2e74-4ed9-a1ec-38615da3adc8">
        <obo:IAO_0000115>Organoids are important research tools for studying organ morphogenesis and differentiation because they recapitulate ex vivo the native 3D organization of cells that is essential for proper cell and organ function. The composition of organoids can be manipulated to incorporate specific cell types to facilitate molecular interrogation of cell-cell interactions during organoid formation. A method for generating organoids derived from both embryonic salivary gland epithelial progenitor cells and ##mesenchymal support cells## is described. Methods for isolating enriched populations of the epithelial cells as clusters and the mesenchyme cells as single cells from mouse embryonic submandibular salivary glands are also provided. Separating the epithelial and mesenchymal cell populations allows for independent molecular manipulation of each cell type. In addition, methods for lentiviral transduction of the mesenchyme cells and quantitative image analysis of organoids are provided. The methods described here are useful for exploring mechanisms driving organ formation.   2018 by John Wiley &amp; Sons, Inc.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6948183</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:30394683</oboInOwl:hasDbXref>
        <rdfs:label>mesenchymal support cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000630"/>
        <skos:relatedMatch rdf:resource="CL:0008019"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/43e84a9f-2e74-4ed9-a1ec-38615da3adc8"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000630"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/43e84a9f-2e74-4ed9-a1ec-38615da3adc8"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0008019"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/43f15575-ecca-4396-a1e8-4c0f7e6da757 -->

    <Class rdf:about="http://example.org/43f15575-ecca-4396-a1e8-4c0f7e6da757">
        <obo:IAO_0000115>Reference strains Ba/Apache-2 and E/Bour were used to infect HeLa 229 and immortalized human conjunctival epithelial (HCjE) cells, primary conjunctival epithelial (CjE) cells and stromal fibroblasts (CjS cells), primary endocervical epithelial (EcE) cells and stromal fibroblasts (##EcS cells##), and endometrial stromal fibroblasts (EmS cells). Cell composition and type were validated prior to our performing each assay using cytokeratin- and fibronectin-specific antibodies (see Fig. S1 in the supplemental material). Table S1 shows the origins of human primary cells by patient age and sex for CjE and CjS cells and by age for EcE, EcS, and EmS cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6426598</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:30890604</oboInOwl:hasDbXref>
        <rdfs:label>EcS cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000057"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/43f15575-ecca-4396-a1e8-4c0f7e6da757"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000057"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/43f87fef-849e-41c7-872b-1ee3fb72978e -->

    <Class rdf:about="http://example.org/43f87fef-849e-41c7-872b-1ee3fb72978e">
        <obo:IAO_0000115>General capillary gCap ECs have been reported to function as progenitor cells capable of differentiating into aerocytes (##aCap ECs##) in response to injurious lung stimuli. Our lineage mapping of gCap EC dynamics following bleomycin-induced lung injury in young animals revealed that gCap ECs move to an activated state coinciding with fibrosis onset and that this state transitions back to a healthy gCap EC state with injury resolution. The shift to an activated state was independent of genetics background, as observations in this lineage tracing model were from a mixed C57B/6-129 genetic background mirrored those from C57B/6 injured mice. Our lineage tracing also demonstrated that under these injury conditions gCap ECs do not differentiate into aCap ECs, but rather acquire transient transcriptional changes in young lungs that are sustained in aged lungs. Previous studies have reported that lung capillary ECs can transform into collagen-producing mesenchymal cells (endothelial mesenchymal transition, EndMT) in response to bleomycin-induced lung injury to give rise to pathogenic collagen-producing cells. Our lineage tracing study using genetically labeled capillary ECs demonstrated that although injured capillary ECs transiently overexpressed mesenchymal-associated genes, these cells largely maintained their endothelial identity and do not undergo mesenchymal cell differentiation.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11211333</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38937456</oboInOwl:hasDbXref>
        <rdfs:label>aCap ECs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:4028003"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/43f87fef-849e-41c7-872b-1ee3fb72978e"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4028003"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/43064c3a-feb2-4a09-b30b-fcfaeabcd298 -->

    <Class rdf:about="http://example.org/43064c3a-feb2-4a09-b30b-fcfaeabcd298">
        <obo:IAO_0000115>Astrocytes play many important functions in response to spinal cord injury (SCI) in an activated manner, including clearance of necrotic tissue, formation of protective barrier, maintenance of microenvironment balance, interaction with immune cells, and formation of the glial scar. More and more studies have shown that the astrocytes are heterogeneous, such as inflammatory astrocyte 1 (##A1##) and neuroprotective astrocyte 2 (A2) types. However, the subtypes of astrocyte resulting from SCI have not been clearly defined. In this study, using single-cell RNA sequencing, we constructed the transcriptomic profile of astrocytes from uninjured spinal cord tissue and injured tissue nearby the lesion epicenter at 0.5, 1, 3, 7, 14, 60, and 90 days after mouse hemisection spinal cord surgery. Our analysis uncovered six transcriptionally distinct astrocyte states, including Atp1b2+ , S100a4+ , Gpr84+ , C3+ /G0s2+ , GFAP+ /Tm4sf1+ , and Gss+ /Cryab+ astrocytes. We used these new signatures combined with canonical astrocyte markers to determine the distribution of morphologically and physiologically distinct astrocyte population at injured sites by immunofluorescence staining. Then we identified the dynamic evolution process of each astrocyte subtype following SCI. Finally, we also revealed the evolution of highly expressed genes in these astrocyte subtypes at different phases of SCI. Together, we provided six astrocyte subtypes at single-cell resolution following SCI. These data not only contribute to understand the heterogeneity of astrocytes during SCI but also help to find new astrocyte subtypes as a target for SCI repair.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMID:35816276</oboInOwl:hasDbXref>
        <rdfs:label>A1</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002627"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/43064c3a-feb2-4a09-b30b-fcfaeabcd298"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002627"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/4329af42-b242-41a8-8e5a-0a090b4b0e8b -->

    <Class rdf:about="http://example.org/4329af42-b242-41a8-8e5a-0a090b4b0e8b">
        <obo:IAO_0000115>Comparison of the single cell landscape between healthy human meniscus and degenerated meniscus. (A) Representative polarised light microscopy images of healthy human and degenerated meniscus. The white and red colours in the angle images are 90  apart in orientation. Dashed lines indicate the surface of the meniscus. Scale bar, 100 microm. (B) Merged t-distributed stochastic neighbour embedding (t-SNE) of single-cell RNA sequencing of healthy meniscus cells and degenerated meniscus cells. (C) Twelve healthy human and degenerated meniscus cell clusters at t-SNE. (D) Proportion of each cluster to the total cells. (E) Proportion of healthy and degenerated meniscus cells in each cluster. (F) Expression of representative marker genes in Vin plot. (G) Heatmap revealing the scaled expression of differentially expressed genes for each cluster. (H) CD146 and CD318 expression in healthy human meniscus cells and degenerated meniscus cells determined by flow cytometry. n&gt;=5, **p&lt;0.01. (I) Representative IHC staining of COL1A1 and COL2A1 healthy human meniscus and degenerated meniscus, and quantification of positive cells. Scale bar, 50 microm. n&gt;=5, **p&lt;0.01. (J) The expression of indicated marker genes in human healthy meniscus cells and degenerated meniscus cells were detected by qRT-PCR. *p&lt;0.05, **p&lt;0.01, otherwise, not significant. n=3, *p&lt;0.05, **p&lt;0.01. CPC, cartilage progenitor cells; DegP, degenerated meniscus progenitor cells; EC, endothelial cells; FC, fibrochondrocytes; FCP, fibrochondrocyte progenitors; HTC, hypertrophic chondrocytes; MoDC, monocyte-derived dendritic cells; PreHTC, prehypertrophic chondrocytes; ProFC, proliferate fibrochondrocytes; RegC, ##regulatory chondrocytes##.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7034356</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31871141</oboInOwl:hasDbXref>
        <rdfs:label>regulatory chondrocytes</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000138"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/4329af42-b242-41a8-8e5a-0a090b4b0e8b"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000138"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/4356e13f-9d09-48ef-8f43-726bee0bff14 -->

    <Class rdf:about="http://example.org/4356e13f-9d09-48ef-8f43-726bee0bff14">
        <obo:IAO_0000115>Results: We showed that two distinct pericyte subpopulations, marked by NG2+ and Tbx18+, had different potency following brain injury. NG2+ pericytes expressed dominant neural reprogramming potential to produce newborn neurons, while ##Tbx18+ pericytes## displayed dominant multipotency to produce endothelial cells, fibroblasts, and microglia following ischemic stroke. In addition, we discovered that AMPK modulators facilitated pericyte-to-neuron conversion by modulating Ser436 phosphorylation status of CBP, to coordinate an acetylation shift between Sox2 and histone H2B, and to regulate Sox2 nuclear-cytoplasmic trafficking during the reprogramming/differentiation process. Finally, we showed that sequential treatment of compound C (CpdC) and metformin, AMPK inhibitor and activator respectively, robustly facilitated the conversion of human pericytes into functional neurons.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11488099</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:39431007</oboInOwl:hasDbXref>
        <rdfs:label>Tbx18+ pericytes</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:4047007"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/4356e13f-9d09-48ef-8f43-726bee0bff14"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4047007"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/438d0116-40cf-4397-9951-e1b1bfe5012d -->

    <Class rdf:about="http://example.org/438d0116-40cf-4397-9951-e1b1bfe5012d">
        <obo:IAO_0000115>The adipose-derived hormone leptin acts via its receptor (LepRb) in the brain to control energy balance. A potentially unidentified population of ##GABAergic hypothalamic LepRb neurons## plays key roles in the restraint of food intake and body weight by leptin. To identify markers for candidate populations of LepRb neurons in an unbiased manner, we performed single-nucleus RNA-Seq of enriched mouse hypothalamic LepRb cells, identifying several previously unrecognized populations of hypothalamic LepRb neurons. Many of these populations displayed strong conservation across species, including GABAergic Glp1r-expressing LepRb (LepRbGlp1r) neurons, which expressed more Lepr than other LepRb cell populations. Ablating Lepr from LepRbGlp1r cells provoked hyperphagic obesity without impairing energy expenditure. Similarly, improvements in energy balance caused by Lepr reactivation in GABA neurons of otherwise Lepr-null mice required Lepr expression in GABAergic Glp1r-expressing neurons. Furthermore, restoration of Glp1r expression in LepRbGlp1r neurons in otherwise Glp1r-null mice enabled food intake suppression by the GLP1R agonist, liraglutide. Thus, the conserved GABAergic LepRbGlp1r neuron population plays crucial roles in the suppression of food intake by leptin and GLP1R agonists.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10541203</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37581939</oboInOwl:hasDbXref>
        <rdfs:label>GABAergic hypothalamic LepRb neurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000617"/>
        <skos:relatedMatch rdf:resource="CL:4042033"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/438d0116-40cf-4397-9951-e1b1bfe5012d"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000617"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/438d0116-40cf-4397-9951-e1b1bfe5012d"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4042033"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/43838c1f-b0cc-4026-ab73-f7bfffe545d4 -->

    <Class rdf:about="http://example.org/43838c1f-b0cc-4026-ab73-f7bfffe545d4">
        <obo:IAO_0000115>3D spheroids have emerged as powerful drug discovery tools given their high-throughput screening (HTS) compatibility. Here, we describe a method for generating functional neural spheroids by cell-aggregation of differentiated human induced pluripotent stem cell (hiPSC)-derived ##neurons## and astrocytes at cell type compositions mimicking specific regions of the human brain. Recordings of intracellular calcium oscillations were used as functional assays, and the utility of this spheroids system was shown through disease modeling, drug testing, and formation of assembloids to model neurocircuitry. As a proof of concept, we generated spheroids incorporating neurons with Alzheimer&apos;s disease-associated alleles, as well as opioid use disorder modeling spheroids induced by chronic treatment of a mu-opioid receptor agonist. We reversed baseline functional deficits in each pilot disease model with clinically approved treatments and showed that assembloid activity can be chemogenetically manipulated. Here, we lay the groundwork for brain region-specific neural spheroids as a robust functional assay platform for HTS studies.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10684574</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38017066</oboInOwl:hasDbXref>
        <rdfs:label>neurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000540"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/43838c1f-b0cc-4026-ab73-f7bfffe545d4"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000540"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/44e5aa89-a275-4d08-bc64-f0b685c753cb -->

    <Class rdf:about="http://example.org/44e5aa89-a275-4d08-bc64-f0b685c753cb">
        <obo:IAO_0000115>Cells Young Lymph Node Old Lymph Node   T lymphocytes effective activation of T cells by antigensefficient proliferationproduction of effector cytokinesmigration to peripheral tissues to fulfill effector functions impaired homeostatic proliferation of T cellsdisturbed movement, localization, and responsesreduced size of the naive T-cell pool including CD4+ and CD8+ T cells, increased memory T lymphocyte poolincreased CD4+ to CD8+ T-cell ratioCD4+ T lymphocyte depletion in the paracortical zonedecreased number of regulatory T-cells in the cords and medullary sinusesreduced number of CD4+ PD1hi Tfh cells and increased number of CD4+ FoxP3hi and Lag3hi suppressor T cells in germinal centers   B lymphocytes correct interactions between B lymphocytes, follicular T helper lymphocytes, and FDCs in germinal centersadequate activation, proliferation, somatic hypermutation, and maturation of antigen-specific B-cellseffective production of antigen-specific antibodies decreased number of CD20hi Ki67hi proliferating B cells in germinal centersloss of an organized B-cell structure in the follicles after immune stimulationdisrupted reciprocal regulation between B and Tfh lymphocytes resulting in an impaired antigen-specific B-cell response and effective selection of lymphocytes producing specific antibodiesimpaired production of IgM and IgG antibodiesdecreased expression of the E47 transcription factor and activation-induced cytidine deaminase resulting in the production of antibodies with reduced affinity for foreign antigensweakened antibody neutralizing function   Neutrophils effective recruitment of neutrophils to the draining lymph nodes upon microbial, viral, or sterile stimulisearch for and capture antigensrelease leukotriene B4 initiating the recruitment of other neutrophils from the vascular systemupon activation, release granular proteins and chromatin, forming extracellular fibers capturing microorganisms to prevent their spread increased number and percentage of ##not proliferating old neutrophils## in the T- and B-cell zones of the lymph nodesweak response to chemotactic signalsdecreased apoptosisdecreased phagocytosisincreased percentage of neutrophils expressing integrin CD11b, ICAM-1, and TGF-beta suggesting involvement in a chronic inflammatory state   </obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8621398</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34831371</oboInOwl:hasDbXref>
        <rdfs:label>not proliferating old neutrophils</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000775"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/44e5aa89-a275-4d08-bc64-f0b685c753cb"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000775"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/441a4b39-95be-4bb9-aab7-6e9a9dfb6229 -->

    <Class rdf:about="http://example.org/441a4b39-95be-4bb9-aab7-6e9a9dfb6229">
        <obo:IAO_0000115>While the heterogeneity of CD103+ TRMs is widely discussed in the literature, the characteristics of TRM subpopulations within the tumor or distant tissues of tumor-bearing mice are less well defined. To characterize tumoral TRMs, scRNA-seq technology provides unprecedented analytical power and allows us to dissect cells with thousands of dimensions. With the hypothesis that particular intratumoral T cells are precursors for TRM development, we extended our scRNA-seq approach to include various effector and memory T cell populations to comprehensively depict their transcriptomic program. From the tumor and distant mucosa of mice bearing established 4T1 tumors, we flow sorted distinct memory T cell populations using a strict gating strategy (Figure S3). We constructed single-cell cDNA libraries from paired intratumoral sorted TCR-beta+CD44+CD62L-CD69+CD103+ cells (TRMs), mucosal sorted TCR-beta+CD44+ CD69+CD103+ cells (##distant mucosa TRMs##), intratumoral TCR-beta+CD44+CD62L+CD69-CD103- cells (TCMs), and TCR-beta+CD44+CD62L-CD69-CD103- cells (TEMs) (Table S2). After data processing and normalization, we performed unbiased clustering and visualized the CD8+ clusters using t-distributed stochastic neighbor embedding (t-SNE; Figure 2A). Through this unsupervised analysis, we found that all four samples could distinctly separate into multiple clusters, confirming continued heterogeneity among the single-cell subsets.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8204287</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33979626</oboInOwl:hasDbXref>
        <rdfs:label>distant mucosa TRMs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000909"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/441a4b39-95be-4bb9-aab7-6e9a9dfb6229"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000909"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/441e8551-3112-452a-a1ed-dcccf9dc5445 -->

    <Class rdf:about="http://example.org/441e8551-3112-452a-a1ed-dcccf9dc5445">
        <obo:IAO_0000115>To evaluate the systemic antitumor immunity induced by NIR-PIT, Ly6G-targeted NIR-PIT was performed unilaterally in a bilateral mEERL-hEGFR tumor model. The treatment schema is shown in Figure 6(a). After NIR light administration, the 700 nm fluorescence signal was significantly decreased in the NIR light irradiated side tumor, while it was unchanged in the contralateral tumor (Figure 6(b,c)). However, tumor growth was significantly suppressed not only in the treated tumors but also in untreated tumors (Figure 6(d)). Also, animals in the NIR-PIT group demonstrated significantly prolonged survival compared to the control group (Figure 6(e)). We then evaluated ##TILs## in the tumors 7 days after unilateral Ly6G-targeted NIR-PIT. The number of CD8+ T cells in the untreated and treated tumors after NIR-PIT was significantly higher than in the control groups (figure 6(f)). No significant changes in helper T cells and Tregs were observed. </obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9718564</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36465486</oboInOwl:hasDbXref>
        <rdfs:label>TILs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000542"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/441e8551-3112-452a-a1ed-dcccf9dc5445"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000542"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/4421bc55-93bd-485e-973a-8cfc4f9e7bd3 -->

    <Class rdf:about="http://example.org/4421bc55-93bd-485e-973a-8cfc4f9e7bd3">
        <obo:IAO_0000115>To investigate the developmental origin of the CD34+PRLR+ cells, freshly isolated CD34+ HSCs were sorted into MLP, CMP, GMP and NK/BP (Fig. 2A), and cultured as described above. PRLR-expressing cells were mainly generated from the GMP compartment (Fig. 2B-D). At day 4 of culture, FACS sorted PRLR+ progenitors lacked all lineage markers except for CD15 and CD43, further supporting their myeloid origin (Fig. 2E). Evaluation of these cells at later time points (day + 14) showed that they remain CD15+, and acquired CD11a, CD11b, CD11c, CD16, CD18, CD45RO and CD123 (Fig. 2F). To study their differentiation, we sorted CD34+PRLR+ cells from four-day expanded CD34+ HSCs (as shown in Fig. 1A). As above, in the presence of ILC promoting cytokines (IL-3, IL-7, IL-15, IL-23, SCF and FLT3L) the CD34+PRLR+ progenitors differentiate into immature myeloid cells (Fig. 3A-C). Addition of GM-CSF at later times (day + 21) resulted in the generation of mature granulocytes expressing CD15, CD16 and CD66b (Fig. 3A-C). Previously, we showed that some myeloid progenitors could give rise to CD56+ lymphocytes. However, sorted CD34+PRLR-, but not CD34+PRLR+ cells gave rise to CD56+ lymphocytes (Fig. 4A-C). Moreover, the CD34+PRLR+ progenitors do not express integrin alpha4beta7, a marker that defines innate lymphoid precursors with the potential to develop into ILCs (Fig. 4C). In further support of these findings, the CD34+PRLR+ progenitors do not differentiate into ##CD94+, CD127+ and CD336+ lymphocytes## (Fig. 4D). Collectively, these findings show that CD34+PRLR+ progenitors develop from the GMPs under the influence of SCF and FLT3L, thereby acquire various myeloid markers and seem to lack lymphoid potential.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7156717</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32286456</oboInOwl:hasDbXref>
        <rdfs:label>CD94+, CD127+ and CD336+ lymphocytes</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0001065"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/4421bc55-93bd-485e-973a-8cfc4f9e7bd3"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0001065"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/44435ba0-bdae-48ba-aed2-bc2a0f78ff29 -->

    <Class rdf:about="http://example.org/44435ba0-bdae-48ba-aed2-bc2a0f78ff29">
        <obo:IAO_0000115>We observe that the sickle sample and normal sample morphological parameters histograms are mostly overlapped; however, a nontrivial number of the sickle cells in the distribution exhibit nearly no phenotypic similarities to healthy cells. This unique subset of sickle cells can be extracted from the distribution through implementing a 21:1 ##SCD##-to-normal ratio thresholding criterion. As described above, this means that each criterion is defined by the region in the histogram where the population of SCD cells have 21x greater incidence of that chosen parameter than the normal cell population. The extraction of morphological parameters that uniquely identify sickling cells is a necessary step to constructing a meaningful, pure SCD ground truth set. Without thresholding, the large overlap between the morphological parameters of sickle and normal cells sample will confound the discrimination capacity of a classification algorithm. Furthermore, through refining the training set, we have narrowed down the focus of the classification algorithm to specifically differentiate SCD cells from healthy cells and greatly increase accuracy. The near ideal ROC curves (Figure 2B and Figure 3B) for LR and CNN algorithms when trained on the refined data, indicates that the algorithm practically predicted no false positives and would excel at identifying critically sickled cells. Overall, we have developed a group of metrics that can delineate critically sickling cells in a heterogeneous SCD sample.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10419148</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37569260</oboInOwl:hasDbXref>
        <rdfs:label>SCD</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000232"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/44435ba0-bdae-48ba-aed2-bc2a0f78ff29"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000232"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/44442231-6d25-4021-8751-a230d8aee287 -->

    <Class rdf:about="http://example.org/44442231-6d25-4021-8751-a230d8aee287">
        <obo:IAO_0000115>Loss of Gba disrupts microglial homeostasis and induces ##damage-associated microglia## (DAM) phenotype and immune cell infiltration in neuronopathic Gaucher disease (nGD) (Gbalsl/lsl) brain.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9381039</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35972072</oboInOwl:hasDbXref>
        <rdfs:label>damage-associated microglia</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000129"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/44442231-6d25-4021-8751-a230d8aee287"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000129"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/447a4b29-6e9a-463a-8cc2-0a671a7ff1cd -->

    <Class rdf:about="http://example.org/447a4b29-6e9a-463a-8cc2-0a671a7ff1cd">
        <obo:IAO_0000115>To investigate the developmental origin of the CD34+PRLR+ cells, freshly isolated CD34+ HSCs were sorted into MLP, CMP, GMP and NK/BP (Fig. 2A), and cultured as described above. PRLR-expressing cells were mainly generated from the GMP compartment (Fig. 2B-D). At day 4 of culture, FACS sorted PRLR+ progenitors lacked all lineage markers except for CD15 and CD43, further supporting their myeloid origin (Fig. 2E). Evaluation of these cells at later time points (day + 14) showed that they remain CD15+, and acquired CD11a, CD11b, CD11c, CD16, CD18, CD45RO and CD123 (Fig. 2F). To study their differentiation, we sorted CD34+PRLR+ cells from four-day expanded CD34+ HSCs (as shown in Fig. 1A). As above, in the presence of ILC promoting cytokines (IL-3, IL-7, IL-15, IL-23, SCF and FLT3L) the ##CD34+PRLR+ progenitors## differentiate into immature myeloid cells (Fig. 3A-C). Addition of GM-CSF at later times (day + 21) resulted in the generation of mature granulocytes expressing CD15, CD16 and CD66b (Fig. 3A-C). Previously, we showed that some myeloid progenitors could give rise to CD56+ lymphocytes. However, sorted CD34+PRLR-, but not CD34+PRLR+ cells gave rise to CD56+ lymphocytes (Fig. 4A-C). Moreover, the CD34+PRLR+ progenitors do not express integrin alpha4beta7, a marker that defines innate lymphoid precursors with the potential to develop into ILCs (Fig. 4C). In further support of these findings, the CD34+PRLR+ progenitors do not differentiate into CD94+, CD127+ and CD336+ lymphocytes (Fig. 4D). Collectively, these findings show that CD34+PRLR+ progenitors develop from the GMPs under the influence of SCF and FLT3L, thereby acquire various myeloid markers and seem to lack lymphoid potential.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7156717</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32286456</oboInOwl:hasDbXref>
        <rdfs:label>CD34+PRLR+ progenitors</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0001059"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/447a4b29-6e9a-463a-8cc2-0a671a7ff1cd"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0001059"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/45ba221e-6a08-44b9-a72f-6eefcce6a430 -->

    <Class rdf:about="http://example.org/45ba221e-6a08-44b9-a72f-6eefcce6a430">
        <obo:IAO_0000115>Airway epithelial cells such as goblet and ciliated cells are required for mucociliary clearance of inhaled particles. Alveolar epithelial type 1 (AT1) cells provide a short-distance barrier for diffusion gas exchange. AT2 cells maintain homeostasis, secrete surfactant, mediate defense against pathogens (including MHCII-dependent antigen presentation), and serve as AT1 progenitors. Pulmonary capillary endothelial cells facilitate gas exchange and leukocyte migration. Other subsets of lung endothelial cells from the pulmonary lymphatics, pulmonary blood vessels, and systemic blood vessels in the lung await functional annotations. Mesenchymal cells, including smooth muscle cells, fibroblasts and mesothelial cells, are involved in homeostasis, repair, and wound healing. Mesothelial cells cover the pleural spaces, secrete glycosaminoglycans and surfactant, and initiate inflammatory responses to pathogens via pro-inflammatory mediators such as interleukins (e.g., IL-6, IL-8) and interferons. Amongst myeloid cells, alveolar macrophages are potent airway scavengers and modulate the magnitude of immune responses and tissue homeostasis. Interstitial macrophages, localized in the parenchyma, function in inflammation, wound healing, and tissue repair. Monocytes patrol the blood and play a role in surveillance of endothelial integrity and are recruited to the inflamed lungs. Dendritic cells activate naive T-cells, initiating adaptive immunity. Granulocytes such as neutrophils and eosinophils modulate immune response and are involved in pathogen killing and clearance. Resident memory CD4+ and CD8+ T-cells function in adaptive immune responses through the secretion of cytokines, activation of macrophages and lung stromal cells, and/or elimination of infected cells. ##Tissue resident B-cells## and plasma cells mediate humoral immunity and pathogen clearance through antibody production.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9173662</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35672453</oboInOwl:hasDbXref>
        <rdfs:label>Tissue resident B-cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000236"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/45ba221e-6a08-44b9-a72f-6eefcce6a430"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000236"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/45e93d96-856e-4fb3-abd7-639883360ed0 -->

    <Class rdf:about="http://example.org/45e93d96-856e-4fb3-abd7-639883360ed0">
        <obo:IAO_0000115>Organoids generation from different types of stem cells. Organoids can be generated from induced pluripotent stem cells (iPSCs), embryonic stem cells (ESCs) and patient-derived adult stem cells from normal and cancerous tissues (##ASCs##). Cells are usually grown in three dimensional systems under specific conditions to stimulate the growth of organoids. Shapes and images are imported from Servier Medical Art by Servier , accessed on 24 May 2021. Licensed under a Creative Commons Attribution 3.0 Unported License .</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8303386</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34299287</oboInOwl:hasDbXref>
        <rdfs:label>ASCs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000034"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/45e93d96-856e-4fb3-abd7-639883360ed0"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000034"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/452a7428-26f1-4688-bec9-980c2d22e972 -->

    <Class rdf:about="http://example.org/452a7428-26f1-4688-bec9-980c2d22e972">
        <obo:IAO_0000115>Brain-derived neurotrophic factor (BDNF) and neurotrophin 3 (NT-3) are known to regulate neuronal morphology and the formation of neural circuits, yet the neuronal targets of each neurotrophin are still to be defined. To address how these neurotrophins regulate the morphological and synaptic differentiation of developing olfactory bulb (OB) GABAergic interneurons, we analyzed the effect of BDNF and NT-3 on GABA+-neurons and on different subtypes of these neurons: tyrosine hydroxylase (TH+); calretinin (Calr+); calbindin (Calb+); and ##parvalbumin## (PVA+). These cells were generated from cultured embryonic mouse olfactory bulb neural stem cells (eOBNSCs) and after 14 days in vitro (DIV), when the neurons expressed TrkB and/or TrkC receptors, BDNF and NT-3 did not significantly change the number of neurons. However, long-term BDNF treatment did produce a longer total dendrite length and/or more dendritic branches in all the interneuron populations studied, except for PVA+-neurons. Similarly, BDNF caused an increase in the cell body perimeter in all the interneuron populations analyzed, except for PVA+-neurons. GABA+- and TH+-neurons were also studied at 21 DIV, when BDNF produced significantly longer neurites with no clear change in their number. Notably, these neurons developed synaptophysin+ boutons at 21 DIV, the size of which augmented significantly following exposure to either BDNF or NT-3. Our results show that in conditions that maintain neuronal survival, BDNF but not NT-3 promotes the morphological differentiation of developing OB interneurons in a cell-type-specific manner. In addition, our findings suggest that BDNF and NT-3 may promote synapse maturation by enhancing the size of synaptic boutons.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMID:33392918</oboInOwl:hasDbXref>
        <rdfs:label>parvalbumin</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:4023018"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/452a7428-26f1-4688-bec9-980c2d22e972"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4023018"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/452289cb-20b1-4fd5-9a84-20cb90860b1f -->

    <Class rdf:about="http://example.org/452289cb-20b1-4fd5-9a84-20cb90860b1f">
        <obo:IAO_0000115>We then examined the dynamism of expression patterns of genes involving VLC during retinal development. ELOVL2 and ELOVL4 are elongases involved in VLC-PUFA-CoA biosynthesis. Elovl4 mRNA levels have been shown to increase during retinal development, especially in the photoreceptor inner segments. Using our previous RNA sequencing data (GSE71462, GSE71464), we found that Elovl2 and Elovl4 were upregulated in CD73-positive rod photoreceptors as early as at P2, which corresponds to the rod photorecetpor birth period (Fig. 4A). During late retinal development, which corresponds to the rod photoreceptor maturation period, although Elovl4 expression levels kept high in CD73-positive cells, Elovl2 expression in CD73-positive cells gradually decreased and became similar to the level of the CD73-negative fraction (Fig. 4A). Although ELOVL5 was also shown to catalyze the elongation of long-chain fatty acids, Elovl5 mRNA levels were higher in nonphotoreceptor cells than in rod photoreceptors (Fig. 4A). Consistently, no mutations in Elovl5 were observed in patients with autosomal recessive retinitis pigmentosa. Nrl is the Maf-family leucine zipper transcription factor, and in the Nrl knockout (Nrl-KO) retina, photoreceptor precursors fated to cells with characteristics of short-wavelength cones. The expression profiling database of flow-sorted rods from Nrlp-GFP mouse retina and GFP-positive ##S-cone-like cells## from NRlp-GFP;Nrl-KO mouse can be used to compare gene expression patterns between rod and S-cone (GSE74660, GFE74657). We confirmed that rod photoreceptor kept high Elovl4 expression pattern after P14, which was in contrast to the low expression level of Elovl2 (Fig. 4B). Of interest, Nrl-KO mice-derived retina showed higher expression levels of Elovl2 and Elovl5, but Elovl4 was lower than Nrl-GFP rod (Fig. 4B), suggesting differential expression patterns of these genes between rod and cone.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7949107</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33465374</oboInOwl:hasDbXref>
        <rdfs:label>S-cone-like cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0003050"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/452289cb-20b1-4fd5-9a84-20cb90860b1f"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0003050"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/454813e4-e36b-4e60-8167-65545a9cf37a -->

    <Class rdf:about="http://example.org/454813e4-e36b-4e60-8167-65545a9cf37a">
        <obo:IAO_0000115>a Due to single-cell annotation and in situ validation (Fig. 2; Supplementary Fig. 3), a draft model of the oral-to-tooth transition zone in humans is presented, with basal and suprabasal keratinocyte markers uniquely identifying the alveolar mucosa (AM), attached gingiva (AG), gingival margin (GM), sulcular epithelium (SK) and junctional epithelium (JK). b These markers allowed for KRT19-high keratinocyte (KC) cell subclustering for the first time (2504 cells in total), including gingival margin keratinocytes (GM), sulcular keratinocytes (SK), and ##junctional keratinocytes## (JK). c A more granular draft (Tier 4) annotation of epithelial cells of the gingival attachment. d Assaying differentially expressed genes in periodontitis, SKs and JKs only share about a quarter of upregulated genes. JKs displayed nearly 125 unique upregulated genes in diseased cells. e Further analysis of basal and suprabasal (differentiating) SK and JK keratinocytes revealed unique cell signatures between basal and suprabasal cell types. This full list is included in Supplementary Data 1. f-i To understand SK and JK developmental progression and cell state alterations, we used partitioned-based graph abstraction (PAGA). f Examining the basal to suprabasal transition, JKs display altered gene expressed comparing health to disease cell types, including broader expression of KRT17 and more expression of JUND, COL17A1, and CDH3. Key differentiation genes such as SPRR family members were also downregulated. g JKs displayed robust cell signaling and inflammatory phenotypes, which appear exacerbated in disease states. h In SKs, differentiation-related genes were uniquely expressed compared to JKs in health but also appeared altered in disease along the basal to suprabasal trajectory. i SKs appeared generally less reactive compared to JKs in disease, with lower overall expression of effector molecules such as CXCL1, CXCL8, IL1A, IL1B, and IL1RN. Abbreviations: Merk Merkel Cells, LC langerhans cells, Mela melanocytes, Muc mucosa, SB suprabasal Keratinocytes; for others, see Fig. 1 legend. For this figure, n = 30-sample, 2504-cell for scRNAseq.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11178863</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38876998</oboInOwl:hasDbXref>
        <rdfs:label>junctional keratinocytes</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002170"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/454813e4-e36b-4e60-8167-65545a9cf37a"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002170"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/46a49873-5cc7-457e-9a5c-ae5f58779389 -->

    <Class rdf:about="http://example.org/46a49873-5cc7-457e-9a5c-ae5f58779389">
        <obo:IAO_0000115> (A) Clusters 2U and 2Sb represent the abundance of manually gated subsets previously identified by the CyTOF automated clustering pipeline, shown here with median and interquartile range. Parent population is labelled on the y-axis. (B) Clusters 1U and 1S represent the expression of CCR7 on Th1-like IL-17+ cells, with median and interquartile range. Points represent RA and HC samples. Mann Whitney U P values are shown above the pairwise comparisons. ##TEM##, T effector memory cell; TCM, T central memory cell.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10196473</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37215131</oboInOwl:hasDbXref>
        <rdfs:label>TEM</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000905"/>
        <skos:relatedMatch rdf:resource="CL:0000913"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/46a49873-5cc7-457e-9a5c-ae5f58779389"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000905"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/46a49873-5cc7-457e-9a5c-ae5f58779389"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000913"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/46a9d04e-a212-4572-85da-ab6204a88598 -->

    <Class rdf:about="http://example.org/46a9d04e-a212-4572-85da-ab6204a88598">
        <obo:IAO_0000115>Considering the close relationship between RGPRG score and immune activity, we sought to further explore the immune infiltrate landscape of two RGPRG score groups. The 22 immune cell composition of HCC patients from the TCGA cohort was shown in Fig. 5A. CD8 T cells, resting memory CD4 T cells, M0 Macrophages, M1 Macrophages, and M2 Macrophages were the main immune cell composition of HCC patients. Many differential immune cell infiltrations could be observed between high- and low-RGPRG score groups (Fig. 5B). Patients with high RGPRG score was characterized by the high infiltration of resting memory CD4 T cells, M0 Macrophages, T cells regulatory (Tregs), naive B cells, memory B cells, Plasma cells, naive CD4 T cells, Eosinophils, indicating a status of immunosuppression in this groups. CD8 T cells, activated memory CD4 T cells, activated NK cells, M1 Macrophages, M2 Macrophages, follicular helper T cells, gamma delta T cells, Neutrophils, resting Dendritic cells, activated Dendritic cells, ##resting NK cells##, Monocytes, resting Mast cells, and activated Mast cells were abundant in the patients with low RGPRG score (Fig. 5C), suggesting enhanced antitumor environment. In addition, the expression of 8 classical immune checkpoint genes between two RGPRG score groups was further estimated in the TCGA cohort, and we found that Patients with high RGPRG score had higher expression levels of CD274, CTLA4, LAG3, PDCD1, and TIGIT (Fig. 5D), which presented another characteristic of immunosuppression.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10832138</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38297333</oboInOwl:hasDbXref>
        <rdfs:label>resting NK cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000623"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/46a9d04e-a212-4572-85da-ab6204a88598"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000623"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/46c464ea-af3b-4cf9-bd9e-47464521ff53 -->

    <Class rdf:about="http://example.org/46c464ea-af3b-4cf9-bd9e-47464521ff53">
        <obo:IAO_0000115>Direct reprogramming of cardiac pericytes into vascular smooth muscle like cells and their potential for angiogenesis. In the injured heart, ##resident cardiac pericytes## can be reprogrammed into vascular smooth muscle like cells that gradually mature and contribute to angiogenesis and arteriogenesis.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10136631</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37190075</oboInOwl:hasDbXref>
        <rdfs:label>resident cardiac pericytes</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000669"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/46c464ea-af3b-4cf9-bd9e-47464521ff53"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000669"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/460b1dfd-5836-4804-a053-28a4fc87c74e -->

    <Class rdf:about="http://example.org/460b1dfd-5836-4804-a053-28a4fc87c74e">
        <obo:IAO_0000115>In Tek-CreERT2;R26T mice, we also observed Tek+ bone-lining cells at the endosteum (Fig. 5a). The frequency of these cells was approximately 2.8 cells/mm endosteum in longitudinal sections, which was significantly higher than that of Cdh5+ bone-lining cells (Fig. 5f). Tek+ endosteal bone-lining cells often exhibited a thin and elongated morphology and were nearly absent for the osteolineage marker RUNX2 (Fig. 5b, g), suggesting that they might correspond to the endosteal fibroblasts detected in the reanalyzed dataset. However, ##Tek+ osteocytes## were hardly detected in these mice (Fig. 5c, h). In other regions of the bone marrow cavity, a small population of trabecular bone-lining cells (Fig. 5d, i) and metaphyseal stromal cells (Fig. 5e, j) were also Tek+.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10733381</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38123537</oboInOwl:hasDbXref>
        <rdfs:label>Tek+ osteocytes</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000137"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/460b1dfd-5836-4804-a053-28a4fc87c74e"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000137"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/4640c046-406c-499d-aced-0b08b01d3cf2 -->

    <Class rdf:about="http://example.org/4640c046-406c-499d-aced-0b08b01d3cf2">
        <obo:IAO_0000115>Expression heterogeneity of CD8+ and CD4+ T cells in the OSCC ecosystem. (A) The t-distributed stochastic neighbor embedding (t-SNE) projection of T cells from cancerous tissue of patients with OSCC, showing the formation of 11 main clusters in different colors. The functional description of each cluster is determined by the gene expression characteristics. Cluster 0: resident memory CD8+ T Cells (C0_CD8+ TRM); Cluster 1: effector memory CD8+ T cells (C1_CD8+ TEM); Cluster 2: regulatory CD4+ T cells (C2_CD4+ Treg); Cluster 3: exhausted CD8+ T cells (C3_##CD8+ T Exhausted##); Cluster 4: effector memory M-phage CD8+ T cells (C4_CD8+ Mitotic TEM); Cluster 5: effector memory CD4+ T cells (C5_CD4+ TEM); Cluster 6: effector memory CD8+ T cells (C6_CD8+ TEM); Cluster 7: effector memory CD4+ T cells (C7_CD4+ TEM); Cluster 8: effector memory CD8+ T cells (C8_CD8+ TEM); Cluster 9: effector memory CD8+ T cells (C9_CD8+ TEM); Cluster 10: effector memory M-phage CD4+ T cells (C10_CD4+ Mitotic TEM); Cluster 11: effector memory CD8+ T cells (C11_CD8+ TEM); Cluster 12: effector memory CD8+ T cells (C12_CD8+ TEM); Cluster 13: gammadelta T. (B) Cell-Cycle Scoring of T cells from cancerous tissue of patients with OSCC, showing the three clusters of cells in different cell cycles in different colors. (C) Heatmap of key genes expressed in each cluster of CD8+ tumor-infiltrating lymphocytes (TILs) with cells grouped by clusters. The columns correspond to the cells; the rows correspond to the genes. Yellow: high expression; purple: low expression. Selected key markers are shown on the right. (D) Heatmap of key genes expressed in each cluster of CD4+ TILs with cells grouped by clusters. The columns correspond to the cells; the rows correspond to the genes. Yellow: high expression; purple: low expression. Selected key genes are shown on the right.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8024729</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33513276</oboInOwl:hasDbXref>
        <rdfs:label>CD8+ T Exhausted</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000795"/>
        <skos:relatedMatch rdf:resource="CL:0011025"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/4640c046-406c-499d-aced-0b08b01d3cf2"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000795"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/4640c046-406c-499d-aced-0b08b01d3cf2"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0011025"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/46556231-afd4-4161-ac5b-6f77683844aa -->

    <Class rdf:about="http://example.org/46556231-afd4-4161-ac5b-6f77683844aa">
        <obo:IAO_0000115>We undertook a comprehensive Mendelian randomization study aimed at uncovering the causal relationship between 744 immune cell types and IVDD [ Supplementary Table 2 ]. In our analysis, we identified 24 specific blood types of immune cells that demonstrated a causal association with disc degeneration through univariable MR [ Supplementary Table 3 ], including Memory B cell %B cell, Naive-mature B cell %B cell, IgD-CD38dim B cell %lymphocyte, CD39+activated CD4 regulatory T cell %CD4 regulatory T cell, CD39+ secreting CD4 regulatory T cell %CD4 regulatory T cell, CD45RA+ CD8+ T cell %CD8+ T cell, CD8+ T cell %leukocyte, CD39+CD4+ T cell %T cell, CD39+ CD4+ T cell %CD4+ T cell,CD39+ CD8+ T cell %T cell, CD39+ CD8+ T cell Absolute Count, CD127- CD8+ T cell Absolute Count, CD28- CD8+ T cell Absolute Count, CD19 on IgD+ CD38+ B cell, CD19 on IgD+ CD38dim B cell, CD19 on IgD- CD38- B cell, CD19 on unswitched memory B cell, CD19 on transitional B cell, CD24 on IgD+ CD38+ B cell,CD28 on CD39+ secreting CD4 regulatory T cell, CD25 on CD39+ CD4+ T cell, CD4 on CD39+ CD4+ T cell, CD4 on CD39+ resting CD4 regulatory T cell and Neutrophil count. We excluded certain exposures due to a limited number of available SNPs to prevent potential bias, including Memory B cell %B cell, Naive-mature B cell %B cell, IgD-CD38dim B cell %lymphocyte, CD8+T cell %leukocyte, ##CD127-CD8+ T cell## Absolute Count, CD19 on IgD-CD38-B cell, CD24 on IgD+ CD38+ B cell, CD28 on CD39+ secreting CD4 regulatory T cell and CD4 on CD39+ resting CD4 regulatory T cell.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10806224</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38268919</oboInOwl:hasDbXref>
        <rdfs:label>CD127-CD8+ T cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000625"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/46556231-afd4-4161-ac5b-6f77683844aa"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000625"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/4658b70c-ffb5-4bc4-8210-bff76e8cf695 -->

    <Class rdf:about="http://example.org/4658b70c-ffb5-4bc4-8210-bff76e8cf695">
        <obo:IAO_0000115>Generation of cardiomyocytes from human-induced pluripotent stem cells resembling ##atrial cells## with ability to respond to adrenoceptor agonists</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10150206</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37122218</oboInOwl:hasDbXref>
        <rdfs:label>atrial cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002129"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/4658b70c-ffb5-4bc4-8210-bff76e8cf695"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002129"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/469e710a-3a0e-4f0d-84d9-89bafe7799e5 -->

    <Class rdf:about="http://example.org/469e710a-3a0e-4f0d-84d9-89bafe7799e5">
        <obo:IAO_0000115>(A) Representative conventional flow plots showing cell-surface expression of indicated markers among low-density peripheral blood cells (PBMC), separating ##iGRANs## from monocytes, residual PMN, and lymphocytes, according to the gating strategy shown in Supplemental Figure 2. (B) Single-cell analysis of PBMCs collected from 2 CMML patients with a fraction of 14% or more and 2 with a lower iGRAN fraction; unsupervised clustering of pooled data separating 15 cluster groups in indicated cell categories. Ery, erythroid cells; My, myeloid cells; MK, megakaryocytes; Gran, granulocytes. (C) Dot plot showing the average expression (color scaled) of selected granulocyte genes and the percentage of cells that expressed those genes in indicated granulocytic clusters. (D) UMAP representation of each patient sample, 2 iGRAN-low (&lt;14%) and 2 iGRAN-high (&gt;=14%) CMML patients. (E) Fraction of each cell type in ITGAM+ clusters corresponding to CD11b+CD33+ cells per CMML patient. Colors are cluster codes defined in B. (F) Expression of indicated genes in enriched fraction of iGRANs, monocytes, and neutrophils measured by RT-qPCR and normalized to RPL32, GUS, and GAPDH housekeeping genes (n = 8 CMML patients). Kruskal-Wallis test. (G) Suppressive activity of iGRANs on T cell proliferation. iGRAN-low (&lt;14%, n = 6, left panels) and iGRAN-high (&gt;=14%, n = 6, right panels) PBMCs were labeled with Cell Trace Violet before activating T cells with anti-CD3 and anti-CD28 antibodies; CD4 (upper panels) and CD8 (lower panels) T cell proliferation was measured at day 4 by flow cytometry. We used PBMCs without any manipulation, PBMCs in which iGRAN have been depleted (iGRAN-dep PBMC), and iGRAN-dep PBMCs with addition of 10% sorted iGRANs. T cell proliferation (%) is relative to the highest proliferation, observed with iGRAN-dep PBMCs. One-way ANOVA, Tukey&apos;s multiple comparison. *P &lt; 0.05; **P &lt; 0.01; ***P &lt; 0.001; ****P &lt; 0.0001.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11563679</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:39545419</oboInOwl:hasDbXref>
        <rdfs:label>iGRANs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000094"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/469e710a-3a0e-4f0d-84d9-89bafe7799e5"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000094"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/47ad713f-5822-4d37-94d2-a82014645afe -->

    <Class rdf:about="http://example.org/47ad713f-5822-4d37-94d2-a82014645afe">
        <obo:IAO_0000115>a, b, Uniform manifold approximation and projection (UMAP) of ##fetal (a) and postnatal (b) epithelial cell## types. Key cell types are circled with a dashed line and arrows depict paths of differentiation towards secretory and absorptive enterocytes as determined by scVelo. M cells, microfold cells; TA, transit-amplifying. c, Dot plot of TMPRSS2 and ACE2 expression in epithelial cells in the fetal intestine as in a. d, UMAP of enteroendocrine (EEC) and enterochromaffin (EC) cell subsets. Arrows depict summarised scVelo differentiation trajectories. C9orf16 is also known as BBLN. e, Heat map of genes that change along the differentiation trajectory from NEUROG3-expressing progenitors to enterochromaffin cells (red arrow in d). Arrows indicate genes that have known associations with enterochromaffin cell differentiation. f, Dot plot with expression of molecules upstream or downstream of the PLCG2 pathway in tuft cells and pooled absorptive (TA and enterocytes) and secretory (Paneth, goblet and EEC) cells. g, Per cent expression of Fcgamma receptor by SiglecF+EpCAM+ and SiglecF-EpCAM+ cells in wild-type mice determined by flow cytometry (individual points represent biological replicates; n = 4). Using a two-way ANOVA we observe significant interaction between Fcgamma receptor expression (F(3, 39) = 42.29, P = 3.05 x 10-11). Post-hoc analysis showed significant differences between non-Tuft epithelial cells and Tuft cells for FcgammaRIIB (mean difference = 2.80, 95% CI [1.80, 3.81], P &lt; 0.0001) and FcgammaRIIB/III (mean difference = 4.88, 95% CI [3.88, 5.89], P &lt; 0.0001) expression. ****Padj &lt; 0.0001 values corrected with Tukey&apos;s test for multiple comparisons. h, Schematic of proposed signalling pathways in tuft cells. RTK, receptor tyrosine kinases.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8426186</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34497389</oboInOwl:hasDbXref>
        <rdfs:label>fetal (a) and postnatal (b) epithelial cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000066"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/47ad713f-5822-4d37-94d2-a82014645afe"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000066"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/47b0e896-509a-4adc-ae77-ce2f1aeb1b59 -->

    <Class rdf:about="http://example.org/47b0e896-509a-4adc-ae77-ce2f1aeb1b59">
        <obo:IAO_0000115>Community 3 contained information on the frequency of innate and adaptive immune cells (Figure 4A). Within the innate cellular compartment, the strongest correlations (Spearman) with GA were increasing frequencies of granulocytes and CD14+CD16- classical monocytes (cMCs) (Figures 4B, C), which are front-line defenders that rapidly respond to injury or infection. In term infants, granulocytes comprised the majority (58%) of immune cell subsets in cord blood, but at earlier GA the proportion of granulocytes falls (average 24.5% of live leukocytes in infants &lt;30 weeks GA) and T lymphocytes predominate (average 47.3% of live leukocytes in infants &lt;30 weeks, of which 64% are CD4+ T cells). In contrast, in the adaptive compartment, the strongest correlations with GA were decreasing frequencies of regulatory T cells (Treg) and CD161+ T cells, including the CD4+ and CD8+ subsets (Figures 4G-I). Treg cells [and possibly fetal CD161+CD4+ T cells ] are immune-regulatory cell subsets that can suppress antigen-specific T cell inflammatory responses. ##CD8+CD161+ T cells## are enriched in mucosal associated invariant T (MAIT) cells that recognize riboflavin metabolites presented by MHC-related 1 (MR1) protein (although our assay did not include MR1 tetramers, which are necessary for the definitive identification of MAITs). Also decreasing in frequency with GA were Natural Killer (NK) T cells, which are enriched in invariant NK (iNK) T cells with a limited T cell receptor (TCR) repertoire specific for lipid antigens presented by the non-classical MHC class I protein CD1d (Figures 4D-F). Together these findings indicate that at early GA the cellular composition of the neonatal immune system is characterized by deficiencies in innate cells involved in the acute response to infection or danger and a relative abundance of suppressor T cells and a reliance on nonconventional T-cell populations with restricted TCR repertoires directed to non-peptide antigens.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8420969</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34497610</oboInOwl:hasDbXref>
        <rdfs:label>CD8+CD161+ T cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000625"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/47b0e896-509a-4adc-ae77-ce2f1aeb1b59"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000625"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/47cdb7b7-69f3-4029-96e9-24d288b2d2a8 -->

    <Class rdf:about="http://example.org/47cdb7b7-69f3-4029-96e9-24d288b2d2a8">
        <obo:IAO_0000115>Direct reprogramming of ##cardiac pericytes## into vascular smooth muscle like cells and their potential for angiogenesis. In the injured heart, resident cardiac pericytes can be reprogrammed into vascular smooth muscle like cells that gradually mature and contribute to angiogenesis and arteriogenesis.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10136631</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37190075</oboInOwl:hasDbXref>
        <rdfs:label>cardiac pericytes</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000669"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/47cdb7b7-69f3-4029-96e9-24d288b2d2a8"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000669"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/4703d719-db9f-4ab3-b2ed-0ce5328188a9 -->

    <Class rdf:about="http://example.org/4703d719-db9f-4ab3-b2ed-0ce5328188a9">
        <obo:IAO_0000115>Pseudobulk differential gene expression analysis showed significant upregulation of genes in all the B cell subclusters in INS, except for ##atBCs## and ASCs (Fig. 2e and Supplementary Fig. 5a). Pathway analysis revealed an enrichment of functions associated with actin cytoskeletal dynamics in all B cell subclusters in INS, while some subclusters (Naive-1, actMBCs, MBC-2, and MZ-like B cells) also showed an enrichment of B cell activation pathways (Supplementary Fig. 5b). The antigen-inexperienced and recently activated B cell subsets (Naive-1 and actMBC) showed the greatest differences in gene expression suggesting that the transcriptional events leading to B cell dysregulation occur early during B cell activation (Fig. 2e and Supplementary Fig. 5a). There was a substantial overlap in the upregulated genes between Naive-1 B cells, actMBCs, MBC-2, and MZ-like B cells including many atBC-associated genes (e.g., ITGB2, ITGB7, FCRLA, FCRL2), POU2F2, POU2AF1, and the extrafollicular response genes TNFRSF13B and GPR183, suggesting a possible developmental sequence or cooperation between these B cell subclusters in generating an extrafollicular B cell response in INS (Fig. 2e).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10667257</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37996443</oboInOwl:hasDbXref>
        <rdfs:label>atBCs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000236"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/4703d719-db9f-4ab3-b2ed-0ce5328188a9"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000236"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/4709eb7e-58f4-4fe9-8b37-e2489f5356c2 -->

    <Class rdf:about="http://example.org/4709eb7e-58f4-4fe9-8b37-e2489f5356c2">
        <obo:IAO_0000115>On occasion Th-CreER; RosaRFP mice were administered tamoxifen and then euthanized shortly after the last injection, within 4 d. When innervation of the tongue was examined using RFP immunolabeling, we observed highly RFP (Th)+ taste bud cells in both fungiform and circumvallate papillae (Fig. 4A). There was never more than one RFP+ cell per taste bud, and only a few taste buds contained these cells. The number of taste buds containing RFP+ receptor cells was quantified, and we observed that only 12% of fungiform taste buds, and 28% of circumvallate taste buds, contained a RFP+ cell (Fig. 4C). If we waited for three weeks after the last tamoxifen injection to euthanize the Th-CreER; RosaRFP mice and perform RFP immunolabeling, no RFP+ cells were observed in any taste bud, indicating that these cells turn over within three weeks. To determine whether these cells were Type II or Type III cells, we used markers specific for these cell classes. CAR4 labels most Type III cells, and CAR4 immunolabeling of taste buds from Th-CreER; RosaRFP mice that were colabeled with RFP demonstrated that these Th-expressing cells did not express CAR4, and were therefore unlikely to be Type III cells (Fig. 4B). Interestingly, immunolabelling taste buds from Th-CreER; RosaRFP mice with TRPM5 antibodies along with RFP antibodies revealed that these Th+ cells were colabeled with TRPM5, indicating that they are a Type II receptor cell (; Fig. 4B). Therefore, ##Th-expressing taste bud cells## are an uncommon Type II cell that turns over within three weeks.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9581578</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36216506</oboInOwl:hasDbXref>
        <rdfs:label>Th-expressing taste bud cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:4033049"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/4709eb7e-58f4-4fe9-8b37-e2489f5356c2"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4033049"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/47493003-e1ed-4136-9da9-c3549f404466 -->

    <Class rdf:about="http://example.org/47493003-e1ed-4136-9da9-c3549f404466">
        <obo:IAO_0000115>Our data showed that the induction of IL-10 production in macrophages reported in IV and IP MSC treatment is also relevant in SC MSC treatment. When administered directly into the inflamed tissue, SC MSC injection induced ##immunoregulatory macrophages## in the local LN draining the inflamed tissue. Interestingly, an expansion in IL-10-producing macrophages was observed only in the MerTK+ SSM and TZM populations, and not in the F4/80+ macrophage populations (MSM and MCM). This could be due to the F4/80+ macrophages residing deeper within the LN and are therefore less accessible. MerTK is an efferocytic receptor, and MerTK+ TZMs have been reported to have a role in clearing apoptotic cells and maintaining immune homeostasis and tolerance. In addition, studies have demonstrated a role for MerTK signalling in attenuating inflammation. The inhibitory role of MerTK signalling pathway has been previously reported in an LPS-induced lung inflammation model. Whether the selective expansion of IL-10-producing MerTK+ macrophages is associated with activation of MerTK-related immunomodulatory pathway should be investigated further.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11572146</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:39551813</oboInOwl:hasDbXref>
        <rdfs:label>immunoregulatory macrophages</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/47493003-e1ed-4136-9da9-c3549f404466"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/47828c48-44ca-4a6a-be47-366cea811bf8 -->

    <Class rdf:about="http://example.org/47828c48-44ca-4a6a-be47-366cea811bf8">
        <obo:IAO_0000115>Immunological characteristics were estimated by the infiltration of immune cells. The heat map exhibited proportion of immune cells in each endometrium by ssGSEA score (Figure 5A). The violin graph revealed that the infiltration of immature B cells (p = 0.036), ##activated dendritic cells## (DCs) (p &lt; 0.001), regulatory T cells (Tregs) (p = 0.005), gammadelta T cells (p = 0.004) and myeloid-derived suppressor cells (MDSC) (p = 0.019) was markedly lower in RIF patients than controls, while the monocytes (p = 0.034) was higher in RIF patients (Figure 5B). GJA1, an important molecule for cell gap junctions, is positively associated with almost all immune cells. FANCD2 was also positively related to the infiltration of type 2 T helper cells, activated CD4 T cells, activated B cells, and central memory CD4 T cell, while were negatively associated with type 17 T helper cells. Furthermore, MUC1 were negatively correlated with immature dendritic cells, MDSCs, helper T cells, natural killer cells macrophages and activated dendritic cells (Figure 5C).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11472029</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:39400935</oboInOwl:hasDbXref>
        <rdfs:label>activated dendritic cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000451"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/47828c48-44ca-4a6a-be47-366cea811bf8"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000451"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/47893e9c-a9f2-48f2-a11a-a62132796fc0 -->

    <Class rdf:about="http://example.org/47893e9c-a9f2-48f2-a11a-a62132796fc0">
        <obo:IAO_0000115>Identification of cell types from whole-brain cells. a UMAP plot shows the unsupervised clustering of 16,028 cells derived from mouse brain (for details, see &quot;Methods&quot;). The 15 cell types were classified by their transcriptional profiles. b Dot plot shows the expression levels of a representative cell-specific marker gene for each cell type. c UMAP plot shows the distribution of Olig2 expression. d Violin plot shows Olig2 expression across all clusters. e UMAP plot shows the distribution of GFAP expression. f Violin plot shows GFAP expression across all clusters. g A total of 3522 cells of the astrocyte subset were derived from cells in mouse brain. They were classified into Olig2(+)/GFAP(-) astrocytes (347 cells), Olig2(+)/GFAP(+) astrocytes (104 cells), Olig2(-)/GFAP(+) astrocytes (848 cells) and Olig2(-)/GFAP(-) astrocytes (2,223 cells). immNEU immature neuron, mNEU mature neuron, OPC oligodendrocyte precursor cell, ##immOLG## immature oligodendrocyte, OLG oligodendrocyte, ASC astrocyte, OEG olfactory ensheathing glia, MG microglia; MAC macrophage, EC endothelial cell, PC pericyte, EPC ependymal cell, VLMC vascular and leptomeningeal cell, ABC arachnoid barrier cell, CP cycling progenitor</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8573876</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34749773</oboInOwl:hasDbXref>
        <rdfs:label>immOLG</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000128"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/47893e9c-a9f2-48f2-a11a-a62132796fc0"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000128"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/48dd4490-05a2-4478-a050-50148e70298f -->

    <Class rdf:about="http://example.org/48dd4490-05a2-4478-a050-50148e70298f">
        <obo:IAO_0000115>Innate Immune Cells	 	Primary Cell Type	Cell subsets	Metabolic Processes	References	 	   Innate Lymphoid Cells	Non-cytolytic:Innate lymphoid cell 1 (ILC1) Innate lymphoid cell 2 (ILC2) Innate lymphoid cell 3 (ILC3)/Lymphoid Tissue Inducers (LTi)Cytolytic:Natural Killer cells (NK)	 Gly FAO/OXPHOS, LM/LDF, Arginine catabolism, Gly Gly/OXPHOS, Vitamin A metabolismGly, AAM, FAO	     	 	  Dendritic Cells	Conventional:Conventional dendritic cell 1 (cDC1) Conventional dendritic cell 2 (cDC2) Conventional dendritic cell 3 (cDC3) Tolerogenic DCs Plasmacytoid DCs (pDCs) ##Inflammatory DCs## Langerhans cells Mononuclear Phagocytes (tumor)	 Na: OXPHOS, Ac: GU, Gly, PPP, Dys: LDFNa: OXPHOS, Ac: GU, Gly, PPP, Dys: LDF Not reported FAO/OXPHOS Gly/OXPHOS/FAO Gly Na/Ac/Ma: Not reported Dys: LDFNa: OXPHOS, Ac: Gly, PPP In tumors/Dys: LM/LDF	         	 	 Macrophages	Inflammatory &quot;M1&quot; macrophage Reparative &quot;M2&quot; macrophage  Tumor Associated macrophage (TAM)	Na: OXPHOS, Ac: GU, Gly, PPP. Arg catabolismNa: FAO/OXPHOS, Ac: FAO/OXPHOS, Gly, PPP.  Upregulates Arg1 Na: OXPHOS, Ac: GU, Gly, Tumor/Dys: FAO, LM/LDF	   	 	</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11240245</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:39007133</oboInOwl:hasDbXref>
        <rdfs:label>Inflammatory DCs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000451"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/48dd4490-05a2-4478-a050-50148e70298f"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000451"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/48ebec09-d0cc-4fdf-bb7e-d78774d2cde5 -->

    <Class rdf:about="http://example.org/48ebec09-d0cc-4fdf-bb7e-d78774d2cde5">
        <obo:IAO_0000115>Systemic lupus erythematosus (SLE) is a heterogeneous autoimmune disease. Knowledge of circulating immune cell types and states associated with SLE remains incomplete. We profiled more than 1.2 million peripheral blood mononuclear cells (162 cases, 99 controls) with multiplexed single-cell RNA sequencing (mux-seq). Cases exhibited elevated expression of type 1 interferon-stimulated genes (ISGs) in monocytes, reduction of naive CD4+ T cells that correlated with monocyte ISG expression, and expansion of repertoire-restricted ##cytotoxic GZMH+ CD8+ T cells##. Cell type-specific expression features predicted case-control status and stratified patients into two molecular subtypes. We integrated dense genotyping data to map cell type-specific cis-expression quantitative trait loci and to link SLE-associated variants to cell type-specific expression. These results demonstrate mux-seq as a systematic approach to characterize cellular composition, identify transcriptional signatures, and annotate genetic variants associated with SLE.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9297655</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35389781</oboInOwl:hasDbXref>
        <rdfs:label>cytotoxic GZMH+ CD8+ T cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000794"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/48ebec09-d0cc-4fdf-bb7e-d78774d2cde5"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000794"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/48ecbe99-6441-48e3-95ee-83cf5d82d407 -->

    <Class rdf:about="http://example.org/48ecbe99-6441-48e3-95ee-83cf5d82d407">
        <obo:IAO_0000115>Lymphocytes such as CD4+ T cells and B cells mainly infiltrate the salivary glands; however, the precise roles and targets of autoreactive T cells and autoantibodies in the pathogenesis of Sjogren&apos;s Syndrome (SS) remain unclear. This study was designed to clarify the role of autoreactive T cells and autoantibodies at the single-cell level involved in the development of sialadenitis. Infiltrated CD4+ T and B cells in the salivary glands of a mouse model resembling SS were single-cell-sorted, and their T cell receptor (TCR) and B cell receptor (BCR) sequences were analyzed. The predominant TCR and BCR clonotypes were reconstituted in vitro, and their pathogenicity was evaluated by transferring reconstituted TCR-expressing CD4+ T cells into Rag2-/- mice and administering recombinant IgG in vivo. The reconstitution of ##Th17 cells## expressing TCR (#G) in Rag2-/- mice resulted in the infiltration of T cells into the salivary glands and development of sialadenitis, while an autoantibody (IgGr22) was observed to promote the proliferation of pathogenic T cells. IgGr22 specifically recognizes double-stranded RNA (dsRNA) and induces the activation of dendritic cells, thereby enhancing the expression of IFN signature and inflammatory genes. TCR#G recognizes antigens related to the gut microbiota. Antibiotic treatment severely reduces the activation of TCR#G-expressing Th17 cells and suppresses sialadenitis development. These data suggest that the anti-dsRNA antibodies and, TCR recognizing the gut microbiota involved in the development of sialadenitis like SS. Thus, our model provides a novel strategy for defining the roles of autoreactive TCR and autoantibodies in the development and pathogenesis of SS.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMID:38762063</oboInOwl:hasDbXref>
        <rdfs:label>Th17 cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000899"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/48ecbe99-6441-48e3-95ee-83cf5d82d407"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000899"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/48f81658-fa30-4a82-91bc-12735765be51 -->

    <Class rdf:about="http://example.org/48f81658-fa30-4a82-91bc-12735765be51">
        <obo:IAO_0000115>Luminal progenitors serve primarily as tumor initiators or cells of origin for prostate cancer. Various hierarchical models have been proposed. A recent model suggests that, during early postnatal development, multipotent basal cells (p63+ CK5+) differentiate into unipotent basal progenitors, luminal progenitors (CK8+ AR low), and NE cells. These ##unipotent basal and luminal progenitors## can undergo self-renewal or differentiate into basal cells and mature luminal cells (AR+ CK8+), respectively. In adults, during homeostasis and regeneration, the bipotent basal progenitor forms unipotent basal and luminal progenitors, which further undergo self-renewal. Unipotent basal progenitors differentiate into basal cells, and luminal cell progenitors differentiate into luminal cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10291985</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37282627</oboInOwl:hasDbXref>
        <rdfs:label>unipotent basal and luminal progenitors</rdfs:label>
    </Class>
    


    <!-- http://example.org/480e2fe4-964b-4fed-882b-5753a689b471 -->

    <Class rdf:about="http://example.org/480e2fe4-964b-4fed-882b-5753a689b471">
        <obo:IAO_0000115>In order for the sensitization we observed in excitatory interneurons to drive the psychophysical phenomenon of allodynia, spinal projection neurons must relay these nociceptive signals supraspinally. We found that capsaicin treatment shifted the overall tuning of ##SPB neurons## towards LT input, consistent with the effects of central sensitization producing allodynia (Fig. 8a, b). Because SPB neurons are heterogeneous with respect to their response properties, we classified them as either wide-dynamic range (WDR), high threshold (HT), or low threshold (LT) (Fig. 8c) using previously published criteria. We found that both HT and WDR SPB showed significant increases in tuning to LT input, however the degree of change was much greater for WDR compared to HT SPB neurons (Fig. 8d). Finally, examining CICADA responses across populations, we found that WDR cells were more frequently responsive to CICADA agonists (71.4%), compared to either LT (40%) or HT (0%) SPB neurons. In particular, all SP-responsive SPB neurons were WDR cells (Fig. 8e). Since capsaicin is known to activate peptidergic afferents that release SP, these findings suggest that capsaicin-induced allodynia may be conveyed to the brain through a population of TACR1 expressing WDR SPB neurons and, to a lesser extent, some HT SPB neurons (Fig. 8f).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9440908</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36057681</oboInOwl:hasDbXref>
        <rdfs:label>SPB neurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000540"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/480e2fe4-964b-4fed-882b-5753a689b471"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000540"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/4815f9a4-af37-4057-84c1-2b2fd122cf7a -->

    <Class rdf:about="http://example.org/4815f9a4-af37-4057-84c1-2b2fd122cf7a">
        <obo:IAO_0000115>Such aging-associated inflammation, so-called inflammaging, is reported to be detrimental to several types of tissue-resident stem cells including hair follicle stem cells, hematopoietic stem cells and neural stem cells. In the present study, RNA-seq and qPCR analysis showed that inflammation markedly contributes to the age-associated transcriptional changes in ##liver ECs## including VESCs (Fig. 5a-d). We also confirmed the enrichment of inflammatory cells in the aged liver (Figs. 5e, f and S6). These findings indicate that the activation of inflammatory signals is a primary signature of aged VESCs. However, data illustrating how inflammation affects VESCs mechanistically is lacking in the present study. This limitation arises because aged mice do not survive well after monoclotalin treatment and irradiation; hence, we were unable to obtain sufficient mice to analyze. Although previous studies showed that age-associated inflammation dysregulates stemness of several types of stem cells, at this time, it remains speculative as to whether inflammation is actually the cause of the proliferative deficit of VESCs. Further investigations are needed to elucidate causal relationships.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10542733</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37563497</oboInOwl:hasDbXref>
        <rdfs:label>liver ECs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000115"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/4815f9a4-af37-4057-84c1-2b2fd122cf7a"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000115"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/482e42f8-cf19-4bb0-ae6c-4938769e641e -->

    <Class rdf:about="http://example.org/482e42f8-cf19-4bb0-ae6c-4938769e641e">
        <obo:IAO_0000115>In order for the sensitization we observed in excitatory interneurons to drive the psychophysical phenomenon of allodynia, spinal projection neurons must relay these nociceptive signals supraspinally. We found that capsaicin treatment shifted the overall tuning of SPB neurons towards LT input, consistent with the effects of central sensitization producing allodynia (Fig. 8a, b). Because SPB neurons are heterogeneous with respect to their response properties, we classified them as either wide-dynamic range (WDR), ##high threshold (HT)##, or low threshold (LT) (Fig. 8c) using previously published criteria. We found that both HT and WDR SPB showed significant increases in tuning to LT input, however the degree of change was much greater for WDR compared to HT SPB neurons (Fig. 8d). Finally, examining CICADA responses across populations, we found that WDR cells were more frequently responsive to CICADA agonists (71.4%), compared to either LT (40%) or HT (0%) SPB neurons. In particular, all SP-responsive SPB neurons were WDR cells (Fig. 8e). Since capsaicin is known to activate peptidergic afferents that release SP, these findings suggest that capsaicin-induced allodynia may be conveyed to the brain through a population of TACR1 expressing WDR SPB neurons and, to a lesser extent, some HT SPB neurons (Fig. 8f).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9440908</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36057681</oboInOwl:hasDbXref>
        <rdfs:label>high threshold (HT)</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000540"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/482e42f8-cf19-4bb0-ae6c-4938769e641e"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000540"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/483d7987-2d53-4a6e-a0ab-fe4ffbaf8a00 -->

    <Class rdf:about="http://example.org/483d7987-2d53-4a6e-a0ab-fe4ffbaf8a00">
        <obo:IAO_0000115>The Table shows the numerical representations of Excitatory Neurons (Deep and Superficial Pyramidal cells) and Inhibitory neurons (Oriens Lacunosum moleculare cells:OLM; Trilaminar cells:##Tri##, Backprojection cells:BP, cholecystokinin positive Basket cells:CCKBC, Parvalbumin positive cells:PVBC, AxoAxonic Cells:AA, Ivy Cells:IVY, Bistratified cells:BS, Schaffer Collateral associated cells:SCA, Perforant Pathway Associated cell:PPA, Neurogliaform:NG) subdivided on the basis of the placement classes (SO, SP, SR, SLM).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9381785</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35974119</oboInOwl:hasDbXref>
        <rdfs:label>Tri</rdfs:label>
    </Class>
    


    <!-- http://example.org/4848d247-54db-4194-a44e-48007f8ec4dc -->

    <Class rdf:about="http://example.org/4848d247-54db-4194-a44e-48007f8ec4dc">
        <obo:IAO_0000115>Organoids generation from different types of stem cells. Organoids can be generated from induced pluripotent stem cells (iPSCs), embryonic stem cells (ESCs) and patient-derived ##adult stem cells## from normal and cancerous tissues (ASCs). Cells are usually grown in three dimensional systems under specific conditions to stimulate the growth of organoids. Shapes and images are imported from Servier Medical Art by Servier , accessed on 24 May 2021. Licensed under a Creative Commons Attribution 3.0 Unported License .</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8303386</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34299287</oboInOwl:hasDbXref>
        <rdfs:label>adult stem cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000034"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/4848d247-54db-4194-a44e-48007f8ec4dc"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000034"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/49e9f18b-fa48-4325-9bc3-2558a14515aa -->

    <Class rdf:about="http://example.org/49e9f18b-fa48-4325-9bc3-2558a14515aa">
        <obo:IAO_0000115>Transcriptomic data were used for correlation analysis between human in vivo fetal yolk sac (YS) hematopoietic clusters (YS_EC, endothelial cells; YS_Mac, ##macrophages##; and YS_YSMP1,2, myeloid-biased progenitors) and PD-L1 WT hematopoietic cell populations (PD-L1_EC, endothelial cells; MC/Mphis, monocyte/macrophages; CMPs, common myeloid progenitors; and granulocytes).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10638094</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37949473</oboInOwl:hasDbXref>
        <rdfs:label>macrophages</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
        <skos:relatedMatch rdf:resource="CL:0000428"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/49e9f18b-fa48-4325-9bc3-2558a14515aa"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/49e9f18b-fa48-4325-9bc3-2558a14515aa"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000428"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/497d2462-c179-4b07-8ef0-04cc9102b0b6 -->

    <Class rdf:about="http://example.org/497d2462-c179-4b07-8ef0-04cc9102b0b6">
        <obo:IAO_0000115>(F) Relative abundance of each cluster in MMPs of vehicle-versus teriparatide-treated mice. OB, osteoblast; preOB, preosteoblast; ##COP##, chondrocyte-like osteoprogenitor; MALP, marrow adipocyte lineage progenitor.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8432334</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34407400</oboInOwl:hasDbXref>
        <rdfs:label>COP</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000138"/>
        <skos:relatedMatch rdf:resource="CL:0007010"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/497d2462-c179-4b07-8ef0-04cc9102b0b6"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000138"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/497d2462-c179-4b07-8ef0-04cc9102b0b6"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0007010"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/4983ade8-af8b-47bf-8cd5-94c8788ec374 -->

    <Class rdf:about="http://example.org/4983ade8-af8b-47bf-8cd5-94c8788ec374">
        <obo:IAO_0000115>KSHV lymphoproliferative disorders occur primarily in the context of immunosuppression, and other studies have shown interactions between T cells and KSHV infected B cells in ##tonsil lymphocyte## cultures affecting the frequency of lytic reactivation. Therefore, we wanted to determine whether the immunological composition of the tonsil lymphocyte environment would affect the establishment of KSHV infection in B lymphocytes and specifically whether overall susceptibility or targeting of particular B cell lineages is influenced by the presence or absence of T cells. Like B cell lineages, levels of CD4+ and CD8+ T cell lineages vary considerably between tonsil donors (Fig 1D). However, unlike B lymphocyte subsets, the distribution of T cell subsets are not generally correlated with donor age (Fig 1E). Examination of whether the ratio of CD4/CD8 T cells in individual tonsil specimens was correlated with the susceptibility of B lymphocytes to KSHV infection revealed no significant correlation (Fig 5A). Next, we examined correlations between B cell infections and baseline levels of various CD4 and CD8+ T cell subsets to determine whether any T cell lineages affected the tropism of KSHV for particular B cell lineages (Fig 5B). Interestingly, levels of naive and stem cell memory CD4+ T cells was positively correlated with infection of plasma cells (Fig 5B and Fig 5C, left panels) with a greater effect on CD20+ plasma cells than CD20- plasma cells, while overall levels of CD45RO+ activated memory T cells were negatively correlated with KSHV infection of plasma cells (Fig 5C, right panel). In addition, although the correlations were too weak to be significant in this data set, nearly every B cell lineage and overall KSHV infection was negatively correlated with the presence of CD4+ T cells expressing a TEMRA phenotype (Fig 5B). Baseline levels of CD8+ T cells had less effect on KSHV infection with only one significant positive correlation observed in our dataset between CD8+ terminal effector cells and KSHV infection of naive B cells (Fig 5B).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7595638</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33075105</oboInOwl:hasDbXref>
        <rdfs:label>tonsil lymphocyte</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000542"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/4983ade8-af8b-47bf-8cd5-94c8788ec374"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000542"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/498456e6-7a4b-438a-94a0-76a42ea7a438 -->

    <Class rdf:about="http://example.org/498456e6-7a4b-438a-94a0-76a42ea7a438">
        <obo:IAO_0000115>A, B, tSNE plot of 4659 CD45+ immune cells from the CNS. Data from this study is integrated with data from; Table 6). C, D, Each dataset represented by one tSNE. Cells are annotated using color representing their cell type. bMicroglia: baseline microglia; aMicroglia: activated microglia; pmMicroglia: proliferation-mediating microglia; maMicroglia: monocyte-activating microglia; DAM: disease-associated microglia in SCI; elMicroglia: embryonic-like microglia; pvMacrophages: perivascular macrophages; mdMacrophages: monocyte-derived macrophages; DCs: dendritic cells; imB-cells: immature B-cells; mB-cells: mature B-cells; pimMicroglia: postnatal immature microglia; ##IEG+Microglia##: immediate early genes microglia; sMicroglia: s-phase microglia; pPAM: postnatal proliferative-region-associated microglia; eMicroglia: embryonic microglia; pcpMacrophages: postnatal choroid plexus macrophages; acpMacrophages: adult choroid plexus macrophages; iMonocytes: inflammatory monocytes; pMonocytes: patrolling monocytes; cpEpithelial cells: choroid plexus epithelial cells. E, tSNE plots of 4659 CD45+ immune cells for selected genes indicating the log2(cpm) expression with a continuous color for each cell separately. F, Proliferation rate of CD45low and CD45high cells at 7 and 21 d post-SCI. Hoechst 33342 expression presented on a log-scale was used for defining cells in S-phase. Right most plot reports the percentage of cells in S-phase. Each dot represents one biological replicate (four mice per time point). Mean is surrounded by a 95% CI. This figure is extended in Extended Data Figure 8-1.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8496189</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34417326</oboInOwl:hasDbXref>
        <rdfs:label>IEG+Microglia</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000129"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/498456e6-7a4b-438a-94a0-76a42ea7a438"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000129"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/5a37d38c-95d1-4dfb-8abc-3e8b15734805 -->

    <Class rdf:about="http://example.org/5a37d38c-95d1-4dfb-8abc-3e8b15734805">
        <obo:IAO_0000115>RECs are devoid of intrinsic stemness capacity but have in situ proximity to putative ##CD34+ LSCs##</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11031376</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38582086</oboInOwl:hasDbXref>
        <rdfs:label>CD34+ LSCs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000034"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/5a37d38c-95d1-4dfb-8abc-3e8b15734805"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000034"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/5a7756d7-14ba-4462-becb-c95a5802b18b -->

    <Class rdf:about="http://example.org/5a7756d7-14ba-4462-becb-c95a5802b18b">
        <obo:IAO_0000115>We undertook a comprehensive Mendelian randomization study aimed at uncovering the causal relationship between 744 immune cell types and IVDD [ Supplementary Table 2 ]. In our analysis, we identified 24 specific blood types of immune cells that demonstrated a causal association with disc degeneration through univariable MR [ Supplementary Table 3 ], including Memory B cell %B cell, Naive-mature B cell %B cell, IgD-CD38dim B cell %lymphocyte, CD39+activated CD4 regulatory T cell %CD4 regulatory T cell, CD39+ secreting CD4 regulatory T cell %CD4 regulatory T cell, ##CD45RA+ CD8+ T cell## %CD8+ T cell, CD8+ T cell %leukocyte, CD39+CD4+ T cell %T cell, CD39+ CD4+ T cell %CD4+ T cell,CD39+ CD8+ T cell %T cell, CD39+ CD8+ T cell Absolute Count, CD127- CD8+ T cell Absolute Count, CD28- CD8+ T cell Absolute Count, CD19 on IgD+ CD38+ B cell, CD19 on IgD+ CD38dim B cell, CD19 on IgD- CD38- B cell, CD19 on unswitched memory B cell, CD19 on transitional B cell, CD24 on IgD+ CD38+ B cell,CD28 on CD39+ secreting CD4 regulatory T cell, CD25 on CD39+ CD4+ T cell, CD4 on CD39+ CD4+ T cell, CD4 on CD39+ resting CD4 regulatory T cell and Neutrophil count. We excluded certain exposures due to a limited number of available SNPs to prevent potential bias, including Memory B cell %B cell, Naive-mature B cell %B cell, IgD-CD38dim B cell %lymphocyte, CD8+T cell %leukocyte, CD127-CD8+ T cell Absolute Count, CD19 on IgD-CD38-B cell, CD24 on IgD+ CD38+ B cell, CD28 on CD39+ secreting CD4 regulatory T cell and CD4 on CD39+ resting CD4 regulatory T cell.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10806224</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38268919</oboInOwl:hasDbXref>
        <rdfs:label>CD45RA+ CD8+ T cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000625"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/5a7756d7-14ba-4462-becb-c95a5802b18b"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000625"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/5a92514c-3583-47fe-9b2f-ac8121f9ce06 -->

    <Class rdf:about="http://example.org/5a92514c-3583-47fe-9b2f-ac8121f9ce06">
        <obo:IAO_0000115>mFbs resemble fibroblastic reticular cells (FRCs) that form conduit-like network in secondary lymphoid organs, and they have also been known as ##thymic FRCs##. Transcriptome analyses on mFbs and LN FRCs revealed possible functional differences between these two morphologically similar cell types. LN FRCs are subdivided into several types based on their expression of functional genes, including chemokines and cytokines: T-cell zone reticular cell (TRC) expressing Ccl19, Ccl21a, and Il7; follicular dendritic cell (FDC) expressing Cxcl13; marginal reticular cell (MRC) expressing Tnfsf11 (RANKL); Cxcl12-expressing reticular cell (CRC); and medullary reticular cell (medRC) expressing Cxcl12, Il6, Tnfsf13, and Tnfsf13b. Most of these FRC-associated genes are not or just barely expressed in mFbs. In the thymus, RANKL is predominantly expressed in SP thymocytes to induce mTEC development, and Ccl19, Ccl21, Cxcl12, and IL-7 are produced by TECs so as to control the relocation and survival of thymocytes. It is likely that the role played by FRCs in the LN is replaced by TECs in the thymus. mFbs highly express other sets of chemokines as well, such as Cx3cl1 and Cxcl14, that are barely expressed in LN FRCs or capFbs, possibly contributing to the regulation of cell migration in the thymic medulla. Thus, mFbs comprise a thymus-specific subset of fibroblasts that is functionally distinct from LN FRCs. It is possible that mFbs also consist of multiple subsets with different functions. A population of CD34+podoplanin+ mFbs are detected in adventitial layers that surround pericytes and endothelial cells, thus referred to as adventitial cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7840694</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33519827</oboInOwl:hasDbXref>
        <rdfs:label>thymic FRCs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0009101"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/5a92514c-3583-47fe-9b2f-ac8121f9ce06"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0009101"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/5a9cf260-0ddc-4ccc-953e-fedb0ef58225 -->

    <Class rdf:about="http://example.org/5a9cf260-0ddc-4ccc-953e-fedb0ef58225">
        <obo:IAO_0000115>A Gating strategy for the Lin-Sca-1 + c-Kit + (LSK) compartment and multipotent progenitors (MPPs), including long-term HSCs (HSCLT), short-term HSCs (HSCST), MPP2, ##MPP3##, and MPP4. PV IgG1, n = 15; PV anti-CD47, n = 15. B LSK fraction determined in the bone marrow (BM) and spleen (SPL). C Composition of the LSK compartment and MPPs in PV mice treated with IgG1 or anti-CD47 determined by flow cytometry at terminal analysis in the BM (top) and SPL (bottom). D Gating strategy for erythroid differentiation. Proerythroblasts (I; FSChi CD44hi), basophilic erythroblasts (II; FSCint CD44hi), polychromatic erythroblasts (III; FSCint CD44int), orthochromatic erythroblasts (IV; FSClo CD44int), and erythroblasts (V; FSClo CD44-). WT IgG1, n = 4; WT anti-CD47, n = 4; PV IgG1, n = 15; PV anti-CD47, n = 15. E Percentages of erythroid progenitors in the BM (left) and SPL (right) (% of FSC CD44 out of CD11b-CD45.2-Ter119+) determined by flow cytometry at terminal analysis. Results are represented as mean +- standard deviation. ns not significant, *p &lt; 0.05 (Kruskal-Wallis test with Dunn&apos;s multiple comparisons for B (BM LSK fraction); two-way ANOVA with Tukey&apos;s multiple comparisons test for B (SPL LSK fraction); unpaired student&apos;s t-test or Mann-Whitney test for C).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10244168</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37095207</oboInOwl:hasDbXref>
        <rdfs:label>MPP3</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000837"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/5a9cf260-0ddc-4ccc-953e-fedb0ef58225"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000837"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/5aa16f99-a749-42c8-b54f-d6a1ec8cd425 -->

    <Class rdf:about="http://example.org/5aa16f99-a749-42c8-b54f-d6a1ec8cd425">
        <obo:IAO_0000115>Transcriptomic data were used for correlation analysis between human in vivo fetal yolk sac (YS) hematopoietic clusters (YS_EC, ##endothelial cells##; YS_Mac, macrophages; and YS_YSMP1,2, myeloid-biased progenitors) and PD-L1 WT hematopoietic cell populations (PD-L1_EC, endothelial cells; MC/Mphis, monocyte/macrophages; CMPs, common myeloid progenitors; and granulocytes).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10638094</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37949473</oboInOwl:hasDbXref>
        <rdfs:label>endothelial cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000115"/>
        <skos:relatedMatch rdf:resource="CL:0000428"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/5aa16f99-a749-42c8-b54f-d6a1ec8cd425"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000115"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/5aa16f99-a749-42c8-b54f-d6a1ec8cd425"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000428"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/5ab3134b-de62-429c-9fff-07298ab790d3 -->

    <Class rdf:about="http://example.org/5ab3134b-de62-429c-9fff-07298ab790d3">
        <obo:IAO_0000115>Human ##piriform and mediotemporal neurons## encode odours, and signal how we perceive, rate and identify scents.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11485236</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:39385026</oboInOwl:hasDbXref>
        <rdfs:label>piriform and mediotemporal neurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000540"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/5ab3134b-de62-429c-9fff-07298ab790d3"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000540"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/5ad58bc2-d1c4-47d7-9dd1-5264f658a1a9 -->

    <Class rdf:about="http://example.org/5ad58bc2-d1c4-47d7-9dd1-5264f658a1a9">
        <obo:IAO_0000115>We compared the functional differences between similar types of epithelial cells in the TZ and the PZ. GSVA revealed that angiogenesis- and inflammation-related pathways were activated in all epithelial cells in the TZ (Figure 4A). Oestrogen, mTOR and stem/progenitor cell biology-regulated NOTCH signalling were more activated in ##TZ club and hillock cells## than in the PZ (Figure 4A). Both oestrogen and mTOR pathways can serve as therapeutic targets for BPH. The E2F targets, the MYC targets and the DNA repair pathway were enriched in PZ luminal cells (Figure 4A).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9574492</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36245324</oboInOwl:hasDbXref>
        <rdfs:label>TZ club and hillock cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0017011"/>
        <skos:relatedMatch rdf:resource="CL:4032000"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/5ad58bc2-d1c4-47d7-9dd1-5264f658a1a9"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0017011"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/5ad58bc2-d1c4-47d7-9dd1-5264f658a1a9"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4032000"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/5afa33e7-62d7-4129-9a7a-0cc8fe43fc3f -->

    <Class rdf:about="http://example.org/5afa33e7-62d7-4129-9a7a-0cc8fe43fc3f">
        <obo:IAO_0000115>Because CD14CTX express chemokine receptors that might facilitate migration into the tissues, we next examined the relationship between circulating and intra-tumoral myeloid states in BTC. We performed scRNA-seq on primary cholangiocarcinoma tumors (n = 4) obtained from standard of care resections (Table S7) and recovered a total of 10,913 myeloid cells. Tissue-associated myeloid cells consisted of dendritic cells (DC), neutrophils (Neut), two populations of macrophages characterized by either high APOE or SPP1 expression (MacAPOE, ##MacSPP1##), CD14+ monocytes (CD14+ mono), CD16+ monocytes (CD16+ mono), and intermediate CD14+CD16+ monocytes (CD14+CD16+ mono) (Figures S4A and S4B). Among the tissue-associated myeloid populations, the expression profile of CD14CTX was most correlated with MacSPP1, exemplified by the shared expression of differentially expressed CD14CTX genes including HAVCR2 and ITGB1 (Figures S4C and S4D). Notably, two genes that differ in expression between MacSPP1 and CD14CTX are related to chemotaxis and extravasation (SERPINB2, TIMP1), suggesting a transition in macrophages that have already migrated to the tumor microenvironment. As an alternate approach to assess the relationship between the circulating and tissue-associated myeloid populations, we co-clustered myeloid cells from circulation with those from the tumors, following batch correction. We found that the intra-tumoral MacSPP1 cluster with the circulating CD14CTX (Figure S4E). An alternative approach using partition-based graph abstraction also found close connectivity between CD14CTX and SPP1+ TAM clusters (Figure S4E). We also found evidence of SPP1+HAVCR2+CD68+ myeloid cells within biliary tumor tissue from on-treatment biopsies by combined in situ hybridization and immunofluorescence, further suggesting the existence of a TAM population in BTC analogous to CD14CTX (Figure S4F).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10060099</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36130508</oboInOwl:hasDbXref>
        <rdfs:label>MacSPP1</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/5afa33e7-62d7-4129-9a7a-0cc8fe43fc3f"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/5b279a2e-6ddf-425a-9c41-6d68516b9f4b -->

    <Class rdf:about="http://example.org/5b279a2e-6ddf-425a-9c41-6d68516b9f4b">
        <obo:IAO_0000115>Expression heterogeneity of CD8+ and CD4+ T cells in the OSCC ecosystem. (A) The t-distributed stochastic neighbor embedding (t-SNE) projection of T cells from cancerous tissue of patients with OSCC, showing the formation of 11 main clusters in different colors. The functional description of each cluster is determined by the gene expression characteristics. Cluster 0: resident memory CD8+ T Cells (C0_CD8+ TRM); Cluster 1: effector memory CD8+ T cells (C1_CD8+ TEM); Cluster 2: regulatory CD4+ T cells (C2_CD4+ Treg); Cluster 3: exhausted CD8+ T cells (C3_CD8+ T Exhausted); Cluster 4: effector memory M-phage CD8+ T cells (C4_##CD8+ Mitotic TEM##); Cluster 5: effector memory CD4+ T cells (C5_CD4+ TEM); Cluster 6: effector memory CD8+ T cells (C6_CD8+ TEM); Cluster 7: effector memory CD4+ T cells (C7_CD4+ TEM); Cluster 8: effector memory CD8+ T cells (C8_CD8+ TEM); Cluster 9: effector memory CD8+ T cells (C9_CD8+ TEM); Cluster 10: effector memory M-phage CD4+ T cells (C10_CD4+ Mitotic TEM); Cluster 11: effector memory CD8+ T cells (C11_CD8+ TEM); Cluster 12: effector memory CD8+ T cells (C12_CD8+ TEM); Cluster 13: gammadelta T. (B) Cell-Cycle Scoring of T cells from cancerous tissue of patients with OSCC, showing the three clusters of cells in different cell cycles in different colors. (C) Heatmap of key genes expressed in each cluster of CD8+ tumor-infiltrating lymphocytes (TILs) with cells grouped by clusters. The columns correspond to the cells; the rows correspond to the genes. Yellow: high expression; purple: low expression. Selected key markers are shown on the right. (D) Heatmap of key genes expressed in each cluster of CD4+ TILs with cells grouped by clusters. The columns correspond to the cells; the rows correspond to the genes. Yellow: high expression; purple: low expression. Selected key genes are shown on the right.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8024729</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33513276</oboInOwl:hasDbXref>
        <rdfs:label>CD8+ Mitotic TEM</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000913"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/5b279a2e-6ddf-425a-9c41-6d68516b9f4b"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000913"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/5b698e23-6bb9-4582-9472-f04ed061efd1 -->

    <Class rdf:about="http://example.org/5b698e23-6bb9-4582-9472-f04ed061efd1">
        <obo:IAO_0000115>Neutrophil CD64 expression has been used as a diagnostic marker of infection and sepsis in the ICU and was found to be superior to C-reactive protein and hematological determinations for detecting systemic infection or sepsis. However, these studies did not distinguish between the differential marker expression due to mature neutrophil activation or due to appearance of another neutrophil population. Because we observed no CD64 expression on mature neutrophils, either from NDN or LDN fractions in GCA (Figure 1), we hypothesize that detection of CD64 expression on neutrophils in sepsis is likely to represent the presence of CD10loCD64+ myelocytes/metamyelocytes in the neutrophil pool. Coincidentally, in a recently deposited open-access manuscript, Meghraoui-Kheddar et al. used a similar single-cell CyToF strategy to identify 2 CD64+ neutrophil subsets unequivocally associated with an onset of sepsis. CD123 and PD-L1 were reported to be the additional and distinctive cellular markers for sepsis-induced ##CD64+ immature neutrophils## compared with noninfectious inflammatory syndrome. Indeed, we observed no CD123 and very weak PD-L1 expression on CD64+ immature neutrophils of GCA patients (Figure 1), supporting a possible new demarcation between CD10loCD64+ released in response to infection and sterile inflammation.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7605529</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32960815</oboInOwl:hasDbXref>
        <rdfs:label>CD64+ immature neutrophils</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000776"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/5b698e23-6bb9-4582-9472-f04ed061efd1"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000776"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/5b86dbbb-e665-44ce-9f30-4f9acf823dac -->

    <Class rdf:about="http://example.org/5b86dbbb-e665-44ce-9f30-4f9acf823dac">
        <obo:IAO_0000115>Limited to the olfactory cleft, the olfactory epithelium (OE) is a true neuroepithelium containing bipolar chemosensory neurons, while the remainder of the nasal cavity is lined by respiratory epithelium consisting of ciliated cells, secretory cells, and basal cells. The OE contains neurogenic populations known as globose basal cells (GBCs) and horizontal basal cells (HBCs). In rodent models, during normal olfactory sensory neuron turnover, the GBCs divide and differentiate to produce new neurons, while the HBCs are relatively quiescent. However, when faced with injuries that disrupt the sustentacular cell layer of the OE, the reserve ##HBC stem cells## are activated and serve as the main source of olfactory sensory neurogenesis. Human OE is exposed continuously to potential damage in the form of viral or other infections, inflammation driven by allergens and other inspired irritants, or trauma. Thus, the proper function of the neurogenic cycle is critical for homeostasis within the OE and, in turn, a functioning sense of smell.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8843745</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34990409</oboInOwl:hasDbXref>
        <rdfs:label>HBC stem cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000034"/>
        <skos:relatedMatch rdf:resource="CL:0002184"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/5b86dbbb-e665-44ce-9f30-4f9acf823dac"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000034"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/5b86dbbb-e665-44ce-9f30-4f9acf823dac"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002184"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/5b882216-0e76-43f4-994c-afa8d27bcb46 -->

    <Class rdf:about="http://example.org/5b882216-0e76-43f4-994c-afa8d27bcb46">
        <obo:IAO_0000115>Innate Immune Cells	 	Primary Cell Type	Cell subsets	Metabolic Processes	References	 	   Innate Lymphoid Cells	Non-cytolytic:Innate lymphoid cell 1 (ILC1) Innate lymphoid cell 2 (ILC2) Innate lymphoid cell 3 (ILC3)/Lymphoid Tissue Inducers (LTi)Cytolytic:Natural Killer cells (NK)	 Gly FAO/OXPHOS, LM/LDF, Arginine catabolism, Gly Gly/OXPHOS, Vitamin A metabolismGly, AAM, FAO	     	 	  Dendritic Cells	Conventional:Conventional dendritic cell 1 (cDC1) Conventional dendritic cell 2 (cDC2) Conventional dendritic cell 3 (cDC3) Tolerogenic DCs Plasmacytoid DCs (pDCs) Inflammatory DCs Langerhans cells Mononuclear Phagocytes (tumor)	 Na: OXPHOS, Ac: GU, Gly, PPP, Dys: LDFNa: OXPHOS, Ac: GU, Gly, PPP, Dys: LDF Not reported FAO/OXPHOS Gly/OXPHOS/FAO Gly Na/Ac/Ma: Not reported Dys: LDFNa: OXPHOS, Ac: Gly, PPP In tumors/Dys: LM/LDF	         	 	 Macrophages	Inflammatory &quot;M1&quot; macrophage Reparative &quot;M2&quot; macrophage  Tumor Associated macrophage (##TAM##)	Na: OXPHOS, Ac: GU, Gly, PPP. Arg catabolismNa: FAO/OXPHOS, Ac: FAO/OXPHOS, Gly, PPP.  Upregulates Arg1 Na: OXPHOS, Ac: GU, Gly, Tumor/Dys: FAO, LM/LDF	   	 	</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11240245</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:39007133</oboInOwl:hasDbXref>
        <rdfs:label>TAM</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/5b882216-0e76-43f4-994c-afa8d27bcb46"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/5b95772b-f5e5-4134-8973-07b6da78ab5c -->

    <Class rdf:about="http://example.org/5b95772b-f5e5-4134-8973-07b6da78ab5c">
        <obo:IAO_0000115>Pancreatic ductal adenocarcinoma (PDAC) has a poor clinical outlook. Responses to immune checkpoint blockade are suboptimal and a much more detailed understanding of the tumor immune microenvironment is needed if this situation is to be improved. Here, we characterized ##tumor-infiltrating T-cell## populations in patients with PDAC using cytometry by time of flight (CyTOF) and single-cell RNA sequencing. T cells were the predominant immune cell subset observed within tumors. Over 30% of CD4+ T cells expressed a CCR6+CD161+ Th17 phenotype and 17% displayed an activated regulatory T-cell profile. Large populations of CD8+ tissue-resident memory (TRM) T cells were also present and expressed high levels of programmed cell death protein 1 (PD-1) and TIGIT. A population of putative tumor-reactive CD103+CD39+ T cells was also observed within the CD8+ tumor-infiltrating lymphocytes population. The expression of PD-1 ligands was limited largely to hemopoietic cells whilst TIGIT ligands were expressed widely within the tumor microenvironment. Programmed death-ligand 1 and CD155 were expressed within the T-cell area of ectopic lymphoid structures and colocalized with PD-1+TIGIT+ CD8+ T cells. Combinatorial anti-PD-1 and TIGIT blockade enhanced IFNgamma secretion and proliferation of T cells in the presence of PD-1 and TIGIT ligands. As such, we showed that the PDAC microenvironment is characterized by the presence of substantial populations of TRM cells with an exhausted PD-1+TIGIT+ phenotype where dual checkpoint receptor blockade represents a promising avenue for future immunotherapy.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10068448</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36689623</oboInOwl:hasDbXref>
        <rdfs:label>tumor-infiltrating T-cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000084"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/5b95772b-f5e5-4134-8973-07b6da78ab5c"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000084"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/5ba0f813-beee-4ff7-8ce9-3e07c8f2bd19 -->

    <Class rdf:about="http://example.org/5ba0f813-beee-4ff7-8ce9-3e07c8f2bd19">
        <obo:IAO_0000115>Ultimately, to show that human MME+ FAPs are also more highly adipogenic than their MME- counterpart, we isolated MME+ and MME- FAPs from human muscle. FAPs were isolated as (MME+ or MME-)CD34+CD31-CD45-CD56-PI- via FACS (Supplementary Fig. 8e) and brought in culture as described before. When reaching 95% confluence, the medium was changed to an adipogenic differentiation medium. In agreement with our mouse data, human MME+ FAPs differentiated much more readily into adipocytes than the ##MME- FAPs## (Fig. 7g, h). Interestingly, the differences in adipogenic potential of human MME+ and MME- FAPs were apparent under full adipogenic stimulation where we found very few MME- FAPs undergoing adipogenic differentiation. Together, these findings show that, in both mice and humans, MME+ FAPs are a highly adipogenic FAP fraction and that MME+ FAPs are reduced under adipogenic conditions.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9883500</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36707617</oboInOwl:hasDbXref>
        <rdfs:label>MME- FAPs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0009099"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/5ba0f813-beee-4ff7-8ce9-3e07c8f2bd19"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0009099"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/5ba95d3e-2522-403d-87f4-f43d3cd08d76 -->

    <Class rdf:about="http://example.org/5ba95d3e-2522-403d-87f4-f43d3cd08d76">
        <obo:IAO_0000115>Quantification confirmed the histological observations and revealed a significant decrease of ##outer hair cells## at 6 h post-ho-sisomicin treatment and complete outer hair cell loss after 14 h (Fig. 4D). TUNEL-positive outer hair cell nuclei peaked at 6 h post-treatment, indicating that most cells enter the late stages of apoptotic cell death between 3 and 6 h after exposure to ho-sisomicin. DNA fragmentation in outer hair cells was evident between 6- and 11- hours post treatment (Fig. 4E). Moreover, the number of missing outer hair cells and outer hair cell debris increased gradually, starting from 6 h post-ho-sisomicin treatment (Fig. 4F).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11237112</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38987330</oboInOwl:hasDbXref>
        <rdfs:label>outer hair cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000601"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/5ba95d3e-2522-403d-87f4-f43d3cd08d76"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000601"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/5bd42b06-f82c-4756-af04-25b5f7d85a81 -->

    <Class rdf:about="http://example.org/5bd42b06-f82c-4756-af04-25b5f7d85a81">
        <obo:IAO_0000115>Proverbially, the tumor microenvironment (TME) influences the development and recurrence of tumors, and immune cells in TME have been found to either promote or prevent tumor growth. Moreover, immune infiltration, a key element of the TME, has been shown to impact tumor development and response to therapy. Using the TIMER2.0 and CAMOIP databases, we observed a robust correlation between PFKFB4 expression and the levels of infiltration of various immune cells, including CD8+ T cells, CD4+ T cells, regulatory T cells (Tregs), macrophages, neutrophils, dendritic cells, activated mast cells, and ##resting NK cells##. This suggests that PFKFB4 may also be a marker for immune status and provide information for immunotherapies.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10539362</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37770581</oboInOwl:hasDbXref>
        <rdfs:label>resting NK cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000623"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/5bd42b06-f82c-4756-af04-25b5f7d85a81"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000623"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/5be0601d-e401-4bfa-9cb5-506d9ffee3d0 -->

    <Class rdf:about="http://example.org/5be0601d-e401-4bfa-9cb5-506d9ffee3d0">
        <obo:IAO_0000115>Developmental processes contributing to cell fate decisions are mediated by precise cell-cell signaling interactions within a cell&apos;s microenvironment. While cells may share transcriptomic gene signatures, cell-autonomous and/or non-cell-autonomous signaling may dictate how these cells develop. Here, we focused on signaling communications between epithelial-epithelial and epithelial-stromal cells. However, it does not preclude the contributions of the immune, endothelial, and neural (Schwann) cells that are also co-developed and residing near the former two cell types. Indeed, contributions of the immune cell population to epithelial development has recently been shown in the fetal lungs. Correspondingly, we saw the expression of interleukin pathways in our trajectory analysis of epithelial cells (Fig. 6), which may indicate signaling from immune cells, and supports recent findings by Barnes et al. In our cell communication and trajectory analysis, we showed temporal changes in the signaling pathways for FGF, WNT, and NOTCH targeting the ##TP cells##. Both spatial and temporal regulation of signaling can alter the intricate microenvironment of the cell and influence its behavior and potential cell fate changes. Previous studies have demonstrated all three pathways play a role in lung branching morphogenesis and epithelial differentiation. For example, lateral inhibition of NOTCH signaling increases PNEC differentiation in Hes1-null mice. Similarly, we observed a dramatic decrease in PNEC in later gestational lung tissues as NOTCH signaling to TP cells increased with signaling from SOX2highCFTR + cells and basal cells. To confirm our lower-resolution Visium results, we used Xenium to refine the spatial proximity of epithelial and stromal cell types and analyzed the putative signaling through TP.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11246468</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:39003323</oboInOwl:hasDbXref>
        <rdfs:label>TP cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:4033048"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/5be0601d-e401-4bfa-9cb5-506d9ffee3d0"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4033048"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/5c33a288-007c-44ee-b548-21edc2435287 -->

    <Class rdf:about="http://example.org/5c33a288-007c-44ee-b548-21edc2435287">
        <obo:IAO_0000115>BACKGROUND: Hundreds of ongoing clinical trials combine radiation therapy, mostly delivered as stereotactic body radiotherapy (SBRT), with immune checkpoint blockade. However, our understanding of the effect of radiotherapy on the intratumoral immune balance is inadequate, hindering the optimal design of trials that combine radiation therapy with immunotherapy. Our objective was to characterize the intratumoral immune balance of the malignant prostate after SBRT in patients. METHODS: Sixteen patients with high-risk, non-metastatic prostate cancer at comparable Gleason Grade disease underwent radical prostatectomy with (n = 9) or without (n = 7) neoadjuvant SBRT delivered in three fractions of 8 Gy over 5 days completed 2 weeks before surgery. Freshly resected prostate specimens were processed to obtain single-cell suspensions, and immune-phenotyped for major lymphoid and myeloid cell subsets by staining with two separate 14-antibody panels and multicolor flow cytometry analysis. RESULTS: Malignant prostates 2 weeks after SBRT had an immune infiltrate dominated by myeloid cells, whereas malignant prostates without preoperative treatment were more lymphoid-biased (myeloid CD45+ cells 48.4 +- 19.7% vs. 25.4 +- 7.0%; adjusted p-value = 0.11; and CD45+ lymphocytes 51.6 +- 19.7% vs. 74.5 +- 7.0%; p = 0.11; CD3+ T cells 35.2 +- 23.8% vs. 60.9 +- 9.7%; p = 0.12; mean +- SD). CONCLUSION: SBRT drives a significant ##lymphoid## to myeloid shift in the prostate-tumor immune infiltrate. This may be of interest when combining SBRT with immunotherapies, particularly in prostate cancer.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7794088</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32647353</oboInOwl:hasDbXref>
        <rdfs:label>lymphoid</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000542"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/5c33a288-007c-44ee-b548-21edc2435287"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000542"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/5c6dd9c9-6ec7-4f8c-a12a-635c2f732c5f -->

    <Class rdf:about="http://example.org/5c6dd9c9-6ec7-4f8c-a12a-635c2f732c5f">
        <obo:IAO_0000115>We next sought to determine the role that the tumor microenvironment plays in the poor survival of HighCYT/HighICG patients by assessing differences in immune cell infiltration. We compared patients with HighCYT/HighICGscore to those with LowCYT/LowICGscore (Fig. 4). HighCYT/HighICGscore patients had significantly higher levels of CD8+ T cell tumor infiltration (p &lt; 0.001) (Fig. 4) and reduced levels of ##resting NK cells## (p = 0.03) (Fig. 4). Patients with HighCYT/HighICGscore also displayed higher levels of immunosuppressive immune cells, including a significantly higher level of M2 Macrophages (p = 0.011) (Fig. 4). Tumor-associated neutrophils, thought to be immunosuppressive, were also higher in HighCYT/HighICGscore patients, trending towards significance (p = 0.055) (Fig. 4). None of the other 22 immune cell types assessed by CIBERSORT were significantly different between subgroups (p &gt; 0.05).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7567862</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33067480</oboInOwl:hasDbXref>
        <rdfs:label>resting NK cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000623"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/5c6dd9c9-6ec7-4f8c-a12a-635c2f732c5f"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000623"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/5c85a778-40b9-4559-8880-a3d5557953eb -->

    <Class rdf:about="http://example.org/5c85a778-40b9-4559-8880-a3d5557953eb">
        <obo:IAO_0000115>Authentic ##hypoblast cells## created from naive human pluripotent stem cells (hPSCs) spontaneously assemble with naive hPSCs to form a three-dimensional bilaminar structure (bilaminoids) with a pro-amniotic-like cavity.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10849967</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38052228</oboInOwl:hasDbXref>
        <rdfs:label>hypoblast cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000223"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/5c85a778-40b9-4559-8880-a3d5557953eb"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000223"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/5cadafd7-4383-4765-b9b3-8f47f9ce44ba -->

    <Class rdf:about="http://example.org/5cadafd7-4383-4765-b9b3-8f47f9ce44ba">
        <obo:IAO_0000115>Top marker characterization has enabled us to distinguish between the following cell types: B cells, CD4 T cytotoxic, CD4 T self-renewing, CD8 T cytotoxic, ##CD8 T exhausted##, CD8 T memory, DC plasmacytoid, Macrophages, NK cells, Plasma cells, T gamma delta cells and T-reg cells (Figure 3a). Additionally, we have managed to increase the resolution of the B-cell lineage to refine it into four different cell subtypes representing known functions and differentiation stages, as well as phenotypes that have not been characterized before and might be induced by the tumor: Naive B cells, featured by MS4A1, IRF8, BANK1, CD22, and TXNIP expression; Naive B cells Immunoglobulins Kappa Light chains (IGK)-high, with the following specific expression markers: IGKV1-39, IGKV1-12, FLJ20373, MS4A1, and ARHGEF39; Naive B cells Immunoglobulins Lambda Light chains (IGL)-high, characterized by the specific expression of IGLV2-23, IGLV2-11, IGLV2-14, IGLC3, IGLC1; Plasma cells, with SDC1, IGHG3, IGJ, CD38, and XBP1 as cell-type markers and Plasmablasts, with the specific expression of IGKV2-28, IGKV2D-28, CD5, IL2RA and FGR) (Figure 3a, Figure S3). Interestingly, apart from the general B-cell lineage, we have managed to identify the specific B-cell population associated with response: the Naive B-cell population, in particular the one characterized by overexpression of IGK (Naive B cells IGK-high) (Figure 3b, Table S7). In addition, we have identified three stromal immune cell types associated with bad response: Plasmacytoid Dendritic Cells, Macrophages and Gamma Delta T cells (Table S7).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9408876</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36012390</oboInOwl:hasDbXref>
        <rdfs:label>CD8 T exhausted</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000625"/>
        <skos:relatedMatch rdf:resource="CL:0011025"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/5cadafd7-4383-4765-b9b3-8f47f9ce44ba"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000625"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/5cadafd7-4383-4765-b9b3-8f47f9ce44ba"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0011025"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/5cd9029a-f492-47e3-bcb3-413685d4bcd6 -->

    <Class rdf:about="http://example.org/5cd9029a-f492-47e3-bcb3-413685d4bcd6">
        <obo:IAO_0000115>The DPP4+ cells identified in this study appear to have overlapping molecular phenotypes with the adipocyte stem cells defined by previous scRNA-seq studies. Previous studies by Burl et al. identified heterogeneous cell types in adipose tissue responding to CL treatment, and the present study aimed to provide a comprehensive characterization of the cellular and molecular heterogeneity of ##PDGFRA+ progenitors## responsible for CL-induced beige adipogenesis in iWAT. This approach allows us to delineate the signaling pathways involved in the sequential differentiation of beige adipocytes. Conversely, Merrick et al. reported that DPP4+ cells are multipotent mesenchymal progenitors that can give rise to more committed adipocyte progenitors and eventually mature adipocytes both in vitro and after in vivo transplantation. Although the adipogenic potential of mesenchymal stem cells has been demonstrated under artificial culture conditions, genetic tracing is necessary to determine the in vivo fate of DPP4+ cell lineages. Elucidation of the contribution of DPP4+ cells to adipose tissue remodeling induced by various stimuli would be beneficial.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11541910</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:39465352</oboInOwl:hasDbXref>
        <rdfs:label>PDGFRA+ progenitors</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002334"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/5cd9029a-f492-47e3-bcb3-413685d4bcd6"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002334"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/5d35f483-ace2-4f95-b424-be94f90ef813 -->

    <Class rdf:about="http://example.org/5d35f483-ace2-4f95-b424-be94f90ef813">
        <obo:IAO_0000115>scRNA-seq of ECs reveal a subpopulation enriched with immune responsive signatures. (A) Schematic showing the experimental design for the scRNA-seq and single-nuclei ATAC sequencing analysis of regenerative mouse hearts (MI at P1 and harvested at P5) and nonregenerative mouse hearts (MI at P8 and harvested at P12). (B) UMAP representation of cardiac cell clusters identified from scRNA-seq analysis. Clusters were color coded according to cell types (left). CM, cardiomyocytes; ##EC##, endothelial cells; CF, fibroblasts; PeriC, pericytes; SMC, smooth muscle cells; EndoC, endocardial cells; EpiC, epicardial cells; MF, macrophages; TC, T-cells. (C) Gene ontology (GO) analysis of differentially expressed genes up-regulated in ECs of regenerative-stage hearts versus nonregenerative-stage hearts after MI. (D) UMAP representation of CD31+-enriched cell clusters from single-cell RNA sequencing (scRNA-seq), color coded according to cell type. CEC, capillary endothelial cell; Angio-EC, angiogenic endothelial cell; Pro-EC1, proliferative endothelial cell 1; Pro-EC2, proliferative endothelial cell 2; IFN-EC, interferon capillary endothelial cell; CVEC, capillary venous endothelial cell; VEC, venous endothelial cell; AEC, arterial endothelial cell; LEC, lymphatic endothelial cell; EndoC, endocardial cell. (E) Gene ontology (GO) analysis of differentially expressed genes up-regulated in the IFN-EC cluster of regenerative-stage hearts versus nonregenerative-stage hearts after MI.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10681909</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38012001</oboInOwl:hasDbXref>
        <rdfs:label>EC</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0010008"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/5d35f483-ace2-4f95-b424-be94f90ef813"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0010008"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/5d41fcfd-3584-40c7-a8e7-385a8512f03c -->

    <Class rdf:about="http://example.org/5d41fcfd-3584-40c7-a8e7-385a8512f03c">
        <obo:IAO_0000115>Pseudobulk differential gene expression analysis showed significant upregulation of genes in all the B cell subclusters in INS, except for atBCs and ASCs (Fig. 2e and Supplementary Fig. 5a). Pathway analysis revealed an enrichment of functions associated with actin cytoskeletal dynamics in all B cell subclusters in INS, while some subclusters (##Naive-1, actMBCs, MBC-2, and MZ-like B cells##) also showed an enrichment of B cell activation pathways (Supplementary Fig. 5b). The antigen-inexperienced and recently activated B cell subsets (Naive-1 and actMBC) showed the greatest differences in gene expression suggesting that the transcriptional events leading to B cell dysregulation occur early during B cell activation (Fig. 2e and Supplementary Fig. 5a). There was a substantial overlap in the upregulated genes between Naive-1 B cells, actMBCs, MBC-2, and MZ-like B cells including many atBC-associated genes (e.g., ITGB2, ITGB7, FCRLA, FCRL2), POU2F2, POU2AF1, and the extrafollicular response genes TNFRSF13B and GPR183, suggesting a possible developmental sequence or cooperation between these B cell subclusters in generating an extrafollicular B cell response in INS (Fig. 2e).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10667257</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37996443</oboInOwl:hasDbXref>
        <rdfs:label>Naive-1, actMBCs, MBC-2, and MZ-like B cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000787"/>
        <skos:relatedMatch rdf:resource="CL:0000788"/>
        <skos:relatedMatch rdf:resource="CL:0000845"/>
        <skos:relatedMatch rdf:resource="CL:0000980"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/5d41fcfd-3584-40c7-a8e7-385a8512f03c"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000787"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/5d41fcfd-3584-40c7-a8e7-385a8512f03c"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000788"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/5d41fcfd-3584-40c7-a8e7-385a8512f03c"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000845"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/5d41fcfd-3584-40c7-a8e7-385a8512f03c"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000980"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/5d52aedc-f5e2-4772-a222-ee2ee9759642 -->

    <Class rdf:about="http://example.org/5d52aedc-f5e2-4772-a222-ee2ee9759642">
        <obo:IAO_0000115>To test whether inflammation was necessary for ##metaplastic pit cell## expansion, we treated Hp+KRAS+ mice with the immunosuppressive glucocorticoid dexamethasone. Mice received dexamethasone ad libitum in the drinking water starting at 2 weeks and were euthanized at 6 weeks. Hp bacterial loads were not significantly different between the two groups (Fig. 3H). As expected, dexamethasone treatment significantly reduced the accumulation of gastric immune cell populations compared with control-treated Hp+KRAS+ mice (Fig. 3A-G). Importantly, gastric Muc4 expression was also significantly reduced, though not eliminated, in dexamethasone-treated mice (Fig. 3I and J). Thus, gastric inflammation is necessary for metaplastic pit cell development in Hp+KRAS+ mice and is primarily comprised of increased gastric macrophages and T cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10478791</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37674528</oboInOwl:hasDbXref>
        <rdfs:label>metaplastic pit cell</rdfs:label>
    </Class>
    


    <!-- http://example.org/5d5d2c15-eedb-48f1-8790-3dafa27d9562 -->

    <Class rdf:about="http://example.org/5d5d2c15-eedb-48f1-8790-3dafa27d9562">
        <obo:IAO_0000115>Immune checkpoint inhibitors exert clinical efficacy against various types of cancer through reinvigoration of exhausted CD8+ T cells that attack cancer cells directly in the tumor microenvironment (TME). Using single-cell sequencing and mouse models, we show that CXCL13, highly expressed in tumor-infiltrating exhausted CD8+ T cells, induces CD4+ follicular helper T (TFH) cell infiltration, contributing to anti-tumor immunity. Furthermore, a part of the TFH cells in the TME exhibits cytotoxicity and directly attacks major histocompatibility complex-II-expressing tumors. TFH-like cytotoxic CD4+ T cells have high LAG-3/BLIMP1 and low TCF1 expression without self-renewal ability, whereas ##non-cytotoxic TFH cells## express low LAG-3/BLIMP1 and high TCF1 with self-renewal ability, closely resembling the relationship between terminally differentiated and stem-like progenitor exhaustion in CD8+ T cells, respectively. Our findings provide deep insights into TFH-like CD4+ T cell exhaustion with helper progenitor and cytotoxic differentiated functions, mediating anti-tumor immunity orchestrally with CD8+ T cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMID:38363680</oboInOwl:hasDbXref>
        <rdfs:label>non-cytotoxic TFH cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002038"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/5d5d2c15-eedb-48f1-8790-3dafa27d9562"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002038"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/5d72c716-47f9-4ead-ad9f-5f876b97df0e -->

    <Class rdf:about="http://example.org/5d72c716-47f9-4ead-ad9f-5f876b97df0e">
        <obo:IAO_0000115>In addition to our embryonic development, many aspects of adult human health are also highly dependent on tightly controlled cell-type-specific gene regulation. For example, human health and homeostasis are tightly regulated by a myriad of different neuropeptides that need to be expressed in precise regions of the hypothalamus, amygdala and sensory neurons to modulate appropriate levels of food intake, mood and pain perception. Thus, identification of the enhancer regions that control the cell-type-specific expression of these neuropeptides, and how they might be affected by polymorphic variation, will be critical to our understanding of health and disease. For example, substance-P (SP; encoded by TAC1 gene) is a neuropeptide expressed in ##c-fibre sensory neurons## and the medial amygdala where it is critical to pain perception and mood modulation. We first used comparative genomics in species as diverse as mammals and birds to identify a highly conserved enhancer that lay 158kb from the TAC1 gene, which drove reporter gene expression in SP expressing amygdala neurons. Later transgenic analysis of an even remoter conserved enhancer (214kb from TAC1 gene) demonstrated its ability to not only drive reporter expression in SP expressing C-fibre sensory neurons but to also switch reporter gene expression to larger diameter A-fibres in response to inflammatory stimuli:an expression of SP associated with hyperalgesia.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7660172</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33113946</oboInOwl:hasDbXref>
        <rdfs:label>c-fibre sensory neurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:3000004"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/5d72c716-47f9-4ead-ad9f-5f876b97df0e"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:3000004"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/5d8b648a-ec88-4440-bdce-9fba66055ae2 -->

    <Class rdf:about="http://example.org/5d8b648a-ec88-4440-bdce-9fba66055ae2">
        <obo:IAO_0000115>Macrophage-depletion of VEGF1R reduces macrophage number and reduces M2 polarization. (A) ELISA for PlGF levels in tissue from all experimental groups. (B) Representative flow charts for analysis and sorting for CD68 and CD163. (C, D) Quantification of ##CD68+ macrophage## percentage (C) and CD163+ cells in total CD68+ cells (D). *p &lt; 0.05. NS, non-significant.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8511710</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34659227</oboInOwl:hasDbXref>
        <rdfs:label>CD68+ macrophage</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/5d8b648a-ec88-4440-bdce-9fba66055ae2"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/5dc31e1c-eddf-4eac-ab76-d68d0c8813b3 -->

    <Class rdf:about="http://example.org/5dc31e1c-eddf-4eac-ab76-d68d0c8813b3">
        <obo:IAO_0000115>However, in contrast to previous studies (e.g.) rather than use multiple Cre-lines to distinguish subpopulations of, for example, GABAergic cells, we have rather studied excitatory and inhibitory classes more generally, using Cre-Off and Cre-On AAVs in Gad2-Cre mice. Thus, the primary goal of this study was not to investigate differences in innervation between the many particular subtypes of inhibitory or excitatory cells, but whether these two classes receive anatomically segregated distant inputs. For comparison, we also examined input to parvalbumin-expressing cells, the largest known subtype of GABAergic neuron in the neocortex, and ##proenkephalin-expressing (penk) cells##, a subtype of excitatory cell present in L2/3 and L6. Although the differences were relatively small, there were noticeable qualitative trends in the fraction of inputs to the different classes, suggesting the potential for more subtle diversity in the excitatory and inhibitory populations than our study could detect.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7925549</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33654118</oboInOwl:hasDbXref>
        <rdfs:label>proenkephalin-expressing (penk) cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000506"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/5dc31e1c-eddf-4eac-ab76-d68d0c8813b3"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000506"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/5ddb7341-4b79-48aa-8b83-5407c1268582 -->

    <Class rdf:about="http://example.org/5ddb7341-4b79-48aa-8b83-5407c1268582">
        <obo:IAO_0000115>To gain a comprehensive view of immune interactions, we performed correlation analyses between the frequency of Ki67+ Tregs and the frequencies of all identified immune cell subpopulations. We did not observe significant association of the frequency of Ki67+ Tregs with lymphocytic subsets (Supplementary Fig. 8). On the other hand, myeloid cells, particularly dendritic cells (DCs), are known to facilitate Treg generation. Therefore, we analyzed the correlation between the frequency of Ki67+ Tregs and that of myeloid cell subsets (including cMo, ##iMo##, ncMo, and DC). The frequency of Ki67+ Tregs was positively associated with the frequencies of HLA-DR+ and CD86+ monocytes and dendritic cells (Supplementary Fig. 9), suggesting their potential roles in the generation of Ki67+ Treg cells via antigen presentation and CD28-dependent signaling. Interestingly, we found that the frequency of Ki67+ Tregs was also positively associated with the frequencies of PD-L1+ monocytes and dendritic cells (Supplementary Fig. 9), which is consistent with previous reports that DCs could induce Treg cells via PD-L1. These results indicate that myeloid cells might play a crucial role in Treg generation.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11496634</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:39438442</oboInOwl:hasDbXref>
        <rdfs:label>iMo</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000576"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/5ddb7341-4b79-48aa-8b83-5407c1268582"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000576"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/5e25fef3-5020-4108-9d53-3726d97674f5 -->

    <Class rdf:about="http://example.org/5e25fef3-5020-4108-9d53-3726d97674f5">
        <obo:IAO_0000115>Brain transcriptional changes after MIA require microglia. (A) Simplified schematic of sample processing pipeline from and bar plots of TORCH pathogen and cytokine receptor expression (mean log counts per million) in each cell type across development. (B) Violin plot of CytoTORCH module score for each cell cluster (MG, P&lt;0.05 for ANOVA and for pairwise comparisons between microglia and all other cell types using Tukey&apos;s HST). (C) Overview of experimental design (top) and UMAP visualization of snRNAseq data from the developing somatosensory cortex of E15.5 wild-type and Csf1r-/- mice after saline or Poly(I:C) maternal injection at E12.5 (two or three embryos per condition from a total of four pregnant dams, 42,736 total cells) (bottom). Cells are colored by cell type assignment. (D) Dot plots of log(fold change) in gene expression between MIA and saline for cell types with significant changes at E15.5. DEG analysis was performed using NEBULA. AP, apical progenitors; IP, intermediate progenitors; ImmN, immature neurons, MN, migrating neurons; (UL/DL) CPN, (upper layer/deep layer) callosal projection neurons; SCPN, subcerebral projection neurons; CThPN, corticothalamic projection neurons; ##LIV##, layer IV stellate neurons; IN, interneurons; CR, Cajal-Retzius cells; Astro, astrocytes; CGC, cycling glial cells; Epend; ependymal cells; OL, oligodendroglia; MG, microglia; Peri, pericytes; EC, endothelial cells; VLMC, vascular and leptomeningeal cells. Created with .</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11190434</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38775708</oboInOwl:hasDbXref>
        <rdfs:label>LIV</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:4030063"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/5e25fef3-5020-4108-9d53-3726d97674f5"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4030063"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/5eb914c2-ad7e-48a7-bfa6-ce93fd22481c -->

    <Class rdf:about="http://example.org/5eb914c2-ad7e-48a7-bfa6-ce93fd22481c">
        <obo:IAO_0000115>In the steady-state, macrophages represented the largest cell population (58.7% of total CD45+ cells) in the mouse hearts, followed by B cells (18.2%), NK cells (8.6%), T cells (4.3%), monocytes (3.7%), and neutrophils (3.1%) (Fig. 1d and Supplementary Table 1); the other ##cardiac leukocyte## populations occupied less than 3% in the steady state. Interestingly, the proportion of macrophages drastically dropped at day 1 (24.9%) but then gradually recovered from day 3 (66.8%), reaching a peak on day 7 (84.0%) post-MI (Fig. 1d). On the contrary, the proportion of neutrophils increased steeply at day 1 (54.4%) and then decreased rapidly (14.8, 1.7, and 1.6% on days 3, 5, and 7, respectively), which was consistent with previous reports. Monocytes were increased in the early phase of MI (days 1 and 3) and then decreased in the late phase of MI (days 5 and 7), while DCs were predominant at days 3 and 5. Lymphocytes (T cells, B cells, NK cells, and ILC2 cells), occupying 31.9% of total CD45+ cells in the steady state, decreased at day 1 and did not reach the steady-state values until day 7 post-MI. Collectively, scRNA-seq targeting cardiac leukocytes showed not only major cell populations but also minor populations, such as mast cells and DC subtypes; our data clearly show that the temporal dynamics after MI are different depending on the cell populations.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9357004</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35933399</oboInOwl:hasDbXref>
        <rdfs:label>cardiac leukocyte</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000738"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/5eb914c2-ad7e-48a7-bfa6-ce93fd22481c"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000738"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/5ec11bb6-e645-4030-a708-d521eaeed11c -->

    <Class rdf:about="http://example.org/5ec11bb6-e645-4030-a708-d521eaeed11c">
        <obo:IAO_0000115>Both D1-medium spiny neurons (MSNs) and D2-MSNs from the NAc form functional synapses in the VP and exert opponent control on reward-related behaviors. Chemogenetic manipulations demonstrate that D1-MSN to VP afferents promote and D2-MSN to VP afferents inhibit reward seeking. How this antagonistic behavioral modulation is achieved on a microcircuit level in the VP remains unclear. However, a rabies tracing study revealed that significantly more D1-MSNs than D2-MSNs in the NAc innervate VPGlutamate cells. Nonetheless, it remains unknown whether the apparently biased connectivity between NAc afferents and ##VP neuronal## subpopulations is reflected in GABA synaptic strength and modulation by cotransmitters differentially released with GABA from D1-MSN and D2-MSN axon terminals.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10348443</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37414552</oboInOwl:hasDbXref>
        <rdfs:label>VP neuronal</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000540"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/5ec11bb6-e645-4030-a708-d521eaeed11c"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000540"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/5ef5a6fc-8cce-4174-8786-b267826b65bb -->

    <Class rdf:about="http://example.org/5ef5a6fc-8cce-4174-8786-b267826b65bb">
        <obo:IAO_0000115>HS scFv binding patterns within human megakaryocyte and erythroid differentiation reveal dynamically and temporally shared HS-modification patterns. (A) Representative FACS density plot (upper panel) and morphology (May-Grunwald-Giemsa stain; lower panel) of human ##CD34+ cells##. Scale bar indicates 20 mum. (B) Histograms of HS scFv binding to human CD34+ cells (donor #1). (C) Cell morphological time course of experimental in vitro erythroid differentiation of human CD34+ cells. A scheme bar indicating the distinct erythroid differentiation stages is included. Pro-E, proerythroblast; Baso-E, basophilic erythroblast; Poly-E, polychromatic erythroblast; Ortho-E, orthochromatic erythroblast. Scale bar indicates 20 mum. (D) Cell morphological time course of experimental in vitro megakaryocytic differentiation of human CD34+ cells. A scheme bar indicating distinct megakaryocytic differentiation stages is included. Scale bar indicates 20 mum. (E) Flow cytometry plots of HS scFv signal overlaid on the erythroid differentiation markers CD71 and CD235a during day 3, 7, 10, and 14 of erythroid differentiation (donor #1). The color coding of scFv-binding MFI is shown at the bottom. (F) Heatmap of HS scFv signal overlaid on the megakaryocyte differentiation markers CD41 and CD42b during day 3, 7, and 14 of megakaryocyte differentiation (donor #1). The color coding of scFv-binding MFI is shown at the bottom. (G) Binding of HS scFvs in stage-matched human (upper panel, donor #1) and mouse (lower panel) erythroid-lineage cells. Pro-E, proerythroblast; Baso-E, basophilic erythroblast; Poly-E, polychromatic erythroblast; Ortho-E, orthochromatic erythroblast. (H) Binding of HS scFvs in stage-matched human (upper panel, donor #1) and mouse (lower panel) megakaryocytic-lineage cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9455685</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36066492</oboInOwl:hasDbXref>
        <rdfs:label>CD34+ cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0001059"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/5ef5a6fc-8cce-4174-8786-b267826b65bb"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0001059"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/5efba1e5-745f-49fd-a3fa-278269745654 -->

    <Class rdf:about="http://example.org/5efba1e5-745f-49fd-a3fa-278269745654">
        <obo:IAO_0000115>Sjogren&apos;s syndrome is a chronic autoimmune disorder whose pathogenesis is poorly understood and that lacks effective therapies. Detailed quantitative and spatial analyses of tissues affected by Sjogren&apos;s syndrome were undertaken, including the quantitation of the frequency of selected cell-cell interactions in the disease milieu. Quantitative analyses of CD4+ T cell subsets and of CD8+ T cells in the labial salivary glands from untreated patients with primary Sjogren&apos;s syndrome revealed that activated CD8+ cytotoxic T cells (##CD8+CTLs##) were the most prominent T cells in these infiltrates. An accumulation of apoptotic glandular epithelial cells, mainly ductal and acinar cells, was observed, consistent with the impaired salivary secretion often observed in patients with this disease. FasL expressing activated CD8+ T cells were seen to accumulate around Fas expressing apoptotic epithelial cells. Quantitative analyses of apoptotic cell types and of conjugates between cytotoxic T cells and epithelial cells undergoing apoptosis suggest that Sjogren&apos;s syndrome is primarily driven by CD8+CTL mediated execution of epithelial cells mainly represented by ductal and acinar cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9475031</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36104369</oboInOwl:hasDbXref>
        <rdfs:label>CD8+CTLs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000794"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/5efba1e5-745f-49fd-a3fa-278269745654"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000794"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/5efc2f35-a71f-4535-b991-b4609ce49078 -->

    <Class rdf:about="http://example.org/5efc2f35-a71f-4535-b991-b4609ce49078">
        <obo:IAO_0000115>Proper development of the placenta, the transient support organ forms after embryo implantation, is essential for a successful pregnancy. However, the regulation of trophoblast invasion, which is most important during placentation, remains largely unknown. Here, rats, mice, and pigs are used as biomedical models, used scRNA-seq to comparatively elucidate the regulatory mechanism of placental trophoblast invasion, and verified it using a human preeclampsia disease model combined with scStereo-seq. A dual-featured type of immune-featured trophoblast (##iTrophoblast##) is unexpectedly discovered. Interestingly, iTrophoblast only exists in invasive placentas and regulates trophoblast invasion during placentation. In a normally developing placenta, iTrophoblast gradually transforms from an immature state into a functional mature state as it develops. Whereas in the developmentally abnormal preeclamptic placenta, disordered iTrophoblast transformation leads to the accumulation of immature iTrophoblasts, thereby disrupting trophoblast invasion and ultimately leading to the progression of preeclampsia.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11558115</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:39234818</oboInOwl:hasDbXref>
        <rdfs:label>iTrophoblast</rdfs:label>
    </Class>
    


    <!-- http://example.org/5f1dc273-45cd-4ec0-ba4a-9c73ee04824f -->

    <Class rdf:about="http://example.org/5f1dc273-45cd-4ec0-ba4a-9c73ee04824f">
        <obo:IAO_0000115>a Due to single-cell annotation and in situ validation (Fig. 2; Supplementary Fig. 3), a draft model of the oral-to-tooth transition zone in humans is presented, with basal and suprabasal keratinocyte markers uniquely identifying the alveolar mucosa (AM), attached gingiva (AG), gingival margin (GM), sulcular epithelium (SK) and junctional epithelium (JK). b These markers allowed for KRT19-high keratinocyte (KC) cell subclustering for the first time (2504 cells in total), including gingival margin keratinocytes (##GM##), sulcular keratinocytes (SK), and junctional keratinocytes (JK). c A more granular draft (Tier 4) annotation of epithelial cells of the gingival attachment. d Assaying differentially expressed genes in periodontitis, SKs and JKs only share about a quarter of upregulated genes. JKs displayed nearly 125 unique upregulated genes in diseased cells. e Further analysis of basal and suprabasal (differentiating) SK and JK keratinocytes revealed unique cell signatures between basal and suprabasal cell types. This full list is included in Supplementary Data 1. f-i To understand SK and JK developmental progression and cell state alterations, we used partitioned-based graph abstraction (PAGA). f Examining the basal to suprabasal transition, JKs display altered gene expressed comparing health to disease cell types, including broader expression of KRT17 and more expression of JUND, COL17A1, and CDH3. Key differentiation genes such as SPRR family members were also downregulated. g JKs displayed robust cell signaling and inflammatory phenotypes, which appear exacerbated in disease states. h In SKs, differentiation-related genes were uniquely expressed compared to JKs in health but also appeared altered in disease along the basal to suprabasal trajectory. i SKs appeared generally less reactive compared to JKs in disease, with lower overall expression of effector molecules such as CXCL1, CXCL8, IL1A, IL1B, and IL1RN. Abbreviations: Merk Merkel Cells, LC langerhans cells, Mela melanocytes, Muc mucosa, SB suprabasal Keratinocytes; for others, see Fig. 1 legend. For this figure, n = 30-sample, 2504-cell for scRNAseq.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11178863</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38876998</oboInOwl:hasDbXref>
        <rdfs:label>GM</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002170"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/5f1dc273-45cd-4ec0-ba4a-9c73ee04824f"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002170"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/5f4076c3-98fb-42b7-a8b3-765227063f37 -->

    <Class rdf:about="http://example.org/5f4076c3-98fb-42b7-a8b3-765227063f37">
        <obo:IAO_0000115>We performed de novo alignment of T cells from the CD8+ and CD4+ T cell clusters along a pseudo-temporal axis representing the continuum of blinatumomab-induced activation. CD8+ cells formed a trajectory from the TC0-CD8+ Naive T cluster, followed by clusters TC1-##CD8+ TEM## and TC2-CD8+ CTL towards cluster TC4-CD8+ Activated T (Additional file 1, Fig. S7A). Similarly, the TC10-CD4+ Activated T cluster was chronologically ordered at the terminal end of the CD4+ activation trajectory (Additional file 1, Fig. S7B). Genes associated with activation were mapped onto the activation trajectory, confirming an increased expression of the genes IL2RA, CD69, TNFRSF18 and TNFRSF4 at the end of the trajectories (Additional file 1, Fig. S7C-D). Both trajectories suggest that the activated CD8+ and CD4+ T cells did not originate from naive T cells, but rather from CD8+ TEM and CD4+ TCM cells, respectively. By contrast, cells from the TC13-Activated T cluster expressed high levels of naive marker genes (Fig. 2b), leading to the conclusion that cells from this CD8+/CD4+ mixed activated T cell cluster arose from naive T cells (TC0 and TC5).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7923532</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33648458</oboInOwl:hasDbXref>
        <rdfs:label>CD8+ TEM</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000913"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/5f4076c3-98fb-42b7-a8b3-765227063f37"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000913"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/5f5dce5a-9725-41c8-94c9-a4826afd63e9 -->

    <Class rdf:about="http://example.org/5f5dce5a-9725-41c8-94c9-a4826afd63e9">
        <obo:IAO_0000115>As central hub of the endocrine system, the pituitary plays a quintessential role in governing the endocrine glands throughout the body, thereby regulating key physiological processes including growth, metabolism, fertility, stress, and immunity. To execute this primordial function, the pituitary has to properly develop into a compound gland of multiple endocrine cells, encompassing somatotropes (producing growth hormone [GH]), corticotropes (adrenocorticotropic hormone [ACTH]), lactotropes (prolactin [PRL]), gonadotropes (luteinizing hormone [LH] and/or follicle-stimulating hormone [FSH]), and thyrotropes (thyroid-stimulating hormone [TSH]). In the mouse, the pituitary undergoes an intense growth and maturation process during the first postnatal weeks, with number and size of hormone-producing cells substantively expanding following proliferation of committed (progenitor) and endocrine cells. Simultaneously, the local stem cell (SOX2+) compartment shows signs of activation including elevated abundance and expression of stemness pathways when compared to the adult ##pituitary stem cells##. The stem cells can give rise to new endocrine cells, a property which has been found most prominent (although not extensive) during this neonatal period. In contrast, stem cells in the mature, adult pituitary are quiescent and do not highly contribute to new endocrine cells during the (slow) homeostatic turnover of the gland. However, the adult stem cells become activated following local injury in the gland, showing a proliferative reaction and signs of differentiation toward the ablated cells, coinciding with substantial regeneration. We recently identified interleukin-6 (IL-6) to be upregulated in the adult pituitary (in particular its stem cells) upon this local damage which activated the stem cells. However, it is not clear what molecular mechanisms underlie the activation status of the stem cells in the neonatal gland.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9333987</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35699412</oboInOwl:hasDbXref>
        <rdfs:label>pituitary stem cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000034"/>
        <skos:relatedMatch rdf:resource="CL:2000004"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/5f5dce5a-9725-41c8-94c9-a4826afd63e9"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000034"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/5f5dce5a-9725-41c8-94c9-a4826afd63e9"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:2000004"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/5f5f1f30-1c14-4624-a4a5-dced06b462bf -->

    <Class rdf:about="http://example.org/5f5f1f30-1c14-4624-a4a5-dced06b462bf">
        <obo:IAO_0000115>Ruxolitinib inhibits IFNgamma-stimulated Sjogren&apos;s ##salivary gland MSC## HLA-DR expression and chemokine-dependent T cell migration.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9536796</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35218354</oboInOwl:hasDbXref>
        <rdfs:label>salivary gland MSC</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000134"/>
        <skos:relatedMatch rdf:resource="CL:0009005"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/5f5f1f30-1c14-4624-a4a5-dced06b462bf"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000134"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/5f5f1f30-1c14-4624-a4a5-dced06b462bf"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0009005"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/5f937f5b-edb9-4c4c-b655-c363671f1953 -->

    <Class rdf:about="http://example.org/5f937f5b-edb9-4c4c-b655-c363671f1953">
        <obo:IAO_0000115>It has been well-documented that total CD4+CD45RA+ naive T cells are reduced, and total CD4+CD45RO+ memory T cells are spared following alemtuzumab treatment. Our data show similar changes in total memory (supplementary Figure S3A) and total naive CD4+ T cells (Figure S3B). Figure S3 also illustrates changes over time in subsets of naive and memory CD4+ T cells, defined as described by Lovett-Racke and colleagues. Briefly, lymphocytes were identified in FSC/SSC plots, followed by gating on CD4+CD45RA+ or CD45RA- cells to identify CD27+ and CD27- lymphocytes (FACS gating strategy not illustrated). Figure S3 shows that the percentage of CD4+CD45RA+CD27+ naive T cells (Figure S3C) was reduced at M5 and M17, while ##CD4+CD45RA-CD27+ central memory T cells## (TCM; Figure S3D) remained relatively stable over time. The percentage of CD4+CD45RA-CD27- effector memory T cells (TEM; Figure S3E) increased at M5, along with CD4+CD45RA+ new effector T cells (new Teff; Figure S3F).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7296935</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32539719</oboInOwl:hasDbXref>
        <rdfs:label>CD4+CD45RA-CD27+ central memory T cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000904"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/5f937f5b-edb9-4c4c-b655-c363671f1953"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000904"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/5f96c117-019b-4dac-8e6f-fb66cb179d23 -->

    <Class rdf:about="http://example.org/5f96c117-019b-4dac-8e6f-fb66cb179d23">
        <obo:IAO_0000115>Collectively, these studies suggest a level of specialization among CAFs concerning pro-angiogenic behavior or association with tumor vessels, necessitating further investigation. Understanding the specific contributions of the cell of origin to these phenotypes, particularly the relationship between vCAFs and perivascular cells, remains a key area of interest. Recent studies are beginning to uncover the distinct role of tumor-associated pericytes as an independent entity from CAFs. Whether these distinct ##CAF## phenotypes signify particular functions associated with vascular regulation and unique distributions within tumors or represent remnants of their lineage (e.g., mural cell- or EC-derived CAFs) is yet to be determined. Future studies employing techniques like scRNAseq and spatial transcriptomics to map tissue/tumor cell composition and cell communication as well as lineage tracing analyses of CAF subtype cellular origins are expected to provide further evidence on the specific pro- or anti-angiogenic roles of CAF subpopulations (Fig. 3).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11322395</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38453816</oboInOwl:hasDbXref>
        <rdfs:label>CAF</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000057"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/5f96c117-019b-4dac-8e6f-fb66cb179d23"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000057"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/5fad9e5f-ba50-4e5b-9ccc-b7573cfa9178 -->

    <Class rdf:about="http://example.org/5fad9e5f-ba50-4e5b-9ccc-b7573cfa9178">
        <obo:IAO_0000115>NKT cells express surface receptors of NK cells (such as NK1.1 in mice and CD161+/CD56+ in humans) and TCR, which is unique to traditional T cells and recognizes lipid antigens through CD1d (an MHC class 1 molecule). NKT cells in the liver respond very quickly to injury, either directly by identifying related lipids or indirectly through secretion of TLR ligands and cytokines (such as IL-12, IL-4, and IFN-gamma) by activated ##APCs## such as KCs, hepatocytes, and myeloid DCs. Furthermore, type I NKT cell-induced inflammation and neutrophil recruitment lead to liver tissue damage, while type II NKT cells have a protective effect against ALD damage. Type I NKT cells are activated after alcohol intake, and inhibition of type I NKT cells by retinoic acid or sulfonamide can prevent ALD.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7852578</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33268887</oboInOwl:hasDbXref>
        <rdfs:label>APCs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000145"/>
        <skos:relatedMatch rdf:resource="CL:0000182"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/5fad9e5f-ba50-4e5b-9ccc-b7573cfa9178"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000145"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/5fad9e5f-ba50-4e5b-9ccc-b7573cfa9178"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000182"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/5fb063c5-c565-41e0-9653-08af9adef416 -->

    <Class rdf:about="http://example.org/5fb063c5-c565-41e0-9653-08af9adef416">
        <obo:IAO_0000115>Macrophages are multi-functional innate immune cells that orchestrate tissue repair, immune responses and inflammation. First described by Elie Metchnikoff, macrophages are derived from embryonic haematopoietic progenitors or monocytes and differentiate into tissue macrophages after entering the tissue. Because macrophages play an indispensable role in maintaining systemic homeostasis and participating in immune defence against pathogens and cellular debris, they are widely distributed across various tissues, including the salivary glands. Recent studies have shown that macrophages perform several other functions in addition to phagocytosis. Macrophages and T cells can collectively regulate inflammation and participate in various functions such as phagocytosis and antigen presentation. This phenomenon has been partly confirmed in a noninflamed murine submandibular salivary gland model, as macrophages facilitate the local accumulation of tissue-resident memory CD8+ T cells (##T+ RM##) at the site of inflammation. Tissue-resident immune cells are thought to be complemented by salivary gland progenitor cells (SGPCs) for the maintenance of normal salivary gland homeostasis. Upon tissue damage, epithelial cells release inflammatory factors and recruit macrophages to induce inflammatory responses. Through their uncontrolled and rapid cytokine production, macrophages recruit more immune cells to amplify the local inflammatory response, thereby bridging innate and adaptive immunity.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10656691</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38022546</oboInOwl:hasDbXref>
        <rdfs:label>T+ RM</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000907"/>
        <skos:relatedMatch rdf:resource="CL:0000913"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/5fb063c5-c565-41e0-9653-08af9adef416"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000907"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/5fb063c5-c565-41e0-9653-08af9adef416"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000913"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/5fc9d24f-5dd5-4647-b82e-0787f00a15eb -->

    <Class rdf:about="http://example.org/5fc9d24f-5dd5-4647-b82e-0787f00a15eb">
        <obo:IAO_0000115>SC-EVs have been shown to promote the proliferation and activation of T cells. For example, in mice with type 1 diabetes, ##islet MSC##-derived exosomes were observed to activate APCs and autologous T and B cells in islets, increase their respective specific memory cells, and induce IFN-gamma production, thus accelerating islet destruction. This evidence provides a perspective that certain SC-EVs serve as autoantigen carriers and trigger autoimmune responses. Additionally, The beta-catenin-loading or GM-CSF (granulocyte-macrophage colony-stimulating factor)-expressing EVs derived from SCs could promote T cell antitumor response. For example, the exosomes derived from rat AD-MSCs were observed to accelerate intratumoral CD8alpha+ type I NK-T cell migration and increase circulating NK-T cells to exert antitumor immunity in rats with hepatocellular carcinoma (HCC) (Table 1). In mice with transplanted lung adenocarcinoma, exosomes derived from GM-CSF-expressing embryonic SCs (ESCs) were observed to suppress the migration of immunosuppressive Tregs, whereas they reinforced migration of tumor-reactive CD8+ T effector cells toward intratumor spaces and elevated intratumoral cytokine responses of TNF-alpha and IFN-gamma, contributing to the clearance of foreign components (Table 1). Therefore, EVs derived from engineered SCs may be utilized as a preventive vaccine against the risk of cancer development in human beings.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7026133</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32117221</oboInOwl:hasDbXref>
        <rdfs:label>islet MSC</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000134"/>
        <skos:relatedMatch rdf:resource="CL:0002351"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/5fc9d24f-5dd5-4647-b82e-0787f00a15eb"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000134"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/5fc9d24f-5dd5-4647-b82e-0787f00a15eb"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002351"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/5fd7a5d4-7d42-4792-afbd-72446e3c6b97 -->

    <Class rdf:about="http://example.org/5fd7a5d4-7d42-4792-afbd-72446e3c6b97">
        <obo:IAO_0000115>To investigate the universal transcriptional program between group 1 ILCs across liver and spleen, we have explored DEGs in Prdm1 cko liver cNK cells and ILC1s using our scRNA-seq data. Compared with liver ILC1s, more DEGs was observed in liver cNK cells, including Junb, Kit, Tcf7, Gzmb, Prf1, etc. (Figure 5:figure supplement 2, A and B). Through the integration of the bulk RNA-seq and scRNA-seq data, we identified 17 DEGs that are regulated by Prdm1 among liver cNK cells, splenic cNK cells, and liver ILC1s. Batf3, Junb, Tcf7, and Nfkb1 was upregulated, whereas Gzmb, Prf1, and Fgl2 downregulated, in both Prdm1 cko liver and splenic cNK cells (Figure 5J). Cxcr6 was downregulated in liver ILC1s and splenic cNK cells in Prdm1 cko mice (Figure 5J). Previous research found that spleen NK cells could be divided into three distinct groups based on their expression levels of CD27, CD62L, CD49a, and CD49b. CD27+CD62L- NK cells have remarkable high expression of Batf3, while it was only barely expressed in ##CD27+CD62L+ and CD27-CD62L+ NK cells##. Based on the sequencing data published by Flommersfeld et al. (GSE180978), a notable negative correlation was observed between the expression levels of Prdm1 and Batf3 (Figure 5:figure supplement 2I). On top of that, our findings unveiled the negative regulatory influence of Prdm1 on Batf3 within both spleen and liver NK cells. This discovery highlights a potential upstream mechanism that may influence the hemostasis of the spleen NK cell subpopulations through Batf3.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11318973</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:39133873</oboInOwl:hasDbXref>
        <rdfs:label>CD27+CD62L+ and CD27-CD62L+ NK cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000814"/>
        <skos:relatedMatch rdf:resource="CL:0000823"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/5fd7a5d4-7d42-4792-afbd-72446e3c6b97"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000814"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/5fd7a5d4-7d42-4792-afbd-72446e3c6b97"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000823"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/50a1e0cb-1219-4324-983a-94b651c1d7e6 -->

    <Class rdf:about="http://example.org/50a1e0cb-1219-4324-983a-94b651c1d7e6">
        <obo:IAO_0000115>It has recently been reviewed by Sun and colleagues in 2021 that dendritic cell (DC)-mediated immune responses are also being regulated by FAO. In an inactive state, DCs perform predominantly catabolic pathways, e.g., fatty acid oxidation (FAO), amino acid metabolism, Krebs cycle, and oxidative phosphorylation (OxPhos). ##Activated DCs##, in turn, switch to increased anabolism in the form of, e.g., glycolysis, fatty acid synthesis, and production of reactive oxygen species (ROS). According to the authors, the role of FAO should be further investigated to gain better insight inside into the complex mechanisms underlying DC-controlled immune responses in allergic diseases.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9832094</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36520269</oboInOwl:hasDbXref>
        <rdfs:label>Activated DCs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000451"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/50a1e0cb-1219-4324-983a-94b651c1d7e6"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000451"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/50a23a0a-608c-4e87-87aa-1b12189cca1c -->

    <Class rdf:about="http://example.org/50a23a0a-608c-4e87-87aa-1b12189cca1c">
        <obo:IAO_0000115>As TNF affected the expression of specific NSC and astrocytic genes during differentiation of NSPs into astrocytes, we sought to expand our analyses by conducting a genome-wide RNA-sequencing analysis of the astrocytic transcriptome at different time points, both under normal and inflammatory conditions. Principal component analysis (PCA) using the top 1000 variable genes showed distinct clustering corresponding to the different conditions (Figure 3A). We identified differentially expressed genes (p &lt; 0.05) between different conditions and compared them at 24 and 72 h under normal or inflammatory conditions. Specifically, we detected 4187 overexpressed genes and 4544 down-regulated genes at 24 h compared to undifferentiated NSPs, both with or without TNF. On the other hand, we detected 1005 and 756 genes, respectively, exclusively up- or down-regulated at 24 h under control conditions, while 1227 and 922 genes were correspondingly enhanced or decreased only under TNF treatments. We obtained similar results at 72 h (Figure 3B). Hierarchical gene clustering of the differentially expressed genes during normal differentiation (up- and down-regulated genes, adjusted p value &lt; 0.05) revealed five major clusters differentially represented across the specific time points (Figure 3C). Corresponding Gene Ontology (GO) enrichment analyses indicated that proliferating NSPs were mainly associated with cluster 1, largely characterized by terms related to RNA processing. Clusters 2 and 4, largely represented in NSPs and 24 h-differentiated astrocytes, were characterized by processes associated with regulation of cell morphogenesis, motility, and migration. Clusters 3 and 5, mostly enriched in ##differentiating astrocytes## at 72 h and 1 week, were characterized by terms linked to cell projection assembly and cilium organization (Figure 3D).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10047363</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36980289</oboInOwl:hasDbXref>
        <rdfs:label>differentiating astrocytes</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002627"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/50a23a0a-608c-4e87-87aa-1b12189cca1c"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002627"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/50ce586e-ccae-445d-a8ef-b0dfb5cdbb6a -->

    <Class rdf:about="http://example.org/50ce586e-ccae-445d-a8ef-b0dfb5cdbb6a">
        <obo:IAO_0000115>In the mouse placenta, there are two lineages of trophoblast cells, the invasive and structural cells, which arise from the trophoblast stem progenitor cells. Trophoblast giant cells are the invasive cells responsible for invading the maternal vasculature and transforming the spiral arteries into high-velocity, low-resistant vessels. Four sub-types of trophoblast giant cells exist, including ##spiral artery trophoblast giant cells## and parietal trophoblast giant cells, which reside in the decidual layer. The canal trophoblast giant cells and sinusoidal trophoblast giant cells are in the labyrinth. The structural cells of the placenta include those located within the junctional zone and the remaining cells of the labyrinth. The spongiotrophoblast and glycogen trophoblast cells are within the junctional zone. The spongiotrophoblast cells are thought to contribute a supportive role to the developing labyrinth and feed into the trophoblast giant cell progenitor pool, while glycogen cells, which arise from the spongiotrophoblast cells, are thought to accumulate glycogen and can migrate into the maternal decidua for spiral artery remodeling. The two different types of syncytiotrophoblast cells, syncytiotrophoblast-I and syncytiotrophoblast-II, are located within the labyrinth zone. These cells function in the material exchange between the mother and fetus and, along with the sinusoidal trophoblast giant cells, make up the interhemal membrane. However, the specific functions of some of these cells are not well understood.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10459728</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37630754</oboInOwl:hasDbXref>
        <rdfs:label>spiral artery trophoblast giant cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002488"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/50ce586e-ccae-445d-a8ef-b0dfb5cdbb6a"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002488"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/50e07c4c-f54a-4172-9635-93c00546113d -->

    <Class rdf:about="http://example.org/50e07c4c-f54a-4172-9635-93c00546113d">
        <obo:IAO_0000115>Next, we merged the datasets for the five time-points using the merge function of the Seurat pipeline, which combines multiple datasets without transforming the data. The merged dataset with a total of 62,202 cells was processed for clustering and then the data were visualized as a UMAP plot (Fig. 3). The same set of cell clusters identified in individual time-point data was also identified in the merged dataset (Fig. 3A,E and Fig. S6). The downregulation of PAX2 and upregulation of FBXO2 from otic prosensory cells to intermediate otic cells and supporting cells were confirmed with this analysis (Fig. 3E). A DACH1+ SPP1+ population was detected adjacent to OC90+ intermediate otic cells (Fig. 3D, Figs S7 and S8), suggesting the existence of another lineage direction in the ##otic lineage## other than the sensory epithelium. TFAP2B+ surface ectoderm cells, NEUROD1+ neuroblasts and S100B+ neural crest/Schwann cells were identified as distinctive clusters (Fig. 3A,D and Fig. S7). An intermediate population between otic prosensory cells and supporting cells expressed not only otic epithelium markers EPCAM and FBXO2, but also other otic progenitor markers COL9A1, SERPINF1, HES1, AATF, COL14A1, OC90, PRSS8 and EYA4 (Fig. S7), suggesting that this is an otic epithelial cell population differentiating into hair cells and supporting cells. Adjacent to the supporting cell cluster, there was a POU4F3+ hair cell cluster that expressed vestibular hair cell markers [CD164L2, ZBBX, TEKT1, SKOR1, TCTEX1D1 (DYNLT5) and NEUROD6] and type II hair cell markers (ANXA4, MAPT and NHLH1) (Fig. 3D and Fig. S8), indicative of an immature type II hair cell identity. However, we were unable to detect the cochlear marker GATA3 or INSM1 in PCP4+ hair cells (Fig. S8G,H). Surprisingly, we were unable to identify common progenitor populations that differentiate into both hair cells and supporting cells in the merged datasets.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10323240</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37381908</oboInOwl:hasDbXref>
        <rdfs:label>otic lineage</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000048"/>
        <skos:relatedMatch rdf:resource="CL:0000202"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/50e07c4c-f54a-4172-9635-93c00546113d"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000048"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/50e07c4c-f54a-4172-9635-93c00546113d"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000202"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/50f53aaa-f9e9-4d94-9b2b-d025f00d05ce -->

    <Class rdf:about="http://example.org/50f53aaa-f9e9-4d94-9b2b-d025f00d05ce">
        <obo:IAO_0000115>The proportion of human peripheral blood T cells containing single TCR, multiple TCR, and abnormal TCR were also analyzed (Table S2). The proportion of cells with potential functional TCR detected in frail, adult young, and old individuals were 68.760, 59.847, and 63.186%, respectively (Table 1). The number of T cells with single TCR was significantly higher than that with abnormal TCR and multiple TCR in all samples (Fig. S2E). Among the three groups, the highest proportion of single TCR was found in frail individuals, the multiple TCR proportion was the highest in old individuals, and the proportion of abnormal TCR is relatively higher in young individuals. We screened functional T cells (excluding ##abnormal TCR T cells##) for further analysis, and the T cells with single TCR dominated in all three groups (Fig. S2D). T cells with multiple TCR appeared more frequently (P &lt; 0.05) in the old population compared to frail and young groups (Fig. 3C).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10390570</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37524693</oboInOwl:hasDbXref>
        <rdfs:label>abnormal TCR T cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000084"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/50f53aaa-f9e9-4d94-9b2b-d025f00d05ce"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000084"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/50faa21d-c5de-44a0-9256-da0edcbff4a5 -->

    <Class rdf:about="http://example.org/50faa21d-c5de-44a0-9256-da0edcbff4a5">
        <obo:IAO_0000115>Immune regulation by helminths acts at many levels to interfere with innate antigen sensitization, induction of adaptive immunity, and mobilization of effector mechanisms. 7  One of the most prominent pathways for parasite immunomodulation is through regulatory T-cells (Tregs). Tregs are classified by their expression of the transcription factor Foxp3 (FOXP3 in humans) and can express a number of surface markers that are key for their function, including CD25, cytotoxic T-lymphocyte-associated protein 4 (CTLA-4), inducible T-cell co-stimulator (ICOS) and T-cell immunoreceptor with Ig and ITIM domains (TIGIT). 8  In both mouse and human studies, Tregs are often defined as CD3+ CD4+ CD25+ Foxp3+ cells, although Treg cells comprise a diverse population. During development, the first set of Tregs are formed in the thymus, making up the natural Treg population (nTreg), while a second type of Tregs can be induced in the periphery from naive CD4 T-cells [induced Tregs (iTreg)/peripheral Tregs (pTreg)] in the presence of specific cytokines such as interleukin (IL)-2 and transforming growth factor beta (TGF-beta); however, the expression of Foxp3, and indeed regulatory activity, is variable depending on the level of demethylation at the Foxp3 locus, and recent studies have identified a number of Treg subtypes delineated by CD25, Foxp3 and the epigenome. 9  Regulatory activity can also be found in other lymphocyte subsets, such as the ##Foxp3-IL-10+ Tr1 cells## (previously defined as Th3 10 ), although their role in controlling immune responses in helminth infection has yet to be established.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7341546</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32153025</oboInOwl:hasDbXref>
        <rdfs:label>Foxp3-IL-10+ Tr1 cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000901"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/50faa21d-c5de-44a0-9256-da0edcbff4a5"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000901"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/50139de0-3409-488a-af7d-ae681784495f -->

    <Class rdf:about="http://example.org/50139de0-3409-488a-af7d-ae681784495f">
        <obo:IAO_0000115>Assessment of major transcriptional profile changes between healthy controls (HCs) and MDD patients at the baseline (before antidepressant treatment). A) A brief experimental flowchart. B) Uniform manifold approximation and projection (UMAP) showing selected marker genes expression derived from scRNA-seq data; C) UMAPs of MDD patients and HCs, showing the ten main cell types (CD14+ monocytes, CD16+ monocytes, myeloid dendritic cell (mDC), plasmacytoid dendritic cells (pDC), naive or central memory T cells (naive T), CD4+ T memory cells (CD4+ Tm), CD8+ T memory cells (CD8+ Tm), ##GZMA+CD8+ Tm##, natural killer cells (NK) and B cells). D) Comparison of the proportions of 10 major cell types between MDD patients and HCs. E) Volcano plot showing differential gene expression between myelocytes from HCs and MDD patients before antidepressant treatment. F) Volcano plot showing differential gene expression between lymphocytes from HCs and MDD patients before antidepressant treatment. G) Number of differentially expressed genes in major cell types with red and grey bars indicating genes located within or external to the MDD GWAS risk loci. H, Pathway analysis for differentially expressed genes in naive T, GZMA+CD8+ T, and B cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11321657</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38867657</oboInOwl:hasDbXref>
        <rdfs:label>GZMA+CD8+ Tm</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000909"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/50139de0-3409-488a-af7d-ae681784495f"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000909"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/51b7033e-a1d3-421e-9a7b-e1c82c8e529e -->

    <Class rdf:about="http://example.org/51b7033e-a1d3-421e-9a7b-e1c82c8e529e">
        <obo:IAO_0000115>Nrp1-expresing Skin Tregs and ##CD25-, CD39-, CTLA-4-, or GzmB-expressing Skin Tregs## Form Distinct Subsets</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6534040</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31156643</oboInOwl:hasDbXref>
        <rdfs:label>CD25-, CD39-, CTLA-4-, or GzmB-expressing Skin Tregs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000815"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/51b7033e-a1d3-421e-9a7b-e1c82c8e529e"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000815"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/51c1e1c9-b6f9-4bd4-b458-bd2d4ff90905 -->

    <Class rdf:about="http://example.org/51c1e1c9-b6f9-4bd4-b458-bd2d4ff90905">
        <obo:IAO_0000115>Immunological changes in ##Foxp3+Helios+ and Foxp3+CD25+ Tregs## during T. pallidum/HIV-1 co-infection. The gating strategy for the analysis of Foxp3+CD25+ and Foxp3+Helios+ (A) cells is indicated. The frequencies of Foxp3+CD25+ Treg cells (B) and Foxp3+Helios+ Treg cells (C) were analyzed by flow cytometry in the HC, RPR+, CHI, and CHI&amp;RPR+ groups. Frequencies of Foxp3+CD25+CD45RA+ Treg cells (D), Foxp3+Helios+CD45RA+ Treg cells (E), Foxp3+CD25+CD45RO+ Tregs (F), and Foxp3+Helios+CD45RO+ Tregs (G) were analyzed by flow cytometry in the HC, RPR+, CHI, and CHI&amp;RPR+ groups. The correlations between the CD4+ T-cell counts and the frequencies of Foxp3+Helios+ Treg cells (H) and Foxp3+Helios+CD45RO+ cells (I) in the CHI group were evaluated with Spearman&apos;s rank correlation test. Significance was assessed by calculating p-values using ANOVA, Student&apos;s t-tests, or Mann-Whitney U-tests, with values of p &lt; 0.05 considered significant.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6465566</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31024549</oboInOwl:hasDbXref>
        <rdfs:label>Foxp3+Helios+ and Foxp3+CD25+ Tregs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000815"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/51c1e1c9-b6f9-4bd4-b458-bd2d4ff90905"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000815"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/51012fbf-c89e-40c1-90d1-47062218d508 -->

    <Class rdf:about="http://example.org/51012fbf-c89e-40c1-90d1-47062218d508">
        <obo:IAO_0000115>In the mouse placenta, there are two lineages of trophoblast cells, the invasive and structural cells, which arise from the trophoblast stem progenitor cells. Trophoblast giant cells are the invasive cells responsible for invading the maternal vasculature and transforming the spiral arteries into high-velocity, low-resistant vessels. Four sub-types of trophoblast giant cells exist, including spiral artery trophoblast giant cells and parietal trophoblast giant cells, which reside in the decidual layer. The canal trophoblast giant cells and sinusoidal trophoblast giant cells are in the labyrinth. The structural cells of the placenta include those located within the junctional zone and the remaining cells of the labyrinth. The spongiotrophoblast and glycogen trophoblast cells are within the junctional zone. The spongiotrophoblast cells are thought to contribute a supportive role to the developing labyrinth and feed into the trophoblast giant cell progenitor pool, while ##glycogen cells##, which arise from the spongiotrophoblast cells, are thought to accumulate glycogen and can migrate into the maternal decidua for spiral artery remodeling. The two different types of syncytiotrophoblast cells, syncytiotrophoblast-I and syncytiotrophoblast-II, are located within the labyrinth zone. These cells function in the material exchange between the mother and fetus and, along with the sinusoidal trophoblast giant cells, make up the interhemal membrane. However, the specific functions of some of these cells are not well understood.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10459728</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37630754</oboInOwl:hasDbXref>
        <rdfs:label>glycogen cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000326"/>
        <skos:relatedMatch rdf:resource="CL:0000351"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/51012fbf-c89e-40c1-90d1-47062218d508"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000326"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/51012fbf-c89e-40c1-90d1-47062218d508"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000351"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/512bfb15-15c7-4840-aea8-f91ca6c82942 -->

    <Class rdf:about="http://example.org/512bfb15-15c7-4840-aea8-f91ca6c82942">
        <obo:IAO_0000115>Supporting cells are essential for the function and survival of inner ear hair cells. During development, hair cells and supporting cells derive from a ##common progenitor##, and the correct proportion of these two cell types is regulated by several signaling pathways, most prominently Notch signaling (reviewed by). Interventions that promote conversion of supporting cells into hair cells without replacing the original supporting cells are unlikely to lead to the restoration of a functional organ of Corti. Non-mammalian vertebrates accomplish this by triggering transient proliferation of at least some supporting cells during the regenerative process, and such transient proliferation may be important to promote functional hair cell regeneration in mammals. However, the generation of reprogrammed hair cells can generate new supporting cells in the surrounding tissue through non-cell-autonomous mechanisms, again including Notch signaling. In the present study, we have shown that the production of large numbers of reprogrammed hair cell-like cells in the GER causes the induction of GLAST + supporting cells that interleave the new hair cells. Of note, the new hair cells produced in the GER resemble inner ear hair cells, and our scRNA-seq and antibody characterization shows that the identity of ectopic supporting cells resembles border cells and inner phalangeal cells, two supporting cell types that normally surround inner hair cells. Reprogramming in the GER is, therefore, able to generate appropriately patterned and location-specific mosaics of hair cells and supporting cells similar to those that occur in vivo.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9708077</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36445327</oboInOwl:hasDbXref>
        <rdfs:label>common progenitor</rdfs:label>
    </Class>
    


    <!-- http://example.org/52f364a9-52d2-4c83-b4d3-ae538119eee8 -->

    <Class rdf:about="http://example.org/52f364a9-52d2-4c83-b4d3-ae538119eee8">
        <obo:IAO_0000115>Basal Forebrain Gating by ##Somatostatin Neurons## Drives Prefrontal Cortical Activity.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMID:29161383</oboInOwl:hasDbXref>
        <rdfs:label>Somatostatin Neurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:4023017"/>
        <skos:relatedMatch rdf:resource="CL:4023121"/>
        <skos:relatedMatch rdf:resource="CL:4023122"/>
        <skos:relatedMatch rdf:resource="CL:4042037"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/52f364a9-52d2-4c83-b4d3-ae538119eee8"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4023017"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/52f364a9-52d2-4c83-b4d3-ae538119eee8"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4023121"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/52f364a9-52d2-4c83-b4d3-ae538119eee8"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4023122"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/52f364a9-52d2-4c83-b4d3-ae538119eee8"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4042037"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/520c7347-a2f9-4c3e-971d-914a4269d047 -->

    <Class rdf:about="http://example.org/520c7347-a2f9-4c3e-971d-914a4269d047">
        <obo:IAO_0000115>Ligand-receptor interactions among ##venous cell## populations.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10783777</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38206912</oboInOwl:hasDbXref>
        <rdfs:label>venous cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002543"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/520c7347-a2f9-4c3e-971d-914a4269d047"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002543"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/522e2b4b-66a0-4a70-8795-a1e9b5b08ad2 -->

    <Class rdf:about="http://example.org/522e2b4b-66a0-4a70-8795-a1e9b5b08ad2">
        <obo:IAO_0000115>As can be seen from Fig. 2b, the fibroblasts which highly expressed HBEGF (average expression of HBEGF higher than 1.5) were distributed into a small group. Then we defined them as HBEGF+ fibroblasts and fibroblasts with low expression of HBEGF were defined as HBEGF- fibroblasts. Referring to the previous studies, macrophages with high or low expression of HBEGF were defined as HBEGF+ macrophages and ##HBEGF- macrophages## separately (Fig. 3a).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9446562</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36068607</oboInOwl:hasDbXref>
        <rdfs:label>HBEGF- macrophages</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/522e2b4b-66a0-4a70-8795-a1e9b5b08ad2"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/5244ea7f-6e4d-4539-84e0-36926e75ddd7 -->

    <Class rdf:about="http://example.org/5244ea7f-6e4d-4539-84e0-36926e75ddd7">
        <obo:IAO_0000115>While the heterogeneity of CD103+ TRMs is widely discussed in the literature, the characteristics of TRM subpopulations within the tumor or distant tissues of tumor-bearing mice are less well defined. To characterize tumoral TRMs, scRNA-seq technology provides unprecedented analytical power and allows us to dissect cells with thousands of dimensions. With the hypothesis that particular intratumoral T cells are precursors for TRM development, we extended our scRNA-seq approach to include various effector and memory T cell populations to comprehensively depict their transcriptomic program. From the tumor and distant mucosa of mice bearing established 4T1 tumors, we flow sorted distinct memory T cell populations using a strict gating strategy (Figure S3). We constructed single-cell cDNA libraries from paired intratumoral sorted TCR-beta+CD44+CD62L-CD69+CD103+ cells (##TRMs##), mucosal sorted TCR-beta+CD44+ CD69+CD103+ cells (distant mucosa TRMs), intratumoral TCR-beta+CD44+CD62L+CD69-CD103- cells (TCMs), and TCR-beta+CD44+CD62L-CD69-CD103- cells (TEMs) (Table S2). After data processing and normalization, we performed unbiased clustering and visualized the CD8+ clusters using t-distributed stochastic neighbor embedding (t-SNE; Figure 2A). Through this unsupervised analysis, we found that all four samples could distinctly separate into multiple clusters, confirming continued heterogeneity among the single-cell subsets.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8204287</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33979626</oboInOwl:hasDbXref>
        <rdfs:label>TRMs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000909"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/5244ea7f-6e4d-4539-84e0-36926e75ddd7"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000909"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/526d1c1c-cead-405a-933b-565508927b68 -->

    <Class rdf:about="http://example.org/526d1c1c-cead-405a-933b-565508927b68">
        <obo:IAO_0000115>Oya et al. reported that investigating the gastric cancer-associated TME may aid in identifying new therapeutic targets. Therefore, we performed a correlation analysis between THSD7A and TICs. The results showed that resting mast cells (P&lt;0.001), M2 macrophages (P=0.008), and regulatory T cells (Tregs; P=0.020) were significantly positively correlated with THSD7A expression. In addition, THSD7A expression showed a negative correlation with follicular helper T cells (P&lt;0.001), ##activated memory CD4+ T cells## (P=0.007), and M1 macrophages (P=0.019), as shown in Figure 6.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10683630</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37905960</oboInOwl:hasDbXref>
        <rdfs:label>activated memory CD4+ T cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000897"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/526d1c1c-cead-405a-933b-565508927b68"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000897"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/526812d5-217c-4b1e-baa5-3606953552fc -->

    <Class rdf:about="http://example.org/526812d5-217c-4b1e-baa5-3606953552fc">
        <obo:IAO_0000115>In all tumor tissues, TAMs replaced resident populations such as lung alveolar macrophages, ##prostate CTRB1+ macrophages##, and renal GPX3+ macrophages (Supplementary Fig. 1a, b, and Supplementary Table 1). Plasmacytoid dendritic cells (pDCs) were marginally elevated in lung, colon, and pancreatic cancers, whereas conventional DCs were drastically reduced in colorectal cancer (Supplementary Fig. 1c). T cells exhibited diverse gene expression profiles including naive-like, activated, follicular helper, and regulatory CD4+ T cells, in addition to cytokine-rich, highly cytotoxic, and exhausted CD8+ effector T cells (Supplementary Fig. 1d-f, and Supplementary Table 1). Compared to normal tissues, CD4+ regulatory and follicular helper T cells were commonly elevated, whereas overall cytotoxic immune cell clusters (CD8 Cytotoxic, NK Cytotoxic, and Innate Lymphoid) were reduced (Supplementary Fig. 1g). In contrast, CD8+ T cell states were differentially regulated in each tumor type. The degree of mixing among four datasets in embeddings of CD45+ cells, Myeloid, and T/NK cells was evaluated by LISI metric. Integration of the four datasets was performed appropriately to assign cell identity covering tissue-specific cell types such as lung alveolar macrophages (Supplementary Fig. 1h).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11014989</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38424167</oboInOwl:hasDbXref>
        <rdfs:label>prostate CTRB1+ macrophages</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/526812d5-217c-4b1e-baa5-3606953552fc"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/528a7f1f-e033-4503-b4e6-526638e0e019 -->

    <Class rdf:about="http://example.org/528a7f1f-e033-4503-b4e6-526638e0e019">
        <obo:IAO_0000115>The tumor immune microenvironment of 10 patients with TNBC was resolved after single-cell RNA sequencing data were analyzed according to the standard workflow of Seurat. A total of 21 different types of cell clusters were annotated (Fig. 7a,b): Cancer Cell (WFDC2, SAA1, SCGB2A2), Endothelial Cell (PLVAP, ACKR1, VWF), Epithelial Cell (CLDN3, MUCL1, TFF3), Exhausted CD8 + T Cell (CD8A, CD8B, CXCR6), Fibroblast (DCN, APOD, LUM), Granulosa Cell (SPP1), Leydig Cell (ASPH, SERPINE1, PFN2), M1 Macrophage (CXCL9, CXCL10, CXCL2), M2 Macrophage (SEPP1, F13A1, FOLR2), Memory T Cell (TRAC, TRBC2), Mesenchymal Cell (RGS5, NDUFA4L2), MKI67+ Progenitor Cell (MKI67, RRM2, UBE2C), Naive B Cell (MS4A1, CD79B, BANK1), Natural Killer (NK) Cell (GNLY, TRDC, NKG7), Natural Killer T (NKT) Cell (RGCC, DNAJB1, DNAJA1), Neutrophil (S100A8, S100P, PI3), Plasma Cell (IGKV3-15, IGKC, IGHG1), Plasmacytoid Dendritic Cell (LILRA4, PLD4, NPC2), Regulatory T (Treg) Cell (BATF, TNFRSF18, TNFRSF1B), T Helper Cell (IL7R, CCR7, CD40LG), Tumor Associate Macrophage(##TAM##) (FCN1, VCAN, EREG).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10662149</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37985782</oboInOwl:hasDbXref>
        <rdfs:label>TAM</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/528a7f1f-e033-4503-b4e6-526638e0e019"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/52932db1-a129-486a-b1a2-45d180adeeca -->

    <Class rdf:about="http://example.org/52932db1-a129-486a-b1a2-45d180adeeca">
        <obo:IAO_0000115>(A) Representative conventional flow plots showing cell-surface expression of indicated markers among low-density peripheral blood cells (PBMC), separating iGRANs from monocytes, residual PMN, and lymphocytes, according to the gating strategy shown in Supplemental Figure 2. (B) Single-cell analysis of PBMCs collected from 2 CMML patients with a fraction of 14% or more and 2 with a lower iGRAN fraction; unsupervised clustering of pooled data separating 15 cluster groups in indicated cell categories. Ery, erythroid cells; My, myeloid cells; MK, megakaryocytes; Gran, granulocytes. (C) Dot plot showing the average expression (color scaled) of selected granulocyte genes and the percentage of cells that expressed those genes in indicated granulocytic clusters. (D) UMAP representation of each patient sample, 2 iGRAN-low (&lt;14%) and 2 iGRAN-high (&gt;=14%) CMML patients. (E) Fraction of each cell type in ITGAM+ clusters corresponding to ##CD11b+CD33+ cells## per CMML patient. Colors are cluster codes defined in B. (F) Expression of indicated genes in enriched fraction of iGRANs, monocytes, and neutrophils measured by RT-qPCR and normalized to RPL32, GUS, and GAPDH housekeeping genes (n = 8 CMML patients). Kruskal-Wallis test. (G) Suppressive activity of iGRANs on T cell proliferation. iGRAN-low (&lt;14%, n = 6, left panels) and iGRAN-high (&gt;=14%, n = 6, right panels) PBMCs were labeled with Cell Trace Violet before activating T cells with anti-CD3 and anti-CD28 antibodies; CD4 (upper panels) and CD8 (lower panels) T cell proliferation was measured at day 4 by flow cytometry. We used PBMCs without any manipulation, PBMCs in which iGRAN have been depleted (iGRAN-dep PBMC), and iGRAN-dep PBMCs with addition of 10% sorted iGRANs. T cell proliferation (%) is relative to the highest proliferation, observed with iGRAN-dep PBMCs. One-way ANOVA, Tukey&apos;s multiple comparison. *P &lt; 0.05; **P &lt; 0.01; ***P &lt; 0.001; ****P &lt; 0.0001.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11563679</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:39545419</oboInOwl:hasDbXref>
        <rdfs:label>CD11b+CD33+ cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000889"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/52932db1-a129-486a-b1a2-45d180adeeca"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000889"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/53d857b9-9059-484b-a8fd-4e37367017aa -->

    <Class rdf:about="http://example.org/53d857b9-9059-484b-a8fd-4e37367017aa">
        <obo:IAO_0000115>Acinar cells secrete digestive enzymes vital for proper gastrointestinal function. They have high levels of protein synthesis and, during fasting, a correspondingly high protein catabolism. In our ##exocrine MVEC## samples, we found multiple enriched gene sets that relate to biosynthesis and biomolecule catabolism. These findings could reflect an increased turnover of proteins also in these cells. No statistically significant enrichment was found in gene sets related to autophagy or endoplasmic reticulum (ER) stress, albeit there was a tendency towards enrichment in sets related to ER stress.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7749106</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33339897</oboInOwl:hasDbXref>
        <rdfs:label>exocrine MVEC</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:2000008"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/53d857b9-9059-484b-a8fd-4e37367017aa"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:2000008"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/53f7fcd9-37e9-46a1-9150-e458141ea149 -->

    <Class rdf:about="http://example.org/53f7fcd9-37e9-46a1-9150-e458141ea149">
        <obo:IAO_0000115>Our novel multi-color flow cytometry panel was also tested on mouse skin. After excluding cellular debris, doublets, and dead cells, we gated with the help of FMO controls (Fig. S10) on viable CD45+ cells (Fig. 2A). In healthy skin, the CD3+ T cell population consists of CD3intCD4+ T cells and CD3highgammadelta T cells, whereas CD8+ T cells, NK cells, B cells, neutrophils and pDC are rare in healthy skin (Fig. 2B). By following gating published earlier, we identified several myeloid non-DC populations (P1-P5) in the dermis (Fig. 2C) and different DC-subsets (Fig. 2D, E). From the non CD11b+CD24- population we identified CD11c+MHC-II+ DC. Next, we divided DC into XCR1+ cDC1, which contain CD103+ and CD103- subsets, and ##CD172a+ DC## which consists mainly of CD207+ LC (Fig. 2D). Dermal cDC2 are characterized from the CD64-Ly-6C- population by gating on CD11c+MHC-II+ cells that express CD11b and CD172a (Fig. 2E). In addition, we investigated CD115, F4/80 and CD64 expression on the non-DC myeloid cell populations P1-P5 (Fig. 2F). Analysis of CD40, PD-L1, PD-L2 and CCR7 on the different DC-subets allows further phenotypical characterization (Fig. 2G). An example for UMAP analysis is shown in Figure S11 confirming manual gating for DC-subsets and non-DC populations.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10087122</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35944142</oboInOwl:hasDbXref>
        <rdfs:label>CD172a+ DC</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000451"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/53f7fcd9-37e9-46a1-9150-e458141ea149"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000451"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/530185e7-0c78-4ccc-9c8b-c4014d7515db -->

    <Class rdf:about="http://example.org/530185e7-0c78-4ccc-9c8b-c4014d7515db">
        <obo:IAO_0000115>A, B, tSNE plot of 4659 CD45+ immune cells from the CNS. Data from this study is integrated with data from; Table 6). C, D, Each dataset represented by one tSNE. Cells are annotated using color representing their cell type. bMicroglia: ##baseline microglia##; aMicroglia: activated microglia; pmMicroglia: proliferation-mediating microglia; maMicroglia: monocyte-activating microglia; DAM: disease-associated microglia in SCI; elMicroglia: embryonic-like microglia; pvMacrophages: perivascular macrophages; mdMacrophages: monocyte-derived macrophages; DCs: dendritic cells; imB-cells: immature B-cells; mB-cells: mature B-cells; pimMicroglia: postnatal immature microglia; IEG+Microglia: immediate early genes microglia; sMicroglia: s-phase microglia; pPAM: postnatal proliferative-region-associated microglia; eMicroglia: embryonic microglia; pcpMacrophages: postnatal choroid plexus macrophages; acpMacrophages: adult choroid plexus macrophages; iMonocytes: inflammatory monocytes; pMonocytes: patrolling monocytes; cpEpithelial cells: choroid plexus epithelial cells. E, tSNE plots of 4659 CD45+ immune cells for selected genes indicating the log2(cpm) expression with a continuous color for each cell separately. F, Proliferation rate of CD45low and CD45high cells at 7 and 21 d post-SCI. Hoechst 33342 expression presented on a log-scale was used for defining cells in S-phase. Right most plot reports the percentage of cells in S-phase. Each dot represents one biological replicate (four mice per time point). Mean is surrounded by a 95% CI. This figure is extended in Extended Data Figure 8-1.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8496189</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34417326</oboInOwl:hasDbXref>
        <rdfs:label>baseline microglia</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000129"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/530185e7-0c78-4ccc-9c8b-c4014d7515db"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000129"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/5334d5f9-5fd5-42d4-9f01-1608e5df7ec5 -->

    <Class rdf:about="http://example.org/5334d5f9-5fd5-42d4-9f01-1608e5df7ec5">
        <obo:IAO_0000115>Skeletal stem and progenitor cell populations are crucial for bone physiology. Characterization of these cell types remains restricted to heterogenous bulk populations with limited information on whether they are unique or overlap with previously characterized cell types. Here we show, through comprehensive functional and single-cell transcriptomic analyses, that postnatal long bones of mice contain at least two types of bone progenitors with bona fide skeletal stem cell (##SSC##) characteristics. An early osteochondral SSC (ocSSC) facilitates long bone growth and repair, while a second type, a perivascular SSC (pvSSC), co-emerges with long bone marrow and contributes to shape the hematopoietic stem cell niche and regenerative demand. We establish that pvSSCs, but not ocSSCs, are the origin of bone marrow adipose tissue. Lastly, we also provide insight into residual SSC heterogeneity as well as potential crosstalk between the two spatially distinct cell populations. These findings comprehensively address previously unappreciated shortcomings of SSC research.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8289409</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34280086</oboInOwl:hasDbXref>
        <rdfs:label>SSC</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000134"/>
        <skos:relatedMatch rdf:resource="CL:0007001"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/5334d5f9-5fd5-42d4-9f01-1608e5df7ec5"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000134"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/5334d5f9-5fd5-42d4-9f01-1608e5df7ec5"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0007001"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/535663a5-fcbe-4451-9ad3-b14a6dfc9467 -->

    <Class rdf:about="http://example.org/535663a5-fcbe-4451-9ad3-b14a6dfc9467">
        <obo:IAO_0000115>scRNA sequencing data was analyzed to further explore the synergistic effect of the IRRS and the TME cells in ESCC. We used the previously profiled transcriptomes of ~208,659 single cells with eight main cell populations ( Figures 4A, B ), among which fibroblasts, endothelial cells, T cells, B cells, pericytes and myeloid cells were analyzed. Next, 40 cell clusters, including T helper 17 (TH17) cells, follicular helper T (TFH1/2) cells, naive T (TN) cells, regulatory T (Treg) cells, memory T (TMEM-CD4/CD8) cells, effector T (TEFF) cells, exhausted T (TEX) cells, monocytes (Mono01-03), tumor-associated macrophages (TAM01-04),dendritic cells (##tDC##, pDC, cDC), mast cells (Mast), resting B cells, activated B cells, germinal center B cells (GCB), plasma cells, normal mucosa fibroblasts (NMF), normal activated fibroblasts (NAF1/2), cancer-associated fibroblasts (CAF1-4), vascular smooth muscle cells (VSMC), normal endothelial cells (NEC1-3) and tumor endothelial cell (TEC1-3) were identified by t-SNE analysis ( Figures 4C-G ;  Figures S6A-E ). We then used CIBERSORTx to infer cell-type abundance from bulk RNA-seq data using scRNA data, and estimated the proportions of the 42 cell types in the training dataset. The proportions of TME cell types between the high- and low-risk groups was compared using the Kruskal-Wallis test. The profiles of the high- and low-risk groups are shown in  Figure 4H  and  Figure S6F . The abundance of TEX, NAF2, CAF4, and VSMC increased, and the abundance of Mono1, TAM03, and NEC2 decreased in the high-risk group (p &lt; 0.05;  Figure 4I ). The cell proportions between low and high risk groups demonstrated significantly distinct TME patterns.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9933905</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36817484</oboInOwl:hasDbXref>
        <rdfs:label>tDC</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000451"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/535663a5-fcbe-4451-9ad3-b14a6dfc9467"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000451"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/54c2863f-2fd7-46de-804c-51d266796a23 -->

    <Class rdf:about="http://example.org/54c2863f-2fd7-46de-804c-51d266796a23">
        <obo:IAO_0000115>For the CM/CF/CS production bioprocess, the following stem and progenitor cell types are of interest: pluripotent stem cells:embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs); adult stem cells (ASCs):mesenchymal stem cells (MSCs), adipose tissue-derived stem cells (ADSCs) and fibro-adipogenic progenitors (FAP), as well as ##resident muscle stem cells##/muscle satellite cells (SCs), a.k.a. myosatellites and myoblasts as progenitors or more precisely, proliferating activated SCs. </obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9138761</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35625626</oboInOwl:hasDbXref>
        <rdfs:label>resident muscle stem cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000056"/>
        <skos:relatedMatch rdf:resource="CL:0008011"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/54c2863f-2fd7-46de-804c-51d266796a23"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000056"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/54c2863f-2fd7-46de-804c-51d266796a23"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0008011"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/540a3856-1b62-4931-b3db-1a09d86b6a98 -->

    <Class rdf:about="http://example.org/540a3856-1b62-4931-b3db-1a09d86b6a98">
        <obo:IAO_0000115>Overview of interactions among chondrocyte subtypes. (A,B) Total number and intensity of interactions in chondrocytes. (C-J) Interactions between different subtypes of chondrocytes. (C) indicates undefined cell subtypes, (D) indicates ECs, (E) indicates FCs, (F) indicates HomCs, (G) indicates HTCs, (H) indicates preHTCs, (I) indicates ProCs, and (J) indicates ##RegCs##.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10475121</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37660146</oboInOwl:hasDbXref>
        <rdfs:label>RegCs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000138"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/540a3856-1b62-4931-b3db-1a09d86b6a98"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000138"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/54192959-7b99-40c8-88ff-dc582229877e -->

    <Class rdf:about="http://example.org/54192959-7b99-40c8-88ff-dc582229877e">
        <obo:IAO_0000115>a Due to single-cell annotation and in situ validation (Fig. 2; Supplementary Fig. 3), a draft model of the oral-to-tooth transition zone in humans is presented, with basal and suprabasal keratinocyte markers uniquely identifying the alveolar mucosa (AM), attached gingiva (AG), gingival margin (GM), sulcular epithelium (SK) and junctional epithelium (JK). b These markers allowed for KRT19-high keratinocyte (KC) cell subclustering for the first time (2504 cells in total), including gingival margin keratinocytes (GM), ##sulcular keratinocytes## (SK), and junctional keratinocytes (JK). c A more granular draft (Tier 4) annotation of epithelial cells of the gingival attachment. d Assaying differentially expressed genes in periodontitis, SKs and JKs only share about a quarter of upregulated genes. JKs displayed nearly 125 unique upregulated genes in diseased cells. e Further analysis of basal and suprabasal (differentiating) SK and JK keratinocytes revealed unique cell signatures between basal and suprabasal cell types. This full list is included in Supplementary Data 1. f-i To understand SK and JK developmental progression and cell state alterations, we used partitioned-based graph abstraction (PAGA). f Examining the basal to suprabasal transition, JKs display altered gene expressed comparing health to disease cell types, including broader expression of KRT17 and more expression of JUND, COL17A1, and CDH3. Key differentiation genes such as SPRR family members were also downregulated. g JKs displayed robust cell signaling and inflammatory phenotypes, which appear exacerbated in disease states. h In SKs, differentiation-related genes were uniquely expressed compared to JKs in health but also appeared altered in disease along the basal to suprabasal trajectory. i SKs appeared generally less reactive compared to JKs in disease, with lower overall expression of effector molecules such as CXCL1, CXCL8, IL1A, IL1B, and IL1RN. Abbreviations: Merk Merkel Cells, LC langerhans cells, Mela melanocytes, Muc mucosa, SB suprabasal Keratinocytes; for others, see Fig. 1 legend. For this figure, n = 30-sample, 2504-cell for scRNAseq.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11178863</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38876998</oboInOwl:hasDbXref>
        <rdfs:label>sulcular keratinocytes</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002170"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/54192959-7b99-40c8-88ff-dc582229877e"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002170"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/5442690e-37c7-48bc-ab4e-7c578a9fa59e -->

    <Class rdf:about="http://example.org/5442690e-37c7-48bc-ab4e-7c578a9fa59e">
        <obo:IAO_0000115>Our results so far indicate that the dura mater layer of the meninges contains a diverse population of stromal cells, including GP38+ and GP38- stromal cells that resemble the stroma of other lymphoid tissues and ECM remodelling. Consistent with our scRNAseq data, using flow cytometry, we observed a significant expansion of GP38+ FRCs, and a distinctive population of MAdCAM1+ CD21/CD35+ cells indicative of the presence of FDC-like cells in the infected murine meninges compared to naive controls (Fig 3D-3F; Gating strategy in S2A Fig, S5 and S6 Data), without significant changes in the lymphatic endothelial cells (LECs) or blood endothelial cells (BECs) (Fig 3E and 3F). Furthermore, using module scoring analysis, which allows us to assess global gene signatures associated with a gene set or pathway (in this case, ectopic lymphoid tissue signatures), we were able to identify that cells within cluster 5 were enriched for genes associated with FDC-like function and stromal lymphoid tissues, including Ccl19 and Cxcl13, compared to the other fibroblast clusters (Fig 3H), and may be derived from ##Ly6a+ pericytes## with a precursor capacity as previously reported. Indeed, using in situ hybridisation on independent tissue sections, we were able to confirm the presence of Ly6a+ Rarres2+ cells that expressed Cxcl13+ during infection (Fig 3I). Together, our data demonstrate the presence of a rich diverse fibroblast population, encompassing Ly6a+ Rarres2+ FRC-like pericytes, including Aldh1a2+ Ccl19+ FRC-like pericytes, myofibroblasts, Fth1+ fibroblasts, and perivascular dura fibroblasts. Our data also suggests that chronic T. brucei infection induces an extensive remodelling of the meningeal stroma compartment, resulting in the expansion of FRCs and FDC-like cells without significant changes in the vasculature (LECs and BECs).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10723712</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37983289</oboInOwl:hasDbXref>
        <rdfs:label>Ly6a+ pericytes</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000669"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/5442690e-37c7-48bc-ab4e-7c578a9fa59e"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000669"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/5454d7b9-5655-496e-b2ca-fd63eb98e782 -->

    <Class rdf:about="http://example.org/5454d7b9-5655-496e-b2ca-fd63eb98e782">
        <obo:IAO_0000115>The retinal neurovascular unit refers to the interdependency between ##vascular endothelial cells##, pericytes, glia, neurons, and immune cells. A better understanding of the contribution of each cell type to DR progression and the molecular mechanisms regulating their crosstalk could be the key to identify new therapeutic targets. In addition to retinal vascular alterations, fibrovascular scarring can ultimately lead to blindness. Fibrosis is an intricate, reparative process that develops in response to acute or chronic injury. The mechanisms that drive fibrosis in DR are not fully understood; hence, there is a great need to better understand this important cause of vision loss. This would be a first step toward new therapies to address progressive preretinal fibrosis and traction detachment and to avoid the concomitant poor visual and anatomic outcomes.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10896003</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37917183</oboInOwl:hasDbXref>
        <rdfs:label>vascular endothelial cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002585"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/5454d7b9-5655-496e-b2ca-fd63eb98e782"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002585"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/5456c00c-5e78-4fca-a530-4d361f67a862 -->

    <Class rdf:about="http://example.org/5456c00c-5e78-4fca-a530-4d361f67a862">
        <obo:IAO_0000115>Rct Random controlled trial, CCT Controlled clinical trial, PBMNCs Peripheral blood-derived mononuclear cells, BMMSCs Bone marrow-derived mesenchymal stem cells, PLAS Human processed lipoaspirate cells, BMMNCs Bone marrow-derived mononuclear cells, BMDC Bone marrow-derived cells, BMTRCs Bone marrow-enriched tissue repair cells, PBPCs Peripheral blood progenitor cells, ##PBMSCs## Peripheral blood mesenchymal stem cells, HUCMSCs Human umbilical cord mesenchymal stem cells, MFAT Micro-fragmented adipose tissue, i.m. Intramuscular injection, i.a. Intra-arterial injection, i.r.w. Injected radially into the wound, Ad.us.ext, ad usum externum (for external use), NS Normal saline, PBS Phosphate-buffered saline</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9375292</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35964145</oboInOwl:hasDbXref>
        <rdfs:label>PBMSCs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000134"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/5456c00c-5e78-4fca-a530-4d361f67a862"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000134"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/55b212af-f8f2-46eb-ba26-ed218b1b050c -->

    <Class rdf:about="http://example.org/55b212af-f8f2-46eb-ba26-ed218b1b050c">
        <obo:IAO_0000115>Identification of cell types from whole-brain cells. a UMAP plot shows the unsupervised clustering of 16,028 cells derived from mouse brain (for details, see &quot;Methods&quot;). The 15 cell types were classified by their transcriptional profiles. b Dot plot shows the expression levels of a representative cell-specific marker gene for each cell type. c UMAP plot shows the distribution of Olig2 expression. d Violin plot shows Olig2 expression across all clusters. e UMAP plot shows the distribution of GFAP expression. f Violin plot shows GFAP expression across all clusters. g A total of 3522 cells of the astrocyte subset were derived from cells in mouse brain. They were classified into Olig2(+)/GFAP(-) astrocytes (347 cells), Olig2(+)/GFAP(+) astrocytes (104 cells), ##Olig2(-)/GFAP(+) astrocytes## (848 cells) and Olig2(-)/GFAP(-) astrocytes (2,223 cells). immNEU immature neuron, mNEU mature neuron, OPC oligodendrocyte precursor cell, immOLG immature oligodendrocyte, OLG oligodendrocyte, ASC astrocyte, OEG olfactory ensheathing glia, MG microglia; MAC macrophage, EC endothelial cell, PC pericyte, EPC ependymal cell, VLMC vascular and leptomeningeal cell, ABC arachnoid barrier cell, CP cycling progenitor</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8573876</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34749773</oboInOwl:hasDbXref>
        <rdfs:label>Olig2(-)/GFAP(+) astrocytes</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000127"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/55b212af-f8f2-46eb-ba26-ed218b1b050c"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000127"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/55c7dfe9-d9e5-4fbc-ba0f-23adea7dc6be -->

    <Class rdf:about="http://example.org/55c7dfe9-d9e5-4fbc-ba0f-23adea7dc6be">
        <obo:IAO_0000115>For the CM/CF/CS production bioprocess, the following stem and progenitor cell types are of interest: pluripotent stem cells:embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs); ##adult stem cells## (ASCs):mesenchymal stem cells (MSCs), adipose tissue-derived stem cells (ADSCs) and fibro-adipogenic progenitors (FAP), as well as resident muscle stem cells/muscle satellite cells (SCs), a.k.a. myosatellites and myoblasts as progenitors or more precisely, proliferating activated SCs. </obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9138761</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35625626</oboInOwl:hasDbXref>
        <rdfs:label>adult stem cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000034"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/55c7dfe9-d9e5-4fbc-ba0f-23adea7dc6be"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000034"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/55cda92d-4192-4ec3-b06b-c73a6b2b63f9 -->

    <Class rdf:about="http://example.org/55cda92d-4192-4ec3-b06b-c73a6b2b63f9">
        <obo:IAO_0000115>Notably, several ##neural crest-derived cell types## outside the Schwann cell lineage are derived from both the neural crest and Schwann cell precursors. One example is the melanocytes, which differentiate either directly from neural crest cells or from Schwann cell precursors, following their migration along nerves. A similar mechanism might possibly be true for enteric glia, as both neural crest cells and Schwann cell precursors were found to populate the gut to differentiate. To date, further cell types which can develop from Schwann cell precursors include endoneurial fibroblasts; postganglionic parasympathetic neurons; enteric neurons; neuroendocrine chromaffin cells of the adrenal medulla and Zuckerkandl organ, a small population of sympathetic neurons in paraganglia; dental pulp mesenchymal stromal cells; and even chondrocytes and osteocytes; as well as, possibly, recently discovered immune-regulating splenic glia. This remarkable developmental potential of multipotent Schwann cell precursors clearly indicates that no terminal commitment to the Schwann cell lineage has happened at this stage. Indeed, recent work using single-cell transcriptomics has confirmed that early Schwann cell precursors are highly similar to late migratory neural crest cells and exhibit multipotency towards various cell fates, while late Schwann cell precursors that progress towards the Schwann cell fate become gradually more restricted. </obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9739763</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36497014</oboInOwl:hasDbXref>
        <rdfs:label>neural crest-derived cell types</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0011012"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/55cda92d-4192-4ec3-b06b-c73a6b2b63f9"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0011012"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/55d6d018-9f2a-45a5-8f1e-cf86ff2185f6 -->

    <Class rdf:about="http://example.org/55d6d018-9f2a-45a5-8f1e-cf86ff2185f6">
        <obo:IAO_0000115>Brain transcriptional changes after MIA require microglia. (A) Simplified schematic of sample processing pipeline from and bar plots of TORCH pathogen and cytokine receptor expression (mean log counts per million) in each cell type across development. (B) Violin plot of CytoTORCH module score for each cell cluster (MG, P&lt;0.05 for ANOVA and for pairwise comparisons between microglia and all other cell types using Tukey&apos;s HST). (C) Overview of experimental design (top) and UMAP visualization of snRNAseq data from the developing somatosensory cortex of E15.5 wild-type and Csf1r-/- mice after saline or Poly(I:C) maternal injection at E12.5 (two or three embryos per condition from a total of four pregnant dams, 42,736 total cells) (bottom). Cells are colored by cell type assignment. (D) Dot plots of log(fold change) in gene expression between MIA and saline for cell types with significant changes at E15.5. DEG analysis was performed using NEBULA. ##AP##, apical progenitors; IP, intermediate progenitors; ImmN, immature neurons, MN, migrating neurons; (UL/DL) CPN, (upper layer/deep layer) callosal projection neurons; SCPN, subcerebral projection neurons; CThPN, corticothalamic projection neurons; LIV, layer IV stellate neurons; IN, interneurons; CR, Cajal-Retzius cells; Astro, astrocytes; CGC, cycling glial cells; Epend; ependymal cells; OL, oligodendroglia; MG, microglia; Peri, pericytes; EC, endothelial cells; VLMC, vascular and leptomeningeal cells. Created with .</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11190434</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38775708</oboInOwl:hasDbXref>
        <rdfs:label>AP</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000031"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/55d6d018-9f2a-45a5-8f1e-cf86ff2185f6"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000031"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/550f9b56-7879-4144-ae36-0acea5c4c47c -->

    <Class rdf:about="http://example.org/550f9b56-7879-4144-ae36-0acea5c4c47c">
        <obo:IAO_0000115>Natural killer (NK) cells are the most abundant leukocytes located at the maternal-fetal interface; they respond to the pregnancy-related hormones and playing a pivotal role in maintaining homeostatic micro-environment during pregnancy. However, due to the high heterogeneity of NK cell subsets, their categorization has been controversial. Here, we systematically review previous studies on ##uterine NK (uNK) cell## subsets, including the classic categorization based on surface markers, functional molecules and developmental stages, as well as single-cell RNA sequencing (scRNA-seq)-based clustering approaches. In addition, we summarize the potential pathways by which endometrial NK (eNK) cells differentiate into decidual NK (dNK) cells, as well as the differentiation pathways of various dNK subsets. Finally, we compared the alterations in the NK cell subsets in various pregnancy-associated diseases, emphasizing the possible contribution of specific subsets to the development of the disease.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMID:39570646</oboInOwl:hasDbXref>
        <rdfs:label>uterine NK (uNK) cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000623"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/550f9b56-7879-4144-ae36-0acea5c4c47c"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000623"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/5501fead-4fbf-4388-a0d0-9eb0dd93db8b -->

    <Class rdf:about="http://example.org/5501fead-4fbf-4388-a0d0-9eb0dd93db8b">
        <obo:IAO_0000115>The cellular content of human myocardium (in descending order by number) predominantly consists of cardiomyocytes, fibroblasts, pericytes and smooth muscle cells, endothelial cells, and immune cells. In the murine heart, macrophage populations can be discerned based on their expression of C-C chemokine receptor type 2 (CCR2), major histocompatibility complex-II (MHC-II), T cell immunoglobulin and mucin domain containing 4 (TIMD4), and Lymphatic Vessel Endothelial Hyaluronan Receptor 1 (LYVE1). Four populations of macrophages have been identified in the murine heart (Fig. 1). The minority are two subsets of CCR2+MHC-IIhigh macrophage populations derived from hematopoietic stem cells, whereas the most dominant subset, cardiac resident macrophages derived from the yolk sac, are CCR2-MHC-IIlowTIMD4+LYVE1-. There also exists a fourth subset that consists of ##CCR2-MHC-IIhighTIMD4+LYVE1+ macrophages##, which are likely derived from CCR2-MHC-IIlow macrophages during postnatal development and partially maintained by CCR2+MHC-IIhigh macrophages. CCR2+MHC-IIhigh macrophages populate the heart soon after birth and are maintained through monocyte recruitment and proliferation. Also, under homeostasis, cardiac macrophages continually self-renew with a turnover period of almost 5 weeks. Recently, this same CCR2+ and CCR2- macrophage distinction has been identified in humans, with the yolk sac-derived CCR2- human counterpart showing CD14+CD45+CD64+CCR2-HLA-DRhigh expression. In a more recent study, Tucker et al. reported two cardiac macrophage subsets within the human heart, which were positive for CD163, COLEC12, mannose receptor MRC1, E3 ubiquitin ligase MARCH1, and natural resistance-associated macrophage protein 1 (NRAMP1). Both of the identified subsets expressed anti-inflammatory (M2) polarization-associated genes, whereas one subset particularly expressed RBPJ, F13A1 and the other expressed transmembrane collagen COL23A1.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9242717</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34088222</oboInOwl:hasDbXref>
        <rdfs:label>CCR2-MHC-IIhighTIMD4+LYVE1+ macrophages</rdfs:label>
    </Class>
    


    <!-- http://example.org/55048a3d-df7d-4e1e-9a97-e6665a002551 -->

    <Class rdf:about="http://example.org/55048a3d-df7d-4e1e-9a97-e6665a002551">
        <obo:IAO_0000115>Neutrophil CD64 expression has been used as a diagnostic marker of infection and sepsis in the ICU and was found to be superior to C-reactive protein and hematological determinations for detecting systemic infection or sepsis. However, these studies did not distinguish between the differential marker expression due to mature neutrophil activation or due to appearance of another neutrophil population. Because we observed no CD64 expression on mature neutrophils, either from NDN or LDN fractions in GCA (Figure 1), we hypothesize that detection of CD64 expression on neutrophils in sepsis is likely to represent the presence of ##CD10loCD64+ myelocytes/metamyelocytes## in the neutrophil pool. Coincidentally, in a recently deposited open-access manuscript, Meghraoui-Kheddar et al. used a similar single-cell CyToF strategy to identify 2 CD64+ neutrophil subsets unequivocally associated with an onset of sepsis. CD123 and PD-L1 were reported to be the additional and distinctive cellular markers for sepsis-induced CD64+ immature neutrophils compared with noninfectious inflammatory syndrome. Indeed, we observed no CD123 and very weak PD-L1 expression on CD64+ immature neutrophils of GCA patients (Figure 1), supporting a possible new demarcation between CD10loCD64+ released in response to infection and sterile inflammation.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7605529</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32960815</oboInOwl:hasDbXref>
        <rdfs:label>CD10loCD64+ myelocytes/metamyelocytes</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002192"/>
        <skos:relatedMatch rdf:resource="CL:0002193"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/55048a3d-df7d-4e1e-9a97-e6665a002551"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002192"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/55048a3d-df7d-4e1e-9a97-e6665a002551"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002193"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/5510224f-e6fe-49a7-b31b-04eb414c4ccb -->

    <Class rdf:about="http://example.org/5510224f-e6fe-49a7-b31b-04eb414c4ccb">
        <obo:IAO_0000115>Variants within the high copy number mitochondrial genome (mtDNA) can disrupt organelle function and lead to severe multisystem disease. The wide range of manifestations observed in patients with mitochondrial disease results from varying fractions of abnormal mtDNA molecules in different cells and tissues, a phenomenon termed heteroplasmy. However, the landscape of heteroplasmy across cell types within tissues and its influence on phenotype expression in affected patients remains largely unexplored. Here, we identify nonrandom distribution of a pathogenic mtDNA variant across a complex tissue using single-cell RNA-Seq, mitochondrial single-cell ATAC sequencing, and multimodal single-cell sequencing. We profiled the transcriptome, chromatin accessibility state, and heteroplasmy in cells from the eyes of a patient with mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) and from healthy control donors. Utilizing the retina as a model for complex multilineage tissues, we found that the proportion of the pathogenic m.3243A&gt;G allele was neither evenly nor randomly distributed across diverse cell types. All ##neuroectoderm-derived neural cells## exhibited a high percentage of the mutant variant. However, a subset of mesoderm-derived lineage, namely the vasculature of the choroid, was near homoplasmic for the WT allele. Gene expression and chromatin accessibility profiles of cell types with high and low proportions of m.3243A&gt;G implicate mTOR signaling in the cellular response to heteroplasmy. We further found by multimodal single-cell sequencing of retinal pigment epithelial cells that a high proportion of the pathogenic mtDNA variant was associated with transcriptionally and morphologically abnormal cells. Together, these findings show the nonrandom nature of mitochondrial variant partitioning in human mitochondrial disease and underscore its implications for mitochondrial disease pathogenesis and treatment.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10443808</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37289546</oboInOwl:hasDbXref>
        <rdfs:label>neuroectoderm-derived neural cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000133"/>
        <skos:relatedMatch rdf:resource="CL:0002319"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/5510224f-e6fe-49a7-b31b-04eb414c4ccb"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000133"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/5510224f-e6fe-49a7-b31b-04eb414c4ccb"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002319"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/554d37c3-6944-4c45-a1da-82aa0772afd2 -->

    <Class rdf:about="http://example.org/554d37c3-6944-4c45-a1da-82aa0772afd2">
        <obo:IAO_0000115>a Schematic of the experimental pipeline. Created with BioRender.com b UMAP visualization of peritoneal immune cells. c Ratio of each population in cell number. d VlnPlot of characteristic gene expressions for macrophage subpopulations. Sham sham control, ELL endometriosis-like lesions, ELL_N niclosamide administration to ELL-induced mouse, Pre-SPMs premature &quot;small&quot; peritoneal macrophages, ##SPMs## &quot;small&quot; peritoneal macrophages, IM1-3 intermediate macrophages subtype 1-3, Timd4+ LPMs Timd4+ &quot;large&quot; peritoneal macrophages, PMs proliferating macrophages, B1a B1a cells, B1b B1b cells, B2 B2 cells, GCBs germinal-centre B cells, PBs plasma blast B cells, Cd4+ Ts Cd4+ T cells, Cd8+ Ts Cd8+ T cells, DN1 double negative T cells 1, DN2 double negative T cells 2, cDC1 conventional dendritic cells 1, MCs Mast cells, NTPs neutrophils.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9652344</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36369244</oboInOwl:hasDbXref>
        <rdfs:label>SPMs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000581"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/554d37c3-6944-4c45-a1da-82aa0772afd2"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000581"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/56bac103-12e6-4f75-9799-18b358200c22 -->

    <Class rdf:about="http://example.org/56bac103-12e6-4f75-9799-18b358200c22">
        <obo:IAO_0000115>RT effects on cell senescence and apoptosis. Primary ##CAF## cultures were checked for senescence (beta-Galactosidase assay,:panel A) and apoptosis (TUNEL assay:panel B) at day five after first radiation exposure. High extent of premature cell senescence (blue-stained cells), but not apoptosis was induced by high-dose radiation regimen. Scale Bar = 15 mum.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8127688</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33899109</oboInOwl:hasDbXref>
        <rdfs:label>CAF</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000057"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/56bac103-12e6-4f75-9799-18b358200c22"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000057"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/56cc78e5-48d3-4f96-afbb-9550871eb03d -->

    <Class rdf:about="http://example.org/56cc78e5-48d3-4f96-afbb-9550871eb03d">
        <obo:IAO_0000115>Several reports found that circulating blood or bone-marrow-derived cells of the monocyte-macrophage lineage are progenitors of LECs in lymphatic neovascularization under pathological conditions. Thus, peripheral blood monocytes were stimulated in vitro to induce podoplanin and other lymphatic endothelial markers by mimicking an inflammatory environment with VEGF-C, fibronectin, TNF-alpha, IL-3, or LPS (Table 1). Also, CD34+ human fetal liver-derived cells expressing CD133, podoplanin, and VEGFR-3, as well as podoplanin-positive mouse bone-marrow-derived cells, were found to behave as ##LEC progenitors## and contribute to postnatal lymphatic neovascularization. More recently, Cimini and colleagues found that the podoplanin-positive cell population associated with the lymphangiogenic and fibrogenic responses during myocardial wound repair after infarction is widely heterogeneous and displays epitopes of fibrogenic and endothelial commitment, suggesting an alternate ability of podoplanin-positive cardiac cells to generate lymphatic endothelium and pro-fibrotic cells. In a pioneering work, Maruyama and coworkers reported the incorporation of mouse CD11b+ and F4/80+ macrophages into lymphatic vessels in the inflamed cornea. These cells, which express podoplanin, LYVE-1. and VEGFR-3 lymphatic markers, were critical for the development and maintenance of inflammation-dependent lymphangiogenesis. In fact, a reduction in the number of these podoplanin-positive cells was associated with delayed wound repair in diabetic mice. Interestingly, podoplanin neutralization with a specific monoclonal antibody (mAb) resulted in suppression of lymphangiogenesis and macrophage infiltration during corneal inflammation and ear wound healing, pointing to podoplanin as a novel therapeutic target for lymphangiogenesis and macrophage-related inflammation.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6386838</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:30736372</oboInOwl:hasDbXref>
        <rdfs:label>LEC progenitors</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002138"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/56cc78e5-48d3-4f96-afbb-9550871eb03d"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002138"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/56e0b6e6-120c-471a-8793-70af7fe09da9 -->

    <Class rdf:about="http://example.org/56e0b6e6-120c-471a-8793-70af7fe09da9">
        <obo:IAO_0000115>In summary, from work done in frontal areas, it is clear that I-S cells are involved in enhancing learning and memory discrimination, are recruited during theta rhythms, and primarily target SOM+ cells, but also ##PV+ cells## (i.e., similar to hippocampal CA1 I-S3 cells; Figures 1A,B). Further characterization of VIP+ cell types in frontal areas is needed to distinguish how much I-S cell types in these areas contact pyramidal cells, compared to non-I-S VIP+ cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7296096</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32581726</oboInOwl:hasDbXref>
        <rdfs:label>PV+ cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:4023018"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/56e0b6e6-120c-471a-8793-70af7fe09da9"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4023018"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/56e2dd8f-8d63-4fe0-a832-3ae1056a1cf8 -->

    <Class rdf:about="http://example.org/56e2dd8f-8d63-4fe0-a832-3ae1056a1cf8">
        <obo:IAO_0000115>To decipher the cellular composition of CRC in a larger population, we employed the newly developed deconvolution tool CIBERSORTx.Signature templates derived from the SMC cohort were created with simplified T-cell subgroups: CD4+ T cells, Treg cells, CD8 + T cells, TEX cells and ILCs (Fig. 2A, Additional file 4: Table S4). The epithelial cell proportions of the SMC cohort skewed toward a low detection rate compared with tumor purity. However, the epithelial cell proportions estimated with CIBERSORTx using our CRC-SRM exhibited a high correlation with the ABSOLUTE estimated purity in the cohort TCGA-COADREAD, indicating the reliability of our CRC-SRM (Fig. 2B). In addition, CIBERSORTx inferred cellular patterns among different consensus molecular subtypes (CMS: CMS1-4) and our TME-driven subtypes (active immune (A.I.), active stroma (A.S.), and mixed types)), revealing increased immune cells in the CMS1 and A.I. subtypes and higher stromal infiltration in the CMS4 and A.S. subtypes, consistent with previous reports (Fig. 2C bottom). However, these immune/stromal cell infiltration patterns of CMS1 and CMS4 were not observed in the SMC cohort (Fig. 2C top). T cells, B cells, TAMs, endothelial cells and ##CAFs## constituted the TME ecosystem of CRCs (Fig. 2D). Increased abundances of epithelial cells, B cells, and stromal cells and fewer T cells and myeloid cells were observed using the cellular deconvolution method (Fig. 2D). Bias exists when inferring cellular compositions using scRNA-seq data. The discrepancy between the immune/stromal cell proportions was largely due to differences in cellular dissociation efficiencies, with stromal cells being more difficult to dissociate due to the extracellular matrix.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9548187</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36209225</oboInOwl:hasDbXref>
        <rdfs:label>CAFs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000057"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/56e2dd8f-8d63-4fe0-a832-3ae1056a1cf8"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000057"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/5638e010-da7b-4bbc-99d9-1372086cbc63 -->

    <Class rdf:about="http://example.org/5638e010-da7b-4bbc-99d9-1372086cbc63">
        <obo:IAO_0000115>To investigate the developmental origin of the CD34+PRLR+ cells, freshly isolated CD34+ HSCs were sorted into MLP, CMP, GMP and NK/BP (Fig. 2A), and cultured as described above. PRLR-expressing cells were mainly generated from the GMP compartment (Fig. 2B-D). At day 4 of culture, FACS sorted PRLR+ progenitors lacked all lineage markers except for CD15 and CD43, further supporting their myeloid origin (Fig. 2E). Evaluation of these cells at later time points (day + 14) showed that they remain CD15+, and acquired CD11a, CD11b, CD11c, CD16, CD18, CD45RO and CD123 (Fig. 2F). To study their differentiation, we sorted CD34+PRLR+ cells from four-day expanded CD34+ HSCs (as shown in Fig. 1A). As above, in the presence of ILC promoting cytokines (IL-3, IL-7, IL-15, IL-23, SCF and FLT3L) the CD34+PRLR+ progenitors differentiate into ##immature myeloid cells## (Fig. 3A-C). Addition of GM-CSF at later times (day + 21) resulted in the generation of mature granulocytes expressing CD15, CD16 and CD66b (Fig. 3A-C). Previously, we showed that some myeloid progenitors could give rise to CD56+ lymphocytes. However, sorted CD34+PRLR-, but not CD34+PRLR+ cells gave rise to CD56+ lymphocytes (Fig. 4A-C). Moreover, the CD34+PRLR+ progenitors do not express integrin alpha4beta7, a marker that defines innate lymphoid precursors with the potential to develop into ILCs (Fig. 4C). In further support of these findings, the CD34+PRLR+ progenitors do not differentiate into CD94+, CD127+ and CD336+ lymphocytes (Fig. 4D). Collectively, these findings show that CD34+PRLR+ progenitors develop from the GMPs under the influence of SCF and FLT3L, thereby acquire various myeloid markers and seem to lack lymphoid potential.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7156717</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32286456</oboInOwl:hasDbXref>
        <rdfs:label>immature myeloid cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000763"/>
        <skos:relatedMatch rdf:resource="CL:0002533"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/5638e010-da7b-4bbc-99d9-1372086cbc63"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000763"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/5638e010-da7b-4bbc-99d9-1372086cbc63"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002533"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/5650584e-90f3-4d2a-9c10-2a12d7324cc5 -->

    <Class rdf:about="http://example.org/5650584e-90f3-4d2a-9c10-2a12d7324cc5">
        <obo:IAO_0000115>a-o, Subcluster spatial maps on representative sample slices for astrocytes (a), oligodendrocytes and oligodendrocyte precursor cells (b), microglia and perivascular macrophages (c), ependymal cells, choroid plexus epithelial cells and subcommissural organ hypendymal cells (d), olfactory inhibitory neurons (e), cerebellum neurons (f), telencephalon projecting inhibitory neurons (g), ##di- and mesencephalon excitatory neurons## (h), glutamatergic neuroblasts (i), non-glutamatergic neuroblasts (j), di- and mesencephalon inhibitory neurons (k), cholinergic and monoaminergic neurons (l), peptidergic neurons (m), hindbrain/spinal cord neurons (n), and vascular cells (o). Also see Methods and Supplementary Table 4.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10709140</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37758947</oboInOwl:hasDbXref>
        <rdfs:label>di- and mesencephalon excitatory neurons</rdfs:label>
    </Class>
    


    <!-- http://example.org/568d507f-3f82-4c16-989c-08d65d90abb3 -->

    <Class rdf:about="http://example.org/568d507f-3f82-4c16-989c-08d65d90abb3">
        <obo:IAO_0000115>After assessing heterogeneity within PRPCs, heterogeneity within NRPCs was examined. As the transition cell state, NRPCs give rise to all ##retinal neurons##. Interestingly, unlike the continuous distribution observed for PRPCs, distinct clusters are observed for NRPCs, suggesting distinct subgroups might exist.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11310509</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:39117640</oboInOwl:hasDbXref>
        <rdfs:label>retinal neurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000540"/>
        <skos:relatedMatch rdf:resource="CL:0009004"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/568d507f-3f82-4c16-989c-08d65d90abb3"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000540"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/568d507f-3f82-4c16-989c-08d65d90abb3"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0009004"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/56878c71-e9af-46ae-bf28-a5b05023af2c -->

    <Class rdf:about="http://example.org/56878c71-e9af-46ae-bf28-a5b05023af2c">
        <obo:IAO_0000115>Coexpression of natural killer cell antigens by T-cell large granular lymphocytes in hydroa vacciniforme lymphoproliferative disorder and the involvement of ##Vdelta1 + epithelial-type gammadeltaT cells##</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10285018</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37133637</oboInOwl:hasDbXref>
        <rdfs:label>Vdelta1 + epithelial-type gammadeltaT cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000801"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/56878c71-e9af-46ae-bf28-a5b05023af2c"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000801"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/5691a8d2-de8b-48af-927a-ffba98853b16 -->

    <Class rdf:about="http://example.org/5691a8d2-de8b-48af-927a-ffba98853b16">
        <obo:IAO_0000115>UMAP projections and corresponding gene-by-cell expression-level heatmaps of splenocytes from: (A) four adult NMRs (n = 2 of each sex), (B) four adult mice (n = 2 of each sex), and (C) the corresponding heatmap of the NK and T -cell subsets of the two species; T cells from spleens of (D) three adult and four old NMRs (all males), (E) four adult and four old mice (all males), and (F) the corresponding heatmap of the two species; Bone-marrow cells from (G) four adult NMRs (n = 2 of each sex), (H) four adult mice (n = 2 of each sex), and (I) the corresponding heatmap of the T-cell subsets of the two species; T cells from (J) cervical and thoracic thymuses of seven adult NMRs (n = 4 females and n = 3 males), (K) thoracic thymuses of four adult mice (n = 2 of each sex), and (L) the corresponding heatmap of the two species. UMAPs provide a two-dimensional overview of all cells, color-coding them by their annotated cell-type subset. Stacked bar charts to the sides of the UMAPs show the proportions of cells assigned to each T-cell subset out of the total immune-cell population in that tissue, as well as the absolute number of cells in each subset. Heatmaps show normalized expression levels of selected marker genes (marker genes relevant for identification of the various T-cell subsets are labeled in red) in each cell, where cells are faceted by their cell subset. Maturation trajectory arrows in (K, L) are knowledge based. M A violin plot of the distributions of the normalized Itgae expression levels in each of the NMR and mouse thymocyte subsets, highlighting the high expression levels unique to the mouse gammadeltaT-cell subset. Abbreviations: APC Antigen Presenting Cell, Cyt Cytotoxic, DC Dendritic Cell, DP Double Positive, ILC Innate Lymphoid Cell, NK Natural Killer, NKT Natural Killer T, ##Non-cyt## Non-cytotoxic, RBC Red Blood Cell, SP Single Positive, Treg Regulatory T. Source data are provided as Source data file.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11009300</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38605005</oboInOwl:hasDbXref>
        <rdfs:label>Non-cyt</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000893"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/5691a8d2-de8b-48af-927a-ffba98853b16"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000893"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/570719fa-ba03-41a1-86c1-df054504cfc6 -->

    <Class rdf:about="http://example.org/570719fa-ba03-41a1-86c1-df054504cfc6">
        <obo:IAO_0000115>(A and B) Isolated CD4+ TILs were stimulated in vitro with PMA/ionomycin and stained and analyzed by flow cytometry. (A) Top left dot plot shows PD-1 versus CD39 expression in CD4 Tconvs. IFN-gamma versus TNF-alpha expression is shown in the indicated ##CD4 Tconv## populations. Proportions of cytokine+ (IFN-gamma and/or TNF-alpha; bottom left) and TNF-alpha+IFN-gamma-, TNF-alpha-IFN-gamma+, and TNF-alpha+IFN-gamma+ cells in PD-1-CD39-, PD-1loCD39-, PD-1hiCD39-, and PD-1hiCD39+ subsets and according to TIM-3 expression (n = 8). (B) Dot plots show CD39 versus IFN-gamma or TNF-alpha in CD4 Tconvs. Numbers in dot plots correspond to MFI of cytokine staining. MFI of IFN-gamma and TNF-alpha staining in IFN-gamma+ and TNF-alpha+ cells, respectively, are summarized for Tconv subpopulations defined as in A (n = 8). Samples in A and B are shown according to the proportion of TIM-3+ cells among PD-1hiCD39+ CD4 Tconv (&lt;50% TIM-3+, square; &gt;=50% TIM-3+, triangle; unknown, round) (C) CD4 Tconv TIL subsets PD-1-CD39- (gray), PD-1loCD39- (green), PD-1hiCD39- (blue), and PD-1hiCD39+ (red) were sorted, expanded in vitro for 10 days, and restimulated or not with PMA/ionomycin overnight. TNF-alpha and IFN-gamma secretion was quantified by CBA in the supernatant (n = 5). (D) Isolated CD4+ TILs were stained ex vivo and analyzed by flow cytometry. Proportions of TOX+ cells in each Tconv subset are summarized (n = 10). Data are presented as mean +- SD. **P &lt; 0.01; ***P &lt; 0.001; ****P &lt; 0.0001. P values were determined using the Wilcoxon (A and B) and 2-tailed paired t tests (D). Bonferroni&apos;s correction was applied to account for multiple testing in D and significance level was adjusted accordingly (*P &lt; 0.0083; **P &lt; 0.00166; ***P &lt; 0.000166). Tconvs, conventional FOXP3- CD4 T cells; CBA, cytometric bead array; TILs, tumor-infiltrating lymphocytes.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7934837</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33332284</oboInOwl:hasDbXref>
        <rdfs:label>CD4 Tconv</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000624"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/570719fa-ba03-41a1-86c1-df054504cfc6"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000624"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/571f2a19-4b20-4221-971e-5c4e1069eab3 -->

    <Class rdf:about="http://example.org/571f2a19-4b20-4221-971e-5c4e1069eab3">
        <obo:IAO_0000115>The culmination of our analysis was the establishment of a PCD index (PCDI) for predicting patient prognosis. A robust predictive model was constructed using 17 PCD genes, showcasing a potential prognostic tool for LIHC. Notably, high PCDI was associated with pathways concerning treatment resistance and tumor invasion. This provides potential explanations for the worsened prognosis seen in patients with a high PCDI. Furthermore, the association between PCDI and immune landscapes, particularly the diminished immune responses in patients with high PCDI and the negative correlation with activated mast cells, sheds light on the immune evasion mechanisms at play. Previous study has proved a connection between ##tumor-infiltrating mast cells## and resistance to anti-PD-1 therapy. This connection further underscores the intricate interplay between PCD and the immune microenvironment, suggesting the potential for combined therapeutic strategies targeting both these aspects in LIHC. Meanwhile, our exploration into pharmacotherapeutic approaches offers promise. By correlating PCD gene expression with drug sensitivities, we&apos;ve identified drugs that might be more efficacious in specific patient subgroups, potentially guiding personalized therapy. In comparison to previous studies, our research has provided a more in-depth understanding of the association between PCD and the immune microenvironment. In comparison with previously published prognosis models, we conducted a comprehensive assessment of the intrinsic heterogeneity among patients with high and low PCD levels, highlighting their varying sensitivity to immunotherapy. Furthermore, we have identified personalized therapeutic strategies for drug treatment based on these insights. Lastly, we verified that PRKDC, seldom mentioned in prior cancer studies, correlated with poorer survival outcomes in LIHC patients. Furthermore, elevated PRKDC levels notably enhanced the proliferation and invasive capabilities of LIHC, suggesting it as a potential therapeutic target for this condition.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11164487</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38787389</oboInOwl:hasDbXref>
        <rdfs:label>tumor-infiltrating mast cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000097"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/571f2a19-4b20-4221-971e-5c4e1069eab3"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000097"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/57149473-516e-4720-95a7-9c3fc9491c42 -->

    <Class rdf:about="http://example.org/57149473-516e-4720-95a7-9c3fc9491c42">
        <obo:IAO_0000115>The signals driving the adaptation of type 2 dendritic cells (DC2s) to diverse peripheral environments remain mostly undefined. We show that differentiation of CD11blo migratory DC2s-a DC2 population unique to the dermis-required IL-13 signaling dependent on the transcription factors STAT6 and KLF4, whereas DC2s in lung and small intestine were STAT6-independent. Similarly, human DC2s in skin expressed an IL-4 and IL-13 gene signature that was not found in blood, spleen and lung DCs. In mice, IL-13 was secreted homeostatically by dermal innate lymphoid cells and was independent of microbiota, TSLP or IL-33. In the absence of IL-13 signaling, dermal DC2s were stable in number but remained CD11bhi and showed defective activation in response to allergens, with diminished ability to support the development of ##IL-4+GATA3+ helper T cells## (TH), whereas antifungal IL-17+RORgammat+ TH cells were increased. Therefore, homeostatic IL-13 fosters a noninflammatory skin environment that supports allergic sensitization.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMID:34795444</oboInOwl:hasDbXref>
        <rdfs:label>IL-4+GATA3+ helper T cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000912"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/57149473-516e-4720-95a7-9c3fc9491c42"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000912"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/571512d5-5bf0-41ed-b294-0d4e498f3407 -->

    <Class rdf:about="http://example.org/571512d5-5bf0-41ed-b294-0d4e498f3407">
        <obo:IAO_0000115>The adipose-derived hormone leptin acts via its receptor (LepRb) in the brain to control energy balance. A potentially unidentified population of GABAergic hypothalamic LepRb neurons plays key roles in the restraint of food intake and body weight by leptin. To identify markers for candidate populations of LepRb neurons in an unbiased manner, we performed single-nucleus RNA-Seq of enriched mouse hypothalamic LepRb cells, identifying several previously unrecognized populations of hypothalamic LepRb neurons. Many of these populations displayed strong conservation across species, including GABAergic Glp1r-expressing LepRb (LepRbGlp1r) neurons, which expressed more Lepr than other LepRb cell populations. Ablating Lepr from ##LepRbGlp1r cells## provoked hyperphagic obesity without impairing energy expenditure. Similarly, improvements in energy balance caused by Lepr reactivation in GABA neurons of otherwise Lepr-null mice required Lepr expression in GABAergic Glp1r-expressing neurons. Furthermore, restoration of Glp1r expression in LepRbGlp1r neurons in otherwise Glp1r-null mice enabled food intake suppression by the GLP1R agonist, liraglutide. Thus, the conserved GABAergic LepRbGlp1r neuron population plays crucial roles in the suppression of food intake by leptin and GLP1R agonists.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10541203</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37581939</oboInOwl:hasDbXref>
        <rdfs:label>LepRbGlp1r cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:4042033"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/571512d5-5bf0-41ed-b294-0d4e498f3407"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4042033"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/5725acbd-d35d-4506-bd0f-9993068c348f -->

    <Class rdf:about="http://example.org/5725acbd-d35d-4506-bd0f-9993068c348f">
        <obo:IAO_0000115>In summary, from work done in frontal areas, it is clear that ##I-S cells## are involved in enhancing learning and memory discrimination, are recruited during theta rhythms, and primarily target SOM+ cells, but also PV+ cells (i.e., similar to hippocampal CA1 I-S3 cells; Figures 1A,B). Further characterization of VIP+ cell types in frontal areas is needed to distinguish how much I-S cell types in these areas contact pyramidal cells, compared to non-I-S VIP+ cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7296096</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32581726</oboInOwl:hasDbXref>
        <rdfs:label>I-S cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000099"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/5725acbd-d35d-4506-bd0f-9993068c348f"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000099"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/574ecf29-a239-4453-b1ae-1b9044d1041e -->

    <Class rdf:about="http://example.org/574ecf29-a239-4453-b1ae-1b9044d1041e">
        <obo:IAO_0000115>The unwounded, normal corneal stroma is a relatively simple, avascular tissue populated with quiescent keratocytes, along with corneal nerves and a few ##resident dendritic and monocyte/macrophage cells##. In the past, the resting keratocytes were thought of as a homogenous cellular population, but recent work has shown local variations in vimentin and nestin expression, and responsiveness to transforming growth factor (TGF)-beta1. Studies have also supported there being &quot;stromal stem cells&quot; in localized areas. After corneal wounding, depending on the site and severity of injury, profound changes in stromal cellularity occur. Anterior or posterior injuries to the epithelium or endothelium, respectively, trigger apoptosis of adjacent keratocytes. Many contiguous keratocytes transition to keratocan-negative corneal fibroblasts that are proliferative and produce limited amounts of disorganized extracellular matrix components. Simultaneously, large numbers of bone marrow-derived cells, including monocytes, neutrophils, fibrocytes and lymphocytes, invade the stroma from the limbal blood vessels. Ongoing adequate levels of TGFbeta1, TGFbeta2 and platelet-derived growth factor (PDGF) from epithelium, tears, endothelium and aqueous humor that penetrate defective or absent epithelial barrier function (EBF) and epithelial basement membrane (EBM) and/or Descemet&apos;s basement membrane (DBM) drive corneal fibroblasts and fibrocytes to differentiate into alpha-smooth muscle actin (SMA)-positive myofibroblasts. If the EBF, EBM and/or DBM are repaired or replaced in a timely manner, typically measured in weeks, then corneal fibroblast and fibrocyte progeny, deprived of requisite levels of TGFbeta1 and TGFbeta2, undergo apoptosis or revert to their precursor cell-types. If the EBF, EBM and/or DBM are not repaired or replaced, stromal levels of TGFbeta1 and TGFbeta2 remain elevated, and mature myofibroblasts are generated from corneal fibroblasts and fibrocyte precursors that produce prodigious amounts of disordered extracellular matrix materials associated with scarring fibrosis. This fibrotic stromal matrix persists, at least until the EBF, EBM and/or DBM are regenerated or replaced, and keratocytes remove and reorganize the affected stromal matrix.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7855915</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33068626</oboInOwl:hasDbXref>
        <rdfs:label>resident dendritic and monocyte/macrophage cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000782"/>
        <skos:relatedMatch rdf:resource="CL:0000864"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/574ecf29-a239-4453-b1ae-1b9044d1041e"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000782"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/574ecf29-a239-4453-b1ae-1b9044d1041e"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000864"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/58ac31fd-9784-4914-b510-502e4e7473bd -->

    <Class rdf:about="http://example.org/58ac31fd-9784-4914-b510-502e4e7473bd">
        <obo:IAO_0000115>Tumor types Mutant genes The contributed cells for tumors References   Trichofolliculomas/papillomatricomas beta-catenin Krt 14+ cells    Pilomatricomas beta-catenin Lgr5+ cells    Dermatofibromas beta-catenin Lgr6+ cells    Trichoadenomas beta-catenin Lrig1+ cells    No tumor beta-catenin Krt15+ cells    Sebaceous tumors Lef1 Krt14+ cells    Basal cell carcinoma(BCC) Patched IFE cells/bulge stem cells(major contribution)    BCC Smoothened IFE cells    BCC Smoothened (in the context of wound) ##Krt15+ bulge stem cells##    Papillomas KRAS Krt19+, Krt15+ and Involucrin+ cells    Invasive squamous cell carcinoma (SCC) P53 and KRAS --    SCC (DMBA-TPA method) HRAS Long-lived stem cells    Papilloma and SCC HRAS Krt5+ cells    </obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9391238</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35143021</oboInOwl:hasDbXref>
        <rdfs:label>Krt15+ bulge stem cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002337"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/58ac31fd-9784-4914-b510-502e4e7473bd"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002337"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/58b9c6d1-fa03-4f22-ae7d-8a5f94a63d4f -->

    <Class rdf:about="http://example.org/58b9c6d1-fa03-4f22-ae7d-8a5f94a63d4f">
        <obo:IAO_0000115>Immune checkpoint inhibitors exert clinical efficacy against various types of cancer through reinvigoration of exhausted CD8+ T cells that attack cancer cells directly in the tumor microenvironment (TME). Using single-cell sequencing and mouse models, we show that CXCL13, highly expressed in ##tumor-infiltrating exhausted CD8+ T cells##, induces CD4+ follicular helper T (TFH) cell infiltration, contributing to anti-tumor immunity. Furthermore, a part of the TFH cells in the TME exhibits cytotoxicity and directly attacks major histocompatibility complex-II-expressing tumors. TFH-like cytotoxic CD4+ T cells have high LAG-3/BLIMP1 and low TCF1 expression without self-renewal ability, whereas non-cytotoxic TFH cells express low LAG-3/BLIMP1 and high TCF1 with self-renewal ability, closely resembling the relationship between terminally differentiated and stem-like progenitor exhaustion in CD8+ T cells, respectively. Our findings provide deep insights into TFH-like CD4+ T cell exhaustion with helper progenitor and cytotoxic differentiated functions, mediating anti-tumor immunity orchestrally with CD8+ T cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMID:38363680</oboInOwl:hasDbXref>
        <rdfs:label>tumor-infiltrating exhausted CD8+ T cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000625"/>
        <skos:relatedMatch rdf:resource="CL:0011025"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/58b9c6d1-fa03-4f22-ae7d-8a5f94a63d4f"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000625"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/58b9c6d1-fa03-4f22-ae7d-8a5f94a63d4f"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0011025"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/58be262c-acf5-4c17-a907-96b7f68fe10f -->

    <Class rdf:about="http://example.org/58be262c-acf5-4c17-a907-96b7f68fe10f">
        <obo:IAO_0000115>In all three datasets, neural progenitors with temporally progressing transcriptional states, glioblasts and astrocytes (SLC1A3 and AQP4) form the most abundant glial lineage (Fig. 1b-e and Extended Data Fig. 6a-f):hereafter collectively referred to as astroglia. In the oligodendrocyte lineage, we discerned proliferating oligodendrocyte progenitor cells (OPCs) (PDGFRA), committed oligodendrocyte precursors (TNR) and ##postmitotic oligodendrocytes## (MAG) (Extended Data Fig. 6a-d,f). Additionally, in human and opossum, we detected an intermediate cell population between glioblasts and OPCs, probably representing a pre-OPC state (EGFR) (Extended Data Fig. 6a-d,f). We distinguished ependymal cells (SPAG17) in the mouse and opossum but not in the human dataset, and in opossum, we further identified ependymal progenitors that share transcriptional traits with glioblasts but express ciliogenesis-related SPAG17 (Extended Data Fig. 6a-d,f). We also detected neural crest- and mesoderm-derived cell types (meningeal, immune (mostly microglia), vascular (mural and endothelial) and erythroid) and small groups of neural cells from neighbouring brain regions, resulting from the migration of a midbrain-originating cell population (LEF1) to the cerebellar primordia or sample contamination (isthmic and midbrain neuroblasts, GABAergic midbrain cells and motor neurons; Fig. 1b,c and Extended Data Fig. 6j).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10808058</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38029793</oboInOwl:hasDbXref>
        <rdfs:label>postmitotic oligodendrocytes</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000128"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/58be262c-acf5-4c17-a907-96b7f68fe10f"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000128"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/58c79a47-af26-4364-ab69-3236b3a7be24 -->

    <Class rdf:about="http://example.org/58c79a47-af26-4364-ab69-3236b3a7be24">
        <obo:IAO_0000115>Id2 and Id3 are involved in both T and B cell development to modulate E protein DNA binding activity. Id2 is particularly important for ILC, NK, and LTi cell development through the suppression of E protein activity. In B cell development, Id3 is induced in response to TGFbeta signaling for survival during early B cell development. Id3 is highly expressed in naive mature B cells and downregulated in ##activated germinal center B (GCB) cells##, while E2A protein abundance is low in naive B cells but high in GCB cells to induce AID expression in cooperation with E2-2. In T cell development, Id3 is first upregulated by pre-TCR signaling in DN3 cells and further upregulated upon positive selection of TCR signaling in DP cells. Similarly, gammadelta TCR-mediated signaling induces high levels of Id3 abundance and E2A-Id3-Tcf1 transcription axis control gammadelta T cell development and effector function. Furthermore, Id3 plays a key role in follicular helper T (TFH) and follicular cytotoxic T(TFC) cell development through the regulation of CXCR5 expression. Notably, Id2 and Id3 have distinct roles in the differentiation of CD8 cytotoxic T cells toward effector and memory T cells. In addition, regulatory T (Treg) cells also critically require Id2 and Id3 expression to suppress systemic TH2 inflammation and function as a gatekeeper for follicular regulatory T (TFR) cell. Taken together, the E-Id protein axis controls the adaptive lymphocyte development and activation to maintain immunological homeostasis.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8199221</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34072618</oboInOwl:hasDbXref>
        <rdfs:label>activated germinal center B (GCB) cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000844"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/58c79a47-af26-4364-ab69-3236b3a7be24"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000844"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/581fb2b8-7c54-4f57-bf45-ee0ca4b20664 -->

    <Class rdf:about="http://example.org/581fb2b8-7c54-4f57-bf45-ee0ca4b20664">
        <obo:IAO_0000115>Using WOT, we then identified the descendants of presumptive I-RGCs at later ages. We found that I-RGCs comprised 4.3% of adult RGCs, consistent with the range of 3-5% noted above. We queried these cells to identify the genes that distinguished putative I-RGCs and C-RGCs throughout the developmental time course. At a fold change of &gt;=1.5, we found 59 differentially expressed (DE) genes at E13 and 89 at E14 (Figure 7e and f). In addition to Zic2, Igfbp5, Isl2, and Igf1, which had been used to define I-RGCs and C-RGCs at E13, they included Igfbpl1, Pou3f1, and Cntn2 enriched in I-RGCs, and Lmo2, Pcsk1n, and Syt4 enriched in C-RGCs. The number of genes differentially expressed between ##I- and C-RGCs## decreased after E14, with 20, 9, and 0 significant genes at E16, P0, and P5, respectively (Figure 7:figure supplement 1d and e), presumably reflecting the downregulation of axon guidance programs once retinorecipient targets have been reached (see Discussion).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8956290</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35191836</oboInOwl:hasDbXref>
        <rdfs:label>I- and C-RGCs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000740"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/581fb2b8-7c54-4f57-bf45-ee0ca4b20664"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000740"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/581877e9-cf72-4502-bd1b-535043f05380 -->

    <Class rdf:about="http://example.org/581877e9-cf72-4502-bd1b-535043f05380">
        <obo:IAO_0000115>C1QC+ macrophages were transcriptionally similar to ##neuronal-associated gut-resident macrophages##</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10403544</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37542039</oboInOwl:hasDbXref>
        <rdfs:label>neuronal-associated gut-resident macrophages</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000540"/>
        <skos:relatedMatch rdf:resource="CL:0000865"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/581877e9-cf72-4502-bd1b-535043f05380"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000540"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/581877e9-cf72-4502-bd1b-535043f05380"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000865"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/588e93d1-117d-4735-82b1-91f086bf1a33 -->

    <Class rdf:about="http://example.org/588e93d1-117d-4735-82b1-91f086bf1a33">
        <obo:IAO_0000115>The above analysis was based on a large number of RNA-seq, so we further used scRNA-seq to determine whether our ORGs signature had immune predictive value on the single cell level. Figure 7A showed that the PRAD samples from GEO datasets were annotated into ##Mast cell##, Epithelial-NE, T/NK, Plasma_B, Epithelial, Neuron, SMC, Fibroblasts and Pericytes, Myeloid and Endothelial. It was obvious that ORGs signature was specifically high in Epithelial-Nk, T/Nk and SMC cells (Figure 7B, 7C). Meanwhile, Figure 7D revealed that significant connection probability of ORGs related signaling pathways in cell clusters which showed specifically high ORGs signature. Furthermore, we chose epithelial cell for analysis. Chemotaxis related pathways including cell chemotaxis, leukocyte chemotaxis, regulation of chemotaxis and regulation of leukocyte chemotaxis were significantly up-regulated in the high ORGs signature group (Figure 7E). What&apos;s more, immune related pathways were all up-regulated in the high ORGs signature group both in GO (Figure 7F) and KEGG (Figure 7G) analysis.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10599753</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37788005</oboInOwl:hasDbXref>
        <rdfs:label>Mast cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000097"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/588e93d1-117d-4735-82b1-91f086bf1a33"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000097"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/58893774-7e27-4fa8-ae3c-9de2d98a5482 -->

    <Class rdf:about="http://example.org/58893774-7e27-4fa8-ae3c-9de2d98a5482">
        <obo:IAO_0000115>The adipose-derived hormone leptin acts via its receptor (LepRb) in the brain to control energy balance. A potentially unidentified population of GABAergic hypothalamic LepRb neurons plays key roles in the restraint of food intake and body weight by leptin. To identify markers for candidate populations of LepRb neurons in an unbiased manner, we performed single-nucleus RNA-Seq of enriched mouse ##hypothalamic LepRb cells##, identifying several previously unrecognized populations of hypothalamic LepRb neurons. Many of these populations displayed strong conservation across species, including GABAergic Glp1r-expressing LepRb (LepRbGlp1r) neurons, which expressed more Lepr than other LepRb cell populations. Ablating Lepr from LepRbGlp1r cells provoked hyperphagic obesity without impairing energy expenditure. Similarly, improvements in energy balance caused by Lepr reactivation in GABA neurons of otherwise Lepr-null mice required Lepr expression in GABAergic Glp1r-expressing neurons. Furthermore, restoration of Glp1r expression in LepRbGlp1r neurons in otherwise Glp1r-null mice enabled food intake suppression by the GLP1R agonist, liraglutide. Thus, the conserved GABAergic LepRbGlp1r neuron population plays crucial roles in the suppression of food intake by leptin and GLP1R agonists.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10541203</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37581939</oboInOwl:hasDbXref>
        <rdfs:label>hypothalamic LepRb cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:4042033"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/58893774-7e27-4fa8-ae3c-9de2d98a5482"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4042033"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/59caff36-458c-4f73-a020-9d3bf8745e83 -->

    <Class rdf:about="http://example.org/59caff36-458c-4f73-a020-9d3bf8745e83">
        <obo:IAO_0000115>The unique multilayered structure of the skin enables an effective barrier against a relentless barrage of pathogens and insults. Anatomically, the skin comprises three consecutive layers, including the stratified epidermis, the fibroblast-rich dermis, and the dermal fat (also known as ##dermal white adipose tissue## (dWAT)). Keratinocytes (KCs) are the main epidermal cell type (~95%), and the remaining epidermal cells include Langerhans cells, melanocytes, Merkel cells, and infiltrated immune cells. Dermal fibroblasts (dFBs), the major resident cell types in the dermis, are highly heterogeneous. While dFBs located in the upper (papilla) dermis support epidermal growth and regulate hair cycling, dFBs located in the lower (reticular) dermis have the potential to commit to preadipocytes (pAd) and differentiate to adipocytes, forming the last and deepest barrier of the skin, dWAT. PRR-mediated innate immune activation of these skin resident cells by PAMPs or DAMPs leads to the production of antimicrobial peptides as well as proinflammatory cytokines that recruit and activate myeloid and lymphatic immune cells, such as neutrophils, monocytes, dendritic cells, macrophages, and T lymphocytes. A proper interplay between innate and adaptive immune cells confers immediate and long-term immune protection against pathogens and insults.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6877906</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31815151</oboInOwl:hasDbXref>
        <rdfs:label>dermal white adipose tissue</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000448"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/59caff36-458c-4f73-a020-9d3bf8745e83"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000448"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/59d7edfa-2197-4606-b89e-686d42404770 -->

    <Class rdf:about="http://example.org/59d7edfa-2197-4606-b89e-686d42404770">
        <obo:IAO_0000115>alpha-SMA	Alpha smooth muscle actin	LEC	Lymphatic endothelial cell	 	ADSCs	Adipose-derived stem cells	Lymphoid-like	##Lymphoid-like cell##	 	ADAMTS	Disintegrin and metalloproteinase with thrombospondin motifs	Mac	Macrophage	 	AEC	Arterial endothelial cells	MAIT	Mucosal-associated invariant T cell	 	AFG	Autologous fat grafting	MMPs	Matrix metalloproteinases	 	APC	Adipocyte precursor cells	MC	Mast cell	 	BC	B cell	mCD8 T	Mature CD8 T cell	 	BKC	Basal keratinocyte	mNK	Mature natural killer cell	 	BMI	Body mass index	Myeloid-like	Myeloid-like cell	 	CCNs	Cellular communication network factors	nCD4 T	Naive CD4 T cell	 	cDC	Classic dendritic cell	nCD8 T	Naive CD8 T cell	 	CEC	Capillary endothelial cell	ncMos	Non-classic monocytes	 	DC	Dendritic cell	NK-like	Natural killer-like cell	 	CD	Cluster of differentiation	PC	Pericyte	 	CTGF	Connective tissue growth factor	PCA	Principal component analysis	 	DEGs	Differentially expressed genes	scRNA-seq	Single-cell RNA sequencing	 	DKC	Differentiating keratinocytes	SMC	Smooth muscle cell	 	EC	Endothelial cell	SNN	Shared nearest neighbour	 	ECM	Extracellular matrix	SSc	Scleroderma	 	EMT	Epithelial-to-mesenchymal transition	SVF	Stromal vascular fraction	 	FACS	Fluorescence-activated cell sorting	TC	T cell	 	FB	Fibroblast	TGF-beta1	Transforming growth factor 1	 	FGFRs	Fibroblast growth factor receptors	TIMPs	Tissue inhibitors of metalloproteinases	 	GEO	Gene expression omnibus	TREG	Regulatory T cells	 	GO	Gene Ontology	UMAP	Uniform manifold approximation and projection	 	IFATS	International Federation for Adipose Therapeutics and Science	VEC	Venous endothelial cell	 	ILC	Innate lymphoid cell	WAT	White adipose tissue	 	KEGG	Kyoto Encyclopedia of Genes and Genomes			 	</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10341100</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37443817</oboInOwl:hasDbXref>
        <rdfs:label>Lymphoid-like cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0001065"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/59d7edfa-2197-4606-b89e-686d42404770"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0001065"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/5918a02f-dfd2-4b4c-b11d-7b3ced6661e9 -->

    <Class rdf:about="http://example.org/5918a02f-dfd2-4b4c-b11d-7b3ced6661e9">
        <obo:IAO_0000115>Although the induced Ca2+ activity persisted under the glutamatergic inhibition for c+ primary neurons, excitability of the secondary neurons discontinued. Secondary neurons exhibited two common excitation profiles depending on whether they were silent or spontaneously active before stimulation. These two profiles were encountered in equal frequencies 30% (both 7 out of 22) all throughout the experiments. In Fig 5B, the ##c+ primary neuron## was observed to excite a previously silent secondary neuron. In the blocked case this excitation was not observed as shown via correlation analysis (p&lt;0.05). A video of this experiment is provided in S1A and S1B Video. Fig 5C shows an example for a secondary neuron which was spontaneously active before stimulation. Spontaneous activity of the secondary neuron was modulated with the induced Ca2+ activity of the primary neuron. Excitation of the secondary neuron continued through the stimulation and the in-phase modulation vanished in the blocked case (p&lt;0.05).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7928449</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33657119</oboInOwl:hasDbXref>
        <rdfs:label>c+ primary neuron</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000540"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/5918a02f-dfd2-4b4c-b11d-7b3ced6661e9"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000540"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/593ef62c-355e-4ac3-8b94-0153a943816f -->

    <Class rdf:about="http://example.org/593ef62c-355e-4ac3-8b94-0153a943816f">
        <obo:IAO_0000115>Highly regulated processes establish intercellular communication between bone-resident cells, each with its own distinctive role, to ensure a finely tuned balance between bone resorption and bone formation. The major bone-resorbing cell type is the osteoclast. Osteoclasts are multinucleated cells formed by the fusion of mononuclear, monocyte-derived, macrophage precursors, and their main function is resorption of cartilage and bone matrices. ##Vessel-associated osteoclasts## drive cartilage resorption during bone growth, whereas bona fide osteoclasts regulate resorption of mineralised bone matrix during bone maintenance and repair. Furthermore, with bone being the largest reservoir for calcium storage in the body, resorption also facilitates calcium release to maintain optimal circulating levels. Osteoblasts play the opposite role to osteoclasts, constituting the major bone-forming cell type. Mesenchymal stem cells (MSCs) are situated at the apex of the osteoblast lineage cell hierarchy, differentiating stepwise into osteoprogenitors, bone lining cells, osteoblasts, and, ultimately, osteocytes. Osteoblast lineage cells have numerous roles depending on their differentiation stage. Osteoprogenitors and bone lining cells constitute a pool of immature osteoblasts, maintained in a quiescent state that can be utilized for bone remodelling and repair. Mature osteoblasts ensure production and secretion of a new protein-rich bone matrix and its subsequent mineralization. Osteocytes are terminally differentiated osteoblasts, entombed within mineralised bone, acting as the main regulatory unit of skeletal homeostasis. Additional cells supporting bone homeostasis include endothelial cells (ECs), adipocytes, and chondrocytes.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8305002</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34298886</oboInOwl:hasDbXref>
        <rdfs:label>Vessel-associated osteoclasts</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000092"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/593ef62c-355e-4ac3-8b94-0153a943816f"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000092"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/5969a790-62c7-4a86-9c3e-b763d2fdbb81 -->

    <Class rdf:about="http://example.org/5969a790-62c7-4a86-9c3e-b763d2fdbb81">
        <obo:IAO_0000115>Introduction: Macrophages and T cells play crucial roles in liver physiology, but their functional diversity in hepatocellular carcinoma (HCC) remains largely unknown. Methods: Two bulk RNA-sequencing (RNA-seq) cohorts for HCC were analyzed using gene co-expression network analysis. Key gene modules and networks were mapped to single-cell RNA-sequencing (scRNA-seq) data of HCC. Cell type fraction of bulk RNA-seq data was estimated by deconvolution approach using single-cell RNA-sequencing data as a reference. Survival analysis was carried out to estimate the prognosis of different immune cell types in bulk RNA-seq cohorts. Cell-cell interaction analysis was performed to identify potential links between immune cell types in HCC. Results: In this study, we analyzed RNA-seq data from two large-scale HCC cohorts, revealing a major and consensus gene co-expression cluster with significant implications for immunosuppression. Notably, these genes exhibited higher enrichment in liver macrophages than T cells, as confirmed by scRNA-seq data from HCC patients. Integrative analysis of bulk and single-cell RNA-seq data pinpointed SPP1 + macrophages as an unfavorable cell type, while VCAN + macrophages, C1QA + macrophages, and CD8 + T cells were associated with a more favorable prognosis for HCC patients. Subsequent scRNA-seq investigations and in vitro experiments elucidated that SPP1, predominantly secreted by SPP1 + macrophages, inhibits CD8 + T cell proliferation. Finally, targeting SPP1 in ##tumor-associated macrophages## through inhibition led to a shift towards a favorable phenotype. Discussion: This study underpins the potential of SPP1 as a translational target in immunotherapy for HCC.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11649653</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:39691723</oboInOwl:hasDbXref>
        <rdfs:label>tumor-associated macrophages</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/5969a790-62c7-4a86-9c3e-b763d2fdbb81"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/597d9480-6cd2-4d1d-92b8-6e0ae72df575 -->

    <Class rdf:about="http://example.org/597d9480-6cd2-4d1d-92b8-6e0ae72df575">
        <obo:IAO_0000115>a Due to single-cell annotation and in situ validation (Fig. 2; Supplementary Fig. 3), a draft model of the oral-to-tooth transition zone in humans is presented, with basal and suprabasal keratinocyte markers uniquely identifying the alveolar mucosa (AM), attached gingiva (AG), gingival margin (GM), sulcular epithelium (SK) and junctional epithelium (JK). b These markers allowed for KRT19-high keratinocyte (KC) cell subclustering for the first time (2504 cells in total), including gingival margin keratinocytes (GM), sulcular keratinocytes (SK), and junctional keratinocytes (JK). c A more granular draft (Tier 4) annotation of epithelial cells of the gingival attachment. d Assaying differentially expressed genes in periodontitis, SKs and JKs only share about a quarter of upregulated genes. JKs displayed nearly 125 unique upregulated genes in diseased cells. e Further analysis of basal and suprabasal (differentiating) SK and JK keratinocytes revealed unique cell signatures between basal and suprabasal cell types. This full list is included in Supplementary Data 1. f-i To understand SK and JK developmental progression and cell state alterations, we used partitioned-based graph abstraction (PAGA). f Examining the basal to suprabasal transition, JKs display altered gene expressed comparing health to disease cell types, including broader expression of KRT17 and more expression of JUND, COL17A1, and CDH3. Key differentiation genes such as SPRR family members were also downregulated. g JKs displayed robust cell signaling and inflammatory phenotypes, which appear exacerbated in disease states. h In SKs, differentiation-related genes were uniquely expressed compared to JKs in health but also appeared altered in disease along the basal to suprabasal trajectory. i SKs appeared generally less reactive compared to JKs in disease, with lower overall expression of effector molecules such as CXCL1, CXCL8, IL1A, IL1B, and IL1RN. Abbreviations: Merk Merkel Cells, LC langerhans cells, Mela melanocytes, Muc ##mucosa##, SB suprabasal Keratinocytes; for others, see Fig. 1 legend. For this figure, n = 30-sample, 2504-cell for scRNAseq.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11178863</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38876998</oboInOwl:hasDbXref>
        <rdfs:label>mucosa</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002170"/>
        <skos:relatedMatch rdf:resource="CL:0002336"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/597d9480-6cd2-4d1d-92b8-6e0ae72df575"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002170"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/597d9480-6cd2-4d1d-92b8-6e0ae72df575"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002336"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/6a4d59bf-81e3-45f5-bc7a-8404257fa4b9 -->

    <Class rdf:about="http://example.org/6a4d59bf-81e3-45f5-bc7a-8404257fa4b9">
        <obo:IAO_0000115>Liver sinusoidal endothelial cells (LSECs) form a highly specialized microvasculature that plays a critical role in liver function and disease. To better understand this role, we developed a strategy to generate LSECs from human pluripotent stem cells (hPSCs) by first optimizing the specification of ##arterial and venous angioblasts## and derivative endothelial populations. Induction of a LSEC-like fate by hypoxia, cyclic AMP (cAMP) agonism, and transforming growth factor beta (TGF-beta) inhibition revealed that venous endothelial cells responded more rapidly and robustly than the arterial cells to upregulate LSEC markers and functions in vitro. Upon intrahepatic transplantation in neonates, venous angioblasts engrafted the liver and generated mature, fenestrated LSECs with scavenger functions and molecular profiles of primary human LSECs. When transplanted into the liver of adult mice, angioblasts efficiently gave rise to mature LSECs with robust factor VIII (FVIII) production. Humanization of the murine liver with hPSC-derived LSECs provides a tractable system for studying the biology of this key liver cell type.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMID:32640183</oboInOwl:hasDbXref>
        <rdfs:label>arterial and venous angioblasts</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000566"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/6a4d59bf-81e3-45f5-bc7a-8404257fa4b9"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000566"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/6a640e1b-f8d9-4192-8ad5-ab833b572349 -->

    <Class rdf:about="http://example.org/6a640e1b-f8d9-4192-8ad5-ab833b572349">
        <obo:IAO_0000115>Despite the crucial physiological processes governed by neurons in the hypothalamic arcuate nucleus (ARC), such as growth, reproduction and energy homeostasis, the developmental pathways and regulators for ##ARC neurons## remain understudied. Our single cell RNA-seq analyses of mouse embryonic ARC revealed many cell type-specific markers for developing ARC neurons. These markers include transcription factors whose expression is enriched in specific neuronal types and often depleted in other closely-related neuronal types, raising the possibility that these transcription factors play important roles in the fate commitment or differentiation of specific ARC neuronal types. We validated this idea with the two transcription factors, Foxp2 enriched for Ghrh-neurons and Sox14 enriched for Kisspeptin-neurons, using Foxp2- and Sox14-deficient mouse models. Taken together, our single cell transcriptome analyses for the developing ARC uncovered a panel of transcription factors that are likely to form a gene regulatory network to orchestrate fate specification and differentiation of ARC neurons.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6697706</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31420539</oboInOwl:hasDbXref>
        <rdfs:label>ARC neurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:4023127"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/6a640e1b-f8d9-4192-8ad5-ab833b572349"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4023127"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/6a6bd29c-8177-4b10-b64b-ce9310692dd0 -->

    <Class rdf:about="http://example.org/6a6bd29c-8177-4b10-b64b-ce9310692dd0">
        <obo:IAO_0000115>Comprehensive account of cortical cell types exemplified in the mouse primary motor cortex (MOp) by cluster analysis and spatial transcriptomics (MERFISH). a Glutamatergic, GABAergic neuronal and non-neuronal cells cluster dendrogram giving an overview of major groups and cell types, which are colored for their identity. Please note that GABAergic neurons not only cluster by major molecular markers but also by developmental origin (MGE: medial ganglionic eminence; CGE: caudal ganglionic eminence). b Spatial distribution of cell types identified by clustering (in a) shown with the same color code by spatial transcriptomics. Please note that due to layer identity being a major factor for the majority cell type of pyramidal neurons, a laminar pattern becomes apparent. Here, a section through MOp is displayed whose location is shown in the upper right corner. c This &quot;six-layered&quot; neocortical laminar pattern becomes even more crisp when the distribution of glutamatergic neurons alone is depicted. Inset: a biocytin-filled ##L2/3 IT (pyramidal) neuron## of unknown t-type is shown, which has a typical spiny dendritic tree with an apical dendritic tuft in L1 and an axon running toward the white matter (Preuss, Witte, Staiger; unpublished material). Scale bars, 200 mum for a and b and 100 mum for the inset. For neuronal cell names, see Tables; for non-neuronal: OGC: oligodendrocyte; OPC: oligodendrocyte precursor cell; PVM: perivascular macrophage; SMC: smooth muscle cell; VLMC: vascular leptomeningeal cell. Modified from BRAIN Initiative Cell Census Network, Nature 2021; with permission</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11033238</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38376567</oboInOwl:hasDbXref>
        <rdfs:label>L2/3 IT (pyramidal) neuron</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000598"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/6a6bd29c-8177-4b10-b64b-ce9310692dd0"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000598"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/6a6d9b13-d287-4ef6-a843-4235639b745d -->

    <Class rdf:about="http://example.org/6a6d9b13-d287-4ef6-a843-4235639b745d">
        <obo:IAO_0000115>Expression heterogeneity of CD8+ and CD4+ T cells in the OSCC ecosystem. (A) The t-distributed stochastic neighbor embedding (t-SNE) projection of T cells from cancerous tissue of patients with OSCC, showing the formation of 11 main clusters in different colors. The functional description of each cluster is determined by the gene expression characteristics. Cluster 0: resident memory CD8+ T Cells (C0_CD8+ TRM); Cluster 1: effector memory CD8+ T cells (C1_CD8+ TEM); Cluster 2: regulatory CD4+ T cells (C2_CD4+ Treg); Cluster 3: exhausted CD8+ T cells (C3_CD8+ T Exhausted); Cluster 4: ##effector memory M-phage CD8+ T cells## (C4_CD8+ Mitotic TEM); Cluster 5: effector memory CD4+ T cells (C5_CD4+ TEM); Cluster 6: effector memory CD8+ T cells (C6_CD8+ TEM); Cluster 7: effector memory CD4+ T cells (C7_CD4+ TEM); Cluster 8: effector memory CD8+ T cells (C8_CD8+ TEM); Cluster 9: effector memory CD8+ T cells (C9_CD8+ TEM); Cluster 10: effector memory M-phage CD4+ T cells (C10_CD4+ Mitotic TEM); Cluster 11: effector memory CD8+ T cells (C11_CD8+ TEM); Cluster 12: effector memory CD8+ T cells (C12_CD8+ TEM); Cluster 13: gammadelta T. (B) Cell-Cycle Scoring of T cells from cancerous tissue of patients with OSCC, showing the three clusters of cells in different cell cycles in different colors. (C) Heatmap of key genes expressed in each cluster of CD8+ tumor-infiltrating lymphocytes (TILs) with cells grouped by clusters. The columns correspond to the cells; the rows correspond to the genes. Yellow: high expression; purple: low expression. Selected key markers are shown on the right. (D) Heatmap of key genes expressed in each cluster of CD4+ TILs with cells grouped by clusters. The columns correspond to the cells; the rows correspond to the genes. Yellow: high expression; purple: low expression. Selected key genes are shown on the right.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8024729</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33513276</oboInOwl:hasDbXref>
        <rdfs:label>effector memory M-phage CD8+ T cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000913"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/6a6d9b13-d287-4ef6-a843-4235639b745d"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000913"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/6a8b426b-75ef-420c-b54d-ee9c63263d43 -->

    <Class rdf:about="http://example.org/6a8b426b-75ef-420c-b54d-ee9c63263d43">
        <obo:IAO_0000115>(a) Balloon-plot of known neuronal and glial cell markers (SOX10-MKI67). Progenitor: SOX10, FOXD3, ASCL1, Neuronal: PHOX2B, PRPH, NRG1, TUBB3, Sympathetic neurons: DBH, TH, Parasympathetic neurons: NOS1, VIP, Sensory neurons: PRDM12, P2RY1, TRPV1, Schwann Cell Progenitors (SCPs): CDH19, MPZ, PLP1, Glial cells: GFAP, S100B, Chromaffin cells: PNMT, PENK, CARTPT and Proliferating cells: MKI67, PCNA. The remaining genes correspond to the top-5, most selective genes for each cluster. From the statistically significant genes (adjusted p-value &lt; 0.001, MAST with Bonferroni correction using all features), the top-10 (log2 fold-change) were sorted according to the percent of positive cells and the top-5 were plotted. Gene order follows the cluster order. Balloon size: percent of positive cells. Color intensity: scaled expression. Blue: high, Gray: low. (b) Balloon-plot of the detected cholinergic-synapse pathway genes (KEGG id: 217716). Balloon size: percent of positive cells. Color intensity: log2(normalized UMI-counts+1) (library size was normalized to 10.000) expression. Blue: high, Gray: low. (c) Heatmap of differentially expressed transcription factors (TFs) along the SCP-neuronal trajectory, according to tradeSeq. Stars: analyzed genes in &apos;D-E&apos;. Color intensity: scaled expression. Dark red: high, Gray: low. (d) UMAP-plots of SOX10, ASCL1 and ISL1 TFs. Expression levels: log2(normalized UMI-counts+1) (library size was normalized to 10.000). Blue: high. Gray: zero. (e) Confocal-microscopy image of an 8.5 pcw ganglion, showing SOX10, ASCL1 and ISL1 expression, detected with immunofluorescence. Dashed outlines: manually segmented nuclei. ##SOX10pos SCPs## (arrows), SOX10pos ASCL1pos transitioning SCPs (asterisks), ASCL1pos SOX10neg immature neurons (hashes), ISL1pos ASCL1neg mature neurons (arrowheads). Scale-bar: 5 microm.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9928586</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36646791</oboInOwl:hasDbXref>
        <rdfs:label>SOX10pos SCPs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002375"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/6a8b426b-75ef-420c-b54d-ee9c63263d43"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002375"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/6a8cfe63-cb9f-46a9-83c4-024707aac8ff -->

    <Class rdf:about="http://example.org/6a8cfe63-cb9f-46a9-83c4-024707aac8ff">
        <obo:IAO_0000115>Astrocytes play many important functions in response to spinal cord injury (SCI) in an activated manner, including clearance of necrotic tissue, formation of protective barrier, maintenance of microenvironment balance, interaction with immune cells, and formation of the glial scar. More and more studies have shown that the astrocytes are heterogeneous, such as inflammatory astrocyte 1 (A1) and neuroprotective astrocyte 2 (##A2##) types. However, the subtypes of astrocyte resulting from SCI have not been clearly defined. In this study, using single-cell RNA sequencing, we constructed the transcriptomic profile of astrocytes from uninjured spinal cord tissue and injured tissue nearby the lesion epicenter at 0.5, 1, 3, 7, 14, 60, and 90 days after mouse hemisection spinal cord surgery. Our analysis uncovered six transcriptionally distinct astrocyte states, including Atp1b2+ , S100a4+ , Gpr84+ , C3+ /G0s2+ , GFAP+ /Tm4sf1+ , and Gss+ /Cryab+ astrocytes. We used these new signatures combined with canonical astrocyte markers to determine the distribution of morphologically and physiologically distinct astrocyte population at injured sites by immunofluorescence staining. Then we identified the dynamic evolution process of each astrocyte subtype following SCI. Finally, we also revealed the evolution of highly expressed genes in these astrocyte subtypes at different phases of SCI. Together, we provided six astrocyte subtypes at single-cell resolution following SCI. These data not only contribute to understand the heterogeneity of astrocytes during SCI but also help to find new astrocyte subtypes as a target for SCI repair.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMID:35816276</oboInOwl:hasDbXref>
        <rdfs:label>A2</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002627"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/6a8cfe63-cb9f-46a9-83c4-024707aac8ff"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002627"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/6a95d374-e7be-4122-b5b0-920c5a013985 -->

    <Class rdf:about="http://example.org/6a95d374-e7be-4122-b5b0-920c5a013985">
        <obo:IAO_0000115>Meningeal ILC2s express Thy1.2, ST2, CD25, spinocerebellar ataxia type 1 (Sca10), and low levels of c-Kit and IL-7Ralpha and are major producers of IL-13 in tissues. As tissue-resident cells, ILC2s exhibit tissue-specific receptor expression patterns, which are imprinted by local signals. Likewise, dural ILC2s are distinct from lung ILC2s. The basal activation state of ##meningeal ILC2s## is lower than that of lung-resident cells. The proximity to brain-derived signals may explain the differences in basal activation observed between the two tissue types. ILC2 precursors originate from bone marrow. Future studies should determine the functional and phenotypic differences between blood-derived ILC2s and the adjacent bone marrow.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10616183</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37429945</oboInOwl:hasDbXref>
        <rdfs:label>meningeal ILC2s</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0001069"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/6a95d374-e7be-4122-b5b0-920c5a013985"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0001069"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/6a98b5ed-11c4-4e53-be14-0d792866937f -->

    <Class rdf:about="http://example.org/6a98b5ed-11c4-4e53-be14-0d792866937f">
        <obo:IAO_0000115>For instance, Yu et al. showed that O6-alkylguanine DNA alkyltransferase (MGMT)-negative glioma cells could take up reactive astrocyte exosomes and obtain a TMZ-resistant phenotype via translation of exogenous exosomal MGMT mRNA both in vitro and in vivo. Exosome-mediated interaction between astrocyte and glioma conferred a chemoresistance property for the relapse of glioma. Sharma et al. further investigated that GDEs were the potential driving force in promoting the differentiation of ##rNSCs## to astrocytes. GDEs induced the astrocytes activation and could shuttle lncRNA-ATB to astrocytes. The shuttled lncRNA-ATB activated recipient astrocytes by inhibiting miR-204-3p in an Argonaute 2-dependent manner and accelerated glioma migration and invasion. Peritumoral hypoxia in solid tumors is characterized by rapid tumor growth that exceeds vascular supply capabilities and/or tumor vasculature malfunctioning. The growth of HT22 cells was restrained by C6 glioma cells under hypoxic conditions, presuming that GDEs might be the communication medium between peritumoral neurons and glioma cells. Hypoxia-induced GDE miRNA-199a-3p was upregulated by the HIF-1alpha activation, and then aggravated oxygen-glucose deprivation and the ischemic injury of peritumoral neurons via repressing the mTOR pathway. GDE ncRNAs mediate the interaction between glioma cells and surrounding non-glioma brain cells to promote tumor evolution in the tumor microenvironment. These results shed light on the underlying mechanism of glioma aggressiveness and may provide new targets based on exosome-mediated peritumoral neuronal or neuroglial signals for combating glioma.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8660802</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34887381</oboInOwl:hasDbXref>
        <rdfs:label>rNSCs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000047"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/6a98b5ed-11c4-4e53-be14-0d792866937f"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000047"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/6ac94ab9-04a2-4856-913a-428ed43218a1 -->

    <Class rdf:about="http://example.org/6ac94ab9-04a2-4856-913a-428ed43218a1">
        <obo:IAO_0000115>We identified 23 immune cell subpopulations in the GSE162454 dataset by TSNE analysis at first. Based on the specific markers, we identified NK/T cells, CAFs (cancer associated fibroblasts), endothelial cells, plasma cells, osteoblastic cells, osteoclasts, B cells, ##M2 TAMs## (tumor associated macrophages), M1 TAMs, monocytes and mast cells (Figure 10A). The expression of marker genes for different cell clusters was displayed in dot plot format in Figure 10B. The expression of OS-related genes was compared in different cell types. Because of the dropout sign of single-cell sequencing, INS was not detected in the GSE162454 dataset. As shown in Figure 10C, HMOX1 were expressed at higher levels in TAMs and osteoclasts. ATF4 and ACADVL are highly expressed in myeloid cells as well as other cell types, which was suggestive of their roles in osteosarcoma progression.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10292890</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37285835</oboInOwl:hasDbXref>
        <rdfs:label>M2 TAMs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000890"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/6ac94ab9-04a2-4856-913a-428ed43218a1"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000890"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/6af4f20f-8ef0-4b67-8f01-e73269548f12 -->

    <Class rdf:about="http://example.org/6af4f20f-8ef0-4b67-8f01-e73269548f12">
        <obo:IAO_0000115>Chemogenetic activation of the ##DMH neurons## inhibits food intake and promotes positive valence.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8609163</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34728342</oboInOwl:hasDbXref>
        <rdfs:label>DMH neurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000540"/>
        <skos:relatedMatch rdf:resource="CL:2000030"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/6af4f20f-8ef0-4b67-8f01-e73269548f12"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000540"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/6af4f20f-8ef0-4b67-8f01-e73269548f12"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:2000030"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/6af6985b-e398-4497-b66b-d9b602aa8a45 -->

    <Class rdf:about="http://example.org/6af6985b-e398-4497-b66b-d9b602aa8a45">
        <obo:IAO_0000115>a Immune cell subsets analyzed by CellChat in the original tSNE plot. b Enhanced number of interactions and interaction strength noted in cSjD. Differential interaction strength c and numbers d are presented on the heatmap. The overall increase in the interaction strength in the signal-receiving effector immune subsets, along with a dramatic increase in the interaction numbers noted between FOXP3low Tregs (or naive Tregs) and myeloid/B subsets, in cSjD compared to HC. Bars refer to the sum of the computed interaction strength or numbers in each column and row. Relative values = the interaction strength/number from source to target in cSjD-the interaction strength/number from source to target in HC. e-g Identification of significant ligand and receptor pairs between immune subsets of interest. e The communication probability of CLEC2C ligand and KLRB1 receptor genes are significantly upregulated between B and effector memory CD4+ T cell subsets in cSjD. f FOXP3low Tregs show increased communication probability with myeloid subsets through CD4 and MHC class II-related genes in cSjD, compared to HC. g Pairs of CLEC ligands and KLRB receptor genes show increased communication probability in gammadelta-T cells of Bx and BxRP, compared to non-cSjD. Mo monocytes, NK natural killer, eff effector, ##em## effector memory, mem memory, cm central memory T cell, nv naive, pDC plasmacytoid dendritic cells, MAIT mucosal-associated invariant T, act activated or FOXP3high, IFN interferon-related, HC healthy control, cSjD childhood Sjogren&apos;s disease, BX biopsy-positive non-cSjD without RP, BXRP biopsy-positive non-cSjD with RP.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11031574</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38641668</oboInOwl:hasDbXref>
        <rdfs:label>em</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000905"/>
        <skos:relatedMatch rdf:resource="CL:0000913"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/6af6985b-e398-4497-b66b-d9b602aa8a45"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000905"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/6af6985b-e398-4497-b66b-d9b602aa8a45"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000913"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/6b2f0132-9cb3-4ff7-8d14-09a0f4830741 -->

    <Class rdf:about="http://example.org/6b2f0132-9cb3-4ff7-8d14-09a0f4830741">
        <obo:IAO_0000115>(A, B) Schematic of ##medial (MOC) and lateral (LOC) olivocochlear neuron## (OCN) subtypes housed in the brainstem (A) and their projections into the cochlea, shown in cross-section (A) and top-down (B). D, dorsal; L, lateral; LSO, lateral superior olive; VNTB, ventral nucleus of the trapezoid body; SOC, superior olivary complex; IHC, inner hair cell; OHC, outer hair cell; SGN, spiral ganglion neuron; IGSB, intraganglionic spiral bundle; ISB, inner spiral bundle; TSB, tunnel spiral bundle. (C) Schematic of single-nucleus collection protocol. The ventral brainstem of ChatCre; Rosa26Sun1-GFP mice was dissected, including the SOC, facial motor nucleus (VII), and trigeminal motor nucleus (V), followed by collection and sequencing of individual GFP+ nuclei. A, anterior; P, posterior. (D) UMAP plot summarizing sequencing data of 45,828 single nuclei from 61 animals across three ages. The data includes 56 clusters, including MOCs, LOCs, and several different motor neuron types, as well as a few non-neuronal populations. (E-H) Feature plots denoting normalized expression levels of selected genetic markers. For visualization purposes, high expression on the color scale is capped at the 95th percentile of gene expression. The majority of clusters express the neuronal marker Snap25 (E). The main non-neuronal population is labeled by Mog, an oligodendrocyte marker (F). Motor neuron clusters express the motor neuron determinant Isl1 (G). Among these brainstem motor neurons, OCNs are identified by expression of the transcription factor Gata3 (H). (I, J) Differential expression of known markers Ucn (I) and Atp1a3 (J) denotes LOCs and MOCs, respectively. (K-M) Cadps2 is a novel marker for OCNs that is expressed by both MOCs and LOCs but not FMNs. (K) Violin plots summarizing transcriptional expression of Cadps2 in mature LOCs, MOCs, and FMNs. (L, M) Fluorescent in situ hybridization (FISH) verifies that Cadps2 is detected in both MOCs and LOCs (L) but not in FMNs (M). Representative images are shown from a total of three animals of either sex, P28.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10147377</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36876911</oboInOwl:hasDbXref>
        <rdfs:label>medial (MOC) and lateral (LOC) olivocochlear neuron</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:2000047"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/6b2f0132-9cb3-4ff7-8d14-09a0f4830741"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:2000047"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/6b300010-c66b-4775-b39a-e0947635c9a2 -->

    <Class rdf:about="http://example.org/6b300010-c66b-4775-b39a-e0947635c9a2">
        <obo:IAO_0000115>Identification of ##OLM## and HS neurons</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10959371</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38470935</oboInOwl:hasDbXref>
        <rdfs:label>OLM</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002608"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/6b300010-c66b-4775-b39a-e0947635c9a2"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002608"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/6b5640a4-8ac0-4c3d-b828-d4b276325598 -->

    <Class rdf:about="http://example.org/6b5640a4-8ac0-4c3d-b828-d4b276325598">
        <obo:IAO_0000115>Innate T cells, including CD1d-restricted invariant natural killer T (iNKT) cells, are characterized by their rapid activation in response to non-peptide antigens, such as lipids. While the transcriptional profiles of naive, effector, and memory adaptive T cells have been well studied, less is known about the transcriptional regulation of different ##iNKT cell## activation states. Here, using single-cell RNA-sequencing, we performed longitudinal profiling of activated murine iNKT cells, generating a transcriptomic atlas of iNKT cell activation states. We found that transcriptional signatures of activation are highly conserved among heterogeneous iNKT cell populations, including NKT1, NKT2, and NKT17 subsets, and human iNKT cells. Strikingly, we found that regulatory iNKT cells, such as adipose iNKT cells, undergo blunted activation and display constitutive enrichment of memory-like cMAF+ and KLRG1+ populations. Moreover, we identify a conserved cMAF-associated transcriptional network among NKT10 cells, providing novel insights into the biology of regulatory and antigen-experienced iNKT cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9831610</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36458691</oboInOwl:hasDbXref>
        <rdfs:label>iNKT cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000921"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/6b5640a4-8ac0-4c3d-b828-d4b276325598"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000921"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/6b6d31bc-3d14-4208-8919-b88045ea0d68 -->

    <Class rdf:about="http://example.org/6b6d31bc-3d14-4208-8919-b88045ea0d68">
        <obo:IAO_0000115>Profiling H3K4me3 and RNA in human ##CD36 cells## using scPCOR-seq</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9270334</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35804086</oboInOwl:hasDbXref>
        <rdfs:label>CD36 cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000232"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/6b6d31bc-3d14-4208-8919-b88045ea0d68"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000232"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/6bb12162-c51e-4de2-8ed8-eaa64f375289 -->

    <Class rdf:about="http://example.org/6bb12162-c51e-4de2-8ed8-eaa64f375289">
        <obo:IAO_0000115>The levels of estradiol produced by our three FSH-responsive lines were similar to those produced by KGN human granulosa tumor cells, which also showed responses to FSH and forskolin (Figure 4A). In contrast, COV434 cells, which showed no FSHR expression in our RNA-seq data (Figure 3A), were unresponsive to FSH alone, producing estradiol only in the presence of forskolin. HGL5 immortalized human granulosa cells did not produce estradiol under any condition. Primary adult mouse ovarian somatic cells produced similar amounts of estradiol to our hiPSC-derived ##granulosa-like cells## (Figure 4A). However, the mouse cells did not show a response to FSH or forskolin, possibly because they were already exposed to FSH in vivo.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9943069</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36803359</oboInOwl:hasDbXref>
        <rdfs:label>granulosa-like cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000501"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/6bb12162-c51e-4de2-8ed8-eaa64f375289"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000501"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/6bb42b90-a60f-4bd5-b06d-7f5f9f3a4513 -->

    <Class rdf:about="http://example.org/6bb42b90-a60f-4bd5-b06d-7f5f9f3a4513">
        <obo:IAO_0000115>Defining ##Mesenchymal Stem/Stromal Cell-Induced Myeloid-Derived Suppressor Cells## Using Single-Cell Transcriptomics.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11184332</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38627968</oboInOwl:hasDbXref>
        <rdfs:label>Mesenchymal Stem/Stromal Cell-Induced Myeloid-Derived Suppressor Cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000134"/>
        <skos:relatedMatch rdf:resource="CL:0000889"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/6bb42b90-a60f-4bd5-b06d-7f5f9f3a4513"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000134"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/6bb42b90-a60f-4bd5-b06d-7f5f9f3a4513"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000889"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/6bbf396f-bdb3-411d-a23d-560aa210fe2f -->

    <Class rdf:about="http://example.org/6bbf396f-bdb3-411d-a23d-560aa210fe2f">
        <obo:IAO_0000115>Potential sources, morphological and phenotypic characterizations of different types of urine-derived stem cells. Upper urinary tract cells can be derived from renal cortical nephron part-renal tubular cells from proximal and distal convoluted tubules, glomerular pericytes, renal interstitial cells and vascular endothelial cells. ##Lower urinary tract urine-derived stem cells## (UDSC) belong to epithelial (urothelial) cells from ureter, urinary bladder and urethra. Original source of UDSC determines their morphology in vitro, culture conditions, phenotype and differentiation capabilities. Image was adapted from original images from Servier Medical Art, as licensed under a Creative Commons Attribution 3.0 Unported License. Text was added to the original images.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7140531</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32121221</oboInOwl:hasDbXref>
        <rdfs:label>Lower urinary tract urine-derived stem cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000034"/>
        <skos:relatedMatch rdf:resource="CL:1000600"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/6bbf396f-bdb3-411d-a23d-560aa210fe2f"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000034"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/6bbf396f-bdb3-411d-a23d-560aa210fe2f"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:1000600"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/6bc0c469-dc07-4426-8857-6185503840e2 -->

    <Class rdf:about="http://example.org/6bc0c469-dc07-4426-8857-6185503840e2">
        <obo:IAO_0000115>Ultimately, to show that human ##MME+ FAPs## are also more highly adipogenic than their MME- counterpart, we isolated MME+ and MME- FAPs from human muscle. FAPs were isolated as (MME+ or MME-)CD34+CD31-CD45-CD56-PI- via FACS (Supplementary Fig. 8e) and brought in culture as described before. When reaching 95% confluence, the medium was changed to an adipogenic differentiation medium. In agreement with our mouse data, human MME+ FAPs differentiated much more readily into adipocytes than the MME- FAPs (Fig. 7g, h). Interestingly, the differences in adipogenic potential of human MME+ and MME- FAPs were apparent under full adipogenic stimulation where we found very few MME- FAPs undergoing adipogenic differentiation. Together, these findings show that, in both mice and humans, MME+ FAPs are a highly adipogenic FAP fraction and that MME+ FAPs are reduced under adipogenic conditions.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9883500</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36707617</oboInOwl:hasDbXref>
        <rdfs:label>MME+ FAPs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0009099"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/6bc0c469-dc07-4426-8857-6185503840e2"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0009099"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/6bf790e4-7321-4cf4-8b1d-6a7df5bd888c -->

    <Class rdf:about="http://example.org/6bf790e4-7321-4cf4-8b1d-6a7df5bd888c">
        <obo:IAO_0000115>We next assessed if iETV2-ECs could also be used to vascularize cerebral organoids (CO), and if presence of ECs would affect the localization of the different neural compartments. We thus generated PSC-derived COs and vascularized COs (eCOs; by allowing organoid formation from a mix of iETV2 and wild type PSCs; PSC:iETV2-hiPSC ratio = 8:2). To generate iETV2-ECs in situ, we activated the ETV2 transgene by addition on day 4 and 7, respectively, low and high concentrations of doxycycline for basal and full transgene activation (Figure  5A). Immunostaining of DIV35 eCO revealed CD31+ vascular structures and relatively smaller and scattered ventricular zones (VZ) (Figure 5B(ii)) in which the radial organization of SOX2+ cells (but not ##TUJ1+ cells##) was less apparent than that of CO not containing ECs (Figure 5B(i)). We also embedded CO and eCO in matrigel alone or in iETV2-ECs laden matrigel. In matrigel alone, we observed VZ-like structures in the CO, however the SOX2+ cells were mostly found outside the VZ (indicated by asterisk; Figure 5B(iii)). In eCO, the radial organization of SOX2+ in VZ was more disrupted (Figure 5B(iv)), whereby the SOX2+ and TUJ1+ cells appeared to spread into the matrigel, and CD31+ cells were found mainly at the periphery. In iETV2-EC</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10837345</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38037510</oboInOwl:hasDbXref>
        <rdfs:label>TUJ1+ cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000047"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/6bf790e4-7321-4cf4-8b1d-6a7df5bd888c"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000047"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/6c161824-30c8-4bb5-8a2c-d203787fc1e1 -->

    <Class rdf:about="http://example.org/6c161824-30c8-4bb5-8a2c-d203787fc1e1">
        <obo:IAO_0000115>Expression heterogeneity of CD8+ and CD4+ T cells in the OSCC ecosystem. (A) The t-distributed stochastic neighbor embedding (t-SNE) projection of T cells from cancerous tissue of patients with OSCC, showing the formation of 11 main clusters in different colors. The functional description of each cluster is determined by the gene expression characteristics. Cluster 0: resident memory CD8+ T Cells (C0_CD8+ TRM); Cluster 1: effector memory CD8+ T cells (C1_CD8+ TEM); Cluster 2: regulatory CD4+ T cells (C2_CD4+ Treg); Cluster 3: exhausted CD8+ T cells (C3_CD8+ T Exhausted); Cluster 4: effector memory M-phage CD8+ T cells (C4_CD8+ Mitotic TEM); Cluster 5: effector memory CD4+ T cells (C5_CD4+ TEM); Cluster 6: effector memory CD8+ T cells (C6_CD8+ TEM); Cluster 7: effector memory CD4+ T cells (C7_CD4+ TEM); Cluster 8: effector memory CD8+ T cells (C8_CD8+ TEM); Cluster 9: effector memory CD8+ T cells (C9_CD8+ TEM); Cluster 10: effector memory M-phage CD4+ T cells (C10_CD4+ Mitotic TEM); Cluster 11: effector memory CD8+ T cells (C11_CD8+ TEM); Cluster 12: effector memory CD8+ T cells (C12_CD8+ TEM); Cluster 13: gammadelta T. (B) Cell-Cycle Scoring of T cells from cancerous tissue of patients with OSCC, showing the three clusters of cells in different cell cycles in different colors. (C) Heatmap of key genes expressed in each cluster of CD8+ tumor-infiltrating lymphocytes (##TILs##) with cells grouped by clusters. The columns correspond to the cells; the rows correspond to the genes. Yellow: high expression; purple: low expression. Selected key markers are shown on the right. (D) Heatmap of key genes expressed in each cluster of CD4+ TILs with cells grouped by clusters. The columns correspond to the cells; the rows correspond to the genes. Yellow: high expression; purple: low expression. Selected key genes are shown on the right.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8024729</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33513276</oboInOwl:hasDbXref>
        <rdfs:label>TILs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000542"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/6c161824-30c8-4bb5-8a2c-d203787fc1e1"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000542"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/6c4b1690-7e34-45c2-b934-388bef0dea3e -->

    <Class rdf:about="http://example.org/6c4b1690-7e34-45c2-b934-388bef0dea3e">
        <obo:IAO_0000115>Cytokines are crucial biomarkers of the progression of various inflammatory disorders including pneumonia. We characterized the relationship between the proinflammatory cytokine IL-6 and T, B, NK, and Treg lymphocyte subsets in the blood samples of 125 COVID-19 patients at inpatient admission. The number of T lymphocyte subsets, including naive T4/T8 cells, central memory T4/T8 cells, ##PD1+ depletes T8 cells##, and effector memory T8 cells, was moderately increased in COVID-19 patients with normal IL-6 levels, and with increasing IL-6 levels, these lymphocyte subset counts declined (Fig. 5A). The other T lymphocyte subset counts showed a decreasing trend with increasing IL-6 levels (Fig. 5A). In B lymphocyte subsets, it is worth noting that the number of plasma blasts was markedly increased in COVID-19 patients, with IL-6 levels above 30-fold higher than normal (Fig. 5B), but other B lymphocyte subsets, including naive B cells, transitional B cells, class switched memory B cells, class unswitched memory B cells, marginal zone B cells, and CD21low CD38low B cells, were obviously decreased with higher IL-6 levels (Fig. 5B). As demonstrated in Fig. 5C, the higher IL-6 the levels in COVID-19 patients, the lower the number of NK lymphocyte subsets, including NKT cells, NK cells, immature NK cells, and mature NK cells (Fig. 5C). Similarly, the numbers of naive Tregs, memory Tregs and activated Tregs were significantly decreased with higher IL-6 levels, but when the level of IL-6 was 30-fold higher than normal, Tregs were instead increased compared to COVID-19 patients with normal IL-6 levels (Fig. 5D).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9675966</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36403042</oboInOwl:hasDbXref>
        <rdfs:label>PD1+ depletes T8 cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000625"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/6c4b1690-7e34-45c2-b934-388bef0dea3e"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000625"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/6c5692e2-6a8e-4829-ad78-b25abf99ac3e -->

    <Class rdf:about="http://example.org/6c5692e2-6a8e-4829-ad78-b25abf99ac3e">
        <obo:IAO_0000115>Our novel multi-color flow cytometry panel was also tested on mouse skin. After excluding cellular debris, doublets, and dead cells, we gated with the help of FMO controls (Fig. S10) on viable CD45+ cells (Fig. 2A). In healthy skin, the CD3+ T cell population consists of CD3intCD4+ T cells and CD3highgammadelta T cells, whereas CD8+ T cells, NK cells, B cells, neutrophils and pDC are rare in healthy skin (Fig. 2B). By following gating published earlier, we identified several myeloid non-DC populations (P1-P5) in the dermis (Fig. 2C) and different DC-subsets (Fig. 2D, E). From the non CD11b+CD24- population we identified CD11c+MHC-II+ DC. Next, we divided DC into XCR1+ cDC1, which contain CD103+ and CD103- subsets, and CD172a+ DC which consists mainly of CD207+ LC (Fig. 2D). Dermal cDC2 are characterized from the CD64-Ly-6C- population by gating on ##CD11c+MHC-II+ cells that express CD11b and CD172a## (Fig. 2E). In addition, we investigated CD115, F4/80 and CD64 expression on the non-DC myeloid cell populations P1-P5 (Fig. 2F). Analysis of CD40, PD-L1, PD-L2 and CCR7 on the different DC-subets allows further phenotypical characterization (Fig. 2G). An example for UMAP analysis is shown in Figure S11 confirming manual gating for DC-subsets and non-DC populations.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10087122</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35944142</oboInOwl:hasDbXref>
        <rdfs:label>CD11c+MHC-II+ cells that express CD11b and CD172a</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000990"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/6c5692e2-6a8e-4829-ad78-b25abf99ac3e"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000990"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/6c82ff48-bcc2-4401-ad90-c99a67f0248f -->

    <Class rdf:about="http://example.org/6c82ff48-bcc2-4401-ad90-c99a67f0248f">
        <obo:IAO_0000115>scRNA sequencing data was analyzed to further explore the synergistic effect of the IRRS and the TME cells in ESCC. We used the previously profiled transcriptomes of ~208,659 single cells with eight main cell populations ( Figures 4A, B ), among which fibroblasts, endothelial cells, T cells, B cells, pericytes and myeloid cells were analyzed. Next, 40 cell clusters, including T helper 17 (TH17) cells, follicular helper T (TFH1/2) cells, naive T (TN) cells, regulatory T (Treg) cells, memory T (TMEM-CD4/CD8) cells, effector T (TEFF) cells, exhausted T (TEX) cells, monocytes (Mono01-03), tumor-associated macrophages (TAM01-04),dendritic cells (tDC, pDC, cDC), mast cells (Mast), resting B cells, activated B cells, germinal center B cells (GCB), plasma cells, normal mucosa fibroblasts (NMF), normal activated fibroblasts (NAF1/2), cancer-associated fibroblasts (##CAF##1-4), vascular smooth muscle cells (VSMC), normal endothelial cells (NEC1-3) and tumor endothelial cell (TEC1-3) were identified by t-SNE analysis ( Figures 4C-G ;  Figures S6A-E ). We then used CIBERSORTx to infer cell-type abundance from bulk RNA-seq data using scRNA data, and estimated the proportions of the 42 cell types in the training dataset. The proportions of TME cell types between the high- and low-risk groups was compared using the Kruskal-Wallis test. The profiles of the high- and low-risk groups are shown in  Figure 4H  and  Figure S6F . The abundance of TEX, NAF2, CAF4, and VSMC increased, and the abundance of Mono1, TAM03, and NEC2 decreased in the high-risk group (p &lt; 0.05;  Figure 4I ). The cell proportions between low and high risk groups demonstrated significantly distinct TME patterns.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9933905</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36817484</oboInOwl:hasDbXref>
        <rdfs:label>CAF</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000057"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/6c82ff48-bcc2-4401-ad90-c99a67f0248f"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000057"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/6ca6b839-876b-4742-947b-ba8b8cba4bad -->

    <Class rdf:about="http://example.org/6ca6b839-876b-4742-947b-ba8b8cba4bad">
        <obo:IAO_0000115>We next leveraged the high number of nuclei and developmental time points sampled in our dataset to quantify cell types across gestational age. Focusing on the germinal matrix where gliogenesis begins, samples were grouped into four stages spanning the latter half of second trimester and third trimester: 17-20 gw (Stage 1), 20-24 gw (Stage 2), 24-28 gw (Stage 3), and 31-41 gw (Stage 4). The stages differed statistically by gestational age but not by sex or tissue collection postmortem interval (Supplementary Data 1-2). By plotting mean fraction of cell type by stage, we observe two trends from second to third trimester: a decrease in the fraction of nIPCs and excitatory neurons (EN: CPN and ##SPN##) and an increase in the fraction of glia (RG/AC, gIPC, astrocyte, OPC, and microglia) (Fig. 1f). To study these trends further, we correlated the fraction of cell types to sample age in gestational weeks (Supplementary Fig. 3). This reveals a significant increase with gestational age in the fraction of gIPCs (p = 0.003; two-tailed Spearman Rank-Order Correlation test), astrocytes (p = 0.015), OPCs (p = 0.0008), and microglia (p = 0.002) (Supplementary Fig. 3a). The fraction of MSNs also increase significantly (p = 0.002). Conversely, there is a significant decrease in the fraction of nIPCs (p = 0.034), late-born L2/3 CPNs (p = 0.009), and TAC (p = 0.002) (Supplementary Fig. 3a). Our GM dataset, therefore, captures the start of the gliogenic period. In the CP, the fraction of TACs, nIPCs, and CRNs exhibit a significant decrease over time (p = 0.002, ~0, 0.0001, respectively), while L4/5a CPNs show a significant increase (p = 0.002) (Supplementary Fig. 3b). Interneurons also increase from second to third trimester (p = 0.001), consistent with their migration into the neocortex. While the fraction of CP glia exhibit a positive trend, only OPC numbers show a significant positive correlation with gestational age (p = 0.026).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9744747</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36509746</oboInOwl:hasDbXref>
        <rdfs:label>SPN</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000540"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/6ca6b839-876b-4742-947b-ba8b8cba4bad"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000540"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/6cb0328b-e01b-4afc-8734-efa3003f4214 -->

    <Class rdf:about="http://example.org/6cb0328b-e01b-4afc-8734-efa3003f4214">
        <obo:IAO_0000115>A, B, tSNE plot of 4659 CD45+ immune cells from the CNS. Data from this study is integrated with data from; Table 6). C, D, Each dataset represented by one tSNE. Cells are annotated using color representing their cell type. bMicroglia: baseline microglia; aMicroglia: activated microglia; pmMicroglia: proliferation-mediating microglia; maMicroglia: monocyte-activating microglia; DAM: disease-associated microglia in SCI; elMicroglia: ##embryonic-like microglia##; pvMacrophages: perivascular macrophages; mdMacrophages: monocyte-derived macrophages; DCs: dendritic cells; imB-cells: immature B-cells; mB-cells: mature B-cells; pimMicroglia: postnatal immature microglia; IEG+Microglia: immediate early genes microglia; sMicroglia: s-phase microglia; pPAM: postnatal proliferative-region-associated microglia; eMicroglia: embryonic microglia; pcpMacrophages: postnatal choroid plexus macrophages; acpMacrophages: adult choroid plexus macrophages; iMonocytes: inflammatory monocytes; pMonocytes: patrolling monocytes; cpEpithelial cells: choroid plexus epithelial cells. E, tSNE plots of 4659 CD45+ immune cells for selected genes indicating the log2(cpm) expression with a continuous color for each cell separately. F, Proliferation rate of CD45low and CD45high cells at 7 and 21 d post-SCI. Hoechst 33342 expression presented on a log-scale was used for defining cells in S-phase. Right most plot reports the percentage of cells in S-phase. Each dot represents one biological replicate (four mice per time point). Mean is surrounded by a 95% CI. This figure is extended in Extended Data Figure 8-1.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8496189</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34417326</oboInOwl:hasDbXref>
        <rdfs:label>embryonic-like microglia</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000129"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/6cb0328b-e01b-4afc-8734-efa3003f4214"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000129"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/6d678599-a5c4-482a-9f38-12901485027d -->

    <Class rdf:about="http://example.org/6d678599-a5c4-482a-9f38-12901485027d">
        <obo:IAO_0000115>Acute leukemia is characterized by a rapid expansion of hematopoietic precursors (blast cells), which remain partially differentiated and proliferate in the bone marrow and peripheral blood as the disease progresses. Two of the most common types of pediatric acute leukemias are acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML). ALL is the most prevalent type of cancer in children (80% of leukemias and 25% of childhood cancers), and 10-15% of these cases represent ##T-cell ALL## (T-ALL). T-ALL arises from T-lymphoblasts in the thymus as a result of an accumulation of mutations in immature thymocytes, altering inter alia cell proliferation and differentiation. The lymphoblasts leave the thymus and access the circulation, from where other organs such as the bone marrow or central nervous system are invaded. AML constitutes about 20% of all childhood leukemias and is caused by abnormal myeloblasts (immature leukocytes of the myeloid lineage). Cancerous myeloblasts have the ability of constant proliferation and avoidance of cell death, leading to an expansion in the myeloblast population and to a disturbed hematopoiesis.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8423305</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34492077</oboInOwl:hasDbXref>
        <rdfs:label>T-cell ALL</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000084"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/6d678599-a5c4-482a-9f38-12901485027d"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000084"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/6d6a3f05-5448-4bae-b3f6-b9cc6b322afe -->

    <Class rdf:about="http://example.org/6d6a3f05-5448-4bae-b3f6-b9cc6b322afe">
        <obo:IAO_0000115>The Table shows the numerical representations of Excitatory Neurons (Deep and Superficial Pyramidal cells) and Inhibitory neurons (Oriens Lacunosum moleculare cells:OLM; Trilaminar cells:Tri, Backprojection cells:BP, cholecystokinin positive Basket cells:##CCKBC##, Parvalbumin positive cells:PVBC, AxoAxonic Cells:AA, Ivy Cells:IVY, Bistratified cells:BS, Schaffer Collateral associated cells:SCA, Perforant Pathway Associated cell:PPA, Neurogliaform:NG) subdivided on the basis of the placement classes (SO, SP, SR, SLM).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9381785</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35974119</oboInOwl:hasDbXref>
        <rdfs:label>CCKBC</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000118"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/6d6a3f05-5448-4bae-b3f6-b9cc6b322afe"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000118"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/6d96cf54-f73f-4a9e-8b7c-b78a5dada880 -->

    <Class rdf:about="http://example.org/6d96cf54-f73f-4a9e-8b7c-b78a5dada880">
        <obo:IAO_0000115>The Table shows the numerical representations of Excitatory Neurons (Deep and Superficial Pyramidal cells) and Inhibitory neurons (Oriens Lacunosum moleculare cells:OLM; Trilaminar cells:Tri, Backprojection cells:BP, cholecystokinin positive Basket cells:CCKBC, ##Parvalbumin positive cells##:PVBC, AxoAxonic Cells:AA, Ivy Cells:IVY, Bistratified cells:BS, Schaffer Collateral associated cells:SCA, Perforant Pathway Associated cell:PPA, Neurogliaform:NG) subdivided on the basis of the placement classes (SO, SP, SR, SLM).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9381785</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35974119</oboInOwl:hasDbXref>
        <rdfs:label>Parvalbumin positive cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:4023018"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/6d96cf54-f73f-4a9e-8b7c-b78a5dada880"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4023018"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/6dea3730-8df9-4dca-a48a-5a21ffbf46b9 -->

    <Class rdf:about="http://example.org/6dea3730-8df9-4dca-a48a-5a21ffbf46b9">
        <obo:IAO_0000115>Overexpression of ICOS rescues iNKT2 and iNKT17 cells of GATA-3-deficient mice. (A) The thymocytes and splenocytes from GATA-3 FF and FFcre mice were stained with TCRbeta, CD4, CD8, CD44, CD62L, NK1.1, loaded CD1d tetramer, CD127, and ICOS. The histogram plots show the surface expression levels of CD127 and ICOS on thymic iNKT cells (TCRbeta+ tetramer+), CD8 single-positive thymocyte (TCRbetahiCD4-CD8+), splenic naive (TCRbeta+CD4-CD8+CD44-CD62L+), and activated/memory (TCRbeta+CD4-CD8+CD44hiCD62L-) CD8 T cells. (B) The gating strategy for identifying ##iNKT17 and iNKT2 cells## from FFcre thymocytes overexpressing ICOS and CD127 via retroviral transduction is illustrated. Cumulative results are presented in the (lower panel). (two-sided unpaired t-test, ns, * p &lt; 0.05, ** p &lt; 0.01).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11201670</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38920701</oboInOwl:hasDbXref>
        <rdfs:label>iNKT17 and iNKT2 cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000921"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/6dea3730-8df9-4dca-a48a-5a21ffbf46b9"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000921"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/6dfff790-2323-4f8f-9087-4384c5fb9e2e -->

    <Class rdf:about="http://example.org/6dfff790-2323-4f8f-9087-4384c5fb9e2e">
        <obo:IAO_0000115>tSNE plot colored by the 17 Seurat clusters including hepatocytes, endothelial cells (liver sinusoidal endothelial cells:LSEC, non-tumor liver vascular endothelial cells:LVEC, and tumor liver vascular endothelial cells:LVECt), mesenchymal cells (Stellate cells, cancer-associated fibroblasts:CAFs, Pericytes, vascular smooth muscle cells:vSMC), immune cells (Kupffer cells, ##scar-associated macrophages##:SAMs, tissue monocytes 1:TM1, cDC1, cDC2, T cells, and B cells), proliferating cells, and carcinoma cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7746227</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33332768</oboInOwl:hasDbXref>
        <rdfs:label>scar-associated macrophages</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/6dfff790-2323-4f8f-9087-4384c5fb9e2e"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/6e36af1e-6272-4c25-9ea8-c3eb0c5788d3 -->

    <Class rdf:about="http://example.org/6e36af1e-6272-4c25-9ea8-c3eb0c5788d3">
        <obo:IAO_0000115>a Schematic overview of the experimental workflow. Forebrain samples were collected from Sox2eGFP mice at 11 developmental timepoints, dissociated into single cells followed by sorting of the GFP + ve /-ve cells and performing single-cell RNA-seq using the 10x Genomics Chromium platform. b Left: two-dimensional Uniform manifold approximation and progression (UMAP) plot with Leiden clustering of 102,504 individual cells identifying 28 transcriptionally and biologically distinct cell types (see Supplementary Fig. 3a and Methods). Each dot represents a single cell and colours correspond to the distinct clusters/cell types. Shown on the right is a dot plot showing the relative fraction (dot size) of the 28 cell types at each developmental timepoint normalized by library size. c UMAP plot of the cells as in (b) but coloured by timepoint. Each dot represents a single cell and the colours correspond to the different timepoints. d, UMAP plot showing the coarse annotation of cells into 4 categories (Neuronal, Glial, Immune and Vascular/other) based on logistic regression from Zeisel et al. 2018. The RNA-velocity field is overlaid on the UMAP. Colours represent the 4 categories of cell annotation and the arrows correspond to the direction of the RNA-velocity flow field (see Methods). RG Radial glia, TAPs Transient amplifying progenitors, aNSCs Active neural stem cells, APCs Astrocyte progenitor cells, EmNBs Embryonic neuroblasts, ##GE NBs## Ganglionic eminence neuroblasts, OPCs Oligoprogenitor cells, PreM-ODCs Immature pre-myelinating oligodendrocytes, INs Interneurons, ImStNeurons Immature striatal neurons, VLMC Vascular leptomeningeal cells, Myeloid-DSCs Myeloid-derived suppressor cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9296666</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35853870</oboInOwl:hasDbXref>
        <rdfs:label>GE NBs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000031"/>
        <skos:relatedMatch rdf:resource="CL:4023063"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/6e36af1e-6272-4c25-9ea8-c3eb0c5788d3"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000031"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/6e36af1e-6272-4c25-9ea8-c3eb0c5788d3"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4023063"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/6e3da76d-c60b-4c5e-b12d-76e55f10f1c9 -->

    <Class rdf:about="http://example.org/6e3da76d-c60b-4c5e-b12d-76e55f10f1c9">
        <obo:IAO_0000115>Although tumor-infiltrating T cells hold a beneficial prognostic role in colorectal cancer, other lymphocytic populations are less characterized. We developed a multiplexed immunofluorescence assay coupled with digital image analysis and machine learning to identify natural killer (NK) cells (NCAM1+CD3-), ##natural killer T-like (NKT-like) cells## (NCAM1+CD3+), and T cells (NCAM1-CD3+) within the PTPRC+ (CD45+) cell population and to measure their granzyme B (GZMB; cytotoxicity marker) and FCGR3A (CD16a; NK-cell maturity marker) expression. We evaluated immune cell densities and spatial configuration in 907 incident colorectal carcinoma cases within two prospective cohort studies. We found that T cells were approximately 100 times more abundant than NK and NKT-like cells. Overall, NK cells showed high GZMB expression and were located closer to tumor cells than T and NKT-like cells. In T and NKT-like cells, GZMB expression was enriched in cells in closer proximity to tumor cells. Higher densities of both T and NKT-like cells associated with longer cancer-specific survival, independent of potential confounders (P trend &lt; 0.0007). Higher stromal GZMB+ and FCGR3A+ NK-cell densities associated with longer cancer-specific survival (P trend &lt; 0.003). For T and NKT-like cells, greater proximity to tumor cells associated with longer cancer-specific survival (P trend &lt; 0.0001). These findings indicate that cytotoxic NCAM1+CD3-GZMB+ NK cells and NCAM1+CD3+ NKT-like cells are relatively rare lymphocytic populations within the colorectal cancer microenvironment and show distinct spatial configuration and associations with patient outcome. The results highlight the utility of a quantitative multimarker assay for in situ, single-cell immune biomarker evaluation and underscore the importance of spatial context for tumor microenvironment characterization.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8816895</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34937729</oboInOwl:hasDbXref>
        <rdfs:label>natural killer T-like (NKT-like) cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000814"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/6e3da76d-c60b-4c5e-b12d-76e55f10f1c9"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000814"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/6e428b2b-e892-4754-9327-e5c5d61dd2dc -->

    <Class rdf:about="http://example.org/6e428b2b-e892-4754-9327-e5c5d61dd2dc">
        <obo:IAO_0000115>Heat maps showing the subsets of T cells, NK and myeloid cells that account for the majority of lymphoid and myeloid cells in each BILs and PBMC fraction. The heat maps show the relative abundance of each cluster as a percentage of the total number of CD4 alphabeta T cells, CD8 alphabeta T cells, gammadelta T cells, NK cells or myeloid cells, respectively in each ##BIL## and PBMC fraction (Table S4).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6362260</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:30761153</oboInOwl:hasDbXref>
        <rdfs:label>BIL</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000542"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/6e428b2b-e892-4754-9327-e5c5d61dd2dc"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000542"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/6e6af9ac-ad75-4909-9962-bdea82fef9ae -->

    <Class rdf:about="http://example.org/6e6af9ac-ad75-4909-9962-bdea82fef9ae">
        <obo:IAO_0000115>However, in contrast to previous studies (e.g.) rather than use multiple Cre-lines to distinguish subpopulations of, for example, GABAergic cells, we have rather studied excitatory and inhibitory classes more generally, using Cre-Off and Cre-On AAVs in Gad2-Cre mice. Thus, the primary goal of this study was not to investigate differences in innervation between the many particular subtypes of inhibitory or excitatory cells, but whether these two classes receive anatomically segregated distant inputs. For comparison, we also examined input to parvalbumin-expressing cells, the largest known subtype of GABAergic neuron in the neocortex, and proenkephalin-expressing (penk) cells, a subtype of ##excitatory cell## present in L2/3 and L6. Although the differences were relatively small, there were noticeable qualitative trends in the fraction of inputs to the different classes, suggesting the potential for more subtle diversity in the excitatory and inhibitory populations than our study could detect.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7925549</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33654118</oboInOwl:hasDbXref>
        <rdfs:label>excitatory cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000540"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/6e6af9ac-ad75-4909-9962-bdea82fef9ae"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000540"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/6e75612f-9432-493c-8518-f5b7cac35fb7 -->

    <Class rdf:about="http://example.org/6e75612f-9432-493c-8518-f5b7cac35fb7">
        <obo:IAO_0000115>A specific ##PD-L1+CD206+ macrophage## risk subgroup is identified in colorectal cancer, which is induced by tumor-derived sEV-miRNAs. This subgroup promotes tumor growth by inducing an immunosuppressive tumor microenvironment. Hence, targeting specific tumor sEV-miRNAs that regulate PD-L1 in tumor-associated macrophages may serve as a novel treatment strategy and a sensitization method for anti-PD-L1 therapy in colorectal cancer.  </obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8948581</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35356153</oboInOwl:hasDbXref>
        <rdfs:label>PD-L1+CD206+ macrophage</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/6e75612f-9432-493c-8518-f5b7cac35fb7"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/6e98b339-8dfd-4f87-9c4a-9365e111d163 -->

    <Class rdf:about="http://example.org/6e98b339-8dfd-4f87-9c4a-9365e111d163">
        <obo:IAO_0000115>(A, B) Schematic of medial (MOC) and lateral (LOC) olivocochlear neuron (OCN) subtypes housed in the brainstem (A) and their projections into the cochlea, shown in cross-section (A) and top-down (B). D, dorsal; L, lateral; LSO, lateral superior olive; VNTB, ventral nucleus of the trapezoid body; SOC, superior olivary complex; IHC, inner hair cell; OHC, outer hair cell; SGN, spiral ganglion neuron; IGSB, intraganglionic spiral bundle; ISB, inner spiral bundle; TSB, tunnel spiral bundle. (C) Schematic of single-nucleus collection protocol. The ventral brainstem of ChatCre; Rosa26Sun1-GFP mice was dissected, including the SOC, facial motor nucleus (VII), and trigeminal motor nucleus (V), followed by collection and sequencing of individual GFP+ nuclei. A, anterior; P, posterior. (D) UMAP plot summarizing sequencing data of 45,828 single nuclei from 61 animals across three ages. The data includes 56 clusters, including MOCs, LOCs, and several different motor neuron types, as well as a few non-neuronal populations. (E-H) Feature plots denoting normalized expression levels of selected genetic markers. For visualization purposes, high expression on the color scale is capped at the 95th percentile of gene expression. The majority of clusters express the neuronal marker Snap25 (E). The main non-neuronal population is labeled by Mog, an oligodendrocyte marker (F). Motor neuron clusters express the motor neuron determinant Isl1 (G). Among these brainstem motor neurons, OCNs are identified by expression of the transcription factor Gata3 (H). (I, J) Differential expression of known markers Ucn (I) and Atp1a3 (J) denotes LOCs and MOCs, respectively. (K-M) Cadps2 is a novel marker for OCNs that is expressed by both MOCs and LOCs but not ##FMNs##. (K) Violin plots summarizing transcriptional expression of Cadps2 in mature LOCs, MOCs, and FMNs. (L, M) Fluorescent in situ hybridization (FISH) verifies that Cadps2 is detected in both MOCs and LOCs (L) but not in FMNs (M). Representative images are shown from a total of three animals of either sex, P28.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10147377</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36876911</oboInOwl:hasDbXref>
        <rdfs:label>FMNs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:2000047"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/6e98b339-8dfd-4f87-9c4a-9365e111d163"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:2000047"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/6ebfce1b-cb0d-412b-ba91-13c02be3aeda -->

    <Class rdf:about="http://example.org/6ebfce1b-cb0d-412b-ba91-13c02be3aeda">
        <obo:IAO_0000115>Furthermore, there are several other origins of CAFs, such as a subset derived from the macrophage lineage found in non-small-cell lung carcinoma, regulated by Smad3-induced macrophage-myofibroblast transition (MMT). Mesothelial cells can also transform into a typical ##antigen-presenting CAFs## (apCAFs) when induced by IL-1 and TGF-beta, discovered in pancreatic cancer. The exact origin of CAFs still lacks precise elaboration, and further approaches like lineage tracing, fate-mapping, pseudotime analysis, and RNA velocity may help uncover new primogenitors of CAFs.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11300527</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38602594</oboInOwl:hasDbXref>
        <rdfs:label>antigen-presenting CAFs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000057"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/6ebfce1b-cb0d-412b-ba91-13c02be3aeda"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000057"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/6eeae77e-5f88-42c0-8dc2-df27ffa29034 -->

    <Class rdf:about="http://example.org/6eeae77e-5f88-42c0-8dc2-df27ffa29034">
        <obo:IAO_0000115>Food intake behavior is regulated by a network of appetite-inducing and appetite-suppressing neuronal populations throughout the brain. The parasubthalamic nucleus (PSTN), a relatively unexplored population of neurons in the posterior hypothalamus, has been hypothesized to regulate appetite due to its connectivity with other anorexigenic neuronal populations and because these neurons express Fos, a marker of neuronal activation, following a meal. However, the individual cell types that make up the PSTN are not well characterized, nor are their functional roles in food intake behavior. Here, we identify and distinguish between two discrete PSTN subpopulations, those that express tachykinin-1 (PSTNTac1 neurons) and those that express corticotropin-releasing hormone (PSTNCRH neurons), and use a panel of genetically encoded tools in mice to show that PSTNTac1 neurons play an important role in appetite suppression. Both subpopulations increase activity following a meal and in response to administration of the anorexigenic hormones amylin, cholecystokinin (CCK), and peptide YY (PYY). Interestingly, chemogenetic inhibition of ##PSTNTac1, but not PSTNCRH neurons##, reduces the appetite-suppressing effects of these hormones. Consistently, optogenetic and chemogenetic stimulation of PSTNTac1 neurons, but not PSTNCRH neurons, reduces food intake in hungry mice. PSTNTac1 and PSTNCRH neurons project to distinct downstream brain regions, and stimulation of PSTNTac1 projections to individual anorexigenic populations reduces food consumption. Taken together, these results reveal the functional properties and projection patterns of distinct PSTN cell types and demonstrate an anorexigenic role for PSTNTac1 neurons in the hormonal and central regulation of appetite.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9119672</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35507386</oboInOwl:hasDbXref>
        <rdfs:label>PSTNTac1, but not PSTNCRH neurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000540"/>
        <skos:relatedMatch rdf:resource="CL:1001505"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/6eeae77e-5f88-42c0-8dc2-df27ffa29034"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000540"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/6eeae77e-5f88-42c0-8dc2-df27ffa29034"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:1001505"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/6f0a92f5-0281-46f3-b997-a9df8e18be50 -->

    <Class rdf:about="http://example.org/6f0a92f5-0281-46f3-b997-a9df8e18be50">
        <obo:IAO_0000115>Another key finding of McCafferty et al. is that T-channel bursts of ##cortical and NRT neurons## are critically involved in the ictal synaptic interactions with thalamocortical neurons, whereas T-channel bursts of thalamocortical neurons do not play a role in the ictal interactions of these neurons with both cortical and NRT neurons. Indeed, localized injection of TTA-P2, a potent and selective pan-T-channel antagonist, by shows that the block of T-channels in the NRT and CIN of GAERS rats drastically decreases absence seizures (see also), whereas blocking T-channels in thalamocortical neurons of the ventrobasal thalamus, one of the somatotopic thalamic nuclei of the GAERS CIN, has no effect on absence seizures (Fig. 5), the rhythmicity of the thalamic output and its synchrony with the SWD spike. Thus, the use of TTA-P2 to provide a fast block of T-channel function without compensatory activities shows that T-channels of ventrobasal thalamocortical neurons (i.e. Cav3.1) are not essential for spontaneous absence seizures in GAERS rats whereas those of the CIN (i.e. Cav3.1, Cav3.2 and Cav3.3) and NRT (i.e Cav3.2 and Cav3.3) are (Fig. 5). </obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7447525</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32437558</oboInOwl:hasDbXref>
        <rdfs:label>cortical and NRT neurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000617"/>
        <skos:relatedMatch rdf:resource="CL:0008031"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/6f0a92f5-0281-46f3-b997-a9df8e18be50"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000617"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/6f0a92f5-0281-46f3-b997-a9df8e18be50"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0008031"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/6f59b676-96fb-4e4d-ae4e-da7f692ff268 -->

    <Class rdf:about="http://example.org/6f59b676-96fb-4e4d-ae4e-da7f692ff268">
        <obo:IAO_0000115>Transcriptional signature of pancreas infiltrating and circulating CD4+ and CD8+ T cell subsets at disease onset. (A) UMAP plot of CD4+ and CD8+ T cells from peripheral blood and pancreas of new-onset diabetic NOD mice. (B) Feature plots depicting gene expression levels of distinct markers driving CD4+ and CD8+ T cell activation states. (C, D) UMAP plot of CD4+ (C) and CD8+ (D) T cells grouped by the annotation in A (left) and grouped by T cell subset classified based on the expression of Cd44 and Sell (right). EM = effector memory (Cd44+Sell-), CM = central memory (Cd44+Sell+), naive (Cd44-Sell+), and ##CD44low CD62L-## (Cd44-Sell-). (E, F) Heatmap depicting row-based z-scores of scaled gene expression levels for marker genes driving T cell heterogeneity across the distinct CD4+ (E) and CD8+ (F) T cell subsets. (G, H) Trajectory of CD4+ (G) and CD8+ (H) naive, CD44low CD62L-, effector memory (EM), and central memory (CM) T cell subsets projected onto the UMAP plot (top). Violin plots depicting the pseudotime of CD4+ (G) and CD8+ (H) T cells per subset (bottom). Each dot represents a single cell. (I, J) Differentially expressed genes of CD4+ Cd44-Sell- (I) and CD8+ Cd44-Sell- (J) T cells between peripheral blood and pancreas.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10667927</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38027120</oboInOwl:hasDbXref>
        <rdfs:label>CD44low CD62L-</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000084"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/6f59b676-96fb-4e4d-ae4e-da7f692ff268"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000084"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/6f5e738d-deec-4f23-b680-dccf6bbb8c42 -->

    <Class rdf:about="http://example.org/6f5e738d-deec-4f23-b680-dccf6bbb8c42">
        <obo:IAO_0000115>aRGC, apical radial glial cell; bRGC, basal radial glial cell; ##IPC##, intermediate progenitor cell; ISVZ, inner subventricular zone; NSPC, neural stem and progenitor cell; OSVZ, outer subventricular zone; RGC, radial glial cell; SVZ, subventricular zone; VZ, ventricular zone</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6816450</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31681469</oboInOwl:hasDbXref>
        <rdfs:label>IPC</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0011026"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/6f5e738d-deec-4f23-b680-dccf6bbb8c42"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0011026"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/6f6f077b-46ce-42de-9806-54a12a16a200 -->

    <Class rdf:about="http://example.org/6f6f077b-46ce-42de-9806-54a12a16a200">
        <obo:IAO_0000115>##cytokeratin-positive interstitial reticulum cells##</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8763651</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34719102</oboInOwl:hasDbXref>
        <rdfs:label>cytokeratin-positive interstitial reticulum cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0009102"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/6f6f077b-46ce-42de-9806-54a12a16a200"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0009102"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/6f757d87-7b2b-4251-813e-a747dddf368c -->

    <Class rdf:about="http://example.org/6f757d87-7b2b-4251-813e-a747dddf368c">
        <obo:IAO_0000115>In the present study, the cell calcification ability, osteogenic differentiation potential, and osteogenic gene expression of DFAT cells and ASCs were compared by in vitro assays. Our findings revealed that both cell types had osteogenic differentiation properties; however, the in vitro results showed that ASCs possessed higher and earlier osteogenic differentiation potential than DFAT cells (Figure 3). In addition, ASCs showed higher expression of early osteoblast marker genes than DFAT cells (Figure 4). Other studies have indicated that DFAT cells have a higher proliferation rate, availability, and cell number than ASCs. The cell population heterogeneity could be induced by local variations in cell density, local buildup of extracellular matrix, and be amplified as the cells grow. Additionally, cell growth and local cell death may trigger some cell differentiation and the loss of all or some pluripotency markers. Therefore, differences between DFAT cells and ASCs in their rate of differentiation into bone tissue and differences in expression markers are thought to be due to the composition of these cell populations. Additionally, we introduced additional steps to enhance ##DFAT cell## preparation, in which DFAT cells were separated from the floating adipocytes and passed through a mesh on the way to the dish bottom. In this way, we addressed disadvantages such as the potential attachment of contaminating cells to the ceiling. This mesh method, and the separation of DFAT cells from adipocytes during preparation improved the homogeneity of DFAT cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8620969</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34830277</oboInOwl:hasDbXref>
        <rdfs:label>DFAT cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002334"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/6f757d87-7b2b-4251-813e-a747dddf368c"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002334"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/6f971f7d-0db1-4c04-9d68-0cb38b10f210 -->

    <Class rdf:about="http://example.org/6f971f7d-0db1-4c04-9d68-0cb38b10f210">
        <obo:IAO_0000115>MOUSE SYMPATHO-ADRENAL CELL TYPES MARKERS   SNPCs Ret Phox2b Ascl1 Mycn Hand2 Gata3Sox10- Plp1-   ##Sympathoblasts extra-adrenal## Phox2b Mycn Th Dbh Ret Cart CartptSox10- Plp1- Sgc10- Ascl1 -   Sympathetic neurons/ganglia/SRG Ret Scg10 Cart Ascl1 Phox2b Th DbhSox10- Plp1-   SCPs Sox10 Plp1 Ascl1 Phox2bRet-   Schwann cells Sox10 Plp1 GfapPhox2b-   Bridge cells Sox10 Plp1 Chga Penk Htr3a Ascl1 Phox2bTh- Ret-   Immature chromaffin cells Chga Chgb Penk Th DbhSox10- Plp1- Ret-   Chromaffin cells Chga Penk Ascl1 Phox2b Th DbhSox10- Plp1- Ret-   Sympathoblasts intra-adrenal Ret Cart Cartpt Phox2b Th Alk Hmx1 PrphSox10- Plp1-   Sympathetic neurons intra-adrenal Ret Cart Ascl1 Phox2b ThSox10- Plp1-   </obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8915499</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35277192</oboInOwl:hasDbXref>
        <rdfs:label>Sympathoblasts extra-adrenal</rdfs:label>
    </Class>
    


    <!-- http://example.org/6fe4c9b5-d683-49f2-aaaa-c249e53e1e69 -->

    <Class rdf:about="http://example.org/6fe4c9b5-d683-49f2-aaaa-c249e53e1e69">
        <obo:IAO_0000115>Our results showed 363 significant enrichments (p value &lt; 1.25 x 10-4) in 59 out of the 127 cell and tissue types analyzed (Fig. 3, Supplementary Data 8). Most of the significant enrichments were found in immune cells. SSc-associated variants displayed the most significant enrichments in H2BK15ac and H2BK20ac marks in the GM12878 lymphoblastoid cell line (OR = 37.33, enrichment p value (Penr) = 4.84 x 10-14; OR = 12.79, Penr = 2.40 x 10-10, respectively), followed by H3K79me1 in primary Natural Killer (NK) cells (BLD.CD56.PC) (OR = 12.23, Penr = 5.73 x 10-09) and primary T cells (BLD.CD3.PPC) (OR = 12.58, Penr = 9.78 x 10-09). The spleen also showed a strong functional enrichment in H2BK15ac (OR = 14.69, Penr = 9.81 x 10-09). There were significant enrichments of associations with SSc within H3K27ac, H3K4me1, H3K4me2, and H3K9ac marks:among others:of several CD4+ T cells (T helper, T regulatory, etc), CD8+ T cells, primary B cells, monocytes, primary neutrophils, and ##thymus## (Fig. 3, Supplementary Data 8). Moreover, the SSc association signals showed different epigenetic enrichment patterns in non-immune cell/tissue types, such as lung, fibroblasts, chondrocytes, keratinocytes, osteoblasts, intestinal mucosa, and esophagus, among others (Fig. 3, Supplementary Data 8).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6823490</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31672989</oboInOwl:hasDbXref>
        <rdfs:label>thymus</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000893"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/6fe4c9b5-d683-49f2-aaaa-c249e53e1e69"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000893"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/60f55e3e-c0e2-4d40-85ed-eb5d5ffd8796 -->

    <Class rdf:about="http://example.org/60f55e3e-c0e2-4d40-85ed-eb5d5ffd8796">
        <obo:IAO_0000115>a Schematic of the experimental pipeline. Created with BioRender.com b UMAP visualization of peritoneal immune cells. c Ratio of each population in cell number. d VlnPlot of characteristic gene expressions for macrophage subpopulations. Sham sham control, ELL endometriosis-like lesions, ELL_N niclosamide administration to ELL-induced mouse, Pre-SPMs ##premature &quot;small&quot; peritoneal macrophages##, SPMs &quot;small&quot; peritoneal macrophages, IM1-3 intermediate macrophages subtype 1-3, Timd4+ LPMs Timd4+ &quot;large&quot; peritoneal macrophages, PMs proliferating macrophages, B1a B1a cells, B1b B1b cells, B2 B2 cells, GCBs germinal-centre B cells, PBs plasma blast B cells, Cd4+ Ts Cd4+ T cells, Cd8+ Ts Cd8+ T cells, DN1 double negative T cells 1, DN2 double negative T cells 2, cDC1 conventional dendritic cells 1, MCs Mast cells, NTPs neutrophils.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9652344</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36369244</oboInOwl:hasDbXref>
        <rdfs:label>premature &quot;small&quot; peritoneal macrophages</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000581"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/60f55e3e-c0e2-4d40-85ed-eb5d5ffd8796"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000581"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/60f63e1d-ae9a-454b-ac66-5fee3564ec0b -->

    <Class rdf:about="http://example.org/60f63e1d-ae9a-454b-ac66-5fee3564ec0b">
        <obo:IAO_0000115>In addition, our data show that WT cells near the HrasG12V clone were also more likely to differentiate. It is noteworthy that similar phenomenon was observed following clonal activation of PI3K, although in that context WT cells were more self-renewing and the oncogenic clone was in the process of being eliminated from the tissue through increased differentiation. Despite having opposite effects on WT cells, both observations suggest that ##epidermal progenitors## can respond to environmental changes in order to promote the stable size of the progenitor compartment necessary for tissue maintenance. This is consistent with a model where regulation of stem cell fate choice, rather than being a sole product of cell autonomous signaling, is subject to progenitor cell dynamics among the nearest neighbors. Of note, while that model was supported by observation that delamination of a basal cell precedes division of a neighboring progenitor in the context of adult tissue homeostasis, it would be interesting to test if oncogenic activation of a potent mitogenic signal in a basal progenitor may reverse the relationship, and promote delamination of its neighbors.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7817173</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33393458</oboInOwl:hasDbXref>
        <rdfs:label>epidermal progenitors</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:1000428"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/60f63e1d-ae9a-454b-ac66-5fee3564ec0b"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:1000428"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/60fa9930-1a46-442d-b58e-dcf77025003a -->

    <Class rdf:about="http://example.org/60fa9930-1a46-442d-b58e-dcf77025003a">
        <obo:IAO_0000115>We observe that the sickle sample and normal sample morphological parameters histograms are mostly overlapped; however, a nontrivial number of the ##sickle cells## in the distribution exhibit nearly no phenotypic similarities to healthy cells. This unique subset of sickle cells can be extracted from the distribution through implementing a 21:1 SCD-to-normal ratio thresholding criterion. As described above, this means that each criterion is defined by the region in the histogram where the population of SCD cells have 21x greater incidence of that chosen parameter than the normal cell population. The extraction of morphological parameters that uniquely identify sickling cells is a necessary step to constructing a meaningful, pure SCD ground truth set. Without thresholding, the large overlap between the morphological parameters of sickle and normal cells sample will confound the discrimination capacity of a classification algorithm. Furthermore, through refining the training set, we have narrowed down the focus of the classification algorithm to specifically differentiate SCD cells from healthy cells and greatly increase accuracy. The near ideal ROC curves (Figure 2B and Figure 3B) for LR and CNN algorithms when trained on the refined data, indicates that the algorithm practically predicted no false positives and would excel at identifying critically sickled cells. Overall, we have developed a group of metrics that can delineate critically sickling cells in a heterogeneous SCD sample.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10419148</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37569260</oboInOwl:hasDbXref>
        <rdfs:label>sickle cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000232"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/60fa9930-1a46-442d-b58e-dcf77025003a"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000232"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/606b3ae2-6d5a-471f-9e39-07dce97e3a70 -->

    <Class rdf:about="http://example.org/606b3ae2-6d5a-471f-9e39-07dce97e3a70">
        <obo:IAO_0000115>In severe (or critical) COVID-19 patients, there is a remarkable expansion of TM4SF1+ and KRT5+ lung progenitor cells. The two distinct populations of progenitor cells could play crucial roles in alveolar cell regeneration and epithelial barrier re-establishment, respectively. The transplanted ##KRT5+ progenitors## could long-term engraft into host lung and differentiate into HOPX+ OCLN+ alveolar barrier cell which restored the epithelial barrier and efficiently prevented inflammatory cell infiltration.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7645905</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33094537</oboInOwl:hasDbXref>
        <rdfs:label>KRT5+ progenitors</rdfs:label>
    </Class>
    


    <!-- http://example.org/606f85f1-7c22-4652-b559-3d4f2aa7ca0c -->

    <Class rdf:about="http://example.org/606f85f1-7c22-4652-b559-3d4f2aa7ca0c">
        <obo:IAO_0000115>MDSC populations were divided into monocyte-derived (CD66b-CD20-CD19-CD3-) and granulocyte-derived (CD66b+) MDSCs (Figure 6G). While the ##granulocytic MDSC## subpopulation remained close to zero, the monocytic MDSCs were about 15% of the total cells stained and dropped nearly 3-fold within the PDAC PBMCs to 5% (p = 0.00018). Even though the total number of monocytic MDSCs decreased and the granulocytic MDSCs were low, both of their populations experienced significantly elevated FcRn positivity in PDAC patients (p = 0.034, p = 0.026, respectively) (Figure 6H). Monocytic MDSC FcRn MMI was significantly increased in PDAC PBMCs (p = 0.021), while granulocytic FcRn MMI had no change (Figure 6I). Together, these results further support the PDAC dependent induction of FcRn expression in highly specific cell populations of monocytic origin.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9266939</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35806069</oboInOwl:hasDbXref>
        <rdfs:label>granulocytic MDSC</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000094"/>
        <skos:relatedMatch rdf:resource="CL:0000889"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/606f85f1-7c22-4652-b559-3d4f2aa7ca0c"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000094"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/606f85f1-7c22-4652-b559-3d4f2aa7ca0c"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000889"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/606838a9-45c2-4f9d-91be-957c6a20d586 -->

    <Class rdf:about="http://example.org/606838a9-45c2-4f9d-91be-957c6a20d586">
        <obo:IAO_0000115>Nowadays, umbilical cord blood (UCB) cells has been increasingly replacing fetal and adult-derived cells in adoptive cell therapy. However, gene expression and chromatin accessibility in umbilical cord blood cells has not yet been fully elucidated. In this study, we used an integration of scRNA-seq with the scATAC-seq technology to perform unbiased analysis of UCBCs over developmental time from 31 gestational week (GW) to 37 GW in humans. We identified several distinct cell types (erythroid cell, T cell, B cell, erythroid precursor cells, NK cell, and ##endothelial progenitor cell##) and subpopulations (6 different clusters of erythroid cells) in UCB cells. In addition, we also identified a series of differentially expressed genes and chromatin accessibility in each cell type between different gestational weeks. Interestingly, the gene expression pattern of umbilical cord blood cells from normal fetuses of similar gestational weeks were more consistent. In conclusion, our analysis presents a better understanding of the chromatin landscape and regulatory networks in UCB cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMID:36375296</oboInOwl:hasDbXref>
        <rdfs:label>endothelial progenitor cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002619"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/606838a9-45c2-4f9d-91be-957c6a20d586"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002619"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/607f163c-c3f0-40a6-8ac3-1229e57dbfeb -->

    <Class rdf:about="http://example.org/607f163c-c3f0-40a6-8ac3-1229e57dbfeb">
        <obo:IAO_0000115>Because CD14CTX express chemokine receptors that might facilitate migration into the tissues, we next examined the relationship between circulating and intra-tumoral myeloid states in BTC. We performed scRNA-seq on primary cholangiocarcinoma tumors (n = 4) obtained from standard of care resections (Table S7) and recovered a total of 10,913 myeloid cells. Tissue-associated myeloid cells consisted of dendritic cells (DC), neutrophils (Neut), two populations of macrophages characterized by either high APOE or SPP1 expression (MacAPOE, MacSPP1), CD14+ monocytes (CD14+ mono), CD16+ monocytes (CD16+ mono), and intermediate CD14+CD16+ monocytes (CD14+CD16+ mono) (Figures S4A and S4B). Among the tissue-associated myeloid populations, the expression profile of CD14CTX was most correlated with MacSPP1, exemplified by the shared expression of differentially expressed CD14CTX genes including HAVCR2 and ITGB1 (Figures S4C and S4D). Notably, two genes that differ in expression between MacSPP1 and CD14CTX are related to chemotaxis and extravasation (SERPINB2, TIMP1), suggesting a transition in macrophages that have already migrated to the tumor microenvironment. As an alternate approach to assess the relationship between the circulating and tissue-associated myeloid populations, we co-clustered myeloid cells from circulation with those from the tumors, following batch correction. We found that the intra-tumoral MacSPP1 cluster with the circulating CD14CTX (Figure S4E). An alternative approach using partition-based graph abstraction also found close connectivity between CD14CTX and SPP1+ TAM clusters (Figure S4E). We also found evidence of SPP1+HAVCR2+CD68+ myeloid cells within biliary tumor tissue from on-treatment biopsies by combined in situ hybridization and immunofluorescence, further suggesting the existence of a ##TAM## population in BTC analogous to CD14CTX (Figure S4F).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10060099</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36130508</oboInOwl:hasDbXref>
        <rdfs:label>TAM</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/607f163c-c3f0-40a6-8ac3-1229e57dbfeb"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/61a8b61d-9207-4d1e-9be3-13330880c5ba -->

    <Class rdf:about="http://example.org/61a8b61d-9207-4d1e-9be3-13330880c5ba">
        <obo:IAO_0000115>Within the 1397 B-cells, we obtained 4 separate clusters (Fig. 6j; Supplementary information, Fig. S6k). Follicular B-cells were composed of &apos;mature-naive&apos; (CD27-) and &apos;memory&apos; (CD27+) B-cells. The former were characterized by a unique CD27-/IGHD+(IgD)/IGHM+(IgM) signature and give rise to the latter by migrating through the germinal center to form CD27+/IGHD-(IgD)/IGHM-(IgM) memory B-cells (Fig. 6k, l). Memory B-cells then further differentiate into antibody-secreting plasma cells (IGHA1, IGHG1, JCHAIN), which themselves can be further classified into short-lived and long-lived plasma cells. We failed to identify long-lived plasma cells (as these are non-proliferating cells residing in bone marrow and spleen, but were able to divide short-lived plasma cells into two subclusters. A first subcluster of &apos;active&apos; plasma cells expressed high levels of PRDM1(Blimp-1) and XBP1, indicating high antibody-secretion capacity, while a second cluster referred to as &apos;terminal&apos; plasma cells was enriched for CCL2 and CCL5, but also characterized by reduced G2M and S cell cycle scores and increased expression of mitochondrial genes, indicating ongoing stress (Fig. 6m). Notably, the latter population was characterized by increased BCR clonality and reduced BCR evenness (Fig. 6n). Compared to non-COVID-19, mature-naive B-cells and active plasma cells were increased in COVID-19, while ##terminal plasma cells## were reduced in COVID-19, albeit non-significantly (Fig. 6o). Although these effects were mainly driven by critical COVID-19 vs non-COVID-19 (Supplementary information, Fig. S6l), there were no significant differences between mild vs critical COVID-19 (Fig. 6p). Overall, this suggests terminal plasma cells in COVID-19 are characterized by sub-optimal differentiation or activation, which may cause defective or counter-productive (possibly low-quality) antibody responses in COVID-19.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8027624</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33473155</oboInOwl:hasDbXref>
        <rdfs:label>terminal plasma cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000975"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/61a8b61d-9207-4d1e-9be3-13330880c5ba"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000975"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/61b2a7f4-0b32-4506-b335-450afe98a1f8 -->

    <Class rdf:about="http://example.org/61b2a7f4-0b32-4506-b335-450afe98a1f8">
        <obo:IAO_0000115>Both D1-medium spiny neurons (MSNs) and D2-MSNs from the NAc form functional synapses in the VP and exert opponent control on reward-related behaviors. Chemogenetic manipulations demonstrate that D1-MSN to VP afferents promote and D2-MSN to VP afferents inhibit reward seeking. How this antagonistic behavioral modulation is achieved on a microcircuit level in the VP remains unclear. However, a rabies tracing study revealed that significantly more D1-MSNs than D2-MSNs in the NAc innervate ##VPGlutamate cells##. Nonetheless, it remains unknown whether the apparently biased connectivity between NAc afferents and VP neuronal subpopulations is reflected in GABA synaptic strength and modulation by cotransmitters differentially released with GABA from D1-MSN and D2-MSN axon terminals.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10348443</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37414552</oboInOwl:hasDbXref>
        <rdfs:label>VPGlutamate cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000679"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/61b2a7f4-0b32-4506-b335-450afe98a1f8"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000679"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/61b37c56-336c-4a6b-ad79-b8b6bd02b0d8 -->

    <Class rdf:about="http://example.org/61b37c56-336c-4a6b-ad79-b8b6bd02b0d8">
        <obo:IAO_0000115>(A, C) Expression level of select marker genes for each identified cluster (A: VGlut2 cKO model; C: Ip3r2 KO model). Circle size denotes expression ratio (percent cells expressing the gene), color represents expression level (in log2 CPM). Bar chart on the left shows cell numbers identified for each cluster are similar for WT and KO groups for each cluster in each model. (B) UMAP clustering of different cell types identified in the NEUN-negative population of the combined samples from Ip3r2 WT and KO mice. 17 clusters were identified including the three main types of glia: astrocytes, oligodendrocytes, and microglia, as well as endothelial cells, and two subtypes of neurons (for A-C - ##M-astrocyte##: mitotic astrocyte; M-OPC: mitotic oligodendrocyte precursor cell; OPC: oligodendrocyte precursor cell; MFOL: myelin-forming oligodendrocyte; NFOL: newly formed oligodendrocyte; MOL: mature oligodendrocyte; VLMC: vascular and leptomeningeal cell; EC: endothelial cell; PC: pericyte; PVM: perivascular macrophage).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8497060</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34494546</oboInOwl:hasDbXref>
        <rdfs:label>M-astrocyte</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000127"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/61b37c56-336c-4a6b-ad79-b8b6bd02b0d8"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000127"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/61d5ecc9-075b-44f0-aec4-1006d58b140c -->

    <Class rdf:about="http://example.org/61d5ecc9-075b-44f0-aec4-1006d58b140c">
        <obo:IAO_0000115>CD4 T cell-secreted IFN-gamma in Sjogren&apos;s syndrome induces ##salivary gland epithelial cell## ferroptosis.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMID:38471652</oboInOwl:hasDbXref>
        <rdfs:label>salivary gland epithelial cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:4052048"/>
        <skos:relatedMatch rdf:resource="CL:4052049"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/61d5ecc9-075b-44f0-aec4-1006d58b140c"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4052048"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/61d5ecc9-075b-44f0-aec4-1006d58b140c"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4052049"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/61e0b5bf-4dbd-4839-97ee-6254d555aea7 -->

    <Class rdf:about="http://example.org/61e0b5bf-4dbd-4839-97ee-6254d555aea7">
        <obo:IAO_0000115>To explore whether fetal adrenal neurocytes have steroidogenic functions, the neurocyte group was further divided into 15 distinct subtypes, including 4 chromaffin cell subtypes, 2 ##sympathoblast## subtypes, and 3 Schwann cell precursor (SCP) subtypes ( Figure 4A, B ;  Table S4 ).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9713933</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36465633</oboInOwl:hasDbXref>
        <rdfs:label>sympathoblast</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002083"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/61e0b5bf-4dbd-4839-97ee-6254d555aea7"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002083"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/6125d6ef-a963-42e8-b07c-6ec43b3340ad -->

    <Class rdf:about="http://example.org/6125d6ef-a963-42e8-b07c-6ec43b3340ad">
        <obo:IAO_0000115>Innate Immune Cells	 	Primary Cell Type	Cell subsets	Metabolic Processes	References	 	   Innate Lymphoid Cells	Non-cytolytic:Innate lymphoid cell 1 (ILC1) Innate lymphoid cell 2 (ILC2) Innate lymphoid cell 3 (ILC3)/Lymphoid Tissue Inducers (LTi)Cytolytic:Natural Killer cells (NK)	 Gly FAO/OXPHOS, LM/LDF, Arginine catabolism, Gly Gly/OXPHOS, Vitamin A metabolismGly, AAM, FAO	     	 	  Dendritic Cells	Conventional:Conventional dendritic cell 1 (cDC1) Conventional dendritic cell 2 (##cDC2##) Conventional dendritic cell 3 (cDC3) Tolerogenic DCs Plasmacytoid DCs (pDCs) Inflammatory DCs Langerhans cells Mononuclear Phagocytes (tumor)	 Na: OXPHOS, Ac: GU, Gly, PPP, Dys: LDFNa: OXPHOS, Ac: GU, Gly, PPP, Dys: LDF Not reported FAO/OXPHOS Gly/OXPHOS/FAO Gly Na/Ac/Ma: Not reported Dys: LDFNa: OXPHOS, Ac: Gly, PPP In tumors/Dys: LM/LDF	         	 	 Macrophages	Inflammatory &quot;M1&quot; macrophage Reparative &quot;M2&quot; macrophage  Tumor Associated macrophage (TAM)	Na: OXPHOS, Ac: GU, Gly, PPP. Arg catabolismNa: FAO/OXPHOS, Ac: FAO/OXPHOS, Gly, PPP.  Upregulates Arg1 Na: OXPHOS, Ac: GU, Gly, Tumor/Dys: FAO, LM/LDF	   	 	</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11240245</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:39007133</oboInOwl:hasDbXref>
        <rdfs:label>cDC2</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000990"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/6125d6ef-a963-42e8-b07c-6ec43b3340ad"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000990"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/614d5926-876b-47fc-8f33-0b3a95123057 -->

    <Class rdf:about="http://example.org/614d5926-876b-47fc-8f33-0b3a95123057">
        <obo:IAO_0000115>The signals driving the adaptation of type 2 dendritic cells (DC2s) to diverse peripheral environments remain mostly undefined. We show that differentiation of CD11blo migratory DC2s-a DC2 population unique to the dermis-required IL-13 signaling dependent on the transcription factors STAT6 and KLF4, whereas DC2s in lung and small intestine were STAT6-independent. Similarly, human DC2s in skin expressed an IL-4 and IL-13 gene signature that was not found in ##blood, spleen and lung DCs##. In mice, IL-13 was secreted homeostatically by dermal innate lymphoid cells and was independent of microbiota, TSLP or IL-33. In the absence of IL-13 signaling, dermal DC2s were stable in number but remained CD11bhi and showed defective activation in response to allergens, with diminished ability to support the development of IL-4+GATA3+ helper T cells (TH), whereas antifungal IL-17+RORgammat+ TH cells were increased. Therefore, homeostatic IL-13 fosters a noninflammatory skin environment that supports allergic sensitization.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMID:34795444</oboInOwl:hasDbXref>
        <rdfs:label>blood, spleen and lung DCs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000451"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/614d5926-876b-47fc-8f33-0b3a95123057"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000451"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/61401e3a-456c-4aa7-9b61-fb9ad15d59de -->

    <Class rdf:about="http://example.org/61401e3a-456c-4aa7-9b61-fb9ad15d59de">
        <obo:IAO_0000115>SC-EVs have been shown to promote the proliferation and activation of T cells. For example, in mice with type 1 diabetes, islet MSC-derived exosomes were observed to activate APCs and autologous T and B cells in islets, increase their respective specific memory cells, and induce IFN-gamma production, thus accelerating islet destruction. This evidence provides a perspective that certain SC-EVs serve as autoantigen carriers and trigger autoimmune responses. Additionally, The beta-catenin-loading or GM-CSF (granulocyte-macrophage colony-stimulating factor)-expressing EVs derived from SCs could promote T cell antitumor response. For example, the exosomes derived from rat AD-MSCs were observed to accelerate intratumoral CD8alpha+ type I NK-T cell migration and increase circulating NK-T cells to exert antitumor immunity in rats with hepatocellular carcinoma (HCC) (Table 1). In mice with transplanted lung adenocarcinoma, exosomes derived from GM-CSF-expressing embryonic SCs (ESCs) were observed to suppress the migration of immunosuppressive Tregs, whereas they reinforced migration of tumor-reactive ##CD8+ T effector cells## toward intratumor spaces and elevated intratumoral cytokine responses of TNF-alpha and IFN-gamma, contributing to the clearance of foreign components (Table 1). Therefore, EVs derived from engineered SCs may be utilized as a preventive vaccine against the risk of cancer development in human beings.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7026133</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32117221</oboInOwl:hasDbXref>
        <rdfs:label>CD8+ T effector cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0001050"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/61401e3a-456c-4aa7-9b61-fb9ad15d59de"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0001050"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/61535522-e129-475e-bfb8-c8423260de7e -->

    <Class rdf:about="http://example.org/61535522-e129-475e-bfb8-c8423260de7e">
        <obo:IAO_0000115>We next leveraged the high number of nuclei and developmental time points sampled in our dataset to quantify cell types across gestational age. Focusing on the germinal matrix where gliogenesis begins, samples were grouped into four stages spanning the latter half of second trimester and third trimester: 17-20 gw (Stage 1), 20-24 gw (Stage 2), 24-28 gw (Stage 3), and 31-41 gw (Stage 4). The stages differed statistically by gestational age but not by sex or tissue collection postmortem interval (Supplementary Data 1-2). By plotting mean fraction of cell type by stage, we observe two trends from second to third trimester: a decrease in the fraction of nIPCs and excitatory neurons (##EN##: CPN and SPN) and an increase in the fraction of glia (RG/AC, gIPC, astrocyte, OPC, and microglia) (Fig. 1f). To study these trends further, we correlated the fraction of cell types to sample age in gestational weeks (Supplementary Fig. 3). This reveals a significant increase with gestational age in the fraction of gIPCs (p = 0.003; two-tailed Spearman Rank-Order Correlation test), astrocytes (p = 0.015), OPCs (p = 0.0008), and microglia (p = 0.002) (Supplementary Fig. 3a). The fraction of MSNs also increase significantly (p = 0.002). Conversely, there is a significant decrease in the fraction of nIPCs (p = 0.034), late-born L2/3 CPNs (p = 0.009), and TAC (p = 0.002) (Supplementary Fig. 3a). Our GM dataset, therefore, captures the start of the gliogenic period. In the CP, the fraction of TACs, nIPCs, and CRNs exhibit a significant decrease over time (p = 0.002, ~0, 0.0001, respectively), while L4/5a CPNs show a significant increase (p = 0.002) (Supplementary Fig. 3b). Interneurons also increase from second to third trimester (p = 0.001), consistent with their migration into the neocortex. While the fraction of CP glia exhibit a positive trend, only OPC numbers show a significant positive correlation with gestational age (p = 0.026).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9744747</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36509746</oboInOwl:hasDbXref>
        <rdfs:label>EN</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000540"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/61535522-e129-475e-bfb8-c8423260de7e"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000540"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/62b88343-c8e6-4b87-8f94-c9a66c9a3f3d -->

    <Class rdf:about="http://example.org/62b88343-c8e6-4b87-8f94-c9a66c9a3f3d">
        <obo:IAO_0000115>Variable Name Data used   TN Naive T-cells Combination of CD4 naive and memory resting T-cells and resting NK cells   Th Helper T-cells Combination of memory activated CD4 T-cells and follicular helper T-cells   TC Cytotoxic cells Combination of CD8 T-cells and activated NK cells   Tr Regulatory T-cells Regulatory T-cells   DN Naive dendritic cells Naive dendritic cells   D Activated dendritic cells Activated dendritic cells   MN ##Naive Macrophages## Combination of Macrophages M0 and Monocytes   M Macrophages Combination of M1 and M2 Macrophages   C Cancer cells Estimated   N Necrotic cells Estimated   A Cancer Associated Adipocytes Assumed to be twice of the total number of immune cells   H HMGB1 HMGB1 gene expression   IL12 IL-12 IL12A and IL12B gene expressions   IL10 IL-10 IL10, IL10RA and IL10RB gene expressions   IL6 IL-6 IL6, IL6ST and IL6RA gene expressions   </obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8959189</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35294447</oboInOwl:hasDbXref>
        <rdfs:label>Naive Macrophages</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/62b88343-c8e6-4b87-8f94-c9a66c9a3f3d"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/62c881f4-bf3a-4436-89b0-bbb2f79a07eb -->

    <Class rdf:about="http://example.org/62c881f4-bf3a-4436-89b0-bbb2f79a07eb">
        <obo:IAO_0000115>(A and B) Isolated CD4+ TILs were stimulated in vitro with PMA/ionomycin and stained and analyzed by flow cytometry. (A) Top left dot plot shows PD-1 versus CD39 expression in CD4 Tconvs. IFN-gamma versus TNF-alpha expression is shown in the indicated CD4 Tconv populations. Proportions of cytokine+ (IFN-gamma and/or TNF-alpha; bottom left) and TNF-alpha+IFN-gamma-, TNF-alpha-IFN-gamma+, and TNF-alpha+IFN-gamma+ cells in PD-1-CD39-, PD-1loCD39-, PD-1hiCD39-, and PD-1hiCD39+ subsets and according to TIM-3 expression (n = 8). (B) Dot plots show CD39 versus IFN-gamma or TNF-alpha in CD4 Tconvs. Numbers in dot plots correspond to MFI of cytokine staining. MFI of IFN-gamma and TNF-alpha staining in IFN-gamma+ and TNF-alpha+ cells, respectively, are summarized for Tconv subpopulations defined as in A (n = 8). Samples in A and B are shown according to the proportion of ##TIM-3+ cells## among PD-1hiCD39+ CD4 Tconv (&lt;50% TIM-3+, square; &gt;=50% TIM-3+, triangle; unknown, round) (C) CD4 Tconv TIL subsets PD-1-CD39- (gray), PD-1loCD39- (green), PD-1hiCD39- (blue), and PD-1hiCD39+ (red) were sorted, expanded in vitro for 10 days, and restimulated or not with PMA/ionomycin overnight. TNF-alpha and IFN-gamma secretion was quantified by CBA in the supernatant (n = 5). (D) Isolated CD4+ TILs were stained ex vivo and analyzed by flow cytometry. Proportions of TOX+ cells in each Tconv subset are summarized (n = 10). Data are presented as mean +- SD. **P &lt; 0.01; ***P &lt; 0.001; ****P &lt; 0.0001. P values were determined using the Wilcoxon (A and B) and 2-tailed paired t tests (D). Bonferroni&apos;s correction was applied to account for multiple testing in D and significance level was adjusted accordingly (*P &lt; 0.0083; **P &lt; 0.00166; ***P &lt; 0.000166). Tconvs, conventional FOXP3- CD4 T cells; CBA, cytometric bead array; TILs, tumor-infiltrating lymphocytes.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7934837</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33332284</oboInOwl:hasDbXref>
        <rdfs:label>TIM-3+ cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000084"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/62c881f4-bf3a-4436-89b0-bbb2f79a07eb"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000084"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/62d42995-e1ed-459e-a14f-b4da6daa3515 -->

    <Class rdf:about="http://example.org/62d42995-e1ed-459e-a14f-b4da6daa3515">
        <obo:IAO_0000115>Brain-derived neurotrophic factor (BDNF) and neurotrophin 3 (NT-3) are known to regulate neuronal morphology and the formation of neural circuits, yet the neuronal targets of each neurotrophin are still to be defined. To address how these neurotrophins regulate the morphological and synaptic differentiation of developing olfactory bulb (OB) GABAergic interneurons, we analyzed the effect of BDNF and NT-3 on GABA+-neurons and on different subtypes of these neurons: tyrosine hydroxylase (TH+); ##calretinin## (Calr+); calbindin (Calb+); and parvalbumin (PVA+). These cells were generated from cultured embryonic mouse olfactory bulb neural stem cells (eOBNSCs) and after 14 days in vitro (DIV), when the neurons expressed TrkB and/or TrkC receptors, BDNF and NT-3 did not significantly change the number of neurons. However, long-term BDNF treatment did produce a longer total dendrite length and/or more dendritic branches in all the interneuron populations studied, except for PVA+-neurons. Similarly, BDNF caused an increase in the cell body perimeter in all the interneuron populations analyzed, except for PVA+-neurons. GABA+- and TH+-neurons were also studied at 21 DIV, when BDNF produced significantly longer neurites with no clear change in their number. Notably, these neurons developed synaptophysin+ boutons at 21 DIV, the size of which augmented significantly following exposure to either BDNF or NT-3. Our results show that in conditions that maintain neuronal survival, BDNF but not NT-3 promotes the morphological differentiation of developing OB interneurons in a cell-type-specific manner. In addition, our findings suggest that BDNF and NT-3 may promote synapse maturation by enhancing the size of synaptic boutons.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMID:33392918</oboInOwl:hasDbXref>
        <rdfs:label>calretinin</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000759"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/62d42995-e1ed-459e-a14f-b4da6daa3515"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000759"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/6203aaea-ea60-4997-8449-131269df0546 -->

    <Class rdf:about="http://example.org/6203aaea-ea60-4997-8449-131269df0546">
        <obo:IAO_0000115>Rct Random controlled trial, CCT Controlled clinical trial, PBMNCs Peripheral blood-derived mononuclear cells, BMMSCs Bone marrow-derived mesenchymal stem cells, PLAS Human processed lipoaspirate cells, BMMNCs Bone marrow-derived mononuclear cells, BMDC Bone marrow-derived cells, BMTRCs Bone marrow-enriched tissue repair cells, PBPCs Peripheral blood progenitor cells, PBMSCs ##Peripheral blood mesenchymal stem cells##, HUCMSCs Human umbilical cord mesenchymal stem cells, MFAT Micro-fragmented adipose tissue, i.m. Intramuscular injection, i.a. Intra-arterial injection, i.r.w. Injected radially into the wound, Ad.us.ext, ad usum externum (for external use), NS Normal saline, PBS Phosphate-buffered saline</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9375292</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35964145</oboInOwl:hasDbXref>
        <rdfs:label>Peripheral blood mesenchymal stem cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000134"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/6203aaea-ea60-4997-8449-131269df0546"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000134"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/6260a938-5bd8-4509-97bd-7a7e7dfe3d0b -->

    <Class rdf:about="http://example.org/6260a938-5bd8-4509-97bd-7a7e7dfe3d0b">
        <obo:IAO_0000115>Diabetic kidney disease (DKD), a chronic kidney disease, is characterized by progressive fibrosis caused due to persistent hyperglycemia. The development of fibrosis in DKD determines the patient prognosis, but no particularly effective treatment. Here, small extracellular vesicles derived from mesenchymal stem cells (MSC-sEV) have been used to treat DKD fibrosis. Single-cell RNA sequencing was used to analyze 27,424 cells of the kidney, we have found that a novel fibrosis-associated TGF-beta1+Arg1+ macrophage subpopulation, which expanded and polarized in DKD and was noted to be profibrogenic. Additionally, Actin+Col4a5+ mesangial cells in DKD differentiated into myofibroblasts. Multilineage ligand-receptor and cell-communication analysis showed that ##fibrosis-associated macrophages## activated the TGF-beta1/Smad2/3/YAP signal axis, which promotes mesangial fibrosis-like change and accelerates renal fibrosis niche. Subsequently, the transcriptome sequencing and LC-MS/MS analysis indicated that MSC-sEV intervention could restore the levels of the kinase ubiquitin system in DKD and attenuate renal interstitial fibrosis via delivering CK1delta/beta-TRCP to mediate YAP ubiquitination degradation in mesangial cells. Our findings demonstrate the unique cellular and molecular mechanisms of MSC-sEV in treating the DKD fibrosis niche at a single-cell level and provide a novel therapeutic strategy for renal fibrosis.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11184851</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38890734</oboInOwl:hasDbXref>
        <rdfs:label>fibrosis-associated macrophages</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000864"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/6260a938-5bd8-4509-97bd-7a7e7dfe3d0b"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000864"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/63bd8ace-b644-4bd2-8330-a26110feec25 -->

    <Class rdf:about="http://example.org/63bd8ace-b644-4bd2-8330-a26110feec25">
        <obo:IAO_0000115>Development of the trophoblastic shell and formation of placental anchoring villi. a Structure of the human trophoblastic shell and its surrounding arterial vessels. b Depiction of a placental anchoring villus, spiral artery (SA) remodelling and interaction of extravillous trophoblasts (EVTs) with different decidual cell types. dCCT distal cell column trophoblast, dMPhi decidual macrophage, DSC decidual stromal cell, eCTB endovascular cytotrophoblast, GC giant cell, ##iCTB## interstitial cytotrophoblast, pCCT proximal cell column trophoblast, pEC placental endothelial cell, pMPhi placental macrophage, pSC placental stromal/mesenchymal cell, SM smooth muscle layer, STB syncytiotrophoblast, TBS trophoblastic shell, TP trophoblast plug, TV tertiary villi, UC umbilical cord, uNK uterine NK cell, vCTB villous cytotrophoblast, YO yolk sac</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6697717</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31049600</oboInOwl:hasDbXref>
        <rdfs:label>iCTB</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000523"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/63bd8ace-b644-4bd2-8330-a26110feec25"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000523"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/63f58f39-1122-4a3a-9d17-316856d23e99 -->

    <Class rdf:about="http://example.org/63f58f39-1122-4a3a-9d17-316856d23e99">
        <obo:IAO_0000115>LCs are the only cell type from the DC family that originate from self-renewing radio-resistant embryonic precursors; other DC subpopulations are short-lived and constantly replenished by BM progenitors. To delineate the radio-resistant properties of the newly identified ##LClike cells##, we generated BM chimeric mice by transplanting congenic CD45.1+ mouse BM cells into irradiated CD45.2+ recipients (Figure 5A). We then analysed the CD45.1+/CD45.2+ ratio in different skin-related DC subpopulations 1 or 4 months after reconstitution.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8110305</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33769279</oboInOwl:hasDbXref>
        <rdfs:label>LClike cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000453"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/63f58f39-1122-4a3a-9d17-316856d23e99"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000453"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/630300f1-9b8a-4e85-91bb-1b9ca7a2a4d0 -->

    <Class rdf:about="http://example.org/630300f1-9b8a-4e85-91bb-1b9ca7a2a4d0">
        <obo:IAO_0000115>This raises puzzling questions about how GABAergic interneurons differentiate. One possibility is that electrophysiological differentiation between interneuron types is not functionally beneficial in the hilus. Another is that there is some degree of differentiation which the markers used in this study were unable to identify. Recent advances in single-cell RNA sequencing (scRNA-seq) are evolving the concept of neuronal classification. Such new tools should promote the identification of new molecular markers suitable to account for the diversity of ##hilar interneurons## and to understand their role in the physiology of the dentate gyrus.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9269967</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35802727</oboInOwl:hasDbXref>
        <rdfs:label>hilar interneurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0011005"/>
        <skos:relatedMatch rdf:resource="CL:4023062"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/630300f1-9b8a-4e85-91bb-1b9ca7a2a4d0"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0011005"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/630300f1-9b8a-4e85-91bb-1b9ca7a2a4d0"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4023062"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/637da624-42ce-4ebf-87f5-d328d3f5873f -->

    <Class rdf:about="http://example.org/637da624-42ce-4ebf-87f5-d328d3f5873f">
        <obo:IAO_0000115>Among spatial features, the dispersion of the FMC event between recording sites made the highest contribution to the prediction. The FMC is a putative extracellular analog of the initial depolarization phase at the recording site. Thus, the lower interelectrode variance of FMC among PYR cells compared with ##PV cells## indicates higher spatial synchrony at the beginning of the spike. This observation is consistent with known morphologic and electrotonic differences between the proximal dendrites of PYR and PV cells. Since the probes were always inserted perpendicularly to CA1 stratum pyramidale, the vertical dendritic tree of both PYR and PV cells was parallel to the extracellular electrode arrays. In CA1, PYR have thick apical dendrites extending for up to 250 mum (diameter, 1.6-2.5 mum), whereas PV cell dendrites in stratum pyramidale are thinner (diameter, 1.3-1.7 mum). The higher FMC synchrony of PYR spikes is consistent with lower axial resistance of the thicker proximal PYR dendrites, yielding synchronized somatic and dendritic potentials.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9744183</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36414411</oboInOwl:hasDbXref>
        <rdfs:label>PV cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:4023018"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/637da624-42ce-4ebf-87f5-d328d3f5873f"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4023018"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/638f1dfd-8396-4c4f-832d-dbdbf84df517 -->

    <Class rdf:about="http://example.org/638f1dfd-8396-4c4f-832d-dbdbf84df517">
        <obo:IAO_0000115>A, B, tSNE plot of 4659 CD45+ immune cells from the CNS. Data from this study is integrated with data from; Table 6). C, D, Each dataset represented by one tSNE. Cells are annotated using color representing their cell type. bMicroglia: baseline microglia; aMicroglia: activated microglia; pmMicroglia: proliferation-mediating microglia; maMicroglia: monocyte-activating microglia; DAM: disease-associated microglia in SCI; ##elMicroglia##: embryonic-like microglia; pvMacrophages: perivascular macrophages; mdMacrophages: monocyte-derived macrophages; DCs: dendritic cells; imB-cells: immature B-cells; mB-cells: mature B-cells; pimMicroglia: postnatal immature microglia; IEG+Microglia: immediate early genes microglia; sMicroglia: s-phase microglia; pPAM: postnatal proliferative-region-associated microglia; eMicroglia: embryonic microglia; pcpMacrophages: postnatal choroid plexus macrophages; acpMacrophages: adult choroid plexus macrophages; iMonocytes: inflammatory monocytes; pMonocytes: patrolling monocytes; cpEpithelial cells: choroid plexus epithelial cells. E, tSNE plots of 4659 CD45+ immune cells for selected genes indicating the log2(cpm) expression with a continuous color for each cell separately. F, Proliferation rate of CD45low and CD45high cells at 7 and 21 d post-SCI. Hoechst 33342 expression presented on a log-scale was used for defining cells in S-phase. Right most plot reports the percentage of cells in S-phase. Each dot represents one biological replicate (four mice per time point). Mean is surrounded by a 95% CI. This figure is extended in Extended Data Figure 8-1.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8496189</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34417326</oboInOwl:hasDbXref>
        <rdfs:label>elMicroglia</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000129"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/638f1dfd-8396-4c4f-832d-dbdbf84df517"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000129"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/6382461f-742d-4903-b518-c07672b13dc5 -->

    <Class rdf:about="http://example.org/6382461f-742d-4903-b518-c07672b13dc5">
        <obo:IAO_0000115>Id2 and Id3 are involved in both T and B cell development to modulate E protein DNA binding activity. Id2 is particularly important for ILC, NK, and LTi cell development through the suppression of E protein activity. In B cell development, Id3 is induced in response to TGFbeta signaling for survival during early B cell development. Id3 is highly expressed in naive mature B cells and downregulated in activated germinal center B (GCB) cells, while E2A protein abundance is low in naive B cells but high in GCB cells to induce AID expression in cooperation with E2-2. In T cell development, Id3 is first upregulated by pre-TCR signaling in DN3 cells and further upregulated upon positive selection of TCR signaling in DP cells. Similarly, gammadelta TCR-mediated signaling induces high levels of Id3 abundance and E2A-Id3-Tcf1 transcription axis control gammadelta T cell development and effector function. Furthermore, Id3 plays a key role in ##follicular helper T (TFH) and follicular cytotoxic T(TFC) cell## development through the regulation of CXCR5 expression. Notably, Id2 and Id3 have distinct roles in the differentiation of CD8 cytotoxic T cells toward effector and memory T cells. In addition, regulatory T (Treg) cells also critically require Id2 and Id3 expression to suppress systemic TH2 inflammation and function as a gatekeeper for follicular regulatory T (TFR) cell. Taken together, the E-Id protein axis controls the adaptive lymphocyte development and activation to maintain immunological homeostasis.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8199221</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34072618</oboInOwl:hasDbXref>
        <rdfs:label>follicular helper T (TFH) and follicular cytotoxic T(TFC) cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000910"/>
        <skos:relatedMatch rdf:resource="CL:0002038"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/6382461f-742d-4903-b518-c07672b13dc5"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000910"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/6382461f-742d-4903-b518-c07672b13dc5"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002038"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/64f6e87b-df1e-494a-a1b0-9a9f833156fc -->

    <Class rdf:about="http://example.org/64f6e87b-df1e-494a-a1b0-9a9f833156fc">
        <obo:IAO_0000115>##Tumor-associated macrophages##</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10388565</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37525158</oboInOwl:hasDbXref>
        <rdfs:label>Tumor-associated macrophages</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/64f6e87b-df1e-494a-a1b0-9a9f833156fc"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/6414420b-5142-4239-a3ab-0f5e3d8932a5 -->

    <Class rdf:about="http://example.org/6414420b-5142-4239-a3ab-0f5e3d8932a5">
        <obo:IAO_0000115>##Meningeal ILC2s## express Thy1.2, ST2, CD25, spinocerebellar ataxia type 1 (Sca10), and low levels of c-Kit and IL-7Ralpha and are major producers of IL-13 in tissues. As tissue-resident cells, ILC2s exhibit tissue-specific receptor expression patterns, which are imprinted by local signals. Likewise, dural ILC2s are distinct from lung ILC2s. The basal activation state of meningeal ILC2s is lower than that of lung-resident cells. The proximity to brain-derived signals may explain the differences in basal activation observed between the two tissue types. ILC2 precursors originate from bone marrow. Future studies should determine the functional and phenotypic differences between blood-derived ILC2s and the adjacent bone marrow.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10616183</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37429945</oboInOwl:hasDbXref>
        <rdfs:label>Meningeal ILC2s</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0001069"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/6414420b-5142-4239-a3ab-0f5e3d8932a5"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0001069"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/642b73f0-6300-4537-9df1-4b58aedb9d78 -->

    <Class rdf:about="http://example.org/642b73f0-6300-4537-9df1-4b58aedb9d78">
        <obo:IAO_0000115>a UMAP dimensionality reduction embedding of PBMCs from DFU-Healers, DFU-Non-healers, Healthy subjects, and non-DFU DM patients. The identified cell types were DCs: dendritic cells; VasEndo: vascular endothelial cells; T-lympho: T lymphocytes; ##CD8T##1: CD8+ T lymphocytes cluster 1; CD8T2: CD8+ T lymphocytes cluster 2; NK: natural killer cells; NKT: natural killer and T cells; B-lympho: B lymphocytes; CD14Mono: CD14+ monocytes; CD16Mono: CD16+ monocytes. Dotted lines are drawn around cell groups of similar lineages. b Bar plots showing percentage of T-lymphocytes (T-lympho) and CD8+ T lymphocytes cluster 2 (CD8T2) per percentage of NKT cells in the CD45+ subset of cells across various clinical groups. DFU-healers depict significantly higher ratio of T-lympho and CDT2 cell cluster in comparison to DFU-Non-healers and Diabetic. Data represent the mean and standard error of mean (SEM) values from n = 2 Non-Healers, n = 3 Healers, n = 2 Diabetic and n = 3 Healthy subjects. p = 0.01 for Healers vs Non-Healers and p = 0.006 for Healers vs Diabetic in T-Lympho; p = 0.036 for Healers vs Non-Healers and p = 0.035 for Healers vs Diabetic in CD8T2 using two-sided Welch&apos;s t-test. c Heatmap showing significant DEGs in Healers compared to Non-healers in the T-lympho, CD8T2 and NKT cell clusters. d Biological pathways that are significantly (P value &lt; 0.01) activated (Z score &gt;1.5) /inhibited (Z score &lt; -1.5) in T-lympho, CD8T2 cells of Healers in contrast to NKT cells of Non-healers. Activation and inhibition of key upstream regulators is shown in pseudo color, where blue represents inhibition, and red represents activation. e Upstream regulatory molecules significantly inhibited (blue) in the T-lympho and CD8T2 cells of Healers as compared to Non-healers at the systemic level. Legend shows shapes and lines annotation for the regulatory network. f Violin plots showing expression levels of 3 key upstream regulator molecules NFKBIA, CCL5, and TGFB1, in the NKT, T-Lympho, and CD8T2 clusters.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8748704</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35013299</oboInOwl:hasDbXref>
        <rdfs:label>CD8T</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000625"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/642b73f0-6300-4537-9df1-4b58aedb9d78"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000625"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/64316014-4d51-441a-aa9d-1389b66cf440 -->

    <Class rdf:about="http://example.org/64316014-4d51-441a-aa9d-1389b66cf440">
        <obo:IAO_0000115>Downstream of the multipotent HSCs and MPPs, the original lineage bifurcation model strictly separated oligopotent Common Lymphoid Progenitors (CLP) from Common Myeloid Progenitors (CMP) which could further diverge into Megakaryocyte/Erythrocyte Progenitors (MEPs), Monocyte (Mo)/Dendritic cell (DC) Progenitors (MDPs) and Granulocyte/Mo Progenitors (GMPs). However, this model has been the subject of ongoing revision in the scRNA-seq era. On the one hand, a Lymphoid-primed MultiPotent Progenitor (LMPP) with combined lymphoid and myeloid potential has been shown to gradually lose myeloid potential by upregulating the interleukin-7 receptor alpha-chain (IL7Ralpha) and differentiate into Dach1- Lymphoid-Primed Progenitors (LPPs) prior to CLPs. On the other hand, erythroid-versus-myeloid fate decisions seem to be made prior to CMP commitment, calling for in-depth revision of all CMP progeny (MEPs, MDPs and GMPs) as well. While the Flt3L+CD115lo CMPs give rise to oligopotent MDPs, the Flt3-CD115- CMPs give rise to GMPs. The former are defined by TF co-expression of CEBPA, IRF8 and RUNX1. MDPs can give rise to IRF8/SATB1 plasmacytoid DC (pDC) Progenitors (pDCPs) and HLA-DR/IRF8/CEBPA Mo/conventional DC (cDC) Progenitors (McDPs). The latter bifurcate in CD11c/CD172ab/CD14 (human) or Ly6C+ Mo (mouse) or IRF8/HLA-DR/CD84/CD172ab Common DC Progenitors (CDPs). In contrast, GMPs (Kit, CD34, Sox4) are very heterogeneous at the transcriptomic and proteomic level and can adjust their functional output towards common Mo Progenitors (##cMoP##) and Granulocyte Progenitors (GPs).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11324509</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:39148724</oboInOwl:hasDbXref>
        <rdfs:label>cMoP</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0001019"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/64316014-4d51-441a-aa9d-1389b66cf440"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0001019"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/644d232c-bfef-4ee7-98a3-cc81d7cd8fad -->

    <Class rdf:about="http://example.org/644d232c-bfef-4ee7-98a3-cc81d7cd8fad">
        <obo:IAO_0000115>Compared with widely used high-throughput approaches that primarily involve viral vector-mediated gene transfer with uncontrollable randomness in cell targeting, 2-SPARSE has a unique advantage in that it enables precisely targeted labelling of single, functionally defined neurons after functional population imaging (Fig. 1). This precision is particularly useful when the functionally defined neurons in a specific brain region are sparse in number but exhibit wide spatial distribution and are intermingled with other neurons in the same region. In recent decades, many such neuronal types have been identified across multiple brain regions. For example, feature-specific neurons have been identified in the AUD and visual cortex for processing of sensory information; place cells and ##grid cells## have been identified in the hippocampus and the entorhinal cortex that participate in spatial navigation; engram cells have been identified in the hippocampus and cortex for memory processing, and holistic bursting cells have been identified in the AUD for complex sound encoding. These types of functionally defined cells constitute just a small proportion of the neuronal population in specific brain regions (e.g., grid cells, ~20%; engram cells, ~4%; and holistic bursting cells, ~5%) and are inevitably spatially intermingled. Moreover, these functional neuron types largely lack known molecular markers. Thus, molecular approaches alone are frequently limited in their potential application for mapping between functional and morphological features. In this case, 2-SPARSE not only provides an ideal solution for acquiring precise data but can also serve as an annotation reference for benchmarking and calibration of high-throughput population mapping methods used to correlate functional and morphological features of neurons.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8940919</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35318336</oboInOwl:hasDbXref>
        <rdfs:label>grid cells</rdfs:label>
    </Class>
    


    <!-- http://example.org/65123c6d-87d2-4571-9c88-2c1ec35acdb8 -->

    <Class rdf:about="http://example.org/65123c6d-87d2-4571-9c88-2c1ec35acdb8">
        <obo:IAO_0000115>The difference of expression patterns of solid tumor antigens (GPC3, B4GALNT1, and ERBB2) in malignant cells and nonmalignant cells. (A) Dot plot shows the expression level of target antigens (CD19, MS4A1, CD22, TNFRSF17, CD38, SDC1, SLAMF7, and TNFRSF8) in B lineage-related cells derived from lymphomas (DLBCL, FL, and tFL) and rLN. (B) Dot plot shows the expression level of target antigens (CD33, IL3RA, and CLEC12A) in hematopoietic stem/progenitor-like cells obtained from BM samples of AML patients and healthy donors, and in normal liver/heart EC clusters. &quot;AML314.D31&quot; represents the sample of patient AML314 after 31 days of treatment. BM5.34p means the sample of ##BM CD34-positive cells## derived from healthy donor BM5, and BM5.34p38n means the sample of BM CD34-positive and CD38-negative cells derived from healthy donor BM5. (C) The expression level of IL3RA in liver sinusoidal endothelial cells and macrovascular endothelial cells. (D) GPC3 expression levels in adjacent liver and hepatocellular carcinoma at scRNA-seq level. (E) GPC3 and ERBB2 expression levels of the epithelial lineages in normal primary gastric tissues and gastric cancers.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8716389</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34975912</oboInOwl:hasDbXref>
        <rdfs:label>BM CD34-positive cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000051"/>
        <skos:relatedMatch rdf:resource="CL:0001059"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/65123c6d-87d2-4571-9c88-2c1ec35acdb8"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000051"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/65123c6d-87d2-4571-9c88-2c1ec35acdb8"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0001059"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/65286d22-495a-4c40-9222-bb3ed157e15e -->

    <Class rdf:about="http://example.org/65286d22-495a-4c40-9222-bb3ed157e15e">
        <obo:IAO_0000115>We compared the functional differences between similar types of ##epithelial cells in the TZ and the PZ##. GSVA revealed that angiogenesis- and inflammation-related pathways were activated in all epithelial cells in the TZ (Figure 4A). Oestrogen, mTOR and stem/progenitor cell biology-regulated NOTCH signalling were more activated in TZ club and hillock cells than in the PZ (Figure 4A). Both oestrogen and mTOR pathways can serve as therapeutic targets for BPH. The E2F targets, the MYC targets and the DNA repair pathway were enriched in PZ luminal cells (Figure 4A).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9574492</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36245324</oboInOwl:hasDbXref>
        <rdfs:label>epithelial cells in the TZ and the PZ</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002231"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/65286d22-495a-4c40-9222-bb3ed157e15e"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002231"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/653c1d87-edfa-4025-bfe7-a3e63bc9ce68 -->

    <Class rdf:about="http://example.org/653c1d87-edfa-4025-bfe7-a3e63bc9ce68">
        <obo:IAO_0000115>BACKGROUND: Hundreds of ongoing clinical trials combine radiation therapy, mostly delivered as stereotactic body radiotherapy (SBRT), with immune checkpoint blockade. However, our understanding of the effect of radiotherapy on the intratumoral immune balance is inadequate, hindering the optimal design of trials that combine radiation therapy with immunotherapy. Our objective was to characterize the intratumoral immune balance of the malignant prostate after SBRT in patients. METHODS: Sixteen patients with high-risk, non-metastatic prostate cancer at comparable Gleason Grade disease underwent radical prostatectomy with (n = 9) or without (n = 7) neoadjuvant SBRT delivered in three fractions of 8 Gy over 5 days completed 2 weeks before surgery. Freshly resected prostate specimens were processed to obtain single-cell suspensions, and immune-phenotyped for major lymphoid and myeloid cell subsets by staining with two separate 14-antibody panels and multicolor flow cytometry analysis. RESULTS: Malignant prostates 2 weeks after SBRT had an immune infiltrate dominated by myeloid cells, whereas malignant prostates without preoperative treatment were more lymphoid-biased (##myeloid CD45+ cells## 48.4 +- 19.7% vs. 25.4 +- 7.0%; adjusted p-value = 0.11; and CD45+ lymphocytes 51.6 +- 19.7% vs. 74.5 +- 7.0%; p = 0.11; CD3+ T cells 35.2 +- 23.8% vs. 60.9 +- 9.7%; p = 0.12; mean +- SD). CONCLUSION: SBRT drives a significant lymphoid to myeloid shift in the prostate-tumor immune infiltrate. This may be of interest when combining SBRT with immunotherapies, particularly in prostate cancer.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7794088</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32647353</oboInOwl:hasDbXref>
        <rdfs:label>myeloid CD45+ cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000763"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/653c1d87-edfa-4025-bfe7-a3e63bc9ce68"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000763"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/6582af4e-7794-42d1-a781-0f12ad2c23f1 -->

    <Class rdf:about="http://example.org/6582af4e-7794-42d1-a781-0f12ad2c23f1">
        <obo:IAO_0000115>Histologically, tumour cells of CM typically form perivascular ring structures, which are embedded in a mucopolysaccharide myxoid matrix. Histopathological analysis indicates that ##vascular## and endothelial differentiation may be the typical paths of myxoma tumour cells, although other lineages, such as neural, muscular, and chondroid lineages, have also been reported. Therefore, it has been postulated that myxoma tumour cells may originate from multipotent mesenchymal cells. However, the histogenesis of CM has been uncertain until a recent study proposed that atrial myxoma is initiated from c-kit+ CD31- CD45- cardiac progenitor/stem cells. Nevertheless, we still lack a systematic understanding of the differentiation trajectory and transcriptomic heterogeneity of myxoma tumour cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10844892</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38318640</oboInOwl:hasDbXref>
        <rdfs:label>vascular</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002139"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/6582af4e-7794-42d1-a781-0f12ad2c23f1"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002139"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/66c94121-f6d8-40ff-adf0-0acb4887404c -->

    <Class rdf:about="http://example.org/66c94121-f6d8-40ff-adf0-0acb4887404c">
        <obo:IAO_0000115>The above analysis was based on a large number of RNA-seq, so we further used scRNA-seq to determine whether our ORGs signature had immune predictive value on the single cell level. Figure 7A showed that the PRAD samples from GEO datasets were annotated into Mast cell, Epithelial-NE, T/NK, Plasma_B, Epithelial, Neuron, SMC, Fibroblasts and ##Pericytes##, Myeloid and Endothelial. It was obvious that ORGs signature was specifically high in Epithelial-Nk, T/Nk and SMC cells (Figure 7B, 7C). Meanwhile, Figure 7D revealed that significant connection probability of ORGs related signaling pathways in cell clusters which showed specifically high ORGs signature. Furthermore, we chose epithelial cell for analysis. Chemotaxis related pathways including cell chemotaxis, leukocyte chemotaxis, regulation of chemotaxis and regulation of leukocyte chemotaxis were significantly up-regulated in the high ORGs signature group (Figure 7E). What&apos;s more, immune related pathways were all up-regulated in the high ORGs signature group both in GO (Figure 7F) and KEGG (Figure 7G) analysis.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10599753</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37788005</oboInOwl:hasDbXref>
        <rdfs:label>Pericytes</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000669"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/66c94121-f6d8-40ff-adf0-0acb4887404c"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000669"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/66dd2e56-f8f0-47f2-a01b-af32588377a8 -->

    <Class rdf:about="http://example.org/66dd2e56-f8f0-47f2-a01b-af32588377a8">
        <obo:IAO_0000115>In order for the sensitization we observed in excitatory interneurons to drive the psychophysical phenomenon of allodynia, spinal projection neurons must relay these nociceptive signals supraspinally. We found that capsaicin treatment shifted the overall tuning of SPB neurons towards LT input, consistent with the effects of central sensitization producing allodynia (Fig. 8a, b). Because SPB neurons are heterogeneous with respect to their response properties, we classified them as either wide-dynamic range (WDR), high threshold (HT), or low threshold (LT) (Fig. 8c) using previously published criteria. We found that both HT and WDR SPB showed significant increases in tuning to LT input, however the degree of change was much greater for WDR compared to HT SPB neurons (Fig. 8d). Finally, examining CICADA responses across populations, we found that WDR cells were more frequently responsive to CICADA agonists (71.4%), compared to either LT (40%) or HT (0%) SPB neurons. In particular, all SP-responsive SPB neurons were WDR cells (Fig. 8e). Since capsaicin is known to activate peptidergic afferents that release SP, these findings suggest that capsaicin-induced allodynia may be conveyed to the brain through a population of TACR1 expressing ##WDR SPB neurons## and, to a lesser extent, some HT SPB neurons (Fig. 8f).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9440908</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36057681</oboInOwl:hasDbXref>
        <rdfs:label>WDR SPB neurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000540"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/66dd2e56-f8f0-47f2-a01b-af32588377a8"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000540"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/66f9fc43-3ea5-42d5-975d-33cc330af083 -->

    <Class rdf:about="http://example.org/66f9fc43-3ea5-42d5-975d-33cc330af083">
        <obo:IAO_0000115>We undertook a comprehensive Mendelian randomization study aimed at uncovering the causal relationship between 744 immune cell types and IVDD [ Supplementary Table 2 ]. In our analysis, we identified 24 specific blood types of immune cells that demonstrated a causal association with disc degeneration through univariable MR [ Supplementary Table 3 ], including Memory B cell %B cell, Naive-mature B cell %B cell, IgD-CD38dim B cell %lymphocyte, CD39+activated CD4 regulatory T cell %CD4 regulatory T cell, CD39+ secreting CD4 regulatory T cell %CD4 regulatory T cell, CD45RA+ CD8+ T cell %CD8+ T cell, CD8+ T cell %leukocyte, CD39+CD4+ T cell %T cell, ##CD39+ CD4+ T cell## %CD4+ T cell,CD39+ CD8+ T cell %T cell, CD39+ CD8+ T cell Absolute Count, CD127- CD8+ T cell Absolute Count, CD28- CD8+ T cell Absolute Count, CD19 on IgD+ CD38+ B cell, CD19 on IgD+ CD38dim B cell, CD19 on IgD- CD38- B cell, CD19 on unswitched memory B cell, CD19 on transitional B cell, CD24 on IgD+ CD38+ B cell,CD28 on CD39+ secreting CD4 regulatory T cell, CD25 on CD39+ CD4+ T cell, CD4 on CD39+ CD4+ T cell, CD4 on CD39+ resting CD4 regulatory T cell and Neutrophil count. We excluded certain exposures due to a limited number of available SNPs to prevent potential bias, including Memory B cell %B cell, Naive-mature B cell %B cell, IgD-CD38dim B cell %lymphocyte, CD8+T cell %leukocyte, CD127-CD8+ T cell Absolute Count, CD19 on IgD-CD38-B cell, CD24 on IgD+ CD38+ B cell, CD28 on CD39+ secreting CD4 regulatory T cell and CD4 on CD39+ resting CD4 regulatory T cell.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10806224</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38268919</oboInOwl:hasDbXref>
        <rdfs:label>CD39+ CD4+ T cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000624"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/66f9fc43-3ea5-42d5-975d-33cc330af083"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000624"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/6667785e-95c8-43d7-9c6f-240f7bbd6331 -->

    <Class rdf:about="http://example.org/6667785e-95c8-43d7-9c6f-240f7bbd6331">
        <obo:IAO_0000115>Heat maps showing the subsets of T cells, NK and myeloid cells that account for the majority of lymphoid and myeloid cells in each ##BILs## and PBMC fraction. The heat maps show the relative abundance of each cluster as a percentage of the total number of CD4 alphabeta T cells, CD8 alphabeta T cells, gammadelta T cells, NK cells or myeloid cells, respectively in each BIL and PBMC fraction (Table S4).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6362260</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:30761153</oboInOwl:hasDbXref>
        <rdfs:label>BILs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000542"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/6667785e-95c8-43d7-9c6f-240f7bbd6331"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000542"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/6672e631-9311-47e7-8a9c-a033022840dc -->

    <Class rdf:about="http://example.org/6672e631-9311-47e7-8a9c-a033022840dc">
        <obo:IAO_0000115>The adipose-derived hormone leptin acts via its receptor (LepRb) in the brain to control energy balance. A potentially unidentified population of GABAergic hypothalamic LepRb neurons plays key roles in the restraint of food intake and body weight by leptin. To identify markers for candidate populations of LepRb neurons in an unbiased manner, we performed single-nucleus RNA-Seq of enriched mouse hypothalamic LepRb cells, identifying several previously unrecognized populations of hypothalamic LepRb neurons. Many of these populations displayed strong conservation across species, including GABAergic Glp1r-expressing LepRb (LepRbGlp1r) neurons, which expressed more Lepr than other LepRb cell populations. Ablating Lepr from LepRbGlp1r cells provoked hyperphagic obesity without impairing energy expenditure. Similarly, improvements in energy balance caused by Lepr reactivation in GABA neurons of otherwise Lepr-null mice required Lepr expression in GABAergic Glp1r-expressing neurons. Furthermore, restoration of Glp1r expression in ##LepRbGlp1r neurons## in otherwise Glp1r-null mice enabled food intake suppression by the GLP1R agonist, liraglutide. Thus, the conserved GABAergic LepRbGlp1r neuron population plays crucial roles in the suppression of food intake by leptin and GLP1R agonists.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10541203</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37581939</oboInOwl:hasDbXref>
        <rdfs:label>LepRbGlp1r neurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:4042033"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/6672e631-9311-47e7-8a9c-a033022840dc"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4042033"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/67aa5e78-b73b-451f-ad05-7774da811fa7 -->

    <Class rdf:about="http://example.org/67aa5e78-b73b-451f-ad05-7774da811fa7">
        <obo:IAO_0000115>(A and B) Isolated CD4+ TILs were stimulated in vitro with PMA/ionomycin and stained and analyzed by flow cytometry. (A) Top left dot plot shows PD-1 versus CD39 expression in CD4 Tconvs. IFN-gamma versus TNF-alpha expression is shown in the indicated CD4 Tconv populations. Proportions of cytokine+ (IFN-gamma and/or TNF-alpha; bottom left) and TNF-alpha+IFN-gamma-, TNF-alpha-IFN-gamma+, and TNF-alpha+IFN-gamma+ cells in PD-1-CD39-, PD-1loCD39-, PD-1hiCD39-, and PD-1hiCD39+ subsets and according to TIM-3 expression (n = 8). (B) Dot plots show CD39 versus IFN-gamma or TNF-alpha in CD4 Tconvs. Numbers in dot plots correspond to MFI of cytokine staining. MFI of IFN-gamma and TNF-alpha staining in IFN-gamma+ and TNF-alpha+ cells, respectively, are summarized for Tconv subpopulations defined as in A (n = 8). Samples in A and B are shown according to the proportion of TIM-3+ cells among ##PD-1hiCD39+ CD4 Tconv## (&lt;50% TIM-3+, square; &gt;=50% TIM-3+, triangle; unknown, round) (C) CD4 Tconv TIL subsets PD-1-CD39- (gray), PD-1loCD39- (green), PD-1hiCD39- (blue), and PD-1hiCD39+ (red) were sorted, expanded in vitro for 10 days, and restimulated or not with PMA/ionomycin overnight. TNF-alpha and IFN-gamma secretion was quantified by CBA in the supernatant (n = 5). (D) Isolated CD4+ TILs were stained ex vivo and analyzed by flow cytometry. Proportions of TOX+ cells in each Tconv subset are summarized (n = 10). Data are presented as mean +- SD. **P &lt; 0.01; ***P &lt; 0.001; ****P &lt; 0.0001. P values were determined using the Wilcoxon (A and B) and 2-tailed paired t tests (D). Bonferroni&apos;s correction was applied to account for multiple testing in D and significance level was adjusted accordingly (*P &lt; 0.0083; **P &lt; 0.00166; ***P &lt; 0.000166). Tconvs, conventional FOXP3- CD4 T cells; CBA, cytometric bead array; TILs, tumor-infiltrating lymphocytes.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7934837</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33332284</oboInOwl:hasDbXref>
        <rdfs:label>PD-1hiCD39+ CD4 Tconv</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000624"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/67aa5e78-b73b-451f-ad05-7774da811fa7"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000624"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/67cd0952-b4ae-44fc-9d4f-d4d90c2baf88 -->

    <Class rdf:about="http://example.org/67cd0952-b4ae-44fc-9d4f-d4d90c2baf88">
        <obo:IAO_0000115>Brain-derived neurotrophic factor (BDNF) and neurotrophin 3 (NT-3) are known to regulate neuronal morphology and the formation of neural circuits, yet the neuronal targets of each neurotrophin are still to be defined. To address how these neurotrophins regulate the morphological and synaptic differentiation of developing olfactory bulb (OB) GABAergic interneurons, we analyzed the effect of BDNF and NT-3 on GABA+-neurons and on different subtypes of these neurons: tyrosine hydroxylase (TH+); calretinin (Calr+); calbindin (Calb+); and parvalbumin (PVA+). These cells were generated from cultured embryonic mouse olfactory bulb neural stem cells (##eOBNSCs##) and after 14 days in vitro (DIV), when the neurons expressed TrkB and/or TrkC receptors, BDNF and NT-3 did not significantly change the number of neurons. However, long-term BDNF treatment did produce a longer total dendrite length and/or more dendritic branches in all the interneuron populations studied, except for PVA+-neurons. Similarly, BDNF caused an increase in the cell body perimeter in all the interneuron populations analyzed, except for PVA+-neurons. GABA+- and TH+-neurons were also studied at 21 DIV, when BDNF produced significantly longer neurites with no clear change in their number. Notably, these neurons developed synaptophysin+ boutons at 21 DIV, the size of which augmented significantly following exposure to either BDNF or NT-3. Our results show that in conditions that maintain neuronal survival, BDNF but not NT-3 promotes the morphological differentiation of developing OB interneurons in a cell-type-specific manner. In addition, our findings suggest that BDNF and NT-3 may promote synapse maturation by enhancing the size of synaptic boutons.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMID:33392918</oboInOwl:hasDbXref>
        <rdfs:label>eOBNSCs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000047"/>
        <skos:relatedMatch rdf:resource="CL:1001434"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/67cd0952-b4ae-44fc-9d4f-d4d90c2baf88"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000047"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/67cd0952-b4ae-44fc-9d4f-d4d90c2baf88"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:1001434"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/67f91a43-6880-4cc0-842d-dd1b5ada316f -->

    <Class rdf:about="http://example.org/67f91a43-6880-4cc0-842d-dd1b5ada316f">
        <obo:IAO_0000115>Downstream of the multipotent HSCs and MPPs, the original lineage bifurcation model strictly separated oligopotent Common Lymphoid Progenitors (CLP) from Common Myeloid Progenitors (CMP) which could further diverge into Megakaryocyte/Erythrocyte Progenitors (MEPs), Monocyte (Mo)/Dendritic cell (DC) Progenitors (MDPs) and Granulocyte/Mo Progenitors (GMPs). However, this model has been the subject of ongoing revision in the scRNA-seq era. On the one hand, a Lymphoid-primed MultiPotent Progenitor (LMPP) with combined lymphoid and myeloid potential has been shown to gradually lose myeloid potential by upregulating the interleukin-7 receptor alpha-chain (IL7Ralpha) and differentiate into Dach1- Lymphoid-Primed Progenitors (LPPs) prior to CLPs. On the other hand, erythroid-versus-myeloid fate decisions seem to be made prior to CMP commitment, calling for in-depth revision of all CMP progeny (MEPs, MDPs and GMPs) as well. While the Flt3L+CD115lo CMPs give rise to oligopotent MDPs, the Flt3-CD115- CMPs give rise to GMPs. The former are defined by TF co-expression of CEBPA, IRF8 and RUNX1. MDPs can give rise to IRF8/SATB1 plasmacytoid DC (pDC) Progenitors (pDCPs) and HLA-DR/IRF8/CEBPA Mo/conventional DC (cDC) Progenitors (McDPs). The latter bifurcate in CD11c/CD172ab/CD14 (human) or Ly6C+ Mo (mouse) or IRF8/HLA-DR/CD84/CD172ab Common DC Progenitors (##CDPs##). In contrast, GMPs (Kit, CD34, Sox4) are very heterogeneous at the transcriptomic and proteomic level and can adjust their functional output towards common Mo Progenitors (cMoP) and Granulocyte Progenitors (GPs).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11324509</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:39148724</oboInOwl:hasDbXref>
        <rdfs:label>CDPs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0001029"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/67f91a43-6880-4cc0-842d-dd1b5ada316f"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0001029"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/67348bd2-88de-4ad8-98e8-141995b3245a -->

    <Class rdf:about="http://example.org/67348bd2-88de-4ad8-98e8-141995b3245a">
        <obo:IAO_0000115>The deficit in type 2 CBCs can already be detected by P10, when the numbers of these cells are already reduced by a magnitude comparable with that in maturity (p &lt; 0.001; compare Figs. 10D, 9H). The loss by this stage is associated with an increase in the frequency of dying cells in Nfia-CKO retinas relative to littermate control retinas on P7, evidenced via either the presence of pyknotic nuclei (Fig. 10G, inset), or by CASP3 immunoreactivity (Fig. 10H, inset). Counts of dying cells, using either of these indices, at five different stages during the first 10 postnatal days in Nfia-CKO and littermate control retinas showed a statistically significant interaction (pyknotic cells, F(4,36) = 6.024, p &lt; 0.001; CASP3+ cells, F(4,36) = 4.138, p = 0.007), with post hoc pairwise comparisons confirming a difference between the Nfia-CKO and littermate control retinas only at P7 (adjusted p &lt; 0.001 for each index; Fig. 10G,H). As no other cell type (of those quantified) was reduced, and as naturally occurring bipolar cell death is normally under way at this stage, this transient increase in dying cells should be responsible for the reduction in ##SYT2+ cell## numbers detected by P10 and then maintained into maturity. This enhanced frequency of dying cells in the Nfia-CKO retinas should not be responsible for the absence of the AII amacrine cells, of course, because their massive loss is already present by P5. Note there is no hint of an increase in the frequency of dying cells at P1, P3, or P5 (Fig. 10G,H), consistent with the depletion of AII amacrine cells reflecting a failure to be specified from the outset. There is, as well, no difference in the frequency of mitotic profiles at either P1 or P5 (Fig. 11), during the period of cone bipolar cell genesis, suggesting that the loss of Nfia in these late-stage progenitors has not yielded a change in type 2 CBC number by affecting proliferation itself.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10711738</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37775301</oboInOwl:hasDbXref>
        <rdfs:label>SYT2+ cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000754"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/67348bd2-88de-4ad8-98e8-141995b3245a"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000754"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/6764f9a4-17e3-446e-a1a8-ec0dcdfd71c5 -->

    <Class rdf:about="http://example.org/6764f9a4-17e3-446e-a1a8-ec0dcdfd71c5">
        <obo:IAO_0000115>Proper development of the placenta, the transient support organ forms after embryo implantation, is essential for a successful pregnancy. However, the regulation of trophoblast invasion, which is most important during placentation, remains largely unknown. Here, rats, mice, and pigs are used as biomedical models, used scRNA-seq to comparatively elucidate the regulatory mechanism of ##placental trophoblast## invasion, and verified it using a human preeclampsia disease model combined with scStereo-seq. A dual-featured type of immune-featured trophoblast (iTrophoblast) is unexpectedly discovered. Interestingly, iTrophoblast only exists in invasive placentas and regulates trophoblast invasion during placentation. In a normally developing placenta, iTrophoblast gradually transforms from an immature state into a functional mature state as it develops. Whereas in the developmentally abnormal preeclamptic placenta, disordered iTrophoblast transformation leads to the accumulation of immature iTrophoblasts, thereby disrupting trophoblast invasion and ultimately leading to the progression of preeclampsia.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11558115</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:39234818</oboInOwl:hasDbXref>
        <rdfs:label>placental trophoblast</rdfs:label>
    </Class>
    


    <!-- http://example.org/677649bd-f334-4f23-8731-e089f5112298 -->

    <Class rdf:about="http://example.org/677649bd-f334-4f23-8731-e089f5112298">
        <obo:IAO_0000115>A, B, tSNE plot of 4659 CD45+ immune cells from the CNS. Data from this study is integrated with data from; Table 6). C, D, Each dataset represented by one tSNE. Cells are annotated using color representing their cell type. bMicroglia: baseline microglia; aMicroglia: activated microglia; pmMicroglia: proliferation-mediating microglia; ##maMicroglia##: monocyte-activating microglia; DAM: disease-associated microglia in SCI; elMicroglia: embryonic-like microglia; pvMacrophages: perivascular macrophages; mdMacrophages: monocyte-derived macrophages; DCs: dendritic cells; imB-cells: immature B-cells; mB-cells: mature B-cells; pimMicroglia: postnatal immature microglia; IEG+Microglia: immediate early genes microglia; sMicroglia: s-phase microglia; pPAM: postnatal proliferative-region-associated microglia; eMicroglia: embryonic microglia; pcpMacrophages: postnatal choroid plexus macrophages; acpMacrophages: adult choroid plexus macrophages; iMonocytes: inflammatory monocytes; pMonocytes: patrolling monocytes; cpEpithelial cells: choroid plexus epithelial cells. E, tSNE plots of 4659 CD45+ immune cells for selected genes indicating the log2(cpm) expression with a continuous color for each cell separately. F, Proliferation rate of CD45low and CD45high cells at 7 and 21 d post-SCI. Hoechst 33342 expression presented on a log-scale was used for defining cells in S-phase. Right most plot reports the percentage of cells in S-phase. Each dot represents one biological replicate (four mice per time point). Mean is surrounded by a 95% CI. This figure is extended in Extended Data Figure 8-1.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8496189</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34417326</oboInOwl:hasDbXref>
        <rdfs:label>maMicroglia</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000129"/>
        <skos:relatedMatch rdf:resource="CL:0000576"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/677649bd-f334-4f23-8731-e089f5112298"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000129"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/677649bd-f334-4f23-8731-e089f5112298"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000576"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/678f4baf-03b3-4c76-b72a-ef9b4d5fd902 -->

    <Class rdf:about="http://example.org/678f4baf-03b3-4c76-b72a-ef9b4d5fd902">
        <obo:IAO_0000115>Systems Organs Cell Types     Respiratory system Lung AT2 cells 0.79% 21.20%   Nose (nasal turbinate epithelial cells) Mesenchymal stromal cells 1.70% 8.50%   Plasma cells 2.00% 8.80%   Nose (nasal brushing epithelial cells) Plasma cells 4.00% 13.80%   Nose (nasal airway epithelial cells) Nasal airway epithelial cells 8.40% 23.10%   Digestive system Gall bladder Primordium cell 2.20% 2.60%   Small intestine (jejunum) Enterocyte progenitor cell 14.00% 6.60%   Goblet cell 9.10% 2.60%   Small intestine (ileum) Intestinal epithelial stem cell 1.50% 4.20%   Enterocyte progenitor cell 2.40% 3.60%   Small intestine (duodenum) LGR5+ stem cell 5.20% 4.50%   Intestinal epithelial stem cell 3.90% 5.80%   Enterocyte progenitor cell 4.40% 6.80%   ##Tuft progenitor cell## 7.40% 6.60%   Enteroendocrine cell 9.40% 3.80%   Large intestine (rectum) Goblet progenitor cell 2.80% 62.50%   MKI67+ progenitor cell 10.30% 75.40%   Enterocyte 13.20% 77.50%   Goblet cell 18.20% 87.30%   Large intestine (colon) Enterocyte 5.70% 52.10%   Goblet cell 11.00% 78.00%   Esophagus Secretory progenitor cell 9.40% 18.80%   Nervous system Brain (substantia nigra and cortex) Oligodendrocyte precursor cell 1.60% 0.90%   Astrocyte 1.90% 1.00%   Reproductive system Fallopian tube Epithelial cells 1.40% 26.50%   Ovarian somatic cell 1.00% 1.00%   Testis Spermatogonium 1.70% 4.50%   Peritubular myoid cell 1.70% 6.30%   Testis somatic cell 2.10% 4.30%   Spermatogonial stem cell 1.40% 2.10%   Circulatory system Heart Cardiomyocyte 6.60% 0.80%   Cardiovascular progenitor cell 12.50% 0.40%   Urinary system Kidney Nephron epithelial cell 2.70% 10.70%   Epithelial cell 2.70% 9.60%   Endothelial cell 2.70% 12.80%   Mesangial cell 3.00% 14.50%   </obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7794913</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33401657</oboInOwl:hasDbXref>
        <rdfs:label>Tuft progenitor cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0009080"/>
        <skos:relatedMatch rdf:resource="CL:0011026"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/678f4baf-03b3-4c76-b72a-ef9b4d5fd902"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0009080"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/678f4baf-03b3-4c76-b72a-ef9b4d5fd902"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0011026"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/68b01601-60d2-4f3d-b535-56ad65664244 -->

    <Class rdf:about="http://example.org/68b01601-60d2-4f3d-b535-56ad65664244">
        <obo:IAO_0000115>In Tek-CreERT2;R26T mice, we also observed Tek+ bone-lining cells at the endosteum (Fig. 5a). The frequency of these cells was approximately 2.8 cells/mm endosteum in longitudinal sections, which was significantly higher than that of Cdh5+ bone-lining cells (Fig. 5f). ##Tek+ endosteal bone-lining cells## often exhibited a thin and elongated morphology and were nearly absent for the osteolineage marker RUNX2 (Fig. 5b, g), suggesting that they might correspond to the endosteal fibroblasts detected in the reanalyzed dataset. However, Tek+ osteocytes were hardly detected in these mice (Fig. 5c, h). In other regions of the bone marrow cavity, a small population of trabecular bone-lining cells (Fig. 5d, i) and metaphyseal stromal cells (Fig. 5e, j) were also Tek+.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10733381</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38123537</oboInOwl:hasDbXref>
        <rdfs:label>Tek+ endosteal bone-lining cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000115"/>
        <skos:relatedMatch rdf:resource="CL:0002157"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/68b01601-60d2-4f3d-b535-56ad65664244"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000115"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/68b01601-60d2-4f3d-b535-56ad65664244"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002157"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/68e97451-a757-4a43-9a2b-d54933e72058 -->

    <Class rdf:about="http://example.org/68e97451-a757-4a43-9a2b-d54933e72058">
        <obo:IAO_0000115>Differentiation trajectory of pathological osteoclasts in arthritis. BM-derived CX3CR1loLy6Chi cells (R1) ingress into the synovium (R2) and produce inflammatory cytokines, chemokines, and VEGFA. Abundant M-CSF in the inflamed synovium induces maturation of some ##R2 cells## into osteoclast precursors, arthritis-associated osteoclastogenic macrophages (AtoMs/R3 cells). When AtoMs localize adjacent to the bone surface, simultaneous stimulation with RANKL and TNF promotes osteoclast formation, leading to joint destruction in arthritis.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9024112</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35464401</oboInOwl:hasDbXref>
        <rdfs:label>R2 cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000860"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/68e97451-a757-4a43-9a2b-d54933e72058"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000860"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/6804a156-9e72-4991-9a84-079cb94259f9 -->

    <Class rdf:about="http://example.org/6804a156-9e72-4991-9a84-079cb94259f9">
        <obo:IAO_0000115>Comparison of the single cell landscape between healthy human meniscus and degenerated meniscus. (A) Representative polarised light microscopy images of healthy human and degenerated meniscus. The white and red colours in the angle images are 90  apart in orientation. Dashed lines indicate the surface of the meniscus. Scale bar, 100 microm. (B) Merged t-distributed stochastic neighbour embedding (t-SNE) of single-cell RNA sequencing of healthy meniscus cells and degenerated meniscus cells. (C) Twelve healthy human and degenerated meniscus cell clusters at t-SNE. (D) Proportion of each cluster to the total cells. (E) Proportion of healthy and degenerated meniscus cells in each cluster. (F) Expression of representative marker genes in Vin plot. (G) Heatmap revealing the scaled expression of differentially expressed genes for each cluster. (H) CD146 and CD318 expression in healthy human meniscus cells and degenerated meniscus cells determined by flow cytometry. n&gt;=5, **p&lt;0.01. (I) Representative IHC staining of COL1A1 and COL2A1 healthy human meniscus and degenerated meniscus, and quantification of positive cells. Scale bar, 50 microm. n&gt;=5, **p&lt;0.01. (J) The expression of indicated marker genes in human healthy meniscus cells and degenerated meniscus cells were detected by qRT-PCR. *p&lt;0.05, **p&lt;0.01, otherwise, not significant. n=3, *p&lt;0.05, **p&lt;0.01. CPC, cartilage progenitor cells; DegP, ##degenerated meniscus progenitor cells##; EC, endothelial cells; FC, fibrochondrocytes; FCP, fibrochondrocyte progenitors; HTC, hypertrophic chondrocytes; MoDC, monocyte-derived dendritic cells; PreHTC, prehypertrophic chondrocytes; ProFC, proliferate fibrochondrocytes; RegC, regulatory chondrocytes.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7034356</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31871141</oboInOwl:hasDbXref>
        <rdfs:label>degenerated meniscus progenitor cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0011026"/>
        <skos:relatedMatch rdf:resource="CL:2000007"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/6804a156-9e72-4991-9a84-079cb94259f9"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0011026"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/6804a156-9e72-4991-9a84-079cb94259f9"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:2000007"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/68767b0c-2b99-4376-b6a0-83eaa2dd791c -->

    <Class rdf:about="http://example.org/68767b0c-2b99-4376-b6a0-83eaa2dd791c">
        <obo:IAO_0000115>By the time the mouse blastocyst is ready to implant into the uterus, it comprises three cell types: pluripotent epiblast and two types of extra-embryonic tissue; primitive endoderm (PE), that will become visceral endoderm (VE) that gives rise to the yolk sac; and trophectoderm (TE), progenitor of the placenta (figure 1). ESCs represent the pluripotent epiblast that forms a compartment distinct from the extra-embryonic cells in the blastocyst. The epiblast arises from a set of cells internalized during the 8- to 16-cell and 16- to 32-cell cleavage stages, the inner cell mass. The cells remaining on the outside of the embryo at this time become the TE. Before implantation, a salt and pepper mixture of inside cells, now specified as PE and epiblast, sort from each other into distinct layers. Just as the epiblast is represented by ESCs, cultured stem cell lines of trophoblast stem cells (TSCs) have been established from the TE and of ##eXtraEmbryoNic stem cells## (XEN cells) from the PE/VE. The trick in recapitulating development beyond gastrulation to form structures representing the entire body plan has been to recreate interactions between the pluripotent ESCs and the two extra-embryonic stem cell types. </obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9833437</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36630196</oboInOwl:hasDbXref>
        <rdfs:label>eXtraEmbryoNic stem cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000349"/>
        <skos:relatedMatch rdf:resource="CL:0002322"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/68767b0c-2b99-4376-b6a0-83eaa2dd791c"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000349"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/68767b0c-2b99-4376-b6a0-83eaa2dd791c"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002322"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/69a16bbe-1f44-439a-af20-dc4cee0542e9 -->

    <Class rdf:about="http://example.org/69a16bbe-1f44-439a-af20-dc4cee0542e9">
        <obo:IAO_0000115>Clusters #3 and #5 expressed the cytokeratins Krt5/14/17 marking the basal ductal cells and MECs in the adult LG (Figure 7A). Both clusters also shared with the MECs the expression of the calcium sensor S100a6. Nonetheless, the ductal clusters #3 and 5 specifically expressed Ly6d that labels ##luminal progenitors## in the prostate, Ly6a (also known as Sca-1) that is found in many stem cells but also in mammary ductal cells and tubular cells in the kidney, and the hormone subunit Gpha2 found in other glands (pancreas and pituitary gland) and in the corneal limbal stem cells that renew corneal epithelium (Figure 7A). These features support our previous cell-lineage tracing studies showing the existence of slow-cycling stem/progenitor cells in the basal ductal compartment of multilayered ducts.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10216974</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37408269</oboInOwl:hasDbXref>
        <rdfs:label>luminal progenitors</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002237"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/69a16bbe-1f44-439a-af20-dc4cee0542e9"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002237"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/69c9e2cc-329f-4878-8d13-2974b04585b0 -->

    <Class rdf:about="http://example.org/69c9e2cc-329f-4878-8d13-2974b04585b0">
        <obo:IAO_0000115>In 12 donors with neuropathologic AD and 12 age- and sex-matched controls (Fig. 1a, Supplementary Fig. 1) we obtained snRNAseq profiles from temporal cortex tissue (TCX) using 10x Genomics platform, which yielded 87,493 single nuclei transcriptomes (Fig. 1b, Supplementary Data 1). Most nuclei isolation methods rely on sucrose gradient or fluorescence-activated nuclear sorting (FANS) for optimal nuclear purity and quality; although detection of rare cell types remain relatively limited. We optimized a nuclei isolation method that enables detection of all known major brain cell types with high purity including rarer cell types (Supplementary Figs. 2, 3). Quality control (QC) and filtration steps were applied based on number of genes, unique molecular identifiers (UMIs) per nuclei and predicted doublets (Supplementary Fig. 4), resulting in 78,396 high quality nuclei in 35 clusters that were annotated for their types according to published cellular markers. Heatmap visualization using well-established cell type markers further confirmed the cell type assignment for the clusters (Fig. 1c, d). All clusters include nuclei from &gt; 20 individuals, i.e. &gt; 80% of cohort, except the two smallest clusters which contain 206 and 105 nuclei (Supplementary Data 2, 3). The clusters represent eight cell types (Fig. 1c) as follows: 14 excitatory neuronal (41% nuclei), 9 ##inhibitory neuronal## (20%), 3 oligodendrocytic (22%), 3 astrocytic (8%), 3 vascular (3%), 2 microglial (3%) and 1 oligodendrocyte progenitor nuclei clusters (3%). We tested the associations of each cell cluster proportion with diagnosis, age, sex, APOEepsilon4 and neuropathology measures (Supplementary Figs. 5, 6, Supplementary Data 4-6). An excitatory neuronal cluster 23 (cl.23) has a lower proportion of cells in AD cases, is likewise negatively associated with both Braak stage and Thal phase and is negatively associated with APOEepsilon4; inhibitory neuronal cl.10 is also negatively associated with Braak stage. An inhibitory neuronal cl.7 is positively and an oligodendrocytic cl.14 is negatively associated with APOEepsilon4. No other cell clusters had nuclei proportion associations with the tested variables.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11190273</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38902234</oboInOwl:hasDbXref>
        <rdfs:label>inhibitory neuronal</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000498"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/69c9e2cc-329f-4878-8d13-2974b04585b0"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000498"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/69fde341-1a56-47f6-983c-2b2225d2fc30 -->

    <Class rdf:about="http://example.org/69fde341-1a56-47f6-983c-2b2225d2fc30">
        <obo:IAO_0000115>Comparison of the single cell landscape between healthy human meniscus and degenerated meniscus. (A) Representative polarised light microscopy images of healthy human and degenerated meniscus. The white and red colours in the angle images are 90  apart in orientation. Dashed lines indicate the surface of the meniscus. Scale bar, 100 microm. (B) Merged t-distributed stochastic neighbour embedding (t-SNE) of single-cell RNA sequencing of healthy meniscus cells and degenerated meniscus cells. (C) Twelve healthy human and degenerated meniscus cell clusters at t-SNE. (D) Proportion of each cluster to the total cells. (E) Proportion of healthy and degenerated meniscus cells in each cluster. (F) Expression of representative marker genes in Vin plot. (G) Heatmap revealing the scaled expression of differentially expressed genes for each cluster. (H) CD146 and CD318 expression in healthy human meniscus cells and degenerated meniscus cells determined by flow cytometry. n&gt;=5, **p&lt;0.01. (I) Representative IHC staining of COL1A1 and COL2A1 healthy human meniscus and degenerated meniscus, and quantification of positive cells. Scale bar, 50 microm. n&gt;=5, **p&lt;0.01. (J) The expression of indicated marker genes in human healthy meniscus cells and degenerated meniscus cells were detected by qRT-PCR. *p&lt;0.05, **p&lt;0.01, otherwise, not significant. n=3, *p&lt;0.05, **p&lt;0.01. CPC, cartilage progenitor cells; DegP, degenerated meniscus progenitor cells; EC, endothelial cells; FC, fibrochondrocytes; FCP, fibrochondrocyte progenitors; HTC, hypertrophic chondrocytes; MoDC, monocyte-derived dendritic cells; PreHTC, prehypertrophic chondrocytes; ProFC, proliferate fibrochondrocytes; ##RegC##, regulatory chondrocytes.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7034356</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31871141</oboInOwl:hasDbXref>
        <rdfs:label>RegC</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000138"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/69fde341-1a56-47f6-983c-2b2225d2fc30"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000138"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/690befa4-7997-4865-9c56-739b4e7413e1 -->

    <Class rdf:about="http://example.org/690befa4-7997-4865-9c56-739b4e7413e1">
        <obo:IAO_0000115>We undertook a comprehensive Mendelian randomization study aimed at uncovering the causal relationship between 744 immune cell types and IVDD [ Supplementary Table 2 ]. In our analysis, we identified 24 specific blood types of immune cells that demonstrated a causal association with disc degeneration through univariable MR [ Supplementary Table 3 ], including Memory B cell %B cell, Naive-mature B cell %B cell, IgD-CD38dim B cell %lymphocyte, CD39+activated CD4 regulatory T cell %CD4 regulatory T cell, CD39+ secreting CD4 regulatory T cell %CD4 regulatory T cell, CD45RA+ CD8+ T cell %CD8+ T cell, CD8+ T cell %leukocyte, CD39+CD4+ T cell %T cell, CD39+ CD4+ T cell %CD4+ T cell,CD39+ CD8+ T cell %T cell, CD39+ CD8+ T cell Absolute Count, CD127- CD8+ T cell Absolute Count, CD28- CD8+ T cell Absolute Count, CD19 on IgD+ CD38+ B cell, CD19 on ##IgD+ CD38dim B cell##, CD19 on IgD- CD38- B cell, CD19 on unswitched memory B cell, CD19 on transitional B cell, CD24 on IgD+ CD38+ B cell,CD28 on CD39+ secreting CD4 regulatory T cell, CD25 on CD39+ CD4+ T cell, CD4 on CD39+ CD4+ T cell, CD4 on CD39+ resting CD4 regulatory T cell and Neutrophil count. We excluded certain exposures due to a limited number of available SNPs to prevent potential bias, including Memory B cell %B cell, Naive-mature B cell %B cell, IgD-CD38dim B cell %lymphocyte, CD8+T cell %leukocyte, CD127-CD8+ T cell Absolute Count, CD19 on IgD-CD38-B cell, CD24 on IgD+ CD38+ B cell, CD28 on CD39+ secreting CD4 regulatory T cell and CD4 on CD39+ resting CD4 regulatory T cell.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10806224</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38268919</oboInOwl:hasDbXref>
        <rdfs:label>IgD+ CD38dim B cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002106"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/690befa4-7997-4865-9c56-739b4e7413e1"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002106"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/6916be58-a768-4392-a4f9-0c4b64c693e1 -->

    <Class rdf:about="http://example.org/6916be58-a768-4392-a4f9-0c4b64c693e1">
        <obo:IAO_0000115>To investigate the developmental origin of the CD34+PRLR+ cells, freshly isolated CD34+ HSCs were sorted into MLP, CMP, GMP and NK/BP (Fig. 2A), and cultured as described above. PRLR-expressing cells were mainly generated from the GMP compartment (Fig. 2B-D). At day 4 of culture, FACS sorted PRLR+ progenitors lacked all lineage markers except for CD15 and CD43, further supporting their myeloid origin (Fig. 2E). Evaluation of these cells at later time points (day + 14) showed that they remain CD15+, and acquired CD11a, CD11b, CD11c, CD16, CD18, CD45RO and CD123 (Fig. 2F). To study their differentiation, we sorted CD34+PRLR+ cells from four-day expanded CD34+ HSCs (as shown in Fig. 1A). As above, in the presence of ILC promoting cytokines (IL-3, IL-7, IL-15, IL-23, SCF and FLT3L) the CD34+PRLR+ progenitors differentiate into immature myeloid cells (Fig. 3A-C). Addition of GM-CSF at later times (day + 21) resulted in the generation of mature granulocytes expressing CD15, CD16 and CD66b (Fig. 3A-C). Previously, we showed that some myeloid progenitors could give rise to CD56+ lymphocytes. However, sorted CD34+PRLR-, but not CD34+PRLR+ cells gave rise to CD56+ lymphocytes (Fig. 4A-C). Moreover, the CD34+PRLR+ progenitors do not express integrin alpha4beta7, a marker that defines ##innate lymphoid precursors## with the potential to develop into ILCs (Fig. 4C). In further support of these findings, the CD34+PRLR+ progenitors do not differentiate into CD94+, CD127+ and CD336+ lymphocytes (Fig. 4D). Collectively, these findings show that CD34+PRLR+ progenitors develop from the GMPs under the influence of SCF and FLT3L, thereby acquire various myeloid markers and seem to lack lymphoid potential.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7156717</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32286456</oboInOwl:hasDbXref>
        <rdfs:label>innate lymphoid precursors</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0001082"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/6916be58-a768-4392-a4f9-0c4b64c693e1"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0001082"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/69772a2d-cf8f-4364-a4cd-da5c83ad1bee -->

    <Class rdf:about="http://example.org/69772a2d-cf8f-4364-a4cd-da5c83ad1bee">
        <obo:IAO_0000115>Next, we analyzed the interactions between these ligand-receptor pairs from the TME among 12 kinds of immune cells, and found that CCL5-CCR1 mainly sends signals of CD8+ T cells and NK Cells, which may interact with pDCs, macrophages, cDC2s, and myeloid cells via the interaction of CCL5 and CCR1. The SELPLG-SELL ligand-receptor pair is the main interaction among CD4+ T cells, NK cells, myeloid cells, and naive B cells. Furthermore, NOTCH2-cDCs interact with pDCs, CD4+ T cells, cCD2s, NK cells, myeloid cells, naive B cells, and cDC1s. Both migDCs and cDC1s interact with CD4+ T cells, pDCs, cCD2s, NK Cells, myeloid cells, and naive B cells. The CXCL10-CXCR3 ligand-receptor pair is the main interaction among pDCs, migDCs, and CD4+ T cells, and the CXCL9-CXCR3 ligand-receptor pair is the main interaction among pDCs, cDC1s, migDCs, and CD4+ T cells (Fig. 8C). We also used a violin plot to visualize the signal gene expression distribution in the three signaling pathways inferred by CellChat. The results showed that CCL5 is mainly expressed on CD8+ T and NK cells, and its corresponding receptors are mainly in macrophages, myeloid cells, cCD2s, and pDCs. SELPLG is mainly expressed on CD4+ T cells, NOTCH2-cDCs, migDCs, and cDC1s, and its corresponding receptor, SELL, is mainly expressed on naive B cells, myeloid cells, NK cells, cCD2s, pDCs, CD4+ T cells, and ##cCD1s##. CXCL9 is mainly expressed on pDCs, migDCs, and cDC1s, CXCL10 is mainly expressed on pDCs and migDCs, and their corresponding receptor, CXCR3, is mainly expressed on CD4+ T cells (Fig. 8D).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9203818</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35710862</oboInOwl:hasDbXref>
        <rdfs:label>cCD1s</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000990"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/69772a2d-cf8f-4364-a4cd-da5c83ad1bee"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000990"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/7a0543f6-0cbf-418a-ab87-aa3451c8cec5 -->

    <Class rdf:about="http://example.org/7a0543f6-0cbf-418a-ab87-aa3451c8cec5">
        <obo:IAO_0000115>Results  A total of 26.53% of gammadelta T DC - control group ( p  &lt; 0.0001) - the proportion of alphabeta T DC was lower in ##splenic cells## than gammadelta T DC ; however, these 2 cell types were reduced in tumor conditions ( p  &lt; 0.0001), and the proportion of IFN-gamma, TNF-alpha, IL-12 and IL-17 cytokines produced by gammadelta T DC was higher than those produced by alphabeta T DC , but it decreased under conditions of tumor-related immune system response ( p  &lt; 0.0001). </obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10302725</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34077988</oboInOwl:hasDbXref>
        <rdfs:label>splenic cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000738"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/7a0543f6-0cbf-418a-ab87-aa3451c8cec5"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000738"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/7a44a409-b265-46df-9346-0cd959689cdb -->

    <Class rdf:about="http://example.org/7a44a409-b265-46df-9346-0cd959689cdb">
        <obo:IAO_0000115>mFbs resemble fibroblastic reticular cells (FRCs) that form conduit-like network in secondary lymphoid organs, and they have also been known as thymic FRCs. Transcriptome analyses on mFbs and LN FRCs revealed possible functional differences between these two morphologically similar cell types. LN FRCs are subdivided into several types based on their expression of functional genes, including chemokines and cytokines: T-cell zone reticular cell (TRC) expressing Ccl19, Ccl21a, and Il7; follicular dendritic cell (FDC) expressing Cxcl13; marginal reticular cell (MRC) expressing Tnfsf11 (RANKL); Cxcl12-expressing reticular cell (CRC); and medullary reticular cell (medRC) expressing Cxcl12, Il6, Tnfsf13, and Tnfsf13b. Most of these FRC-associated genes are not or just barely expressed in mFbs. In the thymus, RANKL is predominantly expressed in SP thymocytes to induce mTEC development, and Ccl19, Ccl21, Cxcl12, and IL-7 are produced by TECs so as to control the relocation and survival of thymocytes. It is likely that the role played by FRCs in the LN is replaced by TECs in the thymus. mFbs highly express other sets of chemokines as well, such as Cx3cl1 and Cxcl14, that are barely expressed in LN FRCs or capFbs, possibly contributing to the regulation of cell migration in the thymic medulla. Thus, mFbs comprise a thymus-specific subset of fibroblasts that is functionally distinct from LN FRCs. It is possible that mFbs also consist of multiple subsets with different functions. A population of ##CD34+podoplanin+ mFbs## are detected in adventitial layers that surround pericytes and endothelial cells, thus referred to as adventitial cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7840694</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33519827</oboInOwl:hasDbXref>
        <rdfs:label>CD34+podoplanin+ mFbs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0009106"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/7a44a409-b265-46df-9346-0cd959689cdb"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0009106"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/7b34601c-bc8f-48e4-ba99-306ebe5a6d2f -->

    <Class rdf:about="http://example.org/7b34601c-bc8f-48e4-ba99-306ebe5a6d2f">
        <obo:IAO_0000115>Sjogren&apos;s syndrome is a chronic autoimmune disorder whose pathogenesis is poorly understood and that lacks effective therapies. Detailed quantitative and spatial analyses of tissues affected by Sjogren&apos;s syndrome were undertaken, including the quantitation of the frequency of selected cell-cell interactions in the disease milieu. Quantitative analyses of CD4+ T cell subsets and of CD8+ T cells in the labial salivary glands from untreated patients with primary Sjogren&apos;s syndrome revealed that ##activated CD8+ cytotoxic T cells## (CD8+CTLs) were the most prominent T cells in these infiltrates. An accumulation of apoptotic glandular epithelial cells, mainly ductal and acinar cells, was observed, consistent with the impaired salivary secretion often observed in patients with this disease. FasL expressing activated CD8+ T cells were seen to accumulate around Fas expressing apoptotic epithelial cells. Quantitative analyses of apoptotic cell types and of conjugates between cytotoxic T cells and epithelial cells undergoing apoptosis suggest that Sjogren&apos;s syndrome is primarily driven by CD8+CTL mediated execution of epithelial cells mainly represented by ductal and acinar cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9475031</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36104369</oboInOwl:hasDbXref>
        <rdfs:label>activated CD8+ cytotoxic T cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000794"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/7b34601c-bc8f-48e4-ba99-306ebe5a6d2f"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000794"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/7b415533-d96f-48a5-ac88-3246dcc342b0 -->

    <Class rdf:about="http://example.org/7b415533-d96f-48a5-ac88-3246dcc342b0">
        <obo:IAO_0000115>##CD301b+ macrophages## have been recently identified as a group of macrophages focused on regulating the immune response and regeneration functions. Sommerfeld et al. demonstrated for the first time that macrophages could be divided by the surface marker CD301b, and CD301b+ macrophages were specific to the regenerative microenvironment, rather than CD206+ macrophages (M2-macrophage) or CD86+ macrophages (M1-macrophage). In another recent research, transplantation with CD301b+/CD206+ macrophages achieved better skin regeneration compared with CD301b-/CD206+ macrophages. Notably, CD301b+ macrophage was not a subpopulation of M2 macrophages, as CD301b+ macrophages possessed both M1 functional factors such as IL1 and M2 functional cytokine genes such as Arg1, which implied a more comprehensive role in conducting tissue regeneration. Our recent study found that there existed strong correlations between the dynamic changes in CD301b+ macrophages and CD206+ macrophages during periodontitis progression, however, the expression pattern and localization of CD301b+ macrophages were largely different from those of CD206+ macrophages in periodontal tissue. Considering the specificity of CD301b+ macrophage phenotype, it is reasonable to explore the strategy to specifically induce CD301b+ macrophages.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10902347</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38418808</oboInOwl:hasDbXref>
        <rdfs:label>CD301b+ macrophages</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/7b415533-d96f-48a5-ac88-3246dcc342b0"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/7b5dc9bd-1648-4088-996f-3aa100626cf7 -->

    <Class rdf:about="http://example.org/7b5dc9bd-1648-4088-996f-3aa100626cf7">
        <obo:IAO_0000115>The intrinsic micro-circuitry regulation of intestinal function consists of five neuronal classes with distinct functional specializations. Sensory neurons, also referred to as intrinsic primary afferent neurons (IPANs), detect chemical and physical alterations in the intestine and transmit the signal via interneurons to ##excitatory motor neurons##, inhibitory motor neurons or secretomotor/vasodilator neurons ( Figure 1 ). Enteric neurons are replenished from neuronal stem cells of the intestine. While the traditional sub-classification was based on the neuronal type, the anatomic location and axonal projection as well as neurochemical signature, recent advances in single-cell sequencing has enabled a comprehensive clustering based on gene expression.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8312561</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34322118</oboInOwl:hasDbXref>
        <rdfs:label>excitatory motor neurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0005024"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/7b5dc9bd-1648-4088-996f-3aa100626cf7"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0005024"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/7b89ccec-b925-401e-97f6-dbd8ad13fb0b -->

    <Class rdf:about="http://example.org/7b89ccec-b925-401e-97f6-dbd8ad13fb0b">
        <obo:IAO_0000115>alpha-SMA	Alpha smooth muscle actin	LEC	Lymphatic endothelial cell	 	ADSCs	Adipose-derived stem cells	Lymphoid-like	Lymphoid-like cell	 	ADAMTS	Disintegrin and metalloproteinase with thrombospondin motifs	Mac	Macrophage	 	AEC	Arterial endothelial cells	MAIT	Mucosal-associated invariant T cell	 	AFG	Autologous fat grafting	MMPs	Matrix metalloproteinases	 	APC	Adipocyte precursor cells	MC	Mast cell	 	BC	B cell	mCD8 T	Mature CD8 T cell	 	BKC	Basal keratinocyte	mNK	Mature natural killer cell	 	BMI	Body mass index	Myeloid-like	Myeloid-like cell	 	CCNs	Cellular communication network factors	nCD4 T	Naive CD4 T cell	 	cDC	Classic dendritic cell	nCD8 T	Naive CD8 T cell	 	CEC	Capillary endothelial cell	ncMos	Non-classic monocytes	 	DC	Dendritic cell	##NK-like##	Natural killer-like cell	 	CD	Cluster of differentiation	PC	Pericyte	 	CTGF	Connective tissue growth factor	PCA	Principal component analysis	 	DEGs	Differentially expressed genes	scRNA-seq	Single-cell RNA sequencing	 	DKC	Differentiating keratinocytes	SMC	Smooth muscle cell	 	EC	Endothelial cell	SNN	Shared nearest neighbour	 	ECM	Extracellular matrix	SSc	Scleroderma	 	EMT	Epithelial-to-mesenchymal transition	SVF	Stromal vascular fraction	 	FACS	Fluorescence-activated cell sorting	TC	T cell	 	FB	Fibroblast	TGF-beta1	Transforming growth factor 1	 	FGFRs	Fibroblast growth factor receptors	TIMPs	Tissue inhibitors of metalloproteinases	 	GEO	Gene expression omnibus	TREG	Regulatory T cells	 	GO	Gene Ontology	UMAP	Uniform manifold approximation and projection	 	IFATS	International Federation for Adipose Therapeutics and Science	VEC	Venous endothelial cell	 	ILC	Innate lymphoid cell	WAT	White adipose tissue	 	KEGG	Kyoto Encyclopedia of Genes and Genomes			 	</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10341100</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37443817</oboInOwl:hasDbXref>
        <rdfs:label>NK-like</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000623"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/7b89ccec-b925-401e-97f6-dbd8ad13fb0b"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000623"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/7b958f6f-ce0f-4862-ab52-bbdc7776bf78 -->

    <Class rdf:about="http://example.org/7b958f6f-ce0f-4862-ab52-bbdc7776bf78">
        <obo:IAO_0000115>Skeletal stem and progenitor cell populations are crucial for bone physiology. Characterization of these cell types remains restricted to heterogenous bulk populations with limited information on whether they are unique or overlap with previously characterized cell types. Here we show, through comprehensive functional and single-cell transcriptomic analyses, that postnatal long bones of mice contain at least two types of ##bone progenitors## with bona fide skeletal stem cell (SSC) characteristics. An early osteochondral SSC (ocSSC) facilitates long bone growth and repair, while a second type, a perivascular SSC (pvSSC), co-emerges with long bone marrow and contributes to shape the hematopoietic stem cell niche and regenerative demand. We establish that pvSSCs, but not ocSSCs, are the origin of bone marrow adipose tissue. Lastly, we also provide insight into residual SSC heterogeneity as well as potential crosstalk between the two spatially distinct cell populations. These findings comprehensively address previously unappreciated shortcomings of SSC research.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8289409</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34280086</oboInOwl:hasDbXref>
        <rdfs:label>bone progenitors</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000062"/>
        <skos:relatedMatch rdf:resource="CL:0007010"/>
        <skos:relatedMatch rdf:resource="CL:0011026"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/7b958f6f-ce0f-4862-ab52-bbdc7776bf78"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000062"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/7b958f6f-ce0f-4862-ab52-bbdc7776bf78"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0007010"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/7b958f6f-ce0f-4862-ab52-bbdc7776bf78"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0011026"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/7ba35a6a-8178-484c-afbd-495a30e51b1e -->

    <Class rdf:about="http://example.org/7ba35a6a-8178-484c-afbd-495a30e51b1e">
        <obo:IAO_0000115>alpha-SMA	Alpha smooth muscle actin	LEC	Lymphatic endothelial cell	 	ADSCs	Adipose-derived stem cells	Lymphoid-like	Lymphoid-like cell	 	ADAMTS	Disintegrin and metalloproteinase with thrombospondin motifs	Mac	Macrophage	 	AEC	Arterial endothelial cells	MAIT	Mucosal-associated invariant T cell	 	AFG	Autologous fat grafting	MMPs	Matrix metalloproteinases	 	APC	Adipocyte precursor cells	MC	Mast cell	 	BC	B cell	mCD8 T	Mature CD8 T cell	 	BKC	Basal keratinocyte	mNK	Mature natural killer cell	 	BMI	Body mass index	Myeloid-like	Myeloid-like cell	 	CCNs	Cellular communication network factors	nCD4 T	Naive CD4 T cell	 	cDC	Classic dendritic cell	nCD8 T	Naive CD8 T cell	 	CEC	Capillary endothelial cell	ncMos	Non-classic monocytes	 	DC	Dendritic cell	NK-like	Natural killer-like cell	 	CD	Cluster of differentiation	PC	Pericyte	 	CTGF	Connective tissue growth factor	PCA	Principal component analysis	 	DEGs	Differentially expressed genes	scRNA-seq	Single-cell RNA sequencing	 	DKC	##Differentiating keratinocytes##	SMC	Smooth muscle cell	 	EC	Endothelial cell	SNN	Shared nearest neighbour	 	ECM	Extracellular matrix	SSc	Scleroderma	 	EMT	Epithelial-to-mesenchymal transition	SVF	Stromal vascular fraction	 	FACS	Fluorescence-activated cell sorting	TC	T cell	 	FB	Fibroblast	TGF-beta1	Transforming growth factor 1	 	FGFRs	Fibroblast growth factor receptors	TIMPs	Tissue inhibitors of metalloproteinases	 	GEO	Gene expression omnibus	TREG	Regulatory T cells	 	GO	Gene Ontology	UMAP	Uniform manifold approximation and projection	 	IFATS	International Federation for Adipose Therapeutics and Science	VEC	Venous endothelial cell	 	ILC	Innate lymphoid cell	WAT	White adipose tissue	 	KEGG	Kyoto Encyclopedia of Genes and Genomes			 	</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10341100</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37443817</oboInOwl:hasDbXref>
        <rdfs:label>Differentiating keratinocytes</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000312"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/7ba35a6a-8178-484c-afbd-495a30e51b1e"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000312"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/7ba76691-66f5-42b4-bd4d-32986321e0da -->

    <Class rdf:about="http://example.org/7ba76691-66f5-42b4-bd4d-32986321e0da">
        <obo:IAO_0000115>Brain transcriptional changes after MIA require microglia. (A) Simplified schematic of sample processing pipeline from and bar plots of TORCH pathogen and cytokine receptor expression (mean log counts per million) in each cell type across development. (B) Violin plot of CytoTORCH module score for each cell cluster (MG, P&lt;0.05 for ANOVA and for pairwise comparisons between microglia and all other cell types using Tukey&apos;s HST). (C) Overview of experimental design (top) and UMAP visualization of snRNAseq data from the developing somatosensory cortex of E15.5 wild-type and Csf1r-/- mice after saline or Poly(I:C) maternal injection at E12.5 (two or three embryos per condition from a total of four pregnant dams, 42,736 total cells) (bottom). Cells are colored by cell type assignment. (D) Dot plots of log(fold change) in gene expression between MIA and saline for cell types with significant changes at E15.5. DEG analysis was performed using NEBULA. AP, apical progenitors; IP, intermediate progenitors; ImmN, immature neurons, MN, migrating neurons; (UL/DL) CPN, (upper layer/deep layer) callosal projection neurons; SCPN, ##subcerebral projection neurons##; CThPN, corticothalamic projection neurons; LIV, layer IV stellate neurons; IN, interneurons; CR, Cajal-Retzius cells; Astro, astrocytes; CGC, cycling glial cells; Epend; ependymal cells; OL, oligodendroglia; MG, microglia; Peri, pericytes; EC, endothelial cells; VLMC, vascular and leptomeningeal cells. Created with .</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11190434</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38775708</oboInOwl:hasDbXref>
        <rdfs:label>subcerebral projection neurons</rdfs:label>
    </Class>
    


    <!-- http://example.org/7bb3790e-123b-4410-8e32-6cc244470e13 -->

    <Class rdf:about="http://example.org/7bb3790e-123b-4410-8e32-6cc244470e13">
        <obo:IAO_0000115>a Schematic of study design. Diagrams depict the brain region of interest, Brodmann area 9, corresponding to the dlPFC. b UMAP plot colored by the broad cell types. c UMAP plot colored by the individual clusters identified and annotated. For UMAP plots, the x and y-axes represent the first and second UMAP co-ordinates respectively. d DotPlot depicting the expression of marker genes (SNAP25 - neurons, SLC17A7 - ##excitatory neurons##, GAD1 - inhibitory neurons, ALDH1L1 - astrocytes, PDGFRA - oligodendrocyte precursor cells, PLP1 - oligodendrocytes, CLDN5 - endothelial cells, CX3CR1 - microglia). The dendrogram next to the cluster names shows the relationship between the clusters by using the distance based on average expression of highly variable genes. e Best hits heatmap from MetaNeighbor showing the correspondence between the clusters in our dataset (columns) and the broad categories of cells identified in the Allen Brain Institute human motor cortex snRNA-seq dataset (rows). f Boxplots showing the proportion of nuclei in each cluster for each subject split by cases and controls for the broad OPC, astrocyte, and excitatory neuron cell types and the Ast1, Ast2, OPC1, and OPC2 clusters (n = 37 cases, 34 controls, representing biologically independent samples for each cluster or broad cell type). The middle line is the median. The lower and upper hinges correspond to the 25th and 75th percentiles. Upper and lower whiskers extend from the upper or lower hinges to the largest or smallest value no further than 1.5 times the inter-quartile range from the hinge, where the inter-quartile range is the distance between the first and third quartiles. Points beyond the end of the whiskers are plotted individually. In Fig. 1c-e, excitatory neuronal cluster names contain approximate layer annotations and inhibitory neuronal cluster names contain MGE or CGE specific marker information as a suffix where applicable, as described in methods: Cluster annotation. For example, ExN10_L46 denotes a cluster of excitatory neurons with enrichment of marker genes from layer 4 to layer 6 of the cortex and InN1_PV denotes a cluster on inhibitory neurons with enrichment of the MGE specific marker PV. This convention is used throughout the paper. Brain diagram in 1a was created with BioRender.com. Source data are provided as a Source Data file.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10203145</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37217515</oboInOwl:hasDbXref>
        <rdfs:label>excitatory neurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000540"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/7bb3790e-123b-4410-8e32-6cc244470e13"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000540"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/7bd318f3-9718-4f48-b685-0b9041be8024 -->

    <Class rdf:about="http://example.org/7bd318f3-9718-4f48-b685-0b9041be8024">
        <obo:IAO_0000115>The classification of pericyte-derived and non-pericyte-derived myofibroblasts (PDGFRbeta-constitutively-expressing and PDGFRbeta-de novo-expressing, respectively) indicates different roles of pulmonary myofibroblasts. With PDGFRbeta as a &apos;specific&apos; marker for pericytes, PDGFRbeta-regulated Cre expression has been used to trace the fate of these cells. However, the constitutive PDGFRbeta-Cre line employed in other studies does not allow discriminating between the two types of myofibroblasts identified in this study, as, after injury, both indistinguishably express PDGFRbeta. Here, we employed the tamoxifen inducible PDGFRbeta-CreERT2 to induce temporally controlled labeling of cells with active PDGFRbeta promotor in the adult lung; in fact, as the intra-alveolar myofibroblasts were found to acquire PDGFRbeta expression after injury, only the inducible lineage tracing strategy allowed us to differentiate between the two types of myofibroblasts. Using a PDGFRbeta-tdTomato reporter mouse in combination with the fact that SMC do not contribute to myofibroblasts, the interstitial myofibroblast can be shown to derive from ##NO-GC+/PDGFRbeta+ pericytes##. We have not yet determined the precursor for the intra-alveolar myofibroblast, although we can exclude pericytes based on our lineage tracing studies. Lipofibroblasts have been shown to be potential myofibroblasts precursors; whether this cell type is linked to the formation of intra-alveolar myofibroblasts has yet to be clarified.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10288756</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37349733</oboInOwl:hasDbXref>
        <rdfs:label>NO-GC+/PDGFRbeta+ pericytes</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000669"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/7bd318f3-9718-4f48-b685-0b9041be8024"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000669"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/7c022f4f-cda2-4323-b2ea-4e240ed5c023 -->

    <Class rdf:about="http://example.org/7c022f4f-cda2-4323-b2ea-4e240ed5c023">
        <obo:IAO_0000115>High levels of Oct4 mRNA were found in the 2-cell blastomere population in all conditions, followed by a decrease at the 4-cell stage and a strong increase in 8-cell blastomeres (Fig. 5E), an expression pattern reflecting the transition of maternal-to-zygotic Oct4 transcripts at the 4-cell stage (Wu and Scholer). There was a decrease of Oct4 expression in the bulk of both Ahr-/- and Ahr+/+-TCDD groups relative to Ahr+/+ at the 8-cell stage and in Ahr-/- than in Ahr+/+ 2-cell blastomeres. Similarly, we found a significant decrease of Oct4 expression in both Ahr-/- and Ahr+/+-TCDD, notably in both embryonic and differentiating blastomeres relative to the corresponding Ahr+/+ 8-cell subpopulations; in all conditions, differentiating blastomeres at 8-cell stage had higher expression levels than their embryonic counterparts (Fig. 5F). Furthermore, the levels of Oct4 transcription in ##Ahr-/- and Ahr+/+-TCDD 4-cell embryonic blastomeres## decreased or had a trend to decrease, respectively, relative to the corresponding Ahr+/+ blastomeres. The levels of Cdx2 mRNA were high in all 8-cell blastomeres analyzed and were significantly decreased or trended to decrease in the bulk of Ahr-/- and Ahr+/+-TCDD relative to the Ahr+/+ 8-cell population (Fig. 5G). The Cdx2 mRNA levels were higher in Ahr+/+ and Ahr-/- 8-cell differentiating blastomeres than in their embryonic counterparts, with the Ahr-/- 8-cell differentiating blastomeres showing lower expression than the corresponding Ahr+/+ subpopulation (Fig. 5H). Additionally, some Ahr+/+-TCDD 8-cell embryonic blastomeres showed unusually high levels of Cdx2 mRNA causing the indistinguishable difference between embryonic and differentiating subpopulations.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10425484</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36029422</oboInOwl:hasDbXref>
        <rdfs:label>Ahr-/- and Ahr+/+-TCDD 4-cell embryonic blastomeres</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000353"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/7c022f4f-cda2-4323-b2ea-4e240ed5c023"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000353"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/7c1c5d20-a729-4c78-afa7-cd033437561d -->

    <Class rdf:about="http://example.org/7c1c5d20-a729-4c78-afa7-cd033437561d">
        <obo:IAO_0000115>Here we hypothesized that upon activation, memory CD8 T cells acquire a noncytotoxic function whereby they interact with naive CD8 T cells and alter their phenotype and activation state. To test this hypothesis, we designed an in vitro system in which human polyclonal naive CD8 T cells were co-cultured with autologous, activated memory CD8 T cell subsets. The phenotype and transcriptional profile of naive cells was analyzed at the end of the co-culture period. We report that in the presence of activated TCM or stem cell memory (TSCM) cells, a small proportion (~3%) of autologous naive CD8 T cells acquired phenotypic and transcriptional features of activated/memory CD8 T cells in an MHC class I-dependent manner, whereas a much larger proportion (~84%) transitioned to a unique activated state, hybrid between ##naive and activated memory##. These findings imply that activated memory T cells can set the activation threshold of neighboring naive T cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9243096</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35768564</oboInOwl:hasDbXref>
        <rdfs:label>naive and activated memory</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000898"/>
        <skos:relatedMatch rdf:resource="CL:0000909"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/7c1c5d20-a729-4c78-afa7-cd033437561d"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000898"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/7c1c5d20-a729-4c78-afa7-cd033437561d"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000909"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/7c631138-c39d-460e-9254-03718a0c8f2a -->

    <Class rdf:about="http://example.org/7c631138-c39d-460e-9254-03718a0c8f2a">
        <obo:IAO_0000115>We undertook a comprehensive Mendelian randomization study aimed at uncovering the causal relationship between 744 immune cell types and IVDD [ Supplementary Table 2 ]. In our analysis, we identified 24 specific blood types of immune cells that demonstrated a causal association with disc degeneration through univariable MR [ Supplementary Table 3 ], including Memory B cell %B cell, Naive-mature B cell %B cell, IgD-CD38dim B cell %lymphocyte, CD39+activated CD4 regulatory T cell %CD4 regulatory T cell, CD39+ secreting CD4 regulatory T cell %CD4 regulatory T cell, CD45RA+ CD8+ T cell %CD8+ T cell, CD8+ T cell %leukocyte, ##CD39+CD4+ T cell## %T cell, CD39+ CD4+ T cell %CD4+ T cell,CD39+ CD8+ T cell %T cell, CD39+ CD8+ T cell Absolute Count, CD127- CD8+ T cell Absolute Count, CD28- CD8+ T cell Absolute Count, CD19 on IgD+ CD38+ B cell, CD19 on IgD+ CD38dim B cell, CD19 on IgD- CD38- B cell, CD19 on unswitched memory B cell, CD19 on transitional B cell, CD24 on IgD+ CD38+ B cell,CD28 on CD39+ secreting CD4 regulatory T cell, CD25 on CD39+ CD4+ T cell, CD4 on CD39+ CD4+ T cell, CD4 on CD39+ resting CD4 regulatory T cell and Neutrophil count. We excluded certain exposures due to a limited number of available SNPs to prevent potential bias, including Memory B cell %B cell, Naive-mature B cell %B cell, IgD-CD38dim B cell %lymphocyte, CD8+T cell %leukocyte, CD127-CD8+ T cell Absolute Count, CD19 on IgD-CD38-B cell, CD24 on IgD+ CD38+ B cell, CD28 on CD39+ secreting CD4 regulatory T cell and CD4 on CD39+ resting CD4 regulatory T cell.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10806224</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38268919</oboInOwl:hasDbXref>
        <rdfs:label>CD39+CD4+ T cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000624"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/7c631138-c39d-460e-9254-03718a0c8f2a"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000624"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/7c81c04e-8828-4890-a2c7-83ecfc09ec91 -->

    <Class rdf:about="http://example.org/7c81c04e-8828-4890-a2c7-83ecfc09ec91">
        <obo:IAO_0000115>Representative and non-representative ventricular AP phenotype. (a) An example AP waveform of a cell with representative ventricular phenotype where the RMP is close to -80 mV and a fast upstroke velocity is observed. The insets at the bottom, on the left a magnification of the depolarization phase of the AP is shown with on the right the first differential of this depolarization phase that represents the dV/dtmax of the AP. (b) An example of a cell with a non-representative ventricular phenotype is represented, displaying a RMP more depolarized than -80 mV and a slow upstroke velocity. Magnification of the depolarization phase and the first differential of it are shown below. (c) Same cell as represented in panel b but now displaying the elicited AP upon a negative current injection (-0.05 nA). By the negative current injection the RMP was brought toward -80 mV. Subsequent induction of an AP leads to a fast upstroke velocity, which indicates that the cell is not a ##nodal type hSC-CM## but a ventricular type cell with a more depolarized RMP</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7817136</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33465001</oboInOwl:hasDbXref>
        <rdfs:label>nodal type hSC-CM</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000746"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/7c81c04e-8828-4890-a2c7-83ecfc09ec91"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000746"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/7c925216-149b-43c8-9741-9f36247e296f -->

    <Class rdf:about="http://example.org/7c925216-149b-43c8-9741-9f36247e296f">
        <obo:IAO_0000115>(A) Pearson&apos;s correlation between IL-6 and B.cells.naive. (B) Pearson&apos;s correlation between IL-6 and Plasma.cells. (C) Pearson&apos;s correlation between IL-6 and T.cells.CD8. (D) Pearson&apos;s correlation between IL-6 and T.cells.CD4.memory.resting. (E) Pearson&apos;s correlation between IL-6 and NK.cells.resting. (F)Pearson&apos;s correlation between IL-6 and Monocytes. (G) Pearson&apos;s correlation between IL-6 and Macrophages.M0. (H) Pearson&apos;s correlation between IL-6 and Macrophages.M2. (I) Pearson&apos;s correlation between IL-6 and ##Dendritic.cells.activated##. (J) Pearson&apos;s correlation between IL-6 and Mast.cells.resting.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9329527</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35909542</oboInOwl:hasDbXref>
        <rdfs:label>Dendritic.cells.activated</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000516"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/7c925216-149b-43c8-9741-9f36247e296f"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000516"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/7ca48cbb-5f4d-4e2f-a292-81d7cdb25d8d -->

    <Class rdf:about="http://example.org/7ca48cbb-5f4d-4e2f-a292-81d7cdb25d8d">
        <obo:IAO_0000115>Marker	Target	Fluorochrome	Clone	Catalog number	 	CD14	Classical and intermediate monocytes	V500	M5E2	BD #561391	 	CD19	B cells 	V500	HIB19	BD # 561121	 	CD8	CD8 T cells	BV510	RPA-T8	BD # 563256	 	CD3	T cell lineage	PacBlue	UCHT1	BD # 558117	 	CD4	CD4 T cells	BV605	SK3	BD #565998	 	CD45RA	Naive T cells 	FITC	HI100	Biolegend # 304106	 	CCR7	Naive and regulatory T cells	PerCP-Cy5.5	G043H7	Biolegend # 353220	 	CD27	T and B cell subsets, NK cells	AF700	M-T271	Biolegend # 356416	 	CD25	##Activated T cells## 	PE-Cy7	M-A251	BD # 557741	 	OX40 (CD134)	Activated T cells 	PE	L106	BD #340420	 	PDL1 (CD274)	Activated T cells 	APC	29E2A3	Biolegend #329708	 	CXCR5 (CD185)**	T-Follicular Helper Cells	BV785	J252D4	Biolegend #359132	 	CXCR3 (CD183)**	Type 1 Helper Cells	BV711	G025H7	Biolegend #353732 	 	</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7672042</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33250895</oboInOwl:hasDbXref>
        <rdfs:label>Activated T cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000896"/>
        <skos:relatedMatch rdf:resource="CL:0001049"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/7ca48cbb-5f4d-4e2f-a292-81d7cdb25d8d"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000896"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/7ca48cbb-5f4d-4e2f-a292-81d7cdb25d8d"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0001049"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/7ccb4c8f-d978-41a5-b589-7498fc57a6a5 -->

    <Class rdf:about="http://example.org/7ccb4c8f-d978-41a5-b589-7498fc57a6a5">
        <obo:IAO_0000115>We observed 3 cell clusters (0, 4 and 5) expressing high levels of SSC-associated genes Gfra1, Nefm, Lhx1, Lhx2, Egr2, Etv5, Foxc2, and Id4 (Fig. 2a-c, Supplementary Fig. 2a, b and Supplementary Data 2). A feature distinguishing these potential SSC clusters included expression of cell cycle-related genes (e.g., Cdc20, Ube2c, Aurka, Top2a, Aspm) (Fig. 2b and Supplementary Fig. 2b). Cluster 4 and 5 cells had the most pronounced expression of cell cycle genes and were termed proliferative SSC-1 and SSC-2 respectively, while cluster 0 cells expressed lower levels of these genes and were termed primitive SSCs in part due to this quiescent signature (see below). Interestingly, cluster 4 and 5 cells were characterised by high levels of Epcam expression (Fig. 2c and Supplementary Fig. 2a). Proliferative SSC clusters were more prominent in the regenerative ##Aundiff## population while the proportion of primitive/quiescent SSCs remained comparable to controls, consistent with expansion of mitotically active SSCs within the regenerative Aundiff pool (Fig. 2a). Gene ontology (GO) analysis of DEGs in each cluster supported distinct cell cycle status of SSC subsets and highlighted importance of signalling pathway control (protein kinase inhibition) for the primitive SSC state and RNA splicing/processing for proliferative SSC states (Fig. 2d). Our analysis indicated that SSCs exist in a series of functional states with distinct cell-cycle status and regulatory pathways and that proliferative SSC states are more evident during regeneration. Given that Aundiff proliferation varies according to periodic cycling of the seminiferous epithelium and function can be affected by proximity to sources of growth factors, these clusters may represent SSCs from different cycle stages and/or distinct locations within the seminiferous tubule.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9076627</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35523793</oboInOwl:hasDbXref>
        <rdfs:label>Aundiff</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000015"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/7ccb4c8f-d978-41a5-b589-7498fc57a6a5"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000015"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/7cd2c6b6-2163-46a4-8838-cb508c48de40 -->

    <Class rdf:about="http://example.org/7cd2c6b6-2163-46a4-8838-cb508c48de40">
        <obo:IAO_0000115>SIRPalpha, signal regulatory protein alpha; cancer single-cell state atlas (CancerSea); GEPIA, Gene Expression Profiling Interaction Analysis; TIMER, Tumor Immune Estimation Resource; KM plotter, Kaplan-Meier plotter; EMT, Epithelial-Mesenchymal Transition; HPA, The Human Protein Atlas; IHC, immunohistochemistry; PFS, progression-free survival; OS, overall survival; HRs, Hazard ratios; M1 cells, macrophage type1 cells; M2 cells, macrophage type2 cells; Treg, regulatory T cells; ##TAMs##, Tumor-associated macrophages.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8710451</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34966389</oboInOwl:hasDbXref>
        <rdfs:label>TAMs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/7cd2c6b6-2163-46a4-8838-cb508c48de40"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/7cfad8cb-011b-4a74-9479-fc6ef675e023 -->

    <Class rdf:about="http://example.org/7cfad8cb-011b-4a74-9479-fc6ef675e023">
        <obo:IAO_0000115>Previous work revealed that GM-CSF cultured BMDCs are a heterogeneous myeloid cell population consisting of bona fide DCs (termed &quot;GM-DC&quot;) and a minor fraction of macrophage-like CD11c+ MHCII+ cells (termed &quot;GM-Mac&quot;). When we refined our flow cytometric analysis for distinguishing GM-DCs and GM-Macs in ##BMDC## cultures, we found a clear shift between both cell populations in 3xGrk -/- BMDC cultures. Among CD11c+ MHCII+ cells, the fraction of GM-DCs was decreased, whereas GM-Macs were markedly increased in both unstimulated and LPS-stimulated 3xGrk -/- GM-CSF cultures ( Figure 5E ). Importantly, the remaining bona fide GM-DCs, which still developed in 3xGrk -/- cultures, also showed reduced expression of CCR7, MHCII and CD40 ( Figure 5F ). Together, these findings provide an explanation for the two observed phenotypes of 3xGrk -/- cells in the under-agarose chemotaxis assays; (a) less responding cells, because GM-Macs do not migrate to CCL19, and (b) reduced displacement of the responding cells, because the remaining bona fide GM-DCs remain lowered in CCR7-expression. Additionally, we noticed that not only DCs derived from GM-CSF cultures showed an altered phenotype, but also DC development in the presence of Flt3 ligand was impaired. In particular, the number of CD11b- DCs was strongly reduced, whereas the CD11b+ DC population was not significantly altered ( Supplementary Figure 3A ).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9703078</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36451830</oboInOwl:hasDbXref>
        <rdfs:label>BMDC</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000451"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/7cfad8cb-011b-4a74-9479-fc6ef675e023"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000451"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/7d1fadf2-75aa-4fa1-aef9-0dfd6f8fe1b9 -->

    <Class rdf:about="http://example.org/7d1fadf2-75aa-4fa1-aef9-0dfd6f8fe1b9">
        <obo:IAO_0000115>Higher immune-suppressive potential coupled with active dysfunction of T cells in cervical cancer compared to precancer: (A) the UMAP plot of T lymphocytes which could be further reclustered into CD8+ T cells and CD4+ T cells; (B) the UMAP plot of the CD8+ T cells reclustered into seven subsets, including CD8+ MAIT, CD8+ Trm, CD8+ Naive, CD8+ Tex, CD8+ intraepithelial lymphocytes (IEL), CD8+ Tem and CD8+ Temra (upper left); the UMAP plot of the CD4+ T cells reclustered into five subsets, including CD4+ Tem, ##CD4+ Th1-like##, CD4+ Th17, CD4+ Naive and CD4+ Treg (lower left); the proportion of different CD8+ T cell subsets (upper right) and CD4+ T cell subsets (lower right), respectively, in four clinical groups, including normal cervix without human papillomavirus (HPV) infection, HPV-infected normal cervix, HPV-infected high-grade squamous intraepithelial lesions (HSIL) and HPV-infected cervical cancer; (C) the violin plots indicating the naiveness score (upper), cytotoxicity score (middle) and exhaustion score (lower) of each CD8+ T cell cluster; (D) the UMAP feature plots of the marker genes of CD8+ Temra (CX3CR1, KLRD1, PRF1) and CD8+ Tex (HAVCR2, CXCL13, CTLA4). (E) The pseudotime plot describing the differentiation trajectories of different subsets of CD8+ T lymphocytes (upper) and trajectory presented in the four clinical groups, respectively, including normal cervix without HPV infection, HPV-infected normal cervix, HPV-infected HSIL and HPV-infected cervical cancer; (F) the UMAP feature plots of the marker genes of CD4+ Th17 (CCR6, IL17A, CTSH), CD4+ Treg (CTLA4, FOXP3, TNFRSF18) and CD4+ Th1-like (CXCL13, IFNG, PDCD1); (G) the pseudotime plot describing the differentiation trajectories of different subsets of CD4+ T lymphocytes (upper) and trajectory presented based on the four clinical groups, including normal cervix without HPV infection, HPV-infected normal cervix, HPV-infected HSIL and HPV-infected cervical cancer; (H) the Kaplan Meier curve predicting the overall survival (OS) of cervical cancer (CC) patients with high and low expression of the Th17 signature (IL17A, CCR6 and CTSH) using TCGA data (p = .02, log rank test).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10040725</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36967539</oboInOwl:hasDbXref>
        <rdfs:label>CD4+ Th1-like</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000545"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/7d1fadf2-75aa-4fa1-aef9-0dfd6f8fe1b9"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000545"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/7d35e9ff-d772-4987-8ecb-2251851a296a -->

    <Class rdf:about="http://example.org/7d35e9ff-d772-4987-8ecb-2251851a296a">
        <obo:IAO_0000115>Taken together, the data-driven FACS gating strategy allowed us to isolate distinct stromal subsets for functional investigation. Both MSSCs and HAGEPs demonstrated considerably higher in vitro colony-forming capacities in comparison with balanced progenitors, OCs, pre-osteoblasts, and pre-fibroblasts. While MSSCs and HAGEPs exhibited full multi-differentiation potentials, pre-fibroblasts had only limited differentiation potentials. OCs showed enhanced osteoblastic and ##chondrogenic## differentiation capacities and compromised adipogenic potential, which is consistent with their differentiation marker expression profiles (Figure 2).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10097421</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36876630</oboInOwl:hasDbXref>
        <rdfs:label>chondrogenic</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000138"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/7d35e9ff-d772-4987-8ecb-2251851a296a"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000138"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/7d4ab3d9-ac20-4192-9427-2c8286ed3432 -->

    <Class rdf:about="http://example.org/7d4ab3d9-ac20-4192-9427-2c8286ed3432">
        <obo:IAO_0000115>LSCs can differentiate into basal, suprabasal and superficial cells of the corneal epithelium. Single-cell profiles allow for inferring cell-state transition and molecular dynamics during tissue development and differentiation. In this study, RNA velocity and pseudotime estimations showed that the degree of cell differentiation progressively increased in the order of LSC, basal cells, suprabasal cells and ##superficial cells##. We also revealed the gene acceleration kinetics that was consistent with gene function during CEC differentiation progression. This study provided detailed insights into the molecular dynamics of corneal epithelial development and differentiation, which facilitates us to better understand corneal homeostasis and pathogenesis.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10766623</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38177186</oboInOwl:hasDbXref>
        <rdfs:label>superficial cells</rdfs:label>
    </Class>
    


    <!-- http://example.org/7d54cb77-3774-4ca2-854b-99d877b74840 -->

    <Class rdf:about="http://example.org/7d54cb77-3774-4ca2-854b-99d877b74840">
        <obo:IAO_0000115>In order for the sensitization we observed in excitatory interneurons to drive the psychophysical phenomenon of allodynia, spinal projection neurons must relay these nociceptive signals supraspinally. We found that capsaicin treatment shifted the overall tuning of SPB neurons towards LT input, consistent with the effects of central sensitization producing allodynia (Fig. 8a, b). Because SPB neurons are heterogeneous with respect to their response properties, we classified them as either wide-dynamic range (WDR), high threshold (HT), or low threshold (LT) (Fig. 8c) using previously published criteria. We found that both HT and WDR SPB showed significant increases in tuning to LT input, however the degree of change was much greater for ##WDR## compared to HT SPB neurons (Fig. 8d). Finally, examining CICADA responses across populations, we found that WDR cells were more frequently responsive to CICADA agonists (71.4%), compared to either LT (40%) or HT (0%) SPB neurons. In particular, all SP-responsive SPB neurons were WDR cells (Fig. 8e). Since capsaicin is known to activate peptidergic afferents that release SP, these findings suggest that capsaicin-induced allodynia may be conveyed to the brain through a population of TACR1 expressing WDR SPB neurons and, to a lesser extent, some HT SPB neurons (Fig. 8f).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9440908</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36057681</oboInOwl:hasDbXref>
        <rdfs:label>WDR</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000540"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/7d54cb77-3774-4ca2-854b-99d877b74840"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000540"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/7d5fe184-c76a-4fff-a0d0-b44498a75a1e -->

    <Class rdf:about="http://example.org/7d5fe184-c76a-4fff-a0d0-b44498a75a1e">
        <obo:IAO_0000115>Characterizing ##tumor endothelial cells## subtypes</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9206324</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35717322</oboInOwl:hasDbXref>
        <rdfs:label>tumor endothelial cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000115"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/7d5fe184-c76a-4fff-a0d0-b44498a75a1e"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000115"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/7da45eff-39c3-4c54-8bf7-8d9ecbd4ae25 -->

    <Class rdf:about="http://example.org/7da45eff-39c3-4c54-8bf7-8d9ecbd4ae25">
        <obo:IAO_0000115>To verify differential gene expression, we employed RNA fluorescence in situ hybridization (FISH) to determine the abundance of select transcripts across spatially-resolved neuronal subsets in prion disease. We examined Ttr and Rbm3 because they were consistently upregulated across multiple neuronal clusters, and Egr1 and Rab6b, which were downregulated in ##cortical glutamatergic and striatal medium spiny neurons##, respectively. Towards this end, six panels of RNA FISH probes were used to measure Ttr, Rbm3, and Egr1, expression in Glutamatergic and GABAergic neurons, and Ttr, Rbm3, and Rab6b expression in medium spiny neurons (Fig. 4 and Supplementary Fig. 6). We collected region of interest (ROI) images targeting the cortex, CA1, and dentate gyrus regions to assess Glutamatergic and GABAergic neurons, and the striatum for medium spiny neurons. This approach confirmed the striking prion-associated increased expression of Rbm3 across several distinct types of neurons (Fig. 4g). Furthermore, Egr1 was strongly downregulated in cortical glutamatergic neurons and GABAergic neurons. We also confirmed the prion-associated downregulation of Rab6b in both Drd1+ and Drd2+ medium spiny neurons. A trend of increased Ttr expression was also detected across the different neuronal classes investigated; however, this trend did not achieve significance. By leveraging previously published bulk RNAseq datasets, we also examined the prion-altered abundance of these genes longitudinally in prion-infected mice (Fig. 4h). Rbm3 upregulation combined with decreased Egr1 and Rab6b was readily detected at the clinical endpoint of prion disease, but not at earlier timepoints. We, therefore, restricted our RNA-FISH validation to the clinical endpoint of prion disease. Overall, these RNA-FISH findings closely resembled the gene expression changes detected within our neuronal single-cell atlas, confirming the robustness of the dataset.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11585576</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:39580485</oboInOwl:hasDbXref>
        <rdfs:label>cortical glutamatergic and striatal medium spiny neurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000679"/>
        <skos:relatedMatch rdf:resource="CL:0008031"/>
        <skos:relatedMatch rdf:resource="CL:1001474"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/7da45eff-39c3-4c54-8bf7-8d9ecbd4ae25"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000679"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/7da45eff-39c3-4c54-8bf7-8d9ecbd4ae25"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0008031"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/7da45eff-39c3-4c54-8bf7-8d9ecbd4ae25"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:1001474"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/7e491dde-99cf-496f-bd5e-5011394500bf -->

    <Class rdf:about="http://example.org/7e491dde-99cf-496f-bd5e-5011394500bf">
        <obo:IAO_0000115>Cellular composition of the T cell compartment varied between healthy and infected groups (Fig. 3d). Based on their relative proportions and differential abundance testing (FDR 10%), we found activated CD4+ T cells expressing IL22, circulating follicular helper T (TFH) cells, type 1 helper T (TH1) cells, CD8+ effector memory T (TEM) cells and MAIT cells relatively enriched in individuals with asymptomatic and mild infection, with NKT, proliferating CD8+ and CD4+, and CD8+ terminal effector T (TTE) cells enriched in individuals with more severe infection (Fig. 3e and Extended Data Fig. 5a,b). Treating disease severity as an ordinal variable (Methods), multiple cell populations displayed nonlinear differences across disease severity (proliferating CD4+ and CD8+ T cells, CD8+ TTE, CD4+ TH1, CD4+ TH17, CD4+ central memory T (TCM) and IL-22+CD4+ T cells), illustrating the complex compositional changes to ##peripheral T cells## that occur with COVID-19 (Fig. 3e and Extended Data Fig. 5b). IL-22-expressing CD4+ T cells seen in asymptomatic and mild disease could be associated with tissue-protective responses that may restrict immunopathology (Fig. 3e) as previously shown for IL-22 in influenza A virus infection and lower viral load in COVID-19 patients&apos; lungs. Proliferating CD4+ and CD8+ T cells coexpressed exhaustion marker genes LAG3 and TOX (Extended Data Fig. 5c), in keeping with previous studies of patients with severe COVID-19 (ref. ). In contrast to disease severity, CD4+ TH1, CD4+ TH2, CD4+IL-22+ and CD4+ TCM cells were enriched among individuals with longer symptom duration, while effector populations with a cytotoxic phenotype (CD8+ TTE, CD8+ TEM, MAIT and NK T cells) were enriched in individuals with shorter symptom duration (Extended Data Fig. 5d).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8121667</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33879890</oboInOwl:hasDbXref>
        <rdfs:label>peripheral T cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000084"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/7e491dde-99cf-496f-bd5e-5011394500bf"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000084"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/7e638a57-e758-4d38-ab9b-14f4088f1d53 -->

    <Class rdf:about="http://example.org/7e638a57-e758-4d38-ab9b-14f4088f1d53">
        <obo:IAO_0000115>To develop a deeper understanding of the nature of B-cell responses in COVID-19, we further divided the B-cell population into more detailed subclusters using their transcriptional signatures and SHM rate obtained from scRNA datasets ( Figures 3A-C ). Previous high-dimensional flow cytometry data indicated that severe COVID-19 patients displayed hallmarks of ##EF B-cell## activation and shared B-cell repertoire features in autoimmune settings. Therefore, our study primarily focused on B-cell subsets representing EF responses. Here, 13 B-cell subclusters, including 3 subsets of plasma cells and 5 subsets of memory B cells, were identified by cluster analysis on UMAP ( Figure 3A ). IGHD-expressing naive B cells were subdivided into TR B cells, resting naive (RN) B cells, and activated naive (AN) B cells according to the differential expression of the specific signature gene set ( Figure 3B ). The AN B cells were IGHD-positive clusters with comparatively higher SHM rates ( Figure 3C ) than other naive B cells and expressed distinct genes, such as FGR and MPP6. During the EF response, AN B cells differentiate into effector cells lacking naive (IgD) and memory (CD27) markers or DN B cells. DN B cells showed a higher SHM rate than AN B cells and expressed ITGAX (CD11C) and CD86 ( Figures 3B, C ). A previous study also reported that the human EF effector B-cell responses are mediated by the expansion of a unique population of CD11c+ AN B cells. Two clusters of atypical memory (AM1 and AM2) B cells were identified within the memory B-cell compartment, which overexpressed CD1C. Interestingly, AM2 B cells shared several transcriptional signatures, including FGR and HLA-DRB1, with EF B-cell subsets, including AN and DN cells. Both AM2 and DN B cells express ITGAX, TBX21, CD86, and ITGB2, but AM2 uniquely expressed CXCR3 and GSN (gelsolin).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9309264</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35899045</oboInOwl:hasDbXref>
        <rdfs:label>EF B-cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000236"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/7e638a57-e758-4d38-ab9b-14f4088f1d53"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000236"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/7e764778-bd7e-40d4-9252-6b871e1cc8be -->

    <Class rdf:about="http://example.org/7e764778-bd7e-40d4-9252-6b871e1cc8be">
        <obo:IAO_0000115>Interestingly, tissue-specific super-enhancers start to be established before cell division to be fully established after division. Thus, transcription factors for which RNA expression is induced before division become fully active in the following cell cycle. Alternatively, some of these proteins could also act as mitotic bookmarking transcription factors to programme the identity of the newly created daughter cells before cellular division. Similar mechanisms seem to exist between the first division-producing ##mesendoderm cells## and the second division-producing endoderm cells. However, the second division is mainly associated with a reduction in the number of super-enhancers. Thus, differentiation could start with the establishment of a diverse set of tissue-specific super-enhancers which are then successively selected or discarded to enable the production of more committed cells (either endoderm or mesoderm). Further functional studies will help to identify the mechanism by which mesendoderm and endoderm transcriptional networks could achieve divergent activities.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9876972</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36697417</oboInOwl:hasDbXref>
        <rdfs:label>mesendoderm cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000222"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/7e764778-bd7e-40d4-9252-6b871e1cc8be"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000222"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/7e8e3132-dbfd-4122-933c-b907aaf09f33 -->

    <Class rdf:about="http://example.org/7e8e3132-dbfd-4122-933c-b907aaf09f33">
        <obo:IAO_0000115>GDNF, Glial cell line-derived neurotrophic factor; SOX1, Sex-determining region Y box1; TGF-beta, Transforming Growth Factor beta; EGFR, epidermal growth factor receptor; PI3-K, phosphatidylinositide 3-kinase; STAT3, signal transduction activator of transcription 3; GSK3 beta, Glycogen synthase kinase 3 beta; PTEN, Phosphatase and Tensin, VEGF, Vascular endothelial growth factor; TMZ, temozolomide; CAF, ##Cancer-Associated Fibroblast##; IL-6, interleukins and TNF-alpha, tumor necrosis factor-alpha.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8980436</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35392088</oboInOwl:hasDbXref>
        <rdfs:label>Cancer-Associated Fibroblast</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000057"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/7e8e3132-dbfd-4122-933c-b907aaf09f33"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000057"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/7e921dc2-60d2-434e-b001-3f39dc02f50a -->

    <Class rdf:about="http://example.org/7e921dc2-60d2-434e-b001-3f39dc02f50a">
        <obo:IAO_0000115>Besides these omental cell types, tumour-associated macrophages (##TAM##) clearly are instrumental in metastasis, in particular the CD163+Tim4+ subset, which promotes the stemness, invasive properties and epithelial to mesenchymal transition (EMT) of tumour cells by paracrine mechanisms. While omentectomy or depletion of CD163+Tim4+ cells prevented metastatic dissemination in a mouse model of ovarian cancer, depletion of monocyte-derived TAM had little impact, emphasising the role of resident omental macrophages. In keeping with these findings, TAM from HGSC patients show a high degree of phenotypic, ontogenetic and tumour-promoting heterogeneity, reflected, for example, by the differential expression of CD163 and cytokines associated with tumour progression. </obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8574964</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34841720</oboInOwl:hasDbXref>
        <rdfs:label>TAM</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/7e921dc2-60d2-434e-b001-3f39dc02f50a"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/7eb33568-a56d-4502-804f-5359377b62b8 -->

    <Class rdf:about="http://example.org/7eb33568-a56d-4502-804f-5359377b62b8">
        <obo:IAO_0000115>a Due to single-cell annotation and in situ validation (Fig. 2; Supplementary Fig. 3), a draft model of the oral-to-tooth transition zone in humans is presented, with basal and suprabasal keratinocyte markers uniquely identifying the alveolar mucosa (AM), attached gingiva (AG), gingival margin (GM), sulcular epithelium (SK) and junctional epithelium (JK). b These markers allowed for KRT19-high keratinocyte (KC) cell subclustering for the first time (2504 cells in total), including gingival margin keratinocytes (GM), sulcular keratinocytes (##SK##), and junctional keratinocytes (JK). c A more granular draft (Tier 4) annotation of epithelial cells of the gingival attachment. d Assaying differentially expressed genes in periodontitis, SKs and JKs only share about a quarter of upregulated genes. JKs displayed nearly 125 unique upregulated genes in diseased cells. e Further analysis of basal and suprabasal (differentiating) SK and JK keratinocytes revealed unique cell signatures between basal and suprabasal cell types. This full list is included in Supplementary Data 1. f-i To understand SK and JK developmental progression and cell state alterations, we used partitioned-based graph abstraction (PAGA). f Examining the basal to suprabasal transition, JKs display altered gene expressed comparing health to disease cell types, including broader expression of KRT17 and more expression of JUND, COL17A1, and CDH3. Key differentiation genes such as SPRR family members were also downregulated. g JKs displayed robust cell signaling and inflammatory phenotypes, which appear exacerbated in disease states. h In SKs, differentiation-related genes were uniquely expressed compared to JKs in health but also appeared altered in disease along the basal to suprabasal trajectory. i SKs appeared generally less reactive compared to JKs in disease, with lower overall expression of effector molecules such as CXCL1, CXCL8, IL1A, IL1B, and IL1RN. Abbreviations: Merk Merkel Cells, LC langerhans cells, Mela melanocytes, Muc mucosa, SB suprabasal Keratinocytes; for others, see Fig. 1 legend. For this figure, n = 30-sample, 2504-cell for scRNAseq.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11178863</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38876998</oboInOwl:hasDbXref>
        <rdfs:label>SK</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002170"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/7eb33568-a56d-4502-804f-5359377b62b8"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002170"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/7eb9090c-1975-4244-ade6-e592e69983a9 -->

    <Class rdf:about="http://example.org/7eb9090c-1975-4244-ade6-e592e69983a9">
        <obo:IAO_0000115>Taken together, two types of arterial VECs, namely the major artery VECs (EP3 and EP5) and ##arterial plexus VECs## (EP7) could be readily discriminated, whereas the morphologically well-defined major veins and venous plexus were largely indistinguishable on a molecular basis. The asymmetric arteriovenous characteristics are different to those seen in adults, where VECs display different properties that correspond to distinct vascular beds (Fig. 2f).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8975889</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35079138</oboInOwl:hasDbXref>
        <rdfs:label>arterial plexus VECs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:1000413"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/7eb9090c-1975-4244-ade6-e592e69983a9"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:1000413"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/7eec7572-ae22-45e6-860a-88773a03bbca -->

    <Class rdf:about="http://example.org/7eec7572-ae22-45e6-860a-88773a03bbca">
        <obo:IAO_0000115>Retention of Somatic Memory Associated with Cell Identity, Age and Metabolism in Induced ##Pluripotent Stem (iPS) Cells## Reprogramming.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMID:32016780</oboInOwl:hasDbXref>
        <rdfs:label>Pluripotent Stem (iPS) Cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002248"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/7eec7572-ae22-45e6-860a-88773a03bbca"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002248"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/7f115322-f0f1-4f4d-a329-fd309c555af9 -->

    <Class rdf:about="http://example.org/7f115322-f0f1-4f4d-a329-fd309c555af9">
        <obo:IAO_0000115>GSVA between clusters 6 and 10 of fibrotic and regenerative myofibroblasts. (A-D) Heatmaps showing the differences in activation of biological processes, cellular components, molecular functions, and KEGG pathways between clusters 6 and 10 of ##fibrotic (fib) and regenerative (reg) myofibroblasts##.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9156976</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35664010</oboInOwl:hasDbXref>
        <rdfs:label>fibrotic (fib) and regenerative (reg) myofibroblasts</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000186"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/7f115322-f0f1-4f4d-a329-fd309c555af9"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000186"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/7f13ee50-b389-4028-bca2-55f0a59fa81b -->

    <Class rdf:about="http://example.org/7f13ee50-b389-4028-bca2-55f0a59fa81b">
        <obo:IAO_0000115>We found that Pianno&apos;s prediction of the distribution of excitatory neuron subtypes displayed similar pattern as Tangram and RCTD (Supplementary Fig. S3), exhibited a high level of consistency with their known locations across the various layers (Fig. 3c). In contrast, the spatial distribution obtained from unsupervised clustering of cell bins in the original paper presented clusters containing neurons from both L5/6 and L2-3. These clusters included neurons assigned as EX L5/6 but displayed a significant enrichment also in upper layers (Fig. 3d). Ectopic mapping of L5/6 neurons to L2-3 was also observed in the results obtained from Cell2location (Supplementary Fig. S3), the tool showing top-performance in a previous benchmarking study of spatial deconvolution methods. These results suggest that even the most advanced deconvolution tool available at the time struggled with precisely assigning these neurons to their correct layers. The mispositioning of L5/6 neurons to L2-3 can likely be attributed to the fact that ##L2-3 and L5 pyramidal neurons## share some similar electrophysiological properties, morphological features, and connectivity patterns, leading to an increased transcriptomic similarity between them.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11271244</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38565531</oboInOwl:hasDbXref>
        <rdfs:label>L2-3 and L5 pyramidal neurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000598"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/7f13ee50-b389-4028-bca2-55f0a59fa81b"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000598"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/7f14c717-844a-4d04-843c-a4d0600aa0bb -->

    <Class rdf:about="http://example.org/7f14c717-844a-4d04-843c-a4d0600aa0bb">
        <obo:IAO_0000115>Results: We showed that two distinct pericyte subpopulations, marked by NG2+ and Tbx18+, had different potency following brain injury. NG2+ pericytes expressed dominant neural reprogramming potential to produce newborn neurons, while Tbx18+ pericytes displayed dominant multipotency to produce endothelial cells, fibroblasts, and ##microglia## following ischemic stroke. In addition, we discovered that AMPK modulators facilitated pericyte-to-neuron conversion by modulating Ser436 phosphorylation status of CBP, to coordinate an acetylation shift between Sox2 and histone H2B, and to regulate Sox2 nuclear-cytoplasmic trafficking during the reprogramming/differentiation process. Finally, we showed that sequential treatment of compound C (CpdC) and metformin, AMPK inhibitor and activator respectively, robustly facilitated the conversion of human pericytes into functional neurons.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11488099</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:39431007</oboInOwl:hasDbXref>
        <rdfs:label>microglia</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000129"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/7f14c717-844a-4d04-843c-a4d0600aa0bb"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000129"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/7f1efd8d-efcd-4d7c-8ba2-d28cf8ffd6d6 -->

    <Class rdf:about="http://example.org/7f1efd8d-efcd-4d7c-8ba2-d28cf8ffd6d6">
        <obo:IAO_0000115>BACKGROUND: Hundreds of ongoing clinical trials combine radiation therapy, mostly delivered as stereotactic body radiotherapy (SBRT), with immune checkpoint blockade. However, our understanding of the effect of radiotherapy on the intratumoral immune balance is inadequate, hindering the optimal design of trials that combine radiation therapy with immunotherapy. Our objective was to characterize the intratumoral immune balance of the malignant prostate after SBRT in patients. METHODS: Sixteen patients with high-risk, non-metastatic prostate cancer at comparable Gleason Grade disease underwent radical prostatectomy with (n = 9) or without (n = 7) neoadjuvant SBRT delivered in three fractions of 8 Gy over 5 days completed 2 weeks before surgery. Freshly resected prostate specimens were processed to obtain single-cell suspensions, and immune-phenotyped for major lymphoid and myeloid cell subsets by staining with two separate 14-antibody panels and multicolor flow cytometry analysis. RESULTS: Malignant prostates 2 weeks after SBRT had an immune infiltrate dominated by ##myeloid cells##, whereas malignant prostates without preoperative treatment were more lymphoid-biased (myeloid CD45+ cells 48.4 +- 19.7% vs. 25.4 +- 7.0%; adjusted p-value = 0.11; and CD45+ lymphocytes 51.6 +- 19.7% vs. 74.5 +- 7.0%; p = 0.11; CD3+ T cells 35.2 +- 23.8% vs. 60.9 +- 9.7%; p = 0.12; mean +- SD). CONCLUSION: SBRT drives a significant lymphoid to myeloid shift in the prostate-tumor immune infiltrate. This may be of interest when combining SBRT with immunotherapies, particularly in prostate cancer.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7794088</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32647353</oboInOwl:hasDbXref>
        <rdfs:label>myeloid cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000763"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/7f1efd8d-efcd-4d7c-8ba2-d28cf8ffd6d6"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000763"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/7f5833e0-1d46-4773-ad5e-c949ff725f00 -->

    <Class rdf:about="http://example.org/7f5833e0-1d46-4773-ad5e-c949ff725f00">
        <obo:IAO_0000115>Liver sinusoidal endothelial cells (LSECs) form a highly specialized microvasculature that plays a critical role in liver function and disease. To better understand this role, we developed a strategy to generate LSECs from human pluripotent stem cells (hPSCs) by first optimizing the specification of arterial and venous angioblasts and derivative endothelial populations. Induction of a LSEC-like fate by hypoxia, cyclic AMP (cAMP) agonism, and transforming growth factor beta (TGF-beta) inhibition revealed that venous endothelial cells responded more rapidly and robustly than the arterial cells to upregulate LSEC markers and functions in vitro. Upon intrahepatic transplantation in neonates, ##venous angioblasts## engrafted the liver and generated mature, fenestrated LSECs with scavenger functions and molecular profiles of primary human LSECs. When transplanted into the liver of adult mice, angioblasts efficiently gave rise to mature LSECs with robust factor VIII (FVIII) production. Humanization of the murine liver with hPSC-derived LSECs provides a tractable system for studying the biology of this key liver cell type.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMID:32640183</oboInOwl:hasDbXref>
        <rdfs:label>venous angioblasts</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000566"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/7f5833e0-1d46-4773-ad5e-c949ff725f00"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000566"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/7f6ec1e2-b273-45c3-aeb6-7a5eb1183d0f -->

    <Class rdf:about="http://example.org/7f6ec1e2-b273-45c3-aeb6-7a5eb1183d0f">
        <obo:IAO_0000115>X-axis are the cell types denoted by layer and gene marker. Y-axis is the GWAS summary statistics used. Class is colour coded, purple are ##excitatory neurons##, pink are inhibitory neurons, white are oligodendrocytes, hot pink are astrocytes, grey are newborn inhibitory neurons, forest green are intermediate progenitor cells, light pink are radial glia (RG), and black are non-neural cells (endothelial, pericytes). The blue is the negative log10 of the FDR q-value (mean analysis). Black boxes represent cell types that reached significance (FDR &lt; 0.05). a Allen Brain Bank adult single nuclei RNA sequencing data. b Kriegstein fetal single cell RNA sequencing data. c Shen fetal RNA sequencing data.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10208966</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36750735</oboInOwl:hasDbXref>
        <rdfs:label>excitatory neurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000540"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/7f6ec1e2-b273-45c3-aeb6-7a5eb1183d0f"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000540"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/7f73a540-7df2-40ef-a2f4-c47563deabfd -->

    <Class rdf:about="http://example.org/7f73a540-7df2-40ef-a2f4-c47563deabfd">
        <obo:IAO_0000115>MOUSE SYMPATHO-ADRENAL CELL TYPES MARKERS   SNPCs Ret Phox2b Ascl1 Mycn Hand2 Gata3Sox10- Plp1-   Sympathoblasts extra-adrenal Phox2b Mycn Th Dbh Ret Cart CartptSox10- Plp1- Sgc10- Ascl1 -   Sympathetic neurons/ganglia/SRG Ret Scg10 Cart Ascl1 Phox2b Th DbhSox10- Plp1-   SCPs Sox10 Plp1 Ascl1 Phox2bRet-   Schwann cells Sox10 Plp1 GfapPhox2b-   Bridge cells Sox10 Plp1 Chga Penk Htr3a Ascl1 Phox2bTh- Ret-   Immature chromaffin cells Chga Chgb Penk Th DbhSox10- Plp1- Ret-   Chromaffin cells Chga Penk Ascl1 Phox2b Th DbhSox10- Plp1- Ret-   Sympathoblasts intra-adrenal Ret Cart Cartpt Phox2b Th Alk Hmx1 PrphSox10- Plp1-   ##Sympathetic neurons intra-adrenal## Ret Cart Ascl1 Phox2b ThSox10- Plp1-   </obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8915499</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35277192</oboInOwl:hasDbXref>
        <rdfs:label>Sympathetic neurons intra-adrenal</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0011103"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/7f73a540-7df2-40ef-a2f4-c47563deabfd"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0011103"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/7fc1978c-3381-472f-bebb-74bc5ec57301 -->

    <Class rdf:about="http://example.org/7fc1978c-3381-472f-bebb-74bc5ec57301">
        <obo:IAO_0000115>We observed 3 cell clusters (0, 4 and 5) expressing high levels of SSC-associated genes Gfra1, Nefm, Lhx1, Lhx2, Egr2, Etv5, Foxc2, and Id4 (Fig. 2a-c, Supplementary Fig. 2a, b and Supplementary Data 2). A feature distinguishing these potential SSC clusters included expression of cell cycle-related genes (e.g., Cdc20, Ube2c, Aurka, Top2a, Aspm) (Fig. 2b and Supplementary Fig. 2b). Cluster 4 and 5 cells had the most pronounced expression of cell cycle genes and were termed proliferative SSC-1 and SSC-2 respectively, while cluster 0 cells expressed lower levels of these genes and were termed primitive SSCs in part due to this quiescent signature (see below). Interestingly, cluster 4 and 5 cells were characterised by high levels of Epcam expression (Fig. 2c and Supplementary Fig. 2a). Proliferative SSC clusters were more prominent in the regenerative Aundiff population while the proportion of ##primitive/quiescent SSCs## remained comparable to controls, consistent with expansion of mitotically active SSCs within the regenerative Aundiff pool (Fig. 2a). Gene ontology (GO) analysis of DEGs in each cluster supported distinct cell cycle status of SSC subsets and highlighted importance of signalling pathway control (protein kinase inhibition) for the primitive SSC state and RNA splicing/processing for proliferative SSC states (Fig. 2d). Our analysis indicated that SSCs exist in a series of functional states with distinct cell-cycle status and regulatory pathways and that proliferative SSC states are more evident during regeneration. Given that Aundiff proliferation varies according to periodic cycling of the seminiferous epithelium and function can be affected by proximity to sources of growth factors, these clusters may represent SSCs from different cycle stages and/or distinct locations within the seminiferous tubule.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9076627</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35523793</oboInOwl:hasDbXref>
        <rdfs:label>primitive/quiescent SSCs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000016"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/7fc1978c-3381-472f-bebb-74bc5ec57301"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000016"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/70b14c93-2f79-4073-b85d-c6bfdb975558 -->

    <Class rdf:about="http://example.org/70b14c93-2f79-4073-b85d-c6bfdb975558">
        <obo:IAO_0000115>Development of the trophoblastic shell and formation of placental anchoring villi. a Structure of the human trophoblastic shell and its surrounding arterial vessels. b Depiction of a placental anchoring villus, spiral artery (SA) remodelling and interaction of extravillous trophoblasts (EVTs) with different decidual cell types. dCCT distal cell column trophoblast, dMPhi decidual macrophage, DSC decidual stromal cell, eCTB endovascular cytotrophoblast, GC giant cell, iCTB ##interstitial cytotrophoblast##, pCCT proximal cell column trophoblast, pEC placental endothelial cell, pMPhi placental macrophage, pSC placental stromal/mesenchymal cell, SM smooth muscle layer, STB syncytiotrophoblast, TBS trophoblastic shell, TP trophoblast plug, TV tertiary villi, UC umbilical cord, uNK uterine NK cell, vCTB villous cytotrophoblast, YO yolk sac</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6697717</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31049600</oboInOwl:hasDbXref>
        <rdfs:label>interstitial cytotrophoblast</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000523"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/70b14c93-2f79-4073-b85d-c6bfdb975558"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000523"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/70f7005e-48ea-4b59-b79d-155f74fd7b90 -->

    <Class rdf:about="http://example.org/70f7005e-48ea-4b59-b79d-155f74fd7b90">
        <obo:IAO_0000115>Advances in the field of T cell memory, including the discovery of tissue residency, continue to add to the list of defined T cell subsets. Here, we briefly review the role of resident memory T cells (##TRM##) in protective immunity, and propose that they exhibit developmental and migrational plasticity. We discuss T cell classification, the concept of cell type versus &apos;subset&apos;, and the difficulty of inferring developmental relationships between cells occupying malleable differentiation states. We propose that popular subsetting strategies do not perfectly define boundaries of developmental potential. We integrate TRM into a &apos;terrace&apos; model that classifies memory T cells along a continuous axis of decreasing developmental potential. This model also segregates cells on the basis of migration properties, although different migration properties are viewed as parallel differentiation states that may be permissive to change.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7198345</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32018169</oboInOwl:hasDbXref>
        <rdfs:label>TRM</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000813"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/70f7005e-48ea-4b59-b79d-155f74fd7b90"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000813"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/700d094b-c32b-45ee-9082-2af548b16eb8 -->

    <Class rdf:about="http://example.org/700d094b-c32b-45ee-9082-2af548b16eb8">
        <obo:IAO_0000115> (A) Clusters 2U and 2Sb represent the abundance of manually gated subsets previously identified by the CyTOF automated clustering pipeline, shown here with median and interquartile range. Parent population is labelled on the y-axis. (B) Clusters 1U and 1S represent the expression of CCR7 on Th1-like IL-17+ cells, with median and interquartile range. Points represent RA and HC samples. Mann Whitney U P values are shown above the pairwise comparisons. TEM, T effector memory cell; ##TCM##, T central memory cell.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10196473</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37215131</oboInOwl:hasDbXref>
        <rdfs:label>TCM</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000904"/>
        <skos:relatedMatch rdf:resource="CL:0000907"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/700d094b-c32b-45ee-9082-2af548b16eb8"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000904"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/700d094b-c32b-45ee-9082-2af548b16eb8"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000907"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/701128cd-418d-4c29-9055-3c210b3b801c -->

    <Class rdf:about="http://example.org/701128cd-418d-4c29-9055-3c210b3b801c">
        <obo:IAO_0000115>Our results implicated CD49f+/ERalpha + prostate cancer cells associated with basal stem-like and EMT features, named EMT-PCBSLCs, in heightened potential for promoting metastasis. NOTCH1 was regulated by E2 in ##CD49fHi EMT-PCBSLCs##. These results contribute to insights into the metastatic mechanisms of EMT-PCBSLCs in PCa.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6533681</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31122254</oboInOwl:hasDbXref>
        <rdfs:label>CD49fHi EMT-PCBSLCs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002341"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/701128cd-418d-4c29-9055-3c210b3b801c"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002341"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/702406ed-55ee-4ddc-8691-5ce4134ca8e9 -->

    <Class rdf:about="http://example.org/702406ed-55ee-4ddc-8691-5ce4134ca8e9">
        <obo:IAO_0000115>Downstream of the multipotent HSCs and MPPs, the original lineage bifurcation model strictly separated oligopotent Common Lymphoid Progenitors (CLP) from Common Myeloid Progenitors (CMP) which could further diverge into Megakaryocyte/Erythrocyte Progenitors (MEPs), Monocyte (Mo)/Dendritic cell (DC) Progenitors (MDPs) and Granulocyte/Mo Progenitors (GMPs). However, this model has been the subject of ongoing revision in the scRNA-seq era. On the one hand, a Lymphoid-primed MultiPotent Progenitor (LMPP) with combined lymphoid and myeloid potential has been shown to gradually lose myeloid potential by upregulating the interleukin-7 receptor alpha-chain (IL7Ralpha) and differentiate into Dach1- Lymphoid-Primed Progenitors (LPPs) prior to CLPs. On the other hand, erythroid-versus-myeloid fate decisions seem to be made prior to CMP commitment, calling for in-depth revision of all CMP progeny (MEPs, MDPs and GMPs) as well. While the Flt3L+CD115lo CMPs give rise to oligopotent MDPs, the ##Flt3-CD115- CMPs## give rise to GMPs. The former are defined by TF co-expression of CEBPA, IRF8 and RUNX1. MDPs can give rise to IRF8/SATB1 plasmacytoid DC (pDC) Progenitors (pDCPs) and HLA-DR/IRF8/CEBPA Mo/conventional DC (cDC) Progenitors (McDPs). The latter bifurcate in CD11c/CD172ab/CD14 (human) or Ly6C+ Mo (mouse) or IRF8/HLA-DR/CD84/CD172ab Common DC Progenitors (CDPs). In contrast, GMPs (Kit, CD34, Sox4) are very heterogeneous at the transcriptomic and proteomic level and can adjust their functional output towards common Mo Progenitors (cMoP) and Granulocyte Progenitors (GPs).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11324509</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:39148724</oboInOwl:hasDbXref>
        <rdfs:label>Flt3-CD115- CMPs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000049"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/702406ed-55ee-4ddc-8691-5ce4134ca8e9"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000049"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/7045eae6-85cc-40fd-bf3b-6405fde56a63 -->

    <Class rdf:about="http://example.org/7045eae6-85cc-40fd-bf3b-6405fde56a63">
        <obo:IAO_0000115>We find that building an extensive callus of a unique type of hybrid osteochondral skeletal cell is essential for successfully bridging large gaps in adult mammalian rib bone. During this process, Hh signaling plays a critical role, distinct from that in the developing growth plate, in promoting the ultimate differentiation of these ##hybrid osteochondral skeletal cells##. Further, we provide genetic evidence that Hh signaling acts upon a rare periosteal subpopulation of Sox9-expressing cells, that behave as messenger cells. These Sox9+ periosteal cells then stimulate, through a yet to be determined signal, their neighboring non-Sox9-lineage cells, which constitute a majority of the callus, to differentiate and build new callus and bone (summarized in Figure 6).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6464605</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:30983567</oboInOwl:hasDbXref>
        <rdfs:label>hybrid osteochondral skeletal cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000062"/>
        <skos:relatedMatch rdf:resource="CL:0000138"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/7045eae6-85cc-40fd-bf3b-6405fde56a63"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000062"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/7045eae6-85cc-40fd-bf3b-6405fde56a63"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000138"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/708e4dd4-50c0-4069-bb5c-26d90f96310a -->

    <Class rdf:about="http://example.org/708e4dd4-50c0-4069-bb5c-26d90f96310a">
        <obo:IAO_0000115>Initially, intratumor heterogeneity was investigated when biopsy specimens were taken from spatially separated areas of a single tumor. The transition to a new level in studies of intratumor heterogeneity, including highly heterogeneous glioblastoma, became possible with the development of single-cell approaches with dramatically increased resolution. Single-cell RNA sequencing (scRNA-seq) has become a key method for comprehensively analyzing cellular states in tissues, both in normal conditions and during pathological processes. It was shown by scRNA-seq that a single glioblastoma tumor consisted of a heterogeneous mixture of cells representing a wide variety of subgroups. Malignant glioblastoma cells from different patients have been found to exist in four reproducible cell states, namely neural progenitor like (NPC-like), oligodendrocyte progenitor like (OPC-like), astrocyte like (AC-like), and ##mesenchymal## like (MES-like). Moreover, intratumor heterogeneity includes non-malignant cells in the tumor microenvironment, such as neuronal, glial, and immune populations, as well as endothelial cells, which can functionally interact with cancer cells and promote tumor development.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11313325</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:39126040</oboInOwl:hasDbXref>
        <rdfs:label>mesenchymal</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0008019"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/708e4dd4-50c0-4069-bb5c-26d90f96310a"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0008019"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/70829dc2-4931-4bc4-969d-d1053413e9b3 -->

    <Class rdf:about="http://example.org/70829dc2-4931-4bc4-969d-d1053413e9b3">
        <obo:IAO_0000115>Proper development of the placenta, the transient support organ forms after embryo implantation, is essential for a successful pregnancy. However, the regulation of trophoblast invasion, which is most important during placentation, remains largely unknown. Here, rats, mice, and pigs are used as biomedical models, used scRNA-seq to comparatively elucidate the regulatory mechanism of placental trophoblast invasion, and verified it using a human preeclampsia disease model combined with scStereo-seq. A dual-featured type of ##immune-featured trophoblast## (iTrophoblast) is unexpectedly discovered. Interestingly, iTrophoblast only exists in invasive placentas and regulates trophoblast invasion during placentation. In a normally developing placenta, iTrophoblast gradually transforms from an immature state into a functional mature state as it develops. Whereas in the developmentally abnormal preeclamptic placenta, disordered iTrophoblast transformation leads to the accumulation of immature iTrophoblasts, thereby disrupting trophoblast invasion and ultimately leading to the progression of preeclampsia.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11558115</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:39234818</oboInOwl:hasDbXref>
        <rdfs:label>immune-featured trophoblast</rdfs:label>
    </Class>
    


    <!-- http://example.org/709d6075-0d55-4a85-9338-6174d413375d -->

    <Class rdf:about="http://example.org/709d6075-0d55-4a85-9338-6174d413375d">
        <obo:IAO_0000115>It has been well-documented that total CD4+CD45RA+ naive T cells are reduced, and total CD4+CD45RO+ memory T cells are spared following alemtuzumab treatment. Our data show similar changes in total memory (supplementary Figure S3A) and total naive CD4+ T cells (Figure S3B). Figure S3 also illustrates changes over time in subsets of naive and memory CD4+ T cells, defined as described by Lovett-Racke and colleagues. Briefly, lymphocytes were identified in FSC/SSC plots, followed by gating on CD4+CD45RA+ or CD45RA- cells to identify CD27+ and CD27- lymphocytes (FACS gating strategy not illustrated). Figure S3 shows that the percentage of CD4+CD45RA+CD27+ naive T cells (Figure S3C) was reduced at M5 and M17, while CD4+CD45RA-CD27+ central memory T cells (TCM; Figure S3D) remained relatively stable over time. The percentage of CD4+CD45RA-CD27- effector memory T cells (TEM; Figure S3E) increased at M5, along with CD4+CD45RA+ new effector T cells (##new Teff##; Figure S3F).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7296935</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32539719</oboInOwl:hasDbXref>
        <rdfs:label>new Teff</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0001044"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/709d6075-0d55-4a85-9338-6174d413375d"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0001044"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/710cfc2c-40af-4bf6-be39-fdd12efb500a -->

    <Class rdf:about="http://example.org/710cfc2c-40af-4bf6-be39-fdd12efb500a">
        <obo:IAO_0000115>MP cells, in particular macrophages, have a key role in tissue repair. Many studies have shown that inflammatory monocytes can be converted in situ into cells exhibiting a reparative phenotype. Our findings show that following corneal chemical injury, Ly6Cint restorative MP (CD11Bhi F4/80int) are mostly highly expressed on day 3 post-injury. Differentiation of corneal MPs based on surface markers is not trivial, and although many studies have considered that all CD11b+ F4/80+ represent macrophages, recent studies have suggested that CD64 surface marker can help differentiate ##corneal macrophages## from monocytes. Our subsequent analysis of the Ly6C expression gating for CD11b+ F4/80int CD11c- CD64+ recruited macrophages showed a similar frequency pattern with a gradual shift in frequency from Ly6Chigh to Ly6Cint on day 3 and Ly6Cneg on day 6.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8910730</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35269717</oboInOwl:hasDbXref>
        <rdfs:label>corneal macrophages</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/710cfc2c-40af-4bf6-be39-fdd12efb500a"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/7117d980-456e-42ba-a1a8-3cd707c6900e -->

    <Class rdf:about="http://example.org/7117d980-456e-42ba-a1a8-3cd707c6900e">
        <obo:IAO_0000115>It has been well-documented that total CD4+CD45RA+ naive T cells are reduced, and total CD4+CD45RO+ memory T cells are spared following alemtuzumab treatment. Our data show similar changes in total memory (supplementary Figure S3A) and total naive CD4+ T cells (Figure S3B). Figure S3 also illustrates changes over time in subsets of naive and memory CD4+ T cells, defined as described by Lovett-Racke and colleagues. Briefly, lymphocytes were identified in FSC/SSC plots, followed by gating on CD4+CD45RA+ or CD45RA- cells to identify ##CD27+ and CD27- lymphocytes## (FACS gating strategy not illustrated). Figure S3 shows that the percentage of CD4+CD45RA+CD27+ naive T cells (Figure S3C) was reduced at M5 and M17, while CD4+CD45RA-CD27+ central memory T cells (TCM; Figure S3D) remained relatively stable over time. The percentage of CD4+CD45RA-CD27- effector memory T cells (TEM; Figure S3E) increased at M5, along with CD4+CD45RA+ new effector T cells (new Teff; Figure S3F).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7296935</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32539719</oboInOwl:hasDbXref>
        <rdfs:label>CD27+ and CD27- lymphocytes</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000542"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/7117d980-456e-42ba-a1a8-3cd707c6900e"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000542"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/715dbfcb-c66b-4e2c-a010-c5a954bcc273 -->

    <Class rdf:about="http://example.org/715dbfcb-c66b-4e2c-a010-c5a954bcc273">
        <obo:IAO_0000115>Proportion of ##Zscan4+ cells## at various timepoints during the time-lapse experiment. Shown are the mean +- s.d. of three independent experiments.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6944916</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31849178</oboInOwl:hasDbXref>
        <rdfs:label>Zscan4+ cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002322"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/715dbfcb-c66b-4e2c-a010-c5a954bcc273"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002322"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/716582f1-9b89-4d3a-94e7-0538c8869316 -->

    <Class rdf:about="http://example.org/716582f1-9b89-4d3a-94e7-0538c8869316">
        <obo:IAO_0000115>In the setting of severe versus mild disease, a higher proportion of endometrial CD44+ classical monocytes, ##CX3CR1+ and CD91+ non-classical monocytes##, and dendritic cells were observed, as well as lower levels of CD91+ macrophages (Fig. 6A). Notably, and as shown above, CD91+ macrophages and CD44+ monocytes appear to have different dynamics throughout the cycle in controls and endometriosis patients, as well as different proportions between the two groups, suggesting that they may be key components for the pathophysiology of the disease.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9011995</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35421980</oboInOwl:hasDbXref>
        <rdfs:label>CX3CR1+ and CD91+ non-classical monocytes</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000875"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/716582f1-9b89-4d3a-94e7-0538c8869316"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000875"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/7169ee91-0923-4272-96c9-c1a463c3664e -->

    <Class rdf:about="http://example.org/7169ee91-0923-4272-96c9-c1a463c3664e">
        <obo:IAO_0000115>Downstream of the multipotent HSCs and MPPs, the original lineage bifurcation model strictly separated oligopotent Common Lymphoid Progenitors (CLP) from Common Myeloid Progenitors (CMP) which could further diverge into Megakaryocyte/Erythrocyte Progenitors (MEPs), Monocyte (Mo)/Dendritic cell (DC) Progenitors (MDPs) and Granulocyte/Mo Progenitors (GMPs). However, this model has been the subject of ongoing revision in the scRNA-seq era. On the one hand, a Lymphoid-primed MultiPotent Progenitor (LMPP) with combined lymphoid and myeloid potential has been shown to gradually lose myeloid potential by upregulating the interleukin-7 receptor alpha-chain (IL7Ralpha) and differentiate into Dach1- Lymphoid-Primed Progenitors (LPPs) prior to CLPs. On the other hand, erythroid-versus-myeloid fate decisions seem to be made prior to CMP commitment, calling for in-depth revision of all CMP progeny (MEPs, MDPs and GMPs) as well. While the Flt3L+CD115lo CMPs give rise to oligopotent MDPs, the Flt3-CD115- CMPs give rise to GMPs. The former are defined by TF co-expression of CEBPA, IRF8 and RUNX1. MDPs can give rise to ##IRF8/SATB1 plasmacytoid DC (pDC) Progenitors## (pDCPs) and HLA-DR/IRF8/CEBPA Mo/conventional DC (cDC) Progenitors (McDPs). The latter bifurcate in CD11c/CD172ab/CD14 (human) or Ly6C+ Mo (mouse) or IRF8/HLA-DR/CD84/CD172ab Common DC Progenitors (CDPs). In contrast, GMPs (Kit, CD34, Sox4) are very heterogeneous at the transcriptomic and proteomic level and can adjust their functional output towards common Mo Progenitors (cMoP) and Granulocyte Progenitors (GPs).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11324509</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:39148724</oboInOwl:hasDbXref>
        <rdfs:label>IRF8/SATB1 plasmacytoid DC (pDC) Progenitors</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002009"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/7169ee91-0923-4272-96c9-c1a463c3664e"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002009"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/718a553b-2b66-4aae-a8aa-1ca09ad015fb -->

    <Class rdf:about="http://example.org/718a553b-2b66-4aae-a8aa-1ca09ad015fb">
        <obo:IAO_0000115>B cells can be further divided into B1 B-cells of the innate immune system and &quot;conventional&quot; B2 B-cells of the adaptive immune system. This division is well-established in mice, where sIgM+CD11b+CD5+ B1a B-cells were first identified through the search for, the still elusive, cell of origin of adult human CLL. B1b B-cells (sIgM+CD11b+CD5-) were subsequently described; both these subtypes are seen predominantly in serous cavities. Further characterization of splenic B1 cells have identified them to be CD5+/-CD19hiCD1dmidCD23-CD43+IgMhiIgDlo. Murine ##B1 B-cell progenitors## are found in the yolk sac prior to the emergence of the first definitive HSCs in the FL, which have both B1 and B2 B-cell output. The B-cell output skews toward B2 B-cells over ontogeny, with B1 B-cell output being exceedingly rare in ABM.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7928347</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33679795</oboInOwl:hasDbXref>
        <rdfs:label>B1 B-cell progenitors</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000819"/>
        <skos:relatedMatch rdf:resource="CL:0011026"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/718a553b-2b66-4aae-a8aa-1ca09ad015fb"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000819"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/718a553b-2b66-4aae-a8aa-1ca09ad015fb"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0011026"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/72a36b8f-a75c-4a93-9f58-b6b91eaf76eb -->

    <Class rdf:about="http://example.org/72a36b8f-a75c-4a93-9f58-b6b91eaf76eb">
        <obo:IAO_0000115>Brain-derived neurotrophic factor (BDNF) and neurotrophin 3 (NT-3) are known to regulate neuronal morphology and the formation of neural circuits, yet the neuronal targets of each neurotrophin are still to be defined. To address how these neurotrophins regulate the morphological and synaptic differentiation of developing olfactory bulb (OB) GABAergic interneurons, we analyzed the effect of BDNF and NT-3 on GABA+-neurons and on different subtypes of these neurons: tyrosine hydroxylase (TH+); calretinin (Calr+); calbindin (##Calb+##); and parvalbumin (PVA+). These cells were generated from cultured embryonic mouse olfactory bulb neural stem cells (eOBNSCs) and after 14 days in vitro (DIV), when the neurons expressed TrkB and/or TrkC receptors, BDNF and NT-3 did not significantly change the number of neurons. However, long-term BDNF treatment did produce a longer total dendrite length and/or more dendritic branches in all the interneuron populations studied, except for PVA+-neurons. Similarly, BDNF caused an increase in the cell body perimeter in all the interneuron populations analyzed, except for PVA+-neurons. GABA+- and TH+-neurons were also studied at 21 DIV, when BDNF produced significantly longer neurites with no clear change in their number. Notably, these neurons developed synaptophysin+ boutons at 21 DIV, the size of which augmented significantly following exposure to either BDNF or NT-3. Our results show that in conditions that maintain neuronal survival, BDNF but not NT-3 promotes the morphological differentiation of developing OB interneurons in a cell-type-specific manner. In addition, our findings suggest that BDNF and NT-3 may promote synapse maturation by enhancing the size of synaptic boutons.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMID:33392918</oboInOwl:hasDbXref>
        <rdfs:label>Calb+</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:4033029"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/72a36b8f-a75c-4a93-9f58-b6b91eaf76eb"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4033029"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/72d7dc23-a7d1-4af8-b334-2c5735ef70d1 -->

    <Class rdf:about="http://example.org/72d7dc23-a7d1-4af8-b334-2c5735ef70d1">
        <obo:IAO_0000115>Variable Name Data used   TN Naive T-cells Combination of CD4 naive and memory resting T-cells and resting NK cells   Th Helper T-cells Combination of memory activated CD4 T-cells and follicular helper T-cells   TC Cytotoxic cells Combination of CD8 T-cells and activated NK cells   Tr Regulatory T-cells Regulatory T-cells   DN Naive dendritic cells Naive dendritic cells   ##D## Activated dendritic cells Activated dendritic cells   MN Naive Macrophages Combination of Macrophages M0 and Monocytes   M Macrophages Combination of M1 and M2 Macrophages   C Cancer cells Estimated   N Necrotic cells Estimated   A Cancer Associated Adipocytes Assumed to be twice of the total number of immune cells   H HMGB1 HMGB1 gene expression   IL12 IL-12 IL12A and IL12B gene expressions   IL10 IL-10 IL10, IL10RA and IL10RB gene expressions   IL6 IL-6 IL6, IL6ST and IL6RA gene expressions   </obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8959189</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35294447</oboInOwl:hasDbXref>
        <rdfs:label>D</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000451"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/72d7dc23-a7d1-4af8-b334-2c5735ef70d1"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000451"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/72ee89b3-7bcf-40fc-a260-757de27ec360 -->

    <Class rdf:about="http://example.org/72ee89b3-7bcf-40fc-a260-757de27ec360">
        <obo:IAO_0000115>First, oligodendrocytes provide metabolites, such as lactate and glucose, to neurons to maintain ion gradients during axonal action potential firing. In this respect, ##vOLs## are well positioned to directly import glucose from endothelial cells and respond rapidly to increased metabolite demand without an intermediate transfer from astrocytes. Such a metabolic coupling could be particularly relevant in learning conditions in which increased energy demand is revealed by functional hypoxia.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10069068</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37013659</oboInOwl:hasDbXref>
        <rdfs:label>vOLs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000128"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/72ee89b3-7bcf-40fc-a260-757de27ec360"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000128"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/72f61bba-fab1-4f50-a85e-6c41246aed2b -->

    <Class rdf:about="http://example.org/72f61bba-fab1-4f50-a85e-6c41246aed2b">
        <obo:IAO_0000115>a Schematic of the experimental pipeline. Created with BioRender.com b UMAP visualization of peritoneal immune cells. c Ratio of each population in cell number. d VlnPlot of characteristic gene expressions for macrophage subpopulations. Sham sham control, ELL endometriosis-like lesions, ELL_N niclosamide administration to ELL-induced mouse, ##Pre-SPMs## premature &quot;small&quot; peritoneal macrophages, SPMs &quot;small&quot; peritoneal macrophages, IM1-3 intermediate macrophages subtype 1-3, Timd4+ LPMs Timd4+ &quot;large&quot; peritoneal macrophages, PMs proliferating macrophages, B1a B1a cells, B1b B1b cells, B2 B2 cells, GCBs germinal-centre B cells, PBs plasma blast B cells, Cd4+ Ts Cd4+ T cells, Cd8+ Ts Cd8+ T cells, DN1 double negative T cells 1, DN2 double negative T cells 2, cDC1 conventional dendritic cells 1, MCs Mast cells, NTPs neutrophils.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9652344</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36369244</oboInOwl:hasDbXref>
        <rdfs:label>Pre-SPMs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000581"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/72f61bba-fab1-4f50-a85e-6c41246aed2b"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000581"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/72187146-c660-497d-812d-e8110115a742 -->

    <Class rdf:about="http://example.org/72187146-c660-497d-812d-e8110115a742">
        <obo:IAO_0000115>Single-cell RNA sequencing reveals PDFGRalpha+ stromal cell subpopulations that promote ##proacinar cell## differentiation in embryonic salivary gland organoids.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8977102</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35224622</oboInOwl:hasDbXref>
        <rdfs:label>proacinar cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000622"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/72187146-c660-497d-812d-e8110115a742"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000622"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/72412bab-74da-4c82-912c-3be5d7fe664c -->

    <Class rdf:about="http://example.org/72412bab-74da-4c82-912c-3be5d7fe664c">
        <obo:IAO_0000115>While the heterogeneity of CD103+ TRMs is widely discussed in the literature, the characteristics of ##TRM## subpopulations within the tumor or distant tissues of tumor-bearing mice are less well defined. To characterize tumoral TRMs, scRNA-seq technology provides unprecedented analytical power and allows us to dissect cells with thousands of dimensions. With the hypothesis that particular intratumoral T cells are precursors for TRM development, we extended our scRNA-seq approach to include various effector and memory T cell populations to comprehensively depict their transcriptomic program. From the tumor and distant mucosa of mice bearing established 4T1 tumors, we flow sorted distinct memory T cell populations using a strict gating strategy (Figure S3). We constructed single-cell cDNA libraries from paired intratumoral sorted TCR-beta+CD44+CD62L-CD69+CD103+ cells (TRMs), mucosal sorted TCR-beta+CD44+ CD69+CD103+ cells (distant mucosa TRMs), intratumoral TCR-beta+CD44+CD62L+CD69-CD103- cells (TCMs), and TCR-beta+CD44+CD62L-CD69-CD103- cells (TEMs) (Table S2). After data processing and normalization, we performed unbiased clustering and visualized the CD8+ clusters using t-distributed stochastic neighbor embedding (t-SNE; Figure 2A). Through this unsupervised analysis, we found that all four samples could distinctly separate into multiple clusters, confirming continued heterogeneity among the single-cell subsets.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8204287</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33979626</oboInOwl:hasDbXref>
        <rdfs:label>TRM</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000909"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/72412bab-74da-4c82-912c-3be5d7fe664c"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000909"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/725e4d0b-4434-4e4e-8ee4-bfbd75996a4e -->

    <Class rdf:about="http://example.org/725e4d0b-4434-4e4e-8ee4-bfbd75996a4e">
        <obo:IAO_0000115>BST-1hi TPECs Function as the Exit Site for Mature Thymocytes, While ##BST-1lo/- TPECs## Serve as the Entry Sites for HPCs</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8281811</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34276703</oboInOwl:hasDbXref>
        <rdfs:label>BST-1lo/- TPECs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0009070"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/725e4d0b-4434-4e4e-8ee4-bfbd75996a4e"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0009070"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/73a5254c-99a6-4187-8cfa-fdde538f4092 -->

    <Class rdf:about="http://example.org/73a5254c-99a6-4187-8cfa-fdde538f4092">
        <obo:IAO_0000115>Gene-Set Significant Cell Types from Zeisel That Are Common between Mouse MIA and Human GWAS Significant Cell Types from Saunders That Are Common between Mouse MIA and Human GWAS   Individual Study DEGs mPFC -Excitatory Neurons (Hindbrain)[SCZ, ASD, EA] No cell types   AM -Inhibitory D1 &amp; D2 Medium Spiny Neurons (Striatum) [EA] -Inhibitory direct/indirect Spiny Projection Neurons (Striatum) [SCZ, EA, IQ]   Meta-analysisDEGs Upregulated -Excitatory Neurons, Pyramidal Cells (Cerebral Cortex) [SCZ, IQ] -##Excitatory Neurons, Deep-layer Pyramidal cells## (Frontal Cortex)[SCZ, IQ]-Excitatory Neurons (Posterior Cortex) [SCZ, IQ]-Excitatory Neurons, Entorhinal Cortex Cells (Hippocampus)[SCZ, IQ]-Excitatory Neurons, CA1 Principal Cells (Hippocampus)[IQ]   </obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8471627</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34573345</oboInOwl:hasDbXref>
        <rdfs:label>Excitatory Neurons, Deep-layer Pyramidal cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000598"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/73a5254c-99a6-4187-8cfa-fdde538f4092"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000598"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/73b33fba-8bb4-4688-9127-f16fb6f7345f -->

    <Class rdf:about="http://example.org/73b33fba-8bb4-4688-9127-f16fb6f7345f">
        <obo:IAO_0000115>In the mouse placenta, there are two lineages of trophoblast cells, the invasive and structural cells, which arise from the trophoblast stem progenitor cells. Trophoblast giant cells are the invasive cells responsible for invading the maternal vasculature and transforming the spiral arteries into high-velocity, low-resistant vessels. Four sub-types of trophoblast giant cells exist, including spiral artery trophoblast giant cells and parietal trophoblast giant cells, which reside in the decidual layer. The ##canal trophoblast giant cells## and sinusoidal trophoblast giant cells are in the labyrinth. The structural cells of the placenta include those located within the junctional zone and the remaining cells of the labyrinth. The spongiotrophoblast and glycogen trophoblast cells are within the junctional zone. The spongiotrophoblast cells are thought to contribute a supportive role to the developing labyrinth and feed into the trophoblast giant cell progenitor pool, while glycogen cells, which arise from the spongiotrophoblast cells, are thought to accumulate glycogen and can migrate into the maternal decidua for spiral artery remodeling. The two different types of syncytiotrophoblast cells, syncytiotrophoblast-I and syncytiotrophoblast-II, are located within the labyrinth zone. These cells function in the material exchange between the mother and fetus and, along with the sinusoidal trophoblast giant cells, make up the interhemal membrane. However, the specific functions of some of these cells are not well understood.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10459728</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37630754</oboInOwl:hasDbXref>
        <rdfs:label>canal trophoblast giant cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002488"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/73b33fba-8bb4-4688-9127-f16fb6f7345f"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002488"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/73be2476-07ed-4f9f-9794-30a49fb6b3fe -->

    <Class rdf:about="http://example.org/73be2476-07ed-4f9f-9794-30a49fb6b3fe">
        <obo:IAO_0000115>Development of the trophoblastic shell and formation of placental anchoring villi. a Structure of the human trophoblastic shell and its surrounding arterial vessels. b Depiction of a placental anchoring villus, spiral artery (SA) remodelling and interaction of extravillous trophoblasts (EVTs) with different decidual cell types. ##dCCT## distal cell column trophoblast, dMPhi decidual macrophage, DSC decidual stromal cell, eCTB endovascular cytotrophoblast, GC giant cell, iCTB interstitial cytotrophoblast, pCCT proximal cell column trophoblast, pEC placental endothelial cell, pMPhi placental macrophage, pSC placental stromal/mesenchymal cell, SM smooth muscle layer, STB syncytiotrophoblast, TBS trophoblastic shell, TP trophoblast plug, TV tertiary villi, UC umbilical cord, uNK uterine NK cell, vCTB villous cytotrophoblast, YO yolk sac</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6697717</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31049600</oboInOwl:hasDbXref>
        <rdfs:label>dCCT</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000351"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/73be2476-07ed-4f9f-9794-30a49fb6b3fe"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000351"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/73d7c839-3290-4313-8d60-ceca74e4d44a -->

    <Class rdf:about="http://example.org/73d7c839-3290-4313-8d60-ceca74e4d44a">
        <obo:IAO_0000115>Acute leukemia is characterized by a rapid expansion of hematopoietic precursors (blast cells), which remain partially differentiated and proliferate in the bone marrow and peripheral blood as the disease progresses. Two of the most common types of pediatric acute leukemias are acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML). ALL is the most prevalent type of cancer in children (80% of leukemias and 25% of childhood cancers), and 10-15% of these cases represent T-cell ALL (##T-ALL##). T-ALL arises from T-lymphoblasts in the thymus as a result of an accumulation of mutations in immature thymocytes, altering inter alia cell proliferation and differentiation. The lymphoblasts leave the thymus and access the circulation, from where other organs such as the bone marrow or central nervous system are invaded. AML constitutes about 20% of all childhood leukemias and is caused by abnormal myeloblasts (immature leukocytes of the myeloid lineage). Cancerous myeloblasts have the ability of constant proliferation and avoidance of cell death, leading to an expansion in the myeloblast population and to a disturbed hematopoiesis.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8423305</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34492077</oboInOwl:hasDbXref>
        <rdfs:label>T-ALL</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000084"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/73d7c839-3290-4313-8d60-ceca74e4d44a"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000084"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/73dc113d-c311-4313-bf25-ac95507a751b -->

    <Class rdf:about="http://example.org/73dc113d-c311-4313-bf25-ac95507a751b">
        <obo:IAO_0000115>In order for the sensitization we observed in excitatory interneurons to drive the psychophysical phenomenon of allodynia, ##spinal projection neurons## must relay these nociceptive signals supraspinally. We found that capsaicin treatment shifted the overall tuning of SPB neurons towards LT input, consistent with the effects of central sensitization producing allodynia (Fig. 8a, b). Because SPB neurons are heterogeneous with respect to their response properties, we classified them as either wide-dynamic range (WDR), high threshold (HT), or low threshold (LT) (Fig. 8c) using previously published criteria. We found that both HT and WDR SPB showed significant increases in tuning to LT input, however the degree of change was much greater for WDR compared to HT SPB neurons (Fig. 8d). Finally, examining CICADA responses across populations, we found that WDR cells were more frequently responsive to CICADA agonists (71.4%), compared to either LT (40%) or HT (0%) SPB neurons. In particular, all SP-responsive SPB neurons were WDR cells (Fig. 8e). Since capsaicin is known to activate peptidergic afferents that release SP, these findings suggest that capsaicin-induced allodynia may be conveyed to the brain through a population of TACR1 expressing WDR SPB neurons and, to a lesser extent, some HT SPB neurons (Fig. 8f).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9440908</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36057681</oboInOwl:hasDbXref>
        <rdfs:label>spinal projection neurons</rdfs:label>
    </Class>
    


    <!-- http://example.org/73224809-f516-4d55-8fb9-0d2ac8aa43bf -->

    <Class rdf:about="http://example.org/73224809-f516-4d55-8fb9-0d2ac8aa43bf">
        <obo:IAO_0000115>A UMAP depicting the del(5q) density across the different hematopoietic progenitors obtained in three patients after lenalidomide treatment. HSC hematopoietic stem cells, LMPP lymphoid-primed multipotent progenitors, GMP granulocyte-monocyte progenitors; ##granulocyte progenitors##; monocyte progenitors; dendritic cell progenitors, CLP common lymphoid progenitors; B-cell progenitors; T-cell progenitors, MEP megakaryocyte-erythroid progenitors, MK_Prog megakaryocyte progenitors; early erythroid progenitors; late erythroid progenitors; basophil progenitors. B Barplots showing the number of del(5q) and non-del(5q) cells composing each cell type for each MDS patient. C Percentage of the cells identified as del(5q) by karyotype, CASPER, CopyKat, and the selection by intersecting the two algorithms. D Heatmap representing the enrichment of del(5q) cells (log10(p-value)) in each cell type. Any color different from white represents a statistically significant enrichment of del(5q) cells (p-value &lt; 0.05). P-values were calculated using the one-sided hypergeometric test. The number of biologically independent replicates (cells) used for the hypergeometric test and the exact enrichment p-values can be found in the Source Data.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11189937</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38902243</oboInOwl:hasDbXref>
        <rdfs:label>granulocyte progenitors</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000557"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/73224809-f516-4d55-8fb9-0d2ac8aa43bf"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000557"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/734e9ba0-b3e5-4f82-b146-d5e8458978f6 -->

    <Class rdf:about="http://example.org/734e9ba0-b3e5-4f82-b146-d5e8458978f6">
        <obo:IAO_0000115>Prophylactic application of GEM + lysate delayed tumorigenesis compared to lysate monotherapy and CPX-pre-treatment (median time of onset: 53 vs. 47 vs. 48 weeks). 33% of mice even remained tumor-free until the experimental endpoint (= 65 weeks). This was accompanied by long-term effect on cytokine plasma levels; ##splenic myeloid derived suppressor cells## (MDSC) as well as regulatory T cell numbers. Assessment of tumor microenvironment from GEM + lysate treated mice revealed low numbers of MDSCs, but enhanced T cell infiltration, in some cases co-expressing PD-L1. Therapeutic chemo-immunotherapy (GEM + lysate) had minor impact on overall survival (median time: 12 (GEM + lysate) vs. 11.5 (lysate) vs. 3 weeks (control)), but induced complete remission in one case. Dendritic and T cell infiltrates increased in both treatment groups. Reactive T cells specifically recognized MLH1-/- tumor cells in IFNgamma ELISpot, but lacked response towards NK cell targets YAC-1.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6329128</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:30630527</oboInOwl:hasDbXref>
        <rdfs:label>splenic myeloid derived suppressor cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000889"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/734e9ba0-b3e5-4f82-b146-d5e8458978f6"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000889"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/735c70b7-befe-4f72-a0ae-8de094204d09 -->

    <Class rdf:about="http://example.org/735c70b7-befe-4f72-a0ae-8de094204d09">
        <obo:IAO_0000115>(A-C) Representative responses to cholinergic agonist (carbachol, 10 muM) by small (L-cells) (A), D-stellate (B), tuberculoventral (TV) cells (C). Small cells were activated by carbachol. D-stellate and TV cells failed to respond to carbachol application. IPSCs in principal cells, bushy cells (D), and ##T-stellate cells## (E) in the VCN were induced by carbachol application, confirming that small inhibitory neurons were local interneurons. (F, H) Time course of sIPSCs from bushy cells and T-stellate (bushy cell, tau = 7.22 +- 1.40 ms, n = 9, T-stellate, tau = 2.28 +- 0.07 ms, n = 9). (G, I) Cumulative histogram of inter-event internal under control and carbachol application. (J). Carbachol application resulted in a significant increase in sIPSCs frequency (inter-event interval, control = 280.44 +- 47.56 ms versus carbachol = 191.21 +- 28.99 ms, p&lt;0.02, t-test).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7744103</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33141020</oboInOwl:hasDbXref>
        <rdfs:label>T-stellate cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000122"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/735c70b7-befe-4f72-a0ae-8de094204d09"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000122"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/7471191f-fe68-4f71-b215-081f39df7246 -->

    <Class rdf:about="http://example.org/7471191f-fe68-4f71-b215-081f39df7246">
        <obo:IAO_0000115>BP, Biological Processes; CC, Cellular Components; CI, Confidence Interval; DEGs, Differentially Expressed Genes; EFS, Event-free Survival; GEO, Gene Expression Omnibus; GEP, Gene Expression Profiling; GO, Gene Ontology; HEV, High Endothelial Venules; HIER, Heat-Induced Antigen Retrieval; HR, Hazards Ratio; ICB, Immune Checkpoint Blockade; IQR, Interquartile Range; KEGG, Kyoto Encyclopedia of Genes and Genomes; LA, Lymphoid Aggregates; LDH, Lactate Dehydrogenase; LLOQ, Lower Limit of Quantification; LT, Lymphotoxin; MDSC, Myeloid-Derived Suppressor Cells; MF, Molecular Functions; NSCLC, Non-small Cell Lung Cancer; OS, Overall Survival; OSCC, Oral Squamous Cell Carcinoma; SKCM, Skin Cutaneous Melanoma; TCGA, The Cancer Genomic Atlas; TIL, ##Tumor Infiltrating Lymphocytes##; TME, Tumor Microenvironment; TLS-kines, TLS-associated chemokines/cytokines; TLS, Tertiary Lymphoid Structures; mIF, Multispectral Immunofluorescence.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10332263</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37435077</oboInOwl:hasDbXref>
        <rdfs:label>Tumor Infiltrating Lymphocytes</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000542"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/7471191f-fe68-4f71-b215-081f39df7246"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000542"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/75c82347-4acc-47df-b5d0-bb697ee82a02 -->

    <Class rdf:about="http://example.org/75c82347-4acc-47df-b5d0-bb697ee82a02">
        <obo:IAO_0000115>Lymphocytes such as CD4+ T cells and B cells mainly infiltrate the salivary glands; however, the precise roles and targets of autoreactive T cells and autoantibodies in the pathogenesis of Sjogren&apos;s Syndrome (SS) remain unclear. This study was designed to clarify the role of autoreactive T cells and autoantibodies at the single-cell level involved in the development of sialadenitis. Infiltrated CD4+ T and B cells in the salivary glands of a mouse model resembling SS were single-cell-sorted, and their T cell receptor (TCR) and B cell receptor (BCR) sequences were analyzed. The predominant TCR and BCR clonotypes were reconstituted in vitro, and their pathogenicity was evaluated by transferring reconstituted TCR-expressing CD4+ T cells into Rag2-/- mice and administering recombinant IgG in vivo. The reconstitution of Th17 cells expressing TCR (#G) in Rag2-/- mice resulted in the infiltration of ##T cells## into the salivary glands and development of sialadenitis, while an autoantibody (IgGr22) was observed to promote the proliferation of pathogenic T cells. IgGr22 specifically recognizes double-stranded RNA (dsRNA) and induces the activation of dendritic cells, thereby enhancing the expression of IFN signature and inflammatory genes. TCR#G recognizes antigens related to the gut microbiota. Antibiotic treatment severely reduces the activation of TCR#G-expressing Th17 cells and suppresses sialadenitis development. These data suggest that the anti-dsRNA antibodies and, TCR recognizing the gut microbiota involved in the development of sialadenitis like SS. Thus, our model provides a novel strategy for defining the roles of autoreactive TCR and autoantibodies in the development and pathogenesis of SS.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMID:38762063</oboInOwl:hasDbXref>
        <rdfs:label>T cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000084"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/75c82347-4acc-47df-b5d0-bb697ee82a02"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000084"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/75179812-ad83-4ce8-9740-19a7cef2bb7b -->

    <Class rdf:about="http://example.org/75179812-ad83-4ce8-9740-19a7cef2bb7b">
        <obo:IAO_0000115>The cellular content of human myocardium (in descending order by number) predominantly consists of cardiomyocytes, fibroblasts, pericytes and smooth muscle cells, endothelial cells, and immune cells. In the murine heart, macrophage populations can be discerned based on their expression of C-C chemokine receptor type 2 (CCR2), major histocompatibility complex-II (MHC-II), T cell immunoglobulin and mucin domain containing 4 (TIMD4), and Lymphatic Vessel Endothelial Hyaluronan Receptor 1 (LYVE1). Four populations of macrophages have been identified in the murine heart (Fig. 1). The minority are two subsets of ##CCR2+MHC-IIhigh macrophage## populations derived from hematopoietic stem cells, whereas the most dominant subset, cardiac resident macrophages derived from the yolk sac, are CCR2-MHC-IIlowTIMD4+LYVE1-. There also exists a fourth subset that consists of CCR2-MHC-IIhighTIMD4+LYVE1+ macrophages, which are likely derived from CCR2-MHC-IIlow macrophages during postnatal development and partially maintained by CCR2+MHC-IIhigh macrophages. CCR2+MHC-IIhigh macrophages populate the heart soon after birth and are maintained through monocyte recruitment and proliferation. Also, under homeostasis, cardiac macrophages continually self-renew with a turnover period of almost 5 weeks. Recently, this same CCR2+ and CCR2- macrophage distinction has been identified in humans, with the yolk sac-derived CCR2- human counterpart showing CD14+CD45+CD64+CCR2-HLA-DRhigh expression. In a more recent study, Tucker et al. reported two cardiac macrophage subsets within the human heart, which were positive for CD163, COLEC12, mannose receptor MRC1, E3 ubiquitin ligase MARCH1, and natural resistance-associated macrophage protein 1 (NRAMP1). Both of the identified subsets expressed anti-inflammatory (M2) polarization-associated genes, whereas one subset particularly expressed RBPJ, F13A1 and the other expressed transmembrane collagen COL23A1.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9242717</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34088222</oboInOwl:hasDbXref>
        <rdfs:label>CCR2+MHC-IIhigh macrophage</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/75179812-ad83-4ce8-9740-19a7cef2bb7b"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/752330e4-92c2-4254-83ce-98d3fd5a982c -->

    <Class rdf:about="http://example.org/752330e4-92c2-4254-83ce-98d3fd5a982c">
        <obo:IAO_0000115>The unwounded, normal corneal stroma is a relatively simple, avascular tissue populated with quiescent keratocytes, along with corneal nerves and a few resident dendritic and monocyte/macrophage cells. In the past, the resting keratocytes were thought of as a homogenous cellular population, but recent work has shown local variations in vimentin and nestin expression, and responsiveness to transforming growth factor (TGF)-beta1. Studies have also supported there being &quot;stromal stem cells&quot; in localized areas. After corneal wounding, depending on the site and severity of injury, profound changes in stromal cellularity occur. Anterior or posterior injuries to the epithelium or endothelium, respectively, trigger apoptosis of adjacent keratocytes. Many ##contiguous keratocytes## transition to keratocan-negative corneal fibroblasts that are proliferative and produce limited amounts of disorganized extracellular matrix components. Simultaneously, large numbers of bone marrow-derived cells, including monocytes, neutrophils, fibrocytes and lymphocytes, invade the stroma from the limbal blood vessels. Ongoing adequate levels of TGFbeta1, TGFbeta2 and platelet-derived growth factor (PDGF) from epithelium, tears, endothelium and aqueous humor that penetrate defective or absent epithelial barrier function (EBF) and epithelial basement membrane (EBM) and/or Descemet&apos;s basement membrane (DBM) drive corneal fibroblasts and fibrocytes to differentiate into alpha-smooth muscle actin (SMA)-positive myofibroblasts. If the EBF, EBM and/or DBM are repaired or replaced in a timely manner, typically measured in weeks, then corneal fibroblast and fibrocyte progeny, deprived of requisite levels of TGFbeta1 and TGFbeta2, undergo apoptosis or revert to their precursor cell-types. If the EBF, EBM and/or DBM are not repaired or replaced, stromal levels of TGFbeta1 and TGFbeta2 remain elevated, and mature myofibroblasts are generated from corneal fibroblasts and fibrocyte precursors that produce prodigious amounts of disordered extracellular matrix materials associated with scarring fibrosis. This fibrotic stromal matrix persists, at least until the EBF, EBM and/or DBM are regenerated or replaced, and keratocytes remove and reorganize the affected stromal matrix.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7855915</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33068626</oboInOwl:hasDbXref>
        <rdfs:label>contiguous keratocytes</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002363"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/752330e4-92c2-4254-83ce-98d3fd5a982c"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002363"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/755f7b27-fd06-4ccc-82cc-d1e9ecf4950d -->

    <Class rdf:about="http://example.org/755f7b27-fd06-4ccc-82cc-d1e9ecf4950d">
        <obo:IAO_0000115>A key result of our study is the presence of Cplx 2 and the most likely absence of Cplx 1 in conventional chemical synapses of normal and displaced amacrine cells (Figure 2, Figure 6, Figure 8 and Figure 10). Cplx 2 (protein and mRNA) was found in GABAergic, cholinergic and dopaminergic amacrine cells but not in glycinergic amacrine cells (Figure 6 and Figure 10), which contain Cplx 3. The glutamatergic vGluT3 amacrine cells also contained no Cplx 2 (Figure 7 and Figure 10). VGluT3 amacrine cells represent an unconventional type of amacrine cell with dual release of glycine and glutamate at segregated synaptic sites. It is suggested that the release of an inhibitory and an excitatory neurotransmitter into two separate neuronal circuits by the vGluT3 amacrine cells facilitates differential detection of visual field uniformity and contrast. As Cplx 3 is found in glycinergic amacrine cells and glutamatergic rod bipolar cells, we analyzed its presence in vGluT3 amacrine cells. We could not detect Cplx 3 in these ##retinal interneurons##, just as we could not detect Cplx 4 in vGluT3 amacrine cells (Figure 7). The absence of Cplxs 1 to 4 from vGluT3 amacrine cells suggests a Cplx-independent release of neurotransmitters. Likewise, for the auditory sensory cells of the cochlea, the inner hair cells, it has been suggested that they release glutamate at their ribbon synapses independent of neuronal SNARE proteins and SNARE regulators, such as Cplxs and synaptotagmins.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8348166</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34360929</oboInOwl:hasDbXref>
        <rdfs:label>retinal interneurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000099"/>
        <skos:relatedMatch rdf:resource="CL:0000748"/>
        <skos:relatedMatch rdf:resource="CL:0009004"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/755f7b27-fd06-4ccc-82cc-d1e9ecf4950d"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000099"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/755f7b27-fd06-4ccc-82cc-d1e9ecf4950d"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000748"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/755f7b27-fd06-4ccc-82cc-d1e9ecf4950d"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0009004"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/7552308a-e3e7-4309-b912-ef3b708d811b -->

    <Class rdf:about="http://example.org/7552308a-e3e7-4309-b912-ef3b708d811b">
        <obo:IAO_0000115>Besides these omental cell types, tumour-associated macrophages (TAM) clearly are instrumental in metastasis, in particular the CD163+Tim4+ subset, which promotes the stemness, invasive properties and epithelial to mesenchymal transition (EMT) of tumour cells by paracrine mechanisms. While omentectomy or depletion of ##CD163+Tim4+ cells## prevented metastatic dissemination in a mouse model of ovarian cancer, depletion of monocyte-derived TAM had little impact, emphasising the role of resident omental macrophages. In keeping with these findings, TAM from HGSC patients show a high degree of phenotypic, ontogenetic and tumour-promoting heterogeneity, reflected, for example, by the differential expression of CD163 and cytokines associated with tumour progression. </obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8574964</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34841720</oboInOwl:hasDbXref>
        <rdfs:label>CD163+Tim4+ cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/7552308a-e3e7-4309-b912-ef3b708d811b"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/756de302-63b4-4523-80f9-cb7f065a45e9 -->

    <Class rdf:about="http://example.org/756de302-63b4-4523-80f9-cb7f065a45e9">
        <obo:IAO_0000115>In all tumor tissues, TAMs replaced resident populations such as lung alveolar macrophages, prostate CTRB1+ macrophages, and renal GPX3+ macrophages (Supplementary Fig. 1a, b, and Supplementary Table 1). Plasmacytoid dendritic cells (pDCs) were marginally elevated in lung, colon, and pancreatic cancers, whereas conventional DCs were drastically reduced in colorectal cancer (Supplementary Fig. 1c). T cells exhibited diverse gene expression profiles including naive-like, activated, follicular helper, and regulatory CD4+ T cells, in addition to ##cytokine-rich, highly cytotoxic, and exhausted CD8+ effector T cells## (Supplementary Fig. 1d-f, and Supplementary Table 1). Compared to normal tissues, CD4+ regulatory and follicular helper T cells were commonly elevated, whereas overall cytotoxic immune cell clusters (CD8 Cytotoxic, NK Cytotoxic, and Innate Lymphoid) were reduced (Supplementary Fig. 1g). In contrast, CD8+ T cell states were differentially regulated in each tumor type. The degree of mixing among four datasets in embeddings of CD45+ cells, Myeloid, and T/NK cells was evaluated by LISI metric. Integration of the four datasets was performed appropriately to assign cell identity covering tissue-specific cell types such as lung alveolar macrophages (Supplementary Fig. 1h).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11014989</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38424167</oboInOwl:hasDbXref>
        <rdfs:label>cytokine-rich, highly cytotoxic, and exhausted CD8+ effector T cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0001050"/>
        <skos:relatedMatch rdf:resource="CL:0011025"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/756de302-63b4-4523-80f9-cb7f065a45e9"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0001050"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/756de302-63b4-4523-80f9-cb7f065a45e9"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0011025"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/757496b0-a0bb-4726-84f4-e1d9b70748a3 -->

    <Class rdf:about="http://example.org/757496b0-a0bb-4726-84f4-e1d9b70748a3">
        <obo:IAO_0000115>We then examined the dynamism of expression patterns of genes involving VLC during retinal development. ELOVL2 and ELOVL4 are elongases involved in VLC-PUFA-CoA biosynthesis. Elovl4 mRNA levels have been shown to increase during retinal development, especially in the photoreceptor inner segments. Using our previous RNA sequencing data (GSE71462, GSE71464), we found that Elovl2 and Elovl4 were upregulated in ##CD73-positive rod photoreceptors## as early as at P2, which corresponds to the rod photorecetpor birth period (Fig. 4A). During late retinal development, which corresponds to the rod photoreceptor maturation period, although Elovl4 expression levels kept high in CD73-positive cells, Elovl2 expression in CD73-positive cells gradually decreased and became similar to the level of the CD73-negative fraction (Fig. 4A). Although ELOVL5 was also shown to catalyze the elongation of long-chain fatty acids, Elovl5 mRNA levels were higher in nonphotoreceptor cells than in rod photoreceptors (Fig. 4A). Consistently, no mutations in Elovl5 were observed in patients with autosomal recessive retinitis pigmentosa. Nrl is the Maf-family leucine zipper transcription factor, and in the Nrl knockout (Nrl-KO) retina, photoreceptor precursors fated to cells with characteristics of short-wavelength cones. The expression profiling database of flow-sorted rods from Nrlp-GFP mouse retina and GFP-positive S-cone-like cells from NRlp-GFP;Nrl-KO mouse can be used to compare gene expression patterns between rod and S-cone (GSE74660, GFE74657). We confirmed that rod photoreceptor kept high Elovl4 expression pattern after P14, which was in contrast to the low expression level of Elovl2 (Fig. 4B). Of interest, Nrl-KO mice-derived retina showed higher expression levels of Elovl2 and Elovl5, but Elovl4 was lower than Nrl-GFP rod (Fig. 4B), suggesting differential expression patterns of these genes between rod and cone.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7949107</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33465374</oboInOwl:hasDbXref>
        <rdfs:label>CD73-positive rod photoreceptors</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000604"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/757496b0-a0bb-4726-84f4-e1d9b70748a3"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000604"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/7594b3dc-5497-4789-b7d3-4cd8e5768e31 -->

    <Class rdf:about="http://example.org/7594b3dc-5497-4789-b7d3-4cd8e5768e31">
        <obo:IAO_0000115>APC and their role as ##secondary effector cells##</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10230044</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37266446</oboInOwl:hasDbXref>
        <rdfs:label>secondary effector cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0001044"/>
        <skos:relatedMatch rdf:resource="CL:0001050"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/7594b3dc-5497-4789-b7d3-4cd8e5768e31"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0001044"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/7594b3dc-5497-4789-b7d3-4cd8e5768e31"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0001050"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/76a12c0a-f284-4c9e-b921-2f15707c0d6b -->

    <Class rdf:about="http://example.org/76a12c0a-f284-4c9e-b921-2f15707c0d6b">
        <obo:IAO_0000115>In vivo fate and in vitro adipogenic differentiation capacity of ##Dpp4+ or Icam1+ progenitors##.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9192766</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35697700</oboInOwl:hasDbXref>
        <rdfs:label>Dpp4+ or Icam1+ progenitors</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0009099"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/76a12c0a-f284-4c9e-b921-2f15707c0d6b"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0009099"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/76df3f92-4e8d-4cec-90db-c1adb3ef3be8 -->

    <Class rdf:about="http://example.org/76df3f92-4e8d-4cec-90db-c1adb3ef3be8">
        <obo:IAO_0000115>To gain a comprehensive view of immune interactions, we performed correlation analyses between the frequency of Ki67+ Tregs and the frequencies of all identified immune cell subpopulations. We did not observe significant association of the frequency of Ki67+ Tregs with lymphocytic subsets (Supplementary Fig. 8). On the other hand, myeloid cells, particularly dendritic cells (DCs), are known to facilitate Treg generation. Therefore, we analyzed the correlation between the frequency of Ki67+ Tregs and that of myeloid cell subsets (including ##cMo##, iMo, ncMo, and DC). The frequency of Ki67+ Tregs was positively associated with the frequencies of HLA-DR+ and CD86+ monocytes and dendritic cells (Supplementary Fig. 9), suggesting their potential roles in the generation of Ki67+ Treg cells via antigen presentation and CD28-dependent signaling. Interestingly, we found that the frequency of Ki67+ Tregs was also positively associated with the frequencies of PD-L1+ monocytes and dendritic cells (Supplementary Fig. 9), which is consistent with previous reports that DCs could induce Treg cells via PD-L1. These results indicate that myeloid cells might play a crucial role in Treg generation.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11496634</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:39438442</oboInOwl:hasDbXref>
        <rdfs:label>cMo</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000576"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/76df3f92-4e8d-4cec-90db-c1adb3ef3be8"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000576"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/76f6292a-a9a7-468f-ad28-d54aaa947da7 -->

    <Class rdf:about="http://example.org/76f6292a-a9a7-468f-ad28-d54aaa947da7">
        <obo:IAO_0000115>Tonsillar CD4+ T cell subsets can be divided into three major groups. Most intrafollicular T cells belong to the follicular B helper T cell group (follicular Th [TFH], CD4+PD1+CXCR5+BCL6high). B cell and TFH interactions are crucial for the formation of the humoral immune response and support B cell somatic hypermutation and Ab class switching. Other tonsillar CD4+ T cell subsets include non-TFH (CD4+PD1-CXCR5-BCL6low) and ##pre-TFH## (CD4+PD1+CXCR5-BCL6mid). Pre-TFH cells develop from activated Ag-specific CD4+ T cells. The transcriptional program that is initiated in pre-TFH cells can induce CXCR5 expression, enabling the cells to migrate toward the B cell follicle.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8278278</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34099545</oboInOwl:hasDbXref>
        <rdfs:label>pre-TFH</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002038"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/76f6292a-a9a7-468f-ad28-d54aaa947da7"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002038"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/766d0a12-35d9-489d-9ab2-7f3912206b93 -->

    <Class rdf:about="http://example.org/766d0a12-35d9-489d-9ab2-7f3912206b93">
        <obo:IAO_0000115>##mFbs## resemble fibroblastic reticular cells (FRCs) that form conduit-like network in secondary lymphoid organs, and they have also been known as thymic FRCs. Transcriptome analyses on mFbs and LN FRCs revealed possible functional differences between these two morphologically similar cell types. LN FRCs are subdivided into several types based on their expression of functional genes, including chemokines and cytokines: T-cell zone reticular cell (TRC) expressing Ccl19, Ccl21a, and Il7; follicular dendritic cell (FDC) expressing Cxcl13; marginal reticular cell (MRC) expressing Tnfsf11 (RANKL); Cxcl12-expressing reticular cell (CRC); and medullary reticular cell (medRC) expressing Cxcl12, Il6, Tnfsf13, and Tnfsf13b. Most of these FRC-associated genes are not or just barely expressed in mFbs. In the thymus, RANKL is predominantly expressed in SP thymocytes to induce mTEC development, and Ccl19, Ccl21, Cxcl12, and IL-7 are produced by TECs so as to control the relocation and survival of thymocytes. It is likely that the role played by FRCs in the LN is replaced by TECs in the thymus. mFbs highly express other sets of chemokines as well, such as Cx3cl1 and Cxcl14, that are barely expressed in LN FRCs or capFbs, possibly contributing to the regulation of cell migration in the thymic medulla. Thus, mFbs comprise a thymus-specific subset of fibroblasts that is functionally distinct from LN FRCs. It is possible that mFbs also consist of multiple subsets with different functions. A population of CD34+podoplanin+ mFbs are detected in adventitial layers that surround pericytes and endothelial cells, thus referred to as adventitial cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7840694</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33519827</oboInOwl:hasDbXref>
        <rdfs:label>mFbs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0009106"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/766d0a12-35d9-489d-9ab2-7f3912206b93"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0009106"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/7672e4d9-b51b-452c-bd1a-9c64a445518d -->

    <Class rdf:about="http://example.org/7672e4d9-b51b-452c-bd1a-9c64a445518d">
        <obo:IAO_0000115>##Tissue-resident lymphocytes## (TRLs) are noncirculating lymphocytes found in nonlymphoid tissues, including the kidneys. Under physiological conditions, TRLs are key players in local immune surveillance, as evidenced by their rapid and strong response against invading pathogens. However, the characteristics of TRLs and their potential to provide antimicrobial protection in transplanted kidneys have not been fully established.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10721264</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37751288</oboInOwl:hasDbXref>
        <rdfs:label>Tissue-resident lymphocytes</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000542"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/7672e4d9-b51b-452c-bd1a-9c64a445518d"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000542"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/77bd09b7-cd0a-4fcf-885a-42e8abbadac4 -->

    <Class rdf:about="http://example.org/77bd09b7-cd0a-4fcf-885a-42e8abbadac4">
        <obo:IAO_0000115>Adenoid cystic carcinoma (ACC) is one of the most common malignancy of the major salivary glands with a high recurrence rate and poor prognosis. Determining tumor heterogeneity and factors in the microenvironment may provide novel therapeutic targets for ACC. We performed single-cell RNA sequencing of one ACC sample and normal salivary gland tissues from a patient to analyze tumor heterogeneity, immunosuppressive landscape, and intercellular communication networks. The heterogeneity of epithelial cells in ACC tissues was significantly higher compared with that in normal tissues, whereas immune cells were almost absent. We found four malignant cell clusters in ACC and explored their characteristics and function. In tumor tissues, CD8 + cytotoxic T cells and CD4 + T helper cells were significantly decreased, whereas IgA + plasma cells were absent. There were two clusters of macrophages, one representing ##IL1B macrophages## and the other consisted of a cluster of macrophages associated with the epithelial mesenchymal transition (EMT). Both were significantly different from the normal tissue composition. In addition, the communication between epithelial cells and other cells in the tumor tissue was enhanced. MIF-CD74 and APP-CD74 were significantly upregulated. We comprehensively described the heterogeneity of ACC and the tumor microenvironment (TME) from a single cell perspective including cell characteristics, immune cell infiltration, and cell communication. CLINICAL RELEVANCE: This study provided further insights into ACC and may lead to new treatment strategies.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMID:37162576</oboInOwl:hasDbXref>
        <rdfs:label>IL1B macrophages</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/77bd09b7-cd0a-4fcf-885a-42e8abbadac4"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/77d8bca4-582f-40f3-9bc2-cf09add054ba -->

    <Class rdf:about="http://example.org/77d8bca4-582f-40f3-9bc2-cf09add054ba">
        <obo:IAO_0000115>Known signalling mechanisms that contribute to mammalian digit tip regeneration. Indicated are the signalling mechanisms that originate from the nail organ (1), from the wound epidermis (2), within the blastema (3) and from nerves (4). During distal digit tip amputation the wound site is covered by regenerating nail epithelial cells that arise from the ##nail stem cells## (NSCs). This epithelium activates Wnt signalling that promotes differentiation of NSCs that give rise to the nail plate. Additionally, through epithelial-mesenchymal (EM) interactions, this Wnt signalling promotes blastema innervation, which in turn enables FGF2 expression in the nail epithelium and promotes blastema cell proliferation. Blastema cell migration is stimulated by the cytokine SDF-1alpha that is expressed by the wound epidermis while the reciprocal receptors CXCR4/7 are detected on blastema cells, together with BMPs and the anti-angiogenic factor Pedf. Schwann cell precursors that arise from injured peripheral nerves migrate into the blastema and secrete growth factors including oncostatin M (OSM) and platelet derived growth factor AA (PDGFAA) that promote blastema proliferation. Nerves are shown in blue; the wound epidermis is indicated in green; the blastema is indicated by the red-hatched line; the nail epithelium is indicated in blue and the nail plate is coloured grey.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7536070</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32993414</oboInOwl:hasDbXref>
        <rdfs:label>nail stem cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000034"/>
        <skos:relatedMatch rdf:resource="CL:4033056"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/77d8bca4-582f-40f3-9bc2-cf09add054ba"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000034"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/77d8bca4-582f-40f3-9bc2-cf09add054ba"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4033056"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/771b64aa-f0f7-4101-bff8-8391a6de1bdc -->

    <Class rdf:about="http://example.org/771b64aa-f0f7-4101-bff8-8391a6de1bdc">
        <obo:IAO_0000115>Immunosuppressive role of tumour-associated macrophages (TAMs). TAMs promote immunosuppression by different mechanisms: TAMs can express programmed cell death ligand 1 and ligand 2 (PD-L1 and PD-L2), which bind the T cell inhibitory receptor programmed cell death protein 1 (PD-1), thereby inducing T cell exhaustion. TAM expression of V-domain Ig suppressor of T cell activation (VISTA) and B7 family molecules, such as B7-H4, can have similar function. TAMs secrete immunosuppressive cytokines such as IL-10 and TGFbeta, which can have direct suppressive functions on CD8+ T cells, or they can induce recruitment of immunosuppressive CD4+ T regulatory (Treg) cells. TAM secreted IL-10 can impair T cells effector functions indirectly either by inhibit dendritic cell (DC) anti-tumorigenic role or by inducing DC expression of PD-L1. Moreover, amino acid metabolism in TAM results in production of arginase and immunosuppressive metabolites via the indoleamine 2,3-dioxygenase (IDO) pathway, which is responsible of metabolic starvation in T cells. TAMs can also indirectly induce immunosuppression by promoting fibrosis. Indeed ##cancer associated fibroblast## (CAF) secreted factors and/or extracellular matrix (ECM) stiffness are responsible for CD8+ T cell immunosuppression and/or exclusion from the tumour nest.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6678757</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31331034</oboInOwl:hasDbXref>
        <rdfs:label>cancer associated fibroblast</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000057"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/771b64aa-f0f7-4101-bff8-8391a6de1bdc"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000057"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/771c0d52-0a91-4782-b8bc-7d26160636ca -->

    <Class rdf:about="http://example.org/771c0d52-0a91-4782-b8bc-7d26160636ca">
        <obo:IAO_0000115>Expression heterogeneity of CD8+ and CD4+ T cells in the OSCC ecosystem. (A) The t-distributed stochastic neighbor embedding (t-SNE) projection of T cells from cancerous tissue of patients with OSCC, showing the formation of 11 main clusters in different colors. The functional description of each cluster is determined by the gene expression characteristics. Cluster 0: resident memory CD8+ T Cells (C0_CD8+ TRM); Cluster 1: effector memory CD8+ T cells (C1_CD8+ TEM); Cluster 2: regulatory CD4+ T cells (C2_CD4+ Treg); Cluster 3: exhausted CD8+ T cells (C3_CD8+ T Exhausted); Cluster 4: effector memory M-phage CD8+ T cells (C4_CD8+ Mitotic TEM); Cluster 5: ##effector memory CD4+ T cells## (C5_CD4+ TEM); Cluster 6: effector memory CD8+ T cells (C6_CD8+ TEM); Cluster 7: effector memory CD4+ T cells (C7_CD4+ TEM); Cluster 8: effector memory CD8+ T cells (C8_CD8+ TEM); Cluster 9: effector memory CD8+ T cells (C9_CD8+ TEM); Cluster 10: effector memory M-phage CD4+ T cells (C10_CD4+ Mitotic TEM); Cluster 11: effector memory CD8+ T cells (C11_CD8+ TEM); Cluster 12: effector memory CD8+ T cells (C12_CD8+ TEM); Cluster 13: gammadelta T. (B) Cell-Cycle Scoring of T cells from cancerous tissue of patients with OSCC, showing the three clusters of cells in different cell cycles in different colors. (C) Heatmap of key genes expressed in each cluster of CD8+ tumor-infiltrating lymphocytes (TILs) with cells grouped by clusters. The columns correspond to the cells; the rows correspond to the genes. Yellow: high expression; purple: low expression. Selected key markers are shown on the right. (D) Heatmap of key genes expressed in each cluster of CD4+ TILs with cells grouped by clusters. The columns correspond to the cells; the rows correspond to the genes. Yellow: high expression; purple: low expression. Selected key genes are shown on the right.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8024729</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33513276</oboInOwl:hasDbXref>
        <rdfs:label>effector memory CD4+ T cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000905"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/771c0d52-0a91-4782-b8bc-7d26160636ca"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000905"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/771cf9a3-1326-46e0-8952-a5ceb80c1e7f -->

    <Class rdf:about="http://example.org/771cf9a3-1326-46e0-8952-a5ceb80c1e7f">
        <obo:IAO_0000115>Next, we merged the datasets for the five time-points using the merge function of the Seurat pipeline, which combines multiple datasets without transforming the data. The merged dataset with a total of 62,202 cells was processed for clustering and then the data were visualized as a UMAP plot (Fig. 3). The same set of cell clusters identified in individual time-point data was also identified in the merged dataset (Fig. 3A,E and Fig. S6). The downregulation of PAX2 and upregulation of FBXO2 from ##otic prosensory cells## to intermediate otic cells and supporting cells were confirmed with this analysis (Fig. 3E). A DACH1+ SPP1+ population was detected adjacent to OC90+ intermediate otic cells (Fig. 3D, Figs S7 and S8), suggesting the existence of another lineage direction in the otic lineage other than the sensory epithelium. TFAP2B+ surface ectoderm cells, NEUROD1+ neuroblasts and S100B+ neural crest/Schwann cells were identified as distinctive clusters (Fig. 3A,D and Fig. S7). An intermediate population between otic prosensory cells and supporting cells expressed not only otic epithelium markers EPCAM and FBXO2, but also other otic progenitor markers COL9A1, SERPINF1, HES1, AATF, COL14A1, OC90, PRSS8 and EYA4 (Fig. S7), suggesting that this is an otic epithelial cell population differentiating into hair cells and supporting cells. Adjacent to the supporting cell cluster, there was a POU4F3+ hair cell cluster that expressed vestibular hair cell markers [CD164L2, ZBBX, TEKT1, SKOR1, TCTEX1D1 (DYNLT5) and NEUROD6] and type II hair cell markers (ANXA4, MAPT and NHLH1) (Fig. 3D and Fig. S8), indicative of an immature type II hair cell identity. However, we were unable to detect the cochlear marker GATA3 or INSM1 in PCP4+ hair cells (Fig. S8G,H). Surprisingly, we were unable to identify common progenitor populations that differentiate into both hair cells and supporting cells in the merged datasets.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10323240</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37381908</oboInOwl:hasDbXref>
        <rdfs:label>otic prosensory cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000048"/>
        <skos:relatedMatch rdf:resource="CL:0000202"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/771cf9a3-1326-46e0-8952-a5ceb80c1e7f"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000048"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/771cf9a3-1326-46e0-8952-a5ceb80c1e7f"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000202"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/7756c7c3-c675-4920-8f22-7f18146db79a -->

    <Class rdf:about="http://example.org/7756c7c3-c675-4920-8f22-7f18146db79a">
        <obo:IAO_0000115>a, Uniform manifold approximation and projections (UMAPs) of cell states in the scRNA-seq dataset. b-e, Dotplots showing the expression of cell state marker genes in (b) myeloid cells, (c) T/NK/IL cells, (d) B/plasma cells, and (e) stromal cells. f-j, cNMF was used to derive GEP scores for individual cells from inflamed samples with RA in (f) T/NK/IL, (g) B, (h) plasma, (i) myeloid, and (j) stromal cells. Mean expression of GEP quantified per cell state. k, Baseline visit samples in the R4RA study were selected for analysis; GEPs positively correlated with inflammation were tested for association with therapy nonresponse. Boxplots show median, first (lower hinge) and third (upper hinge) quartiles; whiskers show 1.5x interquartile range. Wilcoxon signed-rank test used to test for significance (Padj &lt; 0.05, two-sided) between responders (29 patients) and non-responders (39 patients) to rituximab at baseline (also see Supplementary Table 9). l, GO term enrichment for GEPs associated with clinical response to rituximab. GO terms were generated by GOATOOLS overrepresentation analysis of the top 150 weighted genes in constituent GEPs. All genes tested were used as the gene universe. See Supplementary Table 9 for full list of cNMF GEPs in RA and associated GO term enrichment in GEPs. DC, dendritic cell; fibro, fibroblast; GC, germinal centre; hi, high; IFN-resp, interferon-responsive; ILC, innate lymphoid cell; lo, low; macro, macrophage; MAIT, mucosal-associated invariant T; MNP, mononuclear phagocyte; mono, monocyte; MThi, Mitochondrial-high; NK, natural killer cell; pDC, plasmacytoid dendritic cell; Tfh, CD4+ follicular helper T cell; ##Tph##, CD4+ peripheral helper T cell; Treg, CD4+ regulatory T cell.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11519010</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:39438660</oboInOwl:hasDbXref>
        <rdfs:label>Tph</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000492"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/7756c7c3-c675-4920-8f22-7f18146db79a"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000492"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/77986c0b-e68b-4511-af15-e36282a5eaa6 -->

    <Class rdf:about="http://example.org/77986c0b-e68b-4511-af15-e36282a5eaa6">
        <obo:IAO_0000115>Adenoid cystic carcinoma (ACC) is one of the most common malignancy of the major salivary glands with a high recurrence rate and poor prognosis. Determining tumor heterogeneity and factors in the microenvironment may provide novel therapeutic targets for ACC. We performed single-cell RNA sequencing of one ACC sample and normal salivary gland tissues from a patient to analyze tumor heterogeneity, immunosuppressive landscape, and intercellular communication networks. The heterogeneity of epithelial cells in ACC tissues was significantly higher compared with that in normal tissues, whereas immune cells were almost absent. We found four malignant cell clusters in ACC and explored their characteristics and function. In tumor tissues, CD8 + cytotoxic T cells and CD4 + T helper cells were significantly decreased, whereas IgA + plasma cells were absent. There were two clusters of macrophages, one representing IL1B macrophages and the other consisted of a cluster of ##macrophages## associated with the epithelial mesenchymal transition (EMT). Both were significantly different from the normal tissue composition. In addition, the communication between epithelial cells and other cells in the tumor tissue was enhanced. MIF-CD74 and APP-CD74 were significantly upregulated. We comprehensively described the heterogeneity of ACC and the tumor microenvironment (TME) from a single cell perspective including cell characteristics, immune cell infiltration, and cell communication. CLINICAL RELEVANCE: This study provided further insights into ACC and may lead to new treatment strategies.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMID:37162576</oboInOwl:hasDbXref>
        <rdfs:label>macrophages</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/77986c0b-e68b-4511-af15-e36282a5eaa6"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/78a2a475-5b24-46bc-86bb-0ca36604b890 -->

    <Class rdf:about="http://example.org/78a2a475-5b24-46bc-86bb-0ca36604b890">
        <obo:IAO_0000115>We observe that the sickle sample and normal sample morphological parameters histograms are mostly overlapped; however, a nontrivial number of the sickle cells in the distribution exhibit nearly no phenotypic similarities to healthy cells. This unique subset of sickle cells can be extracted from the distribution through implementing a 21:1 SCD-to-normal ratio thresholding criterion. As described above, this means that each criterion is defined by the region in the histogram where the population of SCD cells have 21x greater incidence of that chosen parameter than the normal cell population. The extraction of morphological parameters that uniquely identify ##sickling cells## is a necessary step to constructing a meaningful, pure SCD ground truth set. Without thresholding, the large overlap between the morphological parameters of sickle and normal cells sample will confound the discrimination capacity of a classification algorithm. Furthermore, through refining the training set, we have narrowed down the focus of the classification algorithm to specifically differentiate SCD cells from healthy cells and greatly increase accuracy. The near ideal ROC curves (Figure 2B and Figure 3B) for LR and CNN algorithms when trained on the refined data, indicates that the algorithm practically predicted no false positives and would excel at identifying critically sickled cells. Overall, we have developed a group of metrics that can delineate critically sickling cells in a heterogeneous SCD sample.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10419148</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37569260</oboInOwl:hasDbXref>
        <rdfs:label>sickling cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000232"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/78a2a475-5b24-46bc-86bb-0ca36604b890"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000232"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/7815e69e-aa88-4bf6-9d9b-dde747253cbf -->

    <Class rdf:about="http://example.org/7815e69e-aa88-4bf6-9d9b-dde747253cbf">
        <obo:IAO_0000115>The human retina shows a high degree of topographic heterogeneity. The central 6 mm of the human retina is referred to as the macula, which is clinically recognizable as the area between the superotemporal and inferotemporal vascular arcades. The macula may be broadly divided into four concentric zones with unique anatomic and physiologic features. The central most region of the macula is called the foveola, which is ~250-300 mum in diameter and consists exclusively of medium and long wavelength cone photoreceptor cells and Muller glia. Bipolar cells and retinal ganglion cells (RGCs) are radially displaced away from the foveola, creating a pit of tightly packed cone photoreceptor cells and Muller cell processes. Extending beyond the foveola is the fovea, which is ~1.85 mm in diameter and corresponds to the central 5.5  of the visual field. The fovea contains all ##inner retinal cell## types, and rod and cone photoreceptor cells reach approximately equal densities within this region. The parafovea is ~3 mm in diameter and contains an abundance of RGCs bodies that were displaced from the foveola and fovea. Finally, the perifovea is ~6 mm in diameter. The perifovea contains a decreasing density of RGCs and more abundant rod photoreceptor cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8330894</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34014299</oboInOwl:hasDbXref>
        <rdfs:label>inner retinal cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0009004"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/7815e69e-aa88-4bf6-9d9b-dde747253cbf"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0009004"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/7832bf51-bccf-4a25-b89f-a6fc61a91db7 -->

    <Class rdf:about="http://example.org/7832bf51-bccf-4a25-b89f-a6fc61a91db7">
        <obo:IAO_0000115>Meiosis initiation is a crucial step for the production of haploid gametes, which occurs from anterior to posterior in fetal ovaries. The asynchrony of the transition from mitosis to meiosis results in heterogeneity in the female germ cell populations, which limits the studies of meiosis initiation and progression at a higher resolution level. To dissect the process of meiosis initiation, we investigated the transcriptional profiles of 19 363 single germ cells collected from E12.5, E14.5, and E16.5 mouse fetal ovaries. Clustering analysis identified seven groups and defined dozens of corresponding transcription factors, providing a global view of cellular differentiation from primordial germ cells toward meiocytes. Furthermore, we explored the dynamics of gene expression within the developmental trajectory with special focus on the critical state of meiosis. We found that meiosis initiation occurs as early as E12.5 and the cluster of oogonia_4 is the critical state between mitosis and meiosis. Our data provide key insights into the transcriptome features of ##peri-meiotic female germ cells##, which offers new information not only on meiosis initiation and progression but also on screening pathogenic mutations in meiosis-associated diseases.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMID:32716582</oboInOwl:hasDbXref>
        <rdfs:label>peri-meiotic female germ cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000021"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/7832bf51-bccf-4a25-b89f-a6fc61a91db7"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000021"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/784acafd-4a8c-48b0-91a4-79e39f00daa7 -->

    <Class rdf:about="http://example.org/784acafd-4a8c-48b0-91a4-79e39f00daa7">
        <obo:IAO_0000115>Collectively, the expression patterns of these representative marker genes (Figure S1c) in our scRNA-seq data led us to define cluster 11 as EC1 (portal venous ECs), cluster 9 as EC2 (zone1, periportal LSECs), cluster 0, 1, 2, 4, 5, 6, 10, 12 as EC3 (zone 2, ##midzonal LSECs##), cluster 3, 7as EC4 (zone 3, pericentral LSECs), and cluster 8 as EC5 (central venous ECs), corresponding to liver zonation (Figure S1a).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11241719</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:39000126</oboInOwl:hasDbXref>
        <rdfs:label>midzonal LSECs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:1000398"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/784acafd-4a8c-48b0-91a4-79e39f00daa7"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:1000398"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/78488529-8147-483f-bdcc-c63d6153a299 -->

    <Class rdf:about="http://example.org/78488529-8147-483f-bdcc-c63d6153a299">
        <obo:IAO_0000115>Recent findings have demonstrated a synergic crosstalk between SHH/GLI and PI3K/Akt/mTORC1 signaling in ##glioblastoma progression cells## in vitro and in tumors in mice, but it is not known if this also occurs in human gliomas. We then aimed to investigate the expression of key proteins of these pathways in different human gliomas. The expression of PTEN, phospho-Akt (Ser473), phospho-S6K1 (Thr389), SHH, GLI1, GLI2 and GLI3 was assessed by immunohistochemistry in gliomas and in control brain tissues. The pattern of expression of each protein was established according to glioma type, glioma grade and to cell type; the relative expression of each protein was used to perform statistical analyses. We found that the expression of proteins of both signaling pathways differs between normal brain and glioma tissues. For instance, normal astrocytes had a different protein expression pattern compared with reactive and tumoral astrocytes. Interestingly, we detected a recurrent pattern of expression of GLI3 in oligodendrocytes and of phospho-S6K1 in mitotic neoplastic cells. We also identified differences of cell signaling according to glioma type: oligodendrogliomas and ependymomas are related with the expression of SHH/GLI proteins. Finally, we detected that high grade gliomas statistically correlate with the expression of GLI1 and GLI2, and that GLI1, GLI2, phospho-Akt and phospho-S6K1 are more expressed in patients with less survival, suggesting that activation of these cell signaling influences glioma outcome and patient survival. In summary, our results show that proteins of PI3K/Akt/mTORC1 and SHH/GLI pathways are differentially expressed in human gliomas according to tumor type and grade, and suggest that the activation of these signaling networks is associated with glioma progression.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMID:34371011</oboInOwl:hasDbXref>
        <rdfs:label>glioblastoma progression cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:4047002"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/78488529-8147-483f-bdcc-c63d6153a299"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4047002"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/785b61aa-77df-4acd-a639-0ea046c07ddc -->

    <Class rdf:about="http://example.org/785b61aa-77df-4acd-a639-0ea046c07ddc">
        <obo:IAO_0000115>A, B, tSNE plot of 4659 CD45+ immune cells from the CNS. Data from this study is integrated with data from; Table 6). C, D, Each dataset represented by one tSNE. Cells are annotated using color representing their cell type. bMicroglia: baseline microglia; aMicroglia: activated microglia; pmMicroglia: ##proliferation-mediating microglia##; maMicroglia: monocyte-activating microglia; DAM: disease-associated microglia in SCI; elMicroglia: embryonic-like microglia; pvMacrophages: perivascular macrophages; mdMacrophages: monocyte-derived macrophages; DCs: dendritic cells; imB-cells: immature B-cells; mB-cells: mature B-cells; pimMicroglia: postnatal immature microglia; IEG+Microglia: immediate early genes microglia; sMicroglia: s-phase microglia; pPAM: postnatal proliferative-region-associated microglia; eMicroglia: embryonic microglia; pcpMacrophages: postnatal choroid plexus macrophages; acpMacrophages: adult choroid plexus macrophages; iMonocytes: inflammatory monocytes; pMonocytes: patrolling monocytes; cpEpithelial cells: choroid plexus epithelial cells. E, tSNE plots of 4659 CD45+ immune cells for selected genes indicating the log2(cpm) expression with a continuous color for each cell separately. F, Proliferation rate of CD45low and CD45high cells at 7 and 21 d post-SCI. Hoechst 33342 expression presented on a log-scale was used for defining cells in S-phase. Right most plot reports the percentage of cells in S-phase. Each dot represents one biological replicate (four mice per time point). Mean is surrounded by a 95% CI. This figure is extended in Extended Data Figure 8-1.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8496189</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34417326</oboInOwl:hasDbXref>
        <rdfs:label>proliferation-mediating microglia</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002629"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/785b61aa-77df-4acd-a639-0ea046c07ddc"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002629"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/786a6b9a-bef4-454a-81c0-7ccb4fc00dcf -->

    <Class rdf:about="http://example.org/786a6b9a-bef4-454a-81c0-7ccb4fc00dcf">
        <obo:IAO_0000115>tSNE plot colored by the 17 Seurat clusters including hepatocytes, endothelial cells (liver sinusoidal endothelial cells:LSEC, non-tumor liver vascular endothelial cells:LVEC, and tumor liver vascular endothelial cells:LVECt), mesenchymal cells (Stellate cells, cancer-associated fibroblasts:CAFs, Pericytes, vascular smooth muscle cells:vSMC), immune cells (Kupffer cells, scar-associated macrophages:##SAMs##, tissue monocytes 1:TM1, cDC1, cDC2, T cells, and B cells), proliferating cells, and carcinoma cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7746227</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33332768</oboInOwl:hasDbXref>
        <rdfs:label>SAMs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/786a6b9a-bef4-454a-81c0-7ccb4fc00dcf"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/789027b1-9db1-440c-87b8-4cc52bdb9bbb -->

    <Class rdf:about="http://example.org/789027b1-9db1-440c-87b8-4cc52bdb9bbb">
        <obo:IAO_0000115>In conclusion, these findings suggest that DC2s and ##DC3s## respond similarly to SARS-CoV-2 infection, whereas they show more diversified responses to bacterial infections.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8420462</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34333764</oboInOwl:hasDbXref>
        <rdfs:label>DC3s</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000451"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/789027b1-9db1-440c-87b8-4cc52bdb9bbb"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000451"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/79abb1f1-8df3-4a7b-bddd-d4d776ec5175 -->

    <Class rdf:about="http://example.org/79abb1f1-8df3-4a7b-bddd-d4d776ec5175">
        <obo:IAO_0000115>Identification of cell types from whole-brain cells. a UMAP plot shows the unsupervised clustering of 16,028 cells derived from mouse brain (for details, see &quot;Methods&quot;). The 15 cell types were classified by their transcriptional profiles. b Dot plot shows the expression levels of a representative cell-specific marker gene for each cell type. c UMAP plot shows the distribution of Olig2 expression. d Violin plot shows Olig2 expression across all clusters. e UMAP plot shows the distribution of GFAP expression. f Violin plot shows GFAP expression across all clusters. g A total of 3522 cells of the astrocyte subset were derived from cells in mouse brain. They were classified into Olig2(+)/GFAP(-) astrocytes (347 cells), ##Olig2(+)/GFAP(+) astrocytes## (104 cells), Olig2(-)/GFAP(+) astrocytes (848 cells) and Olig2(-)/GFAP(-) astrocytes (2,223 cells). immNEU immature neuron, mNEU mature neuron, OPC oligodendrocyte precursor cell, immOLG immature oligodendrocyte, OLG oligodendrocyte, ASC astrocyte, OEG olfactory ensheathing glia, MG microglia; MAC macrophage, EC endothelial cell, PC pericyte, EPC ependymal cell, VLMC vascular and leptomeningeal cell, ABC arachnoid barrier cell, CP cycling progenitor</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8573876</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34749773</oboInOwl:hasDbXref>
        <rdfs:label>Olig2(+)/GFAP(+) astrocytes</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000127"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/79abb1f1-8df3-4a7b-bddd-d4d776ec5175"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000127"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/79d8d7b2-6b28-4cd8-a1a8-f810acf42ce9 -->

    <Class rdf:about="http://example.org/79d8d7b2-6b28-4cd8-a1a8-f810acf42ce9">
        <obo:IAO_0000115>High levels of Oct4 mRNA were found in the 2-cell blastomere population in all conditions, followed by a decrease at the 4-cell stage and a strong increase in 8-cell blastomeres (Fig. 5E), an expression pattern reflecting the transition of maternal-to-zygotic Oct4 transcripts at the 4-cell stage (Wu and Scholer). There was a decrease of Oct4 expression in the bulk of both Ahr-/- and Ahr+/+-TCDD groups relative to Ahr+/+ at the 8-cell stage and in ##Ahr-/- than in Ahr+/+ 2-cell blastomeres##. Similarly, we found a significant decrease of Oct4 expression in both Ahr-/- and Ahr+/+-TCDD, notably in both embryonic and differentiating blastomeres relative to the corresponding Ahr+/+ 8-cell subpopulations; in all conditions, differentiating blastomeres at 8-cell stage had higher expression levels than their embryonic counterparts (Fig. 5F). Furthermore, the levels of Oct4 transcription in Ahr-/- and Ahr+/+-TCDD 4-cell embryonic blastomeres decreased or had a trend to decrease, respectively, relative to the corresponding Ahr+/+ blastomeres. The levels of Cdx2 mRNA were high in all 8-cell blastomeres analyzed and were significantly decreased or trended to decrease in the bulk of Ahr-/- and Ahr+/+-TCDD relative to the Ahr+/+ 8-cell population (Fig. 5G). The Cdx2 mRNA levels were higher in Ahr+/+ and Ahr-/- 8-cell differentiating blastomeres than in their embryonic counterparts, with the Ahr-/- 8-cell differentiating blastomeres showing lower expression than the corresponding Ahr+/+ subpopulation (Fig. 5H). Additionally, some Ahr+/+-TCDD 8-cell embryonic blastomeres showed unusually high levels of Cdx2 mRNA causing the indistinguishable difference between embryonic and differentiating subpopulations.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10425484</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36029422</oboInOwl:hasDbXref>
        <rdfs:label>Ahr-/- than in Ahr+/+ 2-cell blastomeres</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000353"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/79d8d7b2-6b28-4cd8-a1a8-f810acf42ce9"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000353"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/794210e1-c756-4c73-94ba-bde664a56329 -->

    <Class rdf:about="http://example.org/794210e1-c756-4c73-94ba-bde664a56329">
        <obo:IAO_0000115>The co-inhibitory programmed death (PD)-1 signaling pathway plays a major role in the context of tumor-specific T cell responses. Conversely, it also contributes to the maintenance of peripheral tolerance, as patients receiving anti-PD-1 treatment are prone to developing immune-related adverse events. Yet, the physiological role of the PD-1/PDL-1 axis in T cell homeostasis is still poorly understood. Herein, we show that under steady-state conditions, the absence of PD-1 signaling led to a preferential expansion of CD8+ T cells in the liver. These cells exhibit an oligoclonal T cell receptor (TCR) repertoire and a terminally differentiated exhaustion profile. The transcription factor EOMES is required for the clonal expansion and acquisition of this differentiation program. Finally, single-cell transcriptomics coupled with TCR repertoire analysis support the notion that these cells arise locally from liver-resident memory CD8+ T cells. Overall, we show a role for PD-1 signaling in ##liver memory T cell## homeostasis.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMID:37543948</oboInOwl:hasDbXref>
        <rdfs:label>liver memory T cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000909"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/794210e1-c756-4c73-94ba-bde664a56329"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000909"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/8a048d66-a7c9-4fd1-ba71-165143499057 -->

    <Class rdf:about="http://example.org/8a048d66-a7c9-4fd1-ba71-165143499057">
        <obo:IAO_0000115>Diagram showing cerebellar neuron and astrocyte cell types and their placement in cerebellar architecture. Neurons = granule neuron, Purkinje neuron, Unipolar brush cell, Lugaro cell, Golgi cell, Basket cell, Stellate cell, ##neuron of cerebellar nuclei##. Astrocytes = Fibrous astrocyte, Velate astrocyte, Bergman glia. (Reprinted from &quot;Cerebellar Astrocytes: Much More Than Passive Bystanders In Ataxia Pathophysiology&quot; by Cerrato, V., 2020, J Clin Med, 9, p. 757)</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11585519</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37950146</oboInOwl:hasDbXref>
        <rdfs:label>neuron of cerebellar nuclei</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:1001611"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/8a048d66-a7c9-4fd1-ba71-165143499057"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:1001611"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/8aa92bd9-f437-4e6f-8fdf-aafa15bced3e -->

    <Class rdf:about="http://example.org/8aa92bd9-f437-4e6f-8fdf-aafa15bced3e">
        <obo:IAO_0000115>Transcriptome analysis of ##NK and NK_like cells##</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10028295</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36960063</oboInOwl:hasDbXref>
        <rdfs:label>NK and NK_like cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000623"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/8aa92bd9-f437-4e6f-8fdf-aafa15bced3e"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000623"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/8ad98ad5-65e8-4de1-a9e7-1ec9e76ab731 -->

    <Class rdf:about="http://example.org/8ad98ad5-65e8-4de1-a9e7-1ec9e76ab731">
        <obo:IAO_0000115>Figure 1 shows the relative abundances of each immune cell subtypes in METABRIC. Over half of the cell subtypes had very low abundances. Cell subtypes with relatively high abundances were M0 macrophages (14.8%), M2 macrophages (11.5%), plasma cells (9.3%), M1 macrophages (8.2%), ##resting mast cells## (8.0%), follicular helper T cells (6.2%), CD8 positive T cells (5.5%), gamma delta T cells (4.8%), activated NK cells (3.9%), and memory B cells (3.2%).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10624674</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37923775</oboInOwl:hasDbXref>
        <rdfs:label>resting mast cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000097"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/8ad98ad5-65e8-4de1-a9e7-1ec9e76ab731"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000097"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/8b147a1e-b971-4466-ae35-e50acaa6b4b3 -->

    <Class rdf:about="http://example.org/8b147a1e-b971-4466-ae35-e50acaa6b4b3">
        <obo:IAO_0000115>The adipose-derived hormone leptin acts via its receptor (LepRb) in the brain to control energy balance. A potentially unidentified population of GABAergic hypothalamic LepRb neurons plays key roles in the restraint of food intake and body weight by leptin. To identify markers for candidate populations of ##LepRb neurons## in an unbiased manner, we performed single-nucleus RNA-Seq of enriched mouse hypothalamic LepRb cells, identifying several previously unrecognized populations of hypothalamic LepRb neurons. Many of these populations displayed strong conservation across species, including GABAergic Glp1r-expressing LepRb (LepRbGlp1r) neurons, which expressed more Lepr than other LepRb cell populations. Ablating Lepr from LepRbGlp1r cells provoked hyperphagic obesity without impairing energy expenditure. Similarly, improvements in energy balance caused by Lepr reactivation in GABA neurons of otherwise Lepr-null mice required Lepr expression in GABAergic Glp1r-expressing neurons. Furthermore, restoration of Glp1r expression in LepRbGlp1r neurons in otherwise Glp1r-null mice enabled food intake suppression by the GLP1R agonist, liraglutide. Thus, the conserved GABAergic LepRbGlp1r neuron population plays crucial roles in the suppression of food intake by leptin and GLP1R agonists.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10541203</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37581939</oboInOwl:hasDbXref>
        <rdfs:label>LepRb neurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:4042033"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/8b147a1e-b971-4466-ae35-e50acaa6b4b3"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4042033"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/8b15b44a-bc28-41f1-a3b5-3113234a6437 -->

    <Class rdf:about="http://example.org/8b15b44a-bc28-41f1-a3b5-3113234a6437">
        <obo:IAO_0000115>Auditory sensory hair cells (HCs) and surrounding nonsensory supporting cells (SCs) differentiate from the common pool of inner ear progenitor cells. HCs in the sensory epithelium are precisely arranged into outer HCs (OHCs) and inner HCs (IHCs), intermixed with various types of SCs, including Deiter&apos; cells (DCs), Hensen&apos;s cells, inner border cells (##IBCs##), and inner phalangeal cells (IPhCs), etc. Sensory HCs act as the mechanoreceptors that transform acoustic waves into electrical signals transmitted to the brain through spiral ganglion neurons innervating the HCs. As terminally differentiated cells, mammalian cochlear HCs are susceptible to genetic mutations and environmental stress. Irreversible damage to HCs is one of the leading causes of sensorineural hearing loss in mammalian or mammalian species. </obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11304307</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38810137</oboInOwl:hasDbXref>
        <rdfs:label>IBCs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002168"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/8b15b44a-bc28-41f1-a3b5-3113234a6437"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002168"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/8b210a49-b6c5-41d2-b19d-894f2adeba8f -->

    <Class rdf:about="http://example.org/8b210a49-b6c5-41d2-b19d-894f2adeba8f">
        <obo:IAO_0000115>HS scFv binding patterns within human megakaryocyte and erythroid differentiation reveal dynamically and temporally shared HS-modification patterns. (A) Representative FACS density plot (upper panel) and morphology (May-Grunwald-Giemsa stain; lower panel) of human CD34+ cells. Scale bar indicates 20 mum. (B) Histograms of HS scFv binding to human CD34+ cells (donor #1). (C) Cell morphological time course of experimental in vitro erythroid differentiation of human CD34+ cells. A scheme bar indicating the distinct erythroid differentiation stages is included. Pro-E, proerythroblast; Baso-E, basophilic erythroblast; Poly-E, polychromatic erythroblast; Ortho-E, orthochromatic erythroblast. Scale bar indicates 20 mum. (D) Cell morphological time course of experimental in vitro megakaryocytic differentiation of human CD34+ cells. A scheme bar indicating distinct megakaryocytic differentiation stages is included. Scale bar indicates 20 mum. (E) Flow cytometry plots of HS scFv signal overlaid on the erythroid differentiation markers CD71 and CD235a during day 3, 7, 10, and 14 of erythroid differentiation (donor #1). The color coding of scFv-binding MFI is shown at the bottom. (F) Heatmap of HS scFv signal overlaid on the megakaryocyte differentiation markers CD41 and CD42b during day 3, 7, and 14 of megakaryocyte differentiation (donor #1). The color coding of scFv-binding MFI is shown at the bottom. (G) Binding of HS scFvs in stage-matched human (upper panel, donor #1) and mouse (lower panel) erythroid-lineage cells. Pro-E, proerythroblast; Baso-E, basophilic erythroblast; Poly-E, polychromatic erythroblast; Ortho-E, orthochromatic erythroblast. (H) Binding of HS scFvs in stage-matched human (upper panel, donor #1) and mouse (lower panel) ##megakaryocytic-lineage cells##.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9455685</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36066492</oboInOwl:hasDbXref>
        <rdfs:label>megakaryocytic-lineage cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000556"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/8b210a49-b6c5-41d2-b19d-894f2adeba8f"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000556"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/8b3444d8-9a74-4028-ab13-f438f18a5799 -->

    <Class rdf:about="http://example.org/8b3444d8-9a74-4028-ab13-f438f18a5799">
        <obo:IAO_0000115>As mentioned above, RelB has pleiotropic effects on MS or EAE pathogenesis via a cell type-specific manner. RelB activation or inhibition in specific cell types could be achieved by regulating upstream signaling pathway. While decreased RelB expression in Th1, ##gammadeltaT17##, DCs, B cells, macrophages and oligodendrocytes may have a beneficial role in MS or the EAE animal model, suppressive processes in other cell types may also cause greater severity. In this scenario, the use of RelB inhibitors in vivo is still in its infancy, and potential harmful effects must not be ignored by researchers. Therefore, we propose that targeted therapies in more specific cell types, such as RelB-inhibited Th1, gammadeltaT17, DCs, B cells, macrophages and oligodendrocytes need to be further investigated. Considering the fact that our research group has successfully alleviated established EAE by adoptive transfer of 1,25-(OH)2D3-induced tolerogenic DCs, in the future, the adoptive transfer of RelB-silenced tolerogenic DCs may be a promising strategy for the precise treatment of MS. However, to our knowledge, limited data about RelB in patients with MS has been reported and most work has been mainly focused on the animal models of MS. Only when we are sufficiently knowledgeable should we consider targeting RelB as a clinical approach to treat patients with MS.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6935142</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31881915</oboInOwl:hasDbXref>
        <rdfs:label>gammadeltaT17</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000798"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/8b3444d8-9a74-4028-ab13-f438f18a5799"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000798"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/8b4b4411-e066-4c04-8aa8-18a42a02a8e5 -->

    <Class rdf:about="http://example.org/8b4b4411-e066-4c04-8aa8-18a42a02a8e5">
        <obo:IAO_0000115>HH signaling has been reported to modulate cell proliferation in several contexts. We thus tested whether epithelial deletion of Shh might lead to tracheal epithelial cell proliferation defects. We examined epithelial cell proliferation first by immunostaining for Ki67, a cell cycle marker, and found that ShhCKO tracheae exhibited a reduced number of Ki67+ cells in the CDH1 marked epithelium compared with controls (Fig. 2H,I). Next, we performed an EdU incorporation assay to assess cells that had entered S-phase during the labeling period. After an ex vivo, 21 h long EdU treatment, ShhCKO tracheae displayed fewer EdU+ cells in their epithelium (Fig. 2J,K), indicating that Hedgehog inactivation compromises cell cycle entry. In a more-detailed analysis, we observed a reduced number of Ki67+SCGB1A1+ cells (Fig. 2L,M), but a similar number of ##PDPN+  and Ki67+PDPN+ basal cells##  in ShhCKO tracheae compared with controls. Interestingly, ShhCKO tracheae exhibited increased ratios of KRT5+ basal cells to acetylated alpha-tubulin+ ciliated cells and to SCGB1A1+ club cells compared with controls . We did not find obvious alterations in caspase3 staining between ShhCKO tracheal epithelium and controls at E18.5, suggesting that apoptosis is not affected in the mutants . To examine for changes in the surrounding mesenchyme, we analyzed SOX9+ chondroblasts, alpha-SMA+ smooth muscle cells and mesenchymal cell proliferation. ShhCKO tracheae exhibited SOX9+ chondroblast condensation defects , but no obvious SOX9+ chondroblast differentiation defects . We also detected reduced numbers of alpha-SMA+ smooth muscle cells and increased numbers of CDH1-Ki67+ mesenchymal cells compared with controls . As HH signaling modulates Fgf10 expression in the lung mesenchyme, we examined Fgf10 mRNA expression levels in ShhCKO tracheae. We detected a 1.5-fold increase in Fgf10 mRNA in ShhCKO mutants  but this was not sufficient to increase basal cell number, as might have been expected from previous studies. Altogether, these results indicate that loss of Shh function reduces club cell proliferation and interferes with ciliated cell differentiation and secretory cell maturation in the tracheal epithelium. In the tracheal mesenchyme, Shh promotes chondrocyte and smooth muscle morphogenesis.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8918789</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35112129</oboInOwl:hasDbXref>
        <rdfs:label>PDPN+  and Ki67+PDPN+ basal cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:4033082"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/8b4b4411-e066-4c04-8aa8-18a42a02a8e5"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4033082"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/8b505db9-ce2e-4b26-bb75-fe02380860d6 -->

    <Class rdf:about="http://example.org/8b505db9-ce2e-4b26-bb75-fe02380860d6">
        <obo:IAO_0000115>Food intake behavior is regulated by a network of appetite-inducing and appetite-suppressing neuronal populations throughout the brain. The parasubthalamic nucleus (PSTN), a relatively unexplored population of neurons in the posterior hypothalamus, has been hypothesized to regulate appetite due to its connectivity with other ##anorexigenic neuronal## populations and because these neurons express Fos, a marker of neuronal activation, following a meal. However, the individual cell types that make up the PSTN are not well characterized, nor are their functional roles in food intake behavior. Here, we identify and distinguish between two discrete PSTN subpopulations, those that express tachykinin-1 (PSTNTac1 neurons) and those that express corticotropin-releasing hormone (PSTNCRH neurons), and use a panel of genetically encoded tools in mice to show that PSTNTac1 neurons play an important role in appetite suppression. Both subpopulations increase activity following a meal and in response to administration of the anorexigenic hormones amylin, cholecystokinin (CCK), and peptide YY (PYY). Interestingly, chemogenetic inhibition of PSTNTac1, but not PSTNCRH neurons, reduces the appetite-suppressing effects of these hormones. Consistently, optogenetic and chemogenetic stimulation of PSTNTac1 neurons, but not PSTNCRH neurons, reduces food intake in hungry mice. PSTNTac1 and PSTNCRH neurons project to distinct downstream brain regions, and stimulation of PSTNTac1 projections to individual anorexigenic populations reduces food consumption. Taken together, these results reveal the functional properties and projection patterns of distinct PSTN cell types and demonstrate an anorexigenic role for PSTNTac1 neurons in the hormonal and central regulation of appetite.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9119672</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35507386</oboInOwl:hasDbXref>
        <rdfs:label>anorexigenic neuronal</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:4042033"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/8b505db9-ce2e-4b26-bb75-fe02380860d6"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4042033"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/8bc410b7-22b3-4494-926d-bef302dc6c9d -->

    <Class rdf:about="http://example.org/8bc410b7-22b3-4494-926d-bef302dc6c9d">
        <obo:IAO_0000115>(A, B) Schematic of medial (MOC) and lateral (LOC) olivocochlear neuron (OCN) subtypes housed in the brainstem (A) and their projections into the cochlea, shown in cross-section (A) and top-down (B). D, dorsal; L, lateral; LSO, lateral superior olive; VNTB, ventral nucleus of the trapezoid body; SOC, superior olivary complex; IHC, inner hair cell; OHC, outer hair cell; SGN, spiral ganglion neuron; IGSB, intraganglionic spiral bundle; ISB, inner spiral bundle; TSB, tunnel spiral bundle. (C) Schematic of single-nucleus collection protocol. The ventral brainstem of ChatCre; Rosa26Sun1-GFP mice was dissected, including the SOC, facial motor nucleus (VII), and trigeminal motor nucleus (V), followed by collection and sequencing of individual GFP+ nuclei. A, anterior; P, posterior. (D) UMAP plot summarizing sequencing data of 45,828 single nuclei from 61 animals across three ages. The data includes 56 clusters, including MOCs, LOCs, and several different motor neuron types, as well as a few non-neuronal populations. (E-H) Feature plots denoting normalized expression levels of selected genetic markers. For visualization purposes, high expression on the color scale is capped at the 95th percentile of gene expression. The majority of clusters express the neuronal marker Snap25 (E). The main non-neuronal population is labeled by Mog, an oligodendrocyte marker (F). Motor neuron clusters express the motor neuron determinant Isl1 (G). Among these brainstem motor neurons, OCNs are identified by expression of the transcription factor Gata3 (H). (I, J) Differential expression of known markers Ucn (I) and Atp1a3 (J) denotes LOCs and MOCs, respectively. (K-M) Cadps2 is a novel marker for OCNs that is expressed by both MOCs and LOCs but not FMNs. (K) Violin plots summarizing transcriptional expression of Cadps2 in ##mature LOCs, MOCs, and FMNs##. (L, M) Fluorescent in situ hybridization (FISH) verifies that Cadps2 is detected in both MOCs and LOCs (L) but not in FMNs (M). Representative images are shown from a total of three animals of either sex, P28.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10147377</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36876911</oboInOwl:hasDbXref>
        <rdfs:label>mature LOCs, MOCs, and FMNs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:2000047"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/8bc410b7-22b3-4494-926d-bef302dc6c9d"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:2000047"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/8be9726e-df3f-423e-8614-23ccd73b1e8f -->

    <Class rdf:about="http://example.org/8be9726e-df3f-423e-8614-23ccd73b1e8f">
        <obo:IAO_0000115>SCLC	Small-cell carcinoma	 	NSCLC	Non-small-cell carcinoma	 	ADC	Adenocarcinoma	 	SqCC	Squamous cell carcinoma	 	LCLC	Large-cell carcinoma	 	PD1	Programmed death 1	 	PDL1	Programmed death 1 ligand	 	ICI	Immune checkpoint inhibitors	 	EV	Extracellular vesicles	 	ESE	Early-sorting endosome	 	ILVs	Intraluminal vesicles	 	MVBs	Multivesicular bodies	 	ESCRT	Endosomal-sorting complex-independent transport	 	ncRNAs	Small noncoding RNAs (ncRNAs)	 	miRNAs	microRNAs	 	TME	Tumor microenvironment	 	circRNA	circular RNA	 	ECM	extracellular matrix	 	HBEC	Human bronchial epithelial cells	 	EMT	Epithelial-mesenchymal transition	 	CRC	colorectal cancer	 	DCs	dendritic cells	 	MSC	Mesenchymal stem cells	 	NK	Natural Killer	 	PBMCs	Peripheral blood mononuclear cells	 	TAMs	Tumor-associated macrophages	 	MDSCs	Myeloid-derived suppressor cells	 	PMN-MDSCs	Polymorphonuclear MDCs	 	M-MDSCs	Monocytic MDSCs	 	LLC	Lewis Lung carcinoma	 	M2 macrophages	Alternatively activated macrophages	 	M1 macrophages	Classically activated macrophages	 	TH1 cell	T helper 1 cell	 	Treg cell	Regulatory T cell	 	Breg cell	Regulatory B cell	 	CTLs	Cytotoxic CD8+ T cells	 	TILs	##Tumor-infiltrating lymphocytes##	 	Tim-3	mucin domain-3 protein	 	TIGIT	T cell immunoglobulin and ITIM domain	 	Lag-3	Lymphocyte-activation gene 3	 	CTLA4	Cytotoxic T lymphocyte antigen-4	 	TH17 cell	T helper 17 cell	 	DNT cell	Double-negative T cells	 	TRAIL	TNF-related apoptosis-inducing ligand	 	MPE	malignant pleural effusions	 	CRISPRi	clustered regularly interspaced short palindromic repeats interference	 	FAP	Fibroblast activation protein- alpha.	 	</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10616833</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37915578</oboInOwl:hasDbXref>
        <rdfs:label>Tumor-infiltrating lymphocytes</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000542"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/8be9726e-df3f-423e-8614-23ccd73b1e8f"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000542"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/8bf6ec50-b425-456c-af13-9c0a0dcac7d5 -->

    <Class rdf:about="http://example.org/8bf6ec50-b425-456c-af13-9c0a0dcac7d5">
        <obo:IAO_0000115>Next, we sought to identify using machine learning, the immune variable (IT or Stromal) that best classifies patients as LTS or NON-LTS and thereby, predicts patient survival. Random-forest (RF) is a decision tree-based machine learning method which uses a bootstrapping method to generate at random, training and testing samples from the dataset. Variable selection was performed through the varSelRF package in R, which uses recursive feature elimination to find a minimal set of variables with the best predictive performance. Using this approach, we determined that stromal densities of iNOS+ and CD68+ cells are the two best discriminatory variables for patient survival. ##Stromal iNOS+ leukocytes## display a potent positive correlation with OS (Figure 7A) while stromal CD68+ (total) macrophages show a strong negative correlation with OS (Figure 7B). The ROC (Receiver Operating Characteristic) curves and ROC values for the final two variables determined by RF selection (i.e., iNOS and CD68) are plotted in Supplementary Figure 7. These findings suggest that iNOS+ leukocytes and CD68+ macrophages are highly relevant prognostic biomarkers in PDAC patients.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7933000</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33679807</oboInOwl:hasDbXref>
        <rdfs:label>Stromal iNOS+ leukocytes</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000738"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/8bf6ec50-b425-456c-af13-9c0a0dcac7d5"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000738"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/8c245490-30ed-4686-b364-223357a9ca20 -->

    <Class rdf:about="http://example.org/8c245490-30ed-4686-b364-223357a9ca20">
        <obo:IAO_0000115>Recent studies investigating the role of B-cells during TB revealed impaired B-cell function and decreased B-cell frequencies during active disease. 16 ,  17  A regulatory B-cell (Breg) subtype, ##killer B-cells##, was recently discovered and has been implicated in a variety of immune conditions, including Mycobacterium tuberculosis infection and disease. 18 ,  19  Emerging evidence has acknowledged B-cells as essential in the defense against M. tuberculosis. Before the participation of B-cells in host immune responses, development and migration of precursor cells known as transitional B-cells from the bone marrow to the spleen is required; where they give rise to mature B-cells in response to antigenic stimulation. 20 ,  21  Immature transitional 1 (T1) B-cells (CD19+CD21-CD23-) form the foundation from which transitional 2 (T2) B-cells (CD19+CD21+CD23+) and mature B-cells sequentially derive. 22  However, T2 B-cells have been found to be more receptive to cellular activation and proliferation, in comparison to T1 B-cells. 23 ,  24  As such, the presence and regulation of these T2 B-cells dramatically affect the course of the mounted immune responses.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7416019</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32639690</oboInOwl:hasDbXref>
        <rdfs:label>killer B-cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000969"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/8c245490-30ed-4686-b364-223357a9ca20"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000969"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/8c55e4bb-750d-4d8f-8570-532bd2e94aa1 -->

    <Class rdf:about="http://example.org/8c55e4bb-750d-4d8f-8570-532bd2e94aa1">
        <obo:IAO_0000115>Interestingly, we found that granulosa cells of preantral follicles and cumulus cells of antral follicles clustered together and shared markers that distinguished them from mural granulosa cells. For example, Kctd14, a member of the potassium channel tetramerisation domain-containing family, was expressed in granulosa cells during the initial growth of early preantral follicles, but also specifically expressed only in cumulus cells, but not mural granulosa cells, of larger antral follicles. Intriguingly, we have previously shown that AMH (anti- Mullerian hormone, a.k.a Mullerian Inhibiting Substance), which is specifically expressed by cumulus cells in antral follicles, regulates KCTD14 expression in preantral follicles. This conservation of cellular state and marker expression from ##preantral granulosa cells## to cumulus cells of antral follicles suggests a continuous lineage, potentially defined and maintained by the close interaction with the oocyte. This interpretation is consistent with the presence of a differentiation fork in the granulosa cell lineage during antrum formation, which would give rise to a distinct mural granulosa cell fate poised to respond to the LH surge. Indeed, the periovulatory granulosa cell state was identified based on its expression of genes regulated by LH such as Smarca1, and we propose Oxtr as a specific marker for these cells (Figure 3:figure supplement 1D). Oxtr expression was found only in the mural cells of large Graafian follicles, suggesting it indeed corresponds to an LH-stimulated mural granulosa cell state.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9545525</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36205477</oboInOwl:hasDbXref>
        <rdfs:label>preantral granulosa cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000501"/>
        <skos:relatedMatch rdf:resource="CL:0000711"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/8c55e4bb-750d-4d8f-8570-532bd2e94aa1"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000501"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/8c55e4bb-750d-4d8f-8570-532bd2e94aa1"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000711"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/8c69a2ec-23c6-48a2-9fca-27264cbe410b -->

    <Class rdf:about="http://example.org/8c69a2ec-23c6-48a2-9fca-27264cbe410b">
        <obo:IAO_0000115>Macrophages, which are immune cells with heterogeneous phenotypes and complex functions, can be divided into circulating and resident macrophages. Primitive hematopoiesis is a source of macrophages in embryos, and the majority of resident macrophages originate from yolk sac erythro-myeloid progenitors. Bone-BM macrophages, synovial macrophages, and microglia play a key role in maintaining tissue homeostasis; phagocytosis and removal of cellular debris and foreign substances; tissue repair, regeneration, and remodeling; and the development and resolution of inflammation. Under physiological conditions, the bone-BM contains multiple different resident macrophage populations, including ##osteal macrophages##, hematopoietic stem cell niche macrophages, and erythroblast island macrophages. Macrophages have remarkable plasticity that allows them to respond efficiently to environmental signals and change their phenotypes.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9226340</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35757427</oboInOwl:hasDbXref>
        <rdfs:label>osteal macrophages</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000137"/>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/8c69a2ec-23c6-48a2-9fca-27264cbe410b"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000137"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/8c69a2ec-23c6-48a2-9fca-27264cbe410b"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/8c94e31b-bba6-4eeb-a69b-66b2f676bd00 -->

    <Class rdf:about="http://example.org/8c94e31b-bba6-4eeb-a69b-66b2f676bd00">
        <obo:IAO_0000115>Expression heterogeneity of CD8+ and CD4+ T cells in the OSCC ecosystem. (A) The t-distributed stochastic neighbor embedding (t-SNE) projection of T cells from cancerous tissue of patients with OSCC, showing the formation of 11 main clusters in different colors. The functional description of each cluster is determined by the gene expression characteristics. Cluster 0: resident memory CD8+ T Cells (C0_CD8+ TRM); Cluster 1: effector memory CD8+ T cells (C1_CD8+ TEM); Cluster 2: regulatory CD4+ T cells (C2_CD4+ Treg); Cluster 3: ##exhausted CD8+ T cells## (C3_CD8+ T Exhausted); Cluster 4: effector memory M-phage CD8+ T cells (C4_CD8+ Mitotic TEM); Cluster 5: effector memory CD4+ T cells (C5_CD4+ TEM); Cluster 6: effector memory CD8+ T cells (C6_CD8+ TEM); Cluster 7: effector memory CD4+ T cells (C7_CD4+ TEM); Cluster 8: effector memory CD8+ T cells (C8_CD8+ TEM); Cluster 9: effector memory CD8+ T cells (C9_CD8+ TEM); Cluster 10: effector memory M-phage CD4+ T cells (C10_CD4+ Mitotic TEM); Cluster 11: effector memory CD8+ T cells (C11_CD8+ TEM); Cluster 12: effector memory CD8+ T cells (C12_CD8+ TEM); Cluster 13: gammadelta T. (B) Cell-Cycle Scoring of T cells from cancerous tissue of patients with OSCC, showing the three clusters of cells in different cell cycles in different colors. (C) Heatmap of key genes expressed in each cluster of CD8+ tumor-infiltrating lymphocytes (TILs) with cells grouped by clusters. The columns correspond to the cells; the rows correspond to the genes. Yellow: high expression; purple: low expression. Selected key markers are shown on the right. (D) Heatmap of key genes expressed in each cluster of CD4+ TILs with cells grouped by clusters. The columns correspond to the cells; the rows correspond to the genes. Yellow: high expression; purple: low expression. Selected key genes are shown on the right.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8024729</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33513276</oboInOwl:hasDbXref>
        <rdfs:label>exhausted CD8+ T cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000795"/>
        <skos:relatedMatch rdf:resource="CL:0011025"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/8c94e31b-bba6-4eeb-a69b-66b2f676bd00"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000795"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/8c94e31b-bba6-4eeb-a69b-66b2f676bd00"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0011025"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/8c9f043d-baf8-426b-8156-d8baff7ec74a -->

    <Class rdf:about="http://example.org/8c9f043d-baf8-426b-8156-d8baff7ec74a">
        <obo:IAO_0000115>To gain a comprehensive view of immune interactions, we performed correlation analyses between the frequency of Ki67+ Tregs and the frequencies of all identified immune cell subpopulations. We did not observe significant association of the frequency of Ki67+ Tregs with lymphocytic subsets (Supplementary Fig. 8). On the other hand, myeloid cells, particularly dendritic cells (DCs), are known to facilitate Treg generation. Therefore, we analyzed the correlation between the frequency of Ki67+ Tregs and that of myeloid cell subsets (including cMo, iMo, ncMo, and DC). The frequency of Ki67+ Tregs was positively associated with the frequencies of ##HLA-DR+ and CD86+ monocytes and dendritic cells## (Supplementary Fig. 9), suggesting their potential roles in the generation of Ki67+ Treg cells via antigen presentation and CD28-dependent signaling. Interestingly, we found that the frequency of Ki67+ Tregs was also positively associated with the frequencies of PD-L1+ monocytes and dendritic cells (Supplementary Fig. 9), which is consistent with previous reports that DCs could induce Treg cells via PD-L1. These results indicate that myeloid cells might play a crucial role in Treg generation.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11496634</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:39438442</oboInOwl:hasDbXref>
        <rdfs:label>HLA-DR+ and CD86+ monocytes and dendritic cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000451"/>
        <skos:relatedMatch rdf:resource="CL:0000576"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/8c9f043d-baf8-426b-8156-d8baff7ec74a"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000451"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/8c9f043d-baf8-426b-8156-d8baff7ec74a"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000576"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/8ccd9f8a-4081-4150-b75e-f6779c11828a -->

    <Class rdf:about="http://example.org/8ccd9f8a-4081-4150-b75e-f6779c11828a">
        <obo:IAO_0000115>Immunoreactivity for perlecan is weak in early lens structures (Figure 6(A1,A2)) but labelling appears to be stronger in the matrix and basement membranes of the E11.5 eye (Figure 6(A3)). At this stage, perlecan is observed in the anterior cells of the lens vesicle (Figure 6(A3)). This pattern of staining is maintained in the fully formed lens at E14.5 and E16.5, with perlecan mostly restricted to the lens capsule and anterior lens epithelium (Figure 6(A4-A8)). Diffuse perlecan staining was observed in the nuclei of some differentiating lens fibre cells (Figure 6(A7)). Both collagen XVIII/endostatin (Figure 6(B1,B2)) and agrin (Figure 6(C1,C2)) were observed in the cells of the lens placode and lens pit. Collagen XVIII/endostatin reactivity was restricted to a punctate label in the primary lens fibres of the lens vesicle (Figure 6(B3)). This label persisted in the E14.5 lens (Figure 6(B4)). At E16.5, collagen XVIII/endostatin labelled in condensed patches throughout the cytoplasm of both lens epithelial and fibre cells (Figure 6(B5-B8)). On the other hand, agrin stained strongly throughout the cells of the lens vesicle, concentrated apically in the presumptive anterior lens epithelial cells, and basally in the new elongating primary lens fibre cells (Figure 6(C3)). From E14.5, agrin immunoreactivity was strongly visible throughput the cytoplasm of the ##central lens fibre cells## (Figure 6(C4)), and this label persisted in the E16.5 lens (Figure 6(C5-C8)). Agrin was clearly associated with a subset of fibre cell nuclei (Figure 6(C4,C7)). Agrin staining was almost completely absent from the anterior lens epithelium and transitional zone (Figure 6(C4,C5,C8) and Table 1).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10216587</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37408198</oboInOwl:hasDbXref>
        <rdfs:label>central lens fibre cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0011004"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/8ccd9f8a-4081-4150-b75e-f6779c11828a"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0011004"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/8ce05791-f750-4500-93d3-4c7ef77ff895 -->

    <Class rdf:about="http://example.org/8ce05791-f750-4500-93d3-4c7ef77ff895">
        <obo:IAO_0000115>Together, these results demonstrate that the output of ##Som+ cells## outpaces that of PKCdelta+ cells in the CeLC but that the cellular mechanisms underlying the differences in excitability in Som+ and PKCdelta+ neurons are distinct for late-firing and regular-spiking cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7877473</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33188006</oboInOwl:hasDbXref>
        <rdfs:label>Som+ cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:4023017"/>
        <skos:relatedMatch rdf:resource="CL:4042037"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/8ce05791-f750-4500-93d3-4c7ef77ff895"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4023017"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/8ce05791-f750-4500-93d3-4c7ef77ff895"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4042037"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/8ce93316-5faf-45d2-8b08-27ed3f5fccdd -->

    <Class rdf:about="http://example.org/8ce93316-5faf-45d2-8b08-27ed3f5fccdd">
        <obo:IAO_0000115>The Table shows the numerical representations of Excitatory Neurons (Deep and Superficial Pyramidal cells) and ##Inhibitory neurons## (Oriens Lacunosum moleculare cells:OLM; Trilaminar cells:Tri, Backprojection cells:BP, cholecystokinin positive Basket cells:CCKBC, Parvalbumin positive cells:PVBC, AxoAxonic Cells:AA, Ivy Cells:IVY, Bistratified cells:BS, Schaffer Collateral associated cells:SCA, Perforant Pathway Associated cell:PPA, Neurogliaform:NG) subdivided on the basis of the placement classes (SO, SP, SR, SLM).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9381785</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35974119</oboInOwl:hasDbXref>
        <rdfs:label>Inhibitory neurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000498"/>
        <skos:relatedMatch rdf:resource="CL:0000617"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/8ce93316-5faf-45d2-8b08-27ed3f5fccdd"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000498"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/8ce93316-5faf-45d2-8b08-27ed3f5fccdd"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000617"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/8cef93e7-f936-4008-835f-e5096ee5cb7b -->

    <Class rdf:about="http://example.org/8cef93e7-f936-4008-835f-e5096ee5cb7b">
        <obo:IAO_0000115>In this study, single-cell analysis was utilized to reveal the heterogeneity and pseudotemporal differentiation trajectory analysis of the neonatal mouse ##spinal cord neuronal cells##. Psgs and Ceacams were found to be the core genes for cluster 3, where the marker genes in these cell subpopulations characterize the transcriptional profile of mouse spinal cord neuronal cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8648463</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34880956</oboInOwl:hasDbXref>
        <rdfs:label>spinal cord neuronal cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000540"/>
        <skos:relatedMatch rdf:resource="CL:0005000"/>
        <skos:relatedMatch rdf:resource="CL:0011001"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/8cef93e7-f936-4008-835f-e5096ee5cb7b"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000540"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/8cef93e7-f936-4008-835f-e5096ee5cb7b"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0005000"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/8cef93e7-f936-4008-835f-e5096ee5cb7b"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0011001"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/8d0f1186-81b2-4593-a797-febb09e972eb -->

    <Class rdf:about="http://example.org/8d0f1186-81b2-4593-a797-febb09e972eb">
        <obo:IAO_0000115>To identify genes with potential interactions in the previously identified nsCL/P-associated cell types (epithelium and ##HAND2+ PA##), co-expression networks were generated. For each cell type, hdWGCNA identified 18 groups of interconnected, positively correlated genes (so-called &apos;gene modules&apos;). Of these, three per cell type were selected for further analysis (see Methods, Tables S7 &amp; S8).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11532359</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:39489835</oboInOwl:hasDbXref>
        <rdfs:label>HAND2+ PA</rdfs:label>
    </Class>
    


    <!-- http://example.org/8d92ca73-22ec-4676-902f-7c37e6798a91 -->

    <Class rdf:about="http://example.org/8d92ca73-22ec-4676-902f-7c37e6798a91">
        <obo:IAO_0000115>a Immune cell subsets analyzed by CellChat in the original tSNE plot. b Enhanced number of interactions and interaction strength noted in cSjD. Differential interaction strength c and numbers d are presented on the heatmap. The overall increase in the interaction strength in the signal-receiving effector immune subsets, along with a dramatic increase in the interaction numbers noted between FOXP3low Tregs (or naive Tregs) and myeloid/B subsets, in cSjD compared to HC. Bars refer to the sum of the computed interaction strength or numbers in each column and row. Relative values = the interaction strength/number from source to target in cSjD-the interaction strength/number from source to target in HC. e-g Identification of significant ligand and receptor pairs between immune subsets of interest. e The communication probability of CLEC2C ligand and KLRB1 receptor genes are significantly upregulated between B and effector memory CD4+ T cell subsets in cSjD. f FOXP3low Tregs show increased communication probability with myeloid subsets through CD4 and MHC class II-related genes in cSjD, compared to HC. g Pairs of CLEC ligands and KLRB receptor genes show increased communication probability in gammadelta-T cells of Bx and BxRP, compared to non-cSjD. Mo monocytes, NK natural killer, eff effector, em effector memory, mem memory, ##cm## central memory T cell, nv naive, pDC plasmacytoid dendritic cells, MAIT mucosal-associated invariant T, act activated or FOXP3high, IFN interferon-related, HC healthy control, cSjD childhood Sjogren&apos;s disease, BX biopsy-positive non-cSjD without RP, BXRP biopsy-positive non-cSjD with RP.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11031574</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38641668</oboInOwl:hasDbXref>
        <rdfs:label>cm</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000904"/>
        <skos:relatedMatch rdf:resource="CL:0000907"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/8d92ca73-22ec-4676-902f-7c37e6798a91"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000904"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/8d92ca73-22ec-4676-902f-7c37e6798a91"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000907"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/8dc1e24e-e630-4efa-9e94-51f5dfcb2312 -->

    <Class rdf:about="http://example.org/8dc1e24e-e630-4efa-9e94-51f5dfcb2312">
        <obo:IAO_0000115>SIRPalpha, signal regulatory protein alpha; cancer single-cell state atlas (CancerSea); GEPIA, Gene Expression Profiling Interaction Analysis; TIMER, Tumor Immune Estimation Resource; KM plotter, Kaplan-Meier plotter; EMT, Epithelial-Mesenchymal Transition; HPA, The Human Protein Atlas; IHC, immunohistochemistry; PFS, progression-free survival; OS, overall survival; HRs, Hazard ratios; M1 cells, macrophage type1 cells; M2 cells, macrophage type2 cells; Treg, regulatory T cells; TAMs, ##Tumor-associated macrophages##.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8710451</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34966389</oboInOwl:hasDbXref>
        <rdfs:label>Tumor-associated macrophages</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/8dc1e24e-e630-4efa-9e94-51f5dfcb2312"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/8de3fbd2-c031-4dee-a06b-008d330a6092 -->

    <Class rdf:about="http://example.org/8de3fbd2-c031-4dee-a06b-008d330a6092">
        <obo:IAO_0000115>In contrast to brown adipocytes, the principal role of white adipocytes is to sequester lipid by lipogenesis or regulating lipolysis. They also secrete bioactive molecules (e.g., extracellular vesicles, lipokines, and adipokines) that target systemic organs. The mean volume of a white adipocyte is proportional to the rate of lipogenesis, the rate of lipolysis, and the nutrient supply/blood flow. EAT and visceral adipose are both predominantly white adipose depots and similar in many respects. Generally, EAT volume correlates with visceral adiposity, as measured by echocardiogram and CT. Epicardial adipocytes and adipocytes from visceral fat depots are smaller than subcutaneous adipocytes. EAT has a greater concentration of capillaries and increased expression of a broad array of inflammatory markers. On the other hand, there are subtle differences between epicardial and adipocytes from fat within the abdominal cavity. Ovine epicardial adipocytes have a greater ratio of oleic acid (18:1) to stearic acid (18:0) than peri-renal or omental adipocytes. Although stearoyl-CoA desaturase (SCD) expression was lowest in epicardial fat compared to all other depots, there was a high correlation between SCD expression and oleic acid content in epicardial adipocytes, whereas there was no correlation in ##visceral adipocytes##. Like visceral adipose tissue, EAT has a greater expression of inflammatory genes than subcutaneous adipose tissue. This is true even in the absence of cardiovascular disease or obesity. In humans with obesity and in animal models of high fat feeding visceral adipose becomes inflamed which leads to dysfunctional adipocyte biology, lipotoxicity, and insulin resistance in remote tissues. This vast field of research (immunometabolism) has ushered in a new era of discovery, investigation, and therapeutic opportunity that is beyond the scope of this review. However, whether epicardial adipose tissue responds in the same way to high fat feeding/obesity has yet to be shown. White perivascular adipose tissue surrounding the abdominal aorta in mice becomes severely inflamed with HFD. Given the similarities between VAT and EAT, it is reasonable to consider the possibility that epicardial fat does too.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10067711</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37020587</oboInOwl:hasDbXref>
        <rdfs:label>visceral adipocytes</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000136"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/8de3fbd2-c031-4dee-a06b-008d330a6092"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000136"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/8dede81a-ce28-4310-af6b-15a579101b6b -->

    <Class rdf:about="http://example.org/8dede81a-ce28-4310-af6b-15a579101b6b">
        <obo:IAO_0000115>To illustrate the application of CSN to developing cells, we feature the developmental trajectory of human excitatory neuron cells in the Developing Cortex Atlas dataset (15), which includes Radial Gila and Progenitors (P), Intermediate Progenitors (IP), Maturing Excitatory (##ExN##), Migrating Excitatory (ExM), Excitatory Upper-layer enriched (ExM-U), and Excitatory Deep layer (ExDp), with cell type labels determined by the authors (SI Appendix, section 3 and Table S2). Using Slingshot, we estimate the developmental path consists of two trajectories, one ending in upper-layer (U curve) and the other in deep-layer (D curve) excitatory neurons (Fig. 3 A and B).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8713783</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34903665</oboInOwl:hasDbXref>
        <rdfs:label>ExN</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000540"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/8dede81a-ce28-4310-af6b-15a579101b6b"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000540"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/8dfef4da-e93e-43ce-b227-1f6c665ef430 -->

    <Class rdf:about="http://example.org/8dfef4da-e93e-43ce-b227-1f6c665ef430">
        <obo:IAO_0000115>SHP2 incites myometrium contraction by regulating PGF2alpha production in epithlium to participate smooth muscle contraction via justacrine. LE Luminal epithelial cells, Str1 ##stromal cells## 1, Str2 stromal cells 2, Dec decidual cells, NK natural killer cells, Mac macrophage cells, Muscle muscle cells, Gland glandular epithelial cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10646072</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37963860</oboInOwl:hasDbXref>
        <rdfs:label>stromal cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000499"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/8dfef4da-e93e-43ce-b227-1f6c665ef430"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000499"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/8e1d3ac0-2c21-4f80-a400-b2f476996459 -->

    <Class rdf:about="http://example.org/8e1d3ac0-2c21-4f80-a400-b2f476996459">
        <obo:IAO_0000115>a, Key attributes of nine single-cell transcriptomic and epigenomic datasets from the mouse MOp. b, c, Two-dimensional projection (uniform manifold approximation and projection (UMAP)) of cells and nuclei based on integrated analysis of seven transcriptomic (scRNA-seq and snRNA-seq) datasets. Cells and nuclei are coloured by dataset (b) using the colours shown in a, or by cell type (c). Non-neuronal cell types are depleted owing to the sampling strategy, which enriched neurons in all datasets except snRNA 10x v3 B. d, Dendrogram showing a hierarchical relationship among the consensus transcriptomic cell types and a proportion of cells of each type per dataset, normalized within major classes. Glu, glutamatergic. e, Expression of selected marker genes for excitatory (top) and inhibitory (bottom) cell classes, across four platforms. f, Differential enrichment of transcripts in single cells versus single nuclei. The long non-coding RNA Malat1 is enriched in nuclei. CPM, counts per million reads mapped. g, The number of replicable clusters across at least two of the seven scRNA-seq and snRNA-seq datasets as a function of the minimal MetaNeighbor score (AUROC). h, The trade-off between the number of clusters and replicability (the per cent of clusters with minimal MetaNeighbor replicability score). The major ##inhibitory neuron## subclasses are Lamp5, Sncg, Vip, Sst and Pvalb. Astro, astrocyte; CT, corticothalamic; endo, endothelial; ET, extratelencephalically projecting; IT, intratelencephalically projecting; micro, microglial cell; NP, near-projecting; oligo, oligodendrocyte; OPC, oligodendrocyte precursor cell; peri, pericyte; PVM, perivascular macrophage; SMC, smooth muscle cell; VLMC, vascular leptomeningeal cell.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8494649</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34616066</oboInOwl:hasDbXref>
        <rdfs:label>inhibitory neuron</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000498"/>
        <skos:relatedMatch rdf:resource="CL:0000617"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/8e1d3ac0-2c21-4f80-a400-b2f476996459"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000498"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/8e1d3ac0-2c21-4f80-a400-b2f476996459"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000617"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/8e32e1fd-d318-4416-b508-d0ecdc82aef9 -->

    <Class rdf:about="http://example.org/8e32e1fd-d318-4416-b508-d0ecdc82aef9">
        <obo:IAO_0000115>Systems Organs Cell Types     Respiratory system Lung AT2 cells 0.79% 21.20%   Nose (nasal turbinate epithelial cells) Mesenchymal stromal cells 1.70% 8.50%   Plasma cells 2.00% 8.80%   Nose (nasal brushing epithelial cells) Plasma cells 4.00% 13.80%   Nose (nasal airway epithelial cells) Nasal airway epithelial cells 8.40% 23.10%   Digestive system Gall bladder Primordium cell 2.20% 2.60%   Small intestine (jejunum) Enterocyte progenitor cell 14.00% 6.60%   Goblet cell 9.10% 2.60%   Small intestine (ileum) Intestinal epithelial stem cell 1.50% 4.20%   Enterocyte progenitor cell 2.40% 3.60%   Small intestine (duodenum) LGR5+ stem cell 5.20% 4.50%   Intestinal epithelial stem cell 3.90% 5.80%   Enterocyte progenitor cell 4.40% 6.80%   Tuft progenitor cell 7.40% 6.60%   Enteroendocrine cell 9.40% 3.80%   Large intestine (rectum) Goblet progenitor cell 2.80% 62.50%   MKI67+ progenitor cell 10.30% 75.40%   Enterocyte 13.20% 77.50%   Goblet cell 18.20% 87.30%   Large intestine (colon) Enterocyte 5.70% 52.10%   Goblet cell 11.00% 78.00%   Esophagus Secretory progenitor cell 9.40% 18.80%   Nervous system Brain (substantia nigra and cortex) Oligodendrocyte precursor cell 1.60% 0.90%   Astrocyte 1.90% 1.00%   Reproductive system Fallopian tube Epithelial cells 1.40% 26.50%   Ovarian somatic cell 1.00% 1.00%   Testis Spermatogonium 1.70% 4.50%   Peritubular myoid cell 1.70% 6.30%   Testis somatic cell 2.10% 4.30%   Spermatogonial stem cell 1.40% 2.10%   Circulatory system Heart Cardiomyocyte 6.60% 0.80%   Cardiovascular progenitor cell 12.50% 0.40%   Urinary system Kidney Nephron epithelial cell 2.70% 10.70%   Epithelial cell 2.70% 9.60%   ##Endothelial cell## 2.70% 12.80%   Mesangial cell 3.00% 14.50%   </obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7794913</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33401657</oboInOwl:hasDbXref>
        <rdfs:label>Endothelial cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000115"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/8e32e1fd-d318-4416-b508-d0ecdc82aef9"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000115"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/8e58cc09-542b-477f-a4fd-5d96d38f574e -->

    <Class rdf:about="http://example.org/8e58cc09-542b-477f-a4fd-5d96d38f574e">
        <obo:IAO_0000115>The aim of this study was to compare and contrast the surfaceomes of MSCs and ##CPCs## using quantitative proteomics. We employed biotinylation and glycocapture together with high throughput shotgun quantitative proteomics to define the surface proteome of these cells. The rationale for this study was to fine-tune an efficient labelling technique to enrich the surfaceome and learn more about the cell biology of MSCs and CPCs.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6588563</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31227739</oboInOwl:hasDbXref>
        <rdfs:label>CPCs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0007009"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/8e58cc09-542b-477f-a4fd-5d96d38f574e"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0007009"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/8e8cd386-de8f-4d17-bd81-07d0b53e9778 -->

    <Class rdf:about="http://example.org/8e8cd386-de8f-4d17-bd81-07d0b53e9778">
        <obo:IAO_0000115>(F) Relative abundance of each cluster in MMPs of vehicle-versus teriparatide-treated mice. OB, osteoblast; preOB, preosteoblast; COP, chondrocyte-like osteoprogenitor; ##MALP##, marrow adipocyte lineage progenitor.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8432334</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34407400</oboInOwl:hasDbXref>
        <rdfs:label>MALP</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0010001"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/8e8cd386-de8f-4d17-bd81-07d0b53e9778"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0010001"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/8ead7f0b-4a76-4432-9c1c-351cacffebe7 -->

    <Class rdf:about="http://example.org/8ead7f0b-4a76-4432-9c1c-351cacffebe7">
        <obo:IAO_0000115>Although the induced Ca2+ activity persisted under the glutamatergic inhibition for ##c+ primary neurons##, excitability of the secondary neurons discontinued. Secondary neurons exhibited two common excitation profiles depending on whether they were silent or spontaneously active before stimulation. These two profiles were encountered in equal frequencies 30% (both 7 out of 22) all throughout the experiments. In Fig 5B, the c+ primary neuron was observed to excite a previously silent secondary neuron. In the blocked case this excitation was not observed as shown via correlation analysis (p&lt;0.05). A video of this experiment is provided in S1A and S1B Video. Fig 5C shows an example for a secondary neuron which was spontaneously active before stimulation. Spontaneous activity of the secondary neuron was modulated with the induced Ca2+ activity of the primary neuron. Excitation of the secondary neuron continued through the stimulation and the in-phase modulation vanished in the blocked case (p&lt;0.05).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7928449</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33657119</oboInOwl:hasDbXref>
        <rdfs:label>c+ primary neurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000540"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/8ead7f0b-4a76-4432-9c1c-351cacffebe7"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000540"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/8eb1dc61-4ff7-4566-87ba-ec452c98f06e -->

    <Class rdf:about="http://example.org/8eb1dc61-4ff7-4566-87ba-ec452c98f06e">
        <obo:IAO_0000115>The change of ILC cell populations during a cascade of colonic lesions. (A-C) Flow cytometry quantification of the frequency of Lin-CD127+CRTH2-CD117- ILC1 cells (A), Lin-CD127+CRTH2+CD117- ILC2 cells (B), and ##Lin-CD127+CRTH2-CD117+ ILC3 cells## (C) in CD45+ PBMCs during a cascade of colonic lesions. (D-F) Flow cytometry quantification of the frequency of Lin-CD127+IFN-gamma+ cells (D), Lin-CD127+IL-5+ cells (E), and Lin-CD127+IL-22+ cells (F) in CD45+ PBMCs during a cascade of colonic lesions. Each dot represents one donor. HC, healthy control. Error bars represent the SEM. *P &lt; 0.05; **P &lt; 0.01 (ANOVA or non-parametric test as appropriate). n = 10-19 in each group.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10853383</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38343544</oboInOwl:hasDbXref>
        <rdfs:label>Lin-CD127+CRTH2-CD117+ ILC3 cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0001071"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/8eb1dc61-4ff7-4566-87ba-ec452c98f06e"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0001071"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/8eb44da3-00b8-42b8-860a-8bad2992a54e -->

    <Class rdf:about="http://example.org/8eb44da3-00b8-42b8-860a-8bad2992a54e">
        <obo:IAO_0000115>The adipokine leptin regulates energy homeostasis through ubiquitously expressed leptin receptors. Leptin has a number of major signaling targets in the brain, including cells of the anterior pituitary (AP). We have previously reported that mice lacking leptin receptors in AP ##somatotropes## display growth hormone (GH) deficiency, metabolic dysfunction, and adult-onset obesity. Among other targets, leptin signaling promotes increased levels of the pituitary transcription factor POU1F1, which in turn regulates the specification of somatotrope, lactotrope, and thyrotrope cell lineages within the AP. Leptin&apos;s mechanism of action on somatotropes is sex dependent, with females demonstrating posttranscriptional control of Pou1f1 messenger RNA (mRNA) translation. Here, we report that the stem cell marker and mRNA translational control protein, Musashi1, exerts repression of the Pou1f1 mRNA. In female somatotropes, Msi1 mRNA and protein levels are increased in the mouse model that lacks leptin signaling (Gh-CRE Lepr-null), coincident with lack of POU1f1 protein, despite normal levels of Pou1f1 mRNA. Single-cell RNA sequencing of pituitary cells from control female animals indicates that both Msi1 and Pou1f1 mRNAs are expressed in Gh-expressing somatotropes, and immunocytochemistry confirms that Musashi1 protein is present in the somatotrope cell population. We demonstrate that Musashi interacts directly with the Pou1f1 mRNA 3&apos; untranslated region and exerts translational repression of a Pou1f1 mRNA translation reporter in a leptin-sensitive manner. Musashi immunoprecipitation from whole pituitary reveals coassociated Pou1f1 mRNA. These findings suggest a mechanism in which leptin stimulation is required to reverse Musashi-mediated Pou1f1 mRNA translational control to coordinate AP somatotrope function with metabolic status.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7814296</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33373440</oboInOwl:hasDbXref>
        <rdfs:label>somatotropes</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002312"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/8eb44da3-00b8-42b8-860a-8bad2992a54e"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002312"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/8eca7ee8-4ecc-40e3-83e0-7911f36ec824 -->

    <Class rdf:about="http://example.org/8eca7ee8-4ecc-40e3-83e0-7911f36ec824">
        <obo:IAO_0000115>An increasing number of human cancers appears to consist of phenotypically divergent tumor cell types, which recapitulate stages of normal development. We and others recently showed that neuroblastoma is composed of two cell types that reflect developmental stages of the adrenergic lineage. Mesenchymal-type (MES) neuroblastoma cells resemble neural crest derived precursor cells, while adrenergic-type (ADRN) cells are committed to the adrenergic lineage. Both cell types can spontaneously interconvert, providing neuroblastoma with a high transcriptional plasticity. Chemotherapy might select for the ##MES type cells##, as suggested by enrichment of these cells in post-treatment samples and in relapses. Also glioblastoma, melanoma, and oligodendroglioma include heterogeneous populations of tumor cells. Both in glioblastoma and neuroblastoma, the more undifferentiated cell types have mesenchymal phenotypes and are more drug resistant, supporting the concept that lineage fate decisions are important drivers of therapy resistance in cancer.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6449373</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:30948783</oboInOwl:hasDbXref>
        <rdfs:label>MES type cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0008019"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/8eca7ee8-4ecc-40e3-83e0-7911f36ec824"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0008019"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/8efc3cdd-b68f-4586-b7ff-9dfd95301fbd -->

    <Class rdf:about="http://example.org/8efc3cdd-b68f-4586-b7ff-9dfd95301fbd">
        <obo:IAO_0000115>The generation of terminally differentiated cell lineages during organogenesis requires multiple, coordinated cell fate choice steps. However, this process has not been clearly delineated, especially in complex solid organs such as the pancreas. Here, we performed single-cell RNA-sequencing in pancreatic cells sorted from multiple genetically modified reporter mouse strains at embryonic stages E9.5-E17.5. We deciphered the developmental trajectories and regulatory strategies of the exocrine and endocrine pancreatic lineages as well as ##intermediate progenitor## populations along the developmental pathways. Notably, we discovered previously undefined programs representing the earliest events in islet alpha- and beta-cell lineage allocation as well as the developmental pathway of the &quot;first wave&quot; of alpha-cell generation. Furthermore, we demonstrated that repressing ERK pathway activity is essential for inducing both alpha- and beta-lineage differentiation. This study provides key insights into the regulatory mechanisms underlying cell fate choice and stepwise cell fate commitment and can be used as a resource to guide the induction of functional islet lineage cells from stem cells in vitro.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6463266</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:30737258</oboInOwl:hasDbXref>
        <rdfs:label>intermediate progenitor</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0011026"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/8efc3cdd-b68f-4586-b7ff-9dfd95301fbd"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0011026"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/8f159537-6798-48cb-a6e3-c942788b4e45 -->

    <Class rdf:about="http://example.org/8f159537-6798-48cb-a6e3-c942788b4e45">
        <obo:IAO_0000115>Checkpoint immunotherapy unleashes T cell control of tumors, but is undermined by immunosuppressive myeloid cells. TREM2 is a myeloid receptor that transmits intracellular signals that sustain microglial responses during Alzheimer&apos;s disease. TREM2 is also expressed by ##tumor-infiltrating macrophages##. Here, we found that Trem2-/- mice are more resistant to growth of various cancers than wild-type mice and are more responsive to anti-PD-1 immunotherapy. Furthermore, treatment with anti-TREM2 mAb curbed tumor growth and fostered regression when combined with anti-PD-1. scRNA-seq revealed that both TREM2 deletion and anti-TREM2 are associated with scant MRC1+ and CX3CR1+ macrophages in the tumor infiltrate, paralleled by expansion of myeloid subsets expressing immunostimulatory molecules that promote improved T cell responses. TREM2 was expressed in tumor macrophages in over 200 human cancer cases and inversely correlated with prolonged survival for two types of cancer. Thus, TREM2 might be targeted to modify tumor myeloid infiltrates and augment checkpoint immunotherapy.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7485282</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32783918</oboInOwl:hasDbXref>
        <rdfs:label>tumor-infiltrating macrophages</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/8f159537-6798-48cb-a6e3-c942788b4e45"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/8f3a2177-7317-42a7-95e4-e24480aa2a87 -->

    <Class rdf:about="http://example.org/8f3a2177-7317-42a7-95e4-e24480aa2a87">
        <obo:IAO_0000115>Cell type	#DHC-thresholded labels/#actual labels with subcellular localization	HBNet:DHC % accuracy (#labels)	 	Cyt	Cyt, Mem	Mem	Nucl	Nucl, Cyt	Nucl, Cyt, Mem	Nucl, Mem	 	Spermatogonia	518/521	99.5 (204/205)	97.6 (41/42)	100.0 (5/5)	99.5 (201/202)	100.0 (40/40)	100.0 (25/25)	100.0(2/2)	 	##Preleptotene spermatocytes##	357/360	100.0 (121/121)	100.0 (30/30)	100.0(2/2)	98.17 (161/164)	100.0(15/15)	100.0(28/28)	0	 	Pachytene spermatocytes	388/391	99.3 (145/146)	100.0 (66/66)	100.0 (4/4)	98.5 (135/137)	100.0 (9/9)	100.0 (29/29)	0	 	Round/early spermatids	361/362	99.2 (131/132)	100.0 (57/57)	0	100.0 (147/147)	100.0 (10/10)	100.0 (16/16)	0	 	Elongated/late spermatids	405/409	98.2 (215/219)	100.0 (83/83)	0	100.0 (67/67)	100.0 (22/22)	100.0 (18/18)	0	 	Sertoli cells	225/231	97.8 (87/89)	100.0 (31/31)	100.0 (6/6)	95.2 (79/83)	100.0 (1/1)	100.0 (11/11)	100.0 (10/10)	 	Leydig cells	466/470	98.9 (277/280)	100.0 (71/71)	100.0 (5/5)	100.0 (81/81)	100.0 (25/25)	100.0 (7/7)	0	 	Peritubular cells	105/120	89.3 (50/56)	100.0 (9/9)	83.7 (46/55)	0	0	0	0	 	Average all cell types	2825/2864	97.78	99.7	97.28	98.77	100	100	100	 	</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8476775</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34425263</oboInOwl:hasDbXref>
        <rdfs:label>Preleptotene spermatocytes</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000656"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/8f3a2177-7317-42a7-95e4-e24480aa2a87"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000656"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/8f563cd8-5c4a-4381-b5cd-78956145e1cb -->

    <Class rdf:about="http://example.org/8f563cd8-5c4a-4381-b5cd-78956145e1cb">
        <obo:IAO_0000115>Overview of interactions among chondrocyte subtypes. (A,B) Total number and intensity of interactions in chondrocytes. (C-J) Interactions between different subtypes of chondrocytes. (C) indicates undefined cell subtypes, (D) indicates ECs, (E) indicates FCs, (F) indicates ##HomCs##, (G) indicates HTCs, (H) indicates preHTCs, (I) indicates ProCs, and (J) indicates RegCs.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10475121</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37660146</oboInOwl:hasDbXref>
        <rdfs:label>HomCs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000138"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/8f563cd8-5c4a-4381-b5cd-78956145e1cb"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000138"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/8faa1f79-cf25-4fe7-a41c-f2c1d65068c6 -->

    <Class rdf:about="http://example.org/8faa1f79-cf25-4fe7-a41c-f2c1d65068c6">
        <obo:IAO_0000115>Other groups have used murine- and blood-based immune population gene profiles to characterize lung adenocarcinoma immune microenvironments with digital cytometry. In order to develop human ##tumor infiltrating leukocyte## profiles specific to stage I lung adenocarcinomas, we performed single-cell RNA-seq (scRNA-seq) analysis on freshly resected samples from six patients who underwent complete surgical resection of stage I tumors at UCSF. Twenty distinct immune cell populations were identified by scRNA-seq analysis including 10 adaptive immune populations (helper T-cells, cytotoxic T-cells, exhausted cytotoxic T-cells, deltagamma T-cells, naive T-cells, regulatory T-cells, B cells, plasma cells, NKT cells, and NK cells) and 10 innate immune populations (M1 macrophages, M2 macrophages, classical monocytes, intermediate monocytes, non-classical monocytes, mast cells, conventional dendritic cells 1, conventional dendritic cells 2, plasmacytoid dendritic cells, and neutrophils) (Fig. 5A). These novel tumor infiltrating leukocyte profiles were used to calculate immune cell population densities from bulk RNA-seq data in the TCGA stage I lung adenocarcinoma population using digital cytometry.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8654957</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34880292</oboInOwl:hasDbXref>
        <rdfs:label>tumor infiltrating leukocyte</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000738"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/8faa1f79-cf25-4fe7-a41c-f2c1d65068c6"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000738"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/8fac0456-2816-4cb1-b3b3-b9f8ef97e2d8 -->

    <Class rdf:about="http://example.org/8fac0456-2816-4cb1-b3b3-b9f8ef97e2d8">
        <obo:IAO_0000115>2.1. Effects of Hyperosmolarity on ##Ocular Surface Epithelial Cells##</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10341472</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37446230</oboInOwl:hasDbXref>
        <rdfs:label>Ocular Surface Epithelial Cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:1000432"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/8fac0456-2816-4cb1-b3b3-b9f8ef97e2d8"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:1000432"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/8fb45710-1ce6-4c90-bdfb-f050f2a2978d -->

    <Class rdf:about="http://example.org/8fb45710-1ce6-4c90-bdfb-f050f2a2978d">
        <obo:IAO_0000115>Next, we analyzed the interactions between these ligand-receptor pairs from the TME among 12 kinds of immune cells, and found that CCL5-CCR1 mainly sends signals of CD8+ T cells and NK Cells, which may interact with pDCs, macrophages, cDC2s, and myeloid cells via the interaction of CCL5 and CCR1. The SELPLG-SELL ligand-receptor pair is the main interaction among CD4+ T cells, NK cells, myeloid cells, and naive B cells. Furthermore, NOTCH2-cDCs interact with pDCs, CD4+ T cells, cCD2s, NK cells, myeloid cells, naive B cells, and cDC1s. Both migDCs and cDC1s interact with CD4+ T cells, pDCs, cCD2s, NK Cells, myeloid cells, and naive B cells. The CXCL10-CXCR3 ligand-receptor pair is the main interaction among pDCs, migDCs, and CD4+ T cells, and the CXCL9-CXCR3 ligand-receptor pair is the main interaction among pDCs, cDC1s, migDCs, and CD4+ T cells (Fig. 8C). We also used a violin plot to visualize the signal gene expression distribution in the three signaling pathways inferred by CellChat. The results showed that CCL5 is mainly expressed on CD8+ T and NK cells, and its corresponding receptors are mainly in macrophages, myeloid cells, cCD2s, and pDCs. SELPLG is mainly expressed on CD4+ T cells, NOTCH2-##cDCs##, migDCs, and cDC1s, and its corresponding receptor, SELL, is mainly expressed on naive B cells, myeloid cells, NK cells, cCD2s, pDCs, CD4+ T cells, and cCD1s. CXCL9 is mainly expressed on pDCs, migDCs, and cDC1s, CXCL10 is mainly expressed on pDCs and migDCs, and their corresponding receptor, CXCR3, is mainly expressed on CD4+ T cells (Fig. 8D).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9203818</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35710862</oboInOwl:hasDbXref>
        <rdfs:label>cDCs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000990"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/8fb45710-1ce6-4c90-bdfb-f050f2a2978d"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000990"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/80b6c09a-1a44-478c-a5d9-bf0e3e8d275b -->

    <Class rdf:about="http://example.org/80b6c09a-1a44-478c-a5d9-bf0e3e8d275b">
        <obo:IAO_0000115>MP cells, in particular macrophages, have a key role in tissue repair. Many studies have shown that inflammatory monocytes can be converted in situ into cells exhibiting a reparative phenotype. Our findings show that following corneal chemical injury, Ly6Cint restorative MP (CD11Bhi F4/80int) are mostly highly expressed on day 3 post-injury. Differentiation of corneal MPs based on surface markers is not trivial, and although many studies have considered that all CD11b+ F4/80+ represent macrophages, recent studies have suggested that CD64 surface marker can help differentiate corneal macrophages from monocytes. Our subsequent analysis of the Ly6C expression gating for ##CD11b+ F4/80int CD11c- CD64+ recruited macrophages## showed a similar frequency pattern with a gradual shift in frequency from Ly6Chigh to Ly6Cint on day 3 and Ly6Cneg on day 6.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8910730</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35269717</oboInOwl:hasDbXref>
        <rdfs:label>CD11b+ F4/80int CD11c- CD64+ recruited macrophages</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/80b6c09a-1a44-478c-a5d9-bf0e3e8d275b"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/801e0479-10f4-4aec-ac4d-e17d4bac68c4 -->

    <Class rdf:about="http://example.org/801e0479-10f4-4aec-ac4d-e17d4bac68c4">
        <obo:IAO_0000115>Focusing on the peripheral, differentiated cDC populations, we next assessed protein expression of the IRF8 transcription factor in tumor-derived cDC populations (Fig. 3a). In the periphery, IRF8 controls survival and function of terminally differentiated ##cDC1s##. Furthermore, increased IRF8 expression in CD11b-CD103- DN cells was shown to promote their differentiation into mature CD103+ cDC1s. Thus, we hypothesized that CD40L-CAR T cell treatment skews the cDC1/cDC2 ratio towards the cDC1 populations by stimulating the DN cells to expand, upregulate IRF8, and differentiate into cDC1s. We specifically noticed upregulation of IRF8 (readout of DN-to-cDC1 differentiation) and Ki-67 (readout for proliferation) in DN cells treated with CD40L-CAR T cell-treated mice (Fig. 3b). The increased expression of Ki-67 in the tumor-derived DN cells also correlated with the observed increase of the DN population in the tumor of CD40L-CAR T cell-treated mice (Fig. 1f), indicating that DN cells receive a proliferative signal upon CD40L-CAR T cell treatment. Intriguingly, splenic DN cells and DN cells from the tdLNs did not upregulate Ki-67 or IRF8 (Fig. 3c, d). Overall, tdLN cDCs did not present with a stimulated phenotype, as suggested by the lack of CD86 or Ki-67 upregulation (Supplementary Fig. 2D-G). This suggested a tumor-specific effect of cDC DN stimulation after m1928z-CD40L treatment.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7710757</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33268774</oboInOwl:hasDbXref>
        <rdfs:label>cDC1s</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000990"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/801e0479-10f4-4aec-ac4d-e17d4bac68c4"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000990"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/802ed803-68db-41f2-9a02-b5ec25761286 -->

    <Class rdf:about="http://example.org/802ed803-68db-41f2-9a02-b5ec25761286">
        <obo:IAO_0000115>Prostate cancer (PC) is the second most common malignancy in men worldwide, and is associated with high morbidity and mortality in patients with high-risk disease. There is an urgent need to dissect the pathophysiological mechanisms of PC progression, which will enable the development of new treatment strategies. While the vast majority of research on PC has focused on malignant epithelial cells, it is evident that the tumour microenvironment (TME), comprised of extracellular matrix (ECM) and diverse cell types, plays a major role in cancer development and progression. Stromal fibroblasts, including ##carcinoma-associated fibroblasts## (CAFs), are a predominant population of cells in the TME and there is convincing evidence that they actively promote progression to advanced disease. CAFs isolated from human prostatic specimens stimulate cancer cell proliferation, increase neovascularisation within the tumour and enhance epithelial-mesenchymal transition (EMT) to facilitate metastasis. CAFs communicate with each other, the other cells within the TME as well as cancer cells in a reciprocal manner via soluble mediators and paracrine signalling. Further understanding the complex signalling mechanisms underpinning tumour stroma-cancer cell interactions during PC progression will enable the identification of novel biomarkers and/or treatment strategies.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9747870</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36169805</oboInOwl:hasDbXref>
        <rdfs:label>carcinoma-associated fibroblasts</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000057"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/802ed803-68db-41f2-9a02-b5ec25761286"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000057"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/8031f56b-ff5b-4fc9-bb49-fb4b8a0e478f -->

    <Class rdf:about="http://example.org/8031f56b-ff5b-4fc9-bb49-fb4b8a0e478f">
        <obo:IAO_0000115>Innate lymphoid cells (ILCs) belong to a family of immune cells. Recently, ILCs have been classified into five different groups that mirror the function of adaptive T cell subsets counterparts. In particular, NK cells mirror CD8+ cytotoxic T cells while ILC1, ILC2, ILC3, and ##Lymphoid tissue inducer (LTi)-like cells## reflect the function of CD4+T helper (Th) cells (Th1, Th2, and Th17 respectively). ILCs are involved in innate host defenses against pathogens and tumors, in lymphoid organogenesis, and in tissue remodeling/repair. In recent years, important molecular inducible checkpoints (PD-1, TIM3, and TIGIT) were shown to control/inactivate different immune cell types. The expression of many of these receptors has been detected on NK cells and subsets of tissue-resident ILCs in both physiological and pathological conditions, including cancer. In particular, it has been demonstrated that the interaction between PD-1+ immune cells and PD-L1/PD-L2+ tumor cells may compromise the anti-tumor effector function leading to tumor immune escape. However, while the effector function of NK cells in tumor is well-established, limited information exists on the other ILC subsets. We will summarize what is known to date on the expression and function of these checkpoint receptors on NK cells and ILCs, with a particular focus on the recent data that reveal an essential contribution of the blockade of PD-1 and TIGIT on NK cells to the immunotherapy of cancer. A better information regarding the presence and the function of different ILCs and of the inhibitory checkpoints in pathological conditions may offer important clues for the development of new immune therapeutic strategies.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6498986</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31105707</oboInOwl:hasDbXref>
        <rdfs:label>Lymphoid tissue inducer (LTi)-like cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0011018"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/8031f56b-ff5b-4fc9-bb49-fb4b8a0e478f"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0011018"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/8047b336-b1fe-4a43-b5d7-897fa1dad1ab -->

    <Class rdf:about="http://example.org/8047b336-b1fe-4a43-b5d7-897fa1dad1ab">
        <obo:IAO_0000115>Although tumor-infiltrating T cells hold a beneficial prognostic role in colorectal cancer, other lymphocytic populations are less characterized. We developed a multiplexed immunofluorescence assay coupled with digital image analysis and machine learning to identify natural killer (NK) cells (NCAM1+CD3-), natural killer T-like (NKT-like) cells (NCAM1+CD3+), and T cells (NCAM1-CD3+) within the PTPRC+ (CD45+) cell population and to measure their granzyme B (GZMB; cytotoxicity marker) and FCGR3A (CD16a; NK-cell maturity marker) expression. We evaluated immune cell densities and spatial configuration in 907 incident colorectal carcinoma cases within two prospective cohort studies. We found that T cells were approximately 100 times more abundant than NK and NKT-like cells. Overall, NK cells showed high GZMB expression and were located closer to tumor cells than ##T and NKT-like cells##. In T and NKT-like cells, GZMB expression was enriched in cells in closer proximity to tumor cells. Higher densities of both T and NKT-like cells associated with longer cancer-specific survival, independent of potential confounders (P trend &lt; 0.0007). Higher stromal GZMB+ and FCGR3A+ NK-cell densities associated with longer cancer-specific survival (P trend &lt; 0.003). For T and NKT-like cells, greater proximity to tumor cells associated with longer cancer-specific survival (P trend &lt; 0.0001). These findings indicate that cytotoxic NCAM1+CD3-GZMB+ NK cells and NCAM1+CD3+ NKT-like cells are relatively rare lymphocytic populations within the colorectal cancer microenvironment and show distinct spatial configuration and associations with patient outcome. The results highlight the utility of a quantitative multimarker assay for in situ, single-cell immune biomarker evaluation and underscore the importance of spatial context for tumor microenvironment characterization.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8816895</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34937729</oboInOwl:hasDbXref>
        <rdfs:label>T and NKT-like cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000084"/>
        <skos:relatedMatch rdf:resource="CL:0000814"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/8047b336-b1fe-4a43-b5d7-897fa1dad1ab"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000084"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/8047b336-b1fe-4a43-b5d7-897fa1dad1ab"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000814"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/807713cd-8378-4b8e-b88c-fbd4303d4c5d -->

    <Class rdf:about="http://example.org/807713cd-8378-4b8e-b88c-fbd4303d4c5d">
        <obo:IAO_0000115>Lung epithelial cells are known primary targets for SARS-CoV-2 infection, but it has recently been proposed that lung ECs may also become infected. Our previously published scRNA-seq dataset of ##pulmonary vascular cells## did not reveal Ace2 expression in lung vascular cells but showed a distinct Ace2 signal in epithelial cells co-expressing markers of multiciliation or surfactant secretion (Figure S4A (http://betsholtzlab.org/VascularSingleCells/database.html), pointing to ciliated bronchial epithelial cells and alveolar type II (AT-II) cells as sites of Ace2 expression. To more precisely define the Ace2-expressing cell type, we integrated data from three published and two unpublished adult mouse lung scRNA-seq datasets (Figures 4A and 4B; available for gene-by-gene browsing at http://betsholtzlab.org/Publications/LungIntegration/search.html). The integrated data showed significant Ace2 expression only in AT-II (surfactant protein C [Sftpc]-positive) and Foxj1-positive multiciliated airway epithelial cells (Figures 4B-4D and S4A). No robust Ace2 expression was observed in any of the subtypes of vascular ECs (Pecam1-positive), mural cells (Notch3-positive), fibroblasts (Pdgfra-positive, Notch3-negative), alveolar macrophages, or other hematopoietic cells (Ptprc-positive) (Figure 4D).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9022216</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35452595</oboInOwl:hasDbXref>
        <rdfs:label>pulmonary vascular cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:1001567"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/807713cd-8378-4b8e-b88c-fbd4303d4c5d"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:1001567"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/8084ad9d-4a7b-4921-ac04-1847b2519568 -->

    <Class rdf:about="http://example.org/8084ad9d-4a7b-4921-ac04-1847b2519568">
        <obo:IAO_0000115>MOUSE ##SYMPATHO-ADRENAL CELL## TYPES MARKERS   SNPCs Ret Phox2b Ascl1 Mycn Hand2 Gata3Sox10- Plp1-   Sympathoblasts extra-adrenal Phox2b Mycn Th Dbh Ret Cart CartptSox10- Plp1- Sgc10- Ascl1 -   Sympathetic neurons/ganglia/SRG Ret Scg10 Cart Ascl1 Phox2b Th DbhSox10- Plp1-   SCPs Sox10 Plp1 Ascl1 Phox2bRet-   Schwann cells Sox10 Plp1 GfapPhox2b-   Bridge cells Sox10 Plp1 Chga Penk Htr3a Ascl1 Phox2bTh- Ret-   Immature chromaffin cells Chga Chgb Penk Th DbhSox10- Plp1- Ret-   Chromaffin cells Chga Penk Ascl1 Phox2b Th DbhSox10- Plp1- Ret-   Sympathoblasts intra-adrenal Ret Cart Cartpt Phox2b Th Alk Hmx1 PrphSox10- Plp1-   Sympathetic neurons intra-adrenal Ret Cart Ascl1 Phox2b ThSox10- Plp1-   </obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8915499</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35277192</oboInOwl:hasDbXref>
        <rdfs:label>SYMPATHO-ADRENAL CELL</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000166"/>
        <skos:relatedMatch rdf:resource="CL:0011012"/>
        <skos:relatedMatch rdf:resource="CL:0011103"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/8084ad9d-4a7b-4921-ac04-1847b2519568"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000166"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/8084ad9d-4a7b-4921-ac04-1847b2519568"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0011012"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/8084ad9d-4a7b-4921-ac04-1847b2519568"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0011103"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/809fd319-d9de-4a81-a5b4-4e3ac80ed2c7 -->

    <Class rdf:about="http://example.org/809fd319-d9de-4a81-a5b4-4e3ac80ed2c7">
        <obo:IAO_0000115>a Due to single-cell annotation and in situ validation (Fig. 2; Supplementary Fig. 3), a draft model of the oral-to-tooth transition zone in humans is presented, with basal and suprabasal keratinocyte markers uniquely identifying the alveolar mucosa (AM), attached gingiva (AG), gingival margin (GM), sulcular epithelium (SK) and junctional epithelium (JK). b These markers allowed for KRT19-high keratinocyte (KC) cell subclustering for the first time (2504 cells in total), including ##gingival margin keratinocytes## (GM), sulcular keratinocytes (SK), and junctional keratinocytes (JK). c A more granular draft (Tier 4) annotation of epithelial cells of the gingival attachment. d Assaying differentially expressed genes in periodontitis, SKs and JKs only share about a quarter of upregulated genes. JKs displayed nearly 125 unique upregulated genes in diseased cells. e Further analysis of basal and suprabasal (differentiating) SK and JK keratinocytes revealed unique cell signatures between basal and suprabasal cell types. This full list is included in Supplementary Data 1. f-i To understand SK and JK developmental progression and cell state alterations, we used partitioned-based graph abstraction (PAGA). f Examining the basal to suprabasal transition, JKs display altered gene expressed comparing health to disease cell types, including broader expression of KRT17 and more expression of JUND, COL17A1, and CDH3. Key differentiation genes such as SPRR family members were also downregulated. g JKs displayed robust cell signaling and inflammatory phenotypes, which appear exacerbated in disease states. h In SKs, differentiation-related genes were uniquely expressed compared to JKs in health but also appeared altered in disease along the basal to suprabasal trajectory. i SKs appeared generally less reactive compared to JKs in disease, with lower overall expression of effector molecules such as CXCL1, CXCL8, IL1A, IL1B, and IL1RN. Abbreviations: Merk Merkel Cells, LC langerhans cells, Mela melanocytes, Muc mucosa, SB suprabasal Keratinocytes; for others, see Fig. 1 legend. For this figure, n = 30-sample, 2504-cell for scRNAseq.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11178863</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38876998</oboInOwl:hasDbXref>
        <rdfs:label>gingival margin keratinocytes</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002170"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/809fd319-d9de-4a81-a5b4-4e3ac80ed2c7"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002170"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/81b6792d-7530-489f-885d-fb3d216e72c3 -->

    <Class rdf:about="http://example.org/81b6792d-7530-489f-885d-fb3d216e72c3">
        <obo:IAO_0000115>To investigate the developmental origin of the CD34+PRLR+ cells, freshly isolated CD34+ HSCs were sorted into MLP, CMP, GMP and NK/BP (Fig. 2A), and cultured as described above. PRLR-expressing cells were mainly generated from the GMP compartment (Fig. 2B-D). At day 4 of culture, FACS sorted PRLR+ progenitors lacked all lineage markers except for CD15 and CD43, further supporting their myeloid origin (Fig. 2E). Evaluation of these cells at later time points (day + 14) showed that they remain CD15+, and acquired CD11a, CD11b, CD11c, CD16, CD18, CD45RO and CD123 (Fig. 2F). To study their differentiation, we sorted CD34+PRLR+ cells from four-day expanded CD34+ HSCs (as shown in Fig. 1A). As above, in the presence of ILC promoting cytokines (IL-3, IL-7, IL-15, IL-23, SCF and FLT3L) the CD34+PRLR+ progenitors differentiate into immature myeloid cells (Fig. 3A-C). Addition of GM-CSF at later times (day + 21) resulted in the generation of mature granulocytes expressing CD15, CD16 and CD66b (Fig. 3A-C). Previously, we showed that some myeloid progenitors could give rise to CD56+ lymphocytes. However, sorted ##CD34+PRLR-##, but not CD34+PRLR+ cells gave rise to CD56+ lymphocytes (Fig. 4A-C). Moreover, the CD34+PRLR+ progenitors do not express integrin alpha4beta7, a marker that defines innate lymphoid precursors with the potential to develop into ILCs (Fig. 4C). In further support of these findings, the CD34+PRLR+ progenitors do not differentiate into CD94+, CD127+ and CD336+ lymphocytes (Fig. 4D). Collectively, these findings show that CD34+PRLR+ progenitors develop from the GMPs under the influence of SCF and FLT3L, thereby acquire various myeloid markers and seem to lack lymphoid potential.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7156717</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32286456</oboInOwl:hasDbXref>
        <rdfs:label>CD34+PRLR-</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0001024"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/81b6792d-7530-489f-885d-fb3d216e72c3"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0001024"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/81d65824-e31b-464c-8a9d-e74d071a4a2a -->

    <Class rdf:about="http://example.org/81d65824-e31b-464c-8a9d-e74d071a4a2a">
        <obo:IAO_0000115>Lung epithelial cells are known primary targets for SARS-CoV-2 infection, but it has recently been proposed that lung ECs may also become infected. Our previously published scRNA-seq dataset of pulmonary vascular cells did not reveal Ace2 expression in ##lung vascular cells## but showed a distinct Ace2 signal in epithelial cells co-expressing markers of multiciliation or surfactant secretion (Figure S4A (http://betsholtzlab.org/VascularSingleCells/database.html), pointing to ciliated bronchial epithelial cells and alveolar type II (AT-II) cells as sites of Ace2 expression. To more precisely define the Ace2-expressing cell type, we integrated data from three published and two unpublished adult mouse lung scRNA-seq datasets (Figures 4A and 4B; available for gene-by-gene browsing at http://betsholtzlab.org/Publications/LungIntegration/search.html). The integrated data showed significant Ace2 expression only in AT-II (surfactant protein C [Sftpc]-positive) and Foxj1-positive multiciliated airway epithelial cells (Figures 4B-4D and S4A). No robust Ace2 expression was observed in any of the subtypes of vascular ECs (Pecam1-positive), mural cells (Notch3-positive), fibroblasts (Pdgfra-positive, Notch3-negative), alveolar macrophages, or other hematopoietic cells (Ptprc-positive) (Figure 4D).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9022216</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35452595</oboInOwl:hasDbXref>
        <rdfs:label>lung vascular cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:1001567"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/81d65824-e31b-464c-8a9d-e74d071a4a2a"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:1001567"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/81ed28ee-7587-4505-bb06-67e246d11299 -->

    <Class rdf:about="http://example.org/81ed28ee-7587-4505-bb06-67e246d11299">
        <obo:IAO_0000115>	Cell clusters (percentage)	Cell ontogeny	Transmigration pathway	Cell subsets	Subset/tissue-specific signatures	References	 	Dura mater	BAMs(35%)	Bone marrow	Peripheral circulation	Dhi-BAM	H2-Aa, Cd74, Ccr2, H2-Eb1	2019 	 	Dlo-BAM	Ccl8, Pla2g2d, Cfp	 	DCs(19%)	-	-	##cDC1##	Flt3, Xcr1	 	cDC2	Flt3, Cd209a, Itgax	 	migDCs	Ccr7, Nudt17	 	pDCs	Siglech, Ccr9, Pacsin1	 	Monocytes(16%)	Adjacent skull and vertebral bone marrow#; peripheral blood*	Bone marrow-dura channels#; peripheral circulation*	Classical monocytes	Ly6c2	2021, 2019 	 	Non-classical monocytes	Itgal	 	Intermediate monocytes	Fcgr1	 	Neutrophils(12%)	Adjacent skull and vertebral bone marrow#; peripheral blood*	Bone marrow-dura channels#; peripheral circulation*	Neutrophils	Ly6g, Itgam	 	B cells(7%)	Adjacent skull and vertebral bone marrow#; peripheral blood*	Bone marrow-dura channels#; peripheral circulation*	Pro-B cells	Vpreb1, Igll1, Dntt, Lef1, Tspan13, Smarca4	2021, 2019 	 	Pre-B cells	Dnajc7, Rag1, Cecr2, Sox4, Myb	 	Immature B cells	Ms4a1, Ly6d, Hck, Cd24a, Spib, Ccnd2, Cd72	 	Mature naive B cells	Rps29, Rpl38, Rps27, Rpl21, Igkc	 	Mitotic B cells	Top2a, Mki67	 	T cells(4%)	Peripheral blood	Peripheral circulation	T cells	Cd3e	2019 	 	NK cells(4%)	-	-	NK cells	Klrb1c	 	Subdural meninges	Microglia(67%)	Embryo	Tissue residency	Microglia	Sparc, Mertk, Cx3cr1, Csf1r, Itgam, Aif1, Cd68, Fcgr1	2019 	 	BAMs(23%)	Embryo	Tissue residency	BAMs	Lyve1, P2rx7, Egfl7	 	DCs(2.6%)	-	-	cDC1	Flt3, Xcr1	 	cDC2	Flt3, Cd209a, Itgax	 	Monocytes(2%)	-	-	Classical monocytes	Ly6c2	 	Non-classical monocytes	Itgal	 	T cells(3%)	-	-	T cells	Cd3e	 	B cells(1%)	-	-	B cells	Cd19	 	NK cells(1%)	-	-	NK cells	Klrb1c	 	</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10210344</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37231449</oboInOwl:hasDbXref>
        <rdfs:label>cDC1</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000990"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/81ed28ee-7587-4505-bb06-67e246d11299"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000990"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/811d46c4-e170-4726-b816-a0515b4ecd62 -->

    <Class rdf:about="http://example.org/811d46c4-e170-4726-b816-a0515b4ecd62">
        <obo:IAO_0000115>A, B, tSNE plot of 4659 CD45+ immune cells from the CNS. Data from this study is integrated with data from; Table 6). C, D, Each dataset represented by one tSNE. Cells are annotated using color representing their cell type. bMicroglia: baseline microglia; aMicroglia: activated microglia; pmMicroglia: proliferation-mediating microglia; maMicroglia: monocyte-activating microglia; DAM: disease-associated microglia in SCI; elMicroglia: embryonic-like microglia; pvMacrophages: perivascular macrophages; mdMacrophages: monocyte-derived macrophages; DCs: dendritic cells; imB-cells: immature B-cells; mB-cells: mature B-cells; pimMicroglia: postnatal immature microglia; IEG+Microglia: immediate early genes microglia; sMicroglia: s-phase microglia; ##pPAM##: postnatal proliferative-region-associated microglia; eMicroglia: embryonic microglia; pcpMacrophages: postnatal choroid plexus macrophages; acpMacrophages: adult choroid plexus macrophages; iMonocytes: inflammatory monocytes; pMonocytes: patrolling monocytes; cpEpithelial cells: choroid plexus epithelial cells. E, tSNE plots of 4659 CD45+ immune cells for selected genes indicating the log2(cpm) expression with a continuous color for each cell separately. F, Proliferation rate of CD45low and CD45high cells at 7 and 21 d post-SCI. Hoechst 33342 expression presented on a log-scale was used for defining cells in S-phase. Right most plot reports the percentage of cells in S-phase. Each dot represents one biological replicate (four mice per time point). Mean is surrounded by a 95% CI. This figure is extended in Extended Data Figure 8-1.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8496189</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34417326</oboInOwl:hasDbXref>
        <rdfs:label>pPAM</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000129"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/811d46c4-e170-4726-b816-a0515b4ecd62"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000129"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/81170ebf-d6d5-4001-a92c-a94e90dab97c -->

    <Class rdf:about="http://example.org/81170ebf-d6d5-4001-a92c-a94e90dab97c">
        <obo:IAO_0000115>High levels of Oct4 mRNA were found in the 2-cell blastomere population in all conditions, followed by a decrease at the 4-cell stage and a strong increase in 8-cell blastomeres (Fig. 5E), an expression pattern reflecting the transition of maternal-to-zygotic Oct4 transcripts at the 4-cell stage (Wu and Scholer). There was a decrease of Oct4 expression in the bulk of both Ahr-/- and Ahr+/+-TCDD groups relative to Ahr+/+ at the 8-cell stage and in Ahr-/- than in Ahr+/+ 2-cell blastomeres. Similarly, we found a significant decrease of Oct4 expression in both Ahr-/- and Ahr+/+-TCDD, notably in both embryonic and differentiating blastomeres relative to the corresponding Ahr+/+ 8-cell subpopulations; in all conditions, differentiating blastomeres at 8-cell stage had higher expression levels than their embryonic counterparts (Fig. 5F). Furthermore, the levels of Oct4 transcription in Ahr-/- and Ahr+/+-TCDD 4-cell embryonic blastomeres decreased or had a trend to decrease, respectively, relative to the corresponding Ahr+/+ blastomeres. The levels of Cdx2 mRNA were high in all 8-cell blastomeres analyzed and were significantly decreased or trended to decrease in the bulk of Ahr-/- and Ahr+/+-TCDD relative to the ##Ahr+/+ 8-cell population## (Fig. 5G). The Cdx2 mRNA levels were higher in Ahr+/+ and Ahr-/- 8-cell differentiating blastomeres than in their embryonic counterparts, with the Ahr-/- 8-cell differentiating blastomeres showing lower expression than the corresponding Ahr+/+ subpopulation (Fig. 5H). Additionally, some Ahr+/+-TCDD 8-cell embryonic blastomeres showed unusually high levels of Cdx2 mRNA causing the indistinguishable difference between embryonic and differentiating subpopulations.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10425484</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36029422</oboInOwl:hasDbXref>
        <rdfs:label>Ahr+/+ 8-cell population</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000353"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/81170ebf-d6d5-4001-a92c-a94e90dab97c"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000353"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/81269755-e91e-4ad6-8b27-0fbc72ab7adc -->

    <Class rdf:about="http://example.org/81269755-e91e-4ad6-8b27-0fbc72ab7adc">
        <obo:IAO_0000115>Molecularly defined cell populations can be highly discrete:such as the distinctions between chandelier and basket interneuron types in the cerebral cortex:or they can vary more continuously, such as the cross-regional differences among ##principal cells## of the striatum and cortex. The cerebellum is known to contain several canonical cell types that exist as morphological and functional continua, such as the basket and stellate interneurons of the molecular layer. To examine continuous features of molecular variation in greater detail within interneuron types, we created a metric to quantify and visualize the continuity of gene expression between two cell clusters. In brief, we fit a logistic curve for differentially expressed genes along the dominant expression trajectory, extracting the maximum slope (m) of the curve (Methods, Fig. 3a). We expect m values to be smaller for genes that are representative of more continuous expression variation (Fig. 3a).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8494635</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34616064</oboInOwl:hasDbXref>
        <rdfs:label>principal cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000540"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/81269755-e91e-4ad6-8b27-0fbc72ab7adc"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000540"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/82d74d5c-f86a-46e3-bd6d-91c409421f9e -->

    <Class rdf:about="http://example.org/82d74d5c-f86a-46e3-bd6d-91c409421f9e">
        <obo:IAO_0000115>Subpopulation identification of pancreatic mesenchymal cells in normal mice. (A) t-SNE illustration of four subgroups identified from sub-clustering of the ##mesenchymal cell## population, colored according to the cluster assignments (left panel). Tables demonstrating the top differentially expressed genes when comparing one subcluster to all other mesenchymal cells (right panel). (B) Violin plots showing representative marker genes in the subgroups. (C) Representative GO terms enriched for marker genes in Mes.4 based on a functional enrichment analysis. (D,E) Representative immunohistochemical images of pancreatic tissues from the control mice stained for Fn1 (red arrow) and Cxcl14 (black arrow). Scale bar = 50 mum.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9222509</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35741777</oboInOwl:hasDbXref>
        <rdfs:label>mesenchymal cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0008019"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/82d74d5c-f86a-46e3-bd6d-91c409421f9e"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0008019"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/82300849-fa46-4775-abe8-194a95797db2 -->

    <Class rdf:about="http://example.org/82300849-fa46-4775-abe8-194a95797db2">
        <obo:IAO_0000115>The quantification of multipotent HSPCs is commonly performed according to the lineage-relationships proposed by the classical model of human hematopoiesis. According to this classical model, HSCs and multipotent progenitors (MPPs) are the only cells containing both myeloid as well as lymphoid differentiation potentials. However, the classical model of hematopoiesis has meanwhile been challenged by several groups proposing alternative lineage-relationships and read-outs for multipotent HSCs/MPPs. In this context, we have shown that human CD133+CD45RA-CD34+ HSPCs are enriched for multipotent HSPCs. In vitro, more than 80% of these cells perform asymmetric cell divisions to create one CD133+CD45RA+CD34+ and one CD133-CD45RA-CD34+ daughter cell. While CD133+CD45RA+CD34+ cells inherit the potential to create all lymphocytes and neutrophils, CD133-CD45RA-CD34+ cells are limited to erythroid, megakaryocytic, basophilic and eosinophilic potentials. The first cell fulfills the criteria of LMPPs and the latter ones correspond to cells that are commonly known as common myeloid progenitors (CMP). As we demonstrated that they are not able to form neutrophils, it is no longer justified to interpret them as CMPs. Accordingly, we re-named them to erythro-myeloid progenitors (##EMPs##) and proposed a revised model for human hematopoiesis in which neutrophils arise from the same branch as lymphocytes (Fig. 1A). The segregation of lineage potentials as predicted in our revised model was recently confirmed in mouse as well as in human steady state BM hematopoiesis using single cell transcriptomics. According to the proposed model, multipotent HSPCs can easily and objectively be identified as CD133 expressing HSPCs containing erythroid differentiation potentials (Fig. 1A).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6733927</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31501490</oboInOwl:hasDbXref>
        <rdfs:label>EMPs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000038"/>
        <skos:relatedMatch rdf:resource="CL:0000839"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/82300849-fa46-4775-abe8-194a95797db2"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000038"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/82300849-fa46-4775-abe8-194a95797db2"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000839"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/824fae7f-da8f-4ab9-a45d-ce8158a658fe -->

    <Class rdf:about="http://example.org/824fae7f-da8f-4ab9-a45d-ce8158a658fe">
        <obo:IAO_0000115>In order to investigate the underlying process that may lead to a poor prognosis for high-risk LUAD patients, an analysis of hallmark pathway gene profiles was conducted, revealing distinct characteristics between high- and low-risk groups. A direct comparison between the Risk-High and Risk-Low groups showed that the top five enriched signatures in the high-risk group were MYC target v1, MYC target v2, mTORC1 signaling, G2M checkpoint, and Glycolysis ( Figure 10A ). GSEA enrichment analysis also indicated that the high-risk group had significantly enriched Cell Cycle (NES = 1.93, p&lt; 0.001) and DNA Replication (NES = 1.78, p = 0.000) ( Figure 10B ). The ssGSEA algorithm was employed to examine differences in immune status across distinct risk groups. Low-risk LUAD patients showed increased infiltration of various immune cells, including Active dendritic cells (aDCs), B cells, CD8+ T cells, Dendritic cells (DCs), Immature dendritic cells (iDCs), Mast cells, neutrophils, T helper cell, ##Tumor-infiltrating lymphocytes## (TILs), and Regulatory T cells (Treg), in their tumor microenvironment (TME). Furthermore, almost all immune-related pathways were significantly expressed in the low-risk group ( Figures 10C, D ).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10073691</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37033259</oboInOwl:hasDbXref>
        <rdfs:label>Tumor-infiltrating lymphocytes</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000542"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/824fae7f-da8f-4ab9-a45d-ce8158a658fe"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000542"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/8248af6e-9613-494e-8d73-70c66fcc920c -->

    <Class rdf:about="http://example.org/8248af6e-9613-494e-8d73-70c66fcc920c">
        <obo:IAO_0000115>Dissecting hematopoietic cells and cytokine profile of patients with AA and HDs.A) Schematic of the study design. B) Uniform Manifold Approximation and Projection (UMAP) of mononuclear cells (MNCs) from BM and PB of HDs and patients with AA or PNH, colored by cell type. Mono: Monocytes; T/NK: T-cells and NK cells; B/Plasma: B cells and plasma cells; Ery: erythroid cells; Pro/pre-B: ##pro-B and pre-B cells##; Gra: granulocytes; Ery HPC: erythroid progenitor cells; HSPCs: hematopoietic stem/progenitor cells; DC HPC: dendritic cell-biased precursors; DC: dendritic cells; pDC: plasmacytoid dendritic cells; Meg: megakaryocyte-biased cells; EC/FB: endothelial cells and fibroblasts. C) UMAP of BMNCs from typical BM samples of HDs and patients with AA or PNH, colored by cell type. Red dashed lines indicate cells other than B, plasma, and T/NK cells. The blue dashed lines indicate T/NK clusters. D) Circle plot showing cellular communication of non-hematopoietic stromal cells and hematopoietic cells. The thickness of the flow indicates the contribution of the cell group or signaling pathway to each latent pattern. Several representative signaling pathway networks from stromal cells are shown. E) Representative dot plots of BM subset repartitioning in an HD and a patient with AA, were analyzed by mass cytometry. Dead and granulocyte-like cells were removed. cMono: classical monocytes. Dot plot coloring is based on the expression level of the target surface marker, blue indicates the lowest expression, and red indicates the highest expression. F) Cytokine profiles of BM plasma samples. Heatmap showing the relative cytokine concentrations in the BM plasma from patients with AA (n = 48) and HDs (n = 7). G) Column charts presented the concentration of representative cytokines (GM-CSF, IL-1beta, IL-4, IL-6, IL-13, and CCL2). P value was determined by unpaired two-tailed Student&apos;s t-test: * p &lt; 0.05, ** p &lt; 0.01, *** p &lt; 0.001, **** p &lt; 0.0001.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10933602</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38145351</oboInOwl:hasDbXref>
        <rdfs:label>pro-B and pre-B cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000817"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/8248af6e-9613-494e-8d73-70c66fcc920c"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000817"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/824991a3-e84e-4b94-8e21-d7d22537473c -->

    <Class rdf:about="http://example.org/824991a3-e84e-4b94-8e21-d7d22537473c">
        <obo:IAO_0000115>Expression heterogeneity of CD8+ and CD4+ T cells in the OSCC ecosystem. (A) The t-distributed stochastic neighbor embedding (t-SNE) projection of T cells from cancerous tissue of patients with OSCC, showing the formation of 11 main clusters in different colors. The functional description of each cluster is determined by the gene expression characteristics. Cluster 0: resident memory CD8+ T Cells (C0_CD8+ TRM); Cluster 1: effector memory CD8+ T cells (C1_CD8+ TEM); Cluster 2: regulatory CD4+ T cells (C2_CD4+ Treg); Cluster 3: exhausted CD8+ T cells (C3_CD8+ T Exhausted); Cluster 4: effector memory M-phage CD8+ T cells (C4_CD8+ Mitotic TEM); Cluster 5: effector memory CD4+ T cells (C5_CD4+ TEM); Cluster 6: effector memory CD8+ T cells (C6_CD8+ TEM); Cluster 7: effector memory CD4+ T cells (C7_CD4+ TEM); Cluster 8: effector memory CD8+ T cells (C8_CD8+ TEM); Cluster 9: effector memory CD8+ T cells (C9_CD8+ TEM); Cluster 10: ##effector memory M-phage CD4+ T cells## (C10_CD4+ Mitotic TEM); Cluster 11: effector memory CD8+ T cells (C11_CD8+ TEM); Cluster 12: effector memory CD8+ T cells (C12_CD8+ TEM); Cluster 13: gammadelta T. (B) Cell-Cycle Scoring of T cells from cancerous tissue of patients with OSCC, showing the three clusters of cells in different cell cycles in different colors. (C) Heatmap of key genes expressed in each cluster of CD8+ tumor-infiltrating lymphocytes (TILs) with cells grouped by clusters. The columns correspond to the cells; the rows correspond to the genes. Yellow: high expression; purple: low expression. Selected key markers are shown on the right. (D) Heatmap of key genes expressed in each cluster of CD4+ TILs with cells grouped by clusters. The columns correspond to the cells; the rows correspond to the genes. Yellow: high expression; purple: low expression. Selected key genes are shown on the right.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8024729</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33513276</oboInOwl:hasDbXref>
        <rdfs:label>effector memory M-phage CD4+ T cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000905"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/824991a3-e84e-4b94-8e21-d7d22537473c"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000905"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/8256a78d-b28f-4517-8a75-d501f6cdb632 -->

    <Class rdf:about="http://example.org/8256a78d-b28f-4517-8a75-d501f6cdb632">
        <obo:IAO_0000115>alpha-SMA	Alpha smooth muscle actin	LEC	Lymphatic endothelial cell	 	ADSCs	Adipose-derived stem cells	Lymphoid-like	Lymphoid-like cell	 	ADAMTS	Disintegrin and metalloproteinase with thrombospondin motifs	Mac	Macrophage	 	AEC	Arterial endothelial cells	MAIT	Mucosal-associated invariant T cell	 	AFG	Autologous fat grafting	MMPs	Matrix metalloproteinases	 	APC	Adipocyte precursor cells	MC	Mast cell	 	BC	B cell	mCD8 T	Mature CD8 T cell	 	BKC	Basal keratinocyte	mNK	Mature natural killer cell	 	BMI	Body mass index	Myeloid-like	##Myeloid-like cell##	 	CCNs	Cellular communication network factors	nCD4 T	Naive CD4 T cell	 	cDC	Classic dendritic cell	nCD8 T	Naive CD8 T cell	 	CEC	Capillary endothelial cell	ncMos	Non-classic monocytes	 	DC	Dendritic cell	NK-like	Natural killer-like cell	 	CD	Cluster of differentiation	PC	Pericyte	 	CTGF	Connective tissue growth factor	PCA	Principal component analysis	 	DEGs	Differentially expressed genes	scRNA-seq	Single-cell RNA sequencing	 	DKC	Differentiating keratinocytes	SMC	Smooth muscle cell	 	EC	Endothelial cell	SNN	Shared nearest neighbour	 	ECM	Extracellular matrix	SSc	Scleroderma	 	EMT	Epithelial-to-mesenchymal transition	SVF	Stromal vascular fraction	 	FACS	Fluorescence-activated cell sorting	TC	T cell	 	FB	Fibroblast	TGF-beta1	Transforming growth factor 1	 	FGFRs	Fibroblast growth factor receptors	TIMPs	Tissue inhibitors of metalloproteinases	 	GEO	Gene expression omnibus	TREG	Regulatory T cells	 	GO	Gene Ontology	UMAP	Uniform manifold approximation and projection	 	IFATS	International Federation for Adipose Therapeutics and Science	VEC	Venous endothelial cell	 	ILC	Innate lymphoid cell	WAT	White adipose tissue	 	KEGG	Kyoto Encyclopedia of Genes and Genomes			 	</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10341100</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37443817</oboInOwl:hasDbXref>
        <rdfs:label>Myeloid-like cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000763"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/8256a78d-b28f-4517-8a75-d501f6cdb632"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000763"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/826089cf-776f-450d-b480-5aba3c279c4a -->

    <Class rdf:about="http://example.org/826089cf-776f-450d-b480-5aba3c279c4a">
        <obo:IAO_0000115>tSNE plot colored by the 17 Seurat clusters including hepatocytes, endothelial cells (liver sinusoidal endothelial cells:LSEC, non-tumor liver vascular endothelial cells:LVEC, and tumor liver vascular endothelial cells:LVECt), mesenchymal cells (Stellate cells, cancer-associated fibroblasts:##CAFs##, Pericytes, vascular smooth muscle cells:vSMC), immune cells (Kupffer cells, scar-associated macrophages:SAMs, tissue monocytes 1:TM1, cDC1, cDC2, T cells, and B cells), proliferating cells, and carcinoma cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7746227</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33332768</oboInOwl:hasDbXref>
        <rdfs:label>CAFs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000057"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/826089cf-776f-450d-b480-5aba3c279c4a"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000057"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/83a5e8b7-8945-4753-9d6d-74f920bf383f -->

    <Class rdf:about="http://example.org/83a5e8b7-8945-4753-9d6d-74f920bf383f">
        <obo:IAO_0000115>Direct reprogramming of cardiac pericytes into ##vascular smooth muscle like cells## and their potential for angiogenesis. In the injured heart, resident cardiac pericytes can be reprogrammed into vascular smooth muscle like cells that gradually mature and contribute to angiogenesis and arteriogenesis.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10136631</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37190075</oboInOwl:hasDbXref>
        <rdfs:label>vascular smooth muscle like cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0019018"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/83a5e8b7-8945-4753-9d6d-74f920bf383f"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0019018"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/831aabe5-f445-4a8d-ad3a-46f49e18098a -->

    <Class rdf:about="http://example.org/831aabe5-f445-4a8d-ad3a-46f49e18098a">
        <obo:IAO_0000115>After SPNs, most of the remaining neurons of the striatum are constituted by a diverse variety of GABAergic interneurons. The most commonly used markers to distinguish between subtypes of striatal GABAergic interneurons are parvalbumin, calretinin, and nitric oxide synthase. In human tissue, apparent LRRK2 expression has been observed in a majority of calretinin-expressing interneurons, as well as a small subset of parvalbumin- and nitric-oxide-synthase-expressing neurons. However, in mice, LRRK2 staining was observed in most ##parvalbumin- and nitric-oxide-synthase-positive neurons## and only a few calretinin-positive cells. In contrast, other groups have found no colocalization between LRRK2 and any of these markers. Single-cell mRNA expression across all types of GABAergic interneurons is approximately an order of magnitude lower than in SPNs. If the expression of the LRRK2 protein correlates with the mRNA levels reported by Saunders and colleagues, striatal interneurons would contain much less protein than the surrounding SPNs. This would increase the difficulty of detection, potentially explaining part of the apparent discrepancy among these studies. </obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8750662</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35011731</oboInOwl:hasDbXref>
        <rdfs:label>parvalbumin- and nitric-oxide-synthase-positive neurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000528"/>
        <skos:relatedMatch rdf:resource="CL:0000540"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/831aabe5-f445-4a8d-ad3a-46f49e18098a"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000528"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/831aabe5-f445-4a8d-ad3a-46f49e18098a"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000540"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/83808276-8d27-4869-aca6-ff5ceb04ab3c -->

    <Class rdf:about="http://example.org/83808276-8d27-4869-aca6-ff5ceb04ab3c">
        <obo:IAO_0000115>The quantification of multipotent HSPCs is commonly performed according to the lineage-relationships proposed by the classical model of human hematopoiesis. According to this classical model, HSCs and multipotent progenitors (MPPs) are the only cells containing both myeloid as well as lymphoid differentiation potentials. However, the classical model of hematopoiesis has meanwhile been challenged by several groups proposing alternative lineage-relationships and read-outs for multipotent HSCs/MPPs. In this context, we have shown that human CD133+CD45RA-CD34+ HSPCs are enriched for multipotent HSPCs. In vitro, more than 80% of these cells perform asymmetric cell divisions to create one CD133+CD45RA+CD34+ and one CD133-CD45RA-CD34+ daughter cell. While CD133+CD45RA+CD34+ cells inherit the potential to create all lymphocytes and neutrophils, ##CD133-CD45RA-CD34+ cells## are limited to erythroid, megakaryocytic, basophilic and eosinophilic potentials. The first cell fulfills the criteria of LMPPs and the latter ones correspond to cells that are commonly known as common myeloid progenitors (CMP). As we demonstrated that they are not able to form neutrophils, it is no longer justified to interpret them as CMPs. Accordingly, we re-named them to erythro-myeloid progenitors (EMPs) and proposed a revised model for human hematopoiesis in which neutrophils arise from the same branch as lymphocytes (Fig. 1A). The segregation of lineage potentials as predicted in our revised model was recently confirmed in mouse as well as in human steady state BM hematopoiesis using single cell transcriptomics. According to the proposed model, multipotent HSPCs can easily and objectively be identified as CD133 expressing HSPCs containing erythroid differentiation potentials (Fig. 1A).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6733927</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31501490</oboInOwl:hasDbXref>
        <rdfs:label>CD133-CD45RA-CD34+ cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000037"/>
        <skos:relatedMatch rdf:resource="CL:0000837"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/83808276-8d27-4869-aca6-ff5ceb04ab3c"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000037"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/83808276-8d27-4869-aca6-ff5ceb04ab3c"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000837"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/84b9f562-844f-4a7a-8108-fb2fbae9c13d -->

    <Class rdf:about="http://example.org/84b9f562-844f-4a7a-8108-fb2fbae9c13d">
        <obo:IAO_0000115>Innate Immune Cells	 	Primary Cell Type	Cell subsets	Metabolic Processes	References	 	   Innate Lymphoid Cells	Non-cytolytic:Innate lymphoid cell 1 (ILC1) Innate lymphoid cell 2 (ILC2) Innate lymphoid cell 3 (ILC3)/Lymphoid Tissue Inducers (LTi)Cytolytic:Natural Killer cells (NK)	 Gly FAO/OXPHOS, LM/LDF, Arginine catabolism, Gly Gly/OXPHOS, Vitamin A metabolismGly, AAM, FAO	     	 	  Dendritic Cells	Conventional:Conventional dendritic cell 1 (cDC1) Conventional dendritic cell 2 (cDC2) Conventional dendritic cell 3 (cDC3) Tolerogenic DCs Plasmacytoid DCs (pDCs) Inflammatory DCs Langerhans cells Mononuclear Phagocytes (tumor)	 Na: OXPHOS, Ac: GU, Gly, PPP, Dys: LDFNa: OXPHOS, Ac: GU, Gly, PPP, Dys: LDF Not reported FAO/OXPHOS Gly/OXPHOS/FAO Gly Na/Ac/Ma: Not reported Dys: LDFNa: OXPHOS, Ac: Gly, PPP In tumors/Dys: LM/LDF	         	 	 Macrophages	Inflammatory &quot;M1&quot; macrophage Reparative &quot;M2&quot; macrophage  ##Tumor Associated macrophage## (TAM)	Na: OXPHOS, Ac: GU, Gly, PPP. Arg catabolismNa: FAO/OXPHOS, Ac: FAO/OXPHOS, Gly, PPP.  Upregulates Arg1 Na: OXPHOS, Ac: GU, Gly, Tumor/Dys: FAO, LM/LDF	   	 	</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11240245</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:39007133</oboInOwl:hasDbXref>
        <rdfs:label>Tumor Associated macrophage</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/84b9f562-844f-4a7a-8108-fb2fbae9c13d"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/84f3cf4a-f7e8-48ad-b7e0-a256f131de3f -->

    <Class rdf:about="http://example.org/84f3cf4a-f7e8-48ad-b7e0-a256f131de3f">
        <obo:IAO_0000115>We next leveraged the high number of nuclei and developmental time points sampled in our dataset to quantify cell types across gestational age. Focusing on the germinal matrix where gliogenesis begins, samples were grouped into four stages spanning the latter half of second trimester and third trimester: 17-20 gw (Stage 1), 20-24 gw (Stage 2), 24-28 gw (Stage 3), and 31-41 gw (Stage 4). The stages differed statistically by gestational age but not by sex or tissue collection postmortem interval (Supplementary Data 1-2). By plotting mean fraction of cell type by stage, we observe two trends from second to third trimester: a decrease in the fraction of nIPCs and excitatory neurons (EN: ##CPN## and SPN) and an increase in the fraction of glia (RG/AC, gIPC, astrocyte, OPC, and microglia) (Fig. 1f). To study these trends further, we correlated the fraction of cell types to sample age in gestational weeks (Supplementary Fig. 3). This reveals a significant increase with gestational age in the fraction of gIPCs (p = 0.003; two-tailed Spearman Rank-Order Correlation test), astrocytes (p = 0.015), OPCs (p = 0.0008), and microglia (p = 0.002) (Supplementary Fig. 3a). The fraction of MSNs also increase significantly (p = 0.002). Conversely, there is a significant decrease in the fraction of nIPCs (p = 0.034), late-born L2/3 CPNs (p = 0.009), and TAC (p = 0.002) (Supplementary Fig. 3a). Our GM dataset, therefore, captures the start of the gliogenic period. In the CP, the fraction of TACs, nIPCs, and CRNs exhibit a significant decrease over time (p = 0.002, ~0, 0.0001, respectively), while L4/5a CPNs show a significant increase (p = 0.002) (Supplementary Fig. 3b). Interneurons also increase from second to third trimester (p = 0.001), consistent with their migration into the neocortex. While the fraction of CP glia exhibit a positive trend, only OPC numbers show a significant positive correlation with gestational age (p = 0.026).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9744747</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36509746</oboInOwl:hasDbXref>
        <rdfs:label>CPN</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000540"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/84f3cf4a-f7e8-48ad-b7e0-a256f131de3f"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000540"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/84116137-5053-4992-901b-ea9d7d939e67 -->

    <Class rdf:about="http://example.org/84116137-5053-4992-901b-ea9d7d939e67">
        <obo:IAO_0000115>A specific PD-L1+CD206+ macrophage risk subgroup is identified in colorectal cancer, which is induced by tumor-derived sEV-miRNAs. This subgroup promotes tumor growth by inducing an immunosuppressive tumor microenvironment. Hence, targeting specific tumor sEV-miRNAs that regulate PD-L1 in ##tumor-associated macrophages## may serve as a novel treatment strategy and a sensitization method for anti-PD-L1 therapy in colorectal cancer.  </obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8948581</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35356153</oboInOwl:hasDbXref>
        <rdfs:label>tumor-associated macrophages</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/84116137-5053-4992-901b-ea9d7d939e67"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/84450c06-f738-4954-96ef-7227b009792d -->

    <Class rdf:about="http://example.org/84450c06-f738-4954-96ef-7227b009792d">
        <obo:IAO_0000115>In the majority of hPSC differentiation studies, obtained cardiomyocytes are a heterogeneous mix of various cardiac subtypes, with ventricular cardiomyocytes being the predominant group. It is worth noting that in the absence of RA or other posterior fate-inducing signals, the default differentiation path of MESP1+ cardiac mesoderm cells in vitro is toward the ventricular lineage in the majority of cell lines and existing differentiation protocols. The RA-degrading enzyme CYP26A1 is expressed at day 3 of differentiation, coinciding with peak MESP1 expression, and is more suited for differentiation toward ventricular cardiomyocytes (; H.D.D., unpublished observations). Furthermore, treatment with an RA antagonist during differentiation, presumably at the ##cardiac mesoderm## stage (day 3) or cardiac progenitor stage (day 5), steered cells toward a ventricular fate.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8581056</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34653403</oboInOwl:hasDbXref>
        <rdfs:label>cardiac mesoderm</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000222"/>
        <skos:relatedMatch rdf:resource="CL:0002494"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/84450c06-f738-4954-96ef-7227b009792d"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000222"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/84450c06-f738-4954-96ef-7227b009792d"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002494"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/8450ecdc-e524-4960-912f-39202f8b85f4 -->

    <Class rdf:about="http://example.org/8450ecdc-e524-4960-912f-39202f8b85f4">
        <obo:IAO_0000115>Skeletal stem and progenitor cell populations are crucial for bone physiology. Characterization of these cell types remains restricted to heterogenous bulk populations with limited information on whether they are unique or overlap with previously characterized cell types. Here we show, through comprehensive functional and single-cell transcriptomic analyses, that postnatal long bones of mice contain at least two types of bone progenitors with bona fide skeletal stem cell (SSC) characteristics. An early osteochondral SSC (##ocSSC##) facilitates long bone growth and repair, while a second type, a perivascular SSC (pvSSC), co-emerges with long bone marrow and contributes to shape the hematopoietic stem cell niche and regenerative demand. We establish that pvSSCs, but not ocSSCs, are the origin of bone marrow adipose tissue. Lastly, we also provide insight into residual SSC heterogeneity as well as potential crosstalk between the two spatially distinct cell populations. These findings comprehensively address previously unappreciated shortcomings of SSC research.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8289409</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34280086</oboInOwl:hasDbXref>
        <rdfs:label>ocSSC</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000134"/>
        <skos:relatedMatch rdf:resource="CL:0000138"/>
        <skos:relatedMatch rdf:resource="CL:0007010"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/8450ecdc-e524-4960-912f-39202f8b85f4"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000134"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/8450ecdc-e524-4960-912f-39202f8b85f4"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000138"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/8450ecdc-e524-4960-912f-39202f8b85f4"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0007010"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/8457944e-1fc9-4785-bd74-a3812ae35453 -->

    <Class rdf:about="http://example.org/8457944e-1fc9-4785-bd74-a3812ae35453">
        <obo:IAO_0000115>Considering the close relationship between RGPRG score and immune activity, we sought to further explore the immune infiltrate landscape of two RGPRG score groups. The 22 immune cell composition of HCC patients from the TCGA cohort was shown in Fig. 5A. CD8 T cells, resting memory CD4 T cells, M0 Macrophages, M1 Macrophages, and M2 Macrophages were the main immune cell composition of HCC patients. Many differential immune cell infiltrations could be observed between high- and low-RGPRG score groups (Fig. 5B). Patients with high RGPRG score was characterized by the high infiltration of resting memory CD4 T cells, M0 Macrophages, T cells regulatory (Tregs), naive B cells, memory B cells, Plasma cells, naive CD4 T cells, Eosinophils, indicating a status of immunosuppression in this groups. CD8 T cells, activated memory CD4 T cells, activated NK cells, M1 Macrophages, M2 Macrophages, follicular helper T cells, gamma delta T cells, Neutrophils, resting Dendritic cells, activated Dendritic cells, resting NK cells, Monocytes, ##resting Mast cells##, and activated Mast cells were abundant in the patients with low RGPRG score (Fig. 5C), suggesting enhanced antitumor environment. In addition, the expression of 8 classical immune checkpoint genes between two RGPRG score groups was further estimated in the TCGA cohort, and we found that Patients with high RGPRG score had higher expression levels of CD274, CTLA4, LAG3, PDCD1, and TIGIT (Fig. 5D), which presented another characteristic of immunosuppression.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10832138</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38297333</oboInOwl:hasDbXref>
        <rdfs:label>resting Mast cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000097"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/8457944e-1fc9-4785-bd74-a3812ae35453"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000097"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/8461b51c-cec8-4d1a-95cf-fee696b343b9 -->

    <Class rdf:about="http://example.org/8461b51c-cec8-4d1a-95cf-fee696b343b9">
        <obo:IAO_0000115>PanglaoDB Cell   Type Confidence   Score Top HPAStainR Result Top   Result   Stained   Score Top    Adjusted   P-value Select Tissue Top    Result Select   Tissue    Top   Stained    Score Select   Tissue   Adjusted   P-value   KIDNEY proximal    tubule cells 66.75 KIDNEY - cells in tubules 66.75 1.59E-18 KIDNEY - cells in tubules 66.75 1.59E-18   HEART MUSCLE   cardiomyocytes 61 HEART MUSCLE -    myocytes 61 1.29E-33 HEART MUSCLE -    myocytes 61 1.29E-33   IMMUNE SYSTEM    neutrophils 60 BONE MARROW -   hematopoietic cells 60 9.99E-13 BONE MARROW -   hematopoietic cells 60 9.99E-13   OLFACTORY SYSTEM    olfactory epithelial    cells 51.25 BRONCHUS -   respiratory epithelial   cells 51.25 2.17E-05 NASOPHARYNX -   respiratory epithelial cells 39.75 0.00076   CONNECTIVE    TISSUE adipocytes 33.75 KIDNEY - cells in tubules 33.75 1 ADIPOSE TISSUE -   adipocytes 24.25 0.02353   CONNECTIVE    TISSUE   chondrocytes 27.25 TONSIL - squamous    epithelial cells 27.25 1 SOFT TISSUE -   chondrocytes 20.75 0.00025   REPRODUCTIVE    granulosa cells 13.6 PLACENTA -   trophoblastic cells 42.5 0.00174 OVARY - follicle cells 25 1   HEART MUSCLE    purkinje fiber cells 5.775 ##CAUDATE - neuronal   cells## 57.75 1 HEART MUSCLE -    myocytes 0 1   BRAIN cholinergic    neurons 5.25 DUODENUM - glandular    cells 37.5 1 CEREBRAL CORTEX    - neuronal cells 31.25 1   EMBRYO   trophoblast    progenitor cells 3 PLACENTA -   trophoblastic cells 50 1 tissue not found NA NA   </obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7802108</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33500778</oboInOwl:hasDbXref>
        <rdfs:label>CAUDATE - neuronal   cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000540"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/8461b51c-cec8-4d1a-95cf-fee696b343b9"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000540"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/847d6b89-f7f9-4566-967d-d5159516320f -->

    <Class rdf:about="http://example.org/847d6b89-f7f9-4566-967d-d5159516320f">
        <obo:IAO_0000115>It is well established, experimentally and theoretically, that inhibition plays a crucial role in generating Gamma rhythms. Nonetheless, it is still controversial whether Gamma oscillations are generated by the exclusively interaction among ##inhibitory neurons## [Interneuron Gamma (ING)] or via the interaction of inhibitory and excitatory neurons [Pyramidal-Interneuron Gamma (PING)]. Furthermore, a third mechanism, less explored in the literature, relies on the presence of pacemaker excitatory cells known as Chattering neurons. We named this third mechanism as Chattering Induced Gamma (CHING).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8478196</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34529655</oboInOwl:hasDbXref>
        <rdfs:label>inhibitory neurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000498"/>
        <skos:relatedMatch rdf:resource="CL:0000617"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/847d6b89-f7f9-4566-967d-d5159516320f"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000498"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/847d6b89-f7f9-4566-967d-d5159516320f"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000617"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/85b40079-b309-4de4-a8b9-3c1807621ea2 -->

    <Class rdf:about="http://example.org/85b40079-b309-4de4-a8b9-3c1807621ea2">
        <obo:IAO_0000115>Most human ##MTL neurons## show a nearly binary coding of identity</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7103760</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32142694</oboInOwl:hasDbXref>
        <rdfs:label>MTL neurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000540"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/85b40079-b309-4de4-a8b9-3c1807621ea2"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000540"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/85c24987-b536-4fa1-9d0a-56ffa6a68c75 -->

    <Class rdf:about="http://example.org/85c24987-b536-4fa1-9d0a-56ffa6a68c75">
        <obo:IAO_0000115>Refinement and annotation of cell clusters in colon tissues. A Reclustering of cells and its UMAP projection in colon tissues. B &quot;Ground truth&quot; cell cluster labels derived from manual cell annotation based on the marker map. C Annotation results based on ACT. D A Sankey diagram to show the comparison of annotation results. Cell types that might be mislabeled are shown in the red box. E Epithelial cells and goblet cells correspond to the iCMS2 and iCMS3 subgroups in the original publication, respectively. CD4_Tn, Naive thymus-derived CD4-positive, alpha-beta T cell; Th17, T helper 17 cell; Treg, Regulatory T cell; CD8_Tem, Effector memory CD8-positive alpha, beta T cell; CTL, Cytotoxic T cell; NK, Natural killer cell; FO_B, Follicular B cell; Plasma, Plasma cell; mregDC, Migratory dendritic cell; Glial, Glial cell, i.e., Entericglial cell; Endo, Endothelial cell; Endo_lymphatic, Lymphatic endothelial cell; Fibro, Fibroblast; Myof, Myofibroblast cell; Goblet, Goblet cell; Epi_colon, Colon epithelial cell; Goblet_T, Malignant goblet cell; Goblet_N, Normal goblet cell; ##McDC##, Monocyte conventional dendritic cell; pDC, Plasmacytoid dendritic cell</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10623726</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37924118</oboInOwl:hasDbXref>
        <rdfs:label>McDC</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000990"/>
        <skos:relatedMatch rdf:resource="CL:0011031"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/85c24987-b536-4fa1-9d0a-56ffa6a68c75"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000990"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/85c24987-b536-4fa1-9d0a-56ffa6a68c75"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0011031"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/85ef880e-1e42-4aac-8ced-3d8c804a96b2 -->

    <Class rdf:about="http://example.org/85ef880e-1e42-4aac-8ced-3d8c804a96b2">
        <obo:IAO_0000115>a Schematic overview of the experimental workflow. Forebrain samples were collected from Sox2eGFP mice at 11 developmental timepoints, dissociated into single cells followed by sorting of the GFP + ve /-ve cells and performing single-cell RNA-seq using the 10x Genomics Chromium platform. b Left: two-dimensional Uniform manifold approximation and progression (UMAP) plot with Leiden clustering of 102,504 individual cells identifying 28 transcriptionally and biologically distinct cell types (see Supplementary Fig. 3a and Methods). Each dot represents a single cell and colours correspond to the distinct clusters/cell types. Shown on the right is a dot plot showing the relative fraction (dot size) of the 28 cell types at each developmental timepoint normalized by library size. c UMAP plot of the cells as in (b) but coloured by timepoint. Each dot represents a single cell and the colours correspond to the different timepoints. d, UMAP plot showing the coarse annotation of cells into 4 categories (Neuronal, Glial, Immune and Vascular/other) based on logistic regression from Zeisel et al. 2018. The RNA-velocity field is overlaid on the UMAP. Colours represent the 4 categories of cell annotation and the arrows correspond to the direction of the RNA-velocity flow field (see Methods). RG Radial glia, TAPs ##Transient amplifying progenitors##, aNSCs Active neural stem cells, APCs Astrocyte progenitor cells, EmNBs Embryonic neuroblasts, GE NBs Ganglionic eminence neuroblasts, OPCs Oligoprogenitor cells, PreM-ODCs Immature pre-myelinating oligodendrocytes, INs Interneurons, ImStNeurons Immature striatal neurons, VLMC Vascular leptomeningeal cells, Myeloid-DSCs Myeloid-derived suppressor cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9296666</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35853870</oboInOwl:hasDbXref>
        <rdfs:label>Transient amplifying progenitors</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0009010"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/85ef880e-1e42-4aac-8ced-3d8c804a96b2"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0009010"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/85005eb4-d7de-431c-a972-cc74a9d43ee2 -->

    <Class rdf:about="http://example.org/85005eb4-d7de-431c-a972-cc74a9d43ee2">
        <obo:IAO_0000115>Liver sinusoidal endothelial cells (LSECs) form a highly specialized microvasculature that plays a critical role in liver function and disease. To better understand this role, we developed a strategy to generate LSECs from human pluripotent stem cells (hPSCs) by first optimizing the specification of arterial and venous angioblasts and derivative endothelial populations. Induction of a LSEC-like fate by hypoxia, cyclic AMP (cAMP) agonism, and transforming growth factor beta (TGF-beta) inhibition revealed that venous endothelial cells responded more rapidly and robustly than the arterial cells to upregulate LSEC markers and functions in vitro. Upon intrahepatic transplantation in neonates, venous angioblasts engrafted the liver and generated mature, ##fenestrated LSECs## with scavenger functions and molecular profiles of primary human LSECs. When transplanted into the liver of adult mice, angioblasts efficiently gave rise to mature LSECs with robust factor VIII (FVIII) production. Humanization of the murine liver with hPSC-derived LSECs provides a tractable system for studying the biology of this key liver cell type.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMID:32640183</oboInOwl:hasDbXref>
        <rdfs:label>fenestrated LSECs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000666"/>
        <skos:relatedMatch rdf:resource="CL:1000398"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/85005eb4-d7de-431c-a972-cc74a9d43ee2"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000666"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/85005eb4-d7de-431c-a972-cc74a9d43ee2"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:1000398"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/8529daf5-e8b9-4004-907c-12de1ad7d5b9 -->

    <Class rdf:about="http://example.org/8529daf5-e8b9-4004-907c-12de1ad7d5b9">
        <obo:IAO_0000115>Data were analyzed using FACSDIVA software, version 8.0.1 (BD Biosciences). Compensation was calculated before each experiment. Approximately 150,000 lymphocytes (50,000 live T cells) were analyzed per colon biopsy. Gating strategies are shown in Figure 1Aix-x. Lymphocyte populations are reported as a proportion of parent populations. Specifically, live CD3+ T cells are reported as percentage of total live lymphocytes (as defined by side scatter vs forward scatter, CD45+, and exclusion of viability dye). CD4+ and CD8+ T cells are reported as a percentage of live T cells. ##CD8+CD103+CD69+ TRM cells## are reported as a percentage of total CD8+ T cells. Activated (HLA-DR+CD38+) cells are reported as percentage of memory CD4+ or CD8+ T cell populations.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8527886</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34147519</oboInOwl:hasDbXref>
        <rdfs:label>CD8+CD103+CD69+ TRM cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000909"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/8529daf5-e8b9-4004-907c-12de1ad7d5b9"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000909"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/852953f2-f45d-43ac-92a5-cfd8977984e5 -->

    <Class rdf:about="http://example.org/852953f2-f45d-43ac-92a5-cfd8977984e5">
        <obo:IAO_0000115>Multipotent adult progenitor cells (MAPC) are not only found in bone marrow but also distributed throughout all organs. These neural stem cells can also differentiate into various hematopoietic cells. It is known that ##mesodermal-derived cells## originate outside of the nervous system, migrate into the hypothalamus where they transdifferentiate into LHRH-producing neurons. Similarly, bone marrow-resident cells can migrate to the brain and differentiate into cells typically found in the CNS. These cells, such as Purkinje cells, demonstrate the capacity of mesodermal-derived cells to adopt neural cell fates. The mechanisms behind this interconversion are still under investigation, but it is known that bone-marrow-derived cells (BMDCs) fuse spontaneously with several cell types like Purkinje neurons, cardiomyocytes and hepatocytes, creating heterokaryons.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11599565</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:39592661</oboInOwl:hasDbXref>
        <rdfs:label>mesodermal-derived cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000222"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/852953f2-f45d-43ac-92a5-cfd8977984e5"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000222"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/856b0dee-7d78-40eb-a3ec-c7dfe1854195 -->

    <Class rdf:about="http://example.org/856b0dee-7d78-40eb-a3ec-c7dfe1854195">
        <obo:IAO_0000115>The Table shows the numerical representations of Excitatory Neurons (Deep and Superficial Pyramidal cells) and Inhibitory neurons (Oriens Lacunosum moleculare cells:OLM; Trilaminar cells:Tri, Backprojection cells:BP, cholecystokinin positive Basket cells:CCKBC, Parvalbumin positive cells:PVBC, AxoAxonic Cells:AA, Ivy Cells:IVY, Bistratified cells:BS, Schaffer Collateral associated cells:##SCA##, Perforant Pathway Associated cell:PPA, Neurogliaform:NG) subdivided on the basis of the placement classes (SO, SP, SR, SLM).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9381785</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35974119</oboInOwl:hasDbXref>
        <rdfs:label>SCA</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:4023060"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/856b0dee-7d78-40eb-a3ec-c7dfe1854195"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4023060"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/858d9cc6-9aa9-4e4b-9682-b6c0ca8b7f48 -->

    <Class rdf:about="http://example.org/858d9cc6-9aa9-4e4b-9682-b6c0ca8b7f48">
        <obo:IAO_0000115>Next, we merged the datasets for the five time-points using the merge function of the Seurat pipeline, which combines multiple datasets without transforming the data. The merged dataset with a total of 62,202 cells was processed for clustering and then the data were visualized as a UMAP plot (Fig. 3). The same set of cell clusters identified in individual time-point data was also identified in the merged dataset (Fig. 3A,E and Fig. S6). The downregulation of PAX2 and upregulation of FBXO2 from otic prosensory cells to intermediate otic cells and supporting cells were confirmed with this analysis (Fig. 3E). A DACH1+ SPP1+ population was detected adjacent to OC90+ intermediate otic cells (Fig. 3D, Figs S7 and S8), suggesting the existence of another lineage direction in the otic lineage other than the sensory epithelium. ##TFAP2B+ surface ectoderm cells##, NEUROD1+ neuroblasts and S100B+ neural crest/Schwann cells were identified as distinctive clusters (Fig. 3A,D and Fig. S7). An intermediate population between otic prosensory cells and supporting cells expressed not only otic epithelium markers EPCAM and FBXO2, but also other otic progenitor markers COL9A1, SERPINF1, HES1, AATF, COL14A1, OC90, PRSS8 and EYA4 (Fig. S7), suggesting that this is an otic epithelial cell population differentiating into hair cells and supporting cells. Adjacent to the supporting cell cluster, there was a POU4F3+ hair cell cluster that expressed vestibular hair cell markers [CD164L2, ZBBX, TEKT1, SKOR1, TCTEX1D1 (DYNLT5) and NEUROD6] and type II hair cell markers (ANXA4, MAPT and NHLH1) (Fig. 3D and Fig. S8), indicative of an immature type II hair cell identity. However, we were unable to detect the cochlear marker GATA3 or INSM1 in PCP4+ hair cells (Fig. S8G,H). Surprisingly, we were unable to identify common progenitor populations that differentiate into both hair cells and supporting cells in the merged datasets.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10323240</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37381908</oboInOwl:hasDbXref>
        <rdfs:label>TFAP2B+ surface ectoderm cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000221"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/858d9cc6-9aa9-4e4b-9682-b6c0ca8b7f48"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000221"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/85889690-4680-430f-a246-e4a7d9dc5bb1 -->

    <Class rdf:about="http://example.org/85889690-4680-430f-a246-e4a7d9dc5bb1">
        <obo:IAO_0000115>Distinct therapy-induced cancer cell transcriptomes were associated with clinical response. Cancer cells from MPR patients exhibited a signature of activated antigen presentation via major histocompatibility complex class II (MHC-II). Further, the transcriptional signatures of FCRL4+FCRL5+ memory B cells and ##CD16+CX3CR1+ monocytes## were enriched in MPR patients and are predictors of immunotherapy response. Cancer cells from NMPR patients exhibited overexpression of estrogen metabolism enzymes and elevated serum estradiol. In all patients, therapy promoted expansion and activation of cytotoxic T cells and CD16+ NK cells, reduction of immunosuppressive Tregs, and activation of memory CD8+T cells into an effector phenotype. Tissue-resident macrophages were expanded after therapy, and tumor-associated macrophages (TAMs) were remodeled into a neutral instead of an anti-tumor phenotype. We revealed the heterogeneity of neutrophils during immunotherapy and identified an aged CCL3+ neutrophil subset was decreased in MPR patients. The aged CCL3+ neutrophils were predicted to interact with SPP1+ TAMs through a positive feedback loop to contribute to a poor therapy response.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9985263</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36869384</oboInOwl:hasDbXref>
        <rdfs:label>CD16+CX3CR1+ monocytes</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002397"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/85889690-4680-430f-a246-e4a7d9dc5bb1"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002397"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/86b46f9c-5e36-4e52-b3e1-e099e760f07c -->

    <Class rdf:about="http://example.org/86b46f9c-5e36-4e52-b3e1-e099e760f07c">
        <obo:IAO_0000115>Postnatal development of the organ of Corti. The postnatal development is shown in this colour-coded illustration: brown = Kolliker&apos;s organ, pink = inner phalangeal cell, dark blue = inner hair cell, orange = inner pillar cell, green = outer pillar cell, light grey = Deiters&apos; cells, yellow = outer hair cells, cyan = Hensen&apos;s cells, red = tectal cells, dark grey = Bottcher and Claudius cells. a P1; In newborn mice, the organ of Corti presents itself as an epithelium of columnar cells. There are no extracellular spaces. b P7; The Corti tunnel initially opens basally between the inner and outer pillared cells. c P14; The Corti tunnel has reached its full size. During the entire development, the cells increase only slightly in height. Cells of Kolliker&apos;s organ have gradually transformed into ##cuboidal cells of the inner sulcus## and are no longer part of the cortical organ</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7723944</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32712744</oboInOwl:hasDbXref>
        <rdfs:label>cuboidal cells of the inner sulcus</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002490"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/86b46f9c-5e36-4e52-b3e1-e099e760f07c"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002490"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/86dacca2-6ffc-43c8-9b91-e09faf406ff9 -->

    <Class rdf:about="http://example.org/86dacca2-6ffc-43c8-9b91-e09faf406ff9">
        <obo:IAO_0000115>To capture the full repertoire of hematopoietic cells during fetal development, we single-cell-sorted phenotypically defined blood populations from matched (i.e., from the same individual) fetal livers, femora, and hip (iliac) bones between 17 and 22 pcw (Figure 1A). Cells from the liver, hip, and femur were sorted and processed independently in all experiments. Thus, each cell can be traced back to the fetus and organ it came from. We used a hierarchical approach where we first isolated non-committed (Lin- [CD3, CD8, CD11b, CD14, CD19, and CD56] CD34+ CD38-) progenitors that contain all immature hematopoietic populations and are present at a frequency of less than 0.1% of the total fetal bone marrow, followed by a more restrictive panel to capture differentiated and mature cell types. We next isolated committed (Lin-, CD34+ CD38+) progenitors as well as phenotypic HSCs, MPPs, common myeloid progenitors (CMPs), megakaryocyte-erythroid progenitors (MEPs), granulocyte-monocyte progenitors (GMPs), and common lymphoid progenitors (CLPs). In addition, based on broad phenotypic markers, we sorted T cells, natural killer (NK) cells, innate lymphoid cells (ILCs), monocytes, dendritic cells, mast cells, basophils, neutrophils, eosinophils, erythroid progenitors, erythrocytes, ##immature megakaryocytes## (MKs), mature MKs, progenitor B cells (pro-B cells), precursor B cells (pre-B cells), mature B cells, and endothelial cells (Table S1; Figure S1).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7939551</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33352111</oboInOwl:hasDbXref>
        <rdfs:label>immature megakaryocytes</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000556"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/86dacca2-6ffc-43c8-9b91-e09faf406ff9"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000556"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/86dc763c-2f08-4b0e-b09a-f2daf4e2e28a -->

    <Class rdf:about="http://example.org/86dc763c-2f08-4b0e-b09a-f2daf4e2e28a">
        <obo:IAO_0000115>Previous work revealed that GM-CSF cultured BMDCs are a heterogeneous myeloid cell population consisting of bona fide DCs (termed &quot;GM-DC&quot;) and a minor fraction of macrophage-like CD11c+ MHCII+ cells (termed &quot;GM-Mac&quot;). When we refined our flow cytometric analysis for distinguishing ##GM-DCs## and GM-Macs in BMDC cultures, we found a clear shift between both cell populations in 3xGrk -/- BMDC cultures. Among CD11c+ MHCII+ cells, the fraction of GM-DCs was decreased, whereas GM-Macs were markedly increased in both unstimulated and LPS-stimulated 3xGrk -/- GM-CSF cultures ( Figure 5E ). Importantly, the remaining bona fide GM-DCs, which still developed in 3xGrk -/- cultures, also showed reduced expression of CCR7, MHCII and CD40 ( Figure 5F ). Together, these findings provide an explanation for the two observed phenotypes of 3xGrk -/- cells in the under-agarose chemotaxis assays; (a) less responding cells, because GM-Macs do not migrate to CCL19, and (b) reduced displacement of the responding cells, because the remaining bona fide GM-DCs remain lowered in CCR7-expression. Additionally, we noticed that not only DCs derived from GM-CSF cultures showed an altered phenotype, but also DC development in the presence of Flt3 ligand was impaired. In particular, the number of CD11b- DCs was strongly reduced, whereas the CD11b+ DC population was not significantly altered ( Supplementary Figure 3A ).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9703078</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36451830</oboInOwl:hasDbXref>
        <rdfs:label>GM-DCs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000451"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/86dc763c-2f08-4b0e-b09a-f2daf4e2e28a"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000451"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/860082bf-b9a7-470a-9686-15dfd6b6468d -->

    <Class rdf:about="http://example.org/860082bf-b9a7-470a-9686-15dfd6b6468d">
        <obo:IAO_0000115>Luminal progenitors serve primarily as tumor initiators or cells of origin for prostate cancer. Various hierarchical models have been proposed. A recent model suggests that, during early postnatal development, multipotent basal cells (p63+ CK5+) differentiate into unipotent basal progenitors, luminal progenitors (CK8+ AR low), and NE cells. These unipotent basal and luminal progenitors can undergo self-renewal or differentiate into basal cells and mature luminal cells (AR+ CK8+), respectively. In adults, during homeostasis and regeneration, the bipotent basal progenitor forms unipotent basal and luminal progenitors, which further undergo self-renewal. ##Unipotent basal progenitors## differentiate into basal cells, and luminal cell progenitors differentiate into luminal cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10291985</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37282627</oboInOwl:hasDbXref>
        <rdfs:label>Unipotent basal progenitors</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000035"/>
        <skos:relatedMatch rdf:resource="CL:0002341"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/860082bf-b9a7-470a-9686-15dfd6b6468d"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000035"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/860082bf-b9a7-470a-9686-15dfd6b6468d"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002341"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/861d3e26-c43d-498b-a5ff-3d6bb4acc9fa -->

    <Class rdf:about="http://example.org/861d3e26-c43d-498b-a5ff-3d6bb4acc9fa">
        <obo:IAO_0000115>Taken together, the data-driven FACS gating strategy allowed us to isolate distinct stromal subsets for functional investigation. Both MSSCs and HAGEPs demonstrated considerably higher in vitro colony-forming capacities in comparison with ##balanced progenitors##, OCs, pre-osteoblasts, and pre-fibroblasts. While MSSCs and HAGEPs exhibited full multi-differentiation potentials, pre-fibroblasts had only limited differentiation potentials. OCs showed enhanced osteoblastic and chondrogenic differentiation capacities and compromised adipogenic potential, which is consistent with their differentiation marker expression profiles (Figure 2).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10097421</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36876630</oboInOwl:hasDbXref>
        <rdfs:label>balanced progenitors</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0011026"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/861d3e26-c43d-498b-a5ff-3d6bb4acc9fa"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0011026"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/864a0ffa-2c64-4b07-aa5e-42e526db736f -->

    <Class rdf:about="http://example.org/864a0ffa-2c64-4b07-aa5e-42e526db736f">
        <obo:IAO_0000115>The difference of expression patterns of solid tumor antigens (GPC3, B4GALNT1, and ERBB2) in malignant cells and nonmalignant cells. (A) Dot plot shows the expression level of target antigens (CD19, MS4A1, CD22, TNFRSF17, CD38, SDC1, SLAMF7, and TNFRSF8) in B lineage-related cells derived from lymphomas (DLBCL, FL, and tFL) and rLN. (B) Dot plot shows the expression level of target antigens (CD33, IL3RA, and CLEC12A) in ##hematopoietic stem/progenitor-like cells## obtained from BM samples of AML patients and healthy donors, and in normal liver/heart EC clusters. &quot;AML314.D31&quot; represents the sample of patient AML314 after 31 days of treatment. BM5.34p means the sample of BM CD34-positive cells derived from healthy donor BM5, and BM5.34p38n means the sample of BM CD34-positive and CD38-negative cells derived from healthy donor BM5. (C) The expression level of IL3RA in liver sinusoidal endothelial cells and macrovascular endothelial cells. (D) GPC3 expression levels in adjacent liver and hepatocellular carcinoma at scRNA-seq level. (E) GPC3 and ERBB2 expression levels of the epithelial lineages in normal primary gastric tissues and gastric cancers.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8716389</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34975912</oboInOwl:hasDbXref>
        <rdfs:label>hematopoietic stem/progenitor-like cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000037"/>
        <skos:relatedMatch rdf:resource="CL:0000837"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/864a0ffa-2c64-4b07-aa5e-42e526db736f"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000037"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/864a0ffa-2c64-4b07-aa5e-42e526db736f"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000837"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/866aeeac-cb74-41e1-94fa-609b8f7f8559 -->

    <Class rdf:about="http://example.org/866aeeac-cb74-41e1-94fa-609b8f7f8559">
        <obo:IAO_0000115>MSCpos-EVs modulate the phenotype and angiogenic ability of endothelial cells. A) Quantification of the number of intersections and network perimeters formed by HUVECs on the Matrigel layer after MSCpos- and MSCneg-EV treatment. Untreated cells were used as a control. (n = 5 per group). B) Flow cytometric analysis of the ##activated HUVEC## phenotype (CD31+/CD34+/CXCR4+) after MSCpos- and MSCneg-EV treatment. Untreated cells (NT) were used as a control (n = 5). C) Tumor growth curves and CD31 IHC staining of 104 lung cancer (A549) cells coinjected with HUVECs pretreated with MSCpos- and MSCneg-EVs in immunodeficient mice (n = 7 for each group). D) Analysis of the relative expression levels of miR-126, pre-miR-126, SPRED1 and VEGF in HUVECs treated with MSCpos- and MSCneg-EVs. Untreated cells (NT) were used as a control (n = 5). E) Tube formation assay of miR-126-overexpressing HUVECs compared to control SCR-expressing HUVECs on Matrigel (n = 5). F) The graphs show the percentages of the CD31+/CD34+/CXCR4+ population among miR-126-overexpressing cells (n = 5) and (G) the in vivo growth curves of 105 A549 cells coinjected with the same HUVECs (n = 5 mice per group). H) Cells pretransfected with LNA 126 were incubated with MSCpos-EVs, and capillary-like structure formation was analyzed (n = 4). I) The panel shows a reduction in the CD31+/CD34+/CXCR4+ HUVEC-LNA126 population after treatment with MSCpos-EVs compared to the corresponding control treatment (n = 4). L) Vessel network formation and M) activation of endothelial cells after treatment with MSCneg-EVs and MSCneg-EVs enriched with mimic-126 (n = 5). *p &lt; 0.05 versus controls. The data are expressed as the mean +- S.E.M. values</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8293562</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34289890</oboInOwl:hasDbXref>
        <rdfs:label>activated HUVEC</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002618"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/866aeeac-cb74-41e1-94fa-609b8f7f8559"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002618"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/8674ab00-8b9f-4a3b-88a6-959e40e381f2 -->

    <Class rdf:about="http://example.org/8674ab00-8b9f-4a3b-88a6-959e40e381f2">
        <obo:IAO_0000115>Signs of mNPDR include microaneurysms and small haemorrhages or transient BRB leakage, which are all related to microvascular damage. Previous studies have demonstrated that STAT3 activation in ##endothelial cells## contributes to the early vascular damage in DR. STAT3 may contribute to the early vascular damage through activating genes related to inflammation and angiogenesis such as VEGF and hypoxia-inducible factor 1. STAT3 activation is also known to be involved in hyperglycaemia-induced endoplasmic reticulum stress in endothelial cells; inhibiting NOX4 can attenuate high-glucose induced reactive oxygen species (ROS) generation and STAT3 activation. Our study suggests that STAT3 activation in leukocytes also contributes to diabetes-induced vascular damage.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6615157</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31286987</oboInOwl:hasDbXref>
        <rdfs:label>endothelial cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000115"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/8674ab00-8b9f-4a3b-88a6-959e40e381f2"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000115"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/87cf61e1-97b9-4525-8d74-9afa16865174 -->

    <Class rdf:about="http://example.org/87cf61e1-97b9-4525-8d74-9afa16865174">
        <obo:IAO_0000115>Angiocrine factors control liver function. The hepatic endothelium is not just a passive conduit for blood. Instead, it acts as instructive gatekeeper regulating the hepatic microenvironment through EC-derived angiocrine factors. Pericentral LSEC are a prime example of angiocrine signaling. They modulate hepatocytic function, by secreting angiocrine Wnt2, Wnt9b, and Rspo3 to establish the spatial division of labor of hepatocytes (&quot;metabolic liver zonation&quot;). Concurrently, angiocrine Wnt-signaling fuels Axin2+, Lgr5+, and glutamine synthase (GS)+ pericentral hepatocytes to maintain the pericentral niche during tissue homeostasis. Moreover, angiocrine Wnt-signaling plays a pivotal role in regulating xenobiotic functions by modulating the hepatic cytochrome activity such as CYP2E1. In the portal zone, hepatocytes are actively involved in gluconeogenesis and urea cycle with increased expression of arginase (Arg1). Portal vein EC and periportal LSEC have high Notch activity with upregulated Dll4 expression. Angiocrine DLL4 may orchestrate monocyte recruitment to establish a niche for KC. Likewise, the hepatic immune zonation is further maintained by LSEC driven CXCL9 and through MYD88 pathway. Periportal LSEC also serve as a niche for ##resident LSEC progenitors## expressing CD157. Midlobular LSEC control iron homeostasis by secretion of the angiocrine factors BMP2 and BMP6</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7982081</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33745018</oboInOwl:hasDbXref>
        <rdfs:label>resident LSEC progenitors</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:1000398"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/87cf61e1-97b9-4525-8d74-9afa16865174"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:1000398"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/87f19201-f362-4b28-bdb7-7e0ae4f1f71c -->

    <Class rdf:about="http://example.org/87f19201-f362-4b28-bdb7-7e0ae4f1f71c">
        <obo:IAO_0000115>a Due to single-cell annotation and in situ validation (Fig. 2; Supplementary Fig. 3), a draft model of the oral-to-tooth transition zone in humans is presented, with ##basal and suprabasal keratinocyte## markers uniquely identifying the alveolar mucosa (AM), attached gingiva (AG), gingival margin (GM), sulcular epithelium (SK) and junctional epithelium (JK). b These markers allowed for KRT19-high keratinocyte (KC) cell subclustering for the first time (2504 cells in total), including gingival margin keratinocytes (GM), sulcular keratinocytes (SK), and junctional keratinocytes (JK). c A more granular draft (Tier 4) annotation of epithelial cells of the gingival attachment. d Assaying differentially expressed genes in periodontitis, SKs and JKs only share about a quarter of upregulated genes. JKs displayed nearly 125 unique upregulated genes in diseased cells. e Further analysis of basal and suprabasal (differentiating) SK and JK keratinocytes revealed unique cell signatures between basal and suprabasal cell types. This full list is included in Supplementary Data 1. f-i To understand SK and JK developmental progression and cell state alterations, we used partitioned-based graph abstraction (PAGA). f Examining the basal to suprabasal transition, JKs display altered gene expressed comparing health to disease cell types, including broader expression of KRT17 and more expression of JUND, COL17A1, and CDH3. Key differentiation genes such as SPRR family members were also downregulated. g JKs displayed robust cell signaling and inflammatory phenotypes, which appear exacerbated in disease states. h In SKs, differentiation-related genes were uniquely expressed compared to JKs in health but also appeared altered in disease along the basal to suprabasal trajectory. i SKs appeared generally less reactive compared to JKs in disease, with lower overall expression of effector molecules such as CXCL1, CXCL8, IL1A, IL1B, and IL1RN. Abbreviations: Merk Merkel Cells, LC langerhans cells, Mela melanocytes, Muc mucosa, SB suprabasal Keratinocytes; for others, see Fig. 1 legend. For this figure, n = 30-sample, 2504-cell for scRNAseq.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11178863</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38876998</oboInOwl:hasDbXref>
        <rdfs:label>basal and suprabasal keratinocyte</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002170"/>
        <skos:relatedMatch rdf:resource="CL:0002187"/>
        <skos:relatedMatch rdf:resource="CL:4033013"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/87f19201-f362-4b28-bdb7-7e0ae4f1f71c"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002170"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/87f19201-f362-4b28-bdb7-7e0ae4f1f71c"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002187"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/87f19201-f362-4b28-bdb7-7e0ae4f1f71c"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4033013"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/870ff84a-56ba-41b7-bbe7-4610be4e042d -->

    <Class rdf:about="http://example.org/870ff84a-56ba-41b7-bbe7-4610be4e042d">
        <obo:IAO_0000115>Innate T cells, including CD1d-restricted invariant natural killer T (iNKT) cells, are characterized by their rapid activation in response to non-peptide antigens, such as lipids. While the transcriptional profiles of naive, effector, and memory adaptive T cells have been well studied, less is known about the transcriptional regulation of different iNKT cell activation states. Here, using single-cell RNA-sequencing, we performed longitudinal profiling of activated murine ##iNKT cells##, generating a transcriptomic atlas of iNKT cell activation states. We found that transcriptional signatures of activation are highly conserved among heterogeneous iNKT cell populations, including NKT1, NKT2, and NKT17 subsets, and human iNKT cells. Strikingly, we found that regulatory iNKT cells, such as adipose iNKT cells, undergo blunted activation and display constitutive enrichment of memory-like cMAF+ and KLRG1+ populations. Moreover, we identify a conserved cMAF-associated transcriptional network among NKT10 cells, providing novel insights into the biology of regulatory and antigen-experienced iNKT cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9831610</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36458691</oboInOwl:hasDbXref>
        <rdfs:label>iNKT cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000921"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/870ff84a-56ba-41b7-bbe7-4610be4e042d"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000921"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/87506282-7e64-458e-b99d-68f53a6399d7 -->

    <Class rdf:about="http://example.org/87506282-7e64-458e-b99d-68f53a6399d7">
        <obo:IAO_0000115>Histologically, tumour cells of CM typically form perivascular ring structures, which are embedded in a mucopolysaccharide myxoid matrix. Histopathological analysis indicates that vascular and ##endothelial## differentiation may be the typical paths of myxoma tumour cells, although other lineages, such as neural, muscular, and chondroid lineages, have also been reported. Therefore, it has been postulated that myxoma tumour cells may originate from multipotent mesenchymal cells. However, the histogenesis of CM has been uncertain until a recent study proposed that atrial myxoma is initiated from c-kit+ CD31- CD45- cardiac progenitor/stem cells. Nevertheless, we still lack a systematic understanding of the differentiation trajectory and transcriptomic heterogeneity of myxoma tumour cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10844892</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38318640</oboInOwl:hasDbXref>
        <rdfs:label>endothelial</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0010008"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/87506282-7e64-458e-b99d-68f53a6399d7"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0010008"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/875147e9-d464-44e3-ba73-cab0a9f17678 -->

    <Class rdf:about="http://example.org/875147e9-d464-44e3-ba73-cab0a9f17678">
        <obo:IAO_0000115>Acute leukemia is characterized by a rapid expansion of hematopoietic precursors (blast cells), which remain partially differentiated and proliferate in the bone marrow and peripheral blood as the disease progresses. Two of the most common types of pediatric acute leukemias are acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML). ALL is the most prevalent type of cancer in children (80% of leukemias and 25% of childhood cancers), and 10-15% of these cases represent T-cell ALL (T-ALL). T-ALL arises from ##T-lymphoblasts## in the thymus as a result of an accumulation of mutations in immature thymocytes, altering inter alia cell proliferation and differentiation. The lymphoblasts leave the thymus and access the circulation, from where other organs such as the bone marrow or central nervous system are invaded. AML constitutes about 20% of all childhood leukemias and is caused by abnormal myeloblasts (immature leukocytes of the myeloid lineage). Cancerous myeloblasts have the ability of constant proliferation and avoidance of cell death, leading to an expansion in the myeloblast population and to a disturbed hematopoiesis.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8423305</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34492077</oboInOwl:hasDbXref>
        <rdfs:label>T-lymphoblasts</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0017005"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/875147e9-d464-44e3-ba73-cab0a9f17678"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0017005"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/8752158d-b6bd-461e-9cf1-7da058945302 -->

    <Class rdf:about="http://example.org/8752158d-b6bd-461e-9cf1-7da058945302">
        <obo:IAO_0000115>Introduction: Macrophages and T cells play crucial roles in liver physiology, but their functional diversity in hepatocellular carcinoma (HCC) remains largely unknown. Methods: Two bulk RNA-sequencing (RNA-seq) cohorts for HCC were analyzed using gene co-expression network analysis. Key gene modules and networks were mapped to single-cell RNA-sequencing (scRNA-seq) data of HCC. Cell type fraction of bulk RNA-seq data was estimated by deconvolution approach using single-cell RNA-sequencing data as a reference. Survival analysis was carried out to estimate the prognosis of different immune cell types in bulk RNA-seq cohorts. Cell-cell interaction analysis was performed to identify potential links between immune cell types in HCC. Results: In this study, we analyzed RNA-seq data from two large-scale HCC cohorts, revealing a major and consensus gene co-expression cluster with significant implications for immunosuppression. Notably, these genes exhibited higher enrichment in liver macrophages than T cells, as confirmed by scRNA-seq data from HCC patients. Integrative analysis of bulk and single-cell RNA-seq data pinpointed SPP1 + macrophages as an unfavorable cell type, while VCAN + macrophages, ##C1QA + macrophages##, and CD8 + T cells were associated with a more favorable prognosis for HCC patients. Subsequent scRNA-seq investigations and in vitro experiments elucidated that SPP1, predominantly secreted by SPP1 + macrophages, inhibits CD8 + T cell proliferation. Finally, targeting SPP1 in tumor-associated macrophages through inhibition led to a shift towards a favorable phenotype. Discussion: This study underpins the potential of SPP1 as a translational target in immunotherapy for HCC.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11649653</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:39691723</oboInOwl:hasDbXref>
        <rdfs:label>C1QA + macrophages</rdfs:label>
    </Class>
    


    <!-- http://example.org/8763df70-4993-47fd-a530-700c7fd8ba88 -->

    <Class rdf:about="http://example.org/8763df70-4993-47fd-a530-700c7fd8ba88">
        <obo:IAO_0000115>To illustrate the application of CSN to developing cells, we feature the developmental trajectory of human excitatory neuron cells in the Developing Cortex Atlas dataset (15), which includes Radial Gila and Progenitors (P), Intermediate Progenitors (IP), Maturing Excitatory (ExN), Migrating Excitatory (ExM), ##Excitatory Upper-layer enriched## (ExM-U), and Excitatory Deep layer (ExDp), with cell type labels determined by the authors (SI Appendix, section 3 and Table S2). Using Slingshot, we estimate the developmental path consists of two trajectories, one ending in upper-layer (U curve) and the other in deep-layer (D curve) excitatory neurons (Fig. 3 A and B).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8713783</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34903665</oboInOwl:hasDbXref>
        <rdfs:label>Excitatory Upper-layer enriched</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:4030059"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/8763df70-4993-47fd-a530-700c7fd8ba88"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4030059"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/8790258f-f300-4c30-932a-9a8bac594508 -->

    <Class rdf:about="http://example.org/8790258f-f300-4c30-932a-9a8bac594508">
        <obo:IAO_0000115>Identification of OLM and ##HS neurons##</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10959371</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38470935</oboInOwl:hasDbXref>
        <rdfs:label>HS neurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002608"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/8790258f-f300-4c30-932a-9a8bac594508"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002608"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/88a2359a-1446-48b0-88ef-5f67a2754461 -->

    <Class rdf:about="http://example.org/88a2359a-1446-48b0-88ef-5f67a2754461">
        <obo:IAO_0000115>Notably, several neural crest-derived cell types outside the Schwann cell lineage are derived from both the neural crest and Schwann cell precursors. One example is the melanocytes, which differentiate either directly from neural crest cells or from Schwann cell precursors, following their migration along nerves. A similar mechanism might possibly be true for enteric glia, as both neural crest cells and Schwann cell precursors were found to populate the gut to differentiate. To date, further cell types which can develop from Schwann cell precursors include endoneurial fibroblasts; postganglionic parasympathetic neurons; enteric neurons; ##neuroendocrine chromaffin cells of the adrenal medulla and Zuckerkandl organ##, a small population of sympathetic neurons in paraganglia; dental pulp mesenchymal stromal cells; and even chondrocytes and osteocytes; as well as, possibly, recently discovered immune-regulating splenic glia. This remarkable developmental potential of multipotent Schwann cell precursors clearly indicates that no terminal commitment to the Schwann cell lineage has happened at this stage. Indeed, recent work using single-cell transcriptomics has confirmed that early Schwann cell precursors are highly similar to late migratory neural crest cells and exhibit multipotency towards various cell fates, while late Schwann cell precursors that progress towards the Schwann cell fate become gradually more restricted. </obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9739763</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36497014</oboInOwl:hasDbXref>
        <rdfs:label>neuroendocrine chromaffin cells of the adrenal medulla and Zuckerkandl organ</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000166"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/88a2359a-1446-48b0-88ef-5f67a2754461"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000166"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/882e2123-bbd0-44af-ab98-41ec1627ab51 -->

    <Class rdf:about="http://example.org/882e2123-bbd0-44af-ab98-41ec1627ab51">
        <obo:IAO_0000115>Combining Seurat clustering analysis with known molecular markers for various cell types (Fig. 2B; Tables S2, S3), we segregated the single cells into 9 major cell clusters based on cell types: immune cells [Microglia, Monocyte/Macrophage, and T/NK (T cell/natural killer cell)], retinal cells [AC/HC/RGC (amacrine cell/horizontal cell/retinal ganglion cell), BC (bipolar cell), Cone, MG (Muller glia)/Astrocyte, and Rod], and vascular endothelial cells (VEC) (Fig. 2A). Comparison of control and EAU cell clusters revealed a decrease in the number of multiple neuronal types in EAU retinas, especially in the BC cluster (20.34-5.02%), Cone cluster (9.49-2.94%), and AC/HC/RGC cluster (3.76-1.28%) (Fig. 2C). In agreement, bulk RNA-seq analysis showed that in EAU retinas, there was downregulation of marker genes for all 6 retinal neuron types including rods, cones, BCs, ACs, HCs, and RGCs (Fig. 2D; S2A, B). Immunostaining analysis further validated these results. In EAU retinas, there was obvious degeneration of rhodopsin+ rod inner and outer segments (Fig. 2E), and in general, progressive loss of Arrestin+ cones, ##Chx10+ BCs##, Tfap2a+ ACs, Rbpms+ RGCs, and Calbindin+ HCs (Fig. 2F-J, L-P). By contrast, EAU did not appear to significantly alter Sox9+ Muller glia although resulting in an upregulation of their marker genes (Fig. 2K, Q). Therefore, EAU may cause not only progressive degeneration of all retinal neuron types but also a switch in the expression profile of Muller glia.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11131209</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38802924</oboInOwl:hasDbXref>
        <rdfs:label>Chx10+ BCs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000748"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/882e2123-bbd0-44af-ab98-41ec1627ab51"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000748"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/8862b307-d24f-4aae-8ff0-e5aac7afd3a6 -->

    <Class rdf:about="http://example.org/8862b307-d24f-4aae-8ff0-e5aac7afd3a6">
        <obo:IAO_0000115>To illustrate the application of CSN to developing cells, we feature the developmental trajectory of human excitatory neuron cells in the Developing Cortex Atlas dataset (15), which includes Radial Gila and Progenitors (P), Intermediate Progenitors (IP), Maturing Excitatory (ExN), Migrating Excitatory (ExM), Excitatory Upper-layer enriched (ExM-U), and Excitatory Deep layer (ExDp), with cell type labels determined by the authors (SI Appendix, section 3 and Table S2). Using Slingshot, we estimate the developmental path consists of two trajectories, one ending in upper-layer (U curve) and the other in deep-layer (D curve) ##excitatory neurons## (Fig. 3 A and B).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8713783</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34903665</oboInOwl:hasDbXref>
        <rdfs:label>excitatory neurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000540"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/8862b307-d24f-4aae-8ff0-e5aac7afd3a6"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000540"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/89a777e3-c3ca-431b-ba87-a5a03476a675 -->

    <Class rdf:about="http://example.org/89a777e3-c3ca-431b-ba87-a5a03476a675">
        <obo:IAO_0000115>In order for the sensitization we observed in excitatory interneurons to drive the psychophysical phenomenon of allodynia, spinal projection neurons must relay these nociceptive signals supraspinally. We found that capsaicin treatment shifted the overall tuning of SPB neurons towards LT input, consistent with the effects of central sensitization producing allodynia (Fig. 8a, b). Because SPB neurons are heterogeneous with respect to their response properties, we classified them as either wide-dynamic range (WDR), high threshold (HT), or low threshold (LT) (Fig. 8c) using previously published criteria. We found that both HT and WDR SPB showed significant increases in tuning to LT input, however the degree of change was much greater for WDR compared to HT SPB neurons (Fig. 8d). Finally, examining CICADA responses across populations, we found that ##WDR cells## were more frequently responsive to CICADA agonists (71.4%), compared to either LT (40%) or HT (0%) SPB neurons. In particular, all SP-responsive SPB neurons were WDR cells (Fig. 8e). Since capsaicin is known to activate peptidergic afferents that release SP, these findings suggest that capsaicin-induced allodynia may be conveyed to the brain through a population of TACR1 expressing WDR SPB neurons and, to a lesser extent, some HT SPB neurons (Fig. 8f).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9440908</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36057681</oboInOwl:hasDbXref>
        <rdfs:label>WDR cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000540"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/89a777e3-c3ca-431b-ba87-a5a03476a675"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000540"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/89ac94cf-a1d3-4abd-b35e-f9d789da8aa2 -->

    <Class rdf:about="http://example.org/89ac94cf-a1d3-4abd-b35e-f9d789da8aa2">
        <obo:IAO_0000115>In the majority of hPSC differentiation studies, obtained cardiomyocytes are a heterogeneous mix of various cardiac subtypes, with ventricular cardiomyocytes being the predominant group. It is worth noting that in the absence of RA or other posterior fate-inducing signals, the default differentiation path of ##MESP1+ cardiac mesoderm cells## in vitro is toward the ventricular lineage in the majority of cell lines and existing differentiation protocols. The RA-degrading enzyme CYP26A1 is expressed at day 3 of differentiation, coinciding with peak MESP1 expression, and is more suited for differentiation toward ventricular cardiomyocytes (; H.D.D., unpublished observations). Furthermore, treatment with an RA antagonist during differentiation, presumably at the cardiac mesoderm stage (day 3) or cardiac progenitor stage (day 5), steered cells toward a ventricular fate.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8581056</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34653403</oboInOwl:hasDbXref>
        <rdfs:label>MESP1+ cardiac mesoderm cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000222"/>
        <skos:relatedMatch rdf:resource="CL:0002494"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/89ac94cf-a1d3-4abd-b35e-f9d789da8aa2"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000222"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/89ac94cf-a1d3-4abd-b35e-f9d789da8aa2"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002494"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/89b3a4cd-11c1-47c2-ad11-c65998b0244b -->

    <Class rdf:about="http://example.org/89b3a4cd-11c1-47c2-ad11-c65998b0244b">
        <obo:IAO_0000115>Our analysis also revealed the erythroid versus ##lympho-myeloid## bifurcation in the proteomic landscape consistent with structures seen in single-cell transcriptomic and epigenetic landscapes. Unlike the traditional model with pan-myeloid (including erythroid) versus lymphoid bifurcation in early progenitors, we observe Ery-Mk progenitors (Cluster 2) and Ly-My progenitors (Cluster 1) immediately downstream of the CD38lo early stem/progenitors with multipotency (Cluster 3 and 5; corresponding to HSCs and MPPs in conventional HSPC cell types) (Fig. 2E). When we compared conventional gating schemes to the unsupervised clustering of HSPCs (Fig. 3E, Supplementary Fig. 3D), we observed cell types in the lympho-myeloid axis, such as CMPs, LMPPs, and GMPs, were dispersed over multiple clusters. This discrepancy between high-dimensional profiling and low-plex cell surface protein-based immunophenotyping in the lympho-myeloid axis emphasizes our current lack of understanding, and possibly over-generalizations, in current models of human early lympho-myeloid development.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11246490</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:39003273</oboInOwl:hasDbXref>
        <rdfs:label>lympho-myeloid</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000049"/>
        <skos:relatedMatch rdf:resource="CL:0000051"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/89b3a4cd-11c1-47c2-ad11-c65998b0244b"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000049"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/89b3a4cd-11c1-47c2-ad11-c65998b0244b"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000051"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/89217845-d505-4c8b-b320-145caea7bf6f -->

    <Class rdf:about="http://example.org/89217845-d505-4c8b-b320-145caea7bf6f">
        <obo:IAO_0000115>a Schematic of study design. Diagrams depict the brain region of interest, Brodmann area 9, corresponding to the dlPFC. b UMAP plot colored by the broad cell types. c UMAP plot colored by the individual clusters identified and annotated. For UMAP plots, the x and y-axes represent the first and second UMAP co-ordinates respectively. d DotPlot depicting the expression of marker genes (SNAP25 - neurons, SLC17A7 - excitatory neurons, GAD1 - inhibitory neurons, ALDH1L1 - astrocytes, PDGFRA - oligodendrocyte precursor cells, PLP1 - oligodendrocytes, CLDN5 - endothelial cells, CX3CR1 - microglia). The dendrogram next to the cluster names shows the relationship between the clusters by using the distance based on average expression of highly variable genes. e Best hits heatmap from MetaNeighbor showing the correspondence between the clusters in our dataset (columns) and the broad categories of cells identified in the Allen Brain Institute human motor cortex snRNA-seq dataset (rows). f Boxplots showing the proportion of nuclei in each cluster for each subject split by cases and controls for the broad OPC, astrocyte, and excitatory neuron cell types and the Ast1, Ast2, ##OPC##1, and OPC2 clusters (n = 37 cases, 34 controls, representing biologically independent samples for each cluster or broad cell type). The middle line is the median. The lower and upper hinges correspond to the 25th and 75th percentiles. Upper and lower whiskers extend from the upper or lower hinges to the largest or smallest value no further than 1.5 times the inter-quartile range from the hinge, where the inter-quartile range is the distance between the first and third quartiles. Points beyond the end of the whiskers are plotted individually. In Fig. 1c-e, excitatory neuronal cluster names contain approximate layer annotations and inhibitory neuronal cluster names contain MGE or CGE specific marker information as a suffix where applicable, as described in methods: Cluster annotation. For example, ExN10_L46 denotes a cluster of excitatory neurons with enrichment of marker genes from layer 4 to layer 6 of the cortex and InN1_PV denotes a cluster on inhibitory neurons with enrichment of the MGE specific marker PV. This convention is used throughout the paper. Brain diagram in 1a was created with BioRender.com. Source data are provided as a Source Data file.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10203145</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37217515</oboInOwl:hasDbXref>
        <rdfs:label>OPC</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002453"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/89217845-d505-4c8b-b320-145caea7bf6f"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002453"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/8946b128-1d30-483e-959d-e4ceb06fe285 -->

    <Class rdf:about="http://example.org/8946b128-1d30-483e-959d-e4ceb06fe285">
        <obo:IAO_0000115>Six-week-old male Lgr4iKO mice and littermates were fed normal chow diet (NCD) for 12 weeks. Single cell RNA sequencing was used to obtain intestinal epithelium single cell transcriptome data from 18-week-old Lgr4iKO mice and littermates. n = 3. a t-SNE plot showing stem cell, TA cell, absorptive cell, goblet cell, paneth cell, enteroendocrine cell and tuft cell marker genes expression in intestinal epithelium. b Defining cell populations with marker gene expression. c Pseudotime ordering on intestinal epithelium cells. d Re-clustering absorptive cells. Enterocytes selective for absorption of long-chain fatty acid, carbohydrate, or both were defined by the expression of Cd36 Fatp4 Glut2 and Sglt1. e The proportions of ##long-chain fatty acid-absorptive enterocytes##, carbohydrate-absorptive enterocytes, and long-chain fatty acid and carbohydrate-absorptive enterocytes.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11116434</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38782937</oboInOwl:hasDbXref>
        <rdfs:label>long-chain fatty acid-absorptive enterocytes</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000584"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/8946b128-1d30-483e-959d-e4ceb06fe285"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000584"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/895a55a2-97b6-458c-bd84-7eeb6e6aa991 -->

    <Class rdf:about="http://example.org/895a55a2-97b6-458c-bd84-7eeb6e6aa991">
        <obo:IAO_0000115>SCLC	Small-cell carcinoma	 	NSCLC	Non-small-cell carcinoma	 	ADC	Adenocarcinoma	 	SqCC	Squamous cell carcinoma	 	LCLC	Large-cell carcinoma	 	PD1	Programmed death 1	 	PDL1	Programmed death 1 ligand	 	ICI	Immune checkpoint inhibitors	 	EV	Extracellular vesicles	 	ESE	Early-sorting endosome	 	ILVs	Intraluminal vesicles	 	MVBs	Multivesicular bodies	 	ESCRT	Endosomal-sorting complex-independent transport	 	ncRNAs	Small noncoding RNAs (ncRNAs)	 	miRNAs	microRNAs	 	TME	Tumor microenvironment	 	circRNA	circular RNA	 	ECM	extracellular matrix	 	HBEC	Human bronchial epithelial cells	 	EMT	Epithelial-mesenchymal transition	 	CRC	colorectal cancer	 	DCs	dendritic cells	 	MSC	Mesenchymal stem cells	 	NK	Natural Killer	 	PBMCs	Peripheral blood mononuclear cells	 	TAMs	Tumor-associated macrophages	 	MDSCs	Myeloid-derived suppressor cells	 	PMN-MDSCs	Polymorphonuclear MDCs	 	##M-MDSCs##	Monocytic MDSCs	 	LLC	Lewis Lung carcinoma	 	M2 macrophages	Alternatively activated macrophages	 	M1 macrophages	Classically activated macrophages	 	TH1 cell	T helper 1 cell	 	Treg cell	Regulatory T cell	 	Breg cell	Regulatory B cell	 	CTLs	Cytotoxic CD8+ T cells	 	TILs	Tumor-infiltrating lymphocytes	 	Tim-3	mucin domain-3 protein	 	TIGIT	T cell immunoglobulin and ITIM domain	 	Lag-3	Lymphocyte-activation gene 3	 	CTLA4	Cytotoxic T lymphocyte antigen-4	 	TH17 cell	T helper 17 cell	 	DNT cell	Double-negative T cells	 	TRAIL	TNF-related apoptosis-inducing ligand	 	MPE	malignant pleural effusions	 	CRISPRi	clustered regularly interspaced short palindromic repeats interference	 	FAP	Fibroblast activation protein- alpha.	 	</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10616833</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37915578</oboInOwl:hasDbXref>
        <rdfs:label>M-MDSCs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000576"/>
        <skos:relatedMatch rdf:resource="CL:0000889"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/895a55a2-97b6-458c-bd84-7eeb6e6aa991"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000576"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/895a55a2-97b6-458c-bd84-7eeb6e6aa991"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000889"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/89639313-9ebb-41f9-9042-bc8a9511a47c -->

    <Class rdf:about="http://example.org/89639313-9ebb-41f9-9042-bc8a9511a47c">
        <obo:IAO_0000115>The implications of specific immune cell types on GBM disease status were unknown. In most cancers, the presence of ##tumor-infiltrating lymphocytes## (TILs) is positively correlated with the improvement of overall survival in patients, but the correlation between the presence of TILs and the improvement of overall survival in GBM patients has not been clearly established. Myeloid cells, especially microglia and macrophages, in the tumor microenvironment regulate GBM progression and influence therapeutic outcomes. Besides, resident fibroblasts, endothelial cells, pericytes, and the extracellular matrix also contribute to cancer progression. Abnormal cytokine expression was found to be associated with glioma progression. Within the heterogeneous GBM microenvironment, tumor cells, normal brain cells, immune cells, and stem cells interact with each other through the complex cytokine network. The formation of the GBM tumor microenvironment has been associated with specific mutations. For example, the IDH mutation has recently been found to be associated with decreased immune cell infiltration, whereas inactivated NF1 has been associated with increased macrophage infiltration. In addition, several major signaling pathways like NFkappaB, Wnt, and PI3K-AKT-mTOR are reported to be involved in the pathogenesis of GBM and have been used as therapeutic targets for GBM.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9851159</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36685556</oboInOwl:hasDbXref>
        <rdfs:label>tumor-infiltrating lymphocytes</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000542"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/89639313-9ebb-41f9-9042-bc8a9511a47c"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000542"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/89872e1a-8c6e-445f-a4af-5c42e8d46ce8 -->

    <Class rdf:about="http://example.org/89872e1a-8c6e-445f-a4af-5c42e8d46ce8">
        <obo:IAO_0000115>Cortical neurons can be broadly divided into two groups:glutamatergic and GABAergic. Glutamatergic neurons, which can project locally to other neurons or long-range to distant cortical or subcortical regions, show layer-specific expression of marker genes in the cortex. From a transcriptome perspective, they can be identified by the expression of glutamatergic genes such as SLC17A7 (VGLUT1). Since glutamate is primarily (but not exclusively) a mediator of excitatory signaling in the adult cortex, glutamatergic neurons coincide with functional and structural definitions of &quot;excitatory&quot; or &quot;projection&quot; neurons. By contrast, most GABAergic neuron subclasses have local projections and show weak layer-specific enrichment; they coincide with &quot;##inhibitory&quot; neurons## (&quot;interneurons&quot;) and are marked by expression of genes in the GABAergic pathway, including GAD1, GAD2, and SLC32A1 (VGAT). Brain-mapping studies have shown that neuronal signatures, especially those of glutamatergic (putatively excitatory) neurons, are brain-region specific and differ even among neighboring cortical regions. Although this region specificity is less pronounced for GABAergic (putatively inhibitory) cortical neurons, it is not entirely absent. Thus, given the regional stereotypy of tau pathology spread in AD, it is likely that these two major classes of neurons are affected in different ways in the course of the disease.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9710120</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36447241</oboInOwl:hasDbXref>
        <rdfs:label>inhibitory&quot; neurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000498"/>
        <skos:relatedMatch rdf:resource="CL:0000617"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/89872e1a-8c6e-445f-a4af-5c42e8d46ce8"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000498"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/89872e1a-8c6e-445f-a4af-5c42e8d46ce8"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000617"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/9a12c662-f591-4fb7-8fcd-9ddece240aff -->

    <Class rdf:about="http://example.org/9a12c662-f591-4fb7-8fcd-9ddece240aff">
        <obo:IAO_0000115>Next, we merged the datasets for the five time-points using the merge function of the Seurat pipeline, which combines multiple datasets without transforming the data. The merged dataset with a total of 62,202 cells was processed for clustering and then the data were visualized as a UMAP plot (Fig. 3). The same set of cell clusters identified in individual time-point data was also identified in the merged dataset (Fig. 3A,E and Fig. S6). The downregulation of PAX2 and upregulation of FBXO2 from otic prosensory cells to intermediate otic cells and supporting cells were confirmed with this analysis (Fig. 3E). A DACH1+ SPP1+ population was detected adjacent to OC90+ intermediate otic cells (Fig. 3D, Figs S7 and S8), suggesting the existence of another lineage direction in the otic lineage other than the sensory epithelium. TFAP2B+ surface ectoderm cells, NEUROD1+ neuroblasts and S100B+ neural crest/Schwann cells were identified as distinctive clusters (Fig. 3A,D and Fig. S7). An intermediate population between otic prosensory cells and supporting cells expressed not only otic epithelium markers EPCAM and FBXO2, but also other otic progenitor markers COL9A1, SERPINF1, HES1, AATF, COL14A1, OC90, PRSS8 and EYA4 (Fig. S7), suggesting that this is an otic epithelial cell population differentiating into hair cells and supporting cells. Adjacent to the supporting cell cluster, there was a POU4F3+ hair cell cluster that expressed vestibular hair cell markers [CD164L2, ZBBX, TEKT1, SKOR1, TCTEX1D1 (DYNLT5) and NEUROD6] and type II hair cell markers (ANXA4, MAPT and NHLH1) (Fig. 3D and Fig. S8), indicative of an immature type II hair cell identity. However, we were unable to detect the cochlear marker GATA3 or INSM1 in ##PCP4+ hair cells## (Fig. S8G,H). Surprisingly, we were unable to identify common progenitor populations that differentiate into both hair cells and supporting cells in the merged datasets.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10323240</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37381908</oboInOwl:hasDbXref>
        <rdfs:label>PCP4+ hair cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000202"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/9a12c662-f591-4fb7-8fcd-9ddece240aff"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000202"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/9a32b965-0396-4a46-bbd4-9ea80f2adc65 -->

    <Class rdf:about="http://example.org/9a32b965-0396-4a46-bbd4-9ea80f2adc65">
        <obo:IAO_0000115>Our results indicated that immune cell composition and immune-related genes in the tumors differed between the high-risk and low-risk groups. Accordingly, we evaluated the relationship between glycolysis and immune cell infiltration. We uploaded the entire cohort&apos;s transcriptome data to ImmuCellAI to analyze each group&apos;s immune cell composition (Fig. 5B). In total, 13 of 24 immune cell types differed between the groups, including naive CD4 T cells, naive CD8 T cells, cytotoxic T cells, exhausted T cells, inducible regulatory T cells (iTreg), helper T cells 1 (Th1), follicular helper T cells (Tfh), ##central memory T cells## (Tcm), mucosal-associated invariant T cells (MAIT), DCs, Macrophages, Neutrophils, and gamma delta T cells (gammadelta T) (Fig. 5C). Correlations between the expression levels of the eight risk genes and immune cell components were also evaluated (Additional file 2: Table S3). The expression of ARTN was related to cellular components, including neutral and central_ memory, Gamma_ delta, Tr1, B_ Cell, and Tfh. Moreover, the risk score negatively correlated with the immune infiltration score (R = - 0.22) (Fig. 5D).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8425093</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34496868</oboInOwl:hasDbXref>
        <rdfs:label>central memory T cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000904"/>
        <skos:relatedMatch rdf:resource="CL:0000907"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/9a32b965-0396-4a46-bbd4-9ea80f2adc65"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000904"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/9a32b965-0396-4a46-bbd4-9ea80f2adc65"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000907"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/9a6b61cf-8d5b-441e-bb8d-f8ee8c977073 -->

    <Class rdf:about="http://example.org/9a6b61cf-8d5b-441e-bb8d-f8ee8c977073">
        <obo:IAO_0000115>To evade such more efficient initial immune recognition and response, NSCLC arising in women develop more complex and redundant mechanisms of resistance, as revealed by the higher expression of multiple immune-checkpoint molecules with inhibitory functions, as well as by the higher abundance of immune-suppressive cells in the TME, such as ##CAFs## and MDSCs, and Tregs. </obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7611463</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34016641</oboInOwl:hasDbXref>
        <rdfs:label>CAFs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000057"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/9a6b61cf-8d5b-441e-bb8d-f8ee8c977073"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000057"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/9a818143-657c-46d4-8d00-aa4f3fc38f80 -->

    <Class rdf:about="http://example.org/9a818143-657c-46d4-8d00-aa4f3fc38f80">
        <obo:IAO_0000115>a, Uniform manifold approximation and projections (UMAPs) of cell states in the scRNA-seq dataset. b-e, Dotplots showing the expression of cell state marker genes in (b) myeloid cells, (c) T/NK/IL cells, (d) B/plasma cells, and (e) stromal cells. f-j, cNMF was used to derive GEP scores for individual cells from inflamed samples with RA in (f) T/NK/IL, (g) B, (h) plasma, (i) myeloid, and (j) stromal cells. Mean expression of GEP quantified per cell state. k, Baseline visit samples in the R4RA study were selected for analysis; GEPs positively correlated with inflammation were tested for association with therapy nonresponse. Boxplots show median, first (lower hinge) and third (upper hinge) quartiles; whiskers show 1.5x interquartile range. Wilcoxon signed-rank test used to test for significance (Padj &lt; 0.05, two-sided) between responders (29 patients) and non-responders (39 patients) to rituximab at baseline (also see Supplementary Table 9). l, GO term enrichment for GEPs associated with clinical response to rituximab. GO terms were generated by GOATOOLS overrepresentation analysis of the top 150 weighted genes in constituent GEPs. All genes tested were used as the gene universe. See Supplementary Table 9 for full list of cNMF GEPs in RA and associated GO term enrichment in GEPs. DC, dendritic cell; fibro, fibroblast; GC, germinal centre; hi, high; IFN-resp, interferon-responsive; ILC, innate lymphoid cell; lo, low; macro, macrophage; MAIT, mucosal-associated invariant T; MNP, mononuclear phagocyte; mono, monocyte; MThi, Mitochondrial-high; NK, natural killer cell; pDC, plasmacytoid dendritic cell; Tfh, CD4+ follicular helper T cell; Tph, ##CD4+ peripheral helper T cell##; Treg, CD4+ regulatory T cell.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11519010</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:39438660</oboInOwl:hasDbXref>
        <rdfs:label>CD4+ peripheral helper T cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000492"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/9a818143-657c-46d4-8d00-aa4f3fc38f80"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000492"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/9a8ef10d-dbe2-4485-829c-2070a6749947 -->

    <Class rdf:about="http://example.org/9a8ef10d-dbe2-4485-829c-2070a6749947">
        <obo:IAO_0000115>a, After keeping the secreted proteins that matched to ligand and receptor genes present in the scDiffCom LRI database, ##mBMM##, hPDE, mNeuron, and hUVEC cells have the highest number of specific proteins (that is only secreted by them), whereas rCM and mMSC-AT cells have most of their secreted proteins in common with other cell types; b-e, several secretomics datasets have their cell line originating from a tissue present in scAgeCom, allowing us to perform tissue-specific association analyses. Odds ratios and p-values were computed from a two-sided Fischer&apos;s exact test and p-values were further adjusted for multiple comparisons (Benjamini-Hochberg procedure); b, for scAgeCom TMS Brain results, the secretome from mNeuron is predominantly associated with CCIs emitted from consistent cell types, namely neuronal stem cells and neurons; c, for scAgeCom TMS Adipose Tissue results, the secretome of mMSC-AT is predominantly associated with CCIs emitted from the corresponding cell type, namely mesenchymal stem cells; d, for scAgeCom TMS Heart results, the secretome of rCM is predominantly associated with CCIs emitted from heart-specific cell types (fibroblast of cardiac tissue and heart valve cell) but is neither positively nor negatively associated with regular ventricular cardiac myocytes; e, for scAgeCom TMS Pancreas results, the secretome of hPDE is predominantly associated with CCIs emitted from endothelial cells and pancreatic stellate cells and to a lesser extent with its corresponding cell type, namely pancreatic ductal cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10645595</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37919434</oboInOwl:hasDbXref>
        <rdfs:label>mBMM</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/9a8ef10d-dbe2-4485-829c-2070a6749947"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/9a9bf364-d594-4896-8cb3-a6320bed0e06 -->

    <Class rdf:about="http://example.org/9a9bf364-d594-4896-8cb3-a6320bed0e06">
        <obo:IAO_0000115>The above analysis was based on a large number of RNA-seq, so we further used scRNA-seq to determine whether our ORGs signature had immune predictive value on the single cell level. Figure 7A showed that the PRAD samples from GEO datasets were annotated into Mast cell, Epithelial-NE, T/NK, Plasma_B, Epithelial, ##Neuron##, SMC, Fibroblasts and Pericytes, Myeloid and Endothelial. It was obvious that ORGs signature was specifically high in Epithelial-Nk, T/Nk and SMC cells (Figure 7B, 7C). Meanwhile, Figure 7D revealed that significant connection probability of ORGs related signaling pathways in cell clusters which showed specifically high ORGs signature. Furthermore, we chose epithelial cell for analysis. Chemotaxis related pathways including cell chemotaxis, leukocyte chemotaxis, regulation of chemotaxis and regulation of leukocyte chemotaxis were significantly up-regulated in the high ORGs signature group (Figure 7E). What&apos;s more, immune related pathways were all up-regulated in the high ORGs signature group both in GO (Figure 7F) and KEGG (Figure 7G) analysis.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10599753</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37788005</oboInOwl:hasDbXref>
        <rdfs:label>Neuron</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000540"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/9a9bf364-d594-4896-8cb3-a6320bed0e06"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000540"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/9aa0de0b-1e0c-41ec-af23-16c9c9281fab -->

    <Class rdf:about="http://example.org/9aa0de0b-1e0c-41ec-af23-16c9c9281fab">
        <obo:IAO_0000115>Regulatory T-cells (Tregs), known as immunosuppressive T-cells, negatively modulate the immune response and protect from autoimmune disease and are the main mediators of immunological tolerance. Tregs have an important impact on tumor development, immunological microenvironment, and patient prognosis. In the CNS were identified two types of Tregs: thymus-derived natural Tregs (nTregs), which account for the majority of ##brain-tumor resident Tregs##, and induced Tregs (iTregs), which develop from mature CD4+ conventional T cells outside of the thymus.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8910233</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35269652</oboInOwl:hasDbXref>
        <rdfs:label>brain-tumor resident Tregs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000815"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/9aa0de0b-1e0c-41ec-af23-16c9c9281fab"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000815"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/9abb0cc1-a70c-4788-93b0-ab139334706c -->

    <Class rdf:about="http://example.org/9abb0cc1-a70c-4788-93b0-ab139334706c">
        <obo:IAO_0000115>Notably, several neural crest-derived cell types outside the Schwann cell lineage are derived from both the neural crest and Schwann cell precursors. One example is the melanocytes, which differentiate either directly from neural crest cells or from Schwann cell precursors, following their migration along nerves. A similar mechanism might possibly be true for enteric glia, as both neural crest cells and Schwann cell precursors were found to populate the gut to differentiate. To date, further cell types which can develop from Schwann cell precursors include endoneurial fibroblasts; ##postganglionic parasympathetic neurons##; enteric neurons; neuroendocrine chromaffin cells of the adrenal medulla and Zuckerkandl organ, a small population of sympathetic neurons in paraganglia; dental pulp mesenchymal stromal cells; and even chondrocytes and osteocytes; as well as, possibly, recently discovered immune-regulating splenic glia. This remarkable developmental potential of multipotent Schwann cell precursors clearly indicates that no terminal commitment to the Schwann cell lineage has happened at this stage. Indeed, recent work using single-cell transcriptomics has confirmed that early Schwann cell precursors are highly similar to late migratory neural crest cells and exhibit multipotency towards various cell fates, while late Schwann cell precursors that progress towards the Schwann cell fate become gradually more restricted. </obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9739763</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36497014</oboInOwl:hasDbXref>
        <rdfs:label>postganglionic parasympathetic neurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0011102"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/9abb0cc1-a70c-4788-93b0-ab139334706c"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0011102"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/9ae136fd-25be-411f-a538-857300a9b018 -->

    <Class rdf:about="http://example.org/9ae136fd-25be-411f-a538-857300a9b018">
        <obo:IAO_0000115>The first blood and immune cells arise from extra-embryonic yolk sac progenitors and for some cell types, such as macrophages or mast cells, yolk sac-derived cells can persist in tissues for extended periods of time after birth. cDCs first arise during embryogenesis in mice and humans, when they are thought to critically contribute to fetomaternal tolerance. However, the origins of cDCs in early life have not been investigated. In adults, cDCs develop downstream of hematopoietic stem cells (HSCs) from a fraction of myeloid bone marrow progenitors capable of generating plasmacytoid DCs (pDCs) and cDCs that has been termed common DC progenitor (CDP). Within CDPs in mice, expression of the C-type lectin receptor DNGR-1 (encoded by the Clec9a gene) distinguishes cDC-restricted progenitors. CDPs further differentiate into pre-cDCs, which continue to express DNGR-1, exit the bone marrow and terminally differentiate into cDC subtypes in peripheral organs and in response to environmental cues. The Clec9a promoter is also active in cDC1 and to a lower extent on pDCs but it is not active in ##cDC2## and other lymphoid or myeloid cells. By crossing mice expressing CRE-recombinase under the Clec9a promoter to Rosalox-stop-lox-yellow fluorescent protein (YFP) or Rosalox-stop-lox-TOMATO mice, we have generated mice that faithfully track cells belonging to the cDC lineage in steady state and under inflammatory conditions. Using these mice, we have found that cDC2 in adult spleen are predominantly derived from CDP/pre-cDC, which is consistent with other studies.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7815729</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33469015</oboInOwl:hasDbXref>
        <rdfs:label>cDC2</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000990"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/9ae136fd-25be-411f-a538-857300a9b018"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000990"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/9b1bc1b6-3752-4d12-a497-d9f09a688067 -->

    <Class rdf:about="http://example.org/9b1bc1b6-3752-4d12-a497-d9f09a688067">
        <obo:IAO_0000115>Community 3 contained information on the frequency of innate and adaptive immune cells (Figure 4A). Within the innate cellular compartment, the strongest correlations (Spearman) with GA were increasing frequencies of granulocytes and CD14+CD16- classical monocytes (cMCs) (Figures 4B, C), which are front-line defenders that rapidly respond to injury or infection. In term infants, granulocytes comprised the majority (58%) of immune cell subsets in cord blood, but at earlier GA the proportion of granulocytes falls (average 24.5% of live leukocytes in infants &lt;30 weeks GA) and T lymphocytes predominate (average 47.3% of live leukocytes in infants &lt;30 weeks, of which 64% are CD4+ T cells). In contrast, in the adaptive compartment, the strongest correlations with GA were decreasing frequencies of regulatory T cells (Treg) and ##CD161+ T cells##, including the CD4+ and CD8+ subsets (Figures 4G-I). Treg cells [and possibly fetal CD161+CD4+ T cells ] are immune-regulatory cell subsets that can suppress antigen-specific T cell inflammatory responses. CD8+CD161+ T cells are enriched in mucosal associated invariant T (MAIT) cells that recognize riboflavin metabolites presented by MHC-related 1 (MR1) protein (although our assay did not include MR1 tetramers, which are necessary for the definitive identification of MAITs). Also decreasing in frequency with GA were Natural Killer (NK) T cells, which are enriched in invariant NK (iNK) T cells with a limited T cell receptor (TCR) repertoire specific for lipid antigens presented by the non-classical MHC class I protein CD1d (Figures 4D-F). Together these findings indicate that at early GA the cellular composition of the neonatal immune system is characterized by deficiencies in innate cells involved in the acute response to infection or danger and a relative abundance of suppressor T cells and a reliance on nonconventional T-cell populations with restricted TCR repertoires directed to non-peptide antigens.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8420969</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34497610</oboInOwl:hasDbXref>
        <rdfs:label>CD161+ T cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000084"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/9b1bc1b6-3752-4d12-a497-d9f09a688067"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000084"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/9b35d0a6-b01f-4d89-9d6c-8b8d0fafa6a5 -->

    <Class rdf:about="http://example.org/9b35d0a6-b01f-4d89-9d6c-8b8d0fafa6a5">
        <obo:IAO_0000115>a Immune cell subsets analyzed by CellChat in the original tSNE plot. b Enhanced number of interactions and interaction strength noted in cSjD. Differential interaction strength c and numbers d are presented on the heatmap. The overall increase in the interaction strength in the signal-receiving effector immune subsets, along with a dramatic increase in the interaction numbers noted between ##FOXP3low Tregs## (or naive Tregs) and myeloid/B subsets, in cSjD compared to HC. Bars refer to the sum of the computed interaction strength or numbers in each column and row. Relative values = the interaction strength/number from source to target in cSjD-the interaction strength/number from source to target in HC. e-g Identification of significant ligand and receptor pairs between immune subsets of interest. e The communication probability of CLEC2C ligand and KLRB1 receptor genes are significantly upregulated between B and effector memory CD4+ T cell subsets in cSjD. f FOXP3low Tregs show increased communication probability with myeloid subsets through CD4 and MHC class II-related genes in cSjD, compared to HC. g Pairs of CLEC ligands and KLRB receptor genes show increased communication probability in gammadelta-T cells of Bx and BxRP, compared to non-cSjD. Mo monocytes, NK natural killer, eff effector, em effector memory, mem memory, cm central memory T cell, nv naive, pDC plasmacytoid dendritic cells, MAIT mucosal-associated invariant T, act activated or FOXP3high, IFN interferon-related, HC healthy control, cSjD childhood Sjogren&apos;s disease, BX biopsy-positive non-cSjD without RP, BXRP biopsy-positive non-cSjD with RP.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11031574</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38641668</oboInOwl:hasDbXref>
        <rdfs:label>FOXP3low Tregs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000815"/>
        <skos:relatedMatch rdf:resource="CL:0002677"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/9b35d0a6-b01f-4d89-9d6c-8b8d0fafa6a5"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000815"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/9b35d0a6-b01f-4d89-9d6c-8b8d0fafa6a5"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002677"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/9b4d9fcb-3817-4ee4-80e2-515640061e7b -->

    <Class rdf:about="http://example.org/9b4d9fcb-3817-4ee4-80e2-515640061e7b">
        <obo:IAO_0000115>##Schwann-cell-like cells## (SCLCs) and putative paracrine signaling with NEO cells</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9587261</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36271074</oboInOwl:hasDbXref>
        <rdfs:label>Schwann-cell-like cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002573"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/9b4d9fcb-3817-4ee4-80e2-515640061e7b"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002573"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/9b6bec51-23e0-4f19-ab93-ed0bb5e2f08f -->

    <Class rdf:about="http://example.org/9b6bec51-23e0-4f19-ab93-ed0bb5e2f08f">
        <obo:IAO_0000115>A, B, tSNE plot of 4659 CD45+ immune cells from the CNS. Data from this study is integrated with data from; Table 6). C, D, Each dataset represented by one tSNE. Cells are annotated using color representing their cell type. ##bMicroglia##: baseline microglia; aMicroglia: activated microglia; pmMicroglia: proliferation-mediating microglia; maMicroglia: monocyte-activating microglia; DAM: disease-associated microglia in SCI; elMicroglia: embryonic-like microglia; pvMacrophages: perivascular macrophages; mdMacrophages: monocyte-derived macrophages; DCs: dendritic cells; imB-cells: immature B-cells; mB-cells: mature B-cells; pimMicroglia: postnatal immature microglia; IEG+Microglia: immediate early genes microglia; sMicroglia: s-phase microglia; pPAM: postnatal proliferative-region-associated microglia; eMicroglia: embryonic microglia; pcpMacrophages: postnatal choroid plexus macrophages; acpMacrophages: adult choroid plexus macrophages; iMonocytes: inflammatory monocytes; pMonocytes: patrolling monocytes; cpEpithelial cells: choroid plexus epithelial cells. E, tSNE plots of 4659 CD45+ immune cells for selected genes indicating the log2(cpm) expression with a continuous color for each cell separately. F, Proliferation rate of CD45low and CD45high cells at 7 and 21 d post-SCI. Hoechst 33342 expression presented on a log-scale was used for defining cells in S-phase. Right most plot reports the percentage of cells in S-phase. Each dot represents one biological replicate (four mice per time point). Mean is surrounded by a 95% CI. This figure is extended in Extended Data Figure 8-1.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8496189</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34417326</oboInOwl:hasDbXref>
        <rdfs:label>bMicroglia</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000129"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/9b6bec51-23e0-4f19-ab93-ed0bb5e2f08f"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000129"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/9b850d23-6433-490c-b243-4c8f2c889833 -->

    <Class rdf:about="http://example.org/9b850d23-6433-490c-b243-4c8f2c889833">
        <obo:IAO_0000115>In the present study, we calculated the difference in immune cell infiltration ratio in the two subclusters using ssGSEA. We found most of the immune cells were decreased in cluster 1 compared with cluster 2, including ##activated dendritic cell## (DC), central memory CD8 T cell, myeloid-derived suppressor cell (MDSC), monocyte, plasmacytoid dendritic cell (DC), regulatory T cell (Tregs), T follicular helper cell (Tfh), CD56dim natural killer (NK) cell, effector memory CD8 T (TEFF) cell, Macrophage, gamma delta T cell, immature B cell, mast cell, natural killer cell (NK), CD56bright natural killer cell (NK), natural killer T (NKT) cell, neutrophil, and activated CD4 T cell (Fig. 6A, B). These findings suggested that higher immune infiltrating in cluster 2 compared with cluster 1.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11481600</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:39407301</oboInOwl:hasDbXref>
        <rdfs:label>activated dendritic cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000451"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/9b850d23-6433-490c-b243-4c8f2c889833"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000451"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/9bb19692-57fd-4ec0-8353-e29ea1f99099 -->

    <Class rdf:about="http://example.org/9bb19692-57fd-4ec0-8353-e29ea1f99099">
        <obo:IAO_0000115>Last, we investigated whether the human materno-fetal immune system in HIS mice was functional. Human ##decidua and splenic CD4+CD25+ Treg cells## were purified from pregnant HIS mice and incubated with the CFSE-labeled human CD45+CD25- splenic cells (responder cells from pregnant HIS mice) in the presence of 30 Gy irradiated BALB/c mouse splenic cells (stimulator). The proliferation of responder cells was quantified 4 days later using FCM. Proliferation of maternal human splenic CD4+ effector T cells after stimulation with paternally (BALB/c) derived antigen reflects the presence of fetal reactive human maternal T cells (Figure 5A). STreg cells were capable of suppressing Tconv cells at 1:2 ratio (Treg/Tconv) (Supplemental Figure 11). However, under a low Treg/Tconv ratio (1:16) condition, the maternal versus fetal T cell reactions (MvFRs) of maternal T cells were significantly inhibited by dTreg but not by sTreg cells (or were only minimally suppressed; Figure 5A).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11529984</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:39435662</oboInOwl:hasDbXref>
        <rdfs:label>decidua and splenic CD4+CD25+ Treg cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000815"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/9bb19692-57fd-4ec0-8353-e29ea1f99099"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000815"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/9be6ed8b-6681-43b0-bb8b-d379f4e9ca80 -->

    <Class rdf:about="http://example.org/9be6ed8b-6681-43b0-bb8b-d379f4e9ca80">
        <obo:IAO_0000115>In conclusion, our study highlights the potential role of CD63 + TAMs in regulating HCC progression and opens up new possibilities for targeted therapy. Recognizing CD63 + TAMs as crucial regulators of HCC progression offer opportunities for therapeutic intervention. Targeting CD63 + TAMs could disrupt the pre-tumorigenic communication between ##TAMs## and HCC cells, leading to the development of novel immunotherapeutic strategies. Additionally, the use of CD63 as a prognostic marker may help guide personalized treatment approaches for HCC patients.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11157766</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38849760</oboInOwl:hasDbXref>
        <rdfs:label>TAMs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/9be6ed8b-6681-43b0-bb8b-d379f4e9ca80"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/9c1ef9a7-b2c6-4f01-980c-708daccccee0 -->

    <Class rdf:about="http://example.org/9c1ef9a7-b2c6-4f01-980c-708daccccee0">
        <obo:IAO_0000115>Our novel multi-color flow cytometry panel was also tested on mouse skin. After excluding cellular debris, doublets, and dead cells, we gated with the help of FMO controls (Fig. S10) on viable CD45+ cells (Fig. 2A). In healthy skin, the CD3+ T cell population consists of CD3intCD4+ T cells and ##CD3highgammadelta T cells##, whereas CD8+ T cells, NK cells, B cells, neutrophils and pDC are rare in healthy skin (Fig. 2B). By following gating published earlier, we identified several myeloid non-DC populations (P1-P5) in the dermis (Fig. 2C) and different DC-subsets (Fig. 2D, E). From the non CD11b+CD24- population we identified CD11c+MHC-II+ DC. Next, we divided DC into XCR1+ cDC1, which contain CD103+ and CD103- subsets, and CD172a+ DC which consists mainly of CD207+ LC (Fig. 2D). Dermal cDC2 are characterized from the CD64-Ly-6C- population by gating on CD11c+MHC-II+ cells that express CD11b and CD172a (Fig. 2E). In addition, we investigated CD115, F4/80 and CD64 expression on the non-DC myeloid cell populations P1-P5 (Fig. 2F). Analysis of CD40, PD-L1, PD-L2 and CCR7 on the different DC-subets allows further phenotypical characterization (Fig. 2G). An example for UMAP analysis is shown in Figure S11 confirming manual gating for DC-subsets and non-DC populations.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10087122</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35944142</oboInOwl:hasDbXref>
        <rdfs:label>CD3highgammadelta T cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000798"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/9c1ef9a7-b2c6-4f01-980c-708daccccee0"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000798"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/9c3227e0-b25e-4859-83be-ab5c45d0c625 -->

    <Class rdf:about="http://example.org/9c3227e0-b25e-4859-83be-ab5c45d0c625">
        <obo:IAO_0000115>Immune checkpoint inhibitors exert clinical efficacy against various types of cancer through reinvigoration of exhausted CD8+ T cells that attack cancer cells directly in the tumor microenvironment (TME). Using single-cell sequencing and mouse models, we show that CXCL13, highly expressed in tumor-infiltrating exhausted CD8+ T cells, induces CD4+ follicular helper T (TFH) cell infiltration, contributing to anti-tumor immunity. Furthermore, a part of the TFH cells in the TME exhibits cytotoxicity and directly attacks major histocompatibility complex-II-expressing tumors. ##TFH-like cytotoxic CD4+ T cells## have high LAG-3/BLIMP1 and low TCF1 expression without self-renewal ability, whereas non-cytotoxic TFH cells express low LAG-3/BLIMP1 and high TCF1 with self-renewal ability, closely resembling the relationship between terminally differentiated and stem-like progenitor exhaustion in CD8+ T cells, respectively. Our findings provide deep insights into TFH-like CD4+ T cell exhaustion with helper progenitor and cytotoxic differentiated functions, mediating anti-tumor immunity orchestrally with CD8+ T cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMID:38363680</oboInOwl:hasDbXref>
        <rdfs:label>TFH-like cytotoxic CD4+ T cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000934"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/9c3227e0-b25e-4859-83be-ab5c45d0c625"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000934"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/9c3828ed-df0f-46c9-b1d7-747c59fda824 -->

    <Class rdf:about="http://example.org/9c3828ed-df0f-46c9-b1d7-747c59fda824">
        <obo:IAO_0000115>As can be seen from Fig. 2b, the fibroblasts which highly expressed HBEGF (average expression of HBEGF higher than 1.5) were distributed into a small group. Then we defined them as HBEGF+ fibroblasts and fibroblasts with low expression of HBEGF were defined as ##HBEGF- fibroblasts##. Referring to the previous studies, macrophages with high or low expression of HBEGF were defined as HBEGF+ macrophages and HBEGF- macrophages separately (Fig. 3a).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9446562</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36068607</oboInOwl:hasDbXref>
        <rdfs:label>HBEGF- fibroblasts</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000057"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/9c3828ed-df0f-46c9-b1d7-747c59fda824"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000057"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/9c48e72c-2c90-4a78-b40d-b45cd6cb594a -->

    <Class rdf:about="http://example.org/9c48e72c-2c90-4a78-b40d-b45cd6cb594a">
        <obo:IAO_0000115>We performed bronchoscopy with bronchoalveolar lavage (BAL) on 8 individuals with acute hypoxemic respiratory failure supported with invasive mechanical ventilation (Bronchoscopy 1 = B1). Four of the participants were sampled again 4 days later (Bronchoscopy 2 = B2). We isolated single cells and assessed them with CITE-seq. A Uniform manifold approximation and projection (UMAP) plot displaying clustering of 64,317 cells based on gene expression. We annotated the clusters by mapping them to published datasets to identify B cell, T cell, myeloid (alveolar macrophages = AM, ##alveolar monocytes## = mono, classical dendritic cells = cDCs), and other cell-types (designated by color). B Cells identified as myeloid (including macrophages, monocytes, and cDCs) in panel A were re-clustered. Color designates assignment of cells to one of the 9 clusters identified by Seurat. C Dot plot comparing the expression of marker genes (x-axis) across nine alveolar myeloid cell clusters (y-axis). Each cluster is annotated based on the marker genes (Table S5). The proportion of each cluster as a percentage of all alveolar myeloid cells is displayed. The dot size is proportional the percentage of cells expressing the gene in each color. The color intensity is proportional to the average scaled log-normalized expression within a cluster. D Bar plot displaying the individual percentages, median, and interquartile range of each subset as a proportion of all alveolar myeloid cells at B1 and B2.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10656558</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37978185</oboInOwl:hasDbXref>
        <rdfs:label>alveolar monocytes</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000576"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/9c48e72c-2c90-4a78-b40d-b45cd6cb594a"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000576"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/9c5820fc-503b-479c-94fb-58853f38e5ad -->

    <Class rdf:about="http://example.org/9c5820fc-503b-479c-94fb-58853f38e5ad">
        <obo:IAO_0000115>This evolution generated the need to unify the nomenclature and refine the concepts that precisely define astrocyte heterogeneity by using a systematic approach to contextualize the contribution of astrocytes to CNS disorders. Recent studies have proposed that mouse astrocytes have two discrete pathological conditions: The ##A1 neurotoxic phenotype## when exposed to specific cytokines secreted by activated microglia and the A2 neuroprotective phenotype when exposed to an experimental paradigm mimicking ischemic stroke. However, this binary polarization should be approached cautiously since more recent studies recommend moving beyond the A1-A2 classification. Indeed, only a subset of mixed A1 and A2 or pan-reactive transcripts are up-regulated in astrocytes of human patients or mouse models of chronic diseases or acute CNS injuries. Moreover, advanced multidimensional data and the co-clustering statistical approach revealed that the A1 and A2 transcriptomes represent only two of the many potential astrocyte transcriptomes. As transcriptomic data are a fundamental tool used to characterize the functional diversity of reactive astrocytes, a multidimensional analysis should be applied to establish the uniqueness of astrocyte phenotypes.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8945600</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35327542</oboInOwl:hasDbXref>
        <rdfs:label>A1 neurotoxic phenotype</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000127"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/9c5820fc-503b-479c-94fb-58853f38e5ad"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000127"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/9c847c48-14e9-4b60-a781-db2634df4e15 -->

    <Class rdf:about="http://example.org/9c847c48-14e9-4b60-a781-db2634df4e15">
        <obo:IAO_0000115>Together, these results demonstrate that the output of Som+ cells outpaces that of ##PKCdelta+ cells## in the CeLC but that the cellular mechanisms underlying the differences in excitability in Som+ and PKCdelta+ neurons are distinct for late-firing and regular-spiking cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7877473</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33188006</oboInOwl:hasDbXref>
        <rdfs:label>PKCdelta+ cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000540"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/9c847c48-14e9-4b60-a781-db2634df4e15"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000540"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/9cd94754-9cdd-40c4-9fc1-50b899014419 -->

    <Class rdf:about="http://example.org/9cd94754-9cdd-40c4-9fc1-50b899014419">
        <obo:IAO_0000115>Highly regulated processes establish intercellular communication between bone-resident cells, each with its own distinctive role, to ensure a finely tuned balance between bone resorption and bone formation. The major bone-resorbing cell type is the osteoclast. Osteoclasts are multinucleated cells formed by the fusion of mononuclear, monocyte-derived, macrophage precursors, and their main function is resorption of cartilage and bone matrices. Vessel-associated osteoclasts drive cartilage resorption during bone growth, whereas bona fide osteoclasts regulate resorption of mineralised bone matrix during bone maintenance and repair. Furthermore, with bone being the largest reservoir for calcium storage in the body, resorption also facilitates calcium release to maintain optimal circulating levels. Osteoblasts play the opposite role to osteoclasts, constituting the major bone-forming cell type. Mesenchymal stem cells (MSCs) are situated at the apex of the ##osteoblast lineage cell## hierarchy, differentiating stepwise into osteoprogenitors, bone lining cells, osteoblasts, and, ultimately, osteocytes. Osteoblast lineage cells have numerous roles depending on their differentiation stage. Osteoprogenitors and bone lining cells constitute a pool of immature osteoblasts, maintained in a quiescent state that can be utilized for bone remodelling and repair. Mature osteoblasts ensure production and secretion of a new protein-rich bone matrix and its subsequent mineralization. Osteocytes are terminally differentiated osteoblasts, entombed within mineralised bone, acting as the main regulatory unit of skeletal homeostasis. Additional cells supporting bone homeostasis include endothelial cells (ECs), adipocytes, and chondrocytes.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8305002</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34298886</oboInOwl:hasDbXref>
        <rdfs:label>osteoblast lineage cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000062"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/9cd94754-9cdd-40c4-9fc1-50b899014419"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000062"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/9d04abab-067f-49d6-8944-588fcfc6b51f -->

    <Class rdf:about="http://example.org/9d04abab-067f-49d6-8944-588fcfc6b51f">
        <obo:IAO_0000115>The analysis above illustrates separately the fraction of neurons in each genetic subset labeled retrogradely from the pial surface (Fig. 4B) or immunostained against each of the protein markers (Fig. 6). However, since the same ROIs and the same neurons were used for both analyses, we could tag each neuron with the following four attributes: its laminar position, its genetic identity, its retrograde label and its protein marker expression, thus allowing us to examine correlations between these attributes. To convey these multidimensional data graphically, we present them in Figure 7 as a 4 x 3 grid of &quot;sunburst charts,&quot; with rows corresponding to the four genetic subsets and columns corresponding to the three protein markers. Each sunburst chart consists of four concentric rings representing the four attributes; the complete ring represents all ##SOM cells##, and the angle subtended by each color sector is proportional to the fraction of cells expressing that attribute, averaged over three brains. Beginning in the inner ring with four sectors corresponding to four laminar positions, each sector is further split two ways with each consecutive ring: by fluorescent protein, by retrograde label, and by immunostaining, ending with 32 sectors in the outer ring corresponding to the 32 distinct combinations of the four attributes. The full numerical dataset is provided as Extended Data Figure 7-1. An interactive version of these plots can be accessed at https://sites.google.com/view/somatostatinsubtypes/home.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10414551</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37463742</oboInOwl:hasDbXref>
        <rdfs:label>SOM cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000540"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/9d04abab-067f-49d6-8944-588fcfc6b51f"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000540"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/9d0ed9ea-3cf0-45b6-9e0f-e4d3b39091fa -->

    <Class rdf:about="http://example.org/9d0ed9ea-3cf0-45b6-9e0f-e4d3b39091fa">
        <obo:IAO_0000115>The liver plays a crucial role in innate immunity, and, under normal conditions, it harbors a number of innate immune cells, including NK cells. The proportion and phenotype of intrahepatic immune cells are altered in patients with acute or chronic liver disease, such as viral hepatitis or steatohepatitis. In HCV- and HBV-infected individuals, intrahepatic NK cells display enhanced expression of NKG2D and CD69, and the levels correlate positively with serum alanine aminotransferase and HCV RNA levels. It is thus plausible that changes in intrahepatic NK cell phenotype and function could be associated with the pathogenesis of NAFLD. We showed that NAFLD was accompanied by increased frequencies of intrahepatic ##NKG2D+ and CD69+ NK cells##, suggesting that hepatic NK cells are activated in this disease. However, the small sample number (n = 4) of our intrahepatic NK cell analysis limited our ability to investigate correlations between intrahepatic NK cell phenotypes or functions and clinical parameters. There are many reports on the distinct phenotype and function of NK cells between in the liver and in the periphery. In general, such spatial difference of NK cells may be augmented in patients with inflammatory liver disease, such as NAFLD. One of the key factors impacting on NK cells is IL-15. IL-15 is present constitutively in the hepatic microenvironment, and upregulated in viral hepatitis. IL-15 is mainly produced by Kupffer cells and monocytes/bone marrow-derived macrophages. IL-15 can restore the downregulated NK cell function in chronic diseases and increases NKG2D expression on NK cells. Although we have not measured intra-hepatic expression of IL-15 in NAFLD patients, the previous reports support the possibility that up-regulated IL-15 might result in higher expression of NKG2D in the liver of patients with NAFLD.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7938755</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33692781</oboInOwl:hasDbXref>
        <rdfs:label>NKG2D+ and CD69+ NK cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000623"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/9d0ed9ea-3cf0-45b6-9e0f-e4d3b39091fa"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000623"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/9d19e499-31e2-44ee-9b2f-2d6f32476a4b -->

    <Class rdf:about="http://example.org/9d19e499-31e2-44ee-9b2f-2d6f32476a4b">
        <obo:IAO_0000115>We then examined the dynamism of expression patterns of genes involving VLC during retinal development. ELOVL2 and ELOVL4 are elongases involved in VLC-PUFA-CoA biosynthesis. Elovl4 mRNA levels have been shown to increase during retinal development, especially in the photoreceptor inner segments. Using our previous RNA sequencing data (GSE71462, GSE71464), we found that Elovl2 and Elovl4 were upregulated in CD73-positive rod photoreceptors as early as at P2, which corresponds to the rod photorecetpor birth period (Fig. 4A). During late retinal development, which corresponds to the rod photoreceptor maturation period, although Elovl4 expression levels kept high in CD73-positive cells, Elovl2 expression in CD73-positive cells gradually decreased and became similar to the level of the CD73-negative fraction (Fig. 4A). Although ELOVL5 was also shown to catalyze the elongation of long-chain fatty acids, Elovl5 mRNA levels were higher in nonphotoreceptor cells than in rod photoreceptors (Fig. 4A). Consistently, no mutations in Elovl5 were observed in patients with autosomal recessive retinitis pigmentosa. Nrl is the Maf-family leucine zipper transcription factor, and in the Nrl knockout (Nrl-KO) retina, ##photoreceptor precursors## fated to cells with characteristics of short-wavelength cones. The expression profiling database of flow-sorted rods from Nrlp-GFP mouse retina and GFP-positive S-cone-like cells from NRlp-GFP;Nrl-KO mouse can be used to compare gene expression patterns between rod and S-cone (GSE74660, GFE74657). We confirmed that rod photoreceptor kept high Elovl4 expression pattern after P14, which was in contrast to the low expression level of Elovl2 (Fig. 4B). Of interest, Nrl-KO mice-derived retina showed higher expression levels of Elovl2 and Elovl5, but Elovl4 was lower than Nrl-GFP rod (Fig. 4B), suggesting differential expression patterns of these genes between rod and cone.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7949107</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33465374</oboInOwl:hasDbXref>
        <rdfs:label>photoreceptor precursors</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002672"/>
        <skos:relatedMatch rdf:resource="CL:0010009"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/9d19e499-31e2-44ee-9b2f-2d6f32476a4b"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002672"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/9d19e499-31e2-44ee-9b2f-2d6f32476a4b"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0010009"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/9d3727e3-f86f-4767-9420-a1d7b9bec589 -->

    <Class rdf:about="http://example.org/9d3727e3-f86f-4767-9420-a1d7b9bec589">
        <obo:IAO_0000115>Our data showed that the induction of IL-10 production in macrophages reported in IV and IP MSC treatment is also relevant in SC MSC treatment. When administered directly into the inflamed tissue, SC MSC injection induced immunoregulatory macrophages in the local LN draining the inflamed tissue. Interestingly, an expansion in IL-10-producing macrophages was observed only in the MerTK+ SSM and TZM populations, and not in the F4/80+ macrophage populations (MSM and MCM). This could be due to the F4/80+ macrophages residing deeper within the LN and are therefore less accessible. MerTK is an efferocytic receptor, and ##MerTK+ TZMs## have been reported to have a role in clearing apoptotic cells and maintaining immune homeostasis and tolerance. In addition, studies have demonstrated a role for MerTK signalling in attenuating inflammation. The inhibitory role of MerTK signalling pathway has been previously reported in an LPS-induced lung inflammation model. Whether the selective expansion of IL-10-producing MerTK+ macrophages is associated with activation of MerTK-related immunomodulatory pathway should be investigated further.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11572146</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:39551813</oboInOwl:hasDbXref>
        <rdfs:label>MerTK+ TZMs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/9d3727e3-f86f-4767-9420-a1d7b9bec589"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/9d5426a7-75d3-484a-a494-edb8c5fdc4ad -->

    <Class rdf:about="http://example.org/9d5426a7-75d3-484a-a494-edb8c5fdc4ad">
        <obo:IAO_0000115>Distinct therapy-induced cancer cell transcriptomes were associated with clinical response. Cancer cells from MPR patients exhibited a signature of activated antigen presentation via major histocompatibility complex class II (MHC-II). Further, the transcriptional signatures of FCRL4+FCRL5+ memory B cells and CD16+CX3CR1+ monocytes were enriched in MPR patients and are predictors of immunotherapy response. Cancer cells from NMPR patients exhibited overexpression of estrogen metabolism enzymes and elevated serum estradiol. In all patients, therapy promoted expansion and activation of cytotoxic T cells and CD16+ NK cells, reduction of immunosuppressive Tregs, and activation of memory CD8+T cells into an effector phenotype. Tissue-resident macrophages were expanded after therapy, and tumor-associated macrophages (TAMs) were remodeled into a neutral instead of an anti-tumor phenotype. We revealed the heterogeneity of neutrophils during immunotherapy and identified an aged ##CCL3+ neutrophil## subset was decreased in MPR patients. The aged CCL3+ neutrophils were predicted to interact with SPP1+ TAMs through a positive feedback loop to contribute to a poor therapy response.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9985263</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36869384</oboInOwl:hasDbXref>
        <rdfs:label>CCL3+ neutrophil</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000775"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/9d5426a7-75d3-484a-a494-edb8c5fdc4ad"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000775"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/9d6ce133-c97e-4671-9c25-8644cddc57c6 -->

    <Class rdf:about="http://example.org/9d6ce133-c97e-4671-9c25-8644cddc57c6">
        <obo:IAO_0000115>We employed the CollecTRI-derived regulons to estimate TF activities in a single-cell RNA-seq dataset of peripheral blood mononuclear cells (PBMCs) to investigate the ability of TF activities in elucidating cell type specific regulatory mechanisms, in particular when compared to TF expression. The single-cell dataset was processed according to the standard preprocessing workflow as described in Seurat and eight different cell types including B cells, CD14+monocytes, ##FCGR3A+monocytes##, naive CD4+T cells, memory CD4+T cells, CD8+T cells, natural killer (NK) cells, dendritic cells and platelets were identified based on the expression of canonical marker genes (Methods: Single-cell RNA-seq processing) (Figure 4A).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10639077</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37843125</oboInOwl:hasDbXref>
        <rdfs:label>FCGR3A+monocytes</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000576"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/9d6ce133-c97e-4671-9c25-8644cddc57c6"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000576"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/9d80ba88-9a56-4e77-a13a-49e12f307255 -->

    <Class rdf:about="http://example.org/9d80ba88-9a56-4e77-a13a-49e12f307255">
        <obo:IAO_0000115>% of migrated individual Cell type # of cluster   81% (21/26 fetus) Myeloid cell 8   50% (13/26 fetus) Endothelial cell 17   46% (12/26 fetus) ##Slamf1-negative multipotent progenitor cell## 14   42% (11/26 fetus) Granulocyte 10   23% (6/26 fetus) Epithelial cell of proximal tubule 21   8% (2/26 fetus) Immature T cell 6   Astrocyte 11   8% (2/26 fetus) Microglial cell 0   Fibroblast 1   B cell 4   Basal cell of epidermis 7   4% (1/26 fetus) Luminal epithelial cell of mammary gland 18   Hepatocyte 22   Epithelial cell of lung 27   </obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9636240</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36333354</oboInOwl:hasDbXref>
        <rdfs:label>Slamf1-negative multipotent progenitor cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000048"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/9d80ba88-9a56-4e77-a13a-49e12f307255"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000048"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/9d848037-0062-4293-a348-0520a5d6e906 -->

    <Class rdf:about="http://example.org/9d848037-0062-4293-a348-0520a5d6e906">
        <obo:IAO_0000115>The 60(PKCdelta):40(SOM) model (A) and 30:70 model (B) were each simulated 100 times using constant 120 pA current and the average, minimum, and maximum pain output was plotted. In both models, pain increases during injury and remains elevated post-injury. However, in the 30:70 model a brief decrease in pain is observed around time t = 125 as spontaneous ##SOM neurons## are converted to regular spiking.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8213159</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34101729</oboInOwl:hasDbXref>
        <rdfs:label>SOM neurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:4023017"/>
        <skos:relatedMatch rdf:resource="CL:4023121"/>
        <skos:relatedMatch rdf:resource="CL:4023122"/>
        <skos:relatedMatch rdf:resource="CL:4042037"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/9d848037-0062-4293-a348-0520a5d6e906"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4023017"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/9d848037-0062-4293-a348-0520a5d6e906"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4023121"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/9d848037-0062-4293-a348-0520a5d6e906"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4023122"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/9d848037-0062-4293-a348-0520a5d6e906"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4042037"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/9dd64fe3-2927-40e2-9a7e-5079bbf23472 -->

    <Class rdf:about="http://example.org/9dd64fe3-2927-40e2-9a7e-5079bbf23472">
        <obo:IAO_0000115>A, B, tSNE plot of 4659 CD45+ immune cells from the CNS. Data from this study is integrated with data from; Table 6). C, D, Each dataset represented by one tSNE. Cells are annotated using color representing their cell type. bMicroglia: baseline microglia; aMicroglia: activated microglia; pmMicroglia: proliferation-mediating microglia; maMicroglia: monocyte-activating microglia; DAM: disease-associated microglia in SCI; elMicroglia: embryonic-like microglia; pvMacrophages: perivascular macrophages; mdMacrophages: monocyte-derived macrophages; DCs: dendritic cells; imB-cells: immature B-cells; mB-cells: mature B-cells; pimMicroglia: postnatal immature microglia; IEG+Microglia: ##immediate early genes microglia##; sMicroglia: s-phase microglia; pPAM: postnatal proliferative-region-associated microglia; eMicroglia: embryonic microglia; pcpMacrophages: postnatal choroid plexus macrophages; acpMacrophages: adult choroid plexus macrophages; iMonocytes: inflammatory monocytes; pMonocytes: patrolling monocytes; cpEpithelial cells: choroid plexus epithelial cells. E, tSNE plots of 4659 CD45+ immune cells for selected genes indicating the log2(cpm) expression with a continuous color for each cell separately. F, Proliferation rate of CD45low and CD45high cells at 7 and 21 d post-SCI. Hoechst 33342 expression presented on a log-scale was used for defining cells in S-phase. Right most plot reports the percentage of cells in S-phase. Each dot represents one biological replicate (four mice per time point). Mean is surrounded by a 95% CI. This figure is extended in Extended Data Figure 8-1.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8496189</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34417326</oboInOwl:hasDbXref>
        <rdfs:label>immediate early genes microglia</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000129"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/9dd64fe3-2927-40e2-9a7e-5079bbf23472"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000129"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/9e0d6609-1b67-4134-af26-78d4384f3f1d -->

    <Class rdf:about="http://example.org/9e0d6609-1b67-4134-af26-78d4384f3f1d">
        <obo:IAO_0000115>We find that building an extensive callus of a unique type of ##hybrid osteochondral skeletal cell## is essential for successfully bridging large gaps in adult mammalian rib bone. During this process, Hh signaling plays a critical role, distinct from that in the developing growth plate, in promoting the ultimate differentiation of these hybrid osteochondral skeletal cells. Further, we provide genetic evidence that Hh signaling acts upon a rare periosteal subpopulation of Sox9-expressing cells, that behave as messenger cells. These Sox9+ periosteal cells then stimulate, through a yet to be determined signal, their neighboring non-Sox9-lineage cells, which constitute a majority of the callus, to differentiate and build new callus and bone (summarized in Figure 6).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6464605</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:30983567</oboInOwl:hasDbXref>
        <rdfs:label>hybrid osteochondral skeletal cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000062"/>
        <skos:relatedMatch rdf:resource="CL:0000138"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/9e0d6609-1b67-4134-af26-78d4384f3f1d"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000062"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/9e0d6609-1b67-4134-af26-78d4384f3f1d"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000138"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/9e2e5b26-863c-4739-b0c6-941f296b94ba -->

    <Class rdf:about="http://example.org/9e2e5b26-863c-4739-b0c6-941f296b94ba">
        <obo:IAO_0000115>Microglia reaction in AD was initially evidenced at the genomic level using bulk RNA-seq studies performed on purified microglia. The molecular heterogeneity of microglia in this pathological context was then studied using top-down approaches (typically scRNA-seq). With these approaches, microglia subtypes are first identified based on transcriptomic similarities, their potential functions are then inferred based on gene-ontology analyses, and finally their location in the tissue are assessed retrospectively based on the expression of a handful of markers. Other studies isolated PAM and/or ##PCM## using FACS, relying on specific markers that were shown to be, on average, up-regulated in PAM. These studies then performed thorough characterization of the positive and negative populations.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9508749</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36153535</oboInOwl:hasDbXref>
        <rdfs:label>PCM</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000129"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/9e2e5b26-863c-4739-b0c6-941f296b94ba"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000129"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/9e352153-a60a-47b6-a98c-733e80b0a38a -->

    <Class rdf:about="http://example.org/9e352153-a60a-47b6-a98c-733e80b0a38a">
        <obo:IAO_0000115>Diabetic kidney disease (DKD), a chronic kidney disease, is characterized by progressive fibrosis caused due to persistent hyperglycemia. The development of fibrosis in DKD determines the patient prognosis, but no particularly effective treatment. Here, small extracellular vesicles derived from mesenchymal stem cells (MSC-sEV) have been used to treat DKD fibrosis. Single-cell RNA sequencing was used to analyze 27,424 cells of the kidney, we have found that a novel fibrosis-associated ##TGF-beta1+Arg1+ macrophage## subpopulation, which expanded and polarized in DKD and was noted to be profibrogenic. Additionally, Actin+Col4a5+ mesangial cells in DKD differentiated into myofibroblasts. Multilineage ligand-receptor and cell-communication analysis showed that fibrosis-associated macrophages activated the TGF-beta1/Smad2/3/YAP signal axis, which promotes mesangial fibrosis-like change and accelerates renal fibrosis niche. Subsequently, the transcriptome sequencing and LC-MS/MS analysis indicated that MSC-sEV intervention could restore the levels of the kinase ubiquitin system in DKD and attenuate renal interstitial fibrosis via delivering CK1delta/beta-TRCP to mediate YAP ubiquitination degradation in mesangial cells. Our findings demonstrate the unique cellular and molecular mechanisms of MSC-sEV in treating the DKD fibrosis niche at a single-cell level and provide a novel therapeutic strategy for renal fibrosis.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11184851</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38890734</oboInOwl:hasDbXref>
        <rdfs:label>TGF-beta1+Arg1+ macrophage</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/9e352153-a60a-47b6-a98c-733e80b0a38a"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/9e8dcb00-6661-42f6-a55b-f354b7a3405c -->

    <Class rdf:about="http://example.org/9e8dcb00-6661-42f6-a55b-f354b7a3405c">
        <obo:IAO_0000115>a UMAP dimensionality reduction embedding of PBMCs from DFU-Healers, DFU-Non-healers, Healthy subjects, and non-DFU DM patients. The identified cell types were DCs: dendritic cells; VasEndo: vascular endothelial cells; T-lympho: T lymphocytes; CD8T1: CD8+ T lymphocytes cluster 1; CD8T2: CD8+ T lymphocytes cluster 2; NK: natural killer cells; NKT: natural killer and T cells; B-lympho: B lymphocytes; CD14Mono: CD14+ monocytes; CD16Mono: CD16+ monocytes. Dotted lines are drawn around cell groups of similar lineages. b Bar plots showing percentage of T-lymphocytes (T-lympho) and CD8+ T lymphocytes cluster 2 (CD8T2) per percentage of NKT cells in the CD45+ subset of cells across various clinical groups. DFU-healers depict significantly higher ratio of T-lympho and CDT2 cell cluster in comparison to DFU-Non-healers and Diabetic. Data represent the mean and standard error of mean (SEM) values from n = 2 Non-Healers, n = 3 Healers, n = 2 Diabetic and n = 3 Healthy subjects. p = 0.01 for Healers vs Non-Healers and p = 0.006 for Healers vs Diabetic in T-Lympho; p = 0.036 for Healers vs Non-Healers and p = 0.035 for Healers vs Diabetic in CD8T2 using two-sided Welch&apos;s t-test. c Heatmap showing significant DEGs in Healers compared to Non-healers in the T-lympho, CD8T2 and NKT cell clusters. d Biological pathways that are significantly (P value &lt; 0.01) activated (Z score &gt;1.5) /inhibited (Z score &lt; -1.5) in T-lympho, ##CD8T2 cells## of Healers in contrast to NKT cells of Non-healers. Activation and inhibition of key upstream regulators is shown in pseudo color, where blue represents inhibition, and red represents activation. e Upstream regulatory molecules significantly inhibited (blue) in the T-lympho and CD8T2 cells of Healers as compared to Non-healers at the systemic level. Legend shows shapes and lines annotation for the regulatory network. f Violin plots showing expression levels of 3 key upstream regulator molecules NFKBIA, CCL5, and TGFB1, in the NKT, T-Lympho, and CD8T2 clusters.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8748704</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35013299</oboInOwl:hasDbXref>
        <rdfs:label>CD8T2 cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000625"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/9e8dcb00-6661-42f6-a55b-f354b7a3405c"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000625"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/9eae31f9-6d97-4fcf-97ee-65819efa4c06 -->

    <Class rdf:about="http://example.org/9eae31f9-6d97-4fcf-97ee-65819efa4c06">
        <obo:IAO_0000115>(A, B) Schematic of medial (MOC) and lateral (LOC) olivocochlear neuron (OCN) subtypes housed in the brainstem (A) and their projections into the cochlea, shown in cross-section (A) and top-down (B). D, dorsal; L, lateral; LSO, lateral superior olive; VNTB, ventral nucleus of the trapezoid body; SOC, superior olivary complex; IHC, inner hair cell; OHC, outer hair cell; SGN, spiral ganglion neuron; IGSB, intraganglionic spiral bundle; ISB, inner spiral bundle; TSB, tunnel spiral bundle. (C) Schematic of single-nucleus collection protocol. The ventral brainstem of ChatCre; Rosa26Sun1-GFP mice was dissected, including the SOC, facial motor nucleus (VII), and trigeminal motor nucleus (V), followed by collection and sequencing of individual GFP+ nuclei. A, anterior; P, posterior. (D) UMAP plot summarizing sequencing data of 45,828 single nuclei from 61 animals across three ages. The data includes 56 clusters, including MOCs, ##LOCs##, and several different motor neuron types, as well as a few non-neuronal populations. (E-H) Feature plots denoting normalized expression levels of selected genetic markers. For visualization purposes, high expression on the color scale is capped at the 95th percentile of gene expression. The majority of clusters express the neuronal marker Snap25 (E). The main non-neuronal population is labeled by Mog, an oligodendrocyte marker (F). Motor neuron clusters express the motor neuron determinant Isl1 (G). Among these brainstem motor neurons, OCNs are identified by expression of the transcription factor Gata3 (H). (I, J) Differential expression of known markers Ucn (I) and Atp1a3 (J) denotes LOCs and MOCs, respectively. (K-M) Cadps2 is a novel marker for OCNs that is expressed by both MOCs and LOCs but not FMNs. (K) Violin plots summarizing transcriptional expression of Cadps2 in mature LOCs, MOCs, and FMNs. (L, M) Fluorescent in situ hybridization (FISH) verifies that Cadps2 is detected in both MOCs and LOCs (L) but not in FMNs (M). Representative images are shown from a total of three animals of either sex, P28.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10147377</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36876911</oboInOwl:hasDbXref>
        <rdfs:label>LOCs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:2000047"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/9eae31f9-6d97-4fcf-97ee-65819efa4c06"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:2000047"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/9eb07b71-66a8-4335-af54-1abc441bde45 -->

    <Class rdf:about="http://example.org/9eb07b71-66a8-4335-af54-1abc441bde45">
        <obo:IAO_0000115>a Schematic overview of the experimental workflow. Forebrain samples were collected from Sox2eGFP mice at 11 developmental timepoints, dissociated into single cells followed by sorting of the GFP + ve /-ve cells and performing single-cell RNA-seq using the 10x Genomics Chromium platform. b Left: two-dimensional Uniform manifold approximation and progression (UMAP) plot with Leiden clustering of 102,504 individual cells identifying 28 transcriptionally and biologically distinct cell types (see Supplementary Fig. 3a and Methods). Each dot represents a single cell and colours correspond to the distinct clusters/cell types. Shown on the right is a dot plot showing the relative fraction (dot size) of the 28 cell types at each developmental timepoint normalized by library size. c UMAP plot of the cells as in (b) but coloured by timepoint. Each dot represents a single cell and the colours correspond to the different timepoints. d, UMAP plot showing the coarse annotation of cells into 4 categories (Neuronal, Glial, Immune and Vascular/other) based on logistic regression from Zeisel et al. 2018. The RNA-velocity field is overlaid on the UMAP. Colours represent the 4 categories of cell annotation and the arrows correspond to the direction of the RNA-velocity flow field (see Methods). RG Radial glia, TAPs Transient amplifying progenitors, aNSCs ##Active neural stem cells##, APCs Astrocyte progenitor cells, EmNBs Embryonic neuroblasts, GE NBs Ganglionic eminence neuroblasts, OPCs Oligoprogenitor cells, PreM-ODCs Immature pre-myelinating oligodendrocytes, INs Interneurons, ImStNeurons Immature striatal neurons, VLMC Vascular leptomeningeal cells, Myeloid-DSCs Myeloid-derived suppressor cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9296666</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35853870</oboInOwl:hasDbXref>
        <rdfs:label>Active neural stem cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000047"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/9eb07b71-66a8-4335-af54-1abc441bde45"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000047"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/9f00bdf1-1764-4694-9af1-c21b8453cef6 -->

    <Class rdf:about="http://example.org/9f00bdf1-1764-4694-9af1-c21b8453cef6">
        <obo:IAO_0000115>The tumor immune microenvironment of 10 patients with TNBC was resolved after single-cell RNA sequencing data were analyzed according to the standard workflow of Seurat. A total of 21 different types of cell clusters were annotated (Fig. 7a,b): Cancer Cell (WFDC2, SAA1, SCGB2A2), Endothelial Cell (PLVAP, ACKR1, VWF), Epithelial Cell (CLDN3, MUCL1, TFF3), ##Exhausted CD8 + T Cell## (CD8A, CD8B, CXCR6), Fibroblast (DCN, APOD, LUM), Granulosa Cell (SPP1), Leydig Cell (ASPH, SERPINE1, PFN2), M1 Macrophage (CXCL9, CXCL10, CXCL2), M2 Macrophage (SEPP1, F13A1, FOLR2), Memory T Cell (TRAC, TRBC2), Mesenchymal Cell (RGS5, NDUFA4L2), MKI67+ Progenitor Cell (MKI67, RRM2, UBE2C), Naive B Cell (MS4A1, CD79B, BANK1), Natural Killer (NK) Cell (GNLY, TRDC, NKG7), Natural Killer T (NKT) Cell (RGCC, DNAJB1, DNAJA1), Neutrophil (S100A8, S100P, PI3), Plasma Cell (IGKV3-15, IGKC, IGHG1), Plasmacytoid Dendritic Cell (LILRA4, PLD4, NPC2), Regulatory T (Treg) Cell (BATF, TNFRSF18, TNFRSF1B), T Helper Cell (IL7R, CCR7, CD40LG), Tumor Associate Macrophage(TAM) (FCN1, VCAN, EREG).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10662149</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37985782</oboInOwl:hasDbXref>
        <rdfs:label>Exhausted CD8 + T Cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000625"/>
        <skos:relatedMatch rdf:resource="CL:0011025"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/9f00bdf1-1764-4694-9af1-c21b8453cef6"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000625"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/9f00bdf1-1764-4694-9af1-c21b8453cef6"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0011025"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/9f16c0ea-6600-4223-a650-ac9c08a0a749 -->

    <Class rdf:about="http://example.org/9f16c0ea-6600-4223-a650-ac9c08a0a749">
        <obo:IAO_0000115>MDSC populations were divided into ##monocyte-derived (CD66b-CD20-CD19-CD3-) and granulocyte-derived (CD66b+) MDSCs## (Figure 6G). While the granulocytic MDSC subpopulation remained close to zero, the monocytic MDSCs were about 15% of the total cells stained and dropped nearly 3-fold within the PDAC PBMCs to 5% (p = 0.00018). Even though the total number of monocytic MDSCs decreased and the granulocytic MDSCs were low, both of their populations experienced significantly elevated FcRn positivity in PDAC patients (p = 0.034, p = 0.026, respectively) (Figure 6H). Monocytic MDSC FcRn MMI was significantly increased in PDAC PBMCs (p = 0.021), while granulocytic FcRn MMI had no change (Figure 6I). Together, these results further support the PDAC dependent induction of FcRn expression in highly specific cell populations of monocytic origin.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9266939</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35806069</oboInOwl:hasDbXref>
        <rdfs:label>monocyte-derived (CD66b-CD20-CD19-CD3-) and granulocyte-derived (CD66b+) MDSCs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000094"/>
        <skos:relatedMatch rdf:resource="CL:0000576"/>
        <skos:relatedMatch rdf:resource="CL:0000889"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/9f16c0ea-6600-4223-a650-ac9c08a0a749"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000094"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/9f16c0ea-6600-4223-a650-ac9c08a0a749"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000576"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/9f16c0ea-6600-4223-a650-ac9c08a0a749"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000889"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/9f1ee1ac-db6d-45dc-ae54-8afac13c5a38 -->

    <Class rdf:about="http://example.org/9f1ee1ac-db6d-45dc-ae54-8afac13c5a38">
        <obo:IAO_0000115>Auditory sensory hair cells (HCs) and surrounding nonsensory supporting cells (SCs) differentiate from the common pool of ##inner ear progenitor cells##. HCs in the sensory epithelium are precisely arranged into outer HCs (OHCs) and inner HCs (IHCs), intermixed with various types of SCs, including Deiter&apos; cells (DCs), Hensen&apos;s cells, inner border cells (IBCs), and inner phalangeal cells (IPhCs), etc. Sensory HCs act as the mechanoreceptors that transform acoustic waves into electrical signals transmitted to the brain through spiral ganglion neurons innervating the HCs. As terminally differentiated cells, mammalian cochlear HCs are susceptible to genetic mutations and environmental stress. Irreversible damage to HCs is one of the leading causes of sensorineural hearing loss in mammalian or mammalian species. </obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11304307</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38810137</oboInOwl:hasDbXref>
        <rdfs:label>inner ear progenitor cells</rdfs:label>
    </Class>
    


    <!-- http://example.org/9fa7ab81-39b5-48ad-a899-4e38867022ab -->

    <Class rdf:about="http://example.org/9fa7ab81-39b5-48ad-a899-4e38867022ab">
        <obo:IAO_0000115>Human germline-soma segregation occurs during weeks 2-3 in gastrulating embryos. Although direct studies are hindered, here, we investigate the dynamics of human primordial germ cell (PGCs) specification using in vitro models with temporally resolved single-cell transcriptomics and in-depth characterisation using in vivo datasets from human and nonhuman primates, including a 3D marmoset reference atlas. We elucidate the molecular signature for the transient gain of competence for germ cell fate during peri-implantation epiblast development. Furthermore, we show that both the PGCs and amnion arise from transcriptionally similar ##TFAP2A-positive progenitors## at the posterior end of the embryo. Notably, genetic loss of function experiments shows that TFAP2A is crucial for initiating the PGC fate without detectably affecting the amnion and is subsequently replaced by TFAP2C as an essential component of the genetic network for PGC fate. Accordingly, amniotic cells continue to emerge from the progenitors in the posterior epiblast, but importantly, this is also a source of nascent PGCs.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10203729</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37217306</oboInOwl:hasDbXref>
        <rdfs:label>TFAP2A-positive progenitors</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0011026"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/9fa7ab81-39b5-48ad-a899-4e38867022ab"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0011026"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/9fae0100-654b-402f-a208-6761f8cb1b86 -->

    <Class rdf:about="http://example.org/9fae0100-654b-402f-a208-6761f8cb1b86">
        <obo:IAO_0000115>In all tumor tissues, TAMs replaced resident populations such as lung alveolar macrophages, prostate CTRB1+ macrophages, and ##renal GPX3+ macrophages## (Supplementary Fig. 1a, b, and Supplementary Table 1). Plasmacytoid dendritic cells (pDCs) were marginally elevated in lung, colon, and pancreatic cancers, whereas conventional DCs were drastically reduced in colorectal cancer (Supplementary Fig. 1c). T cells exhibited diverse gene expression profiles including naive-like, activated, follicular helper, and regulatory CD4+ T cells, in addition to cytokine-rich, highly cytotoxic, and exhausted CD8+ effector T cells (Supplementary Fig. 1d-f, and Supplementary Table 1). Compared to normal tissues, CD4+ regulatory and follicular helper T cells were commonly elevated, whereas overall cytotoxic immune cell clusters (CD8 Cytotoxic, NK Cytotoxic, and Innate Lymphoid) were reduced (Supplementary Fig. 1g). In contrast, CD8+ T cell states were differentially regulated in each tumor type. The degree of mixing among four datasets in embeddings of CD45+ cells, Myeloid, and T/NK cells was evaluated by LISI metric. Integration of the four datasets was performed appropriately to assign cell identity covering tissue-specific cell types such as lung alveolar macrophages (Supplementary Fig. 1h).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11014989</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38424167</oboInOwl:hasDbXref>
        <rdfs:label>renal GPX3+ macrophages</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/9fae0100-654b-402f-a208-6761f8cb1b86"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/9fbad048-b555-475f-9600-5673dd3a20cd -->

    <Class rdf:about="http://example.org/9fbad048-b555-475f-9600-5673dd3a20cd">
        <obo:IAO_0000115>Angiocrine factors control liver function. The hepatic endothelium is not just a passive conduit for blood. Instead, it acts as instructive gatekeeper regulating the hepatic microenvironment through EC-derived angiocrine factors. Pericentral LSEC are a prime example of angiocrine signaling. They modulate hepatocytic function, by secreting angiocrine Wnt2, Wnt9b, and Rspo3 to establish the spatial division of labor of hepatocytes (&quot;metabolic liver zonation&quot;). Concurrently, angiocrine Wnt-signaling fuels ##Axin2+, Lgr5+, and glutamine synthase (GS)+ pericentral hepatocytes## to maintain the pericentral niche during tissue homeostasis. Moreover, angiocrine Wnt-signaling plays a pivotal role in regulating xenobiotic functions by modulating the hepatic cytochrome activity such as CYP2E1. In the portal zone, hepatocytes are actively involved in gluconeogenesis and urea cycle with increased expression of arginase (Arg1). Portal vein EC and periportal LSEC have high Notch activity with upregulated Dll4 expression. Angiocrine DLL4 may orchestrate monocyte recruitment to establish a niche for KC. Likewise, the hepatic immune zonation is further maintained by LSEC driven CXCL9 and through MYD88 pathway. Periportal LSEC also serve as a niche for resident LSEC progenitors expressing CD157. Midlobular LSEC control iron homeostasis by secretion of the angiocrine factors BMP2 and BMP6</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7982081</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33745018</oboInOwl:hasDbXref>
        <rdfs:label>Axin2+, Lgr5+, and glutamine synthase (GS)+ pericentral hepatocytes</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0019029"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/9fbad048-b555-475f-9600-5673dd3a20cd"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0019029"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/9ff3d4a9-f994-41bd-9a8f-d80b498759fb -->

    <Class rdf:about="http://example.org/9ff3d4a9-f994-41bd-9a8f-d80b498759fb">
        <obo:IAO_0000115>We hypothesized that this pattern of expression could be achieved by suppressing CFTR expression in multipotent basal cells via miRNA-mediated silencing. This approach of suppressing transgene expression in a specific cell type is most often referred to as &quot;detargeting&quot;. To this end, we sought to identify a miRNA that was selectively expressed in multipotent basal cells and identified miR-106b. The target sequence of miR-106b was then incorporated into the 3&apos;-untranslated region (UTR) of reporter and CFTR transgene cassettes encoded within bicistronic and bidirectional lentiviral vectors. Here, we describe the challenges and solutions for vector production using this approach, the analysis of dual reporter gene vectors that demonstrate the efficiency of basal cell detargeting of transgene expression, and the functional consequences of downregulating CFTR expression in ##CF human basal cells## by assessing their capacities for generating CFTR currents following differentiation. We believe these vectors created will provide new opportunities for studying pathways that control lineage-commitment of airway basal cells, understanding cell type-specific functions of CFTR function, and ultimately aid in developing more effective gene therapy approaches for CF.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7601932</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33036232</oboInOwl:hasDbXref>
        <rdfs:label>CF human basal cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:1000349"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/9ff3d4a9-f994-41bd-9a8f-d80b498759fb"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:1000349"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/9ff470d6-9149-4107-a86f-0e0d3a2de991 -->

    <Class rdf:about="http://example.org/9ff470d6-9149-4107-a86f-0e0d3a2de991">
        <obo:IAO_0000115>ScRNA-seq reveals an altered differentiation capacity of ##PVASCs## during aging</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6612678</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31087498</oboInOwl:hasDbXref>
        <rdfs:label>PVASCs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002570"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/9ff470d6-9149-4107-a86f-0e0d3a2de991"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002570"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/90b5bac7-cf92-4a6a-90f4-4f1a49c82a5f -->

    <Class rdf:about="http://example.org/90b5bac7-cf92-4a6a-90f4-4f1a49c82a5f">
        <obo:IAO_0000115>Reference strains Ba/Apache-2 and E/Bour were used to infect HeLa 229 and immortalized human conjunctival epithelial (HCjE) cells, primary conjunctival epithelial (CjE) cells and stromal fibroblasts (##CjS cells##), primary endocervical epithelial (EcE) cells and stromal fibroblasts (EcS cells), and endometrial stromal fibroblasts (EmS cells). Cell composition and type were validated prior to our performing each assay using cytokeratin- and fibronectin-specific antibodies (see Fig. S1 in the supplemental material). Table S1 shows the origins of human primary cells by patient age and sex for CjE and CjS cells and by age for EcE, EcS, and EmS cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6426598</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:30890604</oboInOwl:hasDbXref>
        <rdfs:label>CjS cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002550"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/90b5bac7-cf92-4a6a-90f4-4f1a49c82a5f"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002550"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/90d55a3e-b048-4f16-ad0b-697a04d886c0 -->

    <Class rdf:about="http://example.org/90d55a3e-b048-4f16-ad0b-697a04d886c0">
        <obo:IAO_0000115>Sensory neurons can be classified into nociceptors, ##mechanoceptors##, and proprioceptors. The first group expresses the nerve growth factor (NGF)-receptor TRKA (encoded by NTRK1) during maturation, while the others depend on TRKB and TRKC tyrosine kinase signaling. While all peripheral neurons are derived from neural crest progenitors, the TRKA-expressing neurons develop from the subgroup of NGN1-positive neural crest cells. They can be further divided into nociceptor subgroups: Peptidergic neurons release the neuropeptides substance P and calcitonin gene-related peptide and maintain TRKA expression. Non-peptidergic neurons lose expression of TRKA upon maturation, and express the RET neurotrophin receptor instead. Nociceptors can also be distinguished according to their expression of different cation channels like the transient receptor potential (TRP) channels or the purinergic receptor ion channels. Notable members of the TRP family are TRPV1, TRPM8, and TRPA1 channels. The respective major functions are the sensing of heat, cold, or electrophilic chemicals. Temperature-sensing TRP channels are polymodal and can respond to chemical agonists. A prominent example is the TRPV1 channel, which is activated by increased temperatures exceeding the threshold of ~43  C, but also by vanilloid compounds like capsaicin. The purinoceptor P2X3 is the main ATP-activated pain-related channel on nociceptors. As TRPV1 and P2X3 are only found on nociceptors and not on other sensory neurons (eg, stretch receptors), they can serve as characteristic functional biomarkers.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9299516</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35689659</oboInOwl:hasDbXref>
        <rdfs:label>mechanoceptors</rdfs:label>
    </Class>
    


    <!-- http://example.org/90272d55-5afc-4e8c-a308-ecdec4806d86 -->

    <Class rdf:about="http://example.org/90272d55-5afc-4e8c-a308-ecdec4806d86">
        <obo:IAO_0000115>Regarding the metabolic effects of the orexin system, orexin receptors are abundantly expressed in brain regions regulating energy metabolism, such as the medullary raphe, DMH, and ARC. More than 50% of serotonergic neurons in the medullary raphe, including the raphe pallidus nucleus (B1), raphe obscurus nucleus (B2), and raphe magnus nucleus (B3), express Ox1r but not Ox2r, which serve as sympathetic premotor neurons to enhance thermogenesis by brown adipose tissue (BAT). The DMH is one of the major upstream regions of medullary raphe neurons, and the excitatory projection from the DMH to the medullary raphe enhances sympathetic outflows. However, Ox2r-expressing DMH cells were mainly GABAergic. The role of DMH GABAergic neurons in the regulation of sympathetic and other functions remains unclear. In the ARC, GABAergic neurons express Ox2r but not Ox1r. Orexin activates ##ARC GABAergic neurons## and suppresses POMC neurons, a subpopulation of ARC GABAergic neurons. Since the loss of either Ox1r or Ox2r only partially mimics the obesity-prone phenotype of orexin-deficient mice, it is suggested that both Ox1r and Ox2r may function independently to render mice less prone to obesity.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10883752</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38199807</oboInOwl:hasDbXref>
        <rdfs:label>ARC GABAergic neurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000617"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/90272d55-5afc-4e8c-a308-ecdec4806d86"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000617"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/9044960d-60d5-4c24-b656-acba4fd85ace -->

    <Class rdf:about="http://example.org/9044960d-60d5-4c24-b656-acba4fd85ace">
        <obo:IAO_0000115>Tissue-resident lymphocytes (##TRLs##) are noncirculating lymphocytes found in nonlymphoid tissues, including the kidneys. Under physiological conditions, TRLs are key players in local immune surveillance, as evidenced by their rapid and strong response against invading pathogens. However, the characteristics of TRLs and their potential to provide antimicrobial protection in transplanted kidneys have not been fully established.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10721264</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37751288</oboInOwl:hasDbXref>
        <rdfs:label>TRLs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000542"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/9044960d-60d5-4c24-b656-acba4fd85ace"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000542"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/905863bc-1eb8-4086-a13a-abc7eb292df3 -->

    <Class rdf:about="http://example.org/905863bc-1eb8-4086-a13a-abc7eb292df3">
        <obo:IAO_0000115>Notably, several neural crest-derived cell types outside the Schwann cell lineage are derived from both the neural crest and Schwann cell precursors. One example is the melanocytes, which differentiate either directly from neural crest cells or from Schwann cell precursors, following their migration along nerves. A similar mechanism might possibly be true for enteric glia, as both neural crest cells and Schwann cell precursors were found to populate the gut to differentiate. To date, further cell types which can develop from Schwann cell precursors include endoneurial fibroblasts; postganglionic parasympathetic neurons; enteric neurons; neuroendocrine chromaffin cells of the adrenal medulla and Zuckerkandl organ, a small population of sympathetic neurons in paraganglia; dental pulp mesenchymal stromal cells; and even chondrocytes and osteocytes; as well as, possibly, recently discovered immune-regulating ##splenic glia##. This remarkable developmental potential of multipotent Schwann cell precursors clearly indicates that no terminal commitment to the Schwann cell lineage has happened at this stage. Indeed, recent work using single-cell transcriptomics has confirmed that early Schwann cell precursors are highly similar to late migratory neural crest cells and exhibit multipotency towards various cell fates, while late Schwann cell precursors that progress towards the Schwann cell fate become gradually more restricted. </obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9739763</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36497014</oboInOwl:hasDbXref>
        <rdfs:label>splenic glia</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000125"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/905863bc-1eb8-4086-a13a-abc7eb292df3"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000125"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/9096b6f1-9c9f-4bb6-bc4f-4f4abfba3096 -->

    <Class rdf:about="http://example.org/9096b6f1-9c9f-4bb6-bc4f-4f4abfba3096">
        <obo:IAO_0000115>DEG Differentially expressed gene   ESC Embryonic stem cell   FACS Fluorescence-activated cell sorting    GC Granulosa cells   hPGC Human primordial germ cell   MACS Magnetic-activated cell sorting   OSC Oogonial stem cell   PCG Primordial germ cell   ##pre-PGC## Progenitor primordial germ cell   RA Retinoic acid   scRNA-seq Single-cell RNA sequencing   SC-seq Single-cell sequencing   SSC Spermatogenic stem cells   TC Theca cell   TF Transcription factors   t-SNE t-stochastic neighbor embedding   UMI Unique molecular identifier   </obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7829788</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33467661</oboInOwl:hasDbXref>
        <rdfs:label>pre-PGC</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000670"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/9096b6f1-9c9f-4bb6-bc4f-4f4abfba3096"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000670"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/9116753d-44b2-4884-ad58-dc9b7136b26b -->

    <Class rdf:about="http://example.org/9116753d-44b2-4884-ad58-dc9b7136b26b">
        <obo:IAO_0000115>Therefore, in this study, we sought to investigate whether STC1 can affect the proliferation, senescence and differentiation of ##TMSCs##, as well as the autocrine or paracrine regulation of oxidative stress in TMSCs or against macrophages, respectively. To verify the ROS-regulating function on macrophages, we observed the role of MSC-secreted STC1 against NLRP3 inflammasome activation in macrophage-like cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7140534</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32155780</oboInOwl:hasDbXref>
        <rdfs:label>TMSCs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000134"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/9116753d-44b2-4884-ad58-dc9b7136b26b"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000134"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/9184f2ed-728e-413c-8363-bd2b918182bf -->

    <Class rdf:about="http://example.org/9184f2ed-728e-413c-8363-bd2b918182bf">
        <obo:IAO_0000115>Macrophage-depletion of VEGF1R reduces macrophage number and reduces M2 polarization. (A) ELISA for PlGF levels in tissue from all experimental groups. (B) Representative flow charts for analysis and sorting for CD68 and CD163. (C, D) Quantification of CD68+ macrophage percentage (C) and CD163+ cells in total ##CD68+ cells## (D). *p &lt; 0.05. NS, non-significant.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8511710</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34659227</oboInOwl:hasDbXref>
        <rdfs:label>CD68+ cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/9184f2ed-728e-413c-8363-bd2b918182bf"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/923a2701-7d29-4fb5-81de-92fbf55d7e8d -->

    <Class rdf:about="http://example.org/923a2701-7d29-4fb5-81de-92fbf55d7e8d">
        <obo:IAO_0000115>(A and B) Isolated ##CD4+ TILs## were stimulated in vitro with PMA/ionomycin and stained and analyzed by flow cytometry. (A) Top left dot plot shows PD-1 versus CD39 expression in CD4 Tconvs. IFN-gamma versus TNF-alpha expression is shown in the indicated CD4 Tconv populations. Proportions of cytokine+ (IFN-gamma and/or TNF-alpha; bottom left) and TNF-alpha+IFN-gamma-, TNF-alpha-IFN-gamma+, and TNF-alpha+IFN-gamma+ cells in PD-1-CD39-, PD-1loCD39-, PD-1hiCD39-, and PD-1hiCD39+ subsets and according to TIM-3 expression (n = 8). (B) Dot plots show CD39 versus IFN-gamma or TNF-alpha in CD4 Tconvs. Numbers in dot plots correspond to MFI of cytokine staining. MFI of IFN-gamma and TNF-alpha staining in IFN-gamma+ and TNF-alpha+ cells, respectively, are summarized for Tconv subpopulations defined as in A (n = 8). Samples in A and B are shown according to the proportion of TIM-3+ cells among PD-1hiCD39+ CD4 Tconv (&lt;50% TIM-3+, square; &gt;=50% TIM-3+, triangle; unknown, round) (C) CD4 Tconv TIL subsets PD-1-CD39- (gray), PD-1loCD39- (green), PD-1hiCD39- (blue), and PD-1hiCD39+ (red) were sorted, expanded in vitro for 10 days, and restimulated or not with PMA/ionomycin overnight. TNF-alpha and IFN-gamma secretion was quantified by CBA in the supernatant (n = 5). (D) Isolated CD4+ TILs were stained ex vivo and analyzed by flow cytometry. Proportions of TOX+ cells in each Tconv subset are summarized (n = 10). Data are presented as mean +- SD. **P &lt; 0.01; ***P &lt; 0.001; ****P &lt; 0.0001. P values were determined using the Wilcoxon (A and B) and 2-tailed paired t tests (D). Bonferroni&apos;s correction was applied to account for multiple testing in D and significance level was adjusted accordingly (*P &lt; 0.0083; **P &lt; 0.00166; ***P &lt; 0.000166). Tconvs, conventional FOXP3- CD4 T cells; CBA, cytometric bead array; TILs, tumor-infiltrating lymphocytes.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7934837</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33332284</oboInOwl:hasDbXref>
        <rdfs:label>CD4+ TILs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000624"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/923a2701-7d29-4fb5-81de-92fbf55d7e8d"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000624"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/923b12cd-29ae-49a6-b74b-e276dce7b579 -->

    <Class rdf:about="http://example.org/923b12cd-29ae-49a6-b74b-e276dce7b579">
        <obo:IAO_0000115>To further investigate whether somatostatin-expressing CSF-c neurons (pH-sensitive) and ##dopaminergic CSF-c neurons## (non-pH-sensitive) have different types of cilia, expansion was combined with STED microscopy. Using dual-colour imaging of spinal cord slices, either somatostatin or dopamine (TH immunostaining), together with alpha-tubulin immunostaining (Figure 6) was analysed. To have better access to the cilia and CSF-c neurons the central canal of the expanded spinal cord has been cut horizontally and flipped 90  with respect to the coverslip. The central canal can then be visualized in a cylindrical form (Figure 6A-C). To confirm what type of CSF-c neurons the cilia belong to, z-stack scanning for all the imaging was applied. In our data, 70 cilia belong to somatostatin-expressing CSF-c neurons (n = 70). Of these, 60 cilia were primary (9 + 0 symmetry) and 10 cilia were motile (9 + 2 symmetry) (Figure 6D-K, T). Additionally, 20 cilia of dopaminergic CSF-c neurons were all motile cilia (9 + 2 symmetry) (Figure 6L-S, T). We found that somatostatin-expressing CSF-c neurons are sensory neurons expressing mainly sensory cilia. However, the motile cilia in both somatostatin-expressing and dopaminergic CSF-c neurons might be involved in contributing to the flow of CSF through the central canal (Figure 6U).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8809891</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35103591</oboInOwl:hasDbXref>
        <rdfs:label>dopaminergic CSF-c neurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000700"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/923b12cd-29ae-49a6-b74b-e276dce7b579"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000700"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/923604ca-2c46-40f7-8f8c-a31edb69c5b7 -->

    <Class rdf:about="http://example.org/923604ca-2c46-40f7-8f8c-a31edb69c5b7">
        <obo:IAO_0000115>Our results demonstrate for the first time a disruption of ##myeloid-derived cell## homeostasis in periodontitis and highlight a potentially significant role of these cell types in its pathogenesis. Our findings set the stage for future studies that will further dissect the role of monocyte/macrophage signaling pathways in the pathobiology of periodontitis and the therapeutic potential of M2 macrophage induction in the resolution of inflammation.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7067288</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32210958</oboInOwl:hasDbXref>
        <rdfs:label>myeloid-derived cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000763"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/923604ca-2c46-40f7-8f8c-a31edb69c5b7"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000763"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/9250e1b7-da58-4bab-8de0-aa2a2847adae -->

    <Class rdf:about="http://example.org/9250e1b7-da58-4bab-8de0-aa2a2847adae">
        <obo:IAO_0000115>mFbs resemble fibroblastic reticular cells (FRCs) that form conduit-like network in secondary lymphoid organs, and they have also been known as thymic FRCs. Transcriptome analyses on mFbs and LN FRCs revealed possible functional differences between these two morphologically similar cell types. LN FRCs are subdivided into several types based on their expression of functional genes, including chemokines and cytokines: T-cell zone reticular cell (TRC) expressing Ccl19, Ccl21a, and Il7; follicular dendritic cell (FDC) expressing Cxcl13; marginal reticular cell (MRC) expressing Tnfsf11 (RANKL); ##Cxcl12-expressing reticular cell## (CRC); and medullary reticular cell (medRC) expressing Cxcl12, Il6, Tnfsf13, and Tnfsf13b. Most of these FRC-associated genes are not or just barely expressed in mFbs. In the thymus, RANKL is predominantly expressed in SP thymocytes to induce mTEC development, and Ccl19, Ccl21, Cxcl12, and IL-7 are produced by TECs so as to control the relocation and survival of thymocytes. It is likely that the role played by FRCs in the LN is replaced by TECs in the thymus. mFbs highly express other sets of chemokines as well, such as Cx3cl1 and Cxcl14, that are barely expressed in LN FRCs or capFbs, possibly contributing to the regulation of cell migration in the thymic medulla. Thus, mFbs comprise a thymus-specific subset of fibroblasts that is functionally distinct from LN FRCs. It is possible that mFbs also consist of multiple subsets with different functions. A population of CD34+podoplanin+ mFbs are detected in adventitial layers that surround pericytes and endothelial cells, thus referred to as adventitial cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7840694</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33519827</oboInOwl:hasDbXref>
        <rdfs:label>Cxcl12-expressing reticular cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000432"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/9250e1b7-da58-4bab-8de0-aa2a2847adae"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000432"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/92552bd2-ebbf-4155-a0dc-e62d0c588794 -->

    <Class rdf:about="http://example.org/92552bd2-ebbf-4155-a0dc-e62d0c588794">
        <obo:IAO_0000115>Our findings revealed a progenitor population hidden among other microglia under steady-state conditions. Unlike other terminally differentiated myeloid cells, microglia are sufficiently self-maintained. Under acute microglial ablation, the 1-10% remaining microglia can restore the entire empty niche, without needing any external progenitor input. However, due to the unusual plasticity of microglia, it still remains unclear whether a specialized adult progenitor is required to maintain microglial homeostasis. It had been proposed that every microglial cell could have the ability to conduct self-renewal when needed. Consistent with this notion, although we found that MAC2+ cells were highly proliferative during early stage microglial repopulation, a large proportion of ##proliferating microglia## did not express MAC2. And the number of MAC2+ cells returned to Ctrl level by D14. The overall contribution of MAC2+ microglia during repopulation is hard to determine with the current approach since MAC2 expression could be very transient, and rapidly turned off once cell cycle is complete. To determine the overall contribution of MAC2+ cells to microgliogenesis, further lineage tracing studies of the descendants of MAC2+ progenitors are needed.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7591254</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33054973</oboInOwl:hasDbXref>
        <rdfs:label>proliferating microglia</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000129"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/92552bd2-ebbf-4155-a0dc-e62d0c588794"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000129"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/92597847-3ae9-4c2f-8a97-5b8bb8c884fa -->

    <Class rdf:about="http://example.org/92597847-3ae9-4c2f-8a97-5b8bb8c884fa">
        <obo:IAO_0000115>The change of ILC cell populations during a cascade of colonic lesions. (A-C) Flow cytometry quantification of the frequency of ##Lin-CD127+CRTH2-CD117- ILC1 cells## (A), Lin-CD127+CRTH2+CD117- ILC2 cells (B), and Lin-CD127+CRTH2-CD117+ ILC3 cells (C) in CD45+ PBMCs during a cascade of colonic lesions. (D-F) Flow cytometry quantification of the frequency of Lin-CD127+IFN-gamma+ cells (D), Lin-CD127+IL-5+ cells (E), and Lin-CD127+IL-22+ cells (F) in CD45+ PBMCs during a cascade of colonic lesions. Each dot represents one donor. HC, healthy control. Error bars represent the SEM. *P &lt; 0.05; **P &lt; 0.01 (ANOVA or non-parametric test as appropriate). n = 10-19 in each group.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10853383</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38343544</oboInOwl:hasDbXref>
        <rdfs:label>Lin-CD127+CRTH2-CD117- ILC1 cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0001067"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/92597847-3ae9-4c2f-8a97-5b8bb8c884fa"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0001067"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/926596c5-00bf-4989-8e42-db88d34d2e42 -->

    <Class rdf:about="http://example.org/926596c5-00bf-4989-8e42-db88d34d2e42">
        <obo:IAO_0000115>(A) Representative conventional flow plots showing cell-surface expression of indicated markers among low-density peripheral blood cells (PBMC), separating iGRANs from monocytes, residual PMN, and lymphocytes, according to the gating strategy shown in Supplemental Figure 2. (B) Single-cell analysis of PBMCs collected from 2 CMML patients with a fraction of 14% or more and 2 with a lower iGRAN fraction; unsupervised clustering of pooled data separating 15 cluster groups in indicated cell categories. Ery, erythroid cells; My, myeloid cells; MK, megakaryocytes; Gran, granulocytes. (C) Dot plot showing the average expression (color scaled) of selected granulocyte genes and the percentage of cells that expressed those genes in indicated granulocytic clusters. (D) UMAP representation of each patient sample, 2 iGRAN-low (&lt;14%) and 2 iGRAN-high (&gt;=14%) CMML patients. (E) Fraction of each cell type in ITGAM+ clusters corresponding to CD11b+CD33+ cells per CMML patient. Colors are cluster codes defined in B. (F) Expression of indicated genes in enriched fraction of iGRANs, monocytes, and neutrophils measured by RT-qPCR and normalized to RPL32, GUS, and GAPDH housekeeping genes (n = 8 CMML patients). Kruskal-Wallis test. (G) Suppressive activity of iGRANs on T cell proliferation. iGRAN-low (&lt;14%, n = 6, left panels) and iGRAN-high (&gt;=14%, n = 6, right panels) PBMCs were labeled with Cell Trace Violet before activating T cells with anti-CD3 and anti-CD28 antibodies; CD4 (upper panels) and CD8 (lower panels) T cell proliferation was measured at day 4 by flow cytometry. We used PBMCs without any manipulation, PBMCs in which ##iGRAN## have been depleted (iGRAN-dep PBMC), and iGRAN-dep PBMCs with addition of 10% sorted iGRANs. T cell proliferation (%) is relative to the highest proliferation, observed with iGRAN-dep PBMCs. One-way ANOVA, Tukey&apos;s multiple comparison. *P &lt; 0.05; **P &lt; 0.01; ***P &lt; 0.001; ****P &lt; 0.0001.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11563679</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:39545419</oboInOwl:hasDbXref>
        <rdfs:label>iGRAN</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000094"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/926596c5-00bf-4989-8e42-db88d34d2e42"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000094"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/92765d78-0075-4565-b787-e9d7bc54646f -->

    <Class rdf:about="http://example.org/92765d78-0075-4565-b787-e9d7bc54646f">
        <obo:IAO_0000115>Other studies have examined and set out to better characterize human B-1 and B-2 lymphoid development. As indicated earlier, innate-like B-1 (B-1a and B-1b) and conventional B-2 cells constitute two main branches of the murine B cell population. During embryonic and fetal development, murine B-1a subsets are proposed to arise from multiple sites including yolk sac, P-Sp/AGM and fetal liver from HSC independent or dependent precursors, and to a lesser degree from adult bone marrow HSCs. Although much less is known about the equivalent human B-1 B cells, these cells were provisionally identified as CD20+CD27+CD43+CD70- cells in UCB and adult peripheral blood, and in other studies, in fetal liver and fetal bone marrow as well as UCB, reaching their highest frequency in fetal liver around 10 pcw. As this phenotypic cell subset may also contain ##CD20+CD38hi plasmablast## and preplasmablast precursors, it remains possible that the human fetal B-1 B cell frequency has been over estimated. Putative human B-1 cells, the earliest B cells to arise in the human fetus, were therefore subsequently identified phenotypically as CD19+CD20+CD27+CD43+CD38lo/int, while lacking CD3, CD4 and CD8 T cell markers, making them distinct from B-2 lymphoid cells, which are predominantly found in adult tissues. Whether human B-1 and B-2 B cells arise from different progenitors or a common progenitor is unclear. However, recent evidence examining hematopoietic lineage output at the clonal level from the peripheral blood of adult patients with paroxysmal nocturnal hemoglobinuria (PNH) suggests that this putative human B-1 B cell population can also arise in the adult from HSCs, while other studies indicate that human adult B-1 B cell frequency and diversity decline with aging, particularly after the age of 50.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8999121</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35409034</oboInOwl:hasDbXref>
        <rdfs:label>CD20+CD38hi plasmablast</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000980"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/92765d78-0075-4565-b787-e9d7bc54646f"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000980"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/93a085b0-5a99-4a53-9585-5bde87403979 -->

    <Class rdf:about="http://example.org/93a085b0-5a99-4a53-9585-5bde87403979">
        <obo:IAO_0000115>Finally, we sought to understand whether the unique noncoding signature acquired by different cell types is established during early stages of cell development, and if so, how dynamic it is with respect to cellular transcriptome. To address this question, we referred to an in vitro model of early lineage commitment: the differentiation of pluripotent stem cells into embryoid bodies (EBs). The role of ncRNA in maintaining stem cell pluripotency and lineage commitment has been demonstrated previously through bulk experiments. Thus, we hypothesized that applying Smart-seq-total to single cells at different stages of EB formation would allow us to identify coexpressed coding and noncoding transcripts within emerging lineages. As such, we analyzed the RNAome of primed pluripotent stem cells and that of individual cells obtained from dissociated EB at days 4, 8, and 12 of culture (~200 cells per each time point, 913 cells in total) (Fig. 3A). Consistent with previous studies, the number of coding genes expressed by pluripotent stem cells was also higher compared to ##differentiated progenitors## (SI Appendix, Fig. S16A). This was also the case for several ncRNA types, such as lncRNA, miRNA, and scaRNA (SI Appendix, Fig. S16B). Specifically, we observed that the levels of certain snoRNAs (such as Snord17, Snora23, and Snord87), scaRNAs (such as Scarna13 and Scarna6), lncRNAs (Platr3, Lncenc1, Snhg9, Gm31659, and so forth), and miRNAs (Mir92-2, Mir302b, and Mir19b-2) go down (log2FC &gt; 1, adjusted P &lt; 0.01) after cells exit pluripotency (Fig. 3B). In contrast, we also identified that the levels of several lncRNAs (Tug1, Meg3, Lockd) and miRNAs (Mir298, Mir351, Mir370) increase with differentiation (Fig. 3B).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8713755</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34911763</oboInOwl:hasDbXref>
        <rdfs:label>differentiated progenitors</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0011026"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/93a085b0-5a99-4a53-9585-5bde87403979"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0011026"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/93bdb6eb-0fe8-4edc-892f-17d3dfae4015 -->

    <Class rdf:about="http://example.org/93bdb6eb-0fe8-4edc-892f-17d3dfae4015">
        <obo:IAO_0000115>Central to these three types of immunity/inflammation is the polarization of several major immune cells, including T lymphocytes, macrophages, and ILCs, induced by microbial signals, allergens, sterile insults, and microenvironmental cues from damaged tissue (Figure 1). During polarization, innate and adaptive immune cells adopt distinct programs to obtain unique properties and perform specialized functions in associated immune responses. Naive CD4+ T, i.e., Th0, cells can differentiate into Th1, Th2, or Th17 cells in response to specific stimulating signals. ##Polarized Th cells## play critical roles in the initiation, amplification, and resolution or progression of type 1, typ2, or type 3 immunity, accordingly. Similarly, ILCs can polarize into ILC1, ILC2, and ILC3 subpopulations to regulate associated immune responses.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7311785</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32625201</oboInOwl:hasDbXref>
        <rdfs:label>Polarized Th cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000912"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/93bdb6eb-0fe8-4edc-892f-17d3dfae4015"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000912"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/931db72d-c2c5-4c07-bae2-8436a6838d99 -->

    <Class rdf:about="http://example.org/931db72d-c2c5-4c07-bae2-8436a6838d99">
        <obo:IAO_0000115>SCN	Suprachiasmatic nucleus	 	ROR	Retinoic acid receptor-related orphan receptor	 	Rev-ErbA	Reverse c-erb A	 	RRE	Rev-ErbA/ROR response element	 	ROS	Reactive oxygen species	 	UV	Ultraviolet	 	##CBC##	Crypt-base columnar cell	 	ISC	Intestinal stem cell	 	TA	Transit-amplifying	 	EC	Enterocyte	 	GC	Goblet cell	 	EEC	Enteroendocrine cell	 	PC	Paneth cell	 	GI	Gastrointestinal	 	DSS	Dextran-sodium sulfate	 	CRD	Circadian rhythm disruption	 	RNAi	RNA interference	 	ZT	Zeitgeber time	 	BM	Bone marrow	 	HSC	Hematopoietic stem cell 	 	HSPC	Hematopoietic stem and progenitor cell	 	MPP	Multipotent progenitor	 	LT-HSC	Long-term hematopoietic stem cell	 	SP	Side population	 	CAR	CXCL12-abundant reticular	 	NE	Norepinephrine	 	TNF	Tumor necrosis factor	 	MAPK	Mitogen-activated protein kinase	 	</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6539890</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31071906</oboInOwl:hasDbXref>
        <rdfs:label>CBC</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002250"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/931db72d-c2c5-4c07-bae2-8436a6838d99"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002250"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/9353425e-dae1-451d-9f66-c20609126b04 -->

    <Class rdf:about="http://example.org/9353425e-dae1-451d-9f66-c20609126b04">
        <obo:IAO_0000115>MDSC populations were divided into monocyte-derived (CD66b-CD20-CD19-CD3-) and granulocyte-derived (CD66b+) MDSCs (Figure 6G). While the granulocytic MDSC subpopulation remained close to zero, the ##monocytic MDSCs## were about 15% of the total cells stained and dropped nearly 3-fold within the PDAC PBMCs to 5% (p = 0.00018). Even though the total number of monocytic MDSCs decreased and the granulocytic MDSCs were low, both of their populations experienced significantly elevated FcRn positivity in PDAC patients (p = 0.034, p = 0.026, respectively) (Figure 6H). Monocytic MDSC FcRn MMI was significantly increased in PDAC PBMCs (p = 0.021), while granulocytic FcRn MMI had no change (Figure 6I). Together, these results further support the PDAC dependent induction of FcRn expression in highly specific cell populations of monocytic origin.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9266939</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35806069</oboInOwl:hasDbXref>
        <rdfs:label>monocytic MDSCs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000576"/>
        <skos:relatedMatch rdf:resource="CL:0000889"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/9353425e-dae1-451d-9f66-c20609126b04"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000576"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/9353425e-dae1-451d-9f66-c20609126b04"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000889"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/93558d53-b4d2-4954-83f0-dc974e3b1a1e -->

    <Class rdf:about="http://example.org/93558d53-b4d2-4954-83f0-dc974e3b1a1e">
        <obo:IAO_0000115>Heatmap shows an unsupervised clustering of the 3700 genes for the two groups of clones (Fig. 1C and Table S3). Volcano Plot analysis, based on differential expression of genes (DEG) (with adjusted P &lt;= 0.05) shows a total of n = 580 genes, with 54 genes up-regulated and 526 downregulated in ##CD28- vs CD28+ T-cell## clones (Fig. 1D).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10612243</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37898752</oboInOwl:hasDbXref>
        <rdfs:label>CD28- vs CD28+ T-cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000625"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/93558d53-b4d2-4954-83f0-dc974e3b1a1e"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000625"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/936dcc2f-07e3-4df3-ba68-c1ec0c7c1464 -->

    <Class rdf:about="http://example.org/936dcc2f-07e3-4df3-ba68-c1ec0c7c1464">
        <obo:IAO_0000115>HH signaling has been reported to modulate cell proliferation in several contexts. We thus tested whether epithelial deletion of Shh might lead to tracheal epithelial cell proliferation defects. We examined epithelial cell proliferation first by immunostaining for Ki67, a cell cycle marker, and found that ShhCKO tracheae exhibited a reduced number of Ki67+ cells in the CDH1 marked epithelium compared with controls (Fig. 2H,I). Next, we performed an EdU incorporation assay to assess cells that had entered S-phase during the labeling period. After an ex vivo, 21 h long EdU treatment, ShhCKO tracheae displayed fewer EdU+ cells in their epithelium (Fig. 2J,K), indicating that Hedgehog inactivation compromises cell cycle entry. In a more-detailed analysis, we observed a reduced number of Ki67+SCGB1A1+ cells (Fig. 2L,M), but a similar number of PDPN+  and Ki67+PDPN+ basal cells  in ShhCKO tracheae compared with controls. Interestingly, ShhCKO tracheae exhibited increased ratios of KRT5+ basal cells to acetylated alpha-tubulin+ ciliated cells and to SCGB1A1+ club cells compared with controls . We did not find obvious alterations in caspase3 staining between ShhCKO tracheal epithelium and controls at E18.5, suggesting that apoptosis is not affected in the mutants . To examine for changes in the surrounding mesenchyme, we analyzed SOX9+ chondroblasts, alpha-SMA+ smooth muscle cells and mesenchymal cell proliferation. ShhCKO tracheae exhibited SOX9+ chondroblast condensation defects , but no obvious SOX9+ chondroblast differentiation defects . We also detected reduced numbers of alpha-SMA+ smooth muscle cells and increased numbers of ##CDH1-Ki67+ mesenchymal cells## compared with controls . As HH signaling modulates Fgf10 expression in the lung mesenchyme, we examined Fgf10 mRNA expression levels in ShhCKO tracheae. We detected a 1.5-fold increase in Fgf10 mRNA in ShhCKO mutants  but this was not sufficient to increase basal cell number, as might have been expected from previous studies. Altogether, these results indicate that loss of Shh function reduces club cell proliferation and interferes with ciliated cell differentiation and secretory cell maturation in the tracheal epithelium. In the tracheal mesenchyme, Shh promotes chondrocyte and smooth muscle morphogenesis.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8918789</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35112129</oboInOwl:hasDbXref>
        <rdfs:label>CDH1-Ki67+ mesenchymal cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0008019"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/936dcc2f-07e3-4df3-ba68-c1ec0c7c1464"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0008019"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/93622585-d80a-4b9d-9b8b-68f5886993f5 -->

    <Class rdf:about="http://example.org/93622585-d80a-4b9d-9b8b-68f5886993f5">
        <obo:IAO_0000115>K2Taxonomer was remarkably accurate in capturing the higher-order organization of the 28 cell types. The first partition separated all epithelial cell subtypes from non-epithelial cell types (Figure 4B). Further partitioning of the 17 epithelial cell subtypes yielded five subgroups, characterized by shared morphology, labeled as &apos;Ciliated&apos;, &apos;Basal&apos;, &apos;##Submucosal##&apos;, &apos;Brush-like&apos; and &apos;AE&apos; (Alveolar Epithelium). The &apos;Ciliated&apos; subgroup was comprised of differentiated multiciliated cells and their precursor, deuterosomal cells. The &apos;Basal&apos; subgroup was comprised of epithelial cell progenitors, basal and cycling basal cells, as well as epithelial cell intermediary, suprabasal cells. The &apos;Brush-like&apos; subgroup was comprised of three rare airway epithelial cell types: brush, ionocyte, and pulmonary neuroendocrine cells (PNECs), as well as their likely shared &apos;brush-like&apos; precursor cells, as suggested in the original publication of these data. Further partitioning of the 11 non-epithelial cell types yielded two main subgroups characterized by shared progenitor cells: immune and mesenchymal stem cells, with the immune cell subgroup also including endothelial cells. Further partitions of the immune cell subgroup included progeny of monoblasts: monocytes, dendritic cells, and macrophages , followed by endothelial cells separated from all non-monoblast progeny immune cells subtypes in the adjacent subgroup.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8464061</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34226941</oboInOwl:hasDbXref>
        <rdfs:label>Submucosal</rdfs:label>
    </Class>
    


    <!-- http://example.org/939b1f9f-c6a4-4566-8d5b-c4fc6fdac836 -->

    <Class rdf:about="http://example.org/939b1f9f-c6a4-4566-8d5b-c4fc6fdac836">
        <obo:IAO_0000115>Next, we assessed systemic inflammation using Luminex multiplex cytokine assays on plasma samples from the enrolled subjects. Positive correlations emerged between anti-ACKR1 and several cytokines, implicating a connection between proinflammatory factors and generation of anti-ACKR1 autoantibodies (Fig 2B). Certain COVID-19 survivors also exhibited heightened interleukin and chemokine levels. To explore the potential impact of anti-ACKR1 autoantibodies on endothelial dysfunction, we concurrently quantified circulating endothelial cells in their PBMC fractions. Circulating endothelial cells can be found in the bloodstream, representing a population of ##dysfunctional endothelial cells## that are dislodged from damaged blood vessels. Indeed, we observed a significant positive correlation between anti-ACKR1 autoantibody levels and circulating endothelial cell counts (Fig 2B), implicating vascular injury with the presence of anti-ACKR1 autoantibodies.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11091471</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38740432</oboInOwl:hasDbXref>
        <rdfs:label>dysfunctional endothelial cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002342"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/939b1f9f-c6a4-4566-8d5b-c4fc6fdac836"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002342"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/94a9b859-3d2e-4116-9eaa-8c3e55e536bf -->

    <Class rdf:about="http://example.org/94a9b859-3d2e-4116-9eaa-8c3e55e536bf">
        <obo:IAO_0000115>Overexpression of ICOS rescues ##iNKT2 and iNKT17 cells## of GATA-3-deficient mice. (A) The thymocytes and splenocytes from GATA-3 FF and FFcre mice were stained with TCRbeta, CD4, CD8, CD44, CD62L, NK1.1, loaded CD1d tetramer, CD127, and ICOS. The histogram plots show the surface expression levels of CD127 and ICOS on thymic iNKT cells (TCRbeta+ tetramer+), CD8 single-positive thymocyte (TCRbetahiCD4-CD8+), splenic naive (TCRbeta+CD4-CD8+CD44-CD62L+), and activated/memory (TCRbeta+CD4-CD8+CD44hiCD62L-) CD8 T cells. (B) The gating strategy for identifying iNKT17 and iNKT2 cells from FFcre thymocytes overexpressing ICOS and CD127 via retroviral transduction is illustrated. Cumulative results are presented in the (lower panel). (two-sided unpaired t-test, ns, * p &lt; 0.05, ** p &lt; 0.01).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11201670</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38920701</oboInOwl:hasDbXref>
        <rdfs:label>iNKT2 and iNKT17 cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000921"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/94a9b859-3d2e-4116-9eaa-8c3e55e536bf"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000921"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/94b7041e-19a4-4c2b-93fa-0264c16a0def -->

    <Class rdf:about="http://example.org/94b7041e-19a4-4c2b-93fa-0264c16a0def">
        <obo:IAO_0000115>Cellular composition of the T cell compartment varied between healthy and infected groups (Fig. 3d). Based on their relative proportions and differential abundance testing (FDR 10%), we found activated CD4+ T cells expressing IL22, ##circulating follicular helper T (TFH) cells##, type 1 helper T (TH1) cells, CD8+ effector memory T (TEM) cells and MAIT cells relatively enriched in individuals with asymptomatic and mild infection, with NKT, proliferating CD8+ and CD4+, and CD8+ terminal effector T (TTE) cells enriched in individuals with more severe infection (Fig. 3e and Extended Data Fig. 5a,b). Treating disease severity as an ordinal variable (Methods), multiple cell populations displayed nonlinear differences across disease severity (proliferating CD4+ and CD8+ T cells, CD8+ TTE, CD4+ TH1, CD4+ TH17, CD4+ central memory T (TCM) and IL-22+CD4+ T cells), illustrating the complex compositional changes to peripheral T cells that occur with COVID-19 (Fig. 3e and Extended Data Fig. 5b). IL-22-expressing CD4+ T cells seen in asymptomatic and mild disease could be associated with tissue-protective responses that may restrict immunopathology (Fig. 3e) as previously shown for IL-22 in influenza A virus infection and lower viral load in COVID-19 patients&apos; lungs. Proliferating CD4+ and CD8+ T cells coexpressed exhaustion marker genes LAG3 and TOX (Extended Data Fig. 5c), in keeping with previous studies of patients with severe COVID-19 (ref. ). In contrast to disease severity, CD4+ TH1, CD4+ TH2, CD4+IL-22+ and CD4+ TCM cells were enriched among individuals with longer symptom duration, while effector populations with a cytotoxic phenotype (CD8+ TTE, CD8+ TEM, MAIT and NK T cells) were enriched in individuals with shorter symptom duration (Extended Data Fig. 5d).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8121667</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33879890</oboInOwl:hasDbXref>
        <rdfs:label>circulating follicular helper T (TFH) cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002038"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/94b7041e-19a4-4c2b-93fa-0264c16a0def"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002038"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/94c83ead-5561-4128-b487-54a0dc037901 -->

    <Class rdf:about="http://example.org/94c83ead-5561-4128-b487-54a0dc037901">
        <obo:IAO_0000115>Comparison of the single cell landscape between healthy human meniscus and degenerated meniscus. (A) Representative polarised light microscopy images of healthy human and degenerated meniscus. The white and red colours in the angle images are 90  apart in orientation. Dashed lines indicate the surface of the meniscus. Scale bar, 100 microm. (B) Merged t-distributed stochastic neighbour embedding (t-SNE) of single-cell RNA sequencing of healthy meniscus cells and degenerated meniscus cells. (C) Twelve healthy human and degenerated meniscus cell clusters at t-SNE. (D) Proportion of each cluster to the total cells. (E) Proportion of healthy and degenerated meniscus cells in each cluster. (F) Expression of representative marker genes in Vin plot. (G) Heatmap revealing the scaled expression of differentially expressed genes for each cluster. (H) CD146 and CD318 expression in healthy human meniscus cells and degenerated meniscus cells determined by flow cytometry. n&gt;=5, **p&lt;0.01. (I) Representative IHC staining of COL1A1 and COL2A1 healthy human meniscus and degenerated meniscus, and quantification of positive cells. Scale bar, 50 microm. n&gt;=5, **p&lt;0.01. (J) The expression of indicated marker genes in human healthy meniscus cells and degenerated meniscus cells were detected by qRT-PCR. *p&lt;0.05, **p&lt;0.01, otherwise, not significant. n=3, *p&lt;0.05, **p&lt;0.01. ##CPC##, cartilage progenitor cells; DegP, degenerated meniscus progenitor cells; EC, endothelial cells; FC, fibrochondrocytes; FCP, fibrochondrocyte progenitors; HTC, hypertrophic chondrocytes; MoDC, monocyte-derived dendritic cells; PreHTC, prehypertrophic chondrocytes; ProFC, proliferate fibrochondrocytes; RegC, regulatory chondrocytes.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7034356</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31871141</oboInOwl:hasDbXref>
        <rdfs:label>CPC</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0007009"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/94c83ead-5561-4128-b487-54a0dc037901"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0007009"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/94d4239f-a9ed-4cea-8750-2f00aede0176 -->

    <Class rdf:about="http://example.org/94d4239f-a9ed-4cea-8750-2f00aede0176">
        <obo:IAO_0000115>(A) Anatomical locations of n = 29 recorded ##preBotC neurons##. (B) Example traces of an excitatory neuron with pre-I spiking (orange) and without pre-I spiking (green) and an inhibitory neuron (blue) during the inspiratory burst and inter-burst interval (IBI). (C) Quantified spike frequency as a function of time (normalized to burst duration) from n = 9 pre-I excitatory, n = 13 non pre-I excitatory, and n = 7 inhibitory neurons. (D) Quantified mean spike frequency, duration, and shape of inspiratory bursts generated by each type of neuron (one-way ANOVA with Bonferroni post hoc tests). (E) Example quantification of neuronal burst onset time relative to the preBotC population and Poincare plots showing onset time variability from n = 9 pre-I excitatory, n = 13 non pre-I excitatory, and n = 7 inhibitory neurons (20 inspiratory bursts/neuron). (F) Burst onset time variability or &apos;jitter&apos; quantified as the natural log of the root mean square of successive differences (one-way ANOVA with Bonferroni post hoc tests). Data available in Figure 2:source data 1.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6957314</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31804180</oboInOwl:hasDbXref>
        <rdfs:label>preBotC neurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000540"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/94d4239f-a9ed-4cea-8750-2f00aede0176"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000540"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/94dc7404-3ee6-469c-9ab2-cec860147add -->

    <Class rdf:about="http://example.org/94dc7404-3ee6-469c-9ab2-cec860147add">
        <obo:IAO_0000115>Macrophages, which are immune cells with heterogeneous phenotypes and complex functions, can be divided into circulating and resident macrophages. Primitive hematopoiesis is a source of macrophages in embryos, and the majority of resident macrophages originate from yolk sac erythro-myeloid progenitors. Bone-BM macrophages, synovial macrophages, and microglia play a key role in maintaining tissue homeostasis; phagocytosis and removal of cellular debris and foreign substances; tissue repair, regeneration, and remodeling; and the development and resolution of inflammation. Under physiological conditions, the bone-BM contains multiple different resident macrophage populations, including osteal macrophages, ##hematopoietic stem cell niche macrophages##, and erythroblast island macrophages. Macrophages have remarkable plasticity that allows them to respond efficiently to environmental signals and change their phenotypes.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9226340</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35757427</oboInOwl:hasDbXref>
        <rdfs:label>hematopoietic stem cell niche macrophages</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000037"/>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/94dc7404-3ee6-469c-9ab2-cec860147add"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000037"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/94dc7404-3ee6-469c-9ab2-cec860147add"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/946364f0-2ae2-4a92-bd3f-5e0fd5b4264c -->

    <Class rdf:about="http://example.org/946364f0-2ae2-4a92-bd3f-5e0fd5b4264c">
        <obo:IAO_0000115>Pancreatic ductal adenocarcinoma (PDAC) has a poor clinical outlook. Responses to immune checkpoint blockade are suboptimal and a much more detailed understanding of the tumor immune microenvironment is needed if this situation is to be improved. Here, we characterized tumor-infiltrating T-cell populations in patients with PDAC using cytometry by time of flight (CyTOF) and single-cell RNA sequencing. T cells were the predominant immune cell subset observed within tumors. Over 30% of CD4+ T cells expressed a CCR6+CD161+ Th17 phenotype and 17% displayed an activated regulatory T-cell profile. Large populations of CD8+ tissue-resident memory (TRM) T cells were also present and expressed high levels of programmed cell death protein 1 (PD-1) and TIGIT. A population of putative tumor-reactive CD103+CD39+ T cells was also observed within the CD8+ tumor-infiltrating lymphocytes population. The expression of PD-1 ligands was limited largely to hemopoietic cells whilst TIGIT ligands were expressed widely within the tumor microenvironment. Programmed death-ligand 1 and CD155 were expressed within the T-cell area of ectopic lymphoid structures and colocalized with ##PD-1+TIGIT+ CD8+ T cells##. Combinatorial anti-PD-1 and TIGIT blockade enhanced IFNgamma secretion and proliferation of T cells in the presence of PD-1 and TIGIT ligands. As such, we showed that the PDAC microenvironment is characterized by the presence of substantial populations of TRM cells with an exhausted PD-1+TIGIT+ phenotype where dual checkpoint receptor blockade represents a promising avenue for future immunotherapy.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10068448</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36689623</oboInOwl:hasDbXref>
        <rdfs:label>PD-1+TIGIT+ CD8+ T cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000625"/>
        <skos:relatedMatch rdf:resource="CL:0011025"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/946364f0-2ae2-4a92-bd3f-5e0fd5b4264c"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000625"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/946364f0-2ae2-4a92-bd3f-5e0fd5b4264c"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0011025"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/94639da2-362a-42e5-bc9f-c3afc75ab7f7 -->

    <Class rdf:about="http://example.org/94639da2-362a-42e5-bc9f-c3afc75ab7f7">
        <obo:IAO_0000115>While the heterogeneity of CD103+ TRMs is widely discussed in the literature, the characteristics of TRM subpopulations within the tumor or distant tissues of tumor-bearing mice are less well defined. To characterize tumoral TRMs, scRNA-seq technology provides unprecedented analytical power and allows us to dissect cells with thousands of dimensions. With the hypothesis that particular intratumoral T cells are precursors for TRM development, we extended our scRNA-seq approach to include various effector and memory T cell populations to comprehensively depict their transcriptomic program. From the tumor and distant mucosa of mice bearing established 4T1 tumors, we flow sorted distinct memory T cell populations using a strict gating strategy (Figure S3). We constructed single-cell cDNA libraries from paired intratumoral sorted TCR-beta+CD44+CD62L-CD69+CD103+ cells (TRMs), mucosal sorted TCR-beta+CD44+ CD69+CD103+ cells (distant mucosa TRMs), intratumoral TCR-beta+CD44+CD62L+CD69-CD103- cells (##TCMs##), and TCR-beta+CD44+CD62L-CD69-CD103- cells (TEMs) (Table S2). After data processing and normalization, we performed unbiased clustering and visualized the CD8+ clusters using t-distributed stochastic neighbor embedding (t-SNE; Figure 2A). Through this unsupervised analysis, we found that all four samples could distinctly separate into multiple clusters, confirming continued heterogeneity among the single-cell subsets.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8204287</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33979626</oboInOwl:hasDbXref>
        <rdfs:label>TCMs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000907"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/94639da2-362a-42e5-bc9f-c3afc75ab7f7"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000907"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/94996b99-9f06-4d80-88ea-477c3d26aded -->

    <Class rdf:about="http://example.org/94996b99-9f06-4d80-88ea-477c3d26aded">
        <obo:IAO_0000115>Tumor types Mutant genes The contributed cells for tumors References   Trichofolliculomas/papillomatricomas beta-catenin Krt 14+ cells    Pilomatricomas beta-catenin Lgr5+ cells    Dermatofibromas beta-catenin Lgr6+ cells    Trichoadenomas beta-catenin Lrig1+ cells    No tumor beta-catenin Krt15+ cells    Sebaceous tumors Lef1 Krt14+ cells    Basal cell carcinoma(BCC) Patched IFE cells/bulge stem cells(major contribution)    BCC Smoothened IFE cells    BCC Smoothened (in the context of wound) Krt15+ bulge stem cells    Papillomas KRAS Krt19+, Krt15+ and Involucrin+ cells    Invasive squamous cell carcinoma (SCC) P53 and KRAS --    SCC (DMBA-TPA method) HRAS ##Long-lived stem cells##    Papilloma and SCC HRAS Krt5+ cells    </obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9391238</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35143021</oboInOwl:hasDbXref>
        <rdfs:label>Long-lived stem cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000034"/>
        <skos:relatedMatch rdf:resource="CL:0002337"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/94996b99-9f06-4d80-88ea-477c3d26aded"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000034"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/94996b99-9f06-4d80-88ea-477c3d26aded"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002337"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/95c27848-24ca-42ce-bff4-d9a525ddbc94 -->

    <Class rdf:about="http://example.org/95c27848-24ca-42ce-bff4-d9a525ddbc94">
        <obo:IAO_0000115>CH not only alters the composition of the hematopoietic system but also impacts the bone marrow microenvironment, known as the niche, which is crucial for maintaining HSC function and homeostasis. Aging induces significant changes in the bone marrow niche, including a decline in the number and function of MSCs, osteoblasts, and endothelial cells. These alterations, coupled with the production of elevated levels of inflammatory cytokines such as IL-6 and TNF-alpha by ##mutant HSCs## and the aging niche, create a pro-inflammatory and oxidative stress environment. This environment promotes the expansion of CH, impairs normal HSC function, and decreases the secretion of essential factors for HSC maintenance, thus exacerbating the proliferation of clonal HSCs and diminishing the niche&apos;s ability to support normal hematopoiesis. Although there have been numerous reports on the heterogeneity of HSCs associated with aging, our understanding of the effects of aging remains uncertain, and requires further investigation.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11241602</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38999948</oboInOwl:hasDbXref>
        <rdfs:label>mutant HSCs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000037"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/95c27848-24ca-42ce-bff4-d9a525ddbc94"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000037"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/95d3ab91-5866-4862-abfa-d27728bc0af2 -->

    <Class rdf:about="http://example.org/95d3ab91-5866-4862-abfa-d27728bc0af2">
        <obo:IAO_0000115>As macrophages exhibit variable outcomes in response to pathogenic microbes:no infection, infection with pathogen destruction, infection with pathogen persistence:one study performed scRNA-seq on Salmonella-exposed mouse bone marrow-derived macrophages (##BMMs##) to distinguish transcriptional changes alongside immunological response outcomes (Avraham et al.,). Principle component analysis revealed gene clusters that stratified macrophages by exposure and non-exposure to pathogen as well as by infected and uninfected macrophages. One gene cluster enriched for type I interferon (IFN) response, however, was induced in a subset of macrophages and found to distinguish infected from uninfected, yet pathogen exposed, macrophages. Among the sub-population of infected macrophages, genes primarily responsive to intracellular signals of infection were more variable than those responsive to extracellular cues of bacterial expression. This difference suggests the inherent heterogeneity even among phenotypically homogenous populations of infected cells. Upon further investigation of infected macrophages, the expression level of Salmonella virulence factor PhoPQ, known to upregulate genes important for intramacrophage survival, was found to determine the level of type I IFN induction in infected macrophages. In this study, single-cell analysis was critical in the identification of such a population as the type I IFN gene cluster was not highly induced when averaging over all cells. This work highlights the importance of pathogenic variability and host response heterogeneity of infected and bystander cells, suggesting that the state of immune activation does not operate in a silo of the host, but also mirrors the intrinsic variation found in pathogens that subsequently mold the host response.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7591464</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33163417</oboInOwl:hasDbXref>
        <rdfs:label>BMMs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
        <skos:relatedMatch rdf:resource="CL:0000559"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/95d3ab91-5866-4862-abfa-d27728bc0af2"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/95d3ab91-5866-4862-abfa-d27728bc0af2"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000559"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/95e3cdab-acd3-46c9-90d6-b0c98c4bc21e -->

    <Class rdf:about="http://example.org/95e3cdab-acd3-46c9-90d6-b0c98c4bc21e">
        <obo:IAO_0000115>Developmental heterogeneity of monocyte populations. (A) Classical model (green arrow) of monocyte development shows monocytes are generated through Macrophage (Mphi) and DC Precursors (MDPs). Emerging evidence (red, blue arrows) suggest monocytes can be generated through the Granulocyte and Macrophage Progenitors (GMPs). Ly6Chi monocytes give rise to Ly6Clo monocytes in (B) blood or ##monocyte-derived macrophages## in (C) peripheral tissues.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7823291</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33374145</oboInOwl:hasDbXref>
        <rdfs:label>monocyte-derived macrophages</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
        <skos:relatedMatch rdf:resource="CL:0000576"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/95e3cdab-acd3-46c9-90d6-b0c98c4bc21e"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/95e3cdab-acd3-46c9-90d6-b0c98c4bc21e"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000576"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/950faa99-b00e-4162-99a1-c2223b2d9a05 -->

    <Class rdf:about="http://example.org/950faa99-b00e-4162-99a1-c2223b2d9a05">
        <obo:IAO_0000115>MDSC populations were divided into monocyte-derived (CD66b-CD20-CD19-CD3-) and granulocyte-derived (CD66b+) MDSCs (Figure 6G). While the granulocytic MDSC subpopulation remained close to zero, the monocytic MDSCs were about 15% of the total cells stained and dropped nearly 3-fold within the PDAC PBMCs to 5% (p = 0.00018). Even though the total number of monocytic MDSCs decreased and the ##granulocytic MDSCs## were low, both of their populations experienced significantly elevated FcRn positivity in PDAC patients (p = 0.034, p = 0.026, respectively) (Figure 6H). Monocytic MDSC FcRn MMI was significantly increased in PDAC PBMCs (p = 0.021), while granulocytic FcRn MMI had no change (Figure 6I). Together, these results further support the PDAC dependent induction of FcRn expression in highly specific cell populations of monocytic origin.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9266939</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35806069</oboInOwl:hasDbXref>
        <rdfs:label>granulocytic MDSCs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000094"/>
        <skos:relatedMatch rdf:resource="CL:0000889"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/950faa99-b00e-4162-99a1-c2223b2d9a05"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000094"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/950faa99-b00e-4162-99a1-c2223b2d9a05"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000889"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/952bd09e-5db9-4b0f-beb1-56fd3132e110 -->

    <Class rdf:about="http://example.org/952bd09e-5db9-4b0f-beb1-56fd3132e110">
        <obo:IAO_0000115>In addition, myeloid cells, in particular monocytes and DC subsets, upregulated expression of genes involved in TLR signaling pathway (e.g., MyD88, Cxcl9, and CD40), consistent with the fact that 3M-052 stimulates TLR signaling. Other innate immune processes including complement (e.g., C3, Cfb) and inflammasome (e.g., Casp3, Il18, Il1rn) genes were also found to be significantly upregulated mainly in monocytes and tDCs, and to a lesser extent in XCR1- and XCR1+ DCs (Fig. 2d). In comparison, lymphoid cells such as innate lymphoid cells (ILCs), gammadeltaT cells, and CD8+ lymphocytes, exhibited higher expression of genes that are involved in cytokine responses (e.g., Jak2, Nfkbia) when compared to myeloid cell subsets (Fig. 2d). This may indicate indirect activation through cytokines being produced by monocytes and DCs. Furthermore, we observed a downregulation of antigen processing and presentation gene modules defined by genes such as H2-Eb1, H2-Aa, and Cd74 in monocytes, but an upregulation of these genes in XCR1- DCs, ##migratory DCs##, ILC2, and ILC3 (Fig. 2d). This is consistent with previous reports of MHCII gene expression in ILC2 and ILC3 as well as the involvement of these innate lymphoid subsets in antigen presentation. The decrease in MHCII presentation genes also supports the notion that more inflammatory monocytes, which have a relatively low expression of MHCII genes compared to resting monocytes, were recruited to the lymph nodes on day 1 after stimulation.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8795432</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35087093</oboInOwl:hasDbXref>
        <rdfs:label>migratory DCs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000451"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/952bd09e-5db9-4b0f-beb1-56fd3132e110"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000451"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/952c6593-3a22-4e55-943c-68b9a6e1dfe0 -->

    <Class rdf:about="http://example.org/952c6593-3a22-4e55-943c-68b9a6e1dfe0">
        <obo:IAO_0000115>Immunological changes in Foxp3+Helios+ and Foxp3+CD25+ Tregs during T. pallidum/HIV-1 co-infection. The gating strategy for the analysis of Foxp3+CD25+ and Foxp3+Helios+ (A) cells is indicated. The frequencies of Foxp3+CD25+ Treg cells (B) and Foxp3+Helios+ Treg cells (C) were analyzed by flow cytometry in the HC, RPR+, CHI, and CHI&amp;RPR+ groups. Frequencies of ##Foxp3+CD25+CD45RA+ Treg cells## (D), Foxp3+Helios+CD45RA+ Treg cells (E), Foxp3+CD25+CD45RO+ Tregs (F), and Foxp3+Helios+CD45RO+ Tregs (G) were analyzed by flow cytometry in the HC, RPR+, CHI, and CHI&amp;RPR+ groups. The correlations between the CD4+ T-cell counts and the frequencies of Foxp3+Helios+ Treg cells (H) and Foxp3+Helios+CD45RO+ cells (I) in the CHI group were evaluated with Spearman&apos;s rank correlation test. Significance was assessed by calculating p-values using ANOVA, Student&apos;s t-tests, or Mann-Whitney U-tests, with values of p &lt; 0.05 considered significant.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6465566</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31024549</oboInOwl:hasDbXref>
        <rdfs:label>Foxp3+CD25+CD45RA+ Treg cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000815"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/952c6593-3a22-4e55-943c-68b9a6e1dfe0"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000815"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/9526c874-0d91-4724-9ddc-0daacdfa1ee9 -->

    <Class rdf:about="http://example.org/9526c874-0d91-4724-9ddc-0daacdfa1ee9">
        <obo:IAO_0000115>Here, we used a light-induced retinal degeneration model. Light damage (LD) is an environmental risk factor for the degeneration of photoreceptors, which are unique ##light-sensitive neurons##. Intraperitoneal (I.P.) injection of dBET6 rapidly degraded retinal BET proteins. dBET6 preserved retinal structure and function and inhibited retinal inflammation in response to LD. Mechanistically, the RNA-sequencing (RNA-seq) results showed the dramatic induction of cGAS-STING pathway after LD. Furthermore, analysis of published single-cell (sc) RNA-seq results revealed that cGAS and STING are mainly expressed in retinal microglia, and we found administration of dBET6 reduced STING expression in reactive retinal macrophages/microglia after LD. To our knowledge, this is the first evidence showing BET PROTAC-mediated protection in a retinal degenerative disease model, which should provide new therapeutic strategies for treating AMD and RP.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10201800</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37217935</oboInOwl:hasDbXref>
        <rdfs:label>light-sensitive neurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000540"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/9526c874-0d91-4724-9ddc-0daacdfa1ee9"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000540"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/953ac726-6c12-4449-a214-e0beaaeff36c -->

    <Class rdf:about="http://example.org/953ac726-6c12-4449-a214-e0beaaeff36c">
        <obo:IAO_0000115>To characterize the dynamics of neutrophil recruitment to omFALCs during peritonitis, we used the well-established murine model, Zymosan-A-induced peritonitis. Peritonitis led to a transient increase in the number of ##Ly6G+ neutrophils## in the omentum, peaking at 24 h (Figures 3A and S5A). Wholemount immunofluorescence staining and confocal analysis revealed that FALCs were the site of extensive recruitment of Ly6G+ Myeloperoxidase+ (MPO) neutrophils, which formed dense cellular aggregates between 6 and 24 h post-induction of peritonitis (Figures 3B, 3C, and S5B). The volume of omFALCs increased exponentially during the first 18 h post-Zymosan injection (75-fold) before rapidly contracting back to their normal size by 24 h (Figure 3D). This timing coincided with the influx of MPO+ neutrophils and their disappearance by 24 h (Figures 3C and 3D). This accretion of neutrophils was specific to omFALCs and did not happen on the rest of the surface of the omentum, the diaphragm, or the parietal wall (Figures 3E, S5C, and S5D). We then tested whether CXCL1 was involved in the accumulation of neutrophils at omFALCs during peritonitis, using an anti-CXCL1 blocking antibody. Eighteen hours post-Zymosan injection, CXCL1 blockade led to a 2.6-fold decrease in the number of neutrophils recovered from the omentum compared to mice treated with isotype control antibodies. There was no difference in the number of neutrophils recovered from the peritoneal cavity, suggesting that the trafficking of neutrophils through omFALC HEVs was not altered (Figure 3F). Thus, the extensive recruitment of neutrophils to FALCs is not simply a consequence of increased trafficking of neutrophils through HEVs, but the result of active retention dependent upon CXCL1.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7156918</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32294409</oboInOwl:hasDbXref>
        <rdfs:label>Ly6G+ neutrophils</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000775"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/953ac726-6c12-4449-a214-e0beaaeff36c"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000775"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/955e1237-53c5-4708-a289-c79d6a726e63 -->

    <Class rdf:about="http://example.org/955e1237-53c5-4708-a289-c79d6a726e63">
        <obo:IAO_0000115>Establishing the left-right (LR) axis during early embryogenesis is critical for placement and patterning of the heart and visceral organs. In the mouse embryo, the first molecular evidence of LR asymmetry appears at the ventral LRO. The LRO contains two distinct cell types: the central cells, referred to as pit cells, and the outer cells referred to as crown cells. Both cell types contain a single cilium on the ventral surface of the cell, but the pit cilia rotate whereas the ##crown## cilia are immotile.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10314903</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37393374</oboInOwl:hasDbXref>
        <rdfs:label>crown</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000221"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/955e1237-53c5-4708-a289-c79d6a726e63"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000221"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/956a1b5b-7765-4bbd-adf8-0a718b743553 -->

    <Class rdf:about="http://example.org/956a1b5b-7765-4bbd-adf8-0a718b743553">
        <obo:IAO_0000115>Introduction: Macrophages and T cells play crucial roles in liver physiology, but their functional diversity in hepatocellular carcinoma (HCC) remains largely unknown. Methods: Two bulk RNA-sequencing (RNA-seq) cohorts for HCC were analyzed using gene co-expression network analysis. Key gene modules and networks were mapped to single-cell RNA-sequencing (scRNA-seq) data of HCC. Cell type fraction of bulk RNA-seq data was estimated by deconvolution approach using single-cell RNA-sequencing data as a reference. Survival analysis was carried out to estimate the prognosis of different immune cell types in bulk RNA-seq cohorts. Cell-cell interaction analysis was performed to identify potential links between immune cell types in HCC. Results: In this study, we analyzed RNA-seq data from two large-scale HCC cohorts, revealing a major and consensus gene co-expression cluster with significant implications for immunosuppression. Notably, these genes exhibited higher enrichment in liver macrophages than T cells, as confirmed by scRNA-seq data from HCC patients. Integrative analysis of bulk and single-cell RNA-seq data pinpointed ##SPP1 + macrophages## as an unfavorable cell type, while VCAN + macrophages, C1QA + macrophages, and CD8 + T cells were associated with a more favorable prognosis for HCC patients. Subsequent scRNA-seq investigations and in vitro experiments elucidated that SPP1, predominantly secreted by SPP1 + macrophages, inhibits CD8 + T cell proliferation. Finally, targeting SPP1 in tumor-associated macrophages through inhibition led to a shift towards a favorable phenotype. Discussion: This study underpins the potential of SPP1 as a translational target in immunotherapy for HCC.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11649653</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:39691723</oboInOwl:hasDbXref>
        <rdfs:label>SPP1 + macrophages</rdfs:label>
    </Class>
    


    <!-- http://example.org/957995ae-9685-4e63-97ad-ffe6c93e2212 -->

    <Class rdf:about="http://example.org/957995ae-9685-4e63-97ad-ffe6c93e2212">
        <obo:IAO_0000115>It has been reported that ##cortical-projecting## subpopulations of DRN 5-HT neurons express Slc17a8, in agreement with the extensive overlap between the spatial distribution of cortical-projecting neurons and Slc17a8 expression. This suggests that cortical-projecting subpopulations should correspond to subtype 5-HT-IV from the scRNA-seq dataset, which is Slc17a8-expressing and distributed to the ventral DRN. Additionally, we would predict that the Str-projecting subpopulation corresponds to the subtype 5-HT-III, since their distributions overlap extensively in the dorsomedial DRN. Consistent with our hypothesis that 5-HT neuron subtypes innervate different brain regions, we found that the inferred distributions of each 5-HT neuron subtype coincides with a different set of projection-defined subpopulations - the distribution of subtype 5-HT-III was most similar to the distribution of Str-projecting neurons (Figure 6F), whereas the distribution of subtype 5-HT-IV was more similar to that of M1-projecting neurons (Figure 6G). However, neither Str-projecting nor M1-projecting subpopulations were fully contained within the distribution of a single 5-HT neuron subtype. Str-projecting neurons in the ventrolateral DRN (marked cyan in Figure 6D,F,G), where neurons innervating both Str and M1 are located, fell within the distribution of subtype 5-HT-IV but not of subtype 5-HT-III. This suggests that Str is a target of multiple molecular subtypes of 5-HT neurons, and supports the model that some structures are innervated by multiple 5-HT neuron subtypes due to overlaps in the axonal projection fields of different subtypes.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:6726424</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31411560</oboInOwl:hasDbXref>
        <rdfs:label>cortical-projecting</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000850"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/957995ae-9685-4e63-97ad-ffe6c93e2212"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000850"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/9586a476-33e2-4a7d-a614-642205f24720 -->

    <Class rdf:about="http://example.org/9586a476-33e2-4a7d-a614-642205f24720">
        <obo:IAO_0000115> (A) Clusters 2U and 2Sb represent the abundance of manually gated subsets previously identified by the CyTOF automated clustering pipeline, shown here with median and interquartile range. Parent population is labelled on the y-axis. (B) Clusters 1U and 1S represent the expression of CCR7 on Th1-like IL-17+ cells, with median and interquartile range. Points represent RA and HC samples. Mann Whitney U P values are shown above the pairwise comparisons. TEM, T effector memory cell; TCM, ##T central memory cell##.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10196473</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37215131</oboInOwl:hasDbXref>
        <rdfs:label>T central memory cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000904"/>
        <skos:relatedMatch rdf:resource="CL:0000907"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/9586a476-33e2-4a7d-a614-642205f24720"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000904"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/9586a476-33e2-4a7d-a614-642205f24720"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000907"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/9599cb7b-3235-459c-8c27-fa353ec8bd22 -->

    <Class rdf:about="http://example.org/9599cb7b-3235-459c-8c27-fa353ec8bd22">
        <obo:IAO_0000115>The relationship between the size of a neuronal soma, the extent of its axodendritic cell volume, or the length and caliber of its axon is complex. It is not necessarily true that large neuronal soma size equates to an extensive axodendritic tree and thus high metabolic demand. The density of afferent and efferent synaptic connectivity, firing rate, and type of neurotransmitter deployed also determine metabolic rate and neuronal soma size (Sengupta et al.,). For example, the axodendritic volume of an adrenergic neuron in the locus coeruleus diffusely projecting to the cerebrum (Chandler et al.,) is likely larger than that of the Betz cell, yet the Betz cell soma is clearly bigger than that of a catecholaminergic neuron in the locus coeruleus. Further, although the soma sizes of certain neuronal classes increase with total brain size, this is not universally true, either; a complex relationship exists, particularly in primates between brain size, increased number of cortical neurons and cell size (Herculano-Houzel,). Nor can the direct monosynaptic connectivity of primate Betz cells with alpha-motoneurons be used as an argument for the large soma size of Betz cells in primates, as carnivores, particularly feliforms, do possess gigantopyramidal neurons which do not make significant monosynaptic contact to anterior horn cells and instead rely on a disynaptic route via spinal cord interneurons (Strick et al.,). Perhaps primate-specific aspects of relative scaling of ##M1 neurons## in relation to spinal cord neurons may contribute to these puzzling observations (Herculano-Houzel et al.,); however, we are not aware of comparative studies on the M1 neuron/spinal cord neuron ratio that specifically stratifies animals by the presence of gigantopyramidal neurons in M1.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10952528</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38289193</oboInOwl:hasDbXref>
        <rdfs:label>M1 neurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000540"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/9599cb7b-3235-459c-8c27-fa353ec8bd22"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000540"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/96c58887-5aa2-4614-84f8-a02c73583ebd -->

    <Class rdf:about="http://example.org/96c58887-5aa2-4614-84f8-a02c73583ebd">
        <obo:IAO_0000115>Tumor types Mutant genes The contributed cells for tumors References   Trichofolliculomas/papillomatricomas beta-catenin Krt 14+ cells    Pilomatricomas beta-catenin Lgr5+ cells    Dermatofibromas beta-catenin Lgr6+ cells    Trichoadenomas beta-catenin Lrig1+ cells    No tumor beta-catenin Krt15+ cells    Sebaceous tumors Lef1 Krt14+ cells    Basal cell carcinoma(BCC) Patched IFE cells/bulge stem cells(major contribution)    BCC Smoothened IFE cells    BCC Smoothened (in the context of wound) Krt15+ bulge stem cells    Papillomas KRAS ##Krt19+, Krt15+ and Involucrin+ cells##    Invasive squamous cell carcinoma (SCC) P53 and KRAS --    SCC (DMBA-TPA method) HRAS Long-lived stem cells    Papilloma and SCC HRAS Krt5+ cells    </obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9391238</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35143021</oboInOwl:hasDbXref>
        <rdfs:label>Krt19+, Krt15+ and Involucrin+ cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000066"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/96c58887-5aa2-4614-84f8-a02c73583ebd"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000066"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/96edea0f-6ef9-473a-b627-eff44655eaf1 -->

    <Class rdf:about="http://example.org/96edea0f-6ef9-473a-b627-eff44655eaf1">
        <obo:IAO_0000115>alpha-SMA	Alpha smooth muscle actin	LEC	Lymphatic endothelial cell	 	ADSCs	Adipose-derived stem cells	Lymphoid-like	Lymphoid-like cell	 	ADAMTS	Disintegrin and metalloproteinase with thrombospondin motifs	Mac	Macrophage	 	AEC	Arterial endothelial cells	MAIT	Mucosal-associated invariant T cell	 	AFG	Autologous fat grafting	MMPs	Matrix metalloproteinases	 	APC	Adipocyte precursor cells	MC	Mast cell	 	BC	B cell	mCD8 T	Mature CD8 T cell	 	BKC	Basal keratinocyte	mNK	Mature natural killer cell	 	BMI	Body mass index	##Myeloid-like##	Myeloid-like cell	 	CCNs	Cellular communication network factors	nCD4 T	Naive CD4 T cell	 	cDC	Classic dendritic cell	nCD8 T	Naive CD8 T cell	 	CEC	Capillary endothelial cell	ncMos	Non-classic monocytes	 	DC	Dendritic cell	NK-like	Natural killer-like cell	 	CD	Cluster of differentiation	PC	Pericyte	 	CTGF	Connective tissue growth factor	PCA	Principal component analysis	 	DEGs	Differentially expressed genes	scRNA-seq	Single-cell RNA sequencing	 	DKC	Differentiating keratinocytes	SMC	Smooth muscle cell	 	EC	Endothelial cell	SNN	Shared nearest neighbour	 	ECM	Extracellular matrix	SSc	Scleroderma	 	EMT	Epithelial-to-mesenchymal transition	SVF	Stromal vascular fraction	 	FACS	Fluorescence-activated cell sorting	TC	T cell	 	FB	Fibroblast	TGF-beta1	Transforming growth factor 1	 	FGFRs	Fibroblast growth factor receptors	TIMPs	Tissue inhibitors of metalloproteinases	 	GEO	Gene expression omnibus	TREG	Regulatory T cells	 	GO	Gene Ontology	UMAP	Uniform manifold approximation and projection	 	IFATS	International Federation for Adipose Therapeutics and Science	VEC	Venous endothelial cell	 	ILC	Innate lymphoid cell	WAT	White adipose tissue	 	KEGG	Kyoto Encyclopedia of Genes and Genomes			 	</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10341100</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37443817</oboInOwl:hasDbXref>
        <rdfs:label>Myeloid-like</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000763"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/96edea0f-6ef9-473a-b627-eff44655eaf1"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000763"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/96f7e4bb-20e3-4564-92ca-d3347b4ab2fe -->

    <Class rdf:about="http://example.org/96f7e4bb-20e3-4564-92ca-d3347b4ab2fe">
        <obo:IAO_0000115>Next, we examined the upregulated CD marker genes and plasma membrane protein genes in VSMCs stimulated by aortic disease conditions in 8065 markers of human 79 cell types identified in the tissue cell type section in the HPA database (https://www.proteinatlas.org/humanproteome/tissue+cell+type) ( Figure 7C ) and found that 18 cell types exhibit a proportion of upregulated plasma membrane protein genes within the cell-type markers that ranges from 2% to less than 5%, including proximal enterocytes, paneth cells, intestinal goblet cells, basal keratinocytes, squamous epithelial cells, cholangiocytes, enteroendocrine cells, pancreatic endocrine cells, microglial cells, syncytiotrophoblasts, extravillous trophoblasts, cardiomyocytes, skeletal myocytes, melanocytes, monocytes, macrophages, Hofbauer cells, Kupffer cells; 12 cell types exhibit a proportion of upregulated plasma membrane protein genes within the cell-type markers that equal to or greater than 5%, including alveolar cells type 1, alveolar cells type 2, thymic epithelial cells, Leydig cells, endothelial cells, smooth muscle cells, adipocytes, fibroblasts, peritubular cells, endometrial stromal cells, granulocytes, Langerhans cells; 20 cell types exhibit a proportion of upregulated CD marker genes within the cell-type markers that ranges from 2% to less than 5%, including paneth cells, distal enterocytes, basal prostatic cells, ##glandular and luminal cells##, thymic epithelial cells, Leydig cells, extravillous trophoblasts, endothelial cells, smooth muscle cells, adipocytes, melanocytes, fibroblasts, peritubular cells, T-cells, NK-cells, monocytes, macrophages, Hofbauer cells, Kupffer cells, dendritic cells; and 3 cell types exhibit a proportion of upregulated CD marker genes within the cell-type markers that equal to or greater than 5%, including endometrial stromal cells, granulocytes, and Langerhans cells.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10847266</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38327764</oboInOwl:hasDbXref>
        <rdfs:label>glandular and luminal cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000150"/>
        <skos:relatedMatch rdf:resource="CL:0002235"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/96f7e4bb-20e3-4564-92ca-d3347b4ab2fe"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000150"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/96f7e4bb-20e3-4564-92ca-d3347b4ab2fe"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/96223bfe-1c5c-4c6b-8e2e-4d8a8ae38abe -->

    <Class rdf:about="http://example.org/96223bfe-1c5c-4c6b-8e2e-4d8a8ae38abe">
        <obo:IAO_0000115>A, B t-SNE plot of nontumor cells from 15 tumors (indicated by colors). C t-SNE plot of TAFs, ##TAMs## and LSECs from the diversity-low (gray dots) and diversity-high (red dots) groups. D t-SNE plot showing clusters identified by integrated analysis of TAMs and TAFs in diversity-low and diversity-high tumors. E Heatmap and KEGG analysis of genes in clusters of TAFs. At least two independent experiments were performed for all data. For curve Figures and bar Figures, data are presented as means +- SD. Unpaired Student&apos;s t-tests were used for comparing two variables. One-way ANOVA was used for multiple variables comparison. See also Fig. S1.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8943132</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35322024</oboInOwl:hasDbXref>
        <rdfs:label>TAMs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/96223bfe-1c5c-4c6b-8e2e-4d8a8ae38abe"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/9637aea8-6433-452b-b3c5-8e0d5bc0f63b -->

    <Class rdf:about="http://example.org/9637aea8-6433-452b-b3c5-8e0d5bc0f63b">
        <obo:IAO_0000115>Airway epithelial cells such as goblet and ciliated cells are required for mucociliary clearance of inhaled particles. Alveolar epithelial type 1 (AT1) cells provide a short-distance barrier for diffusion gas exchange. AT2 cells maintain homeostasis, secrete surfactant, mediate defense against pathogens (including MHCII-dependent antigen presentation), and serve as ##AT1 progenitors##. Pulmonary capillary endothelial cells facilitate gas exchange and leukocyte migration. Other subsets of lung endothelial cells from the pulmonary lymphatics, pulmonary blood vessels, and systemic blood vessels in the lung await functional annotations. Mesenchymal cells, including smooth muscle cells, fibroblasts and mesothelial cells, are involved in homeostasis, repair, and wound healing. Mesothelial cells cover the pleural spaces, secrete glycosaminoglycans and surfactant, and initiate inflammatory responses to pathogens via pro-inflammatory mediators such as interleukins (e.g., IL-6, IL-8) and interferons. Amongst myeloid cells, alveolar macrophages are potent airway scavengers and modulate the magnitude of immune responses and tissue homeostasis. Interstitial macrophages, localized in the parenchyma, function in inflammation, wound healing, and tissue repair. Monocytes patrol the blood and play a role in surveillance of endothelial integrity and are recruited to the inflamed lungs. Dendritic cells activate naive T-cells, initiating adaptive immunity. Granulocytes such as neutrophils and eosinophils modulate immune response and are involved in pathogen killing and clearance. Resident memory CD4+ and CD8+ T-cells function in adaptive immune responses through the secretion of cytokines, activation of macrophages and lung stromal cells, and/or elimination of infected cells. Tissue resident B-cells and plasma cells mediate humoral immunity and pathogen clearance through antibody production.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9173662</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35672453</oboInOwl:hasDbXref>
        <rdfs:label>AT1 progenitors</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002062"/>
        <skos:relatedMatch rdf:resource="CL:0011026"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/9637aea8-6433-452b-b3c5-8e0d5bc0f63b"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002062"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/9637aea8-6433-452b-b3c5-8e0d5bc0f63b"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0011026"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/967e3d7a-196a-4e1d-b709-56807d6d6ebc -->

    <Class rdf:about="http://example.org/967e3d7a-196a-4e1d-b709-56807d6d6ebc">
        <obo:IAO_0000115>Expression profiles of necroptosis-related biomarkers in the scRNA-seq data. A dimension reduction plot (A) and boxplot (B) showing the profiles of EGF expression in different cell types. The expression levels of PAG1 in scRNA-seq data as shown as a dimension reduction plot (C) and boxplot (D). ZFP36 expression profile in different types of cells in the GSE131882 as shown in a dimension reduction plot (E) and boxplot (F). (Wilcoxon&apos;s test; *p&lt;0.05; **p&lt;0.01; ***p&lt;0.001). Abbreviations: LOH, ##loop of Henle cell##; CD-ICA, collecting duct type A intercalated cell; CT, connecting tubule cell; PEC, parietal epithelial cell; CD-ICB, collecting duct type B intercalated cell; PST, proximal straight tubule cell; DCT, distal convoluted tubule cell; PODO, podocyte cell; ENDO, endothelium cell; PCT, proximal convoluted tubule cell; FIB, fibroblast cell; MES, mesangial cell; LEUK, leukocyte cell; DN: diabetic nephropathy; UMAP: uniform manifold approximation and projection.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10713428</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37988198</oboInOwl:hasDbXref>
        <rdfs:label>loop of Henle cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:1000909"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/967e3d7a-196a-4e1d-b709-56807d6d6ebc"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:1000909"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/96704c50-3831-404d-acd7-45836c0fe583 -->

    <Class rdf:about="http://example.org/96704c50-3831-404d-acd7-45836c0fe583">
        <obo:IAO_0000115>The difference of expression patterns of solid tumor antigens (GPC3, B4GALNT1, and ERBB2) in malignant cells and nonmalignant cells. (A) Dot plot shows the expression level of target antigens (CD19, MS4A1, CD22, TNFRSF17, CD38, SDC1, SLAMF7, and TNFRSF8) in B lineage-related cells derived from lymphomas (DLBCL, FL, and tFL) and rLN. (B) Dot plot shows the expression level of target antigens (CD33, IL3RA, and CLEC12A) in hematopoietic stem/progenitor-like cells obtained from BM samples of AML patients and healthy donors, and in normal liver/heart EC clusters. &quot;AML314.D31&quot; represents the sample of patient AML314 after 31 days of treatment. BM5.34p means the sample of BM CD34-positive cells derived from healthy donor BM5, and BM5.34p38n means the sample of BM CD34-positive and CD38-negative cells derived from healthy donor BM5. (C) The expression level of IL3RA in liver sinusoidal endothelial cells and ##macrovascular endothelial cells##. (D) GPC3 expression levels in adjacent liver and hepatocellular carcinoma at scRNA-seq level. (E) GPC3 and ERBB2 expression levels of the epithelial lineages in normal primary gastric tissues and gastric cancers.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8716389</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34975912</oboInOwl:hasDbXref>
        <rdfs:label>macrovascular endothelial cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0002139"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/96704c50-3831-404d-acd7-45836c0fe583"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0002139"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/97b424f5-e681-4427-8eb6-fe3138389b76 -->

    <Class rdf:about="http://example.org/97b424f5-e681-4427-8eb6-fe3138389b76">
        <obo:IAO_0000115>One possible explanation for these results is that products of NADPH oxidase can compensate for the mitochondrion-targeted catalase-catalyzed H2O2 breakdown. To test this hypothesis, we crossed the mCAT transgene to the p91phox-/- background and generated mixed bone marrow chimeric mice to compare the cell intrinsic fungicidal activities of CD45.1+ p91phox-/- and CD45.2+ p91phox-/- mCATTg/+ leukocytes in the same lung (Fig. S1 and S2), as outlined above. Following infection with FLARE conidia, AM conidial uptake was reduced in p91phox-/- mCATTg/+ AMs (34% +- 5%) compared to p91phox-/- (50% +- 6%) counterparts at 24 h postinfection (Fig. 4A and B). In addition, intraleukocyte conidial viability was higher in p91phox-/- mCATTg/+ AMs (60% +- 2%) compared to ##p91phox-/- (28% +- 7%) counterparts## that had intact mtH2O2 levels, though the difference did not reach statistical significance (Fig. 4C). The previously observed mCAT-dependent defect in conidial uptake by Mo-DCs was not observed in the context of NADPH oxidase deficiency (Fig. 4B). Mo-DC and neutrophil intracellular conidial killing in p91phox-/- mice was slightly higher with mCAT transgene expression compared to nontransgenic counterparts, consistent with the idea that mtH2O2 did not contribute to conidiacidal activity in these cell types (Fig. 4C).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8265640</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34077261</oboInOwl:hasDbXref>
        <rdfs:label>p91phox-/- (28% +- 7%) counterparts</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000583"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/97b424f5-e681-4427-8eb6-fe3138389b76"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000583"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/97becf37-9e21-46fa-ac77-dce6a7439705 -->

    <Class rdf:about="http://example.org/97becf37-9e21-46fa-ac77-dce6a7439705">
        <obo:IAO_0000115>BACKGROUND: Hundreds of ongoing clinical trials combine radiation therapy, mostly delivered as stereotactic body radiotherapy (SBRT), with immune checkpoint blockade. However, our understanding of the effect of radiotherapy on the intratumoral immune balance is inadequate, hindering the optimal design of trials that combine radiation therapy with immunotherapy. Our objective was to characterize the intratumoral immune balance of the malignant prostate after SBRT in patients. METHODS: Sixteen patients with high-risk, non-metastatic prostate cancer at comparable Gleason Grade disease underwent radical prostatectomy with (n = 9) or without (n = 7) neoadjuvant SBRT delivered in three fractions of 8 Gy over 5 days completed 2 weeks before surgery. Freshly resected prostate specimens were processed to obtain single-cell suspensions, and immune-phenotyped for major lymphoid and myeloid cell subsets by staining with two separate 14-antibody panels and multicolor flow cytometry analysis. RESULTS: Malignant prostates 2 weeks after SBRT had an immune infiltrate dominated by myeloid cells, whereas malignant prostates without preoperative treatment were more lymphoid-biased (myeloid CD45+ cells 48.4 +- 19.7% vs. 25.4 +- 7.0%; adjusted p-value = 0.11; and CD45+ lymphocytes 51.6 +- 19.7% vs. 74.5 +- 7.0%; p = 0.11; CD3+ T cells 35.2 +- 23.8% vs. 60.9 +- 9.7%; p = 0.12; mean +- SD). CONCLUSION: SBRT drives a significant lymphoid to ##myeloid## shift in the prostate-tumor immune infiltrate. This may be of interest when combining SBRT with immunotherapies, particularly in prostate cancer.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7794088</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32647353</oboInOwl:hasDbXref>
        <rdfs:label>myeloid</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000763"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/97becf37-9e21-46fa-ac77-dce6a7439705"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000763"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/97cbb92a-4f3a-46ad-8177-79cb83c2a3f4 -->

    <Class rdf:about="http://example.org/97cbb92a-4f3a-46ad-8177-79cb83c2a3f4">
        <obo:IAO_0000115>AIMS: Data suggest pharmacological treatment of depression with selective serotonin reuptake inhibitors (SSRI) may impair bone health. Our group has previously modeled compromised craniofacial healing after treatment with sertraline, a commonly prescribed SSRI, and hypothesized potential culprits: alterations in bone cells, collagen, and/or inflammation. Here we interrogate bone lineage cell alterations due to sertraline treatment as a potential cause of the noted compromised bone healing. MAIN METHODS: Murine pre-osteoblast, ##pre-osteoclast##, osteoblast, and osteoclast cells were treated with clinically relevant concentrations of the SSRI. Studies focused on serotonin pathway targets, cell viability, apoptosis, differentiation, and the osteoblast/osteoclast feedback loop. KEY FINDINGS: All cells studied express neurotransmitters (e.g. serotonin transporter, SLC6A4, SSRI target) and G-protein-coupled receptors associated with the serotonin pathway. Osteoclasts presented the greatest native expression of Slc6a4 with all cell types exhibiting decreases in Slc6a4 expression after SSRI treatment. Pre-osteoclasts exhibited alteration to their differentiation pathway after treatment. Pre-osteoblasts and osteoclasts showed reduced apoptosis after treatment but showed no significant differences in functional assays. RANKL: OPG mRNA and protein ratios were decreased in the osteoblast lineage. Osteoclast lineage cells treated with sertraline demonstrated diminished TRAP positive cells when pre-exposed to sertraline prior to RANKL-induced differentiation. SIGNIFICANCE: These data suggest osteoclasts are a likely target of bone homeostasis disruption due to sertraline treatment, most potently through the osteoblast/clast feedback loop.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7336288</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32450170</oboInOwl:hasDbXref>
        <rdfs:label>pre-osteoclast</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000778"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/97cbb92a-4f3a-46ad-8177-79cb83c2a3f4"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000778"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/97137cd1-de3b-40d9-be19-f1232755ebb4 -->

    <Class rdf:about="http://example.org/97137cd1-de3b-40d9-be19-f1232755ebb4">
        <obo:IAO_0000115>The intrinsic micro-circuitry regulation of intestinal function consists of five neuronal classes with distinct functional specializations. Sensory neurons, also referred to as intrinsic primary afferent neurons (IPANs), detect chemical and physical alterations in the intestine and transmit the signal via interneurons to excitatory motor neurons, inhibitory motor neurons or ##secretomotor/vasodilator neurons## ( Figure 1 ). Enteric neurons are replenished from neuronal stem cells of the intestine. While the traditional sub-classification was based on the neuronal type, the anatomic location and axonal projection as well as neurochemical signature, recent advances in single-cell sequencing has enabled a comprehensive clustering based on gene expression.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8312561</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34322118</oboInOwl:hasDbXref>
        <rdfs:label>secretomotor/vasodilator neurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0005025"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/97137cd1-de3b-40d9-be19-f1232755ebb4"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0005025"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/972a99b4-a4b5-420b-b696-72ccf5d806af -->

    <Class rdf:about="http://example.org/972a99b4-a4b5-420b-b696-72ccf5d806af">
        <obo:IAO_0000115>a Immune cell subsets analyzed by CellChat in the original tSNE plot. b Enhanced number of interactions and interaction strength noted in cSjD. Differential interaction strength c and numbers d are presented on the heatmap. The overall increase in the interaction strength in the signal-receiving effector immune subsets, along with a dramatic increase in the interaction numbers noted between FOXP3low Tregs (or naive Tregs) and myeloid/B subsets, in cSjD compared to HC. Bars refer to the sum of the computed interaction strength or numbers in each column and row. Relative values = the interaction strength/number from source to target in cSjD-the interaction strength/number from source to target in HC. e-g Identification of significant ligand and receptor pairs between immune subsets of interest. e The communication probability of CLEC2C ligand and KLRB1 receptor genes are significantly upregulated between B and effector memory CD4+ T cell subsets in cSjD. f FOXP3low Tregs show increased communication probability with myeloid subsets through CD4 and MHC class II-related genes in cSjD, compared to HC. g Pairs of CLEC ligands and KLRB receptor genes show increased communication probability in gammadelta-T cells of Bx and BxRP, compared to non-cSjD. Mo monocytes, NK natural killer, eff effector, em effector memory, mem memory, cm ##central memory T cell##, nv naive, pDC plasmacytoid dendritic cells, MAIT mucosal-associated invariant T, act activated or FOXP3high, IFN interferon-related, HC healthy control, cSjD childhood Sjogren&apos;s disease, BX biopsy-positive non-cSjD without RP, BXRP biopsy-positive non-cSjD with RP.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:11031574</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:38641668</oboInOwl:hasDbXref>
        <rdfs:label>central memory T cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000904"/>
        <skos:relatedMatch rdf:resource="CL:0000907"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/972a99b4-a4b5-420b-b696-72ccf5d806af"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000904"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/972a99b4-a4b5-420b-b696-72ccf5d806af"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000907"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/973fc244-b1f0-418e-82f7-5745764bce91 -->

    <Class rdf:about="http://example.org/973fc244-b1f0-418e-82f7-5745764bce91">
        <obo:IAO_0000115>The above analysis was based on a large number of RNA-seq, so we further used scRNA-seq to determine whether our ORGs signature had immune predictive value on the single cell level. Figure 7A showed that the PRAD samples from GEO datasets were annotated into Mast cell, Epithelial-NE, T/NK, Plasma_B, Epithelial, Neuron, ##SMC##, Fibroblasts and Pericytes, Myeloid and Endothelial. It was obvious that ORGs signature was specifically high in Epithelial-Nk, T/Nk and SMC cells (Figure 7B, 7C). Meanwhile, Figure 7D revealed that significant connection probability of ORGs related signaling pathways in cell clusters which showed specifically high ORGs signature. Furthermore, we chose epithelial cell for analysis. Chemotaxis related pathways including cell chemotaxis, leukocyte chemotaxis, regulation of chemotaxis and regulation of leukocyte chemotaxis were significantly up-regulated in the high ORGs signature group (Figure 7E). What&apos;s more, immune related pathways were all up-regulated in the high ORGs signature group both in GO (Figure 7F) and KEGG (Figure 7G) analysis.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10599753</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:37788005</oboInOwl:hasDbXref>
        <rdfs:label>SMC</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000192"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/973fc244-b1f0-418e-82f7-5745764bce91"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000192"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/9776fee4-afa6-4edf-9690-1a405ed0d7b0 -->

    <Class rdf:about="http://example.org/9776fee4-afa6-4edf-9690-1a405ed0d7b0">
        <obo:IAO_0000115>(A-C) Representative responses to cholinergic agonist (carbachol, 10 muM) by small (L-cells) (A), D-stellate (B), tuberculoventral (TV) cells (C). Small cells were activated by carbachol. ##D-stellate and TV cells## failed to respond to carbachol application. IPSCs in principal cells, bushy cells (D), and T-stellate cells (E) in the VCN were induced by carbachol application, confirming that small inhibitory neurons were local interneurons. (F, H) Time course of sIPSCs from bushy cells and T-stellate (bushy cell, tau = 7.22 +- 1.40 ms, n = 9, T-stellate, tau = 2.28 +- 0.07 ms, n = 9). (G, I) Cumulative histogram of inter-event internal under control and carbachol application. (J). Carbachol application resulted in a significant increase in sIPSCs frequency (inter-event interval, control = 280.44 +- 47.56 ms versus carbachol = 191.21 +- 28.99 ms, p&lt;0.02, t-test).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7744103</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33141020</oboInOwl:hasDbXref>
        <rdfs:label>D-stellate and TV cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000122"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/9776fee4-afa6-4edf-9690-1a405ed0d7b0"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000122"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/98a205e6-0e83-4145-a245-9eedcf7d333f -->

    <Class rdf:about="http://example.org/98a205e6-0e83-4145-a245-9eedcf7d333f">
        <obo:IAO_0000115>HSPCs, human hematopoietic stem and progenitor cells; IFNgamma, interferon gamma; IL, interleukin; ILCs, innate lymphoid cells; ILCPs, ##innate lymphoid cell precursors##; IV, intravenous; Lin, lineage; NK, natural killer; TCF-1, T cell factor-1; UMAP, Uniform Manifold Approximation and Projection.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:9364238</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:35967297</oboInOwl:hasDbXref>
        <rdfs:label>innate lymphoid cell precursors</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0001065"/>
        <skos:relatedMatch rdf:resource="CL:0011115"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/98a205e6-0e83-4145-a245-9eedcf7d333f"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0001065"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/98a205e6-0e83-4145-a245-9eedcf7d333f"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0011115"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/98c19deb-afde-4d15-8d22-48397fa0741a -->

    <Class rdf:about="http://example.org/98c19deb-afde-4d15-8d22-48397fa0741a">
        <obo:IAO_0000115>Cell type	#DHC-thresholded labels/#actual labels with subcellular localization	HBNet:DHC % accuracy (#labels)	 	Cyt	Cyt, Mem	Mem	Nucl	Nucl, Cyt	Nucl, Cyt, Mem	Nucl, Mem	 	Spermatogonia	518/521	99.5 (204/205)	97.6 (41/42)	100.0 (5/5)	99.5 (201/202)	100.0 (40/40)	100.0 (25/25)	100.0(2/2)	 	Preleptotene spermatocytes	357/360	100.0 (121/121)	100.0 (30/30)	100.0(2/2)	98.17 (161/164)	100.0(15/15)	100.0(28/28)	0	 	##Pachytene spermatocytes##	388/391	99.3 (145/146)	100.0 (66/66)	100.0 (4/4)	98.5 (135/137)	100.0 (9/9)	100.0 (29/29)	0	 	Round/early spermatids	361/362	99.2 (131/132)	100.0 (57/57)	0	100.0 (147/147)	100.0 (10/10)	100.0 (16/16)	0	 	Elongated/late spermatids	405/409	98.2 (215/219)	100.0 (83/83)	0	100.0 (67/67)	100.0 (22/22)	100.0 (18/18)	0	 	Sertoli cells	225/231	97.8 (87/89)	100.0 (31/31)	100.0 (6/6)	95.2 (79/83)	100.0 (1/1)	100.0 (11/11)	100.0 (10/10)	 	Leydig cells	466/470	98.9 (277/280)	100.0 (71/71)	100.0 (5/5)	100.0 (81/81)	100.0 (25/25)	100.0 (7/7)	0	 	Peritubular cells	105/120	89.3 (50/56)	100.0 (9/9)	83.7 (46/55)	0	0	0	0	 	Average all cell types	2825/2864	97.78	99.7	97.28	98.77	100	100	100	 	</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8476775</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34425263</oboInOwl:hasDbXref>
        <rdfs:label>Pachytene spermatocytes</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000656"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/98c19deb-afde-4d15-8d22-48397fa0741a"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000656"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/98c9df72-969f-4131-824b-176e03a72427 -->

    <Class rdf:about="http://example.org/98c9df72-969f-4131-824b-176e03a72427">
        <obo:IAO_0000115>Because clustering is performed using live cells, all major innate and adaptive immune cell populations contribute to the classification task. For the purpose of interpretation, ##CD45+CD66+ granulocytes##, which are the most frequent among all cells, are excluded during the visualization steps to ensure comprehension and enhance identification of smaller populations.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7385162</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32719375</oboInOwl:hasDbXref>
        <rdfs:label>CD45+CD66+ granulocytes</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000094"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/98c9df72-969f-4131-824b-176e03a72427"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000094"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/98cc30fa-2a2d-43dd-a1b7-8a460a667689 -->

    <Class rdf:about="http://example.org/98cc30fa-2a2d-43dd-a1b7-8a460a667689">
        <obo:IAO_0000115>In conclusion, these findings suggest that ##DC2s## and DC3s respond similarly to SARS-CoV-2 infection, whereas they show more diversified responses to bacterial infections.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8420462</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34333764</oboInOwl:hasDbXref>
        <rdfs:label>DC2s</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000990"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/98cc30fa-2a2d-43dd-a1b7-8a460a667689"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000990"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/98126663-81f6-479f-822b-be9a18096a56 -->

    <Class rdf:about="http://example.org/98126663-81f6-479f-822b-be9a18096a56">
        <obo:IAO_0000115>The following are available online at , Figure S1: Time course of the specific uptake of 5-HT into human primary trophoblasts and ##feto-placental endothelial cells##, Figure S2: Uptake of 5-HT into feto-placental endothelial cells, measured over the high-affinity range of 5-HT concentrations, Figure S3: RT-qPCR analysis of SERT, PMAT, OCT1, -2, and -3 mRNAs in pooled samples of human primary trophoblasts and feto-placental endothelial cells, Table S1: Kinetic parameters of 5-HT uptake in human primary trophoblasts, feto-placental endothelial cells, and cord blood platelets, Table S2: Quantification cycle values obtained in RT-qPCR analysis of individual trophoblast and feto-placental endothelial cell samples, Table S3: Characteristics of participants who donated tissue for trophoblast, feto-placental endothelial cell, and cord blood platelet isolation for the study, Table S4: The primer sequences used in qualitative end-point and quantitative real-time PCR analyses.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8346107</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34360573</oboInOwl:hasDbXref>
        <rdfs:label>feto-placental endothelial cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0009092"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/98126663-81f6-479f-822b-be9a18096a56"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0009092"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/98192cb1-8cc3-4653-a070-78b498b892f3 -->

    <Class rdf:about="http://example.org/98192cb1-8cc3-4653-a070-78b498b892f3">
        <obo:IAO_0000115>Neutrophil CD64 expression has been used as a diagnostic marker of infection and sepsis in the ICU and was found to be superior to C-reactive protein and hematological determinations for detecting systemic infection or sepsis. However, these studies did not distinguish between the differential marker expression due to mature neutrophil activation or due to appearance of another neutrophil population. Because we observed no CD64 expression on mature neutrophils, either from NDN or LDN fractions in GCA (Figure 1), we hypothesize that detection of CD64 expression on neutrophils in sepsis is likely to represent the presence of CD10loCD64+ myelocytes/metamyelocytes in the neutrophil pool. Coincidentally, in a recently deposited open-access manuscript, Meghraoui-Kheddar et al. used a similar single-cell CyToF strategy to identify 2 ##CD64+ neutrophil## subsets unequivocally associated with an onset of sepsis. CD123 and PD-L1 were reported to be the additional and distinctive cellular markers for sepsis-induced CD64+ immature neutrophils compared with noninfectious inflammatory syndrome. Indeed, we observed no CD123 and very weak PD-L1 expression on CD64+ immature neutrophils of GCA patients (Figure 1), supporting a possible new demarcation between CD10loCD64+ released in response to infection and sterile inflammation.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7605529</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32960815</oboInOwl:hasDbXref>
        <rdfs:label>CD64+ neutrophil</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000775"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/98192cb1-8cc3-4653-a070-78b498b892f3"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000775"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/983ce11c-a0b2-4868-9a32-96dd2e0ea2a6 -->

    <Class rdf:about="http://example.org/983ce11c-a0b2-4868-9a32-96dd2e0ea2a6">
        <obo:IAO_0000115>The cell clusters from snap-frozen pituitaries were annotated based on differential expression of key pituitary marker genes (see Fig. 2a for merged males and Supplementary Fig. 2a for merged females). In addition to the major pituitary cell types, we identified clusters comprising ##stem (progenitor) cells##, proliferating cells, pituicytes, and various cell types associated with blood and vasculature, including immune cells (macrophages, leukocytes), endothelial cells, and pericytes. Interestingly, two clusters of stem cells were distinguishable (Fig. 2a and Supplementary Fig. 2a). These two clusters differed in their expression of several genes, including the neurotransmitter receptor genes Gabrg3 and Grin2a (Supplementary Fig. 2c). We also identified two gonadotrope clusters, as well as a small cluster of Pit1-negative cells located between the corticotrope and the gonadotrope clusters, which most likely corresponded to undifferentiated corticotrope or gonadotrope cells (Fig. 2a and Supplementary Fig. 2a). We distinguished three distinct somatotrope clusters in males (Fig. 2a) and two in females (Supplementary Fig. 2a). Two clusters of lactotropes were observed only in females (Supplementary Fig. 2a).</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8113460</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33976139</oboInOwl:hasDbXref>
        <rdfs:label>stem (progenitor) cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000034"/>
        <skos:relatedMatch rdf:resource="CL:0011026"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/983ce11c-a0b2-4868-9a32-96dd2e0ea2a6"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000034"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/983ce11c-a0b2-4868-9a32-96dd2e0ea2a6"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0011026"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/98435ea9-d611-4c2e-b3f6-43afb16e74ee -->

    <Class rdf:about="http://example.org/98435ea9-d611-4c2e-b3f6-43afb16e74ee">
        <obo:IAO_0000115>##Skeletal stem and progenitor cell## populations are crucial for bone physiology. Characterization of these cell types remains restricted to heterogenous bulk populations with limited information on whether they are unique or overlap with previously characterized cell types. Here we show, through comprehensive functional and single-cell transcriptomic analyses, that postnatal long bones of mice contain at least two types of bone progenitors with bona fide skeletal stem cell (SSC) characteristics. An early osteochondral SSC (ocSSC) facilitates long bone growth and repair, while a second type, a perivascular SSC (pvSSC), co-emerges with long bone marrow and contributes to shape the hematopoietic stem cell niche and regenerative demand. We establish that pvSSCs, but not ocSSCs, are the origin of bone marrow adipose tissue. Lastly, we also provide insight into residual SSC heterogeneity as well as potential crosstalk between the two spatially distinct cell populations. These findings comprehensively address previously unappreciated shortcomings of SSC research.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8289409</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34280086</oboInOwl:hasDbXref>
        <rdfs:label>Skeletal stem and progenitor cell</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000134"/>
        <skos:relatedMatch rdf:resource="CL:0007001"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/98435ea9-d611-4c2e-b3f6-43afb16e74ee"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000134"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/98435ea9-d611-4c2e-b3f6-43afb16e74ee"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0007001"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/98814c07-c1f8-4f08-878c-10852ad45099 -->

    <Class rdf:about="http://example.org/98814c07-c1f8-4f08-878c-10852ad45099">
        <obo:IAO_0000115>In humans, the number of ENS neurons is about 500 million, many more than in the other parts of the peripheral autonomic nervous system. The longitudinal and circular layers of the muscularis externa are innervated by nerve fibres of sympathetic extrinsic ganglia and nerve fibres of Auerbach&apos;s plexus motoneurons and such organisation regulates proper intestinal motility. Moreover, the peristaltic reflexes of the intestine are coordinated by an abundant network of the myenteric plexuses descending and ascending nerve fibres. The intestinal mucosa is innervated by fibres of secretomotor neurons originating from submucosal plexuses. Secretomotor neurons regulate fluid exchange, intestinal permeability and coordinate proper intestinal reflexes. The lumen of submucosal blood vessels is regulated by axons of the ##vasomotor neurons## (dilatory function) of submucosal plexuses and/or nitrergic (neuronal nitric oxide synthase, i.e., nNOS) neurons and axons of sympathetic neurons of extrinsic ganglia (constrictory function). Moreover, all the layers of the intestine and blood vessels are innervated by the sensory neurons (with mechano-, thermo- and chemoreceptors) of submucosal and myenteric plexuses as well as dorsal root ganglia. All components of the ENS are interconnected by numerous interneurons which functionally integrate them into one system which functions are based on physiological reflexes.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7247003</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32403316</oboInOwl:hasDbXref>
        <rdfs:label>vasomotor neurons</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0005025"/>
        <skos:relatedMatch rdf:resource="CL:0007011"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/98814c07-c1f8-4f08-878c-10852ad45099"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0005025"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/98814c07-c1f8-4f08-878c-10852ad45099"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0007011"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/99b40c98-151c-453a-ba62-c23f255080e9 -->

    <Class rdf:about="http://example.org/99b40c98-151c-453a-ba62-c23f255080e9">
        <obo:IAO_0000115>Comparison of the single cell landscape between healthy human meniscus and degenerated meniscus. (A) Representative polarised light microscopy images of healthy human and degenerated meniscus. The white and red colours in the angle images are 90  apart in orientation. Dashed lines indicate the surface of the meniscus. Scale bar, 100 microm. (B) Merged t-distributed stochastic neighbour embedding (t-SNE) of single-cell RNA sequencing of healthy meniscus cells and degenerated meniscus cells. (C) Twelve healthy human and degenerated meniscus cell clusters at t-SNE. (D) Proportion of each cluster to the total cells. (E) Proportion of healthy and degenerated meniscus cells in each cluster. (F) Expression of representative marker genes in Vin plot. (G) Heatmap revealing the scaled expression of differentially expressed genes for each cluster. (H) CD146 and CD318 expression in healthy human meniscus cells and degenerated meniscus cells determined by flow cytometry. n&gt;=5, **p&lt;0.01. (I) Representative IHC staining of COL1A1 and COL2A1 healthy human meniscus and degenerated meniscus, and quantification of positive cells. Scale bar, 50 microm. n&gt;=5, **p&lt;0.01. (J) The expression of indicated marker genes in human healthy meniscus cells and degenerated meniscus cells were detected by qRT-PCR. *p&lt;0.05, **p&lt;0.01, otherwise, not significant. n=3, *p&lt;0.05, **p&lt;0.01. CPC, cartilage progenitor cells; DegP, degenerated meniscus progenitor cells; EC, endothelial cells; FC, fibrochondrocytes; FCP, fibrochondrocyte progenitors; HTC, hypertrophic chondrocytes; MoDC, monocyte-derived dendritic cells; ##PreHTC##, prehypertrophic chondrocytes; ProFC, proliferate fibrochondrocytes; RegC, regulatory chondrocytes.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7034356</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:31871141</oboInOwl:hasDbXref>
        <rdfs:label>PreHTC</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000138"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/99b40c98-151c-453a-ba62-c23f255080e9"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000138"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/99ec3f28-aabf-4cfd-9fcb-9142a1980430 -->

    <Class rdf:about="http://example.org/99ec3f28-aabf-4cfd-9fcb-9142a1980430">
        <obo:IAO_0000115>High levels of Oct4 mRNA were found in the 2-cell blastomere population in all conditions, followed by a decrease at the 4-cell stage and a strong increase in 8-cell blastomeres (Fig. 5E), an expression pattern reflecting the transition of maternal-to-zygotic Oct4 transcripts at the 4-cell stage (Wu and Scholer). There was a decrease of Oct4 expression in the bulk of both Ahr-/- and Ahr+/+-TCDD groups relative to Ahr+/+ at the 8-cell stage and in Ahr-/- than in Ahr+/+ 2-cell blastomeres. Similarly, we found a significant decrease of Oct4 expression in both Ahr-/- and Ahr+/+-TCDD, notably in both embryonic and differentiating blastomeres relative to the corresponding Ahr+/+ 8-cell subpopulations; in all conditions, ##differentiating blastomeres## at 8-cell stage had higher expression levels than their embryonic counterparts (Fig. 5F). Furthermore, the levels of Oct4 transcription in Ahr-/- and Ahr+/+-TCDD 4-cell embryonic blastomeres decreased or had a trend to decrease, respectively, relative to the corresponding Ahr+/+ blastomeres. The levels of Cdx2 mRNA were high in all 8-cell blastomeres analyzed and were significantly decreased or trended to decrease in the bulk of Ahr-/- and Ahr+/+-TCDD relative to the Ahr+/+ 8-cell population (Fig. 5G). The Cdx2 mRNA levels were higher in Ahr+/+ and Ahr-/- 8-cell differentiating blastomeres than in their embryonic counterparts, with the Ahr-/- 8-cell differentiating blastomeres showing lower expression than the corresponding Ahr+/+ subpopulation (Fig. 5H). Additionally, some Ahr+/+-TCDD 8-cell embryonic blastomeres showed unusually high levels of Cdx2 mRNA causing the indistinguishable difference between embryonic and differentiating subpopulations.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:10425484</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:36029422</oboInOwl:hasDbXref>
        <rdfs:label>differentiating blastomeres</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000353"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/99ec3f28-aabf-4cfd-9fcb-9142a1980430"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000353"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/992a5fde-fe88-4570-8c82-f32c69be0b5b -->

    <Class rdf:about="http://example.org/992a5fde-fe88-4570-8c82-f32c69be0b5b">
        <obo:IAO_0000115>Next, we sought to identify using machine learning, the immune variable (IT or Stromal) that best classifies patients as LTS or NON-LTS and thereby, predicts patient survival. Random-forest (RF) is a decision tree-based machine learning method which uses a bootstrapping method to generate at random, training and testing samples from the dataset. Variable selection was performed through the varSelRF package in R, which uses recursive feature elimination to find a minimal set of variables with the best predictive performance. Using this approach, we determined that stromal densities of ##iNOS+ and CD68+ cells## are the two best discriminatory variables for patient survival. Stromal iNOS+ leukocytes display a potent positive correlation with OS (Figure 7A) while stromal CD68+ (total) macrophages show a strong negative correlation with OS (Figure 7B). The ROC (Receiver Operating Characteristic) curves and ROC values for the final two variables determined by RF selection (i.e., iNOS and CD68) are plotted in Supplementary Figure 7. These findings suggest that iNOS+ leukocytes and CD68+ macrophages are highly relevant prognostic biomarkers in PDAC patients.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7933000</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33679807</oboInOwl:hasDbXref>
        <rdfs:label>iNOS+ and CD68+ cells</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000235"/>
        <skos:relatedMatch rdf:resource="CL:0000738"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/992a5fde-fe88-4570-8c82-f32c69be0b5b"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000235"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/992a5fde-fe88-4570-8c82-f32c69be0b5b"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000738"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/995e6fef-23ae-4408-a22e-6b045a10b2c8 -->

    <Class rdf:about="http://example.org/995e6fef-23ae-4408-a22e-6b045a10b2c8">
        <obo:IAO_0000115>Skeletal stem and progenitor cell populations are crucial for bone physiology. Characterization of these cell types remains restricted to heterogenous bulk populations with limited information on whether they are unique or overlap with previously characterized cell types. Here we show, through comprehensive functional and single-cell transcriptomic analyses, that postnatal long bones of mice contain at least two types of bone progenitors with bona fide skeletal stem cell (SSC) characteristics. An early osteochondral SSC (ocSSC) facilitates long bone growth and repair, while a second type, a perivascular SSC (pvSSC), co-emerges with long bone marrow and contributes to shape the hematopoietic stem cell niche and regenerative demand. We establish that ##pvSSCs##, but not ocSSCs, are the origin of bone marrow adipose tissue. Lastly, we also provide insight into residual SSC heterogeneity as well as potential crosstalk between the two spatially distinct cell populations. These findings comprehensively address previously unappreciated shortcomings of SSC research.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:8289409</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:34280086</oboInOwl:hasDbXref>
        <rdfs:label>pvSSCs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000134"/>
        <skos:relatedMatch rdf:resource="CL:4033054"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/995e6fef-23ae-4408-a22e-6b045a10b2c8"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000134"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/995e6fef-23ae-4408-a22e-6b045a10b2c8"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:4033054"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/997d5b32-74a0-4676-b5d5-ea7e179b7348 -->

    <Class rdf:about="http://example.org/997d5b32-74a0-4676-b5d5-ea7e179b7348">
        <obo:IAO_0000115>AIMS: Data suggest pharmacological treatment of depression with selective serotonin reuptake inhibitors (SSRI) may impair bone health. Our group has previously modeled compromised craniofacial healing after treatment with sertraline, a commonly prescribed SSRI, and hypothesized potential culprits: alterations in bone cells, collagen, and/or inflammation. Here we interrogate bone lineage cell alterations due to sertraline treatment as a potential cause of the noted compromised bone healing. MAIN METHODS: Murine pre-osteoblast, pre-osteoclast, osteoblast, and osteoclast cells were treated with clinically relevant concentrations of the SSRI. Studies focused on serotonin pathway targets, cell viability, apoptosis, differentiation, and the osteoblast/osteoclast feedback loop. KEY FINDINGS: All cells studied express neurotransmitters (e.g. serotonin transporter, SLC6A4, SSRI target) and G-protein-coupled receptors associated with the serotonin pathway. Osteoclasts presented the greatest native expression of Slc6a4 with all cell types exhibiting decreases in Slc6a4 expression after SSRI treatment. ##Pre-osteoclasts## exhibited alteration to their differentiation pathway after treatment. Pre-osteoblasts and osteoclasts showed reduced apoptosis after treatment but showed no significant differences in functional assays. RANKL: OPG mRNA and protein ratios were decreased in the osteoblast lineage. Osteoclast lineage cells treated with sertraline demonstrated diminished TRAP positive cells when pre-exposed to sertraline prior to RANKL-induced differentiation. SIGNIFICANCE: These data suggest osteoclasts are a likely target of bone homeostasis disruption due to sertraline treatment, most potently through the osteoblast/clast feedback loop.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7336288</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:32450170</oboInOwl:hasDbXref>
        <rdfs:label>Pre-osteoclasts</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000778"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/997d5b32-74a0-4676-b5d5-ea7e179b7348"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000778"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
    


    <!-- http://example.org/9978c445-439a-4d35-bb4e-0ea01f960395 -->

    <Class rdf:about="http://example.org/9978c445-439a-4d35-bb4e-0ea01f960395">
        <obo:IAO_0000115>(A and B) Isolated CD4+ TILs were stimulated in vitro with PMA/ionomycin and stained and analyzed by flow cytometry. (A) Top left dot plot shows PD-1 versus CD39 expression in ##CD4 Tconvs##. IFN-gamma versus TNF-alpha expression is shown in the indicated CD4 Tconv populations. Proportions of cytokine+ (IFN-gamma and/or TNF-alpha; bottom left) and TNF-alpha+IFN-gamma-, TNF-alpha-IFN-gamma+, and TNF-alpha+IFN-gamma+ cells in PD-1-CD39-, PD-1loCD39-, PD-1hiCD39-, and PD-1hiCD39+ subsets and according to TIM-3 expression (n = 8). (B) Dot plots show CD39 versus IFN-gamma or TNF-alpha in CD4 Tconvs. Numbers in dot plots correspond to MFI of cytokine staining. MFI of IFN-gamma and TNF-alpha staining in IFN-gamma+ and TNF-alpha+ cells, respectively, are summarized for Tconv subpopulations defined as in A (n = 8). Samples in A and B are shown according to the proportion of TIM-3+ cells among PD-1hiCD39+ CD4 Tconv (&lt;50% TIM-3+, square; &gt;=50% TIM-3+, triangle; unknown, round) (C) CD4 Tconv TIL subsets PD-1-CD39- (gray), PD-1loCD39- (green), PD-1hiCD39- (blue), and PD-1hiCD39+ (red) were sorted, expanded in vitro for 10 days, and restimulated or not with PMA/ionomycin overnight. TNF-alpha and IFN-gamma secretion was quantified by CBA in the supernatant (n = 5). (D) Isolated CD4+ TILs were stained ex vivo and analyzed by flow cytometry. Proportions of TOX+ cells in each Tconv subset are summarized (n = 10). Data are presented as mean +- SD. **P &lt; 0.01; ***P &lt; 0.001; ****P &lt; 0.0001. P values were determined using the Wilcoxon (A and B) and 2-tailed paired t tests (D). Bonferroni&apos;s correction was applied to account for multiple testing in D and significance level was adjusted accordingly (*P &lt; 0.0083; **P &lt; 0.00166; ***P &lt; 0.000166). Tconvs, conventional FOXP3- CD4 T cells; CBA, cytometric bead array; TILs, tumor-infiltrating lymphocytes.</obo:IAO_0000115>
        <dc:type>cell_phenotype</dc:type>
        <oboInOwl:hasDbXref>PMCID:7934837</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>PMID:33332284</oboInOwl:hasDbXref>
        <rdfs:label>CD4 Tconvs</rdfs:label>
        <skos:relatedMatch rdf:resource="CL:0000624"/>
    </Class>
    <Axiom>
        <annotatedSource rdf:resource="http://example.org/9978c445-439a-4d35-bb4e-0ea01f960395"/>
        <annotatedProperty rdf:resource="http://www.w3.org/2004/02/skos/core#relatedMatch"/>
        <annotatedTarget rdf:resource="CL:0000624"/>
        <oboInOwl:hasDbXref>https://github.com/Cellular-Semantics/RS_Lit2CL_matching_data/blob/17943829eac9922120db124900957928bf0c3f15/data/novel_mentions.csv</oboInOwl:hasDbXref>
    </Axiom>
</rdf:RDF>



<!-- Generated by the OWL API (version 4.5.29) https://github.com/owlcs/owlapi -->

